Citrus Sinensis ID: 003847
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 791 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGS3 | 768 | Probable LRR receptor-lik | yes | no | 0.944 | 0.972 | 0.615 | 0.0 | |
| Q94C77 | 757 | Receptor protein kinase-l | no | no | 0.905 | 0.945 | 0.481 | 0.0 | |
| Q9C9N5 | 685 | Probable inactive leucine | no | no | 0.838 | 0.967 | 0.324 | 2e-99 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.836 | 0.844 | 0.290 | 1e-62 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.740 | 0.905 | 0.278 | 3e-62 | |
| Q84MA9 | 652 | Inactive leucine-rich rep | no | no | 0.739 | 0.897 | 0.291 | 7e-58 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.758 | 0.916 | 0.280 | 1e-57 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.737 | 0.603 | 0.262 | 3e-56 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.740 | 0.934 | 0.273 | 5e-56 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.709 | 0.509 | 0.283 | 2e-55 |
| >sp|C0LGS3|Y4372_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g37250 OS=Arabidopsis thaliana GN=At4g37250 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/790 (61%), Positives = 586/790 (74%), Gaps = 43/790 (5%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
V+ F C V+ S LN+DG++L+ FK SVL DPL +L +WNY E+PCSW G++C
Sbjct: 8 VIFFFFCSVLSSS-ALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISC---- 62
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
NNDS+V+ L+LPNSQLLGSIP+DLG + LQ LDLSNNS NG L S FNA +LR LD
Sbjct: 63 --NNDSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLD 120
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
LS+N+ISG +P +G LHNL LNLSDNALAGKLP +L +L++LT+VSL+NNYFS +P
Sbjct: 121 LSSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPG 180
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
+ V+ LDLSSNLINGSLPPD GGYSL+YLN+S+N++SGEIPP+ G P N T+DLSF
Sbjct: 181 GWRVVEFLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSF 240
Query: 256 NNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315
NNLTG IP+S VF+NQES+ FSGN LCG+PT+NPC IPSSP + PTS PAIAAI
Sbjct: 241 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAI 300
Query: 316 PKSIDSTPATNPDDGSVS-KPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIK 374
P +I S P T+P+ PR GLRPG IIGIV+GDIAGIGILAV+F Y+YR K
Sbjct: 301 PNTIGSNPVTDPNSQQTDPNPR----TGLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKK 356
Query: 375 RKNVESTLKKEANSAKDTVSFSP----SSSSSESRGFTRWSCLRKRGDGDEESDASVSDV 430
K V++ + + DT++ S SSS ESR F +WSCLRK D E+ S +
Sbjct: 357 NKIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRK----DPETTPSEEED 412
Query: 431 EDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSI 490
ED+ + NQR D+ LV VDG+KE+E+ETLLKASAYILGA+GSSI
Sbjct: 413 EDDEDEESGYNA-NQRSGDN---------KLVTVDGEKEMEIETLLKASAYILGATGSSI 462
Query: 491 MYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
MYKAVLEDG AVRR+GEN S RF+DFE +R I KLVHPNLVR+ GFYWG DEKL+
Sbjct: 463 MYKAVLEDGRVFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLV 522
Query: 549 IYDFVPNGSLANARYRKMG--SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
IYDFVPNGSL N RYRK G SSP HLPWE RLKIAKG+ARGLA+LHEKKHVHGNLKP N
Sbjct: 523 IYDFVPNGSLVNPRYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHEKKHVHGNLKPSN 582
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+LLG+DMEPKIGDFGLERL+TG+TS +AGGS+R F SKR T S F + P+PS
Sbjct: 583 ILLGHDMEPKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSI----GPTPS 638
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVED 726
PSPSS+G +SPY APES RS+KP+PKWDVY FGVILLELLTGK++ V+E+ GNGL VED
Sbjct: 639 PSPSSVGAMSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLTVED 698
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI-PSS-- 783
+RA+R+AD AIR + +GK+E LL CFKLGYSCASP+PQKRP+MKE+L LE+ P+S
Sbjct: 699 GHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERFHPNSSV 758
Query: 784 --PSPYLYGH 791
S + YGH
Sbjct: 759 IKSSSFHYGH 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/791 (48%), Positives = 498/791 (62%), Gaps = 75/791 (9%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
+VL V Q LNTDGVLLL+FKYS+L+DPL VL +WNY+D PC W GVTC G
Sbjct: 12 LVLFHFLFVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTCTELG 71
Query: 76 EGNNDS--RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRN 133
+ N RV L LPN LLGSI DL I +L+ LDLS+N NGSL S+FNA++L++
Sbjct: 72 KPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNATELQS 131
Query: 134 LDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL 193
+ L +N +SG LP+++ S+ NLQLLNLS NA G++P++++ L++LT+VSL N FS +
Sbjct: 132 ISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTFSGDI 191
Query: 194 PSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDL 253
PS F + Q+LDLSSNL+NGSLP D+GG SL YLNLS+N++ GEI P F EK P NAT+DL
Sbjct: 192 PSGFEAAQILDLSSNLLNGSLPKDLGGKSLHYLNLSHNKVLGEISPNFAEKFPANATVDL 251
Query: 254 SFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIA 313
SFNNLTG IP S +NQ++ SFSGN +LCG+P K C IPS+ + PN + TSP AIA
Sbjct: 252 SFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPPNISETTSP-AIA 310
Query: 314 AIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLI 373
P+S T P + KP Q G L+P TI I + DI G+ + ++ YVY++
Sbjct: 311 VKPRS------TAPINPLTEKPNQTGKSKLKPSTIAAITVADIVGLAFIGLLVLYVYQVR 364
Query: 374 KRKNV-ESTL---------KKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEES 423
KR+ ES+ K EA +K + + S E++ T SC+ G +E+
Sbjct: 365 KRRRYPESSKFSFFKFCLEKNEAKKSKPSTTEVTVPESPEAKT-TCGSCIILTGGRYDET 423
Query: 424 DASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYIL 483
S SDVE+ + +V + D +Q+ + LV VDG+ L+L+TLLKASAYIL
Sbjct: 424 STSESDVEN------QQTVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAYIL 477
Query: 484 GASGSSIMYKAVLEDGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYW 541
G +G+ I+YKAVLE+GTA AVRRI S + ++FE +VR IAKL HPNLVRIRGF W
Sbjct: 478 GTTGTGIVYKAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFCW 537
Query: 542 GVDEKLIIYDFVPNGSL--------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
G DEKL+I D+VPNGSL A++ S L +EARLKIA+G+ARGL++++
Sbjct: 538 GDDEKLLISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYIN 597
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
EKK VHGN+KP N+LL + EP I D GL+RL+ T +R+S
Sbjct: 598 EKKQVHGNIKPNNILLNAENEPIITDLGLDRLM---------------------TPARES 636
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713
GP+ S SPY PE S+KPNPKWDVYSFGVILLELLT KV V
Sbjct: 637 HTT---GPTSS-----------SPYQPPEWSTSLKPNPKWDVYSFGVILLELLTSKVFSV 682
Query: 714 D-ELGQGNGL---LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769
D ++ Q + L E+ R +RL D AIR+D E+A ++CF+LG C S LPQKRPS
Sbjct: 683 DHDIDQFSNLSDSAAEENGRFLRLIDGAIRSDVARHEDAAMACFRLGIECVSSLPQKRPS 742
Query: 770 MKEALQALEKI 780
MKE +Q LEKI
Sbjct: 743 MKELVQVLEKI 753
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9N5|Y1668_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 OS=Arabidopsis thaliana GN=At1g66830 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 256/790 (32%), Positives = 390/790 (49%), Gaps = 127/790 (16%)
Query: 13 RVLVVLVFI-CGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTC 71
++ ++L FI + LN G+ LLSFK S+ + V +WN +D NPCSW GVTC
Sbjct: 3 QLFLILCFILTHFFAIATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTC 62
Query: 72 ASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQL 131
N D RV+ + LPN +L GS+ +G + L++++L +N G L LF L
Sbjct: 63 ------NYDMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGL 116
Query: 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
++L LS N SG +PE +GSL +L L+LS+N+ G + +SL + L + L N FS
Sbjct: 117 QSLVLSGNSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSG 176
Query: 192 GLPSKFNS----VQVLDLSSNLINGSLPPDIGGY-SLR-YLNLSYNRLSGEIPPQFGEKI 245
LP+ S ++ L+LS N + G++P D+G +L+ L+LS+N SG IP G +
Sbjct: 177 DLPTGLGSNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGN-L 235
Query: 246 PVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTA 305
P +DLS+NNL+G IP+ NV +N ++F GN LCG P K C
Sbjct: 236 PELLYVDLSYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISC-------------- 281
Query: 306 PTSPPAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVV 365
S +P + + A + R I+ G +AGI LA +
Sbjct: 282 --STRNTQVVPSQLYTRRANHHS---------------RLCIILTATGGTVAGIIFLASL 324
Query: 366 FFYVYRLIKRKNVESTLKKEANSAKD----TVSFSPSSSSSESRGFTRWSCLRKRGDGDE 421
F Y R K A + KD T + + F C + E
Sbjct: 325 FIYYLR-----------KASARANKDQNNRTCHINEKLKKTTKPEFL---CFKTGNSESE 370
Query: 422 ESDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAY 481
D +N+ QQ + +D + E +L+ LLKASA+
Sbjct: 371 TLD------------------ENKNQQ-----------VFMPMDPEIEFDLDQLLKASAF 401
Query: 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+LG S ++YK VLE+G LAVRR+ + R ++F V +AK+ HPN++ ++ W
Sbjct: 402 LLGKSRIGLVYKVVLENGLMLAVRRLEDKGWLRLKEFLADVEAMAKIKHPNVLNLKACCW 461
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPC-HLPWEARLKIAKGVARGLAFLHE---KKH 597
+EKL+IYD++PNG L +A + GS C L W RLKI +G+A+GL ++HE K++
Sbjct: 462 SPEEKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRY 521
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
VHG++ N+LLG ++EPK+ FGL R+V DTSS + SR+S+
Sbjct: 522 VHGHINTSNILLGPNLEPKVSGFGLGRIV--DTSSDIRSDQISPMETSSPILSRESY--- 576
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
Y APE+ + KP+ KWDVYSFG+++LE++TGK V E+
Sbjct: 577 --------------------YQAPEAASKMTKPSQKWDVYSFGLVILEMVTGKSPVSSEM 616
Query: 717 GQGNGLLVE---DKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773
+ VE ++N+ + A E++++ K+G +C P KRP M+
Sbjct: 617 DL--VMWVESASERNKPAWYVLDPVLARDRDLEDSMVQVIKIGLACVQKNPDKRPHMRSV 674
Query: 774 LQALEKIPSS 783
L++ EK+ +S
Sbjct: 675 LESFEKLVTS 684
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 244/839 (29%), Positives = 362/839 (43%), Gaps = 177/839 (21%)
Query: 9 YLWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLS-------DPLGVLGSWNYNDE 61
+L ++ +L F+ Q+ DGV++ Y L DP G L SWN +
Sbjct: 31 FLLHLIICLLFFVPPCSSQAW----DGVVITQADYQGLQAVKQELIDPRGFLRSWNGSGF 86
Query: 62 NPCS--WNGVTCAS----------PGEGNNDSRVIG-------LALPNSQLLGSIPADLG 102
+ CS W G+ CA G S IG L+L ++ L GSIP LG
Sbjct: 87 SACSGGWAGIKCAQGQVIVIQLPWKSLGGRISEKIGQLQALRKLSLHDNNLGGSIPMSLG 146
Query: 103 MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSD 162
+I L+ + L NN L GS+ SL + L+ LDLSNNL+S +P + L LNLS
Sbjct: 147 LIPNLRGVQLFNNRLTGSIPASLGVSHFLQTLDLSNNLLSEIIPPNLADSSKLLRLNLSF 206
Query: 163 NALAGKLPVSLTTLQSLTIVSLKNNYFS----DGLPSKFNSVQVLDL------------- 205
N+L+G++PVSL+ SL ++L +N S D SK +++VL L
Sbjct: 207 NSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSLDHNSLSGPFPFSL 266
Query: 206 -----------SSNLINGSLPPDIGGYS-LRYLNLSYNRLSGEIPPQFGEKIPVNATIDL 253
S N I G+LP ++ + LR +++S N +SG IP G I +DL
Sbjct: 267 CNLTQLQDFSFSHNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPETLG-NISSLIHLDL 325
Query: 254 SFNNLTGEIP------ESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPT 307
S N LTGEIP ES F N ++ SG P+P+ N+++
Sbjct: 326 SQNKLTGEIPISISDLESLNFFNVSYNNLSG-------------PVPTLLSQKFNSSSFV 372
Query: 308 SPPAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFF 367
+ S TP S K R+ + L II I G +L V+
Sbjct: 373 GNSLLCGYSVS---TPCPTLPSPSPEKERKPSHRNLSTKDIILIASG-----ALLIVMLI 424
Query: 368 YVYRLIKRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASV 427
V L L+K+AN K K G+ + A+
Sbjct: 425 LVCVLC------CLLRKKANETK-----------------------AKGGEAGPGAVAAK 455
Query: 428 SDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASG 487
++ +G + G LV DG + LL A+A I+G S
Sbjct: 456 TEKGGEAEAGGE-----------------TGGKLVHFDGPMAFTADDLLCATAEIMGKST 498
Query: 488 SSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEK 546
+YKA LEDG+ +AV+R+ E ++FE ++ V+ ++ HPNL+ +R +Y G EK
Sbjct: 499 YGTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIRHPNLLALRAYYLGPKGEK 558
Query: 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH-VHGNLKPR 605
L+++D++ GSLA + + H+ W R+ + KG+ARGL +LH + +HGNL
Sbjct: 559 LVVFDYMSRGSLATFLHAR--GPDVHINWPTRMSLIKGMARGLFYLHTHANIIHGNLTSS 616
Query: 606 NVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSP 665
NVLL ++ KI D+GL RL+T SS
Sbjct: 617 NVLLDENITAKISDYGLSRLMTAAAGSSVIA----------------------------- 647
Query: 666 SPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK----VIVVDELGQGNG 721
+ +LG Y APE + K N K DVYS GVI+LELLTGK + +L Q
Sbjct: 648 --TAGALG----YRAPELSKLKKANTKTDVYSLGVIILELLTGKSPSEALNGVDLPQWVA 701
Query: 722 LLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
V+++ + D + D + +L+ KL C P RP ++ + L +I
Sbjct: 702 TAVKEE-WTNEVFDLELLNDVNTMGDEILNTLKLALHCVDATPSTRPEAQQVMTQLGEI 759
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 217/778 (27%), Positives = 331/778 (42%), Gaps = 192/778 (24%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPN 90
L D LLSF+ +V L W+ +PC+W GV C + RV L LP
Sbjct: 31 LAADKSALLSFRSAVGGRTL----LWDVKQTSPCNWTGVLC-------DGGRVTALRLPG 79
Query: 91 SQLLGSIPADL-GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
L G IP + G + L+ L L N L GSL L + S LR L L N SG +PE +
Sbjct: 80 ETLSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVL 139
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNL 209
SL NL LNL++N +G++ L L + L+NN S L S+ ++S+NL
Sbjct: 140 FSLSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQFNVSNNL 199
Query: 210 INGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFM 269
+NGS+P + +
Sbjct: 200 LNGSIPKSLQKF------------------------------------------------ 211
Query: 270 NQESSSFSGNLDLCGQP---TKNPCPIPSSPFDLPNTTAPTSPPAIAAIPKSIDSTPATN 326
+S SF G LCG+P N +PS P + N IP ++
Sbjct: 212 --DSDSFVGT-SLCGKPLVVCSNEGTVPSQPISVGN------------IPGTV------- 249
Query: 327 PDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLKKEA 386
+GS K +++ G G I GIVIG + G+ ++ ++ ++R +K E T +
Sbjct: 250 --EGSEEKKKRKKLSG---GAIAGIVIGCVVGLSLIVMILMVLFR---KKGNERTRAIDL 301
Query: 387 NSAKDTVSFSPSSSSS----ESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSV 442
+ K P ++ E+R + +E S ++V VE N +KL
Sbjct: 302 ATIKHHEVEIPGEKAAVEAPENRSYV-----------NEYSPSAVKAVEVNSSGMKKL-- 348
Query: 443 DNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTAL 502
+ + K +LE LL+ASA +LG YKAVL+ T +
Sbjct: 349 ------------------VFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLV 390
Query: 503 AVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANAR 562
AV+R+ + ++ R+F+ ++ V+ + H NLV +R +Y+ DEKL++YDF+P GSL+
Sbjct: 391 AVKRLKDVTMAD-REFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALL 449
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV--HGNLKPRNVLLGNDMEPKIGDF 620
+ G+ L WE R IA G ARGL +LH + + HGN+K N+LL N + ++ DF
Sbjct: 450 HGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVSDF 509
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
GL +LV+ + S +P+ G Y A
Sbjct: 510 GLAQLVS------------------------------------ASSTTPNRATG---YRA 530
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRA 740
PE + + K DVYSFGV+LLELLTGK N ++ E+ R + R
Sbjct: 531 PEVTDPRRVSQKADVYSFGVVLLELLTGK-------APSNSVMNEEGMDLARWVHSVARE 583
Query: 741 DFEGK---------------EEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783
++ + EE + +LG C P KRP M E ++ ++++ S
Sbjct: 584 EWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQS 641
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 220/756 (29%), Positives = 338/756 (44%), Gaps = 171/756 (22%)
Query: 32 NTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNS 91
++D LLS K S+ DP + W D PC+W GV G RV L L N
Sbjct: 23 SSDVEALLSLKSSI--DPSNSI-PWRGTD--PCNWEGVKKCMKG------RVSKLVLENL 71
Query: 92 QLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
L GS+ L ++ L+ L NSL+GS+ +L L++L L++N SG PE++
Sbjct: 72 NLSGSLNGKSLNQLDQLRVLSFKGNSLSGSIP-NLSGLVNLKSLYLNDNNFSGEFPESLT 130
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLI 210
SLH L+ + LS N +GK+P SL L L +++N FS
Sbjct: 131 SLHRLKTVVLSRNRFSGKIPSSLLRLSRLYTFYVQDNLFS-------------------- 170
Query: 211 NGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
GS+PP + +LR+ N+S N+LSG IPP +
Sbjct: 171 -GSIPP-LNQATLRFFNVSNNQLSGHIPP-------------------------TQALNR 203
Query: 271 QESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPP-AIAAIPKSIDSTPATNPDD 329
SSF+ N+ LCG +N C +TT TS P A AIP
Sbjct: 204 FNESSFTDNIALCGDQIQNSC---------NDTTGITSTPSAKPAIP------------- 241
Query: 330 GSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLKKEANSA 389
V+K R +IGI+ G I G ++ ++ F + L+ R+ + ++E S
Sbjct: 242 --VAKTRSRTK-------LIGIISGSICGGILILLLTFLLICLLWRRKRSKSKREERRSK 292
Query: 390 KDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSVDNQRQQD 449
+ V+ S + ++E+ + G D+++ ++ S + + ++
Sbjct: 293 R--VAESKEAKTAET----------EEGTSDQKN--------------KRFSWEKESEEG 326
Query: 450 HVHERQNKKGTLVIVDGDKEL---ELETLLKASAYILGASGSSIMYKAVLEDGTALAVRR 506
V GTLV + D + ++ LLKASA LG YKAV+E G + V+R
Sbjct: 327 SV-------GTLVFLGRDITVVRYTMDDLLKASAETLGRGTLGSTYKAVMESGFIITVKR 379
Query: 507 IGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARY-RK 565
+ + R +F+ + ++ +L HPNLV +R ++ +E L++YD+ PNGSL + + K
Sbjct: 380 LKDAGFPRMDEFKRHIEILGRLKHPNLVPLRAYFQAKEECLLVYDYFPNGSLFSLIHGSK 439
Query: 566 MGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFGLER 624
+ S L W + LKIA+ +A GL ++H+ + HGNLK NVLLG D E + D+GL
Sbjct: 440 VSGSGKPLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYGLSD 499
Query: 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES- 683
L D S + +A F Y APE
Sbjct: 500 L--HDPYSIEDTSAASLF-----------------------------------YKAPECR 522
Query: 684 -LRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF 742
LR P DVYSFGV+LLELLTG+ D L G + RA+R + + +
Sbjct: 523 DLRKASTQPA-DVYSFGVLLLELLTGRTSFKD-LVHKYGSDISTWVRAVREEETEVSEEL 580
Query: 743 EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778
EE L + + +C + P+ RP+M+E L+ ++
Sbjct: 581 NASEEKLQALLTIATACVAVKPENRPAMREVLKMVK 616
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (573), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 213/760 (28%), Positives = 326/760 (42%), Gaps = 160/760 (21%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPN 90
LN D LLS + +V G WN +PC+W GV C S +RV L LP
Sbjct: 33 LNADRTALLSLRSAVG----GRTFRWNIKQTSPCNWAGVKCES-------NRVTALRLPG 81
Query: 91 SQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
L G IP + N +QLR L L N +SG LP+ +
Sbjct: 82 VALSGDIPEGI-----------------------FGNLTQLRTLSLRLNALSGSLPKDLS 118
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLI 210
+ NL+ L L N +G++P L +L L ++L +N F+ + S F ++
Sbjct: 119 TSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFTNLT--------- 169
Query: 211 NGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
L+ L L N+LSG IP +P+ ++S N+L G IP++
Sbjct: 170 -----------KLKTLFLENNQLSGSIPDL---DLPL-VQFNVSNNSLNGSIPKN--LQR 212
Query: 271 QESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAIPKSIDSTPATNPDDG 330
ES SF LCG+P K CP + P + +PP++ +G
Sbjct: 213 FESDSFL-QTSLCGKPLK-LCPDEETVPSQPTSGGNRTPPSV----------------EG 254
Query: 331 SVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLKKEANSAK 390
S K ++ G G I GIVIG + G ++ ++ + R K++N
Sbjct: 255 SEEKKKKNKLSG---GAIAGIVIGCVVGFALIVLILMVLCR------------KKSNKRS 299
Query: 391 DTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSVDNQRQQDH 450
V S K+ + + D D N +S +
Sbjct: 300 RAVDISTI----------------KQQEPEIPGDKEAVD-NGNVYSVSAAAAAAMTGNGK 342
Query: 451 VHERQNKKGTLVIVDGD--KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIG 508
E ++ G+ K +LE LL+ASA +LG YKAVL+ T +AV+R+
Sbjct: 343 ASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRL- 401
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS 568
++ + ++F+ ++ ++ + H NLV +R +Y+ DEKL++YDF+P GSL+ + G+
Sbjct: 402 KDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGA 461
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEK--KHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
L W+ R +IA G ARGL +LH + HGN+K N+LL + K+ DFGL +LV
Sbjct: 462 GRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLV 521
Query: 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS 686
G SA N R+T Y APE
Sbjct: 522 ---------GSSATN--PNRATG----------------------------YRAPEVTDP 542
Query: 687 IKPNPKWDVYSFGVILLELLTGKV---IVVDELGQGNGLLVEDKNR---AIRLADAAIRA 740
+ + K DVYSFGV+LLEL+TGK V++E G V+ R + D+ + +
Sbjct: 543 KRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLS 602
Query: 741 DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
+EE + +LG C S P +RP M E ++ +E +
Sbjct: 603 LATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 203/773 (26%), Positives = 327/773 (42%), Gaps = 190/773 (24%)
Query: 52 VLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLD 111
+LG+ ++ + N +T P E N SR+ L L +++L+G+IP +LG +E L L+
Sbjct: 305 ILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELN 364
Query: 112 LSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV 171
L+NN L G + ++ + + L ++ NL+SG +P +L +L LNLS N GK+PV
Sbjct: 365 LANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPV 424
Query: 172 SLTTLQSLTIVSLKNNYFSDGLPSKFNSVQ---VLDLSSNLINGSLPPDIGGY-SLRYLN 227
L + +L + L N FS +P ++ +L+LS N ++G LP + G S++ ++
Sbjct: 425 ELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMID 484
Query: 228 LSYNRLSGEIPPQFGE----------------KIPVNAT-------IDLSFNNLTGEIPE 264
+S+N LSG IP + G+ KIP T +++SFNNL+G +P
Sbjct: 485 VSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPP 544
Query: 265 SNVFMNQESSSFSGNLDLCGQPTKNPC-PIPSSPFDLPNTTAPTSPPAIAAIPKSIDSTP 323
F +SF GN LCG + C P+P
Sbjct: 545 MKNFSRFAPASFVGNPYLCGNWVGSICGPLPK---------------------------- 576
Query: 324 ATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLK 383
S+ G +I IV+G I +L ++F VY+ +++K +
Sbjct: 577 ----------------SRVFSRGALICIVLGVIT---LLCMIFLAVYKSMQQKKI----- 612
Query: 384 KEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSVD 443
SS ++ G T+ L D ++ +D
Sbjct: 613 -------------LQGSSKQAEGLTKLVILHM--------DMAIHTFDDIM--------- 642
Query: 444 NQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALA 503
V E N+K +I+G SS +YK L+ +A
Sbjct: 643 ------RVTENLNEK----------------------FIIGYGASSTVYKCALKSSRPIA 674
Query: 504 VRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARY 563
++R+ R+FET++ I + H N+V + G+ L+ YD++ NGSL + +
Sbjct: 675 IKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLH 734
Query: 564 RKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---KHVHGNLKPRNVLLGNDMEPKIGDF 620
+ L WE RLKIA G A+GLA+LH + +H ++K N+LL + E + DF
Sbjct: 735 GSL--KKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDF 792
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
G+ + + P+ S LG I Y
Sbjct: 793 GIAKSI----------------------------------PASKTHASTYVLGTIG-YID 817
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVE-DKNRAIRLADAAIR 739
PE R+ + N K D+YSFG++LLELLTGK V +E +L + D N + D +
Sbjct: 818 PEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADDNTVMEAVDPEVT 877
Query: 740 ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE----------ALQALEKIPS 782
+ F+L C P +RP+M E +LQ +K+PS
Sbjct: 878 VTCMDLGH-IRKTFQLALLCTKRNPLERPTMLEVSRVLLSLVPSLQVAKKLPS 929
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (559), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 216/790 (27%), Positives = 334/790 (42%), Gaps = 204/790 (25%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
VV +F+ + + L +D LL+ + SV PL WN + +PC+W+GV C
Sbjct: 11 VVFLFVFYLAAVTSDLESDRRALLAVRNSVRGRPL----LWNMSASSPCNWHGVHC---- 62
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
+ RV L LP S L GS+P +G I N +QL+ L
Sbjct: 63 ---DAGRVTALRLPGSGLFGSLP--IGGIG---------------------NLTQLKTLS 96
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
L N +SG +P +L L+ L L NA +G++P L TL S+ ++L N FS +P
Sbjct: 97 LRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPD 156
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
NS L L L N+LSG IP +P+ ++S
Sbjct: 157 NVNSAT--------------------RLVTLYLERNQLSGPIPEI---TLPLQ-QFNVSS 192
Query: 256 NNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315
N L G IP S + ++F GN LCG+P
Sbjct: 193 NQLNGSIPSS--LSSWPRTAFEGN-TLCGKP----------------------------- 220
Query: 316 PKSIDSTPATNPDDGSV----SKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYR 371
+D+ A +P+ G + P ++ S L G I+GIVIG + G+ +L ++ F + R
Sbjct: 221 ---LDTCEAESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCR 277
Query: 372 LIKR------KNVESTLKKEANSA---KDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEE 422
K+ +NVE+ + +SA K+TV P + ++ S E
Sbjct: 278 KRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGS-----------------E 320
Query: 423 SDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYI 482
S A D+ V E +L+ LLKASA +
Sbjct: 321 SGAVNKDLT------------------------------FFVKSFGEFDLDGLLKASAEV 350
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
LG YKA E G +AV+R+ + V ++F ++ V+ + H NLV + +Y+
Sbjct: 351 LGKGTVGSSYKASFEHGLVVAVKRLRDVVVPE-KEFRERLHVLGSMSHANLVTLIAYYFS 409
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV--HG 600
DEKL++++++ GSL+ + G+ L WE R IA G AR +++LH + HG
Sbjct: 410 RDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDGTTSHG 469
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
N+K N+LL + E K+ D+GL +++ ++ ++ G
Sbjct: 470 NIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDG----------------------- 506
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG-QG 719
Y APE + K + K DVYSFGV++LELLTGK +L +G
Sbjct: 507 -----------------YRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEG 549
Query: 720 NGL------LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773
L + E + + L R EG E ++ K+G SC + P RPSM E
Sbjct: 550 VDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNEN-IIRLLKIGMSCTAQFPDSRPSMAEV 608
Query: 774 LQALEKIPSS 783
+ +E++ S
Sbjct: 609 TRLIEEVSHS 618
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 205/724 (28%), Positives = 316/724 (43%), Gaps = 163/724 (22%)
Query: 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRN 133
P E N S + L L ++ G +P ++GM+ L L++S+N L G + +FN L+
Sbjct: 498 PREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQR 557
Query: 134 LDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL 193
LD+ N SG LP +GSL+ L+LL LS+N L+G +PV+L L LT + + N F+ +
Sbjct: 558 LDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSI 617
Query: 194 PSKFNSVQ----VLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVN 248
P + S+ L+LS N + G +PP++ L +L L+ N LSGEIP F +
Sbjct: 618 PRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFA-NLSSL 676
Query: 249 ATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTS 308
+ S+N+LTG IP + N SSF GN LCG P N C I + PF AP+
Sbjct: 677 LGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPL-NQC-IQTQPF------APSQ 725
Query: 309 PPAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAV-VFF 367
S KP G+R II I I G+ ++ + +
Sbjct: 726 ----------------------STGKP-----GGMRSSKIIAITAAVIGGVSLMLIALIV 758
Query: 368 YVYRLIKRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASV 427
Y+ R R S + + + F P GFT ++ A+
Sbjct: 759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPP------KEGFTF-----------QDLVAAT 801
Query: 428 SDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASG 487
+ ++++ GR GA G
Sbjct: 802 DNFDESFVVGR---------------------------------------------GACG 816
Query: 488 SSIMYKAVLEDGTALAVRRI-----GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+ +YKAVL G LAV+++ G N+ + F ++ + + H N+V++ GF
Sbjct: 817 T--VYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNH 874
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---KHVH 599
L++Y+++P GSL + C+L W R KIA G A+GLA+LH + H
Sbjct: 875 QGSNLLLYEYMPKGSLGEILH----DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFH 930
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++K N+LL + E +GDFGL +++ D SK
Sbjct: 931 RDIKSNNILLDDKFEAHVGDFGLAKVI--DMPHSK------------------------- 963
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719
S S++ G Y APE ++K K D+YS+GV+LLELLTGK V + QG
Sbjct: 964 --------SMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKA-PVQPIDQG 1014
Query: 720 NGLL--VEDKNRAIRLADAAIRADFEGKEE----ALLSCFKLGYSCASPLPQKRPSMKEA 773
++ V R L+ + A ++E +L+ K+ C S P RPSM++
Sbjct: 1015 GDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074
Query: 774 LQAL 777
+ L
Sbjct: 1075 VLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 791 | ||||||
| 255567891 | 785 | LIM domain kinase, putative [Ricinus com | 0.970 | 0.978 | 0.737 | 0.0 | |
| 224084402 | 773 | predicted protein [Populus trichocarpa] | 0.968 | 0.990 | 0.713 | 0.0 | |
| 224094266 | 733 | predicted protein [Populus trichocarpa] | 0.922 | 0.995 | 0.680 | 0.0 | |
| 225438833 | 781 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.978 | 0.683 | 0.0 | |
| 449468311 | 745 | PREDICTED: probable LRR receptor-like se | 0.911 | 0.967 | 0.662 | 0.0 | |
| 356563574 | 761 | PREDICTED: probable LRR receptor-like se | 0.940 | 0.977 | 0.665 | 0.0 | |
| 4006856 | 766 | receptor kinase-like protein [Arabidopsi | 0.944 | 0.975 | 0.615 | 0.0 | |
| 30690913 | 768 | putative LRR receptor-like serine/threon | 0.944 | 0.972 | 0.615 | 0.0 | |
| 18086496 | 768 | AT4g37250/C7A10_110 [Arabidopsis thalian | 0.944 | 0.972 | 0.615 | 0.0 | |
| 356514266 | 770 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.968 | 0.660 | 0.0 |
| >gi|255567891|ref|XP_002524923.1| LIM domain kinase, putative [Ricinus communis] gi|223535758|gb|EEF37420.1| LIM domain kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1064 bits (2752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/792 (73%), Positives = 668/792 (84%), Gaps = 24/792 (3%)
Query: 8 LYLWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWN 67
+LWW++L +++ + +VVQS GLNTDG+LLLS K+S+LSDPL VL SW+YNDE PCSWN
Sbjct: 10 FHLWWKILALVLLL--LVVQSFGLNTDGILLLSLKFSILSDPLRVLESWSYNDETPCSWN 67
Query: 68 GVTCASPG-EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF 126
GVTC PG + + SRV GL+LPNSQLLGSIPADLGMIE LQ LDLSNNSLNGSL FSLF
Sbjct: 68 GVTCGGPGLDATSFSRVTGLSLPNSQLLGSIPADLGMIEHLQNLDLSNNSLNGSLPFSLF 127
Query: 127 NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186
NA+ LR LDLSNNLISG LPET+G L NL+ LNLSDNA+AG L SL TL +LT++SLKN
Sbjct: 128 NATHLRFLDLSNNLISGELPETVGQLQNLEFLNLSDNAMAGTLHASLATLHNLTVISLKN 187
Query: 187 NYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIP 246
NYF LP F SVQVLDLSSNLINGSLP GG SL YLN+SYNRLSG IP +F +IP
Sbjct: 188 NYFFGVLPGGFVSVQVLDLSSNLINGSLPQGFGGNSLHYLNISYNRLSGSIPQEFASQIP 247
Query: 247 VNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAP 306
NATIDLSFNNLTGEIP+S++F+NQ+ +S++GN DLCGQPT+NPCPIP SP LPN T+P
Sbjct: 248 DNATIDLSFNNLTGEIPDSSIFLNQKITSYNGNPDLCGQPTRNPCPIPCSPSSLPNITSP 307
Query: 307 TSPPAIAAIPKSIDSTPATNPDDGSVSKPRQEG-SQGLRPGTIIGIVIGDIAGIGILAVV 365
TSPPAIAAIPK++ S PAT+P P QE S+GLR GT+IGIV+GDIAG+ IL ++
Sbjct: 308 TSPPAIAAIPKTLASAPATSP-------PSQETESEGLRKGTVIGIVLGDIAGVAILGMI 360
Query: 366 FFYVYRLIKR-KNVESTLKK--EANS-AKDTVSFSPSSSSSESRGFTRWSCLR-KRGDGD 420
FFYVY+ KR KNVE+T K EANS AKD S+ SSSSSES+GFTRWSCLR KRG +
Sbjct: 361 FFYVYQFKKRKKNVETTTLKNQEANSTAKDHESW--SSSSSESKGFTRWSCLRNKRGADN 418
Query: 421 EESDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASA 480
E+ S S ++N + K+ +NQ + E+ +K GTLV VDG+KELELETLLKASA
Sbjct: 419 EDESDSTSSDDNNDNDHPKVQENNQEHR----EQSSKGGTLVTVDGEKELELETLLKASA 474
Query: 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
YILGA+GSSIMYKAVLEDGT+LAVRRIGEN V+RFRDFETQVRVIAKLVHPNLVRIRGFY
Sbjct: 475 YILGATGSSIMYKAVLEDGTSLAVRRIGENHVERFRDFETQVRVIAKLVHPNLVRIRGFY 534
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
WG DEKLIIYDFVPNGSLA+ARYRK+GSSPCHLPWEARLKIAKGVARGL++LH+KK VHG
Sbjct: 535 WGADEKLIIYDFVPNGSLASARYRKVGSSPCHLPWEARLKIAKGVARGLSYLHDKKQVHG 594
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
NLKP N+LLG+DMEP+IGDFGLERLVTGD SSSKAGGS RNFGSKRS+ASRDSFQ+ G
Sbjct: 595 NLKPSNILLGSDMEPRIGDFGLERLVTGD-SSSKAGGSTRNFGSKRSSASRDSFQEFSIG 653
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG- 719
PSPSPSPSPS +GG+SPYHAPESLRS+KPNPKWDV+SFGVILLELLTGKVIVVDELGQG
Sbjct: 654 PSPSPSPSPSLIGGLSPYHAPESLRSLKPNPKWDVFSFGVILLELLTGKVIVVDELGQGS 713
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779
NG+ V+DK+RAIR+AD AIRAD EGKEEALL CFK+GYSCASP+PQKRP+MKE LQ LEK
Sbjct: 714 NGITVDDKSRAIRMADVAIRADVEGKEEALLPCFKVGYSCASPVPQKRPTMKEILQVLEK 773
Query: 780 IPSSPSPYLYGH 791
IPS S Y+YGH
Sbjct: 774 IPSKSSSYMYGH 785
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084402|ref|XP_002307286.1| predicted protein [Populus trichocarpa] gi|222856735|gb|EEE94282.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 566/793 (71%), Positives = 654/793 (82%), Gaps = 27/793 (3%)
Query: 1 MNSSCFNLYLWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYND 60
M+ L+LWWR+L + + + +VVQS GLNTDGVLLLSFKYS+L DPL VL SWN++D
Sbjct: 1 MSFQGVQLHLWWRILALGILL--LVVQSFGLNTDGVLLLSFKYSILDDPLSVLQSWNHSD 58
Query: 61 ENPCSWNGVTCASPGEGNND-SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG 119
+ PCSWNGVTC SPG N SRV GL+LPN QLLG+IPA LG+I+ LQ LDLS+NSLNG
Sbjct: 59 QTPCSWNGVTCGSPGTDNTYYSRVTGLSLPNCQLLGTIPATLGLIQHLQNLDLSDNSLNG 118
Query: 120 SLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179
SL SL NA+QLR LDLS+N+ISG LPET+G L NL+LLNLSDN LAG LP +L L +L
Sbjct: 119 SLPVSLLNATQLRFLDLSSNMISGQLPETIGRLQNLELLNLSDNVLAGTLPANLAALHNL 178
Query: 180 TIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPP 239
T+V LK N FS LPS F +VQVLDLSSNL+NGSLP D GG +L YLN+SYN+LSG IP
Sbjct: 179 TVVYLKKNNFSGDLPSGFQTVQVLDLSSNLLNGSLPQDFGGNNLHYLNISYNKLSGPIPQ 238
Query: 240 QFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFD 299
+F +IP N TIDLSFNNLTGEIPES++F+NQE S+F+GN LCGQPT+N CPIPSS
Sbjct: 239 EFANEIPSNTTIDLSFNNLTGEIPESSLFLNQERSAFAGNPHLCGQPTRNQCPIPSSVSP 298
Query: 300 LPNTTAPTSPPAIAAIPKSIDSTPATN-PDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAG 358
LPN +APTSPPAIAA+P+ I S+PAT P + + + EG GLRPGTI GI++GDIAG
Sbjct: 299 LPNISAPTSPPAIAAVPRIIGSSPATTRPGETATGSGQDEG--GLRPGTIAGIIVGDIAG 356
Query: 359 IGILAVVFFYVYR-LIKRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRG 417
+ +L +VFFYVY L KRK+VE+ +K EAN AKD+ SSSSSESRGFTRW+CL KRG
Sbjct: 357 VAVLGLVFFYVYHCLKKRKHVETNIKNEANIAKDSW----SSSSSESRGFTRWACLHKRG 412
Query: 418 DGDEESDASVSDVEDN--YHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETL 475
+ +E+S ++ +D E HS QR DH H+ QNK+GTLV VDG+KELELETL
Sbjct: 413 ENEEDSGSTSTDNEAGPLDHS--------QRHTDH-HD-QNKEGTLVTVDGEKELELETL 462
Query: 476 LKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVR 535
L+ASAYILGA+GSSI YKAVLEDGT+ AVRRIGEN V+RFRDFETQVRVIAKLVHPNLVR
Sbjct: 463 LRASAYILGATGSSITYKAVLEDGTSFAVRRIGENHVERFRDFETQVRVIAKLVHPNLVR 522
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
IRGFYWGVDEKLIIYDFVPNGSLANARYRK GSSPCHLPWEARL+IAKGVARGL+FLHEK
Sbjct: 523 IRGFYWGVDEKLIIYDFVPNGSLANARYRKAGSSPCHLPWEARLRIAKGVARGLSFLHEK 582
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
K VHGNLKP N+LLG+DMEP+IGDFGLERL+TGDT S K GGSARNFGS RS ASRDS Q
Sbjct: 583 KLVHGNLKPSNILLGSDMEPRIGDFGLERLMTGDT-SYKGGGSARNFGSNRSIASRDSIQ 641
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
D GP PSPSPSPSS+GG+SPYHAPESLRS+KPNPKWDVY+FGVILLELLTGKV+VVDE
Sbjct: 642 DF--GPGPSPSPSPSSIGGLSPYHAPESLRSLKPNPKWDVYAFGVILLELLTGKVVVVDE 699
Query: 716 LGQG-NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774
LGQG NGL+VEDK+RA+R+AD AIRAD EGKE+ALL+CFKLGYSCA PQKRP+MKEAL
Sbjct: 700 LGQGSNGLVVEDKDRAMRVADVAIRADMEGKEDALLACFKLGYSCALHAPQKRPTMKEAL 759
Query: 775 QALEKIPSSPSPY 787
Q +E+ PSS +PY
Sbjct: 760 QVIERFPSSAAPY 772
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094266|ref|XP_002310117.1| predicted protein [Populus trichocarpa] gi|222853020|gb|EEE90567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/794 (68%), Positives = 623/794 (78%), Gaps = 64/794 (8%)
Query: 1 MNSSCFNLYLWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYND 60
M+ L+L WR+L + + + + VQS GL+TDGVLLLSFKYS+LSDPL VL SWN D
Sbjct: 1 MSFESVQLHLRWRILALGLLL--LGVQSFGLSTDGVLLLSFKYSILSDPLSVLQSWNNRD 58
Query: 61 ENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGS 120
+ PCSWNGVTC S G N SRV GL+L N QLLGSIPA+LG+I+ LQ LDLSNNSLNGS
Sbjct: 59 QTPCSWNGVTCGSSGTDNTYSRVTGLSLSNCQLLGSIPANLGVIQHLQNLDLSNNSLNGS 118
Query: 121 LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLT 180
L FSL NA+QLR LDLS+N+ISG+LPET+G L NL+LLNLSDN LAG LP +LT L +LT
Sbjct: 119 LPFSLLNATQLRFLDLSSNMISGYLPETIGRLQNLELLNLSDNDLAGTLPANLTALHNLT 178
Query: 181 IVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQ 240
VSLKNN F+ LPS F +VQVLDLSSNL+NGSLP D GG +LRYLN+SYN+LSG IP +
Sbjct: 179 FVSLKNNNFTGNLPSGFQTVQVLDLSSNLLNGSLPRDFGGNNLRYLNISYNKLSGPIPQE 238
Query: 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDL 300
F +IP N TIDLSFNNLTGEIPES++F+NQ++S+ +GN DLCGQPT+ PC IPSS L
Sbjct: 239 FANEIPSNTTIDLSFNNLTGEIPESSLFLNQQTSALAGNPDLCGQPTRTPCAIPSSVTTL 298
Query: 301 PNTTAPTSPPAIAAIPKSIDSTPATNP-DDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGI 359
PN +AP SP AIAAIPK I S+PAT P D + + EG GLRPGTIIGIVIGD+AG+
Sbjct: 299 PNISAPASPSAIAAIPKIIGSSPATTPPGDTATGSGQDEG--GLRPGTIIGIVIGDVAGV 356
Query: 360 GILAVVFFYVYR-LIKRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGD 418
IL +VFFYVY L KR+NVE+ ++KEA +AKD SC
Sbjct: 357 AILGMVFFYVYHYLKKRRNVEANIEKEATTAKD-------------------SC------ 391
Query: 419 GDEESDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKA 478
+G + + +Q Q+ + QN++GTLV VDG+KELE+ETLLKA
Sbjct: 392 -----------------TGNEADILDQSQRKTGYHEQNREGTLVTVDGEKELEIETLLKA 434
Query: 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG 538
SAYILGA+GSSIMYKAVLEDGT+ AVRRIGEN V+RFRDFETQVR IAKLVHPNLVRIRG
Sbjct: 435 SAYILGATGSSIMYKAVLEDGTSFAVRRIGENHVERFRDFETQVRAIAKLVHPNLVRIRG 494
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
FYWGVDEKLIIYDFVPNG LANARYRK GSSPCHLPWE+RL+IAKG+ARGL+FLH+KKHV
Sbjct: 495 FYWGVDEKLIIYDFVPNGCLANARYRKAGSSPCHLPWESRLRIAKGMARGLSFLHDKKHV 554
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
HGNLKP N+LLG+DMEP+IGDFGLERLVTGDT SSKAG SARNFGSKRSTASRDSFQD G
Sbjct: 555 HGNLKPSNILLGSDMEPRIGDFGLERLVTGDT-SSKAGESARNFGSKRSTASRDSFQDFG 613
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718
G+SPYHAPESLRS+KP+PKWDVYSFGVILLELLTGK +VVDELGQ
Sbjct: 614 T--------------GLSPYHAPESLRSLKPSPKWDVYSFGVILLELLTGKAVVVDELGQ 659
Query: 719 G-NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
G NGL+VEDKNRA+R+AD AIRAD EGKE+ALL+CFKLGYSCASPLPQKRP+MKEALQ +
Sbjct: 660 GSNGLVVEDKNRALRMADVAIRADVEGKEDALLACFKLGYSCASPLPQKRPTMKEALQVI 719
Query: 778 EKIPSSPSPYLYGH 791
EK PSS + Y YG
Sbjct: 720 EKFPSSSASYPYGQ 733
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438833|ref|XP_002278529.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g37250-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/787 (68%), Positives = 623/787 (79%), Gaps = 23/787 (2%)
Query: 1 MNSSCFNLYLWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYND 60
M S+ L+LWWR+L ++ + VQS G+N DG+LLLS KYSVLSDPL L SWN+ D
Sbjct: 1 MKSTSVGLHLWWRILSFVLLL----VQSFGINRDGILLLSLKYSVLSDPLSALESWNHYD 56
Query: 61 ENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGS 120
E PCSW GV C+SPG + SRVI L+L N QLLGSIP DLGMIE L+ LDLSNN+ NGS
Sbjct: 57 ETPCSWKGVRCSSPGMLDTCSRVIALSLSNFQLLGSIPDDLGMIEHLRNLDLSNNAFNGS 116
Query: 121 LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLT 180
L SLFNAS+L+ +DLSNNLISG LPE G L +LQLLNLSDNALAG++P L+TL +LT
Sbjct: 117 LPLSLFNASELQVMDLSNNLISGELPEVDGGLASLQLLNLSDNALAGRIPDYLSTLNNLT 176
Query: 181 IVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQ 240
VSLKNNYFS GLPS S++VLDLSSNLINGSLPPD GG SL YLN+SYNRLSG IP +
Sbjct: 177 SVSLKNNYFSGGLPSGVASIEVLDLSSNLINGSLPPDFGGESLGYLNISYNRLSGSIPLE 236
Query: 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDL 300
F + IP +A +DLSFNNLTGEIPE+NV NQ++ SFSGN LCG+P K PCPIPS+ L
Sbjct: 237 FAQNIPESAILDLSFNNLTGEIPEANVLYNQQTKSFSGNTGLCGKPLKAPCPIPST---L 293
Query: 301 PNTTAPTSPPAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIG 360
N T PTSPPAIAA+PK+IDSTP T+P G+ + R++ GLRP TI+GIV+GDI G+G
Sbjct: 294 YNATEPTSPPAIAAMPKTIDSTPVTSP--GTTNGSRKQDENGLRPATIVGIVLGDIVGVG 351
Query: 361 ILAVVFFYVYRLIKRKNVES---TLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRG 417
ILAV+F YVY+ K+KNV + T K E NSAKD +S SSSSSE+RG T WSCL KRG
Sbjct: 352 ILAVIFLYVYQWKKKKNVANAIKTEKNETNSAKDI--WSSSSSSSETRGVTAWSCLPKRG 409
Query: 418 DGDEESDASVSDVED--NYHSGR-KLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELET 474
D ++ ++ + SD E+ +G Q++Q G LV VDG+KELELET
Sbjct: 410 DEEDSTETTGSDGEEEQTMQTGHSNQRQQEQQKQGGGGGGGGGGGALVTVDGEKELELET 469
Query: 475 LLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLV 534
LLKASAYILGA+GSSIMYKAVLEDGT LAVRRIGE+ V+RFRDFE QV+VIAKLVHPNLV
Sbjct: 470 LLKASAYILGATGSSIMYKAVLEDGTTLAVRRIGESGVERFRDFENQVKVIAKLVHPNLV 529
Query: 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
RIRGFYWGVDEKL+IYDFVPNGSLA+ARYRK+GSSPCH+PWE RLK+AKG ARGL +LH+
Sbjct: 530 RIRGFYWGVDEKLVIYDFVPNGSLASARYRKVGSSPCHMPWEVRLKVAKGAARGLTYLHD 589
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
KKHVHGNLKP N+LLG DMEPKIGDFGLERLV+G+T S KAGGSARNFGSKRSTASRDSF
Sbjct: 590 KKHVHGNLKPSNILLGIDMEPKIGDFGLERLVSGET-SYKAGGSARNFGSKRSTASRDSF 648
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714
QD+ P S G+SPYHAPESLRS+KPNPKWDV+SFGVILLELLTGKVIV D
Sbjct: 649 QDM---PVGPSPSPSPSSLGVSPYHAPESLRSLKPNPKWDVFSFGVILLELLTGKVIVSD 705
Query: 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774
+LG GL EDK R +R+ADAAIRAD EGKE+ALL+CFKLG+SC SP PQKRPSMKEA+
Sbjct: 706 DLGL--GLASEDKGRVLRMADAAIRADLEGKEDALLACFKLGFSCVSPAPQKRPSMKEAV 763
Query: 775 QALEKIP 781
Q LEKIP
Sbjct: 764 QVLEKIP 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449468311|ref|XP_004151865.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g37250-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/764 (66%), Positives = 586/764 (76%), Gaps = 43/764 (5%)
Query: 30 GLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALP 89
GLN DGVLLLSFKY+VL DPL VL +WNY+DE PC W GV C+ G SRV GL+LP
Sbjct: 19 GLNFDGVLLLSFKYAVLDDPLFVLQNWNYSDETPCLWRGVQCSDDG-----SRVTGLSLP 73
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
NSQL+GS+ +DLG+I+ LQ LDLSNNS NGSL SLFNA+ LR LDLS+NLIS +P +
Sbjct: 74 NSQLMGSVSSDLGLIQNLQTLDLSNNSFNGSLPQSLFNATMLRFLDLSDNLISSEVPVPV 133
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNL 209
GSL NLQ+LNLS NAL GK P L +LT+VS+KNNY S +P F +V+VLDLSSNL
Sbjct: 134 GSLANLQVLNLSGNALFGKFPSDFVNLGNLTVVSMKNNYISGEIPGGFKTVEVLDLSSNL 193
Query: 210 INGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFM 269
INGSLP D GG SL Y N+SYN+L+G+IPP F KIP NA IDLSFNNLTGE+P S+VFM
Sbjct: 194 INGSLPADFGGDSLHYFNISYNKLTGQIPPDFAHKIPANAIIDLSFNNLTGEVPVSDVFM 253
Query: 270 NQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAIPKSID-STPATNPD 328
NQE++SF+GN LCG+ TK PCPI SSP L PPAIAAIP +D STP T
Sbjct: 254 NQEANSFTGNRQLCGELTKTPCPITSSPSSL--------PPAIAAIP--LDPSTPET--- 300
Query: 329 DGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKR-KNVESTLKKEAN 387
+ P ++ G +P TI+ IV+GDI G+ IL ++FFYV+ L K+ K VE+ LK E N
Sbjct: 301 ----TSPEKQSETGFKPSTIVAIVLGDIVGLAILCLLFFYVFHLKKKNKAVETHLKNEVN 356
Query: 388 SAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSVDNQRQ 447
AKD+ S+SSSESRGF+RWSCLRK GD +E N LS
Sbjct: 357 LAKDSW----STSSSESRGFSRWSCLRKTGDPEEA----------NSDQASVLSFSGHHD 402
Query: 448 QDHVHERQNKKGTLVIVD-GDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRR 506
NK+GTLV VD G+KELEL+TLLKASAYILGA+GSSI YKAVLEDGTA AVRR
Sbjct: 403 TAEEGGEANKRGTLVTVDGGEKELELDTLLKASAYILGATGSSITYKAVLEDGTAFAVRR 462
Query: 507 IGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKM 566
IG+ V++++DFE Q+R +AKLVHPNLVR+RGFYWGVDEKLIIYDFVPNGSLANARYRK+
Sbjct: 463 IGDGGVEKYKDFENQIRGVAKLVHPNLVRVRGFYWGVDEKLIIYDFVPNGSLANARYRKV 522
Query: 567 GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
GSSPCHLPWEARL+IAKGVARGL++LH+KKHVHGNL+P N+LLG DMEPKIGDFGLE+L
Sbjct: 523 GSSPCHLPWEARLRIAKGVARGLSYLHDKKHVHGNLRPTNILLGFDMEPKIGDFGLEKLF 582
Query: 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS 686
GD S K GGS R FGSKRSTASRDSFQD PSP PSPSS+ G+SPY APESLRS
Sbjct: 583 LGD-SCYKPGGSTRIFGSKRSTASRDSFQDY--VTGPSPGPSPSSISGVSPYLAPESLRS 639
Query: 687 IKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKE 746
+KPN KWDVYSFGVILLELLTGK+IV+DELGQG GL +EDK+R +R+AD AIRAD EG+E
Sbjct: 640 LKPNSKWDVYSFGVILLELLTGKIIVLDELGQGLGLAMEDKSRTLRMADMAIRADVEGRE 699
Query: 747 EALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS-SPSPYLY 789
EALLSCFKLGYSCASP PQKRPSMKEALQ LEK P+ S S + Y
Sbjct: 700 EALLSCFKLGYSCASPAPQKRPSMKEALQVLEKFPTLSVSSHYY 743
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563574|ref|XP_003550036.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g37250-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2357), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/771 (66%), Positives = 607/771 (78%), Gaps = 27/771 (3%)
Query: 10 LWWRVLVVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGV 69
L+ +++ LV + V Q L+ DGVLLLSFKY+VL+DPL VL +WNY+DE PCSWNGV
Sbjct: 4 LFPTLIISLVILLVTVNQCCALSRDGVLLLSFKYAVLNDPLYVLANWNYSDETPCSWNGV 63
Query: 70 TCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNAS 129
+C+ N++RV L LPNSQ LGS+P+DLG IE LQ LDLSNNSLNGSL SL AS
Sbjct: 64 SCS------NENRVTSLLLPNSQFLGSVPSDLGSIEHLQILDLSNNSLNGSLPSSLSQAS 117
Query: 130 QLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189
+LR L+LSNNLI+G +PE++ L NL+ LNLSDNALAGKLP S + +Q+LT+ S KNNY
Sbjct: 118 ELRFLNLSNNLITGEVPESLSQLRNLEFLNLSDNALAGKLPESFSNMQNLTVASFKNNYL 177
Query: 190 SDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNA 249
LPS ++QVLDLSSNL+NGSLP D GG ++RYLN+SYNR SGEIP +F +IP NA
Sbjct: 178 FGFLPSGLRTLQVLDLSSNLLNGSLPKDFGGDNMRYLNISYNRFSGEIPTEFAAEIPGNA 237
Query: 250 TIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSP 309
T+DLSFNNLTGE+P+S VF NQ S SF+GN +LCG+ TKNPCPIPSSP P +AP SP
Sbjct: 238 TVDLSFNNLTGEVPDSTVFTNQNSKSFNGNFNLCGEITKNPCPIPSSPSSEPKASAPISP 297
Query: 310 PAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYV 369
PAIAAIPKS D +P P + +GL+ GTIIGIV+GDI G+GILA++ YV
Sbjct: 298 PAIAAIPKSFDDSPLA---------PTGQKQRGLKQGTIIGIVVGDIIGVGILAMLCVYV 348
Query: 370 YRLIKRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSD 429
YRL K+K+ EST KK + + S S SS++SESRGFTRWSCLRKR + ++ S+ + S
Sbjct: 349 YRLKKKKDAESTKKKNEAAITRSRSESSSSTTSESRGFTRWSCLRKRTEEEDSSETTSSS 408
Query: 430 VEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSS 489
V+ H + N GTLV VDG+++LE+ETLLKASAYILGA+GSS
Sbjct: 409 ES---------EVEGATAATHDNNNNNNTGTLVTVDGERQLEVETLLKASAYILGATGSS 459
Query: 490 IMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
IMYKAVLEDGT+LAVRRIGE+ V+RF+DFE QVR+IAKLVHPNLVR+RGFYWG DEKLII
Sbjct: 460 IMYKAVLEDGTSLAVRRIGESGVERFKDFENQVRLIAKLVHPNLVRVRGFYWGHDEKLII 519
Query: 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
YDFVPNG LAN RYRK+GSSP HLPWE RLKIAKGVARGL +LHEKKHVHGNLKP N+LL
Sbjct: 520 YDFVPNGCLANVRYRKVGSSPSHLPWEIRLKIAKGVARGLTYLHEKKHVHGNLKPSNILL 579
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
GNDMEPKIGDFGLER+VTGDT S KAGGSAR FGSKRSTASRDSFQD+ GPSPSPSPS
Sbjct: 580 GNDMEPKIGDFGLERIVTGDT-SYKAGGSARIFGSKRSTASRDSFQDMTFGPSPSPSPSS 638
Query: 670 SSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNR 729
S +SPYHAPESLR++KP+PKWDVYSFGV+ LELLTGK++V+D++GQG GLLVEDKNR
Sbjct: 639 ISG--VSPYHAPESLRNLKPHPKWDVYSFGVMFLELLTGKIVVLDDMGQGPGLLVEDKNR 696
Query: 730 AIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
A+R+ D IRAD EG+EEALL+ FKLGYSC S +PQKRP MKEALQ LEKI
Sbjct: 697 ALRMVDMVIRADMEGREEALLAYFKLGYSCVSSIPQKRPPMKEALQVLEKI 747
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4006856|emb|CAB16774.1| receptor kinase-like protein [Arabidopsis thaliana] gi|7270708|emb|CAB80391.1| receptor kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/790 (61%), Positives = 586/790 (74%), Gaps = 43/790 (5%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
V+ F C V+ S LN+DG++L+ FK SVL DPL +L +WNY E+PCSW G++C
Sbjct: 6 VIFFFFCSVLSSS-ALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISC---- 60
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
NNDS+V+ L+LPNSQLLGSIP+DLG + LQ LDLSNNS NG L S FNA +LR LD
Sbjct: 61 --NNDSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLD 118
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
LS+N+ISG +P +G LHNL LNLSDNALAGKLP +L +L++LT+VSL+NNYFS +P
Sbjct: 119 LSSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPG 178
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
+ V+ LDLSSNLINGSLPPD GGYSL+YLN+S+N++SGEIPP+ G P N T+DLSF
Sbjct: 179 GWRVVEFLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSF 238
Query: 256 NNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315
NNLTG IP+S VF+NQES+ FSGN LCG+PT+NPC IPSSP + PTS PAIAAI
Sbjct: 239 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAI 298
Query: 316 PKSIDSTPATNPDDGSVS-KPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIK 374
P +I S P T+P+ PR GLRPG IIGIV+GDIAGIGILAV+F Y+YR K
Sbjct: 299 PNTIGSNPVTDPNSQQTDPNPR----TGLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKK 354
Query: 375 RKNVESTLKKEANSAKDTVSFSP----SSSSSESRGFTRWSCLRKRGDGDEESDASVSDV 430
K V++ + + DT++ S SSS ESR F +WSCLRK D E+ S +
Sbjct: 355 NKIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRK----DPETTPSEEED 410
Query: 431 EDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSI 490
ED+ + NQR D+ LV VDG+KE+E+ETLLKASAYILGA+GSSI
Sbjct: 411 EDDEDEESGYNA-NQRSGDN---------KLVTVDGEKEMEIETLLKASAYILGATGSSI 460
Query: 491 MYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
MYKAVLEDG AVRR+GEN S RF+DFE +R I KLVHPNLVR+ GFYWG DEKL+
Sbjct: 461 MYKAVLEDGRVFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLV 520
Query: 549 IYDFVPNGSLANARYRKMG--SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
IYDFVPNGSL N RYRK G SSP HLPWE RLKIAKG+ARGLA+LHEKKHVHGNLKP N
Sbjct: 521 IYDFVPNGSLVNPRYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHEKKHVHGNLKPSN 580
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+LLG+DMEPKIGDFGLERL+TG+TS +AGGS+R F SKR T S F + P+PS
Sbjct: 581 ILLGHDMEPKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSI----GPTPS 636
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVED 726
PSPSS+G +SPY APES RS+KP+PKWDVY FGVILLELLTGK++ V+E+ GNGL VED
Sbjct: 637 PSPSSVGAMSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLTVED 696
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI-PSS-- 783
+RA+R+AD AIR + +GK+E LL CFKLGYSCASP+PQKRP+MKE+L LE+ P+S
Sbjct: 697 GHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERFHPNSSV 756
Query: 784 --PSPYLYGH 791
S + YGH
Sbjct: 757 IKSSSFHYGH 766
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30690913|ref|NP_195442.2| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|264664508|sp|C0LGS3.1|Y4372_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g37250; Flags: Precursor gi|224589651|gb|ACN59358.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332661373|gb|AEE86773.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/790 (61%), Positives = 586/790 (74%), Gaps = 43/790 (5%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
V+ F C V+ S LN+DG++L+ FK SVL DPL +L +WNY E+PCSW G++C
Sbjct: 8 VIFFFFCSVLSSS-ALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISC---- 62
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
NNDS+V+ L+LPNSQLLGSIP+DLG + LQ LDLSNNS NG L S FNA +LR LD
Sbjct: 63 --NNDSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLD 120
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
LS+N+ISG +P +G LHNL LNLSDNALAGKLP +L +L++LT+VSL+NNYFS +P
Sbjct: 121 LSSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPG 180
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
+ V+ LDLSSNLINGSLPPD GGYSL+YLN+S+N++SGEIPP+ G P N T+DLSF
Sbjct: 181 GWRVVEFLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSF 240
Query: 256 NNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315
NNLTG IP+S VF+NQES+ FSGN LCG+PT+NPC IPSSP + PTS PAIAAI
Sbjct: 241 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAI 300
Query: 316 PKSIDSTPATNPDDGSVS-KPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIK 374
P +I S P T+P+ PR GLRPG IIGIV+GDIAGIGILAV+F Y+YR K
Sbjct: 301 PNTIGSNPVTDPNSQQTDPNPR----TGLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKK 356
Query: 375 RKNVESTLKKEANSAKDTVSFSP----SSSSSESRGFTRWSCLRKRGDGDEESDASVSDV 430
K V++ + + DT++ S SSS ESR F +WSCLRK D E+ S +
Sbjct: 357 NKIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRK----DPETTPSEEED 412
Query: 431 EDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSI 490
ED+ + NQR D+ LV VDG+KE+E+ETLLKASAYILGA+GSSI
Sbjct: 413 EDDEDEESGYNA-NQRSGDN---------KLVTVDGEKEMEIETLLKASAYILGATGSSI 462
Query: 491 MYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
MYKAVLEDG AVRR+GEN S RF+DFE +R I KLVHPNLVR+ GFYWG DEKL+
Sbjct: 463 MYKAVLEDGRVFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLV 522
Query: 549 IYDFVPNGSLANARYRKMG--SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
IYDFVPNGSL N RYRK G SSP HLPWE RLKIAKG+ARGLA+LHEKKHVHGNLKP N
Sbjct: 523 IYDFVPNGSLVNPRYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHEKKHVHGNLKPSN 582
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+LLG+DMEPKIGDFGLERL+TG+TS +AGGS+R F SKR T S F + P+PS
Sbjct: 583 ILLGHDMEPKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSI----GPTPS 638
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVED 726
PSPSS+G +SPY APES RS+KP+PKWDVY FGVILLELLTGK++ V+E+ GNGL VED
Sbjct: 639 PSPSSVGAMSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLTVED 698
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI-PSS-- 783
+RA+R+AD AIR + +GK+E LL CFKLGYSCASP+PQKRP+MKE+L LE+ P+S
Sbjct: 699 GHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERFHPNSSV 758
Query: 784 --PSPYLYGH 791
S + YGH
Sbjct: 759 IKSSSFHYGH 768
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18086496|gb|AAL57701.1| AT4g37250/C7A10_110 [Arabidopsis thaliana] gi|25090184|gb|AAN72248.1| At4g37250/C7A10_110 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/790 (61%), Positives = 585/790 (74%), Gaps = 43/790 (5%)
Query: 16 VVLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG 75
V+ F C V+ S LN+DG++L+ FK SVL DPL +L +WNY E+PCSW G++C
Sbjct: 8 VIFFFFCSVLSSS-ALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISC---- 62
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
NNDS+V+ L+LPNSQLLGSIP+DLG + LQ LDLSNNS NG L S FNA +LR LD
Sbjct: 63 --NNDSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLD 120
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
LS+N+ISG +P +G LHNL LNLSDNALAGKLP +L +L++LT+VSL+NNYFS +P
Sbjct: 121 LSSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPG 180
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
+ V+ LDLSSNLINGSLPPD GGYSL+YLN+S+N++SGEIPP+ G P N T+DLSF
Sbjct: 181 GWRVVEFLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSF 240
Query: 256 NNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315
NNLTG IP+S VF+NQES+ FSGN LCG+PT+NPC IPSSP + PTS PAIAAI
Sbjct: 241 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAI 300
Query: 316 PKSIDSTPATNPDDGSVS-KPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIK 374
P +I S P T+P+ PR GLRPG IIGIV+GDIAGIGILAV+F Y+YR K
Sbjct: 301 PNTIGSNPVTDPNSQQTDPNPR----TGLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKK 356
Query: 375 RKNVESTLKKEANSAKDTVSFSP----SSSSSESRGFTRWSCLRKRGDGDEESDASVSDV 430
K V + + + DT++ S SSS ESR F +WSCLRK D E+ S +
Sbjct: 357 NKIVYNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRK----DPETTPSEEED 412
Query: 431 EDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSI 490
ED+ + NQR D+ LV VDG+KE+E+ETLLKASAYILGA+GSSI
Sbjct: 413 EDDEDEESGYNA-NQRSGDN---------KLVTVDGEKEMEIETLLKASAYILGATGSSI 462
Query: 491 MYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
MYKAVLEDG AVRR+GEN S RF+DFE +R I KLVHPNLVR+ GFYWG DEKL+
Sbjct: 463 MYKAVLEDGRVFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLV 522
Query: 549 IYDFVPNGSLANARYRKMG--SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
IYDFVPNGSL N RYRK G SSP HLPWE RLKIAKG+ARGLA+LHEKKHVHGNLKP N
Sbjct: 523 IYDFVPNGSLVNPRYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHEKKHVHGNLKPSN 582
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+LLG+DMEPKIGDFGLERL+TG+TS +AGGS+R F SKR T S F + P+PS
Sbjct: 583 ILLGHDMEPKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSI----GPTPS 638
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVED 726
PSPSS+G +SPY APES RS+KP+PKWDVY FGVILLELLTGK++ V+E+ GNGL VED
Sbjct: 639 PSPSSVGAMSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLTVED 698
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI-PSS-- 783
+RA+R+AD AIR + +GK+E LL CFKLGYSCASP+PQKRP+MKE+L LE+ P+S
Sbjct: 699 GHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERFHPNSSV 758
Query: 784 --PSPYLYGH 791
S + YGH
Sbjct: 759 IKSSSFHYGH 768
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514266|ref|XP_003525827.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g37250-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/769 (66%), Positives = 601/769 (78%), Gaps = 23/769 (2%)
Query: 17 VLVFICGVVVQSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGE 76
L+ +V Q L+ DGVLLLSFKY+VL+DPL L +WNY+DE PCSWNGV+C++
Sbjct: 7 TLIISLVLVNQCCALSRDGVLLLSFKYAVLNDPLYALANWNYSDETPCSWNGVSCST--- 63
Query: 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDL 136
++RV L LPNSQLLGS+P+DLG IE LQ LDLSNNSLNGSL SL AS+LR L+L
Sbjct: 64 ---ENRVTSLFLPNSQLLGSVPSDLGSIEHLQILDLSNNSLNGSLPSSLSQASELRFLNL 120
Query: 137 SNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK 196
SNNLI+G +PE++ L NL+ LNLSDN LAGKLP + +Q+LT S KNNY LPS
Sbjct: 121 SNNLITGEVPESITQLRNLEFLNLSDNDLAGKLPEGFSNMQNLTQASFKNNYLFGFLPSG 180
Query: 197 FNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
++QVLDLS+NL+NGSLP D GG +RYLN+SYNR SGEIP +F +IP NAT+DLSFN
Sbjct: 181 LRTLQVLDLSANLLNGSLPTDFGGDVMRYLNISYNRFSGEIPTEFAARIPGNATVDLSFN 240
Query: 257 NLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAIP 316
NLTGE+P+S VF NQ S SFSGN++LCG+ TKNPCPIPSSP P +AP SPPAIAAIP
Sbjct: 241 NLTGEVPDSAVFTNQNSKSFSGNVNLCGEMTKNPCPIPSSPSSEPKASAPISPPAIAAIP 300
Query: 317 KSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRK 376
K++D +P P + GL+ GTIIGIV+GD+ G+GILAV+F YVYRL K+K
Sbjct: 301 KNLDDSPLA---------PTGQKQSGLKQGTIIGIVVGDVVGVGILAVLFVYVYRLKKKK 351
Query: 377 NVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASV---SDVEDN 433
E + + + S S SS++SESRGFTRWSCLRKR + +E S+ + SD+E
Sbjct: 352 EEEGSKTNNEAAITRSRSESSSSTTSESRGFTRWSCLRKRTEEEESSETTSSSDSDLEGA 411
Query: 434 YHSGRKLSVDNQRQQDHVHERQ--NKKGTLVIVDGDKELELETLLKASAYILGASGSSIM 491
+G+ N + +Q NK GTLV VDG+++LELETLLKASAYILGA+GSSIM
Sbjct: 412 AAAGQNNQNLNNNHNNSKGPQQENNKTGTLVTVDGERQLELETLLKASAYILGATGSSIM 471
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551
YKAVLEDGT+LAVRRIGE+ V+RF+DFE QVRVIAKLVHPNLVR+RGFYWG DEKLIIYD
Sbjct: 472 YKAVLEDGTSLAVRRIGESGVERFKDFENQVRVIAKLVHPNLVRVRGFYWGHDEKLIIYD 531
Query: 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN 611
F+PNG LAN RYRK+G SP HLPWE RLKIAKGVARGLA+LHEKKHVHGNLKP N+LLGN
Sbjct: 532 FIPNGCLANVRYRKLGLSPSHLPWEIRLKIAKGVARGLAYLHEKKHVHGNLKPSNILLGN 591
Query: 612 DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSS 671
DMEPKIGDFGLER+VTGDT S KAGGSAR FGSKRSTASRDSFQD+ GPSPSPSPS S
Sbjct: 592 DMEPKIGDFGLERIVTGDT-SYKAGGSARIFGSKRSTASRDSFQDITFGPSPSPSPSSIS 650
Query: 672 LGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAI 731
+SPYHAPESLR++KP+PKWDVYSFGV+ LELLTGK++V+D++GQG GLLVED NRA+
Sbjct: 651 G--VSPYHAPESLRNLKPHPKWDVYSFGVMFLELLTGKIVVLDDMGQGPGLLVEDNNRAL 708
Query: 732 RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
R+ D AIRAD E +EEALL+ FKLGYSC S +PQKRP MKE LQ LEKI
Sbjct: 709 RMVDMAIRADMECREEALLAYFKLGYSCMSSVPQKRPPMKEVLQVLEKI 757
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 791 | ||||||
| TAIR|locus:2115120 | 768 | AT4G37250 [Arabidopsis thalian | 0.927 | 0.955 | 0.539 | 5.8e-208 | |
| TAIR|locus:2058598 | 773 | AT2G23300 [Arabidopsis thalian | 0.862 | 0.882 | 0.552 | 4.9e-195 | |
| TAIR|locus:2157182 | 751 | RLK "receptor-like kinase" [Ar | 0.495 | 0.521 | 0.587 | 1.9e-190 | |
| TAIR|locus:2124296 | 757 | AT4G34220 [Arabidopsis thalian | 0.753 | 0.787 | 0.450 | 1.3e-152 | |
| TAIR|locus:2049108 | 744 | AT2G15300 [Arabidopsis thalian | 0.740 | 0.787 | 0.454 | 4.6e-148 | |
| TAIR|locus:2038706 | 716 | AT2G01210 [Arabidopsis thalian | 0.396 | 0.438 | 0.412 | 3.4e-111 | |
| TAIR|locus:2033000 | 702 | AT1G25320 [Arabidopsis thalian | 0.379 | 0.427 | 0.410 | 2.8e-103 | |
| TAIR|locus:2008793 | 719 | AT1G67510 [Arabidopsis thalian | 0.399 | 0.439 | 0.391 | 2.1e-94 | |
| TAIR|locus:2033379 | 685 | AT1G66830 [Arabidopsis thalian | 0.321 | 0.370 | 0.382 | 1.4e-91 | |
| TAIR|locus:2095773 | 662 | AT3G57830 [Arabidopsis thalian | 0.404 | 0.483 | 0.348 | 5e-69 |
| TAIR|locus:2115120 AT4G37250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2011 (713.0 bits), Expect = 5.8e-208, P = 5.8e-208
Identities = 421/780 (53%), Positives = 509/780 (65%)
Query: 28 SLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLA 87
S LN+DG++L+ FK SVL DPL +L +WNY E+PCSW G++C NNDS+V+ L+
Sbjct: 19 SSALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISC------NNDSKVLTLS 72
Query: 88 LPNSQLLGSIPADLGMIEFLQYLDXXXXXXXXXXXXXXXXXXQLRNLDLSNNLISGHLPE 147
LPNSQLLGSIP+DLG + LQ LD +LR LDLS+N+ISG +P
Sbjct: 73 LPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLDLSSNMISGEIPS 132
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSS 207
+G LHNL LNLSDNALAGKLP +L +L++LT+VSL+NNYFS +P + V+ LDLSS
Sbjct: 133 AIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPGGWRVVEFLDLSS 192
Query: 208 NLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNV 267
NLINGSLPPD GGYSL+YLN+S+N++SGEIPP+ G P N T+DLSFNNLTG IP+S V
Sbjct: 193 NLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSFNNLTGPIPDSPV 252
Query: 268 FMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNXXXXXXXXXXXXXXXXXXXTPATNP 327
F+NQES+ FSGN LCG+PT+NPC IPSSP + P T+P
Sbjct: 253 FLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAIPNTIGSNPVTDP 312
Query: 328 DDGSVS-KPRQEGSQGLRPXXXXXXXXXXXXXXXXLAVVFFYVYRLIKRKNVESTLKKEA 386
+ PR GLRP LAV+F Y+YR K K V++ +
Sbjct: 313 NSQQTDPNPRT----GLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKKNKIVDNNNNDKQ 368
Query: 387 NSAKDTVXXXXXXXXXXX----RGFTRWSCLRKRGDG--DEESDASVSDVEDNYHSGRKL 440
+ DT+ R F +WSCLRK + EE D D E Y++
Sbjct: 369 RTETDTITLSTFSSSSSSPEESRRFRKWSCLRKDPETTPSEEEDEDDEDEESGYNA---- 424
Query: 441 SVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGT 500
NQR D NK LV VDG+KE+E+ETLLKASAYILGA+GSSIMYKAVLEDG
Sbjct: 425 ---NQRSGD------NK---LVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGR 472
Query: 501 ALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558
AVRR+GEN + RF+DFE +R I KLVHPNLVR+ GFYWG DEKL+IYDFVPNGSL
Sbjct: 473 VFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSL 532
Query: 559 ANARYRKMG--SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616
N RYRK G SSP HLPWE RLKIAKG+ARGLA+LHEKKHVHGNLKP N+LLG+DMEPK
Sbjct: 533 VNPRYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHEKKHVHGNLKPSNILLGHDMEPK 592
Query: 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLXXXXXXXXXXXXXXXXXXX 676
IGDFGLERL+TG+TS +AGGS+R F SKR T S F +
Sbjct: 593 IGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGAMSP--- 649
Query: 677 XYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNXXXXXXXX 736
Y APES RS+KP+PKWDVY FGVILLELLTGK++ V+E+ GNGL VED +
Sbjct: 650 -YCAPESFRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLTVEDGHRAVRMADV 708
Query: 737 XXXXXFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI-PSSP----SPYLYGH 791
+GK+E LL CFKLGYSCASP+PQKRP+MKE+L LE+ P+S S + YGH
Sbjct: 709 AIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERFHPNSSVIKSSSFHYGH 768
|
|
| TAIR|locus:2058598 AT2G23300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1889 (670.0 bits), Expect = 4.9e-195, P = 4.9e-195
Identities = 405/733 (55%), Positives = 475/733 (64%)
Query: 78 NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDXXXXXXXXXXXXXXXXXXQLRNLDLS 137
NNDSRV+ L+LPNS L+GSIP+DLG ++ LQ L+ +LR LDLS
Sbjct: 72 NNDSRVVTLSLPNSNLVGSIPSDLGFLQNLQSLNLSNNSLNGSLPVEFFAADKLRFLDLS 131
Query: 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK- 196
NNLISG +P ++G LHNLQ LNLSDN GKLP +L +L SLT VSLKNNYFS P
Sbjct: 132 NNLISGEIPVSIGGLHNLQTLNLSDNIFTGKLPANLASLGSLTEVSLKNNYFSGEFPGGG 191
Query: 197 FNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
+ SVQ LD+SSNLINGSLPPD G +LRYLN+SYN++SGEIPP G P NAT+D SFN
Sbjct: 192 WRSVQYLDISSNLINGSLPPDFSGDNLRYLNVSYNQISGEIPPNVGAGFPQNATVDFSFN 251
Query: 257 NLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDL-PNXXXXXXXXXXXXX 315
NLTG IP+S V++NQ+S SFSGN LCG PT+NPCPIPSSP + P
Sbjct: 252 NLTGSIPDSPVYLNQKSISFSGNPGLCGGPTRNPCPIPSSPATVSPPTSTPALAAIPKSI 311
Query: 316 XXXXXXTPATNPDDGSVSKPRQEGSQGLRPXXXXXXXXXXXXXXXXLAVVFFYVYRLIKR 375
P N S PR GLRP LA++FFYVY+
Sbjct: 312 GSNRETEPNNN------SNPRT----GLRPGVIIGIIVGDIAGIGILALIFFYVYKYKNN 361
Query: 376 KNVE--STLKKEANSAKDTVXXXXXXXXXXXRG-------FTRWSCLRKRGDGDEESDAS 426
K VE + EA+ AKDT F +WSCLRK ++E+D +
Sbjct: 362 KTVEKKNNHSLEAHEAKDTTSLSPSSSTTTSSSSPEQSSRFAKWSCLRK----NQETDET 417
Query: 427 VSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDG-DKELELETLLKASAYILGA 485
+ E+N SG + E NKKGTLV +DG +KELE+ETLLKASAYILGA
Sbjct: 418 EEEDEENQRSGE------------IGE--NKKGTLVTIDGGEKELEVETLLKASAYILGA 463
Query: 486 SGSSIMYKAVLEDGTALAVRRIGENSVD---RFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+GSSIMYK VLEDGT LAVRR+GEN + RF+DFE +R I KLVHPNLVR+RGFYWG
Sbjct: 464 TGSSIMYKTVLEDGTVLAVRRLGENGLSQQRRFKDFEAHIRAIGKLVHPNLVRLRGFYWG 523
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
DEKL+IYDFVPNGSL NARYRK GSSPCHLPWE RLKI KG+ARGLA+LH+KKHVHGNL
Sbjct: 524 TDEKLVIYDFVPNGSLVNARYRKGGSSPCHLPWETRLKIVKGLARGLAYLHDKKHVHGNL 583
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLXXXXX 662
KP N+LLG DMEPKIGDFGLERL+ GDTS ++A GS+R F SKR TAS F +
Sbjct: 584 KPSNILLGQDMEPKIGDFGLERLLAGDTSYNRASGSSRIFSSKRLTASSREFGTIGPTPS 643
Query: 663 XXXXXXXXXXXXXXXYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
Y APESLR++KPNPKWDV+ FGVILLELLTGK++ +DE+G GNGL
Sbjct: 644 PSPSSVGPISP----YCAPESLRNLKPNPKWDVFGFGVILLELLTGKIVSIDEVGVGNGL 699
Query: 723 LVEDKNXXXXXXXXXXXXXFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP- 781
VED N EGKE+ LL FKLGYSCAS +PQKRP+MKEAL E+ P
Sbjct: 700 TVEDGNRALIMADVAIRSELEGKEDFLLGLFKLGYSCASQIPQKRPTMKEALVVFERYPI 759
Query: 782 --SSPSP-YLYGH 791
S+ SP Y YGH
Sbjct: 760 SSSAKSPSYHYGH 772
|
|
| TAIR|locus:2157182 RLK "receptor-like kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1195 (425.7 bits), Expect = 1.9e-190, Sum P(2) = 1.9e-190
Identities = 248/422 (58%), Positives = 300/422 (71%)
Query: 362 LAVVFFYVYRLIKRKNVESTLKKEANSAKDTVXXXXXXXXXXXRGFTRWSCLRKRG--DG 419
L +VFFY+Y+ KRK V +T K +S V ++W CLRK DG
Sbjct: 352 LGIVFFYIYQSRKRKTVTATSKWSTSSTDSKV--------------SKWYCLRKSVYVDG 397
Query: 420 DEESDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKAS 479
D E + S+ ++ S + V R+ + Q KKGTLV +D +KELE+ETLLKAS
Sbjct: 398 DCEEEEEESETSES-ESDEENPVGPNRRSGL--DDQEKKGTLVNLDSEKELEIETLLKAS 454
Query: 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
AYILGA+GSSIMYKAVL+DGTA+AVRRI E +DRFRDFE QVR +AKL+HPNLVRIRGF
Sbjct: 455 AYILGATGSSIMYKAVLQDGTAVAVRRIAECGLDRFRDFEAQVRAVAKLIHPNLVRIRGF 514
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
YWG DEKL+IYDFVPNGSLANARYRK+GSSPCHLPW+ARLKIAKG+ARGL ++H+KK+VH
Sbjct: 515 YWGSDEKLVIYDFVPNGSLANARYRKVGSSPCHLPWDARLKIAKGIARGLTYVHDKKYVH 574
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLXX 659
GNLKP N+LLG DMEPK+ DFGLE+L+ GD S + GGSA FGSKRST S + F
Sbjct: 575 GNLKPSNILLGLDMEPKVADFGLEKLLIGDMSY-RTGGSAPIFGSKRSTTSLE-FGP--- 629
Query: 660 XXXXXXXXXXXXXXXXXXYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719
Y+APESLRSIKPN KWDVYSFGVILLELLTGK++VVDELGQ
Sbjct: 630 ------SPSPSPSSVGLPYNAPESLRSIKPNSKWDVYSFGVILLELLTGKIVVVDELGQV 683
Query: 720 NGLLVEDKNXXXXXXXXXXXXXFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779
NGL+++D EGKEEA+L+C K+G +CASP+PQ+RP++KEALQ LE+
Sbjct: 684 NGLVIDDGERAIRMADSAIRAELEGKEEAVLACLKMGLACASPIPQRRPNIKEALQVLER 743
Query: 780 IP 781
P
Sbjct: 744 FP 745
|
|
| TAIR|locus:2124296 AT4G34220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1263 (449.7 bits), Expect = 1.3e-152, Sum P(2) = 1.3e-152
Identities = 285/632 (45%), Positives = 373/632 (59%)
Query: 27 QSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDS--RVI 84
Q LNTDGVLLL+FKYS+L+DPL VL +WNY+D PC W GVTC G+ N RV
Sbjct: 23 QLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTCTELGKPNTPDMFRVT 82
Query: 85 GLALPNSQLLGSIPADLGMIEFLQYLDXXXXXXXXXXXXXXXXXXQLRNLDLSNNLISGH 144
L LPN LLGSI DL I +L+ LD +L+++ L +N +SG
Sbjct: 83 SLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNATELQSISLGSNNLSGD 142
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLD 204
LP+++ S+ NLQLLNLS NA G++P++++ L++LT+VSL N FS +PS F + Q+LD
Sbjct: 143 LPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTFSGDIPSGFEAAQILD 202
Query: 205 LSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
LSSNL+NGSLP D+GG SL YLNLS+N++ GEI P F EK P NAT+DLSFNNLTG IP
Sbjct: 203 LSSNLLNGSLPKDLGGKSLHYLNLSHNKVLGEISPNFAEKFPANATVDLSFNNLTGPIPS 262
Query: 265 SNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNXXXXXXXXXXXXXXXXXXXTPA 324
S +NQ++ SFSGN +LCG+P K C IPS+ + PN P
Sbjct: 263 SLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPPNISETTSPAIAVKPRSTAPINPL 322
Query: 325 TNPDDGSVSKPRQEGSQGLRPXXXXXXXXXXXXXXXXLAVVFFYVYRLIKRKNV-ESTL- 382
T KP Q G L+P + ++ YVY++ KR+ ES+
Sbjct: 323 TE-------KPNQTGKSKLKPSTIAAITVADIVGLAFIGLLVLYVYQVRKRRRYPESSKF 375
Query: 383 --------KKEANSAKDTVXXXXXXXXXXXRGFTRWSCLRKRGDGDEESDASVSDVEDNY 434
K EA +K + + T SC+ G +E+ S SDVE+
Sbjct: 376 SFFKFCLEKNEAKKSKPSTTEVTVPESPEAKT-TCGSCIILTGGRYDETSTSESDVENQQ 434
Query: 435 HSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKA 494
+V + D +Q+ + LV VDG+ L+L+TLLKASAYILG +G+ I+YKA
Sbjct: 435 ------TVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAYILGTTGTGIVYKA 488
Query: 495 VLEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552
VLE+GTA AVRRI S + ++FE +VR IAKL HPNLVRIRGF WG DEKL+I D+
Sbjct: 489 VLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFCWGDDEKLLISDY 548
Query: 553 VPNGSL------ANARYRKMGSSPCHLP--WEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
VPNGSL A SS P +EARLKIA+G+ARGL++++EKK VHGN+KP
Sbjct: 549 VPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYINEKKQVHGNIKP 608
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
N+LL + EP I D GL+RL+T S G
Sbjct: 609 NNILLNAENEPIITDLGLDRLMTPARESHTTG 640
|
|
| TAIR|locus:2049108 AT2G15300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.6e-148, Sum P(2) = 4.6e-148
Identities = 279/614 (45%), Positives = 367/614 (59%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDS--RVIGLAL 88
LNTDGV LLSFKYS+L+DPL VL +WNY+DE PCSW GVTC G N RV L L
Sbjct: 24 LNTDGVALLSFKYSILNDPLLVLRNWNYDDETPCSWTGVTCTELGIPNTPDMFRVTSLVL 83
Query: 89 PNSQLLGSIPADLGMIEFLQYLDXXXXXXXXXXXXXXXXXXQLRNLDLSNNLISGHLPET 148
PN QLLGS+ DL I L+ LD +LR L L NN +SG LP +
Sbjct: 84 PNKQLLGSVSPDLFSILHLRILDLSDNFFHGSLPDSVSNASELRILSLGNNKVSGELPRS 143
Query: 149 MGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208
+ ++ +LQLLNLS NAL GK+P +L+ ++LT++SL N FS +PS F +VQVLD+SSN
Sbjct: 144 ISNVASLQLLNLSANALTGKIPPNLSLPKNLTVISLAKNSFSGDIPSGFEAVQVLDISSN 203
Query: 209 LINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVF 268
L++GSLPPD G SL YLNLS N++SG I P F EK P +A IDLSFNNLTG IP +
Sbjct: 204 LLDGSLPPDFRGTSLLYLNLSNNQISGMISPPFAEKFPASAIIDLSFNNLTGPIPNTPPL 263
Query: 269 MNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNXXXXXXXXXXXXXXXXXXXTPATNPD 328
+NQ++ SFSGN+ LCGQP K C IPS+ D PN TP P
Sbjct: 264 LNQKTESFSGNIGLCGQPLKTLCSIPSTLSDPPNISETTSPAIAVMPT-----TPT--PT 316
Query: 329 DGSVSKPRQEGSQGLRPXXXXXXXXXXXXXXXXLAVVFFYVYRLIKRKNVE--STLK--K 384
+ S Q L+P +A+ Y+Y+L KR++ + ST +
Sbjct: 317 NSSTESTNQTAKSKLKPSTIIGITLADIAGLAIIAMFILYIYQLKKRRSYQEYSTFNVLQ 376
Query: 385 EANSAKDTVXXXXXXXXXXXR-GFTRWSCLRKRGDGD-----EESDASVSDVEDNYHSGR 438
+ DT+ FT+ S K G G E SVS E + + +
Sbjct: 377 KCLEKNDTLSVKKSKHNVADALEFTK-SPPAKMGCGSWISRRYEETTSVSS-ESDIENQK 434
Query: 439 KLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSS-IMYKAVLE 497
+ ++ V + N + LV VDG+ +LEL+TLLKASAY+LG + S I+YKAVLE
Sbjct: 435 PVEAFDRTGGGRV--KHNTETQLVTVDGETQLELDTLLKASAYVLGTNRSDGIVYKAVLE 492
Query: 498 DGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
+G A AVRRIG S +F++FE +V+ IAKL HPNLVR+RGF WG +EKL+I D+VPN
Sbjct: 493 NGAAFAVRRIGAESCPAAKFKEFEKEVQGIAKLRHPNLVRVRGFVWGKEEKLLISDYVPN 552
Query: 556 GSLANARYRKMGSSPCHLP--WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
G+L + SS H P +EARLK+A+G+ARG+A++H+KKHVHGN+K N+LL ++
Sbjct: 553 GNLPLSSISAKSSSFSHKPLSFEARLKLARGIARGIAYIHDKKHVHGNIKANNILLDSEF 612
Query: 614 EPKIGDFGLERLVT 627
EP I D GL+R++T
Sbjct: 613 EPVITDMGLDRIMT 626
|
|
| TAIR|locus:2038706 AT2G01210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 3.4e-111, Sum P(2) = 3.4e-111
Identities = 137/332 (41%), Positives = 195/332 (58%)
Query: 461 LVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFET 520
+V +D LE LLKASA++LG SG I+YK VLE+G LAVRR+GE RF++F+T
Sbjct: 388 IVPLDAQVAFNLEELLKASAFVLGKSGIGIVYKVVLENGLTLAVRRLGEGGSQRFKEFQT 447
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSP-CHLPWEARL 579
+V I KL HPN+ +R +YW VDEKL+IYD+V NG+LA A + K G L W RL
Sbjct: 448 EVEAIGKLKHPNIASLRAYYWSVDEKLLIYDYVSNGNLATALHGKPGMMTIAPLTWSERL 507
Query: 580 KIAKGVARGLAFLHE---KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
+I KG+A GL +LHE KK+VHG+LKP N+L+G DMEPKI DFGL RL ++ AG
Sbjct: 508 RIMKGIATGLVYLHEFSPKKYVHGDLKPSNILIGQDMEPKISDFGLARL------ANIAG 561
Query: 637 GSARNFGSKRSTASRDSFQDLXXXXXXXXXXXXXXXXXXXXYH-APESLRSIKPNPKWDV 695
GS+ S R + Q+ Y+ APE+L+ +KP+ KWDV
Sbjct: 562 GSSPTIQSNRIIQTDQQPQERQQHHHKSVSSEFTAHSSSGSYYQAPETLKMVKPSQKWDV 621
Query: 696 YSFGVILLELLTGKVIVVD------ELGQGNGLLVEDKNXXXXXXXXXXXXXFEGKEEAL 749
YS+G+ILLEL+ G+ V+ +L + + +E+K E ++E +
Sbjct: 622 YSYGIILLELIAGRSPAVEVGTSEMDLVRWVQVCIEEKKPLCDVLDPCLAPEAETEDE-I 680
Query: 750 LSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781
++ K+ SC + P+KRP+M+ L+++P
Sbjct: 681 VAVLKIAISCVNSSPEKRPTMRHVSDTLDRLP 712
|
|
| TAIR|locus:2033000 AT1G25320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 2.8e-103, Sum P(2) = 2.8e-103
Identities = 136/331 (41%), Positives = 192/331 (58%)
Query: 461 LVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFET 520
LV++D L+L+ LLKASA++LG G+ I+YK VLEDG +AVRR+GE R ++F+T
Sbjct: 389 LVLLDKHIALDLDELLKASAFVLGKGGNGIVYKVVLEDGLTVAVRRLGEGGSQRCKEFQT 448
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS-SPCHLPWEARL 579
+V I KL HPN+V ++ +YW V+EKL+IYD++PNGSL NA + G S L W RL
Sbjct: 449 EVEAIGKLRHPNIVSLKAYYWSVEEKLLIYDYIPNGSLTNALHGNPGMVSFKPLSWGVRL 508
Query: 580 KIAKGVARGLAFLHE---KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
KI +G++RGL +LHE KK+VHG+LK N+LLG DMEP I DFGL L SS AG
Sbjct: 509 KIMRGISRGLVYLHEFSPKKYVHGSLKLSNILLGQDMEPHISDFGLMHL------SSIAG 562
Query: 637 GSARNFGSKRSTASRDSFQDLXXXXXXXXXXXXXXXXXXXXYHAPESLRS-IKPNPKWDV 695
+ +T R S + Y APE+ ++ +KP+ KWDV
Sbjct: 563 TL------ESTTVDRPSNK--------TASSIGSSANLSSFYLAPEATKATVKPSQKWDV 608
Query: 696 YSFGVILLELLTGKVIVVD------ELGQGNGLLVEDKNXXXXXXXXXXXXXFEGKEEAL 749
YSFGVILLE++TG++ +V E+ + + +++K EE +
Sbjct: 609 YSFGVILLEMITGRLPIVFVGKSEMEIVKWIQMCIDEKKEMSDILDPYLVPNDTEIEEEV 668
Query: 750 LSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
++ K+ +C S P+KRP MK AL +I
Sbjct: 669 IAVLKIAMACVSTSPEKRPPMKHIADALTQI 699
|
|
| TAIR|locus:2008793 AT1G67510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
Identities = 137/350 (39%), Positives = 188/350 (53%)
Query: 452 HERQNKKGT--LVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGE 509
+ER KG LV +D EL+ LL+ASAY+LG SG I+YK VL +G +AVRR+GE
Sbjct: 383 NERGEGKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAVRRLGE 442
Query: 510 NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSS 569
R+++F T+V+ + K+ HPN+V++R +YW DEKL+I DFV NGSLA+A + G
Sbjct: 443 GGEQRYKEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFVNNGSLADALRGRNGQP 502
Query: 570 PCHLPWEARLKIAKGVARGLAFLHE---KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
L W R+KIAKG ARGLA+LHE +K VHG++KP N+LL + P I DFGL RL+
Sbjct: 503 SPSLTWSTRIKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLDSSFTPYISDFGLTRLI 562
Query: 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLXXXXXXXXXXXXXXXXXXXXYHAPES-LR 685
T +S+ + N S S A F Y APE+ L
Sbjct: 563 TITAASASS-----NEPSSSSAAG--GF-----LGGALPYTSIKPSDRSNGYKAPEARLP 610
Query: 686 SIKPNPKWDVYSFGVILLELLTGK---------------VIVVDELGQGNGLLVEDKNXX 730
+P KWDVYSFGV+L+ELLTGK V+ V +L + E++
Sbjct: 611 GGRPTQKWDVYSFGVVLMELLTGKSPDSSPLSSSSTSTVVVEVPDLVKWVRKGFEEETPL 670
Query: 731 XXXXXXXXXXXFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
K++ +LS F L +C P+ RP MK + ++KI
Sbjct: 671 SDMVDPMLLQEVHAKQQ-VLSVFHLALACTEGDPEVRPRMKNVSENIDKI 719
|
|
| TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 1.4e-91, Sum P(3) = 1.4e-91
Identities = 102/267 (38%), Positives = 149/267 (55%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPN 90
LN G+ LLSFK S+ + V +WN +D NPCSW GVTC N D RV+ + LPN
Sbjct: 22 LNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTC------NYDMRVVSIRLPN 75
Query: 91 SQLLGSIPADLGMIEFLQYLDXXXXXXXXXXXXXXXXXXQLRNLDLSNNLISGHLPETMG 150
+L GS+ +G + L++++ L++L LS N SG +PE +G
Sbjct: 76 KRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSGNSFSGFVPEEIG 135
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNS----VQVLDLS 206
SL +L L+LS+N+ G + +SL + L + L N FS LP+ S ++ L+LS
Sbjct: 136 SLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLGSNLVHLRTLNLS 195
Query: 207 SNLINGSLPPDIGGY-SLR-YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
N + G++P D+G +L+ L+LS+N SG IP G +P +DLS+NNL+G IP+
Sbjct: 196 FNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGN-LPELLYVDLSYNNLSGPIPK 254
Query: 265 SNVFMNQESSSFSGNLDLCGQPTKNPC 291
NV +N ++F GN LCG P K C
Sbjct: 255 FNVLLNAGPNAFQGNPFLCGLPIKISC 281
|
|
| TAIR|locus:2095773 AT3G57830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 5.0e-69, Sum P(2) = 5.0e-69
Identities = 124/356 (34%), Positives = 185/356 (51%)
Query: 449 DHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDG--------- 499
D + + K+G V++D ELELE LL+ASAY++G S S I+Y+ V G
Sbjct: 320 DDAADEEEKEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFT 379
Query: 500 --TALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
T +AVRR+ + R +DFE +V I+++ HPN+VR+R +Y+ DE+L+I D++ NG
Sbjct: 380 SSTVVAVRRLSDGDATWRRKDFENEVEAISRVQHPNIVRLRAYYYAEDERLLITDYIRNG 439
Query: 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---KKHVHGNLKPRNVLLGNDM 613
SL +A + ++ L W RL IA+G ARGL ++HE +K+VHGNLK +LL +++
Sbjct: 440 SLYSALHGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDDEL 499
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLXXXXXXXXXXXXXXXX 673
P+I FGL RLV+G SK GS +A+R Q L
Sbjct: 500 LPRISGFGLTRLVSG---YSKLIGSL--------SATR---QSLDQTYLTSATTVTRITA 545
Query: 674 XXXXYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNXXX 731
Y APE+ S K + K DVYSFGV+L+ELLTG++ G L+ +N
Sbjct: 546 PTVAYLAPEARASSGCKLSQKCDVYSFGVVLMELLTGRLPNASSKNNGEELVRVVRNWVK 605
Query: 732 XXXXXXXXXXFE--GKEEA---LLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782
E K A +++ + +C P+ RP M+ ++L +I S
Sbjct: 606 EEKPLSEILDPEILNKGHADKQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRIKS 661
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGS3 | Y4372_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6151 | 0.9443 | 0.9726 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 791 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-26 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-13 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.002 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.003 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.003 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.004 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-39
Identities = 100/271 (36%), Positives = 151/271 (55%), Gaps = 23/271 (8%)
Query: 37 LLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGS 96
LLLSFK S ++DPL L +WN + + C W G+TC NN SRV+ + L + G
Sbjct: 33 LLLSFKSS-INDPLKYLSNWN-SSADVCLWQGITC------NNSSRVVSIDLSGKNISGK 84
Query: 97 IPADLGMIEFLQYLDLSNNSLNGSLSFSLFN-ASQLRNLDLSNNLISGHLPETMGSLHNL 155
I + + + ++Q ++LSNN L+G + +F +S LR L+LSNN +G +P GS+ NL
Sbjct: 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL 142
Query: 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP---SKFNSVQVLDLSSNLING 212
+ L+LS+N L+G++P + + SL ++ L N +P + S++ L L+SN + G
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202
Query: 213 SLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQ 271
+P ++G SL+++ L YN LSGEIP + G +N +DL +NNLTG IP S +
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH-LDLVYNNLTGPIPSSLGNLKN 261
Query: 272 ESSSFSGNLDLCGQPTKNPCPIPSSPFDLPN 302
F L G PIP S F L
Sbjct: 262 LQYLFLYQNKLSG-------PIPPSIFSLQK 285
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LG G +Y A + G +A++ I E+S + ++ ++ KL HPN+V++ G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+ ++ ++ GSL + L + L+I + GL +LH +H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 601 NLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP N+LL +D + K+ DFGL ++ S +S
Sbjct: 117 DLKPENILLDSDNGKVKLADFGL----------------SKLLTSDKSL----------- 149
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLEL 705
++ G Y APE L + K D++S GVIL EL
Sbjct: 150 ---------LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 80/300 (26%), Positives = 118/300 (39%), Gaps = 55/300 (18%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIR 537
LG+ +YKA G +AV+ + E S ++R++ +L HPN+VR+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLI 64
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ D ++ ++ G L + R L + KIA + RGL +LH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H +LKP N+LL + KI DFGL + +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK----------------------------- 150
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDEL 716
S S ++ G Y APE L PK DV+S GVIL ELLTGK
Sbjct: 151 -------SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF---- 199
Query: 717 GQGNGLLVEDKNRAIRLA-DAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+G + D+ + IR + D L C + P KRP+ +E LQ
Sbjct: 200 ---SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-28
Identities = 82/229 (35%), Positives = 119/229 (51%), Gaps = 35/229 (15%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L + L G IP+ LG ++ LQYL L N L+G + S+F+ +L +LDLS+N +SG +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS---KFNSVQV 202
PE + L NL++L+L N GK+PV+LT+L L ++ L +N FS +P K N++ V
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 203 LDLS------------------------SNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237
LDLS SN + G +P +G SLR + L N SGE+
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 238 PPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQ------ESSSFSGNL 280
P +F K+P+ +D+S NNL G I M + F G L
Sbjct: 421 PSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 56/194 (28%), Positives = 82/194 (42%), Gaps = 43/194 (22%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
+F + R++ KL HPN+V++ G + I+ +++ G L + RK L
Sbjct: 46 EEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL-LSYLRKNRP---KLSL 101
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
L A +ARG+ +L K +H +L RN L+G ++ KI DFGL R + D K
Sbjct: 102 SDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR 161
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKW 693
GG P APESL+ K K
Sbjct: 162 GGK-------------------------------------LPIRWMAPESLKEGKFTSKS 184
Query: 694 DVYSFGVILLELLT 707
DV+SFGV+L E+ T
Sbjct: 185 DVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 69/211 (32%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 88 LPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE 147
L ++ G +P++ + + +LD+SNN+L G ++ ++ L+ L L+ N G LP+
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQ---VLD 204
+ GS L+ L+LS N +G +P L +L L + L N S +P + +S + LD
Sbjct: 471 SFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
Query: 205 LSSNLINGSLPPDIGGYS-LRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIP 263
LS N ++G +P L L+LS N+LSGEIP G + +++S N+L G +P
Sbjct: 530 LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG-NVESLVQVNISHNHLHGSLP 588
Query: 264 ESNVFMNQESSSFSGNLDLCGQPTKN---PC 291
+ F+ +S+ +GN+DLCG T + PC
Sbjct: 589 STGAFLAINASAVAGNIDLCGGDTTSGLPPC 619
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 84/305 (27%), Positives = 123/305 (40%), Gaps = 72/305 (23%)
Query: 492 YKAVLEDG----TALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEK 546
YK L+ T +AV+ + E++ + R DF + RV+ KL HPN+VR+ G +
Sbjct: 12 YKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL 71
Query: 547 LIIYDFVPNGSL----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
++ +++ G L +R L + L A +A+G+ +L KK VH +L
Sbjct: 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RN L+G D+ KI DFGL R V D K
Sbjct: 132 AARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-------------------------- 165
Query: 663 PSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG- 719
GG P APESL+ K DV+SFGV+L E+ T LG
Sbjct: 166 ----------GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATP 207
Query: 720 -NGLLVEDKNRAIRLADAAIRADFEGKE-EALLSC----FKLGYSCASPLPQKRPSMKEA 773
GL E+ +R +G C ++L SC P+ RP+ E
Sbjct: 208 YPGLSNEEVLEYLR----------KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
Query: 774 LQALE 778
++ LE
Sbjct: 258 VERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/194 (28%), Positives = 82/194 (42%), Gaps = 42/194 (21%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
+F + R++ KL HPN+V++ G + +I+ +++P G L RK L
Sbjct: 46 EEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL-LDYLRKNRPKE--LSL 102
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
L A +ARG+ +L K +H +L RN L+G ++ KI DFGL R + D
Sbjct: 103 SDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK 162
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKW 693
GG P APESL+ K K
Sbjct: 163 -------------------------------------GGKLPIRWMAPESLKEGKFTSKS 185
Query: 694 DVYSFGVILLELLT 707
DV+SFGV+L E+ T
Sbjct: 186 DVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 71/305 (23%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGF 539
LG +Y A + G +A++ I + + + R +++++ KL HPN+VR+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ D+ ++ ++ G L + +K G EAR + + L +LH K VH
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFD-LLKKRGRLS---EDEAR-FYLRQILSALEYLHSKGIVH 120
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP N+LL D K+ DFGL R + + G+
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTP-------------------- 160
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK---------V 710
Y APE L D++S GVIL ELLTGK +
Sbjct: 161 -----------------EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL 203
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770
+ ++G+ ++ A D + P+KR +
Sbjct: 204 ELFKKIGKPK---PPFPPPEWDISPEAK--DL------IRKLLV-------KDPEKRLTA 245
Query: 771 KEALQ 775
+EALQ
Sbjct: 246 EEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 492 YKAVL-----EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDE 545
YK L T +AV+ + E + + +F + ++ KL HPN+VR+ G +
Sbjct: 16 YKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEP 75
Query: 546 KLIIYDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
I+ +++P G L + + RK G L + L++A +A+G+ +L K VH +L
Sbjct: 76 LYIVTEYMPGGDLLD--FLRKHGE---KLTLKDLLQMALQIAKGMEYLESKNFVHRDLAA 130
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
RN L+ ++ KI DFGL R + D K G
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---------------------------- 162
Query: 665 PSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLTG 708
GG P APESL+ K K DV+SFGV+L E+ T
Sbjct: 163 --------GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 32/209 (15%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L +++ G IP +LG L LDLS N+L G + L ++ L L L +N + G +
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQ------------------------SLTI 181
P+++G+ +L+ + L DN+ +G+LP T L SL +
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM 456
Query: 182 VSLKNNYFSDGLPSKFNSVQV--LDLSSNLINGSLPPDIGGYS-LRYLNLSYNRLSGEIP 238
+SL N F GLP F S ++ LDLS N +G++P +G S L L LS N+LSGEIP
Sbjct: 457 LSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
Query: 239 PQFG--EKIPVNATIDLSFNNLTGEIPES 265
+ +K+ ++DLS N L+G+IP S
Sbjct: 517 DELSSCKKL---VSLDLSHNQLSGQIPAS 542
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 72/197 (36%), Positives = 114/197 (57%), Gaps = 7/197 (3%)
Query: 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRN 133
P N + + L L ++QL+G IP +LG ++ L+++ L N+L+G + + + + L +
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 134 LDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL 193
LDL N ++G +P ++G+L NLQ L L N L+G +P S+ +LQ L + L +N S +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 194 PS---KFNSVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNA 249
P + ++++L L SN G +P + L+ L L N+ SGEIP G+ N
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH--NNL 358
Query: 250 TI-DLSFNNLTGEIPES 265
T+ DLS NNLTGEIPE
Sbjct: 359 TVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 482 ILGASGSSIMYKAVLED-GTALAVR--RIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG 538
+LG +Y A+ +D G +AV+ + +S + E ++R+++ L HPN+VR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 539 FYWGVDEK--LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI-AKGVARGLAFLHEK 595
++ I ++V GSL++ + LP E ++ + + GLA+LH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-----LP-EPVIRKYTRQILEGLAYLHSN 120
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
VH ++K N+L+ +D K+ DFG +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFG--------CAKRLGDIETGEGTG----------- 161
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
S+ G + APE +R + D++S G ++E+ TGK
Sbjct: 162 ---------------SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 80/306 (26%), Positives = 129/306 (42%), Gaps = 69/306 (22%)
Query: 483 LGASGSSIMYKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG--- 538
LG +Y+ V + +AV+ + E+++ +F + V+ ++ HPNLV++ G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 539 ----FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
FY II +F+ G+L + R+ + L +A ++ + +L +
Sbjct: 73 REPPFY-------IITEFMTYGNLLDY-LRECNRQ--EVNAVVLLYMATQISSAMEYLEK 122
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
K +H +L RN L+G + K+ DFGL RL+TGDT ++ AG F K
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA---KFPIK--------- 170
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714
+ APESL K + K DV++FGV+L E+ T +
Sbjct: 171 -----------------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
Query: 715 --ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772
+L Q LL + R+ E E ++L +C P RPS E
Sbjct: 208 GIDLSQVYELL----EKGYRM---------ERPEGCPPKVYELMRACWQWNPSDRPSFAE 254
Query: 773 ALQALE 778
QA E
Sbjct: 255 IHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 30/212 (14%)
Query: 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141
++I L L ++ L G IP + ++ L+ L L +N+ G + +L + +L+ L L +N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 142 SGHLPETMGSLHNLQLLNLSDNALAGKL------------------------PVSLTTLQ 177
SG +P+ +G +NL +L+LS N L G++ P SL +
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 178 SLTIVSLKNNYFSDGLPSKFNSVQV---LDLSSNLINGSLPPDIGGY-SLRYLNLSYNRL 233
SL V L++N FS LPS+F + + LD+S+N + G + SL+ L+L+ N+
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 234 SGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
G +P FG K N +DLS N +G +P
Sbjct: 465 FGGLPDSFGSKRLEN--LDLSRNQFSGAVPRK 494
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-18
Identities = 45/125 (36%), Positives = 72/125 (57%), Gaps = 13/125 (10%)
Query: 56 WNYNDENPCS-----WNGVTCASPGEGNNDSR--VIGLALPNSQLLGSIPADLGMIEFLQ 108
WN +PC W+G C + + + GL L N L G IP D+ + LQ
Sbjct: 392 WN---GDPCVPQQHPWSGADCQF---DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445
Query: 109 YLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGK 168
++LS NS+ G++ SL + + L LDLS N +G +PE++G L +L++LNL+ N+L+G+
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 169 LPVSL 173
+P +L
Sbjct: 506 VPAAL 510
|
Length = 623 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 65/282 (23%)
Query: 503 AVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK----LIIYDFVPNGSL 558
A++ I E ++ DF + +V+ KL HPNLV++ +GV K I+ +++ NG L
Sbjct: 32 AIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQL----YGVCTKQRPIFIVTEYMANGCL 86
Query: 559 AN---ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615
N R K+G+ E L + V + +L +H +L RN L+G D
Sbjct: 87 LNYLRERKGKLGT-------EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVV 139
Query: 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI 675
K+ DFGL R V D +S G F K +
Sbjct: 140 KVSDFGLARYVLDDQYTSSQGT---KFPVKWA---------------------------- 168
Query: 676 SPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLAD 735
PE + + K DV+SFGV++ E+ + + + N +VE + RL
Sbjct: 169 ----PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE--RFSNSEVVESVSAGYRL-- 220
Query: 736 AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
+ A + + YSC P+ RP+ K+ L L
Sbjct: 221 -------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 483 LGASGSSIMYKA-VLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G G +YKA G +A++ I S ++ +++++ K HPN+V+ G Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
DE I+ +F GSL + + S+ L + K + +GL +LH +H +
Sbjct: 68 KKDELWIVMEFCSGGSLKDL----LKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRD 123
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+LL +D E K+ DFGL SA+
Sbjct: 124 IKAANILLTSDGEVKLIDFGL---------------SAQL-------------------- 148
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
S + + +++ G + APE + + K D++S G+ +EL GK
Sbjct: 149 --SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.9 bits (211), Expect = 7e-18
Identities = 67/314 (21%), Positives = 106/314 (33%), Gaps = 39/314 (12%)
Query: 483 LGASGSSIMYKAVLEDGTAL-AVRRIGENSVDRFRDFETQVRVIAKLVHP-NLVRIRGFY 540
LG +Y A AL + + E+ F +++++A L HP N+V++ F+
Sbjct: 8 LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
++ ++V GSL K L L I + L +LH K +H
Sbjct: 68 QDEGSLYLVMEYVDGGSLE--DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125
Query: 601 NLKPRNVLLG-NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++KP N+LL + K+ DFGL +L+ S+S P
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS-----------------------IP 162
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSI---KPNPKWDVYSFGVILLELLTGKVIVVDEL 716
+ +P Y APE L + + D++S G+ L ELLTG E
Sbjct: 163 ALPSTSVGTP-------GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL-Q 775
+ A E + L + P+ R S L
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 776 ALEKIPSSPSPYLY 789
L L
Sbjct: 276 DLLAHLKLKESDLS 289
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 49/220 (22%)
Query: 496 LEDGTA--LAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW--GVDEKLIIYD 551
L+D T +AV+++ ++ + RDFE ++ ++ L H N+V+ +G + G ++ +
Sbjct: 28 LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 552 FVPNGSL----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
++P GSL R R + + +G+ +L K++VH +L RN+
Sbjct: 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEYLGSKRYVHRDLATRNI 139
Query: 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSP 667
L+ ++ KIGDFGL +++ D ++ ++ PG SP
Sbjct: 140 LVESENRVKIGDFGLTKVLPQD---------------------KEYYKVREPGESP---- 174
Query: 668 SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
I Y APESL K + DV+SFGV+L EL T
Sbjct: 175 -------IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 43/196 (21%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLAN--ARYRKMGSSPC 571
DFE ++ ++ L H N+V+ +G + +I +++P+GSL + R+R +
Sbjct: 51 SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK- 109
Query: 572 HLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631
L + + +G+ +L ++++H +L RN+L+ ++ KI DFGL +++ D
Sbjct: 110 -----RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-- 162
Query: 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP 691
+D + PG SP I Y APE LR+ K +
Sbjct: 163 -------------------KDYYYVKEPGESP-----------IFWY-APECLRTSKFSS 191
Query: 692 KWDVYSFGVILLELLT 707
DV+SFGV L EL T
Sbjct: 192 ASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 76/301 (25%), Positives = 124/301 (41%), Gaps = 70/301 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRGFY 540
GA G +YK + LE G +A+++I + + ++ ++ L HPN+V+ G
Sbjct: 11 GAFGV--VYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI 68
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVA---RGLAFLHEKKH 597
D II ++ NGSL +K G P L +A V +GLA+LHE+
Sbjct: 69 ETSDSLYIILEYAENGSLRQ-IIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQGV 120
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H ++K N+L D K+ DFG+ +K + S+D +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGV--------------------ATKLNDVSKDDASVV 160
Query: 658 GPGPSPSPSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
G +PY APE + + D++S G ++ELLTG D L
Sbjct: 161 G-----------------TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD-L 202
Query: 717 GQGNGL--LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774
L +V+D + + + DF L+ CF+ P RP+ K+ L
Sbjct: 203 NPMAALFRIVQDDHPPLPEGISPELKDF------LMQCFQKD-------PNLRPTAKQLL 249
Query: 775 Q 775
+
Sbjct: 250 K 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 51/295 (17%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+G+ +++ + +A++ I E ++ DF + +V+ KL HP LV++ G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
++++F+ +G L++ + G E L + V G+A+L +H +L
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RN L+G + K+ DFG+ R V D +S G F K S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG---TKFPVKWS--------------- 168
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+PE K + K DV+SFGV++ E+ + + + N
Sbjct: 169 -----------------SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN--RSNSE 209
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
+VE N RL + A S ++L C P+ RPS L L
Sbjct: 210 VVETINAGFRLYKPRL---------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 53/278 (19%)
Query: 502 LAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN- 560
+A++ I E S+ +F + +V+ KL H LV++ G I+ +++ NG L N
Sbjct: 31 VAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620
R P L L++ K V G+A+L K+ +H +L RN L+ + K+ DF
Sbjct: 90 LREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDF 144
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
GL R V D +S G F + S
Sbjct: 145 GLSRYVLDDEYTSSVGS---KFPVRWS--------------------------------P 169
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRA 740
PE L K + K DV++FGV++ E+ + + + N VE ++ +RL + +
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--NNSETVEKVSQGLRLYRPHLAS 227
Query: 741 DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778
+ + + YSC ++RP+ ++ L ++E
Sbjct: 228 E---------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRG-F 539
LG S ++YK G A+++I + + FR +++ + P +V+ G F
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 540 YWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH- 597
Y + ++ I+ +++ GSLA+ + +P IA+ + +GL +LH K+H
Sbjct: 69 Y--KEGEISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H ++KP N+L+ + E KI DFG+ +++ + ++F
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLE------------------NTLDQCNTFV-- 161
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G Y +PE ++ + D++S G+ LLE GK
Sbjct: 162 ----------------GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 53/294 (18%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
LGA +++ + + T +AV+ + ++D +DF + +++ KL HP L+++
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ + + GSL G + LP + +A VA G+A+L + ++H +L
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA-LKLP--QLIDMAAQVASGMAYLEAQNYIHRDL 129
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RNVL+G + K+ DFGL R++ D ++ G F K
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGA---KFPIK----------------- 169
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNG 721
+ APE+ + + K DV+SFG++L E++T G++ G N
Sbjct: 170 ---------------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP---GMTNA 211
Query: 722 LLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+++ ++ R+ G + L + + C P RP+ E LQ
Sbjct: 212 EVLQQVDQGYRMPCP------PGCPKEL---YDIMLDCWKEDPDDRPTF-ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 40/212 (18%)
Query: 500 TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559
T +AV+ + ++ F + +++ KL H LV++ + I+ +++ GSL
Sbjct: 31 TKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619
+ + K G L + +A +A G+A+L + ++H +L RN+L+G ++ KI D
Sbjct: 90 D--FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIAD 146
Query: 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH 679
FGL RL+ D +++ G A+ F K +
Sbjct: 147 FGLARLIEDDEYTAREG--AK-FPIK--------------------------------WT 171
Query: 680 APESLRSIKPNPKWDVYSFGVILLELLT-GKV 710
APE+ + K DV+SFG++L E++T G+V
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 58/229 (25%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551
++ + ++ +A++ + + + + +DF+ +V+ + +L H +L+ + + II +
Sbjct: 23 WEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82
Query: 552 FVPNGSL----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
+ GSL + + + + + +A VA G+A+L E+ +H +L RN+
Sbjct: 83 LMEKGSLLAFLRSPEGQVLPVASL-------IDMACQVAEGMAYLEEQNSIHRDLAARNI 135
Query: 608 LLGNDMEPKIGDFGLERLVTGD---TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
L+G D+ K+ DFGL RL+ D +S K
Sbjct: 136 LVGEDLVCKVADFGLARLIKEDVYLSSDKKI----------------------------- 166
Query: 665 PSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV 710
PY APE+ + K DV+SFG++L E+ T G+V
Sbjct: 167 ------------PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 51/159 (32%), Positives = 70/159 (44%), Gaps = 45/159 (28%)
Query: 134 LDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL 193
L L N + G +P + L +LQ +NLS N++ G +P SL ++ SL
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL-------------- 468
Query: 194 PSKFNSVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATID 252
+VLDLS N NGS+P +G SLR LNL+ N LSG +P G + ++
Sbjct: 469 -------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR-LLHRA-- 518
Query: 253 LSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPC 291
SFN F+ N LCG P C
Sbjct: 519 -SFN-------------------FTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 69/263 (26%), Positives = 107/263 (40%), Gaps = 65/263 (24%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARY-RKMGSSPCHLPWEARLKIA 582
V+ L HPNLV++ G + I+ +++ GSL + Y R G + + +L A
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD--YLRSRGRA--VITLAQQLGFA 108
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNF 642
V G+ +L EK VH +L RNVL+ D+ K+ DFGL
Sbjct: 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL-------------------- 148
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
++++ Q G P + APE+LR K + K DV+SFG++L
Sbjct: 149 -------AKEASQGQDSGKLP------------VKWTAPEALREKKFSTKSDVWSFGILL 189
Query: 703 LELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGY 757
E+ + G+V I L D + + EA C +K+
Sbjct: 190 WEIYSFGRV----------------PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233
Query: 758 SCASPLPQKRPSMKEALQALEKI 780
C P KRP+ K+ + L I
Sbjct: 234 DCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 53/277 (19%)
Query: 502 LAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANA 561
+A++ I E ++ DF + +V+ KL HP LV++ G I+ +F+ NG L N
Sbjct: 31 VAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 562 RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621
++ G L + L + + V G+ +L +H +L RN L+ + K+ DFG
Sbjct: 90 LRQRQG----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG 145
Query: 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAP 681
+ R V D +S +G F K S P
Sbjct: 146 MTRYVLDDEYTSSSGA---KFPVKWS--------------------------------PP 170
Query: 682 ESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRA 740
E K + K DV+SFGV++ E+ T GK+ + N +VE +R RL +
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEMISRGFRLYRPKL-- 225
Query: 741 DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
A ++ +++ YSC P+ RP+ E L+A+
Sbjct: 226 -------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 55/238 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVR--RIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
G G +Y AV L+ G +AV+ RI +N ++ +++V+ L HPNLV+ Y
Sbjct: 11 GTFGK--VYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK----Y 64
Query: 541 WGV---DEKLIIY-DFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+GV EK+ I+ ++ G+L + ++ L + GLA+LH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRI------LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
VH ++KP N+ L ++ K+GDFG + K +T + Q
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFG---------CAVKL--------KNNTTTMGEEVQ 161
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW---DVYSFGVILLELLTGKV 710
SL G Y APE + K D++S G ++LE+ TGK
Sbjct: 162 ---------------SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 497 EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
D +AV+ + E + + R DFE + ++ H N+V+ G D +++++++ +
Sbjct: 33 NDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEH 92
Query: 556 GSLAN---------ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
G L A + S L L+IA +A G+ +L + VH +L RN
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN 152
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
L+G D+ KIGDFG+ R V T + GG
Sbjct: 153 CLVGYDLVVKIGDFGMSRDVY-TTDYYRVGGHT--------------------------- 184
Query: 667 PSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT-GK 709
+ P + PES+ K + DV+SFGV+L E+ T GK
Sbjct: 185 --------MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 18/146 (12%)
Query: 497 EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
E T +AV+ + E S D DF+ + ++A+ HPN+V++ G ++++++
Sbjct: 33 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAY 92
Query: 556 GSLAN-----------------ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
G L + RK G +P L +L IAK VA G+A+L E+K V
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLER 624
H +L RN L+G +M KI DFGL R
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 5e-14
Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 39/189 (20%)
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
V+++ KL HPN+++ + + I+ ++ G L + + +K P E L
Sbjct: 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDL-SQKIKKQKKEGKPFPEEQILDW 108
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
+ L +LH +K +H ++KP+N+ L ++ K+GDFG+ ++++ +K
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK------- 161
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGV 700
+ +G +PY+ +PE ++ N K D++S G
Sbjct: 162 ----------------------------TVVG--TPYYLSPELCQNKPYNYKSDIWSLGC 191
Query: 701 ILLELLTGK 709
+L EL T K
Sbjct: 192 VLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 70/268 (26%), Positives = 103/268 (38%), Gaps = 59/268 (22%)
Query: 527 KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVA 586
KL HPN+V++ G +I++++ +L+ +L WE R KIA G+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIA 790
Query: 587 RGLAFLH---EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFG 643
+ L FLH V GNL P +++ EP + L L+ DT +
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFIS-------- 841
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703
S Y APE+ + K D+Y FG+IL+
Sbjct: 842 --------------------------------SAYVAPETRETKDITEKSDIYGFGLILI 869
Query: 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIR------LADAAIRADFEGKEEALLSCFKLGY 757
ELLTGK E G +G +VE D +IR D + ++ L
Sbjct: 870 ELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928
Query: 758 SCASPLPQKRPSMKEALQALEKIPSSPS 785
C + P RP + L+ LE S S
Sbjct: 929 HCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-14
Identities = 41/115 (35%), Positives = 67/115 (58%)
Query: 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140
R+ L L +Q G++P LG + L L LS N L+G + L + +L +LDLS+N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 141 ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
+SG +P + + L L+LS N L+G++P +L ++SL V++ +N+ LPS
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 51/195 (26%), Positives = 79/195 (40%), Gaps = 45/195 (23%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGV--DEKL-IIYDFVPNGSLA-NARYRKMGSSPCH 572
DF + ++ L H NL+R+ +GV L ++ + P GSL R +G
Sbjct: 42 DFLKEAAIMHSLDHENLIRL----YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLIS 97
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
+ ++IA G + +L K+ +H +L RN+LL +D + KIGDFGL
Sbjct: 98 TLCDYAVQIANG----MRYLESKRFIHRDLAARNILLASDDKVKIGDFGL---------- 143
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692
+A + P + APESLR+ +
Sbjct: 144 MRALPQNEDH-------YVMEEHLKVP----------------FAWCAPESLRTRTFSHA 180
Query: 693 WDVYSFGVILLELLT 707
DV+ FGV L E+ T
Sbjct: 181 SDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 530 HPNLVRIRGFYWGVDEKLI--IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR 587
HP ++++ +Y DE+ + + ++ PNG L RK GS R A+ +
Sbjct: 61 HPGIIKL--YYTFQDEENLYFVLEYAPNGELLQY-IRKYGSLDEKC---TRFYAAE-ILL 113
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
L +LH K +H +LKP N+LL DM KI DF G+A+ S
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDF----------------GTAKVLDPNSS 157
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
S +S G + Y +PE L D+++ G I+ ++LT
Sbjct: 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
Query: 708 GK 709
GK
Sbjct: 218 GK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 45/194 (23%), Positives = 84/194 (43%), Gaps = 42/194 (21%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
DF T+ ++ + HPN++R+ G +II +++ NGSL G
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTV 105
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ + +G+A G+ +L E +VH +L RN+L+ +++ K+ DFGL R +
Sbjct: 106 GQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE-------- 157
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKW 693
+ ++ GG P + APE++ K
Sbjct: 158 ----------------------------DSEATYTTKGGKIPIRWTAPEAIAYRKFTSAS 189
Query: 694 DVYSFGVILLELLT 707
DV+SFG+++ E+++
Sbjct: 190 DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-13
Identities = 23/41 (56%), Positives = 27/41 (65%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTC 71
LN D LL+FK S+ DP G L SWN + +PCSW GVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 41/195 (21%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS-SPCHLP 574
RDF ++ ++ + HPN++ + G +II +F+ NG+L + + G + L
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL- 108
Query: 575 WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634
+ + +G+A G+ +L E +VH +L RN+L+ +++ K+ DFGL R + DTS
Sbjct: 109 ----VGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-- 162
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPK 692
P+ + SSLGG P + APE++ K
Sbjct: 163 --------------------------PTYT-----SSLGGKIPIRWTAPEAIAYRKFTSA 191
Query: 693 WDVYSFGVILLELLT 707
DV+S+G+++ E+++
Sbjct: 192 SDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 52/234 (22%), Positives = 108/234 (46%), Gaps = 48/234 (20%)
Query: 482 ILGASGSSIMYKAVLE----DGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRI 536
++GA +++ +L+ A+A++ + ++ R DF ++ ++ + H N++R+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGS-SPCHLPWEARLKIAKGVARGLAFLHEK 595
G +II +++ NG+L G S L + + +G+A G+ +L +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYLSDM 126
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+VH +L RN+L+ +++E K+ DFGL R++ D
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-------------------------- 160
Query: 656 DLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
P + ++ GG P + APE++ K DV+SFG+++ E+++
Sbjct: 161 ---------PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 50/218 (22%)
Query: 498 DGTA--LAVRRI-GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDF 552
DGT +AV+ + E ++ ++ ++ L H N+V+ +G K +I ++
Sbjct: 30 DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89
Query: 553 VPNGSLANARYRKMGSSPCHLPWEARLKI-AKGVARGLAFLHEKKHVHGNLKPRNVLLGN 611
VP GSL + P H A+L + A+ + G+A+LH + ++H +L RNVLL N
Sbjct: 90 VPLGSLRDYL-------PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142
Query: 612 DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSS 671
D KIGDFGL + V G + D
Sbjct: 143 DRLVKIGDFGLAKAVPE--------------GHEYYRVRED------------------- 169
Query: 672 LGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G SP ++A E L+ K + DV+SFGV L ELLT
Sbjct: 170 --GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-13
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 47/221 (21%)
Query: 501 ALAVRRI----GENSVDRFRDFETQVRVIAKLVHPNLVRI--RGFYWGVDEKLIIYDFVP 554
A+ + R E+ RFR ET + A+L HPN+V + G ++++VP
Sbjct: 7 AIKLLRTDAPEEEHQRARFRR-ETAL--CARLYHPNIVALLDSG-EAPPGLLFAVFEYVP 62
Query: 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDM 613
+L G+ LP ++ V LA H + VH +LKP+N+++ +
Sbjct: 63 GRTLR-EVLAADGA----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 614 EP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSS 671
P K+ DFG+ L+ G R+ T + +
Sbjct: 118 RPHAKVLDFGIGTLLPG----------VRDADVATLTRTTEVL----------------- 150
Query: 672 LGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712
G Y APE LR P D+Y++G+I LE LTG+ +V
Sbjct: 151 --GTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 41/219 (18%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550
YK VL+ T +AV+ + F + ++ + HPN+V++ G I+
Sbjct: 12 YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVM 71
Query: 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
+ VP GSL +K L + L+++ A G+ +L K +H +L RN L+G
Sbjct: 72 ELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG 127
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPS 670
+ KI DFG+ R G + G
Sbjct: 128 ENNVLKISDFGMSREEEGGIYTVSDG---------------------------------- 153
Query: 671 SLGGIS-PYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
L I + APE+L + + DV+S+G++L E +
Sbjct: 154 -LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 50/222 (22%)
Query: 497 EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
E T +A++ + EN+ R R +F + V+ + ++VR+ G L++ + +
Sbjct: 34 EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK 93
Query: 556 GSLAN--------ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
G L + A P + +++A +A G+A+L KK VH +L RN
Sbjct: 94 GDLKSYLRSRRPEAENNPGLGPP---TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNC 150
Query: 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSP 667
++ D+ KIGDFG+ R + K G
Sbjct: 151 MVAEDLTVKIGDFGMTRDIYETDYYRKGG------------------------------- 179
Query: 668 SPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G+ P + APESL+ K DV+SFGV+L E+ T
Sbjct: 180 -----KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
+D +AV+ + + S + +DF + ++ L H ++V+ G D +++++++ +G
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 557 SL--------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
L +A G+ P L L IA+ +A G+ +L + VH +L RN L
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 152
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+G ++ KIGDFG+ R V T + GG
Sbjct: 153 VGENLLVKIGDFGMSRDVY-STDYYRVGGHT----------------------------- 182
Query: 669 PSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ P + PES+ K + DV+S GV+L E+ T
Sbjct: 183 ------MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 46/215 (21%)
Query: 499 GTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY---WGVDEKLIIYDFVP 554
G +AV+ + E+ + D + ++ ++ L H N+V+ +G G KLI+ +F+P
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EFLP 91
Query: 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME 614
+GSL R + + +LK A + +G+ +L +++VH +L RNVL+ ++ +
Sbjct: 92 SGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 147
Query: 615 PKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG 674
KIGDFGL + + D K +D
Sbjct: 148 VKIGDFGLTKAIETD---------------KEYYTVKDDLD------------------- 173
Query: 675 ISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
SP ++APE L K DV+SFGV L ELLT
Sbjct: 174 -SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 490 IMYKAVLEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
+ T++A++ + EN ++F + +++ L HPN+V + G +
Sbjct: 26 LTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85
Query: 549 IYDFVPNGSL--------------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+++++ +G L A + + SS L L IA +A G+ +L
Sbjct: 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLHIAIQIAAGMEYLSS 142
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
VH +L RN L+G + KI DFGL R + S D +
Sbjct: 143 HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY----------------------SADYY 180
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
+ S S P + PE++ K + D++SFGV+L E+
Sbjct: 181 R------VQSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 63/239 (26%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI-----GENSVDRFRDFETQVRVIAKLVHPNLVRIR 537
G+ GS +Y+ + L+DG AV+ + G+ + + E ++ +++KL HPN+V+
Sbjct: 11 GSFGS--VYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ-- 66
Query: 538 GFYWGV---DEKLIIY-DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
Y G ++ L I+ + VP GSLA +K GS P + + GL +LH
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSLAKL-LKKYGS----FPEPVIRLYTRQILLGLEYLH 119
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGL-ERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
++ VH ++K N+L+ + K+ DFG+ +++V + S G
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG---------------- 163
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKP-NPKWDVYSFGVILLELLTGK 709
SPY APE + D++S G +LE+ TGK
Sbjct: 164 -----------------------SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 45/195 (23%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
++F + V+A+L HP +VR+ G G + +++ + P G L +K P
Sbjct: 41 KEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPL-LKYLKKRREIP----- 93
Query: 576 EARLKI-AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634
+ LK A VA G+A+L K VH +L RNVLL N + KI DFG+ R
Sbjct: 94 VSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSR---------- 143
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPK 692
A GS A+ G P ++APE + K + K
Sbjct: 144 ----ALGAGSDYYRATT---------------------AGRWPLKWYAPECINYGKFSSK 178
Query: 693 WDVYSFGVILLELLT 707
DV+S+GV L E +
Sbjct: 179 SDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 82/337 (24%), Positives = 131/337 (38%), Gaps = 79/337 (23%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAV-LEDG----TALAVRRIGENSVDR-FRDFETQ 521
KE ELE + +LG+ +YK V + +G +A++ + E + + ++ +
Sbjct: 5 KETELEKI-----KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDE 59
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRK-----MGSSPCHLPWE 576
V+A + HP++VR+ G +LI +P G L Y + +GS +
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLL--DYVRNHKDNIGS-------Q 109
Query: 577 ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
L +A+G+++L EK+ VH +L RNVL+ KI DFGL +L+ D A
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
Query: 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKWD 694
GG P + A ES+ K D
Sbjct: 170 ------------------------------------GGKVPIKWMALESILHRIYTHKSD 193
Query: 695 VYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAI-RADFEGKEEALLSC 752
V+S+GV + EL+T G L+E + RL I D L+ C
Sbjct: 194 VWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---KGERLPQPPICTIDV---YMVLVKC 247
Query: 753 FKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYLY 789
+ + RP+ KE + K+ P YL
Sbjct: 248 WMIDAES-------RPTFKELINEFSKMARDPQRYLV 277
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 50/236 (21%)
Query: 481 YILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFET--QVRVIAKLVHPNLVRIR 537
+G +++K V + D A+++I + ++R E + RV+AKL ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63
Query: 538 GFYWGVDEK---LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+Y +K I+ ++ NG L + G LP + + + GLA LH
Sbjct: 64 -YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP---LPEDQVWRFFIQILLGLAHLHS 119
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
KK +H ++K N+ L KIGD G+ +L++ +T NF
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT----------NFA----------- 158
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK 709
+++ G Y +PE L KP N K DV++ GV+L E TGK
Sbjct: 159 ---------------NTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 45/194 (23%), Positives = 90/194 (46%), Gaps = 41/194 (21%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
RDF ++ ++ + HPN++ + G +I+ +++ NGSL +A RK
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDG---QFTV 105
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ + +G+A G+ +L + +VH +L RN+L+ +++ K+ DFGL R++ D
Sbjct: 106 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD------ 159
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKW 693
P + ++ GG P + APE++ K
Sbjct: 160 -----------------------------PEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 694 DVYSFGVILLELLT 707
DV+S+G+++ E+++
Sbjct: 191 DVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 498 DGTAL-AVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
D L AV+ + ++ D R DF +V+++++L PN+ R+ G +I +++ N
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 556 GSLAN---ARYRKMGSSPCH---LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
G L + C+ L + L +A +A G+ +L VH +L RN L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
G + KI DFG R+ S D ++ G P P
Sbjct: 164 GKNYTIKIADFG----------------------MSRNLYSSDYYRVQGRAPLP------ 195
Query: 670 SSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
I + A ES+ K K DV++FGV L E+LT
Sbjct: 196 -----IR-WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 49/213 (23%)
Query: 505 RRIGENSVDRFRD----FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560
I R +D +++ + L H N+V+ GF + I ++VP GS+ +
Sbjct: 38 ATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS 97
Query: 561 ARYRKMGSSPCHLPWEARL--KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618
R G +E +L + V GLA+LH K +H +LK N+L+ D KI
Sbjct: 98 C-LRTYG------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKIS 150
Query: 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY 678
DFG+ SK+S D+ Q++ S+ G +
Sbjct: 151 DFGI---------------------SKKSDDIYDNDQNM-------------SMQGSVFW 176
Query: 679 HAPESLRSIKP--NPKWDVYSFGVILLELLTGK 709
APE + S + K D++S G ++LE+ G+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 46/221 (20%)
Query: 499 GTALAVRR-----IGENSVDRFRD----FETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
G +AV++ + +S DR R ++ ++ +L H N+V+ G D I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVHGNLKPRNVL 608
++VP GS+A A G+ E ++ + + +GL +LH + +H ++K N+L
Sbjct: 85 LEYVPGGSVA-ALLNNYGAFE-----ETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+ N KI DFG+ + + ++ S+K G +R S Q
Sbjct: 139 VDNKGGIKISDFGISKKLEANSLSTKTNG------------ARPSLQ------------- 173
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G + APE ++ K D++S G +++E+LTGK
Sbjct: 174 -----GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 60/236 (25%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG +YKA E G A + I S + DF ++ ++++ HPN+V + Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK------IAKGVARGLAFLHEK 595
++ I+ +F G+L + L E L + + + L FLH
Sbjct: 73 YENKLWILIEFCDGGALDSIM----------LELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
K +H +LK N+LL D + K+ DFG+ SA+N K + RD+F
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGV---------------SAKN---KSTLQKRDTF- 163
Query: 656 DLGPGPSPSPSPSPSSLGGISPY-HAPESL--RSIKPNP---KWDVYSFGVILLEL 705
+G +PY APE + + K NP K D++S G+ L+EL
Sbjct: 164 -IG-----------------TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 51/225 (22%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
+D +AV+ + + ++ +DF+ + ++ L H ++V+ G D +++++++ +G
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 557 SLANARYRKMGSSPCHL----PWEAR--------LKIAKGVARGLAFLHEKKHVHGNLKP 604
L N R G L P +A+ L IA +A G+ +L + VH +L
Sbjct: 93 DL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
RN L+G ++ KIGDFG+ R V T + GG
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHT------------------------- 185
Query: 665 PSPSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ P + PES+ K + DV+SFGVIL E+ T
Sbjct: 186 ----------MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFY 540
+LG ++K L+D T +AV+ E+ + F ++ R++ + HPN+V++ G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
I+ + VP G + +K L + +K A A G+A+L K +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+L RN L+G + KI DFG+ R SS
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--------------------------- 150
Query: 661 PSPSPSPSPSSLGGIS-PYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
S L I + APE+L + + + DV+S+G++L E +
Sbjct: 151 ---------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 71/269 (26%), Positives = 111/269 (41%), Gaps = 68/269 (25%)
Query: 518 FETQVRVIAKLVHPNLVRIRG--FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
F + V+ KL H NLVR+ G + G+ I+ + + G+L N R G + +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGL---YIVMELMSKGNLVNF-LRTRGRALVSVI- 100
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
L+ + VA G+ +L KK VH +L RN+L+ D K+ DFGL R+
Sbjct: 101 -QLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---------- 149
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
GS S+ + + APE+L+ K + K DV
Sbjct: 150 -------GSMGVDNSKLPVK----------------------WTAPEALKHKKFSSKSDV 180
Query: 696 YSFGVILLELLT-GKV----IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALL 750
+S+GV+L E+ + G+ + + E+ + VE R E E
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKEC----VEKGYR------------MEPPEGCPA 224
Query: 751 SCFKLGYSCASPLPQKRPSMKEALQALEK 779
+ L SC P+KRPS + + LEK
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 50/216 (23%)
Query: 499 GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK---LIIYDFVPN 555
G +AV+ I ++ + F + V+ +L H NLV++ G V+EK I+ +++
Sbjct: 29 GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEYMAK 84
Query: 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615
GSL + R G S L + LK + V + +L VH +L RNVL+ D
Sbjct: 85 GSLVD-YLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVA 141
Query: 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI 675
K+ DFGL T S QD G P
Sbjct: 142 KVSDFGL-------------------------TKEASSTQDTGKLP-------------- 162
Query: 676 SPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710
+ APE+LR K + K DV+SFG++L E+ + G+V
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 84/325 (25%)
Query: 482 ILGASGSSIMYKAVL--EDGTALAVR----RIGENSVDRFRDFETQVRVIAKLVHPNLVR 535
ILG + + L +DG+ L V ++ ++ +F ++ + HPN+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 536 IRGFYWGVDEK------LIIYDFVPNGSL-ANARYRKMGSSPCHLPWEARLKIAKGVARG 588
+ G + ++I F+ +G L + Y ++G P LP + LK +A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
+ +L + +H +L RN +L DM + DFGL + +
Sbjct: 126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY--------------------- 164
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGIS----PYHAPESLRSIKPNPKWDVYSFGVILLE 704
S D ++ G I+ + A ESL K DV++FGV + E
Sbjct: 165 -SGDYYRQ----------------GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 207
Query: 705 LLT---------GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKL 755
+ T + D L GN L + E+ L + L
Sbjct: 208 IATRGQTPYPGVENHEIYDYLRHGNRL--------------------KQPEDCLDELYDL 247
Query: 756 GYSCASPLPQKRPSMKEALQALEKI 780
YSC P+ RP+ + + LE I
Sbjct: 248 MYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 72/281 (25%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGVDEK------LIIYDFVPNGSLAN-ARYRKMGSS 569
DF ++ + + HPN++R+ G E ++I F+ +G L + Y ++G
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL-ERLVTG 628
P +LP + +K +A G+ +L K +H +L RN +L +M + DFGL +++ G
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK 688
D G K + A ESL
Sbjct: 166 DYYRQ---GRIAKMPVK--------------------------------WIAIESLADRV 190
Query: 689 PNPKWDVYSFGVILLELLT-GKVI--------VVDELGQGNGLLVEDKNRAIRLADAAIR 739
K DV+SFGV + E+ T G+ + D L QG NR + D
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--------NRLKQPPDC--- 239
Query: 740 ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
+G + SC+ L P+ RPS + LEK
Sbjct: 240 --LDGLYSLMSSCWLLN-------PKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
+D +AV+ + E S +DF+ + ++ L H ++VR G L++++++ +G
Sbjct: 33 QDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG 92
Query: 557 SL----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
L A +P L L IA +A G+ +L VH +L RN
Sbjct: 93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRN 152
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
L+G + KIGDFG+ R + T + GG R R
Sbjct: 153 CLVGQGLVVKIGDFGMSRDIY-STDYYRVGG--RTMLPIR-------------------- 189
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ PES+ K + D++SFGV+L E+ T
Sbjct: 190 -----------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 44/210 (20%)
Query: 500 TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGS 557
T +A++ + + S+ F + ++ +L HP LVR+ Y V ++ II +++ NGS
Sbjct: 31 TKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRL---YAVVTQEPIYIITEYMENGS 86
Query: 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617
L + G L + +A +A G+AF+ K ++H +L+ N+L+ + KI
Sbjct: 87 LVDFLKTPEGIK---LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKI 143
Query: 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP 677
DFGL RL+ + +++ G F K
Sbjct: 144 ADFGLARLIEDNEYTAREGA---KFPIK-------------------------------- 168
Query: 678 YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ APE++ K DV+SFG++L E++T
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 60/299 (20%)
Query: 483 LGASGSSIMYKAV-LEDGT--ALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
LG +YK L D AL +G S D ++R++A + HPN++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 540 YWGVDEKLIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ ++ I+ ++ P G L+ A RK +P + +I + RGL LHE+K +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKL--IPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +LK N+LL + KIGD G+ +++ + + ++ G
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG---------------------- 163
Query: 659 PGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717
+P Y APE + + K D++S G +L E+ T
Sbjct: 164 -----------------TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF----- 201
Query: 718 QGNGLLVED-KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
++D + + R I + + + S P+ RP+ + L
Sbjct: 202 --EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR------SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 67/302 (22%)
Query: 500 TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558
T +AV+ + EN S RD ++ ++ ++ HP+++++ G L+I ++ GSL
Sbjct: 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 559 AN--ARYRKMG-----------SSPCHLPWEARLKI------AKGVARGLAFLHEKKHVH 599
+ RK+G SS P E L + A ++RG+ +L E K VH
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVH 150
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+L RNVL+ + KI DFGL R V + S K RS + P
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK-----------RS-------KGRIP 192
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719
+ A ESL + DV+SFGV+L E++T LG G
Sbjct: 193 ----------------VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LG-G 227
Query: 720 NGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778
N R L R + E E + + L +C P KRP+ + + LE
Sbjct: 228 NPYPGIAPERLFNLLKTGYRMERPENCSEEM---YNLMLTCWKQEPDKRPTFADISKELE 284
Query: 779 KI 780
K+
Sbjct: 285 KM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 22/162 (13%)
Query: 482 ILGASGSSIMYKA-VLEDGTAL--AVRRIGE-NSVDRFRDFETQVRVIAKL-VHPNLVRI 536
++G + KA + +DG + A++R+ E S D RDF ++ V+ KL HPN++ +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 537 RGFYWGVDEKLIIY---DFVPNGSLAN--ARYRKMGSSPCH---------LPWEARLKIA 582
G + + +Y ++ P+G+L + + R + + P L + L A
Sbjct: 74 LG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
VARG+ +L +K+ +H +L RN+L+G + KI DFGL R
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 54/233 (23%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRG-FY 540
LG +YKA ++ ALA ++ E S + D+ ++ ++A HP +V++ G FY
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 541 WGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHV 598
W D KL I+ +F P G++ +A ++ E +++ I + + L +LH K +
Sbjct: 80 W--DGKLWIMIEFCPGGAV-DAIMLELDRGLT----EPQIQVICRQMLEALQYLHSMKII 132
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +LK NVLL D + K+ DFG+ SA+N ++ RDSF +G
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGV---------------SAKNV---KTLQRRDSF--IG 172
Query: 659 PGPSPSPSPSPSSLGGISPY-HAPESL--RSIKPNP---KWDVYSFGVILLEL 705
+PY APE + ++K P K D++S G+ L+E+
Sbjct: 173 -----------------TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 43/188 (22%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
+++++ HP +V++ + + +EKL ++ ++ P G L + K G AR
Sbjct: 45 NILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFS-HLSKEGRFS---EERARFYA 99
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A+ + L +LH ++ +LKP N+LL D K+ DFGL A+
Sbjct: 100 AE-IVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL----------------AKE 142
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
S+ S ++ G Y APE L D +S GV+
Sbjct: 143 LSSEGSRT--------------------NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVL 182
Query: 702 LLELLTGK 709
L E+LTGK
Sbjct: 183 LYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 78 NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS 137
+ + L L N+ + P + L+ LDLS+N + SL L N L+NLDLS
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLS 171
Query: 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN-YFSDGLP-S 195
N +S LP+ + +L NL L+LS N ++ LP + L +L + L NN S
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLS 229
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
++ L+LS+N + +L L+LS N++S I + +DLS
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISSL--GSLTNLRELDLSG 286
Query: 256 NNLTGEIPESN 266
N+L+ +P
Sbjct: 287 NSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 44/231 (19%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LGA ++ + T +AV+ + G SV F + + ++ L H LVR+
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 70
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+ II +++ GSL + G LP + + +A G+A++ K ++H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLP--KLIDFSAQIAEGMAYIERKNYIHR 127
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+L+ NVL+ + KI DFGL R++ + +++ G F K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA---KFPIK--------------- 169
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710
+ APE++ K DV+SFG++L E++T GK+
Sbjct: 170 -----------------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 54/201 (26%)
Query: 521 QVRVIAKLVHPNLVRIRGFY-WGVDEK----LIIYDFVPNGSLAN--ARYRKMGSSPCHL 573
+V ++ +L HPN+VR +Y +D I+ ++ G LA + +K +
Sbjct: 49 EVNILRELKHPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---I 102
Query: 574 PWEARLKIAKGVARGLAFLHEKKH-----VHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628
E +I + L H + +H +LKP N+ L + K+GDFGL +++
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK 688
D+S +K + G Y +PE L +
Sbjct: 163 DSSFAK------------------------------------TYVGTPYYMSPEQLNHMS 186
Query: 689 PNPKWDVYSFGVILLELLTGK 709
+ K D++S G ++ EL
Sbjct: 187 YDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 45/184 (24%)
Query: 530 HPNLVRIRGFYWGVDEK----LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGV 585
P +V+ G + +DE I ++ GSL ++ Y+K+ + + KIA+ V
Sbjct: 58 SPYIVKYYGAF--LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESV 114
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
+GL++LH +K +H ++KP N+LL + K+ DFG V+G+ +S AG
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAG--------- 161
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
+ G S Y APE ++ + DV+S G+ LLE+
Sbjct: 162 -------------------------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
Query: 706 LTGK 709
+
Sbjct: 197 AQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 43/189 (22%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIA 582
++ K P +V G ++ + I +++ GSL + K +P KIA
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD--KILKEVQGR--IPERILGKIA 106
Query: 583 KGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
V +GL +LHEK + H ++KP N+L+ + + K+ DFG V+G +S A
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTFV-- 160
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
G S Y APE ++ + K D++S G+
Sbjct: 161 --------------------------------GTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 702 LLELLTGKV 710
L+EL TG+
Sbjct: 189 LIELATGRF 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 54/241 (22%)
Query: 483 LGASGSSIMYKAVLED------GTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVR 535
LG ++Y+ D T +AV+ + E++ R R +F + V+ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 536 IRGFYWGVDEKLIIYDFVPNG-------SLANARYRKMGSSPCHLPWEARLKIAKGVARG 588
+ G L++ + + +G SL G P L + +++A +A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 131
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
+A+L+ KK VH +L RN ++ +D KIGDFG+ R + +T + GG
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGK---------- 180
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELL 706
G+ P + APESL+ D++SFGV+L E+
Sbjct: 181 -------------------------GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215
Query: 707 T 707
+
Sbjct: 216 S 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 56/264 (21%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARYRKMGSSPCHLPW 575
F + +++ KL H LV + Y V E+ I+ +F+ GSL + + K G +L
Sbjct: 48 FLQEAQIMKKLRHDKLVPL---YAVVSEEPIYIVTEFMGKGSLLD--FLKEGDGK-YLKL 101
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ +A +A G+A++ ++H +L+ N+L+G+++ KI DFGL RL+ + +++
Sbjct: 102 PQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G F K + APE+ + K DV
Sbjct: 162 GA---KFPIK--------------------------------WTAPEAALYGRFTIKSDV 186
Query: 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFK 754
+SFG++L EL+T G+V G N ++E R R+ +G E+L K
Sbjct: 187 WSFGILLTELVTKGRVPYP---GMVNREVLEQVERGYRMPCP------QGCPESLHELMK 237
Query: 755 LGYSCASPLPQKRPSMKEALQALE 778
L C P +RP+ + LE
Sbjct: 238 L---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 50/209 (23%)
Query: 507 IGENSVDRF---RDFETQVRVIAKLVHPNLVRIRGFYW---GVDEKLIIYDFVPNGSLAN 560
I +N VD+ RD +Q + P +V+ Y+ G ++ +++P G LA
Sbjct: 32 IRKNQVDQVLTERDILSQAQ------SPYVVK---LYYSFQGKKNLYLVMEYLPGGDLA- 81
Query: 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620
+ +GS + AR+ IA+ V L +LH +H +LKP N+L+ ++ K+ DF
Sbjct: 82 SLLENVGSLDEDV---ARIYIAEIVL-ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDF 137
Query: 621 GLERLVTGDTSSSKAGGSARN-FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH 679
GL SK G R + + G Y
Sbjct: 138 GL----------SKVGLVRRQINLNDDEKEDKRIV-------------------GTPDYI 168
Query: 680 APESLRSIKPNPKWDVYSFGVILLELLTG 708
APE + + D +S G IL E L G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 57/263 (21%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARYRKMGSSPCHLPW 575
F + +++ KL H LV++ Y V E+ I+ +++ GSL + + K G L
Sbjct: 48 FLEEAQIMKKLRHDKLVQL---YAVVSEEPIYIVTEYMSKGSLLD--FLKDGEGR-ALKL 101
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ +A VA G+A++ ++H +L+ N+L+G+ + KI DFGL RL+ + +++
Sbjct: 102 PNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G F K + APE+ + K DV
Sbjct: 162 GA---KFPIK--------------------------------WTAPEAALYGRFTIKSDV 186
Query: 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFK 754
+SFG++L EL+T G+V G N ++E R R+ ++ +S +
Sbjct: 187 WSFGILLTELVTKGRVPYP---GMNNREVLEQVERGYRM---------PCPQDCPISLHE 234
Query: 755 LGYSCASPLPQKRPSMKEALQAL 777
L C P++RP+ E LQ+
Sbjct: 235 LMLQCWKKDPEERPTF-EYLQSF 256
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 15/145 (10%)
Query: 495 VLEDGTAL--AVRRIGE-NSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550
+ +DG + A++ + E S + RDF ++ V+ KL HPN++ + G I
Sbjct: 23 IKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82
Query: 551 DFVPNGSLAN--ARYRKMGSSPCH---------LPWEARLKIAKGVARGLAFLHEKKHVH 599
++ P G+L + + R + + P L + L+ A VA G+ +L EK+ +H
Sbjct: 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIH 142
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLER 624
+L RNVL+G ++ KI DFGL R
Sbjct: 143 RDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 493 KAVLEDG--TALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
K V++D T +A++ + E + R R +F + V+ + ++VR+ G L+I
Sbjct: 28 KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87
Query: 550 YDFVPNGSLAN---ARYRKMGSSPCHLP--WEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
+ + G L + + +M ++P P + +++A +A G+A+L+ K VH +L
Sbjct: 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAA 147
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
RN ++ D KIGDFG+ R + +T + GG
Sbjct: 148 RNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGK-------------------------- 180
Query: 665 PSPSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G+ P + +PESL+ DV+SFGV+L E+ T
Sbjct: 181 ---------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 1e-09
Identities = 73/285 (25%), Positives = 111/285 (38%), Gaps = 79/285 (27%)
Query: 520 TQVRVIA---KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWE 576
T +R I+ +L HPN+V++ + +++++ L Y P
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKK--YLDKRPGPLSPNL- 99
Query: 577 ARLK-IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+K I + RGLA+ H + +H +LKP+N+L+ D K+ DFGL
Sbjct: 100 --IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGL------------- 144
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWD 694
AR FG P + + +L Y APE L K + D
Sbjct: 145 ---ARAFGI----------------PLRTYTHEVVTLW----YRAPEILLGSKHYSTAVD 181
Query: 695 VYSFGVILLELLTGKVI-----VVDELGQ--------------GNGLLVEDKNR-----A 730
++S G I E++TGK + +D+L + G L + K
Sbjct: 182 IWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP 241
Query: 731 IRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
L R D EG + LLS L Y+ P KR S KEAL+
Sbjct: 242 KDLEKVLPRLDPEGID--LLSKM-LQYN-----PAKRISAKEALK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 10/122 (8%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN--------ARYRKMGS 568
DF +++++++L +PN++R+ G D +I +++ NG L + + +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER-LVT 627
P + L +A +A G+ +L VH +L RN L+GN KI DFG+ R L +
Sbjct: 123 IPS-VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 628 GD 629
GD
Sbjct: 182 GD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 490 IMYKAVLEDGTAL--AVRRIGE-NSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDE 545
++ + +DG + A++R+ E S D RDF ++ V+ KL HPN++ + G
Sbjct: 11 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70
Query: 546 KLIIYDFVPNGSLAN--ARYRKMGSSPCH---------LPWEARLKIAKGVARGLAFLHE 594
+ ++ P+G+L + + R + + P L + L A VARG+ +L +
Sbjct: 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
K+ +H +L RN+L+G + KI DFGL R
Sbjct: 131 KQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 39/106 (36%), Positives = 60/106 (56%)
Query: 65 SWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFS 124
S N + A P + + S ++ L L ++L G IP +L + L LDLS+N L+G + S
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542
Query: 125 LFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLP 170
L LDLS N +SG +P+ +G++ +L +N+S N L G LP
Sbjct: 543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 57/263 (21%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARYRKMGSSPCHLPW 575
F + +V+ KL H LV++ Y V E+ I+ +++ GSL + + K G +L
Sbjct: 48 FLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLD--FLK-GEMGKYLRL 101
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ +A +A G+A++ +VH +L+ N+L+G ++ K+ DFGL RL+ + +++
Sbjct: 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G F K + APE+ + K DV
Sbjct: 162 GA---KFPIK--------------------------------WTAPEAALYGRFTIKSDV 186
Query: 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFK 754
+SFG++L EL T G+V G N +++ R R+ E S
Sbjct: 187 WSFGILLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPP---------ECPESLHD 234
Query: 755 LGYSCASPLPQKRPSMKEALQAL 777
L C P++RP+ E LQA
Sbjct: 235 LMCQCWRKEPEERPTF-EYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 47/235 (20%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
+G ++++Y A+ L + +A++RI E + +V+ +++ HPN+V+ Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK----Y 64
Query: 541 WG---VDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
+ V ++L ++ ++ GSL + L + K V +GL +LH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLER-LVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+H ++K N+LLG D KI DFG+ L G + K R T
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----------RKT------- 165
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK 709
G + APE + + + K D++SFG+ +EL TG
Sbjct: 166 ----------------FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 40/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 492 YKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550
YKA + G +A++ I D F + ++ ++ + HPN+V G Y D+ I+
Sbjct: 20 YKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79
Query: 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIA---KGVARGLAFLHEKKHVHGNLKPRNV 607
++ GSL + Y ++ P + L+IA + +GLA+LHE +H ++K N+
Sbjct: 80 EYCGGGSLQDI-Y-QVTRGPL-----SELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132
Query: 608 LLGNDMEPKIGDFG 621
LL D + K+ DFG
Sbjct: 133 LLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 70/253 (27%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FE-TQVRVIA---KLVHPNLVRIR 537
G G +YKA + G +A+++I ++ ++ F T +R I KL HPN+VR++
Sbjct: 10 GTYGQ--VYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 538 GFYWGVDEKL-----IIYDFVP---NGSLANARYRKMGSSPCHLPWEARLK-IAKGVARG 588
V K ++++++ G L + + + + K K + G
Sbjct: 65 EI---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQI------KCYMKQLLEG 112
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
L +LH +H ++K N+L+ ND K+ DFGL R T ++ ++ ++ T
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR--------NSADYTNRVIT 164
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLT 707
Y PE L + + P+ D++S G IL EL
Sbjct: 165 LW---------------------------YRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 708 GKVIV--VDELGQ 718
GK I EL Q
Sbjct: 198 GKPIFQGSTELEQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 44/160 (27%)
Query: 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH-VHGNLKPRNVLL 609
+F+ GSL + Y+K G +P E KIA V GL +L+ +H ++KP N+L+
Sbjct: 83 EFMDCGSL-DRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
+ + K+ DFG V+G+ +S A D+F
Sbjct: 138 NSRGQIKLCDFG----VSGELINSIA----------------DTFV-------------- 163
Query: 670 SSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G S Y +PE ++ K K DV+S G+ ++EL GK
Sbjct: 164 ----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 72/311 (23%), Positives = 129/311 (41%), Gaps = 61/311 (19%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
GASG+ +Y A+ + G +A++++ + ++ V+ + HPN+V Y
Sbjct: 30 GASGT--VYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
DE ++ +++ GSL + + + + + + L FLH + +H ++
Sbjct: 88 GDELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K N+LLG D K+ DFG +T + SKRST
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ-------------SKRST-------------- 174
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+ G + APE + PK D++S G++ +E++ G+ ++E N L
Sbjct: 175 ---------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPL 221
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFK-LGYSCASPLPQKRPSMKEALQ----AL 777
RA+ L + + E+ L + F+ C +KR S KE LQ +
Sbjct: 222 ------RALYLIATNGTPELQNPEK-LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
Query: 778 EKIPSSPSPYL 788
K SS +P +
Sbjct: 275 AKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 34/81 (41%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
+ L + + G+IP LG I L+ LDLS NS NGS+ SL + LR L+L+ N +SG +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 146 PETMGS--LHNLQLLNLSDNA 164
P +G LH N +DNA
Sbjct: 507 PAALGGRLLHRAS-FNFTDNA 526
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 473 ETLLKASAYILGASGSSIMYKAV-LEDGTAL----AVRRIGENSVDRFR-DFETQVRVIA 526
ET LK +LG+ +YK + + +G + A++ + E + + +F + ++A
Sbjct: 6 ETELK-RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64
Query: 527 KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKG 584
+ HP+LVR+ G +L+ +P+G L + ++ S L W +
Sbjct: 65 SMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------ 117
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
+A+G+ +L E++ VH +L RNVL+ + KI DFGL RL+ GD A G
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
GASG +YKA G +A++++ ++ ++ HPN+V Y
Sbjct: 30 GASG--EVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
DE ++ +++ GSL + + + P A + + V +GL +LH + +H ++
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIAY--VCREVLQGLEYLHSQNVIHRDI 142
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K N+LL D K+ DFG +T S RN
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLT-------KEKSKRN--------------------- 174
Query: 663 PSPSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTG 708
S+ G +PY APE ++ PK D++S G++ +E+ G
Sbjct: 175 --------SVVG-TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 58/240 (24%), Positives = 109/240 (45%), Gaps = 53/240 (22%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIG---ENSVDRFRDFET---QVRVIAKLVHPNLV 534
LG S Y+A ++ GT +AV+++ S ++ E ++R++A+L HP+++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIA--KGVARGLAFL 592
R+ G + +++ GS+++ K G ++ + I + + RGL++L
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYG------AFKEAVIINYTEQLLRGLSYL 119
Query: 593 HEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTA 649
HE + +H ++K N+L+ G + +I DF G+A +K + A
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRL--RIADF----------------GAAARLAAKGTGA 161
Query: 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
FQ LG I+ + APE LR + DV+S G +++E+ T K
Sbjct: 162 --GEFQG-------------QLLGTIA-FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 56/239 (23%), Positives = 92/239 (38%), Gaps = 52/239 (21%)
Query: 483 LGASGSSIMYKAVLEDGTA--LAVRRI-------GENSVDR---FRDFETQVRVIAK-LV 529
LG+ +YK ++ LA++ I G++ +R D ++V +I + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGL 589
HPN+VR + D I+ D + L + + E I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 590 AFLH-EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
+LH EK+ VH +L P N++LG D + I DFGL +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------------ 162
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
P +S+ G Y PE +++ K DV++FG IL ++ T
Sbjct: 163 -------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARG 588
HPN+V+ + E ++ +F+ GSL H+ E L +A+ + G
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----------HIADEQFLADVARQILSG 180
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV--TGDTSSSKAG 636
+A+LH + VH ++KP N+L+ + KI DFG+ R++ T D +S G
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 67/294 (22%), Positives = 111/294 (37%), Gaps = 76/294 (25%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRR--IGENSVDRFR-DFETQVRVIAKLVHPNLVRIRG 538
+G S++YKA+ L DG +A+++ I E + R D ++ ++ +L HPN+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 539 FYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
+ +E I+ + G L+ ++K +P K + L +H K+
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTIWKYFVQLCSALEHMHSKR 126
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
+H ++KP NV + K+GD GL R F SK + A
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGL----------------GRFFSSKTTAAH------ 164
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
SL G Y +PE + N K D++S G +L E+
Sbjct: 165 --------------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM----------- 199
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA-SPLPQKRPS 769
AA+++ F G + L S K C PLP S
Sbjct: 200 -------------------AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 20/165 (12%)
Query: 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
++ +++P G L N RK P AR IA+ V L +H+ +H ++KP N+
Sbjct: 78 LVMEYMPGGDLMNLLIRK-DVFPEE---TARFYIAELVL-ALDSVHKLGFIHRDIKPDNI 132
Query: 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSP 667
L+ D K+ DFGL K A++ + + F+D
Sbjct: 133 LIDADGHIKLADFGL----------CKKMNKAKDREYYLNDSHNLLFRD-NVLVRRRDHK 181
Query: 668 SP----SSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+S G Y APE LR + D +S GVIL E+L G
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 6/128 (4%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLP 574
DF + +++K H N+VR+ G + + I+ + + G L + R P L
Sbjct: 55 DFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114
Query: 575 WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTS 631
+ L A+ VA+G +L E +H ++ RN LL G KI DFG+ R + S
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR-AS 173
Query: 632 SSKAGGSA 639
+ GG A
Sbjct: 174 YYRKGGRA 181
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 49/228 (21%)
Query: 493 KAVLEDGTA---LAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548
+L G+ +AV+ + + + D+ ++F + +++ HPN+V++ G + + I
Sbjct: 17 TDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76
Query: 549 IYDFVPNGSLAN----ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
I + + G L + AR + G P L + L I VA+G +L + +H +L
Sbjct: 77 IMELMEGGDLLSYLRDARVERFG--PPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAA 134
Query: 605 RNVLLGN-----DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
RN L+ D KIGDFGL R D S D ++ G
Sbjct: 135 RNCLVSEKGYDADRVVKIGDFGLAR----DIYKS------------------DYYRKEGE 172
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G P + APESL K + DV+SFGV++ E+LT
Sbjct: 173 GLLPVR------------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 25/155 (16%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA----SQLRNLDLSNNLISG----HLPETMGSLHNLQLL 158
L+ L L N L G+ +L A L+ L+L+NN I L E + + NL++L
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198
Query: 159 NLSDNAL----AGKLPVSLTTLQSLTIVSLKNN--------YFSDGLPSKFNSVQVLDLS 206
+L++N L A L +L +L+SL +++L +N + L S S+ L LS
Sbjct: 199 DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258
Query: 207 SNLINGSLPPDIGGY-----SLRYLNLSYNRLSGE 236
N I D+ SL L+L N+ E
Sbjct: 259 CNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/269 (21%), Positives = 104/269 (38%), Gaps = 53/269 (19%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN----ARYRKMGSSPCH 572
+F ++ + KL H N+VR+ G + +I ++ G L + + P
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
L + ++ + +A G+ L + VH +L RN L+ + E K+ L + D +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYN 169
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPN 690
S+ + R+ + P + APE+++ +
Sbjct: 170 SE-------YYKLRNA--------------------------LIPLRWLAPEAVQEDDFS 196
Query: 691 PKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALL 750
K DV+SFGV++ E+ T + L +L + + L EG L
Sbjct: 197 TKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKLELPVP------EGCPSRL- 248
Query: 751 SCFKLGYSCASPLPQKRPSMKEALQALEK 779
+KL C + P+ RPS E + AL +
Sbjct: 249 --YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 49/228 (21%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 484 GASGSSIMYKAVLEDGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYW 541
GA G + +Y+ ED + + + + + RD ++ +++ L HPN++ +
Sbjct: 11 GAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM 69
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+ LI ++ G+L + R+ G E L + ++++H+ +H +
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSYIHKAGILHRD 126
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+ L K+GDFG+ ++ GS+ S A
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGI----------------SKILGSEYSMAE----------- 159
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
++ G Y +PE + +K N K D+++ G +L ELLT K
Sbjct: 160 ---------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 66/298 (22%), Positives = 115/298 (38%), Gaps = 60/298 (20%)
Query: 496 LEDGT----ALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK----- 546
EDG+ A+ + + S +F + + + HPN++++ G K
Sbjct: 22 SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81
Query: 547 -LIIYDFVPNGSL-ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
++I F+ +G L ++G P LP + ++ +A G+ +L K +H +L
Sbjct: 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141
Query: 605 RNVLLGNDMEPKIGDFGLER-LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RN +L +M + DFGL + + +GD G A K
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQ---GCASKLPVK------------------ 180
Query: 664 SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLL 723
+ A ESL DV++FGV + E++T GQ
Sbjct: 181 --------------WLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAG 218
Query: 724 VEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
VE+ + + I+ + + + L ++L C SP P+ RPS + LE I
Sbjct: 219 VENS----EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 69/260 (26%), Positives = 102/260 (39%), Gaps = 58/260 (22%)
Query: 530 HPNLVRIRGFYWGVD-EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKG--VA 586
HPN++ + G + L++ ++ +G L R S H P L I G VA
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDL-----RNFIRSETHNPTVKDL-IGFGLQVA 108
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+G+ +L KK VH +L RN +L K+ DFGL AR+ K
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGL----------------ARDIYDKE 152
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
S + P + A ESL++ K K DV+SFGV+L EL+
Sbjct: 153 Y----YSVHNHTGAKLP------------VKWMALESLQTQKFTTKSDVWSFGVLLWELM 196
Query: 707 TGKVIV---VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPL 763
T VD LL + RL D +++ SC P
Sbjct: 197 TRGAPPYPDVDSFDITVYLL-----QGRRLLQPEYCPD---------PLYEVMLSCWHPK 242
Query: 764 PQKRPSMKEALQALEKIPSS 783
P+ RP+ E + +E+I S+
Sbjct: 243 PEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LGA ++ A T +AV+ + G SV+ F + V+ L H LV++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLVKLHAVV 70
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+ II +F+ GSL + GS P + + +A G+AF+ ++ ++H
Sbjct: 71 -TKEPIYIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+L+ N+L+ + KI DFGL R++ + +++ G F K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA---KFPIK--------------- 168
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ APE++ K DV+SFG++L+E++T
Sbjct: 169 -----------------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 44/179 (24%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGL 589
HP LV + G + ++ ++VP G L + RK G P P AR A+ V L
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELF-SHLRKSGRFP--EPV-ARFYAAQ-VVLAL 114
Query: 590 AFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTA 649
+LH V+ +LKP N+LL +D KI DFG + V G T
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------------------- 155
Query: 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+L G Y APE + S D ++ G+++ E+L G
Sbjct: 156 --------------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 32/126 (25%), Positives = 43/126 (34%), Gaps = 37/126 (29%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ L +LH K +H ++KP N+LL I DF + VT DT +
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT------------ 156
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
+S G Y APE L + D +S GV E
Sbjct: 157 -------------------------TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
Query: 705 LLTGKV 710
L GK
Sbjct: 192 CLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 25/159 (15%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI------------ 141
+ S+P+ L + L+ LDLS N L+ L L N S L NLDLS N I
Sbjct: 152 IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSA 210
Query: 142 -------SGHLPETMGSLHN---LQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
+ + E + SL N L L LS+N L LP S+ L +L + L NN S
Sbjct: 211 LEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269
Query: 192 GLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLS 229
+++ LDLS N ++ +LP L L L+
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308
|
Length = 394 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 50/231 (21%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRR-IGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG +YKA ++ LA + I S + D+ ++ ++A HPN+V++ ++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIA-KGVARGLAFLHEKKHVHG 600
+ I+ +F G++ +A ++ E ++++ K L +LHE K +H
Sbjct: 73 YENNLWILIEFCAGGAV-DAVMLELERPLT----EPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+LK N+L D + K+ DFG+ SA+N R+ RDSF +G
Sbjct: 128 DLKAGNILFTLDGDIKLADFGV---------------SAKN---TRTIQRRDSF--IG-- 165
Query: 661 PSPSPSPSPSSLGGISPY-HAPESL--RSIKPNP---KWDVYSFGVILLEL 705
+PY APE + + K P K DV+S G+ L+E+
Sbjct: 166 ---------------TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 46/209 (22%), Positives = 84/209 (40%), Gaps = 43/209 (20%)
Query: 501 ALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560
A+ V + R + + ++ +L +P +VR+ G + +++ + G L
Sbjct: 26 AIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMIGV-CEAEALMLVMEMASGGPL-- 81
Query: 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620
+ + + +++ V+ G+ +L K VH +L RNVLL N KI DF
Sbjct: 82 --NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDF 139
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--Y 678
GL SKA G+ ++ RS G P +
Sbjct: 140 GL----------SKALGADDSYYKARS-------------------------AGKWPLKW 164
Query: 679 HAPESLRSIKPNPKWDVYSFGVILLELLT 707
+APE + K + + DV+S+G+ + E +
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 15/128 (11%)
Query: 517 DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPC 571
DF +V+++++L PN++R+ G D +I +++ NG L ++ K +
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 572 HLP---------WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
+P + + L +A +A G+ +L VH +L RN L+G ++ KI DFG+
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 623 ER-LVTGD 629
R L GD
Sbjct: 185 SRNLYAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 54/233 (23%), Positives = 102/233 (43%), Gaps = 45/233 (19%)
Query: 484 GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV 543
GASG+ + + G +A+++I + ++ V+ +L +PN+V +
Sbjct: 30 GASGT-VFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG 88
Query: 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVHGNL 602
DE ++ +++ GSL + + + C EA++ + + + L FLH + +H ++
Sbjct: 89 DELFVVMEYLAGGSLTD-----VVTETCMD--EAQIAAVCRECLQALEFLHANQVIHRDI 141
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K NVLLG D K+ DFG +T + SKRST
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQ-------------SKRST-------------- 174
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
+ G + APE + PK D++S G++ +E++ G+ ++E
Sbjct: 175 ---------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 7/116 (6%)
Query: 515 FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRKMGSSPCHL 573
F++ + + L H +VR+ G G +L+ P GSL + R + P L
Sbjct: 53 FQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 574 PWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
L +A+G+ +L E + VH NL RN+LL +D +I DFG+ L+ D
Sbjct: 112 -----LNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 74/323 (22%), Positives = 134/323 (41%), Gaps = 80/323 (24%)
Query: 484 GASGSSIMYKAV----LEDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV--HPNLVRI 536
GA G + +AV + + +AV+ + +++ ++ D +++ ++ K++ H N++ +
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM-KMIGKHKNIINL 81
Query: 537 RGFYWGVDEKLIIYDFVPNGSLAN---ARYRKM---GSSPCHLPWE-----ARLKIAKGV 585
G ++ ++ +G+L + AR P E + A V
Sbjct: 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
ARG+ FL KK +H +L RNVL+ D KI DFGL R +
Sbjct: 142 ARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH------------------ 183
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
D ++ G P + APE+L + DV+SFGV+L E+
Sbjct: 184 ----HIDYYRKTTNGRLP------------VKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
Query: 706 LTGKVIVVDELGQGN---GLLVEDKNRAIRLADAAIRADFEGKE-EALLSC----FKLGY 757
T LG G+ G+ VE+ + ++ EG E +C + L
Sbjct: 228 FT--------LG-GSPYPGIPVEELFKLLK----------EGYRMEKPQNCTQELYHLMR 268
Query: 758 SCASPLPQKRPSMKEALQALEKI 780
C +P +RP+ K+ ++ L+++
Sbjct: 269 DCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 48/155 (30%)
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFG 621
Y+K+ +P + KIA + + L +LH K V H ++KP NVL+ + + K+ DFG
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAP 681
++G S A K A G PY AP
Sbjct: 150 ----ISGYLVDSVA---------KTIDA------------------------GCKPYMAP 172
Query: 682 ESLRSIKP-------NPKWDVYSFGVILLELLTGK 709
E I P + K DV+S G+ ++EL TG+
Sbjct: 173 E---RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 73/314 (23%)
Query: 475 LLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNL 533
+++A+AY L S + + + TA + R +++++++ L H N+
Sbjct: 51 VVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---------EALMSELKIMSHLGNHENI 101
Query: 534 VRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
V + G L+I ++ G L N RK S L E L + VA+G+AFL
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLA 158
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
K +H +L RNVLL + KI DFGL R + D S+ G+AR
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNAR------------- 204
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713
P + APES+ + + DV+S+G++L E+ +
Sbjct: 205 --------------LPVK------WMAPESIFNCVYTFESDVWSYGILLWEIFS------ 238
Query: 714 DELGQGN---GLLVEDK-----NRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQ 765
LG N G+ V+ K R+A E + + +C P
Sbjct: 239 --LG-SNPYPGMPVDSKFYKLIKEGYRMAQPE----HAPAE-----IYDIMKTCWDADPL 286
Query: 766 KRPSMKEALQALEK 779
KRP+ K+ +Q + K
Sbjct: 287 KRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY-----WGVDE 545
YKA + L +I + D + + + ++ K HPN+ G + G D+
Sbjct: 23 YKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82
Query: 546 KL-IIYDFVPNGS---LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+L ++ + GS L RK G L E I + RGLA+LHE K +H +
Sbjct: 83 QLWLVMELCGGGSVTDLVK-GLRKKGKR---LKEEWIAYILRETLRGLAYLHENKVIHRD 138
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVT 627
+K +N+LL + E K+ DFG+ +
Sbjct: 139 IKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 41/189 (21%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+V+V+ +L H N+V ++ + +++++V L + +SP LP +A
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL-----ELLEASPGGLPPDAVRS 104
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
+ + +A+ H +H ++KP N+L+ K+ DFG R + A
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR--------ARPAS 156
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFG 699
+T Y APE L DV++ G
Sbjct: 157 PLTDYVATRW---------------------------YRAPELLVGDTNYGKPVDVWAIG 189
Query: 700 VILLELLTG 708
I+ ELL G
Sbjct: 190 CIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 74/243 (30%)
Query: 484 GASGSSIMYKA-VLEDGTALAVRRI--------GENSVDRFRDFETQVRVIAKLVHPNLV 534
GA G I++KA E G +A++++ N R +++ + HP +V
Sbjct: 11 GAHG--IVFKAKDRETGETVALKKVALRRLEGGIPNQALR------EIKALQACQHPYVV 62
Query: 535 RIR-------GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVA 586
++ GF ++ +++P L + LP EA++K + +
Sbjct: 63 KLLDVFPHGSGFV-------LVMEYMP-SDL----SEVLRDEERPLP-EAQVKSYMRMLL 109
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+G+A++H +H +LKP N+L+ D KI DFGL RL
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL--------------------- 148
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLEL 705
S ++ Y APE L + K +P D+++ G I EL
Sbjct: 149 ----------FSEEEPRLYSHQVATRW----YRAPELLYGARKYDPGVDLWAVGCIFAEL 194
Query: 706 LTG 708
L G
Sbjct: 195 LNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/243 (22%), Positives = 99/243 (40%), Gaps = 52/243 (21%)
Query: 483 LGASGSSIMYKAVL-----EDGTALAVRRIGE-NSVDRFRDFETQVRVIAKLVHPNLVRI 536
LG +YK L + +A++ + + N+ ++ +F+ + ++A+L HPN+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 537 RGFYWGVDEKLIIYDFVPNGSL------------ANARYRKMGSSPCHLPWEARLKIAKG 584
G ++++++ G L + G+ L L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+A G+ +L VH +L RN+L+G + KI D GL R +
Sbjct: 133 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY----------------- 175
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
S D ++ P SL I + PE++ K + D++SFGV+L E
Sbjct: 176 -----SADYYR-----------VQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWE 218
Query: 705 LLT 707
+ +
Sbjct: 219 IFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 43/194 (22%)
Query: 520 TQVRVIA---KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWE 576
T +R I+ +L H N+VR+ ++ +++++++ +Y L
Sbjct: 44 TAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDL---KKYMDTHGVRGALDPN 100
Query: 577 ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
+ +G+AF HE + +H +LKP+N+L+ E K+ DFGL
Sbjct: 101 TVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGL-------------- 146
Query: 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDV 695
AR FG +T S + +L Y AP+ L S + D+
Sbjct: 147 --ARAFGIPVNTFSNEVV----------------TLW----YRAPDVLLGSRTYSTSIDI 184
Query: 696 YSFGVILLELLTGK 709
+S G I+ E++TG+
Sbjct: 185 WSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/260 (20%), Positives = 106/260 (40%), Gaps = 50/260 (19%)
Query: 452 HERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLED-GTALAVRRIGEN 510
HE+ +V+ GD L+ +K +G + I+ A ++ G +AV+++
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK-----IGEGSTGIVCIATVKSSGKLVAVKKMDLR 56
Query: 511 SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRKMGSS 569
R +V ++ H N+V + Y DE ++ +F+ G+L + + +M
Sbjct: 57 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE- 115
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
E + V + L+ LH + +H ++K ++LL +D K+ DFG V+ +
Sbjct: 116 ------EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169
Query: 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
P SL G + APE + +
Sbjct: 170 V------------------------------------PRRKSLVGTPYWMAPELISRLPY 193
Query: 690 NPKWDVYSFGVILLELLTGK 709
P+ D++S G++++E++ G+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 41/234 (17%)
Query: 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDR------FRDFETQVRVIAKLVHPNLVR 535
+LG +Y + G +AV+++ ++ + + + +V ++ L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
G + I +FVP GS+++ R G LP K K + G+A+LH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR-FGP----LPEPVFCKYTKQILDGVAYLHNN 121
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
VH ++K NV+L + K+ DFG R +
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA---------------------------- 153
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G + S S+ G + APE + K D++S G + E+ TGK
Sbjct: 154 --WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 6/146 (4%)
Query: 491 MYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
+YKA L G AV+ I D F + ++ ++ + H N+V G Y ++ I
Sbjct: 25 VYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84
Query: 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
++ GSL + + S + + R + +GLA+LH K +H ++K N+LL
Sbjct: 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKMHRDIKGANILL 139
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKA 635
++ + K+ DFG+ +T + K+
Sbjct: 140 TDNGDVKLADFGVAAKITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 56/226 (24%)
Query: 492 YKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG---VDEK 546
YKA+ +A++ I E + D D + +++ +++ P + + Y+G K
Sbjct: 18 YKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK----YYGSFLKGSK 73
Query: 547 L-IIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
L II ++ GS + + K+ I + V GL +LHE+ +H ++K
Sbjct: 74 LWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVLLGLEYLHEEGKIHRDIKA 126
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
N+LL + + K+ DFG V+G +S+ SKR+T F +G
Sbjct: 127 ANILLSEEGDVKLADFG----VSGQLTSTM---------SKRNT-----F--VG------ 160
Query: 665 PSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+P+ APE ++ + K D++S G+ +EL G+
Sbjct: 161 -----------TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 46/210 (21%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+++++ ++ H N++ + Y D ++ D + L RK+ + E+++K
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLT------ESQVK 122
Query: 581 -IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER-----LVTGDTSSSK 634
I + GL LH+ +H +L P N+ + + KI DFGL R + S +
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKW 693
SK T Y APE L + K +
Sbjct: 183 TMQRREEMTSKVVTLW---------------------------YRAPELLMGAEKYHFAV 215
Query: 694 DVYSFGVILLELLTGKVIV-----VDELGQ 718
D++S G I ELLTGK + +D+LG+
Sbjct: 216 DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 44/197 (22%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHL- 573
+ E + +++++L HPN+V R + G D L I+ F G L Y K+ L
Sbjct: 44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL----YHKLKEQKGKLL 99
Query: 574 PWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633
P ++ +A L +LHEK +H +LK +NV L K+GD G+ R++
Sbjct: 100 PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL------- 152
Query: 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPK 692
++ D+ S+L G Y +PE L S KP N K
Sbjct: 153 ------------------ENQCDMA-----------STLIGTPYYMSPE-LFSNKPYNYK 182
Query: 693 WDVYSFGVILLELLTGK 709
DV++ G + E+ T K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 47/228 (20%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
G+ GS +YKA+ E G +A++ + ++ ++ ++ + P +V+ G Y+
Sbjct: 14 GSYGS--VYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ ++ GS+++ M + L E I +GL +LH K +H ++
Sbjct: 70 NTDLWIVMEYCGAGSVSDI----MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K N+LL + + K+ DFG+ S + + A R++ +G
Sbjct: 126 KAGNILLNEEGQAKLADFGV---------SGQLTD---------TMAKRNTV--IG---- 161
Query: 663 PSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGK 709
+P+ APE ++ I N K D++S G+ +E+ GK
Sbjct: 162 -------------TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 39/194 (20%), Positives = 77/194 (39%), Gaps = 43/194 (22%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
R F + + + H N+VR+ G + +I+ +++ NG+L + + G L
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG----QLVA 106
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ + G+A G+ +L E +VH L VL+ +D+ KI F
Sbjct: 107 GQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF--------------- 151
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPNPKW 693
+++ G SP + APE+++ +
Sbjct: 152 ----------------------RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 694 DVYSFGVILLELLT 707
DV+SFG+++ E+++
Sbjct: 190 DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 36/136 (26%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 502 LAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560
+AV+ + E++ R DF +++++++L PN++R+ D +I +++ NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 561 --ARYRKMG----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME 614
+R+ + + + + +A +A G+ +L VH +L RN L+G +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168
Query: 615 PKIGDFGLER-LVTGD 629
KI DFG+ R L +GD
Sbjct: 169 IKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 35/116 (30%), Positives = 62/116 (53%), Gaps = 13/116 (11%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEA 577
FET ++++L H +LV++ G DE +++ ++V G L +R+ + H W
Sbjct: 49 FET-ASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLH--W-- 102
Query: 578 RLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEP----KIGDFGLERLV 626
+L +AK +A L +L +KK VHGN+ +N+L+ G + K+ D G+ V
Sbjct: 103 KLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 60/224 (26%), Positives = 85/224 (37%), Gaps = 58/224 (25%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
R L ++H H +LKP+N+L D + KI DFGL R+ DT ++ F +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI-------FWTD- 165
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI--KPNPKWDVYSFGVILLE 704
A+R Y APE S K P D++S G I E
Sbjct: 166 YVATR-------------------------WYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200
Query: 705 LLTGKVI-----VVDELGQGNGLLVEDKNRAI-RLADAAIRADFEGKEEALLSCFKLGYS 758
+LTGK + VV +L LL I R+ + R + F +
Sbjct: 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP 260
Query: 759 CASPL------------PQKRPSMKEAL-----QALEKIPSSPS 785
A PL P+ RP+ +EAL + L K+ PS
Sbjct: 261 NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 75/315 (23%), Positives = 111/315 (35%), Gaps = 60/315 (19%)
Query: 469 ELELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAK 527
E E E +LG I+Y A L +A++ I E + ++ + +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 528 LVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI-AKGVA 586
L H N+V+ G I + VP GSL+ K G + E + K +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQIL 118
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
GL +LH+ + VH ++K NVL+ KI DFG TS AG
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG--------TSKRLAG--------- 161
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW-----DVYSFGV 700
+P + G Y APE I P+ D++S G
Sbjct: 162 -------------------INPCTETFTGTLQYMAPE---VIDKGPRGYGAPADIWSLGC 199
Query: 701 ILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA 760
++E+ TGK + ELG+ +A + E E C
Sbjct: 200 TIVEMATGKPPFI-ELGEP---------QAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249
Query: 761 SPLPQKRPSMKEALQ 775
P P KR S + LQ
Sbjct: 250 EPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 60/282 (21%), Positives = 105/282 (37%), Gaps = 52/282 (18%)
Query: 498 DGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
D T +AV+ E + F + R++ + HPN+VR+ G I+ + V G
Sbjct: 19 DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78
Query: 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616
+ + L + +++ + A G+ +L K +H +L RN L+ K
Sbjct: 79 DFLTF----LRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLK 134
Query: 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGIS 676
I DFG+ R + G + G + +
Sbjct: 135 ISDFGMSR--------EEEDGVYASTGGMKQIPVK------------------------- 161
Query: 677 PYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLAD 735
+ APE+L + + + DV+SFG++L E + G V + Q +E + +RL
Sbjct: 162 -WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QGVRL-- 215
Query: 736 AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
E + ++L C P +RPS Q L
Sbjct: 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 33/161 (20%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFE-----TQVRVIAKL------VHP 531
GA G +YKA L G +A++++ R E + +R IA L HP
Sbjct: 10 GAYG--TVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 532 NLVRIRGFYWGVDEK-----LIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKG 584
N+VR+ G ++++ V + LA ++ K G P + + +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD-----LMRQ 115
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
+ RG+ FLH + VH +LKP+N+L+ +D + KI DFGL R+
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 38/123 (30%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL-VTGDTSSSKAGGSARNFGSKR 646
GL FLH+K ++ +LK NVLL D KI DFG+ + + G+ +
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA-------------- 153
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
S+ G Y APE L+ K N D +SFGV+L E+L
Sbjct: 154 -----------------------STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 707 TGK 709
G+
Sbjct: 191 IGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 47/195 (24%)
Query: 519 ETQVRVIAKLVHPNLVRIRGFY--WGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPW 575
+ + +V+ L HPN++ +Y + D+ L I+ ++ P G+LA ++ S L
Sbjct: 47 QNECQVLKLLSHPNII---EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS---LLDE 100
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDTSSSK 634
+ L + L +H K +H +LK +N+LL + M KIGDFG+ +++ +S SK
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSK 157
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWD 694
A ++ G Y +PE N K D
Sbjct: 158 A----------------------------------YTVVGTPCYISPELCEGKPYNQKSD 183
Query: 695 VYSFGVILLELLTGK 709
+++ G +L EL + K
Sbjct: 184 IWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 43/189 (22%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583
++++L H +LV G DE +++ ++V GSL Y K + ++ W +L++AK
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT--YLKKNKNLINISW--KLEVAK 107
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFG 643
+A L FL +K HGN+ +NVLL + + K G+ +L
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD---------------- 151
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK----PNPKWDVYSFG 699
PG S + P L I P+ PE + + + KW SFG
Sbjct: 152 ---------------PGISITVLPKEILLERI-PWVPPECIENPQNLSLAADKW---SFG 192
Query: 700 VILLELLTG 708
L E+ +G
Sbjct: 193 TTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 54/260 (20%), Positives = 106/260 (40%), Gaps = 50/260 (19%)
Query: 452 HERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLE-DGTALAVRRIGEN 510
HE+ LV+ GD L++ +K +G + I+ A + G +AV+++
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK-----IGEGSTGIVCIATEKHTGKQVAVKKMDLR 58
Query: 511 SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRKMGSS 569
R +V ++ H N+V + Y DE ++ +F+ G+L + + +M
Sbjct: 59 KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE- 117
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
E + V R L++LH + +H ++K ++LL +D K+ DFG V+ +
Sbjct: 118 ------EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171
Query: 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
P SL G + APE + +
Sbjct: 172 V------------------------------------PKRKSLVGTPYWMAPEVISRLPY 195
Query: 690 NPKWDVYSFGVILLELLTGK 709
+ D++S G++++E++ G+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 33/120 (27%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
V+ G+ +L E VH +L RNVLL KI DFGL SKA G+ N+
Sbjct: 104 VSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL----------SKALGADENY-- 151
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
++ G P ++APE + K + K DV+SFGV++ E
Sbjct: 152 ---------YKAKTHGKWPVK------------WYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 36/127 (28%), Positives = 54/127 (42%), Gaps = 40/127 (31%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
+ GL FLHE+ ++ +LK NVLL ++ KI DFG+ E ++ G T+S+ G
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG------ 158
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
+P Y APE L P D ++ GV+L
Sbjct: 159 -------------------TPD-------------YIAPEILSYQPYGPAVDWWALGVLL 186
Query: 703 LELLTGK 709
E+L G+
Sbjct: 187 YEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 62/227 (27%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQ---LRNLDLSNNLISG------- 143
L S+ L LQ LDLS+N+L L + + L+ L L+NN +
Sbjct: 70 LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129
Query: 144 ----HLPETMGSL---HN-------------------LQLLNLSDNALAG----KLPVSL 173
LP + L N L+ LNL++N + L L
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189
Query: 174 TTLQSLTIVSLKNNYFSD-------GLPSKFNSVQVLDLSSNLI---------NGSLPPD 217
+L ++ L NN +D + S++VL+L N + + L P+
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPN 249
Query: 218 IGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI---DLSFNNLTGE 261
I SL L+LS N ++ + E + ++ DL N E
Sbjct: 250 I---SLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 50/234 (21%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G S +Y A+ + G +A+R++ + ++ V+ + +PN+V Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
DE ++ +++ GSL + + + C + + + + L FLH + +H +
Sbjct: 88 VGDELWVVMEYLAGGSLTD-----VVTETCMDEGQIA-AVCRECLQALEFLHSNQVIHRD 141
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+LLG D K+ DFG +T + SKR
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-------------SKR--------------- 173
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
S++ G + APE + PK D++S G++ +E++ G+ ++E
Sbjct: 174 --------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 52/200 (26%)
Query: 510 NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSS 569
N V RD++ HPN+V + Y DE ++ +F+ G+L + +
Sbjct: 65 NEVVIMRDYQ----------HPNIVEMYSSYLVGDELWVVMEFLEGGALTDI------VT 108
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
+ E + V + L+FLH + +H ++K ++LL +D K+ DFG V+ +
Sbjct: 109 HTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
Query: 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
P SL G + APE + +
Sbjct: 169 V------------------------------------PRRKSLVGTPYWMAPEVISRLPY 192
Query: 690 NPKWDVYSFGVILLELLTGK 709
+ D++S G++++E++ G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 50/234 (21%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G S +Y A+ + G +A++++ + ++ V+ + +PN+V Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
DE ++ +++ GSL + + + C + + + + L FLH + +H +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-----VVTETCMDEGQIA-AVCRECLQALDFLHSNQVIHRD 140
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+LLG D K+ DFG +T + SKRST
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-------------SKRST------------- 174
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
+ G + APE + PK D++S G++ +E++ G+ ++E
Sbjct: 175 ----------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 40/135 (29%), Positives = 56/135 (41%), Gaps = 42/135 (31%)
Query: 580 KIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638
K+ + + L +L EK V H ++KP N+LL K+ DFG+ S
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI---------------S 162
Query: 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW----D 694
R SK T S G + Y APE + PNPK+ D
Sbjct: 163 GRLVDSKAKTRS----------------------AGCAAYMAPERIDPPDPNPKYDIRAD 200
Query: 695 VYSFGVILLELLTGK 709
V+S G+ L+EL TG+
Sbjct: 201 VWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 130 QLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189
L++LDLSNN ++ L NL++L+LS N L P + + L SL + L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
RGL +LH +H +LKP N+L+ ++ + KI DFGL R V D
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 39/186 (20%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583
++AK+ HPN+V + + I+ ++ G L + G P + L+
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFV 107
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFG 643
+ G+ +HEK+ +H ++K +N+ L + + K+GDFG RL+T
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---------------- 151
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703
SP + G Y PE ++ N K D++S G IL
Sbjct: 152 --------------------SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILY 191
Query: 704 ELLTGK 709
EL T K
Sbjct: 192 ELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 48/190 (25%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANA--RYRKMG---SSPCHLPW 575
+ ++++KL HP +V+ + D II ++ L + G S W
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+L + G+ ++H+++ +H +LK +N+ L N++ KIGDFG+ RL+ G
Sbjct: 112 FIQLLL------GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSC----- 159
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
DL ++ G Y +PE+L+ + K D+
Sbjct: 160 --------------------DLA-----------TTFTGTPYYMSPEALKHQGYDSKSDI 188
Query: 696 YSFGVILLEL 705
+S G IL E+
Sbjct: 189 WSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 47/179 (26%), Positives = 70/179 (39%), Gaps = 32/179 (17%)
Query: 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
+ D++P G + + R +G L AR IA+ + + +H+ +H ++KP N+L
Sbjct: 79 VMDYIPGGDMMSLLIR-LGIFEEDL---ARFYIAE-LTCAIESVHKMGFIHRDIKPDNIL 133
Query: 609 LGNDMEPKIGDFGLERLVTGD--TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+ D K+ DFGL TG T SK + K +DS +
Sbjct: 134 IDRDGHIKLTDFGL---CTGFRWTHDSK-------YYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 667 PSPS---------------SLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710
SL G Y APE L D +S GVIL E+L G+
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 38/124 (30%), Positives = 48/124 (38%), Gaps = 37/124 (29%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G+A LH+ +H +LK N+LL N KI DFGL AR +G
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL----------------AREYG--- 157
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLEL 705
SP + L Y APE L K + D++S G I EL
Sbjct: 158 -----------------SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200
Query: 706 LTGK 709
LT K
Sbjct: 201 LTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 39/221 (17%)
Query: 502 LAVRRIGENSVDR---FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP---- 554
+A+++I E+ + + F + ++ A L+HP +V + + +Y +P
Sbjct: 30 VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC---SDGDPVYYTMPYIEG 86
Query: 555 ---NGSLANARYRKMGSSPCHLPWE--ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
L + ++ S A L I + + ++H K +H +LKP N+LL
Sbjct: 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL 146
Query: 610 GNDMEPKIGDFGLERLVTG---DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
G E I D+G D S
Sbjct: 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVD---------------------ERNICYSSM 185
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
P + G Y APE L + + D+Y+ GVIL ++LT
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAV-LEDG----TALAVRRIGENSVDRF-RDFETQ 521
KE EL+ + +LG+ +YK + + DG +A++ + EN+ + ++ +
Sbjct: 5 KETELKKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDE 59
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRK--MGSSPCHLPWEAR 578
V+A + P + R+ G +L+ +P G L + R K +GS L W +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDL-LNWCVQ 117
Query: 579 LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
+A+G+++L E + VH +L RNVL+ + KI DFGL RL+ D + A G
Sbjct: 118 ------IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 7/115 (6%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIA 582
V+A + +P++ R+ G +LI +P G L + R K +L L
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNWC 115
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
+A+G+ +L E++ VH +L RNVL+ KI DFGL +L+ D A G
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 34/112 (30%), Positives = 53/112 (47%)
Query: 511 SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSP 570
+ D F +V+ +L HPN+++ G L++ +F P G L N G
Sbjct: 35 TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVA 94
Query: 571 CHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
+ ++A VA GL +LH+ +H +L RN L D+ KIGD+GL
Sbjct: 95 QMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 34/123 (27%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
VARG+ FL +K +H +L RN+LL + KI DFGL R + D + G AR
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDAR---- 236
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
P + APES+ + DV+SFGV+L E
Sbjct: 237 -----------------------LPLK------WMAPESIFDKVYTTQSDVWSFGVLLWE 267
Query: 705 LLT 707
+ +
Sbjct: 268 IFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+++V+ + P +V G ++ E I + + GSL + +K G +P K
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAG----RIPENILGK 103
Query: 581 IAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
I+ V RGL +L EK K +H ++KP N+L+ + E K+ DFG V+G S A
Sbjct: 104 ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMA---- 155
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
+S G Y +PE L+ + D++S G
Sbjct: 156 ------------------------------NSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 700 VILLELLTGK 709
+ L+E+ G+
Sbjct: 186 LSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 54/267 (20%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS 568
E + D D + ++ V+++ P + + G Y + II +++ GS +
Sbjct: 40 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL------ 93
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628
P L I + + +GL +LH +K +H ++K NVLL E K+ DFG V G
Sbjct: 94 EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG----VAG 149
Query: 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK 688
+ ++ R++F G + APE ++
Sbjct: 150 QLTDTQ--------------IKRNTFV------------------GTPFWMAPEVIKQSA 177
Query: 689 PNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEA 748
+ K D++S G+ +EL G+ EL L + KN L EG
Sbjct: 178 YDSKADIWSLGITAIELAKGEP-PHSELHPMKVLFLIPKNNPPTL---------EGNYSK 227
Query: 749 LLSCFKLGYSCASPLPQKRPSMKEALQ 775
L F +C + P RP+ KE L+
Sbjct: 228 PLKEFV--EACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 42/201 (20%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS 568
E + D D + ++ V+++ P + R G Y + II +++ GS + +
Sbjct: 40 EEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDL----LKP 95
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628
P + A I + + +GL +LH ++ +H ++K NVLL + K+ DFG V G
Sbjct: 96 GPLEETYIA--TILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFG----VAG 149
Query: 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK 688
+ ++ KR+T F + APE ++
Sbjct: 150 QLTDTQI---------KRNTFVGTPF-----------------------WMAPEVIKQSA 177
Query: 689 PNPKWDVYSFGVILLELLTGK 709
+ K D++S G+ +EL G+
Sbjct: 178 YDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 76/330 (23%), Positives = 135/330 (40%), Gaps = 82/330 (24%)
Query: 484 GASGSSIMYKAVLED------GTALAVRRIGENSVDR-FRDFETQVRVIAKLV--HPNLV 534
G G +M +A+ D +AV+ + +++ D+ D +++ ++ K++ H N++
Sbjct: 23 GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM-KMIGKHKNII 81
Query: 535 RIRGFYWGVDEKLIIYDFVPNGSLANAR-YRKMGSSP--------CHLPWEAR-----LK 580
+ G + +Y V S N R Y + P C LP E +
Sbjct: 82 NLLG---ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
A VARG+ +L +K +H +L RNVL+ D KI DFGL R V
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-------------- 184
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGV 700
+ D ++ G P + APE+L + DV+SFGV
Sbjct: 185 --------HNIDYYKKTTNGRLP------------VKWMAPEALFDRVYTHQSDVWSFGV 224
Query: 701 ILLELLTG-----KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKL 755
+L E+ T I V+EL + L+++ +R + A+ + +
Sbjct: 225 LLWEIFTLGGSPYPGIPVEELFK----LLKEGHRMDKPANCT------------HELYMI 268
Query: 756 GYSCASPLPQKRPSMKEALQALEKIPSSPS 785
C +P +RP+ K+ ++ L+++ + S
Sbjct: 269 MRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 27/130 (20%)
Query: 508 GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY------WGVDEKLIIYDFVPNGSLANA 561
G+ S ++++D +VR + +L HPN + +G Y W V E + GS ++
Sbjct: 52 GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-------GSASDI 104
Query: 562 R--YRKMGSSPCHLPWEARLKIA---KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616
++K P ++IA G +GLA+LH + +H ++K N+LL K
Sbjct: 105 LEVHKK----PLQ-----EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVK 155
Query: 617 IGDFGLERLV 626
+ DFG LV
Sbjct: 156 LADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 32/146 (21%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 485 ASGSSIMYKAVLEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
S ++ + + + +A++++ G+ S ++++D +VR + KL HPN ++ RG Y
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
++ ++ + K + + G +GLA+LH +H +
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYLHSHNMIHRD 140
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVT 627
+K N+LL K+GDFG ++
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMA 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 50/204 (24%)
Query: 579 LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638
L+ + VA+G+ FL K +H ++ RNVLL + KI DFGL R + D S+ G+
Sbjct: 215 LRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGN 273
Query: 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698
AR P + APES+ + DV+S+
Sbjct: 274 AR---------------------------LPVK------WMAPESIFDCVYTVQSDVWSY 300
Query: 699 GVILLELLTGKVIVVDELGQG--NGLLVEDK-NRAIRLADAAIRADFEGKEEALLSCFKL 755
G++L E+ + LG+ G+LV K + ++ R DF A + +
Sbjct: 301 GILLWEIFS--------LGKSPYPGILVNSKFYKMVKRGYQMSRPDF-----APPEIYSI 347
Query: 756 GYSCASPLPQKRPSMKEALQALEK 779
C + P +RP+ + Q +++
Sbjct: 348 MKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-06
Identities = 23/59 (38%), Positives = 31/59 (52%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ LDLSNN L + L+ LDLS N ++ PE L +L+ L+LS N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 48/206 (23%)
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
E L + VA+G++FL K +H +L RN+LL + KI DFGL R + D S+
Sbjct: 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVV 272
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G+AR P +P S+ ++ + S DV
Sbjct: 273 KGNAR---------------------LPVKWMAPESI-----FNCVYTFES-------DV 299
Query: 696 YSFGVILLELLTGKVIVVDELGQG--NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCF 753
+S+G++L E+ + LG G+ V+ K ++ R E A +
Sbjct: 300 WSYGILLWEIFS--------LGSSPYPGMPVDSK--FYKMIKEGYR--MLSPECAPSEMY 347
Query: 754 KLGYSCASPLPQKRPSMKEALQALEK 779
+ SC P KRP+ K+ +Q +E+
Sbjct: 348 DIMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 56/235 (23%)
Query: 484 GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQ-----VRVIAKLVHPNLVRIRG 538
G+ G +I+ K+ EDG ++ I + + E + V V++ + HPN+V+ +
Sbjct: 11 GSFGKAILVKSK-EDGKQYVIKEIN---ISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 539 FYWGVDEKLIIYDFVPNGSL---ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ I+ D+ G L NA+ + L W ++ +A L +H++
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR 120
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
K +H ++K +N+ L D K+GDFG+ R++ ++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR--------------------- 159
Query: 656 DLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ +G +PY+ +PE + N K D+++ G +L E+ T K
Sbjct: 160 --------------TCIG--TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 8/119 (6%)
Query: 511 SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARY----RKM 566
SV F + + L H NL++ G V L++ +F P G L Y RK
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK--GYLRSCRKA 92
Query: 567 GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
R+ A +A GL LH+ +H +L RN LL D+ KIGD+GL
Sbjct: 93 ELMTPDPTTLQRM--ACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 67/308 (21%), Positives = 127/308 (41%), Gaps = 70/308 (22%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV--HPNLVRIRGFYWGVDEKLIIYDFV 553
+ +AV+ + +N+ D+ D +++ ++ KL+ H N++ + G +I ++
Sbjct: 42 DQTVTVAVKMLKDNATDKDLADLISEMELM-KLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 554 PNGSLAN-ARYRK----------MGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
G+L R R+ L ++ + A VARG+ +L ++ +H +L
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RNVL+ D KI DFGL R V D ++ G
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGV----------------------HDIDYYKKTSNGRL 198
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-----GKVIVVDELG 717
P + APE+L + DV+SFG+++ E+ T I V+EL
Sbjct: 199 P------------VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
Query: 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
+ L+ + +R + ++ + L C +P +RP+ K+ ++AL
Sbjct: 247 K----LLREGHRMDKPSNCT------------HELYMLMRECWHAVPTQRPTFKQLVEAL 290
Query: 778 EKIPSSPS 785
+K+ ++ S
Sbjct: 291 DKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 46/188 (24%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-ANARYRKMGSSPCHLPWEARLKI 581
RV+ ++ HP ++R+ ++ ++VP G L + R S+ L + + +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A L +LH K+ V+ +LKP N+LL + K+ DFG + + T
Sbjct: 113 A------LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----------- 155
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
+L G Y APE ++S N D ++ G++
Sbjct: 156 ----------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGIL 187
Query: 702 LLELLTGK 709
+ E+L G
Sbjct: 188 IYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 56/237 (23%)
Query: 482 ILG-ASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFE---TQVRVIA-KLVHPNLVRI 536
+LG S +M + E G AV+ + ++ + + D E T+ R+++ HP L ++
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 537 RGFYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKI-AKGVARGLAFLH 593
+ D + +FV G L + R+ EAR + A + L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--------EARARFYAAEITSALMFLH 113
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+K ++ +LK NVLL ++ K+ DFG+ E + G T+S+ G
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG--------------- 158
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+P Y APE L+ + P D ++ GV+L E+L G
Sbjct: 159 ----------TPD-------------YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 76/325 (23%), Positives = 129/325 (39%), Gaps = 72/325 (22%)
Query: 484 GASGSSIMYKAVLEDG------TALAVRRIGENSVDR-FRDFETQV---RVIAKLVHPNL 533
G G +M +A+ D T +AV+ + ++ ++ D +++ ++I K H N+
Sbjct: 29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNI 86
Query: 534 VRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRK-----MGSSPCHLPWEAR-----LKIA 582
+ + G +I ++ G+L R R+ +P +P E + A
Sbjct: 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNF 642
VARG+ +L KK +H +L RNVL+ D KI DFGL
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-------------------- 186
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
R D ++ G P + APE+L + DV+SFGV+L
Sbjct: 187 --ARDIHHIDYYKKTTNGRLP------------VKWMAPEALFDRIYTHQSDVWSFGVLL 232
Query: 703 LELLTGKVIVVDELGQG--NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA 760
E+ T LG G+ VE+ +L R D + + C
Sbjct: 233 WEIFT--------LGGSPYPGVPVEE---LFKLLKEGHRMD--KPSNCTNELYMMMRDCW 279
Query: 761 SPLPQKRPSMKEALQALEKIPSSPS 785
+P +RP+ K+ ++ L++I + S
Sbjct: 280 HAVPSQRPTFKQLVEDLDRILALTS 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 46/195 (23%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEAR 578
++ ++ L HPN+V ++ G +D ++ ++ LA + + P E++
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLA----SLLDNMPTPFS-ESQ 109
Query: 579 LK-IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
+K + + RGL +LHE +H +LK N+LL + KI DFGL
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL--------------- 154
Query: 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW-DVY 696
AR +G P+ +P +L Y APE L D++
Sbjct: 155 -ARTYGL----------------PAKPMTPKVVTLW----YRAPELLLGCTTYTTAIDMW 193
Query: 697 SFGVILLELLTGKVI 711
+ G IL ELL K +
Sbjct: 194 AVGCILAELLAHKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 40/181 (22%), Positives = 71/181 (39%), Gaps = 51/181 (28%)
Query: 531 PNLVRIRGFYWGVDEKLIIY---DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR 587
P + ++ Y+ K +Y +++ G A+ + +G P W A+ IA+ V
Sbjct: 57 PYVAKL---YYSFQSKDYLYLVMEYLNGGDCASL-IKTLGGLP--EDW-AKQYIAE-VVL 108
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
G+ LH++ +H ++KP N+L+ K+ DFGL S+ G + F
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGL----------SRNGLENKKF----- 153
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G Y APE++ + + D +S G ++ E L
Sbjct: 154 -------------------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188
Query: 708 G 708
G
Sbjct: 189 G 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 55/224 (24%)
Query: 495 VLEDGTALAVRRIGENSVDRFRDFETQV----RVIAKLVHPNLVRI-RGFYWGVDEKLI- 548
V A++ + + + + + ++ + HP +V++ R F D+K I
Sbjct: 14 VKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFK---DKKYIY 69
Query: 549 -IYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
+ ++ G L R G + AR IA V +LH + ++ +LKP N
Sbjct: 70 MLMEYCLGGELWTI-LRDRG----LFDEYTARFYIA-CVVLAFEYLHNRGIIYRDLKPEN 123
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+LL ++ K+ DFG + K + +
Sbjct: 124 LLLDSNGYVKLVDFG---------FAKKLKSGQKTW------------------------ 150
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710
+ G Y APE + + + D +S G++L ELLTG+
Sbjct: 151 ----TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+++V+ + P +V G ++ E I + + GSL ++ +P E K
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-----DQVLKEAKRIPEEILGK 107
Query: 581 IAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
++ V RGLA+L EK + H ++KP N+L+ + E K+ DFG V+G S A
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMA---- 159
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
+S G Y +PE L+ + + D++S G
Sbjct: 160 ------------------------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 700 VILLELLTGK 709
+ L+EL G+
Sbjct: 190 LSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 18/38 (47%), Positives = 25/38 (65%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGL +LH +H +LKP N+L+ +D K+ DFGL R
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEA 577
FET ++ ++ H ++V + G E +++ +FV G L +RK S PW
Sbjct: 52 FET-ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK--SDVLTTPW-- 106
Query: 578 RLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612
+ K+AK +A L++L +K VHGN+ +N+LL +
Sbjct: 107 KFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G+ +YKA + G A++ I + F + ++ ++ H N+V G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
D+ I +F GSL + + S + + +R + +GL +LH K +H +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKMHRD 131
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+K N+LL ++ K+ DFG+ +T + K+
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 38/127 (29%), Positives = 52/127 (40%), Gaps = 39/127 (30%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
RGL ++H +H +LKP NV + D+ KIGDFGL R+V D S G + +K
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLVTK 182
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN---PKWDVYSFGVIL 702
Y +P L S PN D+++ G I
Sbjct: 183 W-------------------------------YRSPRLLLS--PNNYTKAIDMWAAGCIF 209
Query: 703 LELLTGK 709
E+LTGK
Sbjct: 210 AEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 52/198 (26%)
Query: 519 ETQVRVIAKLVHPNLVRIRGFYWGVDEK---LIIYDFVPNGSLANARYRKMG---SSPCH 572
+ +V ++AK+ HPN+V F+ E I+ ++ G L R+ G S
Sbjct: 47 KKEVILLAKMKHPNIV---TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI 103
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDTS 631
L W + ++ GL +H++K +H ++K +N+ L N M K+GDFG+ R +
Sbjct: 104 LSWFVQ------ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157
Query: 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP 691
+ + G Y +PE ++ N
Sbjct: 158 LAY------------------------------------TCVGTPYYLSPEICQNRPYNN 181
Query: 692 KWDVYSFGVILLELLTGK 709
K D++S G +L EL T K
Sbjct: 182 KTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQ---------VRVIAKLVHPN 532
+G ++YKA G +A+++I FE++ ++++ +L HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK-------LRFESEGIPKTALREIKLLKELNHPN 59
Query: 533 LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAF 591
++++ + + ++++F+ + Y+ + LP E+ +K + +GLAF
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM----DTDL-YKLIKDRQRGLP-ESLIKSYLYQLLQGLAF 113
Query: 592 LHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
H +H +LKP N+L+ + K+ DFGL R
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/195 (27%), Positives = 81/195 (41%), Gaps = 48/195 (24%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
VARG+ FL +K +H +L RN+LL + KI DFGL R + D + GSAR
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GSAR---- 237
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
P + APES+ + DV+SFGV+L E
Sbjct: 238 -----------------------LPLK------WMAPESIFDKVYTTQSDVWSFGVLLWE 268
Query: 705 LLTGKVIVVDELGQGNGLLVE-DKNRAIRLADAA-IRADFEGKEEALLSCFKLGYSCASP 762
+ + LG V+ ++ RL D +RA E A +++ +C
Sbjct: 269 IFS--------LGASPYPGVQINEEFCQRLKDGTRMRA----PENATPEIYRIMLACWQG 316
Query: 763 LPQKRPSMKEALQAL 777
P++RP+ ++ L
Sbjct: 317 DPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 18/40 (45%), Positives = 27/40 (67%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
RGL ++H +H +LKP N+L+ D E +IGDFG+ R +
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 64/304 (21%), Positives = 114/304 (37%), Gaps = 75/304 (24%)
Query: 488 SSIMYKAVLEDGTALAVRRIG----ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV 543
S + L DG +A++++ ++ R D ++ ++ +L HPN+++ +
Sbjct: 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIED 74
Query: 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
+E I+ + G L+ + +P + K + L +H ++ +H ++K
Sbjct: 75 NELNIVLELADAGDLSRM-IKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK 133
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
P NV + K+GD GL R F S ++TA+
Sbjct: 134 PANVFITATGVVKLGDLGLGR-----------------FFSSKTTAAH------------ 164
Query: 664 SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLL 723
SL G Y +PE + N K D++S G +L E+
Sbjct: 165 -------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------ 199
Query: 724 VEDKNRAIRLADAAIRADFEGKEEALLS-CFKLGYSCASPLPQKRPSMKEALQALEKIPS 782
AA+++ F G + L S C K+ PLP S E L+ L +
Sbjct: 200 ------------AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS--EELRQLVNMCI 245
Query: 783 SPSP 786
+P P
Sbjct: 246 NPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 48/204 (23%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS 568
E + D D + ++ V+++ P + + G Y + II +++ GS + + G
Sbjct: 40 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAG- 96
Query: 569 SPCHLPWEARLKIA---KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
P++ +IA K + +GL +LH +K +H ++K NVLL + K+ DFG
Sbjct: 97 -----PFD-EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFG---- 146
Query: 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR 685
V G + ++ KR+T F + APE ++
Sbjct: 147 VAGQLTDTQI---------KRNTFVGTPF-----------------------WMAPEVIQ 174
Query: 686 SIKPNPKWDVYSFGVILLELLTGK 709
+ K D++S G+ +EL G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/258 (20%), Positives = 100/258 (38%), Gaps = 46/258 (17%)
Query: 452 HERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENS 511
HE+ +V+ GD LE +K G++G + + G +AV+ +
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIKIGE---GSTGIVCIAREK-HSGRQVAVKMMDLRK 58
Query: 512 VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPC 571
R +V ++ H N+V + Y +E ++ +F+ G+L + S
Sbjct: 59 QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI------VSQT 112
Query: 572 HLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631
L E + + V + L +LH + +H ++K ++LL D K+ DFG ++ D
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171
Query: 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP 691
P SL G + APE +
Sbjct: 172 -----------------------------------PKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 692 KWDVYSFGVILLELLTGK 709
+ D++S G++++E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 29/84 (34%), Positives = 47/84 (55%)
Query: 65 SWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFS 124
S N ++ P E ++ +++ L L ++QL G IPA + L LDLS N L+G + +
Sbjct: 507 SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
Query: 125 LFNASQLRNLDLSNNLISGHLPET 148
L N L +++S+N + G LP T
Sbjct: 567 LGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 49/193 (25%)
Query: 522 VRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
V+ + KL HPN+V+++ + DE +++++ G+L + P E+ ++
Sbjct: 48 VKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQL-MKDRKGKP--FS-ESVIR 102
Query: 581 -IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
I + +GLA +H+ H +LKP N+L+ KI DFGL
Sbjct: 103 SIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL----------------- 145
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPES-LRSIKPNPKWDVY 696
R SR + D +S Y APE LRS + D++
Sbjct: 146 -----AREIRSRPPYTDY-----------------VSTRWYRAPEILLRSTSYSSPVDIW 183
Query: 697 SFGVILLELLTGK 709
+ G I+ EL T +
Sbjct: 184 ALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 47/194 (24%), Positives = 74/194 (38%), Gaps = 18/194 (9%)
Query: 519 ETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY---DFVPNGSLANARYRKMGSSPCHLPW 575
T+ ++A L HP L + Y + + D+ P G L R+ G L
Sbjct: 49 LTEQEILATLDHPFLPTL---YASFQTETYLCLVMDYCPGGELFRLLQRQPGKC---LSE 102
Query: 576 E-ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634
E AR A+ + L +LH V+ +LKP N+LL + DF L + S
Sbjct: 103 EVARFYAAEVLL-ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL-------SKQSD 154
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWD 694
+ ++ + S PS +S G Y APE + D
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214
Query: 695 VYSFGVILLELLTG 708
++ G++L E+L G
Sbjct: 215 WWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 38/124 (30%), Positives = 50/124 (40%), Gaps = 40/124 (32%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGSK 645
GL FLH K V+ +LK N+LL D KI DFG+ E ++ G A+
Sbjct: 108 GLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML----------GDAKT---- 153
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
+ G Y APE L K N D +SFGV+L E+
Sbjct: 154 ------------------------CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189
Query: 706 LTGK 709
L G+
Sbjct: 190 LIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGLA+ H+++ +H +LKP+N+L+ E K+ DFGL R
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 23/56 (41%), Positives = 32/56 (57%)
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
P LP E + + RGL FLH VH +LKP N+L+ + + K+ DFGL R+
Sbjct: 102 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 39/144 (27%)
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
Y S P LP + L I K + GL +LH ++ +H ++K N+ + + + IGD G
Sbjct: 146 YLTKRSRP--LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE 682
+ P +P+ L G +APE
Sbjct: 204 AQF-------------------------------------PVVAPAFLGLAGTVETNAPE 226
Query: 683 SLRSIKPNPKWDVYSFGVILLELL 706
L K N K D++S G++L E+L
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 32/165 (19%)
Query: 492 YKAV-LEDGTALAVRRI-GENSVDRF-----RDFETQVRVIAKLVHPNLVRIRGFYW--- 541
YKA ++ G +A+++I N D F R +++++ KL HPN+V +
Sbjct: 25 YKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVPLIDMAVERP 80
Query: 542 --GVDEKLIIYDFVP------NGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFL 592
++ +Y P +G L N + + + K + G+ +L
Sbjct: 81 DKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI------KCYMLQLLEGINYL 131
Query: 593 HEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
HE +H ++K N+L+ N KI DFGL R G + K GG
Sbjct: 132 HENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 49/230 (21%)
Query: 482 ILGASGSSIMYKA-VLEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
ILG +YKA L LAV+ I + +V+ + +++ ++ K P ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
++ + I +F+ GSL YRK+ P +IA V +GL +L K +H
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKI-------PEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++KP N+L+ + K+ DFG+ + + + G +A
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA-------------------- 158
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
Y APE + + DV+S G+ +EL G+
Sbjct: 159 ------------------YMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 48/187 (25%), Positives = 73/187 (39%), Gaps = 48/187 (25%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583
++ +L HP +V + + + + +FV G L RK G P + A+ A+
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELF-THLRKAGRFPNDV---AKFYHAE 126
Query: 584 GVARGLAF--LHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
V LAF LH K ++ +LKP N+LL N K+ DFG + V R
Sbjct: 127 LV---LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----------DRT 172
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
F +L G Y APE ++S D ++ GV+
Sbjct: 173 F----------------------------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVL 204
Query: 702 LLELLTG 708
L E + G
Sbjct: 205 LYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 32/112 (28%), Positives = 57/112 (50%), Gaps = 15/112 (13%)
Query: 520 TQVRVIA---KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWE 576
T +R I+ +L HPN+V++ ++ ++++F L + M +SP
Sbjct: 45 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASP---LSG 96
Query: 577 ARLKIAKG----VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
L + K + +GLAF H + +H +LKP+N+L+ + K+ DFGL R
Sbjct: 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 29/148 (19%)
Query: 576 EARLKIAKGVARGLA--FLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL----------- 622
E R IA+ + LA +H+ ++H ++KP N+LL K+ DFGL
Sbjct: 102 ETRFYIAETI---LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
Query: 623 -ERLVTGDTSSSKAGGSARNFGSKRSTAS-RDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
R+++ S+ ++ SKR + + + + L S G Y A
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA-----------YSTVGTPDYIA 207
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLTG 708
PE N + D +S GVI+ E+L G
Sbjct: 208 PEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGL++ H++K +H +LKP+N+L+ E K+ DFGL R
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 76/275 (27%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANA-RYRKMGSS--PCH 572
+D ++ ++ +L HPN+++ + +E I+ + G L+ +Y K P
Sbjct: 47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER 106
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
W+ +++ V +H ++ +H ++KP NV + K+GD GL R
Sbjct: 107 TVWKYFVQLCSAVEH----MHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------- 154
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692
F S ++TA+ SL G Y +PE + N K
Sbjct: 155 ---------FFSSKTTAAH-------------------SLVGTPYYMSPERIHENGYNFK 186
Query: 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS- 751
D++S G +L E+ AA+++ F G + L S
Sbjct: 187 SDIWSLGCLLYEM------------------------------AALQSPFYGDKMNLFSL 216
Query: 752 CFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786
C K+ PLP + S E L+ L + P P
Sbjct: 217 CQKIEQCDYPPLPTEHYS--EKLRELVSMCIYPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 37/122 (30%), Positives = 51/122 (41%), Gaps = 36/122 (29%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
GL FLH K ++ +LK NV+L D KI DFG+ + FG R+
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--------------ENVFGDNRA 153
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
S+ G Y APE L+ +K D +SFGV+L E+L
Sbjct: 154 ----------------------STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 708 GK 709
G+
Sbjct: 192 GQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 21/50 (42%), Positives = 29/50 (58%), Gaps = 5/50 (10%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
RGL ++H +H +LKP N+LL + + KI DFGL R T+S K
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSEKGD 163
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 37/127 (29%), Positives = 49/127 (38%), Gaps = 39/127 (30%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
GL ++H +H +LKP N+L+ D E KI DFGL R
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR---------------------- 153
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISP---YHAPESLRSIKPNPKW-DVYSFGVIL 702
G S +P + + Y APE + S + K DV+S G IL
Sbjct: 154 -------------GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200
Query: 703 LELLTGK 709
ELL K
Sbjct: 201 AELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 51/185 (27%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA--NARYRKMGSSPCHLPWE-ARLKIAKGVA 586
HP LV + + + +FV G L R RK LP E AR A+ ++
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK-------LPEEHARFYSAE-IS 106
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGS 644
L FLHE+ ++ +LK NVLL + K+ D+G+ E + GDT+S+ G
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG-------- 158
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
+P+ Y APE LR D ++ GV++ E
Sbjct: 159 -----------------TPN-------------YIAPEILRGEDYGFSVDWWALGVLMFE 188
Query: 705 LLTGK 709
++ G+
Sbjct: 189 MMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 60/281 (21%), Positives = 114/281 (40%), Gaps = 64/281 (22%)
Query: 502 LAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558
+AV+++ G+ + ++++D +V+ + +L HPN + +G Y ++ ++ +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618
K + I G +GLA+LH +H ++K N+LL + K+
Sbjct: 109 DLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLA 163
Query: 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY 678
DFG S+SK+ SP+ S +G +PY
Sbjct: 164 DFG---------SASKS------------------------------SPANSFVG--TPY 182
Query: 679 -HAPESLRSI---KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLA 734
APE + ++ + + K DV+S G+ +EL K + + + + L +N + L
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNDSPTLQ 241
Query: 735 DAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
F G + C +PQ+RP+ E L+
Sbjct: 242 SNEWTDSFRGFVD----------YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 26/108 (24%), Positives = 56/108 (51%), Gaps = 5/108 (4%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
++R++ +L HPNLV + + + +++++ + L ++ +P +P K
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL-----NELEKNPRGVPEHLIKK 104
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628
I + + F H+ +H ++KP N+L+ + K+ DFG R++TG
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 19/40 (47%), Positives = 28/40 (70%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+ RGLA+ H +K +H +LKP+N+L+ E K+ DFGL R
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 36/128 (28%), Positives = 50/128 (39%), Gaps = 40/128 (31%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ RGL ++H +H +LKP N+ + D E KI DFGL R T G A +
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW-- 182
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE-SLRSIKPNPKWDVYSFGVILL 703
Y APE L + N D++S G I+
Sbjct: 183 ---------------------------------YRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 704 ELLTGKVI 711
ELLTG+ +
Sbjct: 210 ELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 26/120 (21%), Positives = 54/120 (45%), Gaps = 5/120 (4%)
Query: 508 GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMG 567
G+ S ++++D +V+ + ++ HPN + +G Y ++ ++ + K
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP 121
Query: 568 SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627
+ I G +GLA+LH +H ++K N+LL + K+ DFG + +
Sbjct: 122 LQEVEIA-----AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 18/38 (47%), Positives = 26/38 (68%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+GLAF H +H +LKP+N+L+ + E K+ DFGL R
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 49/198 (24%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
VARG+ +L +K +H +L RNVL+ + KI DFGL R V
Sbjct: 146 VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN----------------- 188
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
+ D ++ G P + APE+L + DV+SFGV++ E
Sbjct: 189 -----NIDYYKKTTNGRLP------------VKWMAPEALFDRVYTHQSDVWSFGVLMWE 231
Query: 705 LLTGKVIVVDELGQG--NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASP 762
+ T LG G+ VE+ +L R D L + + C
Sbjct: 232 IFT--------LGGSPYPGIPVEE---LFKLLKEGHRMDKPANCTNEL--YMMMRDCWHA 278
Query: 763 LPQKRPSMKEALQALEKI 780
+P RP+ K+ ++ L++I
Sbjct: 279 IPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 19/45 (42%), Positives = 28/45 (62%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631
RGL +LH +H ++KP N+L+ ++ KI DFGL R+ D S
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 46/200 (23%)
Query: 513 DRFRDFETQVRVIAKLVH---PNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSS 569
D D + +V ++++L PN+ + G Y II ++ GS+ M +
Sbjct: 41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL----MKAG 96
Query: 570 PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629
P + + I + V L ++H+ +H ++K N+L+ N K+ DFG+ L+ +
Sbjct: 97 PIAEKYIS--VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154
Query: 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
+ SKRST G + APE + K
Sbjct: 155 S-------------SKRST-----------------------FVGTPYWMAPEVITEGKY 178
Query: 690 -NPKWDVYSFGVILLELLTG 708
+ K D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 39/123 (31%), Positives = 54/123 (43%), Gaps = 12/123 (9%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575
R FET HP LV + + D + ++ G L + + S P
Sbjct: 51 RIFET----ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----- 101
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSS 633
A A V GL +LHE K V+ +LK N+LL + KI DFGL E + GD +S+
Sbjct: 102 RAVFYAAC-VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160
Query: 634 KAG 636
G
Sbjct: 161 FCG 163
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 40/123 (32%), Positives = 53/123 (43%), Gaps = 34/123 (27%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
VA G+ FL K VH +L RNVL+ KI DFGL R + D+ N+ S
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS----------NYIS 297
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
K ST F L + APES+ + DV+SFG++L E
Sbjct: 298 KGST-----FLPL-------------------KWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 705 LLT 707
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 37/128 (28%), Positives = 52/128 (40%), Gaps = 44/128 (34%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ RGL ++H VH +LKP N+L+ + + KI DFGL R+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI------------------- 157
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPE-SLRSIKPNPKWDVYSFGVI 701
QD P G +S Y APE L K + + D++S G I
Sbjct: 158 ----------QD------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCI 195
Query: 702 LLELLTGK 709
E+L GK
Sbjct: 196 FAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 18/38 (47%), Positives = 26/38 (68%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGL + H +K +H +LKP+N+L+ E K+ DFGL R
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 34/126 (26%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL ++H +H +LKP N+LL + + KI DFGL R+ G +
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHDHTGFLTEY---- 169
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK-WDVYSFGVILLEL 705
A+R Y APE + + K K D++S G IL E+
Sbjct: 170 -VATR-------------------------WYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
Query: 706 LTGKVI 711
L+ + +
Sbjct: 204 LSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 19/39 (48%), Positives = 28/39 (71%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
RGL FLH + VH +LKP+N+L+ + + K+ DFGL R+
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 114 NNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSL 173
+SL+ LS L + S + +LD S N + +L L L+L+ N L L
Sbjct: 63 PSSLSRLLSLDLLSPSGISSLDGSEN---------LLNLLPLPSLDLNLNRLR-SNISEL 112
Query: 174 TTLQSLTIVSLKNNYFSD--GLPSKFNS-VQVLDLSSNLINGSLPPDIGGY-SLRYLNLS 229
L +LT + L NN +D L S ++ LDLS N I SLP + +L+ L+LS
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLS 171
Query: 230 YNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESS 274
+N LS ++P +N +DLS N ++ ++P ++
Sbjct: 172 FNDLS-DLPKLLSNLSNLN-NLDLSGNKIS-DLPPEIELLSALEE 213
|
Length = 394 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 52/191 (27%), Positives = 80/191 (41%), Gaps = 22/191 (11%)
Query: 533 LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFL 592
+VR+ + D + D++P G + + R MG P L AR IA+ + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDL---ARFYIAELTC-AVESV 117
Query: 593 HEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG-----DTSSSKAGGSARN------ 641
H+ +H ++KP N+L+ D K+ DFG L TG D+ ++G R
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFG---LCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 642 --FGSKRSTASRDSFQDLGPGPSPSPSPS-PSSLGGISPYHAPESLRSIKPNPKWDVYSF 698
+G + D + L + SL G Y APE L D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 699 GVILLELLTGK 709
GVIL E+L G+
Sbjct: 235 GVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 48/186 (25%), Positives = 72/186 (38%), Gaps = 43/186 (23%)
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIA 582
++ L HP LV + + + EKL + D+V G L + + C L AR A
Sbjct: 49 LLKNLKHPFLVGLH-YSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAA 103
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNF 642
+ VA + +LH ++ +LKP N+LL + + DFGL K G
Sbjct: 104 E-VASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL----------CKEG------ 146
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
P + S+ G Y APE LR + D + G +L
Sbjct: 147 --------------------VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVL 186
Query: 703 LELLTG 708
E+L G
Sbjct: 187 YEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 34/128 (26%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 502 LAVRRIGENSVDRFRDFETQVRVIAKLVH-PNLVRIRGFYW-----GVDEKL-IIYDFVP 554
LA ++ + + D + + ++ ++ K H N+ G + G+D++L ++ +F
Sbjct: 33 LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 92
Query: 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME 614
GS+ + G++ L E I + + RGL+ LH+ K +H ++K +NVLL + E
Sbjct: 93 AGSVTDLIKNTKGNT---LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE 149
Query: 615 PKIGDFGL 622
K+ DFG+
Sbjct: 150 VKLVDFGV 157
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 39/202 (19%), Positives = 78/202 (38%), Gaps = 51/202 (25%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL----IIYDFVPNGSLANARYRKMGSSPC 571
E +++ + ++ N+++I GF + + L +I ++ G L ++
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----- 117
Query: 572 HLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
L ++ +L +A +GL L++ + NL + L+ + + KI GLE+
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK------ 171
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI--K 688
S F+++ Y + + L I +
Sbjct: 172 -----------------ILSSPPFKNV----------------NFMVYFSYKMLNDIFSE 198
Query: 689 PNPKWDVYSFGVILLELLTGKV 710
K D+YS GV+L E+ TGK+
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKI 220
|
Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 16/41 (39%), Positives = 26/41 (63%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627
+ L ++H +H +LKP N+LL +D K+ DFGL R ++
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 33/132 (25%), Positives = 48/132 (36%), Gaps = 44/132 (33%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFG 643
G+ +LH +H +LKP N+L+ + KIGD GL RL
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL------------------ 161
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI---SPYHAPESLRSIKP-NPKWDVYSFG 699
F +P + L + Y APE L + D+++ G
Sbjct: 162 ----------FN--------APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
Query: 700 VILLELLTGKVI 711
I ELLT + I
Sbjct: 204 CIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 41/190 (21%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEA 577
FET +++++ H +L + G E +++ +FV +G L ++ G +P
Sbjct: 64 FET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAW 118
Query: 578 RLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
++ +A+ +A L++L +K VHGN+ +N+LL RL + +S
Sbjct: 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLA-------------RLGLAEGTS----- 160
Query: 638 SARNFGSKRSTASRDSFQDLG-PGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDV 695
F L PG S + + I P+ APE + + D
Sbjct: 161 ---------------PFIKLSDPGVSFTALSREERVERI-PWIAPECVPGGNSLSTAADK 204
Query: 696 YSFGVILLEL 705
+SFG LLE+
Sbjct: 205 WSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 45/182 (24%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA--NARYRKMGSSPCHLPWEARLKIAKGVAR 587
+P LV + + ++ ++V G L R RK LP E A +
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-------LPEEHARFYAAEICI 107
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
L FLHE+ ++ +LK NVLL D K+ D+G+ +
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK----------------------- 144
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+ LGPG + S+ G Y APE LR + D ++ GV++ E++
Sbjct: 145 -------EGLGPG------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA 191
Query: 708 GK 709
G+
Sbjct: 192 GR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 39/123 (31%), Positives = 53/123 (43%), Gaps = 34/123 (27%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
VARG+ FL K VH +L RNVLL KI DFGL R + D+ N+ S
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS----------NYVS 295
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
K ST F + + APES+ DV+S+G++L E
Sbjct: 296 KGST-----FLPV-------------------KWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 705 LLT 707
+ +
Sbjct: 332 IFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 21/52 (40%), Positives = 30/52 (57%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
VA+G+ FL +K +H +L RN+LL + KI DFGL R + D + G
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 496 LEDGTALAVRRI--GENSVD---RFRDFETQVRVIAKLVHPNLVRIRGFYWGV---DEKL 547
++ G LAV+++ +S + E +++++ L H +V+ Y+G DE L
Sbjct: 24 VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ----YYGCLRDDETL 79
Query: 548 IIY-DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
I+ +++P GS+ + + + G+ L K + + G+ +LH VH ++K N
Sbjct: 80 SIFMEYMPGGSVKD-QLKAYGA----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGAN 134
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
+L + K+GDFG SKR S
Sbjct: 135 ILRDSAGNVKLGDFG---------------------ASKRLQTIC------------SSG 161
Query: 667 PSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
S+ G + +PE + K DV+S G ++E+LT K
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 40/126 (31%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL ++H +H +LKP N+ + D E KI DFGL R T G A +
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRW---- 180
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE-SLRSIKPNPKWDVYSFGVILLEL 705
Y APE L + N D++S G I+ EL
Sbjct: 181 -------------------------------YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 706 LTGKVI 711
LTGK +
Sbjct: 210 LTGKTL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 35/126 (27%), Positives = 47/126 (37%), Gaps = 40/126 (31%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL ++H +H +LKP NV + D E +I DFGL R G A +
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRW---- 180
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE-SLRSIKPNPKWDVYSFGVILLEL 705
Y APE L + N D++S G I+ EL
Sbjct: 181 -------------------------------YRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 706 LTGKVI 711
L GK +
Sbjct: 210 LKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 17/38 (44%), Positives = 29/38 (76%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGL+++H++ +H +LKP+N+L+ + E K+ DFGL R
Sbjct: 114 RGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 18/44 (40%), Positives = 27/44 (61%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631
GL + H+K +H ++K N+LL N + K+ DFGL RL + S
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 18/38 (47%), Positives = 27/38 (71%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGLA++H + +H +LKP+N+L+ E K+ DFGL R
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 40/203 (19%), Positives = 72/203 (35%), Gaps = 56/203 (27%)
Query: 516 RDFETQVRVIAKLVHPNLVR-IRGFYWGVDEKLIIYDFVPNGSLANARYRK------MGS 568
+ ++ ++ + H ++ I + W + +Y+ S
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWK-----------STVCMVMPKYKCDLFTYVDRS 179
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628
P LP E + I + + LA+LH + +H ++K N+ L +GDFG
Sbjct: 180 GP--LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG------- 230
Query: 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLG-PGPSPSPSPSPSSLGGISPYHAPESLRSI 687
+ + A D+ Q G G + SP +L PY A
Sbjct: 231 --------------AACKLDAHPDTPQCYGWSGTLETNSPELLAL---DPYCA------- 266
Query: 688 KPNPKWDVYSFGVILLELLTGKV 710
K D++S G++L E+ V
Sbjct: 267 ----KTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 521 QVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+++V+ + P +V G ++ E I + + GSL +K G +P + K
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGR----IPEQILGK 107
Query: 581 IAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
++ V +GL +L EK K +H ++KP N+L+ + E K+ DFG V+G S A
Sbjct: 108 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMA---- 159
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
+S G Y +PE L+ + + D++S G
Sbjct: 160 ------------------------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 700 VILLELLTGK 709
+ L+E+ G+
Sbjct: 190 LSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 11/111 (9%)
Query: 530 HPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI-AKGVAR 587
HP LV + + + +KL + D+V G L R+ P E R + A +A
Sbjct: 55 HPFLVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRER-----SFP-EPRARFYAAEIAS 107
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAG 636
L +LH ++ +LKP N+LL + + DFGL E + T+S+ G
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 41/142 (28%)
Query: 572 HLPWEARLKIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
+P E KIA + L +L E+ + H ++KP N+LL + K+ DFG ++G
Sbjct: 103 VIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG----ISGQL 158
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN 690
S A +RD+ G PY APE + +
Sbjct: 159 VDSIA-------------KTRDA--------------------GCRPYMAPERIDPSARD 185
Query: 691 P---KWDVYSFGVILLELLTGK 709
+ DV+S G+ L E+ TGK
Sbjct: 186 GYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 36/130 (27%), Positives = 51/130 (39%), Gaps = 40/130 (30%)
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSA 639
A +A GL FLH K ++ +LK NV+L + KI DFG+ E + G T+
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT-------- 158
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
R F G Y APE + D ++FG
Sbjct: 159 RTF------------------------------CGTPDYIAPEIIAYQPYGKSVDWWAFG 188
Query: 700 VILLELLTGK 709
V+L E+L G+
Sbjct: 189 VLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 36/138 (26%), Positives = 55/138 (39%), Gaps = 39/138 (28%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
G+ LH +H +LKP N+++ +D KI DFGL R T+ + NF
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TACT-------NFMMTPY 182
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+R Y APE + + D++S G I+ EL+
Sbjct: 183 VVTR-------------------------YYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 708 GKVIV--VDELGQGNGLL 723
G VI D + Q N ++
Sbjct: 218 GSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 41/179 (22%), Positives = 66/179 (36%), Gaps = 41/179 (22%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGL 589
HP LV + + D+ + D++ G L + + C L AR A+ +A L
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASAL 109
Query: 590 AFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTA 649
+LH V+ +LKP N+LL + + DFGL +
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK------------------------- 144
Query: 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+ + + S+ G Y APE L + D + G +L E+L G
Sbjct: 145 -----------ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 60/222 (27%)
Query: 520 TQVRVIAKLVHPNLVRIRG-FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEAR 578
T+ ++ + HP++++++G F + LI+ RY+ C+L +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL-----------PRYKT--DLYCYLAAKRN 178
Query: 579 ------LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
L I + V R + +LHE + +H ++K N+ + + + +GDFG D ++
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV-DINA 237
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692
+K G A G +APE L P
Sbjct: 238 NKYYGWA----------------------------------GTIATNAPELLARDPYGPA 263
Query: 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVE-DKNRAIRL 733
D++S G++L E+ T D L + +GL + D +R I+L
Sbjct: 264 VDIWSAGIVLFEMATCH----DSLFEKDGLDGDCDSDRQIKL 301
|
Length = 391 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 12/142 (8%)
Query: 497 EDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555
E A+A++ + + + R+ F+ + + ++L HPN+V + G +I+ + +
Sbjct: 33 EQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH 92
Query: 556 GSL-----ANARYRKMGSSPCHLPWEARLK------IAKGVARGLAFLHEKKHVHGNLKP 604
L + + +GS+ ++ L+ I +A G+ FL VH +L
Sbjct: 93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152
Query: 605 RNVLLGNDMEPKIGDFGLERLV 626
RNVL+ + + KI D GL R V
Sbjct: 153 RNVLVFDKLNVKISDLGLFREV 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 31/123 (25%), Positives = 50/123 (40%), Gaps = 38/123 (30%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE-RLVTGDTSSSKAGGSARNFGSKR 646
GL LH+++ ++ +LKP NVLL ND +I D GL L G + + G+
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT-------- 160
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
PG + APE L+ + + D ++ GV L E++
Sbjct: 161 ------------PG-----------------FMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 707 TGK 709
+
Sbjct: 192 AAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 9/110 (8%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA-NARYRKMGSSPCHLPWEARLKIAKGVARG 588
HP LV + + ++ + DFV G L + + + P AR A+ +A
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAE-IASA 108
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAG 636
L +LH V+ +LKP N+LL + + DFGL E + DT+++ G
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 53/187 (28%), Positives = 76/187 (40%), Gaps = 36/187 (19%)
Query: 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
D + D++P G + + R M P L AR IA+ + + +H+ +H ++K
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIR-MEVFPEVL---ARFYIAE-LTLAIESVHKMGFIHRDIK 128
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGD--TSSSKAGGSARNFGSKRSTASRDSFQ--DLGP 659
P N+L+ D K+ DFG L TG T +SK + K S +DS + DL
Sbjct: 129 PDNILIDLDGHIKLTDFG---LCTGFRWTHNSK-------YYQKGSHIRQDSMEPSDLWD 178
Query: 660 GPSPSPSPS-----------------PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
S SL G Y APE L D +S GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 703 LELLTGK 709
E+L G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 6/61 (9%)
Query: 178 SLTIVSLKNNYF---SDGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNR 232
+L + L NN DG +++VLDLS N + S+ P+ G SLR L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 233 L 233
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 15/38 (39%), Positives = 26/38 (68%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+G+A+ H + +H +LKP+N+L+ + K+ DFGL R
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 8/110 (7%)
Query: 527 KLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGV 585
+ HP++V++ G + + I+ + P G L + S L + + + +
Sbjct: 63 QFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQL 116
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
+ LA+L K+ VH ++ RNVL+ + K+GDFGL R + D S KA
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKA 165
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 4/82 (4%)
Query: 542 GVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
G D++L ++ +F GS+ + G++ L + I + + RGLA LH K +H
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNA---LKEDWIAYICREILRGLAHLHAHKVIHR 145
Query: 601 NLKPRNVLLGNDMEPKIGDFGL 622
++K +NVLL + E K+ DFG+
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGV 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 30/135 (22%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 497 EDGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL--II 549
+ G LAV+++ + + E +++++ L+H +V+ G E+ I
Sbjct: 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84
Query: 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
+ +P GS+ + + + G+ L K + + G+++LH VH ++K N+L
Sbjct: 85 MEHMPGGSIKD-QLKSYGA----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR 139
Query: 610 GNDMEPKIGDFGLER 624
+ K+GDFG +
Sbjct: 140 DSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 17/48 (35%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 575 WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
EAR + + V R + LH+ VHG+L N++L DFGL
Sbjct: 91 EEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 487 GSSIMYKAVLED----GTALAVRRIGENSVDRFRDFE---TQVRVIAKLVHPN-LVRIRG 538
G K +L + A++ + ++ V + D E + RV+A P L ++
Sbjct: 9 GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS 68
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGS--SPCHLPWEARLKIAKGVARGLAFLHEKK 596
+ VD + ++V G L +++G P + + A + + GL FLH +
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISV------GLFFLHRRG 121
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAG 636
++ +LK NV+L ++ KI DFG+ E +V G T+ + G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 29/108 (26%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 520 TQVRVIA---KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWE 576
T +R I+ +L HPN+V ++ +I++F+ S+ +Y ++ E
Sbjct: 45 TAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAE 101
Query: 577 ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+ +G+ F H ++ +H +LKP+N+L+ N K+ DFGL R
Sbjct: 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 49/184 (26%)
Query: 530 HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA--NARYRKMGSSPCHLPWEARLKIAKGVAR 587
HP LV + + + ++V G L R RK LP E + ++
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEISL 107
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGSK 645
L +LHE+ ++ +LK NVLL ++ K+ D+G+ E L GDT+S+ G
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG--------- 158
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
+P+ Y APE LR D ++ GV++ E+
Sbjct: 159 ----------------TPN-------------YIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 706 LTGK 709
+ G+
Sbjct: 190 MAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 40/124 (32%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+GL ++H +H +LKP N+ + D E KI DFGL R T S G +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRW---- 180
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLEL 705
Y APE + + + D++S G I+ E+
Sbjct: 181 -------------------------------YRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
Query: 706 LTGK 709
LTGK
Sbjct: 210 LTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 9/120 (7%)
Query: 520 TQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-ANARYRKMGSSPCHLPWEAR 578
T+ RV+ HP L ++ + D + ++ G L + ++ S AR
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RAR 98
Query: 579 LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAG 636
A+ V+ L +LH V+ +LK N++L D KI DFGL E + G T + G
Sbjct: 99 FYGAEIVS-ALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 15/143 (10%)
Query: 486 SGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE 545
+G + K LE V++I R ++R++ +L H NLV + +
Sbjct: 25 TGQIVAIKKFLESEDDKMVKKIA------MR----EIRMLKQLRHENLVNLIEVFRRKKR 74
Query: 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPR 605
++++FV + L + G L K + RG+ F H +H ++KP
Sbjct: 75 LYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPE 129
Query: 606 NVLLGNDMEPKIGDFGLERLVTG 628
N+L+ K+ DFG R +
Sbjct: 130 NILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 50/195 (25%)
Query: 520 TQVRVIA-KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANA--RYRKMGSSPCHLPWE 576
T+ R++A HP L + + D + ++V G L R RK
Sbjct: 44 TEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------R 97
Query: 577 ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSK 634
+R A+ V L FLH ++ +LK N+LL + K+ DFG+ E ++ G T+++
Sbjct: 98 SRFYAAE-VTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWD 694
G +P Y APE L+ ++ P D
Sbjct: 157 CG-------------------------TPD-------------YIAPEILQELEYGPSVD 178
Query: 695 VYSFGVILLELLTGK 709
++ GV++ E++ G+
Sbjct: 179 WWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 43/168 (25%)
Query: 544 DEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
D KL +I D+V G L Y++ + E R+ IA+ V L LH+ ++ ++
Sbjct: 77 DTKLHLILDYVNGGELFTHLYQREHFTES----EVRVYIAEIVL-ALDHLHQLGIIYRDI 131
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K N+LL ++ + DFGL + + R +
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEE-------RAY-------------------- 164
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKP--NPKWDVYSFGVILLELLTG 708
S G Y APE +R + D +S GV+ ELLTG
Sbjct: 165 --------SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 24/99 (24%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 528 LVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL----ANARYRKMGSSPCHLPWEARLKIAK 583
L HPN+++ G L+++++ G L + ++ + S L ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
+A G+ +H+ +H +L RN L +D+ K+GD+G+
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 34/118 (28%)
Query: 592 LHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+H K +H ++K N+LL ++ K+GDFG ++ S
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD------------------- 199
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
D+G + G Y APE R + K D++S GV+L ELLT K
Sbjct: 200 ----DVG-----------RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 15/47 (31%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
E ++ + V +A LH+ VHG+L N ++ +D + DFGL
Sbjct: 428 EGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGL 473
|
Length = 535 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 28/185 (15%)
Query: 536 IRGFYWGVDEK--LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
++ FY D++ +I +F+P G + +K S + IA+ V + +H
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE----EATQFYIAETVL-AIDAIH 118
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGL---------ERLVTGDTSSSKAGGSARNFGS 644
+ +H ++KP N+LL K+ DFGL T + + S +N S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 645 KRSTAS-RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703
KR + + + + L S G Y APE N D +S GVI+
Sbjct: 179 KRKAETWKKNRRQLA-----------YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 704 ELLTG 708
E+L G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 791 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.75 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.61 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.57 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.56 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.54 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.53 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.43 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.4 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.12 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.93 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.78 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.49 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.46 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-64 Score=624.46 Aligned_cols=537 Identities=28% Similarity=0.494 Sum_probs=353.1
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++++.+|..|..++.|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+
T Consensus 403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ 481 (968)
T PLN00113 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD 481 (968)
T ss_pred CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEE
Confidence 3445555555555555555555555555555555555555555555555666666666666655555544 345667777
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g 235 (791)
|++|++++.+|..|.++++|+.|+|++|++.+.+|..+ ++|++|+|++|.+++.+|..+.. .+|+.|+|++|+++|
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 77777777777777777778888888887777777654 67778888888888777777766 478888888888888
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPAIAAI 315 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c~~~~~~~~~~~~~~~~~p~~~~~~ 315 (791)
.+|..+.. +++|+.|++++|+++|.+|....+..+....+.||+.+|+...... .
T Consensus 562 ~~p~~l~~-l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~------------------------~ 616 (968)
T PLN00113 562 EIPKNLGN-VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG------------------------L 616 (968)
T ss_pred cCChhHhc-CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC------------------------C
Confidence 88877766 7788888888888888888777777777777788888876321100 0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccEEEeehHHHHHHHHHHHHHhhheeecccccchhhhHhhhcccCCCCCC
Q 003847 316 PKSIDSTPATNPDDGSVSKPRQEGSQGLRPGTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLKKEANSAKDTVSF 395 (791)
Q Consensus 316 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ii~iv~g~~~~i~l~~~v~~~~~~~~~rr~~~~~~~~~~~~~~~~~~~ 395 (791)
++ +.. ..+ ....++ ++++++++++++++++++++++++|++.... +.+
T Consensus 617 ~~-------------c~~-----~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---------- 664 (968)
T PLN00113 617 PP-------------CKR-----VRK--TPSWWF-YITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVE---------- 664 (968)
T ss_pred CC-------------Ccc-----ccc--cceeee-ehhHHHHHHHHHHHHHHHHHHHHhhhccccc-ccc----------
Confidence 00 000 000 111122 2222222222222222222222222111000 000
Q ss_pred CCCCCCCCcCCCccccccccCCCCCCCCCCcccccccccccCCccccchhhhhhhhhhhcccCccEEEecCCcccchHHH
Q 003847 396 SPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNYHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETL 475 (791)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 475 (791)
. ..+ .|. ..... . .....+.++++
T Consensus 665 ~------~~~---~~~--------------------~~~~~-~--------------------------~~~~~~~~~~~ 688 (968)
T PLN00113 665 N------EDG---TWE--------------------LQFFD-S--------------------------KVSKSITINDI 688 (968)
T ss_pred c------ccc---ccc--------------------ccccc-c--------------------------ccchhhhHHHH
Confidence 0 000 000 00000 0 00011222222
Q ss_pred hh--hcceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 476 LK--ASAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 476 ~~--~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.. ....+||+|+||.||+|+. .+++.||||++...... ...|++++++++|||||+++++|.+.+..|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 22 2346899999999999995 57899999998754322 23468899999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh---cCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH---EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH---~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
+++|+|.++++. ++|..+.+|+.|+++||+||| +.+|+||||||+||+++.++.+++. ||........
T Consensus 765 ~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred CCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 999999999852 889999999999999999999 6799999999999999999888875 6554332110
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
....||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 836 ----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~ 875 (968)
T PLN00113 836 ----------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875 (968)
T ss_pred ----------------------------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCC
Confidence 0124788999999999999999999999999999999999
Q ss_pred cchhccccCCCCcchh------chhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 710 VIVVDELGQGNGLLVE------DKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.||........ .... .......+.++.+........++..++.+++.+||+.||++||+|+||+++|+++...
T Consensus 876 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 876 SPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCcccCCCC-cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 99854322111 0100 0011122334444333333445677889999999999999999999999999998654
Q ss_pred C
Q 003847 784 P 784 (791)
Q Consensus 784 ~ 784 (791)
.
T Consensus 955 ~ 955 (968)
T PLN00113 955 S 955 (968)
T ss_pred c
Confidence 3
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=410.13 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=216.9
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.+||+|||+.||+++. .+|+.||+|++.+. .....+.+.+||+|.++|+|||||+++++|++.+..|||.|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3467999999999999996 89999999999763 3334578899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+.++|..+++++. ++++.+++.+++||+.||.|||+.+|+|||||..|+|++++.++||+|||+|..+..+..
T Consensus 101 ~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-- 173 (592)
T KOG0575|consen 101 HRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-- 173 (592)
T ss_pred CCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--
Confidence 9999999887543 499999999999999999999999999999999999999999999999999998874422
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||||.|+|||++.....+..+||||+|||+|.|++|++||.
T Consensus 174 ----------------------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 174 ----------------------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ----------------------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 2346789999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .+.+..+......+..+...+.+..+||.++|+.||.+|||+++|+..
T Consensus 220 tk-------------~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 220 TK-------------TVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cc-------------hHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 54 345555555566666666678889999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=411.52 Aligned_cols=274 Identities=38% Similarity=0.641 Sum_probs=225.9
Q ss_pred cccchHHHhhhc-----ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc
Q 003847 468 KELELETLLKAS-----AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542 (791)
Q Consensus 468 ~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 542 (791)
+.|.++++..++ .++||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+++|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 456777777665 479999999999999999999999999877544314569999999999999999999999999
Q ss_pred cC-ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCeecCCCCCCeEecCCCCeEEe
Q 003847 543 VD-EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---KHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 543 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
.+ +.+||||||++|+|.++++..... +++|..+.+||.++|+||+|||+. .||||||||+|||+|+++++||+
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 98 499999999999999999886543 499999999999999999999983 59999999999999999999999
Q ss_pred ccCcccccCC-CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCC-CCCCcccCcccccCCCCCCchhhH
Q 003847 619 DFGLERLVTG-DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSL-GGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 619 DFGla~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|||+|+.... .... ... .||.+|+|||++..+..+.|+|||
T Consensus 220 DFGLa~~~~~~~~~~-------------------------------------~~~~~gt~gY~~PEy~~~g~lt~KsDVy 262 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-------------------------------------STTVMGTFGYLAPEYASTGKLTEKSDVY 262 (361)
T ss_pred CccCcccCCccccce-------------------------------------eeecCCCCccCChhhhccCCcCcccccc
Confidence 9999965432 1100 011 599999999999999999999999
Q ss_pred HHHHHHHHHHhCCcchhccc-------cCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 697 SFGVILLELLTGKVIVVDEL-------GQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
||||+++||+||+.+.+... ..|....+.+. ...+++|+.+. +.+... +....+..++.+|++.+|++||
T Consensus 263 SFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~-~~~~~~~~~a~~C~~~~~~~RP 340 (361)
T KOG1187|consen 263 SFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDE-KEVKKLAELALRCLRPDPKERP 340 (361)
T ss_pred cchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChH-HHHHHHHHHHHHHcCcCCCcCc
Confidence 99999999999998765432 12332233333 56777888776 333321 4778899999999999999999
Q ss_pred CHHHHHHHhccCCCC
Q 003847 769 SMKEALQALEKIPSS 783 (791)
Q Consensus 769 s~~evl~~L~~i~~~ 783 (791)
+|.||+++|+.+...
T Consensus 341 ~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 341 TMSQVVKELEGILSL 355 (361)
T ss_pred CHHHHHHHHHhhccc
Confidence 999999999776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=384.16 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=211.2
Q ss_pred cchHHHhhhcceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-ce
Q 003847 470 LELETLLKASAYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-EK 546 (791)
Q Consensus 470 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~ 546 (791)
+.+.++.+ ...||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+|||||++||.|+.++ ..
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 33444433 358999999999999964 6899999999554 4445678999999999999999999999999999 49
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.|+||||++|+|++++...+ .+++....+|+.+|++||.|||+ ++||||||||+|||++..|++||||||.++.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 99999999999999887764 39999999999999999999996 9999999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~el 705 (791)
+... ...+++||..|||||.+.+..|+.++||||||++++|+
T Consensus 229 lvnS--------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 229 LVNS--------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred hhhh--------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 7533 12356699999999999999999999999999999999
Q ss_pred HhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCcc-chH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKE-EALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 706 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
++|+.||......+ ....++++....+..+ .+. ..+.++.+|+..||++||.+||+++|+++.
T Consensus 271 a~GrfP~~~~~~~~--------~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPY--------LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred hhCCCCCCCcCCCC--------CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999986541111 1234444444443222 122 267889999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=388.36 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=202.9
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCch-------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSV-------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.|-+|. .++|+.||||++++... ......++|+++|++|+|||||+++++|...+..|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 45789999999999998 67899999999976421 12345689999999999999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC---CCeEEeccCcccccC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND---MEPKIGDFGLERLVT 627 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~ 627 (791)
||++||+|.+.+-.+.. +.+..-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+...
T Consensus 256 E~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999887653 7888889999999999999999999999999999999765 679999999999865
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC---CCchhhHHHHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP---NPKWDVYSFGVILLE 704 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~sDvwSlGvil~e 704 (791)
.. ..+..+|||+.|.|||++.+..+ ..++|+||+|||+|-
T Consensus 331 ~~-------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 331 EG-------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred cc-------------------------------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 21 23557899999999999976543 348899999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCc----cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF----EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+++|.+||.+...+. .+.+....+.+ ..+.+...+..+||.+||..||++|||+.|+++
T Consensus 374 cLsG~pPFS~~~~~~------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDP------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred EeccCCCcccccCCc------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 999999998764432 11222223322 234456788999999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=381.31 Aligned_cols=192 Identities=29% Similarity=0.475 Sum_probs=174.3
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.||+|+|++||+|++ +++..||||.+.+. .....+.+..|+++|+.++|||||+++++++.++..|+|||||.||+|
T Consensus 17 ~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 17 EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 499999999999994 56899999999776 555567789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC------CCeEEeccCcccccCCCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND------MEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~------~~~kL~DFGla~~~~~~~~~ 632 (791)
.++++.++. +++.+++.++.|+|.||++||+++||||||||+|||++.. -.+||+|||+|+.+....
T Consensus 97 s~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~-- 169 (429)
T KOG0595|consen 97 SDYIRRRGR-----LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS-- 169 (429)
T ss_pred HHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh--
Confidence 999998763 9999999999999999999999999999999999999764 458999999999886332
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....||++.|||||++..++|+.|+|+||+|+|+|+|++|+.||
T Consensus 170 -----------------------------------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 170 -----------------------------------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF 214 (429)
T ss_pred -----------------------------------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence 234678999999999999999999999999999999999999999
Q ss_pred hcc
Q 003847 713 VDE 715 (791)
Q Consensus 713 ~~~ 715 (791)
...
T Consensus 215 ~a~ 217 (429)
T KOG0595|consen 215 DAE 217 (429)
T ss_pred ccc
Confidence 743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=391.78 Aligned_cols=251 Identities=31% Similarity=0.451 Sum_probs=207.9
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchh--hHHHHHHHHHHHhccCCCCccceeeEEEccC-ceEEEEeccCCCC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-EKLIIYDFVPNGS 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~gs 557 (791)
+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|++.+.. ..++||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 349999999999999975455999999764322 2568999999999999999999999999887 7999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK-HVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.++++.... ..+++..+.+|+.|||+||+|||+.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 127 L~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----- 198 (362)
T KOG0192|consen 127 LSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----- 198 (362)
T ss_pred HHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-----
Confidence 9999988511 24999999999999999999999999 99999999999999997 99999999998765321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc--CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR--SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.
T Consensus 199 -------------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 199 -------------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred -------------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 1122345999999999999 5689999999999999999999999997
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
+... ......+.....+...+. .....+..++.+||+.||++||++.+++..|+.+.
T Consensus 248 ~~~~---------~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 248 DLAP---------VQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCH---------HHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 6421 112223333333333332 26778889999999999999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.63 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=207.8
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceee-EEEccCc-eEEEEeccC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRG-FYWGVDE-KLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lv~e~~~ 554 (791)
.+.||+|.||.|||+. ..+|..||.|.++-. +....++...|+.+|++|+|||||++++ .+.++.+ .+||||||.
T Consensus 24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 3589999999999999 678999999999754 3344567889999999999999999999 4444555 789999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CC--CeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--KK--HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
.|+|.+.++...... ..+++..+++++.|++.||.++|. .+ |+||||||.||+++.+|.+||+|||+++.+....
T Consensus 104 ~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~ 182 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT 182 (375)
T ss_pred ccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh
Confidence 999999987655433 359999999999999999999999 56 9999999999999999999999999999876432
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
. ...+++|||.||+||.+.+.+|++|+||||+||++|||..-++
T Consensus 183 t------------------------------------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 183 T------------------------------------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred H------------------------------------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 2 2346789999999999999999999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCcc-ch-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFE-GK-EEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
||.++ ....+-...-.++++ .+ .-.+..+..||..|+..||+.||+...++..+..
T Consensus 227 PF~g~-------------n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 227 PFYGD-------------NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Ccccc-------------cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99775 123333444445554 22 4467889999999999999999996665555543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.36 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=200.7
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-++||+|+||.||.++ .++++.+|+|++++... ...+....|..+|.+++||.||+++-.|++.+..|+|+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 4689999999999999 45699999999987522 3356788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.|...+.+.+. +++..++-++..|+.||.|||+.|||||||||+|||+|.+|.++|+|||+++......
T Consensus 110 GeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~----- 179 (357)
T KOG0598|consen 110 GELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG----- 179 (357)
T ss_pred ccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-----
Confidence 999999887653 9999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+|||+.|||||++.+..|+.++|.||+|+++|||++|.+||...
T Consensus 180 -------------------------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 180 -------------------------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred -------------------------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 1234578999999999999999999999999999999999999999764
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHH-HHHHHHHHHhhccCCCCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEE-ALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RP 768 (791)
. ...+.+............ ...+..+++.+++..||++|.
T Consensus 229 ~-------------~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 229 D-------------VKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred c-------------HHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2 234444444444222222 566788999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=375.49 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=215.2
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
++++||+|+|++||+|+ .++++.||||++.+.. ....+-+..|-.+|.+| .||.|++|+..|.++...|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 35799999999999999 6689999999997642 22234567888899999 8999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.++|.+.+. +++...+.++.||+.||+|||++|||||||||+|||+|++|++||+|||.|+.+.+.....
T Consensus 157 ~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 157 PNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred CCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 99999999998753 9999999999999999999999999999999999999999999999999999987554332
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
..+. ..........+++||..|.+||++.+...++.+|+|+||||+|+|+.|++||.
T Consensus 232 ~~~~-----------------------~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 232 ENPV-----------------------DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred cCcc-----------------------CcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 1100 00011112456889999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+.. -..++...+.-.++.++..++.+.+|+.+.|..||.+|+++++|.+.
T Consensus 289 a~N-------------eyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 289 AAN-------------EYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ccc-------------HHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 541 23445555555666666667788999999999999999999888764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=381.72 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=211.8
Q ss_pred hhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 477 KASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
......||+|-||.||.|.+.....||+|.++..... .+.|.+|+++|++|+|+|||+++++|..++.+|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3345679999999999999988889999999876433 378899999999999999999999999989999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++....+. .+...+.+.++.|||+|++||+++++|||||...||||+++..+||+|||+|+.+..+......+
T Consensus 287 sLl~yLr~~~~~---~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGG---LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCC---ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999873332 48899999999999999999999999999999999999999999999999999665444332221
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 715 (791)
.. -...|.|||.+...+++.|||||||||+||||+| |+.||...
T Consensus 364 ~k-----------------------------------fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 364 GK-----------------------------------FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred CC-----------------------------------CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 11 1234999999999999999999999999999999 66677543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
. ..+++...-.+ .++.+..++..+.+++..||+.+|++|||++.+...|+++....
T Consensus 409 s-------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 409 S-------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred C-------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 1 12222222111 23445558889999999999999999999999999999887644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=377.41 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=211.9
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...++.|+|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4579999999999998 667899999999887777777889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+.+.... +++.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 358 TDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~------- 424 (550)
T KOG0578|consen 358 TDVVTKTR------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS------- 424 (550)
T ss_pred hhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-------
Confidence 99988764 99999999999999999999999999999999999999999999999999987754321
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....+||++|||||++....|++|+||||||++++||+-|++||..+..
T Consensus 425 -----------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P- 474 (550)
T KOG0578|consen 425 -----------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP- 474 (550)
T ss_pred -----------------------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-
Confidence 23456799999999999999999999999999999999999999965321
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+ ....++.......+...+..+..+.+|+.+||..|+++|+++.|+|+.
T Consensus 475 -----l----rAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 475 -----L----RALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -----H----HHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1 112222222333444555678899999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=369.11 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=211.5
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
-+.||+|.||.||||+ ..+.+.||+|.+.+. ...+.+.+.+|++|+++++|||||.++++|+...+.++|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 4589999999999999 457899999999764 334567899999999999999999999999999999999999976
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..++..... ++++.+..|+.|++.||.|||+.+|+|||+||.|||++..|.+|++|||+|+.+.....
T Consensus 86 ~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~----- 155 (808)
T KOG0597|consen 86 DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS----- 155 (808)
T ss_pred hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-----
Confidence 99999987653 99999999999999999999999999999999999999999999999999998764221
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
..+.+.|||.|||||.+.++.|+..+|+||+|||+||+++|++||...
T Consensus 156 -------------------------------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~- 203 (808)
T KOG0597|consen 156 -------------------------------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR- 203 (808)
T ss_pred -------------------------------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-
Confidence 234566999999999999999999999999999999999999999653
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.+.+++..+.......+......+..|+...+.+||.+|.+..+++.
T Consensus 204 ------------si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 ------------SITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ------------HHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 34556666666555555567888999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=362.38 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=201.0
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC--ceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--EKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e~~~~ 555 (791)
..+.||+|+||.||++... +|+..|||.+........+.+++|+++|++++|||||+++|.....+ .++++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3568999999999999954 59999999997764444677999999999999999999999865555 58999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|+|.+++...++ .+++..++.+++||++||+|||++|||||||||+|||++. ++.+||+|||+++........
T Consensus 101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~-- 174 (313)
T KOG0198|consen 101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK-- 174 (313)
T ss_pred CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc--
Confidence 999999988764 2999999999999999999999999999999999999999 799999999999876531100
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
........||+.|||||++..+ ...+++|||||||++.||+||+.||.
T Consensus 175 -------------------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 175 -------------------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred -------------------------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 0112235599999999999953 33459999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
+.. ........+......+ ..+...+....+|+.+|+..||++||||.++++.--
T Consensus 224 ~~~--------~~~~~~~~ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 224 EFF--------EEAEALLLIGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred hhc--------chHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 530 0011111111111111 222336678899999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.20 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=194.8
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
-.+|+|+||+|||++ .++|+.||||++.+. .+...+-..+|+++|++++|+|+|.++++|......++|+|||+..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 478999999999999 457999999999664 34445667899999999999999999999999999999999997644
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
| +-+.+... .++.+.++++++|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+.+....
T Consensus 88 L-~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg------- 155 (396)
T KOG0593|consen 88 L-HELERYPN----GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG------- 155 (396)
T ss_pred H-HHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-------
Confidence 4 44554433 28999999999999999999999999999999999999999999999999999876321
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
...+.++.|.-|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..
T Consensus 156 -----------------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 156 -----------------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred -----------------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 12334567888999999987 789999999999999999999999886643
Q ss_pred cCCCCcchhch-----hHHHHHHHH--hhhc----Ccc-------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDK-----NRAIRLADA--AIRA----DFE-------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~-----~~~~~~~~~--~~~~----~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+-.....+... .+...++.. ...+ ..+ .......-+++|+..|+..||.+|++-+|++.
T Consensus 207 DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 207 DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 31111110000 000011100 0000 000 01112346789999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=382.85 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=217.0
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|.||+||+|+.. +.+.||||.+++.... ..++|++|++++..++|||||+++|+|.+++..++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 457999999999999842 3578999999987555 678999999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 553 VPNGSLANARYRKMGSS---------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
|..|||.++|....... +.+++..+.+.||.|||.|++||-++.+|||||-..|+||+++..|||+|||++
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLs 650 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLS 650 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccc
Confidence 99999999998754332 234889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+.+-..+.....+.. .=...|||||.+..+++|++||||||||+||
T Consensus 651 RdiYssDYYk~~~~t----------------------------------~lPIRWMppEsIly~kFTteSDVWs~GVvLW 696 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNT----------------------------------LLPIRWMPPESILYGKFTTESDVWSFGVVLW 696 (774)
T ss_pred hhhhhhhhhcccCCc----------------------------------eeeeecCCHHHhhcCcccchhhhhhhhhhhh
Confidence 976543322211110 0134599999999999999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|+++ |+.||++-..+++ +..+.+..+ .+.++..+.++++|+..||+.+|++||+++||-..|+....
T Consensus 697 EIFsyG~QPy~glSn~EV---------Ie~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 697 EIFSYGKQPYYGLSNQEV---------IECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred hhhccccCcccccchHHH---------HHHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 9999 7779876533222 222222222 45566688999999999999999999999999999998876
Q ss_pred CCCCC
Q 003847 783 SPSPY 787 (791)
Q Consensus 783 ~~~p~ 787 (791)
...+|
T Consensus 765 ~s~~~ 769 (774)
T KOG1026|consen 765 ASPKY 769 (774)
T ss_pred cCccc
Confidence 66555
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.91 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=205.2
Q ss_pred hcceeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 478 ASAYILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...++||.|..++||+|+ ...++.||||++.-+ .....+.+++|+..|+.++||||++++..|..+...|+||.||.+
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence 345789999999999999 567899999999754 233368899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++.+++......+ +++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+........
T Consensus 109 GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~- 184 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV- 184 (516)
T ss_pred CcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee-
Confidence 99999998876554 99999999999999999999999999999999999999999999999999877654321100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.+ ...+.||++|||||++.. ..|+.|+||||||++.+||.+|..||.
T Consensus 185 ------------------------------~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 185 ------------------------------TR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ------------------------------Ee-eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 00 145679999999999643 679999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcC----------ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRAD----------FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... ++.-..+.+. .+........+.+++..||..||.+|||++++++-
T Consensus 234 k~pPm-------------kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 234 KYPPM-------------KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChH-------------HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 54221 1111111111 11222244578899999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=368.91 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=216.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++-||.|+.|.|-.|+ .++|+.+|||++.+. .......+++|+-+|+-+.||||+++|++|+++.+.|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 3579999999999999 678999999999764 233346789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|-|.+++-.++. +++.++.++++||+.|+.|+|..+|+||||||+|+|+|.++++||+|||+|....++.
T Consensus 97 GELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk----- 166 (786)
T KOG0588|consen 97 GELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK----- 166 (786)
T ss_pred chhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-----
Confidence 999999988763 9999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||++.|.|||++.+.+| +.++||||.|||||.|+||+.||++
T Consensus 167 --------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 167 --------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred --------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 2345689999999999999998 6799999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+ .+..+.....++.|..+...+.++++|+++|+..||++|.|++||++.
T Consensus 215 d-------------Nir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 215 D-------------NIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred c-------------cHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 5 345666677778888888888999999999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.81 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=204.6
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC----ch-hhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN----SV-DRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...||+|+||.||.|. ..+++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++......|+||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 4689999999999998 557899999987653 11 23456778999999999 99999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~ 631 (791)
+.||+|.+++.... ++.+.+++.+++|++.|++|||++||+||||||+|||+|.+ +++||+|||++......
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~-- 174 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE-- 174 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC--
Confidence 99999999998843 38999999999999999999999999999999999999999 99999999999876311
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CC-CchhhHHHHHHHHHHHhCC
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PN-PKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~~sDvwSlGvil~elltG~ 709 (791)
.......|||+.|+|||++.+.. |+ .++||||+||+||.|++|+
T Consensus 175 ----------------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 175 ----------------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred ----------------------------------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 11234678999999999999977 85 7899999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHH-HHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEA-LLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
.||.+.. ...+......+.+..+... ..++.+++.+|+..||.+|+++.+++
T Consensus 221 ~PF~d~~-------------~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 221 LPFDDSN-------------VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCCcc-------------HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9997731 2223333444555555444 78899999999999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=363.90 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=205.8
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..++.||+|.||+||+|++. -.||||++..+ ..+..+.|++|+..+++-+|.||+-+.|+|..+.. .||+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 34679999999999999975 36999999765 45567899999999999999999999999988777 999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
.+|+.+++.... .+...+.+.|++||++|+.|||.++|||||||..||++.+++.|||+|||++..-..-..
T Consensus 472 sSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g---- 543 (678)
T KOG0193|consen 472 SSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG---- 543 (678)
T ss_pred chhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc----
Confidence 999999987664 489999999999999999999999999999999999999999999999999875432100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
........|+..|||||+++. .+|++.+||||||+|+|||+||..||
T Consensus 544 ------------------------------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 544 ------------------------------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ------------------------------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 001112338889999999964 56899999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
.....+..-.++-.+....+.. ........++.+|+..||.+++++||.+.+|+..|+++..
T Consensus 594 si~~~dqIifmVGrG~l~pd~s--------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLS--------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CCCChhheEEEecccccCccch--------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 8543333322222211001100 1112245678899999999999999999999998887765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.03 Aligned_cols=292 Identities=17% Similarity=0.206 Sum_probs=213.0
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-.+||+|+||.||.|+ ..+|..+|+|++++... ...+.+..|-.+|...++|+||+|+-.|++.+..||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 3589999999999999 55799999999988643 3345678899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++..+|..... |++..++.++.+++.|++-||+.|||||||||+|+|||..|++||+|||++.-+.........
T Consensus 226 GD~mTLL~~~~~-----L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 226 GDMMTLLMRKDT-----LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred ccHHHHHHhcCc-----CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999999987753 999999999999999999999999999999999999999999999999999755432211100
Q ss_pred CCCccccCCcccccccccccC---C---------CCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 636 GGSARNFGSKRSTASRDSFQD---L---------GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
...... ...........+.. . .............+.+|||.|||||++.+..|+..+|.||||||+|
T Consensus 301 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 301 RLDEQM-QINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY 379 (550)
T ss_pred cchhhh-hhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence 000000 00000000000000 0 0000001112233568999999999999999999999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH----
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQA---- 776 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~---- 776 (791)
||+.|.+||..+...... ..+..-...-.++.......+..|||.+|+. ||++|.- ++||.+.
T Consensus 380 EmLvGyPPF~s~tp~~T~---------rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETY---------RKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred HHHhCCCCCCCCCHHHHH---------HHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence 999999999876443221 1222222122233333456788999999999 9999974 6666553
Q ss_pred ---hccCCCCCCCC
Q 003847 777 ---LEKIPSSPSPY 787 (791)
Q Consensus 777 ---L~~i~~~~~p~ 787 (791)
.+.|...+.||
T Consensus 450 ~v~W~~l~~~~apf 463 (550)
T KOG0605|consen 450 GVDWDHLREMPAPF 463 (550)
T ss_pred cCCcchhhcCCCCC
Confidence 34455555555
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.43 Aligned_cols=231 Identities=23% Similarity=0.299 Sum_probs=205.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhh---HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDR---FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-..||.|+||.|..++ ..+|..+|+|++.+...-+ .+...+|.++|+.+.||.++++++.|.+.+..|+||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 4689999999999999 5579999999998764443 34567899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.|..++++.+. +++..++-++.||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus 129 GElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r------ 197 (355)
T KOG0616|consen 129 GELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR------ 197 (355)
T ss_pred ccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc------
Confidence 999999987653 999999999999999999999999999999999999999999999999999987532
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....||||.|+|||++....|+.++|.|||||++|||+.|.+||.+.
T Consensus 198 ---------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 ---------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ---------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 23578999999999999999999999999999999999999999765
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
. ...+.+..+.+....+.-...++.+|+.++++.|-.+|
T Consensus 245 ~-------------~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 245 N-------------PIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred C-------------hHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2 24556666667666666677889999999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=355.78 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
-+.||+|.||.||+|+ ..+|+.||+|++..+. ........+||.||++|+||||++|.+...+. +.+|+|+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4689999999999999 6789999999997654 33345678999999999999999999998877 68999999996
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
. +|.-++..... .+++.+++.+++|++.||+|||++||+|||||.+|||||.+|.+||+|||+|+.+......
T Consensus 202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-- 274 (560)
T KOG0600|consen 202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-- 274 (560)
T ss_pred c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc--
Confidence 5 88777765432 4999999999999999999999999999999999999999999999999999987643321
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
..+..+-|.=|+|||.+.+ ..|+.++|+||.||||.||++|+++|.
T Consensus 275 ---------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 275 ---------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred ---------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 2345557888999999986 579999999999999999999999886
Q ss_pred cccc-----------------CCCCcchhchh--HHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 714 DELG-----------------QGNGLLVEDKN--RAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 714 ~~~~-----------------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
+..+ .|....+.... ....-....+... ....+...++|+..+|..||.+|.||.+++
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~---~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET---FKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH---hccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 5432 11100000000 0000000011110 111234668899999999999999999998
Q ss_pred HH
Q 003847 775 QA 776 (791)
Q Consensus 775 ~~ 776 (791)
+.
T Consensus 399 ~s 400 (560)
T KOG0600|consen 399 QS 400 (560)
T ss_pred cC
Confidence 64
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.34 Aligned_cols=255 Identities=22% Similarity=0.228 Sum_probs=198.9
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhH-HHHHHHHHHHhccC-CCCccceeeEEEccC-ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRF-RDFETQVRVIAKLV-HPNLVRIRGFYWGVD-EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lv~e~~~~ 555 (791)
-+.||.|.||.||+|+ .++|..||||++++.-.... -.-.+|++.|++|+ |||||++.+++.+.+ ..|+|||||+
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md- 93 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD- 93 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-
Confidence 3579999999999999 67899999999987533221 23468999999998 999999999999988 8999999995
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
.+|+++++.+.. .+++.+++.|+.||++||+|+|++|+.|||+||+|||+.....+||+|||+|+.+....
T Consensus 94 ~NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp----- 164 (538)
T KOG0661|consen 94 CNLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP----- 164 (538)
T ss_pred hhHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC-----
Confidence 599999887732 59999999999999999999999999999999999999988899999999999875332
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
+.+.++.|.=|+|||++. ...|+.+.||||+|||++|+.+-++.|.+
T Consensus 165 --------------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 165 --------------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred --------------------------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 344566788899999985 56789999999999999999999998865
Q ss_pred cccC------------CCCcchhchhHHHHHHHHhhhcCcc-----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQ------------GNGLLVEDKNRAIRLADAAIRADFE-----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..+- .....+.+...+.....-.+..... .......++.+++.+|++.||++||||.|+++.
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 4321 0111111111111111111110000 011144678899999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.61 Aligned_cols=258 Identities=20% Similarity=0.281 Sum_probs=207.7
Q ss_pred cccchHHHhhhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhh---HHHHHHHHHHHhccCCCCccceeeEEEc--
Q 003847 468 KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDR---FRDFETQVRVIAKLVHPNLVRIRGFYWG-- 542 (791)
Q Consensus 468 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~-- 542 (791)
+.++.+++.......||+|+++.||+|.. +|+.||||+++...... .+.+.+|+++|++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 45666777666678999999999999998 68999999997643322 4678899999999999999999999877
Q ss_pred --cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEec
Q 003847 543 --VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGD 619 (791)
Q Consensus 543 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~D 619 (791)
....++||||+++|+|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcc
Confidence 346789999999999999987643 38899999999999999999998 5999999999999999999999999
Q ss_pred cCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHH
Q 003847 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYS 697 (791)
Q Consensus 620 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS 697 (791)
||+++...... ....||..|+|||++.+ ..++.++||||
T Consensus 167 fg~~~~~~~~~---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~S 207 (283)
T PHA02988 167 HGLEKILSSPP---------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207 (283)
T ss_pred cchHhhhcccc---------------------------------------ccccCcccccCHHHhhhccccccchhhhhH
Confidence 99988653211 01237888999999976 67899999999
Q ss_pred HHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 698 FGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 698 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
|||++|||++|+.||.+.... .....+....... ..+...+..+.+++.+||+.||++|||++|+++.|
T Consensus 208 lGvil~el~~g~~Pf~~~~~~---------~~~~~i~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 208 LGVVLWEIFTGKIPFENLTTK---------EIYDLIINKNNSL--KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhcCCCC--CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 999999999999999653110 0011111111111 11112566789999999999999999999999999
Q ss_pred ccCC
Q 003847 778 EKIP 781 (791)
Q Consensus 778 ~~i~ 781 (791)
+.+.
T Consensus 277 ~~~~ 280 (283)
T PHA02988 277 SLYK 280 (283)
T ss_pred HHHH
Confidence 8764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.12 Aligned_cols=257 Identities=22% Similarity=0.245 Sum_probs=198.3
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchh--hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+.+|+|.||.||+|+ .++|+.||||+++..... ......+|++.|+.++|+||+.++++|-..+..-+|+|||+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~- 84 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP- 84 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-
Confidence 34689999999999999 678999999999764222 12457899999999999999999999999999999999995
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
.+|+..++.... .++..+++.++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 85 tdLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--- 157 (318)
T KOG0659|consen 85 TDLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--- 157 (318)
T ss_pred ccHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc---
Confidence 589988876543 4899999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.+..+-|.-|+|||.+.| ..|+..+||||.|||+.||+-|.+.|.+
T Consensus 158 ---------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 158 ---------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred ---------------------------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 111245677999999876 6799999999999999999999987765
Q ss_pred ccc------------CCCCcchhchhHHHHHHHHhhhcCcc---chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELG------------QGNGLLVEDKNRAIRLADAAIRADFE---GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+.+ ......+.+...+.+..+-...+..+ .......+.++|+.+|+..||.+|+++.|++++
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 432 00111111111111111111000000 111234567999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=359.00 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=200.0
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC-ceEEE
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD-EKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lv 549 (791)
..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 356899999999999973 235789999997543 33446789999999999 8999999999887654 57899
Q ss_pred EeccCCCChhHHHHhhcCC---------------------------------------------------------CCCC
Q 003847 550 YDFVPNGSLANARYRKMGS---------------------------------------------------------SPCH 572 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 572 (791)
|||+++|+|.+++...... ...+
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999998753210 0124
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccc
Q 003847 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652 (791)
Q Consensus 573 l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (791)
+++.++..++.||++||+|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------------------- 231 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------------------- 231 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh-------------------
Confidence 8888999999999999999999999999999999999999999999999998653221100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHH
Q 003847 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAI 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 731 (791)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .....
T Consensus 232 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~ 288 (338)
T cd05102 232 ---------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQ 288 (338)
T ss_pred ---------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHH
Confidence 0111236678999999999899999999999999999997 99998653211 00001
Q ss_pred HHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 732 RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
.+.+.. ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 289 ~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 289 RLKDGT---RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHhcCC---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111110 011122245678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=351.09 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=207.9
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|.||.||+|. .++++.||+|++.-+ ..+..+++++|+.+|.+++++||.++|+.|..+...+++||||.||
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 34789999999999999 567999999999765 4555788999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
++.+.+.... .+.+..+.-|+++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 97 sv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~----- 166 (467)
T KOG0201|consen 97 SVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK----- 166 (467)
T ss_pred chhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh-----
Confidence 9999887654 257888888999999999999999999999999999999999999999999987754322
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
....++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.+..
T Consensus 167 -------------------------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 167 -------------------------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred -------------------------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 1235679999999999999999999999999999999999999998765
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...+...+.... .+.++. .....+.+|+..||++||+.||+|.++++.
T Consensus 216 PmrvlflIpk~~----------PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 216 PMRVLFLIPKSA----------PPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cceEEEeccCCC----------CCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 533333332211 122222 256678999999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.88 Aligned_cols=240 Identities=20% Similarity=0.246 Sum_probs=197.0
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
+||+|+||.||+++. .+|+.||||+++... ......+.+|++++++++||||+++++++...+..|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 699999999999985 578999999997542 2334567889999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------- 149 (323)
T cd05571 82 LFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------- 149 (323)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-------
Confidence 999887643 38999999999999999999999999999999999999999999999999987532110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 150 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 200 (323)
T cd05571 150 -----------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred -----------------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence 011234599999999999999999999999999999999999999964311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
..............+......+.+++.+||+.||++|| ++.++++
T Consensus 201 -------------~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 201 -------------EKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11111122222222233566788999999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.72 Aligned_cols=241 Identities=20% Similarity=0.331 Sum_probs=207.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|.||.|-+|. ...|+.||||.++++. .+..-.+.+|++||..|+||||+.+|++|++.+.+.|||||..+
T Consensus 58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~ 137 (668)
T KOG0611|consen 58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASG 137 (668)
T ss_pred HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCC
Confidence 4579999999999998 5789999999998753 33445688999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.|++|+.+.+. +++.+++.+++||+.|+.|+|.++++|||||.+|||+|.++++||+|||++.++....
T Consensus 138 GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k----- 207 (668)
T KOG0611|consen 138 GELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK----- 207 (668)
T ss_pred ccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-----
Confidence 999999998764 9999999999999999999999999999999999999999999999999998765322
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
..+.+||++-|.+||++.+.+| ++.+|-|||||+||.|+.|..||++
T Consensus 208 --------------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 208 --------------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred --------------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 2346789999999999999888 6899999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. -..++...-.+.+..+. .+....-||+.||..+|++|.|+.||...
T Consensus 256 ~D-------------hk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 256 RD-------------HKRLVRQISRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ch-------------HHHHHHHhhcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 41 22334444444443332 44566779999999999999999999765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.29 Aligned_cols=239 Identities=20% Similarity=0.230 Sum_probs=195.0
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||.||+|+. .+++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999995 46889999998653 233446778899999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-------
Confidence 99887643 389999999999999999999999999999999999999999999999999875321110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 149 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~- 198 (312)
T cd05585 149 -----------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV- 198 (312)
T ss_pred -----------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-
Confidence 11234589999999999999999999999999999999999999965311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 775 (791)
.+............+......+.+++.+||+.||++||+ +.|+++
T Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 199 ------------NEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ------------HHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 122222222222223335567889999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=355.53 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=204.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
-.+||+|.||+|+++.. .+++.+|||+++++ ..+..+....|.+|+... +||.++.++..|+.+++.|+||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 46999999999999994 56899999999886 344556778888888777 59999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
||++..+.+.. .+++..++-++..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+++.-...
T Consensus 453 Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~----- 521 (694)
T KOG0694|consen 453 GGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ----- 521 (694)
T ss_pred CCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-----
Confidence 99965544332 3999999999999999999999999999999999999999999999999999864311
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
...++.+|||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+
T Consensus 522 -------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 522 -------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred -------------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 1134578999999999999999999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
+. -.+++|..+..+...+...+.+..+++.++|..+|++|.-+
T Consensus 571 dd-------------Eee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 571 DD-------------EEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC-------------HHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 52 25677777776666666678889999999999999999855
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=321.28 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=203.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.++||+|.|+.||++. ..+|+.+|+|++... +....+++++|++|-+.|+|||||++.+.+.+.+..|+|+|+|+|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 4689999999999998 567999999998543 3446788999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|..-+-.+. .+++..+-.+++||++||.|+|.++|||||+||+|+++-. .--+||+|||+|..+.....
T Consensus 96 dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~-- 168 (355)
T KOG0033|consen 96 ELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA-- 168 (355)
T ss_pred HHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc--
Confidence 9987665543 3888999999999999999999999999999999999953 33489999999998762211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.-...|||+|||||+++..+|+..+|||+.|||||-|+.|.+||.
T Consensus 169 -----------------------------------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 169 -----------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred -----------------------------------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 123569999999999999999999999999999999999999997
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
++. ..+++.....+.++.+ ....++..+|+++||..||.+|.|+.|.++
T Consensus 214 ~~~-------------~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 214 DED-------------QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred Ccc-------------HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 742 2445555555544332 335577899999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.92 Aligned_cols=248 Identities=17% Similarity=0.186 Sum_probs=197.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||++.. .+|+.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46899999999999994 679999999986542 22234678899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++...... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 85 g~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 157 (285)
T cd05631 85 GDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---- 157 (285)
T ss_pred CcHHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe----
Confidence 9999887654322 389999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 158 ---------------------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred ---------------------------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 11235899999999999999999999999999999999999999754
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 776 (791)
..... ...+..................+.+|+.+||+.||++||+ ++++++.
T Consensus 205 ~~~~~---------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 205 KERVK---------REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred Ccchh---------HHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 22110 0111111111111122224567889999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=338.95 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=196.1
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch--------------hhHHHHHHHHHHHhccCCCCccceeeEEEcc-
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV--------------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV- 543 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~- 543 (791)
..-||+|.||.|-+|+ ..+++.||||++.+... ...+...+||.+|++++|||||+|+++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 4579999999999999 45799999999965311 1135789999999999999999999998775
Q ss_pred -CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCc
Q 003847 544 -DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622 (791)
Q Consensus 544 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGl 622 (791)
+..|||+|||..|.+...-. .. ..+++.++++|+++++.||+|||.+|||||||||+|+|++++|++||+|||.
T Consensus 182 s~~~YlVley~s~G~v~w~p~----d~-~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGV 256 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPP----DK-PELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGV 256 (576)
T ss_pred cCceEEEEEeccCCccccCCC----Cc-ccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccce
Confidence 57899999999988754211 11 1289999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC----CCCchhhHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK----PNPKWDVYSF 698 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~sDvwSl 698 (791)
+........... -.......|||.|+|||...++. .+.+.||||+
T Consensus 257 s~~~~~~~~~~~-------------------------------d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 257 SNEFPQGSDEGS-------------------------------DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred eeecccCCcccc-------------------------------HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 987643311100 00122346999999999987622 3678999999
Q ss_pred HHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 699 GVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF--EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 699 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||+||.|+.|+.||.++. ..++++.+..... +...++...+.+||.+||.+||++|.+..+|...
T Consensus 306 GVTLYCllfG~~PF~~~~-------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 306 GVTLYCLLFGQLPFFDDF-------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hhhHHHhhhccCCcccch-------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999999999999997652 3444555444333 2233467789999999999999999999998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=347.16 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=197.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 468999999999999954 68999999986532 22345688999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----- 155 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----- 155 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----
Confidence 99999987653 38999999999999999999999999999999999999999999999999987653210
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 156 ----------------------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ----------------------------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1234899999999999988999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 776 (791)
.. ..............+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 202 ~~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 202 NP-------------FGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CH-------------HHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 21 111222222222222224567889999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.13 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=195.9
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
++||+|+||.||+++. .+|+.||+|++... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999994 57899999999754 2233456778999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 9998876543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 1123458999999999999899999999999999999999999986431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
. ..............+......+.+++.+||+.||++|| ++.++++
T Consensus 200 ~-------------~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 200 H-------------ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred H-------------HHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 11111111122222223456788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.47 Aligned_cols=241 Identities=22% Similarity=0.264 Sum_probs=196.8
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
+||+|+||.||+++. .+|+.||||++... .......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 689999999999994 56899999999754 23345678889999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~------ 150 (328)
T cd05593 82 LFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA------ 150 (328)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc------
Confidence 998876543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 151 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 151 ------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred ------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 11234589999999999998999999999999999999999999964311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.+............+......+.+++.+||+.||++|| ++.|+++.
T Consensus 201 -------------~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 201 -------------EKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -------------HHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111111122222223456788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=317.48 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=202.1
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCC--------chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGEN--------SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
..++||.|..++|-++. .++|..+|+|++... .....++-.+|+.||+++ .||+|+++.++|+.+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 45789999999999888 567899999998432 111234567899999998 69999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
|+|.|+.|.|.|++...-. +++...++|++|+.+|++|||.++||||||||+|||+|++.++||+|||+++.+.+
T Consensus 101 VFdl~prGELFDyLts~Vt-----lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKVT-----LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhcccchHHHHhhhhee-----ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999988753 99999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc------CCCCCCchhhHHHHHHH
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR------SIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~~sDvwSlGvil 702 (791)
.. .....||||+|.|||.++ ...|+..+|+||+|||+
T Consensus 176 Ge-------------------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 176 GE-------------------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred ch-------------------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 32 234678999999999985 35688899999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCcc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|.|+.|.+||... ...-+..-.+.+.+. ...+.+....+||.+||+.||.+|.|++|+++.
T Consensus 219 yTLLaGcpPFwHR-------------kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 219 YTLLAGCPPFWHR-------------KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHcCCCchhHH-------------HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 9999999999542 111222233334332 334466778999999999999999999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.96 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=196.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999954 68999999986532 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 172 (329)
T PTZ00263 103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----- 172 (329)
T ss_pred ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----
Confidence 99999887653 38899999999999999999999999999999999999999999999999987653211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 173 ----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 173 ----------------------------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ----------------------------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 1235899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 776 (791)
.. .+.......+....+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 219 ~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 219 TP-------------FRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CH-------------HHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 21 111111111222222224456789999999999999997 6777643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.28 Aligned_cols=239 Identities=26% Similarity=0.398 Sum_probs=200.4
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhH
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 560 (791)
+-||.|+.|.||.|+++ ++.||||+++.- -+.+|+-|++|+|+||+.+.|+|.....+|||||||..|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 57999999999999986 689999987542 2457888999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCcc
Q 003847 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640 (791)
Q Consensus 561 ~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 640 (791)
.++... .+.......|..+||.|++|||.+.|||||||.-||||..+..+||+|||-++.....
T Consensus 202 VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----------- 265 (904)
T KOG4721|consen 202 VLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK----------- 265 (904)
T ss_pred HHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-----------
Confidence 998765 3788889999999999999999999999999999999999999999999999876532
Q ss_pred ccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCC
Q 003847 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGN 720 (791)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~ 720 (791)
.+...++||..|||||+++..++++|+||||||||||||+||..||.+-...-.
T Consensus 266 --------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 266 --------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred --------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 123467899999999999999999999999999999999999999976422111
Q ss_pred CcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 721 GLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
-. .+-...+ ..+.+...+..+.-|+++||+..|..||++.+++..|+-.
T Consensus 320 Iw---------GVGsNsL--~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 320 IW---------GVGSNSL--HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred EE---------eccCCcc--cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00 0000111 1233444677788899999999999999999999998643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=310.74 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=206.8
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+..||+|-||.||.|+ .+++-.||+|++.+... ....++.+|++|-..|+||||+++|++|.+....|+++||.+
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 35689999999999999 56788999999976422 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|.+...+...... ++++.....++.|+|.||.|+|.++|+||||||+|+|++.++..||+|||.+.....
T Consensus 106 ~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~------ 176 (281)
T KOG0580|consen 106 RGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------ 176 (281)
T ss_pred CchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC------
Confidence 99999999865543 488899999999999999999999999999999999999999999999999865421
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......|||..|.+||...+..++..+|+|++|++.||++.|.+||..
T Consensus 177 --------------------------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 177 --------------------------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred --------------------------------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 124467899999999999999999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ..+.+......++..+........++|.+|+..+|.+|.+..|+++.
T Consensus 225 ~~-------------~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 225 QS-------------HSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hh-------------hHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 42 12222333333333344467788999999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=351.85 Aligned_cols=257 Identities=26% Similarity=0.330 Sum_probs=200.0
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 357999999999999963 346789999997542 33446788999999999 8999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCC--------------------------------------------------------------
Q 003847 551 DFVPNGSLANARYRKMGS-------------------------------------------------------------- 568 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 568 (791)
||+++|+|.+++......
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999998754210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCcc
Q 003847 569 --------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640 (791)
Q Consensus 569 --------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 640 (791)
....+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~------ 272 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV------ 272 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc------
Confidence 012478899999999999999999999999999999999999999999999999986543211000
Q ss_pred ccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCC
Q 003847 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQG 719 (791)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~ 719 (791)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 273 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~- 323 (375)
T cd05104 273 ----------------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD- 323 (375)
T ss_pred ----------------------------cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-
Confidence 001225667999999999999999999999999999998 77788543111
Q ss_pred CCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
............... +...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 324 --------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 324 --------SKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------HHHHHHHHhCccCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111112221111111 111345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=352.18 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=201.6
Q ss_pred hhcceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
+...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +|+||+++++++...+..++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 33457899999999999873 234589999997643 33456788999999999 89999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcC-------------------------------------------------------------
Q 003847 549 IYDFVPNGSLANARYRKMG------------------------------------------------------------- 567 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 567 (791)
||||+++|+|.+++.....
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 9999999999999865321
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccC
Q 003847 568 ----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFG 643 (791)
Q Consensus 568 ----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 643 (791)
....++++..+++|+.||+.||+|||++||+||||||+|||+++++.+||+|||+++.+.......
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---------- 269 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---------- 269 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----------
Confidence 001247889999999999999999999999999999999999999999999999987653221100
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCc
Q 003847 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGL 722 (791)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~ 722 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 270 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---- 321 (374)
T cd05106 270 ------------------------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---- 321 (374)
T ss_pred ------------------------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----
Confidence 0011225667999999998899999999999999999997 99998653211
Q ss_pred chhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
............... ....+.++.+++.+||+.||++||++.+++++|+++.
T Consensus 322 -----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 -----SKFYKMVKRGYQMSR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----HHHHHHHHcccCccC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011111111111111 1113467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.55 Aligned_cols=245 Identities=25% Similarity=0.298 Sum_probs=209.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-eEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE-KLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~e~~~~ 555 (791)
-+.+|+|+||.++.+++ .++..||+|.+.-. .....+..++|+.++++++|||||.+.+.|.+++. .+|||+||+|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 46899999999999994 46789999998653 23334578899999999999999999999999998 8999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++.+.+.+..+. .++++.+..|+.|++.|++|||+++|+|||||+.||+++.++.+||+|||+|+.+.....
T Consensus 89 g~l~~~i~~~k~~---~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~---- 161 (426)
T KOG0589|consen 89 GDLAQLIKEQKGV---LFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS---- 161 (426)
T ss_pred CCHHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh----
Confidence 9999999887643 499999999999999999999999999999999999999999999999999998875431
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
...+..||+.||.||++.+.+|+.|+|||||||++|||++-+++|...
T Consensus 162 --------------------------------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 162 --------------------------------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred --------------------------------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 123567999999999999999999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. ...++....... .+.+.....++..++..|+..+|+.||++.+++.+
T Consensus 210 ~-------------m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 210 N-------------MSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-------------hHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 233333333333 23344477889999999999999999999999986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.22 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=191.1
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-----eEEEEec
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE-----KLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~~lv~e~ 552 (791)
..+++|.|+||.||+|. .++++.||||++-.+... -.+|+++|++++|||||++.-+|....+ ..+||||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 45799999999999999 456799999998665332 2468999999999999999998875432 2489999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~ 631 (791)
|+. +|.++++..... ..+++...++-+..||.+||+|||+.||+||||||+|+|+|.+ |.+||||||.|+.+.....
T Consensus 104 mP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred chH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 975 899988753211 1248889999999999999999999999999999999999966 9999999999998864432
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~ 710 (791)
. .++.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++
T Consensus 182 n-------------------------------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 182 N-------------------------------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP 224 (364)
T ss_pred c-------------------------------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence 1 23446788999999876 568999999999999999999999
Q ss_pred chhccccCCCCcc------------hhchhHH-HHHHHHhhhcCcc---chHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 711 IVVDELGQGNGLL------------VEDKNRA-IRLADAAIRADFE---GKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 711 pf~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
.|.++........ +..+... .+...+.+....- .......+..+|+.+++.++|.+|.++.|++
T Consensus 225 lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 225 LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 9977543111000 0000000 0000011111100 1122456789999999999999999999988
Q ss_pred HH
Q 003847 775 QA 776 (791)
Q Consensus 775 ~~ 776 (791)
..
T Consensus 305 ~h 306 (364)
T KOG0658|consen 305 AH 306 (364)
T ss_pred cc
Confidence 64
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=371.69 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=215.8
Q ss_pred cceeccccCceEEEEEEeCC--Cc----EEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLED--GT----ALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
...+||+|.||.||+|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|++.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 45789999999999999543 33 4999999875 55667899999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 552 FVPNGSLANARYRKMGSS--PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
||++|+|..+|++.+... +..++..+.+.++.|||+|++||+++++|||||..+|+|+++...|||+|||+|+.+-..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~ 855 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK 855 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc
Confidence 999999999998763221 235899999999999999999999999999999999999999999999999999965433
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-C
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-G 708 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G 708 (791)
+.....+.. .-...|||||.++.+.++.|+|||||||++||++| |
T Consensus 856 ~yyr~~~~a----------------------------------~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 856 DYYRKHGEA----------------------------------MLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred hheeccCcc----------------------------------ccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 322211100 01134999999999999999999999999999999 6
Q ss_pred CcchhccccCCCCcchhchhHHHHHHH-HhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLAD-AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPY 787 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~ 787 (791)
..||.+... .++.. ....+..+.+..++..++++|..||+.+|++||++..+++++..|.....++
T Consensus 902 ~~PY~~~~n-------------~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 902 ATPYPSRSN-------------FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred CCCCCCcch-------------HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 668865321 11111 2222345555667889999999999999999999999999999987776666
Q ss_pred cCC
Q 003847 788 LYG 790 (791)
Q Consensus 788 ~~~ 790 (791)
-|.
T Consensus 969 ~~~ 971 (1025)
T KOG1095|consen 969 IYG 971 (1025)
T ss_pred ccc
Confidence 554
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=346.15 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=195.4
Q ss_pred eeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 481 YILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
+.||+|+||.||+++. .+++.||||+++... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999984 357899999987532 22335678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999887643 378899999999999999999999999999999999999999999999999875321110
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 156 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf 200 (323)
T cd05584 156 -----------------------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200 (323)
T ss_pred -----------------------------------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence 111245899999999999888999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
..... .........+....+......+.+++.+||+.||++|| ++.++++
T Consensus 201 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 201 TAENR-------------KKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 65321 11122222222222223456788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=312.09 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=206.9
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEec
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~ 552 (791)
....||+|||+.||.++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+. +.|++++|
T Consensus 25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 35689999999999999 7789999999998887778889999999999999999999999875443 48999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
...|+|.+.+.....++. .+++.+++.|+.+|++||++||+.. ++||||||.|||+.+++.++|.|||.+....-..
T Consensus 105 y~~Gsl~d~i~~~k~kg~-~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKIKGN-FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred hccccHHHHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 999999999987665443 5999999999999999999999977 9999999999999999999999999988654221
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHh
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~ellt 707 (791)
......... +.-....-|..|+|||.+. +...++++|||||||++|+|+.
T Consensus 184 ~~~~~a~~l---------------------------Qe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 184 EGSRQALRL---------------------------QEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred echHHHHHH---------------------------HHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence 111000000 0001122577899999984 4567899999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|..||.....+.....+.-.. ..+ .++.....+..+.+++..|++.||.+||++.+++..++.+
T Consensus 237 ~~sPfe~~~~~GgSlaLAv~n-------~q~--s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 237 GESPFERIYQQGGSLALAVQN-------AQI--SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCcchHHhhcCCeEEEeeec-------ccc--ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999997643322111111100 000 1111112667889999999999999999999999998765
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.06 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=199.7
Q ss_pred hcceeccccCceEEEEEEeC----CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 478 ASAYILGASGSSIMYKAVLE----DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...++||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 34578999999999999742 46799999998653 33346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..++.++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+.........
T Consensus 88 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 88 MSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred CCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 999999999876432 3899999999999999999999999999999999999999999999999986543211000
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
......++..|+|||.+.+..++.++|||||||++||+++ |+.|
T Consensus 164 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 164 -----------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred -----------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCC
Confidence 0001225677999999999999999999999999999775 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|.+.... .....+.+. . ..+.....+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 209 ~~~~~~~---------~~~~~~~~~-~--~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 209 YWDMSGQ---------DVIKAVEDG-F--RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred cCcCCHH---------HHHHHHHCC-C--CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 8653211 011111111 0 1112223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.93 Aligned_cols=281 Identities=20% Similarity=0.262 Sum_probs=210.7
Q ss_pred eeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..||.|.-|+||+++.. ++..+|+|++.+.. .....+.+.|-+||+.++||.++.||+.|+.++..|+|||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 47999999999999965 46999999998753 334567888999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..+++++.++ .+++..++-++..|+-||+|||..|||.|||||+||||.++|.+.|+||.++.............
T Consensus 163 dL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 163 DLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred cHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 999988877654 49999999999999999999999999999999999999999999999999987663221111100
Q ss_pred CCccccCCc-cccccccccc------------------CCCCCC-CCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 637 GSARNFGSK-RSTASRDSFQ------------------DLGPGP-SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 637 ~~~~~~~~~-~~~~~~~~~~------------------~~~~~~-~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
......... ........|. ...+.. +........+++||-.|.|||++.+...+.++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 000000000 0000000000 000001 12233456678999999999999999999999999
Q ss_pred HHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC----HHH
Q 003847 697 SFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS----MKE 772 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~e 772 (791)
+|||++|||+.|+.||.+.... .....++...+ .++.....+..+.|||+++|.+||.+|.- +.|
T Consensus 320 tfGIflYEmLyG~TPFKG~~~~---------~Tl~NIv~~~l--~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSNNK---------ETLRNIVGQPL--KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCCch---------hhHHHHhcCCC--cCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9999999999999999775321 12222222221 22333346788999999999999999997 777
Q ss_pred HHH
Q 003847 773 ALQ 775 (791)
Q Consensus 773 vl~ 775 (791)
|.+
T Consensus 389 IK~ 391 (459)
T KOG0610|consen 389 IKR 391 (459)
T ss_pred hhc
Confidence 755
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.02 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=196.6
Q ss_pred ceeccccCceEEEEEEeCC-----------------CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEE
Q 003847 480 AYILGASGSSIMYKAVLED-----------------GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 541 (791)
.+.||+|+||.||+|..++ +..||+|.+.... .....++.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4689999999999997432 3479999997643 334567999999999999999999999999
Q ss_pred ccCceEEEEeccCCCChhHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCe
Q 003847 542 GVDEKLIIYDFVPNGSLANARYRKMGS--------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607 (791)
Q Consensus 542 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NI 607 (791)
+.+..++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Ni 169 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhhe
Confidence 999999999999999999988654211 012478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC
Q 003847 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI 687 (791)
Q Consensus 608 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 687 (791)
|++.++.+||+|||+++.+....... ......++..|+|||++.+.
T Consensus 170 ll~~~~~~kl~DfG~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 170 LVGENLTIKIADFGMSRNLYAGDYYR----------------------------------IQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred EEcCCccEEECCCccceecccCceeE----------------------------------ecCcCCCCccccCHHHHhcC
Confidence 99999999999999987653221100 01122357789999999888
Q ss_pred CCCCchhhHHHHHHHHHHHhC--CcchhccccCCCCcchhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCC
Q 003847 688 KPNPKWDVYSFGVILLELLTG--KVIVVDELGQGNGLLVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 688 ~~~~~sDvwSlGvil~elltG--~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP 764 (791)
.++.++||||||+++|||+++ ..||....... .+.. ........... ........+..+.+++.+||+.||
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIEN---AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHH---HHHHhhhccccccccCCCCCCHHHHHHHHHHccCCc
Confidence 899999999999999999874 45665421110 0000 01111110000 000111245678999999999999
Q ss_pred CCCCCHHHHHHHhcc
Q 003847 765 QKRPSMKEALQALEK 779 (791)
Q Consensus 765 ~~RPs~~evl~~L~~ 779 (791)
++|||+.||.+.|++
T Consensus 290 ~~RPs~~~i~~~l~~ 304 (304)
T cd05096 290 RERPSFSDIHAFLTE 304 (304)
T ss_pred hhCcCHHHHHHHHhC
Confidence 999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.37 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=211.1
Q ss_pred HHhhhcceeccccCceEEEEEEeCCC-cEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceee-EEEc------cC
Q 003847 474 TLLKASAYILGASGSSIMYKAVLEDG-TALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRG-FYWG------VD 544 (791)
Q Consensus 474 ~~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~-~~~~------~~ 544 (791)
.......++|.+|||+.||.|....+ ..||+|++-..+....+...+|+++|++|+ |+|||.|++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 33334467999999999999996665 999999998777888899999999999997 999999999 3322 13
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCCeEEeccCc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDMEPKIGDFGL 622 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~~kL~DFGl 622 (791)
+.+|+||||.||.|-|++..+...+ |++.++++|+.|+++|+++||... |||||||-+||||+.++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~---lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR---LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc---CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6789999999999999998766543 999999999999999999999865 99999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc---cCCCCCCchhhHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL---RSIKPNPKWDVYSFG 699 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~~~~sDvwSlG 699 (791)
|............ ... .. .--...-|+.|+|||++ .+...++|+|||+||
T Consensus 193 att~~~~~~~~~e----------~~~-ve----------------~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 193 ATTKILSPTSAQE----------VNY-VE----------------EEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred cccccCCCccHHH----------HHH-HH----------------HHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 8754322211000 000 00 00011268899999987 577889999999999
Q ss_pred HHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 700 VILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 700 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
|+||-|+....||++... ..+.... . .++........+.+||+.||+.||++||++-+|+..+.+
T Consensus 246 clLYkLCy~t~PFe~sg~----laIlng~---------Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGK----LAILNGN---------Y--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred HHHHHHHHhCCCcCcCcc----eeEEecc---------c--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 999999999999976411 0111110 0 122223478899999999999999999999999999999
Q ss_pred CCCCCCCC
Q 003847 780 IPSSPSPY 787 (791)
Q Consensus 780 i~~~~~p~ 787 (791)
|...+.|.
T Consensus 311 l~~~~~~~ 318 (738)
T KOG1989|consen 311 LANKPCPI 318 (738)
T ss_pred HhcCCCCc
Confidence 98777654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.73 Aligned_cols=242 Identities=21% Similarity=0.249 Sum_probs=195.7
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
++||+|+||.||++.. .+|+.||+|++... .......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999984 57899999999753 2233456788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 9998876543 38999999999999999999997 8999999999999999999999999999875321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 152 --------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 111345899999999999989999999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.. ..............+......+.+++.+||+.||++|+ ++.++++.
T Consensus 200 ~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 200 DH-------------EKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CH-------------HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 11111111112222222456788999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.17 Aligned_cols=248 Identities=18% Similarity=0.248 Sum_probs=196.3
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||+||++.. .+++.||||.+..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 4789999999865422 2335678899999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~------- 152 (280)
T cd05608 81 RYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------- 152 (280)
T ss_pred HHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-------
Confidence 9887643221 12489999999999999999999999999999999999999999999999999876542211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 153 -----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 203 (280)
T cd05608 153 -----------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 203 (280)
T ss_pred -----------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 011235889999999999999999999999999999999999999653211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.. ...................+..+.+++.+||+.||++|| +++++++.
T Consensus 204 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 204 VE---------NKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hh---------HHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 011111112222222223556788999999999999999 77888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=346.70 Aligned_cols=241 Identities=20% Similarity=0.229 Sum_probs=196.2
Q ss_pred cceeccccCceEEEEEEeCC--CcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLED--GTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
....||+|+||.||+|...+ +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 35689999999999998433 368999998643 2233457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 114 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--- 185 (340)
T PTZ00426 114 IGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--- 185 (340)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc---
Confidence 9999999987654 38999999999999999999999999999999999999999999999999987653210
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 186 ------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 186 ------------------------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred ------------------------------------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 12358999999999998889999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
..... ........+....+......+.+++.+|++.||++|+ +++++++.
T Consensus 230 ~~~~~-------------~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 230 ANEPL-------------LIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHH-------------HHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 53211 1111112222222222445678999999999999995 88888764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.14 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=197.8
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 468999999999999954 68999999987642 3345679999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 158 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------ 158 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc------
Confidence 999987643 389999999999999999999985 69999999999999999999999999987553211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 --------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 --------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred --------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112348899999999999899999999999999999999999985321
Q ss_pred cCCCCcc---------------------------------hhchhHHHHHHHHhhhcCccc--hHHHHHHHHHHHhhccC
Q 003847 717 GQGNGLL---------------------------------VEDKNRAIRLADAAIRADFEG--KEEALLSCFKLGYSCAS 761 (791)
Q Consensus 717 ~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~ 761 (791)
....... ........+..+.......+. ......++.+|+.+||+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 286 (331)
T cd06649 207 AKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLI 286 (331)
T ss_pred HHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHcc
Confidence 1000000 000000111111111111000 11145678999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||++|+++.
T Consensus 287 ~~P~~Rpt~~ell~h 301 (331)
T cd06649 287 KNPAERADLKMLMNH 301 (331)
T ss_pred CCcccCCCHHHHhcC
Confidence 999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.69 Aligned_cols=235 Identities=23% Similarity=0.284 Sum_probs=190.6
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|+. .+++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 689999999999995 468999999987532 23345677888888876 6999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 82 DLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred hHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-----
Confidence 9998887653 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 152 -------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred -------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 1123458999999999999899999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
. .++...........+......+.+++.+||+.||++||++
T Consensus 201 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 201 E-------------DDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred H-------------HHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 1111122222222222245678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.12 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=208.8
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 356899999999999984 23567999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 553 VPNGSLANARYRKMG--------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
+++++|.+++..... .....+++..++.++.|++.||+|||+.|++||||||+||++++++.+||+|||+++
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 168 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccc
Confidence 999999999875431 112348999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
.+....... ......++..|+|||++.+..++.++|||||||++||
T Consensus 169 ~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 169 DVYSTDYYR----------------------------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred cccCCceee----------------------------------cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 653221100 0011235678999999998889999999999999999
Q ss_pred HHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 705 LLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 705 llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|++ |+.||...... +..+....+.. ......+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 215 l~t~g~~p~~~~~~~-------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 215 IFTYGKQPWYQLSNN-------------EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHhCCCCCCCCCCHH-------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 999 88888543210 11111111111 1111244678999999999999999999999999999987
Q ss_pred CCCCCc
Q 003847 783 SPSPYL 788 (791)
Q Consensus 783 ~~~p~~ 788 (791)
....|+
T Consensus 282 ~~~~~~ 287 (288)
T cd05093 282 ASPVYL 287 (288)
T ss_pred hccccc
Confidence 665553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=358.06 Aligned_cols=249 Identities=20% Similarity=0.215 Sum_probs=201.1
Q ss_pred cceeccccCceEEEEEEe-CC-CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-ED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|++|.||+|.. .+ ++.||+|.+..........+.+|+++++.++|||||++++++...+..|+||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 457899999999999984 34 6889999886665555567888999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... ..++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 151 ~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~---- 225 (478)
T PTZ00267 151 DLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL---- 225 (478)
T ss_pred CHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc----
Confidence 999988654321 124889999999999999999999999999999999999999999999999999865432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 226 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 226 ------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01223569999999999999999999999999999999999999985431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. .++......+... .+......+.+++.+||..||++||++.+++.
T Consensus 276 ~-------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 276 Q-------------REIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred H-------------HHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 1122222222211 11224567899999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=317.94 Aligned_cols=255 Identities=22% Similarity=0.232 Sum_probs=196.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchh-h-HHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVD-R-FRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
-+.|++|.||.||+|+ .++++.||+|+++.+... . --...+||.+|.+++|||||.+.++.... +.+|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 3679999999999999 567999999999765321 1 12457899999999999999999987654 57999999996
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
-+|..+++.... ++...+++-++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+....
T Consensus 161 -hDLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~---- 231 (419)
T KOG0663|consen 161 -HDLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL---- 231 (419)
T ss_pred -hhHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc----
Confidence 489998887652 49999999999999999999999999999999999999999999999999999876431
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.+.+..+-|.-|+|||.+.+ ..|+++.|+||+|||+.||+++++.|.
T Consensus 232 --------------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 232 --------------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred --------------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 23445667888999999987 568999999999999999999999886
Q ss_pred cccc-----------------CCCCcchhchhH---HHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 714 DELG-----------------QGNGLLVEDKNR---AIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 714 ~~~~-----------------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
+... .|.....-.... .....-..++..+.... ....-.+|+..++.+||++|.|+.|.
T Consensus 280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHh
Confidence 5432 111110000000 00000011222222221 33567889999999999999999999
Q ss_pred HHH
Q 003847 774 LQA 776 (791)
Q Consensus 774 l~~ 776 (791)
|+.
T Consensus 359 L~h 361 (419)
T KOG0663|consen 359 LKH 361 (419)
T ss_pred hcc
Confidence 864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.90 Aligned_cols=241 Identities=21% Similarity=0.256 Sum_probs=193.8
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|+. .+++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 699999999999995 458899999997642 23345677888888866 7999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 82 DLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-----
Confidence 9998886543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 152 -------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred -------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 1123458999999999999899999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-------SMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 776 (791)
. ..............+......+.+++.+||+.||++|| ++.++++.
T Consensus 201 ~-------------~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 201 E-------------DDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred H-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 11112222222222222346788999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=356.93 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=211.7
Q ss_pred hhcceeccccCceEEEEEEeC----CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 477 KASAYILGASGSSIMYKAVLE----DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
....++||.|.||.||+|+++ ....||||.++....+ ...+|..|+.||.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 344689999999999999964 3468999999986443 45689999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
||++|+|+.+|..+.+ ++++.+...++++|+.|++||-+.++|||||...|||++.+..+|++|||+++.+.++..
T Consensus 711 yMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999998875 399999999999999999999999999999999999999999999999999998765442
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCC--CCcccCcccccCCCCCCchhhHHHHHHHHHHHh-C
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG--ISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-G 708 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G 708 (791)
... +...| ...|.|||.+...+++.++||||||+||||.++ |
T Consensus 787 ~~y-----------------------------------tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 787 AAY-----------------------------------TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred ccc-----------------------------------cccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 211 11122 246999999999999999999999999999877 8
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
..||.+-..+.+ ...++... ..+.+.+++..|.+|+..||++|-.+||.+.+|+..|+++-..
T Consensus 832 ERPYWdmSNQdV----------IkaIe~gy--RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 832 ERPYWDMSNQDV----------IKAIEQGY--RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCcccccchHHH----------HHHHHhcc--CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 888865322211 11111111 2234445788999999999999999999999999999886443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.61 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=207.8
Q ss_pred hcceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 478 ASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...-+||+|.||+||-|+ ..+...+|||.+........+-+..|+.+-++|+|.|||+++|.+.+++..-|.||-++||
T Consensus 578 ~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 578 NERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred CceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 345699999999999999 5567889999998877767778999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-CCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++..+-+. -+-.+.++-.+.+||++||.|||++.|||||||-+|||++ -.|.+||+|||-++.+..-
T Consensus 658 SLSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------ 729 (1226)
T KOG4279|consen 658 SLSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------ 729 (1226)
T ss_pred cHHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC------
Confidence 999999876642 1127888889999999999999999999999999999996 5789999999999876421
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.+.+..+.||..|||||++.. ..|+.++|||||||++.||.||++||.
T Consensus 730 ------------------------------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 730 ------------------------------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ------------------------------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 122345669999999999975 458999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHH-hhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADA-AIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.-... ...++.- ..+...+.+++...+...+|.+|+.+||.+||+++++++.
T Consensus 780 Elgsp-----------qAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 780 ELGSP-----------QAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ecCCh-----------hHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 53111 1222221 2223345566688899999999999999999999999874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=341.10 Aligned_cols=239 Identities=24% Similarity=0.251 Sum_probs=189.4
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|+. .+++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 699999999999995 468899999997532 22334556677777654 8999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-----
Confidence 9999887543 389999999999999999999999999999999999999999999999999875422110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 152 -------------------------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred -------------------------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 1123458999999999999899999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK-EAL 774 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 774 (791)
. .++...........+......+.+++.+||+.||++||++. +++
T Consensus 201 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 201 E-------------DELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred H-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 11111111111111122455678999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=327.53 Aligned_cols=251 Identities=28% Similarity=0.384 Sum_probs=201.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
....||+|+||.||+|.. ++++.||+|++..... ..+++.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 346899999999999995 4589999999876533 35678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... ..+++..++.++.|+++||+|||+.|++||||||+||++++++.+||+|||++..........
T Consensus 89 L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~---- 161 (263)
T cd05052 89 LLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---- 161 (263)
T ss_pred HHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec----
Confidence 9999876432 238999999999999999999999999999999999999999999999999987654321100
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 162 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 162 -------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred -------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 001124567999999998899999999999999999998 888885431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.. ............ ......+..+.+++.+||+.||++||++.+++++|+.+
T Consensus 211 ~~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 211 LS----------QVYELLEKGYRM--ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HH----------HHHHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 111111111111 11222456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.31 Aligned_cols=245 Identities=19% Similarity=0.241 Sum_probs=191.7
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 46899999999753 233345678899888877 899999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|..++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----
Confidence 99988876543 389999999999999999999999999999999999999999999999999874321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence 112345899999999999999999999999999999999999999532
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
........ .. ...+...........+......+.+++.+||+.||++||++
T Consensus 200 ~~~~~~~~-~~---~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 200 GSSDNPDQ-NT---EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCcCCccc-cc---HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11111000 00 01111112222222223355678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.19 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=197.4
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
+.||+|+||.||+|+. .+++.||+|.+.... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999995 478999999986543 33456789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 152 (252)
T cd05084 81 LTFLRTEGP----RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST---- 152 (252)
T ss_pred HHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc----
Confidence 999865432 389999999999999999999999999999999999999999999999999875432110000
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 153 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 153 ------------------------------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred ------------------------------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 000113456999999998889999999999999999998 7778854211
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
............. ......+..+.+++.+|++.+|++||++.+++++|++
T Consensus 203 ----------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 203 ----------QQTREAIEQGVRL--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ----------HHHHHHHHcCCCC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1111111111111 1122245678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.42 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=197.8
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..|+||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999964 58999999997542 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999987543 3899999999999999999999999999999999999999999999999998764320
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 155 ---------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred ---------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 11335899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...... ................ ........+.+++.+||..+|++||+++++++.
T Consensus 202 ~~~~~~------~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 202 TPNETW------ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHH------HHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 211000 0000000000000000 001235678899999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.19 Aligned_cols=249 Identities=20% Similarity=0.238 Sum_probs=194.8
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+++. .+++.||||+++.. .....+.+..|..+++++ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 689999999999995 46899999999754 223345688899999988 7999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~------ 150 (329)
T cd05588 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG------ 150 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC------
Confidence 9998876543 39999999999999999999999999999999999999999999999999987421110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 151 ------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred ------------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 01123468999999999999999999999999999999999999996421
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS------MKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 775 (791)
......... ...............+......+.+++.+||+.||.+||+ ++++++
T Consensus 201 ~~~~~~~~~----~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 201 MSDNPDQNT----EDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccccccc----hHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111000000 0111111122222222234567889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=325.52 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
...||+|+||.||++..+++..+|+|.+..... ..+++.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 357999999999999988888999999875433 2467889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++.........
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~------ 157 (256)
T cd05114 88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS------ 157 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec------
Confidence 98875432 38999999999999999999999999999999999999999999999999987653211100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 158 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 158 -----------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred -----------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 011125567999999998889999999999999999999 88898543210
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.....+... .. ...+......+.+++.+||+.+|++||+++|+++.|.
T Consensus 209 ---------~~~~~i~~~-~~--~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 ---------EVVEMISRG-FR--LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---------HHHHHHHCC-CC--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011111110 00 0111123457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.68 Aligned_cols=238 Identities=20% Similarity=0.261 Sum_probs=192.7
Q ss_pred eeccccCceEEEEEEe----CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVL----EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 4689999999975422 233467789999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence 999999886543 389999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 ---------------------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ---------------------------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 11134589999999999988899999999999999999999999964
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
... .+............+......+.+++.+||+.||++||++.+
T Consensus 201 ~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 201 KDR-------------KETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 311 111111222222222234567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.25 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=201.7
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 468999999999999988889999999876433 3468899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++...... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~l~~~~~~---~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~------ 160 (261)
T cd05072 90 DFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA------ 160 (261)
T ss_pred HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec------
Confidence 998765322 38899999999999999999999999999999999999999999999999998754221100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 161 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 161 -----------------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred -----------------------------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 011225667999999988889999999999999999998 88898543111
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. ......... ..+.....+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 212 ---------~-~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 212 ---------D-VMSALQRGY--RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---------H-HHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 111111111 1111122456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.88 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=201.9
Q ss_pred ceeccccCceEEEEEEeCC------CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLED------GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++...+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 4579999999999998532 2689999997543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 553 VPNGSLANARYRKMGSS-----------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
+++++|.+++....... ...+++.+++.++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg 169 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCc
Confidence 99999999987643211 1348899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
+++......... ......+++.|+|||.+.+..++.++|||||||+
T Consensus 170 ~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~i 215 (283)
T cd05048 170 LSRDIYSADYYR----------------------------------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215 (283)
T ss_pred ceeecccccccc----------------------------------ccCCCcccccccCHHHhccCcCchhhhHHHHHHH
Confidence 987653221100 0112236788999999988899999999999999
Q ss_pred HHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 702 LLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 702 l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+|||++ |..||.+.... .....+...... ......+.++.+|+.+||+.||++||++.||++.|+++
T Consensus 216 l~el~~~g~~p~~~~~~~----------~~~~~i~~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 216 LWEIFSYGLQPYYGFSNQ----------EVIEMIRSRQLL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCCCCCCCCCHH----------HHHHHHHcCCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 999998 99898653211 111111111111 11233567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=341.22 Aligned_cols=241 Identities=21% Similarity=0.262 Sum_probs=191.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHH---hccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVI---AKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 45899999999999984 468999999997532 22345566676655 567899999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|..++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 9999998877542 38999999999999999999999999999999999999999999999999986432111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 156 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 156 ----------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred ----------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 0112346899999999999989999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
..... .+..+.........+......+.+++.+||+.||++|| ++.++++
T Consensus 202 ~~~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 202 PGDDE-------------EEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 65311 11112222222222222456788999999999999999 5667665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.35 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=202.5
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..+.||+|++|.||+|...+++.||||.++.... ..+++.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred eEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 3478999999999999987788999999976543 346789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~----- 160 (261)
T cd05068 89 LEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA----- 160 (261)
T ss_pred HHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-----
Confidence 999876542 248999999999999999999999999999999999999999999999999998765221100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 161 ------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred ------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 001113456999999998899999999999999999999 8888854311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.......+.... .+.....+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 211 ----------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 211 ----------AEVLQQVDQGYR--MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----------HHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011111111111 111223457789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.16 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=188.7
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHH-HHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVR-VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||+||+|+. .+|+.||||++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 689999999999995 478999999996532 122234445544 567899999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~------ 150 (323)
T cd05575 82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS------ 150 (323)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC------
Confidence 9999887543 38999999999999999999999999999999999999999999999999986432111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 151 ------------------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ------------------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 01123458999999999999999999999999999999999999996531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
..++.+................+.+++.+||+.||++||++.
T Consensus 201 -------------~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 -------------TAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------------HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111222222222222222456788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.00 Aligned_cols=241 Identities=24% Similarity=0.270 Sum_probs=194.5
Q ss_pred eccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|+.. +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999954 58899999997542 23345677888999888 7999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 82 DLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-----
Confidence 9998876653 389999999999999999999999999999999999999999999999999864221110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 152 -------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred -------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 1112358999999999999999999999999999999999999996432
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM-----KEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 776 (791)
. ..+...........+......+.+++.+||..||++||++ .++++.
T Consensus 201 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 201 E-------------DELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred H-------------HHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 1111111111222222245678899999999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.78 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=197.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCC--CchhhHHHHHHHHHHHhccCCCCccceeeEEEc-----cCceEEEEe
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGE--NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-----VDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~~lv~e 551 (791)
-+.||+|+||.|+.+. .++|+.||||++.. ......++..+|+++|+.++|+||+.+++++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 3579999999999999 56799999999973 455556788899999999999999999999876 346899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
+| +.+|.+.++.... ++...+..++.|+++||+|+|+.+|+||||||+|++++.+..+||+|||+|+..... .
T Consensus 107 lM-etDL~~iik~~~~-----L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQD-----LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-F 179 (359)
T ss_pred HH-hhHHHHHHHcCcc-----ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-C
Confidence 99 6799998887642 899999999999999999999999999999999999999999999999999987543 0
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+.++.|.-|+|||++. ...|+.+.||||+|||+.||++|++
T Consensus 180 ---------------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 180 ---------------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred ---------------------------------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC
Confidence 011234566788899999985 4789999999999999999999999
Q ss_pred chhccccCCCCcch------hchhHHHHHH----HHhhhc-----Cccc---hHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 711 IVVDELGQGNGLLV------EDKNRAIRLA----DAAIRA-----DFEG---KEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 711 pf~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~-----~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
.|.+...-.....+ ........+. ...+.. ..+. ........++|+.+||..||.+|+|++|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 88653220000000 0000011110 001110 0000 0112356789999999999999999999
Q ss_pred HHHH
Q 003847 773 ALQA 776 (791)
Q Consensus 773 vl~~ 776 (791)
+++.
T Consensus 307 AL~h 310 (359)
T KOG0660|consen 307 ALAH 310 (359)
T ss_pred HhcC
Confidence 9864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.94 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=208.0
Q ss_pred CcccchHHHhhhcceeccccCceEEEEEEeCC--C---cEEEEEEcCC---CchhhHHHHHHHHHHHhccCCCCccceee
Q 003847 467 DKELELETLLKASAYILGASGSSIMYKAVLED--G---TALAVRRIGE---NSVDRFRDFETQVRVIAKLVHPNLVRIRG 538 (791)
Q Consensus 467 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--g---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~~ 538 (791)
..++..+++... ..||+|+||.||+|++.. + ..||||..+. ......++|.+|+++|++++|||||++||
T Consensus 151 ~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 151 KWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 344445554443 799999999999999543 2 2389999985 34566789999999999999999999999
Q ss_pred EEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 539 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
++..+...++|||+|.||+|.+++..... .++..++..++.+.|.||+|||+++++||||-.+|+|++.++.+||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999998764 38999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+++.-........ ...-...|+|||.+....|++++|||||
T Consensus 305 DFGLs~~~~~~~~~~~------------------------------------~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKF------------------------------------LKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred ccccccCCcceeeccc------------------------------------cccCcceecChhhhccCccccccchhhe
Confidence 9999875431110000 0002245999999999999999999999
Q ss_pred HHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 699 GVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 699 Gvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
||++||+++ |..||.+.... .....+.....+-.. +...+..+..++.+||..+|++||+|.++.+.|
T Consensus 349 GV~~~Eif~~g~~Py~g~~~~---------~v~~kI~~~~~r~~~--~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 349 GVLLWEIFENGAEPYPGMKNY---------EVKAKIVKNGYRMPI--PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred eeeEEeeeccCCCCCCCCCHH---------HHHHHHHhcCccCCC--CCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 999999999 77788653211 111111111111111 223556777888899999999999999999999
Q ss_pred ccCCCCC
Q 003847 778 EKIPSSP 784 (791)
Q Consensus 778 ~~i~~~~ 784 (791)
+.+....
T Consensus 418 ~~~~~~~ 424 (474)
T KOG0194|consen 418 EALEKKK 424 (474)
T ss_pred HHHHhcc
Confidence 8875443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.04 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=205.8
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..+.||.|+||.||+|...+++.+|+|.+..........+..|+++++.++|+||+++++++...+..++||||+++++|
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence 35689999999999999888999999999877665567899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.+.........
T Consensus 90 ~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~------ 160 (261)
T cd05148 90 LAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL------ 160 (261)
T ss_pred HHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc------
Confidence 9998764332 4899999999999999999999999999999999999999999999999999765422110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 161 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 161 ------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred ------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 001225677999999988889999999999999999998 7888854321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. ............ +.....+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 211 ---------~-~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 211 ---------H-EVYDQITAGYRM--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------H-HHHHHHHhCCcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1 111111111111 11223557788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.36 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=206.7
Q ss_pred ceeccccCceEEEEEEe------CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...||+|+||.||+++. .++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 46899999999999973 245679999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCc
Q 003847 554 PNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGl 622 (791)
++++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~ 169 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 169 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCc
Confidence 999999998764321 112489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil 702 (791)
++......... ......|+..|+|||++.+..++.++|||||||++
T Consensus 170 a~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 170 SRDVYSTDYYR----------------------------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred ccccCCCceee----------------------------------cCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 87654221100 01123367889999999998999999999999999
Q ss_pred HHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 703 LELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 703 ~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|||+| |+.||...... +..+....+.. ......+..+.+++.+||+.||++||++++|+++|+++
T Consensus 216 ~el~t~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 216 WEIFTYGKQPWFQLSNT-------------EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCCCCCHH-------------HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 99999 99898543211 11111111111 11122456788999999999999999999999999999
Q ss_pred CCCCC
Q 003847 781 PSSPS 785 (791)
Q Consensus 781 ~~~~~ 785 (791)
....+
T Consensus 283 ~~~~~ 287 (291)
T cd05094 283 GKATP 287 (291)
T ss_pred HhhcC
Confidence 66443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=338.57 Aligned_cols=244 Identities=24% Similarity=0.329 Sum_probs=203.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchh---hHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVD---RFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...||+|.||.||+++.+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+++.|++....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 368999999999999954 5999999999775332 3468999999999998 9999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC----CCeEEeccCcccccCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND----MEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~~~~~ 630 (791)
||.|.+.+... .+++.++..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||++.......
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 99999998876 18999999999999999999999999999999999999633 579999999999876411
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+||+.|+|||++.+..|+..+||||+||++|.|++|..
T Consensus 194 -------------------------------------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 194 -------------------------------------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred -------------------------------------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 1235679999999999999999999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||.+...... ...+......-..+........+.+++..|+..||.+|+|+.++++
T Consensus 237 PF~~~~~~~~---------~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 237 PFWGETEFEI---------FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCcCCChhHH---------HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 9977532111 1122221111122233445678899999999999999999999998
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.30 Aligned_cols=240 Identities=23% Similarity=0.248 Sum_probs=190.5
Q ss_pred eccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhc-cCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAK-LVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6899999999999954 57899999997542 2234556677888876 48999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 82 DLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-----
Confidence 9999887543 388999999999999999999999999999999999999999999999999874321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 152 -------------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred -------------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 1113458999999999999899999999999999999999999996531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK-EALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 775 (791)
. .+............+......+.+++.+||+.||++||++. ++++
T Consensus 201 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 201 E-------------EELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred H-------------HHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 01111111111111122445678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=311.26 Aligned_cols=273 Identities=21% Similarity=0.280 Sum_probs=222.6
Q ss_pred cccchHHHhhhcceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCc
Q 003847 468 KELELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDE 545 (791)
Q Consensus 468 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 545 (791)
..-.++++.+-+.++||+|+|+.|-.++ ..+|..+|||++.+.......++.+|++++.+. .|+||++++++|+++..
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3456788899999999999999999998 789999999999887666667889999999998 49999999999999999
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCc
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGL 622 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGl 622 (791)
.|+|||-|.||.|...|+++. .+++.++.++.++|+.||+|||.+||.|||+||+|||...... +||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999998876 3999999999999999999999999999999999999976544 79999998
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYS 697 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwS 697 (791)
..-+.....-. +...+.....+|+..|||||+.. ...|+.++|.||
T Consensus 226 gSg~k~~~~~s-----------------------------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwS 276 (463)
T KOG0607|consen 226 GSGIKLNNDCS-----------------------------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWS 276 (463)
T ss_pred ccccccCCCCC-----------------------------CCCCccccCcccchhhcchhHHhhhccccccccccccHHH
Confidence 76543222111 11223455678999999999873 356899999999
Q ss_pred HHHHHHHHHhCCcchhcccc---CCCCcchhchhHHHHHHHHhhhcCccchHHH----HHHHHHHHhhccCCCCCCCCCH
Q 003847 698 FGVILLELLTGKVIVVDELG---QGNGLLVEDKNRAIRLADAAIRADFEGKEEA----LLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 698 lGvil~elltG~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~ 770 (791)
||||+|-|++|.+||.+..+ .|.+-..-.. -...++..+..+.++.++++ +.+..+++..++..|+.+|.++
T Consensus 277 LGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~-CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa 355 (463)
T KOG0607|consen 277 LGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV-CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA 355 (463)
T ss_pred HHHHHHHHHhCCCCccCccCCcCCccCCCccHH-HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence 99999999999999977554 2333222111 12455666666777665443 4567889999999999999999
Q ss_pred HHHHH
Q 003847 771 KEALQ 775 (791)
Q Consensus 771 ~evl~ 775 (791)
.+++.
T Consensus 356 ~~vln 360 (463)
T KOG0607|consen 356 AQVLN 360 (463)
T ss_pred hhccC
Confidence 99887
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.19 Aligned_cols=254 Identities=19% Similarity=0.220 Sum_probs=191.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 46899999999999995 4689999999875422 223567889999999999999999999999999999999997 48
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 89 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~------ 158 (288)
T cd07871 89 LKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK------ 158 (288)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc------
Confidence 9888765432 378999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 159 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 ------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred ------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112347889999999865 568999999999999999999999996532
Q ss_pred cCCCCcch--------hchh----HHHHHHHHhhhcCc------cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLV--------EDKN----RAIRLADAAIRADF------EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~--------~~~~----~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+ .+.+ ...++.. ...... ........++.+++.+||..||.+|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 209 VKEELHLIFRLLGTPTEETWPGITSNEEFRS-YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHHHHhCCCChHHhhccccchhhhc-cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11000000 0000 0000000 000000 000012346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.42 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=201.7
Q ss_pred hcceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEE
Q 003847 478 ASAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 549 (791)
...++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+..|+|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 34568999999999999842 23579999997643 333467899999999996 99999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCC-------------------------------------------------------------
Q 003847 550 YDFVPNGSLANARYRKMGS------------------------------------------------------------- 568 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 568 (791)
||||++|+|.+++......
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 9999999999998754210
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 569 ------------------------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 569 ------------------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
....+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~ 279 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEE
Confidence 01247888999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+++......... ......++..|+|||.+.+..++.++|||||
T Consensus 280 DfGla~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 280 DFGLARDIMHDSNYV----------------------------------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred eCCcceecccccccc----------------------------------ccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 999988654221100 0112236778999999998899999999999
Q ss_pred HHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 699 GVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 699 Gvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
||++|||++ |..||...... . .......... ........+..+.+++.+||+.||++||++.+|.++|
T Consensus 326 Gvil~ellt~g~~P~~~~~~~--------~-~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVD--------S-TFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHHHHHHCCCCCCcccchh--------H-HHHHHHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 999999997 88888543111 0 0111111111 1111223456789999999999999999999999999
Q ss_pred ccCCC
Q 003847 778 EKIPS 782 (791)
Q Consensus 778 ~~i~~ 782 (791)
+++..
T Consensus 395 ~~l~~ 399 (400)
T cd05105 395 ESLLP 399 (400)
T ss_pred HHHcC
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.52 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=201.8
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|... +++.||||.++..... ..+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 468999999999999853 3578999999765443 457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 553 VPNGSLANARYRKMG---------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
+++++|.+++..... .....+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~ 169 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccc
Confidence 999999999976532 11234889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+.+....... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 170 ~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 170 RDVYTTDYYR----------------------------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred eecccCccee----------------------------------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 7653221100 001123567899999999999999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
||++ |+.||...... +..+....+.. ......+..+.+++.+||+.||++||++.|+++.|++
T Consensus 216 e~~~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 216 EIFTYGKQPWYGLSNE-------------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHhcCCCCCCCCCHH-------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 9998 99998543211 11111111111 1112245678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.73 Aligned_cols=240 Identities=23% Similarity=0.242 Sum_probs=190.5
Q ss_pred eeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999954 68999999997542 22345567788888754 899999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----- 150 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-----
Confidence 99999887643 38999999999999999999999999999999999999999999999999986422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 151 -------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 0112345899999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK-EAL 774 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 774 (791)
... .............+......+.+++.+||+.||++||++. +++
T Consensus 200 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 200 DED-------------ELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHH-------------HHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 211 1111111111111112456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.17 Aligned_cols=241 Identities=20% Similarity=0.247 Sum_probs=189.4
Q ss_pred eccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHH-HHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVR-VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++|+||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999954 67899999986532 122234444443 567889999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~----- 151 (325)
T cd05602 82 ELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----- 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-----
Confidence 9999887643 378889999999999999999999999999999999999999999999999875321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 152 -------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred -------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 1123459999999999999999999999999999999999999996432
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .+..+................+.+++.+||+.||.+||++.+.+.+
T Consensus 201 ~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 201 T-------------AEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred H-------------HHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1 1111111112222222345678899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.28 Aligned_cols=259 Identities=23% Similarity=0.325 Sum_probs=203.2
Q ss_pred ceeccccCceEEEEEEe-CCCc----EEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGT----ALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|.. .+++ .|++|.+.... .....++..|+.++++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 46899999999999985 3444 47888886442 234467888999999999999999999875 45678999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+..|+.||+.||+|||+.+++||||||+||++++++.+||+|||+++.........
T Consensus 91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 99999999876442 38999999999999999999999999999999999999999999999999998654221100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......|+..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 167 ----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 167 ----------------------------------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred ----------------------------------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 0112336778999999998899999999999999999998 99898
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCCcC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYLY 789 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~~~ 789 (791)
.+.... ...+........ .........+.+++.+||..||++|||+.|+++.|+.+...+.+|+.
T Consensus 213 ~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~~ 277 (279)
T cd05111 213 AGMRPH----------EVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLV 277 (279)
T ss_pred CCCCHH----------HHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcceec
Confidence 653211 111221111110 11111345678899999999999999999999999999988888874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=342.91 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=189.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 35799999999999995 468999999996543 2334678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+.. ...+..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~------ 223 (353)
T PLN00034 159 LEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD------ 223 (353)
T ss_pred ccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc------
Confidence 86421 256778889999999999999999999999999999999999999999999886542211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......||..|+|||++.. ...+.++|||||||++|||++|+.||
T Consensus 224 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf 273 (353)
T PLN00034 224 ------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273 (353)
T ss_pred ------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 0112358999999998743 23456899999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHh-hhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAA-IRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...... + ........ ..............+.+|+.+||+.||++||++.|+++.
T Consensus 274 ~~~~~~-------~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 274 GVGRQG-------D---WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCc-------c---HHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 632111 0 01111111 011111122245678999999999999999999999975
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.54 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=202.0
Q ss_pred cceeccccCceEEEEEEeC-CCc----EEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLE-DGT----ALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
....||+|+||.||+|++. +++ .||||.++... ....+++.+|+.+++.++||||+++++++... ..++|+||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 3468999999999999843 343 48999997543 34456788999999999999999999998764 57899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 90 ~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 90 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred CCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 999999999876542 3889999999999999999999999999999999999999999999999999876432211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. .....++..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 166 ~~----------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 166 YH----------------------------------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ee----------------------------------ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 00 011124667999999999999999999999999999998 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPY 787 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~ 787 (791)
|.+.... ........... .+........+.+++.+||..+|++||++.+++..|..+...+..|
T Consensus 212 ~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 212 YDGIPAS----------EISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred CCCCCHH----------HHHHHHhCCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 8643110 11111111111 1111123457889999999999999999999999999887666544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.86 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=190.2
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHH-HHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVR-VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|+. .+|+.||||++.... ....+.+..|.. +++.++||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 689999999999994 578999999996531 222344555554 567789999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 151 (325)
T cd05604 82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD----- 151 (325)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-----
Confidence 9998876543 389999999999999999999999999999999999999999999999999874321100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 152 -------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred -------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 1123458999999999999999999999999999999999999996531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .++.+................+.+++.+|++.+|.+||++.+.++.
T Consensus 201 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 201 V-------------AEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred H-------------HHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1 1122222222211112245677899999999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.98 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=200.2
Q ss_pred ceeccccCceEEEEEEe-----CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-----EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~ 552 (791)
...||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 46899999999999974 35789999999877666677899999999999999999999987543 467899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 89 LPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred cCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence 999999999875432 3899999999999999999999999999999999999999999999999999876432211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.. ......++..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 165 ~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 165 YK---------------------------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred ee---------------------------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 00 000112345699999999888999999999999999999987765
Q ss_pred hccccCCCCcchhc------hhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVED------KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
......+....... .....+...... ..+.....+..+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 212 CSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred CCcchhhhhhcccccccccchHHHHHHHhcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 33221111000000 000111111110 11111224467889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.16 Aligned_cols=245 Identities=20% Similarity=0.340 Sum_probs=210.1
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
-..||+|+||.||+|. .++|+.||||.+.-+. ..+++..|+.+|++++.|++|++||.|......|+|||||..|++
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 3579999999999999 5679999999997654 357899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+.+..+.. ++++.++..+++..++||+|||...-+|||||..|||++.+|.+||+|||.|..+.....
T Consensus 116 SDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA------- 184 (502)
T KOG0574|consen 116 SDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA------- 184 (502)
T ss_pred HHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-------
Confidence 999876653 499999999999999999999999999999999999999999999999999987653221
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......||+.|||||++....|+.++||||||++..||.-|++||.+....
T Consensus 185 -----------------------------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM 235 (502)
T KOG0574|consen 185 -----------------------------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM 235 (502)
T ss_pred -----------------------------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence 123456999999999999999999999999999999999999999876443
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..-.++.. ...+.+..++..+.++-+++++||...|++|-|+-++++.
T Consensus 236 RAIFMIPT----------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 236 RAIFMIPT----------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ceeEeccC----------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22222211 1234455667788899999999999999999999988764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=340.59 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=195.0
Q ss_pred ceeccccCceEEEEEEe----CCCcEEEEEEcCCC----chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 480 AYILGASGSSIMYKAVL----EDGTALAVRRIGEN----SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
.+.||+|+||.||+++. .+++.||+|++.+. .....+.+..|+++++++ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46899999999999984 36899999998653 222345678899999999 5999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999887643 38999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~ 709 (791)
.. .....+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 160 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 160 KE-----------------------------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred CC-----------------------------------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 10 11134589999999999865 4789999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.||........ ...+..................+.+++.+||+.||++|| +++++++.
T Consensus 205 ~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 205 SPFTLEGERNT---------QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCCC---------HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 99964322111 011111111122222222456788999999999999999 77787753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.26 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=204.7
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|-||.|..+....+..||||.++..... ..++|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 35789999999999999988899999999886443 45899999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.++.... +.-+...+|+.||+.|++||.+.++|||||.+.|+|+|.++++||+|||+++.+-..+.....++
T Consensus 622 LnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 622 LNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred HHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 999998874321 34455677999999999999999999999999999999999999999999996543332221111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh--CCcchhcc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT--GKVIVVDE 715 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~ 715 (791)
.+=...|||||.+.-++++.++|||+||+++||+++ ...||.+-
T Consensus 699 ----------------------------------~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 699 ----------------------------------AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred ----------------------------------eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 112356999999999999999999999999999876 55688653
Q ss_pred ccCCCCcchhchhHHHHHHHHh-hhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAA-IRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
..+.. +++ ...+++.. .......+.-.+..+++++.+||..|-++||+++++...|++..
T Consensus 745 t~e~v---ven---~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 745 TDEQV---VEN---AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hHHHH---HHh---hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 22111 111 11111111 11111223335678899999999999999999999999887643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.14 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=197.5
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchh--hHHHHHHHHHHHhccCCCC-ccceeeEEEccC------ceEEEE
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVD--RFRDFETQVRVIAKLVHPN-LVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~~~lv~ 550 (791)
+.||+|.||+||+|+ ..+|+.||+|++.-...+ ......+|+.++++++|+| ||++++++...+ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 469999999999999 667999999999765332 2345689999999999999 999999999877 788999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ .-+|..++....... ..++...++.+++||+.||+|||+++|+||||||.|||++++|.+||+|||+|+...-+.
T Consensus 97 e~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~ 174 (323)
T KOG0594|consen 97 EFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM 174 (323)
T ss_pred Eee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence 999 469999998765321 237778999999999999999999999999999999999999999999999999543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~ 709 (791)
...+..++|.-|+|||++.+. .|+...||||+|||++||++++
T Consensus 175 ------------------------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 175 ------------------------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred ------------------------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 123445688889999999876 7899999999999999999999
Q ss_pred cchhcccc-----------------CCCCcchhchhHHHHHHHHhhhcCccc---hHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 710 VIVVDELG-----------------QGNGLLVEDKNRAIRLADAAIRADFEG---KEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 710 ~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
..|.+..+ .|........... .+. ...+.... .........+++.+|++.+|.+|.|
T Consensus 219 ~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-~f~--~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S 295 (323)
T KOG0594|consen 219 PLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-PFP--KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS 295 (323)
T ss_pred CCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-cCc--CCCCccchHHhccccCccHHHHHHHHhccCcccCcC
Confidence 98866433 1111110000000 000 00000000 0011136789999999999999999
Q ss_pred HHHHHHH--hccC
Q 003847 770 MKEALQA--LEKI 780 (791)
Q Consensus 770 ~~evl~~--L~~i 780 (791)
++.+++. +.++
T Consensus 296 a~~al~h~yf~~~ 308 (323)
T KOG0594|consen 296 AKGALTHPYFSEL 308 (323)
T ss_pred HHHHhcChhhccc
Confidence 9999987 5555
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.41 Aligned_cols=245 Identities=17% Similarity=0.243 Sum_probs=192.7
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||.||+++. .+|+.||+|.+..... ...+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 5689999999865321 2234556799999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------- 150 (277)
T cd05607 81 KYHIYNVGER---GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------- 150 (277)
T ss_pred HHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-------
Confidence 9887654332 388999999999999999999999999999999999999999999999999876542110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 151 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~ 200 (277)
T cd05607 151 ------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200 (277)
T ss_pred ------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch
Confidence 01224888999999999888999999999999999999999998643211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccc-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEG-KEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ...+........... ......++.+++.+||+.||++||+++|+++.
T Consensus 201 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 201 VA---------KEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred hh---------HHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 00 011111111111111 11245678899999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.01 Aligned_cols=250 Identities=16% Similarity=0.215 Sum_probs=191.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||++.. .+++.||+|.... +.+.+|++++++++||||+++++++......++|+|++. ++
T Consensus 96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 356899999999999994 5789999997542 356789999999999999999999999999999999995 78
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 169 L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~------ 237 (391)
T PHA03212 169 LYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA------ 237 (391)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc------
Confidence 888776543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 238 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~ 288 (391)
T PHA03212 238 -----------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288 (391)
T ss_pred -----------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccc
Confidence 011234599999999999998999999999999999999999987654321
Q ss_pred CCCCc----c----------------hhchhHHHHHHHHhhh---------cCccchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 718 QGNGL----L----------------VEDKNRAIRLADAAIR---------ADFEGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 718 ~~~~~----~----------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
..... . ................ ..+........++.+|+.+||+.||++||
T Consensus 289 ~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp 368 (391)
T PHA03212 289 LDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP 368 (391)
T ss_pred ccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC
Confidence 10000 0 0000000111100000 00011112345788999999999999999
Q ss_pred CHHHHHH
Q 003847 769 SMKEALQ 775 (791)
Q Consensus 769 s~~evl~ 775 (791)
|++|+++
T Consensus 369 ta~elL~ 375 (391)
T PHA03212 369 SAEALLD 375 (391)
T ss_pred CHHHHhc
Confidence 9999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.99 Aligned_cols=256 Identities=15% Similarity=0.222 Sum_probs=192.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999964 68899999986542 223467889999999999999999999999999999999999987
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+..+..... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---- 156 (287)
T cd07848 86 MLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA---- 156 (287)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc----
Confidence 7765433221 3899999999999999999999999999999999999999999999999998865422110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 157 -------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred -------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0112358899999999998889999999999999999999999996532
Q ss_pred cCCCCcchhc------hhHHHHH-HHHhhh----cCcc--------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVED------KNRAIRL-ADAAIR----ADFE--------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~------~~~~~~~-~~~~~~----~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+.. ....... .++... .... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100000000 0000000 000000 0000 00113456899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.90 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=196.5
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
....||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 4568999999999999954 6889999998764 3334467899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----- 158 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----- 158 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-----
Confidence 9999987643 38899999999999999999997 479999999999999999999999999987553211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 01234888999999999988999999999999999999999998542
Q ss_pred ccCCCCcch-----------------hc--------------hhHHHHHHHHhhhcCccc--hHHHHHHHHHHHhhccCC
Q 003847 716 LGQGNGLLV-----------------ED--------------KNRAIRLADAAIRADFEG--KEEALLSCFKLGYSCASP 762 (791)
Q Consensus 716 ~~~~~~~~~-----------------~~--------------~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~ 762 (791)
......... .. ........+.......+. ......++.+|+.+||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 285 (333)
T cd06650 206 DAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285 (333)
T ss_pred chhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccC
Confidence 210000000 00 000011111111111000 001235688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003847 763 LPQKRPSMKEALQA 776 (791)
Q Consensus 763 dP~~RPs~~evl~~ 776 (791)
||++|||+.|+++.
T Consensus 286 ~P~~Rpt~~ell~h 299 (333)
T cd06650 286 NPAERADLKQLMVH 299 (333)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.24 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=191.7
Q ss_pred ceeccccCceEEEEEEeC-----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE-----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 358999999999999965 3678999999664 3344688999999999999999999999999888899999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++...... .+++..+..|+.||++||+|||+.+++|+||+++||+++.++.+||+|||++..........
T Consensus 84 ~~g~L~~~L~~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKE---PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTT---TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999887221 48999999999999999999999999999999999999999999999999998763221110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
. .....+...|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 161 ~----------------------------------~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~ 206 (259)
T PF07714_consen 161 N----------------------------------DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF 206 (259)
T ss_dssp E----------------------------------STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT
T ss_pred c----------------------------------ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0 011225567999999998889999999999999999999 67787
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
.+.. .......+.+. .. .+.....+..+.+++.+||+.||++||++.++++.|
T Consensus 207 ~~~~---------~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 207 SDYD---------NEEIIEKLKQG-QR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSC---------HHHHHHHHHTT-EE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc---------ccccccccccc-cc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 5431 11111122111 11 111222456788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.61 Aligned_cols=248 Identities=18% Similarity=0.192 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+||+|+||.||++.. .+++.||||++..... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46899999999999995 4689999999965422 2234577899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||++........
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 157 (285)
T cd05605 85 GDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---- 157 (285)
T ss_pred CcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc----
Confidence 999988765432 2489999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 158 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 158 ---------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred ---------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 11234889999999999888999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.... ....+..................+.+++.+||+.||++|| +++++++.
T Consensus 205 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 205 KEKV---------KREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred chhh---------HHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 2110 0011111111111122223556788999999999999999 88898653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.87 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=161.2
Q ss_pred ceeccccCceEEEEEEeC---CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE---DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 554 (791)
+..||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 568999999976432 2457889999999999999999999865 346789999995
Q ss_pred CCChhHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe----cCCCCeEEeccCccccc
Q 003847 555 NGSLANARYRKMGS----SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL----GNDMEPKIGDFGLERLV 626 (791)
Q Consensus 555 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~~ 626 (791)
++|.+++...... ....+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5888877543211 12248999999999999999999999999999999999999 45678999999999865
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~el 705 (791)
...... ........||+.|+|||++.+ ..++.++||||+||++|||
T Consensus 163 ~~~~~~---------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 163 NSPLKP---------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred CCCCcc---------------------------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHH
Confidence 422110 001223458999999999876 4589999999999999999
Q ss_pred HhCCcchhcc
Q 003847 706 LTGKVIVVDE 715 (791)
Q Consensus 706 ltG~~pf~~~ 715 (791)
++|++||...
T Consensus 210 ~~g~~~f~~~ 219 (317)
T cd07868 210 LTSEPIFHCR 219 (317)
T ss_pred HhCCCCccCC
Confidence 9999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=345.88 Aligned_cols=283 Identities=17% Similarity=0.186 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..|+||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46899999999999984 568999999996532 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...........
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999987653 3889999999999999999999999999999999999999999999999998754322111000
Q ss_pred CCC-ccccCCcccccccccccCCCC----------CCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 636 GGS-ARNFGSKRSTASRDSFQDLGP----------GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 636 ~~~-~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
... ..................... .............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000 000000000000000000000 000000111234679999999999998899999999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYS--CASPLPQKRPSMKEALQA 776 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~~ 776 (791)
|++|+.||...... .....+.........+.......++.+++.+ |+..+|.+||+++|+++.
T Consensus 241 lltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPT---------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHH---------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999653211 0111111100011111111234567788877 555666679999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=339.12 Aligned_cols=237 Identities=21% Similarity=0.261 Sum_probs=188.1
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHH-HHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVR-VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468999999986532 122334555554 67889999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|...+.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 99988876543 388999999999999999999999999999999999999999999999999874321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 --------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred --------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 112345899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
. ...+.+.........+......+.+++.+||+.||++||++.
T Consensus 200 ~-------------~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 200 D-------------VSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-------------HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 111222222222222223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=337.20 Aligned_cols=237 Identities=21% Similarity=0.246 Sum_probs=189.7
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCC-CccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHP-NLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..++|+ +|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 468999999999999954 5789999999753 223446678899999999765 58899999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 156 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--- 156 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC---
Confidence 999999886543 389999999999999999999999999999999999999999999999999864321100
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 157 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 157 ---------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred ---------------------------------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 11234589999999999998999999999999999999999999964
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
... .+............+......+.+++.+||..||.+|++.
T Consensus 204 ~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 204 EDE-------------DELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 321 1111111112222222245678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.71 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=200.8
Q ss_pred cceeccccCceEEEEEEeC----CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLE----DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+|... +...||||.++... .....++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 4578999999999999864 24689999987643 333467889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++..... .+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.........
T Consensus 88 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 88 ENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred CCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 99999999876543 48999999999999999999999999999999999999999999999999998764211100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 164 ~----------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 164 T----------------------------------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred e----------------------------------ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence 0 001124567999999998899999999999999999998 88888
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
..... . ...+...... ..+.....+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 210 ~~~~~---------~-~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 210 WDMSN---------Q-DVIKAVEDGY--RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCH---------H-HHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 54211 0 1111111110 1111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=317.95 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=197.9
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
++||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37899999999999988899999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------ 150 (250)
T cd05085 81 SFLRKKKD----ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------ 150 (250)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc------
Confidence 98865432 38899999999999999999999999999999999999999999999999987543211000
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||++.+..++.++||||||+++||+++ |..||......
T Consensus 151 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 151 -----------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred -----------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 001124567999999998889999999999999999998 88898543111
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
............. .....+..+.+++.+|++.+|++||++.|++++|.
T Consensus 202 ----------~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 ----------QAREQVEKGYRMS--CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----------HHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111111111111 11224567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=344.45 Aligned_cols=282 Identities=16% Similarity=0.176 Sum_probs=198.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+++..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 46899999999999995 468999999997532 23345678899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999987643 3899999999999999999999999999999999999999999999999999865432211100
Q ss_pred CCCccccCCc--ccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 636 GGSARNFGSK--RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 636 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.......... ...........................+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0000000000 00000000000000000000001123569999999999999899999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 776 (791)
..... .....+.........+........+.+++.+|+. +|.+|++ ++|+++.
T Consensus 241 ~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQ---------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHH---------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 53211 0111111100000111111234577889999996 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=340.59 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=191.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e 551 (791)
.+.||+|+||.||+|+. .+|+.||||++... .......+.+|++++++++||||+++++++.... ..|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46899999999999994 57899999998743 2233457889999999999999999999886433 4799999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+. ++|.+++.... .+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 995 68988876543 389999999999999999999999999999999999999999999999999876432111
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCC
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~ 709 (791)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 159 ~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~ 205 (338)
T cd07859 159 TA---------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205 (338)
T ss_pred cc---------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCC
Confidence 00 01123458999999999875 67899999999999999999999
Q ss_pred cchhccccCCCCcc------------hhc--hhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLL------------VED--KNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~------------~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||........... ... ................... ......+.+++.+||+.||++|||++
T Consensus 206 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 285 (338)
T cd07859 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285 (338)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHH
Confidence 99865321000000 000 0000001110000000000 01234678999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 286 e~l~h 290 (338)
T cd07859 286 EALAD 290 (338)
T ss_pred HHhcC
Confidence 99965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=324.52 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=203.9
Q ss_pred ceeccccCceEEEEEEe-CCCc----EEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGT----ALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||+||+|+. .+++ .||+|++... .....+.+.+|+.+++.++|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46899999999999984 4454 5899998754 33445678899999999999999999999875 4578999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~ 166 (279)
T cd05109 91 PYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166 (279)
T ss_pred CCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence 99999998876432 38999999999999999999999999999999999999999999999999998764321110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
. .....++..|+|||...+..++.++|||||||++|||++ |..||
T Consensus 167 ~----------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 167 H----------------------------------ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred e----------------------------------cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 0 001124567999999998899999999999999999998 88888
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCCc
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYL 788 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~~ 788 (791)
..... ............ .+........+.+++.+||+.||++||++.++++.|+++...+.||.
T Consensus 213 ~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05109 213 DGIPA----------REIPDLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276 (279)
T ss_pred CCCCH----------HHHHHHHHCCCc--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence 54211 111111111111 11122245678899999999999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.35 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=197.6
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
...||+|+||.||++...++..||||.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 357999999999999987777899999876533 2367899999999999999999999999988999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++........
T Consensus 88 ~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~------- 156 (256)
T cd05113 88 NYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT------- 156 (256)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-------
Confidence 98876432 3899999999999999999999999999999999999999999999999998765322110
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 157 ----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~- 207 (256)
T cd05113 157 ----------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN- 207 (256)
T ss_pred ----------------------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-
Confidence 0011225667999999988889999999999999999999 8888854211
Q ss_pred CCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.+..+...... ..........+.+++.+||+.+|.+||++.++++.|+
T Consensus 208 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 208 ------------SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01111111111 0111124567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.44 Aligned_cols=249 Identities=17% Similarity=0.187 Sum_probs=196.1
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 3457899999999999995 46899999999643 1223355788999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 126 ~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~- 198 (370)
T cd05596 126 PGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV- 198 (370)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-
Confidence 999999988653 2788899999999999999999999999999999999999999999999998765321110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC----CCCCchhhHHHHHHHHHHHhCC
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI----KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~sDvwSlGvil~elltG~ 709 (791)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 199 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 199 ----------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred ----------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence 11234599999999998653 4789999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
.||...... .....+........++.....+..+.+++.+||..+|++ |++++|+++.
T Consensus 245 ~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 245 TPFYADSLV---------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCHH---------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999654210 011111111111111221124567889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.00 Aligned_cols=277 Identities=17% Similarity=0.179 Sum_probs=194.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.++.+++|+||+++++.+.+....|+||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 46899999999999984 468999999997532 22345688899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999987643 3899999999999999999999999999999999999999999999999999866432211000
Q ss_pred CCCccccCCcccccccccccCCC-C----CCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLG-P----GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......... ...+.... . .............+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 161 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 161 RNLNHSLPS------DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccc------cccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 000000000 00000000 0 000000111234679999999999999999999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCAS--PLPQKRPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 776 (791)
||...... .....+........++........+.+++.+|+. .++..||+++|+++.
T Consensus 235 Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQ---------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHH---------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99653211 0011111100000111111134566777777554 233356899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.34 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=194.9
Q ss_pred ccccCceEEEEEEeC---CCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVLE---DGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 456799999976533 33467899999999999999999999875 4578999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+++++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 153 (257)
T cd05115 82 NKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK---- 153 (257)
T ss_pred HHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee----
Confidence 998875432 389999999999999999999999999999999999999999999999999876543221100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
......++..|+|||.+....++.++|||||||++||+++ |+.||.+...
T Consensus 154 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 154 -----------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred -----------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 0011123567999999988889999999999999999996 9999865321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. ............ ..+.....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 205 ~----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 205 P----------EVMSFIEQGKRL--DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred H----------HHHHHHHCCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 111111111111 11122457888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.41 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=189.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 468999999999999954 789999999875432 223467789999999999999999999999999999999995 67
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 158 (303)
T cd07869 89 LCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH------ 158 (303)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc------
Confidence 8777765432 388999999999999999999999999999999999999999999999999875421110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 159 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 159 ------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1112347899999999865 457899999999999999999999996531
Q ss_pred cCCCCcchhchhHHHHHH-----------------HHh-hhc-CccchH------HHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 717 GQGNGLLVEDKNRAIRLA-----------------DAA-IRA-DFEGKE------EALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~-----------------~~~-~~~-~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.. ...+ ....... ++. ... ...... .....+.+++.+||+.||++|||++
T Consensus 209 ~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 209 DI--QDQL---ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred cH--HHHH---HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 10 0000 0000000 000 000 000000 0124577999999999999999999
Q ss_pred HHHH
Q 003847 772 EALQ 775 (791)
Q Consensus 772 evl~ 775 (791)
|+++
T Consensus 284 ~~l~ 287 (303)
T cd07869 284 AALS 287 (303)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.94 Aligned_cols=242 Identities=20% Similarity=0.252 Sum_probs=191.4
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 699999999999995 567999999997642 23345688899999888 6999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-----
Confidence 9998876543 399999999999999999999999999999999999999999999999999874321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 152 -------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred -------------------------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 1123458999999999999999999999999999999999999996432
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
....... . ..............+......+.+++.+||+.||++|+++
T Consensus 201 ~~~~~~~---~---~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 201 DNPDMNT---E---DYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCccccc---H---HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2111110 0 1111111112222222245677899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.75 Aligned_cols=282 Identities=16% Similarity=0.171 Sum_probs=196.6
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||++. ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 4689999999999998 4578999999986532 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...........
T Consensus 86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999887543 3889999999999999999999999999999999999999999999999999754321111000
Q ss_pred CCCccccCCcccccccccccCCCCCC-----------CCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGP-----------SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
.......................... ...........+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00000000000000000000000000 0000001123579999999999999899999999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKR---PSMKEALQA 776 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 776 (791)
|++|+.||...... .....+........++........+.+++.+|+. +|.+| +++.|+++.
T Consensus 241 lltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSH---------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHH---------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999653211 0011111100001111111234577899999997 67665 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=340.94 Aligned_cols=192 Identities=25% Similarity=0.372 Sum_probs=167.6
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-C-----CCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-H-----PNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~lv~e 551 (791)
..++||+|.||.|.+|. .++++.||||+++.... ...+...|+++|..|+ | -|||+++++|...++.|||+|
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 45799999999999999 66799999999987633 3466788999999996 4 389999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC--CCeEEeccCcccccCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND--MEPKIGDFGLERLVTGD 629 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~ 629 (791)
.+ .-+|+++++.+.-.+ ++...++.|+.||+.||.+||+.+|||+||||+||||.+. ..+||+|||.+......
T Consensus 269 LL-~~NLYellK~n~f~G---lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 269 LL-STNLYELLKNNKFRG---LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred hh-hhhHHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99 579999999877654 9999999999999999999999999999999999999643 36999999999876532
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.. .++-+..|+|||++.+.+|+.+.||||||||++||++|.
T Consensus 345 vy---------------------------------------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~ 385 (586)
T KOG0667|consen 345 VY---------------------------------------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE 385 (586)
T ss_pred ce---------------------------------------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc
Confidence 21 234567799999999999999999999999999999998
Q ss_pred cchhc
Q 003847 710 VIVVD 714 (791)
Q Consensus 710 ~pf~~ 714 (791)
+.|.+
T Consensus 386 PLfpG 390 (586)
T KOG0667|consen 386 PLFPG 390 (586)
T ss_pred cccCC
Confidence 87754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.51 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=196.2
Q ss_pred eccccCceEEEEEEe---CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL---EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.||+|+||.||+|.. .++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357899999986543 334567899999999999999999999875 45678999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 9999886543 389999999999999999999999999999999999999999999999999987643221100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 715 (791)
......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 154 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 154 -------------------------------AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred -------------------------------ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0011124577999999988889999999999999999998 89998643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
... ............. .+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 203 ~~~----------~~~~~i~~~~~~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 203 KGN----------EVTQMIESGERME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CHH----------HHHHHHHCCCCCC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 1122222111111 1222556788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.06 Aligned_cols=237 Identities=22% Similarity=0.257 Sum_probs=190.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+ +|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 468999999999999854 67899999987542 22334567788888777 58999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--- 156 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--- 156 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC---
Confidence 999998886543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 157 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 157 ---------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred ---------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 11234589999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
... ..+...........+......+.+++.+|++.||++|++.
T Consensus 204 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 204 EDE-------------DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCH-------------HHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 321 1111112222222222355678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.37 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=202.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+++.||||.+... .......+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999994 57899999987542 233345788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++....... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--- 162 (267)
T cd08228 87 GDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--- 162 (267)
T ss_pred CcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH---
Confidence 99999886533211 24889999999999999999999999999999999999999999999999998865422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 ---------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 163 ---------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ---------------------------------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 01234788899999998888999999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... ...+.+.......+ ........+.+++.+||..+|++||++.+|++.|+.++
T Consensus 210 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 210 KMN-----------LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ccc-----------HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 211 01111111111111 11234567899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.32 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=197.3
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||.||++..+++..+|+|.+..... ...++.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 467999999999999987788999999875433 2356888999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus 88 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~------ 157 (256)
T cd05059 88 NYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS------ 157 (256)
T ss_pred HHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc------
Confidence 99876442 38999999999999999999999999999999999999999999999999987653211100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 158 -----------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 158 -----------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred -----------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 001113456999999998899999999999999999999 78888543111
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
. ........... ......+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 209 ---------~-~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 209 ---------E-VVESVSAGYRL--YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred ---------H-HHHHHHcCCcC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 11111111111 111224667899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.63 Aligned_cols=239 Identities=23% Similarity=0.310 Sum_probs=189.0
Q ss_pred eccccCceEEEEEEeCC-------------CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEE
Q 003847 482 ILGASGSSIMYKAVLED-------------GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 548 (791)
.||+|+||.||+|...+ ...||+|.+..........+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 68999999999998432 23699999877655556678899999999999999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC-------eEEeccC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME-------PKIGDFG 621 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~-------~kL~DFG 621 (791)
||||+++++|..++..... .+++..++.++.||+.||+|||+++|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999988765432 3899999999999999999999999999999999999987654 8999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGV 700 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGv 700 (791)
++...... ....|+..|+|||.+. +..++.++|||||||
T Consensus 158 ~~~~~~~~----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (262)
T cd05077 158 IPITVLSR----------------------------------------QECVERIPWIAPECVEDSKNLSIAADKWSFGT 197 (262)
T ss_pred CCccccCc----------------------------------------ccccccccccChhhhcCCCCCCchhHHHHHHH
Confidence 88654211 1123678899999986 467899999999999
Q ss_pred HHHHHH-hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 701 ILLELL-TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 701 il~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
++|||+ +|+.||..... .+ ....... ...........+.+|+.+||+.||++||++.++++.++
T Consensus 198 ~l~el~~~~~~p~~~~~~-------~~---~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 198 TLWEICYNGEIPLKDKTL-------AE---KERFYEG----QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHHHhCCCCCCCCcch-------hH---HHHHHhc----CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 999998 57777754211 01 0111111 11111113456789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.63 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=198.5
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC--------ceEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--------EKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------~~~l 548 (791)
.++||+|+||+||+|+ ..+|+.||||++... .......+.+|+.++..++|+||+++++.+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 4689999999999998 457999999998654 3344567889999999999999999988775433 3679
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred EEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 99999999999998764322 23589999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 196 ~~~~----------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 196 TVSD----------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred cccc----------------------------------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 2110 011234699999999999999999999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+.||.... ..++......+... .+......+.+++.+||+.||++||++.++++.
T Consensus 242 ~~Pf~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 242 KRPFDGEN-------------MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCC-------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99996431 11222222222111 122245678899999999999999999999864
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.27 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=198.8
Q ss_pred cceeccccCceEEEEEEe-----CCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-----EDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 550 (791)
....||+|+||+||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 346899999999988652 3578999999976532 3456788999999999999999999988764 3578999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999988653 28999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.... ......++..|+|||.+.+..++.++||||||+++|||+||+.
T Consensus 162 ~~~~---------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~ 208 (283)
T cd05080 162 EYYR---------------------------------VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208 (283)
T ss_pred hhhc---------------------------------cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCC
Confidence 1100 0011225567999999988889999999999999999999999
Q ss_pred chhccccCCCCcc-----hhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGLL-----VEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||........... ...........+..... +.....+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 209 SKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCcchhhhhhcccccccchhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 8754321100000 00000111111111111 111224568899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.90 Aligned_cols=249 Identities=18% Similarity=0.192 Sum_probs=194.5
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.....||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 3457899999999999995 46899999998642 2223456788999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 126 ~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~- 198 (370)
T cd05621 126 PGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV- 198 (370)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce-
Confidence 999999988653 2888999999999999999999999999999999999999999999999999865321110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC----CCCCchhhHHHHHHHHHHHhCC
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI----KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~sDvwSlGvil~elltG~ 709 (791)
.....+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 199 ----------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 199 ----------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred ----------------------------------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence 11234599999999998753 3788999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
.||..... ......+.+......++........+.+++.+|+..++.+ |+++.|+++.
T Consensus 245 ~Pf~~~~~---------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 245 TPFYADSL---------VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCCCCH---------HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 99965321 0111222221111112222224567788999999865544 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.76 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEcc-CceEEEE
Q 003847 480 AYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGV-DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~lv~ 550 (791)
.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++ +|+||+++++++... ...+++|
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 56899999999999963 235789999997542 33446788899999999 899999999988754 5678999
Q ss_pred eccCCCChhHHHHhhcCC--------------------------------------------------------CCCCCC
Q 003847 551 DFVPNGSLANARYRKMGS--------------------------------------------------------SPCHLP 574 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l~ 574 (791)
||+++++|.+++...... ...+++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999998653211 012589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccc
Q 003847 575 WEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654 (791)
Q Consensus 575 ~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (791)
+..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--------------------- 230 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------------------- 230 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---------------------
Confidence 99999999999999999999999999999999999999999999999998764221110
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHH
Q 003847 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRL 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 733 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... ......
T Consensus 231 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---------~~~~~~ 288 (337)
T cd05054 231 -------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---------EEFCRR 288 (337)
T ss_pred -------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---------HHHHHH
Confidence 0112235677999999999999999999999999999998 99998653111 001111
Q ss_pred HHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 734 ADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
....... .........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 289 ~~~~~~~--~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 289 LKEGTRM--RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HhccCCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 1112245678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=322.59 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=197.6
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
....||+|+||.||+|... +++.||||.+.... .....++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 3568999999999998743 35789999986532 2344578899999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 552 FVPNGSLANARYRKMGSS-----PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
|+++++|.+++....... ...+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 169 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCcccc
Confidence 999999999987543210 123678899999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
........ .....++..|+|||++.+..++.++|||||||++|||+
T Consensus 170 ~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 170 YETDYYRK----------------------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCcceeec----------------------------------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 42211000 00123567899999999888999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
+ |..||...... ...+....... .......+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 216 ~~~~~p~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 216 TLAEQPYQGMSNE----------QVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCCCCCCCCCHH----------HHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 9 67787543110 11111111100 11112245678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.75 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=198.3
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
...||+|+||.||+|..+++..||+|.+...... .+.+.+|+.++++++|+||+++++++. .+..+++|||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 4679999999999999888889999999765332 367899999999999999999999874 56689999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... ..+++.+++.++.|++.||+|||+.+|+||||||+||++++++.+||+|||++..........
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~------ 159 (260)
T cd05070 89 DFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA------ 159 (260)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc------
Confidence 99876432 238999999999999999999999999999999999999999999999999998654321100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....
T Consensus 160 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 160 -----------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred -----------------------------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001124567999999988889999999999999999999 88888543110
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
...+...... ..+.....+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 211 ----------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 ----------EVLEQVERGY--RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----------HHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111111111 111222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=342.49 Aligned_cols=275 Identities=19% Similarity=0.228 Sum_probs=202.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+.. +|+.||||++.... ......+..|+++++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 468999999999999954 78999999997532 23456788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++............
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 86 GDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999987652 3899999999999999999999999999999999999999999999999999876543211000
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......... ......................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 161 LNDSHNLLF-------RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred ccccccccc-------cccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 000000000 0000000000000111223456999999999999999999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-MKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 776 (791)
... .....+.........+........+.+++.+|+. ||.+||+ ++|+++.
T Consensus 234 ~~~---------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ---------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH---------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 1111111100001111111135678899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=324.05 Aligned_cols=242 Identities=23% Similarity=0.303 Sum_probs=205.6
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhh--HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+-||+|.|++|-.|+ .-+|+.||||++.+...+. ...+.+|++.|+.++|||||++|++...+...|+|+|+-.+|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 4579999999999998 4589999999998764443 346788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe-cCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|++||.++.. .+.+...++++.||+.|+.|+|+..+|||||||+||.+ .+-|-|||.|||++..+.+
T Consensus 103 Dl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P------- 171 (864)
T KOG4717|consen 103 DLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP------- 171 (864)
T ss_pred hHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-------
Confidence 99999987653 39999999999999999999999999999999999876 4568899999999876542
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCC-CchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.......||+..|.|||++.+..|+ +++||||||||||-|++|++||..
T Consensus 172 ------------------------------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 172 ------------------------------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred ------------------------------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 2345567899999999999998885 689999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..+... +..+.| ..+..+.....++.+||..||..||++|.+.+||..
T Consensus 222 ANDSET---------LTmImD----CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 222 ANDSET---------LTMIMD----CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccchhh---------hhhhhc----ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 533322 222222 334445557889999999999999999999999975
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=323.32 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=199.7
Q ss_pred ceeccccCceEEEEEEe-----CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-----EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 36899999999999983 35689999999754 3344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 554 PNGSLANARYRKMG------------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 554 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
++++|.+++..... .....+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG 169 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecccc
Confidence 99999999864321 011247889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
+++......... ......++..|+|||++.+..++.++|||||||+
T Consensus 170 ~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 170 LSREIYSADYYR----------------------------------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred ccccccCCccee----------------------------------cccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 998654221100 0112235677999999988889999999999999
Q ss_pred HHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 702 LLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 702 l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
+|||++ |..||..... ....+...... ..+........+.+++.+||+.||++||++.++++.|+.
T Consensus 216 l~el~~~g~~p~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 216 LWEIFSFGLQPYYGFSN----------QEVIEMVRKRQ--LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCCCCCCCCCH----------HHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 999998 8888854211 01111111111 111122245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=326.26 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=202.1
Q ss_pred hhcceeccccCceEEEEEEeC------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVLE------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
+...+.||+|+||.||++... ....+|+|.+... ......++.+|+++++++ +|+||+++++++...+..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 344578999999999999853 2368999999764 333446788999999999 89999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEE
Q 003847 549 IYDFVPNGSLANARYRKMG-----------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL 617 (791)
+|||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEe
Confidence 9999999999999875421 11235899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHH
Q 003847 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYS 697 (791)
Q Consensus 618 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS 697 (791)
+|||+++.+........ .....++..|+|||++.+..++.++||||
T Consensus 174 ~Dfg~~~~~~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 174 ADFGLARDIHHIDYYRK----------------------------------TTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred Cccccccccccccceec----------------------------------cCCCCCCccccCHHHhccCCcCcccceee
Confidence 99999987643211000 01112456799999998888999999999
Q ss_pred HHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 698 FGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 698 lGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|||++|||++ |..||..... ............. .........+.+++.+||..||++|||+.|+++.
T Consensus 220 lG~il~el~~~g~~p~~~~~~----------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPV----------EELFKLLKEGYRM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCH----------HHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999998 8888754211 0111111111111 1112245678899999999999999999999999
Q ss_pred hccCC
Q 003847 777 LEKIP 781 (791)
Q Consensus 777 L~~i~ 781 (791)
|+++.
T Consensus 288 l~~~~ 292 (293)
T cd05053 288 LDRML 292 (293)
T ss_pred HHHhh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.84 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=196.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 46899999999999994 478999999997642 23446788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 86 ~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 158 (330)
T cd05601 86 GDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--- 158 (330)
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce---
Confidence 999999876532 3899999999999999999999999999999999999999999999999999866432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc------CCCCCCchhhHHHHHHHHHHHhCC
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR------SIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~~sDvwSlGvil~elltG~ 709 (791)
......||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 159 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (330)
T cd05601 159 --------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206 (330)
T ss_pred --------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence 011234899999999986 456789999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.||...... .....+........++........+.+++..|+. +|++||+++++++
T Consensus 207 ~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 207 SPFHEGTSA---------KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCCHH---------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999653211 0111111111011112111245678889999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.31 Aligned_cols=237 Identities=21% Similarity=0.250 Sum_probs=190.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+||+|+||.||+|+. .+|+.||+|++.... ....+.+..|.++++.+. |++|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 46899999999999994 568999999987532 233456778888988885 5778899999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--- 156 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--- 156 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc---
Confidence 999999886643 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 157 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 157 ---------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred ---------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 11234589999999999998999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
... ..............+......+.+++.+||+.+|.+|++.
T Consensus 204 ~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 204 EDE-------------DELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCH-------------HHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 321 1111222222222222345678899999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.96 Aligned_cols=246 Identities=24% Similarity=0.288 Sum_probs=186.5
Q ss_pred ceeccccCceEEEEEEe-C-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhcc---CCCCccceeeEEEc-----cCceE
Q 003847 480 AYILGASGSSIMYKAVL-E-DGTALAVRRIGENS--VDRFRDFETQVRVIAKL---VHPNLVRIRGFYWG-----VDEKL 547 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~~~~ 547 (791)
.+.||+|+||.||+|+. . +++.||||++.... ......+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 46799999999999985 3 47889999986532 22224556677777665 69999999999853 34689
Q ss_pred EEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+||||++ ++|.+++...... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 9999996 6899888754332 38999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 162 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 204 (290)
T cd07862 162 FQM-------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 204 (290)
T ss_pred CCc-------------------------------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc
Confidence 211 1112348999999999988899999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHH------------------hhhcCccc-----hHHHHHHHHHHHhhccCCCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADA------------------AIRADFEG-----KEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP 764 (791)
|++||.+..... ....+.+. ........ .......+.+++.+||+.||
T Consensus 205 g~~~f~~~~~~~---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (290)
T cd07862 205 RKPLFRGSSDVD---------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 275 (290)
T ss_pred CCCCcCCCCHHH---------HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCc
Confidence 999996542210 00111100 00000000 00123466899999999999
Q ss_pred CCCCCHHHHHH
Q 003847 765 QKRPSMKEALQ 775 (791)
Q Consensus 765 ~~RPs~~evl~ 775 (791)
++|||+.|+++
T Consensus 276 ~~R~s~~~~l~ 286 (290)
T cd07862 276 AKRISAYSALS 286 (290)
T ss_pred hhcCCHHHHhc
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.39 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=200.6
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
....||+|+||.||+|... |+.||||.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred ceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 3568999999999999875 78999999987654 457899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.++.......
T Consensus 88 ~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~------- 157 (256)
T cd05039 88 VDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD------- 157 (256)
T ss_pred HHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-------
Confidence 9998765432 389999999999999999999999999999999999999999999999999886532111
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
...++..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 158 --------------------------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 158 --------------------------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred --------------------------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 1113456999999988889999999999999999997 8888854311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. ............ ......+..+.+++.+||..+|++||++.|++++|+.+
T Consensus 206 ~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 206 K----------DVVPHVEKGYRM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred H----------HHHHHHhcCCCC--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 111111111111 11122457788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=336.93 Aligned_cols=259 Identities=22% Similarity=0.268 Sum_probs=201.1
Q ss_pred hhcceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 548 (791)
....+.||+|+||.||+|+.. .++.||||+++... ....+.+.+|++++.++. ||||+++++++...+..++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 334678999999999999853 34689999997653 223457889999999997 9999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCC------------------------------------------------------------
Q 003847 549 IYDFVPNGSLANARYRKMGS------------------------------------------------------------ 568 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------ 568 (791)
||||+++|+|.++++.....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 99999999999999764310
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 569 ---------------------------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 569 ---------------------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
....+++..+..|+.|++.||+|||+.+|+||||||+|||+++++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEE
Confidence 01236788899999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||+++......... ......++..|+|||.+.+..++.++||
T Consensus 279 kL~DfGla~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 279 KICDFGLARDIMRDSNYI----------------------------------SKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEecCcceecccccccc----------------------------------cCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 999999998653221100 0012236788999999998889999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
|||||++|||++ |+.||..... ............... .+......+.+++.+||..+|++||+++||+
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~---------~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPM---------NEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCc---------hHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999999998 8888754210 011111111111111 1112456788999999999999999999999
Q ss_pred HHhccC
Q 003847 775 QALEKI 780 (791)
Q Consensus 775 ~~L~~i 780 (791)
+.|+++
T Consensus 394 ~~L~~~ 399 (401)
T cd05107 394 HLVGDL 399 (401)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=324.10 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=201.2
Q ss_pred hhhcceeccccCceEEEEEEe-----CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceE
Q 003847 476 LKASAYILGASGSSIMYKAVL-----EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKL 547 (791)
Q Consensus 476 ~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 547 (791)
.+..-..||+|+||.||.++. .++..||+|.++... ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 344556899999999999973 357899999997553 33456799999999999999999999998875 5678
Q ss_pred EEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+||||+++++|.+++..... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999865432 38999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
....... ......|+..|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~~~~~~~---------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt 207 (284)
T cd05079 161 TDKEYYT---------------------------------VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207 (284)
T ss_pred cCcccee---------------------------------ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc
Confidence 3211100 0112336777999999988889999999999999999999
Q ss_pred CCcchhccccCCCCcc--hhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 708 GKVIVVDELGQGNGLL--VEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
++.|+........... ................+ ..+.....+..+.+|+.+||+.+|++||+++++++.|++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 208 YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 8776432211000000 00000001111110000 1111222456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.55 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=197.4
Q ss_pred eeccccCceEEEEEEeC-C---CcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLE-D---GTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.||+|+||.||+|+.. . +..||+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999742 2 37899999986543 34567899999999999999999999875 4568999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 99999987654 389999999999999999999999999999999999999999999999999886643221100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 154 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 154 --------------------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred --------------------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 0001114567999999998899999999999999999998 8999854
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.... .......... ..+.....+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 202 ~~~~----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 202 MKGA----------EVIAMLESGE--RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHH----------HHHHHHHcCC--cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3211 1111111111 11112224567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.80 Aligned_cols=281 Identities=18% Similarity=0.219 Sum_probs=196.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..|+||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999994 568999999997542 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++............
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999887643 3889999999999999999999999999999999999999999999999998654321110000
Q ss_pred CC--Cc----cccCCccccc----ccccccCCC-CCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 636 GG--SA----RNFGSKRSTA----SRDSFQDLG-PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 636 ~~--~~----~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
.. .. ..+....... ......... ..............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00 00 0000000000 000000000 0000000111234679999999999999999999999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQ 775 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 775 (791)
|++|+.||...... .....+.........+.......++.+++.+|+ .+|++|++ +.|+++
T Consensus 241 lltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPL---------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHH---------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999653211 011111110000111111224556778887876 59999987 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.61 Aligned_cols=256 Identities=26% Similarity=0.336 Sum_probs=201.4
Q ss_pred hhcceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
+...+.||+|+||.||++.. .++..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 44567899999999999973 235689999987643 33446789999999999 79999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++|+|.+++...... .+++.++..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999998764322 389999999999999999999999999999999999999999999999999876542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT- 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt- 707 (791)
..... ......++..|+|||.+.+..++.++||||+||++|||++
T Consensus 194 ~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~ 239 (302)
T cd05055 194 DSNYV----------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239 (302)
T ss_pred CCcee----------------------------------ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhC
Confidence 21100 0011235678999999998889999999999999999998
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|+.||..... ............... ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 240 g~~p~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 240 GSNPYPGMPV---------DSKFYKLIKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCcCCCCc---------hHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 8889854311 011111211111111 1112346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.70 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=195.7
Q ss_pred ceeccccCceEEEEEEeCC-Cc--EEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEE
Q 003847 480 AYILGASGSSIMYKAVLED-GT--ALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 548 (791)
.+.||+|+||.||+|...+ ++ .||+|.++.. .....+.+..|++++++++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 4689999999999999644 33 6999998754 344457789999999999999999999987532 24689
Q ss_pred EEeccCCCChhHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 549 IYDFVPNGSLANARYRKMG-SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+|||+++|+|.+++..... .....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccC
Confidence 9999999999998754321 222348999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
...... ......+++.|+|||...+..++.++||||||+++|||++
T Consensus 164 ~~~~~~----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 164 NGDYYR----------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred ccccee----------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 321100 0011235667999999999899999999999999999999
Q ss_pred -CCcchhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 708 -GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 708 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|+.||...... ++.+....+. ..........+.+++.+||+.||++|||+.++++.|+++
T Consensus 210 ~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 210 RGQTPYPGVENS-------------EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCCHH-------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 78888542111 1111111111 111122456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.19 Aligned_cols=254 Identities=22% Similarity=0.429 Sum_probs=200.7
Q ss_pred hcceeccccCceEEEEEEeC-CC---cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 478 ASAYILGASGSSIMYKAVLE-DG---TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...+.||+|+||.||+|+.. ++ ..+|+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34678999999999999954 33 37999999765 333456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 88 MENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999999875432 3899999999999999999999999999999999999999999999999998765422111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. .......+..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 164 ~~---------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p 210 (268)
T cd05063 164 TY---------------------------------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210 (268)
T ss_pred ce---------------------------------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCC
Confidence 00 0001113456999999988889999999999999999998 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|..... . .......... ..+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 211 ~~~~~~---------~-~~~~~i~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 211 YWDMSN---------H-EVMKAINDGF--RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCcCCH---------H-HHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 854211 1 1111111111 1112223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.39 Aligned_cols=257 Identities=27% Similarity=0.347 Sum_probs=201.7
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...||+|+||.||+|... ....+|+|.+.... ....+++.+|+.++++++||||+++++.+...+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 468999999999999842 23679999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC
Q 003847 553 VPNGSLANARYRKMG-------------------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~ 613 (791)
+.+++|.+++..... ....++++..+..++.|++.||+|||+.+|+||||||+||++++++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~ 164 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR 164 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC
Confidence 999999998865321 1112488999999999999999999999999999999999999999
Q ss_pred CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCch
Q 003847 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW 693 (791)
Q Consensus 614 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~s 693 (791)
.+||+|||+++......... ......++..|+|||.+.+..++.++
T Consensus 165 ~~kl~dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~ 210 (290)
T cd05045 165 KMKISDFGLSRDVYEEDSYV----------------------------------KRSKGRIPVKWMAIESLFDHIYTTQS 210 (290)
T ss_pred cEEeccccccccccCccchh----------------------------------cccCCCCCccccCHHHHccCCcchHh
Confidence 99999999987653221100 00112356679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 694 DVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 694 DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
||||||+++|||++ |+.||..... .............. ........+.+++.+||+.+|++||+++|
T Consensus 211 Di~slG~~l~el~t~g~~p~~~~~~----------~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 211 DVWSFGVLLWEIVTLGGNPYPGIAP----------ERLFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred HHHHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHhCCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 99999999999999 8888854311 11122222111111 12224567889999999999999999999
Q ss_pred HHHHhccCCC
Q 003847 773 ALQALEKIPS 782 (791)
Q Consensus 773 vl~~L~~i~~ 782 (791)
+++.|+++-.
T Consensus 279 i~~~l~~~~~ 288 (290)
T cd05045 279 ISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.08 Aligned_cols=282 Identities=15% Similarity=0.171 Sum_probs=196.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++.+.+++..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999994 568999999986532 22345688999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus 86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999987643 3889999999999999999999999999999999999999999999999998644311110000
Q ss_pred CCCccccCCcc-ccccccccc-----CCC-CCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 636 GGSARNFGSKR-STASRDSFQ-----DLG-PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 636 ~~~~~~~~~~~-~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
........... ......... ... ..............+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00000000000 000000000 000 00000001112346799999999999999999999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP---SMKEALQA 776 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 776 (791)
+.||...... .....+.........+........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 241 ~~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPA---------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHH---------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999654211 000111110000011111123456778888876 5999999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.75 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
...||+|++|.||++....+..||+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 457999999999999987777899999875433 2467889999999999999999999875 46689999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++..........
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~------ 159 (260)
T cd05069 89 DFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA------ 159 (260)
T ss_pred HHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc------
Confidence 99876432 238899999999999999999999999999999999999999999999999997654221100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||...+..++.++||||||+++|||++ |+.||.+....
T Consensus 160 -----------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 160 -----------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred -----------------------------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 011225677999999988889999999999999999999 88888653211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
...+...... ........+..+.+++.+||+.||++||+++++++.|++
T Consensus 211 ----------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 ----------EVLEQVERGY--RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----------HHHHHHHcCC--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111111111 111122355778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.19 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=201.1
Q ss_pred ceeccccCceEEEEEEe------CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 56899999999999963 246789999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 554 PNGSLANARYRKMGS----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
++++|.+++...... ....+++..++.++.|++.||+|||+.||+||||||+||++++++.+||+|||++
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~ 169 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCce
Confidence 999999998764321 1124889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+......... ......+++.|+|||.+.+..++.++|||||||++|
T Consensus 170 ~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05092 170 RDIYSTDYYR----------------------------------VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215 (280)
T ss_pred eEcCCCceee----------------------------------cCCCccccccccCHHHhccCCcCchhhHHHHHHHHH
Confidence 7653211100 001122567799999999889999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
||++ |+.||..... ... ........ ........+..+.+++.+||+.||.+||+++||++.|++
T Consensus 216 el~~~g~~p~~~~~~---------~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 216 EIFTYGKQPWYQLSN---------TEA-IECITQGR--ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCCCCCCccCCH---------HHH-HHHHHcCc--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 9998 8888854211 011 11111110 111112245678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.51 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
....||+|+||.||+|+..++..||+|++..... ..+.+.+|++++++++|+||+++++++. .+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence 3467999999999999977777899999976433 2367899999999999999999999874 4568999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||.++.+.......
T Consensus 88 ~~~~~~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~----- 159 (262)
T cd05071 88 LDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA----- 159 (262)
T ss_pred HHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc-----
Confidence 9998764322 38899999999999999999999999999999999999999999999999997664321100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
.....++..|+|||+..+..++.++||||||+++|||+| |+.||.....
T Consensus 160 ------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 160 ------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ------------------------------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 011225677999999988889999999999999999999 7778754311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. .......... ........+..+.+++.+|++.||++||++.++++.|++.
T Consensus 210 ~----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 210 R----------EVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred H----------HHHHHHhcCC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1 1111111110 1112233567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.27 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=199.0
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
...||+|+||.||+|..++++.||+|.+...... .+.+.+|+.++++++|+||+++++++ ..+..+++|||+++++|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHH
Confidence 4689999999999999888999999999765432 46789999999999999999999987 456789999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++...... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus 89 ~~~~~~~~~---~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~------ 159 (260)
T cd05067 89 DFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA------ 159 (260)
T ss_pred HHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc------
Confidence 988764432 48999999999999999999999999999999999999999999999999987654211100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.+....
T Consensus 160 -----------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 160 -----------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred -----------------------------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 011225667999999998889999999999999999999 99998643211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
........... .+.....+.++.+++.+|++.+|++||+++++++.|+.+
T Consensus 211 ----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 211 ----------EVIQNLERGYR--MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ----------HHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 01111111111 111122446789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.28 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=187.7
Q ss_pred eccccCceEEEEEEeCC-------------------------CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccce
Q 003847 482 ILGASGSSIMYKAVLED-------------------------GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRI 536 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 536 (791)
.||+|+||.||+|.... ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 24699999976655555678889999999999999999
Q ss_pred eeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC---
Q 003847 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM--- 613 (791)
Q Consensus 537 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~--- 613 (791)
++++......++||||+++|+|..++..... .+++..+..++.|+++||+|||+++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999988865432 389999999999999999999999999999999999997643
Q ss_pred ----CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CC
Q 003847 614 ----EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IK 688 (791)
Q Consensus 614 ----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~ 688 (791)
.+|++|||++...... ....++..|+|||.+.+ ..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----------------------------------------~~~~~~~~~~aPe~~~~~~~ 197 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----------------------------------------EERVERIPWIAPECVPGGNS 197 (274)
T ss_pred CccceeeecCCccccccccc----------------------------------------cccccCCcccCchhhcCCCC
Confidence 3799999987543211 01136777999998865 56
Q ss_pred CCCchhhHHHHHHHHHHH-hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCC
Q 003847 689 PNPKWDVYSFGVILLELL-TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 689 ~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
++.++|||||||++|||+ +|+.||...... .......... ..+ ......+.+++.+||+.+|++|
T Consensus 198 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----------~~~~~~~~~~--~~~--~~~~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPS----------EKERFYEKKH--RLP--EPSCKELATLISQCLTYEPTQR 263 (274)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCccccChH----------HHHHHHHhcc--CCC--CCCChHHHHHHHHHcccChhhC
Confidence 899999999999999995 688888543211 0111111111 111 1123468899999999999999
Q ss_pred CCHHHHHHHhc
Q 003847 768 PSMKEALQALE 778 (791)
Q Consensus 768 Ps~~evl~~L~ 778 (791)
|++.++++.|.
T Consensus 264 ps~~~il~~L~ 274 (274)
T cd05076 264 PSFRTILRDLT 274 (274)
T ss_pred cCHHHHHHhhC
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.81 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=200.0
Q ss_pred eeccccCceEEEEEEeCC--C--cEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLED--G--TALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++||+|++|.||+|...+ + ..||||.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998543 3 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~- 155 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV- 155 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee-
Confidence 999999877542 2489999999999999999999999999999999999999999999999999987643221100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 156 --------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 156 --------------------------------MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred --------------------------------cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 0012336778999999998899999999999999999999 9999853
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
.... . ....... ...........+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus 204 ~~~~---------~-~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 204 LSGS---------Q-ILKKIDK-EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCHH---------H-HHHHHHh-cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 2110 0 1111111 011111122245678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.10 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=203.2
Q ss_pred hhhcceeccccCceEEEEEEe--------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCc
Q 003847 476 LKASAYILGASGSSIMYKAVL--------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDE 545 (791)
Q Consensus 476 ~~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 545 (791)
.+.....||+|+||.||+|+. .++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 334557899999999999973 13458999998754 234457789999999999 89999999999999999
Q ss_pred eEEEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC
Q 003847 546 KLIIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME 614 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~ 614 (791)
.++||||+++|+|.+++...... ....+++.++..++.||+.||+|||+.||+||||||+||+++.++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc
Confidence 99999999999999999764321 1124888999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchh
Q 003847 615 PKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWD 694 (791)
Q Consensus 615 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sD 694 (791)
+||+|||+++......... ......++..|+|||++.+..++.++|
T Consensus 176 ~kl~D~g~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 176 MKIADFGLARDVNNIDYYK----------------------------------KTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred EEECCCccceecccccccc----------------------------------cccCCCCCceeeCchhhccCCCCchhh
Confidence 9999999998664321110 001123567799999999888999999
Q ss_pred hHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 695 VYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 695 vwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
|||||+++|||++ |..||..... ............ .......+..+.+++.+||..+|++||++.|+
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPV----------EELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCH----------HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 9999999999998 6777743211 011111111111 11112245678899999999999999999999
Q ss_pred HHHhccCCCC
Q 003847 774 LQALEKIPSS 783 (791)
Q Consensus 774 l~~L~~i~~~ 783 (791)
++.|++|...
T Consensus 290 l~~l~~~~~~ 299 (304)
T cd05101 290 VEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHh
Confidence 9999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.55 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=201.6
Q ss_pred hhcceeccccCceEEEEEEeC--------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCce
Q 003847 477 KASAYILGASGSSIMYKAVLE--------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 546 (791)
+...+.||+|+||.||+++.. ++..+|+|.++.. ......++..|+++++++ +|+||+++++++...+..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 344578999999999999742 2357999999764 233456788899999999 799999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 547 LIIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcE
Confidence 9999999999999999765321 11248999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||+++.......... .....++..|+|||++.+..++.++||
T Consensus 180 kL~dfg~a~~~~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 180 KIADFGLARDIHHIDYYKK----------------------------------TTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred EECCCcccccccccchhhc----------------------------------cccCCCccceeChHHhccCCCCcHHHH
Confidence 9999999876532111000 001124567999999998889999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
|||||++|||++ |+.||..... ............ .+........+.+++.+||..+|++||++.+++
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPV----------EELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCH----------HHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 999999999998 7778753210 111111111111 112222456788999999999999999999999
Q ss_pred HHhccCCC
Q 003847 775 QALEKIPS 782 (791)
Q Consensus 775 ~~L~~i~~ 782 (791)
+.|+++..
T Consensus 294 ~~l~~~~~ 301 (307)
T cd05098 294 EDLDRILA 301 (307)
T ss_pred HHHHHHHH
Confidence 99988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.08 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=202.8
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|++|.||++. ..+++.||||.+... ......++.+|+++++.++|+||+++++++..++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 4579999999999999 457999999988643 223346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---- 161 (267)
T cd08229 87 GDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---- 161 (267)
T ss_pred CCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc----
Confidence 9999988753321 12489999999999999999999999999999999999999999999999999876532111
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 162 --------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 162 --------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred --------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 011234788899999998888999999999999999999999998643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... .............+ ........+.+++.+||+.||++|||+.+|+++++++.
T Consensus 210 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 210 KMN-----------LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cch-----------HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 211 01111111111111 11224567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.08 Aligned_cols=245 Identities=25% Similarity=0.316 Sum_probs=199.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|++|.||++.. .+++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 46899999999999995 46899999998643 3344577899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++.+......
T Consensus 85 ~L~~~l~~~~~~---~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~---- 157 (256)
T cd08529 85 DLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---- 157 (256)
T ss_pred cHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch----
Confidence 999998865322 4899999999999999999999999999999999999999999999999998865432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....|++.|+|||+..+..++.++|+||||+++|||++|+.||....
T Consensus 158 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 158 --------------------------------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred --------------------------------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 112347888999999998889999999999999999999999985432
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. ............+ ........+.+++.+||+.+|++||++.++++.
T Consensus 206 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 Q-------------GALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred H-------------HHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 1111111111111 111355678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.70 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=160.6
Q ss_pred ceeccccCceEEEEEEeC---CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE---DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 554 (791)
+..||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 458999999999999954 457899999876532 2467889999999999999999998854 456789999996
Q ss_pred CCChhHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe----cCCCCeEEeccCccccc
Q 003847 555 NGSLANARYRKMG----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL----GNDMEPKIGDFGLERLV 626 (791)
Q Consensus 555 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~~ 626 (791)
++|.+++..... .....+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 578777653321 112348899999999999999999999999999999999999 56678999999999866
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~el 705 (791)
....... .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 163 ~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 163 NSPLKPL---------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred CCCcccc---------------------------------cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHH
Confidence 4321100 01123458999999999876 4579999999999999999
Q ss_pred HhCCcchhcc
Q 003847 706 LTGKVIVVDE 715 (791)
Q Consensus 706 ltG~~pf~~~ 715 (791)
+||++||...
T Consensus 210 ~tg~~~f~~~ 219 (317)
T cd07867 210 LTSEPIFHCR 219 (317)
T ss_pred HhCCCCcccc
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.17 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=198.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 35799999999999984 57899999999876555567889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------ 172 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK------ 172 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc------
Confidence 9988643 2789999999999999999999999999999999999999999999999998764321110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 173 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 173 ------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred ------------------------------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11234788999999999888999999999999999999999999654221
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. ...... ................+.+++.+||..+|++||++.|+++.
T Consensus 223 ~---------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 223 R---------ALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred H---------hHHHHh-cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 000000 00011111222345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.45 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=204.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 468999999999999965 7999999988642 223356789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 87 ~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--- 162 (267)
T cd08224 87 GDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--- 162 (267)
T ss_pred CCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc---
Confidence 9999988653321 124899999999999999999999999999999999999999999999999998765322110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 163 ---------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 163 ---------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ---------------------------------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 11234788899999999888999999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc-c-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE-G-KEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... ..+..+....+... . .......+.+++.+||..+|++||++.+|+++|+++.
T Consensus 210 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 210 KMN-----------LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred Ccc-----------HHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 211 11111111111111 1 1134567889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.02 Aligned_cols=245 Identities=21% Similarity=0.291 Sum_probs=203.8
Q ss_pred eccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhH
Q 003847 482 ILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 560 (791)
-||.|+||.||+|..+ ++...|.|+|...+....++|.-|++||..++||+||++++.|+..+..+|+.|||.||-+..
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 3799999999999954 566677899988888888999999999999999999999999999999999999999999998
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCcc
Q 003847 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640 (791)
Q Consensus 561 ~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 640 (791)
++-.-.. .+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+......
T Consensus 119 imlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----------- 183 (1187)
T KOG0579|consen 119 IMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----------- 183 (1187)
T ss_pred HHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----------
Confidence 8776554 4999999999999999999999999999999999999999999999999997654321
Q ss_pred ccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc-----cCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-----RSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-----~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....++.|||+|||||+. +..+|+.++||||||++|.||..+.+|..+-
T Consensus 184 -------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 184 -------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred -------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 1123456799999999987 4688999999999999999999999997653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .++.+..+.... .+..-.+......+.+|+.+||..||..||++.++++.
T Consensus 239 n---------pMRVllKiaKSe-PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 239 N---------PMRVLLKIAKSE-PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c---------hHHHHHHHhhcC-CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 122222222211 22223344467789999999999999999999999864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.26 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
....||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 3468999999999999988889999999976543 346789999999999999999999999998999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~i~~~~~~---~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----- 160 (261)
T cd05034 89 LDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA----- 160 (261)
T ss_pred HHHHhccccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh-----
Confidence 9998765422 38999999999999999999999999999999999999999999999999988654311100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 161 ------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred ------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 001113457999999998889999999999999999999 8889854311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
......+ ..... .......+..+.+++.+|+..+|++||+++++.+.|+.
T Consensus 211 ---------~~~~~~~-~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 ---------REVLEQV-ERGYR--MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------HHHHHHH-HcCCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111111 11111 11112235678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.34 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=200.3
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCC---CchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGE---NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.-||.|+||.||-|+ ..+.+.||||++.. .+.+.+.++..|++.|++++|||++.+.|+|..+...|+||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 459999999999999 56789999999964 35566788999999999999999999999999999999999999 46
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+-.|++.-... ++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|....+
T Consensus 111 SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 111 SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 88887765542 488999999999999999999999999999999999999999999999999886542
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
..+++|||+|||||++. .+.|+-|+||||||++..||.-.++|+.
T Consensus 179 --------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 179 --------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred --------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 23567999999999985 4789999999999999999999999864
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
.-. .+..++.+.... .+... ..+.+..+.+|+..||..-|.+|||.+++++.-
T Consensus 227 nMN---------AMSALYHIAQNe-sPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 227 NMN---------AMSALYHIAQNE-SPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred Cch---------HHHHHHHHHhcC-CCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 321 111222222211 11222 234678889999999999999999999998753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.55 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=195.3
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEE-ccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW-GVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||++... |+.||+|.+..... .+.+.+|+.++++++|+|++++++++. ..+..++||||+++++
T Consensus 10 ~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 3468999999999999864 78899999875432 467889999999999999999999765 4567899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 87 L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~------ 157 (256)
T cd05082 87 LVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------ 157 (256)
T ss_pred HHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC------
Confidence 99998765432 388999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 158 ---------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 158 ---------------------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---------------------------------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1124556999999998889999999999999999998 888885321
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
. ............. ......+..+.+++.+|++.+|++|||+.++++.|++|
T Consensus 205 ~----------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 205 L----------KDVVPRVEKGYKM--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred H----------HHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 0111111111111 11122456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.65 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=196.3
Q ss_pred eeccccCceEEEEEEeC-CCc--EEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLE-DGT--ALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
++||+|+||.||+|..+ ++. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 5789988754 334456788999999999 799999999999999999999999999
Q ss_pred CChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 556 GSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 556 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
|+|.+++...... ....+++.++..++.|++.||+|||+.|++||||||+||++++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999998764321 11248899999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
....... ......+..|+|||++....++.++|||||||++||
T Consensus 161 ~~~~~~~-------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~e 203 (270)
T cd05047 161 GQEVYVK-------------------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203 (270)
T ss_pred ccchhhh-------------------------------------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHH
Confidence 3211000 001123566999999988889999999999999999
Q ss_pred HHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 705 LLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 705 llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|++ |+.||...... ........... .+........+.+++.+||+.+|.+|||+.|+++.|++|.
T Consensus 204 l~~~g~~pf~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 204 IVSLGGTPYCGMTCA----------ELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHcCCCCCccccCHH----------HHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 997 99998543110 11111111111 1111223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=320.53 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=196.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||+|+. .+++.||+|++..........+++|+.++++++||||+++++++..++..++||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 45799999999999994 57899999999765544556788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~------- 161 (267)
T cd06646 94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA------- 161 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-------
Confidence 99886543 389999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 162 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 162 -----------------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----------------------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 011234788899999884 445788999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
........+. ..... .........+..+.+++.+||..+|++||+++++++.|
T Consensus 213 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 213 HPMRALFLMS---------KSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred chhhhheeee---------cCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 2111000000 00000 00111112346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.20 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred ceeccccCceEEEEEEeC-C---CcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc------eE
Q 003847 480 AYILGASGSSIMYKAVLE-D---GTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE------KL 547 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~ 547 (791)
.+.||+|+||.||+|... + +..||||+++.. .......+.+|+++++.++|+||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 468999999999999853 2 478999998754 23345678999999999999999999998876554 68
Q ss_pred EEEeccCCCChhHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 548 IIYDFVPNGSLANARYRKMG-SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
+||||+++|+|..++..... .....+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 163 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeec
Confidence 99999999999998865432 12235899999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
....... ......++..|+|||.+.+..++.++|||||||++|||+
T Consensus 164 ~~~~~~~----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~ 209 (273)
T cd05035 164 YSGDYYR----------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209 (273)
T ss_pred ccccccc----------------------------------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHH
Confidence 4321110 000112456799999998888999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+ |..||.+... .+..+....+ ........+..+.+++.+||+.||++||++.|+++.|+++
T Consensus 210 ~~g~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 210 TRGQTPYPGVEN-------------HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred hCCCCCCCCCCH-------------HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9 7888854311 1111111111 1111223556889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.99 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=198.0
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|++|.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 468999999999999964 36789999987543 33345789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC---CeEEeccCcccccC
Q 003847 553 VPNGSLANARYRKMGS--SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM---EPKIGDFGLERLVT 627 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~~ 627 (791)
+++++|.+++...... ....+++..+++++.||+.||+|||+.+++||||||+||+++.++ .+||+|||+++.+.
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 9999999998765421 122489999999999999999999999999999999999998654 58999999998763
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
....... .....++..|+|||++.+..++.++|||||||++|||++
T Consensus 171 ~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 171 RASYYRK----------------------------------GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred Cccceec----------------------------------CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 2211000 001123456999999998899999999999999999997
Q ss_pred -CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 708 -GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 708 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
|+.||...... .............. ....+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 217 ~g~~pf~~~~~~----------~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 217 LGYMPYPGRTNQ----------EVMEFVTGGGRLDP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCCCCCHH----------HHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 88888643211 11111111111111 12245678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.40 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=200.6
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
....||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 3578999999999999853 24789999987553 3344678899999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 552 FVPNGSLANARYRKMGSS-----PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
|+++++|.+++....... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~ 169 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhh
Confidence 999999999987643211 124788999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
....... ......++..|+|||.+.+..++.++|||||||++|||+
T Consensus 170 ~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 170 YETDYYR----------------------------------KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred ccCcccc----------------------------------cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 4321100 011223677899999998888999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
+ |+.||...... ......... .....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 216 t~g~~p~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 216 TLAEQPYQGLSNE----------EVLKFVIDG--GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ccCCCCCccCCHH----------HHHHHHhcC--CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 8 88888542111 111111111 1111122245778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.76 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++++||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 457899999999999853 3578999999765332 346688999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 553 VPNGSLANARYRKMG-----------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
+++++|.+++..... .....+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+|||
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg 169 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccc
Confidence 999999999864311 011248889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
+++......... ......+++.|+|||.+.+..++.++|||||||+
T Consensus 170 ~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 215 (283)
T cd05091 170 LFREVYAADYYK----------------------------------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215 (283)
T ss_pred cccccccchhee----------------------------------eccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence 988653221100 0111235678999999988889999999999999
Q ss_pred HHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 702 LLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 702 l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
+|||++ |..||.+... .++.+....... +.....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 216 l~el~~~g~~p~~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 216 LWEVFSYGLQPYCGYSN-------------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCCCCCCCCCH-------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 999998 7778754311 111111111111 1122355678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.31 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=189.5
Q ss_pred eeccccCceEEEEEEeCC--------CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 481 YILGASGSSIMYKAVLED--------GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
+.||+|+||.||+|.... ...||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 235889988766555567888999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC--------eEEeccCccc
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME--------PKIGDFGLER 624 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~--------~kL~DFGla~ 624 (791)
+++|+|.+++..... .+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999876543 3899999999999999999999999999999999999987765 5889999876
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILL 703 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ 703 (791)
..... ....++..|+|||++.+ ..++.++|||||||++|
T Consensus 157 ~~~~~----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 157 TVLPK----------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred ccCCc----------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 43211 12337788999999986 45799999999999999
Q ss_pred HHHhCCc-chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 704 ELLTGKV-IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 704 elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
||++|.. ||..... ......... ....+. .....+.+++.+||+.||++|||++++++.|+
T Consensus 197 ~l~~g~~~~~~~~~~----------~~~~~~~~~--~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 197 EIFSGGDKPLSALDS----------QKKLQFYED--RHQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHcCCCCChhhccH----------HHHHHHHHc--cccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999964 5533210 000111111 111111 13456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.96 Aligned_cols=258 Identities=26% Similarity=0.361 Sum_probs=199.5
Q ss_pred ceeccccCceEEEEEEeC-CC--cEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DG--TALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+||+|+||.||+|..+ ++ ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 458999999999999864 33 35789988753 333456789999999999 79999999999999999999999999
Q ss_pred CCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 555 NGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 555 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
+++|.+++...... ....+++..++.|+.|++.||+|||+.||+||||||+|||+++++.+||+|||++
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 166 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCC
Confidence 99999998764311 1124889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
........ ......+..|+|||++.+..++.++|||||||++|
T Consensus 167 ~~~~~~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 167 RGEEVYVK-------------------------------------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred ccccceec-------------------------------------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 64221100 00111345699999999888999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
||++ |+.||...... ............ .........+.+|+.+||+.+|.+||+++++++.|+.+..
T Consensus 210 el~t~g~~pf~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 210 EIVSLGGTPYCGMTCA----------ELYEKLPQGYRM--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHcCCCCCCCCCCHH----------HHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9998 98998543211 111111111111 1112245678899999999999999999999999988765
Q ss_pred CCCC
Q 003847 783 SPSP 786 (791)
Q Consensus 783 ~~~p 786 (791)
...+
T Consensus 278 ~~~~ 281 (297)
T cd05089 278 ARKA 281 (297)
T ss_pred hhcc
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.17 Aligned_cols=252 Identities=30% Similarity=0.411 Sum_probs=201.9
Q ss_pred eeccccCceEEEEEEeCC----CcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLED----GTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999543 889999999875443 367899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 556 GSLANARYRKMGS----SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 556 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
++|.+++...... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999998875211 012489999999999999999999999999999999999999999999999999987653321
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 710 (791)
.. ......++..|+|||.+....++.++||||+|+++|||++ |..
T Consensus 161 ~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 161 YR----------------------------------KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred cc----------------------------------cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 00 0112336788999999988889999999999999999999 588
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
||...... .......+ ..........+.++.+++.+||..+|++||++.|+++.|+
T Consensus 207 p~~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSNE---------EVLEYLRK---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCHH---------HHHHHHHc---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 88654110 01111111 1111222234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.15 Aligned_cols=248 Identities=18% Similarity=0.209 Sum_probs=195.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 35799999999999985 5789999999865422 2234578899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~L~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 157 (285)
T cd05632 85 GDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---- 157 (285)
T ss_pred ccHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc----
Confidence 9999888754322 389999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 158 ---------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 158 ---------------------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred ---------------------------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 11234889999999999889999999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 776 (791)
... .....+..................+.+|+.+|++.||++||+ +.++++.
T Consensus 205 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 205 KEK---------VKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHH---------HHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 110 000111111111111112224456789999999999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.66 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEEeC-CCc--EEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGT--ALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|..+ ++. .+|+|.++.. .....+.+.+|++++.++ +|+||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 468999999999999954 454 5688887653 334456788999999999 89999999999999999999999999
Q ss_pred CCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 555 NGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 555 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
+++|.+++...... ....+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~ 171 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence 99999998765321 1124889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
........ .....++..|+|||++.+..++.++|||||||++|
T Consensus 172 ~~~~~~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 172 RGQEVYVK-------------------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred cccchhhh-------------------------------------cccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 63211000 00112456799999998888999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
||+| |..||...... ........... ..........+.+++.+||+.+|++||++.++++.|+++..
T Consensus 215 ellt~g~~p~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 215 EIVSLGGTPYCGMTCA----------ELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHhcCCCCcccCChH----------HHHHHHhcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9998 99998543111 01111111111 11111234578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.90 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-----hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-----VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 56899999999999984 568999999986432 223457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++.........
T Consensus 87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999887653 38899999999999999999999999999999999999999999999999987653211000
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 162 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 162 ---------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred ---------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 00012347788999999999889999999999999999999999985
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... ............. ...+......+.+++.+||..+|++|||+.|+++.
T Consensus 209 ~~~~---------~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 209 EFEA---------MAAIFKIATQPTN--PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccch---------HHHHHHHhccCCC--CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 4311 0011111111111 11122345678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=351.86 Aligned_cols=275 Identities=21% Similarity=0.220 Sum_probs=203.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||||++|
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 46899999999999995 468999999997532 22346789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 556 GSLANARYRKMGSS------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 556 gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
++|.+++....... ...+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~ 166 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccc
Confidence 99999887532111 123667888999999999999999999999999999999999999999999999876322
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.......... ..+............+||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 167 ~~~~~~l~~~------------------~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 167 EEDLLDIDVD------------------ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred cccccccccc------------------cccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 1110000000 0000000111223456999999999999999999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhccCCC
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-SMKEALQALEKIPS 782 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 782 (791)
.||......... . .....++. ......+.+..+.+++.+|++.||++|| +++++++.|+....
T Consensus 229 ~PF~~~~~~ki~----~---~~~i~~P~---~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKIS----Y---RDVILSPI---EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhh----h---hhhccChh---hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999653211000 0 00000110 0011122456688999999999999995 67778787776543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.39 Aligned_cols=258 Identities=20% Similarity=0.258 Sum_probs=202.4
Q ss_pred cceeccccCceEEEEEEeCC-----CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLED-----GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e 551 (791)
..++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 45789999999999999655 789999998754 33445678899999999999999999998776 467899999
Q ss_pred ccCCCChhHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGS---SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
|+++++|.+++...... ....+++.++..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~ 169 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccC
Confidence 99999999998764322 112489999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT- 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt- 707 (791)
...... .....++..|+|||++.+..++.++||||||+++||+++
T Consensus 170 ~~~~~~----------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 170 MDYHCL----------------------------------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CceEEe----------------------------------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 221100 001225667999999998889999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|+.||...... ........... .......+..+.+++.+||..||++|||+.++++.|+.+..
T Consensus 216 g~~p~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 216 GQTPYVEIDPF----------EMAAYLKDGYR--LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCcCcCCHH----------HHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99998653111 11111111111 11111235678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.28 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=194.6
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhc--cCCCCccceeeEEEccC----ceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAK--LVHPNLVRIRGFYWGVD----EKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lv~e~~~ 554 (791)
++||+|+||.||||.+. ++.||||++.... .+.|+.|-+|.+. ++|+||+++++.-+... +++||+||.+
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 47999999999999985 5999999997643 3567888777764 58999999999876655 7899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc---------CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---------KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.|+|.+|+..+- ++|....+|+.-+++||+|||+ ..|+|||||+.|||+..|++..|+|||+|..
T Consensus 292 kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999874 9999999999999999999997 4699999999999999999999999999998
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC------CCchhhHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP------NPKWDVYSFG 699 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~------~~~sDvwSlG 699 (791)
+....... .....+||..|||||++.+..- -.+.||||+|
T Consensus 366 ~~p~~~~~----------------------------------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 366 LEPGKPQG----------------------------------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred ecCCCCCc----------------------------------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 76432211 1223569999999999976321 1368999999
Q ss_pred HHHHHHHhCCcchh-cccc-------CCCCc--chhchhHHHHHHHHhhhcCccc---hHHHHHHHHHHHhhccCCCCCC
Q 003847 700 VILLELLTGKVIVV-DELG-------QGNGL--LVEDKNRAIRLADAAIRADFEG---KEEALLSCFKLGYSCASPLPQK 766 (791)
Q Consensus 700 vil~elltG~~pf~-~~~~-------~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~ 766 (791)
.|+|||++.-.-+. +..+ ..+.. .+.+.+ ..++..+.++.++. ....+..+.+.+..||..||+.
T Consensus 412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq--~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQ--ELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHH--HHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 99999999654221 1111 11111 111111 12223333333221 1124567889999999999999
Q ss_pred CCCHHHHHHHhccCCCC
Q 003847 767 RPSMKEALQALEKIPSS 783 (791)
Q Consensus 767 RPs~~evl~~L~~i~~~ 783 (791)
|.|+.=|-+++.++...
T Consensus 490 RLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 490 RLTAGCVEERMAELMML 506 (534)
T ss_pred hhhhHHHHHHHHHHhcc
Confidence 99999888888776543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.71 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=199.0
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766999999998765433 4568999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~----- 151 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----- 151 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-----
Confidence 99866432 378999999999999999999999999999999999999999999999999876532110000
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||.+.+..++.++|||||||++|||+| |..||......
T Consensus 152 -----------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 152 -----------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred -----------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 001123556999999988889999999999999999999 77787543110
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
.......... ........+..+.+++.+|+..+|++||++.|+++.|++
T Consensus 203 ----------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 203 ----------QTRERIESGY--RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ----------HHHHHHhcCC--CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1111111111 111122345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.57 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=193.6
Q ss_pred eeccccCceEEEEEEeC----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVLE----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~ 554 (791)
++||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999843 2468999998653 33445788899999999999999999998764 556789999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++..... ..++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.+........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999876432 267888899999999999999999999999999999999999999999999876542211000
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc-chh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV-IVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~-pf~ 713 (791)
.......++..|+|||.+.+..++.++|||||||++|||++|+. ||.
T Consensus 157 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 157 --------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred --------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 00112235677999999988889999999999999999999655 553
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.... .+.......+. .......+..+.+++.+||..+|++||++.|+++.|+++.
T Consensus 205 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 205 DVDS-------------FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCH-------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 3210 01111111111 1111223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.57 Aligned_cols=249 Identities=17% Similarity=0.188 Sum_probs=192.6
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 3457899999999999995 46899999998642 2223356788999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 126 ~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~- 198 (371)
T cd05622 126 PGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV- 198 (371)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-
Confidence 999999988653 2888999999999999999999999999999999999999999999999999865421110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC----CCCCchhhHHHHHHHHHHHhCC
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI----KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~~sDvwSlGvil~elltG~ 709 (791)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 199 ----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 244 (371)
T cd05622 199 ----------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (371)
T ss_pred ----------------------------------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence 11234599999999998753 3789999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
.||...... .....+........++........+.+++.+|+..++.+ |+++.|+++.
T Consensus 245 ~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 245 TPFYADSLV---------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCCHH---------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 999653210 011111111101111222224567888999999844433 7799998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.73 Aligned_cols=252 Identities=21% Similarity=0.386 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEeC----CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE----DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 568999999999999853 23479999987643 3345688999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++..... .+++.++..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..+........
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd05066 89 NGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164 (267)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceee
Confidence 9999999876532 389999999999999999999999999999999999999999999999999987643211000
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~ 713 (791)
......++..|+|||.+.+..++.++|+||||+++||+++ |+.||.
T Consensus 165 ---------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 165 ---------------------------------TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred ---------------------------------ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 0011123567999999998889999999999999999887 999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+.... .....+.+. .. .+.....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 212 ~~~~~---------~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 212 EMSNQ---------DVIKAIEEG-YR--LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCHH---------HHHHHHhCC-Cc--CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 53211 001111110 00 111122456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.21 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=190.3
Q ss_pred eccccCceEEEEEEeCC---CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVLED---GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 4679999987653 2334578899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...........++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~----- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY----- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee-----
Confidence 999987654322224677888899999999999999999999999999999999999999999998653221100
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-------CCCCchhhHHHHHHHHHHHh-CC
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-------KPNPKWDVYSFGVILLELLT-GK 709 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~~~~sDvwSlGvil~ellt-G~ 709 (791)
.......|+..|+|||++.+. .++.++||||||+++|||++ |+
T Consensus 157 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 157 -----------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred -----------------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 011123477889999998642 35789999999999999996 99
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHh-hhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAA-IRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.||...... .......... ... ...........+.+++.+|+ .+|++|||++||++.|+
T Consensus 208 ~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 208 QPYRHLSDE---------QVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCChH---------HHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 998542111 0000000000 000 00000113356778999998 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.23 Aligned_cols=239 Identities=17% Similarity=0.198 Sum_probs=185.5
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhcc---CCCCccceeeEEEccCceEEEEeccCC
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKL---VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
||+|+||+||+|+. .+++.||||++..... .....+..|..++.+. +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 4689999999865321 2223445566777655 699999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---- 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---- 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC----
Confidence 99998886543 389999999999999999999999999999999999999999999999999875321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 152 --------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred --------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 11234599999999998754 479999999999999999999999865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccch-HHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGK-EEALLSCFKLGYSCASPLPQKRP----SMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 775 (791)
... .++......+..... ......+.+++.+||+.||++|| ++.++++
T Consensus 200 ~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 200 EDT-------------QQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCH-------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 311 111111111111111 11346778999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.48 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=200.1
Q ss_pred hcceeccccCceEEEEEEeC--------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceE
Q 003847 478 ASAYILGASGSSIMYKAVLE--------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKL 547 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 547 (791)
.....||+|+||.||+++.. ....||+|.++.. .......+..|+++++++ +||||+++++++...+..+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 34678999999999999742 2467999998754 233456788999999999 6999999999999999999
Q ss_pred EEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeE
Q 003847 548 IIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~k 616 (791)
+||||+++|+|.+++...... ....+++.++..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~k 174 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEE
Confidence 999999999999999764321 112489999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||+++.......... .....++..|+|||++.+..++.++|||
T Consensus 175 L~Dfg~~~~~~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 175 IADFGLARGVHDIDYYKK----------------------------------TSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred Eccccccccccccccccc----------------------------------cccCCCCccccCHHHHccCCcCccchhh
Confidence 999999986542211000 0011244579999999988899999999
Q ss_pred HHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 697 SFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 697 SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||||++|||++ |..||..... ............ .........++.+++.+||+.+|++||++.|+++
T Consensus 221 slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPV----------EELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999 7888754211 011111111111 1111224557889999999999999999999999
Q ss_pred HhccCC
Q 003847 776 ALEKIP 781 (791)
Q Consensus 776 ~L~~i~ 781 (791)
.|+++.
T Consensus 289 ~l~~~~ 294 (314)
T cd05099 289 ALDKVL 294 (314)
T ss_pred HHHHHH
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.16 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=200.0
Q ss_pred cceeccccCceEEEEEEeCC----CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLED----GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
....||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 45789999999999998543 3579999987654 4455689999999999999999999998865 5678999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++..... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 89 PLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 99999999876432 38999999999999999999999999999999999999999999999999988654321100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
.....++..|+|||.+....++.++||||||+++|||++ |+.||
T Consensus 165 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 209 (270)
T cd05056 165 -----------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209 (270)
T ss_pred -----------------------------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence 001124567999999988889999999999999999986 99998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
...... .....+.. ..........+..+.+++.+|+..+|++|||+.++++.|+++....
T Consensus 210 ~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 210 QGVKNN---------DVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCCCHH---------HHHHHHHc---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 553211 00111100 0011112224567889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.86 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=191.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e 551 (791)
.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46899999999999995 57899999998653 2334567889999999999999999999998776 7899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 996 57877765432 389999999999999999999999999999999999999999999999999886432211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~ 710 (791)
. ......+|+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 159 ~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 159 K-----------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred c-----------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence 0 11123478889999998774 47999999999999999999999
Q ss_pred chhccccCCCCcch---------hchhHHH-HHHHHhhhcCc---------cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 711 IVVDELGQGNGLLV---------EDKNRAI-RLADAAIRADF---------EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 711 pf~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
||...........+ .+..... ........... .........+.+|+.+||+.||++|||+.
T Consensus 204 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 283 (372)
T cd07853 204 LFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283 (372)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH
Confidence 99653221000000 0000000 00000000000 00011245678999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 284 e~l~h 288 (372)
T cd07853 284 DALAH 288 (372)
T ss_pred HHhcC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.21 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=196.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHH--HHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFR--DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++||||+++++++......++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 468999999999999954 5679999999876544322 3456999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|+++||+|||+.+|+|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~----- 153 (260)
T PF00069_consen 84 SLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE----- 153 (260)
T ss_dssp BHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-----
T ss_pred cccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 9999998433 389999999999999999999999999999999999999999999999999876411110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......++..|+|||++. +..++.++||||+|+++|+|++|+.||...
T Consensus 154 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 154 -------------------------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp -------------------------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred -------------------------------ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 112344888999999998 788999999999999999999999998653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. .............................+.+++.+||+.||++||++.++++
T Consensus 203 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 203 N------SDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp S------HHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c------chhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00111111111111111111111112378899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.22 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=194.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.++||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 35899999999999984 57899999998654 33445678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|..+. .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~------- 149 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI------- 149 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-------
Confidence 96541 27888999999999999999999999999999999999999999999999987653211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.....||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 150 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 198 (279)
T cd06619 150 -------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQK 198 (279)
T ss_pred -------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcc
Confidence 1123588899999999988899999999999999999999999865322
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
....... ........+. ...... ......++.+++.+|++.+|++||+++|+++.
T Consensus 199 ~~~~~~~--~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 199 NQGSLMP--LQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cccccch--HHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111100 0000111111 111111 11234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.67 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=195.4
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+||+|+||.||+|. ..+++.||+|.+........+.+.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 34689999999999999 45678999999987766667789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++...... ...++..+..++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++..+.....
T Consensus 92 L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~----- 164 (268)
T cd06624 92 LSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----- 164 (268)
T ss_pred HHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-----
Confidence 99998764321 01278889999999999999999999999999999999986 67899999999876532110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--CCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--PNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 165 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 165 -------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred -------------------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 011123788899999986543 78899999999999999999999854
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...... ..... .........+......+.+++.+||+.+|++|||+.|+++.
T Consensus 214 ~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 214 LGEPQA--------AMFKV--GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccChhh--------hHhhh--hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 211000 00000 00001111122245678899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.97 Aligned_cols=271 Identities=20% Similarity=0.264 Sum_probs=196.0
Q ss_pred eecccc--CceEEEEEE-eCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGAS--GSSIMYKAV-LEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G--~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+||+| +|++||++. ..+|+.||||++.... ....+.+++|+++++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 478999 788999998 4678999999997542 33345678899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++...... .+++..++.++.|++.||+|||+.+|+||||||+|||++.++.++++||+..............
T Consensus 84 ~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 84 GSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999998754322 3899999999999999999999999999999999999999999999999876543211100000
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 161 -----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 161 -----------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred -----------------------------cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0000112246778999999976 468999999999999999999999986
Q ss_pred ccccCCC---------Ccchhchh-HHHHHH--------HHhh---------hc------CccchHHHHHHHHHHHhhcc
Q 003847 714 DELGQGN---------GLLVEDKN-RAIRLA--------DAAI---------RA------DFEGKEEALLSCFKLGYSCA 760 (791)
Q Consensus 714 ~~~~~~~---------~~~~~~~~-~~~~~~--------~~~~---------~~------~~~~~~~~~~~l~~li~~cl 760 (791)
....... ........ ...+.. +... .. ..+........+.+++.+||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 291 (327)
T cd08227 212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL 291 (327)
T ss_pred CcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence 4211000 00000000 000000 0000 00 00011123457889999999
Q ss_pred CCCCCCCCCHHHHHHH--hccCCCC
Q 003847 761 SPLPQKRPSMKEALQA--LEKIPSS 783 (791)
Q Consensus 761 ~~dP~~RPs~~evl~~--L~~i~~~ 783 (791)
+.||++|||++|+++. ++++...
T Consensus 292 ~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 292 QRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred hhCchhcCCHHHHhcChhhhhcchh
Confidence 9999999999999873 4444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.75 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEeCC-----------------CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEE
Q 003847 480 AYILGASGSSIMYKAVLED-----------------GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 541 (791)
.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4689999999999988532 3568999987653 344568899999999999999999999999
Q ss_pred ccCceEEEEeccCCCChhHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 542 GVDEKLIIYDFVPNGSLANARYRKMGSS------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 542 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
.++..++||||+++++|.+++....... ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCce
Confidence 9999999999999999999987654211 1248999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
+|+|||+++......... ......++..|+|||++.+..++.++||
T Consensus 170 ~l~dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 170 KIADFGMSRNLYSSDYYR----------------------------------VQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred EEccccceeecccCccee----------------------------------ecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999987654221100 0112236778999999988889999999
Q ss_pred HHHHHHHHHHHh--CCcchhccccCCCCcchhchhHHHHHHHH----hhhcCccchHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 696 YSFGVILLELLT--GKVIVVDELGQGNGLLVEDKNRAIRLADA----AIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 696 wSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
|||||++|||++ |..||...... ......... ......+.....+.++.+++.+||+.||++|||
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQ---------QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChH---------HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence 999999999998 55676432110 000111000 000001111123467899999999999999999
Q ss_pred HHHHHHHhcc
Q 003847 770 MKEALQALEK 779 (791)
Q Consensus 770 ~~evl~~L~~ 779 (791)
+.|+++.|++
T Consensus 287 ~~el~~~L~~ 296 (296)
T cd05051 287 FREIHLFLQR 296 (296)
T ss_pred HHHHHHHhcC
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.67 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=188.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
.+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..|+||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 46899999999999985 56899999999653 2334567889999999999999999999986543 469999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++ +|.+.+.. .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 99965 56665532 27889999999999999999999999999999999999999999999999987542211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 178 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 178 -------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred -------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 0112348899999999999999999999999999999999999
Q ss_pred chhccccCCCCc-ch--------hchhHHHHHHHHhh--hcCcc------------------chHHHHHHHHHHHhhccC
Q 003847 711 IVVDELGQGNGL-LV--------EDKNRAIRLADAAI--RADFE------------------GKEEALLSCFKLGYSCAS 761 (791)
Q Consensus 711 pf~~~~~~~~~~-~~--------~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~l~~li~~cl~ 761 (791)
||.......... .. .-............ ..... ........+.+|+.+||.
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 996532100000 00 00000000000000 00000 000123567899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||+.|+++.
T Consensus 301 ~dP~~R~t~~e~l~h 315 (359)
T cd07876 301 IDPDKRISVDEALRH 315 (359)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.11 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=197.3
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||.||++...+++.+|+|.+...... ..++.+|++++++++||||+++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 4689999999999999777889999998754332 357889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .++++.+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~------ 157 (256)
T cd05112 88 DYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS------ 157 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc------
Confidence 98875432 38899999999999999999999999999999999999999999999999987653221100
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 -----------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 207 (256)
T cd05112 158 -----------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN- 207 (256)
T ss_pred -----------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 011224567999999998889999999999999999998 8889854321
Q ss_pred CCCcchhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.++.+..... ........+..+.+|+.+||+.+|++||++.|+++.|.
T Consensus 208 ------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 208 ------------SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111111100 00011113567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.70 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=195.7
Q ss_pred ceeccccCceEEEEEEeCC---------------CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEcc
Q 003847 480 AYILGASGSSIMYKAVLED---------------GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV 543 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 543 (791)
.+.||+|+||.||+++.+. ...||+|.+... .......+.+|++++++++|+||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4579999999999987532 235999999765 333456799999999999999999999999999
Q ss_pred CceEEEEeccCCCChhHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeE
Q 003847 544 DEKLIIYDFVPNGSLANARYRKMGS-------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616 (791)
Q Consensus 544 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~k 616 (791)
+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+++||||||+||+++.++.+|
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~k 169 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIK 169 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEE
Confidence 9999999999999999998654211 011378899999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||++.......... ......++..|+|||++.+..++.++|||
T Consensus 170 l~dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 170 IADFGMSRNLYSGDYYR----------------------------------IQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred ecccccccccccCccee----------------------------------ccCcCcCceeecChhhhccCCcCchhhHH
Confidence 99999987653211100 00112356789999999888899999999
Q ss_pred HHHHHHHHHHh--CCcchhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 697 SFGVILLELLT--GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 697 SlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
||||++|||++ |..||....... .+.. ............ .......+..+.+|+.+||+.||++||++++|
T Consensus 216 SlG~~l~el~~~~~~~p~~~~~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSLLSDEQ---VIEN---TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcccChHH---HHHH---HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 99999999998 455664421100 0000 011111110000 01111234678999999999999999999999
Q ss_pred HHHhcc
Q 003847 774 LQALEK 779 (791)
Q Consensus 774 l~~L~~ 779 (791)
++.|++
T Consensus 290 ~~~l~~ 295 (295)
T cd05097 290 HHFLRE 295 (295)
T ss_pred HHHHhC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.56 Aligned_cols=255 Identities=18% Similarity=0.282 Sum_probs=184.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc--------CceEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--------DEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~lv 549 (791)
..++||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 457899999999999995 568999999986542 2345799999999999999999987542 135689
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTG 628 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~ 628 (791)
|||++ ++|.+++...... ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++.+..
T Consensus 146 mE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 146 MEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99997 4777766543211 12489999999999999999999999999999999999999664 699999999986542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
... .....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 224 ~~~-------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 224 GQR-------------------------------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred CCC-------------------------------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 111 112358899999999865 468999999999999999999
Q ss_pred CCcchhccccCCCCcch-h----chhHHHHHHHHhhh----cCcc-------chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 708 GKVIVVDELGQGNGLLV-E----DKNRAIRLADAAIR----ADFE-------GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~----~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
|++||.+.........+ . ..........+... .... .+...+.++.+|+.+||..||.+|||+.
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 99999654221000000 0 00000000000000 0000 0011235788999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 347 e~l~h 351 (440)
T PTZ00036 347 EALAD 351 (440)
T ss_pred HHhCC
Confidence 99854
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.88 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=199.0
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||.|++|.||++. ..+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 3579999999999998 467899999999766555567889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~------ 171 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK------ 171 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc------
Confidence 9987643 3899999999999999999999999999999999999999999999999998765422110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....
T Consensus 172 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~- 220 (296)
T cd06655 172 ------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP- 220 (296)
T ss_pred ------------------------------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 1123478889999999988899999999999999999999999965321
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
....... .................+.+++.+||..||++||++.++++.
T Consensus 221 --------~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 221 --------LRALYLI-ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --------HHHHHHH-HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0011111 111111111222345678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.70 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=205.6
Q ss_pred ccchHHHhhhcceeccccCceEEEEEEeC--------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceee
Q 003847 469 ELELETLLKASAYILGASGSSIMYKAVLE--------DGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRG 538 (791)
Q Consensus 469 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 538 (791)
++++....+.....||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34444444555678999999999999732 12479999987543 33456889999999999 7999999999
Q ss_pred EEEccCceEEEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCe
Q 003847 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607 (791)
Q Consensus 539 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NI 607 (791)
++...+..+++|||+++|+|.+++...... ....+++.++..++.|++.||+|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 999999999999999999999998764311 122488999999999999999999999999999999999
Q ss_pred EecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC
Q 003847 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI 687 (791)
Q Consensus 608 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 687 (791)
+++.++.+||+|||+++......... ......++..|+|||++.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~ 211 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYK----------------------------------KTTNGRLPVKWMAPEALFDR 211 (334)
T ss_pred EEcCCCcEEECCcccceecccccccc----------------------------------cccCCCcCceEcCHHHhccC
Confidence 99999999999999988654221100 00111245679999999998
Q ss_pred CCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCC
Q 003847 688 KPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQK 766 (791)
Q Consensus 688 ~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 766 (791)
.++.++||||||+++|||++ |..||..... ............. +........+.+++.+||+.+|++
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~ 279 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----------EELFKLLKEGHRM--DKPANCTHELYMIMRECWHAVPSQ 279 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcccChhh
Confidence 99999999999999999998 7778754211 1111111111111 111224567889999999999999
Q ss_pred CCCHHHHHHHhccCCC
Q 003847 767 RPSMKEALQALEKIPS 782 (791)
Q Consensus 767 RPs~~evl~~L~~i~~ 782 (791)
||++.|+++.|+++..
T Consensus 280 Rps~~ell~~l~~~~~ 295 (334)
T cd05100 280 RPTFKQLVEDLDRVLT 295 (334)
T ss_pred CcCHHHHHHHHHHHhh
Confidence 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.15 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=196.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 356999999999999954 5789999999776666667889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
..++..... ++++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~------- 158 (282)
T cd06643 90 DAVMLELER----PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------- 158 (282)
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-------
Confidence 887765322 489999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......|+..|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 159 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 159 -----------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred -----------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 011234888999999983 4557889999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... .......... .......+......+.+++.+||+.||.+||++.++++.
T Consensus 210 ~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 210 ELNP---------MRVLLKIAKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccCH---------HHHHHHHhhc-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4311 0111111110 011111122245678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.36 Aligned_cols=245 Identities=21% Similarity=0.327 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999985 46899999999766555667789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++.++..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~------- 173 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------- 173 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-------
Confidence 9987542 388999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 174 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 174 -----------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred -----------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 011234788999999998888999999999999999999999998643110
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.......................+.+++.+|+..||.+|||++|+++.
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 225 ----------QAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ----------HHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001111111111111112244568889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=319.10 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=198.5
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...||+|+||.||+|... ++..||+|++.... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 457899999999999853 47899999997653 33456799999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 553 VPNGSLANARYRKMG-----------------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
+++++|.+++..... .....+++.+++.++.|++.||+|||+.+++||||||+||+++.++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 169 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 169 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCce
Confidence 999999999875421 111247889999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||++..+........ .....++..|+|||.+.+..++.++||
T Consensus 170 ~l~dfg~~~~~~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 170 KIADFGLSRNIYSADYYKA----------------------------------SENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred EECccccceecccCccccc----------------------------------cCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999876532211000 001124566999999998899999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
|||||++|||++ |..||.+.... .....+.+... .......+.++.+++.+||+.||++|||+.|++
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~---------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~ 283 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHE---------EVIYYVRDGNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 999999999998 77787542110 01111111111 111222456789999999999999999999999
Q ss_pred HHhcc
Q 003847 775 QALEK 779 (791)
Q Consensus 775 ~~L~~ 779 (791)
+.|++
T Consensus 284 ~~l~~ 288 (288)
T cd05050 284 RILQR 288 (288)
T ss_pred HHhhC
Confidence 99974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.18 Aligned_cols=266 Identities=29% Similarity=0.411 Sum_probs=220.0
Q ss_pred cccchHHHhhhcceeccccCceEEEEEEeCC-CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCce
Q 003847 468 KELELETLLKASAYILGASGSSIMYKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 468 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 546 (791)
..++++.--....+.||.|.||.||.|.++. .-.||||.++.+... .++|..|+.+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3455555545567899999999999999654 678999999988664 58999999999999999999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
|||+|||..|+|.+|+.+..... ++--..+.++.||..|++||..+++|||||...|.|+.++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~e---v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSE---VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhh---cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999876542 677788899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
..+..+...+.. -.+.|.|||-+....++.|+|||+|||+|||+.
T Consensus 416 tgDTYTAHAGAK-----------------------------------FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIA 460 (1157)
T KOG4278|consen 416 TGDTYTAHAGAK-----------------------------------FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIA 460 (1157)
T ss_pred cCCceecccCcc-----------------------------------CcccccCcccccccccccchhhHHHHHHHHHHH
Confidence 876654433211 123499999999999999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
| |..||.+..- ..+..+.....+ ++.++.++..+++|++.||+..|.+||++.|+-+.++.+-.+.
T Consensus 461 TYGMsPYPGidl----------SqVY~LLEkgyR--M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 461 TYGMSPYPGIDL----------SQVYGLLEKGYR--MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred hcCCCCCCCccH----------HHHHHHHhcccc--ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 8 5558765321 123333333322 2344557889999999999999999999999999998875543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.56 Aligned_cols=247 Identities=19% Similarity=0.240 Sum_probs=195.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++|++|+++++.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 46799999999999994 578999999986532 22234577899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 157 (285)
T cd05630 85 GDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---- 157 (285)
T ss_pred CcHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc----
Confidence 9999988654322 389999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 ---------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ---------------------------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 11234899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
..... ........+.. ...+ .......+.+++.+||+.||++||| ++|+++
T Consensus 205 ~~~~~------~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 205 KKKIK------REEVERLVKEV-QEEY--SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Cccch------HHHHHhhhhhh-hhhc--CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 21100 00111111111 1111 1123456789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.61 Aligned_cols=258 Identities=22% Similarity=0.268 Sum_probs=202.8
Q ss_pred cchHHHhhhcceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccC-CCCccceeeEEEccCce
Q 003847 470 LELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 470 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 546 (791)
+.+..-.+..-+.||+||.+.||++...+.+.||+|++... .......|.+|+..|.+|+ |.+||++++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44444455556789999999999999888899999988543 4445678999999999995 99999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
|+||||= ..+|..++..+... ++.-.++.+..||+.|+.++|..||||.||||.|+|+- +|.+||+|||+|..+
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSI----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCC----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9999965 67999999877653 33237888999999999999999999999999999995 579999999999988
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-----------CCCCchhh
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-----------KPNPKWDV 695 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~~sDv 695 (791)
..+.... .....+||+.||+||.+... +.+.++||
T Consensus 510 ~~DTTsI----------------------------------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDv 555 (677)
T KOG0596|consen 510 QPDTTSI----------------------------------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDV 555 (677)
T ss_pred Cccccce----------------------------------eeccccCcccccCHHHHhhccccccCCCcceeecCccch
Confidence 7554322 12345799999999998532 25689999
Q ss_pred HHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 696 YSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 696 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||+|||||+|+.|+.||..... ....+..+.++.-.-.++... ...++++++..||..||++||++.|+|+
T Consensus 556 WSLGCILYqMvYgktPf~~~~n--------~~aKl~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 556 WSLGCILYQMVYGKTPFGQIIN--------QIAKLHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhhhhHHHHHHhcCCchHHHHH--------HHHHHHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 9999999999999999965321 112233344442222222221 2234899999999999999999999987
Q ss_pred H
Q 003847 776 A 776 (791)
Q Consensus 776 ~ 776 (791)
.
T Consensus 627 h 627 (677)
T KOG0596|consen 627 H 627 (677)
T ss_pred C
Confidence 4
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.93 Aligned_cols=255 Identities=19% Similarity=0.225 Sum_probs=190.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 46899999999999995 4688999999875422 2234677899999999999999999999999999999999975 8
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 90 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 159 (309)
T cd07872 90 LKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK------ 159 (309)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc------
Confidence 8887765432 378999999999999999999999999999999999999999999999999875432111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 ------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred ------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112347888999999865 467999999999999999999999996532
Q ss_pred cCCCCcch--------hchhH----HHHHHHHhhhcC-----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLV--------EDKNR----AIRLADAAIRAD-----FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~--------~~~~~----~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+ .+.+. .....+...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 210 VEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 21000000 00000 000000000000 0000113456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.11 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=195.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 45799999999999984 56899999998766555556788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~------- 161 (267)
T cd06645 94 QDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA------- 161 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-------
Confidence 99886543 389999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 162 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 162 -----------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----------------------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 011234888999999974 456889999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... ........... ............+.+++.+||+.+|++||+++++++
T Consensus 213 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 213 HPMR---------ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cchh---------hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 2110 00000000000 000001113356789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.46 Aligned_cols=276 Identities=18% Similarity=0.188 Sum_probs=196.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+++. .+++.||||++... .......+.+|+.++.+++|+||+++++.+.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999995 46899999999653 223346788899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999987643 3899999999999999999999999999999999999999999999999998865432111100
Q ss_pred CCCccccCCcccccccccccCCC-----CCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLG-----PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
........ ...++.... ..............+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 161 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 161 RNLTHNPP------SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccCCc------ccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00000000 000000000 0000000111234579999999999999999999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 776 (791)
||...... .....+........++........+.+++.+|+ .||.+|++ +.|+++.
T Consensus 235 Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQ---------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHH---------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99654211 011111110000111111113456778888876 49999985 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=317.09 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=198.0
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 468999999999999743 25689999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 553 VPNGSLANARYRKMGS-----SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+++|+|.+++...... .....++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~ 170 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccc
Confidence 9999999999764321 11236778899999999999999999999999999999999999999999999988653
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
...... ......++..|+|||.+.+..++.++|||||||++|||++
T Consensus 171 ~~~~~~----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 171 ETDYYR----------------------------------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred cccccc----------------------------------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence 221100 0011225667999999998889999999999999999999
Q ss_pred -CCcchhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 708 -GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 708 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|+.||..... .++.+....+. ..........+.+++.+|++.||++|||+.++++.|++..
T Consensus 217 ~~~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 217 LAEQPYQGLSN-------------EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCH-------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 6778754211 11111111111 1112223567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.81 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=197.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 46899999999999994 46899999998643 33345678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..+..++.|++.||+|||+.||+|+||||+||++++++.++++|||.+........
T Consensus 85 l~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~------ 155 (255)
T cd08219 85 LMQKIKLQRGK---LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA------ 155 (255)
T ss_pred HHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc------
Confidence 99988654322 378999999999999999999999999999999999999999999999999876532111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 156 ------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 205 (255)
T cd08219 156 ------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205 (255)
T ss_pred ------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH
Confidence 01123478889999999988899999999999999999999999964311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.........+... ........+.+++.+||+.||++||++.|++..
T Consensus 206 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 206 -------------KNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------HHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111111111111 112245568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.37 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred eccccCceEEEEEEeCC-------CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 482 ILGASGSSIMYKAVLED-------GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.||+|+||.||+|+..+ ++.||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998532 2689999986543 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-----CeEEeccCccccc
Q 003847 554 PNGSLANARYRKMGS--SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-----EPKIGDFGLERLV 626 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-----~~kL~DFGla~~~ 626 (791)
++++|.+++...... ....+++.++..++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||+++.+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 999999998754321 122478999999999999999999999999999999999999877 8999999998765
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
........ .....++..|+|||++.+..++.++|||||||++|||+
T Consensus 162 ~~~~~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 162 YKSDYYRK----------------------------------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred cccccccc----------------------------------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 42211000 01122567799999999989999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
+ |+.||...... ......... .........+..+.+++.+||..+|++||+++++++.|++
T Consensus 208 t~g~~p~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 208 TLGQQPYPALNNQ----------EVLQHVTAG--GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HcCCCCCcccCHH----------HHHHHHhcC--CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8 89888543110 111111111 1111222355678899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.78 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=202.7
Q ss_pred eeccccCceEEEEEEeC-----CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEec
Q 003847 481 YILGASGSSIMYKAVLE-----DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~ 552 (791)
+.||+|+||.||+++.. +++.||||++...... ..+.+.+|++++++++|+||+++++++.. ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 68999999999999853 3689999999866443 46789999999999999999999999887 5578999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05038 90 LPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165 (284)
T ss_pred CCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence 999999999876542 3899999999999999999999999999999999999999999999999999876532211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 166 ~~~---------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 212 (284)
T cd05038 166 YYV---------------------------------KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212 (284)
T ss_pred eec---------------------------------cCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCc
Confidence 000 00112455699999998888999999999999999999999987
Q ss_pred hccccCCCCcch-----hchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLV-----EDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
............ .......+....... .+.......++.+++.+||+.+|++||++.||+++|++|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 213 QSPPAEFLRMIGIAQGQMIVTRLLELLKEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred ccccchhccccccccccccHHHHHHHHHcCCc--CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 553322111000 000111111111111 1112224467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.85 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=199.2
Q ss_pred cceeccccCceEEEEEEeC-CC---cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLE-DG---TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+|... ++ ..||||.+... .....++|..|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 3568999999999999954 33 36999999764 3444578999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++..... .+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 88 ENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred CCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 99999998876432 38999999999999999999999999999999999999999999999999987654322110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
.. ........+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 164 ~~-------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 164 TY-------------------------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred cc-------------------------------ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 00 00001112456999999998899999999999999999886 99898
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
...... .......... ..+...+.+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 213 ~~~~~~----------~~~~~i~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQ----------DVINAIEQDY--RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHH----------HHHHHHHcCC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 543110 1111111110 1111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.59 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46799999999999994 57999999999766555567788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~------ 171 (297)
T cd06656 104 TDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK------ 171 (297)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC------
Confidence 9988643 2889999999999999999999999999999999999999999999999998765322110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 172 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 172 ------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred ------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 11234788899999999888999999999999999999999999654221
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........ ...............+.+++.+||..+|++||+++++++
T Consensus 222 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 222 RALYLIAT----------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred hheeeecc----------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11000000 000011112224456788999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.04 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=188.3
Q ss_pred eccccCceEEEEEEeCC---CcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVLED---GTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 4578999886543 3334678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...........++.....++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---- 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI---- 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee----
Confidence 9999977543322235678889999999999999999999999999999999999999999999986543211000
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-------CCCCCCchhhHHHHHHHHHHHh-CC
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-------SIKPNPKWDVYSFGVILLELLT-GK 709 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~~sDvwSlGvil~ellt-G~ 709 (791)
......++..|+|||++. ...++.++|||||||++|||++ |.
T Consensus 158 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (269)
T cd05042 158 ------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207 (269)
T ss_pred ------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence 001123567799999874 3456889999999999999999 67
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhh-h-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAI-R-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.||..... ............ . ............+.+++..|+ .||++||+++||++.|.
T Consensus 208 ~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 208 QPYPDLSD---------EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcCCH---------HHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 77754311 001111111000 0 000111123456677888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=322.79 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=218.1
Q ss_pred CCcccchHHHhhhcceeccccCceEEEEEEeCC---C--cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeE
Q 003847 466 GDKELELETLLKASAYILGASGSSIMYKAVLED---G--TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGF 539 (791)
Q Consensus 466 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 539 (791)
+...+++.......+.+||+|-||.||+|.+.+ | -.||||.-+.+ ..+..+.|..|..+|++++||||++++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 334566665556667899999999999999532 3 46889988774 56667899999999999999999999999
Q ss_pred EEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEec
Q 003847 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619 (791)
Q Consensus 540 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~D 619 (791)
|.+ ...|||||.++-|.|..|++.+.. .++......++.||+.||+|||+.++|||||...|||+.....|||+|
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecc
Confidence 965 578999999999999999988765 388999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHH
Q 003847 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699 (791)
Q Consensus 620 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlG 699 (791)
||+++.+..+....... ..=...|||||.+.-.+++.++|||-||
T Consensus 535 FGLSR~~ed~~yYkaS~-----------------------------------~kLPIKWmaPESINfRrFTtASDVWMFg 579 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASR-----------------------------------GKLPIKWMAPESINFRRFTTASDVWMFG 579 (974)
T ss_pred cchhhhccccchhhccc-----------------------------------cccceeecCccccchhcccchhhHHHHH
Confidence 99999987554322110 0012459999999999999999999999
Q ss_pred HHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 700 VILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 700 vil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
|.+||++. |..||.+-....+-..++++.+ .+.++.++..++.|+.+||++||.+||++.|+...|.
T Consensus 580 VCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 580 VCMWEILSLGVKPFQGVKNSDVIGHIENGER------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred HHHHHHHHhcCCccccccccceEEEecCCCC------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 99999977 7889987655544444444332 3445557889999999999999999999999999887
Q ss_pred cCCC
Q 003847 779 KIPS 782 (791)
Q Consensus 779 ~i~~ 782 (791)
++..
T Consensus 648 dv~q 651 (974)
T KOG4257|consen 648 DVLQ 651 (974)
T ss_pred HHHH
Confidence 7643
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=314.68 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=204.8
Q ss_pred cceeccccCceEEEEEEeC-CCc----EEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLE-DGT----ALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|... +|+ .||+|.+.... .....++.+|+.++++++|+||+++++++.. ...++||||
T Consensus 11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 3468999999999999853 333 69999987653 3345678999999999999999999999987 788999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 90 MPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred CCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 999999999876533 3899999999999999999999999999999999999999999999999999876422111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. .....++..|+|||.+....++.++|+||||+++||+++ |+.|
T Consensus 166 ~~----------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 166 YH----------------------------------AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ee----------------------------------cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 00 001113567999999988889999999999999999998 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCCcC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYLY 789 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~~~ 789 (791)
|...... .....+... .....+......+.+++.+||..+|.+||++.++++.|+++...+.-|+.
T Consensus 212 ~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~ 277 (279)
T cd05057 212 YEGIPAV----------EIPDLLEKG--ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYLV 277 (279)
T ss_pred CCCCCHH----------HHHHHHhCC--CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceEe
Confidence 8653111 111111111 01111112345788999999999999999999999999998877776653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=334.70 Aligned_cols=251 Identities=17% Similarity=0.207 Sum_probs=189.5
Q ss_pred hcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 478 ASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.....||+|+||.||++... +++.||||.... ..+.+|++++++++|+|||++++++...+..++|||++. +
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 34568999999999999954 578999996432 345789999999999999999999999999999999994 7
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 245 ~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~---- 316 (461)
T PHA03211 245 DLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST---- 316 (461)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc----
Confidence 88888765432 4899999999999999999999999999999999999999999999999999865321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.......||..|+|||++.+..++.++|||||||++|||++|..++....
T Consensus 317 ------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~ 366 (461)
T PHA03211 317 ------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366 (461)
T ss_pred ------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCC
Confidence 01123459999999999999999999999999999999999887543211
Q ss_pred -cCCCCcchhchhHHHHHHHH----------------------h----hhcC-----ccchHHHHHHHHHHHhhccCCCC
Q 003847 717 -GQGNGLLVEDKNRAIRLADA----------------------A----IRAD-----FEGKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 717 -~~~~~~~~~~~~~~~~~~~~----------------------~----~~~~-----~~~~~~~~~~l~~li~~cl~~dP 764 (791)
......... .+.+++.. . .... +.........+.+|+.+||+.||
T Consensus 367 ~~~~~~~~~~---~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP 443 (461)
T PHA03211 367 RGDERRPYDA---QILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDG 443 (461)
T ss_pred cccccCCcHH---HHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccCh
Confidence 100000000 00000000 0 0000 00000122367889999999999
Q ss_pred CCCCCHHHHHHH
Q 003847 765 QKRPSMKEALQA 776 (791)
Q Consensus 765 ~~RPs~~evl~~ 776 (791)
++|||+.|+++.
T Consensus 444 ~~RPsa~elL~h 455 (461)
T PHA03211 444 ARRPSAAELLRL 455 (461)
T ss_pred hhCcCHHHHhhC
Confidence 999999999874
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.95 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=198.5
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.. ...+++|||+++++|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 468999999999999987788899999876432 34678899999999999999999999887 7789999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+.........
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~------- 158 (260)
T cd05073 89 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT------- 158 (260)
T ss_pred HHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-------
Confidence 99876432 24789999999999999999999999999999999999999999999999998765421110
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
......++..|+|||++....++.++|+|||||++|++++ |+.||......
T Consensus 159 ----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 159 ----------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred ----------------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0011225567999999998889999999999999999999 88888543110
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.......... ..+.....+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 211 ----------~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 211 ----------EVIRALERGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ----------HHHHHHhCCC--CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0111111110 1111223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.71 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
...||+|++|.||+|.. .+++.||+|.+..... ...+.+++|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 45899999999999985 4689999998865322 1235688999999999999999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999987653 3889999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
...... ........|+..|+|||.+.+..++.++|||||||++|+|++|+
T Consensus 160 ~~~~~~------------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~ 209 (267)
T cd06628 160 SLSTKT------------------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209 (267)
T ss_pred cccCCc------------------------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCC
Confidence 111000 00112244888999999999888999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.||..... ......... .... .........+.+++.+||+.||.+||++.|+++
T Consensus 210 ~p~~~~~~---------~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 210 HPFPDCTQ---------LQAIFKIGE-NASP--EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCCCccH---------HHHHHHHhc-cCCC--cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99964311 111111111 1111 111224567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.30 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=196.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||+|+. .+++.||+|.+........+.+.+|++++++++|+||+++++++..++..++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 34799999999999995 45899999999877666678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
..++..... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~------- 165 (292)
T cd06644 97 DAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ------- 165 (292)
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-------
Confidence 887765432 389999999999999999999999999999999999999999999999998865322110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......|+..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 166 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 166 -----------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred -----------------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 011234788899999984 3456889999999999999999999985
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... ......... ..............+.+++.+||..+|++||++.|+++.
T Consensus 217 ~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 217 ELNPM---------RVLLKIAKS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccHH---------HHHHHHhcC-CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 43210 001111110 011111122244678899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.78 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=197.4
Q ss_pred ceeccccCceEEEEEEeC-----------------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEE
Q 003847 480 AYILGASGSSIMYKAVLE-----------------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 541 (791)
.+.||+|+||.||++... ++..||+|++... .......+.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 468999999999998532 2457999999764 3334567899999999999999999999999
Q ss_pred ccCceEEEEeccCCCChhHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 542 GVDEKLIIYDFVPNGSLANARYRKMGSS------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 542 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
..+..++||||+++++|.+++....... ...+++.++..++.|++.||+|||+.||+||||||+||+++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCE
Confidence 9999999999999999999987643221 1247888999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
+|+|||+++.+....... ......++..|+|||...+..++.++||
T Consensus 170 ~l~dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di 215 (296)
T cd05095 170 KIADFGMSRNLYSGDYYR----------------------------------IQGRAVLPIRWMSWESILLGKFTTASDV 215 (296)
T ss_pred EeccCcccccccCCccee----------------------------------ccCcCcCccccCCHHHHhcCCccchhhh
Confidence 999999988653221100 0011124567999999888889999999
Q ss_pred HHHHHHHHHHHh--CCcchhccccCCCCcchhchhHHHHHHHHhh-hcCccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 696 YSFGVILLELLT--GKVIVVDELGQGNGLLVEDKNRAIRLADAAI-RADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 696 wSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
|||||++|||++ |..||....... .+. .......... ....+.....+..+.+++.+||+.||++||++.|
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSDEQ---VIE---NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccChHH---HHH---HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999999999998 666775421110 000 0111111110 0111111224567889999999999999999999
Q ss_pred HHHHhcc
Q 003847 773 ALQALEK 779 (791)
Q Consensus 773 vl~~L~~ 779 (791)
|++.|++
T Consensus 290 i~~~l~~ 296 (296)
T cd05095 290 IHATLLE 296 (296)
T ss_pred HHHHHhC
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=312.49 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCc------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENS------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...||+|+||.||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46899999999999998889999999986432 222356889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++.... ++++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999987643 38899999999999999999999999999999999999999999999999988653211110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
. .........|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 160 ~------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 160 T------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred c------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 0 0001123348899999999998889999999999999999999999995
Q ss_pred ccccCCCCcchhchhHHHHHHHH-hhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADA-AIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... .......... .... .........+.+++.+||+.+|++||++.|+++
T Consensus 210 ~~~~---------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 210 SMDR---------LAAMFYIGAHRGLMP--RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCh---------HHHHHHhhhccCCCC--CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4210 0000111100 0001 111224567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=325.93 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=197.4
Q ss_pred hcceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEcc-CceEE
Q 003847 478 ASAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGV-DEKLI 548 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~l 548 (791)
...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3456899999999999973 357899999997643 33456788999999999 689999999988654 45789
Q ss_pred EEeccCCCChhHHHHhhcCCC-----------------------------------------------------------
Q 003847 549 IYDFVPNGSLANARYRKMGSS----------------------------------------------------------- 569 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~----------------------------------------------------------- 569 (791)
||||+++|+|.+++.......
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 999999999999987532100
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcc
Q 003847 570 ---PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646 (791)
Q Consensus 570 ---~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 646 (791)
...+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||++...........
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~------------ 237 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR------------ 237 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh------------
Confidence 01368888999999999999999999999999999999999999999999999876532211000
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCcchh
Q 003847 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVE 725 (791)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 725 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 238 ----------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------- 288 (343)
T cd05103 238 ----------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------- 288 (343)
T ss_pred ----------------------cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------
Confidence 011225667999999988889999999999999999997 88888542110
Q ss_pred chhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 726 DKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
............. ..+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 289 --~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 289 --EEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --HHHHHHHhccCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011111111111 1111133568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=319.71 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=196.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||++.. .++..+|+|.+... ......++.+|++++++++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 346899999999999994 46889999998754 3334466889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++.... ++++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----- 154 (308)
T cd06615 85 SLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----- 154 (308)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-----
Confidence 9999987653 38999999999999999999997 699999999999999999999999999986542110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ---------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 155 ---------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ---------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 11234788999999998888999999999999999999999998532
Q ss_pred ccCCCCcchh-----------------------chhHHHHHHHHhhhcCccc--hHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 716 LGQGNGLLVE-----------------------DKNRAIRLADAAIRADFEG--KEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 716 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
.......... ......+..+.......+. .......+.+++.+||..+|++||++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 202 DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred chhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 2110000000 0000111111111110000 01134568899999999999999999
Q ss_pred HHHHHH
Q 003847 771 KEALQA 776 (791)
Q Consensus 771 ~evl~~ 776 (791)
.|+++.
T Consensus 282 ~~ll~~ 287 (308)
T cd06615 282 KELTKH 287 (308)
T ss_pred HHHhcC
Confidence 999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.12 Aligned_cols=238 Identities=26% Similarity=0.345 Sum_probs=189.1
Q ss_pred eeccccCceEEEEEEeCC-C----------cEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 481 YILGASGSSIMYKAVLED-G----------TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999654 3 35888887665433 5788999999999999999999999988 788999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-------CeEEeccCc
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-------EPKIGDFGL 622 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-------~~kL~DFGl 622 (791)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999876542 389999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC--CCCCchhhHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI--KPNPKWDVYSFGV 700 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~sDvwSlGv 700 (791)
+....... ...++..|+|||++.+. .++.++||||||+
T Consensus 155 a~~~~~~~----------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 155 PITVLSRE----------------------------------------ERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred cccccccc----------------------------------------ccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 88653210 11256679999999876 7899999999999
Q ss_pred HHHHHHhC-CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 701 ILLELLTG-KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 701 il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
++|||++| ..||...... +. ..... .....+.. ....+.+++.+||..+|.+||++.|+++.|+
T Consensus 195 ~~~~l~~~~~~p~~~~~~~-------~~---~~~~~--~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSS-------EK---ERFYQ--DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHHhCCCCCcccCCch-------hH---HHHHh--cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 99999995 5566443110 00 01111 00111111 2267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.70 Aligned_cols=244 Identities=20% Similarity=0.313 Sum_probs=196.2
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
..||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 3699999999999985 478999999997654445567889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-------- 172 (297)
T cd06659 107 DIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-------- 172 (297)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--------
Confidence 876542 389999999999999999999999999999999999999999999999999875432110
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~ 719 (791)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 223 (297)
T cd06659 173 ----------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV- 223 (297)
T ss_pred ----------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 011234888999999999888999999999999999999999998643110
Q ss_pred CCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.......................+.+++.+||+.+|++||++.++++.
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 224 ---------QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---------HHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001111111111111111234567899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.44 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEe-CCCc----EEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGT----ALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|.. .+|+ .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 46899999999999984 3454 579998876532 3344788999999999999999999998754 567999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 91 PHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999998876532 38899999999999999999999999999999999999999999999999998654221100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 167 ----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 167 ----------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ----------------------------------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 0011225677999999998899999999999999999998 88888
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPY 787 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~ 787 (791)
.+... ....+...... ..+........+.+++.+||..+|++||+++++++.|+++...+..|
T Consensus 213 ~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 213 DGIPT----------REIPDLLEKGE--RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred CCCCH----------HHHHHHHHCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 54311 11111211111 11111123457889999999999999999999999999876555443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=327.38 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=188.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 46899999999999984 46899999999753 2334467788999999999999999999886543 469999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++ +|.+.+.. .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence 99965 66666543 28889999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 174 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 174 -------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred -------------------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0112358899999999999899999999999999999999999
Q ss_pred chhccccCCC------------Ccchhch-hHHHHHHHHh----------------hhcCccchHHHHHHHHHHHhhccC
Q 003847 711 IVVDELGQGN------------GLLVEDK-NRAIRLADAA----------------IRADFEGKEEALLSCFKLGYSCAS 761 (791)
Q Consensus 711 pf~~~~~~~~------------~~~~~~~-~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~ 761 (791)
||........ ....... .......+.. ..............+.+++.+||.
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 9864321000 0000000 0000000000 000000011123467899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||+.|+++.
T Consensus 297 ~dP~~Rps~~ell~h 311 (355)
T cd07874 297 IDPAKRISVDEALQH 311 (355)
T ss_pred CCchhcCCHHHHhcC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.48 Aligned_cols=188 Identities=20% Similarity=0.303 Sum_probs=159.2
Q ss_pred hhcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 477 KASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.....||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++...+..++||||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 344578999999999999954 5789999986443 23468999999999999999999999999999999994
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 141 ~~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 211 (357)
T PHA03209 141 SDLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----- 211 (357)
T ss_pred CcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-----
Confidence 688888765432 48999999999999999999999999999999999999999999999999987432111
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 011234899999999999999999999999999999999976654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.54 Aligned_cols=253 Identities=16% Similarity=0.211 Sum_probs=192.0
Q ss_pred cceeccccCceEEEEEEeC---CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVLE---DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
....||+|+||.||++... .++.||||.+... +...+|++++++++||||+++++++......++|||++.
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 4568999999999999743 4678999998654 245689999999999999999999999999999999995
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 170 ~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~--- 241 (392)
T PHA03207 170 CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--- 241 (392)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc---
Confidence 68888874332 3899999999999999999999999999999999999999999999999998765432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 242 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 242 -------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred -------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 0112345899999999999989999999999999999999999998654
Q ss_pred ccCCCCcchhc----------------hhHHHHHH---HHhhhcCccch-----HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 716 LGQGNGLLVED----------------KNRAIRLA---DAAIRADFEGK-----EEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 716 ~~~~~~~~~~~----------------~~~~~~~~---~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
........+.. .......+ ....+..+..+ ......+.+++.+||..||++||++.
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 32111000000 00000000 00001111100 01234678899999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|++..
T Consensus 371 e~l~~ 375 (392)
T PHA03207 371 DILSL 375 (392)
T ss_pred HHhhC
Confidence 99875
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.73 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=199.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||.|+||.||+|.. .+++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 46799999999999995 46789999999876555678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++.++..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~------- 156 (262)
T cd06613 88 QDIYQVTRG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA------- 156 (262)
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-------
Confidence 998876522 389999999999999999999999999999999999999999999999999876542110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC---CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI---KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 157 -----------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 -----------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -----------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 01123478889999999776 7899999999999999999999998653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ............ .........+..+.+++.+||..+|.+|||+.+++.
T Consensus 208 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 208 HPM---------RALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CHH---------HHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 210 111111111000 011112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=316.70 Aligned_cols=246 Identities=24% Similarity=0.280 Sum_probs=185.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhcc---CCCCccceeeEEEcc-----CceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKL---VHPNLVRIRGFYWGV-----DEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~~~~l 548 (791)
...||+|+||.||+|+. .+++.||+|.++... ......+.+|+++++++ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 45799999999999985 478999999986532 11223456677777665 799999999988642 35789
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+. ++|.+++...... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 85 v~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEcccc-cCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 999997 5888887654322 389999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
... .....||..|+|||++.+..++.++||||+||++|||++|
T Consensus 161 ~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 203 (288)
T cd07863 161 QMA-------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 203 (288)
T ss_pred ccc-------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhC
Confidence 110 1123478899999999988999999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHh------------------hhcC-c----cchHHHHHHHHHHHhhccCCCCC
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAA------------------IRAD-F----EGKEEALLSCFKLGYSCASPLPQ 765 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-~----~~~~~~~~~l~~li~~cl~~dP~ 765 (791)
++||....... ....+.+.. .... . .........+.+++.+||+.||+
T Consensus 204 ~~~f~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 274 (288)
T cd07863 204 KPLFCGNSEAD---------QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH 274 (288)
T ss_pred CcCcCCCCHHH---------HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc
Confidence 99985432110 000000000 0000 0 00011345678999999999999
Q ss_pred CCCCHHHHHH
Q 003847 766 KRPSMKEALQ 775 (791)
Q Consensus 766 ~RPs~~evl~ 775 (791)
+|||+.|++.
T Consensus 275 ~R~t~~~~l~ 284 (288)
T cd07863 275 KRISAFRALQ 284 (288)
T ss_pred cCCCHHHHhc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.01 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEeCC-CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||++...+ ++.||+|.+..... .+++.+|++++++++|+||+++++++......|+++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4579999999999999654 89999999876533 57899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++.........
T Consensus 86 ~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~------ 155 (256)
T cd06612 86 SDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK------ 155 (256)
T ss_pred HHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc------
Confidence 999865432 3899999999999999999999999999999999999999999999999998876432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 156 ------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 156 ------------------------------RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred ------------------------------cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 11223778899999999889999999999999999999999998643211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.. .....................+.+++.+||+.||++|||+.|+++
T Consensus 206 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 206 RA----------IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hh----------hhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 000000111111222224457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.51 Aligned_cols=252 Identities=19% Similarity=0.214 Sum_probs=188.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~ 550 (791)
...||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 46899999999999994 46899999999753 233346788899999999999999999987643 3469999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 99964 67766643 27889999999999999999999999999999999999999999999999997643211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 181 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 181 -------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred -------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 0112358899999999999999999999999999999999999
Q ss_pred chhccccCCCC-cc-----------hhchhH-HHHHHHHh----------hhcC------ccchHHHHHHHHHHHhhccC
Q 003847 711 IVVDELGQGNG-LL-----------VEDKNR-AIRLADAA----------IRAD------FEGKEEALLSCFKLGYSCAS 761 (791)
Q Consensus 711 pf~~~~~~~~~-~~-----------~~~~~~-~~~~~~~~----------~~~~------~~~~~~~~~~l~~li~~cl~ 761 (791)
||......... .. ...... ........ +... ..........+.+++.+||.
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 303 (364)
T cd07875 224 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303 (364)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcC
Confidence 99643210000 00 000000 00000000 0000 00000123467899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||+.|+++.
T Consensus 304 ~dP~~R~t~~e~L~h 318 (364)
T cd07875 304 IDASKRISVDEALQH 318 (364)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.09 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=190.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEcc------CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGV------DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~~~~lv~e 551 (791)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +|+||+++++++... ...|+|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 35799999999999984 4689999999865432 346788999999998 799999999998753 35789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++...... .+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~ 166 (272)
T cd06637 90 FCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166 (272)
T ss_pred cCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc
Confidence 99999999988764322 489999999999999999999999999999999999999999999999999876532110
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~ell 706 (791)
......|+..|+|||++. +..++.++|||||||++|||+
T Consensus 167 ------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~ 210 (272)
T cd06637 167 ------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210 (272)
T ss_pred ------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence 011345888999999986 346788999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|+.||.+.... ........ ...... .....+..+.+++.+||..+|.+|||+.|+++
T Consensus 211 ~g~~p~~~~~~~---------~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 211 EGAPPLCDMHPM---------RALFLIPR-NPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hCCCCccccCHH---------HHHHHHhc-CCCCCC-CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999998543110 00010000 000000 11123457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.58 Aligned_cols=252 Identities=19% Similarity=0.163 Sum_probs=183.6
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC------CCccceeeEEEcc-CceEEE
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH------PNLVRIRGFYWGV-DEKLII 549 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~~~-~~~~lv 549 (791)
...+.||+|+||+||+|.. .+++.||||+++.... ..+.+..|++++++++| .+++++++++... ++.++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 3457899999999999985 4688999999965322 23456667777777654 4588999988765 467899
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCC---------------
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDM--------------- 613 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~--------------- 613 (791)
||++ +++|.+++.... .+++..+..|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9988 778988887643 38999999999999999999998 6999999999999998765
Q ss_pred -CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 614 -EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 614 -~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
.+||+|||.+..... .....+||+.|+|||++.+..++.+
T Consensus 285 ~~vkl~DfG~~~~~~~---------------------------------------~~~~~~gt~~Y~APE~~~~~~~~~~ 325 (467)
T PTZ00284 285 CRVRICDLGGCCDERH---------------------------------------SRTAIVSTRHYRSPEVVLGLGWMYS 325 (467)
T ss_pred ceEEECCCCccccCcc---------------------------------------ccccccCCccccCcHHhhcCCCCcH
Confidence 499999998753211 1123468999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCcchhccccCCCCcchhc-------h-------hHHHHHHHHhh--hcCc-------------c
Q 003847 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVED-------K-------NRAIRLADAAI--RADF-------------E 743 (791)
Q Consensus 693 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-------~-------~~~~~~~~~~~--~~~~-------------~ 743 (791)
+|||||||++|||++|+.||...........+.. . .....+++... .... .
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 9999999999999999999964321100000000 0 00000000000 0000 0
Q ss_pred chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 744 GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 744 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........+.+||.+||..||++|||++|+++
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00011345789999999999999999999997
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.25 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=195.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~ 555 (791)
.+.||+|++|.||++.. .+++.||+|++... .....+.+.+|++++++++|+|++++++.+...+ ..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 46899999999999994 45789999998654 2334567889999999999999999999876544 57899999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... .+++.+++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~l~~~l~~~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 157 (257)
T cd08223 85 GDLYHKLKEQKGK---LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---- 157 (257)
T ss_pred CcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC----
Confidence 9999988764322 389999999999999999999999999999999999999999999999999876532111
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 158 --------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred --------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 011234788899999999989999999999999999999999998542
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .........+.. .........+.+++.+|++.+|++||++.++++.
T Consensus 206 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 206 DM-------------NSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CH-------------HHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 10 011111111111 1122355778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.47 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||.|+||.||++.. .+++.||+|.+........+.+.+|++++++++|+||+++++++..+...++||||+++++|
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence 34699999999999995 46899999999877666667899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++........
T Consensus 90 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------- 158 (280)
T cd06611 90 DSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ------- 158 (280)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-------
Confidence 998876432 389999999999999999999999999999999999999999999999998775432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......|++.|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 159 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 159 -----------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred -----------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 011234788899999974 3456789999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... .....+.. ...............+.+++.+||+.+|++||++.++++.
T Consensus 210 ~~~~~---------~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 210 ELNPM---------RVLLKILK-SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCHH---------HHHHHHhc-CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 53110 01111111 0011111122245678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.03 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 35699999999999984 468899999987543 3445678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++..+.....
T Consensus 89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~------ 156 (277)
T cd06642 89 ALDLLKPG------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI------ 156 (277)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch------
Confidence 99987542 388999999999999999999999999999999999999999999999999876542110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 157 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 157 ------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred ------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 01123478889999999988899999999999999999999999864321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
... ............ .......+.+++.+||+.+|++||++.++++.
T Consensus 207 ~~~----------~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 207 MRV----------LFLIPKNSPPTL--EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhH----------HhhhhcCCCCCC--CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 110 000111111111 11245678899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.31 Aligned_cols=249 Identities=16% Similarity=0.193 Sum_probs=190.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+++. .+++.||||++.+. .....+.+.+|+.+++.++|+||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 46899999999999995 46899999998652 222345688899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 86 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 158 (331)
T cd05597 86 GDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--- 158 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc---
Confidence 999999875432 3899999999999999999999999999999999999999999999999998765422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||+.|+|||++.. ..++.++|||||||++|||++|+.
T Consensus 159 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 159 --------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred --------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence 0112348999999999863 457889999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQ--KRPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 776 (791)
||...... .....+.........+ .....+..+.+++.+|+..+++ .|++++++++.
T Consensus 207 Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 207 PFYAESLV---------ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCCCHH---------HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99653110 0011111100000111 1111355678888887765443 37899988876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.72 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=193.8
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
....||+|+||.||++.. +++.||+|.+..... .+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCH
Confidence 356899999999999975 678899999875432 3678899999999999999999999865 457999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~l~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~------- 155 (254)
T cd05083 86 VNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD------- 155 (254)
T ss_pred HHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC-------
Confidence 9998765322 388999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 156 --------------------------------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 156 --------------------------------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred --------------------------------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 0113456999999988889999999999999999998 8888854311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
. ............ ......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 204 ~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 204 K----------EVKECVEKGYRM--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred H----------HHHHHHhCCCCC--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 111111111111 1122245678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.69 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=186.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~ 550 (791)
...||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++... ...|+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 35899999999999984 578899999997542 22345677899999999999999999987543 3568999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
|++ +++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 988 78998876532 3899999999999999999999999999999999999999999999999998764321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 172 --------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (343)
T cd07878 172 --------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213 (343)
T ss_pred --------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCC
Confidence 112348889999999876 56899999999999999999999
Q ss_pred cchhccccCCCCcchh------chhHHHHH----HHHhhh--cCccch------HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLLVE------DKNRAIRL----ADAAIR--ADFEGK------EEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~------~~~~~~~~----~~~~~~--~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||...........+. .......+ ...... ...+.. ......+.+++.+|+..||++|||+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 214 ALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9985432100000000 00000000 000000 000000 00123467999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 294 ell~h 298 (343)
T cd07878 294 EALAH 298 (343)
T ss_pred HHhcC
Confidence 99964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=324.52 Aligned_cols=249 Identities=16% Similarity=0.196 Sum_probs=191.7
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+++.. +++.||+|++.+. .......+..|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 468999999999999954 5789999998653 122234578899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~--- 158 (332)
T cd05623 86 GDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--- 158 (332)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc---
Confidence 999999876432 3899999999999999999999999999999999999999999999999998754321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.
T Consensus 159 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 159 --------------------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred --------------------------------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 111245999999999986 3467899999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccc-hHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEG-KEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
||...... .....+........++. .......+.+++.+|+..++++ |++++|+++.
T Consensus 207 Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 207 PFYAESLV---------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCCCCHH---------HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99653210 01111111110111111 1124567888999988665544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=354.43 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=203.7
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+..||.|.||.||.|. .++|+..|+|-++.. .....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 35789999999999999 778999999988654 233456788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+.+...+. .++.....+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|..+........
T Consensus 1319 GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~- 1392 (1509)
T KOG4645|consen 1319 GSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP- 1392 (1509)
T ss_pred CcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC-
Confidence 999998876543 67777888999999999999999999999999999999999999999999998865421100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC---CCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI---KPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.......||+.|||||++.+. .-..++||||+|||+.||+||+.||
T Consensus 1393 -------------------------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1393 -------------------------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW 1441 (1509)
T ss_pred -------------------------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch
Confidence 122356799999999999763 3467899999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..-...|.-++ .+. . ....+.++....+-.+|+.+|+..||++|.++.|+++.
T Consensus 1442 ~~~dne~aIMy--------~V~-~--gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1442 AELDNEWAIMY--------HVA-A--GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhccchhHHHh--------HHh-c--cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 76544433221 111 1 11122333367788999999999999999999988764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.55 Aligned_cols=249 Identities=16% Similarity=0.186 Sum_probs=192.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999995 46889999998653 222345578899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--- 158 (331)
T cd05624 86 GDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--- 158 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce---
Confidence 999999876432 3899999999999999999999999999999999999999999999999998765422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 159 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 159 --------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred --------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence 0112358999999999875 467899999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccc-hHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEG-KEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
||...... .....+........++. ....+..+.+++.+|+..++++ |++++++++.
T Consensus 207 Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 207 PFYAESLV---------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CccCCCHH---------HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 99643210 01111111110011111 1123567888999999876544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.44 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=200.2
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..++||+|+||.||.++ ..+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 34689999999999998 456899999998643 344456788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... ..+++.++..++.|++.||+|||+.|++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---- 156 (256)
T cd08221 84 GTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---- 156 (256)
T ss_pred CcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc----
Confidence 999999876532 2489999999999999999999999999999999999999999999999999886543221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 --------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 --------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred --------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 011234788999999998888899999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
.. .+.......+... ........+.+++.+||..+|++||+++|+++.+
T Consensus 205 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 205 NP-------------LNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CH-------------HHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 1111111112111 1122456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.75 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=197.9
Q ss_pred eeccccCceEEEEEEeC------CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 481 YILGASGSSIMYKAVLE------DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 57999999999999853 3468999998765433 4578999999999999999999999999989999999999
Q ss_pred CCCChhHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 554 PNGSLANARYRKMGSS----PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
++++|.+++....... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|||++......
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~ 170 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcc
Confidence 9999999987654221 124899999999999999999999999999999999999999999999999998744221
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-C
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-G 708 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G 708 (791)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 171 ~~~-----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 171 EYY-----------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccc-----------------------------------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 100 0112235677999999988888999999999999999999 6
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
..||.+... ............. .......+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 216 ~~p~~~~~~---------~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 216 ELPFYGLSD---------EEVLNRLQAGKLE--LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCccccch---------HHHHHHHHcCCcC--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 778854211 0111111101110 11112245678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=345.94 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=191.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
...||+|+||.||+|.. .+++.||+|.+... .......+..|+.++++++|||||+++++|... ...|+||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 46899999999999995 46789999998653 233456789999999999999999999988654 46899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCeecCCCCCCeEecC----------------
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-------KHVHGNLKPRNVLLGN---------------- 611 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-------~ivHrDlkp~NILl~~---------------- 611 (791)
+|+|.+++...... ...+++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 98 gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 99999998764321 12499999999999999999999984 4999999999999964
Q ss_pred -CCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CC
Q 003847 612 -DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IK 688 (791)
Q Consensus 612 -~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~ 688 (791)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~-------------------------------------~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESM-------------------------------------AHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred CCCceEEccCCcccccccccc-------------------------------------ccccCCCccccCHHHHhccCCC
Confidence 23489999999976532110 112358999999999854 45
Q ss_pred CCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCC
Q 003847 689 PNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 689 ~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
++.++||||||||+|||+||+.||..... ...+...... ...+ .......+.+||..||..+|.+|
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~------------~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANN------------FSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCc------------HHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHC
Confidence 88999999999999999999999954211 0111111111 1111 11235678899999999999999
Q ss_pred CCHHHHHH--HhccC
Q 003847 768 PSMKEALQ--ALEKI 780 (791)
Q Consensus 768 Ps~~evl~--~L~~i 780 (791)
|++.|++. .+..+
T Consensus 287 PSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 287 PSALQCLGYQIIKNV 301 (1021)
T ss_pred cCHHHHhccHHHhhc
Confidence 99999983 45443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.79 Aligned_cols=256 Identities=20% Similarity=0.208 Sum_probs=191.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|++|.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 35799999999999995 468999999986532 2234678899999999999999999999999999999999997 6
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----- 156 (285)
T cd07861 84 DLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----- 156 (285)
T ss_pred CHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-----
Confidence 888887654321 2489999999999999999999999999999999999999999999999999875432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 157 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 -------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0112236788999998865 45789999999999999999999998653
Q ss_pred ccCCC------------CcchhchhHHHHHHHHhhhcCcc-----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGN------------GLLVEDKNRAIRLADAAIRADFE-----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ............ .......... .......++.+++.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPD-YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CHHHHHHHHHHHhCCCChhhhhcchhhHH-HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 21000 000000000000 0000000000 00113456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.39 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=190.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 550 (791)
..++||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 356899999999999985 56899999998643 122345788999999999999999999988763 5678999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999887543 38899999999999999999999999999999999999999999999999987653211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
... .......|+..|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 161 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 161 MSG---------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred ccC---------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence 000 00112347888999999998889999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||..... .............. ..+......+.+++ +||..+|++||+++||++
T Consensus 208 pf~~~~~---------~~~~~~~~~~~~~~--~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 208 PWAEYEA---------MAAIFKIATQPTNP--QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred Cccccch---------HHHHHHHhcCCCCC--CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 9864310 01111111000011 11222345566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.11 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=199.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.+|++.. .+|+.||+|.+... .....+++.+|++++++++|+||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46899999999999994 56899999998643 2334567899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~l~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---- 157 (256)
T cd08218 85 DLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---- 157 (256)
T ss_pred cHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh----
Confidence 999988764322 3789999999999999999999999999999999999999999999999998765422110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....|++.|+|||+..+..++.++|+|||||++|+|++|+.||....
T Consensus 158 --------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 158 --------------------------------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred --------------------------------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 012237888999999998889999999999999999999999985421
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..+..+....+... ........+.+++.+||+.+|++||++.||++.
T Consensus 206 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 206 -------------MKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -------------HHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11222222222221 122245678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.93 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 35799999999999995 468999999987542 3445788999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... ++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 156 (277)
T cd06640 89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI------ 156 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc------
Confidence 99987642 388999999999999999999999999999999999999999999999999876542110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......++..|+|||++.+..++.++|+|||||++|||++|+.||.....
T Consensus 157 ------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 157 ------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred ------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 01123477889999999888899999999999999999999999865321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
... .......... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 207 ~~~----------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 207 MRV----------LFLIPKNNPP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HhH----------hhhhhcCCCC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 100 1111111111 1122356778899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.75 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=206.6
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|.|+.|..++ ..++..||||.+.+... ...+.+.+|+++|+.++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 4579999999999999 45799999999987533 33456889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+++++..... +.+..+..++.|+.+|++|||+++|||||||.+|||++.+.++||+|||++..+....
T Consensus 141 e~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~------ 209 (596)
T KOG0586|consen 141 ELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL------ 209 (596)
T ss_pred hhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc------
Confidence 99999988764 6678899999999999999999999999999999999999999999999998775322
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++.
T Consensus 210 -------------------------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 210 -------------------------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred -------------------------------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 2346789999999999999877 68999999999999999999999764
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. +..+-++.+.+.+..+.-...++.+++++++..+|.+|++++++.+.
T Consensus 259 ~-------------lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 259 N-------------LKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c-------------cccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2 22233334444444443356678899999999999999999999764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.14 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||+||++.. ++|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 35799999999999995 468999999886543 3345678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 90 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~------ 158 (284)
T cd06620 90 LDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI------ 158 (284)
T ss_pred HHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc------
Confidence 999876643 38999999999999999999997 699999999999999999999999999976542111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 159 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 159 --------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred --------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 012348889999999988889999999999999999999999997543
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
...... .......+........... ........+.+++.+|++.||++||++.|+++..
T Consensus 207 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 207 IDDDGQ--DDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhh--hhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 211100 0001111222222211111 0112446788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.41 Aligned_cols=244 Identities=21% Similarity=0.332 Sum_probs=197.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|++|.||++.. .+++.||+|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999984 57899999998765555556788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... ++++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~------- 170 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP------- 170 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-------
Confidence 9988762 389999999999999999999999999999999999999999999999998775432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 171 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~- 220 (285)
T cd06648 171 -----------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP- 220 (285)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-
Confidence 01123478889999999888899999999999999999999999864311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
......+ .................+.+++.+||+.+|++||++.++++
T Consensus 221 --------~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 221 --------LQAMKRI-RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --------HHHHHHH-HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000111 11111111111114467899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.10 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=197.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||.|++|.||+|+. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 35799999999999995 468999999987543 3445678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... ++++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++.+.....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~------ 153 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS------ 153 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc------
Confidence 99988754 389999999999999999999999999999999999999999999999999987653211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......|+..|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 154 ------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~ 203 (274)
T cd06609 154 ------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203 (274)
T ss_pred ------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence 01123478889999999988899999999999999999999999964321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .. ............... .....+.+++.+||..+|++||+++++++.
T Consensus 204 ~---------~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 204 M---------RV-LFLIPKNNPPSLEGN-KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred H---------HH-HHHhhhcCCCCCccc-ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 00 111111111111111 134578899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.79 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=198.1
Q ss_pred ceeccccCceEEEEEEeCC-----CcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLED-----GTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||.|+||.||++...+ +..||+|.+...... ..+.+..|++++++++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 3579999999999999543 488999999766443 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++...... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 84 EGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred CCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999998765432 18999999999999999999999999999999999999999999999999988765331100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
. ....++..|+|||.+.+..++.++||||+|+++|||++ |+.||
T Consensus 161 ~-----------------------------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 161 K-----------------------------------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred c-----------------------------------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 0 01126778999999988889999999999999999998 77777
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
..... ....+....... .......+.++.+++.+|+..||++|||+.|+++.|
T Consensus 206 ~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 206 PGMSN----------EEVLEYLKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCH----------HHHHHHHhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 54211 111111111111 111222456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.15 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=195.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|+||.||++... +++.||+|.+... .......+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 357999999999999964 7899999998754 33345678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|..++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 86 l~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----- 158 (286)
T cd06622 86 LDKLYAGGVAT--EGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----- 158 (286)
T ss_pred HHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-----
Confidence 99888764211 248999999999999999999997 6999999999999999999999999999876532110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC------CCCCchhhHHHHHHHHHHHhCCc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI------KPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~sDvwSlGvil~elltG~~ 710 (791)
....|+..|+|||.+.+. .++.++|||||||++|||++|+.
T Consensus 159 ---------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 159 ---------------------------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred ---------------------------------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 112377889999998553 34889999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||...... ............. ..........+.+++.+||+.+|++||+++++++.
T Consensus 206 pf~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 206 PYPPETYA----------NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCcchh----------hHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 98543111 0111111111111 11222356778899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.39 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=198.4
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCc------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENS------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
....||+|++|.||++. ..+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 34689999999999998 4678999999986532 1234678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDT 630 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 630 (791)
|+++++|.+++.... ++++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||.+.......
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 84 WMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred ccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999987643 388999999999999999999999999999999999998776 59999999988765321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.
T Consensus 159 ~~~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 159 TGAG--------------------------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred ccCC--------------------------------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence 1000 01112347889999999988889999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||...... ............ ......+......+.+++.+|+..+|++||++.|+++
T Consensus 207 p~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 207 PWNAEKHS------NHLALIFKIASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCCc------chHHHHHHHhcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 98543211 000011111110 1111222335678889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.67 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=195.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 46899999999999995 468999999986532 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..+..++.|++.||+|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 86 GELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999987653 3899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 155 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 155 ---------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred ---------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 01234788899999998888899999999999999999999998643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
.. .........+...........+.+++.+||..||.+|+ +++|+++
T Consensus 202 ~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 202 NP-------------IQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CH-------------HHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 20 01111111122222222456788999999999999999 6676653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.13 Aligned_cols=255 Identities=18% Similarity=0.198 Sum_probs=190.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 45799999999999985 468999999986542 2223467789999999999999999999999999999999996 58
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 90 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------ 159 (301)
T cd07873 90 LKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK------ 159 (301)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC------
Confidence 9888765432 388999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 ------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112236788999999865 457889999999999999999999986532
Q ss_pred cCCCCcchh------chhHHHHHHHHhhhc--Ccc---------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVE------DKNRAIRLADAAIRA--DFE---------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~------~~~~~~~~~~~~~~~--~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+. .......+....... .++ ........+.+++.+|++.||.+|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 210 VEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110000000 000000000000000 000 00112446789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.05 Aligned_cols=246 Identities=21% Similarity=0.285 Sum_probs=191.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 551 (791)
.++||+|+||.||++.. .+++.||||.+... .....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 56899999999999995 56899999988532 122346788999999999999999999988764 45789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999887543 278899999999999999999999999999999999999999999999999886532110
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 162 ~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 162 SG---------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred cc---------------------------------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 00 011123488899999999888899999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|.+... ............ ....+......+.+++.+|+. +|++||+++|+++
T Consensus 209 ~~~~~~---------~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 209 WAEFEA---------MAAIFKIATQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCccch---------HHHHHHHhcCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 854210 001111110000 111223355678889999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.93 Aligned_cols=250 Identities=20% Similarity=0.219 Sum_probs=199.2
Q ss_pred HHHhhhcceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEc----cCce
Q 003847 473 ETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWG----VDEK 546 (791)
Q Consensus 473 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 546 (791)
.+-...+.++||-|-.|.|-.+. ..+|+.+|+|++... ...++|+++--.. .|||||.++++|++ ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 33344456799999999999998 557999999998654 4456778765554 69999999999875 3456
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLE 623 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla 623 (791)
.+|||.|+||.|...+..++.. .+++.++..|++||+.|+.|||+.+|.||||||+|+|... +-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 7999999999999998887654 4999999999999999999999999999999999999964 456899999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+..... ......|-|++|.|||++...+|+..+|+||+||++|
T Consensus 212 K~t~~~-------------------------------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 212 KETQEP-------------------------------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254 (400)
T ss_pred cccCCC-------------------------------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHH
Confidence 865421 1233456899999999999999999999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
-|++|.+||+...+.-. ..+ +......+.+.. +.+.+....++|+.+|..+|.+|.|+.|++..
T Consensus 255 IlLCGyPPFYS~hg~ai----spg-----Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAI----SPG-----MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhhcCCCcccccCCccC----Chh-----HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 99999999987654221 111 111222333332 33456778999999999999999999999863
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.79 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=196.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCC----CchhhHHHHHHHHHHHhccCCCCccceeeEEEccCc--eEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGE----NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE--KLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lv~e~ 552 (791)
.++||+|+|-+||||.. .+|..||--.++. ......++|..|+.+|+.|+|+|||++|.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46899999999999995 4577777433322 244456889999999999999999999999998765 6789999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCeecCCCCCCeEecC-CCCeEEeccCcccccCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--KKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~ 629 (791)
+..|+|..|+.+.+. ++...++.|++||++||.|||+ ..|||||||-+||+|+. .|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 8889999999999999999998 57999999999999975 589999999999987532
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
. .....|||.|||||++. ..|++.+||||||+.++||+|+.
T Consensus 200 ~--------------------------------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 200 H--------------------------------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE 240 (632)
T ss_pred c--------------------------------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence 2 22467999999999998 58999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHH--HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEE--ALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.||..- ....+++.....+..+..-. ..+++.+||.+|+.. .++|||+.|+|+.
T Consensus 241 YPYsEC------------~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 241 YPYSEC------------TNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CChhhh------------CCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 999542 22344555544443322111 235788999999999 8999999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.21 Aligned_cols=242 Identities=20% Similarity=0.232 Sum_probs=186.1
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHH---hccCCCCccceeeEEEccCceEEEEeccC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVI---AKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
+||+|+||.||++.. .+++.||+|.+..... .....+.+|..++ ...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 5689999999865321 1122334444333 33479999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999887543 38999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||..|+|||.+. +..++.++||||+||++|||++|+.||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 ----------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred ----------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 01124889999999986 4568999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
...... ....... ...............+.+++.+||..||++|| +++|+++.
T Consensus 198 ~~~~~~-------~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 198 QHKTKD-------KHEIDRM---TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCCcC-------HHHHHHH---hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 532210 0011111 11111112223556788999999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.86 Aligned_cols=244 Identities=21% Similarity=0.342 Sum_probs=197.4
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
..||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999987655555677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-------- 171 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-------- 171 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--------
Confidence 876542 388999999999999999999999999999999999999999999999998775432110
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~ 719 (791)
......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||......
T Consensus 172 ----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~- 222 (292)
T cd06657 172 ----------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL- 222 (292)
T ss_pred ----------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 011234788899999998888899999999999999999999998543110
Q ss_pred CCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.......................+.+++.+||..+|.+||++.++++.
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 223 ---------KAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ---------HHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111111112222221122245678899999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=306.13 Aligned_cols=250 Identities=17% Similarity=0.224 Sum_probs=186.1
Q ss_pred eccccCceEEEEEEeCCC---cEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVLEDG---TALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 456677776543 3345789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... ....++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~----- 155 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI----- 155 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh-----
Confidence 99998765322 123677788899999999999999999999999999999999999999999997642211000
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-------CCCCCchhhHHHHHHHHHHHhC-C
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-------IKPNPKWDVYSFGVILLELLTG-K 709 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwSlGvil~elltG-~ 709 (791)
.......|+..|+|||++.. ..++.++|||||||++|||+++ .
T Consensus 156 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 206 (268)
T cd05086 156 -----------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206 (268)
T ss_pred -----------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence 00112347888999999743 2457899999999999999975 5
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhh----hcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAI----RADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.||..... ......+..... ..... ......+.+++..|| .+|++||++++|++.|.
T Consensus 207 ~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 207 QPYSHLSD---------REVLNHVIKDQQVKLFKPQLE--LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCH---------HHHHHHHHhhcccccCCCccC--CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 57743211 011111111110 01111 113456778888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.10 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=195.5
Q ss_pred ceeccccCceEEEEEEeC----CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceE
Q 003847 480 AYILGASGSSIMYKAVLE----DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKL 547 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 547 (791)
.++||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 457999999999999843 4689999998754 3344567889999999999999999999886543 237
Q ss_pred EEEeccCCCChhHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 548 IIYDFVPNGSLANARYRKMG-SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
+++||+.+|+|.+++..... .....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~ 163 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccc
Confidence 89999999999988754321 22224789999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
....... ......+++.|++||.+....++.++|||||||++|||+
T Consensus 164 ~~~~~~~----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~ 209 (273)
T cd05074 164 YSGDYYR----------------------------------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209 (273)
T ss_pred cCCccee----------------------------------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHh
Confidence 3221100 001122456799999998888999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+ |+.||...... ......... ............+.+++.+||+.+|++||++.|+++.|+++
T Consensus 210 ~~g~~p~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 210 TRGQTPYAGVENS----------EIYNYLIKG--NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred hCCCCCCCCCCHH----------HHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9 78887543110 011111000 01111122456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.19 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=195.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~~ 555 (791)
.+.||.|++|.||++.. .+++.+|+|.+.... .....++.+|++++++++||||++++++|... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 45899999999999996 468999999987542 23456789999999999999999999998654 367999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 160 (287)
T cd06621 86 GSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---- 160 (287)
T ss_pred CCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc----
Confidence 9999987653321 22488999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 161 ----------------------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 161 ----------------------------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ----------------------------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1123677899999999889999999999999999999999998654
Q ss_pred ccCCCCcchhchhHHHHHHH---HhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLAD---AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... . .......+.. ..+.............+.+++.+||..+|++|||+.|+++
T Consensus 207 ~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 207 GEPPL-G---PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCCC-C---hHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 22100 0 0000111111 1111111111124567899999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.35 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=196.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
....||+|+||.||++.. .+++.+|||.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 356899999999999984 57899999998654 233457889999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++...... .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus 84 ~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--- 157 (256)
T cd08220 84 GTLAEYIQKRCNS---LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--- 157 (256)
T ss_pred CCHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---
Confidence 9999999765432 38999999999999999999999999999999999999855 4589999999886542211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 158 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 158 ----------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred ----------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 1123478889999999988889999999999999999999999854
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... ........... +........+.+++.+||..+|++|||+.|+++.
T Consensus 204 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 204 ANLP-------------ALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CchH-------------HHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 3110 11111111111 1112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.28 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=198.8
Q ss_pred cchHHHhhhcceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCce
Q 003847 470 LELETLLKASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 470 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 546 (791)
.++.++.. -..||.|..|.|++++. .+|..+|||.+.+. +.+..+++...++++.+- ++|+||+.+|||..+...
T Consensus 89 ~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34444443 34699999999999995 56899999999765 555567777888877665 599999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++.||.| ...+..++.+-.+ ++++..+-++...+++||.||.+ ++|+|||+||+|||+|+.|++|+||||++..
T Consensus 167 ~IcMelM-s~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 9999998 3455555554432 48888888999999999999997 7999999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil 702 (791)
+.+.. ..+...|.+.|||||.+. ...|+.++||||||+++
T Consensus 242 lvdSk-------------------------------------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 242 LVDSK-------------------------------------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITL 284 (391)
T ss_pred eeccc-------------------------------------ccccccCCccccCccccCCCCCCccchhhhhhhhccch
Confidence 65432 122345889999999985 35788999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+||.||+.||.....+ -..+..+.+ ...+..+.....+..+++|+..||.+|+.+||...++++.
T Consensus 285 veLaTg~yPy~~c~td--------Fe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 285 VELATGQYPYKGCKTD--------FEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hhhhcccCCCCCCCcc--------HHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 9999999999763211 112233333 2223333333366789999999999999999999998864
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.64 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=195.8
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-----hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-----VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 468999999999999965 78999999985432 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 157 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF-- 157 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc--
Confidence 9999999987543 388999999999999999999999999999999999999999999999999876532210
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....|+..|+|||.+.... ++.++|+||||+++|+|++|+.||
T Consensus 158 -----------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf 202 (258)
T cd06632 158 -----------------------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202 (258)
T ss_pred -----------------------------------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 11234788899999987766 899999999999999999999998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ................ .......+.+++.+||+.+|++||++.++++
T Consensus 203 ~~~~~---------~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 203 SQLEG---------VAAVFKIGRSKELPPI--PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCcH---------HHHHHHHHhcccCCCc--CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 55321 0111111110001111 1124567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.32 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=190.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEE-----ccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYW-----GVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~-----~~~~~~lv~e~ 552 (791)
...||+|+||.||++.. .+++.+|+|++..... ....+.+|+.+++++ +|+||+++++++. ..+..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 35799999999999985 4689999998865322 235688899999999 6999999999884 33568999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++....... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 102 ~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 179 (286)
T cd06638 102 CNGGSVTDLVKGFLKRG-ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL- 179 (286)
T ss_pred cCCCCHHHHHHHhhccC-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC-
Confidence 99999999876533221 2488999999999999999999999999999999999999999999999999886542111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHh
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~ellt 707 (791)
......|++.|+|||++. +..++.++||||+||++|||++
T Consensus 180 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 180 -----------------------------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred -----------------------------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 011224888999999975 3457889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|+.||...... ....... ................+.+++.+||+.||++|||+.|+++.
T Consensus 225 g~~p~~~~~~~---------~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 225 GDPPLADLHPM---------RALFKIP-RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCCCCchh---------HHHhhcc-ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 99998643210 0000000 00000000111123568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.12 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=196.4
Q ss_pred ceeccccCceEEEEEEeCC--CcEEEEEEcCCC----------chhhHHHHHHHHHHHhc-cCCCCccceeeEEEccCce
Q 003847 480 AYILGASGSSIMYKAVLED--GTALAVRRIGEN----------SVDRFRDFETQVRVIAK-LVHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~ 546 (791)
...||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4579999999999999654 789999988532 22234567788888875 7999999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+..
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceee
Confidence 9999999999999987543221 1248999999999999999999996 7899999999999999999999999999876
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~el 705 (791)
..... ......|+..|+|||.+.+..++.++||||||+++|||
T Consensus 164 ~~~~~-------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l 206 (269)
T cd08528 164 KQPES-------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206 (269)
T ss_pred ccccc-------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHH
Confidence 54221 01123478889999999988899999999999999999
Q ss_pred HhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 706 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
++|+.||...... .......+...... . .......+.+++.+||+.||++||++.|+..++++
T Consensus 207 ~~g~~p~~~~~~~---------~~~~~~~~~~~~~~-~-~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 207 CTLQPPFYSTNML---------SLATKIVEAVYEPL-P-EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HhCCCcccccCHH---------HHHHHHhhccCCcC-C-cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 9999998543110 01111111111110 1 11234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.85 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=193.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch----------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV----------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 548 (791)
.+.||+|+||.||+|.. .+|+.||||.++.... ...+.+..|+.++++++|+||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46899999999999984 4689999998853211 113467889999999999999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++++|.+++.... ++++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999887652 389999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--CCCchhhHHHHHHHHHHH
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--PNPKWDVYSFGVILLELL 706 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwSlGvil~ell 706 (791)
.... .......|+..|+|||.+.... ++.++|+||||+++||++
T Consensus 161 ~~~~----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 161 IYDN----------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred cccc----------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 1100 0011234788899999987654 789999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+|+.||..... .....+..........+ ........+.+++.+||..+|++||++++|++.
T Consensus 207 ~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 207 AGRRPWSDEEA---------IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hCCCCCcCcch---------HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 99999853211 00011111111111111 111235678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.79 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=192.4
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||+||++.. .+|+.||+|.+.... ....+.+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468999999986532 22234567899999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~l~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------- 150 (277)
T cd05577 81 KYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------- 150 (277)
T ss_pred HHHHHHcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-------
Confidence 9988765432 389999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 151 ------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 200 (277)
T cd05577 151 ------------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200 (277)
T ss_pred ------------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence 01123677899999998888999999999999999999999998653221
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
.. . ..+..................+.+++.+||+.||++|| ++.++++
T Consensus 201 ~~------~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 201 VE------K---EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cc------H---HHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00 0 11111111111112222456788999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.95 Aligned_cols=261 Identities=19% Similarity=0.232 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46899999999999995 457899999987643 23345788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++...........
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999986643 3899999999999999999999999999999999999999999999999998742211110000
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
..... ............|+..|+|||.+.+..++.++|+|||||++|||++|+.||.+.
T Consensus 161 ~~~~~---------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 161 EGHIE---------------------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccc---------------------cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00000 000000111245788999999998888999999999999999999999998643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCc--c-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADF--E-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
.. .++......... + .....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 220 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 220 TP-------------EELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CH-------------HHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 111111111111 1 111245678899999999999999997777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.88 Aligned_cols=275 Identities=21% Similarity=0.241 Sum_probs=201.7
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchh---hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVD---RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|++|.||+|... +++.||+|.+...... ..+.+..|++++++++|+||+++++.+...+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 457999999999999954 5899999999764322 456788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++............
T Consensus 86 ~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 86 GELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred CCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 999998875432 24899999999999999999999999999999999999999999999999998865432211110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.... ...... .....................||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 163 ~~~~-----~~~~~~--~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 163 ALRK-----GSRRSS--VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccc-----cccccc--ccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 0000 000000 000000000001111223456899999999999888999999999999999999999998643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS----MKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 775 (791)
... .....+..... .++........+.+++.+||..||++||+ ++|+++
T Consensus 236 ~~~---------~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD---------ETFSNILKKEV--TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH---------HHHHHHhcCCc--cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 11111111111 11112124678899999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.29 Aligned_cols=245 Identities=23% Similarity=0.345 Sum_probs=198.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 45799999999999984 56889999998765555557789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~------- 170 (293)
T cd06647 104 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------- 170 (293)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-------
Confidence 9988653 278999999999999999999999999999999999999999999999999875532111
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......|++.|+|||.+.+..++.++||||||+++|++++|+.||......
T Consensus 171 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 171 -----------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred -----------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 011234788899999998888999999999999999999999999653221
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.....+. . ...............+.+++.+||..+|++||++.+++..
T Consensus 222 ~~~~~~~---------~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 222 RALYLIA---------T-NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hheeehh---------c-CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000000 0 0011111222244578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.13 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=191.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEc------cCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWG------VDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~~~~~lv~e 551 (791)
...||.|+||.||+|.. .+++.||+|++..... ...++..|+.+++++ +|+||+++++++.. ....+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 35899999999999995 5689999999865432 346788899999998 79999999999853 356799999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++|+|.+++...... .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 100 FCGAGSVTDLVKNTKGN---ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred eCCCCcHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 99999999988764432 378888999999999999999999999999999999999999999999999876532110
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~ell 706 (791)
......|+..|+|||.+. +..++.++|||||||++|||+
T Consensus 177 ------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~ 220 (282)
T cd06636 177 ------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220 (282)
T ss_pred ------------------------------------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence 011234888999999985 356788999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|+.||.+.... ...... ........ .....+..+.+++.+||..||.+||++.|+++
T Consensus 221 ~g~~p~~~~~~~---------~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 221 EGAPPLCDMHPM---------RALFLI-PRNPPPKL-KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCCCCccccCHH---------hhhhhH-hhCCCCCC-cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999998653211 011111 11101111 11124567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.16 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=191.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 357999999999999965 68999999986432 223356789999999999999999999999999999999999998
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 156 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---- 156 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc----
Confidence 8877654432 3899999999999999999999999999999999999999999999999999876432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||.+.
T Consensus 157 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 157 --------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred --------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 012236778999999876 55789999999999999999999998653
Q ss_pred ccCCCCcchhc-----hhHHHHHHHH------hhhcCc---cc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVED-----KNRAIRLADA------AIRADF---EG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~-----~~~~~~~~~~------~~~~~~---~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........+.. ........+. ...... .. .......+.+++.+||+.+|++||++.|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 21100000000 0000000000 000000 00 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.32 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||++.. .+++.||+|.++.... ...+.+..|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 46899999999999985 4789999999876543 35678999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..|+.|++.||+|||+.||+|+||+|+||++++++.+||+|||++............
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~- 158 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE- 158 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc-
Confidence 9999887643 3788999999999999999999999999999999999999999999999998876432211000
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC---CCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK---PNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 159 -------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~ 207 (264)
T cd06626 159 -------------------------------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207 (264)
T ss_pred -------------------------------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 011234788899999998766 8899999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ....... ........+........+.+++.+||+.+|++||++.|++.
T Consensus 208 ~~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 208 ELDNE--------FQIMFHV-GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcch--------HHHHHHH-hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 43111 0000010 00111111222123567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=324.87 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=212.6
Q ss_pred hcceeccccCceEEEEEEe-CCC----cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 478 ASAYILGASGSSIMYKAVL-EDG----TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
....+||+|+||+||+|.+ ..| -+||+|++... ......++..|+-+|.+++|||++++++++.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999983 333 47999998664 4455688999999999999999999999998765 789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
||+.|+|.++++.++. .+-....+.|..|||+||.|||++++|||||-..|||+..-..+||.|||+++.+..+..
T Consensus 778 ~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999988764 378889999999999999999999999999999999999999999999999999876654
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 710 (791)
....... .-.+.|||=|.+....|+.++|||||||++||++| |..
T Consensus 854 ey~~~~g----------------------------------K~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 854 EYSAPGG----------------------------------KVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred ccccccc----------------------------------ccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC
Confidence 3222111 12345999999999999999999999999999998 888
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCCCc
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYL 788 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p~~ 788 (791)
||.+...+.+...++... ..+.+.....+++.++.+||..|++.||+++++...+.++...|.-|+
T Consensus 900 Py~gi~~~eI~dlle~ge------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl 965 (1177)
T KOG1025|consen 900 PYDGIPAEEIPDLLEKGE------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL 965 (1177)
T ss_pred ccCCCCHHHhhHHHhccc------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence 987653333322222221 133444477889999999999999999999999999998877765553
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=304.88 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=198.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|++|.||++... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++++||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 357999999999999964 68999999987653 3445678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+.........
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 157 (265)
T cd06605 86 LDKILKEVQG----RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---- 157 (265)
T ss_pred HHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----
Confidence 9999876531 48999999999999999999999 99999999999999999999999999998765321100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 158 ----------------------------------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 158 ----------------------------------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred ----------------------------------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 1347788999999999899999999999999999999999986532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCc-cchH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADF-EGKE-EALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... ...+..+....... .... .....+.++|.+||..||++|||+.++++.
T Consensus 204 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 204 DPPD--------GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cccc--------cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1100 01111221111111 1111 145678899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.21 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=194.1
Q ss_pred ceeccccCceEEEEEEeC---CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE---DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 551 (791)
...||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 357999999999999954 47999999997632 33346678899999999999999999999988 78999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC----CCCeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN----DMEPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~----~~~~kL~DFGla~~~~ 627 (791)
|+++ +|.+++..........+++..++.++.|++.||+|||+.+|+||||||+||+++. ++.+||+|||++....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~ 163 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence 9964 6777665443322235899999999999999999999999999999999999999 8999999999988654
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ell 706 (791)
..... ........++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 164 ~~~~~---------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 164 APLKP---------------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred CCccc---------------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 32110 001123457888999998866 45789999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHH------------------------HhhhcCcc--chH-------HHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLAD------------------------AAIRADFE--GKE-------EALLSCF 753 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~--~~~-------~~~~~l~ 753 (791)
+|+.||....................++. ......++ ... .....+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 99999975433221000000000010000 00000000 000 1234688
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 003847 754 KLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+++.+|++.||++|||+.|+++.
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.65 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhc--cCCCCccceeeEEEccC----ceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAK--LVHPNLVRIRGFYWGVD----EKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lv~e~~ 553 (791)
.+.||+|.||.||+|.++ |+.||||++..... +.+.+|.+|.+. |+|+||+.+++.-..++ +.|||++|.
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 468999999999999996 89999999976533 456777777775 59999999998755433 579999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--------CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--------KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
+.|||+||+.+.. ++.+..++++..+|.||+|||. ..|.|||||+.|||+..++.+.|+|+|+|..
T Consensus 292 e~GSL~DyL~r~t------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRNT------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhcc------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 9999999998853 8999999999999999999996 4699999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC----C--CCchhhHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK----P--NPKWDVYSFG 699 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~--~~~sDvwSlG 699 (791)
...+...... .....+||..|||||++...- + -..+||||||
T Consensus 366 h~~~t~~idi--------------------------------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 366 HDSDTDTIDI--------------------------------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG 413 (513)
T ss_pred ecccCCcccC--------------------------------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence 6654322211 123456999999999996421 1 2368999999
Q ss_pred HHHHHHHhC----------CcchhccccCCCCcchhchhHHHHHHHHhhhcCcc---chHHHHHHHHHHHhhccCCCCCC
Q 003847 700 VILLELLTG----------KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE---GKEEALLSCFKLGYSCASPLPQK 766 (791)
Q Consensus 700 vil~elltG----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~ 766 (791)
.|+||+... +.||++-..... ..+++... +-...+++..+ ...+....+.++++.||..+|..
T Consensus 414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--s~eeMrkV--VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 414 LVLWEIARRCESGGIVEEYQLPYYDVVPSDP--SFEEMRKV--VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred HHHHHHHHHhhcCCEehhhcCCcccCCCCCC--CHHHHhcc--eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence 999998763 236655322211 11111110 11122222222 12336678899999999999999
Q ss_pred CCCHHHHHHHhccCCCC
Q 003847 767 RPSMKEALQALEKIPSS 783 (791)
Q Consensus 767 RPs~~evl~~L~~i~~~ 783 (791)
|.|+-.+.+.|.++..+
T Consensus 490 RltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 490 RLTALRIKKTLAKLSNS 506 (513)
T ss_pred hhHHHHHHHHHHHHhcC
Confidence 99999999999887643
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.80 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=191.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC-----ceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD-----EKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-----~~~lv~e~ 552 (791)
...||+|+||.||++.. .+++.+|+|++..... ....+.+|+.+++++ +||||+++++++...+ ..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 35799999999999995 5789999999865422 235678899999999 8999999999987543 57999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++...... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.........
T Consensus 106 ~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 184 (291)
T cd06639 106 CNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184 (291)
T ss_pred CCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc
Confidence 9999999988653221 124899999999999999999999999999999999999999999999999998765421110
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-----CCCCchhhHHHHHHHHHHHh
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-----KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~~sDvwSlGvil~ellt 707 (791)
.....|+..|+|||.+... .++.++|||||||++|||++
T Consensus 185 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 185 ------------------------------------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred ------------------------------------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 0122478889999998543 36889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|+.||..... .......... ..............+.+++.+||+.+|++||++.|+++.
T Consensus 229 g~~p~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 229 GDPPLFDMHP---------VKTLFKIPRN-PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCCcH---------HHHHHHHhcC-CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 9999854311 0111111100 011111122244578899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.69 Aligned_cols=248 Identities=22% Similarity=0.259 Sum_probs=196.9
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 554 (791)
...||.|+||.||++. ..+++.||+|.+... .....+.+..|++++++++|+||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 3579999999999998 457899999998653 33345678899999999999999999998764 345789999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH-----EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-----~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
+++|.+++...... ..++++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 99999998764321 225899999999999999999999 899999999999999999999999999998876432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 164 ~~~------------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 164 SSF------------------------------------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred ccc------------------------------------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 110 11234788899999999888999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.||..... ....+......... ........+.+++.+|++.+|++||++++|++.
T Consensus 208 ~p~~~~~~----------~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 208 PPFTARNQ----------LQLASKIKEGKFRR--IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CcccCcCH----------HHHHHHHhcCCCCC--CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99865321 01111111111111 122355788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.48 Aligned_cols=242 Identities=17% Similarity=0.220 Sum_probs=194.5
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||.|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999954 58999999986532 23446789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc-------
Confidence 99987653 289999999999999999999999999999999999999999999999999886643210
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....+
T Consensus 149 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 149 ------------------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred ------------------------------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 01224788899999998888999999999999999999999999654210
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
............ .....+......+.+++.+||..+|++||+ ++|+++
T Consensus 199 -------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 199 -------PMEIYNDILKGN--GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -------HHHHHHHHhccC--CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011111111111 111122223568899999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.53 Aligned_cols=253 Identities=21% Similarity=0.214 Sum_probs=188.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 35799999999999995 478999999986532 2223567789999999999999999999999999999999996 5
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..++.++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 155 (284)
T cd07839 84 DLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---- 155 (284)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC----
Confidence 78877665332 3899999999999999999999999999999999999999999999999998755321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....++..|+|||++.+. .++.++|||||||++|||+||+.|+...
T Consensus 156 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 156 --------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred --------------------------------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 1122367889999998764 4689999999999999999999986432
Q ss_pred ccCCCCcchhc---------hh---HHHHHHHHhhhcCccc-------hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVED---------KN---RAIRLADAAIRADFEG-------KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... ..... .. ......+......... .......+.+++.+||+.||.+|||++|+++
T Consensus 204 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 204 NDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1100 00000 00 0000000000000000 0113456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.97 Aligned_cols=244 Identities=21% Similarity=0.318 Sum_probs=196.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 345799999999999985 568999999986542 334567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++... .+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 999987642 389999999999999999999999999999999999999999999999999876532110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 157 -------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 157 -------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred -------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 0112347888999999988888999999999999999999999985421
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ............. ........+.+++.+||..+|++||++.++++.
T Consensus 206 ~~----------~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 206 PM----------KVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hH----------HHHHHHhcCCCCC--CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 10 0011111111111 112245678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=293.59 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=202.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-.+||+|.||.|-.++ ..+|+.+|+|+++++. .+....-..|-++|+..+||.+..+.-.|+..+..|+||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 3589999999999999 6689999999998753 33344556788999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.|.-++.+... +++...+-+-..|+.||.|||+++||.||||.+|.|+|.+|.+||+|||+++.--..
T Consensus 253 GeLf~HLsrer~-----FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~------ 321 (516)
T KOG0690|consen 253 GELFFHLSRERV-----FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY------ 321 (516)
T ss_pred ceEeeehhhhhc-----ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc------
Confidence 999888776543 888888999999999999999999999999999999999999999999999853211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
...++.+||||.|.|||++....|+.++|.|.+|||+|||++|+.||+..
T Consensus 322 ------------------------------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 ------------------------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ------------------------------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 12455789999999999999999999999999999999999999999754
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
. . ..++.-.+......+.....+...|+..+|..||.+|. .++||.+
T Consensus 372 d----------h---~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 372 D----------H---EKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred c----------h---hHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2 2 22333334444445555677888899999999999995 4555543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.11 Aligned_cols=250 Identities=22% Similarity=0.248 Sum_probs=192.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh-----hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD-----RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...||+|++|.||+|.. .+|+.||||.+...... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 45799999999999995 46899999999764322 2345778999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+++|.+++.... ..+++..+..++.||++||+|||+.||+|+||||+||+++.++.+||+|||+++........
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 899999887643 13899999999999999999999999999999999999999999999999999876432110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....++..|+|||.+.+ ..++.++|||||||++|||++|.++|
T Consensus 159 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~ 203 (298)
T cd07841 159 -----------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203 (298)
T ss_pred -----------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence 011236778999998854 46789999999999999999997777
Q ss_pred hccccCCCCcchhchhHHHHHH---------------HHhh---hcCcc---chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLA---------------DAAI---RADFE---GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~---~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
....... ......... +... ....+ ........+.+++.+||+.||++|||++
T Consensus 204 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 277 (298)
T cd07841 204 PGDSDID------QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277 (298)
T ss_pred cCCccHH------HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH
Confidence 5432100 000000000 0000 00000 0011346788999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 278 e~l~~ 282 (298)
T cd07841 278 QALEH 282 (298)
T ss_pred HHhhC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.77 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=189.4
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc----------------
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG---------------- 542 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------------- 542 (791)
.+||+||||.|||++ .-||+.||||+|.-. +......+.+|++.|.+|+|||||+++..|.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 489999999999999 448999999999765 33345678899999999999999999865420
Q ss_pred -------------------------------------------------c------------------------------
Q 003847 543 -------------------------------------------------V------------------------------ 543 (791)
Q Consensus 543 -------------------------------------------------~------------------------------ 543 (791)
.
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Q 003847 544 ------------------------DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599 (791)
Q Consensus 544 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivH 599 (791)
-..||-||||+..+|.+++.++... -.....++++++|++||.|+|+.||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH~~giIH 720 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIHDQGIIH 720 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHHhCceee
Confidence 0137899999998888888776421 035678999999999999999999999
Q ss_pred cCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCccc
Q 003847 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH 679 (791)
Q Consensus 600 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 679 (791)
|||||.||++|++..|||+|||+|+............. ..............+..+||..|+
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~------------------~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL------------------SFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc------------------CccccccCCCCcccccccceeeee
Confidence 99999999999999999999999987431100000000 000001112223566788999999
Q ss_pred CcccccCC---CCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHH
Q 003847 680 APESLRSI---KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLG 756 (791)
Q Consensus 680 APE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 756 (791)
|||++.+. .|+.|+|+||+|||++||+. ||...++ ....+..+-+..+........+....-.++|
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHHHHhcccCCCCCCcccccccchHHHHHH
Confidence 99999764 49999999999999999986 5644311 1111111112222111111122344556899
Q ss_pred hhccCCCCCCCCCHHHHHHH
Q 003847 757 YSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 757 ~~cl~~dP~~RPs~~evl~~ 776 (791)
+.|++.||.+||||.|+|+.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999863
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.01 Aligned_cols=257 Identities=24% Similarity=0.301 Sum_probs=193.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|+||+++++++......++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 46799999999999995 478999999987643 333467899999999999999999999999999999999999 99
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---- 155 (286)
T cd07832 84 DLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR---- 155 (286)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC----
Confidence 99998875442 4899999999999999999999999999999999999999999999999998865432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||.+.+. .++.++||||+|+++|||++|+++|...
T Consensus 156 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 156 -------------------------------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -------------------------------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 01123488889999998654 4689999999999999999998777543
Q ss_pred ccCCCCcch--------hchhH-HHHHHH--Hh-hhcCc-----cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLV--------EDKNR-AIRLAD--AA-IRADF-----EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~--------~~~~~-~~~~~~--~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
........+ ...+. ..++.+ .. ..... ....+....+.+++.+|+..+|++||+++++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 205 NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 210000000 00000 000000 00 00000 0001134678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.78 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=197.4
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 499999999976533 3456788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++..+..++.||+.||+|||+.+++||||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~---- 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL---- 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc----
Confidence 99987643 389999999999999999999999999999999999999999999999999875432211000
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
...........++..|+|||......++.++||||||+++|||++|+.||.....
T Consensus 152 ------------------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~- 206 (265)
T cd05579 152 ------------------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP- 206 (265)
T ss_pred ------------------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-
Confidence 0000111234477889999999888889999999999999999999999854321
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHH--HHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEA--LLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.................. ...+.+++.+||+.+|++|||+.++.+.|+
T Consensus 207 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 207 ------------EEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------------HHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111111111122222212 577899999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.10 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||.|+||.||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 46799999999999994 468899999997542 3355789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++....... .+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+|||++..+........
T Consensus 86 l~~~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~--- 160 (267)
T cd06610 86 LLDIMKSSYPRG--GLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR--- 160 (267)
T ss_pred HHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc---
Confidence 999987653211 389999999999999999999999999999999999999999999999999887653321100
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.......|+..|+|||++... .++.++|+|||||++|||++|+.||....
T Consensus 161 -----------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 161 -----------------------------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred -----------------------------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 011234588899999998776 78999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccc---hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEG---KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ........ ....... .......+.+++.+||..||++||++.++++
T Consensus 212 ~~~---------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 212 PMK---------VLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hhh---------hHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 210 00111110 0001111 1124567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.68 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=193.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC------ceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD------EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------~~~lv~e 551 (791)
...||+|++|.||+|.. .+++.+++|++..... ..+.+.+|+++++++ +|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 46899999999999996 4678999999876543 346789999999999 7999999999997654 4799999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++...... ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 168 (275)
T cd06608 90 LCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168 (275)
T ss_pred cCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchh
Confidence 99999999988754311 12489999999999999999999999999999999999999999999999999876532111
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlGvil~ell 706 (791)
......|+..|+|||++.. ..++.++|||||||++|+|+
T Consensus 169 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 169 ------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ------------------------------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 0112348889999998753 34678999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|+.||.+... ......+.. ...............+.+++.+||..||++|||+.|+++
T Consensus 213 ~g~~p~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 213 DGKPPLCDMHP---------MRALFKIPR-NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hCCCCccccch---------HHHHHHhhc-cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999964311 011111111 111111222224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.72 Aligned_cols=241 Identities=19% Similarity=0.231 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-.+||+||||.||-++ ..+|+.+|.|.+.+... ....-..+|-.+|.++..+.||.+--.|+.++..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 3699999999999998 45799999999865422 2234567889999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.-+|+..+.. .+++..++-++.+|+.||++||+.+||.||+||+|||+|+.|+++|+|+|+|..+.....
T Consensus 270 GDLkfHiyn~g~~---gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---- 342 (591)
T KOG0986|consen 270 GDLKFHIYNHGNP---GFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---- 342 (591)
T ss_pred CceeEEeeccCCC---CCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc----
Confidence 9999888877643 399999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||.+|||||++....|+...|.||+||++|||+.|+.||...
T Consensus 343 ---------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 343 ---------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ---------------------------------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 22346999999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
-.. ....++-...+.......+..+.+..+|.+..|..||++|.-
T Consensus 390 KeK---------vk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 390 KEK---------VKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hhh---------hhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111 111122222222222233446678889999999999999963
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.77 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=200.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|++|.||+|... +++.||||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 468999999999999965 599999999876543 446789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++.... .+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 86 L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---- 156 (264)
T cd06623 86 LADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---- 156 (264)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc----
Confidence 999987652 38999999999999999999999 99999999999999999999999999998866432211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 --------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 --------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred --------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 012337788999999998889999999999999999999999986542
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcC-ccchHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRAD-FEGKEE-ALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. . ..+......... ...... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 205 ~~-------~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 205 QP-------S---FFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cc-------C---HHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 10 0 011111111111 111122 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.76 Aligned_cols=262 Identities=20% Similarity=0.219 Sum_probs=190.8
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+|.|+++.||++.. +++.||||++... .....+.+++|++++++++|+||+++++++...+..+++|||+++++|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555555544 6899999998754 3445678999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++...... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||.+............
T Consensus 88 ~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~---- 160 (314)
T cd08216 88 DLLKTHFPE---GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV---- 160 (314)
T ss_pred HHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc----
Confidence 998865332 3889999999999999999999999999999999999999999999999998765422111000
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.........++..|+|||++.. ..++.++|||||||++|||++|+.||.+...
T Consensus 161 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 161 -------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred -------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0011123347788999999875 4588999999999999999999999964311
Q ss_pred CCC---------CcchhchhHHHH----------HHHH--hhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGN---------GLLVEDKNRAIR----------LADA--AIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~---------~~~~~~~~~~~~----------~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
... ...+........ ..+. ...............+.+++.+||..||++|||++++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 216 TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000000000 0000 0000111122244678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.80 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=190.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||.|++|.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 45789999999999985 468999999987542 2233578899999999999999999999999999999999995 6
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++.........
T Consensus 84 ~l~~~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~---- 156 (284)
T cd07860 84 DLKKFMDASPLS---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---- 156 (284)
T ss_pred CHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc----
Confidence 898887654322 4899999999999999999999999999999999999999999999999998765321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....++..|+|||++.+.. ++.++||||||+++|||+||+.||...
T Consensus 157 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 157 --------------------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred --------------------------------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11123678899999887644 588999999999999999999998543
Q ss_pred ccCCCC-cchh-------chh-HHHHHHH--Hhhhc-Cccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNG-LLVE-------DKN-RAIRLAD--AAIRA-DFEG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~-~~~~-------~~~-~~~~~~~--~~~~~-~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
...... .... ... ......+ ..... .... .......+.+++.+||+.||++||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 205 SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 210000 0000 000 0000000 00000 0000 0012356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.28 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=194.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccC---CCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLV---HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 45799999999999994 67899999998754 3334567889999999996 9999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-- 157 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--
Confidence 99999987543 3899999999999999999999999999999999999999999999999998866432210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 158 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 158 ----------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred ----------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 112348888999999865 456899999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
......... ............ ......+.+++.+||+.||++||++.|+++.
T Consensus 204 ~~~~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 204 DVDAFRAMM----------LIPKSKPPRLED-NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCChhhhhh----------ccccCCCCCCCc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 532111000 000000011111 1144678899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.31 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=188.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHH-HhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRV-IAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+++. .+|+.||+|+++... .....++..|+.+ ++.++||||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 45799999999999995 469999999987642 2233455556665 566789999999999999999999999996 6
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++....... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 85 ~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 159 (283)
T cd06617 85 SLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---- 159 (283)
T ss_pred cHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc----
Confidence 8888876543222 3589999999999999999999997 999999999999999999999999999876532110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC----CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS----IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.|
T Consensus 160 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 160 ---------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred ---------------------------------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 011237888999998864 4568899999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|..... ........... .....+ ....+..+.+++.+||..+|++||++.++++
T Consensus 207 ~~~~~~--------~~~~~~~~~~~-~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 207 YDSWKT--------PFQQLKQVVEE-PSPQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcccc--------CHHHHHHHHhc-CCCCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 853211 00111111111 111111 1124567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.60 Aligned_cols=241 Identities=19% Similarity=0.225 Sum_probs=185.7
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHH---HHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQV---RVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
+||+|+||.||++.. .+++.||+|.+..... .....+..|. +.++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 5689999999865321 1112233343 34445689999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++..++.|+.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999998876542 38999999999999999999999999999999999999999999999999987543110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 152 ----------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred ----------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 012248889999999875 468999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
+...... ..............+...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 198 ~~~~~~~----------~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 198 QHKTKDK----------HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCccch----------HHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 5422110 00101111111111222456788999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.41 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=190.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 46799999999999995 46899999998643 23344678899999999999999999999999999999999996
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++.+++..... .+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 99 g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------ 168 (307)
T cd06607 99 GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------ 168 (307)
T ss_pred CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC------
Confidence 577776654332 3899999999999999999999999999999999999999999999999998754311
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
....|+..|+|||++. ...++.++||||||+++|||++|+.||
T Consensus 169 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~ 214 (307)
T cd06607 169 ----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (307)
T ss_pred ----------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 1123777899999874 456889999999999999999999998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...... ......... ..... ........+.+++.+||+.+|++||++.+++..
T Consensus 215 ~~~~~~---------~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 215 FNMNAM---------SALYHIAQN-DSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCccHH---------HHHHHHhcC-CCCCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 543110 001111100 00111 112245678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=306.24 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=195.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+++. .+++.||+|++... .....+.+.+|++++++++|+|++++++++...+..++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 45799999999999994 56899999998643 23344678899999999999999999999999999999999996
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+.+..... ++++.++..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 109 g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------ 178 (317)
T cd06635 109 GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------ 178 (317)
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------
Confidence 578777654432 3899999999999999999999999999999999999999999999999987653211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
....|+..|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 179 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 224 (317)
T cd06635 179 ----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224 (317)
T ss_pred ----------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 1123788899999973 456889999999999999999999998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
.... .......+...... . .........+.+++.+||+.+|.+||++.++++.+-.+...+
T Consensus 225 ~~~~---------~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 225 FNMN---------AMSALYHIAQNESP-T-LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred CCcc---------HHHHHHHHHhccCC-C-CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 5431 01111111111111 1 111224567889999999999999999999998765444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.59 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=188.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||+|++|.||+|..+ +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+. ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 468999999999999954 6899999998654221 22456789999999999999999999999999999999997 48
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~------ 158 (291)
T cd07844 89 LKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK------ 158 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc------
Confidence 9988875432 389999999999999999999999999999999999999999999999999865321110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+..
T Consensus 159 ------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 ------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 0011236778999999875 457899999999999999999999985432
Q ss_pred cCCCCcchhc---------hhHHHHHH--------------HHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 717 GQGNGLLVED---------KNRAIRLA--------------DAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 717 ~~~~~~~~~~---------~~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
... ..+.. ........ ...+....... .....+.+++.+|++.+|++||++.|+
T Consensus 209 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 209 DVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred cHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHH
Confidence 100 00000 00000000 00000000000 012567899999999999999999998
Q ss_pred HH
Q 003847 774 LQ 775 (791)
Q Consensus 774 l~ 775 (791)
++
T Consensus 286 l~ 287 (291)
T cd07844 286 MK 287 (291)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=303.08 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=198.5
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|++|.||++... +++.||+|++..... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 357999999999999965 689999999976544 457788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 103 ~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~------- 171 (286)
T cd06614 103 TDIITQNFV----RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------- 171 (286)
T ss_pred HHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-------
Confidence 999987641 389999999999999999999999999999999999999999999999999865432110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......++..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 172 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 172 -----------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred -----------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 011223778899999998888999999999999999999999998542110
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
........... ............+.+++.+||+.+|.+||++.++++.
T Consensus 223 ---------~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 223 ---------RALFLITTKGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---------HHHHHHHhcCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111111111 1111122245678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=330.44 Aligned_cols=262 Identities=18% Similarity=0.163 Sum_probs=181.7
Q ss_pred cceeccccCceEEEEEEeCC--CcEEEEEEc--------------C---CCchhhHHHHHHHHHHHhccCCCCccceeeE
Q 003847 479 SAYILGASGSSIMYKAVLED--GTALAVRRI--------------G---ENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 539 (791)
....||+|+||.||++..+. +..+++|.+ . .........+++|++++++++|+||++++++
T Consensus 152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 34689999999999987432 222222211 0 0112234568899999999999999999999
Q ss_pred EEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEec
Q 003847 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619 (791)
Q Consensus 540 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~D 619 (791)
+...+..|+|+|++. ++|.+++...............++.|+.||+.||+|||++|||||||||+|||++.++.+||+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999994 6777776544322111244667888999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHH
Q 003847 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699 (791)
Q Consensus 620 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlG 699 (791)
||+++.+...... ......||..|+|||++.+..++.++||||||
T Consensus 311 FGla~~~~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 355 (501)
T PHA03210 311 FGTAMPFEKEREA-----------------------------------FDYGWVGTVATNSPEILAGDGYCEITDIWSCG 355 (501)
T ss_pred CCCceecCccccc-----------------------------------ccccccCCcCCCCchhhcCCCCCcHHHHHHHH
Confidence 9999866422110 01134589999999999999999999999999
Q ss_pred HHHHHHHhCCcc-hhccccCCCCcch--------------hchhHHHHHHHHhhhc-CccchH------HHHHHHHHHHh
Q 003847 700 VILLELLTGKVI-VVDELGQGNGLLV--------------EDKNRAIRLADAAIRA-DFEGKE------EALLSCFKLGY 757 (791)
Q Consensus 700 vil~elltG~~p-f~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~-~~~~~~------~~~~~l~~li~ 757 (791)
|++|||++|+.+ |............ .........++..... ...... .....+.+++.
T Consensus 356 vil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 435 (501)
T PHA03210 356 LILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV 435 (501)
T ss_pred HHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHH
Confidence 999999999864 4322111000000 0000011111100000 000000 01235677899
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 003847 758 SCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 758 ~cl~~dP~~RPs~~evl~~ 776 (791)
+||+.||++|||+.|+++.
T Consensus 436 kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 436 KMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhccCcccCcCHHHHhhC
Confidence 9999999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.77 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=189.0
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+. ++
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-IS 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CC
Confidence 5799999999999994 468999999987542 334567889999999996 9999999999999999999999985 46
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+.++...........+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----- 163 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA----- 163 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-----
Confidence 5554322111111248999999999999999999997 5999999999999999999999999999876532111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC---CCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI---KPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 164 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 164 --------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred --------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 0122378889999999765 68999999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHH---HhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLAD---AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... . .....+... +.+.. ......+..+.+|+.+||+.+|++|||+++|++.
T Consensus 212 ~~~~-----~---~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 212 KWNS-----V---FDQLTQVVKGDPPILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcch-----H---HHHHhhhcCCCCCcCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4310 0 000111110 01111 1111245678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.97 Aligned_cols=243 Identities=19% Similarity=0.228 Sum_probs=187.7
Q ss_pred eccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHH-hccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVI-AKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.||+|+||.||+|.. .+++.||||.+..... .....+..|..++ ...+|+||+++++++...+..|+|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 589999999999985 4689999999875432 2223445555544 4558999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------- 150 (260)
T cd05611 83 DCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------- 150 (260)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-------
Confidence 9999887643 3899999999999999999999999999999999999999999999999998753210
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
....|+..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 151 ---------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 151 ---------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred ---------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 01237778999999988888999999999999999999999985431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
.. ........................+.+++.+||+.+|++||++.++.+.|+
T Consensus 198 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 198 PD---------AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HH---------HHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 10 000111110100000111124567899999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.06 Aligned_cols=244 Identities=22% Similarity=0.235 Sum_probs=197.0
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 3568999999999999964 68999999997542 2345788999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... ++++..+..++.|+++||+|||+.+++|+||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 155 (258)
T cd05578 84 GGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--- 155 (258)
T ss_pred CCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---
Confidence 999999887652 389999999999999999999999999999999999999999999999999876542210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 156 ----------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 156 ----------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred ----------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 0122377889999999888899999999999999999999999865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM--KEAL 774 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 774 (791)
..... .......... .....+...+..+.+++.+||..||.+||++ +|++
T Consensus 202 ~~~~~-------~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 202 HSRTI-------RDQIRAKQET---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCccH-------HHHHHHHhcc---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 43210 0011111110 1112222355788999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=295.18 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=200.1
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++...+..++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 468999999999999964 6899999999876555667899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~------- 153 (253)
T cd05122 85 KDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA------- 153 (253)
T ss_pred HHHHhhcCC----CCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-------
Confidence 998876531 389999999999999999999999999999999999999999999999999876643211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 154 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~- 202 (253)
T cd05122 154 ------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP- 202 (253)
T ss_pred ------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-
Confidence 1123478889999999888899999999999999999999999854311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
....... .................+.+++.+||+.||++|||+.|+++.
T Consensus 203 --------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 203 --------MKALFKI-ATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --------HHHHHHH-HhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011111 111111111111125678999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.18 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=195.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||++.. .+|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 46899999999999995 468999999986532 233467889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++...... .+++..+..++.|++.||+|||+.+++|+||||+||++++++ .+||+|||.+.........
T Consensus 85 ~L~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--- 158 (257)
T cd08225 85 DLMKRINRQRGV---LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--- 158 (257)
T ss_pred cHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc---
Confidence 999988764322 379999999999999999999999999999999999999875 4699999998765422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 159 ---------------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 159 ---------------------------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred ---------------------------------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11234788899999998888999999999999999999999998542
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .............. ........+.+++.+|+..+|++|||+.|+++.
T Consensus 206 ~~---------~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 206 NL---------HQLVLKICQGYFAP---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cH---------HHHHHHHhcccCCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 10 00111111111111 111234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.94 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=191.8
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 468999999999999965 58999999986532 223457889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.++..... .+++..++.++.|++.||+|||+.+++||||+|+||++++++.++|+|||++..+.....
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~----- 155 (286)
T cd07846 86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----- 155 (286)
T ss_pred HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-----
Confidence 8887655432 389999999999999999999999999999999999999999999999999876532211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 156 -------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred -------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 0112347888999999875 45788999999999999999999888543
Q ss_pred ccCC--------CCcchhchhHHH---HHHHHhhhcCcc-------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQG--------NGLLVEDKNRAI---RLADAAIRADFE-------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... ............ .+.+........ ........+.+++.+||+.+|++||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 2100 000000000000 000000000000 00113467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.69 Aligned_cols=263 Identities=21% Similarity=0.252 Sum_probs=191.3
Q ss_pred ecccc--CceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGAS--GSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.||+| +||+||++.. .+|+.||+|++... .....+.+++|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 8999999995 57999999998753 2334577899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|++||+.+............
T Consensus 85 ~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~- 160 (328)
T cd08226 85 SANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV- 160 (328)
T ss_pred CHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc-
Confidence 999988765432 3899999999999999999999999999999999999999999999999876543221110000
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 161 ----------------------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ----------------------------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0000011225667999999976 3478999999999999999999999864
Q ss_pred cccCCCC--------------cchhchhHHH-----H----HHHHhhh-----------cCccchHHHHHHHHHHHhhcc
Q 003847 715 ELGQGNG--------------LLVEDKNRAI-----R----LADAAIR-----------ADFEGKEEALLSCFKLGYSCA 760 (791)
Q Consensus 715 ~~~~~~~--------------~~~~~~~~~~-----~----~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl 760 (791)
....... .......... . +.+.... ...+........+.+|+.+||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 292 (328)
T cd08226 213 MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292 (328)
T ss_pred cChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence 3210000 0000000000 0 0000000 001112235567899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 003847 761 SPLPQKRPSMKEALQA 776 (791)
Q Consensus 761 ~~dP~~RPs~~evl~~ 776 (791)
..||++|||++|+++.
T Consensus 293 ~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 293 QQDPEKRPSASSLLSH 308 (328)
T ss_pred cCCcccCCCHHHHhhC
Confidence 9999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.29 Aligned_cols=196 Identities=27% Similarity=0.380 Sum_probs=168.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEEe
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~e 551 (791)
.+.||+|+||.||+++ .++|+.||||.+.... ....+..-+|+++|++++|+|||+++++-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3589999999999999 6789999999998753 333466789999999999999999999865544 4589999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec--CCC--CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG--NDM--EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~--~~~--~~kL~DFGla~~~~ 627 (791)
||.+|+|...+..-.+.. .+++.+.+.++.+++.||.|||++|||||||||.||++- ++| ..||+|||.|+.+.
T Consensus 98 yC~gGsL~~~L~~PEN~~--GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAY--GLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred ecCCCcHHHHhcCccccc--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 999999999987654433 499999999999999999999999999999999999983 334 36999999999876
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~ell 706 (791)
++. ...+++||..|.+||.+. .+.|+..+|.|||||++||.+
T Consensus 176 d~s-------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 176 DNS-------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred CCC-------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh
Confidence 433 234567999999999998 488999999999999999999
Q ss_pred hCCcchhc
Q 003847 707 TGKVIVVD 714 (791)
Q Consensus 707 tG~~pf~~ 714 (791)
||..||..
T Consensus 219 TG~lPF~p 226 (732)
T KOG4250|consen 219 TGELPFIP 226 (732)
T ss_pred ccCCCCCc
Confidence 99999854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.32 Aligned_cols=259 Identities=13% Similarity=0.118 Sum_probs=181.4
Q ss_pred ceeccccCceEEEEEEeCC----CcEEEEEEcCCCchhhH-----------HHHHHHHHHHhccCCCCccceeeEEEccC
Q 003847 480 AYILGASGSSIMYKAVLED----GTALAVRRIGENSVDRF-----------RDFETQVRVIAKLVHPNLVRIRGFYWGVD 544 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 544 (791)
.++||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+||+++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 4689999999999999543 45667776433221110 11223344556778999999999766543
Q ss_pred ----ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEecc
Q 003847 545 ----EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620 (791)
Q Consensus 545 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DF 620 (791)
..++++|++. .++.+.+.... ..++..+..|+.|++.||+|||+.+|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 97 CRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred CCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 3467888874 46666655432 2678889999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHH
Q 003847 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGV 700 (791)
Q Consensus 621 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGv 700 (791)
|+++........... .........||+.|+|||+..+..++.++|||||||
T Consensus 171 Gla~~~~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~ 221 (294)
T PHA02882 171 GIASHFIIHGKHIEY-----------------------------SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGY 221 (294)
T ss_pred CCceeeccCCccccc-----------------------------ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHH
Confidence 999876432111000 001112345999999999999999999999999999
Q ss_pred HHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 003847 701 ILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778 (791)
Q Consensus 701 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 778 (791)
++|||++|+.||........ .+... ..++......+.... ...+..+.+++..|+..+|++||++.++++.|+
T Consensus 222 ~l~el~~g~~P~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGN--LIHAA--KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhCCCCCCccccchH--HHHHh--HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 99999999999965422111 00000 011111111111111 113467889999999999999999999998774
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.70 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred ceeccccCceEEEEEEeC--CC--cEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE--DG--TALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.++||+|.||+|++|.+. +| ..||||.++.+... ...+|.+|+.+|.+|+|+|+++|||+..+ ....+|||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 358999999999999964 23 57999999876544 67899999999999999999999999887 67889999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
.|+|.+.++... +. .|.......++.|||.|+.||.++++|||||-..|+|+-....+||+|||+.+-+...+....
T Consensus 194 lGSLldrLrka~-~~--~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK-KA--ILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhcc-cc--ceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999998732 22 488889999999999999999999999999999999999888999999999998876554322
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC-Ccchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG-KVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG-~~pf~ 713 (791)
.... ..-...|.|||.++...++.++|||+|||++|||+|+ ..||.
T Consensus 271 m~p~---------------------------------rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 271 MAPQ---------------------------------RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred ecCC---------------------------------CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 1111 0123459999999999999999999999999999994 45876
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
+-.+. .+.+.+|. ....+.++.++.++++++..||..+|++|||+..|.+.+
T Consensus 318 G~~g~----------qIL~~iD~--~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 318 GCRGI----------QILKNIDA--GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCHH----------HHHHhccc--cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 54221 12222331 122344455788999999999999999999999997543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.63 Aligned_cols=260 Identities=19% Similarity=0.191 Sum_probs=189.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCc-----eEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDE-----KLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~-----~~lv 549 (791)
....||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++ |+||+++++++...+. .|+|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 346899999999999995 468999999986542 223357888999999995 6999999999987666 7999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTG 628 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~ 628 (791)
|||+++ +|.+++..........+++..++.++.||+.||+|||+.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 999975 8988887654322235899999999999999999999999999999999999998 88999999999875532
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
... ......+++.|+|||++.+ ..++.++||||||+++|||++
T Consensus 164 ~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 164 PVK------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred Ccc------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 110 0111236778999998865 457899999999999999999
Q ss_pred CCcchhccccCCCCc-chh-----chh---HHHHHHHHhhhcCcc------chHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 708 GKVIVVDELGQGNGL-LVE-----DKN---RAIRLADAAIRADFE------GKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 708 G~~pf~~~~~~~~~~-~~~-----~~~---~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
|+.||.......... ... ... ......+........ ........+.++|.+||..||.+||+++|
T Consensus 208 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 208 KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 999986432100000 000 000 000000000000000 00123466889999999999999999999
Q ss_pred HHH
Q 003847 773 ALQ 775 (791)
Q Consensus 773 vl~ 775 (791)
++.
T Consensus 288 il~ 290 (295)
T cd07837 288 ALT 290 (295)
T ss_pred Hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=303.40 Aligned_cols=253 Identities=20% Similarity=0.219 Sum_probs=187.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|++++++++|+||+++++++...+..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 35799999999999984 56899999998654322 23467789999999999999999999999999999999995 67
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~------ 158 (291)
T cd07870 89 LAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ------ 158 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC------
Confidence 7776654322 378888999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 ------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 0112236788999999875 357889999999999999999999986432
Q ss_pred cCCCCcchhchhH---------------HHHHHHHhhhcCccc-------hHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 717 GQGNGLLVEDKNR---------------AIRLADAAIRADFEG-------KEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 717 ~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
.. ...+.+... ............... .......+.+++.+|+..||++|||++|++
T Consensus 209 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 209 DV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 10 000000000 000000000000000 001235678899999999999999999987
Q ss_pred H
Q 003847 775 Q 775 (791)
Q Consensus 775 ~ 775 (791)
.
T Consensus 287 ~ 287 (291)
T cd07870 287 L 287 (291)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.32 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=194.2
Q ss_pred ceeccccCceEEEEEEeCC-----CcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLED-----GTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e 551 (791)
...||+|.||.||+|...+ ...+|+|+++.... .......+|+.+++.++||||+.+..+|.. +...++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 3469999999999996322 24799999976421 123457889999999999999999999887 778899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC----CCeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND----MEPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~~ 627 (791)
|.+. +|.+.++.........++...++.|+.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||+++.+.
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~ 187 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFN 187 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence 9975 89998887665554579999999999999999999999999999999999999877 999999999999886
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ell 706 (791)
....... .....+-|.-|+|||.+.+ ..||++.||||+|||+.||+
T Consensus 188 ~plkpl~---------------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 188 NPLKPLA---------------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred ccccccc---------------------------------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 4432111 1223457888999999987 56899999999999999999
Q ss_pred hCCcchhccccCCCCc---chhchhHHHHHH---------------------HHhhhcCccc---------hHHHHHHHH
Q 003847 707 TGKVIVVDELGQGNGL---LVEDKNRAIRLA---------------------DAAIRADFEG---------KEEALLSCF 753 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~---~~~~~~~~~~~~---------------------~~~~~~~~~~---------~~~~~~~l~ 753 (791)
|-++.|.......... ......++.++. .......+.. .........
T Consensus 235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~ 314 (438)
T KOG0666|consen 235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSAL 314 (438)
T ss_pred ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHH
Confidence 9998876533211111 011111111110 0000000000 000112367
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 003847 754 KLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+|+.++|..||.+|.|+++.++.
T Consensus 315 ~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 315 DLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHhccCchhhccHHHHhcc
Confidence 89999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=288.52 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=194.4
Q ss_pred ccchHHHhhhcceeccccCceEEEEEE-eCCCcEEEEEEcCCCch-hhHHHHHHHHHHHhcc-CCCCccceeeEEEccCc
Q 003847 469 ELELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSV-DRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDE 545 (791)
Q Consensus 469 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 545 (791)
.|+-+++.. ...||.|+||+|+|.. .+.|+.+|||++..... ...+++..|.+...+- +.||||++||.+..++.
T Consensus 60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 344444433 3469999999999998 45799999999987644 4567788888865554 79999999999999999
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
.|+.||+| ..+|..+-..........+++...-.|..-.+.||+||-+ ..||||||||+|||+|..|.+||||||++.
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999999 4576554332211112248999999999999999999997 799999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc--CCCCCCchhhHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR--SIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwSlGvil 702 (791)
.+..... .+...|...|||||.+. +..|+-++||||||++|
T Consensus 217 qLv~SiA-------------------------------------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL 259 (361)
T KOG1006|consen 217 QLVDSIA-------------------------------------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL 259 (361)
T ss_pred hHHHHHH-------------------------------------hhhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence 7653321 22334788899999995 34589999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCcc---ch---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE---GK---EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||+.||+.||..- . ...+-+.....++.+ .. .+....+.+++..|+.+|-..||...++++.
T Consensus 260 ~EvAtG~fPyr~w----~--------svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 260 YEVATGNFPYRKW----D--------SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eeeecCCCCcchH----H--------HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 9999999998542 1 111111111222211 11 2256788999999999999999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=297.47 Aligned_cols=234 Identities=17% Similarity=0.212 Sum_probs=183.5
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCChhH
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 560 (791)
||+|+||.||++.. .+++.+|+|.+....... . |+.....+ +|+||+++++++...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 79999999999994 578999999986542221 1 22222222 79999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCcCCCCc
Q 003847 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 561 ~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
++.... .+++.++..++.|+++||+|||+.|++||||||+||+++.++ .++|+|||+++......
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--------- 164 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--------- 164 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---------
Confidence 987653 389999999999999999999999999999999999999988 99999999987653211
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~ 719 (791)
...|+..|+|||++.+..++.++||||+|+++|||++|+.||.......
T Consensus 165 -------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 165 -------------------------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred -------------------------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 1237888999999998889999999999999999999999996432211
Q ss_pred CCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 003847 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-MKEALQ 775 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 775 (791)
.. ...+.. ...............+.+++.+||+.+|.+||+ ++|+++
T Consensus 214 ~~--------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LD--------LESLLK-RQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hh--------HHHHHH-hhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 011111 111111222235678899999999999999996 588874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.47 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 468999999999999854 688999999977643 45578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999887652 3899999999999999999999999999999999999999999999999999876532210
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....|+..|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 156 --------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 156 --------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred --------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 112347888999999988888999999999999999999999985431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. ........ ..............+.+++.+||..+|++||++.|++.
T Consensus 204 ~---------~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 P---------MAALFRIV---QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred H---------HHHHHHHh---ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 01111111 11111112224567889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.96 Aligned_cols=254 Identities=23% Similarity=0.248 Sum_probs=189.7
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
.+.||.|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++... +..|+||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 468999999999999964 689999999965422 2234567899999999999999999998877 88999999996
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++..... .+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++........
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--- 161 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--- 161 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc---
Confidence 599888776432 389999999999999999999999999999999999999999999999999886543210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.
T Consensus 162 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 162 ---------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred ---------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 01122367889999998764 46899999999999999999999986
Q ss_pred ccccCCCCcch--------hchhHHH-H-----------HHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 714 DELGQGNGLLV--------EDKNRAI-R-----------LADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 714 ~~~~~~~~~~~--------~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
..........+ ...+... . .....+...++.. .....+.+++.+||+.||++|||+.|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHH
Confidence 43211000000 0000000 0 0000000111100 024567899999999999999999999
Q ss_pred HH
Q 003847 774 LQ 775 (791)
Q Consensus 774 l~ 775 (791)
++
T Consensus 288 l~ 289 (293)
T cd07843 288 LK 289 (293)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=301.98 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=192.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 468999999999999954 6889999998653 2333467899999999999999999999999999999999999987
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+..+..... .+++..+..++.||+.||+|||+.+++||||+|+||++++++.+||+|||++.........
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~---- 156 (288)
T cd07833 86 LLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS---- 156 (288)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc----
Confidence 7765543322 3899999999999999999999999999999999999999999999999998876432210
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 157 -------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 157 -------------------------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred -------------------------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11123478889999999887 7899999999999999999999988643
Q ss_pred ccCCCCc--------chhchhHHHHHHHHhhhc----Cc--------cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGL--------LVEDKNRAIRLADAAIRA----DF--------EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
....... ......... ..+....+ .. .........+.+++.+||..+|++||+++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELF-SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhc-ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 1100000 000000000 00000000 00 000112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.70 Aligned_cols=254 Identities=17% Similarity=0.216 Sum_probs=186.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccC-CCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
...||+|+||.||+|.. .+++.||+|+++... ........+|+.+++++. |+||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 45799999999999994 568999999987642 222234457888899885 99999999999987 88999999996
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++..... .+++.++..++.|++.||+|||+.|++||||||+||+++. +.+||+|||+++.+.....
T Consensus 84 -~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--- 154 (282)
T cd07831 84 -MNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--- 154 (282)
T ss_pred -ccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---
Confidence 588877765432 3899999999999999999999999999999999999999 9999999999876532111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....++..|+|||.+. +..++.++|||||||++|||++|+.||.
T Consensus 155 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 155 ----------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred ----------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 01223778899999764 4557899999999999999999999996
Q ss_pred ccccCCCCcch-----hchhHHHHHHHHhhhcCcc-----------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLV-----EDKNRAIRLADAAIRADFE-----------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
........... .................+. .....+..+.+++.+||+.+|++||+++++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 43211000000 0000000000000000000 011235788999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.11 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=192.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 550 (791)
..+.||+|+||.||+|.. .+++.||+|.+... .....+.+++|++++++++|+||+++++++.+. +..++|+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 356899999999999994 56899999987432 233456789999999999999999999998764 4578999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 86 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999887543 38899999999999999999999999999999999999999999999999988653211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.. ........|+..|+|||.+.+..++.++|+|||||++|||++|+.
T Consensus 161 ~~---------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 161 MS---------------------------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred cc---------------------------------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 00 001123448889999999998889999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||.+.. ............... ..+......+.+++.+|+. +|.+||++.+++.
T Consensus 208 p~~~~~---------~~~~~~~~~~~~~~~--~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 208 PWAEYE---------AMAAIFKIATQPTKP--MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCccC---------HHHHHHHHHcCCCCC--CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 986421 011111111111111 1123355678999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.65 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=188.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
...||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++|+||+++++++.... ..|+||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46899999999999994 57899999998653 2333456778999999999999999999886443 469999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+. ++|.+.+... +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 101 e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 101 ELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred eccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 9995 5888776532 7889999999999999999999999999999999999999999999999997653211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.
T Consensus 173 ~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 173 M-------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred C-------------------------------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 0 112347888999999999999999999999999999999999
Q ss_pred chhccccCCCC-cch----hchhHHHHHH----HHhhhcC----------------ccc-----hHHHHHHHHHHHhhcc
Q 003847 711 IVVDELGQGNG-LLV----EDKNRAIRLA----DAAIRAD----------------FEG-----KEEALLSCFKLGYSCA 760 (791)
Q Consensus 711 pf~~~~~~~~~-~~~----~~~~~~~~~~----~~~~~~~----------------~~~-----~~~~~~~l~~li~~cl 760 (791)
||......... ... .......... ....... ++. .......+.+++.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 98543210000 000 0000000000 0000000 000 1113456789999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 003847 761 SPLPQKRPSMKEALQA 776 (791)
Q Consensus 761 ~~dP~~RPs~~evl~~ 776 (791)
+.||++|||+.|+++.
T Consensus 296 ~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 296 VIDPEKRISVDDALQH 311 (353)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.90 Aligned_cols=256 Identities=20% Similarity=0.212 Sum_probs=190.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||.|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..+++|||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 45799999999999985 479999999986543 2223568889999999999999999999999999999999995 6
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... ..+++..+..++.|+++||+|||+.+++||||+|+||+++.++.++|+|||++.........
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---- 155 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---- 155 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc----
Confidence 89998876542 23899999999999999999999999999999999999999999999999998754321100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 --------------------------------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred --------------------------------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0112367789999988664 5689999999999999999999998543
Q ss_pred ccCCC-Ccchh-------chh----HHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGN-GLLVE-------DKN----RAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~-~~~~~-------~~~----~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ....+ ... ...+............ .......+.+++.+|++.||++||+++|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 204 SEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 21000 00000 000 0000000000000000 0112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.41 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=192.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||.|++|.||+|+. .+|+.||||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 46899999999999996 4689999999876432 2345677899999999999999999999999999999999975 8
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||++........
T Consensus 84 l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~------ 155 (284)
T cd07836 84 LKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN------ 155 (284)
T ss_pred HHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc------
Confidence 88887654422 2489999999999999999999999999999999999999999999999999875432110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 156 ------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 ------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112236788999998865 456889999999999999999999986542
Q ss_pred cCCCCcchhc------hhHHHHHHH-HhhhcCcc---------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVED------KNRAIRLAD-AAIRADFE---------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~------~~~~~~~~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+.+ ......+.+ +.....++ ........+.+++.+|++.||.+||++.|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 206 NEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2100000000 000000000 00000000 00113456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.45 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=200.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... +..++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 468999999999999965 789999999876542 4567899999999999999999999999988 88999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999987654 3899999999999999999999999999999999999999999999999998876543210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 158 --------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 158 --------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred --------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 001123478889999999888899999999999999999999999865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ............... ..+......+.+++.+|++.+|++||++.|+++
T Consensus 206 ~~~--------~~~~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 206 LGN--------PMAALYKIGSSGEPP--EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCc--------hHHHHHhccccCCCc--CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 420 000111111101111 112224678899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=307.77 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=191.1
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEec
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~ 552 (791)
.+.||+|+||.||+|. ..+|+.||||.+... .......+.+|+.++++++|+||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 4689999999999998 457899999998643 2233466888999999999999999999876543 47999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
++ ++|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 96 5787766543 3899999999999999999999999999999999999999999999999998865432110
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
. .......||..|+|||.+.+ ..++.++||||+||++|+|++|+.|
T Consensus 163 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 163 T---------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred c---------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 0 01123458899999998754 5689999999999999999999999
Q ss_pred hhccccCCCCcch------hchhHHHHHHHHh----h---hcCccc-----hHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 712 VVDELGQGNGLLV------EDKNRAIRLADAA----I---RADFEG-----KEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 712 f~~~~~~~~~~~~------~~~~~~~~~~~~~----~---~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
|.+.........+ ........+.+.. . ...... ......++.+++.+||+.||++|||+.|+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 8543210000000 0000000000000 0 000000 01124568899999999999999999999
Q ss_pred HHH--hccC
Q 003847 774 LQA--LEKI 780 (791)
Q Consensus 774 l~~--L~~i 780 (791)
++. ++..
T Consensus 290 l~hp~~~~~ 298 (336)
T cd07849 290 LAHPYLEQY 298 (336)
T ss_pred hcCcccccc
Confidence 986 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=301.04 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=196.8
Q ss_pred ceeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 480 AYILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
.+.||+|++|.||+++. .+++.||||.++... ....+.+.+|+++++++ +|+||+++++.+...+..++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46899999999999984 357899999987532 22345688999999999 5999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+++||||||+||+++.++.++|+|||+++......
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 85 DYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred ecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999886542 38899999999999999999999999999999999999999999999999987653221
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--CCCchhhHHHHHHHHHHHhC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--PNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwSlGvil~elltG 708 (791)
.. ......|+..|+|||.+.+.. .+.++||||||+++|||++|
T Consensus 160 ~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 160 EE-----------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred cc-----------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 10 011234788899999987654 78899999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+.||....... ...++.........+........+.+++.+||+.||++|||+.++.+.|+..
T Consensus 205 ~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 205 ASPFTVDGEQN---------SQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCcccCcccc---------hHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 99985421110 0011111111222222222456788999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.48 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=198.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+++ ..+++.+|+|.+... .......+.+|++++++++|+||+++++++......++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 4689999999999998 457899999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 85 ~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----- 158 (256)
T cd08530 85 DLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----- 158 (256)
T ss_pred CHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc-----
Confidence 999988764321 12489999999999999999999999999999999999999999999999999877643210
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 159 ---------------------------------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 159 ---------------------------------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ---------------------------------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11237788999999999889999999999999999999999985432
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .++........++ .......++.+++.+|++.+|++||++.|+++.
T Consensus 206 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 206 M-------------QDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred H-------------HHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 0111111111111 122356778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.85 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=193.3
Q ss_pred ceeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 480 AYILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
...||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46899999999999985 478999999987532 22345678899999999 5999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++.... ++++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999887643 38899999999999999999999999999999999999999999999999987653221
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG 708 (791)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 160 ~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 160 VE-----------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred cc-----------------------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 10 0112347888999999875 3467899999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
+.||...... ....++.+.......+........+.+++.+||+.||++|| ++.++++.
T Consensus 205 ~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 205 ASPFTVDGEK---------NSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCcCCcc---------ccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 9998532111 01112222222222222222456788999999999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.59 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=191.1
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
...||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 457999999999999954 58999999997653 33345788999999999999999999999988 78999999997
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||++++++.+||+|||++.........
T Consensus 84 -~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 84 -HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred -ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 48888876542 14899999999999999999999999999999999999999999999999998866432210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 157 ---------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 157 ---------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred ---------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 0111236778999998764 457899999999999999999999986
Q ss_pred ccccCCCCcchhc--------hh----HH--H------HHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 714 DELGQGNGLLVED--------KN----RA--I------RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 714 ~~~~~~~~~~~~~--------~~----~~--~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
..........+.. .. .. . ......+...+. ......+.+++.+||..+|++||+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred CCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhc--ccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 4321100000000 00 00 0 000000000000 0025678899999999999999999999
Q ss_pred HH
Q 003847 774 LQ 775 (791)
Q Consensus 774 l~ 775 (791)
++
T Consensus 282 l~ 283 (287)
T cd07840 282 LQ 283 (287)
T ss_pred hh
Confidence 76
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.16 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||.|+||.||++... +++.||+|++..... ...+.+.+|++++++++|+|++++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 467999999999999954 689999999976533 45577899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 158 (258)
T cd08215 85 DLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD----- 158 (258)
T ss_pred cHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-----
Confidence 999988775311 12489999999999999999999999999999999999999999999999999876543210
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......|++.|+|||...+..++.++||||+|+++++|++|+.||....
T Consensus 159 -------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 159 -------------------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred -------------------------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 0112347888999999988889999999999999999999999985431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .++......... .........+.+++.+||..+|++||++.|+++.
T Consensus 208 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 208 L-------------LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred H-------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 111111111111 1111245678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.19 Aligned_cols=242 Identities=23% Similarity=0.344 Sum_probs=189.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++|+|++++++++.+....|+||||+.
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 345799999999999985 56899999998643 23344678899999999999999999999999999999999995
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|++.+++..... ++++.++..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 105 -~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------ 173 (313)
T cd06633 105 -GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ 173 (313)
T ss_pred -CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------
Confidence 577777665432 389999999999999999999999999999999999999999999999998753211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 174 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p 219 (313)
T cd06633 174 ----------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219 (313)
T ss_pred ----------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01234788899999984 45688899999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|..... ............ ... ........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~---------~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 220 LFNMNA---------MSALYHIAQNDS-PTL-QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCh---------HHHHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 855311 000111110000 000 111133568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.32 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=188.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++++++|+||+++++++... +..++||||++
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 45799999999999995 4689999999864322 1223566899999999999999999998765 46799999996
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++..... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 92 -~~l~~~l~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 164 (309)
T cd07845 92 -QDLASLLDNMPT----PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-- 164 (309)
T ss_pred -CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--
Confidence 588888765432 4899999999999999999999999999999999999999999999999998876432100
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 165 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 165 ----------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred ----------------------------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 011225677999999865 457899999999999999999999986
Q ss_pred ccccCCCCcchhch-----hHH-HHHHH------Hhhhc-Cccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDK-----NRA-IRLAD------AAIRA-DFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~-----~~~-~~~~~------~~~~~-~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..........+... ... ..... ..... ..... ......+.+++.+|++.||++|||++|+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 43221000000000 000 00000 00000 00000 0124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.93 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred cchHHHhhhc-ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCc
Q 003847 470 LELETLLKAS-AYILGASGSSIMYKAV-LEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE 545 (791)
Q Consensus 470 ~~~~~~~~~~-~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 545 (791)
.++..+.... .++||.|.||+||-|+ .++|+.||||++.+.. ......+++|+.||++++||.||.+...|+..+.
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 4444444443 5899999999999999 5689999999997642 2234678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC---CCeEEeccCc
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND---MEPKIGDFGL 622 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~---~~~kL~DFGl 622 (791)
.++|||-+.|.-|.-++....+ ++++...+-++.||+.||.|||.++|||+||||+|||+... -++||||||+
T Consensus 638 vFVVMEKl~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence 9999999955444444444333 39999999999999999999999999999999999999643 4699999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil 702 (791)
|+.+.+.. ...+.+||+.|.|||+++...|+..-|+||+|||+
T Consensus 714 ARiIgEks-------------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIi 756 (888)
T KOG4236|consen 714 ARIIGEKS-------------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVII 756 (888)
T ss_pred eeecchhh-------------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEE
Confidence 99986432 23356799999999999999999999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|--++|..||..+.+ .. .++......-....+.+.....++||..+|+..-.+|-+.++.+.
T Consensus 757 YVsLSGTFPFNEdEd--In---------dQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 757 YVSLSGTFPFNEDED--IN---------DQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred EEEecccccCCCccc--hh---------HHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 999999999965421 10 111111122222345567778899999999999999999887653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=299.09 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=191.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+. .+++.||+|.+... .....+++.+|+++++.++|+|++++++++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 45799999999999995 46889999998642 23345678889999999999999999999999999999999996
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++.+++..... ++++.++..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 99 ~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------ 168 (308)
T cd06634 99 GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168 (308)
T ss_pred CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------
Confidence 688777654332 3889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||
T Consensus 169 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 214 (308)
T cd06634 169 ----------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (308)
T ss_pred ----------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 1123778899999974 356788999999999999999999998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
..... ........... .... ........+.+++.+||..+|++||++.++++.---
T Consensus 215 ~~~~~---------~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 215 FNMNA---------MSALYHIAQNE-SPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ccccH---------HHHHHHHhhcC-CCCc-CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 54211 00111111111 1111 111245678899999999999999999999977443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.91 Aligned_cols=256 Identities=18% Similarity=0.192 Sum_probs=187.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||+|... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 468999999999999954 789999999865422 234568889999999999999999999999999999999995 5
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||+++. ++.+||+|||++........
T Consensus 86 ~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~---- 158 (294)
T PLN00009 86 DLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---- 158 (294)
T ss_pred cHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc----
Confidence 78777654332 13678889999999999999999999999999999999985 55799999999976532110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......|++.|+|||++.+ ..++.++||||+||++|+|+||+.||..
T Consensus 159 --------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 159 --------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred --------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 0112236788999998866 4578999999999999999999999864
Q ss_pred cccCCCCc------------chhchhHHHHHHHH--hhhcCc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGL------------LVEDKNRAIRLADA--AIRADF--EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~------------~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........ .............. ...... .........+.+++.+|++.+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 32100000 00000000000000 000000 000113456789999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.76 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=189.3
Q ss_pred hcceeccccCceEEEEEEeCC-CcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 478 ASAYILGASGSSIMYKAVLED-GTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...+.||+|++|.||+|...+ ++.||||+++... ......+..|+.++.+. .|+||+++++++......|+||||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 345799999999999999754 8999999997542 23345666777777666 59999999999999999999999985
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|.+++..... .+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++..+.....
T Consensus 98 -~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-- 170 (296)
T cd06618 98 -TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-- 170 (296)
T ss_pred -cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--
Confidence 577777655332 48999999999999999999997 6999999999999999999999999999876532111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC----CCCchhhHHHHHHHHHHHhCC
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK----PNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~sDvwSlGvil~elltG~ 709 (791)
.....|+..|+|||.+.+.. ++.++||||||+++|||++|+
T Consensus 171 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 215 (296)
T cd06618 171 -----------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215 (296)
T ss_pred -----------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence 01123677899999987543 788999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.||..... ............. ...+.......++.+++.+||..||++||++.++++.
T Consensus 216 ~p~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 216 FPYKNCKT--------EFEVLTKILQEEP-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCcchh--------HHHHHHHHhcCCC-CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99854210 0011111111110 1111111245678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.89 Aligned_cols=260 Identities=23% Similarity=0.213 Sum_probs=192.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhh--------------HHHHHHHHHHHhccCCCCccceeeEEEccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDR--------------FRDFETQVRVIAKLVHPNLVRIRGFYWGVD 544 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 544 (791)
..+||+|+||.||+|.. .+++.||||.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 45799999999999994 468999999986542211 124778999999999999999999999999
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
..++||||+. ++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999996 68988886543 38999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILL 703 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ 703 (791)
............... ............++..|+|||.+.+. .++.++|||||||++|
T Consensus 168 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 168 RYGYPPYSDTLSKDE----------------------TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225 (335)
T ss_pred ecccccccccccccc----------------------cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence 765322111000000 00000111223478889999998764 4689999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhh--------------------hcCcc----chHHHHHHHHHHHhhc
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAI--------------------RADFE----GKEEALLSCFKLGYSC 759 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~----~~~~~~~~l~~li~~c 759 (791)
||++|+.||....... ....+..... ..... ........+.+++.+|
T Consensus 226 el~tg~~p~~~~~~~~---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (335)
T PTZ00024 226 ELLTGKPLFPGENEID---------QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296 (335)
T ss_pred HHHhCCCCCCCCCHHH---------HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence 9999999986542110 0000000000 00000 0011245678999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 003847 760 ASPLPQKRPSMKEALQA 776 (791)
Q Consensus 760 l~~dP~~RPs~~evl~~ 776 (791)
|+.+|++||+++|++..
T Consensus 297 l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 297 LKLNPLERISAKEALKH 313 (335)
T ss_pred cCCCchhccCHHHHhcC
Confidence 99999999999999863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.43 Aligned_cols=236 Identities=22% Similarity=0.296 Sum_probs=192.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 589999999876432 2456789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-------
Confidence 99987653 389999999999999999999999999999999999999999999999999876543210
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......|+..|+|||...+...+.++|+||||+++|+|++|+.||.....
T Consensus 149 -----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~- 198 (250)
T cd05123 149 -----------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR- 198 (250)
T ss_pred -----------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-
Confidence 01123478889999999888889999999999999999999999854311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
..............+......+.+++.+||..||++||++.+
T Consensus 199 ------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 199 ------------KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------------HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111111111222222224567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.80 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=193.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 35799999999999995 4789999999876432 2456788999999999999999999999999999999999975
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~l~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 83 DLYKLIKDRQR----GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred CHHHHHHhhcc----cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 88887766432 389999999999999999999999999999999999999999999999999876643220
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 154 -------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 154 -------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred -------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 00112367789999998776 7899999999999999999999988543
Q ss_pred ccCCC------------CcchhchhHHHHHHHHhhhcC-----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGN------------GLLVEDKNRAIRLADAAIRAD-----FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ..................... ..........+.+++.+||+.||.+||++.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 21000 000000000000000000000 0011224567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.28 Aligned_cols=246 Identities=26% Similarity=0.313 Sum_probs=189.2
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch--hhHHHHHHHHHHHhcc---CCCCccceeeEEEccCc-----eEE
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV--DRFRDFETQVRVIAKL---VHPNLVRIRGFYWGVDE-----KLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~-----~~l 548 (791)
...||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 468999999999999965 589999999974322 2234566787777665 69999999999988776 899
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
+|||+. ++|.+++...... .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~e~~~-~~l~~~l~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPKP---GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred Eehhcc-cCHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999996 5898888764322 489999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
... .....++..|+|||++.+..++.++|||||||++|||++|
T Consensus 160 ~~~-------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~ 202 (287)
T cd07838 160 EMA-------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR 202 (287)
T ss_pred Ccc-------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhC
Confidence 211 0112367889999999998899999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHh----------------------hhcCc-cchHHHHHHHHHHHhhccCCCCC
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAA----------------------IRADF-EGKEEALLSCFKLGYSCASPLPQ 765 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~-~~~~~~~~~l~~li~~cl~~dP~ 765 (791)
++||.+..... ....+.+.. ..... .........+.+++.+||+.||+
T Consensus 203 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (287)
T cd07838 203 RPLFRGTSEAD---------QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH 273 (287)
T ss_pred CCcccCCChHH---------HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCc
Confidence 98886532110 011111100 00000 00112346778999999999999
Q ss_pred CCCCHHHHHH
Q 003847 766 KRPSMKEALQ 775 (791)
Q Consensus 766 ~RPs~~evl~ 775 (791)
+||+++|+++
T Consensus 274 ~Rp~~~~il~ 283 (287)
T cd07838 274 KRISAFEALQ 283 (287)
T ss_pred cCCCHHHHhc
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.15 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=186.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCc--------eEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE--------KLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--------~~l 548 (791)
...||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||+++++++...+. .++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 46799999999999995 468999999986432 2223456789999999999999999999876543 499
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+. ++|.+++..... .+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 97 v~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred EEcCCC-cCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 999996 578877755432 389999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ellt 707 (791)
...... .......++..|+|||.+.+. .++.++||||||+++|||++
T Consensus 172 ~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t 219 (310)
T cd07865 172 SKNSKP--------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219 (310)
T ss_pred CcccCC--------------------------------CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence 221100 011123477889999988664 46889999999999999999
Q ss_pred CCcchhccccCCCCcchh------------chhHHHHHHHHh-hhcCcc-c------hHHHHHHHHHHHhhccCCCCCCC
Q 003847 708 GKVIVVDELGQGNGLLVE------------DKNRAIRLADAA-IRADFE-G------KEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~R 767 (791)
|+.||...........+. .... ....+.. ...... . .......+.+++.+||..||++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R 298 (310)
T cd07865 220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDK-LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR 298 (310)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc-hhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhc
Confidence 999885432110000000 0000 0000000 000000 0 00012456789999999999999
Q ss_pred CCHHHHHH
Q 003847 768 PSMKEALQ 775 (791)
Q Consensus 768 Ps~~evl~ 775 (791)
||++|+++
T Consensus 299 ~t~~e~l~ 306 (310)
T cd07865 299 IDADTALN 306 (310)
T ss_pred cCHHHHhc
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=294.80 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=200.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...||+|+||.||++.. .+++.||+|++... .....+.+..|++++++++ |+||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 45799999999999995 47999999998753 2233467889999999998 9999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++..+..|+.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999887653 399999999999999999999999999999999999999999999999999887654322111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
...... .................|+..|+|||+..+..++.++||||||++++++++|+.||..
T Consensus 161 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 161 NKGDAT----------------NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred CCCCCc----------------cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 000000 0000000111223345588899999999888899999999999999999999999864
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM----KEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 775 (791)
.. ........ ..............+.+++.+||+.+|++||++ +|+++
T Consensus 225 ~~---------~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 225 SN---------EYLTFQKI----LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cc---------HHHHHHHH----HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 32 01111111 112222222345678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.81 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=191.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~ 552 (791)
.+.||+|++|.||+|.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 45799999999999994 56999999998754 22334677889999999999999999998764 3467999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+. ++|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 95 68888876543 3899999999999999999999999999999999999999999999999998765432111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
. ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 164 ~--------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p 211 (334)
T cd07855 164 H--------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211 (334)
T ss_pred C--------------------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence 0 001123358888999999865 4689999999999999999999999
Q ss_pred hhccccCCC------------Ccchhc--hhHHHHHHHHhh-hcCccc---hHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 712 VVDELGQGN------------GLLVED--KNRAIRLADAAI-RADFEG---KEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 712 f~~~~~~~~------------~~~~~~--~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
|.+...... ...... .....+..+... ...... .......+.+++.+||+.+|++||++.++
T Consensus 212 f~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 291 (334)
T cd07855 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291 (334)
T ss_pred cCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 955321000 000000 000001111000 000000 01235678999999999999999999999
Q ss_pred HHH
Q 003847 774 LQA 776 (791)
Q Consensus 774 l~~ 776 (791)
+..
T Consensus 292 l~~ 294 (334)
T cd07855 292 LQH 294 (334)
T ss_pred HhC
Confidence 874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=293.16 Aligned_cols=256 Identities=23% Similarity=0.280 Sum_probs=190.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch-hhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV-DRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|++|.||+|... +++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 457999999999999964 588999999865422 22234567899999998 999999999999999999999999 88
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (283)
T cd07830 83 NLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----- 154 (283)
T ss_pred CHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-----
Confidence 99988876542 1389999999999999999999999999999999999999999999999999876532111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....|+..|+|||++. ...++.++|+||||++++||++|+.||...
T Consensus 155 --------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 11234778899999875 455789999999999999999999988543
Q ss_pred ccCCC--------Ccc----hhchhHHHHHHHHhhhcCccc-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGN--------GLL----VEDKNRAIRLADAAIRADFEG-----KEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~--------~~~----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... ... ..+........+......... .......+.+++.+||+.||++||+++|++..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 21000 000 000000000000000000000 00123568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.70 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=190.1
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC--ceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD--EKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--~~~lv~e~~ 553 (791)
.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +|+||+++++++...+ ..++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 467999999999999954 6899999988542 233345677899999999 9999999999986543 579999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+ ++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 6 5998887654 28899999999999999999999999999999999999999999999999998664322110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.........||..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 165 -------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf 213 (337)
T cd07852 165 -------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213 (337)
T ss_pred -------------------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence 0011123458899999998754 45788999999999999999999998
Q ss_pred hccccCCCCcc--------hhc-h-----hHHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 713 VDELGQGNGLL--------VED-K-----NRAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 713 ~~~~~~~~~~~--------~~~-~-----~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
........... ... . .....+.+......... .......+.+++.+||+.||++|||+.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il 293 (337)
T cd07852 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293 (337)
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence 54321100000 000 0 00000011000000000 011245788999999999999999999999
Q ss_pred HH
Q 003847 775 QA 776 (791)
Q Consensus 775 ~~ 776 (791)
+.
T Consensus 294 ~~ 295 (337)
T cd07852 294 EH 295 (337)
T ss_pred hC
Confidence 75
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.85 Aligned_cols=261 Identities=24% Similarity=0.293 Sum_probs=189.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc--------------C
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--------------D 544 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------------~ 544 (791)
.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46899999999999995 56899999999776555667889999999999999999999876654 3
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLE 623 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla 623 (791)
..++||||++ ++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 4689999996 5888877532 3899999999999999999999999999999999999974 557899999998
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVIL 702 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil 702 (791)
+.+....... .......|+..|+|||.+.+ ..++.++|||||||++
T Consensus 163 ~~~~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (342)
T cd07854 163 RIVDPHYSHK---------------------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209 (342)
T ss_pred eecCCccccc---------------------------------cccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence 7653211100 00112247888999998754 5678899999999999
Q ss_pred HHHHhCCcchhccccCCCCcc---------hhchhHHHHHHHHhhh-----cCccc---hHHHHHHHHHHHhhccCCCCC
Q 003847 703 LELLTGKVIVVDELGQGNGLL---------VEDKNRAIRLADAAIR-----ADFEG---KEEALLSCFKLGYSCASPLPQ 765 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~l~~li~~cl~~dP~ 765 (791)
|||++|+.||........... ..+............. ...+. .......+.+++.+||..||+
T Consensus 210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 289 (342)
T cd07854 210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCch
Confidence 999999999964321000000 0000000000000000 00000 011335678999999999999
Q ss_pred CCCCHHHHHH--HhccC
Q 003847 766 KRPSMKEALQ--ALEKI 780 (791)
Q Consensus 766 ~RPs~~evl~--~L~~i 780 (791)
+|||+.|+++ .++.+
T Consensus 290 ~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 290 DRLTAEEALMHPYMSCY 306 (342)
T ss_pred hccCHHHHhCCCccccc
Confidence 9999999984 35543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.10 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=187.1
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccC----------ce
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD----------EK 546 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----------~~ 546 (791)
...||+|+||.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 468999999999999964 68999999996532 223356788999999999999999999987655 78
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
++|+||+++ ++.+.+..... .+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+|||++...
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGLV----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred EEEEcccCc-cHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 999999975 77776654321 4899999999999999999999999999999999999999999999999998866
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~el 705 (791)
...... ......++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 167 ~~~~~~-----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 167 NSEESR-----------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred cCCccc-----------------------------------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 432210 0011225677999998864 4568999999999999999
Q ss_pred HhCCcchhccccCCCCcchhchhHHHHHHHHh---hhcC--------------------ccchHHHHHHHHHHHhhccCC
Q 003847 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAA---IRAD--------------------FEGKEEALLSCFKLGYSCASP 762 (791)
Q Consensus 706 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------------~~~~~~~~~~l~~li~~cl~~ 762 (791)
++|+.||...... .......+..... .... .......+..+.+++.+||..
T Consensus 212 ~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 212 FTKKPIFQANQEL------AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HhCCCCCCCCChH------HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC
Confidence 9999998643210 0000000000000 0000 000001245788999999999
Q ss_pred CCCCCCCHHHHHH
Q 003847 763 LPQKRPSMKEALQ 775 (791)
Q Consensus 763 dP~~RPs~~evl~ 775 (791)
||.+||+++++++
T Consensus 286 ~P~~Rp~~~~il~ 298 (302)
T cd07864 286 DPSKRCTAEEALN 298 (302)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.17 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=191.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~e 551 (791)
...||+|+||+||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45899999999999994 57899999998653 222345677899999999999999999988654 34799999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+. ++|.+++.... ++++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 90 LMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred CCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 995 68888876543 389999999999999999999999999999999999999999999999999876542210
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.
T Consensus 164 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 164 ------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred ------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 0112347788999998864 468899999999999999999999
Q ss_pred chhccccCC---------------CCcchhchhHHHHHHHHhhhcC-c---cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 711 IVVDELGQG---------------NGLLVEDKNRAIRLADAAIRAD-F---EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 711 pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
||....... ....+... ............. . .........+.+++.+||+.+|++|||++
T Consensus 208 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 208 LFPGKDYVHQLKLITELLGSPSEEDLGFIRNE-KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHhhhcCch-hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 985431100 00000000 0000000000000 0 00112346788999999999999999999
Q ss_pred HHHHH--hccC
Q 003847 772 EALQA--LEKI 780 (791)
Q Consensus 772 evl~~--L~~i 780 (791)
|+++. ++.+
T Consensus 287 ell~h~~~~~~ 297 (337)
T cd07858 287 EALAHPYLASL 297 (337)
T ss_pred HHHcCcchhhh
Confidence 99977 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=300.09 Aligned_cols=265 Identities=22% Similarity=0.249 Sum_probs=198.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e 551 (791)
...||.|++|.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..|+|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 468999999999999954 58999999997643 444567899999999999999999999988775 7899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|++ ++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 997 58888876543 389999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~ 710 (791)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.
T Consensus 159 ~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~ 205 (330)
T cd07834 159 EK---------------------------------GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205 (330)
T ss_pred cc---------------------------------ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCC
Confidence 00 011123478889999999887 78999999999999999999999
Q ss_pred chhccccCCC------------Ccchh--chhHHHHHHHHhhhc-Ccc---chHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 711 IVVDELGQGN------------GLLVE--DKNRAIRLADAAIRA-DFE---GKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 711 pf~~~~~~~~------------~~~~~--~~~~~~~~~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
||........ ..... ............... ... ........+.+++.+||+.+|++||++.+
T Consensus 206 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred CcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9865421100 00000 000000000000000 000 00113456889999999999999999999
Q ss_pred HHHH--hccCCCC
Q 003847 773 ALQA--LEKIPSS 783 (791)
Q Consensus 773 vl~~--L~~i~~~ 783 (791)
+++. ++.+...
T Consensus 286 ll~~~~~~~~~~~ 298 (330)
T cd07834 286 ALAHPYLAQLHDP 298 (330)
T ss_pred HHhCccHHhhccc
Confidence 9985 5655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=288.70 Aligned_cols=246 Identities=21% Similarity=0.265 Sum_probs=190.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+++.. .+..+++|.++.. .......+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 468999999999999854 3455666665432 2223345778999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++....... ..+++..++.++.|++.||+|||+.|++|+||||+||+++. +.+||+|||++.........
T Consensus 85 ~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~- 161 (260)
T cd08222 85 EGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL- 161 (260)
T ss_pred CCCCHHHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCccc-
Confidence 9999999887533221 24899999999999999999999999999999999999975 56999999998765322110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 162 -----------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 162 -----------------------------------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred -----------------------------------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 112337888999999988888999999999999999999999985
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... .........+.. .........+.+++.+||..+|++||++.|+++.
T Consensus 207 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 207 GQNF-------------LSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CccH-------------HHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 3210 011111111111 1122355688899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.21 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=190.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~~ 555 (791)
...||.|+||.||++. ..+++.||||++... .....+.+.+|++++++++||||+++++++.. .+..++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 4689999999999998 447999999988643 22234678889999999999999999999876 45789999999 5
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++... .+++..+..++.|+++||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----- 162 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM----- 162 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----
Confidence 6888877543 37888899999999999999999999999999999999999999999999987542110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 163 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 163 ----------------------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ----------------------------------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11236778999998765 5689999999999999999999999854
Q ss_pred cccCCCCcchh--------c------hhHHHHHHHHh-hhcCccch---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVE--------D------KNRAIRLADAA-IRADFEGK---EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~--------~------~~~~~~~~~~~-~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.........+. + .....++.... .....+.. ......+.+++.+||+.+|++||++.+++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 32100000000 0 00000000000 00000100 0123678899999999999999999999876
Q ss_pred --hccCCC
Q 003847 777 --LEKIPS 782 (791)
Q Consensus 777 --L~~i~~ 782 (791)
++....
T Consensus 289 ~~~~~~~~ 296 (328)
T cd07856 289 PYLAPYHD 296 (328)
T ss_pred CccccccC
Confidence 544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.69 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=186.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
...||+|+||.||++. ..+++.||||++... .....+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 4579999999999998 557999999998653 2223456889999999999999999999987654 358999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +++|.+++... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 999 77998877542 38999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+
T Consensus 173 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 173 ---------------------------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred ---------------------------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 11236788999999876 45789999999999999999999
Q ss_pred cchhccccCCCC-cchh-----chhH--------HHHHHHHhhhc---Cc-cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNG-LLVE-----DKNR--------AIRLADAAIRA---DF-EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~-~~~~-----~~~~--------~~~~~~~~~~~---~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||......... .... .... ........... .+ .........+.+++.+|++.||++|||+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 998643210000 0000 0000 00000000000 00 00011234678999999999999999999
Q ss_pred HHHH
Q 003847 772 EALQ 775 (791)
Q Consensus 772 evl~ 775 (791)
++++
T Consensus 294 ~~l~ 297 (343)
T cd07880 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=285.37 Aligned_cols=220 Identities=20% Similarity=0.196 Sum_probs=175.9
Q ss_pred cCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhHHHHh
Q 003847 486 SGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYR 564 (791)
Q Consensus 486 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 564 (791)
|.+|.||+++. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999994 578999999997653 233455555666799999999999999999999999999999998876
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCC
Q 003847 565 KMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644 (791)
Q Consensus 565 ~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 644 (791)
.. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+.......
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------------- 139 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------------- 139 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--------------
Confidence 53 38999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcch
Q 003847 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLV 724 (791)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~ 724 (791)
....++..|+|||.+.+..++.++||||+|+++|||++|+.|+........
T Consensus 140 -------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---- 190 (237)
T cd05576 140 -------------------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---- 190 (237)
T ss_pred -------------------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----
Confidence 011256679999999888899999999999999999999988743211100
Q ss_pred hchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 725 EDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.. .....+......+.+++.+|++.||++||++.
T Consensus 191 -~~------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 191 -TH------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -cc------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 00 00011112345678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=319.88 Aligned_cols=142 Identities=18% Similarity=0.275 Sum_probs=127.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|... +++.||||+++... ......+..|+.+++.++|+||+++++++...+..|+||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999954 68999999997532 23346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
++|.+++.... .+++..++.|+.||+.||+|||+.+||||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999987643 3889999999999999999999999999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.33 Aligned_cols=235 Identities=23% Similarity=0.267 Sum_probs=194.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
-.+||+|+||.|..|..+ +.+.+|||+++++.. +..+--..|-++|..- +-|.+++++.+|+..+..|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 468999999999999854 578999999987522 2223334566667655 57889999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
||+|--.+++.+. +.+..+.-+|..||-||-+||++|||.||||.+|||+|.+|.+||+|||+++.---+
T Consensus 434 GGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~----- 503 (683)
T KOG0696|consen 434 GGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD----- 503 (683)
T ss_pred CchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-----
Confidence 9999888877653 888899999999999999999999999999999999999999999999999853211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
..++..+|||+.|+|||++..++|+..+|.|||||+||||+.|++||.+
T Consensus 504 -------------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 504 -------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred -------------------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 1234578999999999999999999999999999999999999999987
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
+.. .+++..........+...+.+...+....+...|.+|.
T Consensus 553 eDE-------------~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 553 EDE-------------DELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CCH-------------HHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 532 23444444444455555777888899999999999995
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=303.56 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=186.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
...||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999994 578999999986532 222356789999999999999999999987543 468999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+. .+|..++.. .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 100 PYMQ-TDLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred cccc-cCHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 9996 467654321 3899999999999999999999999999999999999999999999999998754211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 171 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 171 --------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred --------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 012236788999999876 46889999999999999999999
Q ss_pred cchhccccCCCCc-chh----chhHHHHHHH----Hh-h--hcCccch------HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGL-LVE----DKNRAIRLAD----AA-I--RADFEGK------EEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~-~~~----~~~~~~~~~~----~~-~--~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||.......... ... .......... .. . ....... ......+.+++.+||+.||++||++.
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9996532100000 000 0000000000 00 0 0000000 01234678999999999999999999
Q ss_pred HHHHH--hccCC
Q 003847 772 EALQA--LEKIP 781 (791)
Q Consensus 772 evl~~--L~~i~ 781 (791)
|++.. ++.++
T Consensus 293 e~l~h~~f~~~~ 304 (342)
T cd07879 293 EALEHPYFDSFR 304 (342)
T ss_pred HHhcCcchhhcc
Confidence 99854 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.90 Aligned_cols=266 Identities=20% Similarity=0.226 Sum_probs=187.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccC--------ceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--------EKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------~~~l 548 (791)
...||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 45799999999999995 4689999999854322 12345778999999999999999999876543 3599
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+.+ +|.+.+..... .+++..+..++.|+++||+|||+.||+||||||+||++++++.+||+|||+++....
T Consensus 93 v~~~~~~-~l~~~~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 93 VTPYMDH-DLSGLLENPSV----KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167 (311)
T ss_pred EEecCCc-CHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence 9999964 67666654321 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
......... ...........|++.|+|||.+.+ ..++.++|||||||++|||++
T Consensus 168 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~ 222 (311)
T cd07866 168 PPPNPKGGG-------------------------GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222 (311)
T ss_pred CCcccccCC-------------------------cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh
Confidence 221111000 001112234567889999998765 457899999999999999999
Q ss_pred CCcchhccccCCCCcchh------------chhHHHHHHHHhhhcCccc-----hHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 708 GKVIVVDELGQGNGLLVE------------DKNRAIRLADAAIRADFEG-----KEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
|++||.+.........+. .........+.......+. .......+.+++.+|++.||++|||+
T Consensus 223 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~ 302 (311)
T cd07866 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302 (311)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence 999986432210000000 0000000000000000000 00122567899999999999999999
Q ss_pred HHHHH
Q 003847 771 KEALQ 775 (791)
Q Consensus 771 ~evl~ 775 (791)
.|++.
T Consensus 303 ~ell~ 307 (311)
T cd07866 303 SDALE 307 (311)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=294.86 Aligned_cols=259 Identities=22% Similarity=0.220 Sum_probs=187.0
Q ss_pred ceeccccCceEEEEEEeC-C--CcEEEEEEcCCC--chhhHHHHHHHHHHHhcc-CCCCccceeeEEEcc----CceEEE
Q 003847 480 AYILGASGSSIMYKAVLE-D--GTALAVRRIGEN--SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGV----DEKLII 549 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~~lv 549 (791)
...||+|+||.||++... + +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 468999999999999953 4 789999998653 222346778899999999 599999999875432 457889
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
+||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 99885 68988876433 3899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG 708 (791)
.... ........||..|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 159 ~~~~--------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 159 PGEN--------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred cccc--------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1110 001123458999999998765 5689999999999999999999
Q ss_pred CcchhccccCCCCcc-h-----hchhHHHHHHHHh-------h--h--cCcc-chHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 709 KVIVVDELGQGNGLL-V-----EDKNRAIRLADAA-------I--R--ADFE-GKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~-~-----~~~~~~~~~~~~~-------~--~--~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
+.||........... + ........+.... . . ..+. ........+.+++.+|++.||++|||+
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 286 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 999864321000000 0 0000000000000 0 0 0000 000123568899999999999999999
Q ss_pred HHHHHH
Q 003847 771 KEALQA 776 (791)
Q Consensus 771 ~evl~~ 776 (791)
.|+++.
T Consensus 287 ~~ll~~ 292 (332)
T cd07857 287 EEALEH 292 (332)
T ss_pred HHHhcC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=292.70 Aligned_cols=255 Identities=22% Similarity=0.264 Sum_probs=192.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 357999999999999954 58999999997653 2334677889999999999999999999999999999999997 5
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..+..++.|++.||+|||+.||+||||+|+||++++++.+||+|||++........
T Consensus 83 ~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 83 DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred CHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 89999887531 389999999999999999999999999999999999999999999999999876542211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 154 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 -------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred -------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 01112356779999998766 7899999999999999999999998553
Q ss_pred ccCCCCcchh------chhHHHHH-----HHHhhhcC----c-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVE------DKNRAIRL-----ADAAIRAD----F-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~------~~~~~~~~-----~~~~~~~~----~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........+. .......+ .+...... . .........+.+++.+||..||++||++.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 2100000000 00000000 00000000 0 000012457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=297.31 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=185.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~ 550 (791)
...||+|+||.||++. ..+++.||+|++.... ....+.+.+|++++++++|+||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 3579999999999998 4578999999997532 22345678899999999999999999988643 3467888
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
+++ +++|.+++... .+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 877 78998877543 2899999999999999999999999999999999999999999999999998754211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 174 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 174 --------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred --------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 012247888999999866 56789999999999999999999
Q ss_pred cchhccccCCCCcch-h-----chhHHHHH-------HHHhhhc--Cccc---hHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLLV-E-----DKNRAIRL-------ADAAIRA--DFEG---KEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~-~-----~~~~~~~~-------~~~~~~~--~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||...........+ . .......+ .-..+.. .... .......+.+++.+|++.||.+||++.
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 998542110000000 0 00000000 0000000 0000 001234678999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
+++..
T Consensus 296 e~l~h 300 (345)
T cd07877 296 QALAH 300 (345)
T ss_pred HHhcC
Confidence 99865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.74 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=187.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc------eEEEE
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE------KLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lv~ 550 (791)
...||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 468999999999999954 6899999998653 22334567789999999999999999998876654 89999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +++|.+++... ++++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 999 67999887652 3899999999999999999999999999999999999999999999999998765321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 172 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 172 --------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred --------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 012236778999999865 46789999999999999999999
Q ss_pred cchhccccCCCCcchhc------hh--------HHHHHHHHhhhc---Ccc-chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLLVED------KN--------RAIRLADAAIRA---DFE-GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~------~~--------~~~~~~~~~~~~---~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||...........+.+ .. ............ .+. ........+.+++.+||+.||++|||+.
T Consensus 214 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 99854321100000000 00 000000000000 000 0001246788999999999999999999
Q ss_pred HHHH
Q 003847 772 EALQ 775 (791)
Q Consensus 772 evl~ 775 (791)
||++
T Consensus 294 ell~ 297 (343)
T cd07851 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=316.61 Aligned_cols=259 Identities=17% Similarity=0.189 Sum_probs=208.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-.+||+|+||.|..++. .+++.||.|++.+- ......-|..|-++|..-+.+-|+.++-.|.++.+.|+|||||+|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 35899999999999995 57899999999772 223345688899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|..++.... ++++..++.++..|+.||+-||+.|+|||||||+|||+|..|++||+|||.|-.+..+...
T Consensus 160 GDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V--- 231 (1317)
T KOG0612|consen 160 GDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV--- 231 (1317)
T ss_pred chHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE---
Confidence 99999988765 3999999999999999999999999999999999999999999999999999888754321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc----C-CCCCCchhhHHHHHHHHHHHhCCc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR----S-IKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+|||-|++||++. + +.|++.+|.||+||++|||+.|..
T Consensus 232 --------------------------------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 232 --------------------------------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred --------------------------------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 123456999999999985 3 678999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH-------hccC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS---MKEALQA-------LEKI 780 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~-------L~~i 780 (791)
||+.+.-. .....+.+..-.-.++...+.+....+||.+.+. +|+.|.. ++|+... ...|
T Consensus 280 PFYadslv---------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 280 PFYADSLV---------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred cchHHHHH---------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence 99764211 1122233322222344334467788888888764 5888887 8887654 3567
Q ss_pred CCCCCCCc
Q 003847 781 PSSPSPYL 788 (791)
Q Consensus 781 ~~~~~p~~ 788 (791)
+....||.
T Consensus 350 R~~~pP~v 357 (1317)
T KOG0612|consen 350 RESVPPVV 357 (1317)
T ss_pred hhcCCCCC
Confidence 77777775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.36 Aligned_cols=232 Identities=22% Similarity=0.255 Sum_probs=190.1
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.-+|.|+|+.|-.+. ..+++..+||++.+.. .+..+|+.++... +||||+++.+.+.+..+.|+|||++.|+-+
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred cccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 349999999999998 5678999999997762 2345677676666 799999999999999999999999999988
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe-cCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
.+.+.... .....+..|+.+|+.|+.|||++|||||||||+|||+ +..++++|+|||.++.......
T Consensus 404 l~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~------ 471 (612)
T KOG0603|consen 404 LRRIRSKP------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD------ 471 (612)
T ss_pred HHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc------
Confidence 88776554 2336777899999999999999999999999999999 6899999999999998764311
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
..+=|..|.|||+.....|++++|+||||++||+|++|+.||.....
T Consensus 472 ---------------------------------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 472 ---------------------------------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred ---------------------------------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 12356779999999999999999999999999999999999965422
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+ .++......+.+. ...+....+|+.+||+.||.+||+|.++..
T Consensus 519 ~------------~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 519 G------------IEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred h------------HHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2 2222223333332 446778899999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.60 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=200.8
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEc-----cCceEEEEec
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWG-----VDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~~~lv~e~ 552 (791)
.++||.|.+|.||+++ .++++..|||++..... ..++++.|.++++.+ .|||++.++|+|.. ++..||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 3689999999999999 67899999999876533 347788899999988 69999999999874 4678999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
|.+|+..|+++...+. .+.|+.+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.+..+....
T Consensus 103 C~gGSVTDLVKn~~g~---rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-- 177 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTKGN---RLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-- 177 (953)
T ss_pred cCCccHHHHHhhhccc---chhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--
Confidence 9999999999877633 49999999999999999999999999999999999999999999999999998765321
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHh
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~ellt 707 (791)
.......||++|||||++. ...|+..+|+||||++..||.-
T Consensus 178 ----------------------------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 178 ----------------------------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred ----------------------------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 1223456999999999994 3457889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHH--HhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLAD--AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|.+|+.+-... ..++. +.-.+....++....++.++|..||..|-++||++.++++
T Consensus 224 G~PPl~DmHPm------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 224 GAPPLCDMHPM------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCccCcchh------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 99998764321 11111 1111222334557789999999999999999999998875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=282.30 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=190.2
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-C-C----CccceeeEEEccCceEEEEecc
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-H-P----NLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+|+|.||.|-++. .+++..||||+++..... .+...-|+++|+++. + | -+|.+.+||.-.++.+||+|.+
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 479999999999998 455899999999765443 255677999999993 2 2 3899999999999999999998
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC--------------------CC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN--------------------DM 613 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~--------------------~~ 613 (791)
|-++.+++..+.-. +++...++.|+.|++++++|||+.+++|-||||+|||+.. +-
T Consensus 174 -G~S~~dFlk~N~y~---~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~ 249 (415)
T KOG0671|consen 174 -GLSTFDFLKENNYI---PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKST 249 (415)
T ss_pred -ChhHHHHhccCCcc---ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCc
Confidence 77999999876543 5899999999999999999999999999999999999931 23
Q ss_pred CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCch
Q 003847 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW 693 (791)
Q Consensus 614 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~s 693 (791)
.+||+|||.|....+.. +..+.|..|+|||++.+-.++.++
T Consensus 250 ~I~vIDFGsAtf~~e~h---------------------------------------s~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 250 AIKVIDFGSATFDHEHH---------------------------------------STIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceEEEecCCcceeccCc---------------------------------------ceeeeccccCCchheeccCcCCcc
Confidence 48999999998755332 234578889999999999999999
Q ss_pred hhHHHHHHHHHHHhCCcchhccccCC------------CCcchhchhHHHHHHHHh----------------------hh
Q 003847 694 DVYSFGVILLELLTGKVIVVDELGQG------------NGLLVEDKNRAIRLADAA----------------------IR 739 (791)
Q Consensus 694 DvwSlGvil~elltG~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~----------------------~~ 739 (791)
||||+||||+|+.||...|..-.... ...++.... ....+... +.
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~ 369 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLK 369 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhhhcCCccHH
Confidence 99999999999999999886532110 000000000 00000000 00
Q ss_pred cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 740 ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 740 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........+..++++|+++||..||.+|+|+.|++.
T Consensus 370 ~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 370 KYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 001112234567999999999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=312.80 Aligned_cols=257 Identities=27% Similarity=0.343 Sum_probs=203.1
Q ss_pred hcceeccccCceEEEEEEeC--------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceE
Q 003847 478 ASAYILGASGSSIMYKAVLE--------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKL 547 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 547 (791)
...+.||+|.||.|++|... ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|++...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44559999999999999832 1468999999865 334567899999999999 6999999999999999999
Q ss_pred EEEeccCCCChhHHHHhhc---------CCCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeE
Q 003847 548 IIYDFVPNGSLANARYRKM---------GSSPC--HLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~k 616 (791)
+|+||++.|+|.+++...+ ..... .++..+...++.|||.|++||++.++|||||-..|||+.++..+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 9999999999999998876 11111 288999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCC--CcccCcccccCCCCCCchh
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI--SPYHAPESLRSIKPNPKWD 694 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt--~~y~APE~~~~~~~~~~sD 694 (791)
|+|||+|+........... .-.|+ ..|||||.+....|+.|+|
T Consensus 459 IaDFGlar~~~~~~~y~~~-----------------------------------~~~~~LP~kWmApEsl~~~~ft~kSD 503 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTK-----------------------------------SSAGTLPVKWMAPESLFDRVFTSKSD 503 (609)
T ss_pred EccccceeccCCCCceEec-----------------------------------CCCCccceeecCHHHhccCcccccch
Confidence 9999999976543322110 00122 2399999999999999999
Q ss_pred hHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 695 VYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 695 vwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
||||||++|||+| |..||.+- .....+.+...... ....+.....+++++++.||+.+|++||++.++
T Consensus 504 VWSfGI~L~EifsLG~~PYp~~---------~~~~~l~~~l~~G~--r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 504 VWSFGILLWEIFTLGGTPYPGI---------PPTEELLEFLKEGN--RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred hhHHHHHHHHHhhCCCCCCCCC---------CcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 9999999999999 56687541 10011111111111 123334457889999999999999999999999
Q ss_pred HHHhccC
Q 003847 774 LQALEKI 780 (791)
Q Consensus 774 l~~L~~i 780 (791)
.+.++..
T Consensus 573 ~~~~~~~ 579 (609)
T KOG0200|consen 573 VEFFEKH 579 (609)
T ss_pred HHHHHHH
Confidence 9999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-34 Score=271.33 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=190.5
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc-hhh-HHHHHHHHHHHhccCCCCccceeeEEEcc--------CceEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS-VDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGV--------DEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~l 548 (791)
-..||+|.||.||+|+ ..+|+.||+|++-.+. ... -....+|+++|..++|+|++.+++.|... ...|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 4579999999999999 4568889998764321 111 23567899999999999999999988643 34799
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||++|+. +|..++..... +++..++.+++.+++.||.|+|+..|+|||+|+.|+||+.+|.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999964 78877765432 489999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
...... ...+..+-|.-|++||.+.+ ..|+++.|||..|||+.||+|
T Consensus 177 ~~n~~k--------------------------------prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt 224 (376)
T KOG0669|consen 177 SKNVVK--------------------------------PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT 224 (376)
T ss_pred ccccCC--------------------------------CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence 332211 11334456889999999876 678999999999999999999
Q ss_pred CCcchhccccCC------------CCcchhchhH--HHHHH--HHhhhcCccchHHHH------HHHHHHHhhccCCCCC
Q 003847 708 GKVIVVDELGQG------------NGLLVEDKNR--AIRLA--DAAIRADFEGKEEAL------LSCFKLGYSCASPLPQ 765 (791)
Q Consensus 708 G~~pf~~~~~~~------------~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~ 765 (791)
|.+.+.+..... ....+.+... +...+ .+...+.+...++.. ....+++..++..||.
T Consensus 225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~ 304 (376)
T KOG0669|consen 225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT 304 (376)
T ss_pred cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence 999886643311 1111111110 11111 001111111111122 2667899999999999
Q ss_pred CCCCHHHHHHH
Q 003847 766 KRPSMKEALQA 776 (791)
Q Consensus 766 ~RPs~~evl~~ 776 (791)
+|+++++++..
T Consensus 305 kR~~ad~alnh 315 (376)
T KOG0669|consen 305 KRIDADQALNH 315 (376)
T ss_pred cCcchHhhhch
Confidence 99999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=290.94 Aligned_cols=241 Identities=16% Similarity=0.189 Sum_probs=197.9
Q ss_pred eccccCceEEEEEEeCCC-cEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVLEDG-TALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
-||-||||.|-.+..... ..+|+|++++.. ....+.+..|-++|...+.|.||++|..|.+....|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 589999999999986543 359999997642 2334567789999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|+..+..++. ++..+.+-++..+++|++|||++|||.|||||+|.++|.+|.+||.|||+|+.+....
T Consensus 507 lWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~------- 574 (732)
T KOG0614|consen 507 LWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR------- 574 (732)
T ss_pred hhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-------
Confidence 9999887653 8999999999999999999999999999999999999999999999999999886432
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.+-.+|||+.|.|||++.....+.++|.||||+++|||++|++||.....
T Consensus 575 ------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 575 ------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ------------------------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 23467899999999999999999999999999999999999999976532
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
. .....+....-.- ..+........++++++...+|.+|.- +.||-+
T Consensus 625 m---------ktYn~ILkGid~i--~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 625 M---------KTYNLILKGIDKI--EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred H---------HHHHHHHhhhhhh--hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 2 1111111111111 222335667788999999999999974 555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=246.99 Aligned_cols=255 Identities=22% Similarity=0.246 Sum_probs=188.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
-+.||+|.||+||+|+ .++++.||+|++.-+. ...-....+|+-+++.++|.|||+++++...+...-+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 4689999999999999 5678999999986542 222346789999999999999999999999999999999999 56
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..+.....+ .++.+.++.++.|+++||.|+|++++.|||+||.|.|++.+|++|++|||+++..+-...
T Consensus 86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr----- 156 (292)
T KOG0662|consen 86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR----- 156 (292)
T ss_pred HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-----
Confidence 88887766544 389999999999999999999999999999999999999999999999999987652211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
-.+..+-|.-|++|.++.+. -|++..|+||.|||+.|+.. |++.|.+
T Consensus 157 -------------------------------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 -------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred -------------------------------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 11223467789999999875 47999999999999999987 5554543
Q ss_pred cccCCCC--------cchhchh-HHHHHHHHhhhcCccc---hHHHH----HHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNG--------LLVEDKN-RAIRLADAAIRADFEG---KEEAL----LSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~----~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
...+... ...++.+ .+..+.|...-+.++. ..+.. ..-.+++.+.+.-+|.+|.++++.++
T Consensus 206 ~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 206 NDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2110000 0000000 0011111111111111 11111 23357888899999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=252.69 Aligned_cols=206 Identities=24% Similarity=0.349 Sum_probs=168.6
Q ss_pred cchHHHhhhcceeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCce
Q 003847 470 LELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 470 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 546 (791)
|++.+-.-....-||+|+||.|-+.+ ..+|+..|+|++... ..+..++..+|+.+..+. .+|.+|.+||.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44444444455679999999999998 568999999999765 344556788888876655 799999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++.||.| ..+|..+-.+.... ...+++...-+|+..+.+||.|||+ ..++|||+||+|||++.+|++|+||||.+..
T Consensus 121 wIcME~M-~tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999 45787765543322 2358999999999999999999998 6899999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc----CCCCCCchhhHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR----SIKPNPKWDVYSFGVI 701 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~~~~sDvwSlGvi 701 (791)
+..... .+...|...|||||.+. ...|+-|+||||||++
T Consensus 199 L~dSiA-------------------------------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt 241 (282)
T KOG0984|consen 199 LVDSIA-------------------------------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT 241 (282)
T ss_pred ehhhhH-------------------------------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence 754322 11234778899999984 3478999999999999
Q ss_pred HHHHHhCCcchhc
Q 003847 702 LLELLTGKVIVVD 714 (791)
Q Consensus 702 l~elltG~~pf~~ 714 (791)
+.||.+++.||..
T Consensus 242 miElA~lr~PY~~ 254 (282)
T KOG0984|consen 242 MIEMAILRFPYES 254 (282)
T ss_pred hhhhhhccccccc
Confidence 9999999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=304.95 Aligned_cols=249 Identities=28% Similarity=0.396 Sum_probs=190.0
Q ss_pred hhhcceeccccCce-EEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 476 LKASAYILGASGSS-IMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 476 ~~~~~~~lG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.....+++|.|..| .||+|..+ |+.||||++-... ..-.++|+..|+.- +|||||++++.-.++...||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34456789999876 68999985 7899999986543 34578899999887 6999999999988999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---C--CCeEEeccCcccccCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---D--MEPKIGDFGLERLVTG 628 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~--~~~kL~DFGla~~~~~ 628 (791)
..+|.+++... ............+.++.|+++||++||+.+||||||||.||||+. + .+++|+|||+++.+..
T Consensus 586 -~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 -ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 56999999874 111111121455788999999999999999999999999999975 3 4689999999998875
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
+..... ......||-+|+|||++....-+.++||||+|||+|+.++|
T Consensus 664 ~~sS~~---------------------------------r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 664 GKSSFS---------------------------------RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred Ccchhh---------------------------------cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecC
Confidence 443211 13345699999999999998888999999999999999997
Q ss_pred -CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 709 -KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 709 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.+||.+...+.......+. . + .......+. ...+||.+|+++||..||+|.+|+.
T Consensus 711 G~HpFGd~~~R~~NIl~~~~-~--------L-~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 711 GSHPFGDSLERQANILTGNY-T--------L-VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CccCCCchHHhhhhhhcCcc-c--------e-eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 7799775433221111100 0 0 001111112 6789999999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=286.71 Aligned_cols=239 Identities=18% Similarity=0.223 Sum_probs=180.9
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchh---hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVD---RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-.-||-|+||.|.+++ .++...||.|.+.+...- ....++.|-+||...+.+-||+||-.|.+++..|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3569999999999998 556788999998764322 234577899999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|++-.+|-+.+- +++..++.++..+..|+++.|..|+|||||||+|||||.+|.+||+|||+|.-+.-.....+.
T Consensus 714 GDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 714 GDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred ccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999998887653 888899999999999999999999999999999999999999999999998755432222211
Q ss_pred CCCccccCCcccccc-cccccCCCCCCC-------C-CCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 636 GGSARNFGSKRSTAS-RDSFQDLGPGPS-------P-SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~-------~-~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
... .+.+..... .....+.+...- . .........+||+.|+|||++....|+..+|.||.|||||||+
T Consensus 789 q~g---dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 789 QEG---DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cCC---CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 100 000000000 000000000000 0 0011234578999999999999999999999999999999999
Q ss_pred hCCcchhccccCCCCcchhc
Q 003847 707 TGKVIVVDELGQGNGLLVED 726 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~ 726 (791)
.|+.||.++........+.+
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN 885 (1034)
T ss_pred hCCCCccCCCCCcceeeeee
Confidence 99999988766544444433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=267.32 Aligned_cols=243 Identities=20% Similarity=0.258 Sum_probs=195.9
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
-.+||+|+|+.|..++ .++.+.+|+|++++. ..+...=.+.|-.+..+. +||.+|.++.+|..+...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 3589999999999999 567899999999874 222334466777777766 79999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
||+|--.+++++ +++++.++-+...|..||.|||++|||.||||.+|+|+|..|.+||+|+|+++.--.
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~------ 403 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG------ 403 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC------
Confidence 999977666554 399999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
+...++.+|||+.|+|||++++..|+..+|.|++||+++||+.|+.||.-
T Consensus 404 ------------------------------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 404 ------------------------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ------------------------------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 22345678999999999999999999999999999999999999999953
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
--.+.. +...-..++.-.+......+...+.....++..-+++||.+|.
T Consensus 454 vgm~n~-----d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 454 VGMDNP-----DMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ecCCCc-----ccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 221111 1111223333344444444444566677888899999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=278.12 Aligned_cols=255 Identities=24% Similarity=0.284 Sum_probs=195.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chh-----hHHHHHHHHHHHhccCCCCccceeeEEEcc-CceEEEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVD-----RFRDFETQVRVIAKLVHPNLVRIRGFYWGV-DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~ 550 (791)
-++||+|||+.||+|. +...+.||||+-.-. -.+ -.+...+|.+|-+.|+||.||++|++|.-+ +.+|-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 3689999999999998 566899999986432 111 123466899999999999999999999754 5678999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCeecCCCCCCeEec---CCCCeEEeccCcccc
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--KKHVHGNLKPRNVLLG---NDMEPKIGDFGLERL 625 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~ 625 (791)
|||+|.+|.-+++.+.. +++.+++.|+.||+.||.||.+ ..|||-||||.|||+- ..|.+||.|||+++.
T Consensus 548 EYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 99999999999988764 8999999999999999999998 6899999999999994 457899999999999
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC----CCCCCchhhHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS----IKPNPKWDVYSFGVI 701 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~~sDvwSlGvi 701 (791)
+..+......+. ...+...||.-|++||.+.- .+.+.|+||||+|||
T Consensus 623 MdddSy~~vdGm-----------------------------eLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 623 MDDDSYNSVDGM-----------------------------ELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred ccCCccCcccce-----------------------------eeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 876554333221 12334569999999999843 346889999999999
Q ss_pred HHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 702 LLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|..+.|+.||..+..+. ..++ ... ++.. ..-.++.......+...||++||++--++|....++..
T Consensus 674 FyQClYGrKPFGhnqsQQ--dILq-eNT---IlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 674 FYQCLYGRKPFGHNQSQQ--DILQ-ENT---ILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhhhccCCCCCCchhHH--HHHh-hhc---hhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 999999999996542210 0111 111 1111 11123333345677889999999999999988877754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=269.72 Aligned_cols=235 Identities=26% Similarity=0.353 Sum_probs=192.1
Q ss_pred CceEEEEEEeC-CCcEEEEEEcCCCchhh-HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhHHHHh
Q 003847 487 GSSIMYKAVLE-DGTALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYR 564 (791)
Q Consensus 487 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 564 (791)
+||.||++... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999997764443 67899999999999999999999999999999999999999999998876
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCC
Q 003847 565 KMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644 (791)
Q Consensus 565 ~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 644 (791)
... +++..+..++.+++.+++|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~------------- 142 (244)
T smart00220 81 RGR-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL------------- 142 (244)
T ss_pred ccC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc-------------
Confidence 432 78999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcch
Q 003847 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLV 724 (791)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~ 724 (791)
.....++..|++||...+..++.++||||||+++++|++|..||....
T Consensus 143 ------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------- 190 (244)
T smart00220 143 ------------------------LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------- 190 (244)
T ss_pred ------------------------cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 112347788999999988888999999999999999999999985420
Q ss_pred hchhHHHHHHHHhhhcCccchHH---HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 725 EDKNRAIRLADAAIRADFEGKEE---ALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+. ....+............ ....+.+++.+|+..+|++||++.++++
T Consensus 191 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 191 -QL---LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -cH---HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11 11111111111111111 4467889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=291.76 Aligned_cols=260 Identities=19% Similarity=0.222 Sum_probs=176.8
Q ss_pred cceeccccCceEEEEEEe-----------------CCCcEEEEEEcCCCchhhHHH--------------HHHHHHHHhc
Q 003847 479 SAYILGASGSSIMYKAVL-----------------EDGTALAVRRIGENSVDRFRD--------------FETQVRVIAK 527 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~ 527 (791)
..++||+|+||+||+|.. .+++.||||++........++ ...|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999963 245789999987543322233 3346777777
Q ss_pred cCCCC-----ccceeeEEEc--------cCceEEEEeccCCCChhHHHHhhcCC-------------------CCCCCCH
Q 003847 528 LVHPN-----LVRIRGFYWG--------VDEKLIIYDFVPNGSLANARYRKMGS-------------------SPCHLPW 575 (791)
Q Consensus 528 l~H~n-----Iv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~ 575 (791)
++|.+ +++++++|.. .+..++||||+++++|.++++..... ....+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 76655 4777887753 35689999999999999998753211 0123577
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCccccccccccc
Q 003847 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655 (791)
Q Consensus 576 ~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (791)
..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~----------------------- 365 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF----------------------- 365 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----------------------
Confidence 889999999999999999999999999999999999999999999998754321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--------------------C--CCchhhHHHHHHHHHHHhCCc-ch
Q 003847 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--------------------P--NPKWDVYSFGVILLELLTGKV-IV 712 (791)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--------------------~--~~~sDvwSlGvil~elltG~~-pf 712 (791)
......+|+.|+|||.+.... + ..+.||||+||++|+|++|.. ||
T Consensus 366 ------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 366 ------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 001112578899999875422 1 234799999999999999986 66
Q ss_pred hccccCCCCcchhc-hhHHHHHHH-HhhhcCccchHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVED-KNRAIRLAD-AAIRADFEGKEEALLSCFKLGYSCASPLP---QKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 775 (791)
.+...... .... ......+.. ......++..........+++.+||..+| .+|+|++|+++
T Consensus 434 ~~~~~f~~--~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 434 ANIRLFNT--ELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cchhhhhh--HHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 43211000 0000 000000000 00011222222345678899999999866 68999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=300.61 Aligned_cols=259 Identities=19% Similarity=0.155 Sum_probs=163.2
Q ss_pred cceeccccCceEEEEEEeC-C----CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeE------EEccCceE
Q 003847 479 SAYILGASGSSIMYKAVLE-D----GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGF------YWGVDEKL 547 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~~~~~~~ 547 (791)
..+.||+|+||.||+|+.. + +..||||++...... +....| .++...+.+++.++.. .......+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 3578999999999999954 4 689999998654321 111111 1222223333333222 23456789
Q ss_pred EEEeccCCCChhHHHHhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-
Q 003847 548 IIYDFVPNGSLANARYRKMGSS---------------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN- 611 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~- 611 (791)
+||||+++++|.+++....... ........+..|+.|++.||+|||+++|+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 9999999999999887542100 001123456689999999999999999999999999999986
Q ss_pred CCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC----
Q 003847 612 DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI---- 687 (791)
Q Consensus 612 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---- 687 (791)
++.+||+|||+++.+...... ......||+.|+|||.+...
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~-----------------------------------~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINY-----------------------------------IPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred CCcEEEEeCCCcccccccccc-----------------------------------CCcccccCCCccChHHhhccCCCC
Confidence 578999999999865322110 11234588999999965321
Q ss_pred ------------------CCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHH---HHHhh----hcCc
Q 003847 688 ------------------KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRL---ADAAI----RADF 742 (791)
Q Consensus 688 ------------------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~----~~~~ 742 (791)
.++.++|||||||++|||+++..++....................+ ..... ...+
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF 416 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhh
Confidence 2345679999999999999987664332110000000000000000 00000 0000
Q ss_pred cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 743 EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 743 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...........+|+.+||+.||++|||++|+++.
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 0000012235689999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.87 Aligned_cols=258 Identities=19% Similarity=0.263 Sum_probs=200.0
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEcc-CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e 551 (791)
..++-+|.||.||.|.+. +.+.|-||.++... .-....+..|...+..+.|||+.++.+++.++ +..+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 456789999999999643 34667788876653 33345688899999999999999999998765 45689999
Q ss_pred ccCCCChhHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGSS---PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
++.-|+|..++...++.. ...++-.+...++.|++.|++|||+.||||.||...|.++|+.-++||+|=.+++.+-+
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP 448 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCc
Confidence 999999999998554432 23466677888999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT- 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt- 707 (791)
.+...-.... .....||+||.+....|+.++|||||||++|||+|
T Consensus 449 ~DYhcLGDnE----------------------------------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 449 GDYHCLGDNE----------------------------------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred ccccccCCCC----------------------------------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 4432211110 02334999999999999999999999999999998
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
|+.||.+..+.++..++.++.+ ...+.+++++++.++.-||..+|++||+.+|+..-|.+....
T Consensus 495 g~~PyaeIDPfEm~~ylkdGyR------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 495 GKLPYAEIDPFEMEHYLKDGYR------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CCCCccccCHHHHHHHHhccce------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 7789866433222222222211 122334778899999999999999999999999998876443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=255.03 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=187.7
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC-----ceEEEEec
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~ 552 (791)
.-||.|+||+||.+. -++|+.||+|++... +....+++-+|+++|..++|.|++..+++..-.. +.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 468999999999998 457999999998653 3344578889999999999999999999876543 56889998
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
| ..+|..++-. +.+++-..++.+++||++||+|||+.+|.||||||.|.|++.+-.+||+|||+++....+...
T Consensus 139 m-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 139 M-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred H-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8 4577665543 235889999999999999999999999999999999999999999999999999976543321
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.++..+-|.+|+|||++.+ ..|+.+.||||+|||+.|++-.+..
T Consensus 213 -----------------------------------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL 257 (449)
T KOG0664|consen 213 -----------------------------------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL 257 (449)
T ss_pred -----------------------------------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh
Confidence 1223346788999999987 5689999999999999999988887
Q ss_pred hhccccCCCCcc---------hhchhHHHHH-HHHhhhcCc-----------cchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 712 VVDELGQGNGLL---------VEDKNRAIRL-ADAAIRADF-----------EGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 712 f~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
|.....-....+ .+.++..-+- ....+++.. ........+..++...++..||++|.+.
T Consensus 258 FQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~ 337 (449)
T KOG0664|consen 258 FQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV 337 (449)
T ss_pred hhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH
Confidence 754322110000 0111111000 011111111 0111122345678889999999999999
Q ss_pred HHHHHHh
Q 003847 771 KEALQAL 777 (791)
Q Consensus 771 ~evl~~L 777 (791)
.+.+..+
T Consensus 338 ~~A~~~~ 344 (449)
T KOG0664|consen 338 EEALQHR 344 (449)
T ss_pred hhhcccc
Confidence 9887654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=310.47 Aligned_cols=224 Identities=39% Similarity=0.719 Sum_probs=153.8
Q ss_pred CChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCE
Q 003847 30 GLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQY 109 (791)
Q Consensus 30 ~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~ 109 (791)
..+.|..+|++||.++ .+|.+.+.+|+. +.+||.|.||+|+. .++|+.|+|++|++.|.++..|..+++|+.
T Consensus 26 ~~~~~~~~l~~~~~~~-~~~~~~~~~w~~-~~~~c~w~gv~c~~------~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 26 LHAEELELLLSFKSSI-NDPLKYLSNWNS-SADVCLWQGITCNN------SSRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred CCHHHHHHHHHHHHhC-CCCcccCCCCCC-CCCCCcCcceecCC------CCcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 4557899999999998 578888999974 45899999999972 468999999999999999989999999999
Q ss_pred EeCcCCCCCCCCccccc-CCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCc
Q 003847 110 LDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNY 188 (791)
Q Consensus 110 L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 188 (791)
|+|++|++.+.+|..+. ++++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..+.++++|++|+|++|.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 99999999888887655 777777777777777765554 345556666666666655555555555666666666665
Q ss_pred CCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC
Q 003847 189 FSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264 (791)
Q Consensus 189 l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~ 264 (791)
+.+.+|..+ ++|++|+|++|.+++.+|..++. .+|++|+|++|++++.+|..+.. +++|++|+|++|++++.+|.
T Consensus 176 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~ 254 (968)
T PLN00113 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLVYNNLTGPIPS 254 (968)
T ss_pred ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc-CCCCCEEECcCceeccccCh
Confidence 555555433 45555555555555555555544 34555555555555555555544 55555555555555554443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=268.62 Aligned_cols=266 Identities=18% Similarity=0.206 Sum_probs=201.6
Q ss_pred CcccchHHHhhhcc---eeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC------CCCccce
Q 003847 467 DKELELETLLKASA---YILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV------HPNLVRI 536 (791)
Q Consensus 467 ~~~~~~~~~~~~~~---~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l 536 (791)
...+.+.+++...- -..|+|-|++|..|.. ..|..||||+|..... ..+.-..|+++|++|+ -.|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34566666665433 3568999999999994 4588999999976533 3456678999999995 4589999
Q ss_pred eeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCe
Q 003847 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEP 615 (791)
Q Consensus 537 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~ 615 (791)
+..|...++.|||+|-+ ..+|.+++...+..- .|....+..++.|+.-||..|-..||+|.||||+|||+++. ..+
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 99999999999999988 579999998876544 38889999999999999999999999999999999999875 457
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||||||.|........+++ .-+..|+|||++.+..|+...|+
T Consensus 577 KLCDfGSA~~~~eneitPY--------------------------------------LVSRFYRaPEIiLG~~yd~~iD~ 618 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITPY--------------------------------------LVSRFYRAPEIILGLPYDYPIDT 618 (752)
T ss_pred eeccCccccccccccccHH--------------------------------------HHHHhccCcceeecCcccCCccc
Confidence 9999999988765544322 24556999999999999999999
Q ss_pred HHHHHHHHHHHhCCcchhccccC------------CCCcchhchh---------------------------------HH
Q 003847 696 YSFGVILLELLTGKVIVVDELGQ------------GNGLLVEDKN---------------------------------RA 730 (791)
Q Consensus 696 wSlGvil~elltG~~pf~~~~~~------------~~~~~~~~~~---------------------------------~~ 730 (791)
||+||+||||.||+..|.+.... ....++.... ..
T Consensus 619 WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt 698 (752)
T KOG0670|consen 619 WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT 698 (752)
T ss_pred eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc
Confidence 99999999999999887542220 0001111100 00
Q ss_pred HHHHHHhhhcC--c-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 731 IRLADAAIRAD--F-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 731 ~~~~~~~~~~~--~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.++ ...+.+. + ........++.+|+..|+..||++|.|..++|+
T Consensus 699 kdl-~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 699 KDL-GSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhH-HHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111 1111111 1 122335567889999999999999999999886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=255.51 Aligned_cols=126 Identities=18% Similarity=0.266 Sum_probs=108.2
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-----C---CCccceeeEEEcc----Cc
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-----H---PNLVRIRGFYWGV----DE 545 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~~----~~ 545 (791)
....||-|.|++||++. .++.+.||+|+.+.... -.+....||++|++++ | .+||+|+++|... .+
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 35789999999999998 56789999999876433 2356788999999983 3 3699999999854 47
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEe
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLL 609 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl 609 (791)
.++|+|++ |.+|..+|.....++ ++...+++|++||+.||.|||+ .||||-||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~YrG---lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYRG---LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCCC---CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 89999999 789999988776554 9999999999999999999998 799999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=252.46 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=184.8
Q ss_pred eccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEEec
Q 003847 482 ILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIYDF 552 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~e~ 552 (791)
-+|.|.. .|..|. .-.++.||+|++... .....++..+|..++..++|+||++++.+|.-.. +.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4566666 444444 235899999998553 2334567889999999999999999999986443 57999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
| ..+|.+.+... ++-+.+..|..|++.|++|||+.||+||||||+||++..+..+||.|||+|+....+
T Consensus 103 m-~~nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--- 171 (369)
T KOG0665|consen 103 M-DANLCQVILME-------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--- 171 (369)
T ss_pred h-hhHHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---
Confidence 9 57999888732 777899999999999999999999999999999999999999999999999865422
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
...+.++.|..|+|||++.+..|.+.+||||+||++.||++|+..|
T Consensus 172 ----------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 172 ----------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred ----------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 1244567899999999999988999999999999999999999877
Q ss_pred hccc--cCCCCc----------chhchhHHHHHH-----------------HHhhhcCccchHHHHHHHHHHHhhccCCC
Q 003847 713 VDEL--GQGNGL----------LVEDKNRAIRLA-----------------DAAIRADFEGKEEALLSCFKLGYSCASPL 763 (791)
Q Consensus 713 ~~~~--~~~~~~----------~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~d 763 (791)
.+.. ++|... ...+.....+.+ |.......+........+.+++.+||..|
T Consensus 218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 5421 111111 000000000000 01111111112123345678999999999
Q ss_pred CCCCCCHHHHHHH
Q 003847 764 PQKRPSMKEALQA 776 (791)
Q Consensus 764 P~~RPs~~evl~~ 776 (791)
|++|.+++++|+.
T Consensus 298 pe~Risv~daL~H 310 (369)
T KOG0665|consen 298 PEKRISVDDALRH 310 (369)
T ss_pred hhhcccHHHHhcC
Confidence 9999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=238.79 Aligned_cols=247 Identities=15% Similarity=0.228 Sum_probs=184.6
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccC--ceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVD--EKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv~e~~~~g 556 (791)
..+|+|-|+.||.|. ..+++.++||+++.. ..+.+.+|+.||+.|. ||||++++++..++. ...+|+||+.+.
T Consensus 44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 479999999999999 567899999999864 3478899999999997 999999999988765 457999999988
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+...+.. .++..+++.++.+++.||.|+|+.||+|||+||.|+++|.. -.++|+|+|+|....+.....
T Consensus 121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn-- 190 (338)
T KOG0668|consen 121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN-- 190 (338)
T ss_pred cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee--
Confidence 7765432 27888999999999999999999999999999999999965 458999999999876543221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
..+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||..
T Consensus 191 -----------------------------------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 191 -----------------------------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred -----------------------------------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 2235666899999865 5678999999999999999999999854
Q ss_pred cccCCCCcc-hhc---hhHH---------------HHHHHHhhhcCc------cchHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 715 ELGQGNGLL-VED---KNRA---------------IRLADAAIRADF------EGKEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 715 ~~~~~~~~~-~~~---~~~~---------------~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
......... +.. ...+ ..+.....+..+ ....-..++.++++.+.|..|..+|+|
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 322110000 000 0000 000100000000 000112357889999999999999999
Q ss_pred HHHHHH
Q 003847 770 MKEALQ 775 (791)
Q Consensus 770 ~~evl~ 775 (791)
++|.+.
T Consensus 316 akEam~ 321 (338)
T KOG0668|consen 316 AKEAMA 321 (338)
T ss_pred hHHHhc
Confidence 999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=267.89 Aligned_cols=193 Identities=19% Similarity=0.259 Sum_probs=166.0
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchh--------hHHHHHHHHHHHhccC---CCCccceeeEEEccCce
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVD--------RFRDFETQVRVIAKLV---HPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~ 546 (791)
+-..+|+|+||.|+.|.++ +...|+||.+.+...- ....+-.|+.||..++ |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 3467999999999999954 5678999998764221 1223567999999997 99999999999999999
Q ss_pred EEEEecc-CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 547 LIIYDFV-PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 547 ~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
||+||-- ++.+|.+++..+.. +++.++..|++||+.|+++||+.||||||||-+||.++.+|-+||+|||.+.+
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred EEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999964 56799999988764 99999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLE 704 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~e 704 (791)
..... ...++||..|.|||++.+.+| +..-|||++|++||.
T Consensus 720 ~ksgp--------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyt 761 (772)
T KOG1152|consen 720 TKSGP--------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYT 761 (772)
T ss_pred hcCCC--------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeE
Confidence 65322 124569999999999999888 667999999999999
Q ss_pred HHhCCcchhc
Q 003847 705 LLTGKVIVVD 714 (791)
Q Consensus 705 lltG~~pf~~ 714 (791)
++....||+.
T Consensus 762 ivykenpyyn 771 (772)
T KOG1152|consen 762 IVYKENPYYN 771 (772)
T ss_pred EEeccCCCcC
Confidence 9998888853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-28 Score=240.87 Aligned_cols=211 Identities=31% Similarity=0.498 Sum_probs=182.1
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhH
Q 003847 483 LGASGSSIMYKAVLE-DGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560 (791)
Q Consensus 483 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 560 (791)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999876442 34679999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 561 ~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
++.... ..+++..+..++.+++++|+|||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------- 148 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------- 148 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--------
Confidence 987653 13889999999999999999999999999999999999999 89999999999886643211
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......+...|++||..... .++.+.|+|++|+++++|
T Consensus 149 ----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------- 187 (215)
T cd00180 149 ----------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187 (215)
T ss_pred ----------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------
Confidence 01112366779999999877 788999999999999998
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 -------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4567889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-30 Score=274.73 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=198.9
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
..+|.|.||.|||++ ..+++..|||+++-...+.+...++|+-+++..+|+|||.+++.|...+..++.||||.+|+|+
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 479999999999999 5679999999999887777888999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+.-+..+ ++++.++...++..++||+|||+.|-+|||||-.||++++.|.+|++|||.+..+.....
T Consensus 101 diy~~Tg-----plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-------- 167 (829)
T KOG0576|consen 101 DIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-------- 167 (829)
T ss_pred ceeeecc-----cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--------
Confidence 8655443 499999999999999999999999999999999999999999999999999887653211
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc---cCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL---RSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
...++.||++|||||+. +.+.|..++|||++|+...|+---++|..+-.
T Consensus 168 ----------------------------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 168 ----------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred ----------------------------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 23356799999999987 45789999999999999999988777754432
Q ss_pred cCCCCcchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.. +...-+...... ............+.+|++.|+..+|++||+++.++.
T Consensus 220 pm---------r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 220 PM---------RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hH---------HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 21 111111111110 111122235567889999999999999999987653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=252.52 Aligned_cols=225 Identities=21% Similarity=0.304 Sum_probs=166.6
Q ss_pred ceeccccCceEEEEEEeC----CCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE----DGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|.|++||++... .++.||+|.+...+.. ..+.+|+++|..+ -+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 468999999999999843 4789999999765433 5688999999999 59999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~ 633 (791)
.....++... ++..++..+++.++.||+++|.+|||||||||+|+|.+. .+.-.|+|||+|..........
T Consensus 119 H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 9888776553 778999999999999999999999999999999999984 4678999999998432211110
Q ss_pred cCCC----Cccc-cCCcccccc-cccccCCCCCC--CCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHH
Q 003847 634 KAGG----SARN-FGSKRSTAS-RDSFQDLGPGP--SPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 634 ~~~~----~~~~-~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~e 704 (791)
.... .... -+....... ...-...++.. ............||++|+|||++.. ...++++||||.|||++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0000 0000 000000000 00001112222 1223334556789999999999865 456889999999999999
Q ss_pred HHhCCcchhc
Q 003847 705 LLTGKVIVVD 714 (791)
Q Consensus 705 lltG~~pf~~ 714 (791)
+++++.||..
T Consensus 271 lls~~~PFf~ 280 (418)
T KOG1167|consen 271 LLSRRYPFFK 280 (418)
T ss_pred hhcccccccc
Confidence 9999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=233.30 Aligned_cols=196 Identities=30% Similarity=0.460 Sum_probs=169.4
Q ss_pred ceeccccCceEEEEEEeCC-CcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLED-GTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999764 899999999876544 56789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~----- 154 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA----- 154 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-----
Confidence 9999876542 1788999999999999999999999999999999999999999999999998876533200
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc-cCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 01123467779999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=228.08 Aligned_cols=256 Identities=21% Similarity=0.235 Sum_probs=182.2
Q ss_pred cchHHHhhhcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeE-EEccCce
Q 003847 470 LELETLLKASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGF-YWGVDEK 546 (791)
Q Consensus 470 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~ 546 (791)
+++++. +.....+|+|.||.+-.++++ +.+.+|+|.+..... ..++|.+|..---.| .|.||+.-|++ |+..+.+
T Consensus 20 v~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred cchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 444443 334568999999999999954 578999999976533 357899888765555 59999988775 5666778
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe-c-CCCCeEEeccCccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL-G-NDMEPKIGDFGLER 624 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl-~-~~~~~kL~DFGla~ 624 (791)
++++||++.|+|..-+...+ +-+...++++.|+++||.|||+.++||||||.+|||+ + +..++||||||..+
T Consensus 98 vF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 89999999999987665533 7888999999999999999999999999999999999 3 34579999999988
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFG 699 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlG 699 (791)
..+.... ...-+..|.|||.... -...+.+|||.||
T Consensus 172 k~g~tV~---------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 172 KVGTTVK---------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred ccCceeh---------------------------------------hhhhhcccCCcHHHhhccccceEecccccchhee
Confidence 6542211 1113556999998743 2347889999999
Q ss_pred HHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 700 VILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 700 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
+++|.++||+.||......... . ........................+.++.++-+..+|++|-...++.++.
T Consensus 213 Ii~f~cltG~~PWQka~~~d~~-Y----~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 213 IIFFYCLTGKFPWQKASIMDKP-Y----WEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred eeeeeeecCCCcchhhhccCch-H----HHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 9999999999999743221111 1 11111111111111111112345677788899999999996555555543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=273.19 Aligned_cols=227 Identities=18% Similarity=0.131 Sum_probs=147.0
Q ss_pred ccCC-CCccceeeEE-------EccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCe
Q 003847 527 KLVH-PNLVRIRGFY-------WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598 (791)
Q Consensus 527 ~l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iv 598 (791)
.++| +||++++++| ...+..++++||+ +++|.+++.... ..+++.+++.|+.||++||+|||++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4455 5888888887 2334567788887 669999987532 1389999999999999999999999999
Q ss_pred ecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccc--cccccCCCCCCCCCC-CCCCCCCCCC
Q 003847 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS--RDSFQDLGPGPSPSP-SPSPSSLGGI 675 (791)
Q Consensus 599 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~gt 675 (791)
||||||+||||+..+.+|++|||++.....+..... ....|+..+.... ........ .....+ .......+||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~---ki~DfG~a~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATT---KSREIGSSRREEILSERRIEKLE-EVKKQPFPMKQILAMEM 178 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcc---cccccccccccccccccchhhhh-ccccCCCcccccccCCC
Confidence 999999999998888888888887765432211000 0001111100000 00000000 000000 0111234689
Q ss_pred CcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHH
Q 003847 676 SPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKL 755 (791)
Q Consensus 676 ~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 755 (791)
+.|||||++.+..|+.++|||||||++|||++|..|+.... .....+....... ..........++
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----------~~~~~~~~~~~~~---~~~~~~~~~~~~ 244 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----------RTMSSLRHRVLPP---QILLNWPKEASF 244 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----------HHHHHHHHhhcCh---hhhhcCHHHHHH
Confidence 99999999999999999999999999999999988764321 0011111111111 011123445688
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 003847 756 GYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 756 i~~cl~~dP~~RPs~~evl~~ 776 (791)
+.+||+.+|.+||++.|+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=214.51 Aligned_cols=164 Identities=25% Similarity=0.191 Sum_probs=124.9
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... ++++.+++.|+.|++.||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 689998876432 3999999999999999999999998 999999999999999 99987653210
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ------------------------------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ------------------------------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ------------------------------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 13788999999999999999999999999999999999998543
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhc---CccchHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRA---DFEGKEEALL--SCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
... ......+....... .......... .+.+++.+||+.+|++||++.|+++.+..+
T Consensus 108 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 108 REL--------SAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred chh--------cHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 210 00111111111111 0011122222 689999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=221.67 Aligned_cols=133 Identities=22% Similarity=0.204 Sum_probs=108.6
Q ss_pred ceeccccCceEEEEEEeC--CCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccc-eeeEEEccCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE--DGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVR-IRGFYWGVDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lv~e 551 (791)
...||+|+||+||+|... +++.||||++... .....+.+.+|+++|++++|+||++ +++ .+..|+|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEE
Confidence 468999999999999854 5788899987533 1223467999999999999999985 443 246899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCC-CCCCeEecCCCCeEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL-KPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl-kp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
|++|++|... . . .. ...++.|+++||+|||+.||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 99 ~~~G~~L~~~-~--~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 99 WTEGVPLHLA-R--P------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred ccCCCCHHHh-C--c------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 9999999621 1 0 11 1467899999999999999999999 99999999999999999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=215.50 Aligned_cols=261 Identities=19% Similarity=0.193 Sum_probs=188.9
Q ss_pred cceeccccCceEEEEEEeCC--CcEEEEEEcCCCchhhHHHHHHHHHHHhccCC----CCccceeeEE-EccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLED--GTALAVRRIGENSVDRFRDFETQVRVIAKLVH----PNLVRIRGFY-WGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~lv~e 551 (791)
....||+|+||.||.+.... ...+|+|............+..|+.++..+.. +++..+++.. ......|+||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 34689999999999999554 35899998766433322367888999988863 6899999998 47778899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-----CCeEEeccCccccc
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-----MEPKIGDFGLERLV 626 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-----~~~kL~DFGla~~~ 626 (791)
.+ |.+|.++...... ..++..++.+|+.|++.+|++||+.|++||||||+|++++.. ..+.|.|||+++..
T Consensus 102 l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred cc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 88 8899998765542 249999999999999999999999999999999999999865 35899999999833
Q ss_pred C--CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCC-CCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 627 T--GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS-PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 627 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
. ...... .. +... .....||..|.++.+..+...+.+.|+||++.++.
T Consensus 178 ~~~~~~~~~--~~---------------------------~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~ 228 (322)
T KOG1164|consen 178 KYVGDSGGN--LR---------------------------PPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLL 228 (322)
T ss_pred cccCCCCcc--cc---------------------------cCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHH
Confidence 2 111100 00 0011 23456999999999999999999999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|++.|..||........ ............... ........+.++...+-..+..++|....+...|+..
T Consensus 229 el~~g~LPW~~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 229 ELLKGSLPWEALEMTDL------KSKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhcCCCCCccccccch------HHHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 99999999854322111 111111111111110 0011223455555556668899999999999887665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=200.61 Aligned_cols=204 Identities=17% Similarity=0.212 Sum_probs=172.5
Q ss_pred hhcceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 477 KASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
+..+..||+|.||+++.|+ +-+++.||||.-...+. ..++..|.+..+.| ..++|...|-+..+..+-.+|+|++
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 3446789999999999999 66899999998765433 25788899988888 4789999988888888889999998
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-----CeEEeccCcccccCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-----EPKIGDFGLERLVTGD 629 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-----~~kL~DFGla~~~~~~ 629 (791)
|.+|.|+..-... .++..++..||.|++.-++|+|++.+|.|||||+|+||...+ .+.|+|||+|+.+.+.
T Consensus 107 GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 8999998877665 399999999999999999999999999999999999997543 4899999999988755
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
...... +.....+..||..||+-....+..-+.+.|+-|+|-++.+.+-|.
T Consensus 183 ~TkqHI-----------------------------PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 183 KTKQHI-----------------------------PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred cccccC-----------------------------ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 443322 233455677999999999999988999999999999999999999
Q ss_pred cchhccc
Q 003847 710 VIVVDEL 716 (791)
Q Consensus 710 ~pf~~~~ 716 (791)
.||.+--
T Consensus 234 LPWQGLK 240 (449)
T KOG1165|consen 234 LPWQGLK 240 (449)
T ss_pred Ccccccc
Confidence 9997743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=239.09 Aligned_cols=257 Identities=19% Similarity=0.211 Sum_probs=187.7
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcC----C-Cchhh-HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIG----E-NSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
....++|.|++|.|+.+.. .....++.|... . ..... ...+..|+.+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567999999998887763 334444444432 1 11111 122667787888899999999888887777776679
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
|||++ +|..++.... .+...++..++.|++.|++|+|+.||.|||+|++|++++.+|.+||+|||.+.....+.
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999887752 27888999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCC-chhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP-KWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~sDvwSlGvil~elltG~ 709 (791)
.. ........+|+.+|+|||++.+..|.+ ..||||.|+++..|++|+
T Consensus 475 e~--------------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 475 EK--------------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred ch--------------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 21 112344677999999999999999976 689999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.||...........-.... . -.....+........+.....++.+||+.||.+|.|+++|++.
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYS--D--QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred Cccccccccccchhhhccc--c--ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 9986543322211000000 0 0000111112223345667889999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=188.39 Aligned_cols=200 Identities=18% Similarity=0.252 Sum_probs=164.6
Q ss_pred eeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 481 YILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..||.|+||.+|.|. ..+|+.||||.-..... ..++..|.++.+.|+ ...|..+..+..+.....+|||.+ |.+|
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 579999999999999 67899999998765433 256778899999886 467888888888889999999998 8999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCCCCcC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
.++..-... .++..+++.++-|++.-++|+|.+++|||||||+|+|+.- ...+.++|||+|+...+.......
T Consensus 98 EdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 98 EDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred HHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 998765543 3899999999999999999999999999999999999963 356899999999987643322211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
+...-....||..|.+-....+...+.+.|+-|+|.++....-|..||.+-
T Consensus 174 -----------------------------pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 174 -----------------------------PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred -----------------------------ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 122334566999999988777777788999999999999999999999774
Q ss_pred c
Q 003847 716 L 716 (791)
Q Consensus 716 ~ 716 (791)
.
T Consensus 225 k 225 (341)
T KOG1163|consen 225 K 225 (341)
T ss_pred c
Confidence 3
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=196.68 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=184.5
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.|.+...|..|+|+++ |..+++|++.-. .....++|..|.-.|+-+.||||+.+++.|..+.+..++..||+.|+|+
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 5777889999999986 556677877543 3344578999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-C-CeecCCCCCCeEecCCCCeEEe--ccCcccccCCCCCCCcC
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-K-HVHGNLKPRNVLLGNDMEPKIG--DFGLERLVTGDTSSSKA 635 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~-ivHrDlkp~NILl~~~~~~kL~--DFGla~~~~~~~~~~~~ 635 (791)
+.+++...- ..+..++.+++.+|++|++|||+. . |..--|.+..+++|++.+++|+ |--++.
T Consensus 276 nvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----------- 341 (448)
T KOG0195|consen 276 NVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----------- 341 (448)
T ss_pred HHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----------
Confidence 999986542 367788999999999999999993 3 4455688999999999887764 221111
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC---CCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP---NPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~sDvwSlGvil~elltG~~pf 712 (791)
|.. ...-.+.||+||.+...+- -.++|+|||.+++||+.|...||
T Consensus 342 -------------------qe~-------------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 342 -------------------QEV-------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred -------------------ecc-------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 111 1113566999999976543 35799999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.+-......+. +.-..++...+ ......+.+++.-|++.||.+||.++.|+-.||++.
T Consensus 390 adlspmecgmk---------ialeglrv~ip--pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 390 ADLSPMECGMK---------IALEGLRVHIP--PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCchhhhhh---------hhhccccccCC--CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 77543322221 11122222222 225567788999999999999999999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=203.68 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=193.0
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchh---hHHHHHHHHHHHhccCCC-CccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVD---RFRDFETQVRVIAKLVHP-NLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 457899999999999976 88999999765332 367899999999999988 799999999777778999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++.+++...... ..+.......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++..........
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999766554311 1388899999999999999999999999999999999999988 799999999985543221110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.. .......||..|+|||.+.+ ..++...|+||+|++++++++|..|
T Consensus 161 ~~------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p 210 (384)
T COG0515 161 IP------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210 (384)
T ss_pred cc------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 00 12234569999999999987 5789999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhc--CccchH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRA--DFEGKE----EALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|...... ................ ...... .....+.+++..|+..+|..|.++.+....
T Consensus 211 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 211 FEGEKNS------SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCcc------ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 6443211 0001111111111111 000110 112467889999999999999998887664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=191.64 Aligned_cols=139 Identities=16% Similarity=0.180 Sum_probs=109.2
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchh--h------------------------HHHHHHHHHHHhccCCCCcc
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVD--R------------------------FRDFETQVRVIAKLVHPNLV 534 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nIv 534 (791)
..||+|++|.||+|...+|+.||||+++..... . ....+.|++++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999878999999999654211 0 01224599999999888775
Q ss_pred ceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCeecCCCCCCeEecCCC
Q 003847 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFL-HEKKHVHGNLKPRNVLLGNDM 613 (791)
Q Consensus 535 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~ivHrDlkp~NILl~~~~ 613 (791)
....+.. ...++||||++++++........ .+++.++..++.|++.+|+|+ |+.||+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 4443322 23489999999887765432221 388999999999999999999 689999999999999998 47
Q ss_pred CeEEeccCcccccC
Q 003847 614 EPKIGDFGLERLVT 627 (791)
Q Consensus 614 ~~kL~DFGla~~~~ 627 (791)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=224.86 Aligned_cols=250 Identities=19% Similarity=0.167 Sum_probs=177.1
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCc-hhhHHHHHHHHHH--HhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENS-VDRFRDFETQVRV--IAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+.||.+.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-..+...|+|-+|+.
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk- 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK- 104 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-
Confidence 4568999999999999988887 8999985542 2223344433333 445689999999888777788899999994
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
-+|+|.+..+. .+...+.+-|+.|++.||..+|+.||+|||||.+|||++.-..+.|+||..-+..--..+....
T Consensus 105 hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 105 HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 58988876654 3778888999999999999999999999999999999999999999999876532211111110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC----------C-CCCchhhHHHHHHHHH
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI----------K-PNPKWDVYSFGVILLE 704 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------~-~~~~sDvwSlGvil~e 704 (791)
+.+-+.+. ..-.+|.|||.+... . .+++.||||+||+++|
T Consensus 180 -----------------------f~fFFDTS------rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE 230 (1431)
T KOG1240|consen 180 -----------------------FTFFFDTS------RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE 230 (1431)
T ss_pred -----------------------ceEEEecC------CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence 00001111 122459999988431 1 5789999999999999
Q ss_pred HHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 705 LLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 705 llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
|++ |+++|.-. +++..+-.+..... .-+...+.+++..|++.||++|.++++.|+.-..
T Consensus 231 Lf~Eg~PlF~LS----------------QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 231 LFLEGRPLFTLS----------------QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHhcCCCcccHH----------------HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 988 57777432 11111111100000 0012357789999999999999999999998554
Q ss_pred C
Q 003847 780 I 780 (791)
Q Consensus 780 i 780 (791)
+
T Consensus 295 ~ 295 (1431)
T KOG1240|consen 295 L 295 (1431)
T ss_pred c
Confidence 3
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=189.50 Aligned_cols=133 Identities=11% Similarity=0.181 Sum_probs=109.1
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHH---H------HHHHHHHHhccCCCCccceeeEEEcc------
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFR---D------FETQVRVIAKLVHPNLVRIRGFYWGV------ 543 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~nIv~l~~~~~~~------ 543 (791)
..+++|.|+||.||.+.. ++..+|||.+........+ . +++|++.+.++.|++|..+.+++...
T Consensus 35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 357999999999999766 5778999999764332222 2 68999999999999999999987643
Q ss_pred --CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 544 --DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 544 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
+..++||||++|.+|.++.. ++. ....+++.+|..+|+.|++|||+||+||+++.++ ++|+|||
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999987621 333 2456999999999999999999999999999988 9999999
Q ss_pred ccccc
Q 003847 622 LERLV 626 (791)
Q Consensus 622 la~~~ 626 (791)
.....
T Consensus 180 ~~~~~ 184 (232)
T PRK10359 180 GKRCT 184 (232)
T ss_pred Ccccc
Confidence 87654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-22 Score=213.29 Aligned_cols=200 Identities=25% Similarity=0.233 Sum_probs=142.6
Q ss_pred cCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCC
Q 003847 88 LPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG 167 (791)
Q Consensus 88 L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 167 (791)
|..|++...-.+.|-.|.++++|+|+.|++...-.+.+.+|+.|+.||||+|.|..+-++.+.-.++|++|+|++|+|+.
T Consensus 252 lqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~ 331 (873)
T KOG4194|consen 252 LQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR 331 (873)
T ss_pred hhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence 33344433334445555555566666666655555556666666666666666665556666666666666666666665
Q ss_pred CCccccCCCCCCCEEeCCCCcCCCCCCCC---CcccceeccccccccccCCCCcC---C-ccccEEEccCCcCcccCchh
Q 003847 168 KLPVSLTTLQSLTIVSLKNNYFSDGLPSK---FNSVQVLDLSSNLINGSLPPDIG---G-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 168 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~ls~N~l~~~~p~~~~---~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
..+..|..|..|++|+|++|.+....-.. +++|+.|||++|.|++.+.+.-. + .+|+.|+|.+|+|. .||..
T Consensus 332 l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~kr 410 (873)
T KOG4194|consen 332 LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKR 410 (873)
T ss_pred CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchh
Confidence 55666666666666666666655433222 37899999999999987776432 2 48999999999999 99999
Q ss_pred HhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCC
Q 003847 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 288 (791)
.+..+++|+.|||.+|.+...-|....-+++..+.+.....+|+|.+.
T Consensus 411 Afsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~ 458 (873)
T KOG4194|consen 411 AFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLK 458 (873)
T ss_pred hhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHH
Confidence 888899999999999999999998888889999999999999999865
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=183.83 Aligned_cols=140 Identities=19% Similarity=0.254 Sum_probs=111.8
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchh--------------------------hHHHHHHHHHHHhccCCCCcc
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVD--------------------------RFRDFETQVRVIAKLVHPNLV 534 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~nIv 534 (791)
..||+|++|.||+|...+|+.||||++...... ....++.|.+.+.++.|++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 479999999999999778999999998754210 012246789999999999886
Q ss_pred ceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCC
Q 003847 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDM 613 (791)
Q Consensus 535 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~ 613 (791)
....+... ..++||||++++++........ .++..+...++.|++.++.++|+ .||+||||||+||+++ ++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 55544433 3489999999886544322221 37888999999999999999999 9999999999999999 88
Q ss_pred CeEEeccCcccccCC
Q 003847 614 EPKIGDFGLERLVTG 628 (791)
Q Consensus 614 ~~kL~DFGla~~~~~ 628 (791)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-21 Score=194.95 Aligned_cols=230 Identities=20% Similarity=0.218 Sum_probs=147.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCC---CchhhHHHHHHHHHHHhccCC----------CCccceeeEEEcc--
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGE---NSVDRFRDFETQVRVIAKLVH----------PNLVRIRGFYWGV-- 543 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~~~-- 543 (791)
+.+||.|+++.||.++. ++|+.+|||++.. ......+++++|.-....+.+ -.++..++.....
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 56899999999999995 5699999998743 233456777777755555432 2333333332211
Q ss_pred -------C--------ceEEEEeccCCCChhHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCC
Q 003847 544 -------D--------EKLIIYDFVPNGSLANARYR---KMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPR 605 (791)
Q Consensus 544 -------~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~ 605 (791)
. ..+++|+-+ .++|.+++.. .... ...+....+..+..|+++.+++||+.|+||+||||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~ 174 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE 174 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence 1 236788887 5688887553 2211 112444566778899999999999999999999999
Q ss_pred CeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc
Q 003847 606 NVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR 685 (791)
Q Consensus 606 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~ 685 (791)
|++++++|.++|+||+.....+..... ...+..|.+||...
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~---------------------------------------~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRC---------------------------------------SEFPVAFTPPELES 215 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEG---------------------------------------GGS-TTTS-HHHHH
T ss_pred eEEEcCCCCEEEcChHHHeecCceeec---------------------------------------cCCCcccCChhhhh
Confidence 999999999999999887655421110 01345689999874
Q ss_pred C--------CCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHh
Q 003847 686 S--------IKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGY 757 (791)
Q Consensus 686 ~--------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 757 (791)
. ..++.+.|.|++|+++|.|++|+.||........... .+....+.+..+.+||.
T Consensus 216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------------~f~~C~~~Pe~v~~LI~ 278 (288)
T PF14531_consen 216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------------DFSRCRDMPEPVQFLIR 278 (288)
T ss_dssp HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------------GGTTSS---HHHHHHHH
T ss_pred hhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----------------cchhcCCcCHHHHHHHH
Confidence 3 3478899999999999999999999965432221111 11111246778899999
Q ss_pred hccCCCCCCC
Q 003847 758 SCASPLPQKR 767 (791)
Q Consensus 758 ~cl~~dP~~R 767 (791)
.+|+.+|.+|
T Consensus 279 ~lL~~~~~~R 288 (288)
T PF14531_consen 279 GLLQRNPEDR 288 (288)
T ss_dssp HHT-SSGGGS
T ss_pred HHccCCcccC
Confidence 9999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=175.61 Aligned_cols=196 Identities=15% Similarity=0.101 Sum_probs=139.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhh----HHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDR----FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...|++|+||+||.+.. .+++++.+.+.....-. ...+++|+++|++|. |++|++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999997766 68889888887653311 225889999999995 5889999886 45799999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCC-CCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL-KPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDl-kp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
|.+|.+.... . ...++.|++.+|+++|+.||+|||| ||+|||++.++.++|+|||++..........
T Consensus 82 G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998643211 1 1357889999999999999999999 7999999999999999999998544221100
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCC-CchhhHHHHHHHHHHHhCCcc
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPN-PKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~-~~sDvwSlGvil~elltG~~p 711 (791)
.. ...++- ..........++.|++|+...-. ..+ ...+.++.|.-+|.++|++.+
T Consensus 150 r~------------L~~rDl-----------~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 150 RL------------LAREDL-----------RHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred HH------------HHHHHH-----------HHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 00 000000 00000001156678888765432 233 567888999999999999997
Q ss_pred hhcc
Q 003847 712 VVDE 715 (791)
Q Consensus 712 f~~~ 715 (791)
+..+
T Consensus 207 ~~~~ 210 (218)
T PRK12274 207 HWED 210 (218)
T ss_pred cccc
Confidence 6443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=208.61 Aligned_cols=225 Identities=21% Similarity=0.241 Sum_probs=182.0
Q ss_pred eccccCceEEEEEE----eCCCcEEEEEEcCCCchhh--HHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccC
Q 003847 482 ILGASGSSIMYKAV----LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
++|+|.||.|+.++ .+.|..+|.|++++..... ......|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999886 3447889999886642211 114556777888886 9999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|.|...+.... .+.+.....+...++-|++++|+.+|+|||+|++||+++.+|.+|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999987665543 27778888899999999999999999999999999999999999999999998653211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
..|||..|||||++. ....++|.||||++++||+||..||..
T Consensus 152 ------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 127999999999998 467899999999999999999999954
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
+.....+......+.+......+++..++..+|..|.-.
T Consensus 194 -----------------~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 -----------------DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -----------------HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 222333333445556677778889999999999999644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=178.63 Aligned_cols=136 Identities=18% Similarity=0.192 Sum_probs=107.0
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-----CCCCccceeeEEEccC---ceE-EE
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-----VHPNLVRIRGFYWGVD---EKL-II 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~~-lv 549 (791)
...+||+|+||.||. .-+++.. +||++........+.+.+|+++++++ +||||++++|+++++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356899999999996 3234444 79998765444567899999999999 5799999999998874 333 78
Q ss_pred Eec--cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCeecCCCCCCeEecC----CCCeEEeccCc
Q 003847 550 YDF--VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGL-AFLHEKKHVHGNLKPRNVLLGN----DMEPKIGDFGL 622 (791)
Q Consensus 550 ~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~ivHrDlkp~NILl~~----~~~~kL~DFGl 622 (791)
+|| +.+++|.+++.+.. +++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 55799999996532 5555 35678888888 9999999999999999999974 34799999544
Q ss_pred cc
Q 003847 623 ER 624 (791)
Q Consensus 623 a~ 624 (791)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-21 Score=203.52 Aligned_cols=211 Identities=23% Similarity=0.203 Sum_probs=134.7
Q ss_pred eeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc
Q 003847 69 VTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET 148 (791)
Q Consensus 69 v~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 148 (791)
|+-...+.|+++..+..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.|+..-...
T Consensus 185 It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~ 264 (873)
T KOG4194|consen 185 ITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGA 264 (873)
T ss_pred ccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcc
Confidence 33333444555555555555555555444445555555555555555555322334555555555555555555444555
Q ss_pred cCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCCc-ccc
Q 003847 149 MGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGY-SLR 224 (791)
Q Consensus 149 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~~-~L~ 224 (791)
|-.|.++++|+|+.|+++..-.+++.+|++|+.|+|++|.|..+-++.+ .+|++|+||+|+|+...+.+|..+ .|+
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 6666667777777777776666677777777777777777777666654 578888888888876666666553 678
Q ss_pred EEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC----CcccccccccccCCC
Q 003847 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES----NVFMNQESSSFSGNL 280 (791)
Q Consensus 225 ~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~----~~~~~~~~~~~~~n~ 280 (791)
+|+|++|+++ .+-+..+..+.+|+.|||+.|.|+..|.+. ..+..+..+.+.||.
T Consensus 345 ~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 345 ELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred hhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 8888888887 677777777888888888888888777654 234455556666664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=196.20 Aligned_cols=216 Identities=26% Similarity=0.360 Sum_probs=162.7
Q ss_pred HhccCCCCccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-eecCCC
Q 003847 525 IAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH-VHGNLK 603 (791)
Q Consensus 525 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i-vHrDlk 603 (791)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+..... .+++.-...++++|+.||+|||...| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 4678999999999999999999999999999999999887432 48999999999999999999999766 999999
Q ss_pred CCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccc
Q 003847 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES 683 (791)
Q Consensus 604 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~ 683 (791)
+.|.++|....+||+|||+............ .....-..-|.|||.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~----------------------------------~~~~~~~~lw~aPel 122 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEA----------------------------------HHPIRKALLWTAPEL 122 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccc----------------------------------cchhHHHHhccCHHH
Confidence 9999999999999999999876643100000 000012344999999
Q ss_pred ccCC-------CCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHH---HhhhcCccchHHHHHHHH
Q 003847 684 LRSI-------KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLAD---AAIRADFEGKEEALLSCF 753 (791)
Q Consensus 684 ~~~~-------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~ 753 (791)
+.+. ..+.+.||||||++++|+++.+.||......... .+....+.+ ...++......+....+.
T Consensus 123 lr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~ 197 (484)
T KOG1023|consen 123 LRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-----DEIILRVKKGGSNPFRPSIELLNELPPELL 197 (484)
T ss_pred hcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh-----HHHHHHHHhcCCCCcCcchhhhhhcchHHH
Confidence 9763 1467899999999999999999999764322211 111111111 112222221223445789
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 754 KLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.++.+||..+|++||++++|-..++.+...
T Consensus 198 ~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 198 LLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999999999999999999999999887654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=208.16 Aligned_cols=203 Identities=16% Similarity=0.181 Sum_probs=159.5
Q ss_pred CcccchHHHhhhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC---CCCccceeeEEEcc
Q 003847 467 DKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV---HPNLVRIRGFYWGV 543 (791)
Q Consensus 467 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 543 (791)
...+++....+.....||+|+||+||+|...+|+.||+|+-+....- +|---.+++.+|+ -+-|+.+...+...
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34455555555667889999999999999888999999997664332 1111223444444 34566666667778
Q ss_pred CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-------CCCCeE
Q 003847 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-------NDMEPK 616 (791)
Q Consensus 544 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-------~~~~~k 616 (791)
+..++|+||.+.|+|.+++.... .++|..+..++.|++..+++||..+|||+||||+|+||. ....++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 88899999999999999988433 399999999999999999999999999999999999994 234589
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||.+-.+.--. ..+.....++|-.+-.+|+..+..++..+|.|
T Consensus 842 lIDfG~siDm~lfp----------------------------------~~~~F~~~~~td~f~C~EM~~grpWtYq~Dyf 887 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFP----------------------------------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYF 887 (974)
T ss_pred EEecccceeeeEcC----------------------------------CCcEEeeeeccccchhHHHhcCCCCchhhhhH
Confidence 99999987654211 11223455688889999999999999999999
Q ss_pred HHHHHHHHHHhCCcc
Q 003847 697 SFGVILLELLTGKVI 711 (791)
Q Consensus 697 SlGvil~elltG~~p 711 (791)
.++.+++-|+.|+..
T Consensus 888 GlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 888 GLAATVHVMLFGKYM 902 (974)
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=201.24 Aligned_cols=135 Identities=37% Similarity=0.613 Sum_probs=82.1
Q ss_pred CCChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCc-----eeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCC
Q 003847 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPC-----SWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGM 103 (791)
Q Consensus 29 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c-----~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~ 103 (791)
.....|..+|+.+|..+. ++.. .+|+. +|| .|.||.|..... .....|+.|+|++|++.|.+|..|+.
T Consensus 368 ~t~~~~~~aL~~~k~~~~-~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~-~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLG-LPLR--FGWNG---DPCVPQQHPWSGADCQFDST-KGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccCchHHHHHHHHHHhcC-Cccc--CCCCC---CCCCCcccccccceeeccCC-CCceEEEEEECCCCCccccCCHHHhC
Confidence 456678999999999873 4432 48963 455 799999962111 11224677777777776666666666
Q ss_pred CCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCc
Q 003847 104 IEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLP 170 (791)
Q Consensus 104 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 170 (791)
|++|+.|+|++|+|.|.+|..+.++++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP 507 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCC
Confidence 6666666666666666555555555555555555555555555555555555555444444444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=175.05 Aligned_cols=201 Identities=19% Similarity=0.230 Sum_probs=138.8
Q ss_pred CCCCccceeeEEEcc---------------------------CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHH
Q 003847 529 VHPNLVRIRGFYWGV---------------------------DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581 (791)
Q Consensus 529 ~H~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 581 (791)
+|||||++.++|.+. ...|+||.-++ .+|.+++..+. .+......|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 599999999887531 24689999884 58999887654 566677889
Q ss_pred HHHHHHHHHHHhcCCCeecCCCCCCeEe--cCCC--CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCC
Q 003847 582 AKGVARGLAFLHEKKHVHGNLKPRNVLL--GNDM--EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657 (791)
Q Consensus 582 ~~qi~~gL~yLH~~~ivHrDlkp~NILl--~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (791)
+.|+++|+.|||++||.|||+|++|||+ |+|+ .+.|+|||++---..-.-... +.
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp-------y~-------------- 405 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP-------YE-------------- 405 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc-------cc--------------
Confidence 9999999999999999999999999998 4444 368999998753221000000 00
Q ss_pred CCCCCCCCCCCCCCCCCCCcccCcccccCCC-----C-CCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHH
Q 003847 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIK-----P-NPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAI 731 (791)
Q Consensus 658 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 731 (791)
...-...|...-||||+....+ . -.|+|.|+.|.+.||++....||+..-.. .+ +...
T Consensus 406 ---------S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L-~~r~-- 469 (598)
T KOG4158|consen 406 ---------SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LL-DTRT-- 469 (598)
T ss_pred ---------cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----ee-chhh--
Confidence 0011234777899999986432 1 24899999999999999999999763111 11 1111
Q ss_pred HHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 732 RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
+.....+. .++..+..+.+++...++.||.+|++..-....|
T Consensus 470 --Yqe~qLPa--lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 470 --YQESQLPA--LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred --hhhhhCCC--CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11111111 1223556788999999999999999876555544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-20 Score=197.03 Aligned_cols=196 Identities=30% Similarity=0.365 Sum_probs=148.8
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
.+..++.|||++|+|. ..|..+..-.++-.|+||+|+|..+...-|.+|+.|-+||||+|+|. .+|..+.+|.+|+.|
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 4567888888888886 56777777888888888888888544455678888888888888887 777778888888888
Q ss_pred eCcCCcCC-------------------------CCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccc
Q 003847 159 NLSDNALA-------------------------GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLI 210 (791)
Q Consensus 159 ~ls~N~l~-------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l 210 (791)
.|++|.|. .-+|.++..|.+|..+|||.|.|.- +|+.+ .+|+.|+||+|+|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCce
Confidence 88888764 2356677777788888888888765 55543 7888889999998
Q ss_pred cccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCc-ccCCCC-CcccccccccccCCC
Q 003847 211 NGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT-GEIPES-NVFMNQESSSFSGNL 280 (791)
Q Consensus 211 ~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~-~~~p~~-~~~~~~~~~~~~~n~ 280 (791)
+ .+....+. .+|++|+||.|+|+ .+|+.+.+ |++|+.|.+.+|+|+ .-+|+. +.+..++.+...+|.
T Consensus 258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcK-L~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCK-LTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred e-eeeccHHHHhhhhhhccccchhc-cchHHHhh-hHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence 8 44444444 37999999999999 99999987 999999999999986 234443 556666666666665
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-19 Score=185.35 Aligned_cols=221 Identities=23% Similarity=0.232 Sum_probs=169.4
Q ss_pred eeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccC-CcC
Q 003847 67 NGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN-NLI 141 (791)
Q Consensus 67 ~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l 141 (791)
.-|.|...+- -+-+...+.|+|..|+|+.+.+.+|+.+++|+.||||+|.|+.+-|..|.+|.+|..|-|.+ |+|
T Consensus 49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 3467763321 12345788999999999988889999999999999999999988999999999887776655 899
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCcc------------------------ccCCCCCCCEEeCCCCcCCC------
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPV------------------------SLTTLQSLTIVSLKNNYFSD------ 191 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~------------------------~~~~l~~L~~L~L~~N~l~~------ 191 (791)
+...-..|++|.+|+.|.+.-|++.-.... .|..+.+++.+.|..|.+..
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 855555677777777666666666533333 45555566666666665210
Q ss_pred -----------------CCC------------------------C------------------CCcccceeccccccccc
Q 003847 192 -----------------GLP------------------------S------------------KFNSVQVLDLSSNLING 212 (791)
Q Consensus 192 -----------------~~p------------------------~------------------~l~~L~~L~ls~N~l~~ 212 (791)
..| + .+++|+.|+|++|+|++
T Consensus 209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 000 0 13689999999999998
Q ss_pred cCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC-cccccccccccCCCCCCCCCCC
Q 003847 213 SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN-VFMNQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 213 ~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~~~~~ 288 (791)
.-+.+|.. ..|++|.|..|+|. .+....++.+..|+.|+|.+|+++..-|-.. ....+..+.+.+|||.|+|.+.
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 88888877 48999999999999 8888888899999999999999999888664 3446677889999999998764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-20 Score=166.88 Aligned_cols=176 Identities=28% Similarity=0.429 Sum_probs=96.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...++.|.|++|.++ .+|+.++.|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344555555555554 34444555555555555555555 44555555555555555555554 4555555555555555
Q ss_pred CcCCcCC-CCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALA-GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
|++|+++ ..+|+.|..|+. |+-|+|+.|.+. .+|..++. .+|+.|.+.+|.|- ++
T Consensus 109 ltynnl~e~~lpgnff~m~t---------------------lralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~l 165 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTT---------------------LRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SL 165 (264)
T ss_pred ccccccccccCCcchhHHHH---------------------HHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hC
Confidence 5555553 234444444444 455555555554 55656655 46777777777766 67
Q ss_pred chhHhhcCCCCcEEEcccCcCcccCCCCCccc---ccccccccCCCCC
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGEIPESNVFM---NQESSSFSGNLDL 282 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~---~~~~~~~~~n~~l 282 (791)
|.+++. +..|+.|.+.+|+|+-..|+...+. +........|||.
T Consensus 166 pkeig~-lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 166 PKEIGD-LTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred cHHHHH-HHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 777766 7777777777777776555542221 1222344566663
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=172.00 Aligned_cols=140 Identities=16% Similarity=0.219 Sum_probs=109.2
Q ss_pred cceeccccCceEEEEEE--eCCCcEEEEEEcCCCchh------------------------hHHHHHHHHHHHhccCCCC
Q 003847 479 SAYILGASGSSIMYKAV--LEDGTALAVRRIGENSVD------------------------RFRDFETQVRVIAKLVHPN 532 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 532 (791)
..+.||+|++|.||+|. ..+|+.||||++...... ....++.|+++++++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 35689999999999998 568999999998643210 1123678999999997533
Q ss_pred --ccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CeecCCCCCCeEe
Q 003847 533 --LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK-HVHGNLKPRNVLL 609 (791)
Q Consensus 533 --Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-ivHrDlkp~NILl 609 (791)
+.+++++ ...++||||+++++|........ .+...+...++.|++.+|+|||+.| |+||||||+||++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 3444432 24589999999988876542221 2556677899999999999999999 9999999999999
Q ss_pred cCCCCeEEeccCcccccCC
Q 003847 610 GNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 610 ~~~~~~kL~DFGla~~~~~ 628 (791)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999886553
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-19 Score=192.90 Aligned_cols=179 Identities=32% Similarity=0.432 Sum_probs=131.9
Q ss_pred CCcEEEEEcCCCCCc-cCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc-cCCCCCCCE
Q 003847 80 DSRVIGLALPNSQLL-GSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET-MGSLHNLQL 157 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~ 157 (791)
++++.++.+.+|+|. .-+|..+..|..|+.||||+|+++ ..|..+....++..|+||+|+|. .||.. |.+|+-|-.
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh
Confidence 566777778888874 346778888888888888888888 77888888888888888888887 45544 678888888
Q ss_pred EeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC----CCC---------------------CC---Ccccceecccccc
Q 003847 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD----GLP---------------------SK---FNSVQVLDLSSNL 209 (791)
Q Consensus 158 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p---------------------~~---l~~L~~L~ls~N~ 209 (791)
||||+|+|. .+|+.+..|..|++|.|++|.|.. .+| .. +.+|..+|||.|.
T Consensus 155 LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~ 233 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENN 233 (1255)
T ss_pred hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccC
Confidence 888888888 778888888888888888886552 122 22 2466777777777
Q ss_pred ccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 210 INGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 210 l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
|. .+|+.+.. .+|+.|+||+|+|+ .+...... +.+|+.|+||.|+|+ .+|+.
T Consensus 234 Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~-W~~lEtLNlSrNQLt-~LP~a 286 (1255)
T KOG0444|consen 234 LP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGE-WENLETLNLSRNQLT-VLPDA 286 (1255)
T ss_pred CC-cchHHHhhhhhhheeccCcCcee-eeeccHHH-Hhhhhhhccccchhc-cchHH
Confidence 76 66666555 47777777777777 55555555 667777777777777 44544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-20 Score=167.69 Aligned_cols=146 Identities=28% Similarity=0.426 Sum_probs=118.7
Q ss_pred eeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCC-CCC
Q 003847 67 NGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS-GHL 145 (791)
Q Consensus 67 ~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~ 145 (791)
+-++.. |.....+.++..|+|.+|++. .+|..++.|+.|+.|+++-|++. ..|..|+.++.|+.|||.+|+++ ..+
T Consensus 43 NKl~~v-ppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~l 119 (264)
T KOG0617|consen 43 NKLTVV-PPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSL 119 (264)
T ss_pred Cceeec-CCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccC
Confidence 334443 444566788999999999997 78999999999999999999998 89999999999999999999998 468
Q ss_pred ccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCc
Q 003847 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDI 218 (791)
Q Consensus 146 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~ 218 (791)
|..|-.++.|+.|+|++|.|. .+|..+++|++|+.|.|..|.+-. +|..+ ..|+.|.+.+|+++ .+|+.+
T Consensus 120 pgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgnrl~-vlppel 192 (264)
T KOG0617|consen 120 PGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGNRLT-VLPPEL 192 (264)
T ss_pred CcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccceee-ecChhh
Confidence 999999999999999999999 999999999999999999998864 33322 44444555555554 333333
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=166.16 Aligned_cols=134 Identities=14% Similarity=0.259 Sum_probs=114.2
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCch--------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSV--------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..||+|++|.||+|.. +|..|+||+...... .....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3689999999999987 678899998654321 1124578899999999999998888887778889999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++|++|.+++... .. .+..++.+++.+|.++|+.+++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999987542 12 7889999999999999999999999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=165.09 Aligned_cols=130 Identities=18% Similarity=0.278 Sum_probs=107.6
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCCch--------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSV--------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
+||+|++|.||++.. +|..|++|+...... ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998654211 11356788999999999887766666666677789999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
+|++|.+++.... . .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988764421 1 7899999999999999999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-18 Score=182.11 Aligned_cols=180 Identities=27% Similarity=0.395 Sum_probs=130.5
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
..||.|++|...+|.+|+.+..... ..++...+.++.|++.|++| ++.+|||+||.||++..+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 4689999999999999997654432 37888999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
......... ......+...||.-||+||.+.+..|+.|+||||||++++|
T Consensus 405 s~~~~~~~~------------------------------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~E 454 (516)
T KOG1033|consen 405 SQDKDETVA------------------------------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAE 454 (516)
T ss_pred ecccCCccc------------------------------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHH
Confidence 765433100 01123445669999999999999999999999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
+++ +|... .+......++-+..+.+.+ ....+.-..|+.+++...|.+||++.++
T Consensus 455 L~~---~f~T~--------~er~~t~~d~r~g~ip~~~---~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 455 LLI---QFSTQ--------FERIATLTDIRDGIIPPEF---LQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHH---HhccH--------HHHHHhhhhhhcCCCChHH---hhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 987 12111 0111111222222221111 1111233568889999999999955443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-17 Score=161.90 Aligned_cols=137 Identities=14% Similarity=0.164 Sum_probs=107.9
Q ss_pred hhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchh----------------------hHHHHHHHHHHHhccCCCC--
Q 003847 477 KASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVD----------------------RFRDFETQVRVIAKLVHPN-- 532 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n-- 532 (791)
+...+.||+|+||.||++..++|+.||||++...... ....+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3345789999999999999888999999987542200 1123677899999998774
Q ss_pred ccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC
Q 003847 533 LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612 (791)
Q Consensus 533 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~ 612 (791)
++..++ ....++||||+++++|.+.... .....++.+++.++.++|+.||+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 444443 2456899999999998764220 2346788999999999999999999999999999999
Q ss_pred CCeEEeccCcccccCC
Q 003847 613 MEPKIGDFGLERLVTG 628 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~ 628 (791)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=183.39 Aligned_cols=133 Identities=17% Similarity=0.247 Sum_probs=109.1
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEE-cCCC-c------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRR-IGEN-S------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..++||+|+||.||++...... +++|+ +.+. . ....+.+.+|++++++++|++++..+.++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999875443 44443 2221 1 112356889999999999999998888888878889999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
||+++++|.+++. ....++.|++++|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999988764 246789999999999999999999999999999 5779999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-19 Score=181.52 Aligned_cols=192 Identities=29% Similarity=0.389 Sum_probs=144.8
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..++..|+.+.|.+. .+|+.++.+..|..|+..+|+++ ..|..++++.+|..|++.+|.+.. +|+..-++++|++||
T Consensus 113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld 189 (565)
T KOG0472|consen 113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLD 189 (565)
T ss_pred hhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcc
Confidence 445566666666665 45566667777777777777776 566677777777777777777773 333344477788888
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC--ccccEEEccCCcCc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG--YSLRYLNLSYNRLS 234 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~--~~L~~L~l~~N~l~ 234 (791)
...|.++ .+|..++.|.+|+.|+|.+|+|.. +| .| +.|+.|+++.|+|. .+|..... .+|..|||.+|+|+
T Consensus 190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 190 CNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred cchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc
Confidence 8888777 788888888888888888888875 44 44 56888899999887 77777653 47899999999999
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
++|+++.. +.+|.+||||+|.+++..++-+.+ .+..+.+.|||-
T Consensus 266 -e~Pde~cl-LrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 266 -EVPDEICL-LRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred -cCchHHHH-hhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 89999887 888999999999999777666555 777788888864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-17 Score=185.27 Aligned_cols=212 Identities=21% Similarity=0.257 Sum_probs=140.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
-.+|..|+||.||.++++ +.+.+|.|+ .++.. +.+- ++.....|.+| |+-
T Consensus 88 IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee---------------------chh
Confidence 358899999999999854 467888843 32211 0000 22222333333 333
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC-CcCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS-SKAGG 637 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~ 637 (791)
...++.-+ +++.. ++.+++|||+.||+|||+||+|.+|+.-|.+|+.|||+++........ .+.+.
T Consensus 139 ~tllk~~g-----~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 139 ATLLKNIG-----PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhcccCC-----CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 33332221 23332 278999999999999999999999999999999999998864332211 11111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
... ......-...|||+.|+|||++..+.|+..+|.|++|+|+||.+.|..||.++..
T Consensus 206 I~k----------------------~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 206 IEK----------------------DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hHH----------------------HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 100 1112223456899999999999999999999999999999999999999987633
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCc---cchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADF---EGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
+ ++++..+.... +..+....+..+++.++|..+|..|-
T Consensus 264 e-------------elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 264 E-------------ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred H-------------HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2 12221111111 11222456788899999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-16 Score=157.16 Aligned_cols=140 Identities=19% Similarity=0.162 Sum_probs=109.6
Q ss_pred hhhcceecc-ccCceEEEEEEeCCCcEEEEEEcCCCc-------------hhhHHHHHHHHHHHhccCCCCc--cceeeE
Q 003847 476 LKASAYILG-ASGSSIMYKAVLEDGTALAVRRIGENS-------------VDRFRDFETQVRVIAKLVHPNL--VRIRGF 539 (791)
Q Consensus 476 ~~~~~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~ 539 (791)
....+.+|| .||.|+||.+... +..++||++.... ......+.+|++++.+++|++| ++.+++
T Consensus 32 ~~~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 32 WQQQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred HhhcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 344567898 8999999999875 7789999885321 1223567889999999998875 677776
Q ss_pred EEccCc----eEEEEeccCC-CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC
Q 003847 540 YWGVDE----KLIIYDFVPN-GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME 614 (791)
Q Consensus 540 ~~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~ 614 (791)
...... .++||||++| .+|.+++... .++.. .+.|++.+|.+||+.||+||||||.|||++.++.
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC
Confidence 544322 2599999997 6898877542 24543 3578999999999999999999999999999889
Q ss_pred eEEeccCccccc
Q 003847 615 PKIGDFGLERLV 626 (791)
Q Consensus 615 ~kL~DFGla~~~ 626 (791)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=150.32 Aligned_cols=136 Identities=17% Similarity=0.215 Sum_probs=99.8
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchh--hHHH----------------------HHHHHHHHhccCCCC--cc
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVD--RFRD----------------------FETQVRVIAKLVHPN--LV 534 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--Iv 534 (791)
..||+|+||.||+|...+|+.||||++...... .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 479999999999999888999999998653211 1111 135666666664432 44
Q ss_pred ceeeEEEccCceEEEEeccCCCChhHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCC
Q 003847 535 RIRGFYWGVDEKLIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGND 612 (791)
Q Consensus 535 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~ 612 (791)
+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+|+||||||+||+++ +
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 55443 246899999998654321 11111 11 5678899999999999999 9999999999999999 8
Q ss_pred CCeEEeccCcccccCC
Q 003847 613 MEPKIGDFGLERLVTG 628 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~ 628 (791)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=174.70 Aligned_cols=157 Identities=31% Similarity=0.342 Sum_probs=90.0
Q ss_pred CCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCcc---ccCC-------------C-CCCCEEeCcCCcCCCC
Q 003847 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE---TMGS-------------L-HNLQLLNLSDNALAGK 168 (791)
Q Consensus 106 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~-------------l-~~L~~L~ls~N~l~~~ 168 (791)
.|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|. .+.. + .+|+.|+|++|+|+ .
T Consensus 283 ~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~ 356 (788)
T PRK15387 283 GLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-S 356 (788)
T ss_pred hcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-C
Confidence 3555556666555 2332 12456666666666653 222 1111 1 36788888888888 4
Q ss_pred CccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCC
Q 003847 169 LPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVN 248 (791)
Q Consensus 169 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l 248 (791)
+|.. ..+|+.|++++|+|++ +|....+|+.|+|++|+|+ .+|... .+|+.|+|++|+|+ .+|.. ..+|
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~-LP~l~~~L~~LdLs~N~Lt-~LP~l~--s~L~~LdLS~N~Ls-sIP~l----~~~L 424 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTS-LPALPSGLKELIVSGNRLT-SLPVLP--SELKELMVSGNRLT-SLPML----PSGL 424 (788)
T ss_pred CCCC---Ccccceehhhcccccc-CcccccccceEEecCCccc-CCCCcc--cCCCEEEccCCcCC-CCCcc----hhhh
Confidence 5543 2456667777777765 5555566777777777776 344332 35777777777776 46642 2345
Q ss_pred cEEEcccCcCcccCCCC-CcccccccccccCCCC
Q 003847 249 ATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLD 281 (791)
Q Consensus 249 ~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 281 (791)
+.|+|++|+|+ .+|.. ..+..+..+.+.+|+.
T Consensus 425 ~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 425 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred hhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 66777777776 44543 2344455555666653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.3e-15 Score=172.39 Aligned_cols=138 Identities=29% Similarity=0.453 Sum_probs=66.9
Q ss_pred CCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCC
Q 003847 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLK 185 (791)
Q Consensus 106 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 185 (791)
+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 4444444444444 2333221 23445555555544 3444332 24555555555555 3444332 355555555
Q ss_pred CCcCCCCCCCCC-cccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCc
Q 003847 186 NNYFSDGLPSKF-NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259 (791)
Q Consensus 186 ~N~l~~~~p~~l-~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~ 259 (791)
+|+|++ +|..+ ++|+.|+|++|+|+ .+|..+. .+|++|++++|.|+ .+|..+ .++|+.|+|++|+|+
T Consensus 292 ~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt-~LP~~l~-~sL~~L~Ls~N~Lt-~LP~~l---~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 292 DNSIRT-LPAHLPSGITHLNVQSNSLT-ALPETLP-PGLKTLEAGENALT-SLPASL---PPELQVLDVSKNQIT 359 (754)
T ss_pred CCcccc-CcccchhhHHHHHhcCCccc-cCCcccc-ccceeccccCCccc-cCChhh---cCcccEEECCCCCCC
Confidence 555554 23222 34555555555555 2333221 35666666666665 455544 245666666666665
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=137.76 Aligned_cols=131 Identities=18% Similarity=0.184 Sum_probs=112.4
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC--CCccceeeEEEccCceEEEEeccCCCCh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH--PNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..||+|.++.||++...+ ..++||....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999754 7899999876543 4678899999999976 5899999988888889999999988877
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---KHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
..+ +......++.+++++|+++|.. +++|+|++|+||++++.+.++++|||.+...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 543 4456678899999999999984 7999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.3e-15 Score=170.09 Aligned_cols=178 Identities=30% Similarity=0.322 Sum_probs=117.4
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccC-----------------CCCccEEEccCCcCCC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFN-----------------ASQLRNLDLSNNLISG 143 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----------------l~~L~~L~L~~N~l~~ 143 (791)
.+++.|+|.+|+|+. +|. .+++|++|+|++|+|+. +|..+.+ ..+|+.|+|++|+|+
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt- 295 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT- 295 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-
Confidence 356777777777764 443 24677777777777773 3432111 134555666666666
Q ss_pred CCccccCCCCCCCEEeCcCCcCCCCCccc---cC----------CC----CCCCEEeCCCCcCCCCCCCCCcccceeccc
Q 003847 144 HLPETMGSLHNLQLLNLSDNALAGKLPVS---LT----------TL----QSLTIVSLKNNYFSDGLPSKFNSVQVLDLS 206 (791)
Q Consensus 144 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~---~~----------~l----~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls 206 (791)
.+|. .+++|+.|+|++|+|++ +|.. +. .+ .+|+.|+|++|+|++ +|....+|+.|+++
T Consensus 296 ~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls 370 (788)
T PRK15387 296 SLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTLPSELYKLWAY 370 (788)
T ss_pred cccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCC-CCCCCcccceehhh
Confidence 3443 23689999999999985 3431 11 11 267788888888876 55555778888888
Q ss_pred cccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 207 SNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 207 ~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
+|+|+ .+|... .+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|++ +|.. ..++..+.+.+|.
T Consensus 371 ~N~L~-~LP~l~--~~L~~LdLs~N~Lt-~LP~l----~s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~Nq 433 (788)
T PRK15387 371 NNRLT-SLPALP--SGLKELIVSGNRLT-SLPVL----PSELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQ 433 (788)
T ss_pred ccccc-cCcccc--cccceEEecCCccc-CCCCc----ccCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCc
Confidence 88887 466433 47999999999999 67753 4679999999999986 5643 2234445555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-16 Score=181.49 Aligned_cols=249 Identities=22% Similarity=0.224 Sum_probs=183.9
Q ss_pred eccccCceEEEEEEeC--CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCC
Q 003847 482 ILGASGSSIMYKAVLE--DGTALAVRRIGENS--VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
-||+|.|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++.+++.....+..+++++|..++
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 3889999999888753 34567777775543 333345556777777776 999999999999999999999999999
Q ss_pred ChhHHHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCC
Q 003847 557 SLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLH-EKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~ 633 (791)
++.+.+. ... . ..+......++.|+..++.|+| ..++.||||||+|.+++..+ ..|++|||+|........
T Consensus 107 ~~f~~i~~~~~-~---~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g-- 180 (601)
T KOG0590|consen 107 SLFSKISHPDS-T---GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG-- 180 (601)
T ss_pred ccccccccCCc-c---CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC--
Confidence 9988773 222 0 2666778889999999999999 99999999999999999999 999999999987654110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCC-CCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcc
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG-ISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~p 711 (791)
........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|
T Consensus 181 -------------------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 181 -------------------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred -------------------------------cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 0112234457 9999999999884 457889999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+.......... ..+....................+++.+++..+|..|.+.+++..
T Consensus 230 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 230 WDFPSRKDGRY--------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccccccccc--------eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 86543322111 111111111111222234556778888999999999999887643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.5e-17 Score=167.21 Aligned_cols=193 Identities=27% Similarity=0.421 Sum_probs=141.3
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
++..++.|++.+|+++ .+|++++.+..++.|+.++|++. .+|.+++.+.+|..|+.++|.+. .+|+.++.+..|+.|
T Consensus 66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl 142 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDL 142 (565)
T ss_pred cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhh
Confidence 4566788888888887 56777888888888888888887 67777777777777777777776 666667777777777
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC----------------------CC---Ccccceecccccccccc
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP----------------------SK---FNSVQVLDLSSNLINGS 213 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----------------------~~---l~~L~~L~ls~N~l~~~ 213 (791)
+..+|+++ ..|+.+.++.+|..|++.+|++....| .. +.+|..|+|..|+|. .
T Consensus 143 ~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~ 220 (565)
T KOG0472|consen 143 DATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-F 220 (565)
T ss_pred hccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-c
Confidence 77777777 566666555555555555555554333 22 256777778888887 6
Q ss_pred CCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccc-cccccccCC
Q 003847 214 LPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN-QESSSFSGN 279 (791)
Q Consensus 214 ~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~-~~~~~~~~n 279 (791)
+| .|.+ ..|++|+++.|+|+ .+|.+....++++.+|||.+|+++ .+|+..+..+ +..+.+.+|
T Consensus 221 lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN 285 (565)
T KOG0472|consen 221 LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNN 285 (565)
T ss_pred CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCC
Confidence 66 4444 56888888888888 889998878999999999999998 5676655554 666666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.9e-15 Score=172.64 Aligned_cols=178 Identities=30% Similarity=0.418 Sum_probs=134.8
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+++.|+|++|+|+ .+|..+. .+|+.|+|++|+|. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 4566666666665 3454443 47999999999998 6777664 58999999999999 6787664 589999999
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhH
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQF 241 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~ 241 (791)
+|+|+ .+|..+. ++|+.|+|++|+|+...+...++|+.|++++|.|++ +|..+. .+|+.|+|++|+|+ .+|..+
T Consensus 292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~L~-~LP~~l 365 (754)
T PRK15370 292 DNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALTS-LPASLP-PELQVLDVSKNQIT-VLPETL 365 (754)
T ss_pred CCccc-cCcccch--hhHHHHHhcCCccccCCccccccceeccccCCcccc-CChhhc-CcccEEECCCCCCC-cCChhh
Confidence 99999 4666553 579999999999997433344789999999999984 676554 58999999999998 788766
Q ss_pred hhcCCCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 242 GEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 242 ~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
.++|+.|+|++|+|+. +|.... ..+..+.+.+|
T Consensus 366 ---p~~L~~LdLs~N~Lt~-LP~~l~-~sL~~LdLs~N 398 (754)
T PRK15370 366 ---PPTITTLDVSRNALTN-LPENLP-AALQIMQASRN 398 (754)
T ss_pred ---cCCcCEEECCCCcCCC-CCHhHH-HHHHHHhhccC
Confidence 4689999999999985 454321 23444445554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.8e-16 Score=160.58 Aligned_cols=197 Identities=21% Similarity=0.208 Sum_probs=150.4
Q ss_pred eeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcC-CCCCCCCcccccCCCCccEEEccCCcCCCC
Q 003847 66 WNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSN-NSLNGSLSFSLFNASQLRNLDLSNNLISGH 144 (791)
Q Consensus 66 w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 144 (791)
-++|+-..++.|..+.++..|||++|+|+.+-|.+|..|..|..|-|.+ |+|+......|.+|..|+.|.|.-|++.-.
T Consensus 76 qN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Ci 155 (498)
T KOG4237|consen 76 QNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCI 155 (498)
T ss_pred cCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcch
Confidence 5788888889999999999999999999999999999999988887666 899866556666666665555555555443
Q ss_pred Ccc------------------------ccCCCCCCCEEeCcCCcCC----------------------------------
Q 003847 145 LPE------------------------TMGSLHNLQLLNLSDNALA---------------------------------- 166 (791)
Q Consensus 145 ~p~------------------------~~~~l~~L~~L~ls~N~l~---------------------------------- 166 (791)
..+ +|..+.+++.+.+..|.+-
T Consensus 156 r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~R 235 (498)
T KOG4237|consen 156 RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKR 235 (498)
T ss_pred hHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHH
Confidence 333 4555555555555555421
Q ss_pred ---------------------------CCCc-cccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCC
Q 003847 167 ---------------------------GKLP-VSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLP 215 (791)
Q Consensus 167 ---------------------------~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p 215 (791)
+.-| ..|..|++|+.|+|++|+|+++-+..| ..|+.|.|..|+|...-.
T Consensus 236 i~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~ 315 (498)
T KOG4237|consen 236 INQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSS 315 (498)
T ss_pred hcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHH
Confidence 0000 136688999999999999999888777 689999999999985555
Q ss_pred CCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCC
Q 003847 216 PDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIP 263 (791)
Q Consensus 216 ~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p 263 (791)
..|.+ ..|+.|+|.+|+|+ .+-...|+.+.+|..|+|-.|++.+..-
T Consensus 316 ~~f~~ls~L~tL~L~~N~it-~~~~~aF~~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 316 GMFQGLSGLKTLSLYDNQIT-TVAPGAFQTLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred HhhhccccceeeeecCCeeE-EEecccccccceeeeeehccCcccCccc
Confidence 55655 47999999999999 5555556669999999999999986654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.2e-16 Score=172.87 Aligned_cols=196 Identities=26% Similarity=0.379 Sum_probs=134.7
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...++.++++.|++++. |.+++.+.+|+.|+..+|+|. .+|..+...++|+.|++.+|.++ .+|....+++.|++|+
T Consensus 240 p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD 316 (1081)
T ss_pred cccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence 45678888888888854 488899999999999999985 66666666666666666666666 5666666666666666
Q ss_pred CcCCcCC-------------------------------------------------CCCccccCCCCCCCEEeCCCCcCC
Q 003847 160 LSDNALA-------------------------------------------------GKLPVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 160 ls~N~l~-------------------------------------------------~~~p~~~~~l~~L~~L~L~~N~l~ 190 (791)
|..|+|. ...-+.|.+.++|+.|+|++|+|.
T Consensus 317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 6666665 222223345556666666666665
Q ss_pred CCCCC----CCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCc-ccCCC
Q 003847 191 DGLPS----KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT-GEIPE 264 (791)
Q Consensus 191 ~~~p~----~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~-~~~p~ 264 (791)
. +|+ .|..|+.|+||+|+|+ .+|..+.. ..|++|...+|+|. ..| ++.+ ++.|+++|||.|+|+ ..+|.
T Consensus 397 ~-fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~-l~qL~~lDlS~N~L~~~~l~~ 471 (1081)
T KOG0618|consen 397 S-FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ-LPQLKVLDLSCNNLSEVTLPE 471 (1081)
T ss_pred c-CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh-cCcceEEecccchhhhhhhhh
Confidence 4 332 2345666666666666 55555544 35666666666666 666 5555 899999999999997 45566
Q ss_pred CCcccccccccccCCCCCC
Q 003847 265 SNVFMNQESSSFSGNLDLC 283 (791)
Q Consensus 265 ~~~~~~~~~~~~~~n~~lc 283 (791)
...+.+++.+.+.||.|+-
T Consensus 472 ~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 472 ALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred hCCCcccceeeccCCcccc
Confidence 5566888999999999743
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-13 Score=170.57 Aligned_cols=198 Identities=21% Similarity=0.230 Sum_probs=157.3
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
...+++.|+|.+|++. .++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|..-..+|..++++++|+.|
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L 686 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEE
Confidence 3567888999998886 567778889999999999876555777 48889999999999887666889999999999999
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcC-------------------
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIG------------------- 219 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~------------------- 219 (791)
+|++|..-..+|..+ ++++|+.|+|++|...+.+|....+|+.|+|++|.++ .+|..+.
T Consensus 687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccc
Confidence 999875545777766 7899999999998777777777788999999999886 5554321
Q ss_pred ------------CccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 220 ------------GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 220 ------------~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
..+|+.|+|++|...+.+|..+.. +++|+.|+|++|+..+.+|....+..+..+.+.++..
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~-L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN-LHKLEHLEIENCINLETLPTGINLESLESLDLSGCSR 837 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhC-CCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCc
Confidence 126888899988877789998876 9999999999987666778776666677777776544
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.3e-16 Score=163.46 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=157.7
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
+...+.+||+.|++. .+|.++..+..|+.|.|+.|.|. .+|..+.+|..|++|||+.|+++ .+|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 456678899999997 78889999999999999999999 89999999999999999999999 8999899887 99999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCC--CCcccceeccccccccccCCCCcCCccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~i 237 (791)
+++|+++ .+|..++.+..|..|+.+.|.+....+. .+.+|+.|++..|++. .+|..+..+.|..||+|+|+++ .|
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YL 226 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ec
Confidence 9999999 8999999999999999999999874433 2478999999999998 7787887889999999999999 99
Q ss_pred chhHhhcCCCCcEEEcccCcCccc
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
|..|.+ |..|++|-|.+|+|+..
T Consensus 227 Pv~fr~-m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 227 PVDFRK-MRHLQVLQLENNPLQSP 249 (722)
T ss_pred chhhhh-hhhheeeeeccCCCCCC
Confidence 999988 99999999999999843
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=153.05 Aligned_cols=141 Identities=21% Similarity=0.289 Sum_probs=102.0
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhH----------------------------------------HHHHH
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRF----------------------------------------RDFET 520 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~ 520 (791)
+-||+|++|.||+|++++|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865321110 02445
Q ss_pred HHHHHhccC----CCCccceeeEEE-ccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 003847 521 QVRVIAKLV----HPNLVRIRGFYW-GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR-GLAFLHE 594 (791)
Q Consensus 521 E~~~l~~l~----H~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~-gL~yLH~ 594 (791)
|++.+.+++ |.+-+.+-.++. ..+..++||||++|++|.++....... . ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG----L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC----C---CHHHHHHHHHHHHHHHHHh
Confidence 666555552 332233323332 234679999999999999876543211 2 23456666666 4788999
Q ss_pred CCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 595 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
.|++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-12 Score=163.79 Aligned_cols=59 Identities=32% Similarity=0.333 Sum_probs=28.7
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN 139 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 139 (791)
..+++.|+|++++..+.+| .++.+++|+.|+|++|.....+|..+.++++|+.|+|++|
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 3445555555544333443 2445555555555554433344555555555555555543
|
syringae 6; Provisional |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=150.08 Aligned_cols=257 Identities=19% Similarity=0.130 Sum_probs=182.3
Q ss_pred ccchHHHhhhcceeccc--cCceEEEEEEe---CCCcEEEEEEcCC--CchhhHHHHHHHHHHHhccC-CCCccceeeEE
Q 003847 469 ELELETLLKASAYILGA--SGSSIMYKAVL---EDGTALAVRRIGE--NSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY 540 (791)
Q Consensus 469 ~~~~~~~~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~ 540 (791)
.+++.+.......-+|. |.+|.||.+.. +++..+|+|+-+. ........=.+|+...++++ |+|.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34445555555677899 99999999985 5688999998433 22222233345666666664 99999999999
Q ss_pred EccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCeecCCCCCCeEecCC-CCe
Q 003847 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR----GLAFLHEKKHVHGNLKPRNVLLGND-MEP 615 (791)
Q Consensus 541 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~ivHrDlkp~NILl~~~-~~~ 615 (791)
...+..++-+|++ +.+|..+.+.... .++....+.+..+..+ ||.++|+.+++|-|+||.||+...+ ...
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence 9999999999998 5788888776543 3777788888888888 9999999999999999999999998 889
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
+++|||+...+........... .....|...|++||...+ -++.+.|+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~-------------------------------~~r~~~~~~Y~~ke~~~~-l~~~~~di 310 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKV-------------------------------SKRPEGDCIYAAKELLNG-LATFASDI 310 (524)
T ss_pred ecCCcceeEEccCCccccceee-------------------------------eecCCCCceEeChhhhcc-ccchHhhh
Confidence 9999999988865442211100 011135666999999876 67899999
Q ss_pred HHHHHHHHHHHhCCcchhcc-ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLTGKVIVVDE-LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~elltG~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
|++|.++.+..++...+... ...|...- ... +-+... ..-..++...+..|++.+|..|++.+.+.
T Consensus 311 ~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~~~----ip~e~~-------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 311 FSLGEVILEAILGSHLPSVGKNSSWSQLR--QGY----IPLEFC-------EGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cchhhhhHhhHhhcccccCCCCCCccccc--ccc----Cchhhh-------cCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 99999999999988754322 22222110 000 000011 01123334478899999999999888765
Q ss_pred H
Q 003847 775 Q 775 (791)
Q Consensus 775 ~ 775 (791)
.
T Consensus 378 ~ 378 (524)
T KOG0601|consen 378 A 378 (524)
T ss_pred c
Confidence 4
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-14 Score=156.94 Aligned_cols=182 Identities=26% Similarity=0.312 Sum_probs=135.6
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCC---CCEEeCcCCCCCC----CCcccccCC-CCccEEEccCCcCCCC----Cc
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEF---LQYLDLSNNSLNG----SLSFSLFNA-SQLRNLDLSNNLISGH----LP 146 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p 146 (791)
...+++.|+|++|.+.+..+..+..+.. |++|+|++|++++ .+...+..+ ++|+.|+|++|.|++. ++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 3668999999999998777776666666 9999999999883 233455666 8999999999999843 34
Q ss_pred cccCCCCCCCEEeCcCCcCCCC----CccccCCCCCCCEEeCCCCcCCCCCC-------CCCcccceeccccccccccCC
Q 003847 147 ETMGSLHNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSLKNNYFSDGLP-------SKFNSVQVLDLSSNLINGSLP 215 (791)
Q Consensus 147 ~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p-------~~l~~L~~L~ls~N~l~~~~p 215 (791)
..+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++... ..+++|++|++++|.+++...
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 4577788999999999999842 34456667899999999999875332 234789999999999875222
Q ss_pred CCcC------CccccEEEccCCcCcc----cCchhHhhcCCCCcEEEcccCcCccc
Q 003847 216 PDIG------GYSLRYLNLSYNRLSG----EIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 216 ~~~~------~~~L~~L~l~~N~l~g----~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
..+. ...|++|++++|.++. .+...+.. +++|++|++++|.++..
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~-~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE-KESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhc-CCCccEEECCCCCCcHH
Confidence 2211 2479999999999972 23444444 68899999999999744
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-14 Score=162.30 Aligned_cols=199 Identities=26% Similarity=0.263 Sum_probs=159.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+.++|-+....+.. .-.+|+++++++|+++ .+|..+..+.+|+.|+..+|+|+ .+|..+...++|+.|.
T Consensus 218 g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~ 293 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLS 293 (1081)
T ss_pred CcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHH
Confidence 357788888888887443322 2357999999999999 56799999999999999999997 8999999999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCC----------------------------Ccccceecccccccc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK----------------------------FNSVQVLDLSSNLIN 211 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~----------------------------l~~L~~L~ls~N~l~ 211 (791)
+.+|.++ -+|.....+++|++|+|..|+|....+.. ++.|+.|.|.+|.|+
T Consensus 294 ~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 294 AAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 9999999 78888999999999999999998633211 145788999999997
Q ss_pred ccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCC
Q 003847 212 GSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQ 285 (791)
Q Consensus 212 ~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~ 285 (791)
...-+.+.+ ..|+.|+|++|+|. ++|.....++..|+.|+||+|+|+.. |++ ..+..+..+...+|.-+|-+
T Consensus 373 d~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~L-p~tva~~~~L~tL~ahsN~l~~fP 446 (1081)
T KOG0618|consen 373 DSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTL-PDTVANLGRLHTLRAHSNQLLSFP 446 (1081)
T ss_pred ccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhh-hHHHHhhhhhHHHhhcCCceeech
Confidence 644444444 68999999999998 99999998899999999999999854 444 44445555556666666643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.7e-14 Score=152.02 Aligned_cols=180 Identities=28% Similarity=0.280 Sum_probs=135.8
Q ss_pred CCcEEEEEcCCCCCcc------CCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCC---ccEEEccCCcCCC----CCc
Q 003847 80 DSRVIGLALPNSQLLG------SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQ---LRNLDLSNNLISG----HLP 146 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p 146 (791)
...++.|+++++.+.+ .++..|..+++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+.
T Consensus 50 ~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 50 QPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 4458888888888762 33456778899999999999998777777766666 9999999999983 344
Q ss_pred cccCCC-CCCCEEeCcCCcCCCC----CccccCCCCCCCEEeCCCCcCCCC----CCCCC---cccceeccccccccccC
Q 003847 147 ETMGSL-HNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSLKNNYFSDG----LPSKF---NSVQVLDLSSNLINGSL 214 (791)
Q Consensus 147 ~~~~~l-~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l---~~L~~L~ls~N~l~~~~ 214 (791)
..+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++..+ ++|+.|+|++|.+++..
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence 556677 8999999999999843 344667788999999999999852 22223 58999999999987433
Q ss_pred CC----CcCC-ccccEEEccCCcCcccCchhHhhc----CCCCcEEEcccCcCc
Q 003847 215 PP----DIGG-YSLRYLNLSYNRLSGEIPPQFGEK----IPVNATIDLSFNNLT 259 (791)
Q Consensus 215 p~----~~~~-~~L~~L~l~~N~l~g~ip~~~~~~----l~~l~~l~l~~N~l~ 259 (791)
.. .+.. .+|++|++++|.+++.....+... .+.|+.|++++|.++
T Consensus 210 ~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 210 ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 22 2222 479999999999986444444443 378999999999987
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.7e-12 Score=130.22 Aligned_cols=206 Identities=21% Similarity=0.244 Sum_probs=140.2
Q ss_pred HHHHhccCCCCccceeeEEEccC-----ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--
Q 003847 522 VRVIAKLVHPNLVRIRGFYWGVD-----EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-- 594 (791)
Q Consensus 522 ~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-- 594 (791)
...|-++.|.|||+++.|+.+.. ...+++|||+.|++..++++..... ..+......+|+-||+.||.|||+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 44556678999999999987543 4688999999999999998754322 247888899999999999999998
Q ss_pred CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCC
Q 003847 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG 674 (791)
Q Consensus 595 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 674 (791)
..|+|+++.-+-|++..+|-+|+.----.. ....... . .....+...|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~---~----------------------------~~~Ek~~~~~ 244 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNS---T----------------------------REAEKSVNTS 244 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhh---h----------------------------hHhhhhcccc
Confidence 689999999999999998888874221110 0000000 0 0001112236
Q ss_pred CCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc-hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHH
Q 003847 675 ISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI-VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCF 753 (791)
Q Consensus 675 t~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 753 (791)
-++|.|||.=.....+.++|||+||...+||..+..- -..... . .. .+.....+.+.-+ ..=.
T Consensus 245 ~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~-----~-~~----ee~ia~~i~~len------~lqr 308 (458)
T KOG1266|consen 245 LPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK-----V-EV----EENIANVIIGLEN------GLQR 308 (458)
T ss_pred CCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce-----e-eh----hhhhhhheeeccC------cccc
Confidence 7889999987777778899999999999999887652 111100 0 00 0111111111111 1113
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 003847 754 KLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+++..|++..|..||+|++++..
T Consensus 309 ~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 309 GSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred CcCcccccCCCCCCcchhhhhcC
Confidence 57889999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-12 Score=122.16 Aligned_cols=127 Identities=17% Similarity=0.204 Sum_probs=97.1
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCcc-ceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLV-RIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
+.++.|.++.||++... ++.|++|....... ....+++|+++++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 35788999999999875 78899999865532 123568899999988655544 455443 33468999999998876
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----eecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH-----VHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i-----vHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
+. . . ....++.+++++|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0 1 113457899999999999875 9999999999999 66899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-11 Score=132.38 Aligned_cols=166 Identities=21% Similarity=0.244 Sum_probs=127.2
Q ss_pred eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCH
Q 003847 496 LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPW 575 (791)
Q Consensus 496 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~ 575 (791)
..++.+|.|+..+...........+-++.|+.++||||+++++.++..+..|+|+|-+. .|..++.+ +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 55788888888877655445567778899999999999999999999999999999984 56666665 345
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccc
Q 003847 576 EARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654 (791)
Q Consensus 576 ~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (791)
..+.-.+.||+.||.|||+ .+++|++|.-+.|+++..|..||++|.++..........
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--------------------- 162 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--------------------- 162 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc---------------------
Confidence 6677789999999999985 889999999999999999999999999876543211100
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
....--..|..|+.+.... -..|.|-||++++|++.|.
T Consensus 163 ---------------~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 163 ---------------KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ---------------ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 0000111256666543322 3569999999999999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-12 Score=143.47 Aligned_cols=141 Identities=14% Similarity=0.229 Sum_probs=92.1
Q ss_pred eeccccCceEEEEEEeCC-CcEEEEEEcCCCchhh----------------------------------HH------HHH
Q 003847 481 YILGASGSSIMYKAVLED-GTALAVRRIGENSVDR----------------------------------FR------DFE 519 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~~------~~~ 519 (791)
+-||+|++|.||+|++++ |+.||||+.+..-... .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999877 9999999997541100 01 133
Q ss_pred HHHHHHhccC----CCCccceeeEEEc-cCceEEEEeccCCCChhHHHHhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003847 520 TQVRVIAKLV----HPNLVRIRGFYWG-VDEKLIIYDFVPNGSLANARYRK-MGSSPCHLPWEARLKIAKGVARGLAFLH 593 (791)
Q Consensus 520 ~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~gL~yLH 593 (791)
+|+..+.+++ +...+.+-.+|.+ ....++||||++|+.+.++-.-. .+.....+....+..++.| ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 4444444442 3333433343433 34678999999999998743211 1100001222233333333 44
Q ss_pred cCCCeecCCCCCCeEecCCC----CeEEeccCcccccCC
Q 003847 594 EKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVTG 628 (791)
Q Consensus 594 ~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~~ 628 (791)
..|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 69999999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=3e-11 Score=117.96 Aligned_cols=136 Identities=14% Similarity=0.103 Sum_probs=100.3
Q ss_pred eeccccCceEEEEEEeCC-------CcEEEEEEcCCC-------------c---------hhhHHHH----HHHHHHHhc
Q 003847 481 YILGASGSSIMYKAVLED-------GTALAVRRIGEN-------------S---------VDRFRDF----ETQVRVIAK 527 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 527 (791)
..||.|--+.||.|...+ +..+|||+.+.. . ....+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998543 579999987421 0 0112223 389999999
Q ss_pred cCC--CCccceeeEEEccCceEEEEeccCCCChhH-HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCeecCCC
Q 003847 528 LVH--PNLVRIRGFYWGVDEKLIIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFL-HEKKHVHGNLK 603 (791)
Q Consensus 528 l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~ivHrDlk 603 (791)
+.. -++.+.+++ ...++||||+.++.+.. .+... .++..+...+..+++.+|.+| |+.||||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 853 466677764 56789999997654432 12211 255566778899999999999 89999999999
Q ss_pred CCCeEecCCCCeEEeccCcccccC
Q 003847 604 PRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 604 p~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+.||+++ ++.++|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999987664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.8e-12 Score=140.64 Aligned_cols=177 Identities=36% Similarity=0.539 Sum_probs=109.9
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCC-CCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIE-FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..++.|++.+|+++ .+++..+.+. +|+.|++++|++. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 34666777777665 4455555553 6777777777776 45555666777777777777776 5555555666777777
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC--CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCccc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP--SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ 236 (791)
+++|+++ .+|.....+..|++|.+++|.+...+. ..+.++..|.+++|++. .++..++. .+|++|++++|+++ .
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-S 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-c
Confidence 7777776 566555555567777777774322111 23356666667777765 33444444 35777777777777 5
Q ss_pred CchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 237 IPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 237 ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
++. ++. +.+++.|++++|.++..+|..
T Consensus 270 i~~-~~~-~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 270 ISS-LGS-LTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ccc-ccc-cCccCEEeccCccccccchhh
Confidence 555 433 677777777777776655543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.8e-12 Score=135.89 Aligned_cols=241 Identities=22% Similarity=0.178 Sum_probs=171.9
Q ss_pred eeccccCceEEEEEEe--CCCcEEEEEEcCCCchhhHH--HHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVL--EDGTALAVRRIGENSVDRFR--DFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..||.|.|+.||+... .++..|++|.+......... .-..|+.+...+ .|.++++++..|......|+--|||++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4789999999999873 46889999998765322222 223466666655 599999999888888888999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++...+.... .+.+..++++..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+..+.-....
T Consensus 351 ~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~-- 423 (524)
T KOG0601|consen 351 GSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV-- 423 (524)
T ss_pred cchhhhhHHHH-----hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceeccc--
Confidence 99877653222 27778899999999999999999999999999999999876 77899999998643211000
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcc-cCcccccCCCCCCchhhHHHHHHHHHHHhCCcc-h
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGKVI-V 712 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y-~APE~~~~~~~~~~sDvwSlGvil~elltG~~p-f 712 (791)
...++..| .+++......+..+.|+||||..+.|.++|... .
T Consensus 424 ------------------------------------~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 424 ------------------------------------FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ------------------------------------ccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 00123334 356666677788999999999999999998762 2
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... .|.. +. .+..+........+..+...++..++..||.+.++....+.+.
T Consensus 468 ~~~--~~~~--i~-------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 468 SGV--QSLT--IR-------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ccc--ccee--ee-------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111 1110 00 1111111123356677888999999999999998877655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-10 Score=107.19 Aligned_cols=131 Identities=22% Similarity=0.310 Sum_probs=100.5
Q ss_pred eccccCceEEEEEEeCCCcEEEEEE-cCCC--ch-----hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRR-IGEN--SV-----DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~--~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
++++|+-+.+|.+.+. |..+++|. +++. .+ -..++-.+|++++.+++--.|.-.+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999764 44466664 3332 11 12345678999999987666665555666888889999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
+|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..+. +.++|||++..-
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998887654 245677788888999999999999999999997664 999999998753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-12 Score=139.85 Aligned_cols=186 Identities=30% Similarity=0.401 Sum_probs=150.6
Q ss_pred EEcCCCCCccCCC-cCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCc
Q 003847 86 LALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164 (791)
Q Consensus 86 L~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 164 (791)
|.|++-.+....- .+=-.|+.-...||+.|++. .+|.++..+..|+.|.|++|.|. .+|..+++|..|++|||+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 4555555543322 22245677788999999999 89999999999999999999998 899999999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchh
Q 003847 165 LAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
++ .+|..+..|+ |+.|.+++|+++. +|..+ ..|..||.+.|.|. .+|..++. .+|+.|++..|++. .+|++
T Consensus 133 lS-~lp~~lC~lp-Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~E 207 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP-LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEE 207 (722)
T ss_pred hh-cCChhhhcCc-ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence 99 8888887774 8999999999986 44433 78999999999998 67777666 59999999999999 89999
Q ss_pred HhhcCCCCcEEEcccCcCcccCCCCC-cccccccccccCCCC
Q 003847 241 FGEKIPVNATIDLSFNNLTGEIPESN-VFMNQESSSFSGNLD 281 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~ 281 (791)
+.. |+ |..||+|.|+++ .+|-.. .+..+..+.+.+||.
T Consensus 208 l~~-Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 208 LCS-LP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred HhC-Cc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 883 64 778999999998 456554 444556666667764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5e-10 Score=104.48 Aligned_cols=143 Identities=17% Similarity=0.276 Sum_probs=107.4
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEE-cCCC-------chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRR-IGEN-------SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.++-+|+-+.|+++... |+...||. +.+. ..-..++..+|+++|.++.--.|.-..=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 57889999999999875 77777764 3221 111235677899999998765665555566677777899999
Q ss_pred cCC-CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCcccccC
Q 003847 553 VPN-GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLVT 627 (791)
Q Consensus 553 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~ 627 (791)
++| .++.+++....... ...+....++.+|-+.+.-||..+|+|+||..+||++..++. +.++|||++..-.
T Consensus 92 ~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred ccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 976 48888887765432 233334788999999999999999999999999999965543 5899999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-10 Score=115.65 Aligned_cols=139 Identities=23% Similarity=0.278 Sum_probs=108.3
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCC--CccceeeEEEccC---ceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHP--NLVRIRGFYWGVD---EKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~---~~~lv~e~~~ 554 (791)
+.||.|..+.||++...+|+.+++|....... .....+..|+++++.+.+. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46889999999999987778999999865432 1345789999999999753 4577777766542 5689999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---------------------------------------- 594 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------------------------------------- 594 (791)
|.++.+.+.. . .++..+...++.+++++|.+||+
T Consensus 84 G~~l~~~~~~-~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR-P-----ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC-C-----CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988765431 1 26777788888888888888884
Q ss_pred ----------------CCCeecCCCCCCeEecC--CCCeEEeccCcccc
Q 003847 595 ----------------KKHVHGNLKPRNVLLGN--DMEPKIGDFGLERL 625 (791)
Q Consensus 595 ----------------~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~ 625 (791)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.9e-11 Score=132.57 Aligned_cols=189 Identities=33% Similarity=0.418 Sum_probs=151.5
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCC-CccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNAS-QLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
.|.+..+.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5788888774333 34556689999999999999 6777777775 9999999999998 78788999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCC--CCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchh
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
+++ .+|.....+++|+.|++++|+++...+. ....|++|++++|.+. .++..+.. .++..|.+.+|++. .++..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 999 7777777899999999999999985554 3356999999999654 44444544 57889999999998 55666
Q ss_pred HhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
+.. +++++.|++++|+++...+ .....++..+.+.+|..
T Consensus 251 ~~~-l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~ 289 (394)
T COG4886 251 IGN-LSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSL 289 (394)
T ss_pred hcc-ccccceecccccccccccc-ccccCccCEEeccCccc
Confidence 665 8899999999999985544 55566666677767653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.2e-11 Score=137.44 Aligned_cols=89 Identities=33% Similarity=0.671 Sum_probs=58.8
Q ss_pred ccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceecccc
Q 003847 131 LRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSS 207 (791)
Q Consensus 131 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~ 207 (791)
++.|+|++|.|+|.+|..++.|++|+.|+|++|+|.|.+|..+..+++|+.|+|++|+|+|.+|..+ ++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 5566666666666666666666666666666666666666666666666666666666666666543 5666667777
Q ss_pred ccccccCCCCcC
Q 003847 208 NLINGSLPPDIG 219 (791)
Q Consensus 208 N~l~~~~p~~~~ 219 (791)
|+|+|.+|..++
T Consensus 500 N~l~g~iP~~l~ 511 (623)
T PLN03150 500 NSLSGRVPAALG 511 (623)
T ss_pred CcccccCChHHh
Confidence 777777776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=112.01 Aligned_cols=149 Identities=14% Similarity=0.072 Sum_probs=106.4
Q ss_pred HHHhhhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchh-hHH----------HHHHHHHHHhccCCCCc--cceeeE
Q 003847 473 ETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVD-RFR----------DFETQVRVIAKLVHPNL--VRIRGF 539 (791)
Q Consensus 473 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~nI--v~l~~~ 539 (791)
+.+.....+++-.-....|+++.. +|+.|.||+....... ..+ .+.+|.+.+.++...+| ++.+++
T Consensus 20 ~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 20 EEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred HHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 344444445555555555777766 5788999987543321 111 47789999988854443 445555
Q ss_pred EEc-----cCceEEEEeccCCC-ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC--
Q 003847 540 YWG-----VDEKLIIYDFVPNG-SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-- 611 (791)
Q Consensus 540 ~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-- 611 (791)
.+. ....++|||++++. +|.+++...... +.+...+..++.+++..+.-||..||+|+|+++.|||++.
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~---~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~ 175 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWATN---PPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPF 175 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccc
Confidence 543 23478999999876 898887543221 2566778899999999999999999999999999999975
Q ss_pred -----CCCeEEeccCcccc
Q 003847 612 -----DMEPKIGDFGLERL 625 (791)
Q Consensus 612 -----~~~~kL~DFGla~~ 625 (791)
++.+.++||+.+..
T Consensus 176 ~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 176 PGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cCCCCCceEEEEECCcccc
Confidence 46799999998864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=111.41 Aligned_cols=104 Identities=37% Similarity=0.481 Sum_probs=25.1
Q ss_pred cEEEEEcCCCCCccCCCcCCC-CCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCcccc-CCCCCCCEEe
Q 003847 82 RVIGLALPNSQLLGSIPADLG-MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM-GSLHNLQLLN 159 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 159 (791)
+++.|+|.+|+|+.+ +.++ .|.+|+.|+|++|.|+. ++ .+..+++|++|+|++|+|+ .+.+.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 445555555555432 2343 35555555555555552 22 2444555555555555555 232222 2355555555
Q ss_pred CcCCcCCCCC-ccccCCCCCCCEEeCCCCcCC
Q 003847 160 LSDNALAGKL-PVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 160 ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 190 (791)
|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 5555554211 123444555555555555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.5e-11 Score=135.18 Aligned_cols=266 Identities=21% Similarity=0.237 Sum_probs=164.4
Q ss_pred ccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 483 LGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 483 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
+-+|.++.++.+.- ..|...+.|...... ..+.+....+-.++-..+||-+++..-.+......+++++|+.+++|
T Consensus 812 ~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~ 891 (1205)
T KOG0606|consen 812 SQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDL 891 (1205)
T ss_pred ccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCc
Confidence 44566676666652 224334444432211 11112222222222233456666555545556788999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
...++.... .+.+-.+.....+..+++|||...++|||++|.|++...++..++.|||......--.......+.
T Consensus 892 ~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 892 PSKLHNSGC-----LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred hhhhhcCCC-----cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 988876552 455556667778889999999999999999999999999999999999965543322111111000
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
. +.+..+.... ..+. ...............||+.|.+||...+......+|.|++|++++|.++|.+||.....+
T Consensus 967 ~-~~~~~~~~~~--~~~~--~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 967 S-SSGTPRRLSR--SERR--PQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred c-ccCccccccc--cccc--cccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0000000000 0000 000000112234567999999999999999999999999999999999999999765332
Q ss_pred CCCcchhchhHHHHHHHHhhhcCc---cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADF---EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
++++....+.. ....+......+++...+..+|.+|-.|.
T Consensus 1042 -------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 -------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 22232222222 12333556778888899999999997765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-11 Score=120.59 Aligned_cols=129 Identities=31% Similarity=0.502 Sum_probs=102.8
Q ss_pred CCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC--CCCCcccceec
Q 003847 127 NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL--PSKFNSVQVLD 204 (791)
Q Consensus 127 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~l~~L~~L~ 204 (791)
....|++||||+|.|+ .+.+++.-++.++.|++|+|.|. .+- .++.|.+|+.|||++|.++... -..+.+.++|.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLK 358 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeee
Confidence 3467999999999998 88888888999999999999998 343 4889999999999999988633 34568899999
Q ss_pred cccccccccCCCCcCC-ccccEEEccCCcCcccCch--hHhhcCCCCcEEEcccCcCcccC
Q 003847 205 LSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP--QFGEKIPVNATIDLSFNNLTGEI 262 (791)
Q Consensus 205 ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~--~~~~~l~~l~~l~l~~N~l~~~~ 262 (791)
|+.|.|. .+. .++. .+|.+||+++|+|. .+.. .+++ +|.|+.|.|.+|+|.+.+
T Consensus 359 La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~-LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIE-TLS-GLRKLYSLVNLDLSSNQIE-ELDEVNHIGN-LPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHh-hhh-hhHhhhhheeccccccchh-hHHHhccccc-ccHHHHHhhcCCCccccc
Confidence 9999986 222 1222 48999999999997 4332 3455 899999999999998654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-09 Score=104.73 Aligned_cols=126 Identities=19% Similarity=0.251 Sum_probs=85.6
Q ss_pred EEEEEEeCCCcEEEEEEcCCC---------------c------h-----hhHHHHHHHHHHHhccCCC--CccceeeEEE
Q 003847 490 IMYKAVLEDGTALAVRRIGEN---------------S------V-----DRFRDFETQVRVIAKLVHP--NLVRIRGFYW 541 (791)
Q Consensus 490 ~Vy~~~~~~g~~vavK~~~~~---------------~------~-----~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 541 (791)
.||.|...+|..+|||+.+.. . . ......++|++.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999987421 0 0 0123467899999999765 566776542
Q ss_pred ccCceEEEEeccC--CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 542 GVDEKLIIYDFVP--NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAF-LHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 542 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
..++||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 4579999998 65565443322 2234456778888886655 579999999999999999887 99999
Q ss_pred ccCcccccC
Q 003847 619 DFGLERLVT 627 (791)
Q Consensus 619 DFGla~~~~ 627 (791)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.7e-09 Score=110.67 Aligned_cols=140 Identities=20% Similarity=0.283 Sum_probs=109.6
Q ss_pred ceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEeccCC-CChhHH
Q 003847 488 SSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYDFVPN-GSLANA 561 (791)
Q Consensus 488 ~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 561 (791)
-.+.||+. ..||..|++|+++.........-..-+++++++.|.|||++.++|.. +...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 56899999999954433222233445789999999999999998873 3467899999875 577775
Q ss_pred HHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 562 RYRKMGS----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 562 l~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
-...... .+...++...+.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|+..|....+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4332211 12357889999999999999999999999999999999999999999999888876554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.6e-10 Score=109.21 Aligned_cols=86 Identities=33% Similarity=0.414 Sum_probs=24.8
Q ss_pred CCCCCCCCEEeCcCCCCCCCCccccc-CCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCcccc-CCCCC
Q 003847 101 LGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSL-TTLQS 178 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~ 178 (791)
+.+...+++|+|++|+|+. +. .++ .+.+|+.|||++|.|+ .++ .+..+++|+.|+|++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4555677888888888873 32 354 4678888888888887 343 36777888888888888874 43333 35778
Q ss_pred CCEEeCCCCcCCC
Q 003847 179 LTIVSLKNNYFSD 191 (791)
Q Consensus 179 L~~L~L~~N~l~~ 191 (791)
|++|+|++|+|..
T Consensus 90 L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 90 LQELYLSNNKISD 102 (175)
T ss_dssp --EEE-TTS---S
T ss_pred CCEEECcCCcCCC
Confidence 8888888887765
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.3e-11 Score=116.21 Aligned_cols=134 Identities=33% Similarity=0.276 Sum_probs=107.8
Q ss_pred CCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCE
Q 003847 102 GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTI 181 (791)
Q Consensus 102 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 181 (791)
..-..|++||||+|.|+ .+..+..-+++++.|+||+|.|. .+.. +..|++|+.||||+|.++ .+.++-..|.+.+.
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 33456999999999998 67777888899999999999998 4444 889999999999999999 66677778899999
Q ss_pred EeCCCCcCCCC-CCCCCcccceeccccccccccC-CCCcCC-ccccEEEccCCcCcccCchh
Q 003847 182 VSLKNNYFSDG-LPSKFNSVQVLDLSSNLINGSL-PPDIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 182 L~L~~N~l~~~-~p~~l~~L~~L~ls~N~l~~~~-p~~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
|.|+.|.|... -...+-+|..||+++|+|.... -..++. +.|++|.|.+|.|. .+|+.
T Consensus 357 L~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~-~~vdY 417 (490)
T KOG1259|consen 357 LKLAQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA-GSVDY 417 (490)
T ss_pred eehhhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc-ccchH
Confidence 99999988752 1234578999999999997321 234555 57999999999999 44443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.4e-10 Score=119.33 Aligned_cols=180 Identities=23% Similarity=0.178 Sum_probs=113.5
Q ss_pred CCcEEEEEcCCCCCccCCC-cCCCCCCCCCEEeCcCCCCCCCCc--ccccCCCCccEEEccCCcCCCCCccc-cCCCCCC
Q 003847 80 DSRVIGLALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGSLS--FSLFNASQLRNLDLSNNLISGHLPET-MGSLHNL 155 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L 155 (791)
...+..+.|.+....-... .....|++++.||||.|-|....| .....|++|+.|+|+.|+|.-..... -..++.|
T Consensus 120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l 199 (505)
T KOG3207|consen 120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL 199 (505)
T ss_pred HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence 4566667777666532111 356678888888888888874432 33457888888888888887333222 2356778
Q ss_pred CEEeCcCCcCCCC-CccccCCCCCCCEEeCCCCcCCC--CCCC-CCcccceeccccccccccC--CCCcCCccccEEEcc
Q 003847 156 QLLNLSDNALAGK-LPVSLTTLQSLTIVSLKNNYFSD--GLPS-KFNSVQVLDLSSNLINGSL--PPDIGGYSLRYLNLS 229 (791)
Q Consensus 156 ~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~--~~p~-~l~~L~~L~ls~N~l~~~~--p~~~~~~~L~~L~l~ 229 (791)
+.|.|+.+.|+-. +-..+..+++|+.|+|..|.... ..+. .+..|+.|||++|++-... +.....+.|+.|+++
T Consensus 200 K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls 279 (505)
T KOG3207|consen 200 KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLS 279 (505)
T ss_pred heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcc
Confidence 8888888888722 12234467888888888885221 1222 2367888888888876322 111122467888888
Q ss_pred CCcCccc-Cchh----HhhcCCCCcEEEcccCcCc
Q 003847 230 YNRLSGE-IPPQ----FGEKIPVNATIDLSFNNLT 259 (791)
Q Consensus 230 ~N~l~g~-ip~~----~~~~l~~l~~l~l~~N~l~ 259 (791)
.+.++.. +|+. ....+++|++|+++.|++.
T Consensus 280 ~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 280 STGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 8877621 2332 1234788889999998884
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-09 Score=85.48 Aligned_cols=59 Identities=42% Similarity=0.524 Sum_probs=26.7
Q ss_pred CCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCc
Q 003847 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164 (791)
Q Consensus 106 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 164 (791)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444443333444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-09 Score=84.55 Aligned_cols=61 Identities=36% Similarity=0.561 Sum_probs=55.6
Q ss_pred CCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcC
Q 003847 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189 (791)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 189 (791)
++|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999977778899999999999999999988888999999999999999975
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9e-10 Score=122.73 Aligned_cols=172 Identities=30% Similarity=0.273 Sum_probs=106.5
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...+..|+|.+|+|..+.. .+..+++|++|+|++|.|+...+ +..++.|+.|++++|.|+ .+. .+..+.+|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hcc-CCccchhhhccc
Confidence 4567777777777764432 25667777777777777764433 455666777777777776 222 244567777777
Q ss_pred CcCCcCCCCCc-cccCCCCCCCEEeCCCCcCCCCCCC-CCcccceeccccccccccCCCCcCCcc--ccEEEccCCcCcc
Q 003847 160 LSDNALAGKLP-VSLTTLQSLTIVSLKNNYFSDGLPS-KFNSVQVLDLSSNLINGSLPPDIGGYS--LRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~L~~L~ls~N~l~~~~p~~~~~~~--L~~L~l~~N~l~g 235 (791)
+++|++...-+ . +..+.+|+.+++.+|.+...-.- .+..+..+++..|.++. +-....... |+.+++++|.+.
T Consensus 169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~-~~~l~~~~~~~L~~l~l~~n~i~- 245 (414)
T KOG0531|consen 169 LSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISK-LEGLNELVMLHLRELYLSGNRIS- 245 (414)
T ss_pred CCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHHHHHHhhccccccee-ccCcccchhHHHHHHhcccCccc-
Confidence 77777773333 2 45667777777777776643322 22455555777777762 222222222 778888888887
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcc
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
.++..+.. +..+..|++.+|++..
T Consensus 246 ~~~~~~~~-~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 246 RSPEGLEN-LKNLPVLDLSSNRISN 269 (414)
T ss_pred cccccccc-cccccccchhhccccc
Confidence 55444443 7777788888887763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.6e-08 Score=98.40 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=104.4
Q ss_pred hhhcceeccccCceEEEEEEeCCCcEEEEEEcCCC--------------------c--hhhHHHHHHHHHHHhccCCC--
Q 003847 476 LKASAYILGASGSSIMYKAVLEDGTALAVRRIGEN--------------------S--VDRFRDFETQVRVIAKLVHP-- 531 (791)
Q Consensus 476 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~-- 531 (791)
..+.+..||-|--+.||.|....|.++|||.-+.. + .......++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44567899999999999999999999999974211 0 00123467899999999654
Q ss_pred CccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC
Q 003847 532 NLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN 611 (791)
Q Consensus 532 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~ 611 (791)
.+.+.+++ +...+||||++|--|...- ++.+....|+..|++-+.-+-..||||+|+.+-||++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 67777654 4668999999987765421 223444556666666666666899999999999999999
Q ss_pred CCCeEEeccCcccccC
Q 003847 612 DMEPKIGDFGLERLVT 627 (791)
Q Consensus 612 ~~~~kL~DFGla~~~~ 627 (791)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998877654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8e-10 Score=115.43 Aligned_cols=155 Identities=26% Similarity=0.225 Sum_probs=81.8
Q ss_pred CCcEEEEEcCCCCCccCCC--cCCCCCCCCCEEeCcCCCCCCCCcccc-cCCCCccEEEccCCcCCC-CCccccCCCCCC
Q 003847 80 DSRVIGLALPNSQLLGSIP--ADLGMIEFLQYLDLSNNSLNGSLSFSL-FNASQLRNLDLSNNLISG-HLPETMGSLHNL 155 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L 155 (791)
..+|+.|||+.|-+....+ .-...|++|+.|+|+.|++.-...... ..+++|+.|.|+.+.|+- .+-..+..+++|
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 4566666666665544322 234556666666666666652222111 235666666666666651 122334456666
Q ss_pred CEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC----CCCCcccceeccccccccc-cCCCC------cCCcccc
Q 003847 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL----PSKFNSVQVLDLSSNLING-SLPPD------IGGYSLR 224 (791)
Q Consensus 156 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~L~~L~ls~N~l~~-~~p~~------~~~~~L~ 224 (791)
+.|+|..|..-+.--.....+..|++|+|++|++-... -..|+.|+.|+++.+.+.. .+|+. ....+|+
T Consensus 225 ~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~ 304 (505)
T KOG3207|consen 225 EVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE 304 (505)
T ss_pred HHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence 66666666432233334445566666666666665422 1234666666666666653 12222 1113566
Q ss_pred EEEccCCcCc
Q 003847 225 YLNLSYNRLS 234 (791)
Q Consensus 225 ~L~l~~N~l~ 234 (791)
+|+++.|++.
T Consensus 305 ~L~i~~N~I~ 314 (505)
T KOG3207|consen 305 YLNISENNIR 314 (505)
T ss_pred eeecccCccc
Confidence 6666666664
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.4e-09 Score=75.40 Aligned_cols=41 Identities=56% Similarity=1.052 Sum_probs=31.3
Q ss_pred hhhHHHHHHHHhhccCCCCCccCCCCCCC-CCCceeeeeeeC
Q 003847 32 NTDGVLLLSFKYSVLSDPLGVLGSWNYND-ENPCSWNGVTCA 72 (791)
Q Consensus 32 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~-~~~c~w~gv~C~ 72 (791)
+.|.++|++||.++..+|.+.+.+|+... .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57899999999999878889999999764 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.9e-08 Score=95.50 Aligned_cols=106 Identities=20% Similarity=0.217 Sum_probs=84.7
Q ss_pred HHHHHHHHHHhccCCC--CccceeeEEEccC----ceEEEEeccCCC-ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 003847 516 RDFETQVRVIAKLVHP--NLVRIRGFYWGVD----EKLIIYDFVPNG-SLANARYRKMGSSPCHLPWEARLKIAKGVARG 588 (791)
Q Consensus 516 ~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~g 588 (791)
....+|.+.+.++... .+.+.+++.+... ..++|+|++++. +|.+++..... .+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence 4677888888887533 3556666665532 358999999874 79888876432 4566788999999999
Q ss_pred HHHHhcCCCeecCCCCCCeEecCCC---CeEEeccCccccc
Q 003847 589 LAFLHEKKHVHGNLKPRNVLLGNDM---EPKIGDFGLERLV 626 (791)
Q Consensus 589 L~yLH~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~ 626 (791)
++-||+.||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 131 i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999999887 7999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.5e-09 Score=119.16 Aligned_cols=172 Identities=27% Similarity=0.263 Sum_probs=127.0
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...+..++|..|.+.. +-..+..+++|+.|+|.+|+|.+ +...+..+++|++|+|++|+|+...+ +..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhhe
Confidence 3456666677777764 44557888999999999999984 33337788999999999999984433 66777799999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC---CCCcccceeccccccccccCCCCcCCccccEEEccCCcCccc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP---SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGE 236 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ 236 (791)
+++|.|+ .+ ..+..+++|+.++|++|++...-+ ..+.+|+.+++++|.+. .+...-....+..+++..|.++ .
T Consensus 147 l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~-~ 222 (414)
T KOG0531|consen 147 LSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKIS-K 222 (414)
T ss_pred eccCcch-hc-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccce-e
Confidence 9999998 33 345668999999999999998777 67789999999999987 2222222235666689999987 3
Q ss_pred CchhHhhcCCC--CcEEEcccCcCccc
Q 003847 237 IPPQFGEKIPV--NATIDLSFNNLTGE 261 (791)
Q Consensus 237 ip~~~~~~l~~--l~~l~l~~N~l~~~ 261 (791)
+-... . +.. |+.+++++|++.-.
T Consensus 223 ~~~l~-~-~~~~~L~~l~l~~n~i~~~ 247 (414)
T KOG0531|consen 223 LEGLN-E-LVMLHLRELYLSGNRISRS 247 (414)
T ss_pred ccCcc-c-chhHHHHHHhcccCccccc
Confidence 32211 1 333 78899999999743
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.8e-09 Score=115.26 Aligned_cols=158 Identities=26% Similarity=0.324 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCC
Q 003847 582 AKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660 (791)
Q Consensus 582 ~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (791)
+.+++.|+.|+|. .++||++|.|++|.++..+..||+.|+++...............
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd---------------------- 162 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYD---------------------- 162 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCC----------------------
Confidence 3455599999997 78999999999999999999999999998766543221110000
Q ss_pred CCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH-hCCcchhccccCCCCcchhchhHHHHHHHHhhh
Q 003847 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL-TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIR 739 (791)
Q Consensus 661 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (791)
.....-..-...|.|||++.....+.++|+||+||++|.+. .|+..+.............. ..+..
T Consensus 163 -----~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~-- 229 (700)
T KOG2137|consen 163 -----PPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAG-- 229 (700)
T ss_pred -----CCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------ccccc--
Confidence 00001112345699999999988899999999999999999 45554433211111110000 00000
Q ss_pred cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 740 ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 740 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.+-...+.+.++.+=+.+++..++..||++.++..
T Consensus 230 -~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 230 -AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred -cccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 00111235567777788999999999997776644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5e-07 Score=94.60 Aligned_cols=260 Identities=17% Similarity=0.128 Sum_probs=156.0
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeE----EE--ccC-ceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGF----YW--GVD-EKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~----~~--~~~-~~~lv~e 551 (791)
+.-||+|+-+.+|-.--- ..-+.|++.........+. +..|... .||-+-.-+.+ .+ +.+ ..-++|+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456899999999976421 2234577766544322222 2233333 56644331111 11 112 2567888
Q ss_pred ccCCCC-hhHHHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 552 FVPNGS-LANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 552 ~~~~gs-L~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
.+++.- +..+.. ..+.+......|.-.++.++.++.+.+.||+.|.+-+|+.++|+|+++++.+.|.|-..-.....+
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCC
Confidence 877652 112111 111222335899999999999999999999999999999999999999999999986543332111
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHH
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~e 704 (791)
. .....+|...|.+||.-. +..-+...|.|.||+++++
T Consensus 171 ~-------------------------------------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~ 213 (637)
T COG4248 171 T-------------------------------------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFH 213 (637)
T ss_pred c-------------------------------------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHH
Confidence 1 111234788899999864 3445778999999999999
Q ss_pred HHhC-CcchhccccCCCCc-----chhchhHHHHHHHHhhhcCc-----cchHHHHHHHHHHHhhccCCC--CCCCCCHH
Q 003847 705 LLTG-KVIVVDELGQGNGL-----LVEDKNRAIRLADAAIRADF-----EGKEEALLSCFKLGYSCASPL--PQKRPSMK 771 (791)
Q Consensus 705 lltG-~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ 771 (791)
++.| ++||.+.......- -+..... ....+ ...+.. ....-....+.-+..+|+..- +.-|||++
T Consensus 214 lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f-~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 214 LLFGGRHPYSGIPLISDAPNPLETDIAHGRF-AYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred HHhcCCCCCCcccccCCCCCcchhhhhccee-eechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 9987 88997632211000 0000000 00000 001111 111223455666777887654 56899999
Q ss_pred HHHHHhccCCCC
Q 003847 772 EALQALEKIPSS 783 (791)
Q Consensus 772 evl~~L~~i~~~ 783 (791)
..+..|.++..+
T Consensus 292 aW~aAl~al~~~ 303 (637)
T COG4248 292 AWVAALDALRQQ 303 (637)
T ss_pred HHHHHHHHHHHh
Confidence 998888765444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.8e-07 Score=86.45 Aligned_cols=137 Identities=20% Similarity=0.140 Sum_probs=102.4
Q ss_pred cccCceEEEEEEeCCCcEEEEEEcCCC---c---hhhHHHHHHHHHHHhccCCCC--ccceeeEEE-cc----CceEEEE
Q 003847 484 GASGSSIMYKAVLEDGTALAVRRIGEN---S---VDRFRDFETQVRVIAKLVHPN--LVRIRGFYW-GV----DEKLIIY 550 (791)
Q Consensus 484 G~G~~g~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~-~~----~~~~lv~ 550 (791)
|+||.+-|++..++ |..+-||+-... + +.....|.+|+..+.+|...+ +.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888899998775 447888986521 1 334578999999999985333 44444 332 11 1357999
Q ss_pred eccCC-CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC--eEEeccCcccc
Q 003847 551 DFVPN-GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME--PKIGDFGLERL 625 (791)
Q Consensus 551 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~ 625 (791)
|-++| .+|.+++...... +.+...+..++.+++..+.-||+.|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~---~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS---PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC---CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 5888887554322 3677888999999999999999999999999999999986667 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.6e-07 Score=100.82 Aligned_cols=150 Identities=17% Similarity=0.309 Sum_probs=101.0
Q ss_pred chHHHhhhcc-eeccccCceEEEEEEeCCCcEEEEEEcCCCchhh------------------------------H----
Q 003847 471 ELETLLKASA-YILGASGSSIMYKAVLEDGTALAVRRIGENSVDR------------------------------F---- 515 (791)
Q Consensus 471 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------~---- 515 (791)
.++++....+ +-|+.++-|.||+|++++|+.||||+.+..-... .
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 4556666655 7899999999999999999999999975421110 0
Q ss_pred ------HHHHHHHHHHhccC-----CCCccceeeEEE-ccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHH
Q 003847 516 ------RDFETQVRVIAKLV-----HPNLVRIRGFYW-GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583 (791)
Q Consensus 516 ------~~~~~E~~~l~~l~-----H~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~ 583 (791)
-++.+|...+.+++ .+++ ++=.+|+ -.+...++|||++|-.+.+....... + .+. ..++.
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g---~d~---k~ia~ 271 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-G---IDR---KELAE 271 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc-C---CCH---HHHHH
Confidence 02344555555542 2332 2222333 34677899999999999887433321 1 442 33333
Q ss_pred HHHHH-HHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 584 GVARG-LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 584 qi~~g-L~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
.++++ +..+-..|+.|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus 272 ~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 272 LLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33332 3444558999999999999999999999999999887654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.7e-09 Score=115.64 Aligned_cols=128 Identities=26% Similarity=0.197 Sum_probs=85.3
Q ss_pred CCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC--cccceeccc
Q 003847 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF--NSVQVLDLS 206 (791)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l--~~L~~L~ls 206 (791)
..|.+.+.++|.|. ....++.-++.|+.|||++|+++... .+..|+.|++|||+.|.|....--.. ..|..|.|+
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeec
Confidence 35777777888887 67777777788888888888887433 67778888888888888775322222 347888888
Q ss_pred cccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcc
Q 003847 207 SNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 207 ~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
+|.++ .+-..-...+|+.|||++|-|++.-.-.....|..|..|+|.+|+|.+
T Consensus 241 nN~l~-tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALT-TLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHH-hhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 88776 222211224677888888877754333333336677778888888754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-08 Score=102.82 Aligned_cols=176 Identities=22% Similarity=0.241 Sum_probs=97.8
Q ss_pred cEEEEEcCCCCCccCCCcC----CCCCCCCCEEeCcCCCCCCC-------------CcccccCCCCccEEEccCCcCCCC
Q 003847 82 RVIGLALPNSQLLGSIPAD----LGMIEFLQYLDLSNNSLNGS-------------LSFSLFNASQLRNLDLSNNLISGH 144 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~-------------~p~~~~~l~~L~~L~L~~N~l~~~ 144 (791)
+++.|+|++|-+.-.-++. +.+++.|++|+|.||.+.-. ...-...-++|+++..++|++...
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 6777777777665433332 44566777777777766511 111223345677777777776521
Q ss_pred ----CccccCCCCCCCEEeCcCCcCCCC----CccccCCCCCCCEEeCCCCcCCCC-------CCCCCcccceecccccc
Q 003847 145 ----LPETMGSLHNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSLKNNYFSDG-------LPSKFNSVQVLDLSSNL 209 (791)
Q Consensus 145 ----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-------~p~~l~~L~~L~ls~N~ 209 (791)
+...|...+.|+.+.++.|.|... +-..|..+++|+.|||..|.|+.. ....|++|+.|+++.+.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 233455666777777777766511 123456677777777777776631 22344566777777776
Q ss_pred ccccCCCCc----C--CccccEEEccCCcCccc----CchhHhhcCCCCcEEEcccCcC
Q 003847 210 INGSLPPDI----G--GYSLRYLNLSYNRLSGE----IPPQFGEKIPVNATIDLSFNNL 258 (791)
Q Consensus 210 l~~~~p~~~----~--~~~L~~L~l~~N~l~g~----ip~~~~~~l~~l~~l~l~~N~l 258 (791)
++..-...+ . .++|+.|.|.+|.++-. +-..+.. .+.|..|+|++|.|
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~e-k~dL~kLnLngN~l 310 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAE-KPDLEKLNLNGNRL 310 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhc-chhhHHhcCCcccc
Confidence 653222222 1 13566777777766421 1122222 55666666666666
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.9e-09 Score=91.10 Aligned_cols=128 Identities=23% Similarity=0.263 Sum_probs=89.8
Q ss_pred CcEEEEEcCCCCCccCCC---cCCCCCCCCCEEeCcCCCCCCCCccccc-CCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 81 SRVIGLALPNSQLLGSIP---ADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
..+-.++|++++|. .++ ..+.....|+..+|++|.|. ..|..|. .++.++.|+|++|.|+ .+|.++..++.|+
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 34556777777764 333 34555667777889999888 4555554 4568888999999998 7888888899999
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC--cccceeccccccccc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF--NSVQVLDLSSNLING 212 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l--~~L~~L~ls~N~l~~ 212 (791)
.|+++.|.|. ..|..+..|.+|..|+..+|.+....-+.| +.+-..++.+|.+.+
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccc
Confidence 9999999988 777777778888888888888765333322 223334455555554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-08 Score=111.32 Aligned_cols=180 Identities=23% Similarity=0.291 Sum_probs=122.6
Q ss_pred CcCCCCCCCCCEEeCcCCCCCCCCcccccCC-CCccEEEccCCcCCC---CCc---cccCC---CCCCCEEeCcCCcCCC
Q 003847 98 PADLGMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISG---HLP---ETMGS---LHNLQLLNLSDNALAG 167 (791)
Q Consensus 98 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~---~~p---~~~~~---l~~L~~L~ls~N~l~~ 167 (791)
|-.|..+.+|+.|.|.+..|... ..+..+ .+|+.| +-+|.+.. .+. ..+.+ .-.|...+.++|+|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhh-hhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 55567778888888888877631 111111 223332 22333220 000 11111 235788899999998
Q ss_pred CCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCC-CcCCccccEEEccCCcCcccCchhHhhcC
Q 003847 168 KLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPP-DIGGYSLRYLNLSYNRLSGEIPPQFGEKI 245 (791)
Q Consensus 168 ~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~-~~~~~~L~~L~l~~N~l~g~ip~~~~~~l 245 (791)
....++.-++.|+.|+|++|+++... ...++.|++|||+.|.|+ .+|. ......|+.|+|++|.++ ++- .+.+ |
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~-tL~-gie~-L 253 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALT-TLR-GIEN-L 253 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhc-cccccchhhhhheeeeecccHHH-hhh-hHHh-h
Confidence 77788888999999999999999754 234589999999999998 4442 233357999999999998 432 3444 9
Q ss_pred CCCcEEEcccCcCcccCC--CCCcccccccccccCCCCCCCC
Q 003847 246 PVNATIDLSFNNLTGEIP--ESNVFMNQESSSFSGNLDLCGQ 285 (791)
Q Consensus 246 ~~l~~l~l~~N~l~~~~p--~~~~~~~~~~~~~~~n~~lc~~ 285 (791)
.+|..|||++|-|.+.-- ....++.+..+.+.|||--|..
T Consensus 254 ksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 254 KSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999999999975432 2255667778889999987753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-06 Score=84.38 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=85.9
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCC--ccceeeEEEccCceEEEEeccCCCC-
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPN--LVRIRGFYWGVDEKLIIYDFVPNGS- 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gs- 557 (791)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567889887643 2345788999999886443 4677888777777889999998863
Q ss_pred hhHH--------------HHh---hcCCC-CCCCCHHHHH-HHHH----------HHHH-HHHHHhc----CCCeecCCC
Q 003847 558 LANA--------------RYR---KMGSS-PCHLPWEARL-KIAK----------GVAR-GLAFLHE----KKHVHGNLK 603 (791)
Q Consensus 558 L~~~--------------l~~---~~~~~-~~~l~~~~~~-~i~~----------qi~~-gL~yLH~----~~ivHrDlk 603 (791)
+... +-+ ....- .......... ++-. .+.. ..++|.. ..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 000 00000 0011111111 0100 0111 1222221 357899999
Q ss_pred CCCeEecCCCCeEEeccCcccc
Q 003847 604 PRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 604 p~NILl~~~~~~kL~DFGla~~ 625 (791)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.8e-06 Score=82.70 Aligned_cols=137 Identities=19% Similarity=0.225 Sum_probs=96.0
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCCchhh-------------------HHH-----HHHHHHHHhccC--CCCccc
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDR-------------------FRD-----FETQVRVIAKLV--HPNLVR 535 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------~~~-----~~~E~~~l~~l~--H~nIv~ 535 (791)
.|..|--+.||+|...++..+|||+++...... .++ .++|+.-|+++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 677888899999998889999999985421111 000 245777777763 445555
Q ss_pred eeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCC
Q 003847 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDME 614 (791)
Q Consensus 536 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~ 614 (791)
.+++. ...|||||+..... ....-...++...+...+..++++.+.-|-. .++||+||..-|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 55544 34699999954311 0000001123344677888899999988887 9999999999999999 889
Q ss_pred eEEeccCcccccCC
Q 003847 615 PKIGDFGLERLVTG 628 (791)
Q Consensus 615 ~kL~DFGla~~~~~ 628 (791)
+.|+|||.|.....
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999999887653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.4e-06 Score=80.63 Aligned_cols=130 Identities=15% Similarity=0.200 Sum_probs=82.9
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHH---------HHHHHHHhccCCC---CccceeeEEEc-----c
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDF---------ETQVRVIAKLVHP---NLVRIRGFYWG-----V 543 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H~---nIv~l~~~~~~-----~ 543 (791)
+++-......|.+... +|+.+++|..........+.| .+++..+.+++.. ..+.++...+- .
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3444444555555555 478899998876533322222 3344444444332 22332222221 2
Q ss_pred CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 544 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
...+++|||++|..|.+... +++ .++..+.+++.-||+.|++|+|..|.|++++.+ .++++||+..
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccc
Confidence 34568999999988866421 332 245667788999999999999999999999865 5999999876
Q ss_pred cc
Q 003847 624 RL 625 (791)
Q Consensus 624 ~~ 625 (791)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 791 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 791 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-61 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-61 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-57 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-50 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-46 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-44 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-43 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-41 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-11 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-39 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-38 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-37 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-37 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-36 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-34 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-34 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-33 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-33 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-32 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-30 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-29 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-27 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-27 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-11 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-09 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-07 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-31 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-31 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-25 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-25 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-11 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 9e-29 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-28 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-24 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-27 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-25 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-25 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-10 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-15 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-13 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-07 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-26 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-21 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-20 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-16 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-07 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-24 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-23 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-23 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-21 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-22 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-13 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-10 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-23 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-21 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-11 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 9e-20 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-13 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-22 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-22 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-13 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-12 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-04 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-19 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-17 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-21 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-21 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-21 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-21 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-21 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 7e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-15 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-20 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-20 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-18 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-18 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-20 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-09 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-20 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-20 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-20 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-20 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-20 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-19 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-19 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-19 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-19 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-19 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-19 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-15 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-04 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-19 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-19 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-19 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-19 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-17 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-04 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-17 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-17 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-15 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-18 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-18 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-18 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-18 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-18 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-18 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-18 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-18 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-18 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-18 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-18 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-18 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-05 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 9e-18 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-16 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-14 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-17 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-17 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-17 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-17 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-17 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-17 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-10 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-17 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-17 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-05 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-16 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-16 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-16 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-16 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-16 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-11 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-16 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-16 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-16 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-16 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-08 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-05 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-15 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-15 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-11 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-14 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-14 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-05 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-08 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-07 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-13 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-13 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-13 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-09 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-08 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-12 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-12 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-12 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-12 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-12 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-07 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-12 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 7e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-11 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-11 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-11 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-11 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-11 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-11 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-09 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-11 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-11 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-11 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-11 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-11 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-11 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-10 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-10 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-10 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-10 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-10 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-05 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-09 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-04 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-09 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-08 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-07 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-08 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-08 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-08 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-07 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-05 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-07 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-07 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-07 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-07 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-07 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-07 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-07 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 9e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-06 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-06 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-06 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-06 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-05 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-05 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-05 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-05 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-05 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-05 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-05 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-05 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-04 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 4e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 5e-04 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 5e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-61
Identities = 89/325 (27%), Positives = 148/325 (45%), Gaps = 60/325 (18%)
Query: 473 ETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGE----NSVDRFRDFETQVRVIAKL 528
E + +G G ++YK + + T +AV+++ + + + F+ +++V+AK
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87
Query: 529 VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARG 588
H NLV + GF D+ ++Y ++PNGSL + G+ P L W R KIA+G A G
Sbjct: 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAANG 145
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV-TGDTS--SSKAGGSARNFGSK 645
+ FLHE H+H ++K N+LL KI DFGL R + +S+ G+
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT---TA-- 200
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
Y APE+LR + PK D+YSFGV+LLE+
Sbjct: 201 --------------------------------YMAPEALRG-EITPKSDIYSFGVVLLEI 227
Query: 706 LTGKVIVVDELGQGNGLLVE-------DKNRAIRLADAAIRADFEGKEEALLSCFKLGYS 758
+TG VDE + LL++ ++ D + D + + + + +
Sbjct: 228 ITGLP-AVDE-HREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTS--VEAMYSVASQ 282
Query: 759 CASPLPQKRPSMKEALQALEKIPSS 783
C KRP +K+ Q L+++ +S
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-61
Identities = 92/325 (28%), Positives = 158/325 (48%), Gaps = 54/325 (16%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRF-RDFETQVRVIA 526
+EL++ + ++ ILG G +YK L DGT +AV+R+ E F+T+V +I+
Sbjct: 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82
Query: 527 KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVA 586
VH NL+R+RGF E+L++Y ++ NGS+A+ + S P L W R +IA G A
Sbjct: 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRIALGSA 141
Query: 587 RGLAFLHEKKH---VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS--SSKAGGSARN 641
RGLA+LH+ +H ++K N+LL + E +GDFGL +L+ + ++ G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--- 198
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
G + APE L + K + K DV+ +GV+
Sbjct: 199 IG----------------------------------HIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 702 LLELLTGK--VIVVDELGQGNGLLVE------DKNRAIRLADAAIRADFEGKEEALLSCF 753
LLEL+TG+ + + +L++ + + L D ++ +++ +E +
Sbjct: 225 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE--VEQLI 282
Query: 754 KLGYSCASPLPQKRPSMKEALQALE 778
++ C P +RP M E ++ LE
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-57
Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 43/306 (14%)
Query: 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG 538
+++G +YK VL DG +A++R S +FET++ ++ HP+LV + G
Sbjct: 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
F +E ++IY ++ NG+L Y + WE RL+I G ARGL +LH + +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H ++K N+LL + PKI DFG+ SK G + ST + + G
Sbjct: 162 HRDVKSINILLDENFVPKITDFGI----------SKKGTELDQ--THLSTVVKGTL---G 206
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718
Y PE + K DVYSFGV+L E+L + +V L +
Sbjct: 207 -------------------YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 719 GNGLLVE------DKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772
L E + + ++ D + + E+L C + + RPSM +
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKI--RPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 773 ALQALE 778
L LE
Sbjct: 306 VLWKLE 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-56
Identities = 79/314 (25%), Positives = 121/314 (38%), Gaps = 63/314 (20%)
Query: 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWN-YNDENPCSWNGVTCASPGEGNNDSRVIG-- 85
L D LL K L +P L SW D +W GV C + RV
Sbjct: 2 LCNPQDKQALLQIKKD-LGNP-TTLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLD 56
Query: 86 -------------------------------------------------LALPNSQLLGS 96
L + ++ + G+
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 97 IPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNL- 155
IP L I+ L LD S N+L+G+L S+ + L + N ISG +P++ GS L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLING 212
+ +S N L GK+P + L +L V L N F + Q + L+ N +
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 213 SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQE 272
L +L L+L NR+ G +P ++ ++++SFNNL GEIP+ +
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294
Query: 273 SSSFSGNLDLCGQP 286
S+++ N LCG P
Sbjct: 295 VSAYANNKCLCGSP 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 2e-50
Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 28 SLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLA 87
S L + L+SFK VL D +L W+ +++NPC+++GVTC D +V +
Sbjct: 7 SQSLYREIHQLISFK-DVLPDK-NLLPDWS-SNKNPCTFDGVTC-------RDDKVTSID 56
Query: 88 LPNSQL---LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH 144
L + L ++ + L + L+ L LSN+ +NGS+S ++ L +LDLS N +SG
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 145 LPETM--GSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFSDGLPS------ 195
+ GS L+ LN+S N L VS L SL ++ L N S
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLS 254
++ L +S N I+G + + +L +L++S N S I P G +D+S
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLG-DCSALQHLDIS 231
Query: 255 FNNLTGEIPES 265
N L+G+ +
Sbjct: 232 GNKLSGDFSRA 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-46
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 9/212 (4%)
Query: 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEF--LQYLDLSNNSLNGSLSFSLFNASQLRNL 134
N + ++ L L ++ G I +L LQ L L NN G + +L N S+L +L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 135 DLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP 194
LS N +SG +P ++GSL L+ L L N L G++P L +++L + L N + +P
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
Query: 195 S---KFNSVQVLDLSSNLINGSLPPDIGGYS-LRYLNLSYNRLSGEIPPQFGEKIPVNAT 250
S ++ + LS+N + G +P IG L L LS N SG IP + G
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG-DCRSLIW 542
Query: 251 IDLSFNNLTGEIPES--NVFMNQESSSFSGNL 280
+DL+ N G IP + ++ +G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR 574
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-44
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 14/221 (6%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L N+ G IP L L L LS N L+G++ SL + S+LR+L L N++ G +
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS---KFNSVQV 202
P+ + + L+ L L N L G++P L+ +L +SL NN + +P + ++ +
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 203 LDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
L LS+N +G++P ++G SL +L+L+ N +G IP + ++ N + G+
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF-----KQSGKIAANFIAGK 573
Query: 262 IPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPN 302
++ G + L
Sbjct: 574 RYVY-----IKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-43
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 72 ASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQL 131
+ + LA+ +++ G + + L++LD+S+N+ + + L + S L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
++LD+S N +SG + + L+LLN+S N G +P L+SL +SL N F+
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283
Query: 192 GLPS----KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIP 246
+P +++ LDLS N G++PP G L L LS N SGE+P K+
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 247 VNATIDLSFNNLTGEIPES 265
+DLSFN +GE+PES
Sbjct: 344 GLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-41
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN 138
N S ++ L L + L G+IP+ LG + L+ L L N L G + L L L L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 139 NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--- 195
N ++G +P + + NL ++LS+N L G++P + L++L I+ L NN FS +P+
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGG---------------------YSLRYLNLSYN--R 232
S+ LDL++NL NG++P + + + + N
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
G Q ++ +++ G +
Sbjct: 596 FQGIRSEQLN-RLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 47/235 (20%)
Query: 65 SWNGVTCASPGEGNNDSRVIGLALPNS--QLLGSIPADLGMIEFLQYLDLSNNSLNGSLS 122
+ N + ND + + G L + ++++ G S
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 123 FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
+ N + LD+S N++SG++P+ +GS+ L +LNL N ++G +P + L+ L
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-- 683
Query: 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242
L+LS N+L G IP
Sbjct: 684 ------------------------------------------ILDLSSNKLDGRIPQAMS 701
Query: 243 EKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSP 297
+ + IDLS NNL+G IPE F + F N LCG P P +
Sbjct: 702 A-LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG 755
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-11
Identities = 32/169 (18%), Positives = 53/169 (31%), Gaps = 56/169 (33%)
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNL 209
+ ++ L + N + SL +L L + L LS++
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGL---------------------ESLFLSNSH 88
Query: 210 INGSLPPDIGGYSLRYLNLSYNRLSGEIPP------------------QFGEKIPVNA-- 249
INGS+ SL L+LS N LSG + V+
Sbjct: 89 INGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL 148
Query: 250 ------TIDLSFNNLTGEIPESNVFMNQESS---------SFSGNLDLC 283
+DLS N+++G V + SG++D+
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS 197
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 63/345 (18%), Positives = 117/345 (33%), Gaps = 73/345 (21%)
Query: 469 ELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL 528
L +++ + ++KA L +AV+ ++ E +V + +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGM 75
Query: 529 VHPNLVRIRGF----YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKG 584
H N+++ G + +I F GSL + ++ + W IA+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL----SDFLKANV--VSWNELCHIAET 129
Query: 585 VARGLAFLHEKKH----------VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634
+ARGLA+LHE H ++K +NVLL N++ I DFGL S+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA-- 187
Query: 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKP 689
G + G++R Y APE L
Sbjct: 188 -GDTHGQVGTRR-------------------------------YMAPEVLEGAINFQRDA 215
Query: 690 NPKWDVYSFGVILLELLTGKVIV-----------VDELGQGNGLLVEDKNRAIRLADAAI 738
+ D+Y+ G++L EL + +E+GQ L + + +
Sbjct: 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL 275
Query: 739 RADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783
R ++ K + + C + R S + + ++
Sbjct: 276 RDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 67/315 (21%), Positives = 118/315 (37%), Gaps = 53/315 (16%)
Query: 483 LGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG K E G + ++ + + R F +V+V+ L HPN+++ F
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK---FI- 73
Query: 542 GV---DEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
GV D++L I +++ G+L + S PW R+ AK +A G+A+LH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTL----RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H +L N L+ + + DFGL RL+ + + + S + K+
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV------ 183
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717
G + APE + + K DV+SFG++L E++ +
Sbjct: 184 ----------------GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV-NADPDYL 226
Query: 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEA 773
+ + +C F + C P+KRPS +
Sbjct: 227 PRTMDFGLNVRGFLDR-------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273
Query: 774 LQALEKIPSSPSPYL 788
LE + + +L
Sbjct: 274 EHWLETLRMHLAGHL 288
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 69/313 (22%), Positives = 126/313 (40%), Gaps = 74/313 (23%)
Query: 485 ASGS-SIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV 543
SGS +YK A+ + + + + + F+ +V V+ K H N++ F G
Sbjct: 33 GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL---FM-GY 88
Query: 544 --DEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+L I+ + SL Y + +S + + IA+ ARG+ +LH K +H
Sbjct: 89 STAPQLAIVTQWCEGSSL----YHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+LK N+ L D KIGDFGL + + S + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS--------------------- 183
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNP---KWDVYSFGVILLELLTGKV------- 710
G + APE +R NP + DVY+FG++L EL+TG++
Sbjct: 184 -------------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
Query: 711 --IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP 768
+++ +G+G+ + + +R++ + + L++ C +RP
Sbjct: 231 RDQIIEMVGRGS----------LSPDLSKVRSNCPKRMKRLMA------ECLKKKRDERP 274
Query: 769 SMKEALQALEKIP 781
S L +E++
Sbjct: 275 SFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 70/331 (21%), Positives = 134/331 (40%), Gaps = 73/331 (22%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAK 527
KE+E+E ++G ++ KA +A+++I S + F ++R +++
Sbjct: 8 KEIEVEE-------VVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSR 57
Query: 528 LVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVA 586
+ HPN+V++ G + ++ ++ GSL N + + + +
Sbjct: 58 VNHPNIVKLYGA---CLNPVCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCS 112
Query: 587 RGLAFLHEKKH---VHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNF 642
+G+A+LH + +H +LKP N+LL KI DFG + +++K GSA
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA-- 168
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
+ APE + K DV+S+G+IL
Sbjct: 169 -----------------------------------WMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASP 762
E++T + DE+G ++ + R + + E+L++ C S
Sbjct: 194 WEVITRR-KPFDEIGGPAFRIMWAVHNGTRP---PLIKNLPKPIESLMT------RCWSK 243
Query: 763 LPQKRPSMKEALQALEKI----PSSPSPYLY 789
P +RPSM+E ++ + + P + P Y
Sbjct: 244 DPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 82/317 (25%), Positives = 123/317 (38%), Gaps = 72/317 (22%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
+GA +++A G+ +AV+ + + +R +F +V ++ +L HPN+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH--V 598
I+ +++ GSL R + L RL +A VA+G+ +LH + V
Sbjct: 104 TQPPNLSIVTEYLSRGSLY--RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG-GSARNFGSKRSTASRDSFQDL 657
H NLK N+L+ K+ DFGL RL SSK+ G+
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE----------------- 204
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV------- 710
+ APE LR N K DVYSFGVIL EL T +
Sbjct: 205 --------------------WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 711 -IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769
VV +G RL I + + A++ C + P KRPS
Sbjct: 245 AQVVAAVGFKC----------KRL---EIPRNLNPQVAAIIE------GCWTNEPWKRPS 285
Query: 770 MKEALQALEKIPSSPSP 786
+ L + S P
Sbjct: 286 FATIMDLLRPLIKSAVP 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/332 (18%), Positives = 129/332 (38%), Gaps = 82/332 (24%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVD-------RFRDFE 519
E+E E +G G +++K ++D + +A++ + + +F++F+
Sbjct: 19 NEIEYEK-------QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 520 TQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARL 579
+V +++ L HPN+V++ G + ++ +FVP G L Y ++ + W +L
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL----YHRLLDKAHPIKWSVKL 125
Query: 580 KIAKGVARGLAFLHEKKH--VHGNLKPRNVLLGN-----DMEPKIGDFGLERLVTGDTSS 632
++ +A G+ ++ + VH +L+ N+ L + + K+ DFGL + + S
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSVS 184
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP--N 690
G + APE++ + +
Sbjct: 185 GLLG-----------NF---------------------------QWMAPETIGAEEESYT 206
Query: 691 PKWDVYSFGVILLELLTGKV--IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEA 748
K D YSF +IL +LTG+ ++ ++ R I D +
Sbjct: 207 EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--RP---TIPEDCPPRLRN 261
Query: 749 LLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
++ C S P+KRP ++ L ++
Sbjct: 262 VIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 77/337 (22%), Positives = 118/337 (35%), Gaps = 96/337 (28%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRI----GENSVDRFRDFETQVR 523
EL LE I+G G +Y+A G +AV+ E+ + + +
Sbjct: 7 AELTLEE-------IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 524 VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583
+ A L HPN++ +RG ++ +F G L K +P + + A
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAV 112
Query: 584 GVARGLAFLHEKKH---VHGNLKPRNVLLGNDMEP--------KIGDFGLERLVTGDTSS 632
+ARG+ +LH++ +H +LK N+L+ +E KI DFGL R T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692
S AG + APE +R+ +
Sbjct: 173 SAAG-----------AY---------------------------AWMAPEVIRASMFSKG 194
Query: 693 WDVYSFGVILLELLTGKV---------IVVDELGQGNGLLVEDKNRAIRLADAAIRADFE 743
DV+S+GV+L ELLTG+V + V L I +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYG---------VAMNKL--AL---PIPSTCP 240
Query: 744 GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
L+ C +P P RPS L L I
Sbjct: 241 EPFAKLME------DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 68/348 (19%), Positives = 112/348 (32%), Gaps = 89/348 (25%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVR-----IRGFYWGVDEK 546
YK L D +AV+ + F E + + + H N+ R R G E
Sbjct: 30 YKGSL-DERPVAVKVFSFANRQNFI-NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87
Query: 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH--------- 597
L++ ++ PNGSL W + ++A V RGLA+LH +
Sbjct: 88 LLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
H +L RNVL+ ND I DFGL +TG+
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR--------------------------- 174
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSI-------KPNPKWDVYSFGVILLELLTGKV 710
+ S G Y APE L + D+Y+ G+I E+
Sbjct: 175 -LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 711 IVV-------------DELGQGNGL-----LVEDKNRAIRLADAAIRADFEGKEEALLSC 752
+ E+G LV + + R ++ A+ S
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ--RP---KFPEAWKENSLAVRSL 288
Query: 753 FKLGYSCASPLPQKRPSMKEALQALEKI---------PSSPSPYLYGH 791
+ C + R + + A + + ++ S + + + H
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 56/305 (18%), Positives = 103/305 (33%), Gaps = 77/305 (25%)
Query: 503 AVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560
A+R I ++ D+ + F+ +V + H N+V G II +L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL-- 116
Query: 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620
Y + + L +IA+ + +G+ +LH K +H +LK +NV N + I DF
Sbjct: 117 --YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDF 173
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
GL + + + G + A
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLC-------------------------------HLA 202
Query: 681 PESLRSIKP---------NPKWDVYSFGVILLELLTGKV--------IVVDELGQGNGLL 723
PE +R + P + DV++ G I EL + ++ ++G G
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262
Query: 724 VEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP-- 781
+ ++D +L C + ++RP+ + + LEK+P
Sbjct: 263 LSQIGMGKEISD-------------ILL------FCWAFEQEERPTFTKLMDMLEKLPKR 303
Query: 782 -SSPS 785
S
Sbjct: 304 NRRLS 308
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 41/253 (16%), Positives = 86/253 (33%), Gaps = 29/253 (11%)
Query: 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSL--------NGSLSFSL 125
+ +N + + + N L +P L + +Q ++++ N +
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 126 FNASQLRNLDLS-NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSL 184
+++ + + NNL + + ++ + L +L N L GKLP + + L ++L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360
Query: 185 KNNYFS---DGLPSKFNSVQVLDLSSNLINGSLPPDIGG---YSLRYLNLSYNRLSGEIP 238
N + V+ L + N + +P + ++ SYN +
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 239 PQFGEKIPVNA------TIDLSFNNLTGEIPESNVFMNQESSSF---SGNLDLCGQPTKN 289
F P +I+LS N ++ E F S GN+ L P +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKEL--FSTGSPLSSINLMGNM-LTEIPKNS 476
Query: 290 PCPIPSSPFDLPN 302
+ +
Sbjct: 477 LKDENENFKNTYL 489
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 44/199 (22%), Positives = 71/199 (35%), Gaps = 29/199 (14%)
Query: 94 LGSIPADL-GMIEFLQYLDLSNNSLNG-SLSFSLFNASQLRNLDLSNNLISG-------H 144
+ IPA+ G E ++ L ++N L F + S + +D S N I
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD-------GLPSKF 197
L T N+ +NLS+N ++ +T L+ ++L N ++ F
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 198 ---NSVQVLDLSSNLINGSLPPDIGG---YSLRYLNLSYNRLSGEIPPQFG-----EKIP 246
+ +DL N + L D L ++LSYN S P Q +
Sbjct: 485 KNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 247 VNATIDLSFNNLTGEIPES 265
+ D N E PE
Sbjct: 543 IRNQRDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 35/191 (18%), Positives = 60/191 (31%), Gaps = 25/191 (13%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-------HLP 146
+ + ++LSNN ++ S L +++L N+++
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 147 ETMGSLHNLQLLNLSDNALAGKLPVSL--TTLQSLTIVSLKNNYFSDGLPS--------- 195
E + + L ++L N L L TTL L + L N FS P+
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLK 539
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLS 254
F D N P I SL L + N + + + I + +D+
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNI---SVLDIK 595
Query: 255 FNNLTGEIPES 265
N
Sbjct: 596 DNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 27/265 (10%), Positives = 69/265 (26%), Gaps = 32/265 (12%)
Query: 27 QSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPG----------- 75
+L + + LS + D L + W+ + S G
Sbjct: 10 NALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMW 69
Query: 76 ------EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG----SLSFSL 125
N++ RV GL+L G +P +G + L+ L L ++ +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 126 FNASQLRNLDLSNNLISGHLPETMGSLH--NLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183
+ +L ++ + + S T +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 184 LKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQ 240
+N + + ++ + ++ + N Y + +
Sbjct: 190 QLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEA----WENENSEYAQQYKTEDLK 244
Query: 241 FGEKIPVNATIDLSFNNLTGEIPES 265
+ + +++ ++P
Sbjct: 245 WD-NLKDLTDVEVYNCPNLTKLPTF 268
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 35/221 (15%), Positives = 74/221 (33%), Gaps = 44/221 (19%)
Query: 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140
S +I + + SI + + +N++ +S ++ ++LR + N+
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSP 217
Query: 141 ISGH-------------------LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTI 181
+L +L + + + KLP L L + +
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 182 VSLKNNYFSDGLP-----------SKFNSVQVLDLSSN-LINGSLPPDIGG-YSLRYLNL 228
+++ N G +Q++ + N L + + L L
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 229 SYNRLSGEIPPQFGEKIPVNAT----IDLSFNNLTGEIPES 265
YN+L G P FG + ++L++N +T IP +
Sbjct: 338 LYNQLEG-KLPAFG-----SEIKLASLNLAYNQITE-IPAN 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 30/174 (17%), Positives = 46/174 (26%), Gaps = 32/174 (18%)
Query: 93 LLGSIPADLGMIEFLQYLDLSNNSLNG-SLSFSLFNASQLRNLDLSNNLISGHLPETMGS 151
L + L +DL N L S F L +DLS N S P +
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 152 LHNLQLL------NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205
L+ + N + P +T SL L +
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL---------------------TQLQI 573
Query: 206 SSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
SN I + I ++ L++ N I L ++
Sbjct: 574 GSNDIR-KVNEKITP-NISVLDIKDNPNISIDLSYVCPYIEAG-MYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 15/104 (14%), Positives = 29/104 (27%), Gaps = 9/104 (8%)
Query: 94 LGSIPADLGMIEFLQYLDLSN------NSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE 147
P L+ + N N + L L + +N I + E
Sbjct: 525 FSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
+ N+ +L++ DN + + L + D
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 9/78 (11%), Positives = 25/78 (32%), Gaps = 3/78 (3%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
++ L P + + L L + +N + ++ + + LD+ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISID 603
Query: 146 PETMGSLHNLQLLNLSDN 163
+ + L +
Sbjct: 604 LSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 17/108 (15%), Positives = 27/108 (25%), Gaps = 9/108 (8%)
Query: 199 SVQVLDLSSNLINGSLPPDIGGYS-LRYLNLSYNRLSGEIPPQFGEKIPVNAT---IDLS 254
V L L +G +P IG + L L L + + I N +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 255 FNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPN 302
+ + + FS + C I S
Sbjct: 142 RMHYQKTFVDYD-----PREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 65/331 (19%), Positives = 111/331 (33%), Gaps = 90/331 (27%)
Query: 468 KELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRI--GENSVDRFRDFETQVRVI 525
K+L T L + S ++K G + V+ + + S + RDF + +
Sbjct: 10 KQLNFLT-------KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 526 AKLVHPNLVRIRGFYW-GVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAK 583
HPN++ + G +I ++P GSL N + + +K A
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFAL 118
Query: 584 GVARGLAFLHEKKH--VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
+ARG+AFLH + L R+V++ DM +I ++
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF----------------- 161
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP---KWDVYSF 698
S +S + APE+L+ + D++SF
Sbjct: 162 --SFQSPGRM----------------------YAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 699 GVILLELLTGKV---------IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEAL 749
V+L EL+T +V I + +G +R I L
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMKVALEG-----------LRP---TIPPGISPHVSKL 243
Query: 750 LSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
+ C + P KRP + LEK+
Sbjct: 244 MK------ICMNEDPAKRPKFDMIVPILEKM 268
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-31
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 8/188 (4%)
Query: 86 LALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH 144
L +S L + L YLD+S+ + + S L L ++ N +
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 145 L-PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSV 200
P+ L NL L+LS L P + +L SL ++++ +N F + NS+
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 201 QVLDLSSNLINGSLPPDIGG--YSLRYLNLSYNRLSGEIPPQ-FGEKIPVNATIDLSFNN 257
QVLD S N I S ++ SL +LNL+ N + Q F + I + +
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 580
Query: 258 LTGEIPES 265
+ P
Sbjct: 581 MECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 10/195 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
IP +L + LDLS N L S+S F+ +L+ LDLS I SL
Sbjct: 19 FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLI 210
+L L L+ N + + + L SL + + +++ L+++ NLI
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 211 NGSLPPDIGG--YSLRYLNLSYNRLSGEIPPQFG---EKIPVNATIDLSFNNLTGEIPES 265
P+ +L +L+LS N++ + +N ++DLS N + P +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 266 NVFMNQESSSFSGNL 280
+ + N
Sbjct: 197 FKEIRLHKLTLRNNF 211
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 43/222 (19%), Positives = 71/222 (31%), Gaps = 12/222 (5%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L + L LQ LDLS + + + S L L L+ N I
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQ 201
L +LQ L + LA + L++L +++ +N ++ +++
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 202 VLDLSSNLINGSLPPDIGG-----YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
LDLSSN I D+ L+LS N ++ P F K + L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKLTLRNN 210
Query: 257 NLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPF 298
+ + + + N S
Sbjct: 211 FDSLNVM-KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 10/166 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSLHNLQLLNLSDNA 164
L+ L ++N + S + L LDLS N +S G ++ +L+ L+LS N
Sbjct: 327 LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFSDGLP----SKFNSVQVLDLSSNLINGSLPPDIGG 220
+ + + L+ L + +++ ++ LD+S + G
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 221 -YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
SL L ++ N P ++ +DLS L P +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 32/202 (15%), Positives = 61/202 (30%), Gaps = 30/202 (14%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
L I + + L + ++ FS ++L+L N +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKL 324
Query: 150 GS-------------------LHNLQLLNLSDNALA--GKLPVSLTTLQSLTIVSLKNNY 188
S L +L+ L+LS N L+ G S SL + L N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 189 FSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGE 243
+ S F ++ LD + + + +L YL++S+ F
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN- 442
Query: 244 KIPVNATIDLSFNNLTGEIPES 265
+ + ++ N+
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPD 464
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 43/227 (18%), Positives = 70/227 (30%), Gaps = 17/227 (7%)
Query: 65 SWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSF 123
S N + PG R+ L L N+ ++ + + L+ L +
Sbjct: 185 SLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 124 SLFNASQ---LRNLDLSNN------LISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLT 174
F+ S L NL + + + L N+ +L + S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY- 302
Query: 175 TLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234
+ L N F K S++ L +SN ++ SL +L+LS N LS
Sbjct: 303 -NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLS 360
Query: 235 --GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279
G +DLSFN + E F +
Sbjct: 361 FKGCCSQSDF-GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 30/147 (20%), Positives = 56/147 (38%), Gaps = 7/147 (4%)
Query: 90 NSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET 148
+ + D + L +LDLS L + + S L+ L++S+N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 149 MGSLHNLQLLNLSDNALAGKLPVSLTTL-QSLTIVSLKNNYFSDGLPSK-----FNSVQV 202
L++LQ+L+ S N + L SL ++L N F+ + +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 203 LDLSSNLINGSLPPDIGGYSLRYLNLS 229
L + + + P D G + LN++
Sbjct: 574 LLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 39/196 (19%), Positives = 75/196 (38%), Gaps = 8/196 (4%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L + + + P + L+ L+L +N L+ + + L L L +N I
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN-----SV 200
NL L+LS N L+ + L++L + L NN + + S+
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 201 QVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNA--TIDLSFNN 257
+ L+LSSN I P L L L+ +L + + ++ + + LS +
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 258 LTGEIPESNVFMNQES 273
L+ + + + +
Sbjct: 234 LSTTSNTTFLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 16/200 (8%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG--SLSFSLFNASQLRNLDLSNNLISG 143
+ L ++ L ++ LQ L L +L S L LDLSNN I+
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 144 HLPETMGSLHNLQLLNLSDN--------ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
+ + L L++L+L N A G L L L I++L++N F +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 196 KFN---SVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNAT 250
F ++++DL N +N LP + SL+ LNL N ++ FG
Sbjct: 555 VFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 251 IDLSFNNLTGEIPESNVFMN 270
+D+ FN F+N
Sbjct: 614 LDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 9/203 (4%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L ++QL A+ L LD+ N+++ L+ L+L +N +S
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQV 202
+T NL L+L N++ ++L + L +N S ++Q
Sbjct: 90 DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQE 149
Query: 203 LDLSSNLINGSLPPDIGG---YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L LS+N I ++ SL+ L LS N++ P F + + L+ L
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF-GLFLNNVQLG 208
Query: 260 GEIPESNVFMNQESSSFSGNLDL 282
+ E + + ++S NL L
Sbjct: 209 PSLTE-KLCLELANTSIR-NLSL 229
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 44/221 (19%), Positives = 81/221 (36%), Gaps = 20/221 (9%)
Query: 64 CSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEF--LQYLDLSNNSLNGSL 121
++ + L+L NSQL + +++ L LDLS N+LN
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 122 SFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL---------PVS 172
+ S QL L N I ++ L N++ LNL + + S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 173 LTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPP-----DIGGYSLR 224
L+ L +++++N + F +++ L LS++ + + L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
LNL+ N++S F + +DL N + E+
Sbjct: 385 ILNLTKNKISKIESDAFS-WLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 41/222 (18%), Positives = 77/222 (34%), Gaps = 42/222 (18%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLI 141
L + ++ + G + L+YL LSN+ + + +F S L L+L+ N I
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFSDGLPSKFN-- 198
S + L +L++L+L N + +L L+++ + L N + + F
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 199 -SVQVLDLSSNLING--SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG------------ 242
S+Q L L + S P +L L+LS N ++
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 243 ---EKIPVNA----------------TIDLSFNNLTGEIPES 265
++ +A ++L N E
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 34/171 (19%), Positives = 61/171 (35%), Gaps = 8/171 (4%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ D S+ L + L + + L+L++N + L L++ N ++
Sbjct: 6 HEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLINGSLPPDIGG-YS 222
P L L +++L++N S F ++ L L SN I +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 223 LRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQES 273
L L+LS+N LS ++ + LS N + E S
Sbjct: 123 LITLDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-19
Identities = 33/162 (20%), Positives = 63/162 (38%), Gaps = 14/162 (8%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLN--------GSLSFSLFNASQLRNLDLS 137
L L N+ + L +E L+ LDL +N+L G + L S L L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS----DGL 193
+N E L L++++L N L SL ++L+ N +
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 194 PSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSG 235
F ++ LD+ N + + + + + ++N ++ +
Sbjct: 605 GPAFRNLTELDMRFNPFDCT--CESIAWFVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-17
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 8/150 (5%)
Query: 88 LPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE 147
L G L + L L+L +N + + +L+ +DL N ++
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLS 206
+ +L+ LNL N + ++LT + ++ N F S V ++ +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
Query: 207 SNLING-------SLPPDIGGYSLRYLNLS 229
I + PP G+ +R + S
Sbjct: 639 HTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 24/117 (20%), Positives = 45/117 (38%), Gaps = 10/117 (8%)
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLI 210
+ ++ + S L ++P L ++T+++L +N + F + LD+ N I
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 211 NGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVN-ATIDLSFNNLTGEIPES 265
+ P L+ LNL +N LS F N + L N++
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF--CTNLTELHLMSNSIQKIKNNP 116
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 68/350 (19%), Positives = 116/350 (33%), Gaps = 94/350 (26%)
Query: 468 KELELETLLKASAYILGASGS-SIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIA 526
+++ L + G +++ G +AV+ + ET++
Sbjct: 8 RDITLLECV--------GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWF-RETELYNTV 57
Query: 527 KLVHPNLVRIRGFYWGVDEK--------LIIYDFVPNGSLANARYRKMGSSPCHLPWEAR 578
L H N++ F D +I + GSL Y + + L +
Sbjct: 58 MLRHENILG---FI-ASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTT--LDTVSC 107
Query: 579 LKIAKGVARGLAFLHEKKH--------VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
L+I +A GLA LH + H +LK +N+L+ + + I D GL + + T
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN 690
+ G + R G+KR Y APE L
Sbjct: 168 NQLDVGNNPRV-GTKR-------------------------------YMAPEVLDE-TIQ 194
Query: 691 PKW-------DVYSFGVILLELLTGKVI--VVDELGQ------GNGLLVEDKNRAI---- 731
D+++FG++L E+ V +V++ N ED + +
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254
Query: 732 -RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
R I + + L S KL C P R + + L KI
Sbjct: 255 QRP---NIPNRWF-SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-28
Identities = 41/214 (19%), Positives = 66/214 (30%), Gaps = 39/214 (18%)
Query: 91 SQLLGSIPADLGMIEFLQYLDLSNNSLNG-------------------SLSFSLFNASQL 131
+ + I + + LQ + +N+ + S N L
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493
Query: 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG---------KLPVSLTTLQSLTIV 182
+++L N LP+ + L LQ LN++ N +L T + I
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 183 SLKNNYFSDGLP-----SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGE 236
+ N P K + +LD N + G L L L YN++ E
Sbjct: 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-E 609
Query: 237 IPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
IP F + S N L IP +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-27
Identities = 38/213 (17%), Positives = 77/213 (36%), Gaps = 20/213 (9%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-- 143
++ + ++ L ++L N L L++ +L++L+++ N
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 144 -------HLPETMGSLHNLQLLNLSDNALAGKLPVS--LTTLQSLTIVSLKNNYFSDGLP 194
L + + +Q+ + N L P S L + L ++ +N L
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LE 589
Query: 195 S--KFNSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVN-A 249
+ + L L N I +P D + + L S+N+L IP F K
Sbjct: 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647
Query: 250 TIDLSFNNLTGEIPESNVFMNQESSSFSGNLDL 282
++D S+N + E + M+ + + L
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-27
Identities = 34/233 (14%), Positives = 75/233 (32%), Gaps = 21/233 (9%)
Query: 43 YSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLG 102
YS + +WN+N E W +N+ RV GL+L G +P +G
Sbjct: 289 YSGTINNTIHSLNWNFNKE-LDMWGDQPGVDL---DNNGRVTGLSLAGFGAKGRVPDAIG 344
Query: 103 MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE-TMGSLHNLQLLNLS 161
+ L+ L +S S + + I H + + L L +L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSD------GLPSKF---NSVQVLDLSSNLING 212
+A+ + ++ + +SLK+ + + +Q++ +++
Sbjct: 405 QDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462
Query: 213 SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
+ N Y + + + ++L ++P+
Sbjct: 463 -DNIAV---DWEDANSDYAKQYENEELSWS-NLKDLTDVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 34/198 (17%), Positives = 65/198 (32%), Gaps = 30/198 (15%)
Query: 94 LGSIPADLGM--IEFLQYLDLSNNSL-----NGSLSFSLFNASQLRNLDLSNNLISGHLP 146
L IP + + +D S N + N S S + + LS N I
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 147 ETMGSLHNLQLLNLSDNAL-------AGKLPVSLTTLQSLTIVSLKNNYFSDGLP----- 194
E + + + LS+N + + LT + L+ N + L
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
Query: 195 SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSY------NRLSGEIPPQFGEKIPV 247
+ + +D+S N + S P L+ + + NR+ + P P
Sbjct: 750 TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT-TCPS 807
Query: 248 NATIDLSFNNLTGEIPES 265
+ + N++ ++ E
Sbjct: 808 LIQLQIGSNDIR-KVDEK 824
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 33/226 (14%), Positives = 69/226 (30%), Gaps = 36/226 (15%)
Query: 73 SPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSL-------NGSLSFSL 125
+ + L +++ + + LSNN + +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 126 FNASQLRNLDLSNNLISGHLPETM--GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183
N L +DL N ++ L + +L L +++S N + P L
Sbjct: 725 KNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFG 782
Query: 184 LKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG 242
+++ D N I P I SL L + N + ++ +
Sbjct: 783 IRHQ---------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT 826
Query: 243 EKIPVNATIDLSFNNLTGEIPESNVFMNQESS----SFSGNLDLCG 284
++ +D++ N I ++V E+ + D+ G
Sbjct: 827 PQL---YILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 69/344 (20%), Positives = 115/344 (33%), Gaps = 72/344 (20%)
Query: 468 KELELETLLKASAYILGASGS-SIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIA 526
K++++ + G ++ G +AV+ + ET++
Sbjct: 37 KQIQMVKQI--------GKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF-RETEIYQTV 86
Query: 527 KLVHPNLVRIRGFYWGVDEK--------LIIYDFVPNGSLANARYRKMGSSPCHLPWEAR 578
+ H N++ F D K +I D+ NGSL Y + S+ L ++
Sbjct: 87 LMRHENILG---FI-AADIKGTGSWTQLYLITDYHENGSL----YDYLKSTT--LDAKSM 136
Query: 579 LKIAKGVARGLAFLHEKKH--------VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
LK+A GL LH + H +LK +N+L+ + I D GL DT
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN 690
+ + R G+KR P L + +S
Sbjct: 197 NEVDIPPNTRV-GTKRYMP-------------------PEVLDESLNRNHFQSYI----- 231
Query: 691 PKWDVYSFGVILLELLTGKVI--VVDELGQGNGLLVEDKNRAIRLADAAIRA-------D 741
D+YSFG+IL E+ V +V+E LV + + +
Sbjct: 232 -MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 742 FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPS 785
+E L KL C + P R + + L K+ S
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 43/210 (20%), Positives = 66/210 (31%), Gaps = 15/210 (7%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L ++ + L L L+ N + S + L NL ++
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 146 PETMGSLHNLQLLNLSDNALAG-KLPVSLTTLQSLTIVSLKNNYFS-------DGLPSKF 197
+G L L+ LN++ N + KLP + L +L V L NY L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 198 NSVQVLDLSSNLINGSLPPDIG-GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
LD+S N I+ + G L L L N S I + + L
Sbjct: 181 QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 257 NLTG----EIPESNVFMNQESSSFSGNLDL 282
EI E ++ + L
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTID-EFRL 268
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 9/173 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSL 152
+ A+ +E LQ+LD +++L FS F + +L LD+S L
Sbjct: 388 AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 153 HNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFSD---GLPSKFNSVQVLDLSSN 208
+L L ++ N+ + +LT + L G+ + +Q+L++S N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 209 LINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ L YSL L+ S+NR+ A +L+ N++
Sbjct: 508 NLL-FLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 10/197 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L +P D+ + +DLS N L S+S N S+L+ LDLS I + LH
Sbjct: 23 LSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLH 80
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLI 210
+L L L+ N + P S + L SL + + +++ L+++ N I
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 211 NG-SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG---EKIPVNATIDLSFNNLTGEIPES 265
+ LP +L +++LSYN + E VN ++D+S N + ++
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200
Query: 266 NVFMNQESSSFSGNLDL 282
+ + GN +
Sbjct: 201 FQGIKLHELTLRGNFNS 217
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 10/166 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP-ETMGSLHNLQLLNLSDNAL 165
L++LDLS N +S + +L++LD ++ + SL L L++S
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQVLDLSSNLINGSLPPDI--G 219
L SL + + N F D S ++ LDLS + + +
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDT 495
Query: 220 GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
+ L+ LN+S+N L + + ++ T+D SFN +
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLS-TLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 40/183 (21%), Positives = 70/183 (38%), Gaps = 11/183 (6%)
Query: 92 QLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGS 151
L LQ+LDLS + + L NL L+ N I P +
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 152 LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD-GLPSKF---NSVQVLDLSS 207
L +L+ L + LA + L +L +++ +N+ LP+ F ++ +DLS
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 208 NLINGSLPPDIGG-----YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEI 262
N I D+ L++S N + I Q + I ++ + L N + I
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLH-ELTLRGNFNSSNI 220
Query: 263 PES 265
++
Sbjct: 221 MKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 33/196 (16%), Positives = 66/196 (33%), Gaps = 14/196 (7%)
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
EG D + L + + + + L+ S+ + + ++L
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
+ + P L L+ L L+ N + L SL+ + L N S
Sbjct: 314 IIRCQLK-QFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 196 KF-----NSVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNA 249
+ NS++ LDLS N + + G L++L+ ++ L +
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 250 TIDLSFNNLTGEIPES 265
+D+S+ N +
Sbjct: 428 YLDISYTNTKIDFDGI 443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 31/184 (16%), Positives = 57/184 (30%), Gaps = 13/184 (7%)
Query: 86 LALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLFNAS--------QLRNLDL 136
L L + +I L + L L + +F S + L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 137 SNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK 196
+ L N+ ++L+ ++ K + +S+
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLD 326
Query: 197 FNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVN-ATIDLSF 255
++ L L+ N + + SL YL+LS N LS + + + +DLSF
Sbjct: 327 LPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 256 NNLT 259
N
Sbjct: 386 NGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 1/100 (1%)
Query: 92 QLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
+ ++ L +LDLS L +L+ L++S+N +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS 190
L++L L+ S N + + +SL +L NN +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 19/76 (25%), Positives = 29/76 (38%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
QL + LQ L++S+N+L S L LD S N I
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 150 GSLHNLQLLNLSDNAL 165
+L NL++N++
Sbjct: 542 HFPKSLAFFNLTNNSV 557
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/356 (16%), Positives = 109/356 (30%), Gaps = 100/356 (28%)
Query: 468 KELELETLLKASAYILGASGS-SIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIA 526
+ + L+ + G +++ G +AV+ + E ++
Sbjct: 42 RTIVLQESI--------GKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTV 91
Query: 527 KLVHPNLVRIRGFYWGVDEK--------LIIYDFVPNGSLANARYRKMGSSPCHLPWEAR 578
L H N++ F D K ++ D+ +GSL + + + E
Sbjct: 92 MLRHENILG---FI-AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYT--VTVEGM 141
Query: 579 LKIAKGVARGLAFLHEKKH--------VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
+K+A A GLA LH + H +LK +N+L+ + I D GL T
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---- 686
+ + R G+KR Y APE L
Sbjct: 202 DTIDIAPNHR-VGTKR-------------------------------YMAPEVLDDSINM 229
Query: 687 --IKPNPKWDVYSFGVILLELLTGKVIVVDE----------------LGQGNGLLVEDKN 728
+ + D+Y+ G++ E+ I + + ++ E K
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 729 R-AIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783
R I + EAL K+ C R + + L ++
Sbjct: 290 RPNIP--------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 19/204 (9%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGS--LSFSLFNASQLRNLDLSNNLISGHLPE 147
N++ L L +E L+ LDLS++ + S + L N S L++L+LS N E
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVL 203
L+LL+L+ L K S L L +++L ++ S+ L ++Q L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
Query: 204 DLSSNLINGSLPPDIGG----YSLRYLNLSYNRLSGEIPPQFGEKIPVNAT----IDLSF 255
+L N L L LS+ LS F + +DLS
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT-----SLKMMNHVDLSH 509
Query: 256 NNLTGEIPESNVFMNQESSSFSGN 279
N LT E+ + + + N
Sbjct: 510 NRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 9/192 (4%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L IP L + L+ S N L + + L LDL+ I +T S H
Sbjct: 24 LNEIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLI 210
L L L+ N L +L+ ++L + S + +++ L L SN I
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 211 NGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG--EKIPVNATIDLSFNNLTGEIPESNV 267
+ P L+ L+ N + ++ N +++L+ N++ G P +
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT-NLSLNLNGNDIAGIEPGAFD 200
Query: 268 FMNQESSSFSGN 279
+S +F G
Sbjct: 201 SAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 49/183 (26%), Positives = 72/183 (39%), Gaps = 10/183 (5%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGH 144
L L ++ L L+ LDL+ L + S F N L+ L+LS++L+
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 145 LPETMGSLHNLQLLNLSDNALAG---KLPVSLTTLQSLTIVSLKNNYFSDGLP----SKF 197
+ L LQ LNL N + SL TL L I+ L S + +
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSL 499
Query: 198 NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257
+ +DLS N + S + YLNL+ N +S I P + TI+L N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISI-ILPSLLPILSQQRTINLRQNP 558
Query: 258 LTG 260
L
Sbjct: 559 LDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 43/198 (21%), Positives = 75/198 (37%), Gaps = 10/198 (5%)
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLD 135
EG + V + L LQ LDL+ L+ L L S L+ L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL-PVSLTTLQSLTIVSLKNN--YFSDG 192
LS N + + +L L++ N +L L L++L + L ++ SD
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 193 LPSKF---NSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPV 247
+ + +Q L+LS N SL + L L+L++ RL + + + +
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 248 NATIDLSFNNLTGEIPES 265
++LS + L +
Sbjct: 427 LKVLNLSHSLLDISSEQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 40/211 (18%), Positives = 72/211 (34%), Gaps = 12/211 (5%)
Query: 65 SWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEF--LQYLDLSNNSLNG--S 120
+ N + PG ++ + L +Q L I L L +
Sbjct: 187 NGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 121 LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLT 180
F + +++L + T LQ L+L+ L+ +LP L L +L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304
Query: 181 IVSLKNNYFS---DGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSG 235
+ L N F S F S+ L + N L +LR L+LS++ +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 236 -EIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
+ + +++LS+N E+
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 8/189 (4%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L + L + L +LDL+ + + + +L L L+ N +
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQV 202
+ L+ L ++ + L ++L + L +N+ S K ++V
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKV 157
Query: 203 LDLSSNLINGSLPPDIGG---YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
LD +N I+ D+ + LNL+ N ++ I P + +++
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQ-SLNFGGTQNL 215
Query: 260 GEIPESNVF 268
I +
Sbjct: 216 LVIFKGLKN 224
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 32/187 (17%), Positives = 54/187 (28%), Gaps = 8/187 (4%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L Q+ L L L+ N L +L L++L IS
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQ---- 201
+ + L+ L L N ++ + L ++ +NN +S+Q
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 202 -VLDLSSNLINGSLPPDIG-GYSLRYLNLSYNRLSGEIPPQF-GEKIPVNATIDLSFNNL 258
L+L+ N I + P + LN + I I +
Sbjct: 182 LSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 259 TGEIPES 265
P
Sbjct: 241 EDISPAV 247
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 10/156 (6%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSL---NGSLSFSLFNASQLRNLDLSNNLIS 142
L L +S L S + LQ+L+L N N + SL +L L LS +S
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 143 GHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NS 199
SL + ++LS N L +L+ L+ + + +L +N+ S LPS +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQ 548
Query: 200 VQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSG 235
+ ++L N ++ + + L + + +L
Sbjct: 549 QRTINLRQNPLDCT--CSNIYF-LEWYKENMQKLED 581
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 42/181 (23%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 93 LLGSIPADLGMIEFLQYLDLSNNSLN--GSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
G+ +++ + L++LDLS N L+ G S S F + L+ LDLS N + +
Sbjct: 336 KGGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393
Query: 151 SLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLS 206
L L+ L+ + L S +L++L + + + + +G+ + +S++VL ++
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
N + PDI +L +L+LS +L ++ P + ++++ N L +P+
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPD 511
Query: 265 S 265
Sbjct: 512 G 512
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-22
Identities = 34/172 (19%), Positives = 65/172 (37%), Gaps = 14/172 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSLHNLQLLNLSDNA 164
L+ L ++N + S + L LDLS N +S G ++ +L+ L+LS N
Sbjct: 327 LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFSD----GLPSKFNSVQVLDLSSNLINGSLPPDI-- 218
+ + + L+ L + +++ + ++ LD+S I
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 442
Query: 219 GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
G SL L ++ N P ++ +DLS L ++ F +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP-TAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-21
Identities = 35/186 (18%), Positives = 59/186 (31%), Gaps = 14/186 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L L L+ N + + S L+ L ++ +G L L+ LN++ N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 167 -GKLPVSLTTLQSLTIVSLKNNYFS-------DGLPSKFNSVQVLDLSSNLINGSLPPDI 218
KLP + L +L + L +N L LDLS N +N + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 219 G-GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG----EIPESNVFMNQES 273
L L L N S + + + L E + + +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 274 SSFSGN 279
+
Sbjct: 257 LTIEEF 262
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 12/196 (6%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
IP +L + LDLS N L S+S F+ +L+ LDLS I SL
Sbjct: 19 FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSNLI 210
+L L L+ N + + + L SL + + + +++ L+++ NLI
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 211 N-GSLPPDIGG-YSLRYLNLSYNRLSGEIPP----QFGEKIPVNATIDLSFNNLTGEIPE 264
LP +L +L+LS N++ I + +N ++DLS N + P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 265 SNVFMNQESSSFSGNL 280
+ + + N
Sbjct: 196 AFKEIRLHKLTLRNNF 211
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 36/148 (24%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSL 152
+ ++ ++ +E L++LD +++L FS+F + L LD+S+ L
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 153 HNLQLLNLSDNALAGKL-PVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSN 208
+L++L ++ N+ P T L++LT + L S + +S+QVL+++SN
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 209 LINGSLPPDIGGY--SLRYLNLSYNRLS 234
+ S+P I SL+ + L N
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 4/113 (3%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL-PETMGSLHNLQLLNLSDNAL 165
L YLD+S+ + + S L L ++ N + P+ L NL L+LS L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 166 AGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLP 215
P + +L SL ++++ +N DG+ + S+Q + L +N + S P
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 35/186 (18%), Positives = 61/186 (32%), Gaps = 16/186 (8%)
Query: 86 LALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNG-----SLSFSLFN---ASQLRNLDL 136
L L N+ ++ + + L+ L S + L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 137 S-NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFSDGLP 194
+ + + + L N+ +L + S Q L +V+ K F
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP---T 321
Query: 195 SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSG-EIPPQFGEKIPVNATIDL 253
K S++ L +SN + ++ SL +L+LS N LS Q +DL
Sbjct: 322 LKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 254 SFNNLT 259
SFN +
Sbjct: 381 SFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 33/212 (15%), Positives = 71/212 (33%), Gaps = 20/212 (9%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLN-GSLSFSLFNASQLRNLDLSNNLISGH 144
L + L +G ++ L+ L++++N + L N + L +LDLS+N I
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 145 LPETMGSLHNLQL----LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF--- 197
+ LH + L L+LS N + + L ++L+NN+ S +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 198 -NSVQVLDLSSNLING---------SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPV 247
++V L S + ++ L+Y + +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 248 NATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279
++ L + + + + +
Sbjct: 284 VSSFSLVSVTIE-RVKDFSYNFGWQHLELVNC 314
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 30/185 (16%), Positives = 59/185 (31%), Gaps = 17/185 (9%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQY----LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141
L L ++++ DL ++ + LDLS N +N + F +L L L NN
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFD 212
Query: 142 SGHLPETM-GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSV 200
S ++ +T L L++ L + +L + L N + +
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEF--RNEGNLEKFDKSALEGLCNLTIEE------FRL 264
Query: 201 QVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
LD + I ++ +L + + ++ F
Sbjct: 265 AYLDYYLDDIIDLFN---CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 261 EIPES 265
+S
Sbjct: 322 LKLKS 326
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 39/188 (20%), Positives = 80/188 (42%), Gaps = 9/188 (4%)
Query: 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN 138
N +R + +S L ++ + ++ LDLS N L+ + L ++L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 139 NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN 198
N++ + + SL L+ L+L++N + L S+ + NN S S+
Sbjct: 68 NVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 199 SVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257
+ + L++N I D G ++YL+L N + + ++L +N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 258 LTGEIPES 265
+ ++
Sbjct: 181 IY-DVKGQ 187
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-21
Identities = 34/184 (18%), Positives = 64/184 (34%), Gaps = 12/184 (6%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-HLPETMGSL 152
+ + G + + + L+NN + S+++ LDL N I + E S
Sbjct: 111 ISRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNL 209
L+ LNL N + + L + L +N + + +F V + L +N
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 210 INGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDL-SFNNLTGEIPESNV 267
+ + + +L + +L N F K T+ + LTG+ E
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 268 FMNQ 271
Sbjct: 285 VPTL 288
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 39/176 (22%), Positives = 70/176 (39%), Gaps = 17/176 (9%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L DL + L+ LDL+NN + L + L +NN IS +
Sbjct: 70 LYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQ 120
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS----DGLPSKFNSVQVLDLSSNL 209
+ + L++N + + + + LK N L + ++++ L+L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 210 INGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
I + + L+ L+LS N+L+ + P+F V I L N L I ++
Sbjct: 181 IY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISLRNNKLV-LIEKA 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 29/141 (20%), Positives = 63/141 (44%), Gaps = 9/141 (6%)
Query: 120 SLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179
++ N ++ + ++++ + L S N++ L+LS N L+ L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 180 TIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIP 238
+++L +N + L ++++ LDL++N + L G S+ L+ + N +S +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNIS-RVS 115
Query: 239 PQFGEKIPVNATIDLSFNNLT 259
G+ I L+ N +T
Sbjct: 116 CSRGQGKK---NIYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 25/201 (12%), Positives = 57/201 (28%), Gaps = 35/201 (17%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
+ + + + L+ LDLS+N L + +A+ + + L NN + + + +
Sbjct: 181 IYDVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 154 NLQLLNLSDN--------------------------ALAGKLPVSLTTLQ-----SLTIV 182
NL+ +L N L G+ T +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242
L + + K +L + R ++ + + Q
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVT 356
Query: 243 EKIPVNATIDLSFNNLTGEIP 263
+ T++ L ++
Sbjct: 357 LRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 18/208 (8%), Positives = 46/208 (22%), Gaps = 38/208 (18%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L + + + ++ L NN L + +L + L + DL N
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSK 260
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD---------------------- 191
N ++ ++ + + T+ D
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 192 ---------GLPSKFNSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQ 240
+ +D ++ + + L L ++
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 241 FGE--KIPVNATIDLSFNNLTGEIPESN 266
++ + L E +
Sbjct: 380 RRAHAELDGTLQQAVGQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 22/196 (11%), Positives = 52/196 (26%), Gaps = 12/196 (6%)
Query: 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLN-------GSLSFSLFNA 128
G N+ L + + L L ++L L N
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNY 188
++ R +D + + L AL ++ L +
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 189 FSD--GLPSKFNSVQVLDLSSNLINGSL--PPDIGGYSLRYLNLSYNRLSG-EIPPQFGE 243
+ + + +Q+L + ++R ++ ++ + +
Sbjct: 396 QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLK 455
Query: 244 KIPVNATIDLSFNNLT 259
K+ A + L+ N T
Sbjct: 456 KLNGEADLALASANAT 471
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 64/309 (20%), Positives = 105/309 (33%), Gaps = 79/309 (25%)
Query: 492 YKAVL-EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
+ L D T +AV+ E + F + R++ + HPN+VR+ G I+
Sbjct: 131 FSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190
Query: 550 YDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
+ V G + R G+ L + L++ A G+ +L K +H +L RN L
Sbjct: 191 MELVQGGDFLT--FLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+ KI DFG+ R ++ G R K +
Sbjct: 246 VTEKNVLKISDFGMSREEADGVYAASGG--LRQVPVKWT--------------------- 282
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI---------VVDELGQG 719
APE+L + + + DV+SFG++L E + + + +G
Sbjct: 283 -----------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEALQ 775
RL C F+L C + P +RPS Q
Sbjct: 332 G-----------RL-------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
Query: 776 ALEKIPSSP 784
L+ I
Sbjct: 368 ELQSIRKRH 376
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 61/315 (19%), Positives = 109/315 (34%), Gaps = 65/315 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
+LG + KA D A+++I ++V ++A L H +VR +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVRYYAAW 71
Query: 541 ----------WGVDEKLIIY---DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR 587
V +K ++ ++ NG+L + + S + + ++ + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD----LIHSENLNQQRDEYWRLFRQILE 127
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
L+++H + +H +LKP N+ + KIGDFGL +K
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL---------------------AKNV 166
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKP-NPKWDVYSFGVILLEL 705
S D + S S++G + Y A E L N K D+YS G+I E+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIG--TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 706 LTGKVIVVDELGQGNGLLVEDKNRA-----IRLADAAIRADFEGKEEALLSCFKLGYSCA 760
+ R +R DF+ + + K+
Sbjct: 225 IYP--------------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK--KIIRLLI 268
Query: 761 SPLPQKRPSMKEALQ 775
P KRP + L
Sbjct: 269 DHDPNKRPGARTLLN 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 39/188 (20%), Positives = 80/188 (42%), Gaps = 9/188 (4%)
Query: 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN 138
N +R + +S L ++ + ++ LDLS N L+ + L ++L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 139 NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN 198
N++ + + SL L+ L+L++N + L S+ + NN S S+
Sbjct: 68 NVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
Query: 199 SVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257
+ + L++N I D G ++YL+L N + + ++L +N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 258 LTGEIPES 265
+ ++
Sbjct: 181 IY-DVKGQ 187
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 36/167 (21%), Positives = 75/167 (44%), Gaps = 8/167 (4%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ ++++SL +L+ +A ++ LDLS N +S + L+LLNLS N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
+ L +L +L + L NNY + L S++ L ++N I+ + G + +
Sbjct: 72 -ETL-DLESLSTLRTLDLNNNYVQE-LLV-GPSIETLHAANNNIS-RVSCSR-GQGKKNI 125
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQES 273
L+ N+++ + +DL N + + + + + ++
Sbjct: 126 YLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDT 170
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 34/189 (17%), Positives = 64/189 (33%), Gaps = 12/189 (6%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-HLPETMGSL 152
+ + G + + + L+NN + S+++ LDL N I + E S
Sbjct: 111 ISRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNL 209
L+ LNL N + + L + L +N + + +F V + L +N
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 210 INGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDL-SFNNLTGEIPESNV 267
+ + + +L + +L N F K T+ + LTG+ E
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 268 FMNQESSSF 276
Sbjct: 285 VPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 28/147 (19%), Positives = 64/147 (43%), Gaps = 12/147 (8%)
Query: 120 SLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179
++ N ++ + ++++ + L S N++ L+LS N L+ L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 180 TIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEI 237
+++L +N + ++++ LDL++N + L G S+ L+ + N +S +
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNIS-RV 114
Query: 238 PPQFGEKIPVNATIDLSFNNLTGEIPE 264
G+ I L+ N +T + +
Sbjct: 115 SCSRGQGKK---NIYLANNKIT-MLRD 137
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 26/152 (17%), Positives = 62/152 (40%), Gaps = 6/152 (3%)
Query: 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNL 155
+ + L++L+L N + + + ++L+ LDLS+N ++ + S +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF--NSVQVLDLSSNLINGS 213
++L +N L + +L Q+L L+ N F G F + +V ++ +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 214 LPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKI 245
+ ++ L ++P F +++
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 18/115 (15%), Positives = 41/115 (35%), Gaps = 4/115 (3%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L + + + ++ L NN L + +L + L + DL N
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSK 260
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208
N ++ ++ + KL ++ + Y + LP+ F +++ L +
Sbjct: 261 NQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD-RLIALGHH 313
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 26/173 (15%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L ++P L + L + +N+L SL +LR L++S N ++ LP L
Sbjct: 52 LTTLPDCLP--AHITTLVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLL 104
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGS 213
L + + LP + L L + N + LP +Q L +S N + S
Sbjct: 105 ELSIFSNPLT----HLPALPSGLCKLW---IFGNQLTS-LPVLPPGLQELSVSDNQLA-S 155
Query: 214 LPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVN-ATIDLSFNNLTGEIPES 265
LP L L N+L+ +P + +S N L +P
Sbjct: 156 LPALPS--ELCKLWAYNNQLT-SLPMLPS-----GLQELSVSDNQLA-SLPTL 199
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 25/218 (11%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L S+PA L L NN L SL S L+ L +S+N ++ LP L+
Sbjct: 153 LASLPALPSE---LCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQLA-SLPTLPSELY 204
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGS 213
L N + LP + L+ L + N + LP + ++ L +S N + S
Sbjct: 205 KLWAYNNRLTS----LPALPSGLKELI---VSGNRLTS-LPVLPSELKELMVSGNRLT-S 255
Query: 214 LPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQES 273
LP L L++ N+L+ +P + T++L N L+ E + +
Sbjct: 256 LPMLPS--GLLSLSVYRNQLT-RLPESLI-HLSSETTVNLEGNPLS-ERTLQALREITSA 310
Query: 274 SSFSGNLDLCGQPTKNPCPIPSSPFDLPNTTAPTSPPA 311
+SG + P L A PA
Sbjct: 311 PGYSGPIIRFDM---AGASAPRETRALHLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 39/153 (25%), Positives = 56/153 (36%), Gaps = 13/153 (8%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L S+PA L+ L +S N L SL S+L+ L +S N ++ LP
Sbjct: 213 LTSLPALPSG---LKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLPS--- 261
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGS 213
L L++ N L +LP SL L S T V+L+ N S+ + S I
Sbjct: 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRF 320
Query: 214 LPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIP 246
+P + GE P
Sbjct: 321 DMAGASAPRETRALHLAAADW-LVPAREGEPAP 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 24/115 (20%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 152 LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLIN 211
+ +LN+ ++ L LP L +T + + +N + LP+ ++ L++S N +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPELRTLEVSGNQLT 94
Query: 212 GSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
SLP G L + L +P + + + N LT +P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK-------LWIFGNQLT-SLPVL 139
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 43/214 (20%), Positives = 69/214 (32%), Gaps = 30/214 (14%)
Query: 71 CASPGEGNNDSRVIGLALPNSQLLGSIPADLGMI--EFLQYLDLSNNSLNGSLSFSLFNA 128
S N + L + L L+L + L F
Sbjct: 46 WHSAWRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103
Query: 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNY 188
S L+++ + + LP+TM L+ L L+ N L LP S+ +L L +S++
Sbjct: 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 189 FSDGLPSKFN------------SVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235
LP ++Q L L I SLP I +L+ L + + LS
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219
Query: 236 EIPPQFGE----KIPVNATIDLSFNNLTGEIPES 265
+ P + +DL P
Sbjct: 220 ALGPAIHHLPKLE-----ELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 38/188 (20%), Positives = 69/188 (36%), Gaps = 19/188 (10%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSL---------NGSLSFSLFNASQLRNLDLSNNLISGH 144
L ++PA + + L+ L + + S L++L L I
Sbjct: 139 LRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-S 197
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQ 201
LP ++ +L NL+ L + ++ L+ L ++ L L + L+ P F ++
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 202 VLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN---N 257
L L +LP DI L L+L +P ++P N I + +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA-QLPANCIILVPPHLQAQ 315
Query: 258 LTGEIPES 265
L P +
Sbjct: 316 LDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 19/157 (12%), Positives = 38/157 (24%), Gaps = 23/157 (14%)
Query: 119 GSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQS 178
GS ++S NL + + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 179 LTIVSLKNNYFSDGLPS-----KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNR 232
I + L+L S + P L+++ +
Sbjct: 58 PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 233 LSGEIPPQFGEKIPVNAT----IDLSFNNLTGEIPES 265
L E+P + L+ N L +P S
Sbjct: 116 LM-ELPDTMQ-----QFAGLETLTLARNPLR-ALPAS 145
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 3/92 (3%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L L + P G L+ L L + S +L + +QL LDL + L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 146 PETMGSLHNLQLLNLSDNALAG---KLPVSLT 174
P + L ++ + + A PV+
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 68/310 (21%), Positives = 125/310 (40%), Gaps = 77/310 (24%)
Query: 499 GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNG 556
G +AV+++ ++ + RDFE ++ ++ L H N+V+ +G + + +I +++P G
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 557 SLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615
SL + Y +K + L+ + +G+ +L K+++H +L RN+L+ N+
Sbjct: 99 SLRD--YLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI 675
KIGDFGL +++ D K G
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKE-----------------------------------PGE 178
Query: 676 SP--YHAPESLR----SIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDK-- 727
SP ++APESL S+ DV+SFGV+L EL T + ++ DK
Sbjct: 179 SPIFWYAPESLTESKFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 728 ----NRAIRLADAAIRADFEGKEEALLSC--------FKLGYSCASPLPQKRPSMKEALQ 775
I L R L + + C + +RPS ++
Sbjct: 235 QMIVFHLIELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 776 ALEKIPSSPS 785
+++I + +
Sbjct: 285 RVDQIRDNMA 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-23
Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 22/198 (11%)
Query: 81 SRVIGLALPNSQLLGSIPADLGMIEF--LQYLDLSNNSLNGSLSF----SLFNASQLRNL 134
S + L L N ++ G+ P L L L+L N S ++ + L+ L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 135 DLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLT----TLQSLTIVSLKNNYFS 190
++ E + L L+LSDN G+ + +L +++L+N
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 191 D------GLPSKFNSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFG 242
L + +Q LDLS N + + + L LNLS+ L ++P
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 243 EKIPVNATIDLSFNNLTG 260
K+ V +DLS+N L
Sbjct: 274 AKLSV---LDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 34/158 (21%), Positives = 52/158 (32%), Gaps = 9/158 (5%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSL----SFSLFNASQLRNLDLSNNL- 140
L++ + L + + L LDLS+N G + L+ L L N
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 141 --ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTT-LQSLTIVSLKNNYFSDGLPSKF 197
SG + LQ L+LS N+L L ++L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 198 NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSG 235
+ VLDLS N ++ P + L+L N
Sbjct: 274 AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 45/234 (19%), Positives = 79/234 (33%), Gaps = 25/234 (10%)
Query: 57 NYNDENPCSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDL 112
N++D P + C + G S L +++ D+ L+ L +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 113 SNNSLNGSLSFS---LFNASQLRNLDLSNNLISGHLPETMGSLHNLQL--LNLSDNALAG 167
+ + F + S L+ L L N ++G P + L LNL + + A
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 168 KL-------PVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLP----- 215
+ L+ L+I + FS F ++ LDLS N G
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 216 PDIGGYSLRYLNLSYNR---LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
+ +L+ L L SG ++ + +DLS N+L +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ-GLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 32/191 (16%), Positives = 60/191 (31%), Gaps = 24/191 (12%)
Query: 92 QLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
LG+ +L G L + + + + L+ L + I +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 150 GSLHN---LQLLNLSDNALAGKLPVSLT--TLQSLTIVSLKNNYFSDGLPSKFNSVQVLD 204
+ LQ L L + + G P L T L I++L+N ++
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT----------RDA 138
Query: 205 LSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
+ L P L+ L+++ + P +T+DLS N GE
Sbjct: 139 WLAELQQWLKP------GLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 265 SNVFMNQESSS 275
+ + +
Sbjct: 192 ISALCPLKFPT 202
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 82/315 (26%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVP 554
G +AV+++ + D+ RDF+ +++++ L +V+ RG +G + ++ +++P
Sbjct: 50 NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 555 NGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
+G L + + ++ + L L + + +G+ +L ++ VH +L RN+L+ ++
Sbjct: 110 SGCLRD--FLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLG 673
KI DFGL +L+ D
Sbjct: 165 HVKIADFGLAKLLPLDKDYYVVRE-----------------------------------P 189
Query: 674 GISP--YHAPESLR----SIKPNPKWDVYSFGVILLELLT------------GKVIVVDE 715
G SP ++APESL S + DV+SFGV+L EL T +++ +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQS----DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMK 771
L+E RL A +C +L C +P PQ RPS
Sbjct: 246 DVPALSRLLELLEEGQRL-------------PAPPACPAEVHELMKLCWAPSPQDRPSFS 292
Query: 772 EALQALEKIPSSPSP 786
L+ + S
Sbjct: 293 ALGPQLDMLWSGSRG 307
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 9/170 (5%)
Query: 91 SQLLGSIPADLGMIEFLQYLDLSNNSLN--GSLSFSLFNASQLRNLDLSNNLISGHLPET 148
+ A G LQ L LS N L L L +LD+S N +P++
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405
Query: 149 MGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208
++ LNLS + + + Q+L ++ + NN +Q L +S N
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQELYISRN 461
Query: 209 LINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNL 258
+ +LP L + +S N+L +P +++ I L N
Sbjct: 462 KLK-TLPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-21
Identities = 44/239 (18%), Positives = 86/239 (35%), Gaps = 32/239 (13%)
Query: 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPN 90
L G +L ++ L L + + + + C+ NG+ +P E + S + +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 91 SQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
++ L + L LS +++ + + N+ +
Sbjct: 288 ----------------IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331
Query: 151 SLHNLQLLNLSDNAL---AGKLPVSLTTLQSLTIVSLKNNYFSD-----GLPSKFNSVQV 202
L +L+ L+LS+N + K SL + L N+ + ++
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 203 LDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATI-DLSFNNLT 259
LD+S N + +P +R+LNLS + + IP + D+S NNL
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT----CIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-19
Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 9/172 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
SIP+ L ++ LDLS N + L + L+ L L ++ I+ + SL
Sbjct: 17 FTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLG 74
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS----DGLPSKFNSVQVLDLSSNL 209
+L+ L+LSDN L+ L SL ++L N + L ++Q L + +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 210 INGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ G SL L + L Q + I + L +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 39/245 (15%), Positives = 76/245 (31%), Gaps = 52/245 (21%)
Query: 86 LALPNSQLLGSIPA-DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH 144
L + N + I D + L L++ SL S SL + + +L L + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 145 LPETMGSLHNLQLLNLSDNALAG----------------------------------KLP 170
L L +++ L L D LA KL
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 171 VSLTTLQSLTIVSLKNNYFSDGLPSKFN-----------SVQVLDLSSNLINGSLPPDIG 219
+ L + N D PS+ + +++ L + + L
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 220 GY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESS---- 274
++ + + +++ +P F + + +DLS N + E +++ S
Sbjct: 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 275 SFSGN 279
S N
Sbjct: 367 VLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 31/156 (19%), Positives = 60/156 (38%), Gaps = 10/156 (6%)
Query: 110 LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL 169
D + S S+ L + +++LDLS N I+ + + NLQ+L L + +
Sbjct: 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 170 PVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPD--IGG-YSL 223
+ +L SL + L +N S +S++ L+L N +L +L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNL 125
Query: 224 RYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ L + EI + +++ +L
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 32/210 (15%), Positives = 77/210 (36%), Gaps = 26/210 (12%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG---SLSFSLFNASQLRNLDLSNNLIS 142
L L S+ + ++ ++YL+L + +L S +S ++ L ++++
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 143 G-------HLPETMGSLHNLQLLNLSDNAL---AGKLPVSLTTLQSLTIVSLKNNYFSD- 191
L + L ++ + + N L ++ L + V+++ +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 192 -------GLPSKFNSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFG 242
+ S V+ + + ++ + +P + SL +L+LS N + E
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 243 EKIPVNA--TIDLSFNNLTGEIPESNVFMN 270
K + T+ LS N+L + +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 72/358 (20%), Positives = 134/358 (37%), Gaps = 66/358 (18%)
Query: 444 NQRQQDHV---HERQNKKGTLVIVDGDKELELETLLKASAYILGASGS-SIMYKAV-LED 498
+ H E +G +VI+D L ++ L G S + L D
Sbjct: 3 SSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKL---------GEGGFSYVDLVEGLHD 53
Query: 499 GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW----GVDEKLIIYDFVP 554
G A++RI + + + + + HPN++R+ + E ++ F
Sbjct: 54 GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 555 NGSLANARYRKMGSSPCHLPWEAR-LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
G+L N ++ L E + L + G+ RGL +H K + H +LKP N+LLG++
Sbjct: 114 RGTLWN-EIERLKDKGNFLT-EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLG 673
+P + D G S+ + +++ ++R T
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI------------------------ 207
Query: 674 GISPYHAPE--SLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRA 730
Y APE S++S + + DV+S G +L ++ G+ + +
Sbjct: 208 ---SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------------GPYDMVFQK 252
Query: 731 IRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786
A++ + S ++L S + P +RP + L LE + P+P
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL-QPPAP 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 54/307 (17%), Positives = 108/307 (35%), Gaps = 76/307 (24%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
G+ + +YK + E +A + + + + F+ + ++ L HPN+VR +
Sbjct: 37 GSFKT--VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW 94
Query: 541 WGVDEK---LIIY-DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
+ +++ + + +G+L Y K + + + + +GL FLH +
Sbjct: 95 ESTVKGKKCIVLVTELMTSGTLKT--YLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 597 H--VHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
+H +LK N+ + G KIGD GL L + + G
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG----------------- 192
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712
+P APE K + DVY+FG+ +LE+ T +
Sbjct: 193 ----------------------TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 229
Query: 713 VDELGQGNGLLV---EDKNRAI-RLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP 768
+ K + ++A ++ + + C + +R
Sbjct: 230 SECQNAAQIYRRVTSGVKPASFDKVAIPEVK-EI------IEGCIR-------QNKDERY 275
Query: 769 SMKEALQ 775
S+K+ L
Sbjct: 276 SIKDLLN 282
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 53/220 (24%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVP 554
G +AV+++ ++ + RDFE ++ ++ L H N+V+ +G + + +I +++P
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 555 NGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
GSL + Y +K + L+ + +G+ +L K+++H +L RN+L+ N+
Sbjct: 128 YGSLRD--YLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLG 673
KIGDFGL +++ D K
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKE-----------------------------------P 207
Query: 674 GISP--YHAPESLR----SIKPNPKWDVYSFGVILLELLT 707
G SP ++APESL S+ DV+SFGV+L EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVAS----DVWSFGVVLYELFT 243
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 46/239 (19%), Positives = 94/239 (39%), Gaps = 58/239 (24%)
Query: 483 LGASGSSIMYKA---VLEDGTALAVRRIG----ENSVDRFRDFETQVRVIAKLVHPNLVR 535
LG G S +Y A +L A+ I E ++ RF +V ++L H N+V
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE---REVHNSSQLSHQNIVS 75
Query: 536 IRGFYWGVDEKL--IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
+ ++ ++ +++ +L + G L + + + G+ H
Sbjct: 76 M--IDVDEEDDCYYLVMEYIEGPTL-SEYIESHG----PLSVDTAINFTNQILDGIKHAH 128
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD--TSSSKAGGSARNFGSKRSTASR 651
+ + VH ++KP+N+L+ ++ KI DFG+ + ++ T ++ G+ +
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ----------- 177
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710
Y +PE + + D+YS G++L E+L G+
Sbjct: 178 --------------------------YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 8e-22
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 21/190 (11%)
Query: 78 NNDSRVIGLALPNSQLLGSIPADL-GMIEFLQYLDLSNNSLNGSLSF-SLFNASQLRNLD 135
NN+ + + N+ + AD + + L + N ++S +Q L
Sbjct: 8 NNNFSLSQNSFYNT--ISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ 65
Query: 136 LSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195
L+ +S LP+ + + +L ++ NAL LP +L+ L +N S LP
Sbjct: 66 LNRLNLS-SLPDNLPP--QITVLEITQNAL-ISLPELPASLEYL---DACDNRLST-LPE 117
Query: 196 KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
S++ LD+ +N + LP L Y+N N+L+ +P + +
Sbjct: 118 LPASLKHLDVDNNQLT-MLPELPA--LLEYINADNNQLT-MLPELPTS----LEVLSVRN 169
Query: 256 NNLTGEIPES 265
N LT +PE
Sbjct: 170 NQLT-FLPEL 178
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 9e-13
Identities = 24/153 (15%), Positives = 45/153 (29%), Gaps = 15/153 (9%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L +P L+ L + NN L L L LD+S NL+ LP H
Sbjct: 152 LTMLPELPTS---LEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SLPAVPVRNH 203
Query: 154 NLQ----LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN--SVQVLDLSS 207
+ + +N + +P ++ +L + L++N S + + + Q
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
Query: 208 NLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQ 240
+ +
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 34/145 (23%), Positives = 49/145 (33%), Gaps = 20/145 (13%)
Query: 129 SQLRNLDLSNNLISGHLPET-------MGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTI 181
N LS N + T L + N L L + +
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 182 VSLKNNYFSDGLPSK-FNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQ 240
+ L S LP + VL+++ N + SLP SL YL+ NRLS +P
Sbjct: 64 LQLNRLNLSS-LPDNLPPQITVLEITQNAL-ISLPELPA--SLEYLDACDNRLS-TLPEL 118
Query: 241 FGEKIPVNATIDLSFNNLTGEIPES 265
+D+ N LT +PE
Sbjct: 119 PASLK----HLDVDNNQLT-MLPEL 138
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 20/99 (20%), Positives = 32/99 (32%), Gaps = 14/99 (14%)
Query: 176 LQSLTIVSLKNNYFS-------DGLPSKFNSVQVLDLSSNLING--SLPPDIGGYSLRYL 226
L SL N F S ++ + L N SL + L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
L+ LS +P +I ++++ N L +PE
Sbjct: 65 QLNRLNLS-SLPDNLPPQI---TVLEITQNALI-SLPEL 98
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 83/311 (26%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LII 549
+ T +A++ + ++ F + +V+ KL H LV++ V E+ I+
Sbjct: 201 WMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIV 256
Query: 550 YDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
+++ GSL + + + + +L + +A +A G+A++ +VH +L+ N+L
Sbjct: 257 TEYMSKGSLLD--FLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+G ++ K+ DFGL RL+ + +++ G F K +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGA---KFPIKWT--------------------- 348
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI--------VVDELGQG 719
APE+ + K DV+SFG++L EL T G+V V+D++ +G
Sbjct: 349 -----------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEALQ 775
R+ C L C P++RP+ +
Sbjct: 398 Y-----------RM-------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433
Query: 776 ALEKIPSSPSP 786
LE +S P
Sbjct: 434 FLEDYFTSTEP 444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 33/185 (17%), Positives = 63/185 (34%), Gaps = 8/185 (4%)
Query: 87 ALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP 146
P I ++L + + + + F + + + N+ +
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 147 ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVL 203
+ S ++LLNL+D + + ++ + + N Y + + VL
Sbjct: 63 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 204 DLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
L N ++ SLP I L L++S N L I + + LS N LT
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-H 179
Query: 262 IPESN 266
+ S
Sbjct: 180 VDLSL 184
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
+Q L + N++ L +F N L L L N +S LP + + L L++S+N
Sbjct: 95 IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
L + SL + L +N + S S+ ++S NL++ +L I ++
Sbjct: 153 LERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-TLAIPI---AVE 208
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L+ S+N ++ + ++ + L NNLT
Sbjct: 209 ELDASHNSIN-VVRGPVNVELT---ILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 33/158 (20%), Positives = 63/158 (39%), Gaps = 15/158 (9%)
Query: 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
++ LD S+NS+N + + +L L L +N ++ + + L ++LS N L
Sbjct: 206 AVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL 260
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLINGSLPPDIGG-Y 221
+ +Q L + + NN L +++VLDLS N + + +
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318
Query: 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L L L +N + + + + LS N+
Sbjct: 319 RLENLYLDHNSIV-TLKLSTHHTLK---NLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159
DL +I L + ++S N L+ +L + LD S+N I+ + L +L
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 160 LSDNALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPP 216
L N L L L V L N K ++ L +S+N + +L
Sbjct: 233 LQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289
Query: 217 DIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
+L+ L+LS+N L + + + + L N++ + S
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV-TLKLST 337
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 66/308 (21%), Positives = 123/308 (39%), Gaps = 77/308 (25%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV---DEKLI 548
+ T +AV+ + + S+ F + ++ +L H LVR+ + V + I
Sbjct: 30 WMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL----YAVVTQEPIYI 84
Query: 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
I +++ NGSL + + K S L L +A +A G+AF+ E+ ++H +L+ N+L
Sbjct: 85 ITEYMENGSLVD--FLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+ + + KI DFGL RL+ + +++ G F K +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGA---KFPIKWT--------------------- 177
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ------GNGL 722
APE++ K DV+SFG++L E++T G+ N
Sbjct: 178 -----------APEAINYGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMTNPE 218
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEALQALE 778
++++ R R+ +C ++L C P+ RP+ LE
Sbjct: 219 VIQNLERGYRM-------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
Query: 779 KIPSSPSP 786
++
Sbjct: 266 DFFTATEG 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 50/231 (21%), Positives = 79/231 (34%), Gaps = 42/231 (18%)
Query: 492 YKAV-LEDGTALAVRRIGENSVDRFRDFETQ-VRVIAKLVHPNLVRIRGFYWGVDEKL-- 547
++A D A++RI + + R+ + V+ +AKL HP +VR + +
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81
Query: 548 ----------IIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
I +L + R L I +A + FLH K
Sbjct: 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER---ERSVCLHIFLQIAEAVEFLHSKG 138
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
+H +LKP N+ D K+GDFGL + D +
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV------- 191
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G Y +PE + + K D++S G+IL ELL
Sbjct: 192 -----------------GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 39/329 (11%), Positives = 77/329 (23%), Gaps = 80/329 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPN----- 532
L S+++ +E A++ ENS A+L+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 533 ----------LVRIRGFYWGVDEKLIIYDF----------VPNGSLAN--ARYRKMGSSP 570
V ++ D+ + L + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 571 CHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630
A + + R A L K VHG+ P N+ + D +GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA-------- 240
Query: 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL--RSIK 688
G++ Y E L +
Sbjct: 241 --------LWKVGTRGPA-----------------------SSVPVTYAPREFLNASTAT 269
Query: 689 PNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEA 748
+ + G+ + + + G R A + +
Sbjct: 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV 329
Query: 749 --LLSCFKLGYSCASPLPQKRPSMKEALQ 775
L+ F L + ++R EA++
Sbjct: 330 KTLIGRF-LNFD-----RRRRLLPLEAME 352
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 71/307 (23%)
Query: 492 YKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550
Y+ V + +AV+ + E++++ +F + V+ ++ HPNLV++ G II
Sbjct: 237 YEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 551 DFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
+F+ G+L + Y R+ + L +A ++ + +L +K +H NL RN L+
Sbjct: 296 EFMTYGNLLD--YLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV 351
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
G + K+ DFGL RL+TGDT ++ AG F K +
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGA---KFPIKWT---------------------- 386
Query: 670 SSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI--------VVDELGQGN 720
APESL K + K DV++FGV+L E+ T G V + L +
Sbjct: 387 ----------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436
Query: 721 GLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
R+ E E ++L +C P RPS E QA E +
Sbjct: 437 -----------RM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
Query: 781 PSSPSPY 787
S
Sbjct: 477 FQESSIS 483
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 65/310 (20%), Positives = 116/310 (37%), Gaps = 85/310 (27%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551
+ + +A++ I E ++ DF + V+ KL HP LV++ G ++ +
Sbjct: 25 HLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83
Query: 552 FVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
F+ +G L++ R ++ + L L + V G+A+L E +H +L RN L+G
Sbjct: 84 FMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSPSPSP 667
+ K+ DFG+ R V D +S G K +
Sbjct: 139 ENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWA------------------- 172
Query: 668 SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQ 718
+PE + + K DV+SFGV++ E+ + GK+ VV+++
Sbjct: 173 ------------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEAL 774
G RL +++ C P+ RP+ L
Sbjct: 221 GF-----------RL-------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLL 256
Query: 775 QALEKIPSSP 784
+ L +I S
Sbjct: 257 RQLAEIAESG 266
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 83/315 (26%)
Query: 492 YKAVLEDG-TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEK-- 546
Y+ V + +AV+ + E++++ +F + V+ ++ HPNLV++ GV E
Sbjct: 30 YEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL----LGVCTREPPF 84
Query: 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
II +F+ G+L + Y + + + L +A ++ + +L +K +H +L RN
Sbjct: 85 YIITEFMTYGNLLD--YLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSP 663
L+G + K+ DFGL RL+TGDT ++ AG K + TA
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGDTYTAHAGA-------KFPIKWTA-------------- 180
Query: 664 SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVD 714
PESL K + K DV++FGV+L E+ T G V +
Sbjct: 181 -----------------PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223
Query: 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774
L + R+ E E ++L +C P RPS E
Sbjct: 224 LLEKDY-----------RM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263
Query: 775 QALEKIPSSPSPYLY 789
QA E + S
Sbjct: 264 QAFETMFQESSISDE 278
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 39/192 (20%), Positives = 72/192 (37%), Gaps = 14/192 (7%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--LPE 147
NS+ L S+P + L+L +N L +QL L LS+N +S +
Sbjct: 15 NSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS----DGLPSKFNSVQVL 203
+ +L+ L+LS N + + + L+ L + +++ + ++ L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 204 DLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
D+S I G SL L ++ N P ++ +DLS L +
Sbjct: 132 DISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 189
Query: 262 IPESNVFMNQES 273
+ F + S
Sbjct: 190 LSP-TAFNSLSS 200
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLS-NNLISGHLPETMGSLHNLQLLNLSDNAL 165
L YLD+S+ + + S L L ++ N+ LP+ L NL L+LS L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 166 AGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDI---G 219
P + +L SL ++++ +N NS+QVLD S N I +
Sbjct: 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHF 246
Query: 220 GYSLRYLNLSYNRLS 234
SL +LNL+ N +
Sbjct: 247 PSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 29/170 (17%), Positives = 57/170 (33%), Gaps = 13/170 (7%)
Query: 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG 167
+ ++ L S+ + S L+L +N + L L L+LS N L+
Sbjct: 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 168 K--LPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDI--GG 220
K S SL + L N + S F ++ LD + + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
+L YL++S+ + + ++ N+ ++F
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTE 173
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 65/311 (20%), Positives = 108/311 (34%), Gaps = 85/311 (27%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551
+A++ I E S+ +F + +V+ L H LV++ G II +
Sbjct: 41 KYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99
Query: 552 FVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
++ NG L N R + L L++ K V + +L K+ +H +L RN L+
Sbjct: 100 YMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSPSPSP 667
+ K+ DFGL R V D +S G K R +
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGS-------KFPVRWS------------------- 188
Query: 668 SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQ 718
PE L K + K D+++FGV++ E+ + GK+ + + Q
Sbjct: 189 ------------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEAL 774
G RL + + YSC +RP+ K L
Sbjct: 237 GL-----------RL-------------YRPHLASEKVYTIMYSCWHEKADERPTFKILL 272
Query: 775 QALEKIPSSPS 785
+ + S
Sbjct: 273 SNILDVMDEES 283
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-20
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 19/201 (9%)
Query: 98 PADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQ 156
+ +E LQ L+L + ++ F N LR LDL ++ I P+ L +L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 157 LLNLSDNALAGKL--PVSLTTLQSLTIVSLKNNYFS----DGLPSKFNSVQVLDLSSNLI 210
L L L+ + L++LT + L N K NS++ +D SSN I
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 211 NGSLPPD----IGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNA-----TIDLSFNNLTGE 261
+ + G +L + +L+ N L + +G+ + +D+S N T +
Sbjct: 161 F-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219
Query: 262 IPESNVFMNQESSSFSGNLDL 282
I F N S S + +L L
Sbjct: 220 IT--GNFSNAISKSQAFSLIL 238
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 46/225 (20%), Positives = 77/225 (34%), Gaps = 32/225 (14%)
Query: 86 LALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISG 143
L L + +I + + L+ LDL ++ + L F L L L +S
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 144 HL--PETMGSLHNLQLLNLSDNALAG-KLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN-- 198
+ +L L L+LS N + L S L SL + +N +
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 199 ---SVQVLDLSSNLINGSLPPDIGGY-------SLRYLNLSYNRLSGEIPPQFGEKIPVN 248
++ L++N + + D G L L++S N + +I F I +
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 249 A-----------TIDLSFNNLTGEIPESNVFMNQESSSFSGNLDL 282
F+N+ P+ N F SS +LDL
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIK--DPDQNTFAGLARSSVR-HLDL 273
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-19
Identities = 41/182 (22%), Positives = 70/182 (38%), Gaps = 14/182 (7%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL-PETMGSL 152
L +P L + L LS N + + S QL+ L+L + + E +L
Sbjct: 16 LTQVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNL 72
Query: 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD-----GLPSKFNSVQVLDLSS 207
NL++L+L + + P + L L + L SD G ++ LDLS
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 208 NLING-SLPPDIGG-YSLRYLNLSYNRLSGEIPPQ--FGEKIPVNATIDLSFNNLTGEIP 263
N I L P G SL+ ++ S N++ + + + L+ N+L +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 264 ES 265
Sbjct: 192 VD 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-18
Identities = 48/235 (20%), Positives = 87/235 (37%), Gaps = 24/235 (10%)
Query: 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNG--SLSFSLFNASQLRNL 134
N V ++ + S L + + +++ +F+ S +R+L
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 135 DLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP 194
DLS+ + +L +L++LNL+ N + + L +L +++L N +
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331
Query: 195 SKFN---SVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNA 249
S F V +DL N I + + L+ L+L N L+ I IP
Sbjct: 332 SNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-TIHF-----IPSIP 384
Query: 250 TIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIPSSPFDLPNTT 304
I LS N L +P+ N+ N + L +N I +P+
Sbjct: 385 DIFLSGNKLV-TLPKINLTANL--------IHLSENRLEN-LDILYFLLRVPHLQ 429
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 6/168 (3%)
Query: 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ L+L+ N +N + + L+ L+LS NL+ L + ++L N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
A + L+ L + L++N + S+ + LS N + +LP +
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALTT--IHFIPSIPDIFLSGNKLV-TLPK--INLTANL 405
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQES 273
++LS NRL F ++P + L+ N + S
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPS 452
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-18
Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 24/197 (12%)
Query: 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-HLPETMGSLHNLQLL 158
+ I + + LS N L +L + LS N + + + + +LQ+L
Sbjct: 376 TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQIL 431
Query: 159 NLSDNALAGKLPVSL-TTLQSLTIVSLKNNYFSDGLPSKFN--------SVQVLDLSSNL 209
L+ N + + SL + L N ++ +QVL L+ N
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 210 INGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI-DLSFNNLTGEIPESN 266
+N SLPP + +LR L+L+ NRL+ + +P N I D+S N L P +
Sbjct: 492 LN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHND---LPANLEILDISRNQLL--APNPD 544
Query: 267 VFMNQESSSFSGNLDLC 283
VF++ + N +C
Sbjct: 545 VFVSLSVLDITHNKFIC 561
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 1e-20
Identities = 32/185 (17%), Positives = 62/185 (33%), Gaps = 8/185 (4%)
Query: 87 ALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP 146
P I ++L + + + + F + + + N+ +
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68
Query: 147 ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVL 203
+ S ++LLNL+D + + ++ + + N + + VL
Sbjct: 69 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128
Query: 204 DLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
L N ++ SLP I L L++S N L I + + LS N LT
Sbjct: 129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-H 185
Query: 262 IPESN 266
+ S
Sbjct: 186 VDLSL 190
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 13/160 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L L +SNN+L + F + L+NL LS+N ++ H+ + +L N+S N L
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL 204
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
+ +L ++ + +N + + +L L N + + L
Sbjct: 205 S-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVE 258
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
++LSYN L +I K+ + +S N L +
Sbjct: 259 VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLY 296
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 31/131 (23%), Positives = 58/131 (44%), Gaps = 9/131 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L L L +N+L + N L +DLS N + + + L+ L +S+N L
Sbjct: 234 LTILKLQHNNLTDTAWLL--NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPS---KFNSVQVLDLSSNLINGSLPPDIGGYSL 223
L + + +L ++ L +N+ + +F+ ++ L L N I +L ++L
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST-HHTL 347
Query: 224 RYLNLSYNRLS 234
+ L LS+N
Sbjct: 348 KNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 27/169 (15%), Positives = 58/169 (34%), Gaps = 14/169 (8%)
Query: 112 LSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQL-----LNLSDNALA 166
N + +++ + + I + ++ L + ++ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 167 GKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGY-- 221
L + + + +++L + + +++Q L + N I LPP +
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 123
Query: 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
L L L N LS +P P T+ +S NNL I + + F
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L ++ I L+ LDLS+N L + + +L NL L +N I L + H
Sbjct: 290 LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHH 345
Query: 154 NLQLLNLSDNAL 165
L+ L LS N
Sbjct: 346 TLKNLTLSHNDW 357
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK---LI 548
+ A T +AV+ + S+ F + V+ L H LV++ V K I
Sbjct: 205 WMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKL----HAVVTKEPIYI 259
Query: 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
I +F+ GSL + + K P + + +A G+AF+ ++ ++H +L+ N+L
Sbjct: 260 ITEFMAKGSLLD--FLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+ + KI DFGL R++ + +++ G F K +
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGA---KFPIKWT--------------------- 352
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
APE++ K DV+SFG++L+E++T
Sbjct: 353 -----------APEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-20
Identities = 63/311 (20%), Positives = 121/311 (38%), Gaps = 83/311 (26%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LII 549
+ T +A++ + ++ F + +V+ KL H LV++ V E+ I+
Sbjct: 284 WMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIV 339
Query: 550 YDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
+++ GSL + + + + +L + +A +A G+A++ +VH +L+ N+L
Sbjct: 340 TEYMSKGSLLD--FLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
+G ++ K+ DFGL RL+ + +++ G F K +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGA---KFPIKWT--------------------- 431
Query: 669 PSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI---------VVDELGQG 719
APE+ + K DV+SFG++L EL T + V+D++ +G
Sbjct: 432 -----------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEALQ 775
R+ C L C P++RP+ +
Sbjct: 481 Y-----------RM-------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516
Query: 776 ALEKIPSSPSP 786
LE +S P
Sbjct: 517 FLEDYFTSTEP 527
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 48/220 (21%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551
+ +AV+ I E S+ +F + + + KL HP LV+ G I+ +
Sbjct: 25 KLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83
Query: 552 FVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
++ NG L N R G P L L++ V G+AFL + +H +L RN L+
Sbjct: 84 YISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESHQFIHRDLAARNCLVD 138
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSPSPSP 667
D+ K+ DFG+ R V D S G K + +
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGT-------KFPVKWS------------------- 172
Query: 668 SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
APE K + K DV++FG+++ E+ +
Sbjct: 173 ------------APEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 62/319 (19%), Positives = 110/319 (34%), Gaps = 86/319 (26%)
Query: 492 YKAVLEDG-----TALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGV-- 543
YK + +A++ + E + + ++ + V+A + +P++ R+ G+
Sbjct: 32 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL----LGICL 87
Query: 544 -DEKLIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+I +P G L + R K +L L +A+G+ +L +++ VH +
Sbjct: 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDRRLVHRD 142
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
L RNVL+ KI DFGL +L+ + A
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE------------------------- 177
Query: 662 SPSPSPSPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV-------- 710
GG P + A ES+ + DV+S+GV + EL+T G
Sbjct: 178 -----------GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770
+ L +G RL + + + C RP
Sbjct: 227 EISSILEKGE-----------RL---------PQPPICTIDVYMIMRKCWMIDADSRPKF 266
Query: 771 KEALQALEKIPSSPSPYLY 789
+E + K+ P YL
Sbjct: 267 RELIIEFSKMARDPQRYLV 285
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 47/197 (23%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARY-RKMGSSPCH 572
++ ++ ++ L H ++++ +G ++ ++VP GSL + Y +
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQ 135
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
L L A+ + G+A+LH + ++H +L RNVLL ND KIGDFGL + V
Sbjct: 136 L-----LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP--YHAPESLRSIKPN 690
+ G SP ++APE L+ K
Sbjct: 191 YRVRE-----------------------------------DGDSPVFWYAPECLKEYKFY 215
Query: 691 PKWDVYSFGVILLELLT 707
DV+SFGV L ELLT
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 46/217 (21%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRG--FYWGVDEKLIIYDFV 553
G +AV+ + S D + ++ ++ L H N+V+ +G G + +I +F+
Sbjct: 48 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 554 PNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612
P+GSL K + LK A + +G+ +L +++VH +L RNVL+ ++
Sbjct: 108 PSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSL 672
+ KIGDFGL + + D
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYTVKD----------------------------------- 187
Query: 673 GGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
SP ++APE L K DV+SFGV L ELLT
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 49/208 (23%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL------IIYDFVPNGSLANAR 562
+ RFR + + A L HP +V + + G E I+ ++V +L
Sbjct: 53 PSFYLRFR---REAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTL-RDI 106
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622
G + + +++ + L F H+ +H ++KP N+++ K+ DFG+
Sbjct: 107 VHTEG----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE 682
R + +S + G TA Y +PE
Sbjct: 163 ARAIADSGNSVTQTAAV--IG----TAQ---------------------------YLSPE 189
Query: 683 SLRSIKPNPKWDVYSFGVILLELLTGKV 710
R + + DVYS G +L E+LTG+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 61/312 (19%), Positives = 120/312 (38%), Gaps = 79/312 (25%)
Query: 491 MYKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549
+ + +A++ + +R R DF ++ ++ + HPN++R+ G +I+
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
+++ NGSL + + + + + +GV G+ +L + +VH +L RNVL+
Sbjct: 129 TEYMENGSLDT--FLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
+++ K+ DFGL R++ D ++
Sbjct: 185 DSNLVCKVSDFGLSRVLEDDPDAAYT---------------------------------- 210
Query: 670 SSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQ 718
+ GG P APE++ + DV+SFGV++ E+L G+ V+ + +
Sbjct: 211 -TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEAL 774
G RL A + C +L C +RP + +
Sbjct: 270 GY-----------RL-------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 775 QALEKIPSSPSP 786
L+ + SP
Sbjct: 306 SVLDALIRSPES 317
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 46/228 (20%), Positives = 84/228 (36%), Gaps = 37/228 (16%)
Query: 492 YKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY--WGVD 544
+K V DG A++R SVD ++ +V A L H ++VR ++ W D
Sbjct: 28 FKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAVLGQHSHVVR---YFSAWAED 83
Query: 545 EKLIIY-DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
+ ++I ++ GSLA+A + + + V RGL ++H VH ++K
Sbjct: 84 DHMLIQNEYCNGGSLADA-ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK 142
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSS-KAGGSARNFGSKRSTASRDSFQDLGPGPS 662
P N+ + P + K G + G +S +
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG----DLGHVTRISSPQVEE------- 191
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK 709
G S + A E L+ PK D+++ + ++ +
Sbjct: 192 -----------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 49/207 (23%)
Query: 506 RIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARY 563
+ N + + V+ +L +P +VR+ G + + +++ + G L Y
Sbjct: 53 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGI---CEAESWMLVMEMAELGPLNK--Y 107
Query: 564 RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623
+ H+ + +++ V+ G+ +L E VH +L RNVLL KI DFGL
Sbjct: 108 LQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 624 RLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
+ + D + KA K + A
Sbjct: 165 KALRADENYYKAQT-----HGKWPVKWY-------------------------------A 188
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLT 707
PE + K + K DV+SFGV++ E +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 59/290 (20%), Positives = 99/290 (34%), Gaps = 77/290 (26%)
Query: 516 RDFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LIIYDFVPNGSLANARY-RKMGSSPCH 572
+ + +++ +L +P +VR+ G + +++ + G L +
Sbjct: 55 EEMMREAQIMHQLDNPYIVRLIGV---CQAEALMLVMEMAGGGPLHK--FLVGKRE---E 106
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
+P ++ V+ G+ +L EK VH +L RNVLL N KI DFGL + + D S
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH--APESLRSIKPN 690
A G P APE + K +
Sbjct: 167 YTA-----------------------------------RSAGKWPLKWYAPECINFRKFS 191
Query: 691 PKWDVYSFGVILLELLT-GKV--------IVVDELGQGNGLLVEDKNRAIRLADAAIRAD 741
+ DV+S+GV + E L+ G+ V+ + QG R+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----------RM-------- 232
Query: 742 FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSPYLYGH 791
E E + L C + RP Q + S + + GH
Sbjct: 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 67/340 (19%), Positives = 116/340 (34%), Gaps = 76/340 (22%)
Query: 450 HVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLEDGTALAVRRIGE 509
+ + + T V++ G + +L GA G+ + + D +AV+RI
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGH-----GAEGT--IVYRGMFDNRDVAVKRI-- 56
Query: 510 NSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGS 568
+ F + +V+++ + HPN++R + I + +L +
Sbjct: 57 -LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE-YVEQKDF 113
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-----DMEPKIGDFGLE 623
+ HL E + + GLA LH VH +LKP N+L+ ++ I DFGL
Sbjct: 114 A--HLGLEPI-TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL- 169
Query: 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES 683
K+ R SF S + G + APE
Sbjct: 170 --------------------CKKLAVGRHSFSRR------------SGVPGTEGWIAPEM 197
Query: 684 LRSI---KPNPKWDVYSFGVILLELLTGKVIVVDELGQ---GNGLLVEDKNRAIRLADAA 737
L P D++S G + +++ G G L + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE--------GSHPFGKSLQRQANILLGACSLDC 249
Query: 738 IRADFEGKEEA--LLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ + A L+ + PQKRPS K L+
Sbjct: 250 LHPEKHEDVIARELIE------KMIAMDPQKRPSAKHVLK 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 60/318 (18%), Positives = 121/318 (38%), Gaps = 84/318 (26%)
Query: 492 YKAVLEDGTAL-----AVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDE 545
YK +L+ + A++ + ++ R DF + ++ + H N++R+ G
Sbjct: 61 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPR 605
+II +++ NG+L + + + + +G+A G+ +L +VH +L R
Sbjct: 121 MMIITEYMENGALDK--FLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 176
Query: 606 NVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSP 665
N+L+ +++ K+ DFGL R++ D ++
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYT------------------------------ 206
Query: 666 SPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVD 714
+ GG P APE++ K DV+SFG+++ E++T G+ V+
Sbjct: 207 -----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261
Query: 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSM 770
+ G RL + C ++L C +RP
Sbjct: 262 AINDGF-----------RL-------------PTPMDCPSAIYQLMMQCWQQERARRPKF 297
Query: 771 KEALQALEKIPSSPSPYL 788
+ + L+K+ +P
Sbjct: 298 ADIVSILDKLIRAPDSLK 315
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 492 YKAV-LEDGTALAVRRI----GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK 546
Y+A L DG +A++++ ++ R D ++ ++ +L HPN+++ + +E
Sbjct: 49 YRAACLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
I+ + G L+ + +P K + L +H ++ +H ++KP N
Sbjct: 108 NIVLELADAGDLSR-MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPS 666
V + K+GD GL R F SK + A
Sbjct: 167 VFITATGVVKLGDLGL----------------GRFFSSKTTAAH---------------- 194
Query: 667 PSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGK 709
S +G +PY+ +PE + N K D++S G +L E+ +
Sbjct: 195 ---SLVG--TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 35/163 (21%), Positives = 65/163 (39%), Gaps = 13/163 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L L L+ N + + + + L N I+ + ++ L L + +N +
Sbjct: 179 LYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKIT 234
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP--SKFNSVQVLDLSSNLINGSLPPDIGG-YSL 223
P L L LT + + N SD + +++L++ SN I+ + L
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 224 RYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
L L+ N+L E G + T+ LS N++T P ++
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLT-TLFLSQNHITDIRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 32/187 (17%), Positives = 73/187 (39%), Gaps = 14/187 (7%)
Query: 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN 138
+ + I L + + + +E + L ++ + S+ + + L L+L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNG 75
Query: 139 NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKF 197
N I+ + +L L L + N + +L L +L + L + SD P +
Sbjct: 76 NQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLANL 131
Query: 198 NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
+ L+L +N S + L YL ++ +++ + P + ++ L++N
Sbjct: 132 TKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD-VTP-IANLTDLY-SLSLNYN 187
Query: 257 NLTGEIP 263
+ P
Sbjct: 188 QIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 7e-17
Identities = 29/131 (22%), Positives = 49/131 (37%), Gaps = 10/131 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L L + NN + + N SQL L++ N IS + L L++LN+ N ++
Sbjct: 223 LNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGYSL 223
L L L + L NN + ++ L LS N I + P +
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLASLSKM 335
Query: 224 RYLNLSYNRLS 234
+ + +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 26/167 (15%), Positives = 65/167 (38%), Gaps = 12/167 (7%)
Query: 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNL 155
+ + L + L+ L L+ ++++ + N +++ +L+L N + ++ L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSD-LSPLSNMTGL 157
Query: 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSL 214
L ++++ + P + L L +SL N D P + S+ N I
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDI- 214
Query: 215 PPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
+ L L + N+++ P ++ +++ N ++
Sbjct: 215 -TPVANMTRLNSLKIGNNKITDLSPLANLSQL---TWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 27/160 (16%), Positives = 60/160 (37%), Gaps = 13/160 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L +N F + ++ L ++ T L ++ L ++ +A
Sbjct: 2 AATLATLPAPINQI--FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGY-SLR 224
+ + L +L ++L N +D P S + L + +N I + + +LR
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
L L+ + +S P K+ +++L N+ ++
Sbjct: 114 ELYLNEDNISDISPLANLTKM---YSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 15/57 (26%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS 142
L L N+QL +G + L L LS N + + + S++ + D +N +I
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 54/225 (24%), Positives = 77/225 (34%), Gaps = 53/225 (23%)
Query: 492 YKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEK 546
+K EDG AV+R DR +V K+ HP VR+ W
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGI 131
Query: 547 LIIY-DFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVHGNLKP 604
L + + SL G+ LP EA++ + LA LH + VH ++KP
Sbjct: 132 LYLQTELC-GPSLQQ-HCEAWGA---SLP-EAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
N+ LG K+GDFGL + + G R
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR------------------------ 221
Query: 665 PSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
Y APE L+ DV+S G+ +LE+
Sbjct: 222 -------------YMAPELLQG-SYGTAADVFSLGLTILEVACNM 252
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 68/301 (22%), Positives = 112/301 (37%), Gaps = 78/301 (25%)
Query: 492 YKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL--- 547
+KA DG ++R+ + E +V+ +AKL H N+V G + G D
Sbjct: 28 FKAKHRIDGKTYVIKRV---KYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83
Query: 548 -------------IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
I +F G+L ++ G L L++ + + +G+ ++H
Sbjct: 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFEQITKGVDYIHS 140
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
KK ++ +LKP N+ L + + KIGDFGL + D +++ G+
Sbjct: 141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT---------------- 184
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714
Y +PE + S + D+Y+ G+IL ELL
Sbjct: 185 ------LR---------------YMSPEQISSQDYGKEVDLYALGLILAELLHVCD---- 219
Query: 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774
E L D I F+ KE+ LL S P+ RP+ E L
Sbjct: 220 -------TAFETSKFFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEIL 266
Query: 775 Q 775
+
Sbjct: 267 R 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 39/201 (19%), Positives = 63/201 (31%), Gaps = 49/201 (24%)
Query: 515 FRD-FETQVRVIAKLVHPNLVRIRGFYWGVDEKL--IIYDFVPNGSLANARYRKMGSSPC 571
FR + + R +L P++V I +G + + + LA A R+ G
Sbjct: 77 FRTRMQREARTAGRLQEPHVVPI--HDFGEIDGQLYVDMRLINGVDLA-AMLRRQG---- 129
Query: 572 HLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV--TGD 629
L + I + + L H H ++KP N+L+ D + DFG+
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189
Query: 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
T G+ Y APE
Sbjct: 190 TQLGNTVGTLY-------------------------------------YMAPERFSESHA 212
Query: 690 NPKWDVYSFGVILLELLTGKV 710
+ D+Y+ +L E LTG
Sbjct: 213 TYRADIYALTCVLYECLTGSP 233
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-19
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 31/184 (16%)
Query: 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNL 155
+L + FL + NN L +L L L++ +N ++ LPE SL L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLT-DLPELPQSLTFL 282
Query: 156 QLLNLSDNALAGKLPVSLTTL--------------QSLTIVSLKNNYFSDGLPSKFNSVQ 201
+ + L+ +LP +L L SL +++ NN + LP+ ++
Sbjct: 283 DVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE 340
Query: 202 VLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
L S N + +P +L+ L++ YN L E P DL N+ E
Sbjct: 341 RLIASFNHLA-EVPELPQ--NLKQLHVEYNPLR-EFPDIPES------VEDLRMNSHLAE 390
Query: 262 IPES 265
+PE
Sbjct: 391 VPEL 394
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 39/184 (21%), Positives = 69/184 (37%), Gaps = 29/184 (15%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFN-------------ASQLRNLDLSNNL 140
L +P + ++ + + + Q L+L+N
Sbjct: 23 LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82
Query: 141 ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSV 200
+S LPE +L+ L S N+L +LP +L+SL + + SD LP +
Sbjct: 83 LS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPP---LL 133
Query: 201 QVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
+ L +S+N + LP L+ +++ N L ++P I N L
Sbjct: 134 EYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE----FIAAGNNQLE- 186
Query: 261 EIPE 264
E+PE
Sbjct: 187 ELPE 190
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 35/190 (18%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L +P +L FL+ +D+ NNSL L L + NN + LPE + +L
Sbjct: 143 LEKLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPE-LQNLP 195
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLIN 211
L + +N+L KLP +L+S+ NN + LP + + +NL+
Sbjct: 196 FLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILEE-LPELQNLPFLTTIYADNNLLK 250
Query: 212 GSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG---------------EKIPVN-ATIDLSF 255
+LP SL LN+ N L+ ++P ++P N ++ S
Sbjct: 251 -TLPDLPP--SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 306
Query: 256 NNLTGEIPES 265
N + + +
Sbjct: 307 NEIR-SLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 28/135 (20%), Positives = 58/135 (42%), Gaps = 17/135 (12%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L++SNN L L +L L S N ++ +PE NL+ L++ N L
Sbjct: 319 LEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR 370
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
+ P +++ L + N++ ++ +P +++ L + +N + P S+ L
Sbjct: 371 -EFPDIPESVEDLRM----NSHLAE-VPELPQNLKQLHVETNPLR-EFPDIPE--SVEDL 421
Query: 227 NLSYNRLSGEIPPQF 241
++ R+
Sbjct: 422 RMNSERVVDPYEFAH 436
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 37/159 (23%), Positives = 64/159 (40%), Gaps = 22/159 (13%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L YL+ S+N + SL L L++SNN + LP L+ L S N LA
Sbjct: 299 LYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA 350
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
++P L+ L ++ N + P SV+ L ++S+L +P +L+ L
Sbjct: 351 -EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLRMNSHLA--EVPELPQ--NLKQL 401
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
++ N L E P + ++ + +
Sbjct: 402 HVETNPLR-EFPDIPESVE----DLRMNSERVVDPYEFA 435
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 32/168 (19%), Positives = 55/168 (32%), Gaps = 25/168 (14%)
Query: 98 PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQL 157
P ++ FLQ +++L + N + + + P G + +
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPD 217
L D + + L N S LP ++ L S N + LP
Sbjct: 63 SRLRDC-----------LDRQAHELELNNLGLSS-LPELPPHLESLVASCNSLT-ELPEL 109
Query: 218 IGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
SL N + LS ++PP + +S N L ++PE
Sbjct: 110 PQSLKSLLVDNNNLKALS-DLPPLLEY-------LGVSNNQLE-KLPE 148
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 22/134 (16%), Positives = 45/134 (33%), Gaps = 25/134 (18%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
L +PA L+ L S N L + N L+ L + N + P+ S+
Sbjct: 329 LIELPALPPR---LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVE 380
Query: 154 ----------------NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF 197
NL+ L++ N L + P +++ L + S + +
Sbjct: 381 DLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLRMNSERVVDPYEFAHETT 439
Query: 198 NSVQVLDLSSNLIN 211
+ ++ + +
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 9/76 (11%), Positives = 22/76 (28%), Gaps = 7/76 (9%)
Query: 88 LPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE 147
L + L +P L+ L + N L + +L +++ +
Sbjct: 382 LRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEF 434
Query: 148 TMGSLHNLQLLNLSDN 163
+ L+ +
Sbjct: 435 AHETTDKLEDDVFEHH 450
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 63/326 (19%), Positives = 113/326 (34%), Gaps = 92/326 (28%)
Query: 492 YKAVLEDG----TALAVR--RIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGF------ 539
+A L+ +AV+ + + +F + + + HP++ ++ G
Sbjct: 40 REAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99
Query: 540 YWGVDEKLIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ ++I F+ +G L ++G +P +LP + ++ +A G+ +L + +
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +L RN +L DM + DFGL R + S D ++
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSRKI----------------------YSGDYYRQGC 197
Query: 659 PGPSP----SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--- 710
P + ESL DV++FGV + E++T G+
Sbjct: 198 ASKLPVKWLAL----------------ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 711 -----IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCAS 761
+ + L GN RL + C + L Y C S
Sbjct: 242 GIENAEIYNYLIGGN-----------RL-------------KQPPECMEEVYDLMYQCWS 277
Query: 762 PLPQKRPSMKEALQALEKIPSSPSPY 787
P++RPS LE I S
Sbjct: 278 ADPKQRPSFTCLRMELENILGHLSVL 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 53/232 (22%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
G+ G +++ + G AV+++ ++ FR E + A L P +V + G
Sbjct: 69 GSFGE--VHRMKDKQTGFQCAVKKV---RLEVFRVEE--LVACAGLSSPRIVPLYGAVRE 121
Query: 543 VDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVH 599
I + + GSL + + E R GL +LH ++ +H
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLP--------EDRALYYLGQALEGLEYLHTRRILH 173
Query: 600 GNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
G++K NVLL +D + DFG + D G +S + D G
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPD-------------GLGKSLLTGDYIP--G 218
Query: 659 PGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ H APE + + K D++S ++L +L G
Sbjct: 219 -----------------TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 13/178 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L LDL+NN ++ S ++L L L N IS + L L L L++N L
Sbjct: 245 LTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLE 300
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGY-SLR 224
P ++ L++LT ++L N SD P S +Q L +N ++ + ++
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNIN 356
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDL 282
+L+ +N++S P +I + L+ T ++ ++ + L
Sbjct: 357 WLSAGHNQISDLTPLANLTRI---TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 37/182 (20%), Positives = 77/182 (42%), Gaps = 16/182 (8%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L +QL P + ++ L YL L N+++ S + ++L+ L NN +S
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD-- 345
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205
++ +L N+ L+ N ++ P L L +T + L + +++ + +V + +
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 206 SSNLINGSLPPDI--GGYSLRYLNLSYNRLS--GEIPPQFGEKIPVNATIDLSFNNLTGE 261
N+ + P G S ++++N S E+ F + + TI +G
Sbjct: 404 VKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPV----TIGKGTTTFSGT 459
Query: 262 IP 263
+
Sbjct: 460 VT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 38/186 (20%), Positives = 68/186 (36%), Gaps = 13/186 (6%)
Query: 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141
+ + + I D + E L ++ ++S + + Q+ L I
Sbjct: 2 PLGSATITQDTPINQIFTDTALAE-KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSV 200
+ + L+NL +N S+N L P L L L + + NN +D P + ++
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNL 114
Query: 201 QVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
L L +N I + P +L L LS N +S + + N +T
Sbjct: 115 TGLTLFNNQIT-DIDPLKNLTNLNRLELSSNTISDISALSGLTSL---QQLSFG-NQVTD 169
Query: 261 EIPESN 266
P +N
Sbjct: 170 LKPLAN 175
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
LQ L N + L N + L LD+S+N +S + L NL+ L ++N ++
Sbjct: 158 LQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 212
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP--SKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
P L L +L +SL N D + + ++ LDL++N I+ +L P G L
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQIS-NLAPLSGLTKLT 268
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
L L N++S P + ++L+ N L P SN
Sbjct: 269 ELKLGANQISNISP--LAGLTALT-NLELNENQLEDISPISN 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-15
Identities = 36/176 (20%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L + + ++ ++ + L + S+ + + L ++ SNN ++
Sbjct: 29 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT 84
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLD 204
P + +L L + +++N +A L L +LT ++L NN +D P ++ L+
Sbjct: 85 P--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 140
Query: 205 LSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
LSSN I+ + G SL+ L+ N+++ P + +D+S N ++
Sbjct: 141 LSSNTIS-DISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLE-RLDISSNKVSD 191
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 39/230 (16%), Positives = 83/230 (36%), Gaps = 51/230 (22%)
Query: 490 IMYKAVLEDGTALAVRRIGE-NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL- 547
K++LE + + ++ DF+ ++++I + + + G +++
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG-IITNYDEVY 119
Query: 548 IIYDFVPNGSLAN---ARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHV-HGNL 602
IIY+++ N S+ + + C +P + I K V +++H +K++ H ++
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIKSVLNSFSYIHNEKNICHRDV 178
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
KP N+L+ + K+ DFG S K
Sbjct: 179 KPSNILMDKNGRVKLSDFGE---------------SEYMVDKKIKG-------------- 209
Query: 663 PSPSPSPSSLGGISP-YHAPESLRSIKP--NPKWDVYSFGVILLELLTGK 709
S G + + PE + K D++S G+ L +
Sbjct: 210 --------SRG--TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 47/190 (24%)
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKLI--IYDFVPNGSLANARYRKMGSSPCHLPWEARL 579
V + + L HPN++R+ G++ D + I ++ P G++ YR++
Sbjct: 60 VEIQSHLRHPNILRLYGYFH--DATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA- 112
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
+A L++ H K+ +H ++KP N+LLG+ E KI DFG S
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW---------------SV 157
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
S+R+ L G Y PE + + K D++S G
Sbjct: 158 HAPSSRRTD-----------------------LCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 700 VILLELLTGK 709
V+ E L GK
Sbjct: 195 VLCYEFLVGK 204
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 52/225 (23%)
Query: 492 YKAVLEDG---TALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEK- 546
+ V +A++ + + + + + +++ +L +P +VR+ G +
Sbjct: 353 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV---CQAEA 409
Query: 547 -LIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
+++ + G L ++ +P ++ V+ G+ +L EK VH NL
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
RNVLL N KI DFGL + + D S A
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTA----------------------------- 495
Query: 665 PSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
G P APE + K + + DV+S+GV + E L+
Sbjct: 496 ------RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 59/313 (18%), Positives = 125/313 (39%), Gaps = 81/313 (25%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550
K + ++A++ + ++ R DF + ++ + HPN++R+ G +I+
Sbjct: 66 LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125
Query: 551 DFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL 609
+++ NGSL + + RK + + + +G+A G+ +L + +VH +L RN+L+
Sbjct: 126 EYMENGSLDS--FLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180
Query: 610 GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSP 669
+++ K+ DFGL R++ D ++
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEAAYT---------------------------------- 206
Query: 670 SSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQ 718
+ GG P +PE++ K DV+S+G++L E+++ G+ V+ + +
Sbjct: 207 -TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRPSMKEAL 774
G RL + C ++L C RP ++ +
Sbjct: 266 GY-----------RL-------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 775 QALEKIPSSPSPY 787
L+K+ +P
Sbjct: 302 SILDKLIRNPGSL 314
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 81/303 (26%)
Query: 503 AVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGV---DEKLIIYDFVPNGSL 558
A++ + E + + ++ + V+A + +P++ R+ G+ +I +P G L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRL----LGICLTSTVQLITQLMPFGCL 103
Query: 559 ANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617
+ R K +L L +A+G+ +L +++ VH +L RNVL+ KI
Sbjct: 104 LDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158
Query: 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP 677
DFGL +L+ + A GG P
Sbjct: 159 TDFGLAKLLGAEEKEYHAE------------------------------------GGKVP 182
Query: 678 --YHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQGNGLLVED 726
+ A ES+ + DV+S+GV + EL+T G + L +G
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------ 236
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786
RL + + + C RP +E + K+ P
Sbjct: 237 -----RL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282
Query: 787 YLY 789
YL
Sbjct: 283 YLV 285
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 63/303 (20%), Positives = 105/303 (34%), Gaps = 81/303 (26%)
Query: 503 AVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGV---DEKLIIYDFVPNGSL 558
++ I + S + F+ + I L H ++VR+ G+ ++ ++P GSL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL----LGLCPGSSLQLVTQYLPLGSL 101
Query: 559 ANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617
+ R + P L L +A+G+ +L E VH NL RNVLL + + ++
Sbjct: 102 LDHVRQHRGALGPQLL-----LNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156
Query: 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP 677
DFG+ L+ D +P
Sbjct: 157 ADFGVADLLPPDDKQLLYS------------------------------------EAKTP 180
Query: 678 --YHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVVDELGQGNGLLVED 726
+ A ES+ K + DV+S+GV + EL+T G V D L +G
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE------ 234
Query: 727 KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786
RL + + + + C RP+ KE ++ P
Sbjct: 235 -----RL---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280
Query: 787 YLY 789
YL
Sbjct: 281 YLV 283
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 66/321 (20%), Positives = 111/321 (34%), Gaps = 87/321 (27%)
Query: 492 YKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVD 544
Y+ + +AV+ + E ++ DF + +I+K H N+VR G
Sbjct: 47 YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106
Query: 545 EKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ + + G L + R S P L L +A+ +A G +L E +H ++
Sbjct: 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 166
Query: 603 KPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
RN LL G KIGDFG+ R + S + GG A
Sbjct: 167 AARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAM------------------- 206
Query: 660 GPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV------ 710
P PE+ K D +SFGV+L E+ + G +
Sbjct: 207 ----------------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 711 --IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLP 764
V++ + G R+ + +C +++ C P
Sbjct: 251 NQEVLEFVTSGG-----------RM-------------DPPKNCPGPVYRIMTQCWQHQP 286
Query: 765 QKRPSMKEALQALEKIPSSPS 785
+ RP+ L+ +E P
Sbjct: 287 EDRPNFAIILERIEYCTQDPD 307
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 503 AVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANAR 562
++ + + + F +++KL H +LV G DE +++ +FV GSL
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT-- 101
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP------- 615
Y K + ++ W+ L++AK +A + FL E +HGN+ +N+LL + +
Sbjct: 102 YLKKNKNCINILWK--LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 616 -KIGDFGLERLVTGD 629
K+ D G+ V
Sbjct: 160 IKLSDPGISITVLPK 174
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 38/207 (18%), Positives = 70/207 (33%), Gaps = 57/207 (27%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIR--GFYWGVDEKLIIY---DFVPNGSLANARY 563
+ E + +A++VHP++V+I + + Y ++V SL ++
Sbjct: 120 AEAQAMAM-AER--QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG 176
Query: 564 RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623
+ LP + + L++LH V+ +LKP N++L + + K+ D G
Sbjct: 177 Q-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228
Query: 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES 683
+ S L G + APE
Sbjct: 229 SRIN----------------------------------------SFGYLYGTPGFQAPEI 248
Query: 684 LRSIKPNPKWDVYSFGVILLELLTGKV 710
+R+ P D+Y+ G L L
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLP 274
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 47/190 (24%)
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKLI--IYDFVPNGSLANARYRKMGSSPCHLPWEARL 579
+ + + L HPN++R+ ++ D K I + +F P G L Y+++ +
Sbjct: 65 IEIQSHLRHPNILRMYNYFH--DRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSAT 118
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
+ + +A L + HE+K +H ++KP N+L+G E KI DFG S
Sbjct: 119 FMEE-LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW---------------SV 162
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
+R T + G Y PE + + K D++ G
Sbjct: 163 HAPSLRRRT-----------------------MCGTLDYLPPEMIEGKTHDEKVDLWCAG 199
Query: 700 VILLELLTGK 709
V+ E L G
Sbjct: 200 VLCYEFLVGM 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 65/321 (20%), Positives = 110/321 (34%), Gaps = 87/321 (27%)
Query: 492 YKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVD 544
Y+ + +AV+ + E ++ DF + +I+K H N+VR G
Sbjct: 88 YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147
Query: 545 EKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ + + G L + R S P L L +A+ +A G +L E +H ++
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 207
Query: 603 KPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
RN LL G KIGDFG+ R + + GG A
Sbjct: 208 AARNCLLTCPGPGRVAKIGDFGMARDIY-RAGYYRKGGCAM------------------- 247
Query: 660 GPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV------ 710
P PE+ K D +SFGV+L E+ + G +
Sbjct: 248 ----------------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 711 --IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLP 764
V++ + G R+ + +C +++ C P
Sbjct: 292 NQEVLEFVTSGG-----------RM-------------DPPKNCPGPVYRIMTQCWQHQP 327
Query: 765 QKRPSMKEALQALEKIPSSPS 785
+ RP+ L+ +E P
Sbjct: 328 EDRPNFAIILERIEYCTQDPD 348
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 54/232 (23%)
Query: 492 YKAVLEDG----TALAVR--RIGENSVDRFRDFETQVRVIAKLVHPNLVR-----IRGFY 540
+ L+ +AV+ ++ +S +F ++ + HPN++R I
Sbjct: 51 MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110
Query: 541 WGVDEKLIIYDFVPNGSLANA-RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
G+ + ++I F+ G L Y ++ + P H+P + LK +A G+ +L + +H
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+L RN +L +DM + DFGL + + S D ++
Sbjct: 171 RDLAARNCMLRDDMTVCVADFGLSKKI----------------------YSGDYYRQGRI 208
Query: 660 GPSP----SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
P + ESL K DV++FGV + E+ T
Sbjct: 209 AKMPVKWIAI----------------ESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 44/234 (18%), Positives = 72/234 (30%), Gaps = 52/234 (22%)
Query: 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
I +L + R+ L I +A + FLH K +H +LKP N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLED--REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSP 667
D K+GDFGL + D
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVL------------------------TPMPAYA 231
Query: 668 SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG------KVIVVDELGQGNG 721
+ + G Y +PE + + K D++S G+IL ELL +V ++ ++
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK- 290
Query: 722 LLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
F K + SP P +RP + ++
Sbjct: 291 ----------------FPLLFTQKYPQE---HMMVQDMLSPSPTERPEATDIIE 325
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 70/319 (21%), Positives = 120/319 (37%), Gaps = 96/319 (30%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEK--LIIYDF 552
+D +AV+ + + ++ +DF+ + ++ L H ++V+ FY GV D ++++++
Sbjct: 43 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK---FY-GVCGDGDPLIMVFEY 98
Query: 553 VPNGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+ +G L + + L L IA +A G+ +L + VH +
Sbjct: 99 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLG 658
L RN L+G ++ KIGDFG+ R V T + GG R
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHT-----MLPIRWMP--------- 203
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV------- 710
PES+ K + DV+SFGVIL E+ T GK
Sbjct: 204 ----------------------PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 711 -IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQ 765
V++ + QG L E C + + C PQ
Sbjct: 242 TEVIECITQGR-----------VL-------------ERPRVCPKEVYDVMLGCWQREPQ 277
Query: 766 KRPSMKEALQALEKIPSSP 784
+R ++KE + L + +
Sbjct: 278 QRLNIKEIYKILHALGKAT 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 6e-18
Identities = 33/221 (14%), Positives = 64/221 (28%), Gaps = 47/221 (21%)
Query: 501 ALAVRRI-GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV----PN 555
L +R + G + + + + + P ++ + ++ F
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 556 GSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
+L S+ L ARL++ V R LA LH VH L+P +++L
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLG 673
+ F G+ + G G +P P
Sbjct: 249 GVFLTGFEH----------------LVRDGASAVSPI-------GRGFAP-PE------- 277
Query: 674 GISPYHAPESLRSIKPNPKW-----DVYSFGVILLELLTGK 709
A L + +P D ++ G+ + +
Sbjct: 278 ----TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 53/224 (23%)
Query: 491 MYKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEK--L 547
+Y + A+A++ + D R F + + + HP++V++ G + E
Sbjct: 35 IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVW 91
Query: 548 IIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
II + G L + + RK L + A ++ LA+L K+ VH ++ RN
Sbjct: 92 IIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLESKRFVHRDIAARN 146
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSP 663
VL+ ++ K+GDFGL R + T + G K + A
Sbjct: 147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-------KLPIKWMA-------------- 185
Query: 664 SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
PES+ + DV+ FGV + E+L
Sbjct: 186 -----------------PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 48/198 (24%), Positives = 75/198 (37%), Gaps = 50/198 (25%)
Query: 522 VRVIAKLVHPNLVRIRG-FYWGVDEKLIIY-DFVPNGSLANA--RYRKMGSSPCHLPWEA 577
V ++ +L HPN+VR + L I ++ G LA+ + K +L E
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ---YLDEEF 112
Query: 578 RLKIAKGVARGLAFLHEKKH-----VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
L++ + L H + +H +LKP NV L K+GDFGL
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL---------- 162
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNP 691
AR S A + +G +PY+ +PE + + N
Sbjct: 163 ------ARILNHDTSFAK-------------------TFVG--TPYYMSPEQMNRMSYNE 195
Query: 692 KWDVYSFGVILLELLTGK 709
K D++S G +L EL
Sbjct: 196 KSDIWSLGCLLYELCALM 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 48/203 (23%), Positives = 76/203 (37%), Gaps = 48/203 (23%)
Query: 510 NSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKL-IIYDFVPNGSLANARYRKM 566
+ + DF +V + L H NL+R+ +GV + ++ + P GSL + +
Sbjct: 60 SQPEAMDDFIREVNAMHSLDHRNLIRL----YGVVLTPPMKMVTELAPLGSLLD--RLR- 112
Query: 567 GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
H + A VA G+ +L K+ +H +L RN+LL KIGDFGL R +
Sbjct: 113 -KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH--APESL 684
+ P+ APESL
Sbjct: 172 PQNDDHYVM-----------------------------------QEHRKVPFAWCAPESL 196
Query: 685 RSIKPNPKWDVYSFGVILLELLT 707
++ + D + FGV L E+ T
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 30/170 (17%), Positives = 53/170 (31%), Gaps = 27/170 (15%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
LQ L +S N L + +L S L L + +N I L N+ + + N L
Sbjct: 104 LQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 167 GKLPVSLTTLQ--SLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYS 222
L + + + ++ L L N I ++ +
Sbjct: 161 -NSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSK 218
Query: 223 LRYLNLSYNRLSGEIPPQFGEKIPVNA--------TIDLSFNNLTGEIPE 264
L L L +N++ I + + L N L+ +P
Sbjct: 219 LYRLGLGHNQIR---------MIENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 32/176 (18%), Positives = 66/176 (37%), Gaps = 18/176 (10%)
Query: 107 LQYLDLSNNSL-NGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
+ +++ N L N F+ +L L +S ++ +P+ L L+L N +
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 166 AGKLPV-SLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG- 220
+ + L L + L +N +G S +++ L L +N ++ +P +
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263
Query: 221 YSLRYLNLSYNRLSGEIPP------QFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
L+ + L N ++ ++ FG K I L N + + F
Sbjct: 264 KLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 33/169 (19%), Positives = 64/169 (37%), Gaps = 21/169 (12%)
Query: 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ + S+ L ++ + LDL NN IS + L +L L L +N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSL 223
+ + + L+ L + + N+ + P+ +S+ L + N I +P + G ++
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNM 149
Query: 224 RYLNLSYNRLSGEIPPQFGEKIPVNA-------TIDLSFNNLTGEIPES 265
+ + N L A + +S LT IP+
Sbjct: 150 NCIEMGGNPLE-------NSGFEPGAFDGLKLNYLRISEAKLT-GIPKD 190
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 25/131 (19%), Positives = 40/131 (30%), Gaps = 23/131 (17%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L L L +N + + LR L L NN +S +P + L LQ++ L N
Sbjct: 219 LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN- 275
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSD-GLPSKFNSVQVLDLSSNLI-NGSLPPDI--GGY 221
I + N F G K + L +N + + P
Sbjct: 276 ---------------ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 222 SLRYLNLSYNR 232
+ +
Sbjct: 321 DRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 14/79 (17%), Positives = 29/79 (36%), Gaps = 10/79 (12%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-------NASQLRNLDLSNNLISGHL- 145
L +PA L ++ LQ + L N++ + + F + + L NN +
Sbjct: 253 LSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311
Query: 146 -PETMGSLHNLQLLNLSDN 163
P T + + + +
Sbjct: 312 QPATFRCVTDRLAIQFGNY 330
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 41/224 (18%), Positives = 87/224 (38%), Gaps = 53/224 (23%)
Query: 491 MYKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEK--L 547
+Y + +AV+ ++ + F ++ ++ L HP++V++ G ++E+
Sbjct: 32 VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI---IEEEPTW 88
Query: 548 IIYDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
II + P G L + Y + +S L + + + + +A+L VH ++ RN
Sbjct: 89 IIMELYPYGELGH--YLERNKNS---LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143
Query: 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---RSTASRDSFQDLGPGPSP 663
+L+ + K+GDFGL R + + + + +
Sbjct: 144 ILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWM--------------- 181
Query: 664 SPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707
+PES+ + DV+ F V + E+L+
Sbjct: 182 ----------------SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 31/164 (18%), Positives = 67/164 (40%), Gaps = 8/164 (4%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L L +L + +L + L L L + I+ + L+ L++L +S
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSNLINGSLPPDI--GGY 221
+ + +LT +S+ + + ++ L+LS N I+ ++ +
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELL 272
Query: 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
L+ + L +L+ + P + +++S N LT + ES
Sbjct: 273 RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEES 314
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 37/171 (21%), Positives = 64/171 (37%), Gaps = 9/171 (5%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153
++P + + LDL N + + L L+L+ N++S P +L
Sbjct: 23 FVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLI 210
NL+ L L N L T L +LT + + N L F +++ L++ N +
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 211 NGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ G SL L L L+ IP + + + L N+
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 10/164 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ L++ +N L +S F+ + L L L ++ E + LH L +L L +
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLINGSLPPDI--GG 220
S L L ++ + + + D + ++ L ++ + ++P
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247
Query: 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
LR+LNLSYN +S I ++ I L L +
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEP 289
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 28/134 (20%), Positives = 57/134 (42%), Gaps = 8/134 (5%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE-TMGSLHNLQLLNLSDNAL 165
L+ L++S+ +++ + L +L +++ ++ +P + L L+ LNLS N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 166 AGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDI--GG 220
+ L L L + L N ++VL++S N + +L +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSV 319
Query: 221 YSLRYLNLSYNRLS 234
+L L L N L+
Sbjct: 320 GNLETLILDSNPLA 333
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQ-----VRVIAKLVHPNLVRIR 537
G+ G EDG ++ I ++ R E + V V+A + HPN+V+ R
Sbjct: 35 GSFGK--AILVKSTEDGRQYVIKEI---NISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ I+ D+ G L + G + L + L +H++K
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDRKI 146
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H ++K +N+ L D ++GDFG+ AR S A
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGI----------------ARVLNSTVELAR------- 183
Query: 658 GPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ +G +PY+ +PE + N K D+++ G +L EL T K
Sbjct: 184 ------------ACIG--TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 63/323 (19%), Positives = 112/323 (34%), Gaps = 91/323 (28%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554
+ +AV+ + ++ ++++V++ L H N+V + G L+I ++
Sbjct: 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110
Query: 555 NGSL-------------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
G L + M L E L + VA+G+AFL K +H +
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
L RN+LL + KI DFGL R + D++ G
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKG------------------------- 205
Query: 662 SPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV-------- 710
P APES+ + + DV+S+G+ L EL + G
Sbjct: 206 -----------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 711 -IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQ 765
+ +G R+ + + + +C P
Sbjct: 255 SKFYKMIKEGF-----------RM-------------LSPEHAPAEMYDIMKTCWDADPL 290
Query: 766 KRPSMKEALQALEKIPSSPSPYL 788
KRP+ K+ +Q +EK S + ++
Sbjct: 291 KRPTFKQIVQLIEKQISESTNHI 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 73/328 (22%), Positives = 120/328 (36%), Gaps = 94/328 (28%)
Query: 492 YKAVLEDG---TALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEK 546
KA ++ A++R+ E + RDF ++ V+ KL HPN++ + G
Sbjct: 42 LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101
Query: 547 LIIYDFVPNGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ ++ P+G+L + + S+ L + L A VARG+ +L +K
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+ +H +L RN+L+G + KI DFGL R R
Sbjct: 162 QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR--------------- 202
Query: 656 DLGPGPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV-- 710
L P A ESL DV+S+GV+L E+++ G
Sbjct: 203 -L-------------------PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 711 ------IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCA 760
+ ++L QG RL E L+C + L C
Sbjct: 243 CGMTCAELYEKLPQGY-----------RL-------------EKPLNCDDEVYDLMRQCW 278
Query: 761 SPLPQKRPSMKEALQALEKIPSSPSPYL 788
P +RPS + L +L ++ Y+
Sbjct: 279 REKPYERPSFAQILVSLNRMLEERKTYV 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 40/234 (17%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNL--VRIRG 538
+G+ GSS +++ + E A++ + D + ++ + KL + +R+
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ ++ + N L + +K S PWE + K + + +H+ V
Sbjct: 77 YEITDQYIYMVMECG-NIDLNS-WLKKKKSID---PWERK-SYWKNMLEAVHTIHQHGIV 130
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +LKP N L+ + M K+ DFG+ + DT+S +DS +G
Sbjct: 131 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV----------------KDSQ--VG 171
Query: 659 PGPSPSPSP---SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ P ++ K +PK DV+S G IL + GK
Sbjct: 172 -------TVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 29/204 (14%), Positives = 57/204 (27%), Gaps = 32/204 (15%)
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGF---YWGVDEKLIIYDFVPNGSLANARYRK 565
+ F ++ ++R+R W + + N
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 566 MGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625
S+ L ARL++ V R LA LH VH L+P +++L + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--- 252
Query: 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR 685
G++ ++ S P L + R
Sbjct: 253 -------------LVRDGARVVSSV-------------SRGFEPPELEARRATISYHRDR 286
Query: 686 SIKPNPKWDVYSFGVILLELLTGK 709
+D ++ G+++ +
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 54/225 (24%), Positives = 84/225 (37%), Gaps = 48/225 (21%)
Query: 492 YKAVLEDG----TALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK 546
Y L D AV+ + + F T+ ++ HPN++ + G +
Sbjct: 42 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101
Query: 547 -LIIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
L++ ++ +G L N R + L + VA+G+ +L KK VH +L
Sbjct: 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLASKKFVHRDLAA 156
Query: 605 RNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPS 664
RN +L K+ DFGL R + S +
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-------------------------- 190
Query: 665 PSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
G P A ESL++ K K DV+SFGV+L EL+T
Sbjct: 191 --------GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 65/311 (20%), Positives = 113/311 (36%), Gaps = 91/311 (29%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG--------FYWGV 543
G +AV+ I ++ + F + V+ +L H NLV++ G Y
Sbjct: 210 MLGDYR-GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--- 263
Query: 544 DEKLIIYDFVPNGSLANARY-RKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
I+ +++ GSL + Y R G L + LK + V + +L VH +L
Sbjct: 264 ----IVTEYMAKGSLVD--YLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RNVL+ D K+ DFGL + + + K K +
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-------LPVKWT--------------- 353
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV--------IVV 713
APE+LR K + K DV+SFG++L E+ + G+V VV
Sbjct: 354 -----------------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
Query: 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773
+ +G ++ + + + + + +C RP+ +
Sbjct: 397 PRVEKGY-----------KM---------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436
Query: 774 LQALEKIPSSP 784
+ LE I +
Sbjct: 437 REQLEHIRTHE 447
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 40/234 (17%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNL--VRIRG 538
+G+ GSS +++ + E A++ + D + ++ + KL + +R+
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ ++ + N L + +K S PWE + K + + +H+ V
Sbjct: 96 YEITDQYIYMVMECG-NIDLNS-WLKKKKSID---PWERK-SYWKNMLEAVHTIHQHGIV 149
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +LKP N L+ + M K+ DFG+ + DT+S +DS +G
Sbjct: 150 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV----------------KDSQ--VG 190
Query: 659 PGPSPSPSP---SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ P ++ K +PK DV+S G IL + GK
Sbjct: 191 -------TVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 10/140 (7%)
Query: 497 EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556
+D +AV+ + E S +DF+ + ++ L H ++VR G L++++++ +G
Sbjct: 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 128
Query: 557 SL----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606
L A +P L L +A VA G+ +L VH +L RN
Sbjct: 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188
Query: 607 VLLGNDMEPKIGDFGLERLV 626
L+G + KIGDFG+ R +
Sbjct: 189 CLVGQGLVVKIGDFGMSRDI 208
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 21/154 (13%)
Query: 94 LGSIPADLGMIEF--LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMG 150
+ +IP L L L L N + + + + L L LS N IS ++
Sbjct: 183 ITTIPQGL----PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---------DGLPSKFNSVQ 201
+ +L+ L+L++N L K+P L + + +V L NN S G +K S
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 202 VLDLSSNLIN-GSLPPDI--GGYSLRYLNLSYNR 232
+ L SN + + P Y + L +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 39/196 (19%), Positives = 73/196 (37%), Gaps = 21/196 (10%)
Query: 94 LGSIPADLGMIEF--LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI-SGHLPE-TM 149
L +P + LQ L + N + +Q+ ++L N + S +
Sbjct: 112 LKELPEKM----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLS 206
+ L + ++D + +P L SLT + L N N++ L LS
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
N I+ ++ LR L+L+ N+L ++P + + L NN++ I
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD-HKYIQVVYLHNNNIS-AIG- 279
Query: 265 SNVFMNQESSSFSGNL 280
SN F ++ +
Sbjct: 280 SNDFCPPGYNTKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 39/171 (22%), Positives = 62/171 (36%), Gaps = 24/171 (14%)
Query: 106 FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ + S+ L + L LDL NN I+ +L NL L L +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK-FNSVQVLDLSSNLINGSLPPDI--GGYS 222
+ P + L L + L N + LP K ++Q L + N I + + G
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 223 LRYLNLSYNRLSGEIPPQFGEKIPVNA--------TIDLSFNNLTGEIPES 265
+ + L N L I A I ++ N+T IP+
Sbjct: 147 MIVVELGTNPLK-------SSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 189
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 14/187 (7%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
+ L +P + + L+L N + S + L L LS N I
Sbjct: 51 VRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF 108
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLS 206
L NL L L DN L + L L + L+NN ++ S++ LDL
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168
Query: 207 S-NLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIP 263
++ + G +LRYLNL+ L EIP + +DLS N+L+ I
Sbjct: 169 ELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLS-AIR 223
Query: 264 ESNVFMN 270
F
Sbjct: 224 P-GSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 14/160 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLS-NNLISGHLPETM-GSLHNLQLLNLSDN 163
L+ L L NN + S+ FN LR LDL +S ++ E L NL+ LNL+
Sbjct: 138 LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMC 195
Query: 164 ALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDI-- 218
L ++P +LT L L + L N G +Q L + + I + +
Sbjct: 196 NLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
Query: 219 GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNL 258
SL +NL++N L+ +P + I L N
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 10/145 (6%)
Query: 94 LGSIPADL-GMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGS 151
+ SIP+ I L+ LDL +S F S LR L+L+ + +P +
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTP 205
Query: 152 LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSN 208
L L L+LS N L+ P S L L + + + S+ ++L+ N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 209 LINGSLPPDI--GGYSLRYLNLSYN 231
+ LP D+ + L ++L +N
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 31/128 (24%), Positives = 56/128 (43%), Gaps = 8/128 (6%)
Query: 86 LALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143
L L + L I G+ L+YL+L+ +L + + +L LDLS N +S
Sbjct: 165 LDLGELKRLSYISEGAFEGLSN-LRYLNLAMCNLREIPNLT--PLIKLDELDLSGNHLSA 221
Query: 144 HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSV 200
P + L +LQ L + + + + LQSL ++L +N + L + + +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281
Query: 201 QVLDLSSN 208
+ + L N
Sbjct: 282 ERIHLHHN 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 38/183 (20%), Positives = 64/183 (34%), Gaps = 42/183 (22%)
Query: 528 LVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVA 586
L HP+++ + ++ + ++ + NG + R + + EAR +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQII 122
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G+ +LH +H +L N+LL +M KI DFGL + K
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-------------HEKH 169
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
T L G Y +PE + DV+S G + LL
Sbjct: 170 YT-----------------------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
Query: 707 TGK 709
G+
Sbjct: 207 IGR 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 60/325 (18%), Positives = 110/325 (33%), Gaps = 82/325 (25%)
Query: 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY 540
ILG S + G +AV+R+ +D +++++ + HPN++R
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 541 WGVDEKLIIYDFVPNGSLAN---ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
I + N +L + ++ + + + + +A G+A LH K
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSLKI 136
Query: 598 VHGNLKPRNVLL-------------GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+H +LKP+N+L+ ++ I DFGL
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL---------------------C 175
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-------KPNPKWDVYS 697
K+ + + SF+ PS + + APE L + D++S
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSG-----------WRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 698 FGVILLELLTGKVIVVDELGQ---GNGLLVEDK--NRAIRLADAAIRADFEGKEEA--LL 750
G + +L+ G+ G+ E L + D EA L+
Sbjct: 225 MGCVFYYILSK--------GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLI 276
Query: 751 SCFKLGYSCASPLPQKRPSMKEALQ 775
S P KRP+ + L+
Sbjct: 277 S------QMIDHDPLKRPTAMKVLR 295
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 52/232 (22%), Positives = 85/232 (36%), Gaps = 48/232 (20%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
G G +Y L + +A++ I E + ++ + L H N+V+ G +
Sbjct: 33 GTYGI--VYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVHGN 601
I + VP GSL+ K G + E + K + GL +LH+ + VH +
Sbjct: 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 602 LKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+K NVL+ KI DFG SKR
Sbjct: 148 IKGDNVLINTYSGVLKISDFGT---------------------SKRLAGI---------- 176
Query: 661 PSPSPSPSPSSLGGISPYH-APESLRSIKP--NPKWDVYSFGVILLELLTGK 709
+P + G + + APE + D++S G ++E+ TGK
Sbjct: 177 -----NPCTETFTG-TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 13/166 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L L L +N L + + F + L LDLS+N + L L L+L
Sbjct: 58 LTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 165 LAGKLPV-SLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLSSNLINGSLPPDI-- 218
L +L L +L + L++N D ++ L L N I+ S+P
Sbjct: 117 LQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFR 174
Query: 219 GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
G +SL L L NR++ + P + T+ L NNL+ +P
Sbjct: 175 GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 42/195 (21%), Positives = 71/195 (36%), Gaps = 28/195 (14%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
Q L ++P + Q + L N ++ + S L L L +N+++
Sbjct: 19 PQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 150 GSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDL 205
L L+ L+LSDNA + + L L + L GL ++Q L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 206 SSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNA--------TIDLSF 255
N + +LP D +L +L L NR+S +P A + L
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS---------SVPERAFRGLHSLDRLLLHQ 186
Query: 256 NNLTGEIPESNVFMN 270
N + + + F +
Sbjct: 187 NRVA-HVHP-HAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 38/144 (26%), Positives = 59/144 (40%), Gaps = 31/144 (21%)
Query: 94 LGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETM- 149
L + L G+ LQYL L +N+L +L F + L +L L N IS +PE
Sbjct: 117 LQELGPGLFRGLAA-LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAF 173
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNL 209
LH+L L L N + + + F L + L L +N
Sbjct: 174 RGLHSLDRLLLHQNR----------------VAHVHPHAF-RDLG----RLMTLYLFANN 212
Query: 210 INGSLPPDI--GGYSLRYLNLSYN 231
++ +LP + +L+YL L+ N
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/60 (30%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L L L N + + F + +L L L N +S E + L LQ L L+DN
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 49/224 (21%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554
+ +AV+ + + +++++++ L H N+V + G L+I ++
Sbjct: 74 DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 555 NGSLAN---------ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPR 605
G L N + L + VA+G+AFL K +H ++ R
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 606 NVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSP 665
NVLL N KIGDFGL R + D S+ G+AR L
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNAR----------------L-------- 228
Query: 666 SPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
P APES+ + DV+S+G++L E+ +
Sbjct: 229 -----------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/314 (19%), Positives = 123/314 (39%), Gaps = 74/314 (23%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554
++ +AV+ + +++ ++ D +++ ++ + H N++ + G +I ++
Sbjct: 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 555 NGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
G+L Y + ++ + +ARG+ +L +K +H +L
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RNVL+ + KI DFGL R + + K + R L
Sbjct: 185 ARNVLVTENNVMKIADFGLARDIN-NIDYYKKTTNGR----------------L------ 221
Query: 664 SPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV----IVVDEL 716
P APE+L + DV+SFGV++ E+ T G I V+EL
Sbjct: 222 -------------PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776
+ L+++ +R + + + C +P +RP+ K+ ++
Sbjct: 269 FK----LLKEGHR------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 777 LEKI--PSSPSPYL 788
L++I ++ YL
Sbjct: 313 LDRILTLTTNEEYL 326
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 48/194 (24%), Positives = 73/194 (37%), Gaps = 45/194 (23%)
Query: 518 FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPW 575
++ + L H ++V GF+ D ++ + SL R + +
Sbjct: 88 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------EP 141
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
EAR + + G +LH + +H +LK N+ L D+E KIGDFGL V D
Sbjct: 142 EAR-YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------ 194
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G ++ L G Y APE L + + DV
Sbjct: 195 -------GERKKV-----------------------LCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 696 YSFGVILLELLTGK 709
+S G I+ LL GK
Sbjct: 225 WSIGCIMYTLLVGK 238
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 64/226 (28%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRG--------FYWGV 543
G +AV+ I ++ + F + V+ +L H NLV++ G Y
Sbjct: 38 MLGDYR-GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--- 91
Query: 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
I+ +++ GSL + Y + L + LK + V + +L VH +L
Sbjct: 92 ----IVTEYMAKGSLVD--YLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RNVL+ D K+ DFGL ++++
Sbjct: 145 ARNVLVSEDNVAKVSDFGL---------------------------TKEASS-------- 169
Query: 664 SPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
+ G P APE+LR K + K DV+SFG++L E+ +
Sbjct: 170 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 59/302 (19%), Positives = 109/302 (36%), Gaps = 54/302 (17%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNL--VRIRG 538
+G+ GSS +++ + E A++ + D + ++ + KL + +R+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ ++ + N L + +K S PWE + K + + +H+ V
Sbjct: 124 YEITDQYIYMVMECG-NIDLNS-WLKKKKSID---PWERK-SYWKNMLEAVHTIHQHGIV 177
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +LKP N L+ + M K+ DFG+ + DT+S +DS +G
Sbjct: 178 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV----------------KDSQ--VG 218
Query: 659 PGPSPSPSP---SPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
+ P ++ K +PK DV+S G IL + GK
Sbjct: 219 -------AVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------ 264
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPSMKEA 773
+ I A I + E + + + C P++R S+ E
Sbjct: 265 ------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 774 LQ 775
L
Sbjct: 319 LA 320
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/185 (25%), Positives = 70/185 (37%), Gaps = 45/185 (24%)
Query: 527 KLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKG 584
L H ++V GF+ D ++ + SL R + + EAR +
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------EPEAR-YYLRQ 123
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ G +LH + +H +LK N+ L D+E KIGDFGL V D G
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-------------GE 170
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
++ L G Y APE L + + DV+S G I+
Sbjct: 171 RKKV-----------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207
Query: 705 LLTGK 709
LL GK
Sbjct: 208 LLVGK 212
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 51/222 (22%)
Query: 492 YKAVLEDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVDEK--LI 548
Y + A+A++ + D R F + + + HP++V++ G + E I
Sbjct: 411 YMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVWI 467
Query: 549 IYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
I + G L + + RK L + A ++ LA+L K+ VH ++ RNV
Sbjct: 468 IMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLESKRFVHRDIAARNV 522
Query: 608 LLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSP 667
L+ ++ K+GDFGL R + D++ KA
Sbjct: 523 LVSSNDCVKLGDFGLSRYME-DSTYYKAS------------------------------- 550
Query: 668 SPSSLGGISP--YHAPESLRSIKPNPKWDVYSFGVILLELLT 707
G P + APES+ + DV+ FGV + E+L
Sbjct: 551 -----KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 70/321 (21%), Positives = 107/321 (33%), Gaps = 87/321 (27%)
Query: 492 YKAVLEDG----TALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK 546
Y L D AV+ + + F T+ ++ HPN++ + G +
Sbjct: 106 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165
Query: 547 -LIIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
L++ ++ +G L N R + L + VA+G+ FL KK VH +L
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFLASKKFVHRDLAA 220
Query: 605 RNVLLGNDMEPKIGDFGLERLV-TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RN +L K+ DFGL R + + S
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-------------------------- 254
Query: 664 SPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLTGKVI---------V 712
G P A ESL++ K K DV+SFGV+L EL+T +
Sbjct: 255 ---------GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305
Query: 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC----FKLGYSCASPLPQKRP 768
L QG RL C +++ C P + RP
Sbjct: 306 TVYLLQGR-----------RL-------------LQPEYCPDPLYEVMLKCWHPKAEMRP 341
Query: 769 SMKEALQALEKIPSSPSPYLY 789
S E + + I S+ Y
Sbjct: 342 SFSELVSRISAIFSTFIGEHY 362
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 52/227 (22%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKL-IIYDFV 553
+AV+ + E + R ++++++ + H N+V + G L +I +F
Sbjct: 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 114
Query: 554 PNGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
G+L + L E + + VA+G+ FL +K +H +L
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RN+LL KI DFGL R + G AR L
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDAR----------------L----- 212
Query: 663 PSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
P APE++ + DV+SFGV+L E+ +
Sbjct: 213 --------------PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 65/309 (21%), Positives = 119/309 (38%), Gaps = 72/309 (23%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554
T +AV+ + ++ ++ D +++ ++ + H N++ + G +I ++
Sbjct: 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 158
Query: 555 NGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLK 603
G+L Y + L + + A VARG+ +L KK +H +L
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218
Query: 604 PRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RNVL+ D KI DFGL R + K + R L
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGR----------------L------ 255
Query: 664 SPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV----IVVDEL 716
P APE+L + DV+SFGV+L E+ T G + V+EL
Sbjct: 256 -------------PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776
+ L+++ +R + + + C +P +RP+ K+ ++
Sbjct: 303 FK----LLKEGHR------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 777 LEKIPSSPS 785
L++I + S
Sbjct: 347 LDRIVALTS 355
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 12/186 (6%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
+ L +P + +YL+L N++ + + + L L L N I
Sbjct: 62 TRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLS 206
L +L L L DN L + L L + L+NN ++ S+ LDL
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
+ G ++L+YLNL + ++ P + +++S N+ EI
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM-PNL-TPLVGLEELEMSGNHFP-EIRP 235
Query: 265 SNVFMN 270
F
Sbjct: 236 -GSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 15/174 (8%)
Query: 94 LGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSN-NLISGHLPETM 149
L IP+ + + L+ L L NN + S+ FN L LDL +
Sbjct: 135 LTVIPSGAFEYLSK-LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 150 GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVLDLS 206
L NL+ LNL + +P +LT L L + + N G +S++ L +
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNL 258
++ ++ + + G SL LNL++N LS +P + + L N
Sbjct: 251 NSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 8/128 (6%)
Query: 86 LALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143
L L + L I G+ L+YL+L ++ + + L L++S N
Sbjct: 176 LDLGELKKLEYISEGAFEGLFN-LKYLNLGMCNIKDMPNLT--PLVGLEELEMSGNHFPE 232
Query: 144 HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSV 200
P + L +L+ L + ++ ++ + L SL ++L +N S L + +
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292
Query: 201 QVLDLSSN 208
L L N
Sbjct: 293 VELHLHHN 300
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 6e-16
Identities = 48/239 (20%), Positives = 88/239 (36%), Gaps = 50/239 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGF 539
LG G + + + + G +A+++ + + R+ + +++++ KL HPN+V R
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 540 Y------WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
D L+ ++ G L Y + C L + ++ L +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRK--YLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 594 EKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
E + +H +LKP N++L + KI D G + + ++ G+
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT------------ 186
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
Y APE L K D +SFG + E +TG
Sbjct: 187 --------L-----------------QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 50/226 (22%)
Query: 492 YKAVLEDG----TALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDE- 545
Y D A++ + + + F + ++ L HPN++ + G +
Sbjct: 38 YHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97
Query: 546 KLIIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
++ ++ +G L R + + L + VARG+ +L E+K VH +L
Sbjct: 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYLAEQKFVHRDLAA 152
Query: 605 RNVLLGNDMEPKIGDFGLERLV-TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSP 663
RN +L K+ DFGL R + + S + AR
Sbjct: 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR----------------------- 189
Query: 664 SPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
P A ESL++ + K DV+SFGV+L ELLT
Sbjct: 190 ------------LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 7e-16
Identities = 46/238 (19%), Positives = 79/238 (33%), Gaps = 49/238 (20%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
G + A G + VRRI S + + ++ V HPN+V R +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 541 WGVDEKL-IIYDFVPNGSLAN-ARYRKMGSSPCHLPWEARLKIA---KGVARGLAFLHEK 595
D +L ++ F+ GS + M E IA +GV + L ++H
Sbjct: 96 I-ADNELWVVTSFMAYGSAKDLICTHFMDGMN-----EL--AIAYILQGVLKALDYIHHM 147
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+VH ++K ++L+ D + + S G ++
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLR----SNLSMISH---------GQRQRVVHDFPKY 194
Query: 656 DLGPGPSPSPSPSPSSLGGISPY-HAPESLRSIKP--NPKWDVYSFGVILLELLTGKV 710
+ +PE L+ + K D+YS G+ EL G V
Sbjct: 195 SVK-----------------VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 12/147 (8%)
Query: 492 YKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGVD 544
Y+ V E T +A++ + E + R R +F + V+ + ++VR+ G
Sbjct: 42 YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101
Query: 545 EKLIIYDFVPNGSLAN---ARYRKMGSSPCHLPWEAR--LKIAKGVARGLAFLHEKKHVH 599
L+I + + G L + + M ++P P +++A +A G+A+L+ K VH
Sbjct: 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLV 626
+L RN ++ D KIGDFG+ R +
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMTRDI 188
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 51/241 (21%), Positives = 88/241 (36%), Gaps = 66/241 (27%)
Query: 492 YKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGV- 543
YK L E A+A++ + + + R +F + + A+L HPN+V + GV
Sbjct: 26 YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL----LGVV 81
Query: 544 -DEK--LIIYDFVPNGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGL 589
++ +I+ + +G L + L + + +A G+
Sbjct: 82 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 590 AFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK---R 646
+L VH +L RNVL+ + + KI D GL R V K G S R
Sbjct: 142 EYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-AADYYKLLG-----NSLLPIR 195
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
A PE++ K + D++S+GV+L E+
Sbjct: 196 WMA-------------------------------PEAIMYGKFSIDSDIWSYGVVLWEVF 224
Query: 707 T 707
+
Sbjct: 225 S 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 49/244 (20%), Positives = 79/244 (32%), Gaps = 55/244 (22%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGF 539
ILG ++ +++ + G A++ S R D + V+ KL H N+V++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 540 YWGVDEKLI--IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ I +F P GSL + S+ LP L + + V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYT--VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 598 VHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
VH N+KP N++ + K+ DFG R + D G+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT--------------- 178
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP--------NPKWDVYSFGVILLEL 705
Y P+ D++S GV
Sbjct: 179 -----EE-----------------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 706 LTGK 709
TG
Sbjct: 217 ATGS 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 43/234 (18%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
GA+ + A +A++RI E + +++ +++ HPN+V +
Sbjct: 26 GATAV--VQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 542 GVDEKL-IIYDFVPNGSLAN---ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
V ++L ++ + GS+ + K L I + V GL +LH+
Sbjct: 84 -VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H ++K N+LLG D +I DFG+ S+ A G R T F +
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGV--------SAFLATGGDITRNKVRKT-----F--V 187
Query: 658 GPGPSPSPSPSPSSLGGISPY-HAPESLRSIKP-NPKWDVYSFGVILLELLTGK 709
G +P APE + ++ + K D++SFG+ +EL TG
Sbjct: 188 G-----------------TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 23/136 (16%), Positives = 53/136 (38%), Gaps = 13/136 (9%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
++ L ++N + + + S L L + ++ + L +L LL++S +A
Sbjct: 68 IKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 167 GKLPVSLTTLQSLTIVSL-KNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYS-- 222
+ + TL + + L N +D +P ++ L++ + ++ D G
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-----DYRGIEDF 180
Query: 223 --LRYLNLSYNRLSGE 236
L L + G+
Sbjct: 181 PKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 29/131 (22%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L Y+ L+N ++ L+ + A +++L ++N + + L NL+ L + +
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT 101
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSNLINGSLPPDIGGYSL 223
+L+ L SLT++ + ++ D + +K N V +DLS N + P L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPEL 161
Query: 224 RYLNLSYNRLS 234
+ LN+ ++ +
Sbjct: 162 KSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 17/107 (15%), Positives = 42/107 (39%), Gaps = 5/107 (4%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS-NNLISGH 144
L + + +L + L LD+S+++ + S+ + ++ ++DLS N I+
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD- 151
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
+ +L L+ LN+ + + + L + +
Sbjct: 152 -IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 25/135 (18%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 130 QLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189
N L + + T +++L + L++ + L + ++ +++ N +
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHA 78
Query: 190 SDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPV 247
++ P S ++++ L + + P++ G SL L++S++ I + V
Sbjct: 79 TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138
Query: 248 NATIDLSFNNLTGEI 262
N +IDLS+N +I
Sbjct: 139 N-SIDLSYNGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 17/121 (14%), Positives = 43/121 (35%), Gaps = 16/121 (13%)
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSN 208
+ L ++ A ++ + SLT ++L N +D G+ ++++ L +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGI-EYAHNIKDLTINNI 76
Query: 209 LINGSLPPDIGGYS----LRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
+ S L L + ++ + P + +D+S + I
Sbjct: 77 HAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNL-SGLTSLTLLDISHSAHDDSILT 130
Query: 265 S 265
Sbjct: 131 K 131
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 58/266 (21%), Positives = 97/266 (36%), Gaps = 50/266 (18%)
Query: 459 GTLVIVDGDKELELETLLKASAYILGASGS-SIMYKAV-LEDGTALAVRRIGENSVDRFR 516
G V + + L A G + +Y+A + G A++R+ N ++ R
Sbjct: 20 GQTVELGELRLRVRRVL---------AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR 70
Query: 517 DFETQVRVIAKLV-HPNLVRIRGFYWGVDEK-------LIIYDFVPNGSLANARYRKMGS 568
+V + KL HPN+V+ E+ ++ + G L +
Sbjct: 71 AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130
Query: 569 SPCHLPWEARLKIAKGVARGLAFLHEKKH--VHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
P L + LKI R + +H +K +H +LK N+LL N K+ DFG +
Sbjct: 131 GP--LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
Query: 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE--SL 684
+ S SA+ +R++ +P Y PE L
Sbjct: 189 SHYPDYSW---SAQRRALVEEEITRNT--------TP-------------MYRTPEIIDL 224
Query: 685 RSIKP-NPKWDVYSFGVILLELLTGK 709
S P K D+++ G IL L +
Sbjct: 225 YSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPET 148
+S L SIP+ L E ++ LDLSNN + +S S L+ L L++N I+ + E
Sbjct: 39 SSGSLNSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEED 94
Query: 149 M-GSLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKNNYFS----DGLPSKFNSVQV 202
SL +L+ L+LS N L+ L S L SLT ++L N + L S +Q+
Sbjct: 95 SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153
Query: 203 LDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L + + + G L L + + L P+ + I + + L
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 36/208 (17%), Positives = 74/208 (35%), Gaps = 19/208 (9%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
LQ L L++N +N ++ F++ L +LDLS N +S L +L LNL N
Sbjct: 78 LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
Query: 166 AGKLPVSL-TTLQSLTIVSLKNNYF----SDGLPSKFNSVQVLDLSSNLINGSLPPDI-- 218
SL + L L I+ + N + ++ L++ ++ + S P
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLK 195
Query: 219 GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG----EIPESNVFMNQESS 274
++ +L L + + F + ++L +L E+ + +
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS-TGETNSLIKK 253
Query: 275 SFSGNLDLCGQPTKNPCPIPSSPFDLPN 302
N+ + + + +
Sbjct: 254 FTFRNVKITDESLFQ---VMKLLNQISG 278
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 31/160 (19%), Positives = 55/160 (34%), Gaps = 16/160 (10%)
Query: 86 LALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143
L + N I G+ FL+ L++ + L SL + + +L L
Sbjct: 154 LRVGNMDTFTKIQRKDFAGL-TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212
Query: 144 HLPETMGSLHNLQLLNLSDNALAG----KLPV----SLTTLQSLTIVSLKNNYFSDGLPS 195
L + +++ L L D L +L SL + V + + +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272
Query: 196 KFN--SVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYN 231
+ L+ S N + S+P I SL+ + L N
Sbjct: 273 LNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 37/170 (21%), Positives = 63/170 (37%), Gaps = 20/170 (11%)
Query: 111 DLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLP 170
S+ SLN S+ L +++LDLSNN I+ + NLQ L L+ N +
Sbjct: 37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 171 VSLTTLQSLTIVSLKNNYFS-------DGLPSKFNSVQVLDLSSNLINGSLPPDI---GG 220
S ++L SL + L NY S L S+ L+L N +L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLS----SLTFLNLLGNPYK-TLGETSLFSHL 148
Query: 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMN 270
L+ L + +I + + +++ ++L +
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEP-KSLKS 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 45/232 (19%), Positives = 90/232 (38%), Gaps = 51/232 (21%)
Query: 491 MYKAVLEDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLI 548
+ K ++ +AV+ + +++ ++ D +++ ++ + H N++ + G +
Sbjct: 105 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164
Query: 549 IYDFVPNGSL-----------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
I ++ G+L Y + ++ + +ARG+ +L +K
Sbjct: 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H +L RNVL+ + KI DFGL R + + K + R L
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTTNGR----------------L 267
Query: 658 GPGPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
P APE+L + DV+SFGV++ E+ T
Sbjct: 268 -------------------PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 65/325 (20%), Positives = 109/325 (33%), Gaps = 88/325 (27%)
Query: 497 EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVP 554
+AV+ + E + ++++++ +L H N+V + G +I+++
Sbjct: 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132
Query: 555 NGSL------------------ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
G L N + + L +E L A VA+G+ FL K
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
VH +L RNVL+ + KI DFGL R + S+ G+AR
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSNYVVRGNAR---------------- 235
Query: 657 LGPGPSPSPSPSPSSLGGISPYH--APESLRSIKPNPKWDVYSFGVILLELLT-GKV--- 710
L P APESL K DV+S+G++L E+ + G
Sbjct: 236 L-------------------PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 711 ------IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLP 764
+ G ++ + A + + SC +
Sbjct: 277 GIPVDANFYKLIQNGF-----------KM---------DQPFYATEEIYIIMQSCWAFDS 316
Query: 765 QKRPSMKEALQALEKIPSSPSPYLY 789
+KRPS L + +Y
Sbjct: 317 RKRPSFPNLTSFLGCQLADAEEAMY 341
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 54/277 (19%)
Query: 437 GRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAVL 496
G+KL +Q +R+ + L EL+ + K S LGA +++K
Sbjct: 1 GKKLEELELDEQ----QRKRLEAFLTQKQKVGELKDDDFEKIS--ELGAGNGGVVFKVSH 54
Query: 497 -EDGTALAVRRI-GENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554
G +A + I E +++V+ + P +V G ++ E I + +
Sbjct: 55 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114
Query: 555 NGSLANARYRKMGSSPCHLPWEARL-KIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGND 612
GSL +K G P E L K++ V +GL +L EK + H ++KP N+L+ +
Sbjct: 115 GGSLDQV-LKKAGRIP-----EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 168
Query: 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSL 672
E K+ DFG V+G S A +SF
Sbjct: 169 GEIKLCDFG----VSGQLIDSMA----------------NSFV----------------- 191
Query: 673 GGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G Y +PE L+ + + D++S G+ L+E+ G+
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 30/249 (12%), Positives = 74/249 (29%), Gaps = 61/249 (24%)
Query: 483 LGASGSSIMYKAV------LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRI 536
LG + +Y+A ++ ++ + F + + + ++
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCH-LPWEARLKIAKGVARGLAFLHEK 595
+ + +++ + G+L N ++P +P + A + + +H+
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLN-AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 596 KHVHGNLKPRNVLLGNDMEP-----------KIGDFGL----ERLVTGDTSSSKAGGSAR 640
+ +HG++KP N +LGN + D G + G ++K
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE---- 247
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGV 700
+ + E L + N + D +
Sbjct: 248 ---------------------TSG-------------FQCVEMLSNKPWNYQIDYFGVAA 273
Query: 701 ILLELLTGK 709
+ +L G
Sbjct: 274 TVYCMLFGT 282
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 38/243 (15%), Positives = 77/243 (31%), Gaps = 17/243 (6%)
Query: 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLAL 88
+ + F + S + +WN + + V ++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI--RILQLVWHTTVWYFSI 254
Query: 89 PNSQLLGSIPADLGMIEF-----LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143
N +L G + L + ++ S+ S + + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 144 HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD-----GLPSKFN 198
+ L+ S+N L + + L L + L+ N + + ++
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 199 SVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
S+Q LD+S N ++ SL LN+S N L+ I +I V +DL N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKV---LDLHSN 431
Query: 257 NLT 259
+
Sbjct: 432 KIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 10/165 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ + + + S +LD SNNL++ + E G L L+ L L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 167 --GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQVLDLSSNLINGSLPPDIGG 220
K+ T ++SL + + N S S+ L++SSN++
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-DTIFRCLP 420
Query: 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
++ L+L N++ IP Q K+ ++++ N L +P+
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQLK-SVPDG 462
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 42/250 (16%), Positives = 81/250 (32%), Gaps = 21/250 (8%)
Query: 91 SQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150
L +P DL + L++S N ++ + + + S+LR L +S+N I
Sbjct: 9 KNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 151 SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD----GLPSKFNSVQVLDLS 206
L+ L+LS N L +S +L + L N F + ++ L LS
Sbjct: 67 FNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 207 SNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
+ + S I L + + E + T L T +
Sbjct: 124 TTHLEKSSVLPI--AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 267 VFMNQESSSFSGNLDLCGQPTKNPCPIPSSPF----------DLPNTTAPTSPPAIAAIP 316
+ ++ ++ + ++ N C S +L T+ + I
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 317 KSIDSTPATN 326
+ + T
Sbjct: 242 QLVWHTTVWY 251
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 14/58 (24%), Positives = 31/58 (53%), Gaps = 3/58 (5%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDN 163
++ LDL +N + S+ + L+ L++++N + +P+ + L +LQ + L N
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 34/165 (20%)
Query: 492 YKAVLEDG------TALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRGFYWGV- 543
++A T +AV+ + E + + DF+ + ++A+ +PN+V++ GV
Sbjct: 64 FQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL----LGVC 119
Query: 544 ---DEKLIIYDFVPNGSL-------------------ANARYRKMGSSPCHLPWEARLKI 581
++++++ G L + R R P L +L I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
A+ VA G+A+L E+K VH +L RN L+G +M KI DFGL R +
Sbjct: 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 34/200 (17%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPE- 147
IP +L + LDLS N L L F + +L+ LDLS I + +
Sbjct: 15 MELNFYKIPDNLPF--STKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 148 TMGSLHNLQLLNLSDN---ALAGKLPVSLTTLQSLT-----IVSLKNNYFSDGLPSKFNS 199
SL +L L L+ N +LA L++LQ L + SL+N L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI-GHLK----T 125
Query: 200 VQVLDLSSNLINGSLPPDIGGY-----SLRYLNLSYNRLSGEIPPQFGEKIP----VNAT 250
++ L+++ NLI S Y +L +L+LS N++ I + +N +
Sbjct: 126 LKELNVAHNLIQ-SFKLP--EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS 181
Query: 251 IDLSFNNLTGEIPESNVFMN 270
+DLS N + I F
Sbjct: 182 LDLSLNPMN-FIQP-GAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L L L+ N + SL+ F+ S L+ L ++ +G L L+ LN++ N +
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 166 AGKLPV-----SLTTLQSLT-----IVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLP 215
+ +LT L+ L I S+ L LDLS N +N +
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 216 PDI-GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
P L+ L L N+L +P +++ I L N
Sbjct: 194 PGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 17/165 (10%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
LQ LDLS + ++ + + S L L L+ N I L L +LQ L +
Sbjct: 54 LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYF----SDGLPSKFNSVQVLDLSSNLINGSLPPDI-- 218
LA + L++L +++ +N S +++ LDLSSN I S+
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
Query: 219 GGYSLRY----LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ + L+LS N ++ I P ++I + + L N L
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK-ELALDTNQLK 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 60/332 (18%), Positives = 100/332 (30%), Gaps = 73/332 (21%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQ-VRVIAKLVHPNLVRIRGF 539
ILG ++ +++ + G A++ S R D + + V+ KL H N+V++
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 540 Y--WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
K++I +F P GSL + S+ LP L + + V G+ L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYT--VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 598 VHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
VH N+KP N++ + K+ DFG R + D G+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE-------------- 179
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP--------NPKWDVYSFGVILLEL 705
Y P+ D++S GV
Sbjct: 180 -----------------------EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSC------ 759
TG + G V K + + A S + SC
Sbjct: 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS-GDMPVSCSLSRGL 275
Query: 760 ---ASPL--------PQKRPSMKEALQALEKI 780
+P+ +K + I
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ + +N+ + S+ + + L L+ N ++ + + + +L NL L L +N +
Sbjct: 45 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK 100
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
L SL L+ L +SL++N SD GL ++ L L +N I + L
Sbjct: 101 -DLS-SLKDLKKLKSLSLEHNGISDINGL-VHLPQLESLYLGNNKIT-DITVLSRLTKLD 156
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCG 284
L+L N++S +I P + + LS N+++ ++ N + L+L
Sbjct: 157 TLSLEDNQIS-DIVPL--AGLTKLQNLYLSKNHIS-DLRALAGLKNLDV------LELFS 206
Query: 285 QPTKNPCPIPSSPFDLPNT 303
Q N S +PNT
Sbjct: 207 QECLNKPINHQSNLVVPNT 225
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 8e-11
Identities = 56/299 (18%), Positives = 95/299 (31%), Gaps = 18/299 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L L +N ++ ++ L + QL +L L NN I+ + L L L+L DN ++
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
+ L L L + L N+ SD + ++ VL+L S +L
Sbjct: 167 -DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQ--SNLVV 222
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQ 285
N N G + + +L E + Q + G+
Sbjct: 223 PNTVKN-TDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGR 281
Query: 286 PTKNPCPIPSSPFDLPNTTAPTSPPAIAAIPKSIDSTPATNPDDGSVSKPRQEGSQGLRP 345
T+ + + +D+ T T A I T G V K G
Sbjct: 282 VTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPT-----KQGYVFKGWYTEKNG--- 333
Query: 346 GTIIGIVIGDIAGIGILAVVFFYVYRLIKRKNVESTLKKEANSAKDTVSFSPSSSSSES 404
G ++G F K N+ +K +A +S +
Sbjct: 334 GHEWNFNTDYMSGNDFTLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPREDNSLKQG 392
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 25/161 (15%), Positives = 59/161 (36%), Gaps = 25/161 (15%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRN---LDLSNNLISGHLPETMGSLHNLQLLNLSDN 163
+ + + +F +L ++ T L+++ + +++
Sbjct: 1 MGETITVSTPIK-----QIFPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS 53
Query: 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYS 222
+ + + L ++T + L N +D P + ++ L L N I D+
Sbjct: 54 DIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-----DLSSLK 106
Query: 223 ----LRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L+ L+L +N +S +I +P ++ L N +T
Sbjct: 107 DLKKLKSLSLEHNGIS-DINGL--VHLPQLESLYLGNNKIT 144
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 26/161 (16%)
Query: 492 YKAVL------EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVD 544
KA T +AV+ + EN+ RD ++ V+ ++ HP+++++ G
Sbjct: 40 VKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99
Query: 545 EKLIIYDFVPNGSL-------------------ANARYRKMGSSPCHLPWEARLKIAKGV 585
L+I ++ GSL + L + A +
Sbjct: 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626
++G+ +L E K VH +L RN+L+ + KI DFGL R V
Sbjct: 160 SQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 54/282 (19%)
Query: 433 NYHSGRKLSVDNQRQQDHV--HERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSI 490
++ SG L +N Q V HE+ +V+ GD L L++ +K G++G
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGE---GSTGI-- 60
Query: 491 MYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL-I 548
+ A G +AV+ + R +V ++ H N+V + Y V E+L +
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL-VGEELWV 119
Query: 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608
+ +F+ G+L + + + A + + V + LA+LH + +H ++K ++L
Sbjct: 120 LMEFLQGGALTDI----VSQVRLNEEQIAT--VCEAVLQALAYLHAQGVIHRDIKSDSIL 173
Query: 609 LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPS 668
L D K+ DFG S KR +
Sbjct: 174 LTLDGRVKLSDFG----FCAQISKDV---------PKRKS-------------------- 200
Query: 669 PSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
L G +PY APE + + D++S G++++E++ G+
Sbjct: 201 ---LVG-TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 49/229 (21%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
GASG+ +Y A+ + G +A+R++ + ++ V+ + +PN+V Y
Sbjct: 31 GASGT--VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL- 87
Query: 543 VDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
V ++L ++ +++ GSL + + + A + + + L FLH + +H +
Sbjct: 88 VGDELWVVMEYLAGGSLTDV----VTETCMDEGQIAA--VCRECLQALEFLHSNQVIHRD 141
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+LLG D K+ DFG + + SKRST
Sbjct: 142 IKSDNILLGMDGSVKLTDFG----FCAQITPEQ---------SKRST------------- 175
Query: 662 SPSPSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ G +PY APE + PK D++S G++ +E++ G+
Sbjct: 176 ----------MVG-TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
G+ G ++K + +A++ I E + D D + ++ V+++ P + + G Y
Sbjct: 33 GSFGE--VFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90
Query: 542 GVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
D KL II +++ GS + + P A I + + +GL +LH +K +H
Sbjct: 91 -KDTKLWIIMEYLGGGSALDL----LEPGPLDETQIA--TILREILKGLDYLHSEKKIHR 143
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
++K NVLL E K+ DFG V G + ++ KR+T
Sbjct: 144 DIKAANVLLSEHGEVKLADFG----VAGQLTDTQ---------IKRNT------------ 178
Query: 661 PSPSPSPSPSSLGGISPY-HAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+G +P+ APE ++ + K D++S G+ +EL G+
Sbjct: 179 ----------FVG--TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 57/272 (20%), Positives = 115/272 (42%), Gaps = 53/272 (19%)
Query: 441 SVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYKAV-LEDG 499
S++ + ++ RQ KK + E + L K LG +YKA+ E G
Sbjct: 1 SLETVQLRNP-PRRQLKKLDEDSLTKQPEEVFDVLEK-----LGEGSYGSVYKAIHKETG 54
Query: 500 TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSL 558
+A++++ ++ ++ ++ + P++V+ G Y+ + L I+ ++ GS+
Sbjct: 55 QIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF-KNTDLWIVMEYCGAGSV 111
Query: 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618
++ + L + I + +GL +LH + +H ++K N+LL + K+
Sbjct: 112 SDI----IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLA 167
Query: 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY 678
DFG V G + + +KR+T +G +P+
Sbjct: 168 DFG----VAGQLTDTM---------AKRNT----------------------VIG--TPF 190
Query: 679 -HAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
APE ++ I N D++S G+ +E+ GK
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ L+LS N L ++S ++ ++ LDL++ I+ + L NLQ+L L N +
Sbjct: 87 ITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT 142
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
+ L L +L +S+ N SD L + + + L N I+ + P +L
Sbjct: 143 -NIS-PLAGLTNLQYLSIGNAQVSDLTPL-ANLSKLTTLKADDNKIS-DISPLASLPNLI 198
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
++L N++S ++ P + L+ +T + N
Sbjct: 199 EVHLKNNQIS-DVSPL--ANTSNLFIVTLTNQTITNQPVFYN 237
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 31/154 (20%), Positives = 62/154 (40%), Gaps = 9/154 (5%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
++ LDL++ + + S L+ L L N I+ + L NLQ L++ + ++
Sbjct: 109 IKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS 164
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
L L L LT + +N SD P + ++ + L +N I+ + P +L
Sbjct: 165 -DLT-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFI 221
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ L+ ++ P + + V +
Sbjct: 222 VTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 29/154 (18%), Positives = 63/154 (40%), Gaps = 11/154 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ +++ +++ + + + L ++ + E + L+NL L L DN +
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQIT 76
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
L L L +T + L N + + S++ LDL+S I + P G +L+
Sbjct: 77 -DLA-PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQV 133
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L L N+++ I P + + + ++
Sbjct: 134 LYLDLNQIT-NISPL--AGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
LQYL + N ++ L+ L N S+L L +N IS + + SL NL ++L +N ++
Sbjct: 153 LQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRY- 225
P L +L IV+L N ++ N++ V ++ + P + Y
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYA 266
Query: 226 -LNLSYNRLS--GEIPPQFGEKIPVNAT 250
NL++N S + F + + T
Sbjct: 267 SPNLTWNLTSFINNVSYTFNQSVTFKNT 294
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 20/118 (16%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 123 FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
F + + + ++ T L + L+ + + + L +L +
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 183 SLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPP 239
LK+N +D P + L+LS N + ++ G S++ L+L+ +++ ++ P
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQIT-DVTP 124
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 27/166 (16%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L YL+ N L + L L+ + N ++ + + L L+ N
Sbjct: 108 LTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKI 161
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRY 225
KL V+ LT + N ++ S+ + L+ +N I L D+ L +
Sbjct: 162 TKLDVT--PQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTF 216
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNA-----TIDLSFNNLTGEIPESN 266
L+ S N+L+ +I V D S N LT E+ S
Sbjct: 217 LDCSSNKLT---------EIDVTPLTQLTYFDCSVNPLT-ELDVST 252
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 40/201 (19%), Positives = 69/201 (34%), Gaps = 21/201 (10%)
Query: 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159
DL L Y L + + +QL LD I+ L + L L
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324
Query: 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP--SKFNSVQVLDLSSNLINGSLPPD 217
L++ L +L VS L +S N + D K ++ + ++P +
Sbjct: 325 LNNTELT-ELDVSH--NTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTI-TMPKE 379
Query: 218 IGGYSLRYLNLSYNRLSG-----EIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQE 272
+ + +S + L I P G AT +++ NL+ + P E
Sbjct: 380 TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQ-ATNTITWENLSTDNPAVTYTFTSE 438
Query: 273 SSSFSGNLDLCGQPTKNPCPI 293
+ + G + P + P PI
Sbjct: 439 NGAIVGTV---TTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 34/206 (16%), Positives = 63/206 (30%), Gaps = 46/206 (22%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L ++ + + D+ L LD S N + L S L L+ N I+ L
Sbjct: 153 LDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNIT-KL 206
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205
+ L L+ S N L + +T L LT N ++ S + + L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHC 261
Query: 206 SSNLI-------------------NGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKI 245
+ D+ L L+ ++ ++
Sbjct: 262 IQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---------EL 312
Query: 246 PVNA-----TIDLSFNNLTGEIPESN 266
++ + L+ LT E+ S+
Sbjct: 313 DLSQNPKLVYLYLNNTELT-ELDVSH 337
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 25/172 (14%)
Query: 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159
D+ L YL+ + N+L + + +QL LD N L + L L+
Sbjct: 122 DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLD 176
Query: 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLIN----GSL 214
S N + + ++ + L ++ N + L ++ + LD SSN + L
Sbjct: 177 CSFNKITE---LDVSQNKLLNRLNCDTNNITK-LDLNQNIQLTFLDCSSNKLTEIDVTPL 232
Query: 215 PPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
L Y + S N L+ E+ K+ T+ +L EI ++
Sbjct: 233 T------QLTYFDCSVNPLT-ELDVSTLSKLT---TLHCIQTDLL-EIDLTH 273
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 28/160 (17%), Positives = 58/160 (36%), Gaps = 11/160 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ + + + S + L +LD N+ I+ + + L L L + N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
L +S +LT ++ +N ++ + + L+ +N + L L YL
Sbjct: 78 -TLDLS--QNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLDVS-QNPLLTYL 132
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
N + N L+ EI +D N ++ +
Sbjct: 133 NCARNTLT-EIDV---SHNTQLTELDCHLNKKITKLDVTP 168
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 12/116 (10%)
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP--SKFNSVQVLDLSSNLIN 211
N + + +S L +LT + N+ +D + K + L +SN I
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT 77
Query: 212 GSLPPDIGGY-SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266
+L D+ +L YL N+L+ + + ++ N LT ++ S
Sbjct: 78 -TL--DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT-KLDVSQ 125
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 58/238 (24%), Positives = 86/238 (36%), Gaps = 56/238 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI-GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY 540
GA GS + K V G +AV+RI + + V+ + P +V+ G
Sbjct: 33 GAYGS--VNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARL-KIAKGVARGLAFLHEKKHV- 598
+ + I + + + S +P E L KI + L L E +
Sbjct: 91 FREGDCWICMELM-STSFDKFYKYVYSVLDDVIP-EEILGKITLATVKALNHLKENLKII 148
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H ++KP N+LL K+ DFG ++G S A K A
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSIA---------KTRDA--------- 186
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP-------KWDVYSFGVILLELLTGK 709
G PY APE R I P+ + DV+S G+ L EL TG+
Sbjct: 187 ---------------GCRPYMAPE--R-IDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 36/199 (18%), Positives = 70/199 (35%), Gaps = 21/199 (10%)
Query: 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPE-TMGSLH 153
+PA + Y+DLS NS+ L+ + F L+ L + + T L
Sbjct: 27 ELPAHV------NYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 154 NLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYF-SDGLPS----KFNSVQVLDLSS 207
+L +L L N +L L +L +++L L S+++L L
Sbjct: 80 SLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 208 NLINGSLPPDI---GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264
N I + P L+L++N++ I + L +++T +
Sbjct: 139 NNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 265 SNVFMNQESSSFSGNLDLC 283
++ + N +
Sbjct: 197 EYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 33/183 (18%)
Query: 107 LQYLDLSNNSLNGSLS---FSLFNASQLRNLDLSNNLISG---------HLPETM---GS 151
+ LDLS N S++ F +++++L LSN+ G
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273
Query: 152 LHNLQLLNLSDNALA---GKLPVSLTTLQSLT-----IVSLKNNYFSDGLPSKFNSVQVL 203
++ +LS + + + T L+ LT I + +N F GL + L
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF-WGLTH----LLKL 328
Query: 204 DLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261
+LS N + GS+ + L L+LSYN + + Q +P + L N L
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 262 IPE 264
+P+
Sbjct: 386 VPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 38/193 (19%), Positives = 64/193 (33%), Gaps = 36/193 (18%)
Query: 107 LQYLDLSNNSLNG--SLSFSLFNASQLRNLDLSNNLISGHLPETMGS---------LHNL 155
LDL+ N + F L LS+ + + E ++
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSI 214
Query: 156 QLLNLSDNALAGKLP------VSLTTLQSLT-------IVSLKNNYFSDGLPSKF----- 197
L+LS N + ++ T +QSL S + F D F
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274
Query: 198 NSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255
+ V+ DLS + I +L + L L L+ N ++ +I + ++LS
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 256 NNLTGEIPESNVF 268
N L I +F
Sbjct: 333 NFLG-SIDS-RMF 343
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 29/83 (34%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L L+LS N L GS+ +F +L LDLS N I L + L NL+ L L N
Sbjct: 325 LLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQ 382
Query: 165 LAGKLPVSLTTLQSLTIVSLKNN 187
L L SL + L N
Sbjct: 383 LKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 52/234 (22%), Positives = 84/234 (35%), Gaps = 50/234 (21%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIR 537
+LG + G AV+ I + V +V+++ +L HPN++++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
F+ ++ + G L + +I + V G+ ++H+ K
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFD-EIISRK----RFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 598 VHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
VH +LKP N+LL + D +I DFGL G+A
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-------------- 193
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
Y APE L + K DV+S GVIL LL+G
Sbjct: 194 -----------------------YIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 3e-13
Identities = 39/153 (25%), Positives = 57/153 (37%), Gaps = 24/153 (15%)
Query: 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141
R L S+ L ++ L L++ L L L + +LDLS+N +
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRL 475
Query: 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQ 201
LP + +L L++L SDNAL + + L L + L NN ++Q
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ-----SAAIQ 527
Query: 202 VLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234
L S P L LNL N L
Sbjct: 528 PL--------VSCP------RLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 32/163 (19%), Positives = 58/163 (35%), Gaps = 6/163 (3%)
Query: 98 PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQL 157
D E L +LS S L + +L+ L+ N + M +L L
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSE-LESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPD 217
+ + V L + K + L ++ V+VL L+ + ++
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCH 458
Query: 218 IGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ + +L+LS+NRL +PP + + S N L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLE-VLQASDNALE 499
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 52/234 (22%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
GA G +YKA E G A + I S + D+ ++ ++A HP +V++ G Y+
Sbjct: 30 GAFGK--VYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY- 86
Query: 543 VDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
D KL I+ +F P G++ M L + + + L FLH K+ +H +
Sbjct: 87 HDGKLWIMIEFCPGGAVDAI----MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
LK NVL+ + + ++ DFG V+ + KR +
Sbjct: 143 LKAGNVLMTLEGDIRLADFG----VSAKNLKTL---------QKRDS------------- 176
Query: 662 SPSPSPSPSSLGGISPY-HAPE-----SLRSIKPNPKWDVYSFGVILLELLTGK 709
+G +PY APE +++ + K D++S G+ L+E+ +
Sbjct: 177 ---------FIG--TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 56/234 (23%), Positives = 83/234 (35%), Gaps = 49/234 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRG 538
LG+ + A++ I + SV +V V+ L HPN++++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
F+ ++ + G L + I K V G+ +LH+ V
Sbjct: 104 FFEDKRNYYLVMECYKGGELFD-EIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 599 HGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
H +LKP N+LL + D KI DFGL + + G+A
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY--------------- 203
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
Y APE LR K + K DV+S GVIL LL G
Sbjct: 204 ----------------------YIAPEVLRK-KYDEKCDVWSIGVILFILLAGY 234
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 59/308 (19%), Positives = 97/308 (31%), Gaps = 84/308 (27%)
Query: 450 HVHERQNKKGTLVIVDGDKELELE---TLLKASAYILGASGSSIMYKAV-LEDGTALAV- 504
H H + + G LEL+ L +G ++ A+ + A+
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKG----AIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 505 ----RRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-- 558
+I + + +T+VR++ KL HPN+ R+ Y ++ + G L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 559 ------------ANARYRKMGSSPCHLPWEARL---------------------KIAKGV 585
K PC E + I + +
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGND--MEPKIGDFGLERLVTGDTSSSKAGGSARNFG 643
L +LH + H ++KP N L + E K+ DFGL ++ F
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGL----------------SKEFY 221
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP--NPKWDVYSFGVI 701
+ G +P + APE L + PK D +S GV+
Sbjct: 222 KLNNGEYYGMTTKAG---TPY-------------FVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 702 LLELLTGK 709
L LL G
Sbjct: 266 LHLLLMGA 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 46/237 (19%), Positives = 81/237 (34%), Gaps = 59/237 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
+G + AV A ++I + V+ F+ ++ ++ L HPN++R+ +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 541 WGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ ++ + G L +R+ +A +I K V +A+ H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRES---------DAA-RIMKDVLSAVAYCHKL 125
Query: 596 KHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
H +LKP N L D K+ DFGL G+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGT-------------- 171
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTG 708
P Y +P+ L P+ D +S GV++ LL G
Sbjct: 172 ------PY-----------------YVSPQVLE--GLYGPECDEWSAGVMMYVLLCG 203
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 48/167 (28%), Positives = 66/167 (39%), Gaps = 15/167 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
++ +L +L L L LS NL+ T+ L LNL L
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSV---QVLDLSSNLINGSLPPDI--GGY 221
KL V TL L + L +N LP ++ VLD+S N + SLP G
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVF 268
L+ L L N L +PP P + L+ NNLT E+P +
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPA-GLL 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 47/163 (28%), Positives = 64/163 (39%), Gaps = 18/163 (11%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L L + L A L L L+L L L LDLS+N + L
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQ-SL 92
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPV----SLTTLQSLTIVSLKNN---YFSDGLPSKFN 198
P +L L +L++S N L LP+ L LQ L LK N GL +
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL---YLKGNELKTLPPGLLTPTP 148
Query: 199 SVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPP 239
++ L L++N + LP + G +L L L N L IP
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 33/141 (23%), Positives = 52/141 (36%), Gaps = 27/141 (19%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETM-GS 151
L S+P + L LD+S N L SL +L+ L L N + LP +
Sbjct: 89 LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 152 LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLIN 211
L+ L+L++N L L +GL ++ L L N +
Sbjct: 147 TPKLEKLSLANNNLT----------------ELPAGLL-NGLE----NLDTLLLQENSLY 185
Query: 212 GSLPPDI-GGYSLRYLNLSYN 231
++P G + L + L N
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 33/158 (20%), Positives = 67/158 (42%), Gaps = 11/158 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
+L+ + N F + +L+ L L N + + + N+ L D +L
Sbjct: 355 FTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412
Query: 166 ----AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF-NSVQVLDLSSNLINGSLPPDIGG 220
+ + +S+ +++L +N + + V+VLDL +N I S+P D+
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTH 471
Query: 221 -YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257
+L+ LN++ N+L +P +++ I L N
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 33/188 (17%), Positives = 60/188 (31%), Gaps = 15/188 (7%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L + ++ L + N S +++ LS +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS--DGLPSKFNSVQVL 203
S + LN + N + +TL+ L + L+ N + ++ L
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405
Query: 204 DLSSNLINGSLPPDI------GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI-DLSFN 256
+ +N SL S+ LNLS N L+G + +P + DL N
Sbjct: 406 ETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVF----RCLPPKVKVLDLHNN 460
Query: 257 NLTGEIPE 264
+ IP+
Sbjct: 461 RIM-SIPK 467
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 35/149 (23%), Positives = 54/149 (36%), Gaps = 12/149 (8%)
Query: 129 SQLRNLDLSNNLISGHLPET-MGSLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKN 186
+ + L LS N IS L + L L++L LS N + L + Q L + + +
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109
Query: 187 NYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGY-----SLRYLNLSYNRLSGEIPPQF 241
N + S++ LDLS N + LP L +L LS +
Sbjct: 110 NRLQNISCCPMASLRHLDLSFNDFD-VLPV--CKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 242 GEKIPVNATIDLSFNNLTGEIPESNVFMN 270
+DL ++ G ES N
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESLQIPN 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 42/223 (18%), Positives = 81/223 (36%), Gaps = 44/223 (19%)
Query: 489 SIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKL 547
++++ G A + + +++ ++ L HP LV + + +E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNV 607
+IY+F+ G L + K+ + + ++ + V +GL +HE +VH +LKP N+
Sbjct: 231 MIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286
Query: 608 LLGNDMEP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSP 665
+ K+ DFGL + S G+
Sbjct: 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT--------------------AE----- 321
Query: 666 SPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+ APE D++S GV+ LL+G
Sbjct: 322 ------------FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 56/238 (23%), Positives = 90/238 (37%), Gaps = 57/238 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI-GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY 540
GA G + K + G +AV+RI + + + + + V P V G
Sbjct: 18 GAYGV--VEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARL-KIAKGVARGLAFLHEKKHV- 598
+ + I + + + SL Y+++ +P E L KIA + + L LH K V
Sbjct: 76 FREGDVWICMELM-DTSLDKF-YKQVIDKGQTIP-EDILGKIAVSIVKALEHLHSKLSVI 132
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H ++KP NVL+ + K+ DFG ++G A +D
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFG----ISGYLVDDVA---------------KDIDA--- 170
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP-------KWDVYSFGVILLELLTGK 709
G PY APE R I P K D++S G+ ++EL +
Sbjct: 171 ---------------GCKPYMAPE--R-INPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 50/244 (20%), Positives = 83/244 (34%), Gaps = 60/244 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI-------------GENSVDRFRDFETQVRVIAK 527
LG+ + + A++ I +N + ++ ++
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 528 LVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVAR 587
L HPN++++ + ++ +F G L + I K +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE-QIINRH----KFDECDAANIMKQILS 157
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
G+ +LH+ VH ++KP N+LL N + KI DFGL + D G+
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT------ 211
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
Y APE L+ K N K DV+S GVI+
Sbjct: 212 --------------AY-----------------YIAPEVLKK-KYNEKCDVWSCGVIMYI 239
Query: 705 LLTG 708
LL G
Sbjct: 240 LLCG 243
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 47/240 (19%), Positives = 80/240 (33%), Gaps = 67/240 (27%)
Query: 488 SSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVR---VIAKLV-HPNLVRIRGFY--W 541
++ +A R + R QV I K + HPN+V++
Sbjct: 49 KKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL---VEVL 105
Query: 542 GVDEKLIIY---DFVPNGSL----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+ +Y + V G + + +AR + + +G+ +LH
Sbjct: 106 DDPNEDHLYMVFELVNQGPVMEVPTLKPLSED---------QAR-FYFQDLIKGIEYLHY 155
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGL-ERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
+K +H ++KP N+L+G D KI DFG+ D S G+
Sbjct: 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGT--------------- 200
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN---PKWDVYSFGVILLELLTGKV 710
P + APESL + DV++ GV L + G+
Sbjct: 201 -----P-----------------AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 57/239 (23%), Positives = 87/239 (36%), Gaps = 61/239 (25%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRG 538
+LG + K AV+ I + S +V ++ KL HPN++++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 539 FYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
I+ + G L R+ + +A +I K V G+ ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---------DAA-RIIKQVFSGITYMH 138
Query: 594 EKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
+ VH +LKP N+LL + D + KI DFGL +T G+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT------------ 186
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTG 708
Y APE LR + K DV+S GVIL LL+G
Sbjct: 187 --------AY-----------------YIAPEVLR--GTYDEKCDVWSAGVILYILLSG 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 59/241 (24%), Positives = 89/241 (36%), Gaps = 65/241 (26%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRG 538
+LG + K AV+ I + S +V ++ KL HPN++++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 539 FYWGVDEKL--IIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAF 591
D I+ + G L R+ + +A +I K V G+ +
Sbjct: 89 IL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEH---------DAA-RIIKQVFSGITY 136
Query: 592 LHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
+H+ VH +LKP N+LL + D + KI DFGL +T G+A
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-------- 188
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLT 707
Y APE LR + K DV+S GVIL LL+
Sbjct: 189 -----------------------------YIAPEVLR--GTYDEKCDVWSAGVILYILLS 217
Query: 708 G 708
G
Sbjct: 218 G 218
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 10/153 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+L S+ L S S ++N + N+ I L M NL+ L+LS N ++
Sbjct: 21 AVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS 76
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
L L L L +S+ N + + L L +N + I +L L
Sbjct: 77 -DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELR-DTDSLIHLKNLEIL 133
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
++ N+L I + +DL N +T
Sbjct: 134 SIRNNKLK-SIVM--LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 36/189 (19%), Positives = 67/189 (35%), Gaps = 18/189 (9%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L ++ N L + + ++ L L L NN + +++ L NL++L++ +N L
Sbjct: 87 LEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRY 225
+ L L L ++ L N ++ ++ V +DL+ P L
Sbjct: 142 -SIV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKC--VNEPVKYQPELYI 197
Query: 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSS-----FSGNL 280
N + I P + + + S F + F G +
Sbjct: 198 TNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTV 257
Query: 281 DLCGQPTKN 289
QP KN
Sbjct: 258 T---QPIKN 263
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 21/114 (18%), Positives = 40/114 (35%), Gaps = 9/114 (7%)
Query: 123 FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
F + +L ++ + L +Q N ++ + L + +L +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 183 SLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234
L +N SD L ++ L ++ N + +L I L L L N L
Sbjct: 69 HLSHNQISDLSPL-KDLTKLEELSVNRNRLK-NLNG-IPSACLSRLFLDNNELR 119
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 34/190 (17%), Positives = 64/190 (33%), Gaps = 15/190 (7%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLP-E 147
+ IP+DL L L + F L +++S N + + +
Sbjct: 17 QESKVTEIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 148 TMGSLHNLQLLNLSD-NALAGKLPVSLTTLQSLTIVSLKNN---YFSDGLPSKFNSVQVL 203
+L L + + N L P + L +L + + N + D +L
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133
Query: 204 DLSSNLINGSLPPDI---GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260
D+ N+ ++ + + L L+ N + EI ++ NNL
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE- 191
Query: 261 EIPESNVFMN 270
E+P +VF
Sbjct: 192 ELPN-DVFHG 200
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 38/213 (17%), Positives = 71/213 (33%), Gaps = 29/213 (13%)
Query: 86 LALPNSQLLGSIPADLGMIEF-----LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140
+ + + L I + F LQYL +SN + ++ Q LD+ +N+
Sbjct: 84 IRIEKANNLLYINPEA----FQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139
Query: 141 ISGHLPETM--GSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPS 195
+ G +L L+ N + + Q + NN + +
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 196 KFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDL 253
+ +LD+S I+ SLP LR + + ++P EK+ L
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-L-EKLVALMEASL 253
Query: 254 S-------FNNLTGEIPESNVFMNQESSSFSGN 279
+ F N +I E + N+ +
Sbjct: 254 TYPSHCCAFANWRRQISELHPICNKSILRQEVD 286
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ + +N+ + S+ + + L L+ N ++ + + + +L NL L L +N +
Sbjct: 48 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK 103
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
L SL L+ L +SL++N SD GL ++ L L +N I + L
Sbjct: 104 -DL-SSLKDLKKLKSLSLEHNGISDINGL-VHLPQLESLYLGNNKIT-DITVLSRLTKLD 159
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
L+L N++S +I P + + LS N+++
Sbjct: 160 TLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 10/130 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+L S+ +++ + + + + +N+ I + + + L N+ L L+ N L
Sbjct: 26 TIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLR 224
P L L++L + L N D L ++ L L N I+ + + L
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVKDLSSL-KDLKKLKSLSLEHNGIS-DINGLVHLPQLE 137
Query: 225 YLNLSYNRLS 234
L L N+++
Sbjct: 138 SLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 31/148 (20%), Positives = 61/148 (41%), Gaps = 10/148 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L L NN + ++ L ++L L L +N IS + + L LQ L LS N ++
Sbjct: 136 LESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI----GGYS 222
L L++L ++ L + + + +++ V + N + P+I G Y
Sbjct: 192 DLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
Query: 223 LRYLNLSYNRLSGEIPPQFGEKIPVNAT 250
+ + E+ F + + +
Sbjct: 250 KPNVKWHLPEFTNEVSFIFYQPVTIGKA 277
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 20/113 (17%), Positives = 47/113 (41%), Gaps = 6/113 (5%)
Query: 123 FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
FS ++ +L ++ T L+++ + +++ + + + L ++T +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 183 SLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234
L N +D P + ++ L L N + L L+ L+L +N +S
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGIS 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 41/198 (20%), Positives = 67/198 (33%), Gaps = 44/198 (22%)
Query: 101 LGMIEFLQYLDLSNNSLNGSLSFSLFNA-----SQLRNLDLSNNLIS----GHLPETMGS 151
L + LQ L LS+N L + L +L L L +S L + +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 152 LHNLQLLNLSDN--------ALAGKLPVSLTTLQSLTIVSLKNN--------YFSDGLPS 195
+ + L +S+N L L S L++L L++ + S
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL---KLESCGVTSDNCRDLCGIVAS 225
Query: 196 KFNSVQVLDLSSN---------LINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIP 246
K S++ L L SN L G L P LR L + ++ + +
Sbjct: 226 K-ASLRELALGSNKLGDVGMAELCPGLLHPS---SRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 247 VNATI---DLSFNNLTGE 261
++ L+ N L E
Sbjct: 282 AKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 31/185 (16%), Positives = 65/185 (35%), Gaps = 30/185 (16%)
Query: 107 LQYLDLSNNSLN----GSLSFSLFNASQLRNLDLSNNLISG----HLPETMGSLH-NLQL 157
Q + L + L +S +L L L+L +N + + + + + +Q
Sbjct: 30 CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 89
Query: 158 LNLSDNAL----AGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSVQVLDL 205
L+L + L G L +L TL +L + L +N D GL ++ L L
Sbjct: 90 LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 149
Query: 206 SSNLINGSLPPDIGGY-----SLRYLNLSYNRLSGEIPPQFGEKIPVNA----TIDLSFN 256
++ + + + L +S N ++ + + + + L
Sbjct: 150 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209
Query: 257 NLTGE 261
+T +
Sbjct: 210 GVTSD 214
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 31/185 (16%), Positives = 59/185 (31%), Gaps = 30/185 (16%)
Query: 107 LQYLDLSNNSLN----GSLSFSLFNASQLRNLDLSNNLISG----HLPETMGSLH-NLQL 157
L+ L L + + L + + + LR L L +N + L + L+
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 158 LNLSDNAL----AGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSVQVLDL 205
L + + + G L L +SL +SL N D L ++ L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 206 SSNLINGSLPPDIGG-----YSLRYLNLSYNRLSGEIPPQFGEKIPVN----ATIDLSFN 256
S + L L +S NRL + + + + L+
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380
Query: 257 NLTGE 261
+++
Sbjct: 381 DVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 36/185 (19%), Positives = 61/185 (32%), Gaps = 30/185 (16%)
Query: 107 LQYLDLSNNSLN----GSLSFSLFNASQLRNLDLSNNLISG----HLPETMGSLH-NLQL 157
L+ L + + G L L L+ L L+ N + L ET+ L+
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 158 LNLSDNAL----AGKLPVSLTTLQSLTIVSLKNN--------YFSDGLPSKFNSVQVLDL 205
L + + L + L + + NN GL + ++VL L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 206 SSNLINGSLPPDIG-----GYSLRYLNLSYNRLSGEIPPQFGEKIPVNA----TIDLSFN 256
+ ++ S + +SLR L+LS N L Q E + + L
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 257 NLTGE 261
+ E
Sbjct: 438 YWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 34/184 (18%), Positives = 57/184 (30%), Gaps = 38/184 (20%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLIS----GHLPETMGSLHNLQLLNLS 161
+Q LD+ L+ + L Q + + L + ++ + + L LNL
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 162 DN--------ALAGKLPVSLTTLQSLTIVSLKNNYFSD-------GLPSKFNSVQVLDLS 206
N + L +Q L SL+N + ++Q L LS
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKL---SLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 207 SNLINGS---------LPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI---DLS 254
NL+ + L P L L L Y LS + +S
Sbjct: 122 DNLLGDAGLQLLCEGLLDP---QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 255 FNNL 258
N++
Sbjct: 179 NNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 29/155 (18%), Positives = 58/155 (37%), Gaps = 22/155 (14%)
Query: 129 SQLRNLDLSNNLIS-GHLPETMGSLHNLQLLNLSDNAL----AGKLPVSLTTLQSLTIVS 183
+++LD+ +S E + L Q++ L D L + +L +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 184 LKNNYFSD--------GLPSKFNSVQVLDLSSNLINGSLPPDIGGY-----SLRYLNLSY 230
L++N D GL + +Q L L + + G+ + +L+ L+LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 231 NRLSGEIPPQFGEKI----PVNATIDLSFNNLTGE 261
N L E + + L + +L+
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 55/236 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI-GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFY 540
G G ++K + G +AV+++ + + + + V+ K P +V+ G +
Sbjct: 36 GTCGQ--VWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARL-KIAKGVARGLAFLHEKKHV- 598
+ I + + + ++M +P E L K+ + + L +L EK V
Sbjct: 94 ITNTDVFIAMELMGTCAEK--LKKRMQGP---IP-ERILGKMTVAIVKALYYLKEKHGVI 147
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H ++KP N+LL + K+ DFG ++G KA K +A
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKA---------KDRSA--------- 185
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKP-----NPKWDVYSFGVILLELLTGK 709
G + Y APE + P + + DV+S G+ L+EL TG+
Sbjct: 186 ---------------GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 57/236 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
+LG+ S ++ G A++ I ++ R E ++ V+ K+ H N+V + Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 541 WGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
++ V G L Y + +A + + V + +LHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEK---------DAS-LVIQQVLSAVKYLHEN 125
Query: 596 KHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
VH +LKP N+L + + I DFGL ++ S+ G
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG---------------- 169
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+P Y APE L + D +S GVI LL G
Sbjct: 170 ---------TPG-------------YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 18/145 (12%), Positives = 41/145 (28%), Gaps = 15/145 (10%)
Query: 483 LGASGSSIMYKA---VLEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRG 538
G ++A L+ AL D ++ ++++ P + R+
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV-- 96
Query: 539 FYWGVDEKL--IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
++ +++ GSL P A ++ + +A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSP------SPVGA-IRAMQSLAAAADAAHRAG 149
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFG 621
P V + D + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA 174
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 36/156 (23%), Positives = 54/156 (34%), Gaps = 38/156 (24%)
Query: 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM 613
+ S L E + + VA+G+ FL +K +H +L RN+LL
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 230
Query: 614 EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLG 673
KI DFGL R + D + G
Sbjct: 231 VVKICDFGLARDIYKDPDYVRKG------------------------------------D 254
Query: 674 GISPYH--APESLRSIKPNPKWDVYSFGVILLELLT 707
P APE++ + DV+SFGV+L E+ +
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 54/248 (21%), Positives = 90/248 (36%), Gaps = 70/248 (28%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI--------GENSVDRFRDFETQVRVIAKLVHPN 532
LG+ + A + +A++ I D + ET++ ++ KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 533 LVRIRGFYWGVDEKL-IIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVA 586
+++I+ F+ E I+ + + G L N R ++ + +
Sbjct: 77 IIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA---------TCK-LYFYQML 124
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFG 643
+ +LHE +H +LKP NVLL + E KI DFG +++ + G+
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT----- 179
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP---NPKWDVYSFGV 700
P Y APE L S+ N D +S GV
Sbjct: 180 ---------------PT-----------------YLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 701 ILLELLTG 708
IL L+G
Sbjct: 208 ILFICLSG 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 70/247 (28%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI--------GENSVDRFRDFETQVRVIAKLVHPNL 533
LG+ + A + +A+R I D + ET++ ++ KL HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 534 VRIRGFYWGVDEKL-IIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVAR 587
++I+ F+ E I+ + + G L N R ++ + +
Sbjct: 203 IKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA---------TCK-LYFYQMLL 250
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ +LHE +H +LKP NVLL + E KI DFG +++ + G+
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT------ 304
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP---NPKWDVYSFGVI 701
P Y APE L S+ N D +S GVI
Sbjct: 305 --------------PT-----------------YLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 702 LLELLTG 708
L L+G
Sbjct: 334 LFICLSG 340
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 42/240 (17%), Positives = 85/240 (35%), Gaps = 54/240 (22%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI------GENSVDRFRDFETQVRVIAKLVHPNLV 534
++G S++ + + E G AV+ + + D + + + L HP++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHPHIV 89
Query: 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+ Y ++++F+ L ++ + + A + + L + H+
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS-HYMRQILEALRYCHD 148
Query: 595 KKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVT--GDTSSSKAGGSARNFGSKRSTA 649
+H ++KP VLL + K+G FG+ + G + + G
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG------------- 195
Query: 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYH-APESLRSIKPNPKWDVYSFGVILLELLTG 708
+P+ APE ++ DV+ GVIL LL+G
Sbjct: 196 --------------------------TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 36/229 (15%), Positives = 81/229 (35%), Gaps = 45/229 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG I+++ V + + D+ + ++ ++ H N++ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
++E ++I++F+ + + ++ +S L + V L FLH H +
Sbjct: 72 SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 602 LKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++P N++ KI +FG R + + + P
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--------------------P 167
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
Y+APE + + D++S G ++ LL+G
Sbjct: 168 E-----------------YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 57/238 (23%), Positives = 87/238 (36%), Gaps = 58/238 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRG 538
LG S++ + V G A + I S F+ E + R+ KL HPN+VR+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 539 FYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
+++D V G L A Y + +A + + +A+ H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DAS-HCIQQILESIAYCH 122
Query: 594 EKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
VH NLKP N+LL + + K+ DFGL V + G+
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT------------ 170
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
PG Y +PE L+ + D+++ GVIL LL G
Sbjct: 171 --------PG-----------------YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 50/234 (21%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIG-ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LG+ ++ G ++ I + S E ++ V+ L HPN+++I +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 541 WGVDEKLIIYDFVPNGSLAN---ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
I+ + G L + + L ++ K + LA+ H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGK----ALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 598 VHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
VH +LKP N+L + KI DFGL L D S+ A G+
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT---------------- 189
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
Y APE + K D++S GV++ LLTG
Sbjct: 190 ----AL-----------------YMAPEVFKR-DVTFKCDIWSAGVVMYFLLTG 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 51/244 (20%), Positives = 86/244 (35%), Gaps = 65/244 (26%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI-------GENSVDRFRDFETQVRVIAKLVHPNL 533
LG+ +I+ K G A + I V R + E +V ++ +++H N+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSILRQVLHHNV 77
Query: 534 VRIRGFYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARG 588
+ + Y + ++I + V G L + EA K + G
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---------EAT-SFIKQILDG 127
Query: 589 LAFLHEKKHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+ +LH KK H +LKP N++L + P K+ DFGL + G+
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT------ 181
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
P + APE + + D++S GVI
Sbjct: 182 --------------PE-----------------FVAPEIVNYEPLGLEADMWSIGVITYI 210
Query: 705 LLTG 708
LL+G
Sbjct: 211 LLSG 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 39/229 (17%), Positives = 79/229 (34%), Gaps = 44/229 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG+ ++++ V G + I + ++ ++ +L HP L+ + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
E ++I +F+ G L + ++ + + + + GL +HE VH +
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174
Query: 602 LKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+KP N++ KI DFGL + D +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT--------------------A 214
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+ APE + D+++ GV+ LL+G
Sbjct: 215 E-----------------FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNN---SLNGSLSFSLFNASQLRNLDLSNNLISGHLP 146
+ Q L ++P L + LDLS+N L + + + L +L LS+N ++
Sbjct: 26 SKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPT--RLTNLHSLLLSHNHLNFISS 81
Query: 147 ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLS 206
E + NL+ L+LS N L TL F L + ++VL L
Sbjct: 82 EAFVPVPNLRYLDLSSN--------HLHTLDEFL--------F-SDLQA----LEVLLLY 120
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPP---QFGEKIPVNATIDLSFNNLT 259
+N I + + L+ L LS N++S P + G K+P +DLS N L
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 14/134 (10%)
Query: 86 LALPNSQLLGSIPAD-LGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISG 143
L L ++ L I ++ + L+YLDLS+N L+ +L LF + L L L NN I
Sbjct: 69 LLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV 126
Query: 144 HLPETMGSLHNLQLLNLSDNALAGKLP----VSLTTLQSLTIVSLKNNYFSDGLPSKFNS 199
+ LQ L LS N ++ + P L L ++ L +N +
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
Query: 200 -----VQVLDLSSN 208
L L +N
Sbjct: 186 LPAWVKNGLYLHNN 199
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 52/252 (20%), Positives = 87/252 (34%), Gaps = 75/252 (29%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI---------GENSVDRFRDFETQVRVIAKL-VH 530
ILG SS++ + + AV+ I E + +V ++ K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 531 PNLVRIRGFYWGVDEKLIIY---DFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIA 582
PN+++++ Y + + D + G L + E R KI
Sbjct: 84 PNIIQLKDTY---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETR-KIM 130
Query: 583 KGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNF 642
+ + + LH+ VH +LKP N+LL +DM K+ DFG + + G+
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT---- 186
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP------NPKWDVY 696
P Y APE + + D++
Sbjct: 187 ----------------PS-----------------YLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 697 SFGVILLELLTG 708
S GVI+ LL G
Sbjct: 214 STGVIMYTLLAG 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 42/231 (18%), Positives = 77/231 (33%), Gaps = 64/231 (27%)
Query: 496 LEDGTALAVRRIGENSVDRFRDFETQVR---VIAKLV-HPNLVRIRGFY--WGVDEKLII 549
E AV+ + + + R + E V+ + + + H N++++ +EK +
Sbjct: 27 SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL---VDVLYNEEKQKM 83
Query: 550 Y---DFVPNGS------LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
Y ++ G + R+ +A + GL +LH + VH
Sbjct: 84 YMVMEYCVCGMQEMLDSVPEKRFP---------VCQAH-GYFCQLIDGLEYLHSQGIVHK 133
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
++KP N+LL KI G+ + + T+ G
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAA-----------DDTCRTSQ-------G-- 173
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKP--NPKWDVYSFGVILLELLTGK 709
SP + PE + K D++S GV L + TG
Sbjct: 174 -SP-------------AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 56/212 (26%)
Query: 505 RRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY---DFVPNGSLAN- 560
++ S+ + +VR++ L HPN+V++ + ++ + +Y ++ G + +
Sbjct: 51 TQLNPTSLQKLF---REVRIMKILNHPNIVKL---FEVIETEKTLYLIMEYASGGEVFDY 104
Query: 561 -ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619
+ +M EAR + + + + H+K+ VH +LK N+LL DM KI D
Sbjct: 105 LVAHGRMKEK------EAR-SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIAD 157
Query: 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYH 679
FG T G+ PY
Sbjct: 158 FGFSNEFTVGGKLDAFCGA-------------------------------------PPYA 180
Query: 680 APESLRSIKPN-PKWDVYSFGVILLELLTGKV 710
APE + K + P+ DV+S GVIL L++G +
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 58/236 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LG +SI+Y+ A++ + + +VD+ + T++ V+ +L HPN+++++ +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDK-KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 541 WGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
E ++ + V G L Y + +A K + +A+LHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSER---------DAA-DAVKQILEAVAYLHEN 167
Query: 596 KHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
VH +LKP N+L D KI DFGL ++V G+
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT-------------- 213
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
PG Y APE LR P+ D++S G+I LL G
Sbjct: 214 ------PG-----------------YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 56/239 (23%), Positives = 86/239 (35%), Gaps = 59/239 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRF--RDFETQVRVIAKLVHPNLVRIRG 538
LG S++ + V + G A I + + E + R+ L HPN+VR+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 539 FYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
+I+D V G L A Y + +A + + + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEA---------DAS-HCIQQILEAVLHCH 127
Query: 594 EKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSS-SKAGGSARNFGSKRSTA 649
+ VH NLKP N+LL + ++ K+ DFGL V G+ + G+
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT----------- 176
Query: 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
PG Y +PE LR D+++ GVIL LL G
Sbjct: 177 ---------PG-----------------YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 29/213 (13%), Positives = 63/213 (29%), Gaps = 51/213 (23%)
Query: 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE-TMGSLHN 154
S+P Q L L L S + N + + +S ++ L + +L
Sbjct: 28 SLPPST------QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 155 LQLLNLSDNALAGKLP----VSLTTLQSLT-----IVSLKNNYFSDGLPSKFNSVQVLDL 205
+ + + + + L L+ L + + F +L++
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFF----ILEI 137
Query: 206 SSNLINGSLPPDIGGY---SLRYLNLSYNRLSGEIPP----------------QFGEKIP 246
+ N S+P + L L N + + ++ I
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 247 VNA---------TIDLSFNNLTGEIPESNVFMN 270
+A +D+S ++T +P S +
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALP-SKGLEH 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 56/238 (23%), Positives = 87/238 (36%), Gaps = 58/238 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRG 538
LG S++ + V G A + I + F+ E + R+ KL HPN+VR+
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 539 FYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
+++D V G L A Y + +A + + +A+ H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DAS-HCIQQILESIAYCH 145
Query: 594 EKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
VH NLKP N+LL + + K+ DFGL V + G+
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT------------ 193
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
PG Y +PE L+ + D+++ GVIL LL G
Sbjct: 194 --------PG-----------------YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 40/152 (26%), Positives = 62/152 (40%), Gaps = 27/152 (17%)
Query: 131 LRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKNNYF 189
+ LDL +N +S + L L+LL L+DN L LP + L++L + + +N
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 190 S---DGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEK 244
G+ + ++ L L N + SLPP + L YL+L YN L
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ---------S 147
Query: 245 IPVNA--------TIDLSFNNLTGEIPESNVF 268
+P + L N L +PE F
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK-RVPE-GAF 177
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 42/162 (25%), Positives = 64/162 (39%), Gaps = 21/162 (12%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ L L++N L +L +F L L +++N + L NL L L N L
Sbjct: 63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121
Query: 166 AGKLPV----SLTTLQSLT-----IVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPP 216
LP SLT L L+ + SL F D L S++ L L +N + +P
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVF-DKLT----SLKELRLYNNQLK-RVPE 174
Query: 217 DI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256
L+ L L N+L +P + + + L N
Sbjct: 175 GAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 25/128 (19%), Positives = 50/128 (39%), Gaps = 25/128 (19%)
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSNLI 210
+ + L+L N L+ + L L ++ L +N G+ + +++ L ++ N +
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 211 NGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNA--------TIDLSFNNLTG 260
+LP + +L L L N+L +P + L +N L
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK---------SLPPRVFDSLTKLTYLSLGYNELQ- 146
Query: 261 EIPESNVF 268
+P+ VF
Sbjct: 147 SLPK-GVF 153
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 61/359 (16%), Positives = 117/359 (32%), Gaps = 88/359 (24%)
Query: 374 KRKNVESTLKKEANSAKDTVSFSPSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDN 433
V++ KE A+ + P+ + + R F R D
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIR-----------SLRDDPSQSANLL 55
Query: 434 YHSGRKLSVDNQRQQDHVHERQNKKGTLVIVDGDKELELETLLKASAYILGASGSSIMYK 493
+ + + ++ + + L KE + K ++G SS++ +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKD---VIGRGVSSVVRR 112
Query: 494 AV-LEDGTALAVRRI--------GENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGV 543
V G AV+ + E + + ++ ++ HP+++ + Y
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--- 169
Query: 544 DEKLIIY---DFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ ++ D + G L + E R I + + ++FLH
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEK---------ETR-SIMRSLLEAVSFLHAN 219
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
VH +LKP N+LL ++M+ ++ DFG + + G+
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGT----------------- 262
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP------NPKWDVYSFGVILLELLTG 708
PG Y APE L+ + D+++ GVIL LL G
Sbjct: 263 ---PG-----------------YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 50/242 (20%), Positives = 85/242 (35%), Gaps = 63/242 (26%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI------GENSVDRFRDFETQVRVIAKLVHPNLVR 535
LG+ +I+ K G A + I + E +V ++ +++HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 536 IRGFYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAKGVARGLA 590
+ Y + ++I + V G L + EA K + G+
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---------EAT-SFIKQILDGVN 129
Query: 591 FLHEKKHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+LH KK H +LKP N++L + P K+ DFGL + G+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT-------- 181
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
P + APE + + D++S GVI LL
Sbjct: 182 ------------PE-----------------FVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 707 TG 708
+G
Sbjct: 213 SG 214
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 52/240 (21%), Positives = 102/240 (42%), Gaps = 57/240 (23%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVR-----I 536
G G +YK ++ G A++ + + + D + + ++ ++ K H N+ I
Sbjct: 35 GTYGQ--VYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 537 RGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ G+D++L ++ +F GS+ + + + W A I + + RGL+ LH+
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIA--YICREILRGLSHLHQH 148
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
K +H ++K +NVLL + E K+ DFG V+ + +R+T
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTV---------GRRNT------- 188
Query: 656 DLGPGPSPSPSPSPSSLGGISPY-HAPESLRSIKP-----NPKWDVYSFGVILLELLTGK 709
+G +PY APE + + + K D++S G+ +E+ G
Sbjct: 189 ---------------FIG--TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 40/188 (21%), Positives = 62/188 (32%), Gaps = 38/188 (20%)
Query: 107 LQYLDLSNNSLNG----SLSFSL-FNASQLRNLDLSNNLISG----HLPETMGSLH-NLQ 156
+ L+LS N L+ L +L + LDL N S + +L ++
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 157 LLNLSDN--------ALAGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSV 200
LNL N L L + SL +L+ N + L S SV
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGNNLASKNCAELAKFLASIPASV 198
Query: 201 QVLDLSSNLINGSLPPDIG------GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI--- 251
LDLS+NL+ ++ + LNL N L G +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 252 DLSFNNLT 259
L ++ +
Sbjct: 259 YLDYDIVK 266
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/196 (20%), Positives = 70/196 (35%), Gaps = 49/196 (25%)
Query: 107 LQYLDLSNNSLNGS----LSFSL-FNASQLRNLDLSNNLIS----GHLPETMGSLH-NLQ 156
+ LDLS N+L L + + + +L+LS N + L + + ++ N+
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 157 LLNLSDN--------ALAGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSV 200
LNLS N L L T+ L L N FS + S+
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVL---DLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 201 QVLDLSSNLINGSLPPDIGG-----------YSLRYLNLSYNRLSGEIPPQFGEKIP-VN 248
L+L N + ++ LNL N L+ + + + + +
Sbjct: 141 TSLNLRGNDLG-----IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195
Query: 249 ATI---DLSFNNLTGE 261
A++ DLS N L +
Sbjct: 196 ASVTSLDLSANLLGLK 211
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 27/157 (17%), Positives = 51/157 (32%), Gaps = 30/157 (19%)
Query: 107 LQYLDLSNNSLNGS----LSFSL-FNASQLRNLDLSNNLISG----HLPETMGSLHNLQL 157
+ LDLS N L L++ + + +L+L N + G +L SL +LQ
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 158 LNLSDNAL-------AGKLPVSLTTLQSLTIVSLKNN--------YFSDGLPSKFNSVQV 202
+ L + + L + +Q + +V S+ + V
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 203 LDLSSNLIN--GSLPPDIGGYS----LRYLNLSYNRL 233
L + + +I + LR + L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/184 (20%), Positives = 62/184 (33%), Gaps = 39/184 (21%)
Query: 114 NNSLNGS-----LSFSLFNASQLRNLDLSNNLISG----HLPETMGSLH-NLQLLNLSDN 163
N L + + +LDLS N + L + + ++ LNLS N
Sbjct: 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 164 --------ALAGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSVQVLDLSS 207
L L + SL +L N+ S L + ++ VLDL
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSL---NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 208 NLINGSLPPDIGGY------SLRYLNLSYNRLSGEIPPQFGEKIP-VNATI---DLSFNN 257
N + + S+ LNL N L + + + + + A + +L NN
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 258 LTGE 261
L +
Sbjct: 179 LASK 182
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 28/144 (19%), Positives = 50/144 (34%), Gaps = 27/144 (18%)
Query: 107 LQYLDLSNNSLN----GSLSFSLFNA-SQLRNLDLSNNLIS----GHLPETMGSLHN-LQ 156
+ L+L N+L L+ L + + + +LDLS NL+ L S+ N +
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 157 LLNLSDNAL----AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLING 212
LNL N L L + +L+ L V L + + Q L + N
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE-----QCKALGAAFPNI 283
Query: 213 SLPPDIGGYSLRYLNLSYNRLSGE 236
+ ++ + +
Sbjct: 284 Q--------KIILVDKNGKEIHPS 299
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 51/249 (20%), Positives = 89/249 (35%), Gaps = 69/249 (27%)
Query: 481 YILGA---SGS-SIMYKAV-LEDGTALAVRRI-------GENSVDRFRDFETQVRVIAKL 528
Y +G SG +I+ K G A + I V R + E +V ++ ++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNILREI 65
Query: 529 VHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAK 583
HPN++ + + + ++I + V G L + EA + K
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED---------EAT-QFLK 115
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSA 639
+ G+ +LH K+ H +LKP N++L + P K+ DFG+ + G+
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT- 174
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
P + APE + + D++S G
Sbjct: 175 -------------------PE-----------------FVAPEIVNYEPLGLEADMWSIG 198
Query: 700 VILLELLTG 708
VI LL+G
Sbjct: 199 VITYILLSG 207
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 25/101 (24%), Positives = 32/101 (31%), Gaps = 2/101 (1%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSL-SFSLFNASQLRNLDLSNNLISGHLPET 148
L E L L + N L L +LRNL + + + P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 149 MGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189
L LNLS NAL L SL + L N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 26/112 (23%), Positives = 38/112 (33%), Gaps = 24/112 (21%)
Query: 124 SLFNASQLRNLDLSNNLISGHLP-ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
L A L L + N HL + L L+ L + + +
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG----------------LR 69
Query: 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI-GGYSLRYLNLSYNRL 233
+ + F P + L+LS N + SL G SL+ L LS N L
Sbjct: 70 FVAPDAFH-FTPR----LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 53/249 (21%), Positives = 87/249 (34%), Gaps = 69/249 (27%)
Query: 481 YILGA---SGS-SIMYKAV-LEDGTALAVRRI-------GENSVDRFRDFETQVRVIAKL 528
Y G SG +++ K G A + I V R D E +V ++ ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSILKEI 71
Query: 529 VHPNLVRIRGFYWGVDEKLIIYDFVPNGSL-----ANARYRKMGSSPCHLPWEARLKIAK 583
HPN++ + Y + ++I + V G L + EA + K
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE---------EAT-EFLK 121
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSA 639
+ G+ +LH + H +LKP N++L + P KI DFGL + G+
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT- 180
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
P + APE + + D++S G
Sbjct: 181 -------------------PE-----------------FVAPEIVNYEPLGLEADMWSIG 204
Query: 700 VILLELLTG 708
VI LL+G
Sbjct: 205 VITYILLSG 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 67/312 (21%), Positives = 108/312 (34%), Gaps = 77/312 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGF 539
LG SI K V + A AV+ I + + + ++ + HPN+V++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHV 598
+ ++ + + G L R +K H EA I + + ++ +H+ V
Sbjct: 75 FHDQLHTFLVMELLNGGELFE-RIKKKK----HFSETEAS-YIMRKLVSAVSHMHDVGVV 128
Query: 599 HGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSS-SKAGGSARNFGSKRSTASRDSF 654
H +LKP N+L + ++E KI DFG RL D +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL--------------- 173
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714
Y APE L + D++S GVIL +L+G+V
Sbjct: 174 ----------------------HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211
Query: 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGK------EEA--LLSCFKLGYSCASPL--- 763
+ + I+ D FEG+ +EA L+ L L
Sbjct: 212 HDRSLTCTSAVEIMKKIKKGD----FSFEGEAWKNVSQEAKDLIQ--GL-------LTVD 258
Query: 764 PQKRPSMKEALQ 775
P KR M
Sbjct: 259 PNKRLKMSGLRY 270
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 67/320 (20%), Positives = 111/320 (34%), Gaps = 70/320 (21%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGF 539
+LG + + + L AV+ I + +V ++ + H N++ + F
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHV 598
+ D ++++ + GS+ + K H EA + + VA L FLH K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILS-HIHKRR----HFNELEAS-VVVQDVASALDFLHNKGIA 133
Query: 599 HGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
H +LKP N+L + + KI DF L + +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN----------------------GDCS 171
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW-----DVYSFGVILLELLTGKV 710
+ +P S Y APE + + D++S GVIL LL+G
Sbjct: 172 PISTPELLTPCGSAE-------YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 711 IVVDELGQGNGLLVEDKNRAI--RLADAAIRA--DFEGK------EEA--LLSCFKLGYS 758
V G G + A L ++ +F K A L+S KL
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS--KL--- 279
Query: 759 CASPL---PQKRPSMKEALQ 775
L ++R S + LQ
Sbjct: 280 ----LVRDAKQRLSAAQVLQ 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 37/143 (25%), Positives = 72/143 (50%), Gaps = 13/143 (9%)
Query: 484 GASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
G+ G+ +Y A + + +A++++ G+ S ++++D +VR + KL HPN ++ RG
Sbjct: 65 GSFGA--VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 540 YWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
Y + ++ ++ GS ++ + L + G +GLA+LH +
Sbjct: 123 YL-REHTAWLVMEYCL-GSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 599 HGNLKPRNVLLGNDMEPKIGDFG 621
H ++K N+LL K+GDFG
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFG 199
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 36/114 (31%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 76 EGNNDSRVIGLALPNSQL-LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNL 134
+ V L L N + G I L++L L N L S+S +L +L+ L
Sbjct: 19 RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKL 76
Query: 135 DLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNN 187
+LS N I G L L NL LNLS N L + L L+ L + L N
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 30/128 (23%), Positives = 48/128 (37%), Gaps = 26/128 (20%)
Query: 107 LQYLDLSNNSLN-GSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSLHNLQLLNLSDN 163
++ L L N N G + L L L N + +LP L L+ L LS+N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSEN 81
Query: 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSL 223
+ G L + L +LT ++L N D ++++ L L L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKD-----ISTLEPLK--------KLE------CL 122
Query: 224 RYLNLSYN 231
+ L+L
Sbjct: 123 KSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 14/111 (12%)
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS-DGLPSKFNSVQVLDLSSNLING 212
+ + L + P ++ L + + K+N +GL ++F +++ L L + +
Sbjct: 7 GMDMKRRIHLELRNRTPAAVREL---VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI- 62
Query: 213 SLPPDIGG----YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ L+ L LS NR+ G EK+P ++LS N L
Sbjct: 63 ----SVSNLPKLPKLKKLELSENRIFG-GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFN-ASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L+ +DLSNN ++ L+ F L +L L N I+ LP+++ L +LQLL L+ N
Sbjct: 58 LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK 115
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSN 208
+ + L +L ++SL +N G S ++Q + L+ N
Sbjct: 116 INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 37/142 (26%), Positives = 56/142 (39%), Gaps = 34/142 (23%)
Query: 97 IPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPE-TMGSLHN 154
+P + + L N++ + F +LR +DLSNN IS L L +
Sbjct: 30 LPETI------TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 155 LQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSL 214
L L L N + L + F +GL S+Q+L L++N IN L
Sbjct: 82 LNSLVLYGNKIT----------------ELPKSLF-EGLF----SLQLLLLNANKIN-CL 119
Query: 215 PPDIGGY--SLRYLNLSYNRLS 234
D +L L+L N+L
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 6/105 (5%)
Query: 86 LALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLIS 142
+ L N+Q+ + D G+ L L L N + L SLF L+ L L+ N I+
Sbjct: 61 IDLSNNQI-SELAPDAFQGLRS-LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 143 GHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187
+ LHNL LL+L DN L + + L+++ + L N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)
Query: 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS-------DGLPSKFNSVQVLDLS 206
+ + L N + P + + + L + L NN S GL S+ L L
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR----SLNSLVLY 88
Query: 207 SNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
N I LP + G +SL+ L L+ N+++ + + + + L N L
Sbjct: 89 GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 49/231 (21%), Positives = 89/231 (38%), Gaps = 46/231 (19%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
ILG ++K G LA + I + + + ++ V+ +L H NL+++ +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHVH 599
++ +++ ++V G L + ++ +L + K + G+ +H+ +H
Sbjct: 156 ESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTI-LFMKQICEGIRHMHQMYILH 210
Query: 600 GNLKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+LKP N+L N KI DFGL R NFG+
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NFGT------------- 251
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
P + APE + + D++S GVI LL+G
Sbjct: 252 -PE-----------------FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 32/197 (16%), Positives = 59/197 (29%), Gaps = 42/197 (21%)
Query: 107 LQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLISG----HLPETMGSLHNLQLL 158
++ L +++ S+ L ++ + LS N I L E + S +L++
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 159 NLSDNAL----------AGKLPVSLTTLQSLTIVSLKNNYFSD-------GLPSKFNSVQ 201
SD L +L L V L +N F SK ++
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 202 VLDLSSNLI--------------NGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPV 247
L L +N + LR + NRL ++ +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 248 NATI---DLSFNNLTGE 261
+ + + N + E
Sbjct: 186 HRLLHTVKMVQNGIRPE 202
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 26/204 (12%), Positives = 51/204 (25%), Gaps = 55/204 (26%)
Query: 107 LQYLDLSNNSLN----------GSLSFSLFNASQLRNLDLSNNLISG----HLPETMGSL 152
L+ + S+ L +L +L + LS+N L + +
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 153 HNLQLLNLSDN--------ALAGKLP-----VSLTTLQSLTIVSLKNN--------YFSD 191
L+ L L +N +A L L + N ++
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 192 GLPSKFNSVQVLDLSSNLINGSLPPDIGGY-----------SLRYLNLSYNRLSGEIPPQ 240
+ + + N I G L+ L+L N +
Sbjct: 182 TF-QSHRLLHTVKMVQNGIR-----PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235
Query: 241 FGEKIPVNAT---IDLSFNNLTGE 261
+ + L+ L+
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 36/199 (18%), Positives = 66/199 (33%), Gaps = 52/199 (26%)
Query: 107 LQYLDLSNNSL-------------NGSLSFSLFNASQLRNLDLSNNLISG----HLPETM 149
L++L L NN L +++ NA LR++ N + +T
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 150 GSLHNLQLLNLSDNAL-----AGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSK 196
S L + + N + L L Q L ++ L++N F+ L S
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 197 FNSVQVLDLSSNLINGSLPPDIGGY------------SLRYLNLSYNRLSGEIPPQFGEK 244
+++ L L+ L++ G L+ L L YN + +
Sbjct: 244 -PNLRELGLNDCLLS-----ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 245 IPVNAT----IDLSFNNLT 259
I ++L+ N +
Sbjct: 298 IDEKMPDLLFLELNGNRFS 316
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 28/141 (19%), Positives = 55/141 (39%), Gaps = 21/141 (14%)
Query: 110 LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL 169
L + + +L ++L LS N I + ++ + NL++L+L N + K+
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 170 PVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLIN--------GSLPPDIG 219
+L + + N + G+ K +++VL +S+N I +L
Sbjct: 86 ENLDAVADTLEELWISYNQIASLSGI-EKLVNLRVLYMSNNKITNWGEIDKLAALD---- 140
Query: 220 GYSLRYLNLSYNRLSGEIPPQ 240
L L L+ N L +
Sbjct: 141 --KLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 4/88 (4%)
Query: 101 LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160
L +E L+ L L N + + A L L +S N I+ L + L NL++L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122
Query: 161 SDNALAGKLPVS-LTTLQSLTIVSLKNN 187
S+N + + L L L + L N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 86 LALPNSQL-LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH 144
L L NS+ G + E L++L N L S++ +L ++L+ L+LS+N +SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGG 79
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNN 187
L NL LNLS N + + L L++L + L N
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 26/128 (20%)
Query: 107 LQYLDLSNNSLN-GSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSLHNLQLLNLSDN 163
++ L L N+ N G L +L L N ++ +LP L+ L+ L LSDN
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDN 74
Query: 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSL 223
++G L V +LT ++L N D ++++ L L +L
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKD-----LSTIEPL--------KKLE------NL 115
Query: 224 RYLNLSYN 231
+ L+L
Sbjct: 116 KSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 11/93 (11%)
Query: 172 SLTTLQSLTIVSLKNNYFS-DGLPSKFNSVQVLDLSSNLINGSLPPDIGG----YSLRYL 226
+ + ++ L + + ++N +GL +F ++ L + + I L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
LS NR+SG EK P ++LS N +
Sbjct: 70 ELSDNRVSG-GLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/274 (19%), Positives = 94/274 (34%), Gaps = 69/274 (25%)
Query: 452 HERQNKKGTLVIVDG--DKELELETLLKASAYILGASGSSIMYKAV-LEDGTALAVRRIG 508
H + G V+ G K+ + + S +LG + + + G A++ +
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL- 62
Query: 509 ENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY----WGVDEKLIIYDFVPNGSL------ 558
+S ++ + + P++V I Y G LII + + G L
Sbjct: 63 YDSPKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE 119
Query: 559 -ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DME 614
+ + + EA +I + + + FLH H ++KP N+L + D
Sbjct: 120 RGDQAFTER---------EAA-EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV 169
Query: 615 PKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG 674
K+ DFG + T + + +P
Sbjct: 170 LKLTDFGFAKETTQNALQTPCY-------------------------TP----------- 193
Query: 675 ISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
Y APE L K + D++S GVI+ LL G
Sbjct: 194 --YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 40/235 (17%), Positives = 84/235 (35%), Gaps = 55/235 (23%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGF 539
+G S+ + + AV+ I ++ D ++ ++ + HPN++ ++
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV 84
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLP-WEARLKIAKGVARGLAFLHEKKHV 598
Y ++ + + G L + + + EA + + + + +LH + V
Sbjct: 85 YDDGKYVYVVTELMKGGELLD-KILRQK----FFSEREAS-AVLFTITKTVEYLHAQGVV 138
Query: 599 HGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSS-SKAGGSARNFGSKRSTASRDS 653
H +LKP N+L ++ +I DFG + + + +A
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA-------------- 184
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
+ APE L + D++S GV+L +LTG
Sbjct: 185 -----------------------NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 14/129 (10%)
Query: 110 LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSLHNLQLLNLSDNALAG 167
+ L+ + + NA + R LDL I +L T L ++ SDN +
Sbjct: 2 VKLTAELIEQAAQ--YTNAVRDRELDLRGYKIPVIENLGAT---LDQFDAIDFSDNEIR- 55
Query: 168 KLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSNLIN--GSLPPDIGGYS 222
KL L+ L + + NN +GL + L L++N + G L P S
Sbjct: 56 KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 223 LRYLNLSYN 231
L YL + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+D S+N + L +L+ L ++NN I +L +L L L++N+L
Sbjct: 44 FDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
Query: 167 GKLPVS-LTTLQSLTIVSLKNN 187
+ L +L+SLT + + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 18/108 (16%), Positives = 36/108 (33%), Gaps = 14/108 (12%)
Query: 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKFNSVQVLDLSSNLINGSLP 215
+ L+ + T + L+ L + + +D S N I
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI----- 54
Query: 216 PDIGG----YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
+ G L+ L ++ NR+ I + +P + L+ N+L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV 101
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 38/179 (21%), Positives = 65/179 (36%), Gaps = 46/179 (25%)
Query: 64 CSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSF 123
C V C++ L IP + ++ L L+NN +
Sbjct: 11 CEGTTVDCSNQK------------------LNKIPEHIP--QYTAELRLNNNEFTVLEAT 50
Query: 124 SLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182
+F QLR ++ SNN I+ + + L+ N L
Sbjct: 51 GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE---------------- 94
Query: 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPP 239
++++ F GL S++ L L SN I + D G S+R L+L N+++ + P
Sbjct: 95 NVQHKMF-KGLE----SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 7/107 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFN-ASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L+ ++ SNN + + F AS + + L++N + + M L +L+ L L N
Sbjct: 59 LRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNR 116
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSN 208
+ S L S+ ++SL +N + G +S+ L+L +N
Sbjct: 117 ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+ L L +N + + F S +R L L +N I+ P +LH+L LNL N
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 45/190 (23%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMG--SSPCHLPWEARL 579
V+++L HP V++ F + DEKL + NG L RK+G C R
Sbjct: 82 DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLK-YIRKIGSFDETC-----TRF 134
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
A+ + L +LH K +H +LKP N+LL DM +I DFG ++++ ++ ++A
Sbjct: 135 YTAE-IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---- 189
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
+S G + Y +PE L D+++ G
Sbjct: 190 ------------------------------NSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 700 VILLELLTGK 709
I+ +L+ G
Sbjct: 220 CIIYQLVAGL 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 50/220 (22%), Positives = 83/220 (37%), Gaps = 56/220 (25%)
Query: 499 GTALAVRRIGENSVDRFRDFETQVRVIA--KLV-HPNLVRIRGFYWGVDEKLIIY---DF 552
G +AV+ + + R I KL HP+++++ Y + + ++
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL---YQVISTPTDFFMVMEY 92
Query: 553 VPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
V G L + ++ ++ EAR ++ + + + + H VH +LKP NVLL
Sbjct: 93 VSGGELFDYICKHGRVEEM------EAR-RLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPS 670
M KI DFGL +++ + GS P
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRTSCGS--------------------P----------- 174
Query: 671 SLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTGK 709
Y APE + P+ D++S GVIL LL G
Sbjct: 175 ------NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 34/219 (15%), Positives = 71/219 (32%), Gaps = 67/219 (30%)
Query: 505 RRIGENSVDRFRDFET---QVRVIAKLVHPNLVRI------RGFYWGVDEKLI----IYD 551
++ E+ ++ +++++ H N++++ +GF+ V EK ++
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFA 119
Query: 552 F-VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610
F + L A I + + + +L K +H ++K N+++
Sbjct: 120 FIDRHPRLDEP--------------LAS-YIFRQLVSAVGYLRLKDIIHRDIKDENIVIA 164
Query: 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPS 670
D K+ DFG + G+
Sbjct: 165 EDFTIKLIDFGSAAYLERGKLFYTFCGT--------------------I----------- 193
Query: 671 SLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTG 708
Y APE L P+ +++S GV L L+
Sbjct: 194 ------EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 2e-08
Identities = 25/184 (13%), Positives = 65/184 (35%), Gaps = 31/184 (16%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGS-- 151
+ L + L L + + +LS L++L++ + + + E +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 152 LHNLQLLNL---SDNALAGKLPVSL------TTLQSLTIVSLKNNYFSDGLPSKF----- 197
L NL+ L L ++ +L + + + + + F
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 198 -NSVQVLDLSSNLIN--------GSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVN 248
++ +D+S+ ++ + L+++N+ YN LS E+ + + +P+
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKI---KHLKFINMKYNYLSDEMKKELQKSLPMK 334
Query: 249 ATID 252
+
Sbjct: 335 IDVS 338
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 48/216 (22%), Positives = 77/216 (35%), Gaps = 74/216 (34%)
Query: 513 DRFRDFETQVR---VIAKLV-HPNLVRIRGFYWGVDEKLIIY---DFVPNGSLAN--ARY 563
R D ++ I K++ H N+V+ FY E I Y ++ G L +
Sbjct: 43 KRAVDCPENIKKEICINKMLNHENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPD 99
Query: 564 RKMGSSPCHLPWEARLK----IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619
M +A+ +A G+ +LH H ++KP N+LL KI D
Sbjct: 100 IGMP------EPDAQRFFHQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
Query: 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL------GPGPSPSPSPSPSSLG 673
FGL +T R + ++ G +
Sbjct: 149 FGL------------------------ATVFRYNNRERLLNKMCG---TL---------- 171
Query: 674 GISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTG 708
PY APE L+ + + DV+S G++L +L G
Sbjct: 172 ---PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/254 (19%), Positives = 84/254 (33%), Gaps = 56/254 (22%)
Query: 573 LPWEARLKIAKGVARGLAFLHEKKH-VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631
LP KI + V +GL +LH K +H ++KP N+LL + E I E +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN-EQYIRRLAAEATEWQRSG 201
Query: 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGG-----------ISP--Y 678
+ G + +TA L P + + LG I Y
Sbjct: 202 APPPSG--SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQY 259
Query: 679 HAPESLRSIKPNPKWDVYSFGVILLELLTGKVI------------------VVDELGQ-- 718
+ E L N D++S + EL TG + +++ LG+
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319
Query: 719 ---------------GNGLLVEDKN-RAIRLADAAIRA-DFEGKEEALLSCFKLGYSCAS 761
G L + L + + ++ +E A + F
Sbjct: 320 RKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF--LLPMLE 377
Query: 762 PLPQKRPSMKEALQ 775
+P+KR + E L+
Sbjct: 378 LIPEKRATAAECLR 391
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 80/512 (15%), Positives = 156/512 (30%), Gaps = 135/512 (26%)
Query: 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL-- 165
Y++ + N + F+ +N S R + L LL L
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVS--R-------------LQPYLKLRQA-LLELRPAKNVL 154
Query: 166 ------AGKLPVSLTTLQSLTI----------VSLKNNYFSDGLPSKFNSV------QVL 203
+GK V+L S + ++LKN + + +
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 204 DLSSNLINGSLPPDIGGYSLRYL--NLSYNR-L-------SGEIPPQF--GEKIPVNATI 251
S + N L LR L + Y L + + F KI + T
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-TTR 273
Query: 252 DLSFNNLTGEIPESNVFMNQESSSFSG--NLDLCGQPTKNPCPIPSSPFDLPNTTAPTSP 309
+ +++ ++ S + + L + P DLP T+P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC------RPQDLPREVLTTNP 327
Query: 310 PAIAAIPKSIDSTPAT-----NPDDGSVSKPRQEGSQGLRPG------------------ 346
++ I +SI AT + + ++ + L P
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 347 --TIIGIVIGDIAGIGILAVV-FFYVYRLIKRKNVEST-------LKKEANSAKDTVSFS 396
++ ++ D+ ++ VV + Y L++++ EST L+ + +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY---- 443
Query: 397 PSSSSSESRGFTRWSCLRKRGDGDEESDASVSDVEDNY---HSGRKLSVDNQRQQDHVHE 453
+ ++ + D D+ D Y H G L ++ +
Sbjct: 444 ----ALHRSIVDHYNIPKTF-DSDDLIP----PYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 454 RQNKKGTLVIVDGDKELE-LETLLKASAYILGASGSSI-------MYKAVLEDGTALAVR 505
V +D LE ++ + ASGS + YK + D R
Sbjct: 495 M-------VFLD----FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543
Query: 506 RIGENSVDRF-RDFETQVRVIAKLVHPNLVRI 536
+ N++ F E + + +K + +L+RI
Sbjct: 544 LV--NAILDFLPKIEENL-ICSK--YTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 8e-07
Identities = 80/526 (15%), Positives = 139/526 (26%), Gaps = 176/526 (33%)
Query: 376 KNVESTLKKEANSAK-DTVSFSPSSSSSESRGFTRWSCLRKR--------GDGDE----- 421
K+V+ K + + D + S + S R F W+ L K+ +
Sbjct: 36 KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKF 93
Query: 422 ------ESDASVSDVEDNYHSGR-KLSVDNQR-QQDHVHERQNKKGTLVIVDGDKELELE 473
S + Y R +L DNQ + +V R L ++ LE
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV-SRLQPYLKL------RQALLE 146
Query: 474 TLLKASAYIL--GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHP 531
L+ + +L G GS K + V DF
Sbjct: 147 --LRPAKNVLIDGVLGSG---KTWV---ALDVCL---SYKVQCKMDF------------- 182
Query: 532 NLVRIRGFYW------GVDEKLIIYDFVPNGSLANARYR--KMGSSPCHLPWEARLKIAK 583
+W E ++ L Y+ +S +L+I
Sbjct: 183 ------KIFWLNLKNCNSPETVLE-------MLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 584 GVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD-FGLE-R-LV-TGDTSSSKAGGSA 639
A L K + + L NV + K + F L + L+ T + +A
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNV---QN--AKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 640 RNFGSKRSTASRDSFQDLGPGPSP-------------SPSPSPSSLGGISPYH---APES 683
T + S +P P P + +P ES
Sbjct: 285 --------TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 684 LRSIKPNPKWDVY-----------------------------SFGV------I---LLEL 705
+R WD + V I LL L
Sbjct: 337 IRD-GLA-TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394
Query: 706 LTGKVI------VVDELGQGNGLLVED-KNRAIRLADAAIRADFEGKEEA-----LLSCF 753
+ VI VV++L L+ + K I + + + + E ++ +
Sbjct: 395 IWFDVIKSDVMVVVNKL-HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 754 KL--GYSCASPLPQKRPS---------MKEALQALEKIPSSPSPYL 788
+ + +P +K E++ +L
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFRMVFL 498
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 44/236 (18%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 483 LGASGSSIMYKAV-LEDGTALAV-----RRIGENSVDRFRDFETQVRVIAKLVH-PNLVR 535
LG +++ + + G A RR G++ + ++ V+ P ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVIN 93
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ Y E ++I ++ G + + + + +++ K + G+ +LH+
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFS---LCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 596 KHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
VH +LKP+N+LL + KI DFG+ R + + G+
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT-------------- 196
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
P Y APE L D+++ G+I LLT
Sbjct: 197 ------PE-----------------YLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 37/125 (29%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G+ LH +H +LKP N+++ +D KI DFGL R + +F
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFMMTP 185
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
+R Y APE + + D++S G I+ E++
Sbjct: 186 YVVTR-------------------------YYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 707 TGKVI 711
G V+
Sbjct: 221 KGGVL 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 30/129 (23%), Positives = 51/129 (39%), Gaps = 33/129 (25%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
R + LH +H +LKP N+L+ ++ + K+ DFGL R++ + + ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG---- 178
Query: 647 ST---ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVIL 702
A+R Y APE + + + DV+S G IL
Sbjct: 179 MVEFVATR-------------------------WYRAPEVMLTSAKYSRAMDVWSCGCIL 213
Query: 703 LELLTGKVI 711
EL + I
Sbjct: 214 AELFLRRPI 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 48/216 (22%), Positives = 77/216 (35%), Gaps = 74/216 (34%)
Query: 513 DRFRDFETQVR---VIAKLV-HPNLVRIRGFYWGVDEKLIIY---DFVPNGSLAN--ARY 563
R D ++ I K++ H N+V+ FY E I Y ++ G L +
Sbjct: 43 KRAVDCPENIKKEICINKMLNHENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPD 99
Query: 564 RKMGSSPCHLPWEARLK----IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619
M +A+ +A G+ +LH H ++KP N+LL KI D
Sbjct: 100 IGMP------EPDAQRFFHQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
Query: 620 FGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL------GPGPSPSPSPSPSSLG 673
FGL +T R + ++ G +
Sbjct: 149 FGL------------------------ATVFRYNNRERLLNKMCG---TL---------- 171
Query: 674 GISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTG 708
PY APE L+ + + DV+S G++L +L G
Sbjct: 172 ---PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 32/141 (22%), Positives = 46/141 (32%), Gaps = 24/141 (17%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G+ ++H +H +LKP N L+ D K+ DFGL AR
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL----------------ARTVDYPE 210
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGIS-------PYHAPESLRSIKP-NPKWDVYSF 698
+ S+ + P +L Y APE + + DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
Query: 699 GVILLELLTGKVIVVDELGQG 719
G I ELL V
Sbjct: 271 GCIFAELLNMIKENVAYHADR 291
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 28/125 (22%), Positives = 47/125 (37%), Gaps = 37/125 (29%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G+ LH +H +LKP N+++ +D KI DFGL R + +F
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFMMTP 222
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706
+R Y APE + + D++S G I+ E++
Sbjct: 223 YVVTR-------------------------YYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
Query: 707 TGKVI 711
K++
Sbjct: 258 RHKIL 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 46/245 (18%), Positives = 79/245 (32%), Gaps = 72/245 (29%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGF 539
+LG + + + A++ + +V + + P++VRI
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 540 Y----WGVDEKLIIYDFVPNGSL-------ANARY--RKMGSSPCHLPWEARLKIAKGVA 586
Y G LI+ + + G L + + R EA +I K +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----------EAS-EIMKSIG 171
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFG 643
+ +LH H ++KP N+L + K+ DFG + T S + +
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---- 227
Query: 644 SKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703
Y APE L K + D++S GVI+
Sbjct: 228 ---------------------------------YYVAPEVLGPEKYDKSCDMWSLGVIMY 254
Query: 704 ELLTG 708
LL G
Sbjct: 255 ILLCG 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 47/254 (18%), Positives = 91/254 (35%), Gaps = 67/254 (26%)
Query: 484 GASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
G G + G ++A++++ ++ R R+ + ++ +A L HPN+V+++ +++
Sbjct: 34 GTFG--TVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSYFYT 90
Query: 543 VDEK-------LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ E+ ++ ++VP+ +L + R P + R + LH
Sbjct: 91 LGERDRRDIYLNVVMEYVPD-TL-HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 596 KH--VHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST---- 648
H ++KP NVL+ D K+ DFG A+
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGS----------------AKKLSPSEPNVAYI 192
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILLELLT 707
SR Y APE + D++S G I E++
Sbjct: 193 CSR-------------------------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 708 GKVI-----VVDEL 716
G+ I +L
Sbjct: 228 GEPIFRGDNSAGQL 241
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 33/127 (25%), Positives = 47/127 (37%), Gaps = 19/127 (14%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
G F+HE +H +LKP N LL D K+ DFGL AR S++
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL----------------ARTINSEK 183
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGIS--PYHAPE-SLRSIKPNPKWDVYSFGVILL 703
T + ++ + + + Y APE L D++S G I
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 704 ELLTGKV 710
ELL
Sbjct: 244 ELLNMLQ 250
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 38/123 (30%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
+ + H K VH +LKP N+LL +++ KI DFGL ++T + GS
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS--------- 170
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELL 706
P Y APE + P+ DV+S G++L +L
Sbjct: 171 -----------P-----------------NYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 707 TGK 709
G+
Sbjct: 203 VGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 46/192 (23%), Positives = 74/192 (38%), Gaps = 54/192 (28%)
Query: 525 IAKLV-HPNLVRIRGFYWGVDEKLIIY---DFVPNGSLAN--ARYRKMGSSPCHLPWEAR 578
KL HP+++++ Y + I+ ++V G L + + ++ E+R
Sbjct: 69 NLKLFRHPHIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------ESR 119
Query: 579 LKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638
+ ++ G+ + H VH +LKP NVLL M KI DFGL +++ + GS
Sbjct: 120 RLFQQILS-GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 178
Query: 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYS 697
P Y APE + P+ D++S
Sbjct: 179 --------------------P-----------------NYAAPEVISGRLYAGPEVDIWS 201
Query: 698 FGVILLELLTGK 709
GVIL LL G
Sbjct: 202 SGVILYALLCGT 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 33/132 (25%), Positives = 53/132 (40%), Gaps = 28/132 (21%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+ + +LH +H ++KP N+LL + K+ DFGL +R+F + R
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL----------------SRSFVNIR 163
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISP------YHAPES-LRSIKPNPKWDVYSFG 699
+ + + ++ Y APE L S K D++S G
Sbjct: 164 RVTNNIP-----LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 700 VILLELLTGKVI 711
IL E+L GK I
Sbjct: 219 CILGEILCGKPI 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 32/129 (24%), Positives = 46/129 (35%), Gaps = 49/129 (37%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL FLH + VH +LKP+N+L+ + + K+ DFGL AR +
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL----------------ARIYS--- 171
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISP------YHAPESLRSIKPNPKWDVYSFGV 700
+L + Y APE L D++S G
Sbjct: 172 ---------------------FQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 207
Query: 701 ILLELLTGK 709
I E+ K
Sbjct: 208 IFAEMFRRK 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 36/137 (26%), Positives = 51/137 (37%), Gaps = 47/137 (34%)
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKAGG 637
K A + + L LH+ + +H +LKP N+LL K+ DFG SS
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---------SSC---- 250
Query: 638 SARNFGSKRSTA---SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWD 694
+ +R SR F Y APE + + D
Sbjct: 251 ----YEHQRVYTYIQSR--F-----------------------YRAPEVILGARYGMPID 281
Query: 695 VYSFGVILLELLTGKVI 711
++S G IL ELLTG +
Sbjct: 282 MWSLGCILAELLTGYPL 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 37/124 (29%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RG+A H+ + +H +LKP+N+L+ +D K+ DFGL AR FG
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL----------------ARAFGI-- 171
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLEL 705
P S + +L Y AP+ L S K + D++S G I E+
Sbjct: 172 --------------PVRSYTHEVVTLW----YRAPDVLMGSKKYSTSVDIWSIGCIFAEM 213
Query: 706 LTGK 709
+TGK
Sbjct: 214 ITGK 217
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 28/176 (15%), Positives = 56/176 (31%), Gaps = 40/176 (22%)
Query: 105 EFLQYLDLSNNSLNGS----LSFSL-FNASQLRNLDLSNNLISGH-LPETMGSLHNLQLL 158
L+ L+L+ + ++ L L ++L++ + L + + L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 159 NLSDN--------ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVL--DLSSN 208
L N L L + +L L NN + V VL L+ N
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTL---RLSNNPLTA------AGVAVLMEGLAGN 182
Query: 209 LINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI---DLSFNNLTGE 261
S+ +L+L + L E ++ N + ++++N
Sbjct: 183 ------------TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 32/141 (22%), Positives = 48/141 (34%), Gaps = 29/141 (20%)
Query: 107 LQYLDLSNNSLN----GSLSFSL-FNASQLRNLDLSNNLISG----HLPETMGSLHNLQL 157
+ L L NSL L L + Q+ L LSNN ++ L E + ++
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187
Query: 158 LNLSDNAL----AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGS 213
L+L L L L + L +++ N D L L+
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD--------TAALALARAAREHP 239
Query: 214 LPPDIGGYSLRYLNLSYNRLS 234
SL L+L +N LS
Sbjct: 240 --------SLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 25/157 (15%), Positives = 44/157 (28%), Gaps = 16/157 (10%)
Query: 107 LQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLIS----GHLPETMGSLHNLQLL 158
LQ L+++ N + L+ + L L L N +S L + G+ +
Sbjct: 213 LQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARV 272
Query: 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI 218
+S L VS L+ V N + + + + DL + P
Sbjct: 273 VVS---LTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRK 329
Query: 219 GGY-----SLRYLNLSYNRLSGEIPPQFGEKIPVNAT 250
+R L + A
Sbjct: 330 AQLLRVEGEVRALLEQLGSSGSPSGSWSHPQFEKGAG 366
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 30/132 (22%), Positives = 42/132 (31%), Gaps = 45/132 (34%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
GL ++H K +H ++K NVL+ D K+ DFGL AR F
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL----------------ARAFS--- 175
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISP------YHAPESLR-SIKPNPKWDVYSFG 699
S + Y PE L P D++ G
Sbjct: 176 -------------------LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 700 VILLELLTGKVI 711
I+ E+ T I
Sbjct: 217 CIMAEMWTRSPI 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 37/190 (19%), Positives = 72/190 (37%), Gaps = 44/190 (23%)
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
+R++ +L HPNLV + + +L +++++ + ++ ++ +P
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEYCDH-TV----LHELDRYQRGVPEHLVKS 106
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
I + + F H+ +H ++KP N+L+ K+ DFG AR
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF----------------AR 150
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFG 699
PS ++ Y +PE L + P DV++ G
Sbjct: 151 LLTG----------------PSDYYDDEVATRW----YRSPELLVGDTQYGPPVDVWAIG 190
Query: 700 VILLELLTGK 709
+ ELL+G
Sbjct: 191 CVFAELLSGV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 32/129 (24%), Positives = 43/129 (33%), Gaps = 49/129 (37%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL FLH VH +LKP N+L+ + K+ DFGL AR +
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL----------------ARIYSY-- 172
Query: 647 STASRDSFQDLGPGPSPSPSPSPSSLGGISP------YHAPESLRSIKPNPKWDVYSFGV 700
++P Y APE L D++S G
Sbjct: 173 --------------QMA-----------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207
Query: 701 ILLELLTGK 709
I E+ K
Sbjct: 208 IFAEMFRRK 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 36/230 (15%), Positives = 73/230 (31%), Gaps = 64/230 (27%)
Query: 496 LEDGTALAVRRIGENSVDRFRDFETQVRV-----IAKLV---HPNLVRIRGFYWGVDEKL 547
+ D +A++ + ++ + + + RV + K V ++R+ ++ D +
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 548 IIYDFV-PNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKP 604
+I + P L + + AR V + H +H ++K
Sbjct: 125 LILERPEPVQDLFDFITERGALQEE------LAR-SFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 605 RNVLL-GNDMEPKIGDFGLERLVTG---DTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
N+L+ N E K+ DFG L+
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD---------------------------- 209
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGK 709
G Y PE +R + V+S G++L +++ G
Sbjct: 210 -------------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 16/38 (42%), Positives = 26/38 (68%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+GL F H + +H +LKP+N+L+ + E K+ +FGL R
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 17/38 (44%), Positives = 26/38 (68%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+GLAF H + +H +LKP+N+L+ + K+ DFGL R
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 17/38 (44%), Positives = 28/38 (73%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
G+A+ H+++ +H +LKP+N+L+ + E KI DFGL R
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 80/249 (32%)
Query: 492 YKAV---LEDGTALAVRRIGENSVDRFRDFETQVRVIA---KLVHPNLVRIRG-FYWGVD 544
YKA +D A+++I + + R IA +L HPN++ ++ F D
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKVFLSHAD 92
Query: 545 EKL-IIYDFVPN---GSLANARYRKMGSSPCHLPWEARLK-IAKGVARGLAFLHEKKHVH 599
K+ +++D+ + + R K P LP +K + + G+ +LH +H
Sbjct: 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDGIHYLHANWVLH 151
Query: 600 GNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+LKP N+L+ + KI D G AR F
Sbjct: 152 RDLKPANILVMGEGPERGRVKIADMGF----------------ARLFN------------ 183
Query: 656 DLGPGPSPSPSPSPSSLGGISP------YHAPESL-------RSIKPNPKWDVYSFGVIL 702
SP + L P Y APE L ++I D+++ G I
Sbjct: 184 --------SPLKPLADL---DPVVVTFWYRAPELLLGARHYTKAI------DIWAIGCIF 226
Query: 703 LELLTGKVI 711
ELLT + I
Sbjct: 227 AELLTSEPI 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 31/129 (24%), Positives = 43/129 (33%), Gaps = 44/129 (34%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
GL LHE VH +L P N+LL ++ + I DF L R T D
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---------------N 189
Query: 647 ST---ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVIL 702
T R Y APE + K D++S G ++
Sbjct: 190 KTHYVTHR-------------------------WYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 703 LELLTGKVI 711
E+ K +
Sbjct: 225 AEMFNRKAL 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 36/190 (18%), Positives = 72/190 (37%), Gaps = 44/190 (23%)
Query: 522 VRVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLK 580
++++ +L H NLV + ++ ++++FV + ++ + P L ++ K
Sbjct: 75 IKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDH-TI----LDDLELFPNGLDYQVVQK 128
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
+ G+ F H +H ++KP N+L+ K+ DFG AR
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF----------------AR 172
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFG 699
+ P ++ Y APE L +K DV++ G
Sbjct: 173 TLAA----------------PGEVYDDEVATRW----YRAPELLVGDVKYGKAVDVWAIG 212
Query: 700 VILLELLTGK 709
++ E+ G+
Sbjct: 213 CLVTEMFMGE 222
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 24/161 (14%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETM 149
+ + + + + +N+ + +R L L N + +
Sbjct: 27 KKKSVTDAVTQNELNS-IDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-----DI 78
Query: 150 G---SLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKNNYFS---DGLPSKFNSVQV 202
L NL L L+ N L LP + L +L + L N DG+ K ++
Sbjct: 79 SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137
Query: 203 LDLSSNLINGSLPPDIGGY----SLRYLNLSYNRLSGEIPP 239
L+L+ N + SLP G + +L L+LSYN+L +P
Sbjct: 138 LNLAHNQLQ-SLPK--GVFDKLTNLTELDLSYNQLQ-SLPE 174
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 28/142 (19%), Positives = 50/142 (35%), Gaps = 52/142 (36%)
Query: 580 KIAKGVARGLAFLHEKKHV-HGNLKPRNVLLGNDMEP------KIGDFGLERLVTGDTSS 632
+I+K + GL ++H + + H ++KP NVL+ P KI D G ++
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---------NA 185
Query: 633 SKAGGSARNFGSKRSTA---SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP 689
+ + T +R Y +PE L
Sbjct: 186 C--------WYDEHYTNSIQTR-------------------------EYRSPEVLLGAPW 212
Query: 690 NPKWDVYSFGVILLELLTGKVI 711
D++S ++ EL+TG +
Sbjct: 213 GCGADIWSTACLIFELITGDFL 234
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 36/236 (15%), Positives = 73/236 (30%), Gaps = 67/236 (28%)
Query: 492 YKAV-LEDGTALAVRRIGENSVDRFRDFETQVRV-----IAKLV-----HPNLVRIRGFY 540
+ L D +A++ I N V + V + V HP ++R+ ++
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107
Query: 541 WGVDEKLIIYDF-VPNGSLAN--ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ +++ + +P L + +G +R V + H +
Sbjct: 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEG------PSR-CFFGQVVAAIQHCHSRGV 160
Query: 598 VHGNLKPRNVLL-GNDMEPKIGDFGLERLVTG---DTSSSKAGGSARNFGSKRSTASRDS 653
VH ++K N+L+ K+ DFG L+
Sbjct: 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--------------------- 199
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTG 708
G Y PE + + + V+S G++L +++ G
Sbjct: 200 --------------------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 20/38 (52%), Positives = 28/38 (73%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+GLAF HE K +H +LKP+N+L+ + K+GDFGL R
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 46/209 (22%), Positives = 71/209 (33%), Gaps = 59/209 (28%)
Query: 512 VDRFRDFETQVR---VIAKLV-HPNLVRIRGFYWGVDEKLIIY---DFVPNGSLAN--AR 562
++R + V+ + + + HPN+VR F + + ++ G L
Sbjct: 53 IERGAAIDENVQREIINHRSLRHPNIVR---FKEVILTPTHLAIIMEYASGGELYERICN 109
Query: 563 YRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP--KIGDF 620
+ EAR + ++ G+++ H + H +LK N LL P KI DF
Sbjct: 110 AGRFSED------EARFFFQQLLS-GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF 162
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
G S S S P S G Y A
Sbjct: 163 GY--------SKSSVLHSQ-----------------------------PKSTVGTPAYIA 185
Query: 681 PESLRSIKPN-PKWDVYSFGVILLELLTG 708
PE L + + DV+S GV L +L G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 35/138 (25%), Positives = 52/138 (37%), Gaps = 47/138 (34%)
Query: 580 KIAKGVARGLAFLHEKKH--VHGNLKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKA 635
K A+ + L FL + +H +LKP N+LL N KI DF
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF--------------- 205
Query: 636 GGSARNFGSKRST--ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW 693
GS+ G + SR F Y +PE L + +
Sbjct: 206 -GSSCQLGQRIYQYIQSR--F-----------------------YRSPEVLLGMPYDLAI 239
Query: 694 DVYSFGVILLELLTGKVI 711
D++S G IL+E+ TG+ +
Sbjct: 240 DMWSLGCILVEMHTGEPL 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 35/129 (27%), Positives = 51/129 (39%), Gaps = 40/129 (31%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL ++H +H +LKP N+LL + KI DFGL R+ D +
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF----------- 187
Query: 647 ST---ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVIL 702
T A+R Y APE + + K D++S G IL
Sbjct: 188 LTEYVATR-------------------------WYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 703 LELLTGKVI 711
E+L+ + I
Sbjct: 223 AEMLSNRPI 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARY--RKMGSSPCHLPWEARL 579
+++ L HP LV + + + +E + ++ D + G L RY ++ E +
Sbjct: 67 QIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFK-----EETV 117
Query: 580 K--IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637
K I + + L +L ++ +H ++KP N+LL I DF + ++ +T
Sbjct: 118 KLFICE-LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI----- 171
Query: 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP---NPKWD 694
+++ G PY APE S K + D
Sbjct: 172 --------------------------------TTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 695 VYSFGVILLELLTGK 709
+S GV ELL G+
Sbjct: 200 WWSLGVTAYELLRGR 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 19/38 (50%), Positives = 27/38 (71%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
RGLA+ H +K +H +LKP+N+L+ E K+ DFGL R
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 35/128 (27%), Positives = 52/128 (40%), Gaps = 44/128 (34%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+GL ++H VH +LKP N+ + D E KI DFGL AR+ ++
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL----------------ARHADAEM 180
Query: 647 ST--ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILL 703
+ +R Y APE L + N D++S G I+
Sbjct: 181 TGYVVTR-------------------------WYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 704 ELLTGKVI 711
E+LTGK +
Sbjct: 216 EMLTGKTL 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 16/38 (42%), Positives = 25/38 (65%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+GL +LH+ +H +LKP N+LL + K+ DFGL +
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 40/190 (21%), Positives = 71/190 (37%), Gaps = 43/190 (22%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
+++AK+ +V + + + L ++ + G + Y +P A
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSA 639
A+ + GL LH++ ++ +LKP NVLL +D +I D GL E + AG
Sbjct: 296 AQ-IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG--- 351
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
T PG + APE L + + D ++ G
Sbjct: 352 --------T----------PG-----------------FMAPELLLGEEYDFSVDYFALG 376
Query: 700 VILLELLTGK 709
V L E++ +
Sbjct: 377 VTLYEMIAAR 386
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 44/128 (34%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
+GL ++H +H +LKP N+ + D E KI DFGL AR S+
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL----------------ARQADSEM 182
Query: 647 ST--ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILL 703
+ +R Y APE L ++ D++S G I+
Sbjct: 183 TGYVVTR-------------------------WYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 704 ELLTGKVI 711
E++TGK +
Sbjct: 218 EMITGKTL 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 46/190 (24%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARY--RKMGSSPCHLPWEARLK 580
+++ K+ +V + Y D ++ + G L ++ MG + A
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFPEA-RAVFY 291
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL-ERLVTGDTSSSKAGGSA 639
A+ + GL LH ++ V+ +LKP N+LL + +I D GL + G T + G
Sbjct: 292 AAE-ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG--- 347
Query: 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFG 699
T G Y APE +++ + D ++ G
Sbjct: 348 --------T----------VG-----------------YMAPEVVKNERYTFSPDWWALG 372
Query: 700 VILLELLTGK 709
+L E++ G+
Sbjct: 373 CLLYEMIAGQ 382
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 41/130 (31%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
RGL ++H +H +LKP N+ + D+ KIGDFGL R++ S
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH---------- 180
Query: 646 RST---ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVI 701
+ ++ Y +P L S D+++ G I
Sbjct: 181 -LSEGLVTK-------------------------WYRSPRLLLSPNNYTKAIDMWAAGCI 214
Query: 702 LLELLTGKVI 711
E+LTGK +
Sbjct: 215 FAEMLTGKTL 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 50/257 (19%), Positives = 102/257 (39%), Gaps = 80/257 (31%)
Query: 484 GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIA---KLVHPNLVRIRGFY 540
G+ G ++++A L + +A++++ +D + R + + HPN+V ++ F+
Sbjct: 51 GSFG--VVFQAKLVESDEVAIKKV-------LQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 541 WGVDEKL------IIYDFVPNGSLANARYRKM---GSSPCHLPWEARLKIAKG----VAR 587
+ +K ++ ++VP ++ YR +P + + K + R
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TV----YRASRHYAKLKQTMP----MLLIKLYMYQLLR 152
Query: 588 GLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLER-LVTGDTSSSKAGGSARNFGSK 645
LA++H H ++KP+N+LL K+ DFG + L+ G+ + S
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI---------- 202
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILLE 704
SR Y APE + D++S G ++ E
Sbjct: 203 ---CSR-------------------------YYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 705 LLTGKVI-----VVDEL 716
L+ G+ + +D+L
Sbjct: 235 LMQGQPLFPGESGIDQL 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 36/128 (28%), Positives = 52/128 (40%), Gaps = 44/128 (34%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKR 646
RGL ++H +H +LKP N+ + D E KI DFGL AR+ +
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL----------------ARHTADEM 186
Query: 647 ST--ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILL 703
+ A+R Y APE L + N D++S G I+
Sbjct: 187 TGYVATR-------------------------WYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 704 ELLTGKVI 711
ELLTG+ +
Sbjct: 222 ELLTGRTL 229
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 29/109 (26%), Positives = 41/109 (37%), Gaps = 8/109 (7%)
Query: 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSL-TTLQSLTIVSLKNN--- 187
LDL + ++ T L L LNL N L L + L L + L NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 188 YFSDGLPSKFNSVQVLDLSSNLINGSLPPDI--GGYSLRYLNLSYNRLS 234
G+ + L L N + SLP + L+ L L+ N+L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 38/174 (21%)
Query: 97 IPADLGMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETMGSLHNL 155
IPAD + LDL + L +LS + F ++L L+L N + L L
Sbjct: 33 IPADT------EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 156 QLLNLSDNALAGKLPV----SLTTLQSLTIVSLKNNYFSDGLPSK-FNS---VQVLDLSS 207
L L++N LA LP+ LT L L L N LPS F+ ++ L L++
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKL---YLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 208 NLINGSLPPDI--GGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259
N + S+P +L+ L+LS N+L +P A F+ L
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS---------VPHGA-----FDRLG 179
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 13/131 (9%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGH 144
L L ++ L A + L +L+L N L +LS +F+ ++L L L+NN ++
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPV----SLTTLQSLTIVSLKNNYFS---DGLPSKF 197
L L L L N L LP LT L+ L L N G K
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL---RLNTNQLQSIPAGAFDKL 154
Query: 198 NSVQVLDLSSN 208
++Q L LS+N
Sbjct: 155 TNLQTLSLSTN 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/111 (31%), Positives = 49/111 (44%), Gaps = 18/111 (16%)
Query: 86 LALPNSQLLGSIPADLGMIEF-----LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNN 139
L L N+QL S+P + F L L L N L SL +F ++L+ L L+ N
Sbjct: 88 LGLANNQL-ASLPLGV----FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN 141
Query: 140 LISGHLPETMG---SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187
+ +P G L NLQ L+LS N L + L L ++L N
Sbjct: 142 QLQS-IPA--GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 41/128 (32%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLER-LVTGDTSSSKAGGSARNFGS 644
R + F+H H ++KP+N+L+ D K+ DFG + L+ + S +
Sbjct: 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYI--------- 202
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE-SLRSIKPNPKWDVYSFGVILL 703
SR Y APE L + + P D++S G +
Sbjct: 203 ----CSR-------------------------FYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 704 ELLTGKVI 711
EL+ GK +
Sbjct: 234 ELILGKPL 241
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 107 LQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L L+L N L + + F AS ++ L L N I + M LH L+ LNL DN
Sbjct: 56 LVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ 113
Query: 165 LAGKLPVSLTTLQSLTIVSLKNN 187
++ +P S L SLT ++L +N
Sbjct: 114 ISCVMPGSFEHLNSLTSLNLASN 136
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 30/159 (18%), Positives = 57/159 (35%), Gaps = 35/159 (22%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGF 539
+LG + + + A++ + +V + + P++VRI
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 540 Y----WGVDEKLIIYDFVPNGSL-------ANARY--RKMGSSPCHLPWEARLKIAKGVA 586
Y G LI+ + + G L + + R EA +I K +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----------EAS-EIMKSIG 127
Query: 587 RGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGL 622
+ +LH H ++KP N+L + + K+ DFG
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 34/142 (23%)
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
+ + L +L + H +LKP N+LL +D + + R+ G S
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILL-DDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 640 R----NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY----H--APESLRSIKP 689
+FG +T D APE + ++
Sbjct: 200 GIKLIDFGC--ATFKSDY---------------------HGSIINTRQYRAPEVILNLGW 236
Query: 690 NPKWDVYSFGVILLELLTGKVI 711
+ D++SFG +L EL TG ++
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLL 258
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 70/243 (28%)
Query: 484 GASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
G+ G ++Y+A L + G +A++++ ++ + R +++++ KL H N+VR+R F++
Sbjct: 65 GSFG--VVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYS 118
Query: 543 VDEKL------IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKG----VARGLAFL 592
EK ++ D+VP ++ R + LP + K + R LA++
Sbjct: 119 SGEKKDEVYLNLVLDYVPE-TV-YRVARHYSRAKQTLP----VIYVKLYMYQLFRSLAYI 172
Query: 593 HEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST--- 648
H H ++KP+N+LL + K+ DFG A+
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGS----------------AKQLVRGEPNVSY 216
Query: 649 -ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPES-LRSIKPNPKWDVYSFGVILLELL 706
SR Y APE + DV+S G +L ELL
Sbjct: 217 ICSR-------------------------YYRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 707 TGK 709
G+
Sbjct: 252 LGQ 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 45/199 (22%), Positives = 73/199 (36%), Gaps = 64/199 (32%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWE----- 576
RV+ HP L ++ + + ++L + ++ G L HL E
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFF-----------HLSRERVFSE 247
Query: 577 --ARLKIAKGVARGLAFLHEKKH-VHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTS 631
AR A+ + L +LH +K+ V+ +LK N++L D KI DFGL E + G T
Sbjct: 248 DRARFYGAE-IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306
Query: 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPN 690
+ G +P Y APE L
Sbjct: 307 KTFCG---------------------------------------TPEYLAPEVLEDNDYG 327
Query: 691 PKWDVYSFGVILLELLTGK 709
D + GV++ E++ G+
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 5/43 (11%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLL-----GNDMEPKIGDFGLER 624
G+ F H ++ +H +LKP+N+LL KIGDFGL R
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 63/198 (31%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWE----- 576
RV+ HP L ++ + + ++L + ++ G L HL E
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL-------F----FHLSRERVFTE 104
Query: 577 --ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSS 632
AR A+ + L +LH + V+ ++K N++L D KI DFGL E + G T
Sbjct: 105 ERARFYGAE-IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNP 691
+ G +P Y APE L
Sbjct: 164 TFCG---------------------------------------TPEYLAPEVLEDNDYGR 184
Query: 692 KWDVYSFGVILLELLTGK 709
D + GV++ E++ G+
Sbjct: 185 AVDWWGLGVVMYEMMCGR 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 42/128 (32%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
+A GL FL K ++ +LK NV+L ++ KI DFG+ E + G T+ + G
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG------ 504
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVI 701
+P Y APE + D ++FGV+
Sbjct: 505 ---------------------------------TPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 702 LLELLTGK 709
L E+L G+
Sbjct: 532 LYEMLAGQ 539
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/123 (23%), Positives = 42/123 (34%), Gaps = 39/123 (31%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRS 647
GL +H + V+ +LKP N+LL +I D GL + + G
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----------- 352
Query: 648 TASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELL 706
T G Y APE L+ + D +S G +L +LL
Sbjct: 353 T----------HG-----------------YMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 707 TGK 709
G
Sbjct: 386 RGH 388
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 14/101 (13%)
Query: 94 LGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETM-GS 151
+P +L + L +DLSNN ++ +LS F N +QL L LS N + +P
Sbjct: 43 FTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDG 100
Query: 152 LHNLQLLNLSDNALAGKLPVSL-----TTLQSLTIVSLKNN 187
L +L+LL+L N ++ + L +L+ +++ N
Sbjct: 101 LKSLRLLSLHGNDIS-----VVPEGAFNDLSALSHLAIGAN 136
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 37/126 (29%), Positives = 51/126 (40%), Gaps = 40/126 (31%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
+ GL FLH K V+ +LK N+LL D KI DFG+ E ++ +++ G
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG------ 180
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702
+P Y APE L K N D +SFGV+L
Sbjct: 181 -------------------TPD-------------YIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 703 LELLTG 708
E+L G
Sbjct: 209 YEMLIG 214
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 42/128 (32%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
+A GL FL K ++ +LK NV+L ++ KI DFG+ E + G T+ + G
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG------ 183
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVI 701
+P Y APE + D ++FGV+
Sbjct: 184 ---------------------------------TPDYIAPEIIAYQPYGKSVDWWAFGVL 210
Query: 702 LLELLTGK 709
L E+L G+
Sbjct: 211 LYEMLAGQ 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 32/194 (16%), Positives = 62/194 (31%), Gaps = 48/194 (24%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
V+ + ++ F + + L ++ ++ G L + P + AR +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYL 168
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A+ + + +H +VH ++KP N+LL ++ DFG +
Sbjct: 169 AE-IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS----------CLKLRADGT 217
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY----- 696
S G Y +PE L+++ P Y
Sbjct: 218 VRSL-------------------------VAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 697 --SFGVILLELLTG 708
+ GV E+ G
Sbjct: 253 WWALGVFAYEMFYG 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 44/198 (22%), Positives = 74/198 (37%), Gaps = 63/198 (31%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWE----- 576
++ ++ HP +V++ + + + KL +I DF+ G L L E
Sbjct: 78 DILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFT-----------RLSKEVMFTE 125
Query: 577 --ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSS 632
+ +A+ +A L LH ++ +LKP N+LL + K+ DFGL E + +
Sbjct: 126 EDVKFYLAE-LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNP 691
S G + Y APE +
Sbjct: 185 SFCG---------------------------------------TVEYMAPEVVNRRGHTQ 205
Query: 692 KWDVYSFGVILLELLTGK 709
D +SFGV++ E+LTG
Sbjct: 206 SADWWSFGVLMFEMLTGT 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 42/128 (32%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
++ L +LHE+ ++ +LK NVLL ++ K+ D+G+ E L GDT+S+ G
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG------ 215
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVI 701
+P Y APE LR D ++ GV+
Sbjct: 216 ---------------------------------TPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 702 LLELLTGK 709
+ E++ G+
Sbjct: 243 MFEMMAGR 250
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 35/187 (18%), Positives = 67/187 (35%), Gaps = 46/187 (24%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI- 581
R++ + P LV++ + ++ ++V G + + R++G E +
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFS-----EPHARFY 146
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A + +LH ++ +LKP N+L+ ++ DFG + V G T
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----------- 195
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
+L G APE + S N D ++ GV+
Sbjct: 196 ----------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 702 LLELLTG 708
+ E+ G
Sbjct: 228 IYEMAAG 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 8e-05
Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 42/125 (33%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGSK 645
L +LHE+ ++ +LK NVLL ++ K+ D+G+ E L GDT+S+ G
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG--------- 172
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVILLE 704
+P Y APE LR D ++ GV++ E
Sbjct: 173 ------------------------------TPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 705 LLTGK 709
++ G+
Sbjct: 203 MMAGR 207
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 40/142 (28%)
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639
+A + L FLHE + H +LKP N+L N + + + K+ +
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN-------EHKSCEEKSVKNT 179
Query: 640 R----NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP------YHAPESLRSIKP 689
+FGS +T + + Y PE + +
Sbjct: 180 SIRVADFGS--ATFDHEH---------------------HTTIVATRHYRPPEVILELGW 216
Query: 690 NPKWDVYSFGVILLELLTGKVI 711
DV+S G IL E G +
Sbjct: 217 AQPCDVWSIGCILFEYYRGFTL 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 35/192 (18%), Positives = 67/192 (34%), Gaps = 46/192 (23%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
V+ + + + + D L ++ D+ G L + P AR +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE---MARFYL 181
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A+ + + +H+ +VH ++KP N+L+ + ++ DFG
Sbjct: 182 AE-MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS----------CLKLMEDGT 230
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-----NPKWDVY 696
S S G Y +PE L++++ P+ D +
Sbjct: 231 VQS-------------------------SVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 697 SFGVILLELLTG 708
S GV + E+L G
Sbjct: 266 SLGVCMYEMLYG 277
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 31/128 (24%), Positives = 46/128 (35%), Gaps = 42/128 (32%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNF 642
+A L +LH V+ +LKP N+LL + + DFGL E + T+S+ G
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG------ 201
Query: 643 GSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVI 701
+P Y APE L + D + G +
Sbjct: 202 ---------------------------------TPEYLAPEVLHKQPYDRTVDWWCLGAV 228
Query: 702 LLELLTGK 709
L E+L G
Sbjct: 229 LYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 18/51 (35%), Positives = 31/51 (60%), Gaps = 2/51 (3%)
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSS 633
+ L FLH+K ++ +LK NVLL ++ K+ DFG+ E + G T+++
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 29/125 (23%), Positives = 46/125 (36%), Gaps = 42/125 (33%)
Query: 588 GLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL--ERLVTGDTSSSKAGGSARNFGSK 645
L LH+K ++ +LKP N++L + K+ DFGL E + G + + G
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG--------- 183
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISP-YHAPESLRSIKPNPKWDVYSFGVILLE 704
+ Y APE L N D +S G ++ +
Sbjct: 184 ------------------------------TIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 705 LLTGK 709
+LTG
Sbjct: 214 MLTGA 218
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 30/140 (21%), Positives = 52/140 (37%), Gaps = 36/140 (25%)
Query: 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG--- 636
K+A + + + FLH K H +LKP N+L ++ + ++ + +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILF---VQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 637 ---GSARNFGSKRST--ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP 691
GSA ST ++R Y APE + ++ +
Sbjct: 179 VDFGSATYDDEHHSTLVSTR--H-----------------------YRAPEVILALGWSQ 213
Query: 692 KWDVYSFGVILLELLTGKVI 711
DV+S G IL+E G +
Sbjct: 214 PCDVWSIGCILIEYYLGFTV 233
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 16/165 (9%)
Query: 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNL 140
VI P S + + +Q++DLSN+ + S + + S+L+NL L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129
Query: 141 ISGHLPETMGSLHNLQLLNLS------DNALAGKLPVSLTTLQSLTI---VSLKNNYFSD 191
+S + T+ NL LNLS + AL L S + L L + +
Sbjct: 130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ-TLLSSCSRLDELNLSWCFDFTEKHVQV 188
Query: 192 GLPSKFNSVQVLDLS--SNLINGSLPPDIGGY--SLRYLNLSYNR 232
+ ++ L+LS + S + +L +L+LS +
Sbjct: 189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 10/39 (25%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 587 RGLAFLHEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLER 624
+ L + H +H ++KP NV++ + ++ D+GL
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 39/191 (20%), Positives = 65/191 (34%), Gaps = 47/191 (24%)
Query: 523 RVIAKLVHPNLVRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKI 581
++A P +V++ + + D L ++ +++P G L N AR
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT 174
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
A+ V L +H +H ++KP N+LL K+ DFG
Sbjct: 175 AE-VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT----------CMKMNKEGM 223
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKW----DVYS 697
+ G Y +PE L+S + + D +S
Sbjct: 224 VRCD-------------------------TAVGTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 698 FGVILLELLTG 708
GV L E+L G
Sbjct: 259 VGVFLYEMLVG 269
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 14/115 (12%)
Query: 124 SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183
++ SQ + LDL + + + +LN +A L + + L ++
Sbjct: 123 KRYDGSQ-QALDLKGL----RSDPDLVAQNIDVVLNRRSC-MAATLRIIEENIPELLSLN 176
Query: 184 LKNNYFSD-----GLPSKFNSVQVLDLSSNLIN--GSLPPDIGGYSLRYLNLSYN 231
L NN + K ++++L+LS N + L I G L L L N
Sbjct: 177 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK-IKGLKLEELWLDGN 230
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNA 164
L+ L L +N L +L +F++ +QL LDL N ++ LP + L +L+ L + N
Sbjct: 66 LKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNK 123
Query: 165 LAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFN---SVQVLDLSSN 208
L +LP + L LT ++L N F+ S+ L N
Sbjct: 124 LT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 791 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.91 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.91 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.89 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.89 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.89 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.88 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.88 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.88 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.88 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.88 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.87 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.87 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.87 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.87 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.87 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.87 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.86 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.86 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.86 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.86 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.85 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.85 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.85 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.83 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.83 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.83 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.83 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.82 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.82 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.82 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.81 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.81 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.81 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.8 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.78 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.76 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.76 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.73 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.73 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.72 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.7 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.7 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.7 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.7 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.69 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.69 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.69 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.68 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.68 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.56 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.44 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.15 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.02 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.96 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.84 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.58 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.12 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.97 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.34 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.96 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.52 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.58 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.63 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 84.05 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.93 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.41 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=456.87 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=209.1
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..|||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 468999999999999854 47899999998877777789999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 554 PNGSLANARYRKMGS----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
++|+|.++++..... ...+++|.+++.|+.||++||+|||+++||||||||+|||+++++.+||+|||++
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla 205 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccc
Confidence 999999999865321 1235999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+.+...... ......+||+.|||||++.+..|+.++|||||||++|
T Consensus 206 ~~~~~~~~~----------------------------------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~ 251 (329)
T 4aoj_A 206 RDIYSTDYY----------------------------------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251 (329)
T ss_dssp ------------------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred eeccCCCcc----------------------------------eecCcccccccccChhhhcCCCCCccccccchHHHHH
Confidence 876432211 0122346999999999999999999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
||+| |+.||.+... . .....+.... ..+.+...+.++.+|+.+||+.||++|||++||++.|+.|..
T Consensus 252 Ellt~G~~Pf~~~~~---------~-~~~~~i~~g~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 252 EIFTYGKQPWYQLSN---------T-EAIDCITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHTTSCCTTCSSCH---------H-HHHHHHHHTC--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCH---------H-HHHHHHHcCC--CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 9999 8999965321 1 1111111111 122233356788999999999999999999999999999987
Q ss_pred CCCCCc
Q 003847 783 SPSPYL 788 (791)
Q Consensus 783 ~~~p~~ 788 (791)
.|.-|+
T Consensus 320 ~pp~~l 325 (329)
T 4aoj_A 320 APPVYL 325 (329)
T ss_dssp SCC---
T ss_pred CCcccc
Confidence 776554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=453.05 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=212.1
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..|+|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 468999999999999853 47899999998877777789999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhc--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 554 PNGSLANARYRKM--------GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 554 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++|+|.++++... ......++|.++..|+.||++||+|||+++||||||||+|||+++++.+||+|||+|+.
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~ 177 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHH
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCccccee
Confidence 9999999997643 12233599999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~el 705 (791)
........ .....+||+.|||||++.+..|+.++|||||||++|||
T Consensus 178 ~~~~~~~~----------------------------------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~El 223 (299)
T 4asz_A 178 VYSTDYYR----------------------------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223 (299)
T ss_dssp HTGGGCEE----------------------------------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcee----------------------------------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 64322110 01123589999999999999999999999999999999
Q ss_pred Hh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 706 LT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 706 lt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
+| |+.||.+... .++......+. .+.+...+.++.+|+.+||+.||++|||++||++.|+++...
T Consensus 224 lt~G~~Pf~~~~~-------------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 224 FTYGKQPWYQLSN-------------NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTTTCCTTTTSCH-------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCH-------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99 8999965321 11111111111 122333567889999999999999999999999999988654
Q ss_pred CCCC
Q 003847 784 PSPY 787 (791)
Q Consensus 784 ~~p~ 787 (791)
...|
T Consensus 291 ~p~~ 294 (299)
T 4asz_A 291 SPVY 294 (299)
T ss_dssp SCCC
T ss_pred CCcc
Confidence 4333
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=449.84 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=205.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||+||+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999995 57999999999765555556789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~------- 225 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------- 225 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-------
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-------
Confidence 9988753 399999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 226 -----------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~- 275 (346)
T 4fih_A 226 -----------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP- 275 (346)
T ss_dssp -----------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -----------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-
Confidence 12346799999999999999999999999999999999999999965421
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
......+..............+.++.+|+.+||+.||++|||++|+++
T Consensus 276 ---------~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 276 ---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---------HHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------HHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111222222333335678899999999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=441.51 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=201.4
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||+||+|++++ .||||+++.. .....+.|.+|+++|++++|||||++++++. ++..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 35689999999999998753 5999999753 3445678999999999999999999999875 46789999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.++++.... ++++.++..|+.||+.||+|||+++||||||||+|||+++++.+||+|||+|+........
T Consensus 117 sL~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~---- 188 (307)
T 3omv_A 117 SLYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS---- 188 (307)
T ss_dssp BHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred CHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc----
Confidence 99999976543 4999999999999999999999999999999999999999999999999999865432111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 189 ------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 189 ------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 11234579999999999964 468999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhh-hcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAI-RADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
+... ............ .+.. ......+..+.+|+.+||+.||++|||+.||++.|+.++++-
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 239 HINN---------RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCC---------HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCh---------HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 5321 111111111111 1111 112235577899999999999999999999999998876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=442.23 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=207.7
Q ss_pred ceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||+||+|++ .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 45799999999999985 357899999997643 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 553 VPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
|++|+|.+++...... ....++|.++.+|+.|||+||+|||+++||||||||+|||+++++.+||+|||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFG 190 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 190 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcc
Confidence 9999999999764321 11359999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
+++.+...... ......+||+.|||||++.+..|+.++|||||||+
T Consensus 191 lar~~~~~~~~----------------------------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvv 236 (308)
T 4gt4_A 191 LFREVYAADYY----------------------------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 236 (308)
T ss_dssp CBCGGGGGGCB----------------------------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cceeccCCCce----------------------------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHH
Confidence 99876432111 11224569999999999999999999999999999
Q ss_pred HHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 702 LLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 702 l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+|||+| |+.||.+.... .....+.... ..+.+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 237 l~El~t~g~~Pf~~~~~~----------~~~~~i~~~~--~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 237 LWEVFSYGLQPYCGYSNQ----------DVVEMIRNRQ--VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTTCCTTTTCCHH----------HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhCCCCCCCCCCHH----------HHHHHHHcCC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999 88999653211 1111111111 1122334667889999999999999999999999999986
Q ss_pred C
Q 003847 781 P 781 (791)
Q Consensus 781 ~ 781 (791)
.
T Consensus 305 ~ 305 (308)
T 4gt4_A 305 G 305 (308)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=441.77 Aligned_cols=243 Identities=20% Similarity=0.260 Sum_probs=206.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||+++++|++++..|+|||||+
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 356899999999999994 57999999999753 22345779999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
||+|.+++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+......
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~-- 188 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-- 188 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC--
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc--
Confidence 999999998764 3999999999999999999999999999999999999999999999999999976532211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+
T Consensus 189 --------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 189 --------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp --------------------------------CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 123356899999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
.. ..++........+..+...+.++.+|+.+||+.||++|||++|+
T Consensus 237 ~~-------------~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 237 GN-------------EGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp SS-------------HHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CC-------------HHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 31 12233333334444444466788999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=444.50 Aligned_cols=261 Identities=20% Similarity=0.182 Sum_probs=207.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+. .+|+.||||+++.... ..+|++++++++|||||++++++.+++..|||||||+||+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 346799999999999995 5799999999976432 2469999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.......
T Consensus 137 L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~--- 208 (336)
T 4g3f_A 137 LGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK--- 208 (336)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc---
Confidence 999998764 399999999999999999999999999999999999999987 59999999999775432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
........+||+.|||||++.+..|+.++|||||||++|||+||+.||.+..
T Consensus 209 ----------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 209 ----------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred ----------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 0112234679999999999999999999999999999999999999997653
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc----cCCCCCCCCcCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE----KIPSSPSPYLYG 790 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~----~i~~~~~p~~~~ 790 (791)
...... .+..... .....+...+..+.+++.+||+.||++|||+.|+++.|. ++.....||+-+
T Consensus 261 ~~~~~~---------~i~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 261 RGPLCL---------KIASEPP-PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CSCCHH---------HHHHSCC-GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHH---------HHHcCCC-CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 322111 1111100 000112235567889999999999999999999988764 455667788754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=447.48 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=198.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|||||||+||
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 46899999999999995 57999999999654 3344578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 109 ~L~~~i~~~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~----- 180 (350)
T 4b9d_A 109 DLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE----- 180 (350)
T ss_dssp BHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-----
T ss_pred cHHHHHHHcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-----
Confidence 999999765432 379999999999999999999999999999999999999999999999999987542110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+..
T Consensus 181 -------------------------------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 181 -------------------------------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -------------------------------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 0123469999999999999999999999999999999999999996542
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. .+++.....+.++ .....+.++.+|+.+||+.||++|||++|+++
T Consensus 230 ~-------------~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 230 M-------------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp H-------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1222222222221 12235677899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=451.53 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=205.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|||||||+||+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 346799999999999995 5799999999976655556778999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... .+++.++..|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~------ 302 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------ 302 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC------
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc------
Confidence 99998653 299999999999999999999999999999999999999999999999999987643211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 303 ------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 303 ------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp ------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 12346799999999999999999999999999999999999999965421
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
......+..............+..+.+|+.+||..||++|||+.|+++
T Consensus 353 ----------~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 353 ----------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ----------HHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------HHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111122222222335678899999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=425.92 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=190.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46899999999999994 579999999996542 233467999999999999999999999999999999999999 6
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... ++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----- 166 (275)
T 3hyh_A 97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----- 166 (275)
T ss_dssp EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-----
Confidence 89999987654 39999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|||||++.+..| +.++||||+||++|||+||+.||.+
T Consensus 167 --------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 167 --------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ----------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 1224579999999999998776 5899999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.. ...+......+....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 215 ~~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 215 ES-------------IPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SS-------------HHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-------------HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 31 1122222223333333335678899999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=424.49 Aligned_cols=240 Identities=21% Similarity=0.312 Sum_probs=194.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~ 552 (791)
.+.||+|+||+||+|+. .+++.||||++... .....+.|.+|+++|++++|||||+++++|.+ ++..|+||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 35799999999999995 56899999999653 33445779999999999999999999999875 3457999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEec-CCCCeEEeccCcccccCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~ 629 (791)
|++|+|.+++.+.. .+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999998764 3999999999999999999999988 99999999999998 4789999999999754311
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+
T Consensus 186 --------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~ 226 (290)
T 3fpq_A 186 --------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp --------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence 1124579999999999875 6999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADF--EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.||.+... ...+......+.. ......+.++.+|+.+||+.||++|||++|+++
T Consensus 227 ~Pf~~~~~------------~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 227 YPYSECQN------------AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CTTTTCSS------------HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCc------------HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99964311 0111111111111 111123457889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=430.59 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=196.3
Q ss_pred cceeccccCceEEEEEEe----CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVL----EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 456899999999999985 247899999997542 22234688999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
|+||+|.+++.... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 180 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 180 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--
Confidence 99999999998764 39999999999999999999999999999999999999999999999999998653211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||
T Consensus 181 ----------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 181 ----------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp ----------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ----------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence 1123467999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM-----KEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 775 (791)
.+.. ..++...........+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 227 ~~~~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 227 QGKD-------------RKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCSS-------------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCcC-------------HHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 6532 12222333333333344466788999999999999999984 67764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=428.91 Aligned_cols=264 Identities=20% Similarity=0.224 Sum_probs=198.8
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC----ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD----EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e~~~~ 555 (791)
.+.||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||++++++.+++ ..|||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 46899999999999998 5899999999765332 233456677777899999999999998764 57999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK--------KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
|+|.++++.. +++|+.+.+|+.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999764 289999999999999999999986 99999999999999999999999999998765
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC------CCCCchhhHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI------KPNPKWDVYSFGVI 701 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~sDvwSlGvi 701 (791)
....... ......+||+.|||||++.+. .++.++|||||||+
T Consensus 160 ~~~~~~~--------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 160 SATDTID--------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp TTTTEES--------------------------------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CCCCcee--------------------------------eecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence 3322110 112245699999999999764 36789999999999
Q ss_pred HHHHHhCCcchhccccCCCC--cchh---chhHH-HHHHHHhhhcCccc---hHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 702 LLELLTGKVIVVDELGQGNG--LLVE---DKNRA-IRLADAAIRADFEG---KEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~--~~~~---~~~~~-~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
+|||+||+.||......... .... ..... ..+.+...++..+. ..+....+.+|+.+||+.||++||||.|
T Consensus 208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999999887543221110 0000 00111 11122222222221 1235667899999999999999999999
Q ss_pred HHHHhccCCCC
Q 003847 773 ALQALEKIPSS 783 (791)
Q Consensus 773 vl~~L~~i~~~ 783 (791)
|++.|++|...
T Consensus 288 i~~~L~~l~~~ 298 (303)
T 3hmm_A 288 IKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHHH
Confidence 99999887543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=416.73 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=189.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-----------
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE----------- 545 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----------- 545 (791)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+.+.
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 346899999999999995 579999999996543 3345679999999999999999999999976543
Q ss_pred -eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 546 -KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 546 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
.|+|||||++|+|.+++....... ..++..++.|+.||++||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCTIE--ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCSGG--GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCC--hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 689999999999999998654322 25677889999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
.+............ .......+..+||+.|||||++.+..|+.++|||||||++||
T Consensus 167 ~~~~~~~~~~~~~~------------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 167 AMDQDEEEQTVLTP------------------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp -------------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ecCCCccccccccc------------------------cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHH
Confidence 87643322110000 001112345679999999999999999999999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhccC
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ--ALEKI 780 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 780 (791)
|++ ||.... .. ...........++ ........+.+|+.+||+.||++|||+.|+++ .++++
T Consensus 223 ll~---Pf~~~~-----------~~-~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 223 LLY---PFSTQM-----------ER-VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHS---CCSSHH-----------HH-HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred Hcc---CCCCcc-----------HH-HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 996 664321 01 1111111112222 22234456788999999999999999999987 45554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=429.99 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=206.6
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCC-CCccceeeEEEcc-CceEEE
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVH-PNLVRIRGFYWGV-DEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~-~~~~lv 549 (791)
..+.||+|+||+||+|+.. .++.||||+++... ....+.|.+|+++|++++| ||||+++|+|.+. +..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 4578999999999999843 24689999997653 3445789999999999965 8999999999765 568999
Q ss_pred EeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 550 YDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
||||++|+|.++++..... ....+++.++..|+.|||+||+|||+++||||||||+|||+++++.+||+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~ 227 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 227 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEEC
Confidence 9999999999999864321 11348999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+|+.+..+.... .....+||+.|||||++.+..|+.++|||||
T Consensus 228 DFGlar~~~~~~~~~----------------------------------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~ 273 (353)
T 4ase_A 228 DFGLARDIYKDPDYV----------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273 (353)
T ss_dssp CCGGGSCTTTCTTSE----------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cchhhhhcccCCCce----------------------------------eeccccccccccCHHHHhcCCCCCcccEeeh
Confidence 999998765332111 1123458999999999999999999999999
Q ss_pred HHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 699 GVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 699 Gvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
||++|||+| |+.||.+.... ......+....+. +.+...+.++.+++.+||+.||++|||+.||++.|
T Consensus 274 Gv~l~El~t~G~~Pf~~~~~~---------~~~~~~i~~g~~~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 274 GVLLWEIFSLGASPYPGVKID---------EEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHH---------HHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 999999998 89999653211 1112222222111 22223567889999999999999999999999999
Q ss_pred ccCC
Q 003847 778 EKIP 781 (791)
Q Consensus 778 ~~i~ 781 (791)
+++.
T Consensus 343 ~~ll 346 (353)
T 4ase_A 343 GNLL 346 (353)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=411.27 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=195.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc------cCceEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG------VDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~~lv 549 (791)
..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+..|+|
T Consensus 58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence 346899999999999995 57999999999754 23345678899999999999999999998764 3578999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
||||+ |+|.+++.... ++++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 138 mE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 99995 68999887643 4999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG 708 (791)
... ........+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus 212 ~~~--------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 212 PAE--------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp ------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred ccc--------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence 111 11123456899999999998875 569999999999999999999
Q ss_pred CcchhccccCCCCcchh------------c--hhHHHHHHHHhhhcCccch-----HHHHHHHHHHHhhccCCCCCCCCC
Q 003847 709 KVIVVDELGQGNGLLVE------------D--KNRAIRLADAAIRADFEGK-----EEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
++||.+.........+. . ........ ..+....+.. .....++.+|+.+||..||++|||
T Consensus 260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 338 (398)
T 4b99_A 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 338 (398)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 99996542110000000 0 00000000 0000000000 012456889999999999999999
Q ss_pred HHHHHHH
Q 003847 770 MKEALQA 776 (791)
Q Consensus 770 ~~evl~~ 776 (791)
++|+++.
T Consensus 339 a~e~L~H 345 (398)
T 4b99_A 339 AAAALRH 345 (398)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=400.12 Aligned_cols=218 Identities=17% Similarity=0.221 Sum_probs=166.1
Q ss_pred cceeccccCceEEEEEEeC----CCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLE----DGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||+||+|+.+ +++.||||++..... ..++.+|+++|+++ +|||||+++++|.+.+..|+|||||
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 3568999999999999842 478999999876533 35688999999998 6999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~ 632 (791)
++|+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+........
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 9999999873 28999999999999999999999999999999999999876 79999999999876543221
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~p 711 (791)
........ .. ......................+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus 175 ~~~~~~~~------~~--~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 175 LLKFVQSE------AQ--QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp GGGGC----------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cccccccc------cc--ccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 11000000 00 0000000000001112234567899999999999775 589999999999999999999999
Q ss_pred hhc
Q 003847 712 VVD 714 (791)
Q Consensus 712 f~~ 714 (791)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 954
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=417.86 Aligned_cols=245 Identities=19% Similarity=0.216 Sum_probs=199.0
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCCc------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGENS------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
....+||+|+||.||+|+. .+|+.||||++.+.. .........++.+++.++|||||+++++|.+.+..|+||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3457899999999999995 579999999996531 111222334567778889999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
|||+||+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 272 Ey~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp CCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 9999999999998764 39999999999999999999999999999999999999999999999999998764211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~ 709 (791)
....+||+.|||||++. +..|+.++|||||||++|||++|+
T Consensus 347 --------------------------------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 347 --------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388 (689)
T ss_dssp --------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 22457999999999996 457999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
.||.+..... ...+...........+...+.++.+|+.+||..||++|++ ++||++
T Consensus 389 ~PF~~~~~~~----------~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 389 SPFRQHKTKD----------KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CTTCGGGCCC----------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCCChHH----------HHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 9997643211 1122222333333333345678899999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=423.34 Aligned_cols=247 Identities=20% Similarity=0.273 Sum_probs=204.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|+|||||+||+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 456899999999999995 5799999999987666666789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC--CCeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND--MEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.+++....+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 241 L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---- 312 (573)
T 3uto_A 241 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---- 312 (573)
T ss_dssp HHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE----
T ss_pred HHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc----
Confidence 9998865432 39999999999999999999999999999999999999854 8999999999997653211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 313 ---------------------------------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 313 ---------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp ---------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---------------------------------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12346999999999999999999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .....+...............+..+.+||.+||..||++|||+.|+++
T Consensus 360 ~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 360 NDD---------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SHH---------HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHH---------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211 111111111111111111224567889999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=371.46 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=203.2
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+|. ..+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 4689999999999999 467999999999766555567889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++.... +++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------- 171 (297)
T 3fxz_A 105 TDVVTETC------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------- 171 (297)
T ss_dssp HHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-------
T ss_pred HHHHhhcC------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-------
Confidence 99987642 89999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 172 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 221 (297)
T 3fxz_A 172 -----------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP- 221 (297)
T ss_dssp -----------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -----------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 11234599999999999999999999999999999999999999965311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
....... .................+.+++.+||+.||++|||++|+++
T Consensus 222 --------~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 222 --------LRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --------HHHHHHH-HHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------HHHHHHH-HhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111111 11111122223335667889999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=375.90 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=203.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46899999999999995 68999999999654 3345577889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~------ 168 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG------ 168 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC------
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC------
Confidence 9999987764 39999999999999999999999999999999999999999999999999998654221
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCC-CchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.+.
T Consensus 169 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 169 -------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp -------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------------------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 11234699999999999887775 7999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. ..++......+.+..+...+..+.+++.+||..||.+|||++|+++.
T Consensus 218 ~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 218 N-------------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp S-------------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C-------------HHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 12222233333333333355678899999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=370.68 Aligned_cols=266 Identities=24% Similarity=0.377 Sum_probs=210.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 56899999999999995 46899999999877777778899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++.++..|+.|++.||+|||+.||+||||||+||+++.++.+||+|||+++..............
T Consensus 95 ~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (310)
T 3s95_A 95 RGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170 (310)
T ss_dssp HHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred HHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence 999987432 3999999999999999999999999999999999999999999999999999876543321110000
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
. ...........+||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 171 ~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 171 L----------------------KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp -------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred c----------------------cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 0 000111222457999999999999999999999999999999999999988654332
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
....... .....+...... .+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 229 ~~~~~~~----~~~~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 229 TMDFGLN----VRGFLDRYCPPN------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CTTSSBC----HHHHHHHTCCTT------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhh----hhccccccCCCC------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2211111 111222221111 3456788999999999999999999999998874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.14 Aligned_cols=269 Identities=30% Similarity=0.472 Sum_probs=215.2
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
....||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 34689999999999999888999999999877666678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 123 ~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------ 195 (321)
T 2qkw_B 123 KRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT------ 195 (321)
T ss_dssp GGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC------
T ss_pred HHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc------
Confidence 9988654321 224899999999999999999999999999999999999999999999999999865322110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 196 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 196 ----------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp ----------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred ----------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 0112334899999999998889999999999999999999999999765443
Q ss_pred CCCcchhchhHH------HHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 719 GNGLLVEDKNRA------IRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 719 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
............ ....++.... ....+....+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 248 EMVNLAEWAVESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SCCCHHHHTHHHHTTTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHhhhccccccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 222211110000 0000111111 123457788999999999999999999999999998765433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.93 Aligned_cols=256 Identities=29% Similarity=0.371 Sum_probs=199.9
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3457899999999999987 58999999997653 34456789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
|+|.+++....... .+++..++.++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.......
T Consensus 119 ~~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 194 (309)
T 3p86_A 119 GSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-- 194 (309)
T ss_dssp CBHHHHHHSTTHHH--HSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred CcHHHHHhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--
Confidence 99999987643211 2899999999999999999999999 99999999999999999999999999975432110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 195 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 195 ----------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred ----------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1123458999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.... . ........ .......+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 241 ~~~~---------~-~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 241 NLNP---------A-QVVAAVGF-KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCH---------H-HHHHHHHH-SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCH---------H-HHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 5311 0 11111100 1111122223556789999999999999999999999999887544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=376.22 Aligned_cols=257 Identities=20% Similarity=0.319 Sum_probs=206.9
Q ss_pred cceeccccCceEEEEEEe--------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 479 SAYILGASGSSIMYKAVL--------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
..+.||+|+||.||+|+. .++..||||+++.. .....+.+.+|+++++++ +||||+++++++...+..|+
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 457899999999999984 24568999999765 334457899999999999 89999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEE
Q 003847 549 IYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL 617 (791)
||||+++|+|.+++...... ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 244 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEE
Confidence 99999999999999875421 1124899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHH
Q 003847 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYS 697 (791)
Q Consensus 618 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS 697 (791)
+|||+++......... ......||+.|+|||++.+..++.++||||
T Consensus 245 ~DFG~a~~~~~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 290 (370)
T 2psq_A 245 ADFGLARDINNIDYYK----------------------------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290 (370)
T ss_dssp CCCSSCEETTCCCTTC----------------------------------TTTTTTSCGGGCCHHHHHTCCCCHHHHHHH
T ss_pred ccccCCcccCccccee----------------------------------cccCCCcccceECHhHhcCCCCCcHHHHHH
Confidence 9999998764322110 112234788999999999999999999999
Q ss_pred HHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 698 FGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 698 lGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|||++|||++ |+.||.+.... ............ ..+......+.+++.+||+.||++||++.|+++.
T Consensus 291 lG~il~ellt~g~~p~~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 291 FGVLMWEIFTLGGSPYPGIPVE----------ELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGG----------GHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCHH----------HHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999 99998653211 111111111111 1122245678999999999999999999999999
Q ss_pred hccCC
Q 003847 777 LEKIP 781 (791)
Q Consensus 777 L~~i~ 781 (791)
|++|.
T Consensus 359 L~~il 363 (370)
T 2psq_A 359 LDRIL 363 (370)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.98 Aligned_cols=243 Identities=20% Similarity=0.253 Sum_probs=202.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|++++++++||||+++++++...+..|+||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999995 46999999999754 223456788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---- 160 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---- 160 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC----
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC----
Confidence 99999987654 389999999999999999999999999999999999999999999999999975322110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 161 --------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp --------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------------------------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 122456999999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
.. ..+...........+......+.+++.+||+.||++|| +++|+++.
T Consensus 209 ~~-------------~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 209 DH-------------ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11 11222222222222333567789999999999999999 89999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=367.69 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=203.0
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 3468999999999999965 799999999977655566789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 129 L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------ 196 (321)
T 2c30_A 129 LTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 196 (321)
T ss_dssp HHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC------
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc------
Confidence 99987643 389999999999999999999999999999999999999999999999999987643211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 197 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 197 ------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp ------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11234599999999999999999999999999999999999999965321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .....+ ..............+..+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~---------~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 V---------QAMKRL-RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H---------HHHHHH-HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H---------HHHHHH-hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011111 111111111222245678899999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.52 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=207.8
Q ss_pred hhcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 477 KASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+...+.||+|+||.||+|+..+++.||||++...... .+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 3345789999999999999888999999999865433 367999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 91 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 162 (269)
T 4hcu_A 91 CLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---- 162 (269)
T ss_dssp BHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH----
T ss_pred cHHHHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc----
Confidence 99999876543 4899999999999999999999999999999999999999999999999999865432110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 163 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 163 -------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp -------------------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -------------------------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 0112337788999999998899999999999999999999 89998653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
... .....+ ..... ...+......+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 212 ~~~---------~~~~~~-~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 212 SNS---------EVVEDI-STGFR--LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CHH---------HHHHHH-HTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHH---------HHHHHH-hcCcc--CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111 111111 11111 111222456788999999999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=372.14 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=205.7
Q ss_pred cceeccccCceEEEEEEeC----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLE----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 4578999999999999963 4556999999765 3444578999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+..|+.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 133 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 133 ENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp TTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 99999999875532 39999999999999999999999999999999999999999999999999998765432111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 209 ~---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 255 (325)
T 3kul_A 209 Y---------------------------------TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255 (325)
T ss_dssp E---------------------------------ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred e---------------------------------eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 0 0112236788999999998899999999999999999999 99998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
...... .......... ..+.....+..+.+++.+||..||++|||+.|+++.|+.+...+
T Consensus 256 ~~~~~~----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 256 WNMTNR----------DVISSVEEGY--RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TTSCHH----------HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ccCCHH----------HHHHHHHcCC--CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 553111 1111111111 11222235567899999999999999999999999999875443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=372.29 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=203.8
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCc----eEEEEecc
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE----KLIIYDFV 553 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lv~e~~ 553 (791)
...+.||+|+||.||+|+.. ++.||||++...... ...+++|+.++++++||||+++++++..... .++||||+
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 34578999999999999875 799999999765433 3456779999999999999999999987653 69999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------CCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK----------KHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----------~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
++|+|.+++... .+++..++.|+.|++.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 105 ~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 105 EKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999764 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSF 698 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSl 698 (791)
+........ .......||+.|+|||++.+ ..++.++|||||
T Consensus 179 ~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 179 LKFEAGKSA----------------------------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp EEECTTSCC----------------------------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred cccccccCc----------------------------------cccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 876532211 01223469999999999986 345678899999
Q ss_pred HHHHHHHHhCCcchhccccCCCCcchhc---hhHHHHHHHHhh----hcCcc---chHHHHHHHHHHHhhccCCCCCCCC
Q 003847 699 GVILLELLTGKVIVVDELGQGNGLLVED---KNRAIRLADAAI----RADFE---GKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 699 Gvil~elltG~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
||++|||+||+.||.............. ......+.+... ..... ........+.+|+.+||+.||++||
T Consensus 225 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp HHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 9999999999999976544322221110 001111111111 11111 1123556799999999999999999
Q ss_pred CHHHHHHHhccCC
Q 003847 769 SMKEALQALEKIP 781 (791)
Q Consensus 769 s~~evl~~L~~i~ 781 (791)
|+.|+++.|++|.
T Consensus 305 s~~ell~~L~~l~ 317 (322)
T 3soc_A 305 SAGCVGERITQMQ 317 (322)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=369.86 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=200.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh------hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD------RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 356899999999999995 46899999999654321 24679999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC----CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~ 627 (791)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 96 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp CCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999986543 399999999999999999999999999999999999998776 79999999998764
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
... .....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 171 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~ 213 (361)
T 2yab_A 171 DGV-------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (361)
T ss_dssp TTC-------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CCC-------------------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh
Confidence 321 1123469999999999999899999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKE----EALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|+.||.+... .+.........+.... ..+..+.+|+.+||..||++|||+.|+++
T Consensus 214 g~~Pf~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 214 GASPFLGDTK-------------QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSCCSSH-------------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCH-------------HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999965321 1112222222222211 23467889999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=358.21 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=207.4
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.....||+|+||.||+|...++..||||++...... .+++.+|++++++++||||+++++++...+..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 345789999999999999988889999999765433 3678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 90 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~---- 161 (268)
T 3sxs_A 90 LLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS---- 161 (268)
T ss_dssp HHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE----
T ss_pred HHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc----
Confidence 9999977542 38999999999999999999999999999999999999999999999999998764322110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
.....||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 162 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 162 -------------------------------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp -------------------------------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred -------------------------------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 112236788999999998889999999999999999999 999985431
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.. .....+.. . .....+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 211 ~~---------~~~~~~~~-~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 211 NS---------EVVLKVSQ-G--HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HH---------HHHHHHHT-T--CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred hH---------HHHHHHHc-C--CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 11111111 1 01111122356788999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=365.59 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=204.5
Q ss_pred cceeccccCceEEEEEEe-----CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL-----EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 551 (791)
..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 356899999999999984 36899999999887777778899999999999999999999998654 45899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++|+|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp CCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred eCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence 9999999999977543 389999999999999999999999999999999999999999999999999987653321
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
... ......|+..|+|||++.+..++.++||||||+++|||+||..|
T Consensus 170 ~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 170 FFK---------------------------------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp ---------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred eee---------------------------------eccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 100 11123477889999999999999999999999999999999988
Q ss_pred hhccccCCCC---cchhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 712 VVDELGQGNG---LLVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 712 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|......... .............+.... ...+.+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp TCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 7542111000 000000001111111111 1112223355788999999999999999999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=373.15 Aligned_cols=242 Identities=23% Similarity=0.269 Sum_probs=198.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..|+||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 46899999999999995 46899999999754 223346688899999988 79999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~---- 178 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG---- 178 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC----
Confidence 999999988764 39999999999999999999999999999999999999999999999999997532111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 179 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 179 --------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 112345699999999999998999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM------KEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 775 (791)
... .++...........+......+.+++.+||+.||++||++ +|+++
T Consensus 227 ~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 227 ENE-------------DDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 421 1222333333333333355678899999999999999998 77765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=375.27 Aligned_cols=256 Identities=21% Similarity=0.378 Sum_probs=196.0
Q ss_pred hhcceeccccCceEEEEEEeC----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 477 KASAYILGASGSSIMYKAVLE----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
+...+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 344679999999999999854 5788999999765 33445689999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++|+|.+++..... .+++.++..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 127 ~~~~~sL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 127 YMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp CCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999976532 489999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 710 (791)
... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 203 ~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 203 AAY---------------------------------TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp --------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred cce---------------------------------eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 100 0111235778999999999999999999999999999998 999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||..... ............. +.....+..+.+++.+||+.||++||++.||++.|+++.
T Consensus 250 P~~~~~~----------~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 250 PYWEMSN----------QDVIKAVDEGYRL--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp TTTTCCH----------HHHHHHHHTTEEC--CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCH----------HHHHHHHHcCCCC--CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 9854311 1112222211111 112234567899999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=368.53 Aligned_cols=266 Identities=34% Similarity=0.546 Sum_probs=209.1
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchh-hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVD-RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 34 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence 34789999999999999888999999999765322 23468999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++....... ..+++..+..|+.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 114 L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 190 (326)
T 3uim_A 114 VASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-- 190 (326)
T ss_dssp HHHHHHCCSTTC-CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC--
T ss_pred HHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc--
Confidence 999998754322 3599999999999999999999999 9999999999999999999999999999876432211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 191 ---------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp ---------------------------------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred ---------------------------------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 11234589999999999888899999999999999999999999953
Q ss_pred cccCCCCcchh-c-------hhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 715 ELGQGNGLLVE-D-------KNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 715 ~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
........... + ........+..... .........+.+++.+||+.||++|||+.||++.|++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp HHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred cccccccchhHHHHHHHHhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 21110000000 0 00001111111111 2234577889999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.62 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=202.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 46899999999999994 56899999998542 334457899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... ++++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--- 167 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT--- 167 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc---
Confidence 99999998764 3899999999999999999999999999999999999999999999999999865422110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 168 --------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ---------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred --------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 112345899999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccc-----hHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhccCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEG-----KEEALLSCFKLGYSCASPLPQKRP-SMKEALQALEKIPSSP 784 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 784 (791)
... ...........+. ....+..+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus 216 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 216 TAV-------------SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CHH-------------HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ChH-------------HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 210 0000111111110 112346788999999999999998 9999999999886544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=372.17 Aligned_cols=246 Identities=21% Similarity=0.231 Sum_probs=197.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46899999999999995 57999999999877666678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe--cCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL--GNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----- 244 (373)
T 2x4f_A 174 FDRIIDESY----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----- 244 (373)
T ss_dssp HHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-----
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-----
Confidence 998875432 38999999999999999999999999999999999999 5678899999999987643211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 245 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 245 --------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp --------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112359999999999998899999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. ......+..................+.+|+.+||+.||++|||+.|+++
T Consensus 293 ~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 293 D---------AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp H---------HHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred H---------HHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 1111222211111111111224567899999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.44 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=199.8
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 3457899999999999995 46899999999654 33445778999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC---CCeEEeccCcccccCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND---MEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~ 631 (791)
+|+|.+++.... .+++.++..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 112 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 112 GGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp SCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 999999887543 38999999999999999999999999999999999999865 459999999998654221
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 186 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 186 ------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp ------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 11234599999999999998999999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|.+... ......+...............+..+.+|+.+||+.||++||++.|+++.
T Consensus 230 f~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 230 FWDEDQ---------HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SCCSSH---------HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCH---------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 965321 01111111111110111112245678899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=377.60 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=199.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 357899999999999984 579999999996543 33456789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec---CCCCeEEeccCcccccCCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG---NDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~~~ 632 (791)
|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++.......
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 99999887654 399999999999999999999999999999999999998 467899999999976543211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....+||+.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus 169 -----------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 169 -----------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp -----------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 112346999999999999989999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCcc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFE----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.+... .++......+.+. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 214 ~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 214 WDEDQ-------------HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCSSH-------------HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCccH-------------HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 65321 1111222222111 112245678899999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=372.43 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=199.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...+||+|+||.||+|+. .+++.||||++++.. ....+.+.+|..+++++ +||||+++++++.+.+..|+||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 346899999999999995 468999999997642 22334678899999887 8999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--- 207 (396)
T 4dc2_A 136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--- 207 (396)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC---
Confidence 9999999988754 39999999999999999999999999999999999999999999999999997532111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 208 ---------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 208 ---------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp ---------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ---------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 11234579999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM------KEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 775 (791)
........... ....+...........+......+.+|+.+||+.||++||++ .|+++
T Consensus 255 ~~~~~~~~~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 255 IVGSSDNPDQN----TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp TTTC------C----CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccccccccchh----hHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 43221111100 011122222333333333356778999999999999999996 56654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.12 Aligned_cols=243 Identities=22% Similarity=0.301 Sum_probs=199.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh------hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD------RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 457899999999999995 46899999998654221 35779999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC----CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~ 627 (791)
|+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999986543 399999999999999999999999999999999999999887 79999999998764
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
.... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 170 ~~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 170 FGNE-------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212 (326)
T ss_dssp TTSC-------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCc-------------------------------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence 2211 123459999999999999899999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|+.||..... .+............. ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 213 g~~pf~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 213 GASPFLGDTK-------------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SCCSSCCSSH-------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CcCCCCCCCH-------------HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999965321 011111111111111 1234578899999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.15 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=203.7
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||++...++..||||++...... .+++.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 345789999999999999988899999999865433 3678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus 106 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~---- 177 (283)
T 3gen_A 106 LLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---- 177 (283)
T ss_dssp HHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS----
T ss_pred HHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc----
Confidence 9999876432 38999999999999999999999999999999999999999999999999998664321110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
.....||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 178 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 178 -------------------------------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp -------------------------------TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred -------------------------------ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 112237788999999998899999999999999999998 999986531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
. . ............ .........+.+++.+||+.||++|||++|+++.|+++..
T Consensus 227 ~---------~-~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 227 N---------S-ETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp H---------H-HHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h---------h-HHHHHHhcccCC--CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1 1 111111111111 1112234678899999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.40 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=200.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 46899999999999995 479999999997542 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~------ 159 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------ 159 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc------
Confidence 99999987654 3899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 160 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 160 ---------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp ---------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 11345999999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
.. ..............+......+.+++.+||..||++|| +++|+++
T Consensus 207 ~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 207 NT-------------MKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 11122222222222223456788999999999999999 8999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=357.20 Aligned_cols=262 Identities=32% Similarity=0.554 Sum_probs=207.4
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCC----chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGEN----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
+.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 6899999999999987 5899999998653 2334578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++....... ++++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus 116 ~L~~~l~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--- 190 (307)
T 2nru_A 116 SLLDRLSCLDGTP--PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--- 190 (307)
T ss_dssp BHHHHHHTGGGCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE---
T ss_pred cHHHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc---
Confidence 9999987654332 49999999999999999999999999999999999999999999999999998654321110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 191 -------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 191 -------------------------------MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp -------------------------------ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred -------------------------------cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 1123458999999999876 58999999999999999999999997643
Q ss_pred cCCCCcchhch-----hHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 717 GQGNGLLVEDK-----NRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 717 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.......+... .......+..+ ..........+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp SSSBTTHHHHHHHTTSCCHHHHSCSSC---SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred chHHHHHHHHHhhhhhhhhhhhccccc---cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 32211111110 00111111111 122344677899999999999999999999999999988653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.92 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=199.6
Q ss_pred hcceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-----hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 478 ASAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-----VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 106 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106 (351)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3457899999999999995 578999999985421 1135779999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~~ 628 (791)
|+++++|.+++....... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 107 ~~~g~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 185 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAG-FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185 (351)
T ss_dssp CCSSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred CCCCCCHHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence 999999998876543221 24899999999999999999999999999999999999986654 99999999987643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 186 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 186 SGL------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp TSC------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCe------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence 211 11234599999999999998999999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+.||.+.. .+.......+.+... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~pf~~~~--------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 230 CLPFYGTK--------------ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSSCSSH--------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCcH--------------HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99996531 111112222222111 123567889999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=376.68 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=205.5
Q ss_pred hcceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 478 ASAYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...+.||+|+||.||+|+.. +++.||||+++... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 34578999999999999965 78999999997653 33345788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 197 g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~- 271 (377)
T 3cbl_A 197 GDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS- 271 (377)
T ss_dssp CBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC-
T ss_pred CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec-
Confidence 999999986542 389999999999999999999999999999999999999999999999999986432211000
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 272 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 272 ---------------------------------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp ---------------------------------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---------------------------------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 001125677999999998889999999999999999998 8989865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... ....+...... ..+.+...+..+.+++.+||+.||++|||+.++++.|++|.
T Consensus 319 ~~~----------~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 319 LSN----------QQTREFVEKGG--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp SCH----------HHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCH----------HHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 311 11122222111 11222224567889999999999999999999999998875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.22 Aligned_cols=242 Identities=18% Similarity=0.230 Sum_probs=200.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+|.. .+++.||+|.+..... ....+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 46899999999999995 4689999999976533 346789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC--CCCeEEeccCcccccCCCCCCCcCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN--DMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+++..... .+++.++..++.|++.||+|||+.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 89 ~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~----- 159 (321)
T 1tki_A 89 FERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----- 159 (321)
T ss_dssp HHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-----
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-----
Confidence 998865432 4899999999999999999999999999999999999987 78999999999987643211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 160 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 160 --------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp --------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 112348999999999998888999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. .+............. ...+.++.+++.+||..||++|||+.|+++.
T Consensus 208 ~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 208 N-------------QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H-------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred H-------------HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 112222222222211 1235678999999999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.97 Aligned_cols=241 Identities=22% Similarity=0.236 Sum_probs=198.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.++||+|+||.||+|+. .+|+.||||+++... ....+.+..|.++++++ +||||+++++++.+.+..|+||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 46899999999999996 468999999997542 23346678899999877 89999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--- 173 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--- 173 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC---
Confidence 999999988754 389999999999999999999999999999999999999999999999999975422110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 174 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 174 ---------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp ---------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 12245699999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK-EAL 774 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 774 (791)
... .++...........+......+.+++.+||..||++||++. |++
T Consensus 221 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 221 QDE-------------EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCH-------------HHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 321 11222222222222222456788999999999999999997 664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.95 Aligned_cols=241 Identities=21% Similarity=0.298 Sum_probs=198.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46899999999999995 678999999986532 222357899999999999999999999999999999999999 7
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~----- 162 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----- 162 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-----
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-----
Confidence 89999887654 39999999999999999999999999999999999999999999999999998654221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+
T Consensus 163 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 163 --------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp --------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred --------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 1123469999999999988776 7899999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.........+.. ..+..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 211 ~~~~~~~~~i~~-------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 211 EFIPNLFKKVNS-------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SSSTTCBCCCCS-------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ccHHHHHHHHHc-------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 543322222111 1111112245678899999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=369.03 Aligned_cols=259 Identities=23% Similarity=0.309 Sum_probs=207.7
Q ss_pred hhcceeccccCceEEEEEEe--------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCce
Q 003847 477 KASAYILGASGSSIMYKAVL--------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 546 (791)
+...+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++++ +||||+++++++...+..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 33457899999999999984 23468999999765 334457899999999999 999999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 547 LIIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
++||||+++|+|.+++...... ....+++.+++.|+.||+.||+|||+.||+||||||+|||++.++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcE
Confidence 9999999999999999876421 11249999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 231 kL~DFG~a~~~~~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di 276 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYK----------------------------------KTTNGRLPVKWMAPEALFDRIYTHQSDV 276 (382)
T ss_dssp EECSCSCCCCSSCCCTTC----------------------------------CCTTCCCGGGGSCHHHHHSCCCCHHHHH
T ss_pred EEcccCcccccccccccc----------------------------------cccCCCCCcceeCHHHhcCCCCCchhHH
Confidence 999999998664322110 1122347889999999999999999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
|||||++|||++ |+.||..... .............. ........+.+++.+||+.||++|||++|++
T Consensus 277 wslG~il~ellt~g~~p~~~~~~----------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGVPV----------EELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCH----------HHHHHHHHTTCCCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999999999999 9999864311 11112221111111 1122456788999999999999999999999
Q ss_pred HHhccCC
Q 003847 775 QALEKIP 781 (791)
Q Consensus 775 ~~L~~i~ 781 (791)
+.|+++.
T Consensus 345 ~~L~~~~ 351 (382)
T 3tt0_A 345 EDLDRIV 351 (382)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.84 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=205.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccC--ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e~~~~ 555 (791)
.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 468999999999999954 58999999997643 333567889999999999999999999998765 67999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe----cCCCCeEEeccCcccccCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL----GNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~~~~~~~ 631 (791)
++|.+++....... .+++.+++.|+.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 94 ~~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~ 171 (319)
T 4euu_A 94 GSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171 (319)
T ss_dssp CBHHHHHHSGGGTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC
T ss_pred CCHHHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc
Confidence 99999998764332 38999999999999999999999999999999999999 7788899999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc--------CCCCCCchhhHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR--------SIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~~sDvwSlGvil~ 703 (791)
.....||+.|+|||++. +..++.++|||||||++|
T Consensus 172 -------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 214 (319)
T 4euu_A 172 -------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (319)
T ss_dssp -------------------------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHH
T ss_pred -------------------------------------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHH
Confidence 11345899999999986 567899999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhh---------------------hcCccchHHHHHHHHHHHhhccCC
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAI---------------------RADFEGKEEALLSCFKLGYSCASP 762 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~ 762 (791)
||++|+.||........ .......+..... .............+.+++.+||+.
T Consensus 215 el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 215 HAATGSLPFRPFEGPRR-----NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHSSCSEECTTCGGG-----CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHhCCCCCCCCCccch-----hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 99999999964321110 0111111111110 011122345677889999999999
Q ss_pred CCCCCCCHHHHHHHhccCCC
Q 003847 763 LPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 763 dP~~RPs~~evl~~L~~i~~ 782 (791)
||++|||++|+++...+...
T Consensus 290 dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 290 DQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CTTTSCCHHHHHHHHHHHTC
T ss_pred ChhhhccHHHhhhccHHHhh
Confidence 99999999999999876554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.96 Aligned_cols=240 Identities=18% Similarity=0.217 Sum_probs=201.5
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
....||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 346899999999999995 479999999996542 2335678899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 125 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~---- 195 (350)
T 1rdq_E 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---- 195 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc----
Confidence 999999998754 38999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 196 -----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 196 -----------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp -----------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------------------------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 124599999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
... .++......+....+......+.+++.+||+.||++||+ ++|+++
T Consensus 241 ~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 241 DQP-------------IQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 311 122222222222223335677899999999999999998 888875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=361.04 Aligned_cols=243 Identities=19% Similarity=0.240 Sum_probs=191.9
Q ss_pred cceeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.||+++. .+|+.||||+++... ......+.+|++++++++||||+++++++...+..|+||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 346899999999999996 478999999997642 223456788999999999999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 9999999999987654 38999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 176 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 176 T------------------------------------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp ---------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred c------------------------------------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 0 1123469999999999999899999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
||..... ..............+......+.+++.+||..||++|| ++.|+++
T Consensus 220 pf~~~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 220 PFTGENR-------------KKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp SCCCSSH-------------HHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9965311 11122222222222223456788999999999999999 7888876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.10 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=197.4
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-----------
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE----------- 545 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----------- 545 (791)
..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||++++++|.+.+.
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 3468999999999999965 7999999999654 33345789999999999999999999999866432
Q ss_pred ----------------------------------------------eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHH
Q 003847 546 ----------------------------------------------KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARL 579 (791)
Q Consensus 546 ----------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~ 579 (791)
.++||||+++++|.+++....... ..++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~--~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE--DREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG--GSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc--chhhHHHH
Confidence 799999999999999998754332 36777899
Q ss_pred HHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCC
Q 003847 580 KIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659 (791)
Q Consensus 580 ~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (791)
.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..............
T Consensus 168 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~--------------------- 226 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP--------------------- 226 (332)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------------------
T ss_pred HHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc---------------------
Confidence 99999999999999999999999999999999999999999999987644321110000
Q ss_pred CCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhh
Q 003847 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIR 739 (791)
Q Consensus 660 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (791)
..........+||+.|+|||++.+..++.++|||||||++|||++|..|+... .........
T Consensus 227 ---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------------~~~~~~~~~ 288 (332)
T 3qd2_B 227 ---MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------------VRIITDVRN 288 (332)
T ss_dssp --------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------------HHHHHHHHT
T ss_pred ---ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------------HHHHHHhhc
Confidence 00011233456999999999999999999999999999999999998776332 111111111
Q ss_pred cCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 740 ADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 740 ~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
...+ ........+.+++.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1211 123345677899999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=380.10 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=207.7
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|+++|++++||||+++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 34578999999999999998899999999986543 3578999999999999999999999986 667899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 269 L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~----- 340 (454)
T 1qcf_A 269 LLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----- 340 (454)
T ss_dssp HHHHHHSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-----
T ss_pred HHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-----
Confidence 99999765321 2889999999999999999999999999999999999999999999999999876422110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
......+|..|+|||++....++.++|||||||++|||+| |+.||.+..
T Consensus 341 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 341 ------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp ------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 0112236788999999998899999999999999999999 999996531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
. ......+.... ..+.+...+..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 391 ~----------~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 391 N----------PEVIRALERGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp H----------HHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred H----------HHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1 11111111111 11222335678899999999999999999999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=362.61 Aligned_cols=251 Identities=19% Similarity=0.232 Sum_probs=199.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...||+|+||.||+|+. .+++.||||++... .....+.+.+|..+++++ +||||+++++++.+.+..|+||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 46899999999999995 46899999999754 233456788999999988 89999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~---- 164 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 164 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT----
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC----
Confidence 999999987654 39999999999999999999999999999999999999999999999999997532111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 --------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp --------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --------------------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 012245699999999999999999999999999999999999999964
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM------KEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 775 (791)
......... .. ...+...........+......+.+++.+||+.||++||++ .|+++
T Consensus 213 ~~~~~~~~~-~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 213 VGSSDNPDQ-NT---EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp TTC--------C---HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ccccccccc-cc---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 211111000 00 11122222222222233356678999999999999999996 56654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=365.24 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=199.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+||+|+||.||+|+.. +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 468999999999999965 58999999997542 23346788999999988 79999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---- 175 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---- 175 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC----
Confidence 999999988654 39999999999999999999999999999999999999999999999999998532111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 176 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 176 --------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp --------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 012245699999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
... .++...........+...+..+.+++.+||..||++||+ ++|+++
T Consensus 224 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 224 EDE-------------DELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 311 122222222333333335678899999999999999995 577765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.57 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=194.5
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhc--cCCCCccceeeEEEcc----CceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAK--LVHPNLVRIRGFYWGV----DEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|+. +++.||||++.... .+.+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46899999999999988 68999999997543 3455566666655 7999999999987653 4579999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH--------EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
++|+|.+++... .+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999998543 3999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC------CCCCchhhHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI------KPNPKWDVYSFG 699 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~sDvwSlG 699 (791)
......... .......||+.|+|||++.+. .++.++||||||
T Consensus 163 ~~~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG 210 (301)
T 3q4u_A 163 HSQSTNQLD--------------------------------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210 (301)
T ss_dssp EETTTTEEE--------------------------------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH
T ss_pred ccccccccc--------------------------------ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHH
Confidence 653322110 011234599999999999876 445799999999
Q ss_pred HHHHHHHhC----------CcchhccccCCCCcchhchhHHHHHHH-HhhhcCcc---chHHHHHHHHHHHhhccCCCCC
Q 003847 700 VILLELLTG----------KVIVVDELGQGNGLLVEDKNRAIRLAD-AAIRADFE---GKEEALLSCFKLGYSCASPLPQ 765 (791)
Q Consensus 700 vil~elltG----------~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~ 765 (791)
|++|||++| +.||.......... ........ .......+ ........+.+++.+||+.||+
T Consensus 211 ~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 211 LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-----EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-----HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhhhcCccccccccccccccCCCCcch-----hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChh
Confidence 999999999 67775432211110 01111110 00111111 1223667899999999999999
Q ss_pred CCCCHHHHHHHhccC
Q 003847 766 KRPSMKEALQALEKI 780 (791)
Q Consensus 766 ~RPs~~evl~~L~~i 780 (791)
+|||+.|+++.|++|
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=367.58 Aligned_cols=245 Identities=18% Similarity=0.266 Sum_probs=199.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
....||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||++
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 346899999999999995 468999999986532 2335678899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---- 169 (384)
T 4fr4_A 99 GGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---- 169 (384)
T ss_dssp TEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC----
Confidence 999999987643 39999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 170 ---------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~P 216 (384)
T 4fr4_A 170 ---------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216 (384)
T ss_dssp ---------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCC
Confidence 1224569999999999964 4589999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-MKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 775 (791)
|....... ...+...........+......+.+|+.+||+.||++||+ ++++++
T Consensus 217 f~~~~~~~----------~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 217 YHIRSSTS----------SKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCCCTTSC----------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCCcc----------HHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 96432211 1112222222222222335577899999999999999998 677664
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=362.57 Aligned_cols=259 Identities=14% Similarity=0.109 Sum_probs=203.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46899999999999994 6799999999865432 24688999999999 9999999999999999999999999 999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC-----eEEeccCcccccCCCCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME-----PKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~~~~~~~~ 632 (791)
|.+++..... .+++..++.|+.|++.||+|||+.||+||||||+|||++.++. +||+|||+++........
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 91 LEDLFDLCDR----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred HHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 9999886532 4999999999999999999999999999999999999998887 999999999876533221
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
... +.......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 167 ~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 167 KHI-----------------------------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp CBC-----------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccc-----------------------------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 100 111223556999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.+........ ....+..................+.+++..||+.||.+||++++|++.|+++
T Consensus 218 ~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 218 QGLKADTLKE------RYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp TTCCCSSHHH------HHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cccccccHHH------HHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 7642221111 1111111111111000000112789999999999999999999999999765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=352.85 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=190.7
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCch----hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSV----DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence 3568999999999999975 89999999875422 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CeecCCCCCCeEecC--------CCCeEEeccCcc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK---HVHGNLKPRNVLLGN--------DMEPKIGDFGLE 623 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---ivHrDlkp~NILl~~--------~~~~kL~DFGla 623 (791)
+++|.+++... .+++..++.++.|++.||+|||+.| |+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999988533 3899999999999999999999998 899999999999986 678999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+....... ....||+.|+|||++.+..++.++||||||+++|
T Consensus 164 ~~~~~~~~--------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 205 (271)
T 3dtc_A 164 REWHRTTK--------------------------------------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205 (271)
T ss_dssp --------------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred cccccccc--------------------------------------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHH
Confidence 76542211 1234899999999999989999999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
||++|+.||..... ............. .+.....+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 206 ~l~~g~~p~~~~~~---------~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 206 ELLTGEVPFRGIDG---------LAVAYGVAMNKLA--LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHCCCTTTTSCH---------HHHHHHHHTSCCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHhCCCCCCCCCH---------HHHHHhhhcCCCC--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999965311 0111111111111 111222456788999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=382.88 Aligned_cols=255 Identities=28% Similarity=0.379 Sum_probs=209.0
Q ss_pred hcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 478 ASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...+.||+|+||.||+|+.. +++.||||+++.... ..++|.+|+++|++++||||+++++++...+..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 34578999999999999965 489999999986543 3578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++...... .+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 302 ~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---- 374 (495)
T 1opk_A 302 NLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT---- 374 (495)
T ss_dssp BHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE----
T ss_pred CHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee----
Confidence 999999764332 3899999999999999999999999999999999999999999999999999876432111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 715 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 375 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 375 -------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp -------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred -------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0112236788999999998889999999999999999999 88898653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
... ...+.+...... ..+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 424 ~~~----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 424 DLS----------QVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CGG----------GHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CHH----------HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 211 112222222111 12223556788999999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.10 Aligned_cols=254 Identities=22% Similarity=0.244 Sum_probs=193.6
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++ ++
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 468999999999999998899999999975422 234678899999999999999999999999999999999997 58
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 105 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~------ 174 (311)
T 3niz_A 105 LKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR------ 174 (311)
T ss_dssp HHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc------
Confidence 8887765432 389999999999999999999999999999999999999999999999999987542211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 ------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 175 ------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ---------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 1123358999999999876 568999999999999999999999996543
Q ss_pred cCCCCcchh------------chhHHHHHHHHhhhcCcc------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVE------------DKNRAIRLADAAIRADFE------GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......+. .........+... ..+. .......++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 225 DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF-QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHHHHCCCChHHhhhhhccchhhhccc-ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 211100000 0000000000000 0000 00012356789999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=363.83 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 4578999999999999963 4589999999865 33445789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC
Q 003847 552 FVPNGSLANARYRKMGSS-------------------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~ 612 (791)
|+++|+|.+++....... ...+++.+++.|+.||+.||+|||+.||+||||||+|||++.+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~ 210 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 210 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCC
Confidence 999999999998743210 1359999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
+.+||+|||+++......... ......||+.|+|||++.+..++.+
T Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~ 256 (343)
T 1luf_A 211 MVVKIADFGLSRNIYSADYYK----------------------------------ADGNDAIPIRWMPPESIFYNRYTTE 256 (343)
T ss_dssp GCEEECCCSCHHHHTGGGCBC--------------------------------------CCBCGGGCCHHHHHHCCCCHH
T ss_pred CeEEEeecCCCcccccCcccc----------------------------------ccCCCcccceecChhhhccCCcCcc
Confidence 999999999998764221100 0112347889999999998899999
Q ss_pred hhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 693 WDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 693 sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
+||||||+++|||++ |+.||.+... ......+.+... .......+..+.+++.+||+.||++||++.
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAH---------EEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCCh---------HHHHHHHhCCCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 999999999999999 9999865311 011111111111 111222456789999999999999999999
Q ss_pred HHHHHhccCCCCC
Q 003847 772 EALQALEKIPSSP 784 (791)
Q Consensus 772 evl~~L~~i~~~~ 784 (791)
|+++.|+++....
T Consensus 325 ~~~~~L~~~~~~~ 337 (343)
T 1luf_A 325 SIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHHTTC--
T ss_pred HHHHHHHHHHhhh
Confidence 9999999987644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=359.68 Aligned_cols=259 Identities=27% Similarity=0.336 Sum_probs=208.1
Q ss_pred hhcceeccccCceEEEEEEe------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 477 KASAYILGASGSSIMYKAVL------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
+...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34457899999999999985 34589999999764 344567899999999999999999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec
Q 003847 550 YDFVPNGSLANARYRKMGSS-------------------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~ 610 (791)
|||+++++|.+++....... ...+++.+++.++.||+.||+|||+.||+||||||+||+++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc
Confidence 99999999999998754311 12389999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCC
Q 003847 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN 690 (791)
Q Consensus 611 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 690 (791)
.++.+||+|||+++......... ......||+.|+|||++.+..++
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 230 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYV----------------------------------KRSQGRIPVKWMAIESLFDHIYT 230 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEE----------------------------------CSSCCCSCGGGCCHHHHHHCEEC
T ss_pred CCCCEEEccccccccccccccce----------------------------------eccCCCCcccccChhhhcCCCcC
Confidence 99999999999998764322110 01123478889999999988899
Q ss_pred CchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 691 PKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 691 ~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
.++||||||+++|||++ |+.||...... ............ ......+..+.+++.+||+.||++||+
T Consensus 231 ~~~Di~slG~il~el~t~g~~p~~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPE----------RLFNLLKTGHRM--ERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------GHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHH----------HHHHHhhcCCcC--CCCccCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999 99998654211 111111111111 112224567899999999999999999
Q ss_pred HHHHHHHhccCC
Q 003847 770 MKEALQALEKIP 781 (791)
Q Consensus 770 ~~evl~~L~~i~ 781 (791)
+.|+++.|+++.
T Consensus 299 ~~~l~~~l~~~~ 310 (314)
T 2ivs_A 299 FADISKDLEKMM 310 (314)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=362.44 Aligned_cols=267 Identities=24% Similarity=0.346 Sum_probs=208.6
Q ss_pred cceeccccCceEEEEEEe-----CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL-----EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e 551 (791)
..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 357899999999999983 4689999999988777777889999999999999999999999874 456889999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++..... .+++..++.|+.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 107 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp CCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred ecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 9999999999987543 389999999999999999999999999999999999999999999999999987653321
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
... ......||..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 183 ~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 183 YYV---------------------------------VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp EEE---------------------------------CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred cce---------------------------------eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 110 11123488899999999988899999999999999999999999
Q ss_pred hhccccCCCCc-----chhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 712 VVDELGQGNGL-----LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 712 f~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
|.......... ................. .......+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQR--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp GGSHHHHHHHHCC----CCHHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred CccccchhhhhcccccccccHHHHHHHhhcccC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 86532210000 00000111111111111 1122235567899999999999999999999999999885443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.44 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=206.3
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||++...+++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 345789999999999999888999999999875433 3678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 90 L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~----- 160 (267)
T 3t9t_A 90 LSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----- 160 (267)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-----
T ss_pred HHHHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc-----
Confidence 9999876532 3899999999999999999999999999999999999999999999999999865421100
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
......||..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 161 ------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp ------------------------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ------------------------------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 0112337788999999998899999999999999999999 888986531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
.. .....+ ...... ..+......+.+++.+||+.||++||++.|+++.|+++..
T Consensus 211 ~~---------~~~~~i-~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 211 NS---------EVVEDI-STGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HH---------HHHHHH-HTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---------HHHHHH-hcCCcC--CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 10 011111 111111 1112245678899999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.59 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=198.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.++||+|+||.||+|+ ..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 4579999999999999 457999999999776555567899999999985 79999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++...........
T Consensus 98 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 98 ILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 999998764 3899999999999999999999999999999999999998766 99999999886542211100
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----CCCCCchhhHHHHHHHHHHHhCC
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwSlGvil~elltG~ 709 (791)
. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 173 ~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 173 I-----------------------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp --------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred c-----------------------------cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 0 0011223469999999999875 55789999999999999999999
Q ss_pred cchhccccCCCCcchhc--hhHHHHHHHHhhhcCccchH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVED--KNRAIRLADAAIRADFEGKE----EALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.||.............. ......+...........+. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99976433211111000 00011122222222222221 134678999999999999999999999983
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=369.27 Aligned_cols=248 Identities=19% Similarity=0.235 Sum_probs=201.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 356899999999999995 4689999999987665556789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC--CCCeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN--DMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.+++..... .+++..+..++.||+.||+|||+.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 135 L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---- 206 (387)
T 1kob_A 135 LFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---- 206 (387)
T ss_dssp HHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC----
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc----
Confidence 9998765432 3899999999999999999999999999999999999974 57799999999987643211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 207 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 207 ---------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp ---------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---------------------------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 11234899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ......+...............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 254 DD---------LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SH---------HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CH---------HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 21 01111111111100111112245678899999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=369.56 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=204.5
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCc-eEEE
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDE-KLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~-~~lv 549 (791)
..+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+++++++ +||||+++++++...+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 457899999999999973 34689999999764 334456799999999999 79999999999987655 8999
Q ss_pred EeccCCCChhHHHHhhcCCC------------------------------------------------------------
Q 003847 550 YDFVPNGSLANARYRKMGSS------------------------------------------------------------ 569 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~------------------------------------------------------------ 569 (791)
|||+++|+|.+++.......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999998754310
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccc
Q 003847 570 -PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648 (791)
Q Consensus 570 -~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (791)
...+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--------------- 250 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--------------- 250 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE---------------
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch---------------
Confidence 1128999999999999999999999999999999999999999999999999998654322110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhch
Q 003847 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDK 727 (791)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 727 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 251 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------- 302 (359)
T 3vhe_A 251 -------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------- 302 (359)
T ss_dssp -------------------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------
T ss_pred -------------------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------
Confidence 1123348899999999999999999999999999999998 99999653211
Q ss_pred hHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 728 NRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
............. ..+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 303 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 303 EEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111112211111 112224567889999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=368.37 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred ceeccccCceEEEEEEeC------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 468999999999999843 4678999999764 344456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC---CeEEeccCcccccC
Q 003847 553 VPNGSLANARYRKMGS--SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM---EPKIGDFGLERLVT 627 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~~ 627 (791)
+++|+|.+++...... ....+++.+++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~ 235 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccc
Confidence 9999999999876532 123489999999999999999999999999999999999999554 59999999998653
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
...... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 236 ~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 236 RAGYYR----------------------------------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp HHSSCT----------------------------------TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccccc----------------------------------cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 221100 1112347889999999999899999999999999999998
Q ss_pred -CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 708 -GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 708 -G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|+.||..... ........... ........+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 282 ~g~~pf~~~~~----------~~~~~~i~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 282 LGYMPYPSKSN----------QEVLEFVTSGG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TSCCSSTTCCH----------HHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCH----------HHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 9999865321 11111111111 11122234567889999999999999999999999997753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.91 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=197.4
Q ss_pred cceeccccCceEEEEEEe-CCCc----EEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVL-EDGT----ALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|+. .+++ .||+|.+... .....+.+.+|++++++++||||+++++++... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 346899999999999994 3444 4688888653 334457899999999999999999999999875 47899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 98 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp CTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 999999999887543 3899999999999999999999999999999999999999999999999999876533211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 174 ~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 174 Y----------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred c----------------------------------cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 1 1112347889999999999999999999999999999999 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|...... ........... ..........+.+++.+||+.||++||++.|+++.|+++..
T Consensus 220 ~~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 220 YDGIPAS----------EISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTTCCGG----------GHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCCHH----------HHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9653211 11222221111 11222245678899999999999999999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=362.68 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=182.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|+.+++++. ||||+++++++.+.+..|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 46899999999999995 46899999999654 3367789999999997 9999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC---CeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM---EPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++.... .+++.++..|+.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--- 164 (325)
T 3kn6_A 93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--- 164 (325)
T ss_dssp HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence 999987753 399999999999999999999999999999999999998765 799999999986543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 165 ---------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ---------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 11234589999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
......... ..++......+.+... ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 212 ~~~~~~~~~------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 212 HDRSLTCTS------AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ------CCC------HHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred Ccccccccc------HHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 432211111 1222222222222211 2245678999999999999999999998743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=377.75 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=203.6
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..+.||+|+||.||+|...++..||||+++.... ..+++.+|+++|++++||||+++++++.+ +..++||||+++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 4568999999999999988888999999986543 24689999999999999999999999866 778999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 266 ~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~------ 336 (452)
T 1fmk_A 266 LDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT------ 336 (452)
T ss_dssp HHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred HHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee------
Confidence 9999754322 3899999999999999999999999999999999999999999999999999876432111
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 337 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 337 -----------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp -----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred -----------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 0112236788999999998899999999999999999999 8999865311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p 786 (791)
. .....+.... ..+.+...+..+.+++.+||+.||++|||++++++.|+.+.....|
T Consensus 388 ~----------~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 388 R----------EVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp H----------HHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred H----------HHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 0 1111111111 1122223566789999999999999999999999999998765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=357.85 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=208.3
Q ss_pred hhcceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
+...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34457899999999999984 357899999997653 34457899999999999 99999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 549 IYDFVPNGSLANARYRKMGS-------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.||+||||||+||+++.++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCE
Confidence 99999999999999875421 11248999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||+++......... ......||+.|+|||++.+..++.++||
T Consensus 185 kl~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYV----------------------------------VKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp EECCCGGGSCTTSCTTSE----------------------------------ECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred EEccccccccccccccce----------------------------------eccCCCCcceeeChHHhcCCCCChHHHH
Confidence 999999998765332110 0112347888999999998899999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
||||+++|||++ |+.||...... ............... ....+..+.+++.+||+.||++|||+.|++
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVD---------SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSS---------HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcccch---------hHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 999999999999 99998653211 111222222221111 122456789999999999999999999999
Q ss_pred HHhccCC
Q 003847 775 QALEKIP 781 (791)
Q Consensus 775 ~~L~~i~ 781 (791)
+.|+++.
T Consensus 300 ~~L~~~~ 306 (313)
T 1t46_A 300 QLIEKQI 306 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=352.50 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=193.5
Q ss_pred hhcceeccccCceEEEEEEeC----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 477 KASAYILGASGSSIMYKAVLE----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
+...+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEe
Confidence 344678999999999999854 2567999998764 334456799999999999999999999998 4567899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 96 LCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp CCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999999876532 389999999999999999999999999999999999999999999999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 710 (791)
. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 172 ~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 172 Y-----------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp ------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred c-----------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCC
Confidence 0 0112236788999999998899999999999999999997 888
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||.+.... .....+.... ..+.....+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 217 pf~~~~~~---------~~~~~i~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 217 PFQGVKNN---------DVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TTTTCCGG---------GHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCCHH---------HHHHHHHcCC---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 98653211 1111111111 11112234567889999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.86 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=196.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh-------hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD-------RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 46899999999999995 57899999999653221 1267899999999999999999999986554 79999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCC-----eEEeccCccc
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDME-----PKIGDFGLER 624 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~-----~kL~DFGla~ 624 (791)
|+++|+|.+++..... .+++..++.++.|++.||+|||+.| |+||||||+||+++.++. +||+|||+++
T Consensus 102 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp CCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred ecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 9999999998876532 4999999999999999999999999 999999999999988776 9999999987
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc--CCCCCCchhhHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR--SIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwSlGvil 702 (791)
..... .....||+.|+|||++. ...++.++|||||||++
T Consensus 178 ~~~~~---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 178 QSVHS---------------------------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp CCSSC---------------------------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 43321 11234899999999984 45678999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|||++|+.||...... ................. ....+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 219 ~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 219 YTILTGEGPFDEYSYG-------KIKFINMIREEGLRPTI--PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSSCTTTTCCCC-------HHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHcCCCCCcccccc-------HHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999999653211 01011111111111111 223556789999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=360.20 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=193.8
Q ss_pred hcceeccccCceEEEEEEeCC-C---cEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCce-----
Q 003847 478 ASAYILGASGSSIMYKAVLED-G---TALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK----- 546 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~----- 546 (791)
...+.||+|+||.||+|+... + ..||||+++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 345789999999999999543 3 28999999764 344567899999999999999999999999887655
Q ss_pred -EEEEeccCCCChhHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 547 -LIIYDFVPNGSLANARYRKMGS-SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 547 -~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
++||||+++|+|.+++...... ....+++..++.|+.|++.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~ 185 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence 9999999999999998765432 22248999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~e 704 (791)
......... ......+++.|+|||++.+..++.++|||||||++||
T Consensus 186 ~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (323)
T 3qup_A 186 KIYSGDYYR----------------------------------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWE 231 (323)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccc----------------------------------ccccccCcccccCchhhcCCCCCCccchhhHHHHHHH
Confidence 764322110 0112236788999999999999999999999999999
Q ss_pred HHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 705 LLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 705 llt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|++ |+.||.+.... .....+.... ........+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 232 ll~~g~~p~~~~~~~---------~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 232 IMTRGQTPYAGIENA---------EIYNYLIGGN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHTTSCCTTTTCCGG---------GHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCccccChH---------HHHHHHhcCC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999 88898653211 1111111111 111222345678999999999999999999999999988643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.80 Aligned_cols=248 Identities=20% Similarity=0.264 Sum_probs=196.6
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 468999999999999954 78999999986542 2234678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----- 161 (323)
T 3tki_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----- 161 (323)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-----
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc-----
Confidence 999876543 3899999999999999999999999999999999999999999999999999865422110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 162 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 162 -----------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp -----------------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred -----------------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 01123469999999999987765 779999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
... .......... ............+.+|+.+||+.||++|||+.|+++.
T Consensus 213 ~~~--------~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 213 DSC--------QEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTS--------HHHHHHHTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hHH--------HHHHHHhccc--ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 210 0111111111 1111112245677899999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.09 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=203.3
Q ss_pred cceeccccCceEEEEEEe-----CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-----EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 550 (791)
..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... ...++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 356899999999999983 46899999999754 333457899999999999999999999999877 6689999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 105 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp ECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 99999999999976543 38999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.
T Consensus 181 ~~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 181 EYYT---------------------------------VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp CEEE---------------------------------CCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccee---------------------------------ccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 1100 1123348889999999998889999999999999999999999
Q ss_pred chhccccCCCCc--chhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 711 IVVDELGQGNGL--LVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 711 pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|+.......... ..........+....... ..+.....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 864431100000 000001111111111111 1112223456789999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=374.03 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=202.6
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC-ceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD-EKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|... |+.||||+++... ..+.+.+|+++|++++||||+++++++...+ ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 3578999999999999975 7899999998654 3478999999999999999999999987765 7899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 274 L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------- 343 (450)
T 1k9a_A 274 LVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------- 343 (450)
T ss_dssp HHHHHHHHCTT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-------
Confidence 99999876432 37999999999999999999999999999999999999999999999999998543211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 344 --------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 344 --------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp -----------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred --------------------------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 01136778999999999999999999999999999998 999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
... ....+..... .+.+...+..+.+++.+||+.||++|||+.++++.|+.|..
T Consensus 392 ~~~----------~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 392 LKD----------VVPRVEKGYK--MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TTT----------HHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----------HHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 211 1111111111 12222356788999999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=372.87 Aligned_cols=248 Identities=17% Similarity=0.196 Sum_probs=199.7
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...+||+|+||.||+|+.. +++.||+|++.+... ...+.+.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3468999999999999954 689999999965311 122457889999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-- 224 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-- 224 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE--
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc--
Confidence 99999988653 2899999999999999999999999999999999999999999999999999876432110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC----CCCchhhHHHHHHHHHHHhCCc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK----PNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 225 ---------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 225 ---------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp ---------------------------------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred ---------------------------------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 122456999999999998655 7899999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
||..... ......+........++.....+..+.+|+.+||..+|++ ||+++||++.
T Consensus 272 Pf~~~~~---------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 272 PFYADSL---------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TTCCSSH---------HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCCCCh---------hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 9965421 1111222222211222222224567889999999999988 9999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.01 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=200.0
Q ss_pred cceeccccCceEEEEEEeC-CC-------cEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVLE-DG-------TALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.||+|+.. ++ +.||+|++........+.+.+|++++++++||||+++++++...+..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 3568999999999999843 33 579999998776666788999999999999999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC--------eEEeccCc
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME--------PKIGDFGL 622 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~--------~kL~DFGl 622 (791)
||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 92 e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp ECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred ECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 99999999999987542 3899999999999999999999999999999999999998887 99999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVI 701 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvi 701 (791)
+....... ...||+.|+|||++.+ ..++.++||||||++
T Consensus 168 ~~~~~~~~----------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 207 (289)
T 4fvq_A 168 SITVLPKD----------------------------------------ILQERIPWVPPECIENPKNLNLATDKWSFGTT 207 (289)
T ss_dssp CTTTSCHH----------------------------------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHH
T ss_pred cccccCcc----------------------------------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHH
Confidence 87543211 1237888999999987 678999999999999
Q ss_pred HHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 702 LLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
+|||++|..|+..... .......... ....+. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 208 l~el~~g~~~~~~~~~---------~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 208 LWEICSGGDKPLSALD---------SQRKLQFYED--RHQLPA--PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHHHTTTCCTTTTSC---------HHHHHHHHHT--TCCCCC--CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHHHHcCCCCCccccc---------hHHHHHHhhc--cCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999997665432211 0011111111 111111 13456789999999999999999999999999997
Q ss_pred CCC
Q 003847 782 SSP 784 (791)
Q Consensus 782 ~~~ 784 (791)
.+.
T Consensus 275 ~p~ 277 (289)
T 4fvq_A 275 TPD 277 (289)
T ss_dssp ---
T ss_pred CCC
Confidence 654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=366.71 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=189.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHH-HhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRV-IAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.++||+|+||.||+|+.. +++.||||++.+... ...+.+.+|..+ ++.++||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999954 689999999976432 223456667766 567899999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~---- 193 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 193 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC----
Confidence 999999988754 38999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 194 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 194 --------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp --------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 112345699999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
... .++.+................+.+++.+||+.||++||++.+.+
T Consensus 242 ~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 242 RNT-------------AEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SBH-------------HHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCH-------------HHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 311 12222222222222223456788999999999999999985433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.96 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=204.7
Q ss_pred hcceeccccCceEEEEEEe-----CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEE
Q 003847 478 ASAYILGASGSSIMYKAVL-----EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLII 549 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 549 (791)
...+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 4457899999999998864 268999999998653 34457799999999999999999999999874 567999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+++++|.+++.... +++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999886542 899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
..... ......||..|+|||++.+..++.++||||||+++|||++|+
T Consensus 188 ~~~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 188 HEYYR---------------------------------VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp CSEEE---------------------------------C---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccccc---------------------------------cccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 21100 111234788899999999888999999999999999999999
Q ss_pred cchhccccCC-----CCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 710 VIVVDELGQG-----NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 710 ~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.||....... ............+....... .+.....+..+.+|+.+||+.||++|||+.|+++.|+++.
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp CGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccchhhhhhhcccccchhHHHHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 9986532110 00000001111111111111 1122235578899999999999999999999999998763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.11 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=193.4
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 468999999999999998899999999965432 2246788999999999999999999999999999999999975 9
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------ 155 (288)
T 1ob3_A 86 LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR------ 155 (288)
T ss_dssp HHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc------
Confidence 9988876432 389999999999999999999999999999999999999999999999999987642211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 ------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 156 ------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp ------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1112358999999999976 458999999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhh----------------hcCc---------cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAI----------------RADF---------EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.. .....+..... ...+ .........+.+++.+||+.||++|||++
T Consensus 206 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 276 (288)
T 1ob3_A 206 EA---------DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (288)
T ss_dssp HH---------HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HH---------HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 10 00111110000 0000 00011345778999999999999999999
Q ss_pred HHHH
Q 003847 772 EALQ 775 (791)
Q Consensus 772 evl~ 775 (791)
|+++
T Consensus 277 e~l~ 280 (288)
T 1ob3_A 277 QALE 280 (288)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.97 Aligned_cols=260 Identities=14% Similarity=0.149 Sum_probs=205.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +|+||+++++++......++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46899999999999994 6799999999865432 24678899999999 7999999999999999999999999 999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC-----eEEeccCcccccCCCCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME-----PKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~~~~~~~~ 632 (791)
|.+++..... ++++..+..++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++........
T Consensus 92 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 92 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred HHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 9999986532 3899999999999999999999999999999999999987776 999999999877543221
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
... .........||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 168 QHI-----------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp CBC-----------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccc-----------------------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 110 011233456999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
........ ......+.......... .....+..+.+++.+||+.||++||++++|++.|+++.
T Consensus 219 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 219 QGLKAATN------KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp SSCCSCCH------HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred chhhcccc------HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 76422111 11111111111111100 00123467889999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=362.86 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=185.0
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
....||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3468999999999999965 58899999997643 23678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 205 (349)
T 2w4o_A 135 LFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---- 205 (349)
T ss_dssp HHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc----
Confidence 999887543 3899999999999999999999999999999999999975 8899999999998654211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 206 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 206 ---------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp ----------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ---------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 01234589999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.... ......+.........+........+.+|+.+||+.||++|||+.|+++.
T Consensus 253 ~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 253 ERGD--------QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTCH--------HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cccc--------HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3211 00111111111100001112245678899999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.11 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=201.2
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc--CceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+.. ++.||||++... .....+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 3568999999999999985 899999999764 334456799999999999999999999999887 77899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+|+|.+++...... .+++..++.|+.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---- 165 (271)
T 3kmu_A 93 YGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---- 165 (271)
T ss_dssp TCBHHHHHHSCSSC---CCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred CCcHHHHHhhcccC---CCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence 99999999865432 4899999999999999999999999 99999999999999999999999998654221
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCC---chhhHHHHHHHHHHHhCC
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP---KWDVYSFGVILLELLTGK 709 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~---~sDvwSlGvil~elltG~ 709 (791)
....||+.|+|||++.+..++. ++||||||+++|||++|+
T Consensus 166 -------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 208 (271)
T 3kmu_A 166 -------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208 (271)
T ss_dssp -------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCS
T ss_pred -------------------------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 1224889999999998755544 899999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
.||.+... ................ ....+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 209 ~p~~~~~~---------~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 209 VPFADLSN---------MEIGMKVALEGLRPTI--PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTTTTSCH---------HHHHHHHHHSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCccccCh---------HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99964311 1111111111111111 22245678999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=354.79 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=188.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--------------------------hhHHHHHHHHHHHhccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--------------------------DRFRDFETQVRVIAKLVHPN 532 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~n 532 (791)
.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46899999999999995 5689999999865421 11356889999999999999
Q ss_pred ccceeeEEEc--cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec
Q 003847 533 LVRIRGFYWG--VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610 (791)
Q Consensus 533 Iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~ 610 (791)
|+++++++.+ .+..++||||+++++|.+++... ++++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999987 56789999999999998754321 499999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--
Q 003847 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-- 688 (791)
Q Consensus 611 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-- 688 (791)
.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 215 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA------------------------------------LLSNTVGTPAFMAPESLSETRKI 215 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC------------------------------------EECCCCSCGGGCCGGGCCTTCCC
T ss_pred CCCCEEEecCCCccccccccc------------------------------------cccCCcCCccccChhhhccCCCC
Confidence 999999999999987643211 011235899999999998755
Q ss_pred -CCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCC
Q 003847 689 -PNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 689 -~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
++.++|||||||++|||++|+.||.+.... .....+.... ..++........+.+++.+||+.||++|
T Consensus 216 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~R 284 (298)
T 2zv2_A 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIM---------CLHSKIKSQA--LEFPDQPDIAEDLKDLITRMLDKNPESR 284 (298)
T ss_dssp EESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCC--CCCCSSSCCCHHHHHHHHHHTCSCTTTS
T ss_pred CCCchhhhHhHHHHHHHHHHCCCCCCCccHH---------HHHHHHhccc--CCCCCccccCHHHHHHHHHHhhcChhhC
Confidence 378899999999999999999999653110 0011111111 1111112245678899999999999999
Q ss_pred CCHHHHHH
Q 003847 768 PSMKEALQ 775 (791)
Q Consensus 768 Ps~~evl~ 775 (791)
||+.|+++
T Consensus 285 ~s~~e~l~ 292 (298)
T 2zv2_A 285 IVVPEIKL 292 (298)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.13 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=203.3
Q ss_pred ceeccccCceEEEEEEeC---CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE---DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred hccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 348999999999999853 6789999999875 344567899999999999999999999999 55678999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 94 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~- 168 (287)
T 1u59_A 94 GPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT- 168 (287)
T ss_dssp EEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC-
T ss_pred CCHHHHHHhCCc----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee-
Confidence 999999865432 489999999999999999999999999999999999999999999999999987653221100
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 169 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 169 --------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp --------------------------------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred --------------------------------ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 1112347889999999988889999999999999999999 9999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.... ............ ..+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 217 ~~~~----------~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 217 MKGP----------EVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp CCTH----------HHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH----------HHHHHHhcCCcC--CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3211 111111111111 112235678899999999999999999999999998863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.06 Aligned_cols=241 Identities=21% Similarity=0.274 Sum_probs=199.5
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 3568999999999999954 578999999977655556889999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||++ +.++.+||+|||++........
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--- 164 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--- 164 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---
Confidence 999887654 38999999999999999999999999999999999999 7889999999999987543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||+.|+|||++.+. ++.++||||||+++|||++|+.||..
T Consensus 165 ----------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 165 ----------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp ----------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----------------------------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 1123589999999998764 89999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKE----EALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .+.............. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 210 PTD-------------SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCH-------------HHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 311 1111111122222221 23567899999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=376.17 Aligned_cols=243 Identities=21% Similarity=0.241 Sum_probs=192.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+. .+|+.||||++... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 357899999999999994 57899999999753 23334567889999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|+|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++......
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 303 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 303 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC---
Confidence 999999987654 38999999999999999999998 999999999999999999999999999987533211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 304 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 304 ---------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp ------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------------------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 11224569999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
.... ..+...........+......+.+|+.+||+.||++|| +++|+++
T Consensus 351 ~~~~-------------~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 351 NQDH-------------EKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CSSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCH-------------HHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 5311 12222222222223333557789999999999999999 9999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=362.81 Aligned_cols=263 Identities=24% Similarity=0.265 Sum_probs=205.4
Q ss_pred hhcceeccccCceEEEEEEe------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 477 KASAYILGASGSSIMYKAVL------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
+...+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 34467999999999999995 24678999999754 233457899999999999 89999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCC------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec
Q 003847 549 IYDFVPNGSLANARYRKMGSS------------------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG 610 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~ 610 (791)
||||+++|+|.+++....... ...+++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 206 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc
Confidence 999999999999998654210 12379999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCC
Q 003847 611 NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPN 690 (791)
Q Consensus 611 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 690 (791)
.++.+||+|||++.......... ......||+.|+|||++.+..++
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYV----------------------------------VRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSE----------------------------------EETTEEECGGGCCHHHHHHCCCC
T ss_pred CCCcEEeCCCccCcccccCccce----------------------------------eccCccCccCccCHHHhccCCCC
Confidence 99999999999998664322110 01123378889999999988999
Q ss_pred CchhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 691 PKWDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 691 ~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
.++|||||||++|||+| |+.||...... .............. .....+..+.+++.+||+.||++|||
T Consensus 253 ~~~Di~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps 321 (344)
T 1rjb_A 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVD---------ANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPS 321 (344)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhHhHHHHHHHHHHHHcCCCCCcccCCcH---------HHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 99999999999999998 99999654211 11122222211111 11224567889999999999999999
Q ss_pred HHHHHHHhccCCCCC
Q 003847 770 MKEALQALEKIPSSP 784 (791)
Q Consensus 770 ~~evl~~L~~i~~~~ 784 (791)
+.|+++.|+.+....
T Consensus 322 ~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 322 FPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHHHHHC---
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.51 Aligned_cols=270 Identities=20% Similarity=0.236 Sum_probs=202.3
Q ss_pred cceecccc--CceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGAS--GSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+| +||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 35689999 99999999964 7999999999754 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||.+..........
T Consensus 109 ~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~ 185 (389)
T 3gni_B 109 AYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185 (389)
T ss_dssp TTCBHHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred CCCCHHHHHhhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence 999999998775332 38999999999999999999999999999999999999999999999999987653221110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 186 ~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 236 (389)
T 3gni_B 186 RV-----------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236 (389)
T ss_dssp SC-----------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cc-----------------------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 00 0011223469999999999987 6789999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHh----------------------------------hhcCccchHHHHHHHHHHHh
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAA----------------------------------IRADFEGKEEALLSCFKLGY 757 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~l~~li~ 757 (791)
|.+.............. .....+.. .....+........+.+|+.
T Consensus 237 f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 315 (389)
T 3gni_B 237 FKDMPATQMLLEKLNGT-VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315 (389)
T ss_dssp TTTCCSTTHHHHC---------------------------------------------------------CCHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCC-CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHH
Confidence 96532211100000000 00000000 00000011223456889999
Q ss_pred hccCCCCCCCCCHHHHHHH--hccCC
Q 003847 758 SCASPLPQKRPSMKEALQA--LEKIP 781 (791)
Q Consensus 758 ~cl~~dP~~RPs~~evl~~--L~~i~ 781 (791)
+||+.||++|||+.|+++. ++++.
T Consensus 316 ~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 316 QCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 9999999999999999864 45443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.44 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=202.4
Q ss_pred hhcceeccccCceEEEEEEeC-C---CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCce-EEEE
Q 003847 477 KASAYILGASGSSIMYKAVLE-D---GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK-LIIY 550 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lv~ 550 (791)
+...++||+|+||.||+|+.. + +..||+|++... .....+.+.+|++++++++||||+++++++...+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 344678999999999999843 2 237999999764 334557899999999999999999999999877665 9999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+.+|+|.+++..... .+++..+..|+.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ecccCCCHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999876432 38999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
... ........||+.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 179 ~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 226 (298)
T 3pls_A 179 YYS--------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226 (298)
T ss_dssp GGC--------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred ccc--------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCC
Confidence 110 011223458899999999999999999999999999999999766
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|+...... ............ .......+..+.+++.+||+.||++|||++++++.|+++.
T Consensus 227 ~~~~~~~~---------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 227 PPYRHIDP---------FDLTHFLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp CTTTTSCG---------GGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCH---------HHHHHHhhcCCC--CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 54332111 011111111111 1112224567889999999999999999999999998874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.01 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=191.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCce----EEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK----LIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~----~lv~e 551 (791)
.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++...... |+|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46899999999999994 67899999999764 233456789999999999999999999998876544 99999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 999999999998654 389999999999999999999999999999999999999999999999999987643221
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 172 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 218 (311)
T 3ork_A 172 SV---------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218 (311)
T ss_dssp -------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cc---------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 10 112234589999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHhccC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEAL-QALEKI 780 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i 780 (791)
|..... ............... ...+..+.+++.+||+.||++||++.+++ ..|.++
T Consensus 219 f~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 219 FTGDSP-------------VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCSSH-------------HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCh-------------HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 965321 011111111111111 11346788999999999999999666554 445443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.53 Aligned_cols=262 Identities=16% Similarity=0.169 Sum_probs=196.9
Q ss_pred ceeccccCceEEEEEEeCC------CcEEEEEEcCCCchhhH-----------HHHHHHHHHHhccCCCCccceeeEEEc
Q 003847 480 AYILGASGSSIMYKAVLED------GTALAVRRIGENSVDRF-----------RDFETQVRVIAKLVHPNLVRIRGFYWG 542 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~~~~~ 542 (791)
...||+|+||.||+|...+ ++.||||++........ ..+..|+..++.++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4689999999999998654 47899999876532211 123456667778899999999999887
Q ss_pred c----CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec--CCCCeE
Q 003847 543 V----DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG--NDMEPK 616 (791)
Q Consensus 543 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~--~~~~~k 616 (791)
. ...++||||+ +++|.+++..... .+++..++.|+.||+.||+|||+.||+||||||+|||++ .++.+|
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence 5 4479999999 9999999876532 499999999999999999999999999999999999999 889999
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||+++.+......... ........+||+.|+|||++.+..++.++|||
T Consensus 195 l~DFG~a~~~~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 245 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAY-----------------------------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLE 245 (364)
T ss_dssp ECCCTTCEESSGGGCCCCS-----------------------------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHH
T ss_pred EEECCcceecccCCccccc-----------------------------ccCcccccCCCCCccCHHHhCCCCCCchhhHH
Confidence 9999999876532211100 01112345699999999999999999999999
Q ss_pred HHHHHHHHHHhCCcchhccccCCCCcchhch---hHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 697 SFGVILLELLTGKVIVVDELGQGNGLLVEDK---NRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
||||++|||+||+.||.+............. .....+.+..+.. ...+..+.+++..||+.||++||++.++
T Consensus 246 slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l 320 (364)
T 3op5_A 246 ILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENL 320 (364)
T ss_dssp HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence 9999999999999999764221100000000 0011111111100 1134678899999999999999999999
Q ss_pred HHHhccC
Q 003847 774 LQALEKI 780 (791)
Q Consensus 774 l~~L~~i 780 (791)
++.|+++
T Consensus 321 ~~~l~~~ 327 (364)
T 3op5_A 321 RDILLQG 327 (364)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.71 Aligned_cols=253 Identities=28% Similarity=0.382 Sum_probs=206.6
Q ss_pred hhcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 477 KASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.....||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 344578999999999999965 589999999976543 457899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++...... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 94 ~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-- 168 (288)
T 3kfa_A 94 GNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-- 168 (288)
T ss_dssp EEHHHHHHHCCTT---TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE--
T ss_pred CcHHHHHHhcccC---CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc--
Confidence 9999999764432 48999999999999999999999999999999999999999999999999998765322110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
.....||+.|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus 169 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 169 ---------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp ---------------------------------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---------------------------------ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112236788999999998899999999999999999999 8889865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.... ...+........ ......+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 216 ~~~~----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 216 IDLS----------QVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCGG----------GHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH----------HHHHHHhccCCC--CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 3211 111222211111 11222456789999999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.44 Aligned_cols=245 Identities=21% Similarity=0.237 Sum_probs=190.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 468999999999999954 7899999999764332 36788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC--eEEeccCcccccCCCCCCCcCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME--PKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~ 636 (791)
.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||+++......
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~------ 172 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------ 172 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC------
Confidence 99987654 3999999999999999999999999999999999999987765 9999999987432111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc-hhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK-WDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...
T Consensus 173 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 173 -------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred -------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 1123459999999999988777655 89999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADF--EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... ............. +........+.+|+.+||+.||++|||+.|+++.
T Consensus 222 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 222 EEPRD---------YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCC---------HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccHHH---------HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22111 1111111111111 1111235678899999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.76 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=205.5
Q ss_pred hhcceeccccCceEEEEEEe--------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCce
Q 003847 477 KASAYILGASGSSIMYKAVL--------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEK 546 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 546 (791)
+...+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++++ +||||+++++++...+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 34467899999999999985 35788999999765 334457899999999999 899999999999999999
Q ss_pred EEEEeccCCCChhHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCe
Q 003847 547 LIIYDFVPNGSLANARYRKMGSS-----------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEP 615 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~ 615 (791)
++||||+++|+|.+++....... ...+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCE
Confidence 99999999999999998654211 1248999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDv 695 (791)
||+|||+++......... ......+|+.|+|||++.+..++.++||
T Consensus 197 kL~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 242 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYK----------------------------------KTTNGRLPVKWMAPEALFDRVYTHQSDV 242 (334)
T ss_dssp EECCCTTCEECTTTSSEE----------------------------------CCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred EEcccccccccccccccc----------------------------------ccCCCCcccceeChHHhcCCCcChHHHH
Confidence 999999998764322110 0112347888999999988889999999
Q ss_pred HHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 696 YSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 696 wSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
||||+++|||++ |+.||.+... .............. ........+.+++.+||+.||++|||+.|++
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~----------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPV----------EELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCH----------HHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcCcCCH----------HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999 9999865311 11111111111111 1122456788999999999999999999999
Q ss_pred HHhccCC
Q 003847 775 QALEKIP 781 (791)
Q Consensus 775 ~~L~~i~ 781 (791)
+.|+++.
T Consensus 311 ~~L~~l~ 317 (334)
T 2pvf_A 311 EDLDRIL 317 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=365.82 Aligned_cols=246 Identities=20% Similarity=0.232 Sum_probs=189.0
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhc-cCCCCccceeeEEEc----cCceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAK-LVHPNLVRIRGFYWG----VDEKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~~lv~e~~~ 554 (791)
++||+|+||.||++.. .+|+.||||++... ..+.+|++++.+ .+||||++++++|.. .+..|+||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 5899999999999995 46899999998643 456788888754 589999999999875 567899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~ 631 (791)
+|+|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 99999999765322 4999999999999999999999999999999999999997 7889999999998653211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 219 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 262 (400)
T 1nxk_A 219 ------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_dssp --------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 11234689999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|............. ..+..................+.+|+.+||+.||++|||+.|+++.
T Consensus 263 f~~~~~~~~~~~~~-----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 263 FYSNHGLAISPGMK-----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCTTCSSCCSHH-----HHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCccccccHHHH-----HHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 97653322111110 1111111100001112245678999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.89 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=200.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999964 79999999996542 22346789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 101 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~----- 170 (476)
T 2y94_A 101 GELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----- 170 (476)
T ss_dssp EEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-----
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-----
Confidence 99999886543 39999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+
T Consensus 171 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 171 --------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp --------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 1123469999999999988765 6899999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ..+......+.+..+......+.+++.+||..||++|||+.|+++
T Consensus 219 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 219 DHV-------------PTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp SSS-------------HHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCH-------------HHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 321 111122222222222224567889999999999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.57 Aligned_cols=250 Identities=16% Similarity=0.196 Sum_probs=199.4
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..++||+|+||.||+|+.. +++.||||++.+... ...+.+.+|+.++..++||||++++++|.+.+..|+||||++
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 3468999999999999965 589999999965321 122348899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++..... .+++..++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||+++........
T Consensus 158 gg~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 231 (437)
T 4aw2_A 158 GGDLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 231 (437)
T ss_dssp TCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE--
T ss_pred CCcHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc--
Confidence 9999999976432 3999999999999999999999999999999999999999999999999999865432110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCC
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....+||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 232 ---------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 232 ---------------------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp ---------------------------------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 122356999999999997 567899999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccch-HHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK-EEALLSCFKLGYSCASPLPQK--RPSMKEALQA 776 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 776 (791)
.||..... ......+........++.. ...+..+.+|+.+||..+|++ ||+++|+++.
T Consensus 279 ~Pf~~~~~---------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 279 TPFYAESL---------VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CTTCCSSH---------HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCCCCh---------hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 99965321 1111222221111111111 124567889999999998888 9999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.75 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=196.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 46899999999999985 457899999986532 22246788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----- 163 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----- 163 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-----
Confidence 99999987764 38999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 164 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 164 ---------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp -------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 11235899999999999999999999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ..............+......+.+++.+||+.||++|||++|+++.
T Consensus 211 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 211 TY-------------QETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp SH-------------HHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred cH-------------HHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11 1111111112222222245678899999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.14 Aligned_cols=247 Identities=22% Similarity=0.295 Sum_probs=193.8
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCC--CCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVH--PNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++| +||+++++++...+..++|||+ .
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence 45689999999999999888999999998654 33445788999999999986 9999999999999999999994 5
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++.++..|+.||+.||+|||+.||+||||||+|||++ ++.+||+|||+++........
T Consensus 92 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~-- 163 (343)
T 3dbq_A 92 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-- 163 (343)
T ss_dssp SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc--
Confidence 889999998753 389999999999999999999999999999999999997 578999999999876432111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----------CCCCCchhhHHHHHHHH
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----------IKPNPKWDVYSFGVILL 703 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~~sDvwSlGvil~ 703 (791)
......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 164 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 164 --------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211 (343)
T ss_dssp --------------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred --------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence 01123469999999999864 67899999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||++|+.||..... .........+......++.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 212 ell~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 212 YMTYGKTPFQQIIN--------QISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHSSCTTTTCCS--------HHHHHHHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCCCcchhhhh--------HHHHHHHHhcCCcccCCccc--CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 99999999964311 11122222222222222211 34568899999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=361.60 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=198.8
Q ss_pred ceeccccCceEEEEEEe-CCCcE----EEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTA----LAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...||+|+||.||+|+. .+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 46899999999999995 34544 8888875432 233456788999999999999999999885 56789999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 97 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 172 (325)
T 3kex_A 97 PLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172 (325)
T ss_dssp TTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred CCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence 99999999876532 38899999999999999999999999999999999999999999999999998765332110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......||..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 173 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 173 ----------------------------------LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp ----------------------------------C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ----------------------------------cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 1123457889999999998899999999999999999999 99999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
...... ............ .........+.+++.+||+.||++||++.|+++.|+++...
T Consensus 219 ~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 219 AGLRLA----------EVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTSCTT----------HHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cccCHH----------HHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 654211 111111111111 11112345678899999999999999999999999887543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.36 Aligned_cols=246 Identities=25% Similarity=0.328 Sum_probs=198.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 46899999999999995 46899999998654 3344577899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-- 163 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--
Confidence 9999887664 3899999999999999999999999999999999999986655 99999999976542211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 164 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 164 -----------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp -----------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 112458999999999999999999999999999999999999995
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+... ......+.........+........+.+++.+||+.||++|||+.|+++.
T Consensus 209 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 209 DEDQ---------HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CSSH---------HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCch---------hHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5311 01111111111111111112245678899999999999999999999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.62 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=198.9
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchh------hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVD------RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 4578999999999999954 6899999998654221 35779999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC----CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~ 627 (791)
|+++++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++...
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp CCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999987643 389999999999999999999999999999999999999887 79999999998764
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
.... .....||+.|+|||++.+..++.++||||||+++|||++
T Consensus 171 ~~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 171 DGVE-------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (321)
T ss_dssp TTCC-------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccc-------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH
Confidence 3211 123358999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|+.||..... .+............. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 214 g~~pf~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 214 GASPFLGDTK-------------QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SCCSSCCSSH-------------HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCH-------------HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999965311 111111111111111 113456889999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.44 Aligned_cols=264 Identities=14% Similarity=0.157 Sum_probs=198.5
Q ss_pred ceeccccCceEEEEEEeC----CCcEEEEEEcCCCchh-----------hHHHHHHHHHHHhccCCCCccceeeEEEc--
Q 003847 480 AYILGASGSSIMYKAVLE----DGTALAVRRIGENSVD-----------RFRDFETQVRVIAKLVHPNLVRIRGFYWG-- 542 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-- 542 (791)
.+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 468999999999999965 5789999998764321 11346678889999999999999999988
Q ss_pred --cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC--CeEEe
Q 003847 543 --VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM--EPKIG 618 (791)
Q Consensus 543 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~--~~kL~ 618 (791)
....++||||+ +++|.+++.... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++ .+||+
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 67889999999 999999887654 399999999999999999999999999999999999999877 99999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+++.+......... .........||+.|+|||++.+..++.++|||||
T Consensus 196 Dfg~a~~~~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQY-----------------------------QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp CCTTCEESSGGGCCCCC-----------------------------CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred eCCCceecccccccccc-----------------------------hhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 99999876532211000 0011123469999999999999899999999999
Q ss_pred HHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchH-------HHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 699 GVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKE-------EALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 699 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
||++|||++|+.||........ ...... .......+... ..+..+.+++.+||+.||++||+++
T Consensus 247 G~il~ell~g~~pf~~~~~~~~--------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 317 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDPV--------AVQTAK-TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ 317 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCHH--------HHHHHH-HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHHHHHHhCCCCccccccccH--------HHHHHH-HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence 9999999999999965322111 001110 11111111100 2345789999999999999999999
Q ss_pred HHHHHhccCCCCCCCC
Q 003847 772 EALQALEKIPSSPSPY 787 (791)
Q Consensus 772 evl~~L~~i~~~~~p~ 787 (791)
+|++.|+++.....+.
T Consensus 318 ~l~~~L~~~~~~~~~~ 333 (345)
T 2v62_A 318 ALKKILNPHGIPLGPL 333 (345)
T ss_dssp HHHHHHCTTCCCCCCC
T ss_pred HHHHHHhccCCcccCC
Confidence 9999999887655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=351.28 Aligned_cols=240 Identities=22% Similarity=0.200 Sum_probs=188.9
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
....||+|+||+||+|+.. +|+.||||++... .......+..|+..+.++ +||||+++++++.+.+..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 4568999999999999965 7999999998653 223334555666666555 8999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++..... .+++..++.|+.||+.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 140 ~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--- 212 (311)
T 3p1a_A 140 GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--- 212 (311)
T ss_dssp CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---
Confidence 7799998877643 399999999999999999999999999999999999999999999999999876542211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||+.|+|||++.+ .++.++|||||||++|||++|..++..
T Consensus 213 ----------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 213 ----------------------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp ------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred ----------------------------------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112348999999999886 789999999999999999999776533
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.. ....+....... .........+.+++.+||+.||++|||++|+++
T Consensus 258 ~~------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 258 GE------------GWQQLRQGYLPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH------------HHHHHTTTCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc------------HHHHHhccCCCc--ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 21 011111110000 001123467889999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.92 Aligned_cols=247 Identities=21% Similarity=0.219 Sum_probs=192.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 46899999999999995 46899999999654 233346788999999999999999999999999999999999975
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
++.+.+..... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 156 (292)
T 3o0g_A 86 DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR----- 156 (292)
T ss_dssp EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-----
T ss_pred CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-----
Confidence 66665554332 399999999999999999999999999999999999999999999999999987542211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 157 -------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 157 -------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp -------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred -------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 112345899999999997765 799999999999999999998886432
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhc-------------------------CccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRA-------------------------DFEGKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
... ......+....... ...........+.+|+.+||+.||++|||+
T Consensus 206 ~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 277 (292)
T 3o0g_A 206 NDV--------DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277 (292)
T ss_dssp SSH--------HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCH--------HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence 110 00111111100000 000011234577899999999999999999
Q ss_pred HHHHH
Q 003847 771 KEALQ 775 (791)
Q Consensus 771 ~evl~ 775 (791)
+|+++
T Consensus 278 ~e~l~ 282 (292)
T 3o0g_A 278 EEALQ 282 (292)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.48 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=197.9
Q ss_pred cceeccccCceEEEEEEeCC-----CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLED-----GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|.... +..||||++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 35789999999999998532 346999999765 333456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++..... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 128 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 128 MENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 999999999876532 3899999999999999999999999999999999999999999999999999876532211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 204 ~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 250 (333)
T 1mqb_A 204 TY---------------------------------TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250 (333)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cc---------------------------------ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 00 0112236788999999999899999999999999999999 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|..... . .....+.... ..+.....+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 251 f~~~~~---------~-~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 251 YWELSN---------H-EVMKAINDGF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp TTTCCH---------H-HHHHHHHTTC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCCH---------H-HHHHHHHCCC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 854311 0 1111111111 11122234567889999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.43 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=202.7
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 34578999999999999988888999999976543 3478999999999999999999999886 456899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 94 L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----- 165 (279)
T 1qpc_A 94 LVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----- 165 (279)
T ss_dssp HHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-----
T ss_pred HHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-----
Confidence 99998754321 3899999999999999999999999999999999999999999999999999876432111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 166 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 166 ------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ------------------------------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 0112236788999999998889999999999999999999 888986531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.. ............ ......+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 216 ~~----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 216 NP----------EVIQNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HH----------HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----------HHHHHHhcccCC--CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 10 111111111111 111224567889999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=352.18 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=192.8
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||.||+++.. ++.||||++.... ..+.+.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 468999999999999975 7899999997543 3478999999999999999999999876 4589999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc---CCCeecCCCCCCeEecCCCC-eEEeccCcccccCCCCCCCcC
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---KKHVHGNLKPRNVLLGNDME-PKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---~~ivHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~ 635 (791)
+++...... ..+++..++.++.|+++||+|||+ +||+||||||+||+++.++. +||+|||++.......
T Consensus 88 ~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 88 NVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHHCSSSE--ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHhccCCC--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 998765322 137899999999999999999999 89999999999999998886 7999999987543211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 161 ----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 ----------------------------------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ----------------------------------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 1224899999999999999999999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
... ........... .........+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 207 ~~~--------~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 207 GGP--------AFRIMWAVHNG--TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CSS--------HHHHHHHHHTT--CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred Ccc--------HHHHHHHHhcC--CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 211 00000001111 111112224567889999999999999999999999997753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=355.87 Aligned_cols=261 Identities=22% Similarity=0.267 Sum_probs=197.1
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc--CCCCccceeeEEEcc----CceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL--VHPNLVRIRGFYWGV----DEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~~~lv~e~ 552 (791)
..+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 3578999999999999975 8999999986542 23445556666554 899999999999887 678999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK--------KHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
+++|+|.+++... .+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 117 HENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999654 289999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc------hhhHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK------WDVYSF 698 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~------sDvwSl 698 (791)
.......... .......||+.|+|||++.+..++.+ +|||||
T Consensus 191 ~~~~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 191 KFISDTNEVD--------------------------------IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp ECC-----------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred eecccccccc--------------------------------CCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 7643221100 01223469999999999988766665 999999
Q ss_pred HHHHHHHHhCC----------cchhccccCCCCcchhchhHHHHHH-HHhhhcCccc---hHHHHHHHHHHHhhccCCCC
Q 003847 699 GVILLELLTGK----------VIVVDELGQGNGLLVEDKNRAIRLA-DAAIRADFEG---KEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 699 Gvil~elltG~----------~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP 764 (791)
||++|||+||. .||........ ......... ........+. .......+.+++.+||+.||
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 313 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-----SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-----CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCC-----chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhCh
Confidence 99999999994 44433211110 001111111 1111111111 22467789999999999999
Q ss_pred CCCCCHHHHHHHhccCCCCCCC
Q 003847 765 QKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 765 ~~RPs~~evl~~L~~i~~~~~p 786 (791)
++|||+.|+++.|+++..+...
T Consensus 314 ~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 314 ASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp GGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhCCCHHHHHHHHHHHHhhccc
Confidence 9999999999999988765543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=346.59 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=200.2
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc---------------
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--------------- 542 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------------- 542 (791)
..+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 3568999999999999965 79999999997653 356789999999999999999998864
Q ss_pred -cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 543 -VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 543 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
....++||||+++++|.+++...... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcch
Confidence 34579999999999999999765422 38999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
++........ .....||+.|+|||++.+..++.++||||||++
T Consensus 168 ~~~~~~~~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (284)
T 2a19_B 168 LVTSLKNDGK-------------------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210 (284)
T ss_dssp TCEESSCCSC-------------------------------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred hheecccccc-------------------------------------ccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence 9987643211 112348999999999999999999999999999
Q ss_pred HHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 702 LLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
+|||++|..|+.... .....+. ....+ ......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 211 l~~l~~~~~~~~~~~-----------~~~~~~~----~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 211 LAELLHVCDTAFETS-----------KFFTDLR----DGIIS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHSCCSSHHHHH-----------HHHHHHH----TTCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHhcCCcchhHH-----------HHHHHhh----ccccc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999875321 0011111 11111 113456789999999999999999999999999887
Q ss_pred CCCC
Q 003847 782 SSPS 785 (791)
Q Consensus 782 ~~~~ 785 (791)
..+.
T Consensus 274 ~~~~ 277 (284)
T 2a19_B 274 KSPE 277 (284)
T ss_dssp C---
T ss_pred hCCC
Confidence 6654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=350.73 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=188.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 45899999999999995 468999999996543 2234678899999999999999999999999999999999997 69
Q ss_pred hhHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 558 LANARYRKMG-SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 558 L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
|.+++..... .....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----- 163 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN----- 163 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-----
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-----
Confidence 9998876542 2223489999999999999999999999999999999999999999999999999987542211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 -------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 164 -------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp -------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1123358999999999976 46899999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHh--------------------------------hhcCccchHHHHHHHHHHHhhccCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAA--------------------------------IRADFEGKEEALLSCFKLGYSCASPL 763 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~l~~li~~cl~~d 763 (791)
... .....+.+.. +.... .......+.+|+.+||+.|
T Consensus 213 ~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 213 NDE---------EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT--KEPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp SHH---------HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC--SSCCCHHHHHHHHHHSCSS
T ss_pred ChH---------HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc--cccCCHHHHHHHHHHCCCC
Confidence 211 0001111000 00000 0013457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003847 764 PQKRPSMKEALQA 776 (791)
Q Consensus 764 P~~RPs~~evl~~ 776 (791)
|++|||++|+++.
T Consensus 282 P~~Rpt~~e~l~h 294 (317)
T 2pmi_A 282 PDMRLSAKQALHH 294 (317)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=345.84 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=199.4
Q ss_pred cceeccccCceEEEEEEeCC----CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVLED----GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+|+..+ +..||||.+... .....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 45789999999999998432 346999999765 34456789999999999999999999999764 5678999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++++|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 95 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 169 (281)
T 3cc6_A 95 PYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY- 169 (281)
T ss_dssp TTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc-
Confidence 99999999976543 3899999999999999999999999999999999999999999999999999876432110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 170 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 170 ----------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp -------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ----------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCc
Confidence 0112347888999999998899999999999999999998 99998
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
...... .......... ..+.....+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 216 ~~~~~~----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 216 FWLENK----------DVIGVLEKGD--RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTSCGG----------GHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCChH----------HHHHHHhcCC--CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 643211 0111111111 11112224567889999999999999999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=356.53 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=195.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 346899999999999994 67999999999653 23345678999999999999999999999999999999999997
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|+|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 138 -g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 138 -GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp -EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred -CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 688888765432 4999999999999999999999999999999999999999999999999998764311
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
....||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 208 -----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 252 (348)
T 1u5q_A 208 -----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252 (348)
T ss_dssp -----------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 1235899999999984 56789999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|..... ......+..... ... .....+..+.+++.+||+.||++|||++++++.
T Consensus 253 ~~~~~~---------~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 253 LFNMNA---------MSALYHIAQNES-PAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TTTSCH---------HHHHHHHHHSCC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCh---------HHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 865311 011111111111 111 111245678899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=380.42 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=207.8
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||+|...++..||||+++.... ..++|.+|+++|++++|+||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 34578999999999999988888999999986543 24689999999999999999999999866 77899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++.+++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 348 L~~~l~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~----- 419 (535)
T 2h8h_A 348 LLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT----- 419 (535)
T ss_dssp HHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-----
T ss_pred HHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-----
Confidence 99999754322 3899999999999999999999999999999999999999999999999999865421100
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 420 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 420 ------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp ------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred ------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0112236788999999998899999999999999999999 898986531
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p 786 (791)
. ......+.... ..+........+.+|+.+||+.||++|||+++|++.|+.+.....|
T Consensus 470 ~----------~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 470 N----------REVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp H----------HHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred H----------HHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1 01111111111 1112223556789999999999999999999999999998765544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.05 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEEe-CCCcE----EEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTA----LAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|+. .+++. ||+|.+... .....+.+.+|++++++++||||+++++++... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEec
Confidence 46899999999999994 34544 577877543 334457899999999999999999999999875 488999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp SSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 99999999887543 38999999999999999999999999999999999999999999999999998764322111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 175 ----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 220 (327)
T 3lzb_A 175 ----------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp ---------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ----------------------------------cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence 1112337888999999999999999999999999999999 99999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
...... ........... .+........+.+++.+||+.||++||++.|+++.|+++...+
T Consensus 221 ~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 221 DGIPAS----------EISSILEKGER--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TTCCGG----------GHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCHH----------HHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 654221 11122221111 1122224567889999999999999999999999999876554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=365.98 Aligned_cols=249 Identities=14% Similarity=0.162 Sum_probs=198.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..++||+|+||.||+|+. .+|+.||||++.+.. ....+.+.+|.+++.+++||||+++++++.+.+..|+||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 356899999999999996 479999999997532 1223458899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 145 gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-- 218 (412)
T 2vd5_A 145 GGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-- 218 (412)
T ss_dssp SCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE--
T ss_pred CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc--
Confidence 9999999986542 3999999999999999999999999999999999999999999999999999876432110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-------CCCCCCchhhHHHHHHHHHHHh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-------SIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~~sDvwSlGvil~ellt 707 (791)
.....+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 219 ---------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 219 ---------------------------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp ---------------------------------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 112346999999999997 3568999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccc-hHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEG-KEEALLSCFKLGYSCASPLPQKR---PSMKEALQA 776 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 776 (791)
|+.||...... .....+........++. ....+.++.+|+.+||. +|++| |+++|+++.
T Consensus 266 G~~Pf~~~~~~---------~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 266 GQTPFYADSTA---------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp SSCTTCCSSHH---------HHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCCCCCCCHH---------HHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 99999654211 11122222111111111 12245678999999999 99998 589999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=361.56 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=194.5
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccC--CCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLV--HPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..|+||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 35689999999999999888999999998653 3445578999999999996 5999999999999999999999 56
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++.++..|+.||+.||+|||+.||+||||||+|||++ ++.+||+|||+++.+......
T Consensus 139 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~-- 210 (390)
T 2zmd_A 139 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-- 210 (390)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc--
Confidence 889999988654 389999999999999999999999999999999999996 579999999999876432111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----------CCCCCchhhHHHHHHHH
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----------IKPNPKWDVYSFGVILL 703 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~~sDvwSlGvil~ 703 (791)
......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 211 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 211 --------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp -----------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred --------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 01123469999999999865 46899999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||++|+.||..... .......+.+......++.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 259 ell~G~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 259 YMTYGKTPFQQIIN--------QISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHSSCTTTTCCC--------HHHHHHHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCcchhhhH--------HHHHHHHHhCccccCCCCcc--chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 99999999964311 11112222222222122211 24578899999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=348.46 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=192.3
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|+.. ..||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 4578999999999999864 35999999754 344457899999999999999999999965 566789999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 105 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 176 (289)
T 3og7_A 105 SLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS---- 176 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred cHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc----
Confidence 99998865432 4899999999999999999999999999999999999999999999999999765421110
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.......||+.|+|||++. +..++.++||||||+++|||++|+.||.
T Consensus 177 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 177 ------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp -------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 0112345899999999986 5678889999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHh-hhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAA-IRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
.... .....+..... ...... .....+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 227 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 227 NINN---------RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCC---------HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccch---------HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 5311 11112222111 111111 111245678999999999999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=357.98 Aligned_cols=257 Identities=20% Similarity=0.234 Sum_probs=196.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-----chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-----SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 357899999999999995 56899999998653 234457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 003847 553 VPNGSLANARYRKMGS-----------------------------------SPCHLPWEARLKIAKGVARGLAFLHEKKH 597 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 597 (791)
+++|+|.+++...... ....+++..++.|+.||+.||+|||+.||
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 189 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999987521110 01124677888999999999999999999
Q ss_pred eecCCCCCCeEecCCC--CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCC
Q 003847 598 VHGNLKPRNVLLGNDM--EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGI 675 (791)
Q Consensus 598 vHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 675 (791)
+||||||+||+++.++ .+||+|||+++.+....... ........||
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~--------------------------------~~~~~~~~gt 237 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE--------------------------------YYGMTTKAGT 237 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------------------------------------CCC
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccc--------------------------------cccccccCCC
Confidence 9999999999998776 89999999998654321110 0012234599
Q ss_pred CcccCcccccC--CCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHH
Q 003847 676 SPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCF 753 (791)
Q Consensus 676 ~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 753 (791)
+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.........+........+.
T Consensus 238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (345)
T 3hko_A 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---------ADTISQVLNKKLCFENPNYNVLSPLAR 308 (345)
T ss_dssp GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHCCCCTTSGGGGGSCHHHH
T ss_pred ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---------HHHHHHHHhcccccCCcccccCCHHHH
Confidence 99999999975 6789999999999999999999999965321 111122222221111122222456788
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 003847 754 KLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+++.+||+.||++||++.|+++.
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.25 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=198.7
Q ss_pred eeccccCceEEEEEEe---CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVL---EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 3899999999999963 347899999997642 33357899999999999999999999999 56778999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 102 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 175 (291)
T 1xbb_A 102 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 175 (291)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE-
T ss_pred CCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc-
Confidence 99999997643 389999999999999999999999999999999999999999999999999987653321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 176 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 176 --------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp --------------------------------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred --------------------------------ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 0112236788999999988889999999999999999999 9999865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
... ............. ......+..+.+++.+||+.||++||++.|+++.|+++
T Consensus 224 ~~~----------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 224 MKG----------SEVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCH----------HHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCH----------HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 321 1111111111111 11222456789999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.24 Aligned_cols=256 Identities=18% Similarity=0.178 Sum_probs=196.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 46899999999999995 478999999997642 23346789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--- 190 (309)
T 2h34_A 119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT--- 190 (309)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc---
Confidence 99999988654 3899999999999999999999999999999999999999999999999998765432110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 191 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 191 --------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp --------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred --------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 111335899999999999989999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhccCCCCCC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-SMKEALQALEKIPSSPS 785 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~ 785 (791)
... ....................+..+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 239 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 239 QLS----------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHH----------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred hHH----------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111 1111111111000011122445788999999999999999 99999999998765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.65 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 468999999999999964 5889999998654 234456789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 170 (294)
T 2rku_A 100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---- 170 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc----
Confidence 99999887654 389999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 171 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 171 --------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp --------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 011245899999999999988999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .+............+......+.+++.+||+.||++|||++|+++.
T Consensus 219 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 219 CL-------------KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp SH-------------HHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CH-------------HHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 21 0111111112222222245678899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=354.30 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 468999999999999954 5889999998654 234456789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---- 196 (335)
T 2owb_A 126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---- 196 (335)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc----
Confidence 99999887654 389999999999999999999999999999999999999999999999999987642211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 197 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 197 --------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp --------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 011245899999999999989999999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .+...................+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 245 CL-------------KETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp SH-------------HHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CH-------------HHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 0111111112222222245678899999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=351.93 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=196.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 346899999999999995 57999999999752 34445778999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++...... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 116 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--- 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--- 191 (310)
T ss_dssp SCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred CCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc---
Confidence 99999998753321 12489999999999999999999999999999999999999999999999999876542211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.+
T Consensus 192 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 192 ---------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ----------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ---------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 01123488999999999998999999999999999999999999865
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p 786 (791)
.... . ...........++ ........+.+++.+||+.||++|||+.++++.|+++.....+
T Consensus 239 ~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 239 DKMN--------L---YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp --CC--------H---HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cchh--------H---HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 3211 0 1111111111111 0112456788999999999999999999999999998654433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.08 Aligned_cols=191 Identities=21% Similarity=0.303 Sum_probs=167.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-----CCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-----HPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.+.||+|+||.||+|+. .+++.||||++.... ...+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 46899999999999995 578999999997542 33467788999999986 999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC----------------------
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---------------------- 611 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---------------------- 611 (791)
+++|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 194 (360)
T 3llt_A 119 -GPSLYEIITRNNYN---GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194 (360)
T ss_dssp -CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred -CCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccccc
Confidence 99999999875432 3899999999999999999999999999999999999975
Q ss_pred ---CCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC
Q 003847 612 ---DMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK 688 (791)
Q Consensus 612 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 688 (791)
++.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 195 ~~~~~~~kl~DFG~a~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 195 RTKSTGIKLIDFGCATFKSDY---------------------------------------HGSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp EESCCCEEECCCTTCEETTSC---------------------------------------CCSCCSCGGGCCHHHHTTCC
T ss_pred ccCCCCEEEEeccCceecCCC---------------------------------------CcCccCcccccCcHHHcCCC
Confidence 788999999999864321 11345899999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 689 PNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 689 ~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 236 WDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999965
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=376.64 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=202.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
...+||+|+||.||+|+. .+|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..|+||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 357899999999999995 479999999996532 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++...... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 268 gg~L~~~l~~~~~~---~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--- 341 (576)
T 2acx_A 268 GGDLKFHIYHMGQA---GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 341 (576)
T ss_dssp SCBHHHHHHSSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---
T ss_pred CCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc---
Confidence 99999988765422 389999999999999999999999999999999999999999999999999987642211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 342 ----------------------------------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 342 ----------------------------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp ----------------------------------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred ----------------------------------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 1124699999999999998999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 776 (791)
...... ....... ............+..+.+|+.+||+.||++|| +++|+++.
T Consensus 388 ~~~~~~------~~~i~~~---i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 388 RKKKIK------REEVERL---VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SSSCCC------HHHHHHH---HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccchh------HHHHHHH---hhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 432211 1111111 11111112223557789999999999999999 78888753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=349.49 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=196.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 356899999999999995 4799999999986654455678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||++ +.++.+||+|||+++......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---- 163 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---- 163 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----
Confidence 999987654 38999999999999999999999999999999999999 788999999999987543210
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 164 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 164 ----------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp ----------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0122488999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ......+.........+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 210 ETE---------SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCH---------HHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCH---------HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321 0111111111110011111224567889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=364.96 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=186.4
Q ss_pred chHHHhhhcceeccccCceEEEEEEeC---CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCc
Q 003847 471 ELETLLKASAYILGASGSSIMYKAVLE---DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDE 545 (791)
Q Consensus 471 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~ 545 (791)
.+++.....+.+||+|+||.||+|+.. +++.||||++...... +.+.+|++++++++||||+++++++.. ...
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 344554455678999999999999965 5789999999765332 568899999999999999999999954 667
Q ss_pred eEEEEeccCCCChhHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe----cCCCCeEE
Q 003847 546 KLIIYDFVPNGSLANARYRKMG----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL----GNDMEPKI 617 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl----~~~~~~kL 617 (791)
.++||||++ ++|.+++..... .....+++..++.|+.||+.||+|||+.||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 899999996 588887764321 112248999999999999999999999999999999999999 67889999
Q ss_pred eccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhH
Q 003847 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVY 696 (791)
Q Consensus 618 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvw 696 (791)
+|||+++........ .......+||+.|+|||++.+ ..++.++|||
T Consensus 174 ~Dfg~a~~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 220 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP---------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220 (405)
T ss_dssp CCTTCCC-------------------------------------------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred EECCCceecCCCCcc---------------------------------cccCCCceecCcccCchhhcCCCcccchhhhH
Confidence 999999876432110 011223569999999999987 4589999999
Q ss_pred HHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHh------------------------hhcCccc---hH---
Q 003847 697 SFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAA------------------------IRADFEG---KE--- 746 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~---~~--- 746 (791)
||||++|||++|+.||....................++... ....+.. ..
T Consensus 221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence 99999999999999996543211110000011111111100 0000000 00
Q ss_pred ----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 747 ----EALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 747 ----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.....+.+|+.+||..||++|||++|+++.
T Consensus 301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 013467899999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=373.20 Aligned_cols=250 Identities=16% Similarity=0.235 Sum_probs=202.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..|+||||++|
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 46899999999999996 469999999996542 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++...... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 270 g~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~---- 344 (543)
T 3c4z_A 270 GDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT---- 344 (543)
T ss_dssp CBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC----
T ss_pred CCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc----
Confidence 9999998765422 12499999999999999999999999999999999999999999999999999987643211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 345 --------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 345 --------------------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp --------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred --------------------------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 112346999999999999999999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM-----KEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 775 (791)
..... ...+...........+...+..+.+++.+||+.||++||++ +++++
T Consensus 393 ~~~~~---------~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 393 GEKVE---------NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TCCCC---------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ccchh---------HHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 22111 11222222222222233356788999999999999999965 66664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=345.71 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=192.6
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 356899999999999995 568999999986643 334578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++....... ..+++..++.|+.|++.||+|||+.||+||||||+||++ +.++.+||+|||++........
T Consensus 106 ~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~-- 182 (285)
T 3is5_A 106 ELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-- 182 (285)
T ss_dssp BHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------
T ss_pred cHHHHHHhhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc--
Confidence 9999886542111 249999999999999999999999999999999999999 4567899999999976543211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||+.|+|||++.+ .++.++||||||+++|||++|+.||.
T Consensus 183 -----------------------------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 183 -----------------------------------STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp ---------------------------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------------------------------CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCC
Confidence 113358999999999864 68999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... ......... ..... ........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~----------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 227 GTSLE----------EVQQKATYK-EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CSSHH----------HHHHHHHHC-CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCHH----------HHHhhhccC-CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 53210 011100000 00111 00113467889999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=364.38 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=192.0
Q ss_pred cceeccccCceEEEEEEeC--C--CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLE--D--GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~--~--g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|+.. + +..||||.+... .....+++.+|+.++++++||||+++++++.. .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4568999999999999853 2 246899999754 34456789999999999999999999998764 4578999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 173 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 173 MKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 999999999875432 3889999999999999999999999999999999999999999999999999866432211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |.+|
T Consensus 249 ~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 249 SV--------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp -----------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cc--------------------------------cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 00 01122347888999999999999999999999999999999 5667
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|.+...... ...+.... ....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 297 ~~~~~~~~~---------~~~~~~~~---~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 297 YPDVNTFDI---------TVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CTTSCSSCH---------HHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHH---------HHHHHcCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 754322110 01111110 11111224567889999999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.97 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=206.2
Q ss_pred hcceeccccCceEEEEEEe-----CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC--ceEEEE
Q 003847 478 ASAYILGASGSSIMYKAVL-----EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--EKLIIY 550 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 550 (791)
...+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 3457899999999999983 468999999998876666788999999999999999999999987654 679999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+++++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 124 e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CCCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred ECCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 99999999999976542 38999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.... ......++..|+|||++.+..++.++||||||+++|||+||..
T Consensus 200 ~~~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 200 EYYK---------------------------------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp SEEE---------------------------------CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred cccc---------------------------------cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 1100 0112237788999999998889999999999999999999999
Q ss_pred chhccccCCCCc---chhchhHHHHHHHHhhh-cCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGL---LVEDKNRAIRLADAAIR-ADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||.......... ..........+.+.... ...+.....+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp GGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 875421100000 00000001111111111 111122234567899999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=381.77 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred eeccccCceEEEEEEeC---CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVLE---DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..||+|+||.||+|... ++..||||+++... ....+++.+|+++|++++|||||++++++.. +..++||||+++|
T Consensus 342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 36999999999999853 56789999998653 3356789999999999999999999999976 5689999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+........
T Consensus 421 ~L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-- 494 (613)
T 2ozo_A 421 PLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-- 494 (613)
T ss_dssp BHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred cHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee--
Confidence 99999865432 499999999999999999999999999999999999999999999999999987643221100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~ 715 (791)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 495 -------------------------------~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 495 -------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp --------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -------------------------------eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 0112236688999999998899999999999999999998 99999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
... .....+..... ...+...+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 544 ~~~----------~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 544 KGP----------EVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CSH----------HHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHH----------HHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 211 11111111111 122223567889999999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=347.98 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=179.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46899999999999995 5799999999965421 2246789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 167 (278)
T 3cok_A 96 GEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---- 167 (278)
T ss_dssp EEHHHHHHTCSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred CcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC----
Confidence 999999876432 489999999999999999999999999999999999999999999999999986542211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 168 --------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp --------------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 011235899999999999988999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
....... .........+......+.+++.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 216 TVKNTLN-------------KVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC------------------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHHHHHH-------------HHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2211100 0011111111224467889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=383.85 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=199.0
Q ss_pred eeccccCceEEEEEEe---CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVL---EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.||+|+||.||+|.+ .+++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999964 356899999997643 2335789999999999999999999999864 568999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 527 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 527 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-
Confidence 99999997643 389999999999999999999999999999999999999999999999999987654321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 528 --------------------------------~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 528 --------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp ---------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred --------------------------------cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1112337788999999999999999999999999999998 9999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
... ......+...... ..+...+..+.+|+.+||+.||++||++.+|++.|+++
T Consensus 576 ~~~----------~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 576 MKG----------SEVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCH----------HHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCH----------HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 321 1112222221111 12223567889999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=347.86 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=198.7
Q ss_pred cceeccccCceEEEEEEeCC----CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEE-ccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLED----GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYW-GVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~ 552 (791)
..+.||+|+||.||+|+..+ ...||||.+... .....+.+.+|++++++++||||+++++++. .++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 45789999999999998532 246899998764 3445578999999999999999999999865 45678999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..+..|+.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 109 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 109 MKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CTTCBHHHHHHCTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 999999999875432 3899999999999999999999999999999999999999999999999999876432211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc-c
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV-I 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~-p 711 (791)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|.. |
T Consensus 185 ~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 185 SV--------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp BC-------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cc--------------------------------ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 00 11223447889999999999899999999999999999999554 5
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
|....... ......... .. ......+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 233 ~~~~~~~~---------~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 233 YPDVNTFD---------ITVYLLQGR-RL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp STTSCTTT---------HHHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHH---------HHHHHhcCC-CC--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 54332110 011111110 11 1111234678899999999999999999999999988754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.94 Aligned_cols=270 Identities=22% Similarity=0.285 Sum_probs=204.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 356899999999999995 6799999999977666667889999999999999999999999873 34779999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++....... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 113 ~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~ 191 (317)
T 2buj_A 113 KRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191 (317)
T ss_dssp TTCBHHHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESH
T ss_pred CCCcHHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccc
Confidence 9999999988643221 259999999999999999999999999999999999999999999999999987643211000
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC---CCCchhhHHHHHHHHHHHhCCc
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK---PNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~~sDvwSlGvil~elltG~~ 710 (791)
... .. ........||+.|+|||++.+.. ++.++||||||+++|||++|+.
T Consensus 192 ~~~----------~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 192 RQA----------LT-----------------LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp HHH----------HH-----------------HHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ccc----------cc-----------------ccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 000 00 00000123788999999987544 6899999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p 786 (791)
||........ .......... ..+........+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus 245 p~~~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 245 PYDMVFQKGD--------SVALAVQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp TTHHHHHTTS--------CHHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred Chhhhhcccc--------hhhHHhhccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 9864321110 0011111111 1111122456788999999999999999999999999999766543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.37 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=204.5
Q ss_pred cceeccccCceEEEEEEeCC-C-----cEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVLED-G-----TALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.||+|.... + ..||||.+... .....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 45789999999999999532 2 48999999765 334457799999999999 8999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 551 DFVPNGSLANARYRKMGS---------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
||+++|+|.+++...... ....+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 209 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccc
Confidence 999999999998765310 01248999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH
Q 003847 622 LERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 622 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi 701 (791)
+++......... ......||+.|+|||++.+..++.++|||||||+
T Consensus 210 ~~~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 255 (333)
T 2i1m_A 210 LARDIMNDSNYI----------------------------------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255 (333)
T ss_dssp GGCCGGGCTTSE----------------------------------ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccccccccccee----------------------------------ecCCCCCCccccCHHHhccCCCChHHHHHHHHHH
Confidence 998654322110 0112337888999999998899999999999999
Q ss_pred HHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 702 LLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 702 l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
+|||+| |..||.+.... ............... +...+..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 256 l~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 256 LWEIFSLGLNPYPGILVN---------SKFYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHTTTSCCSSTTCCSS---------HHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCcccchh---------HHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 999999 88898653211 111222222211111 112356788999999999999999999999999875
Q ss_pred C
Q 003847 781 P 781 (791)
Q Consensus 781 ~ 781 (791)
.
T Consensus 325 ~ 325 (333)
T 2i1m_A 325 A 325 (333)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.81 Aligned_cols=237 Identities=18% Similarity=0.273 Sum_probs=195.9
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCch--------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSV--------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
....||+|+||.||+|+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 34689999999999999 45789999999975421 1234677899999999999999999999999999999
Q ss_pred EeccCCC-ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 550 YDFVPNG-SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 550 ~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
|||+.+| +|.+++.... .+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 9999777 9999887653 399999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~ellt 707 (791)
... ....+||+.|+|||++.+..+ +.++|||||||++|||++
T Consensus 183 ~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 225 (335)
T 3dls_A 183 GKL-------------------------------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225 (335)
T ss_dssp TCC-------------------------------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred CCc-------------------------------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence 211 112458999999999988776 789999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|+.||....... . .....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 226 g~~pf~~~~~~~---------------~----~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 226 EENPFCELEETV---------------E----AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCSCSSGGGGT---------------T----TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCCchhhHHHHH---------------h----hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999996521110 0 0001111134568899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.78 Aligned_cols=253 Identities=18% Similarity=0.218 Sum_probs=188.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv 549 (791)
..+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+ ..|+|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 346899999999999984 56899999999754 3444577889999999999999999999997653 56999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+++ +|.+.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 999975 46555532 2899999999999999999999999999999999999999999999999999865421
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 218 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 260 (464)
T 3ttj_A 218 F-------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260 (464)
T ss_dssp C-------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred c-------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCC
Confidence 1 122356999999999999999999999999999999999999
Q ss_pred cchhccccCCCCc------------chhch-hHHHHHHHH---------------h-hhcCccchHHHHHHHHHHHhhcc
Q 003847 710 VIVVDELGQGNGL------------LVEDK-NRAIRLADA---------------A-IRADFEGKEEALLSCFKLGYSCA 760 (791)
Q Consensus 710 ~pf~~~~~~~~~~------------~~~~~-~~~~~~~~~---------------~-~~~~~~~~~~~~~~l~~li~~cl 760 (791)
.||.+........ ..... ......... . ..............+.+|+.+||
T Consensus 261 ~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 340 (464)
T 3ttj_A 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340 (464)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHc
Confidence 9996532100000 00000 000000000 0 00000011123567899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 003847 761 SPLPQKRPSMKEALQA 776 (791)
Q Consensus 761 ~~dP~~RPs~~evl~~ 776 (791)
..||++|||++|+++.
T Consensus 341 ~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 341 VIDPAKRISVDDALQH 356 (464)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred CCChhhCCCHHHHhcC
Confidence 9999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.97 Aligned_cols=241 Identities=20% Similarity=0.286 Sum_probs=198.9
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 3568999999999999954 68899999986532 2224678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 168 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---- 168 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc----
Confidence 999999988764 38999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 169 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 169 ----------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp ----------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ----------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 1123589999999999998999999999999999999999999964
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .+............+......+.+++.+||+.||++||+++|+++
T Consensus 215 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 215 PSH-------------TETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SSH-------------HHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCH-------------hHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 311 011111111222222224567889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.02 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=205.0
Q ss_pred hcceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEE
Q 003847 478 ASAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 34578999999999999853 47899999997643 334567899999999999999999999999999999999
Q ss_pred eccCCCChhHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 551 DFVPNGSLANARYRKMG-----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
||+++|+|.+++..... .....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccc
Confidence 99999999999876431 1112479999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~el 705 (791)
........ ......||+.|+|||++.+..++.++||||||+++|||
T Consensus 188 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 233 (322)
T 1p4o_A 188 IYETDYYR----------------------------------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233 (322)
T ss_dssp GGGGGCEE----------------------------------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccc----------------------------------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 54221100 00122368889999999988999999999999999999
Q ss_pred Hh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcC-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 706 LT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRAD-FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 706 lt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
++ |+.||..... ........... .......+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 234 ~~~g~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 234 ATLAEQPYQGLSN-------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTSCCTTTTSCH-------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhcCCCccccCCH-------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 99 7888854311 11111111111 11122245678899999999999999999999999988744
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=356.21 Aligned_cols=242 Identities=18% Similarity=0.275 Sum_probs=194.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|.. .+|+.||||++..... ...+|++++.++ +||||+++++++.+.+..|+||||+++|
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 346899999999999995 4689999999976533 235688888888 7999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC----CCeEEeccCcccccCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND----MEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~~~~~~~ 632 (791)
+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||+..+ +.+||+|||+++.......
T Consensus 102 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 102 ELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp BHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 9999887653 38999999999999999999999999999999999998533 3599999999987643211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 176 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 176 -----------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp -----------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred -----------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 112345899999999998888899999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
...... ...++......+.+.. ....+..+.+|+.+||..||++||++.|+++
T Consensus 221 ~~~~~~----------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 221 ANGPDD----------TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSSTTS----------CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcC----------CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 653211 0112222222222211 1224567889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.27 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=195.1
Q ss_pred hhhcceeccccCceEEEEEEeC----CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc----
Q 003847 476 LKASAYILGASGSSIMYKAVLE----DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE---- 545 (791)
Q Consensus 476 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 545 (791)
.+...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3445678999999999999843 3568999999754 33445779999999999999999999999987653
Q ss_pred -eEEEEeccCCCChhHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 546 -KLIIYDFVPNGSLANARYRKMG-SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 546 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
.++||||+++++|.+++..... .....+++..++.|+.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 4999999999999999864321 22235999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+......... ......+++.|+|||.+.+..++.++||||||+++|
T Consensus 195 ~~~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 195 KKIYSGDYYR----------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp --------------------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred eecccccccC----------------------------------cccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 8664321100 011234788899999999999999999999999999
Q ss_pred HHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 704 ELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 704 ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||++ |+.||...... .....+... .. .......+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 241 el~~~g~~p~~~~~~~---------~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 241 EIATRGMTPYPGVQNH---------EMYDYLLHG-HR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHHTTSCCSSTTCCGG---------GHHHHHHTT-CC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCccCCHH---------HHHHHHHcC-CC--CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999 88888653211 011111111 11 1112234567899999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.06 Aligned_cols=261 Identities=15% Similarity=0.167 Sum_probs=201.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEE-EccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY-WGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|+. .+++.||||++..... .+.+.+|++++++++|++++..+.++ ...+..++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 356899999999999995 6789999998755432 24578899999999988877776665 5566779999999 99
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||+++.........
T Consensus 90 ~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 90 SLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp BHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 99999875432 39999999999999999999999999999999999999 788999999999998765432211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.. +........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 166 ~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 166 HI-----------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp BC-----------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cC-----------------------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 10 0112234569999999999999999999999999999999999999997
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
............ .+.......... .....+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 217 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 217 GLKAATKRQKYE------RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SCCCSSSSSHHH------HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccchhhhhhhhh------hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 643332222211 111111111100 00112467889999999999999999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.21 Aligned_cols=242 Identities=21% Similarity=0.311 Sum_probs=196.6
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCch------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSV------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3568999999999999965 689999999865321 135789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC----CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~ 627 (791)
|+++++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 89 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 89 LVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999997654 389999999999999999999999999999999999998877 79999999998654
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
.... .....||+.|+|||++.+..++.++||||||+++|||++
T Consensus 164 ~~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 164 AGNE-------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206 (283)
T ss_dssp ---------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCc-------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH
Confidence 2211 112348999999999999899999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|+.||...... +............. ...+..+.+++.+||+.||++||++.|+++
T Consensus 207 g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 207 GASPFLGETKQ-------------ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp SSCTTCCSSHH-------------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcchH-------------HHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 99999653210 11111111111111 113456889999999999999999999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.13 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=197.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 45899999999999994 56899999999776655667899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-CCCeEEeccCcccccCCCCCCCcCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
.+++...... ..+++..+..++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 107 ~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~------ 178 (295)
T 2clq_A 107 SALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------ 178 (295)
T ss_dssp HHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---------
T ss_pred HHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC------
Confidence 9998765432 23778999999999999999999999999999999999987 89999999999986542110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC--CCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--PNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 179 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 ------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 011335899999999997643 789999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .............. .........+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~--------~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 229 GEP--------QAAMFKVGMFKVHP--EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SSH--------HHHHHHHHHHCCCC--CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred Cch--------hHHHHhhccccccc--cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 00001110111111 112224567889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.27 Aligned_cols=242 Identities=22% Similarity=0.355 Sum_probs=196.7
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--------hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEE
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENS--------VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 548 (791)
..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3478999999999999964 79999999986532 11245688999999999 79999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+..
T Consensus 178 v~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999999987654 399999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC------CCCCCchhhHHHHHHH
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS------IKPNPKWDVYSFGVIL 702 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~sDvwSlGvil 702 (791)
... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 253 ~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 253 GEK-------------------------------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp TCC-------------------------------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred Ccc-------------------------------------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 211 123459999999999863 3578999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|||++|+.||..... .........+..... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 296 ~ell~g~~pf~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 296 FTLLAGSPPFWHRRQ-------------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHSSCSSCCSSH-------------HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCH-------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999965311 111111111111111 113456889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.03 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=198.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 46899999999999995 47899999998643 2223567899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec---CCCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG---NDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++.... .+++..+..|+.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++......
T Consensus 107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--- 178 (486)
T 3mwu_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178 (486)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---
Confidence 9999887664 399999999999999999999999999999999999995 45679999999998654221
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.
T Consensus 179 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 179 ----------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp -------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1123459999999999986 58999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+... ......+.........+.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 224 GKNE---------YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSSH---------HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCH---------HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 5321 11111111111111122223345678999999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.49 Aligned_cols=260 Identities=14% Similarity=0.162 Sum_probs=201.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEE-EccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY-WGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|++++++++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46899999999999995 6799999999865433 24688999999999988877666655 4556779999999 999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++..........
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 91 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 9999875432 39999999999999999999999999999999999999 4888999999999987654322111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
. +........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 ~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 167 I-----------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp C-----------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred c-----------------------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 0 01122345699999999999999999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.......... ..+.........+ .....+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 218 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 218 LKAATKRQKY------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CCCSSSSSHH------HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred cCchhhhhhh------hhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 4332222211 1111111111100 00113467889999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=352.69 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=196.5
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ .||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 478999999999999954 68999999997642 23357889999999999 469999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~ 632 (791)
|+|.+++..... ..+++..++.|+.|++.||+|||+.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 114 ~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~- 189 (327)
T 3lm5_A 114 GEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189 (327)
T ss_dssp EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred CcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc-
Confidence 999998754322 24999999999999999999999999999999999999987 78999999999987642211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 190 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (327)
T 3lm5_A 190 ------------------------------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233 (327)
T ss_dssp ----------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ------------------------------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 11245899999999999999999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..... ......+..................+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 234 VGEDN---------QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCSSH---------HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCCc---------hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 55311 11111111111111111112245678899999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=362.23 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=204.1
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccC--ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD--EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e~~~~ 555 (791)
.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 468999999999999954 58999999997643 233567889999999999999999999998765 67999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe----cCCCCeEEeccCcccccCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL----GNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+|.+++....... .+++..++.|+.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 94 g~L~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~ 171 (396)
T 4eut_A 94 GSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171 (396)
T ss_dssp EEHHHHTTSGGGTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG
T ss_pred CCHHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc
Confidence 99999987654322 38999999999999999999999999999999999999 7778899999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--------CCCCCchhhHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--------IKPNPKWDVYSFGVILL 703 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwSlGvil~ 703 (791)
.....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 172 -------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~ 214 (396)
T 4eut_A 172 -------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (396)
T ss_dssp -------------------------------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred -------------------------------------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence 112458999999999865 56788999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHh---------------------hhcCccchHHHHHHHHHHHhhccCC
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAA---------------------IRADFEGKEEALLSCFKLGYSCASP 762 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~ 762 (791)
||++|+.||......... ......+.... ..............+.+++.+||+.
T Consensus 215 el~tg~~Pf~~~~~~~~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 215 HAATGSLPFRPFEGPRRN-----KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHSSCSEECTTCTTTC-----HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHCCCCCCCCCcccch-----HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 999999999653221110 01111111110 0001112245677889999999999
Q ss_pred CCCCCCCHHHHHHHhccCCC
Q 003847 763 LPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 763 dP~~RPs~~evl~~L~~i~~ 782 (791)
||++||+++|+++.++++..
T Consensus 290 dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 290 DQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTTSCCHHHHHHHHHHHHT
T ss_pred ChhhhccHHHHHHHHHHHhh
Confidence 99999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.65 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=191.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-----hhhHHHHHHHHHHHhcc---CCCCccceeeEEEccC-----c
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-----VDRFRDFETQVRVIAKL---VHPNLVRIRGFYWGVD-----E 545 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~-----~ 545 (791)
...||+|+||.||+|+. .+++.||||++.... ......+.+|+++++++ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46899999999999994 678999999986422 11124567777777766 4999999999998765 4
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.++||||+. ++|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred EEEEehhhh-cCHHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence 789999996 6999998765432 389999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~el 705 (791)
...... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 170 ~~~~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 212 (308)
T 3g33_A 170 YSYQMA-------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212 (308)
T ss_dssp STTCCC-------------------------------------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHT
T ss_pred cCCCcc-------------------------------------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHH
Confidence 532111 1234589999999999999999999999999999999
Q ss_pred HhCCcchhccccCCCCcchhchhHHHHHHHHhhh------------------cCcc-----chHHHHHHHHHHHhhccCC
Q 003847 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIR------------------ADFE-----GKEEALLSCFKLGYSCASP 762 (791)
Q Consensus 706 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-----~~~~~~~~l~~li~~cl~~ 762 (791)
++|+.||...... .....+.+.... .... ...+....+.+|+.+||+.
T Consensus 213 ~~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (308)
T 3g33_A 213 FRRKPLFCGNSEA---------DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283 (308)
T ss_dssp TTSSCSCCCSSHH---------HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred HhCCCCCCCCCHH---------HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence 9999999653211 011111111000 0000 0011345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 003847 763 LPQKRPSMKEALQ 775 (791)
Q Consensus 763 dP~~RPs~~evl~ 775 (791)
||++|||+.|+++
T Consensus 284 dP~~R~t~~e~l~ 296 (308)
T 3g33_A 284 NPHKRISAFRALQ 296 (308)
T ss_dssp STTTSCCHHHHHT
T ss_pred CCccCCCHHHHhc
Confidence 9999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=344.09 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=192.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 468999999999999964 58999999986543 233567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 157 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD----- 157 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-----
Confidence 9998876543 389999999999999999999999999999999999999999999999999987642211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 158 -------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp ---------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1113358999999999976 67899999999999999999999999653
Q ss_pred ccCCCCcchhch-----hHHHHHHH-Hhhhc--Cc------cc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDK-----NRAIRLAD-AAIRA--DF------EG----KEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~-----~~~~~~~~-~~~~~--~~------~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
........+... ........ ..... .. .. ....+..+.+++.+||+.||++|||++|+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 211000000000 00000000 00000 00 00 01134568899999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=358.31 Aligned_cols=249 Identities=16% Similarity=0.157 Sum_probs=198.1
Q ss_pred hcceeccccCceEEEEEE------eCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC---CCCccceeeEEEccCceEE
Q 003847 478 ASAYILGASGSSIMYKAV------LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV---HPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~l 548 (791)
...+.||+|+||.||+|. ..+++.||||++..... .++..|++++++++ |+||+++++++...+..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 345789999999999993 45689999999976543 56777888888886 9999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-----------CCCeEE
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-----------DMEPKI 617 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-----------~~~~kL 617 (791)
||||+++|+|.+++..........+++..++.|+.||+.||+|||+.|||||||||+|||++. ++.+||
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence 999999999999998654333345999999999999999999999999999999999999998 899999
Q ss_pred eccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHH
Q 003847 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYS 697 (791)
Q Consensus 618 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS 697 (791)
+|||+++.+...... ......+||+.|+|||++.+..++.++||||
T Consensus 225 ~DFG~a~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 270 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKG----------------------------------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270 (365)
T ss_dssp CCCTTCEEGGGSCTT----------------------------------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHH
T ss_pred eeCchhhhhhccCCC----------------------------------ceeeeecCCCCCCChHHhcCCCCCccccHHH
Confidence 999999765421110 0122346999999999999999999999999
Q ss_pred HHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHH
Q 003847 698 FGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKR-PSMKEALQA 776 (791)
Q Consensus 698 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~ 776 (791)
|||++|||+||+.||......... ... .. .... ....+.+++..|++.+|.+| |+++++.+.
T Consensus 271 lG~il~elltg~~pf~~~~~~~~~--~~~----------~~-~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 271 VAATVYCMLFGTYMKVKNEGGECK--PEG----------LF-RRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp HHHHHHHHHHSSCCCEEEETTEEE--ECS----------CC-TTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhCCCccccCCCCcee--ech----------hc-cccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 999999999999998654221000 000 00 0111 23456678889999999999 688888888
Q ss_pred hccC
Q 003847 777 LEKI 780 (791)
Q Consensus 777 L~~i 780 (791)
|+++
T Consensus 334 l~~~ 337 (365)
T 3e7e_A 334 LKKV 337 (365)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.90 Aligned_cols=240 Identities=21% Similarity=0.313 Sum_probs=192.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc----CceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV----DEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~~~~lv~e~ 552 (791)
...||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 45899999999999995 56889999998654 344457799999999999999999999998753 457999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEec-CCCCeEEeccCcccccCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~ 629 (791)
+++++|.+++.... .+++..++.|+.|++.||+|||+.+ |+||||||+||+++ .++.+||+|||++......
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999997754 3899999999999999999999999 99999999999998 7899999999999754321
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
. .....||+.|+|||++.+ .++.++||||||+++|+|++|+
T Consensus 186 ~--------------------------------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 186 F--------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp S--------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred c--------------------------------------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCC
Confidence 1 112348999999998875 5899999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcC--ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRAD--FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.||..... . ........... ..........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~pf~~~~~---------~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 227 YPYSECQN---------A---AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CTTTTCSS---------H---HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCcCc---------H---HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99964311 0 11111111110 0111113357889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=344.48 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc-CceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-DEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||++... |+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||+++++
T Consensus 25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 4578999999999999874 8999999997653 346789999999999999999999997654 47899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 102 L~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------- 171 (278)
T 1byg_A 102 LVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------- 171 (278)
T ss_dssp HHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHhcccc---cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-------
Confidence 99998765321 27899999999999999999999999999999999999999999999999987543211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 172 --------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 --------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred --------------------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 01236788999999998899999999999999999998 999986532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.. ........... .......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 220 ~~----------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 220 LK----------DVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp GG----------GHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----------HHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11 01111111111 1112224567889999999999999999999999998875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.58 Aligned_cols=275 Identities=21% Similarity=0.262 Sum_probs=186.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccC-CCCccceeeEEEccC--ceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVD--EKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv~e~~ 553 (791)
...||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++...+ ..|+||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46899999999999994 57999999998653 3444567889999999997 999999999998654 689999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+ ++|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 7 6899888763 38999999999999999999999999999999999999999999999999998765322111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
..... . .. ................+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 167 ~~~~~----~----------~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 167 NNIPL----S----------IN-ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCGGG----C----------CC----------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccc----c----------cc-ccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 00000 0 00 000000011123445679999999999976 67899999999999999999999999
Q ss_pred hccccCCCCcchhc------h--------hHHHHHHHH----------hhhcCcc----------chHHHHHHHHHHHhh
Q 003847 713 VDELGQGNGLLVED------K--------NRAIRLADA----------AIRADFE----------GKEEALLSCFKLGYS 758 (791)
Q Consensus 713 ~~~~~~~~~~~~~~------~--------~~~~~~~~~----------~~~~~~~----------~~~~~~~~l~~li~~ 758 (791)
.+.........+.. . ......... .....++ ........+.+|+.+
T Consensus 232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 65321100000000 0 000000000 0000000 000124578899999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 003847 759 CASPLPQKRPSMKEALQA 776 (791)
Q Consensus 759 cl~~dP~~RPs~~evl~~ 776 (791)
||..||++|||++|+++.
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=381.86 Aligned_cols=243 Identities=21% Similarity=0.244 Sum_probs=203.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
...+||+|+||.||+|+. .+++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+..|+||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 356899999999999995 46899999999753 223346788899999988 7999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++.... .+++..++.|+.||+.||+|||+.|||||||||+|||++.++.+||+|||+++.......
T Consensus 425 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-- 497 (674)
T 3pfq_A 425 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-- 497 (674)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--
Confidence 9999999998764 399999999999999999999999999999999999999999999999999985432111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 498 ----------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 498 ----------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp ----------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 1234579999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM-----KEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 775 (791)
+.. ..++....+......+.....++.+|+.+||+.||++||++ +||++
T Consensus 544 ~~~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 544 GED-------------EDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CSS-------------HHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCC-------------HHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 531 12233333334333344466788999999999999999997 77764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=357.75 Aligned_cols=250 Identities=18% Similarity=0.247 Sum_probs=198.8
Q ss_pred cceeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 549 (791)
..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 457899999999999996 478999999997532 22345677899999999 699999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999998754 3899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHh
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~ellt 707 (791)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 213 ~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 213 ETE-----------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp GGG-----------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred CCC-----------------------------------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 110 0113458999999999985 457899999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQAL 777 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 777 (791)
|+.||........ ...+..................+.+|+.+||..||++|| +++|+++..
T Consensus 258 g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 258 GASPFTVDGEKNS---------QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SSCTTSCTTSCCC---------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCCccCCccch---------HHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 9999965422111 111222222222222233456788999999999999999 999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.78 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=192.3
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 468999999999999965 79999999986532 23346789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 166 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---- 166 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc----
Confidence 99999997754 389999999999999999999999999999999999999999999999999886542210
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..
T Consensus 167 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 167 ---------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp -------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 112348899999999988765 6899999999999999999999864
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
... ..............+......+.+++.+||+.||++|||+.|+++.
T Consensus 214 ~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 214 EHV-------------PTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CcH-------------HHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 311 1111111112112222245678899999999999999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.56 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=203.5
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC-ceEEE
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD-EKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lv 549 (791)
..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 457899999999999983 356899999997653 33456799999999999 7999999999988765 48999
Q ss_pred EeccCCCChhHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 550 YDFVPNGSLANARYRKMGSS-----------PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
|||+++++|.+++....... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 190 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEC
Confidence 99999999999998654310 1127899999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+++......... ......||+.|+|||++.+..++.++|||||
T Consensus 191 Dfg~~~~~~~~~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 191 DFGLARDIYKDPDYV----------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp CCGGGSCTTTCTTSE----------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCccccccccCccce----------------------------------eccCCCcceeecCchhhccccccchhHHHHH
Confidence 999998654322110 0112347889999999999899999999999
Q ss_pred HHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 699 GVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 699 Gvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
|+++|||+| |+.||...... ............. .........+.+++.+||+.||++|||+.|+++.|
T Consensus 237 G~il~~l~t~g~~p~~~~~~~---------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 237 GVLLWEIFSLGASPYPGVKID---------EEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHHHHHTTSCCSSTTCCCS---------HHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccchh---------HHHHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999998 99998653211 0111111111111 11122456788999999999999999999999999
Q ss_pred ccCC
Q 003847 778 EKIP 781 (791)
Q Consensus 778 ~~i~ 781 (791)
+++.
T Consensus 306 ~~~~ 309 (316)
T 2xir_A 306 GNLL 309 (316)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=353.05 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=201.7
Q ss_pred cceeccccCceEEEEEEe-CCCcE--EEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTA--LAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||.||+|+. .+++. ||||++... .....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 356899999999999994 45664 499998653 333456789999999999 8999999999999999999999999
Q ss_pred CCCChhHHHHhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCc
Q 003847 554 PNGSLANARYRKMG-----------SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGL 622 (791)
Q Consensus 554 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGl 622 (791)
++++|.+++..... .....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~ 188 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCc
Confidence 99999999876530 1112489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil 702 (791)
++...... ......+++.|+|||++.+..++.++||||||+++
T Consensus 189 ~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 189 SRGQEVYV-------------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp EESSCEEC-------------------------------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred Cccccccc-------------------------------------cccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 87432110 01122367889999999988899999999999999
Q ss_pred HHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 703 LELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 703 ~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|||++ |+.||...... ........... ..........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 232 ~ellt~g~~pf~~~~~~----------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCA----------ELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHTTSCCTTTTCCHH----------HHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCcHH----------HHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99998 99999653210 11111111111 1112224567889999999999999999999999998875
Q ss_pred CCCCCC
Q 003847 782 SSPSPY 787 (791)
Q Consensus 782 ~~~~p~ 787 (791)
.....+
T Consensus 300 ~~~~~~ 305 (327)
T 1fvr_A 300 EERKTY 305 (327)
T ss_dssp HSSSCS
T ss_pred HhhcCc
Confidence 554443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=354.50 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=186.6
Q ss_pred hhcceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEc--------cCce
Q 003847 477 KASAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWG--------VDEK 546 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--------~~~~ 546 (791)
+...+.||+|+||.||+|+. .+++.||||++........+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 34457999999999999995 578999999997766666778999999999996 9999999999852 3347
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
++||||+. |+|.+++....... .+++.+++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTC--SCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEEEEecC-CCHHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 89999995 79999887644332 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc---cCCCCCCchhhHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL---RSIKPNPKWDVYSFGVI 701 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~---~~~~~~~~sDvwSlGvi 701 (791)
.............. ...........||+.|+|||++ .+..++.++|||||||+
T Consensus 187 ~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 187 TISHYPDYSWSAQR------------------------RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp CCSSCC-------------------------------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred eccccCcccccccc------------------------cccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 76543221100000 0000112234589999999998 56778999999999999
Q ss_pred HHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 702 LLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
+|||++|+.||.+.... ......... +........+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 243 l~el~~g~~p~~~~~~~-------------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKL-------------RIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp HHHHHHSSCCC-------------------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCcchhHH-------------HhhcCcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999653211 011111110 111112345778999999999999999999999998763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=355.74 Aligned_cols=256 Identities=15% Similarity=0.150 Sum_probs=198.1
Q ss_pred ceeccccCceEEEEEEeC---------CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccc---------------
Q 003847 480 AYILGASGSSIMYKAVLE---------DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVR--------------- 535 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------------- 535 (791)
.+.||+|+||.||+|+.. +++.||||++... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 468999999999999965 3889999998754 45789999999999999988
Q ss_pred eeeEEEc-cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-
Q 003847 536 IRGFYWG-VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM- 613 (791)
Q Consensus 536 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~- 613 (791)
+++++.. .+..++||||+ +++|.+++...... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH---VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCC
Confidence 6777766 67789999999 99999999865221 399999999999999999999999999999999999999998
Q ss_pred -CeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 614 -EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 614 -~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
.+||+|||+++.+......... .........||+.|+|||++.+..++.+
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAY-----------------------------VEGSRSPHEGDLEFISMDLHKGCGPSRR 248 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCC-----------------------------CTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred ceEEEecCcceeeccCCCccccc-----------------------------cccccccccCCccccCHHHHccCCCCch
Confidence 8999999999876532211100 0011223469999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch------HHHHHHHHHHHhhccCCCCCC
Q 003847 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK------EEALLSCFKLGYSCASPLPQK 766 (791)
Q Consensus 693 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~ 766 (791)
+|||||||++|||++|+.||...... ................... ...+..+.+++.+||+.||++
T Consensus 249 ~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLPWTNCLPN--------TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCTTGGGTTC--------HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred hhHHHHHHHHHHHHhCCCCcccCCcC--------HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence 99999999999999999999764211 0111111111111110000 013467889999999999999
Q ss_pred CCCHHHHHHHhccCC
Q 003847 767 RPSMKEALQALEKIP 781 (791)
Q Consensus 767 RPs~~evl~~L~~i~ 781 (791)
||+++++++.|+++.
T Consensus 321 Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 321 KPPYAMLRNNLEALL 335 (352)
T ss_dssp CCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999998763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.59 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=192.0
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHH--HhccCCCCccceeeEEEcc-----CceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRV--IAKLVHPNLVRIRGFYWGV-----DEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~-----~~~~lv~e~ 552 (791)
.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++++... ...++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 46899999999999987 689999999975433 334444444 5568999999999865432 256899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------CCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK---------KHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
+++|+|.+++.... .++..+..|+.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999997653 68999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-------CCCCCchhhH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-------IKPNPKWDVY 696 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvw 696 (791)
+.+......... .........+||+.|+|||++.+ ..++.++|||
T Consensus 168 ~~~~~~~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 168 MRLTGNRLVRPG----------------------------EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp EECSSSSCC-------------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred eecccccccCcc----------------------------ccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 876543211100 00111234569999999999986 4567799999
Q ss_pred HHHHHHHHHHhCCcchhccccC-CCCcchhc-------hhHHHHHH-HHhhhc----CccchHHHHHHHHHHHhhccCCC
Q 003847 697 SFGVILLELLTGKVIVVDELGQ-GNGLLVED-------KNRAIRLA-DAAIRA----DFEGKEEALLSCFKLGYSCASPL 763 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~~~-~~~~~~~~-------~~~~~~~~-~~~~~~----~~~~~~~~~~~l~~li~~cl~~d 763 (791)
||||++|||++|+.||...... ........ ........ ...... ........+..+.+|+.+||+.|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 9999999999998876443221 11111100 00000110 011111 11112235667999999999999
Q ss_pred CCCCCCHHHHHHHhccCC
Q 003847 764 PQKRPSMKEALQALEKIP 781 (791)
Q Consensus 764 P~~RPs~~evl~~L~~i~ 781 (791)
|++|||++|+++.|+++.
T Consensus 300 P~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELM 317 (336)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcchHHHHHHHHHHH
Confidence 999999999999998863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=367.96 Aligned_cols=245 Identities=26% Similarity=0.304 Sum_probs=193.5
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3568999999999999954 78999999997542 23356789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCCCC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~ 632 (791)
|+|.+++.... .+++..+..|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 121 g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~- 194 (494)
T 3lij_A 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194 (494)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC-
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc-
Confidence 99999887664 3899999999999999999999999999999999999976 45599999999987643211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||
T Consensus 195 ------------------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 195 ------------------------------------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp ------------------------------------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ------------------------------------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCC
Confidence 123459999999999874 6899999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
...... .....+.........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 238 GGQTDQ---------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSSHH---------HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHH---------HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 653211 111111111111111111234567889999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.92 Aligned_cols=245 Identities=20% Similarity=0.240 Sum_probs=186.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
.+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 4689999999999998 45789999999975432 224567899999999999999999999999999999999997 5
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-----CCCCeEEeccCcccccCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-----NDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-----~~~~~kL~DFGla~~~~~~~~ 631 (791)
+|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++.......
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 9999887654 389999999999999999999999999999999999994 455699999999987642211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 193 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 193 ------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp -------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 11233589999999999874 48999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhc----------------Cc-----c-----chHHHHHHHHHHHhhccCCCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRA----------------DF-----E-----GKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~-----~-----~~~~~~~~l~~li~~cl~~dP 764 (791)
||...... .....+....... .+ . ........+.+|+.+||+.||
T Consensus 237 pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 307 (329)
T 3gbz_A 237 LFPGDSEI---------DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307 (329)
T ss_dssp SSCCSSHH---------HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred CcCCCCHH---------HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence 99653210 0111111100000 00 0 000023567899999999999
Q ss_pred CCCCCHHHHHH
Q 003847 765 QKRPSMKEALQ 775 (791)
Q Consensus 765 ~~RPs~~evl~ 775 (791)
++|||++|+++
T Consensus 308 ~~R~t~~e~l~ 318 (329)
T 3gbz_A 308 VKRISAKNALE 318 (329)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhC
Confidence 99999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.65 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=199.5
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 3568999999999999954 79999999985432 3345789999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~ 631 (791)
+|+|.+++.... .+++..+..|+.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 110 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 110 GGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp SCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999999887653 39999999999999999999999999999999999999 5678999999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
....+||+.|+|||++.+ .++.++||||+||++|+|++|+.|
T Consensus 185 -------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 185 -------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp -------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence 112358999999999976 689999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|..... ......+.........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 f~~~~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 227 FNGANE---------YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SCCSSH---------HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCH---------HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 965321 1111111111111112222335677899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.56 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=190.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
...||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..|+||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46899999999999995 57999999999653 3334567899999999999999999999998763 459999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +++|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 999 88999988763 3899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 182 --------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 182 --------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp --------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 123458999999999877 67999999999999999999999
Q ss_pred cchhccccCCCCcchhc--------------hhHHHHHHHHhh---hcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLLVED--------------KNRAIRLADAAI---RADFE-GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~---~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||.+.........+.. ............ ...+. ........+.+|+.+||..||++|||+.
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 99965321100000000 000000000000 00000 0011345788999999999999999999
Q ss_pred HHHHH--hccCC
Q 003847 772 EALQA--LEKIP 781 (791)
Q Consensus 772 evl~~--L~~i~ 781 (791)
|+++. ++++.
T Consensus 304 e~l~hp~f~~~~ 315 (367)
T 1cm8_A 304 EALAHPYFESLH 315 (367)
T ss_dssp HHHHSGGGTTTC
T ss_pred HHhcChHHHhhc
Confidence 99983 55543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.50 Aligned_cols=238 Identities=15% Similarity=0.160 Sum_probs=185.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCC---CchhhHHHHHHHH---HHHhccCCCCcccee-------eEEEccCc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGE---NSVDRFRDFETQV---RVIAKLVHPNLVRIR-------GFYWGVDE 545 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~~~~~~ 545 (791)
.+.||+|+||.||+|+. .+|+.||||++.. ......+.+.+|+ +++++++|||||+++ +++...+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 56899999999999994 6799999999963 2334567899999 455566899999998 66665532
Q ss_pred -----------------eEEEEeccCCCChhHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCC
Q 003847 546 -----------------KLIIYDFVPNGSLANARYRKMGSS--PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606 (791)
Q Consensus 546 -----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~N 606 (791)
.|+||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+.||+||||||+|
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 236 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 78999999 689999998653211 0124458888999999999999999999999999999
Q ss_pred eEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC
Q 003847 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS 686 (791)
Q Consensus 607 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 686 (791)
||++.++.+||+|||+++..... ....+| +.|+|||++.+
T Consensus 237 Ill~~~~~~kL~DFG~a~~~~~~---------------------------------------~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 237 IVLDQRGGVFLTGFEHLVRDGAR---------------------------------------VVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp EEECTTCCEEECCGGGCEETTCE---------------------------------------EECCCC-TTCCCHHHHHH
T ss_pred EEEcCCCCEEEEechhheecCCc---------------------------------------ccCCCC-cCccChhhhcc
Confidence 99999999999999999853311 112347 88999999988
Q ss_pred C-----------CCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHH
Q 003847 687 I-----------KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKL 755 (791)
Q Consensus 687 ~-----------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 755 (791)
. .++.++|||||||++|||++|+.||...........+.. . . ...+..+.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-------------~-~---~~~~~~~~~l 339 (377)
T 3byv_A 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-------------S-C---KNIPQPVRAL 339 (377)
T ss_dssp HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-------------S-C---CCCCHHHHHH
T ss_pred cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-------------h-c---cCCCHHHHHH
Confidence 7 899999999999999999999999966433221111110 0 0 1134568899
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 003847 756 GYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 756 i~~cl~~dP~~RPs~~evl~ 775 (791)
+.+||+.||++|||+.|+++
T Consensus 340 i~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 340 LEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=361.67 Aligned_cols=215 Identities=18% Similarity=0.236 Sum_probs=151.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~ 550 (791)
..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++|++++||||+++++++... ...|+||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 356899999999999984 47899999999653 334457889999999999999999999998543 5689999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +++|.+++.... .+++..++.|+.||+.||+|||+.|||||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 137 EIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred ecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 998 579998886543 39999999999999999999999999999999999999999999999999999775432
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc-cCCCCCCchhhHHHHHHHHHHHhC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwSlGvil~elltG 708 (791)
.......... .. .....................+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 211 ~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISP----RE-----DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCc----cc-----cccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2111000000 00 000000000000111234566799999999986 566799999999999999999994
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.32 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=185.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS--------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
..+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 457899999999999984 568999999986532 112235789999999999999999999975 4568999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC---CCeEEeccCccccc
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND---MEPKIGDFGLERLV 626 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~ 626 (791)
|||+++|+|.+++.... .+++..++.|+.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 218 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 99999999998876543 39999999999999999999999999999999999999754 45999999999875
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILL 703 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~ 703 (791)
.... .....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 293 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ 335 (419)
T 3i6u_A 293 GETS-------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335 (419)
T ss_dssp C------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHH
T ss_pred CCCc-------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHH
Confidence 4211 1123469999999999853 56788999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||++|+.||........ ..... ..+..... ......+.+++.+||+.||++|||++|+++
T Consensus 336 ~lltg~~pf~~~~~~~~---------~~~~i---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 336 ICLSGYPPFSEHRTQVS---------LKDQI---TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHSSCSSCCCSSSCC---------HHHHH---HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCcchHH---------HHHHH---hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999965322111 01111 11111111 123567889999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=367.45 Aligned_cols=241 Identities=23% Similarity=0.291 Sum_probs=195.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch-------------hhHHHHHHHHHHHhccCCCCccceeeEEEccCc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV-------------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE 545 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 545 (791)
.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 46899999999999995 4689999999865321 234678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC---CeEEeccCc
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM---EPKIGDFGL 622 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~---~~kL~DFGl 622 (791)
.++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 999999999999999887654 399999999999999999999999999999999999998775 699999999
Q ss_pred ccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHH
Q 003847 623 ERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 623 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil 702 (791)
++....... ....+||+.|+|||++.+ .++.++||||+||++
T Consensus 196 a~~~~~~~~-------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 237 (504)
T 3q5i_A 196 SSFFSKDYK-------------------------------------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIM 237 (504)
T ss_dssp CEECCTTSC-------------------------------------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHH
T ss_pred CEEcCCCCc-------------------------------------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHH
Confidence 987643211 123459999999999875 689999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|+|++|+.||.+... .++......+.+... ...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 238 ~~ll~g~~pf~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 238 YILLCGYPPFGGQND-------------QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHSSCSSCCSSH-------------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCCCCCCCH-------------HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999965321 112222222222111 1235678999999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=342.37 Aligned_cols=244 Identities=21% Similarity=0.351 Sum_probs=195.4
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 468999999999999964 58999999997643 246789999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 112 ~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 180 (314)
T 3com_A 112 SDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA------- 180 (314)
T ss_dssp HHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-------
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-------
Confidence 999875432 389999999999999999999999999999999999999999999999999986643211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 181 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 230 (314)
T 3com_A 181 -----------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP- 230 (314)
T ss_dssp -----------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -----------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 01123589999999999998999999999999999999999999964311
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ...........+......+..+.+++.+||+.||++|||+.++++
T Consensus 231 --------~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 231 --------MRA-IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --------HHH-HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------HHH-HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001 111111111112222224567889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.84 Aligned_cols=243 Identities=22% Similarity=0.330 Sum_probs=199.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46899999999999984 568999999996542 3446789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~------ 174 (303)
T 3a7i_A 107 ALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI------ 174 (303)
T ss_dssp HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC------
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc------
Confidence 99988642 389999999999999999999999999999999999999999999999999987643211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 175 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 224 (303)
T 3a7i_A 175 ------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224 (303)
T ss_dssp ------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence 01133589999999999999999999999999999999999999864311
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
. ............... ......+.+++.+||+.||++|||+.|+++.
T Consensus 225 ---------~-~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 225 ---------M-KVLFLIPKNNPPTLE--GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---------H-HHHHHHHHSCCCCCC--SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---------H-HHHHHhhcCCCCCCc--cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 111111111111111 1244678899999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.60 Aligned_cols=258 Identities=20% Similarity=0.272 Sum_probs=200.2
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhc--cCCCCccceeeEEEccC----ceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAK--LVHPNLVRIRGFYWGVD----EKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lv~e~ 552 (791)
..+.||+|+||.||+|+. +|+.||||++.... .+.+.+|+++++. ++||||+++++++...+ ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 357899999999999998 58999999997542 3567788888887 78999999999998876 78999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH--------EKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
+++|+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 9999999999754 2899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC------CCCchhhHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK------PNPKWDVYSF 698 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~~sDvwSl 698 (791)
.......... .......||+.|+|||++.+.. ++.++|||||
T Consensus 196 ~~~~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 196 RHDSATDTID--------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp EEETTTTEEE--------------------------------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred eccccccccc--------------------------------cccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 7653321100 0112345999999999997652 3368999999
Q ss_pred HHHHHHHHhC----------CcchhccccCCCCcchhchhHHHH-HHHHhhhcCccc---hHHHHHHHHHHHhhccCCCC
Q 003847 699 GVILLELLTG----------KVIVVDELGQGNGLLVEDKNRAIR-LADAAIRADFEG---KEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 699 Gvil~elltG----------~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP 764 (791)
||++|||++| +.||......... ...... +.........+. ..+....+.+++.+||+.||
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-----VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-----HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCccc-----HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccCh
Confidence 9999999999 5666543211110 001111 111112222221 12466789999999999999
Q ss_pred CCCCCHHHHHHHhccCCCC
Q 003847 765 QKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 765 ~~RPs~~evl~~L~~i~~~ 783 (791)
++|||+.||++.|++|...
T Consensus 319 ~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 319 AARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp GGSCCHHHHHHHHHHHHHT
T ss_pred hhCCCHHHHHHHHHHHHHH
Confidence 9999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=355.08 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=195.8
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC--------CCCccceeeEEE----ccCc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV--------HPNLVRIRGFYW----GVDE 545 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~----~~~~ 545 (791)
..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++ |+||+++++++. ....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 346899999999999984 568999999997543 34567889999999985 788999999998 5567
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCC-----------
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDM----------- 613 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~----------- 613 (791)
.++||||+ +++|.+++...... .+++..++.|+.||+.||+|||++ ||+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNYQ---GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred EEEEEecc-CccHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 89999999 66776766554322 399999999999999999999998 999999999999999775
Q ss_pred --------------------------------------CeEEeccCcccccCCCCCCCcCCCCccccCCccccccccccc
Q 003847 614 --------------------------------------EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655 (791)
Q Consensus 614 --------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (791)
.+||+|||+++.....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------------------------- 249 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------------------------- 249 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------------------------
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------------------------
Confidence 7999999999865421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHH
Q 003847 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLAD 735 (791)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 250 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 316 (397)
T 1wak_A 250 -------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316 (397)
T ss_dssp -------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC
T ss_pred -------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC
Confidence 1123589999999999999999999999999999999999999975433222111111000000000
Q ss_pred -----------------------------------HhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 736 -----------------------------------AAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 736 -----------------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..+...+.........+.+|+.+||+.||++|||++|+++
T Consensus 317 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001112223456778999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.17 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=197.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 468999999999999964 7899999998654 23445788999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~----- 161 (276)
T 2yex_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----- 161 (276)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-----
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch-----
Confidence 999876432 3899999999999999999999999999999999999999999999999999865422110
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 162 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 162 -----------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp -----------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred -----------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 01123458999999999987665 779999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .......... ............+.+++.+||+.||++|||++|+++
T Consensus 213 ~~~--------~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 213 DSC--------QEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTS--------HHHHHHHTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHH--------HHHHHhhhcc--cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 210 0011111110 011111224567889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.39 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=200.0
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++...+..++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 346899999999999983 35789999999754 34455678999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCccccc
Q 003847 552 FVPNGSLANARYRKMGSS--PCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLV 626 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~ 626 (791)
|+++++|.+++....... ...+++..++.++.|++.||+|||+.||+||||||+|||++. +..+||+|||+++..
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence 999999999998764321 134899999999999999999999999999999999999984 446999999999865
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
....... ......||+.|+|||++.+..++.++||||||+++|||+
T Consensus 194 ~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 239 (327)
T 2yfx_A 194 YRASYYR----------------------------------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239 (327)
T ss_dssp HC----------------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccc----------------------------------cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 4322110 011234788999999999889999999999999999999
Q ss_pred h-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 707 T-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 707 t-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
| |+.||..... ............ .......+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 240 t~g~~p~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 240 SLGYMPYPSKSN----------QEVLEFVTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTSCCSSTTCCH----------HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCcCH----------HHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 8 8889865311 111111111111 1112224567889999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=349.71 Aligned_cols=248 Identities=21% Similarity=0.221 Sum_probs=192.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh-----hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD-----RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
....||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 346899999999999995 46899999999753221 124678999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++ +|.+++..... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 167 (346)
T 1ua2_A 94 MET-DLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 167 (346)
T ss_dssp CSE-EHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCC-CHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-
Confidence 975 88888765432 388899999999999999999999999999999999999999999999999986542211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+|
T Consensus 168 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~ 212 (346)
T 1ua2_A 168 -----------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212 (346)
T ss_dssp -----------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 1123458999999999975 4589999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhc------------------Ccc------chHHHHHHHHHHHhhccCCCCCCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRA------------------DFE------GKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~------~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
|..... ......+....... ..+ ........+.+|+.+||+.||++|
T Consensus 213 ~~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 283 (346)
T 1ua2_A 213 LPGDSD---------LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283 (346)
T ss_dssp SCCSSH---------HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred CCCCCH---------HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhC
Confidence 865321 01111111110000 000 001134678999999999999999
Q ss_pred CCHHHHHHH
Q 003847 768 PSMKEALQA 776 (791)
Q Consensus 768 Ps~~evl~~ 776 (791)
||+.|+++.
T Consensus 284 pt~~ell~h 292 (346)
T 1ua2_A 284 ITATQALKM 292 (346)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.50 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=193.0
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEcc--------CceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV--------DEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~~~l 548 (791)
.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46899999999999996 579999999986542 22245788999999999999999999999873 46899
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++ +|.+.+..... .+++.+++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 v~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 176 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176 (351)
T ss_dssp EEECCSE-EHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred EEeccCC-CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence 9999974 77777765432 399999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 177 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 224 (351)
T 3mi9_A 177 AKNSQ--------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224 (351)
T ss_dssp CSSSS--------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred ccccc--------------------------------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh
Confidence 22111 011234568999999999876 457999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHH---Hhhhc----------------CccchHH------HHHHHHHHHhhccCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLAD---AAIRA----------------DFEGKEE------ALLSCFKLGYSCASP 762 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----------------~~~~~~~------~~~~l~~li~~cl~~ 762 (791)
|+.||.......... ....... ..... ......+ ....+.+|+.+||+.
T Consensus 225 g~~pf~~~~~~~~~~------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 225 RSPIMQGNTEQHQLA------LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp SSCSCCCSSHHHHHH------HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred CCCCCCCCChHHHHH------HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 999986532110000 0000000 00000 0000000 134578999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003847 763 LPQKRPSMKEALQA 776 (791)
Q Consensus 763 dP~~RPs~~evl~~ 776 (791)
||++|||++|+++.
T Consensus 299 dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 299 DPAQRIDSDDALNH 312 (351)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhCC
Confidence 99999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.83 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=199.2
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
....||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 3568999999999999954 7899999999765 3444578999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 186 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----- 186 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-----
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc-----
Confidence 9999998764 389999999999999999999995 99999999999999999999999999987653211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 ---------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -------------------------------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---------------------------------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11235899999999999999999999999999999999999998643
Q ss_pred ccCCCCcch-----------------------------hchhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCC
Q 003847 716 LGQGNGLLV-----------------------------EDKNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 716 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP 764 (791)
......... .......+..+........ ........+.+|+.+||+.||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp CHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcCh
Confidence 211000000 0000001111111111111 011134578899999999999
Q ss_pred CCCCCHHHHHH
Q 003847 765 QKRPSMKEALQ 775 (791)
Q Consensus 765 ~~RPs~~evl~ 775 (791)
++|||++|+++
T Consensus 314 ~~Rpt~~ell~ 324 (360)
T 3eqc_A 314 AERADLKQLMV 324 (360)
T ss_dssp TTSCCHHHHHT
T ss_pred hhCCCHHHHhh
Confidence 99999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.02 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=193.2
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 3568999999999999964 7999999998753 233456788999999999 99999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-------------------CCe
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-------------------MEP 615 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-------------------~~~ 615 (791)
+++|.+++....... ..+++..++.|+.||+.||+|||+.||+||||||+||+++.+ ..+
T Consensus 95 ~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (289)
T 1x8b_A 95 GGSLADAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173 (289)
T ss_dssp TCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCE
T ss_pred CCcHHHHHHhhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEE
Confidence 999999997653211 148999999999999999999999999999999999999844 479
Q ss_pred EEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchh
Q 003847 616 KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWD 694 (791)
Q Consensus 616 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sD 694 (791)
||+|||.+....... ...||+.|+|||++.+. .++.++|
T Consensus 174 kl~Dfg~~~~~~~~~----------------------------------------~~~gt~~y~aPE~~~~~~~~~~~~D 213 (289)
T 1x8b_A 174 KIGDLGHVTRISSPQ----------------------------------------VEEGDSRFLANEVLQENYTHLPKAD 213 (289)
T ss_dssp EECCCTTCEETTCSC----------------------------------------CCCCCGGGCCHHHHTTCCTTHHHHH
T ss_pred EEcccccccccCCcc----------------------------------------ccCCCccccChhHhcCCCCCCchhh
Confidence 999999988654211 12389999999999765 5668999
Q ss_pred hHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 695 VYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 695 vwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
||||||++|||++|.+++.... ....+..... ...+ ......+.+++.+||+.||++|||+.|++
T Consensus 214 i~slG~il~~l~~~~~~~~~~~------------~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 214 IFALALTVVCAAGAEPLPRNGD------------QWHEIRQGRL-PRIP--QVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHHHHHHHHTTCCCCCSSSH------------HHHHHHTTCC-CCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCcchh------------HHHHHHcCCC-CCCC--cccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 9999999999999998653320 1111111111 1111 12456788999999999999999999998
Q ss_pred HH
Q 003847 775 QA 776 (791)
Q Consensus 775 ~~ 776 (791)
+.
T Consensus 279 ~h 280 (289)
T 1x8b_A 279 KH 280 (289)
T ss_dssp TC
T ss_pred hC
Confidence 63
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.21 Aligned_cols=255 Identities=18% Similarity=0.186 Sum_probs=187.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhh-HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 468999999999999964 78999999997543221 1245679999999999999999999999999999999997 58
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~------ 155 (324)
T 3mtl_A 86 LKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK------ 155 (324)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc------
Confidence 9988876542 389999999999999999999999999999999999999999999999999976432111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 156 ------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 156 ------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp -------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1123358999999999876 568999999999999999999999996532
Q ss_pred cCCCCcc------------hhchhHHHHHHHHhhhcC-----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLL------------VEDKNRAIRLADAAIRAD-----FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
....... .................. ..........+.+|+.+||+.||++|||++|+++
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 206 VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1100000 000000000000000000 0000112456789999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.15 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=196.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---------hhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---------VDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 548 (791)
...||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++++. ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 46899999999999996 468999999986532 122456889999999995 9999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 999999999999998754 389999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc------CCCCCCchhhHHHHHHH
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR------SIKPNPKWDVYSFGVIL 702 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~~sDvwSlGvil 702 (791)
... .....||+.|+|||++. ...++.++||||||+++
T Consensus 177 ~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 177 GEK-------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp TCC-------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred Ccc-------------------------------------cccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 211 11235899999999985 45678999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|||++|+.||..... ......+.........+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 220 YTLLAGSPPFWHRKQ---------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHSSCSSCCSSH---------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCcCccH---------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 999999999854311 0111111111111111111234567899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.19 Aligned_cols=255 Identities=19% Similarity=0.260 Sum_probs=191.2
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 468999999999999954 58999999985542 333466889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 179 (331)
T 4aaa_A 110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----- 179 (331)
T ss_dssp HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-----
Confidence 9988765443 389999999999999999999999999999999999999999999999999986543211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 180 -------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 180 -------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11123589999999999875 7899999999999999999999998654
Q ss_pred ccCCCCcchhc-----hhHHHHHHHHh--hh----c----Ccc---chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVED-----KNRAIRLADAA--IR----A----DFE---GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~-----~~~~~~~~~~~--~~----~----~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
........+.. ........... .. . ... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 21100000000 00000000000 00 0 000 00113467899999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.58 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=198.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 46899999999999995 47899999999654 33445679999999999999999999998854 567899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK-----HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
+++|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 91 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169 (279)
T ss_dssp TEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred CCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence 99999998765422 124899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
... .....||+.|+|||++.+..++.++||||||+++|||++|+
T Consensus 170 ~~~------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 170 TSF------------------------------------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp CHH------------------------------------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred ccc------------------------------------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 110 00123788999999999989999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.||..... ......+... ..... ....+..+.+++.+||+.||++||++.|+++.+..-
T Consensus 214 ~p~~~~~~---------~~~~~~i~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 214 PPFTAFSQ---------KELAGKIREG-KFRRI--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CSSCCSSH---------HHHHHHHHHT-CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred CCCcccCH---------HHHHHHHhhc-ccccC--CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 99865311 0111111111 11111 122456788999999999999999999999877543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.73 Aligned_cols=192 Identities=21% Similarity=0.263 Sum_probs=166.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc------CCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL------VHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+++++.+ +|+||+++++++...+..++||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 46899999999999985 468999999997653 3346778888888877 577999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC--eEEeccCcccccCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME--PKIGDFGLERLVTGDT 630 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~ 630 (791)
+. ++|.+++...... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++. +||+|||+++.....
T Consensus 181 ~~-~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~- 255 (429)
T 3kvw_A 181 LS-MNLYELIKKNKFQ---GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR- 255 (429)
T ss_dssp CC-CBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred cC-CCHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-
Confidence 95 6999988775432 3899999999999999999999999999999999999999887 999999999754321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 256 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 256 --------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp --------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 113458999999999999999999999999999999999999
Q ss_pred chhcc
Q 003847 711 IVVDE 715 (791)
Q Consensus 711 pf~~~ 715 (791)
||...
T Consensus 298 pf~~~ 302 (429)
T 3kvw_A 298 LLPGE 302 (429)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 98654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.55 Aligned_cols=246 Identities=21% Similarity=0.306 Sum_probs=194.0
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
...||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 457999999999999964 5899999999876666678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 104 ~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------- 172 (302)
T 2j7t_A 104 DAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ------- 172 (302)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-------
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-------
Confidence 998876432 389999999999999999999999999999999999999999999999999764321100
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc-----cCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-----RSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-----~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
......||+.|+|||++ .+..++.++||||||+++|||++|+.||.
T Consensus 173 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 173 -----------------------------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp -----------------------------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------------------------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 01123489999999998 46678999999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... ........... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~---------~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 224 ELNP---------MRVLLKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TSCH---------HHHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCH---------HHHHHHHhccC-CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 5311 01111111110 1111112224567889999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.15 Aligned_cols=214 Identities=21% Similarity=0.314 Sum_probs=162.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~e 551 (791)
.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++... +..|+|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 46899999999999995 56899999999763 334457889999999999999999999999776 56899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|++ ++|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 111 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 111 IAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp CCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred cCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 996 69999887543 399999999999999999999999999999999999999999999999999997754322
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc-cCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.......... ...++ ............+||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 185 ~~~~~~~~~~-------------~~~~~-~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 185 TNIVNDLEEN-------------EEPGP-HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp ----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred cccccccccc-------------ccccc-cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 1100000000 00000 000001123566799999999986 56679999999999999999998766
Q ss_pred chh
Q 003847 711 IVV 713 (791)
Q Consensus 711 pf~ 713 (791)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.88 Aligned_cols=246 Identities=17% Similarity=0.228 Sum_probs=193.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhccCCCCccceeeEEE--ccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS----VDRFRDFETQVRVIAKLVHPNLVRIRGFYW--GVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lv~e~ 552 (791)
.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46899999999999995 568999999997642 234578999999999999999999999985 44578999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
++++ |.+++...... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~-l~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPEK---RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp CSEE-HHHHHHHSTTC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred ccCC-HHHHHHhCccc---ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 9876 77777654322 4999999999999999999999999999999999999999999999999999876432111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC--CCchhhHHHHHHHHHHHhCCc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP--NPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~sDvwSlGvil~elltG~~ 710 (791)
. ......||+.|+|||++.+... +.++||||||+++|||++|+.
T Consensus 166 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (305)
T 2wtk_C 166 D----------------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211 (305)
T ss_dssp C----------------------------------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred c----------------------------------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCC
Confidence 0 0112348999999999976443 779999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||..... .....................+.+++.+||+.||++|||+.|+++.
T Consensus 212 p~~~~~~-------------~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 212 PFEGDNI-------------YKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCCCSSH-------------HHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCchH-------------HHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9965311 1111211222222222345678899999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.17 Aligned_cols=252 Identities=19% Similarity=0.219 Sum_probs=186.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
...||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 46899999999999984 46899999999653 3344567889999999999999999999998765 679999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||++ ++|.+++.. .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 9996 578877752 28999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 182 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 182 -------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp ---------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 1123458999999999999999999999999999999999999
Q ss_pred chhccccCCCCc------------chhch-hHHHHHHH---------------Hhh-hcCccchHHHHHHHHHHHhhccC
Q 003847 711 IVVDELGQGNGL------------LVEDK-NRAIRLAD---------------AAI-RADFEGKEEALLSCFKLGYSCAS 761 (791)
Q Consensus 711 pf~~~~~~~~~~------------~~~~~-~~~~~~~~---------------~~~-~~~~~~~~~~~~~l~~li~~cl~ 761 (791)
||.+........ ..... ........ ... .............+.+|+.+||.
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 996532100000 00000 00000000 000 00001112235678999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||++|+++.
T Consensus 305 ~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 305 IDASKRISVDEALQH 319 (371)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CChhhCCCHHHHhCC
Confidence 999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.57 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=193.2
Q ss_pred ceeccccCceEEEEEEeC--CCc--EEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE--DGT--ALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|+.. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.... .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 468999999999999842 333 6999998754 2344678999999999999999999999997654 8899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++++|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 102 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred ccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 999999999886542 3899999999999999999999999999999999999999999999999999876533211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. ......||..|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 178 ~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 178 YV---------------------------------MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp EE---------------------------------C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred hh---------------------------------hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 00 1112347888999999998889999999999999999999 9999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
|..... ......+.... ...+.....+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 225 ~~~~~~---------~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 225 WIGLNG---------SQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp TTTCCH---------HHHHHHHHTSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cccCCH---------HHHHHHHHccC--CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 865311 01111111110 111122235567899999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.39 Aligned_cols=248 Identities=15% Similarity=0.187 Sum_probs=191.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEc--cCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWG--VDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 46899999999999984 678999999997543 367899999999997 9999999999988 5678999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~ 634 (791)
++|.+++.. +++.++..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++.......
T Consensus 118 ~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--- 186 (330)
T 3nsz_A 118 TDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 186 (330)
T ss_dssp CCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---
T ss_pred hhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---
Confidence 999887642 88999999999999999999999999999999999999776 899999999986543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 187 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 187 ----------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ----------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ----------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 123358999999999977 678999999999999999999999985
Q ss_pred ccccCCCCc-chh---chhHHHHHHHHhhhcC---------------------ccchHHHHHHHHHHHhhccCCCCCCCC
Q 003847 714 DELGQGNGL-LVE---DKNRAIRLADAAIRAD---------------------FEGKEEALLSCFKLGYSCASPLPQKRP 768 (791)
Q Consensus 714 ~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~l~~li~~cl~~dP~~RP 768 (791)
......... .+. .........+...... ..........+.+|+.+||+.||++||
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence 432110000 000 0000000000000000 000111356789999999999999999
Q ss_pred CHHHHHH
Q 003847 769 SMKEALQ 775 (791)
Q Consensus 769 s~~evl~ 775 (791)
|++|+++
T Consensus 313 ta~e~l~ 319 (330)
T 3nsz_A 313 TAREAME 319 (330)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.58 Aligned_cols=259 Identities=16% Similarity=0.218 Sum_probs=200.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC-CCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH-PNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+++.||||++...... +++.+|+++++.++| ++|..+..++...+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 46899999999999995 67999999987654332 457889999999987 55666666667778889999999 999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe---cCCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+++..... .+++.+++.|+.||+.||+|||+.|||||||||+|||+ +.++.+||+|||+++.+........
T Consensus 89 L~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 89 LEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 9999875432 39999999999999999999999999999999999999 6889999999999987654322111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 165 ~-----------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 165 I-----------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp C-----------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred c-----------------------------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 0 01122345699999999999999999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccc-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEG-KEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
....... .....+........... ....+.++.+++..||+.||++||++.+|++.|+++
T Consensus 216 ~~~~~~~------~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 216 LKAGTKK------QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CCCSSHH------HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccchhHH------HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 4221111 11112222221111110 011346789999999999999999999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=338.03 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=181.9
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-h-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-V-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
....||+|+||.||+|+. .+|+.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 356899999999999995 579999999997642 2 222334455556888899999999999999999999999997
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|+|.+++....... ..+++..++.|+.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~l~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 165 (290)
T 3fme_A 90 TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--- 165 (290)
T ss_dssp EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------------
T ss_pred cchHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---
Confidence 58888776532211 2499999999999999999999997 999999999999999999999999999986543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc----cCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL----RSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....||+.|+|||++ .+..++.++||||||+++|||++|+.
T Consensus 166 ----------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (290)
T 3fme_A 166 ----------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211 (290)
T ss_dssp --------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred ----------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1123489999999996 56678999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||..... .............. ... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 212 p~~~~~~--------~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 212 PYDSWGT--------PFQQLKQVVEEPSP-QLP-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SSCCCSC--------HHHHHHHHHHSCCC-CCC-TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CccccCc--------hHHHHHHHhccCCC-Ccc-cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9954211 11111111111111 111 1124567889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.68 Aligned_cols=252 Identities=19% Similarity=0.322 Sum_probs=190.0
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCc------eEEEEe
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE------KLIIYD 551 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lv~e 551 (791)
...++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .++|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 34578999999999999987777799998865422 22469999999999999999999976543 789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-CCCCeEEeccCcccccCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~ 630 (791)
|++++.+.......... ..+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++......
T Consensus 119 ~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLK--QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CCSEEHHHHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccCccHHHHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 99875444433322212 2499999999999999999999999999999999999999 78999999999998764221
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~ 709 (791)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 197 ~-------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 197 P-------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp C-------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred C-------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 1 1234589999999998764 5899999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHH--------------hh-hcCcc----------chHHHHHHHHHHHhhccCCCC
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADA--------------AI-RADFE----------GKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------~~-~~~~~----------~~~~~~~~l~~li~~cl~~dP 764 (791)
.||.+.... .....+... .. ...++ ........+.+|+.+||+.||
T Consensus 240 ~pf~~~~~~---------~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (394)
T 4e7w_A 240 PLFPGESGI---------DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310 (394)
T ss_dssp CSSCCSSHH---------HHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred CCCCCCCHH---------HHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCCh
Confidence 999654211 001111110 00 00000 000134578999999999999
Q ss_pred CCCCCHHHHHHH--hccCC
Q 003847 765 QKRPSMKEALQA--LEKIP 781 (791)
Q Consensus 765 ~~RPs~~evl~~--L~~i~ 781 (791)
++|||+.|+++. ++++.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 311 SARLTAIEALCHPFFDELR 329 (394)
T ss_dssp GGSCCHHHHHTSGGGSTTT
T ss_pred hhCCCHHHHhcChhhhhhc
Confidence 999999999974 55543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.92 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=186.5
Q ss_pred hhcceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEE
Q 003847 477 KASAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLII 549 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv 549 (791)
+...++||+|+||.||+|+. .+|+.||||++..... ...+|++++++++|||||+++++|...+ ..++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 34457899999999999996 4699999999865422 2347999999999999999999986432 35789
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTG 628 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~ 628 (791)
|||+++ +|.+.+...... ...+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCE-EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred hhcccc-cHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 999975 666665432111 1249999999999999999999999999999999999999965 5689999999987542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ellt 707 (791)
... .....||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 210 ~~~-------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 210 GEP-------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp TCC-------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCC-------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 211 1234589999999998764 78999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHh----------hhcC-----cc----------chHHHHHHHHHHHhhccCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAA----------IRAD-----FE----------GKEEALLSCFKLGYSCASP 762 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~----------~~~~~~~~l~~li~~cl~~ 762 (791)
|+.||.+.... ....+++... .... ++ ........+.+|+.+||..
T Consensus 253 G~~pf~~~~~~---------~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 253 GQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp SSCSSCCSSHH---------HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCCCCCHH---------HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence 99999654211 0111111100 0000 00 0011246789999999999
Q ss_pred CCCCCCCHHHHHH
Q 003847 763 LPQKRPSMKEALQ 775 (791)
Q Consensus 763 dP~~RPs~~evl~ 775 (791)
||++|||+.|+++
T Consensus 324 dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 324 TPTARLTPLEACA 336 (420)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhHCCCHHHHhC
Confidence 9999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=345.56 Aligned_cols=257 Identities=20% Similarity=0.250 Sum_probs=193.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~e~ 552 (791)
...||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 46899999999999995 47899999999754 333457789999999999999999999999765 368999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
++ ++|.+++... .+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 96 5999988653 2899999999999999999999999999999999999999999999999999876432111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 185 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 231 (364)
T 3qyz_A 185 T---------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231 (364)
T ss_dssp C---------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred c---------------------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCC
Confidence 0 01223469999999998754 4589999999999999999999999
Q ss_pred hhccccCCCCcchhc------hh--------HHHHHHHHhhhcC-cc---chHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 712 VVDELGQGNGLLVED------KN--------RAIRLADAAIRAD-FE---GKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 712 f~~~~~~~~~~~~~~------~~--------~~~~~~~~~~~~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
|...........+.. .. ............. .+ ........+.+|+.+||+.||++|||+.|+
T Consensus 232 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 232 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp SCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 965422110000000 00 0000000000000 00 001124568899999999999999999999
Q ss_pred HHH
Q 003847 774 LQA 776 (791)
Q Consensus 774 l~~ 776 (791)
++.
T Consensus 312 l~h 314 (364)
T 3qyz_A 312 LAH 314 (364)
T ss_dssp HTS
T ss_pred hcC
Confidence 873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.43 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=177.1
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEEE
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~ 550 (791)
...||+|+||.||+|. ..+|+.||||++... .....+.+.+|++++++++||||+++++++... ...|+|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 4689999999999998 457899999999753 334456788999999999999999999998754 5679999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +++|.+++... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 114 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp ECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred ccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 999 78999887652 3999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 186 --------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 186 --------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp -------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 112358999999999877 67899999999999999999999
Q ss_pred cchhccccCCCCcchhc--------------hhHHHHHHHHhhhc--Cccch---HHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 710 VIVVDELGQGNGLLVED--------------KNRAIRLADAAIRA--DFEGK---EEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~--~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
.||.+.........+.. ......... .+.. ..... ......+.+|+.+||..||++|||+
T Consensus 228 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~ 306 (367)
T 2fst_X 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306 (367)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence 99965321000000000 000000000 0000 00000 0123568899999999999999999
Q ss_pred HHHHHH
Q 003847 771 KEALQA 776 (791)
Q Consensus 771 ~evl~~ 776 (791)
.|+++.
T Consensus 307 ~e~L~h 312 (367)
T 2fst_X 307 AQALAH 312 (367)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.79 Aligned_cols=245 Identities=20% Similarity=0.312 Sum_probs=189.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEc------cCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWG------VDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~~~~~lv~e 551 (791)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 46899999999999995 5789999999865433 346789999999999 79999999999987 457899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++...... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 108 ~~~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 184 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184 (326)
T ss_dssp CCTTEEHHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred cCCCCcHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence 99999999999865322 389999999999999999999999999999999999999999999999999876542110
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHH
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~ell 706 (791)
......||+.|+|||++. +..++.++|||||||++|||+
T Consensus 185 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 185 ------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp ------------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred ------------------------------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 011235899999999986 567899999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|+.||.+... ......+..... ... .....+..+.+++.+||..||++||++.|+++
T Consensus 229 ~g~~p~~~~~~---------~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 229 EGAPPLCDMHP---------MRALFLIPRNPA-PRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSSCTTTTSCH---------HHHHHHHHHSCC-CCC-SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCcH---------HHHHHHhhcCcc-ccC-CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99999854311 011111111100 111 01113467889999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=355.01 Aligned_cols=249 Identities=14% Similarity=0.009 Sum_probs=177.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHHHHHHHHHhcc--CCCCcccee-------eEEEcc--
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDFETQVRVIAKL--VHPNLVRIR-------GFYWGV-- 543 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~~~~-- 543 (791)
..+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 457899999999999995 4799999999977432 3345677885544444 699988755 444433
Q ss_pred ---------------CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCeecCC
Q 003847 544 ---------------DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEAR------LKIAKGVARGLAFLHEKKHVHGNL 602 (791)
Q Consensus 544 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~gL~yLH~~~ivHrDl 602 (791)
...|+||||++ |+|.+++..... .+++..+ ..++.||+.||+|||++||+||||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 23799999998 899999987532 1455555 778899999999999999999999
Q ss_pred CCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcc
Q 003847 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPE 682 (791)
Q Consensus 603 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE 682 (791)
||+|||++.++.+||+|||+++....... ...||+.|+|||
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~---------------------------------------~~~~t~~y~aPE 261 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGP---------------------------------------ASSVPVTYAPRE 261 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEE---------------------------------------GGGSCGGGCCHH
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCcc---------------------------------------CccCCcCCcChh
Confidence 99999999999999999999986542110 122668899999
Q ss_pred cccC--CCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhcc
Q 003847 683 SLRS--IKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA 760 (791)
Q Consensus 683 ~~~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 760 (791)
++.+ ..++.++|||||||++|||++|+.||................ ... ......++.....+..+.+|+.+||
T Consensus 262 ~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL--RVP--GTDSLAFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp HHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCT--TSC--CCCSCCCTTSSCCCHHHHHHHHHHT
T ss_pred hccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhh--hhc--cccccchhhccCCCHHHHHHHHHHc
Confidence 9987 779999999999999999999999997653321111100000 000 0000011111124567889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 003847 761 SPLPQKRPSMKEALQ 775 (791)
Q Consensus 761 ~~dP~~RPs~~evl~ 775 (791)
+.||++|||+.|+++
T Consensus 338 ~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 338 NFDRRRRLLPLEAME 352 (371)
T ss_dssp CSSTTTCCCHHHHTT
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.44 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=188.9
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEE--------------ccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW--------------GVD 544 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--------------~~~ 544 (791)
.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++. +.+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 468999999999999965 58999999998776666788999999999999999999999874 335
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-CCCCeEEeccCcc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLE 623 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-~~~~~kL~DFGla 623 (791)
..++||||++ |+|.+++... ++++..++.++.|++.||+|||+.||+||||||+||+++ +++.+||+|||++
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 7799999997 6999988542 389999999999999999999999999999999999997 5678999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVIL 702 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil 702 (791)
+......... .......||..|+|||++.+ ..++.++||||||+++
T Consensus 169 ~~~~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 169 RIMDPHYSHK---------------------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp BCC-----------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred cccCCCcccc---------------------------------cccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 8764321110 01122347889999998865 6789999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchh------chhHHHHHH-------HHhhhcCccc----hHHHHHHHHHHHhhccCCCCC
Q 003847 703 LELLTGKVIVVDELGQGNGLLVE------DKNRAIRLA-------DAAIRADFEG----KEEALLSCFKLGYSCASPLPQ 765 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~ 765 (791)
|||++|+.||...........+. ......++. .......... ....+..+.+++.+||+.||+
T Consensus 216 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (320)
T 2i6l_A 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295 (320)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc
Confidence 99999999996542110000000 000000000 0000000000 011346788999999999999
Q ss_pred CCCCHHHHHHH--hccC
Q 003847 766 KRPSMKEALQA--LEKI 780 (791)
Q Consensus 766 ~RPs~~evl~~--L~~i 780 (791)
+|||++|+++. ++.+
T Consensus 296 ~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 296 DRLTAEEALSHPYMSIY 312 (320)
T ss_dssp GSCCHHHHHTSHHHHTT
T ss_pred ccCCHHHHhCCcccccc
Confidence 99999999873 4443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.52 Aligned_cols=249 Identities=16% Similarity=0.229 Sum_probs=193.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-----------CCCccceeeEEEccC---
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-----------HPNLVRIRGFYWGVD--- 544 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~~--- 544 (791)
.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++ |+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 46899999999999995 578999999997643 23467889999999886 899999999998654
Q ss_pred -ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEec------CCCCeE
Q 003847 545 -EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLG------NDMEPK 616 (791)
Q Consensus 545 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~------~~~~~k 616 (791)
..++||||+ +++|.+++...... .+++..+..|+.||+.||+|||++ ||+||||||+|||++ ..+.+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEHR---GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhcc---CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence 689999999 89999998875432 389999999999999999999998 999999999999994 445799
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||+++..... .....||+.|+|||++.+..++.++|||
T Consensus 179 l~Dfg~a~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 219 (373)
T 1q8y_A 179 IADLGNACWYDEH---------------------------------------YTNSIQTREYRSPEVLLGAPWGCGADIW 219 (373)
T ss_dssp ECCCTTCEETTBC---------------------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHH
T ss_pred EcccccccccCCC---------------------------------------CCCCCCCccccCcHHHhCCCCCchHhHH
Confidence 9999999865421 1123489999999999999999999999
Q ss_pred HHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHH--------------------------------------Hhh
Q 003847 697 SFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLAD--------------------------------------AAI 738 (791)
Q Consensus 697 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~ 738 (791)
||||++|||++|+.||............ .....+.+ ...
T Consensus 220 slG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (373)
T 1q8y_A 220 STACLIFELITGDFLFEPDEGHSYTKDD---DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 296 (373)
T ss_dssp HHHHHHHHHHHSSCCC---------CHH---HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcccccCChH---HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh
Confidence 9999999999999999754322111110 01111110 011
Q ss_pred hcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 739 RADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 739 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.............+.+|+.+||+.||++|||++|+++
T Consensus 297 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 297 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 1122233456788999999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=343.38 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=188.8
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 549 (791)
..+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++...+ .++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 356899999999999995 4689999999865321 22345889999999999999999999987654 8999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCccccc
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLV 626 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~ 626 (791)
|||+++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++..
T Consensus 93 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 99999999999886543 3899999999999999999999999999999999999987654 999999999876
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~ 703 (791)
..... .....||+.|+|||++. ...++.++|||||||++|
T Consensus 168 ~~~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 210 (322)
T 2ycf_A 168 GETSL-------------------------------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210 (322)
T ss_dssp CCCHH-------------------------------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHH
T ss_pred ccccc-------------------------------------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHH
Confidence 42210 01124889999999974 567899999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||++|+.||........ ............. ......+..+.+++.+||+.||++||++.|+++
T Consensus 211 ~l~~g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 211 ICLSGYPPFSEHRTQVS---------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHSSCSSCSTTCSSC---------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCcccchHHH---------HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99999999965322111 0111110000000 001123467889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.34 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=187.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc--------------
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-------------- 543 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------------- 543 (791)
..+.||+|+||.||+|+. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 356899999999999984 6799999999865432 234799999999999999999998543
Q ss_pred ------------------------CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Q 003847 544 ------------------------DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599 (791)
Q Consensus 544 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivH 599 (791)
...++||||++ |+|.+.+....... ..+++..++.++.||+.||+|||+.||+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi~H 164 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG-RSIPMNLISIYIYQLFRAVGFIHSLGICH 164 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCcCcc
Confidence 23789999997 58888776532111 24999999999999999999999999999
Q ss_pred cCCCCCCeEec-CCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcc
Q 003847 600 GNLKPRNVLLG-NDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPY 678 (791)
Q Consensus 600 rDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 678 (791)
|||||+|||++ .++.+||+|||+++....... .....||+.|
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------~~~~~~t~~y 207 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------SVAYICSRFY 207 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-------------------------------------CCCCCCCSSC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-------------------------------------CcCcccCCCc
Confidence 99999999998 688999999999987643211 1233589999
Q ss_pred cCcccccCC-CCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhh----------hcC-----c
Q 003847 679 HAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAI----------RAD-----F 742 (791)
Q Consensus 679 ~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~ 742 (791)
+|||++.+. .++.++||||+||++|||++|+.||.+.... .....+..... ... +
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 278 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI---------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRF 278 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHHHCCCCHHHHHHHCTTC--CCC
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCHHHHHHhCcccccccC
Confidence 999998764 4899999999999999999999999654211 00111110000 000 0
Q ss_pred -----c-----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 743 -----E-----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 743 -----~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00113456889999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.87 Aligned_cols=244 Identities=24% Similarity=0.300 Sum_probs=195.8
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 468999999999999964 7899999998653 2234578899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC---CCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND---MEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++........
T Consensus 107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-- 179 (287)
T 2wei_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179 (287)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--
Confidence 9999887654 38999999999999999999999999999999999999754 4699999999886543211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 180 -----------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 180 -----------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp -----------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 112237888999999876 48999999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..... .....+.........+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 224 GKNEY---------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSSHH---------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHH---------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 53110 111111111111111111224567889999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.69 Aligned_cols=243 Identities=19% Similarity=0.305 Sum_probs=195.6
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhh-----------------HHHHHHHHHHHhccCCCCccceeeEEE
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDR-----------------FRDFETQVRVIAKLVHPNLVRIRGFYW 541 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~~~~~ 541 (791)
..+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 346899999999999999 89999999986532211 178999999999999999999999999
Q ss_pred ccCceEEEEeccCCCChhHH------HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCC
Q 003847 542 GVDEKLIIYDFVPNGSLANA------RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDME 614 (791)
Q Consensus 542 ~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~ 614 (791)
+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc
Confidence 99999999999999999998 44321 1259999999999999999999999 99999999999999999999
Q ss_pred eEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCC-c
Q 003847 615 PKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNP-K 692 (791)
Q Consensus 615 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-~ 692 (791)
+||+|||++....... .....||+.|+|||++.+. .++. +
T Consensus 191 ~kl~dfg~~~~~~~~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~ 232 (348)
T 2pml_X 191 VKLSDFGESEYMVDKK--------------------------------------IKGSRGTYEFMPPEFFSNESSYNGAK 232 (348)
T ss_dssp EEECCCTTCEECBTTE--------------------------------------ECSSCSCGGGCCGGGGSSCCCEEHHH
T ss_pred EEEecccccccccccc--------------------------------------ccCCCCCcCccCchhhcCCCCCCcch
Confidence 9999999998754321 1123489999999999876 5666 9
Q ss_pred hhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch-------------------HHHHHHHH
Q 003847 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK-------------------EEALLSCF 753 (791)
Q Consensus 693 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~ 753 (791)
+||||||+++|||++|+.||...... .+............+ ......+.
T Consensus 233 ~Di~slG~il~~l~~g~~pf~~~~~~------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 233 VDIWSLGICLYVMFYNVVPFSLKISL------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSCS------------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcH------------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHH
Confidence 99999999999999999999653220 000111111100000 22456788
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 003847 754 KLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 754 ~li~~cl~~dP~~RPs~~evl~ 775 (791)
+++.+||+.||++|||+.|+++
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.39 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=189.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCce------EEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEK------LII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~------~lv 549 (791)
....||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 356899999999999994 56899999999764 333457788999999999999999999999877655 999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+. ++|.+++.. .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 99996 688776532 3899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG 708 (791)
.....||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 198 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 238 (371)
T 4exu_A 198 ---------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238 (371)
T ss_dssp -----------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 112358999999999987 7889999999999999999999
Q ss_pred CcchhccccCCCCcchh--------------chhHHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 709 KVIVVDELGQGNGLLVE--------------DKNRAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
+.||...........+. ................... .......+.+|+.+||+.||++|||+
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 318 (371)
T 4exu_A 239 KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318 (371)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH
Confidence 99996532100000000 0000000000000000000 01124678999999999999999999
Q ss_pred HHHHHH
Q 003847 771 KEALQA 776 (791)
Q Consensus 771 ~evl~~ 776 (791)
.|+++.
T Consensus 319 ~ell~h 324 (371)
T 4exu_A 319 AQALTH 324 (371)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=369.25 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=200.5
Q ss_pred hhcceeccccCceEEEEEEeC----CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 477 KASAYILGASGSSIMYKAVLE----DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
+...+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence 445678999999999999853 2568999998764 3344578999999999999999999999984 567899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++|+|.+++..... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 471 ~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp CCTTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred cCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 9999999999876532 389999999999999999999999999999999999999999999999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~ 710 (791)
. ......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 547 ~-----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 547 Y-----------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp ------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred e-----------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 0 0112336788999999998899999999999999999997 888
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||.+.... .....+.. ... .+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 592 Pf~~~~~~---------~~~~~i~~-~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 592 PFQGVKNN---------DVIGRIEN-GER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTTTCCHH---------HHHHHHHH-TCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHH---------HHHHHHHc-CCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 98653111 11111111 111 1122234567889999999999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.54 Aligned_cols=255 Identities=19% Similarity=0.211 Sum_probs=186.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCch-----------hhHHHHHHHHHHHhccCCCCccceeeEEEcc-----
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSV-----------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGV----- 543 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 543 (791)
.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 468999999999999988899999999864321 1237899999999999999999999998543
Q ss_pred CceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 544 DEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 544 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
...++||||++ |+|.+++..... .+++..+..|+.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 181 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQRI----VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-
T ss_pred ceEEEEEccCC-CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcc
Confidence 35799999997 688888775432 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVIL 702 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil 702 (791)
+....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 182 ~~~~~~~~-------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 182 REDTADAN-------------------------------------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp ---------------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred cccccccc-------------------------------------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 75432111 123458999999999876 6789999999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhc--------------hhHHHHHHHHhhhcCcc-----chHHHHHHHHHHHhhccCCC
Q 003847 703 LELLTGKVIVVDELGQGNGLLVED--------------KNRAIRLADAAIRADFE-----GKEEALLSCFKLGYSCASPL 763 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~d 763 (791)
|||++|+.||...........+.. ................. ........+.+|+.+||+.|
T Consensus 225 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 999999999965321100000000 00000000000000000 00112356889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003847 764 PQKRPSMKEALQA 776 (791)
Q Consensus 764 P~~RPs~~evl~~ 776 (791)
|++|||+.|+++.
T Consensus 305 P~~Rpt~~ell~h 317 (362)
T 3pg1_A 305 PQRRISTEQALRH 317 (362)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHHcC
Confidence 9999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=338.63 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=195.0
Q ss_pred ceeccccCceEEEEEEe--CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCC------CccceeeEEEccCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL--EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHP------NLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~~~lv~e 551 (791)
.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++.++|+ +|+++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46899999999999985 368999999997643 3356788999999988665 49999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-------------------C
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-------------------D 612 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-------------------~ 612 (791)
|+ +++|.+++...... ++++..+..++.||+.||+|||+.||+||||||+|||++. +
T Consensus 98 ~~-~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~ 173 (339)
T 1z57_A 98 LL-GLSTYDFIKENGFL---PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173 (339)
T ss_dssp CC-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESC
T ss_pred CC-CCCHHHHHHhcCCC---CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccC
Confidence 99 89999998765432 4899999999999999999999999999999999999987 6
Q ss_pred CCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
+.+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 174 ~~~kl~Dfg~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 214 (339)
T 1z57_A 174 PDIKVVDFGSATYDDEH---------------------------------------HSTLVSTRHYRAPEVILALGWSQP 214 (339)
T ss_dssp CCEEECCCSSCEETTSC---------------------------------------CCSSCSCGGGCCHHHHTTSCCCTH
T ss_pred CCceEeeCcccccCccc---------------------------------------cccccCCccccChHHhhCCCCCcc
Confidence 68999999998764321 112358999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCcchhccccCCCCcchhc----------------------------hhHHHHHHHHh---hhcC
Q 003847 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVED----------------------------KNRAIRLADAA---IRAD 741 (791)
Q Consensus 693 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~---~~~~ 741 (791)
+|||||||++|||++|+.||...........+.. ........... ....
T Consensus 215 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (339)
T 1z57_A 215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294 (339)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence 9999999999999999999864321100000000 00000000000 0000
Q ss_pred ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 742 FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 742 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
..........+.+|+.+||+.||++|||+.|+++.
T Consensus 295 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 11122356788999999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.16 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=180.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||++++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 356899999999999994 478999999987542 334567889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGS---SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++...... ....+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 178 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC------
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc
Confidence 999998752111 12248999999999999999999999999999999999999999999999999998764322110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||
T Consensus 179 ~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 227 (303)
T 2vwi_A 179 R-------------------------------NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227 (303)
T ss_dssp ----------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred c-------------------------------hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0 001123458999999999875 56899999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhc------CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRA------DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
....... ............ ...........+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 228 HKYPPMK---------VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTSCGGG---------HHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCchhh---------HHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 6532110 000000000000 00000113356889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=344.86 Aligned_cols=257 Identities=19% Similarity=0.261 Sum_probs=193.6
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||.||+|+..+ .||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 35789999999999998753 59999987532 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... .+++..++.++.||+.||+|||+.||+||||||+||+++ ++.+||+|||+++..........
T Consensus 115 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~-- 187 (319)
T 2y4i_B 115 TLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR-- 187 (319)
T ss_dssp EHHHHTTSSCC----CCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------------
T ss_pred cHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc--
Confidence 99998865432 489999999999999999999999999999999999998 67999999999876532111100
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---------CCCCCchhhHHHHHHHHHHHh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---------IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---------~~~~~~sDvwSlGvil~ellt 707 (791)
........||+.|+|||++.+ ..++.++||||||+++|||++
T Consensus 188 -----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 188 -----------------------------EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp -----------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 011123348999999999874 457889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSP 784 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 784 (791)
|+.||...... .....+.. ....... ....+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 239 g~~p~~~~~~~---------~~~~~~~~-~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 239 REWPFKTQPAE---------AIIWQMGT-GMKPNLS-QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp SSCSSSSCCHH---------HHHHHHHT-TCCCCCC-CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCCCHH---------HHHHHhcc-CCCCCCC-cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999653211 01111111 1111111 1113456889999999999999999999999999987554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.06 Aligned_cols=249 Identities=20% Similarity=0.219 Sum_probs=170.2
Q ss_pred hhcceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEe
Q 003847 477 KASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYD 551 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e 551 (791)
....++||+|+||.||+|+.. +|+.||||++..... ........++.++||||+++++++.. ....++|||
T Consensus 31 ~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 31 QLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 333568999999999999965 799999999965421 12222334566799999999999976 445799999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~ 628 (791)
|+++|+|.+++...... .+++.+++.|+.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++....
T Consensus 107 ~~~gg~L~~~l~~~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQ---AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CC---CCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred ccCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999999999865432 4999999999999999999999999999999999999976 45599999999986542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
.. .....||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 184 ~~--------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (336)
T 3fhr_A 184 NA--------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225 (336)
T ss_dssp ----------------------------------------------------------CHHHHHHHHHHHHHHHHHHHHS
T ss_pred cc--------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 11 1123489999999999888899999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+.||.............. .+.........+........+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 226 FPPFYSNTGQAISPGMKR-----RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp SCCC--------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCccchhhhhhHHH-----hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999966433221111000 00000000001111224567889999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=335.59 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=192.1
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccC--CCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLV--HPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
...||+|+||.||++...+++.||||++... .....+.+.+|++++++++ |+||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999888999999998653 3445678999999999997 5999999999999999999999 558
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||++++ +.+||+|||+++.........
T Consensus 112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~-- 183 (313)
T 3cek_A 112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV-- 183 (313)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc--
Confidence 89999988653 3899999999999999999999999999999999999965 799999999998664321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-----------CCCCCchhhHHHHHHHHH
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-----------IKPNPKWDVYSFGVILLE 704 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~~sDvwSlGvil~e 704 (791)
......||+.|+|||++.+ ..++.++||||||+++||
T Consensus 184 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 231 (313)
T 3cek_A 184 --------------------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231 (313)
T ss_dssp --------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHH
T ss_pred --------------------------------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHH
Confidence 1123458999999999875 468889999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|++|+.||..... .........+......++. .....+.+++.+||+.||++||++.|+++.
T Consensus 232 l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 232 MTYGKTPFQQIIN--------QISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHSSCTTTTCCS--------HHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCchhhHHH--------HHHHHHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 9999999964311 1111222222222211211 134578899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=332.02 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=186.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc-------------cC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-------------VD 544 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------------~~ 544 (791)
....||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++||||+++++++.+ .+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 346899999999999995 57999999999653 3345788999999999999999999998865 35
Q ss_pred ceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccc
Q 003847 545 EKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624 (791)
Q Consensus 545 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~ 624 (791)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ceEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 67999999999999999976432 37889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHH
Q 003847 625 LVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILL 703 (791)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ 703 (791)
............. ..............||+.|+|||++.+. .++.++|||||||++|
T Consensus 165 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (303)
T 1zy4_A 165 NVHRSLDILKLDS----------------------QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222 (303)
T ss_dssp CTTC-----------------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHH
T ss_pred hcccccchhcccc----------------------ccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHH
Confidence 7653221100000 0000011122345689999999999764 6899999999999999
Q ss_pred HHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 704 ELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 704 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||++ ||.... ........+...............+..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~l~~---p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 223 EMIY---PFSTGM--------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHS---CCSSHH--------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh---ccCCch--------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 9998 332110 000001111110000000111224456889999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=340.11 Aligned_cols=267 Identities=21% Similarity=0.232 Sum_probs=195.5
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~e~ 552 (791)
...||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 468999999999999954 6899999999754 333456788999999999999999999988754 678999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+. ++|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 96 6999988763 3899999999999999999999999999999999999999999999999999876533211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 169 ~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 169 NSEPT--------------------------GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp -------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcc--------------------------ccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 10000 00011234569999999998764 6789999999999999999999999
Q ss_pred hhccccCC----------------CCcchhchhHHHHHHHHhhhcCccc----hHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 712 VVDELGQG----------------NGLLVEDKNRAIRLADAAIRADFEG----KEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 712 f~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
|.+..... ....... ....+............ .......+.+++.+||+.||++|||+.
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIES-PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCSTTTTTTCCC-HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcHHHHHHHHHHhCCCchhcccccccc-chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 96532100 0000000 00011111000000000 012345788999999999999999999
Q ss_pred HHHHH--hccC
Q 003847 772 EALQA--LEKI 780 (791)
Q Consensus 772 evl~~--L~~i 780 (791)
|+++. ++.+
T Consensus 302 ell~hp~~~~~ 312 (353)
T 2b9h_A 302 EALEHPYLQTY 312 (353)
T ss_dssp HHHTSGGGTTT
T ss_pred HHhcCcccccc
Confidence 99973 5544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.47 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=178.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-------eEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE-------KLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-------~~lv~e 551 (791)
.+.||+|+||.||+|+. .+|+.||||++...... ...+.+|++.++.++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 46899999999999996 46899999998654322 2456778888899999999999999976544 789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCeecCCCCCCeEecC-CCCeEEeccCcccccCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH--EKKHVHGNLKPRNVLLGN-DMEPKIGDFGLERLVTG 628 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~ 628 (791)
|+++ +|.+.+...... ...+++..+..++.|++.||+||| +.||+||||||+|||++. ++.+||+|||+++....
T Consensus 107 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184 (360)
T ss_dssp CCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT
T ss_pred cccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC
Confidence 9976 555544432211 124899999999999999999999 999999999999999996 89999999999986643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ellt 707 (791)
... .....||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 185 ~~~-------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~ 227 (360)
T 3e3p_A 185 SEP-------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227 (360)
T ss_dssp TSC-------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCC-------------------------------------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 211 1234589999999998654 48999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHh----------h-h----------cCc-------cchHHHHHHHHHHHhhc
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAA----------I-R----------ADF-------EGKEEALLSCFKLGYSC 759 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~-~----------~~~-------~~~~~~~~~l~~li~~c 759 (791)
|+.||...... .....+.... + . ... .........+.+|+.+|
T Consensus 228 g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 228 GEPIFRGDNSA---------GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp SSCSSCCSSHH---------HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred CCCCcCCCChH---------HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 99999653211 0011111000 0 0 000 00001356789999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 003847 760 ASPLPQKRPSMKEALQA 776 (791)
Q Consensus 760 l~~dP~~RPs~~evl~~ 776 (791)
|+.||++|||+.|+++.
T Consensus 299 L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCH 315 (360)
T ss_dssp TCSSGGGSCCHHHHTTS
T ss_pred hccCccccCCHHHHhcC
Confidence 99999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.37 Aligned_cols=192 Identities=21% Similarity=0.282 Sum_probs=164.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CC-----CccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HP-----NLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|+. .+++.||||+++... ...+++..|+++++.++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 46899999999999995 468999999997543 33467788999998885 55 499999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCeecCCCCCCeEec--CCCCeEEeccCcccccCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH--EKKHVHGNLKPRNVLLG--NDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~ 628 (791)
++ ++|.+++...... .+++..++.++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++....
T Consensus 138 ~~-~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp CC-CBHHHHHHHTTTS---CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred CC-CCHHHHHhhcCcC---CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 95 5999998875432 3899999999999999999999 47999999999999994 578899999999987542
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
. .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 214 ~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 214 R---------------------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp C---------------------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred c---------------------------------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1 1124589999999999999999999999999999999999
Q ss_pred Ccchhcc
Q 003847 709 KVIVVDE 715 (791)
Q Consensus 709 ~~pf~~~ 715 (791)
+.||...
T Consensus 255 ~~pf~~~ 261 (382)
T 2vx3_A 255 EPLFSGA 261 (382)
T ss_dssp SCSSCCS
T ss_pred CCCCCCC
Confidence 9999653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.09 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=190.9
Q ss_pred cceeccccCceEEEEEEe--CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhcc---CCCCccceeeEEE-----ccCce
Q 003847 479 SAYILGASGSSIMYKAVL--EDGTALAVRRIGENSV--DRFRDFETQVRVIAKL---VHPNLVRIRGFYW-----GVDEK 546 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~-----~~~~~ 546 (791)
....||+|+||.||+|+. .+|+.||||++..... .....+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 346899999999999996 4689999999864321 1123566777777666 8999999999987 55678
Q ss_pred EEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 547 LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 547 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
++||||++ |+|.+++...... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred EEEEecCC-CCHHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 99999997 6999998765432 3899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 171 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 213 (326)
T 1blx_A 171 SFQM-------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213 (326)
T ss_dssp CGGG-------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cCCC-------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 3211 011235899999999999989999999999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhc----------------------C-ccchHHHHHHHHHHHhhccCCC
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRA----------------------D-FEGKEEALLSCFKLGYSCASPL 763 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~-~~~~~~~~~~l~~li~~cl~~d 763 (791)
+|+.||...... .....+.+..... . ..........+.+|+.+||+.|
T Consensus 214 ~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (326)
T 1blx_A 214 RRKPLFRGSSDV---------DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284 (326)
T ss_dssp HSSCSCCCSSHH---------HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred cCCCCCCCCCHH---------HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC
Confidence 999999653210 0111111100000 0 0000113456789999999999
Q ss_pred CCCCCCHHHHHH
Q 003847 764 PQKRPSMKEALQ 775 (791)
Q Consensus 764 P~~RPs~~evl~ 775 (791)
|++|||+.|+++
T Consensus 285 P~~Rpt~~e~l~ 296 (326)
T 1blx_A 285 PAKRISAYSALS 296 (326)
T ss_dssp TTTSCCHHHHHT
T ss_pred cccCCCHHHHhc
Confidence 999999999995
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=348.74 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=184.1
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+.+..|+||||+. |
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 34578999999997665566899999999976433 2356899999999 79999999999999999999999996 6
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-----CCCeEEeccCcccccCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-----DMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~~~~~~~ 631 (791)
+|.+++...... ..+..+..|+.||+.||+|||+.||+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 TLQEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EHHHHHHSSSCC----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CHHHHHHhcCCC----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999998765432 455567899999999999999999999999999999953 33588999999987643211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc---CCCCCCchhhHHHHHHHHHHHh-
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR---SIKPNPKWDVYSFGVILLELLT- 707 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwSlGvil~ellt- 707 (791)
.. ......+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 179 ~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 179 SF---------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp ----------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred ce---------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 10 1122356999999999997 4567889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|+.||...... .......................+.+|+.+||+.||++|||+.|+++
T Consensus 226 g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 226 GSHPFGKSLQR----------QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SCBTTBSTTTH----------HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcchhhHH----------HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 88888543111 00111110001111112224556789999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.90 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=188.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc------eEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE------KLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~lv~ 550 (791)
...||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46899999999999995 56999999999764 23335678899999999999999999999987654 49999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||++ ++|.+++.. .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 9997 688776532 3899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 180 --------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 180 --------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp ------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence 112348999999999876 67899999999999999999999
Q ss_pred cchhccccCCCCcchhc--------------hhHHHHHHHHhh---hcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGLLVED--------------KNRAIRLADAAI---RADF-EGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~---~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||...........+.. ............ ...+ .........+.+++.+||+.||++|||+.
T Consensus 222 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp CSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 99965321000000000 000000000000 0000 00112356789999999999999999999
Q ss_pred HHHHH
Q 003847 772 EALQA 776 (791)
Q Consensus 772 evl~~ 776 (791)
|+++.
T Consensus 302 e~l~h 306 (353)
T 3coi_A 302 QALTH 306 (353)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.11 Aligned_cols=235 Identities=19% Similarity=0.306 Sum_probs=192.3
Q ss_pred cceeccccCceEEEEEE-eCCCcEEEEEEcCCCchh------hHHHHHHHHHHHhccC--CCCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAV-LEDGTALAVRRIGENSVD------RFRDFETQVRVIAKLV--HPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv 549 (791)
..+.||+|+||.||+|+ ..+++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 34689999999999998 457899999999654221 2245678999999996 59999999999999999999
Q ss_pred EeccCC-CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-CCCCeEEeccCcccccC
Q 003847 550 YDFVPN-GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERLVT 627 (791)
Q Consensus 550 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~ 627 (791)
|||+.+ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+++...
T Consensus 127 ~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 127 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 999976 89999988754 389999999999999999999999999999999999999 78899999999998764
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELL 706 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~ell 706 (791)
... .....||+.|+|||++.+..+ +.++||||||+++|||+
T Consensus 202 ~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 202 DTV--------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp SSC--------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred ccc--------------------------------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 211 112348999999999987665 68899999999999999
Q ss_pred hCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 707 TGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 707 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+|+.||.... .... ............+.+++.+||+.||++|||++|+++
T Consensus 244 ~g~~pf~~~~---------------~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 244 CGDIPFEHDE---------------EIIR----GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HSSCSCCSHH---------------HHHH----CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HCCCCCCChh---------------hhhc----ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999985421 0111 111111123467889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=336.17 Aligned_cols=236 Identities=21% Similarity=0.325 Sum_probs=188.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchh------hHHHHHHHHHHHhcc----CCCCccceeeEEEccCceE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVD------RFRDFETQVRVIAKL----VHPNLVRIRGFYWGVDEKL 547 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~~~~~~~~~~ 547 (791)
..+.||+|+||.||+|+. .+++.||||++...... ....+.+|+++++++ +|+||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 356899999999999984 57899999999764321 223456789999988 8999999999999999999
Q ss_pred EEEec-cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec-CCCCeEEeccCcccc
Q 003847 548 IIYDF-VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG-NDMEPKIGDFGLERL 625 (791)
Q Consensus 548 lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~ 625 (791)
+|||| +.+++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++ .++.+||+|||+++.
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 99999 78999999998754 389999999999999999999999999999999999999 889999999999987
Q ss_pred cCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHH
Q 003847 626 VTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLE 704 (791)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~e 704 (791)
..... .....||..|+|||++.+..+ +.++||||||+++||
T Consensus 190 ~~~~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 231 (312)
T 2iwi_A 190 LHDEP--------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231 (312)
T ss_dssp CCSSC--------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred cccCc--------------------------------------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence 64321 112348999999999977666 458999999999999
Q ss_pred HHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 705 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|++|+.||.... ..... ...........+.+++.+||+.||++|||++|+++.
T Consensus 232 l~~g~~pf~~~~---------------~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 232 MVCGDIPFERDQ---------------EILEA----ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHSSCSCCSHH---------------HHHHT----CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCCChH---------------HHhhh----ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999985421 11111 111112245678899999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=336.26 Aligned_cols=252 Identities=18% Similarity=0.246 Sum_probs=191.9
Q ss_pred ceeccccCceEEEEEEeC-CC-cEEEEEEcCCCchhhHHHHHHHHHHHhccCCCC------ccceeeEEEccCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE-DG-TALAVRRIGENSVDRFRDFETQVRVIAKLVHPN------LVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~~lv~e 551 (791)
.+.||+|+||.||+|... ++ +.||||+++... ...+.+.+|++++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 468999999999999953 44 799999997643 33467889999999997665 9999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEe-------------------cCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLL-------------------GND 612 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl-------------------~~~ 612 (791)
|+ +++|.+++...... .+++.+++.|+.||+.||+|||+.||+||||||+|||+ +.+
T Consensus 103 ~~-~~~l~~~l~~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 178 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178 (355)
T ss_dssp CC-CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC
T ss_pred cc-CCChHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCC
Confidence 99 66777777654322 38999999999999999999999999999999999999 567
Q ss_pred CCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
+.+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 179 ~~~kl~Dfg~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~ 219 (355)
T 2eu9_A 179 TSIRVADFGSATFDHEH---------------------------------------HTTIVATRHYRPPEVILELGWAQP 219 (355)
T ss_dssp CCEEECCCTTCEETTSC---------------------------------------CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred CcEEEeecCcccccccc---------------------------------------ccCCcCCCcccCCeeeecCCCCCc
Confidence 89999999999764321 112458999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCcchhccccCCCCcchhc----------------------------hhHHHHHHHHh---hhcC
Q 003847 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVED----------------------------KNRAIRLADAA---IRAD 741 (791)
Q Consensus 693 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~---~~~~ 741 (791)
+|||||||++|||++|+.||...........+.. ........... ....
T Consensus 220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (355)
T 2eu9_A 220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence 9999999999999999999965321100000000 00000000000 0000
Q ss_pred ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 742 FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 742 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0111224568899999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=337.46 Aligned_cols=250 Identities=23% Similarity=0.293 Sum_probs=174.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHH-HHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVR-VIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
....||+|+||.||+|.. .+|+.||||++.... .....++..|+. +++.++||||+++++++...+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 356899999999999996 479999999997642 333445666666 67778999999999999999999999999975
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|.+++..........+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 181 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--- 181 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---
Confidence 888877643221122489999999999999999999998 999999999999999999999999999976542211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc----cCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL----RSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....||+.|+|||++ .+..++.++||||||+++|||++|+.
T Consensus 182 ----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 182 ----------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp ----------------------------------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred ----------------------------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 1122489999999998 45678999999999999999999999
Q ss_pred chhccccC--CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQ--GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||...... .......... +.+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 228 pf~~~~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 228 PYPKWNSVFDQLTQVVKGDP-------PQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCC-------CCCCCSCC-------CCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchHHHHHHHHhcCCC-------CCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99653211 0000000000 00000 000113467889999999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=349.37 Aligned_cols=249 Identities=22% Similarity=0.260 Sum_probs=184.4
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..|+||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 46899999999987777789999999986542 35678899999886 89999999999999999999999995 699
Q ss_pred hHHHHhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-------------CCeEEeccCcc
Q 003847 559 ANARYRKMGSSP--CHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-------------MEPKIGDFGLE 623 (791)
Q Consensus 559 ~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-------------~~~kL~DFGla 623 (791)
.+++........ ...++..++.|+.||+.||+|||+.||+||||||+|||++.+ +.+||+|||++
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 999976543211 011334567899999999999999999999999999999754 47999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-------CCCCCchhhH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-------IKPNPKWDVY 696 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvw 696 (791)
+.......... ......+||+.|+|||++.+ ..++.++|||
T Consensus 176 ~~~~~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 176 KKLDSGQSSFR--------------------------------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp EECCC----------------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred eecCCCCccce--------------------------------eeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 87653221100 01123469999999999975 6789999999
Q ss_pred HHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhh-c--CccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 697 SFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIR-A--DFEGKEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 697 SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
||||++|||++ |+.||.+.... . ..+...... . ...........+.+++.+||+.||++|||+.|
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~-------~----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSR-------E----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTH-------H----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hHHHHHHHHHhCCCCCCCCchhh-------H----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence 99999999999 89998543211 0 111111100 0 00112345678899999999999999999999
Q ss_pred HHH
Q 003847 773 ALQ 775 (791)
Q Consensus 773 vl~ 775 (791)
+++
T Consensus 293 il~ 295 (434)
T 2rio_A 293 VLR 295 (434)
T ss_dssp HHT
T ss_pred HHh
Confidence 985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.61 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=175.2
Q ss_pred hcceeccccCceEEEEEEeC-CCcEEEEEEcCCCch-hh-HHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 478 ASAYILGASGSSIMYKAVLE-DGTALAVRRIGENSV-DR-FRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.....||+|+||.||+|+.. +|+.||||++..... .. .+.+..+..+++.++||||+++++++...+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34568999999999999964 789999999976432 22 233445556788889999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++.+..+...... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 180 (318)
T 2dyl_A 107 GTCAEKLKKRMQG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-- 180 (318)
T ss_dssp SEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--
Confidence 5555555443322 389999999999999999999995 999999999999999999999999999876542211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhC
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG 708 (791)
.....||+.|+|||++. ...++.++||||||+++|||++|
T Consensus 181 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 181 -----------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp -----------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred -----------------------------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 11234899999999994 56789999999999999999999
Q ss_pred CcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 709 KVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 709 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+.||..... ........... .....+.....+..+.+++.+||+.||.+||+++|+++
T Consensus 226 ~~pf~~~~~--------~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 226 QFPYKNCKT--------DFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCTTTTCCS--------HHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCCc--------cHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 999964211 01111111111 11111111123467889999999999999999999976
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.74 Aligned_cols=255 Identities=30% Similarity=0.560 Sum_probs=205.7
Q ss_pred CCChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCce--eeeeeeCCCCCCCCCCcEEEEEcCCCCCcc--CCCcCCCCC
Q 003847 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCS--WNGVTCASPGEGNNDSRVIGLALPNSQLLG--SIPADLGMI 104 (791)
Q Consensus 29 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~--w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~~~~~~l 104 (791)
.|.++|..||++||.++ .||. .+++|+. +.+||. |.||+|+... ..++|+.|+|++|++.| .+|..|+++
T Consensus 2 ~c~~~~~~aL~~~k~~~-~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~---~~~~l~~L~L~~~~l~~~~~~~~~l~~l 75 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDL-GNPT-TLSSWLP-TTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GGTTCCT-TSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHhc-CCcc-cccCCCC-CCCCCcCCCcceEeCCCC---CCceEEEEECCCCCccCCcccChhHhCC
Confidence 47788999999999998 5776 7899975 468998 9999997321 12689999999999998 889999999
Q ss_pred CCCCEEeCcC-CCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEe
Q 003847 105 EFLQYLDLSN-NSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183 (791)
Q Consensus 105 ~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 183 (791)
++|++|+|++ |.+.+.+|..|.++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 9999999994 889888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCCcCCCCCCCCC---c-ccceeccccccccccCCC-----------------------Cc------------------
Q 003847 184 LKNNYFSDGLPSKF---N-SVQVLDLSSNLINGSLPP-----------------------DI------------------ 218 (791)
Q Consensus 184 L~~N~l~~~~p~~l---~-~L~~L~ls~N~l~~~~p~-----------------------~~------------------ 218 (791)
|++|++++.+|..+ . +|++|+|++|++++.+|. .+
T Consensus 156 L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred CcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceee
Confidence 88888876666443 2 444444444444433222 11
Q ss_pred -----CC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCCCCC
Q 003847 219 -----GG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPC 291 (791)
Q Consensus 219 -----~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c 291 (791)
.. .+|++|+|++|+|+|.+|..+.. +++|++|+|++|+++|.+|....+.++..+.+.+|+++||.|+. .|
T Consensus 236 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGG-CTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ecCcccccCCCCEEECcCCcccCcCChHHhc-CcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 11 36888888888888888988876 99999999999999999999888889999999999999998765 46
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.83 Aligned_cols=223 Identities=12% Similarity=0.100 Sum_probs=178.7
Q ss_pred ceeccccCceEEEEEEeC-CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLE-DGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 368999999999999964 58999999997652 33457899999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
++|.+++... ....++.+|+.|++.||+|||+.||+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 9999998432 3556788999999999999999999999999999999999999998443
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
|++| ++.++|||||||++|||+||+.||...
T Consensus 175 ------------------------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 175 ------------------------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp ------------------------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred ------------------------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3433 688999999999999999999999765
Q ss_pred ccCCCC----cchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 716 LGQGNG----LLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 716 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
...... ......... ..... ...+..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 206 ~~~~~~~~~~~~~~~~~~~----~~~~~------~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 206 GVRSGLAPAERDTAGQPIE----PADID------RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SBCCCSEECCBCTTSCBCC----HHHHC------TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CcchhhHHHHHHhccCCCC----hhhcc------cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 432211 000000000 00000 1134568899999999999999 999999999886443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=354.37 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=193.0
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc------cCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG------VDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~~lv~ 550 (791)
..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 346899999999999995 56899999999764 44445779999999999999999999998765 66779999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCC---eEEeccCcccccC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDME---PKIGDFGLERLVT 627 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~ 627 (791)
||+++|+|.+++....... .+++..++.|+.|++.||+|||+.||+||||||+||+++.++. +||+|||++....
T Consensus 98 Ey~~ggsL~~~L~~~~~~~--~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~ 175 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFENCC--GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175 (676)
T ss_dssp ECCSSCBHHHHHHSSSCTT--CCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTT
T ss_pred EeCCCCCHHHHHHhcccCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccc
Confidence 9999999999988754322 3889999999999999999999999999999999999997665 8999999998654
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
.... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 176 ~~~~-------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 176 QGEL-------------------------------------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp SCCC-------------------------------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred cccc-------------------------------------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 2211 123458999999999999999999999999999999999
Q ss_pred CCcchhcccc--CCCCcchhchhHHHHHHHH----------hhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 708 GKVIVVDELG--QGNGLLVEDKNRAIRLADA----------AIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 708 G~~pf~~~~~--~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
|+.||..... .|.......... ...... ...............+.+++.+||..||++|||+.|+
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKSNE-HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC-------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred CCCCCCcccchhhhhhhhhcccch-hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 9999854211 111111000000 000000 0000001122256788999999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=353.26 Aligned_cols=232 Identities=22% Similarity=0.299 Sum_probs=187.3
Q ss_pred ceeccccCceEEEEEEeC--CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc-----eEEEEe
Q 003847 480 AYILGASGSSIMYKAVLE--DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE-----KLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~~lv~e 551 (791)
...||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++...+. .|+|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 468999999999999964 6899999998654 33445678999999999999999999999988766 699999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++.. .+++.+++.|+.||+.||+|||+.||+||||||+|||++.+ .+||+|||+++.....
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence 9999999887643 39999999999999999999999999999999999999885 8999999999865421
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
....||+.|+|||++.+. ++.++|||||||++|||++|..|
T Consensus 235 --------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~ 275 (681)
T 2pzi_A 235 --------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275 (681)
T ss_dssp --------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCE
T ss_pred --------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCC
Confidence 123589999999998764 48999999999999999999998
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhcc
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-MKEALQALEK 779 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~ 779 (791)
|......... .. .........+.+++.+||+.||++||+ ++++...|..
T Consensus 276 ~~~~~~~~~~----~~---------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 276 RNGRYVDGLP----ED---------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ETTEECSSCC----TT---------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cccccccccc----cc---------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 8654322111 00 001113456789999999999999995 5666665544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.79 Aligned_cols=222 Identities=19% Similarity=0.252 Sum_probs=174.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHH-hccCCCCccceeeEEEc----cCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVI-AKLVHPNLVRIRGFYWG----VDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~lv~e~~ 553 (791)
.++||+|+||.||+|.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 36799999999999995 57899999998643 4567888888 55689999999999987 66789999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~ 630 (791)
++|+|.+++...... .+++..++.++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 999999999875432 4999999999999999999999999999999999999998 7889999999987532
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
+..++.++|||||||++|||++|+.
T Consensus 172 -------------------------------------------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 172 -------------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp -------------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 1235789999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
||............... ......... ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 197 pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 197 PFYSNHGLAISPGMKTR---------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCC-------CCSCCS---------SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCcchhhhHHHHHH---------HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99654321111000000 000000000 1235678899999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=333.69 Aligned_cols=238 Identities=17% Similarity=0.152 Sum_probs=176.3
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCC-CCccce---------eeE------
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVH-PNLVRI---------RGF------ 539 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l---------~~~------ 539 (791)
.++||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+.+++.++| +|.... .+.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 4689999999999999 5679999999997432 2235789999999999987 322111 111
Q ss_pred ------EEc-----cCceEEEEeccCCCChhHHHHhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCC
Q 003847 540 ------YWG-----VDEKLIIYDFVPNGSLANARYRKM--GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRN 606 (791)
Q Consensus 540 ------~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~N 606 (791)
+.. ....+++|+++ +++|.+++.... ......+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~N 241 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccce
Confidence 111 12456777766 689999885321 1111247888999999999999999999999999999999
Q ss_pred eEecCCCCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccc--
Q 003847 607 VLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESL-- 684 (791)
Q Consensus 607 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~-- 684 (791)
||++.++.+||+|||+++..... ....+| +.|+|||++
T Consensus 242 ILl~~~~~~kL~DFG~a~~~~~~---------------------------------------~~~~~g-~~y~aPE~~~~ 281 (413)
T 3dzo_A 242 IVLDQRGGVFLTGFEHLVRDGAS---------------------------------------AVSPIG-RGFAPPETTAE 281 (413)
T ss_dssp EEECTTCCEEECCGGGCEETTEE---------------------------------------ECCCCC-TTTCCHHHHHH
T ss_pred EEEecCCeEEEEeccceeecCCc---------------------------------------cccCCC-CceeCchhhhc
Confidence 99999999999999998865321 112347 889999999
Q ss_pred --------cCCCCCCchhhHHHHHHHHHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHH
Q 003847 685 --------RSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLG 756 (791)
Q Consensus 685 --------~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 756 (791)
.+..++.++|||||||++|||++|+.||........... .+.... ..+..+.+|+
T Consensus 282 ~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-------------~~~~~~----~~~~~~~~li 344 (413)
T 3dzo_A 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-------------IFRSCK----NIPQPVRALL 344 (413)
T ss_dssp HTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------------GGSSCC----CCCHHHHHHH
T ss_pred cccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------------HHhhcc----cCCHHHHHHH
Confidence 556688899999999999999999999966432221111 111111 1345688999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 003847 757 YSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 757 ~~cl~~dP~~RPs~~evl~ 775 (791)
.+||+.||++||++.|+++
T Consensus 345 ~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 345 EGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHTCSSGGGSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHHh
Confidence 9999999999999877753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=321.83 Aligned_cols=235 Identities=13% Similarity=0.086 Sum_probs=178.8
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCc--------hhhHHHHHHHHHHHhccC---------CCCccceeeEE
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENS--------VDRFRDFETQVRVIAKLV---------HPNLVRIRGFY 540 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l~~~~ 540 (791)
...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+++.+++
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3457899999999999998 68999999997542 223477899999998886 66666665553
Q ss_pred -----------------Ec-------------cCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 003847 541 -----------------WG-------------VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLA 590 (791)
Q Consensus 541 -----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~ 590 (791)
.+ .+..|+||||+++|++.+.+... .+++..++.|+.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHHHHH
Confidence 32 67899999999999776665331 3899999999999999999
Q ss_pred HHh-cCCCeecCCCCCCeEecCCC--------------------CeEEeccCcccccCCCCCCCcCCCCccccCCccccc
Q 003847 591 FLH-EKKHVHGNLKPRNVLLGNDM--------------------EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTA 649 (791)
Q Consensus 591 yLH-~~~ivHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (791)
||| +.||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------------------- 235 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------------------- 235 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------------------
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------------------
Confidence 999 89999999999999999887 8999999999876421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHH-HHHHHhCCcchhccccCCCCcchhchh
Q 003847 650 SRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI-LLELLTGKVIVVDELGQGNGLLVEDKN 728 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvi-l~elltG~~pf~~~~~~~~~~~~~~~~ 728 (791)
..+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+.. ....
T Consensus 236 ---------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~ 285 (336)
T 2vuw_A 236 ---------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHY 285 (336)
T ss_dssp ---------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHH
T ss_pred ---------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhH
Confidence 124899999999998766 899999998777 788899999985420 0000
Q ss_pred HHHHHHHHhhhc---CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 729 RAIRLADAAIRA---DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 729 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
....+....... ........+.++.+|+.+||+.| |++|++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 011111110011 11123346788999999999876 999998
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=311.57 Aligned_cols=241 Identities=28% Similarity=0.403 Sum_probs=204.6
Q ss_pred ccCCChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccC---CC-----
Q 003847 27 QSLGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGS---IP----- 98 (791)
Q Consensus 27 ~~~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~---~~----- 98 (791)
++.+.++|+.||++||+++. ||. .+++|+ .+.+||.|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 6 ~~~~~~~~~~all~~k~~~~-~~~-~l~~W~-~~~~~C~w~gv~C~-------~~~v~~L~L~~~~l~g~~~~l~~~l~~ 75 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLP-DKN-LLPDWS-SNKNPCTFDGVTCR-------DDKVTSIDLSSKPLNVGFSAVSSSLLS 75 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCS-CTT-SSTTCC-TTSCGGGSTTEEEE-------TTEEEEEECTTSCCCEEHHHHHHHTTT
T ss_pred cccCCHHHHHHHHHHHhhCC-Ccc-cccCCC-CCCCCcCCcceEEC-------CCcEEEEECCCCCcCCccCccChhHhc
Confidence 34567789999999999985 887 899998 45689999999997 47999999999999886 43
Q ss_pred ------------------cCCCCCCCCCEEeCcCCCCCCCCcc--cccCCCCccEEEccCCcCCCCCcccc-CCCCCCCE
Q 003847 99 ------------------ADLGMIEFLQYLDLSNNSLNGSLSF--SLFNASQLRNLDLSNNLISGHLPETM-GSLHNLQL 157 (791)
Q Consensus 99 ------------------~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~ 157 (791)
..|+.+++|++|+|++|.|+|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++
T Consensus 76 L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp CTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred cCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 5788888999999999999888888 88899999999999999988888776 78899999
Q ss_pred EeCcCCcCCCCCccc---cCCCCCCCEEeCCCCcCCCCCCC-CCcccceeccccccccccCCCCcCC-ccccEEEccCCc
Q 003847 158 LNLSDNALAGKLPVS---LTTLQSLTIVSLKNNYFSDGLPS-KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNR 232 (791)
Q Consensus 158 L~ls~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~-~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~ 232 (791)
|+|++|++++..|.. +.++++|++|+|++|++++.+|. .+++|++|+|++|++++.+|. ++. .+|++|+|++|+
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~ 234 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSC
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCc
Confidence 999999998888877 78899999999999998886664 568999999999999988887 665 589999999999
Q ss_pred CcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 233 l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
+++.+|..+.. +++|++|+|++|++++.+|.. .+.+++.+.+.+|.
T Consensus 235 l~~~~~~~l~~-l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~ 280 (768)
T 3rgz_A 235 LSGDFSRAIST-CTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENK 280 (768)
T ss_dssp CCSCHHHHTTT-CSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSE
T ss_pred CCCcccHHHhc-CCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCc
Confidence 99888888876 999999999999999888876 56666777776664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=306.17 Aligned_cols=186 Identities=15% Similarity=0.066 Sum_probs=132.7
Q ss_pred eccccCceEEEEEE-eCCCcEEEEEEcCCC----------chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEE
Q 003847 482 ILGASGSSIMYKAV-LEDGTALAVRRIGEN----------SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 549 (791)
-.+.|+.|.++.++ ...|+.||||++... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777777765 446899999999653 122346799999999999 799999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||++|++|.+++.... +++.. +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997653 26553 58999999999999999999999999999999999999999999866432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.. .....+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 393 ~~------------------------------------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CS------------------------------------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -C------------------------------------CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred Cc------------------------------------cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 11 1224569999999999986 4678899999999999988877
Q ss_pred cch
Q 003847 710 VIV 712 (791)
Q Consensus 710 ~pf 712 (791)
.++
T Consensus 436 ~~~ 438 (569)
T 4azs_A 436 SNW 438 (569)
T ss_dssp HHH
T ss_pred chh
Confidence 665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=277.32 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=208.6
Q ss_pred ccCCChhhHHHHHHHHhhccCCCCCccCCCC---CCCCCCceeeeeeeCCCCC---CCCCCcEEEEEcCCCCCccCCCcC
Q 003847 27 QSLGLNTDGVLLLSFKYSVLSDPLGVLGSWN---YNDENPCSWNGVTCASPGE---GNNDSRVIGLALPNSQLLGSIPAD 100 (791)
Q Consensus 27 ~~~~~~~~~~~ll~~k~~~~~~~~~~l~sw~---~~~~~~c~w~gv~C~~~~~---~~~~~~v~~L~L~~~~l~~~~~~~ 100 (791)
...+..+|..||++||..+..|+.+.+++|. ....++|.|.|+.|..... .....+|+.|+|++|++. .+|..
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 4457778999999999998888988889994 4456889999999951000 012468999999999998 77888
Q ss_pred CCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCC-----
Q 003847 101 LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTT----- 175 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~----- 175 (791)
++.+++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~ 177 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence 999999999999999999 88999999999999999999999 88999999999999999999988899987764
Q ss_pred ----CCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCC
Q 003847 176 ----LQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPV 247 (791)
Q Consensus 176 ----l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~ 247 (791)
+++|++|+|++|+|+ .+|..+ ++|++|+|++|+|++ +|..+.. .+|++|+|++|.+.+.+|..+.. +++
T Consensus 178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~-l~~ 254 (328)
T 4fcg_A 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAP 254 (328)
T ss_dssp CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTC-CCC
T ss_pred hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcC-CCC
Confidence 999999999999998 566654 789999999999985 5656665 58999999999999899988876 999
Q ss_pred CcEEEcccCcCcccCCCCC-cccccccccccCCCCC
Q 003847 248 NATIDLSFNNLTGEIPESN-VFMNQESSSFSGNLDL 282 (791)
Q Consensus 248 l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~l 282 (791)
|++|+|++|++.+.+|... .+.++..+.+.+|+..
T Consensus 255 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 255 LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp CCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 9999999999999998763 4556667777776543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=304.98 Aligned_cols=215 Identities=33% Similarity=0.514 Sum_probs=182.0
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|++++.+|..|+.+++|++|+|++|++++.+|..|+++++|++|+|++|+++|.+|..++++++|+
T Consensus 462 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 541 (768)
T 3rgz_A 462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCC
T ss_pred HcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCC
Confidence 34456777777777887777777788888888888888888878888888888888888888888888888888888888
Q ss_pred EEeCcCCcCCCCCcccc---------------------------------------------------------------
Q 003847 157 LLNLSDNALAGKLPVSL--------------------------------------------------------------- 173 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~--------------------------------------------------------------- 173 (791)
.|+|++|+++|.+|..+
T Consensus 542 ~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 621 (768)
T 3rgz_A 542 WLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621 (768)
T ss_dssp EEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEE
T ss_pred EEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceec
Confidence 88888888877666533
Q ss_pred -------CCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHh
Q 003847 174 -------TTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG 242 (791)
Q Consensus 174 -------~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~ 242 (791)
..+++|+.|+|++|+|+|.+|..+ ++|+.|+|++|+|+|.+|..++. .+|++|||++|+|+|.+|..+.
T Consensus 622 g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~ 701 (768)
T 3rgz_A 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701 (768)
T ss_dssp EECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGG
T ss_pred ccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHh
Confidence 335678889999999998888766 67899999999999999999988 5899999999999999999998
Q ss_pred hcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCCCCCCC
Q 003847 243 EKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPI 293 (791)
Q Consensus 243 ~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c~~ 293 (791)
. +++|++|||++|+|+|.+|+...+..+....|.||+++||.|+. +|..
T Consensus 702 ~-l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 702 A-LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp G-CCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred C-CCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 7 99999999999999999999999999999999999999999887 7854
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=298.62 Aligned_cols=240 Identities=24% Similarity=0.391 Sum_probs=207.1
Q ss_pred CChhhHHHHHHHHhhccCCCCCc-------cCCCCCCCCCCcee---eeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCc
Q 003847 30 GLNTDGVLLLSFKYSVLSDPLGV-------LGSWNYNDENPCSW---NGVTCASPGEGNNDSRVIGLALPNSQLLGSIPA 99 (791)
Q Consensus 30 ~~~~~~~~ll~~k~~~~~~~~~~-------l~sw~~~~~~~c~w---~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~ 99 (791)
....|..||.+++.++..+.+.. ..+|+. +.+||.| .||+|+. .++|+.|+|+++++.|.+|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~------~~~V~~L~L~~~~l~g~lp~ 99 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNS------NGRVTGLSLEGFGASGRVPD 99 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECT------TCCEEEEECTTSCCEEEECG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcC------CCCEEEEEecCcccCCcCCh
Confidence 34468999999999975544432 348985 5789999 9999973 37999999999999999999
Q ss_pred CCCCCCCCCEEeCcCCCC--------------------------------------------------------------
Q 003847 100 DLGMIEFLQYLDLSNNSL-------------------------------------------------------------- 117 (791)
Q Consensus 100 ~~~~l~~L~~L~L~~N~l-------------------------------------------------------------- 117 (791)
+|++|++|++|+|++|.+
T Consensus 100 ~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~ 179 (636)
T 4eco_A 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179 (636)
T ss_dssp GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCC
T ss_pred HHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccc
Confidence 999999999999999843
Q ss_pred ----------------CCCCcccccCCCCccEEEccCCcCCCC-----------------CccccC--CCCCCCEEeCcC
Q 003847 118 ----------------NGSLSFSLFNASQLRNLDLSNNLISGH-----------------LPETMG--SLHNLQLLNLSD 162 (791)
Q Consensus 118 ----------------~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~ls~ 162 (791)
+| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++
T Consensus 180 ~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~ 258 (636)
T 4eco_A 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258 (636)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEEC
T ss_pred ccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecC
Confidence 35 788999999999999999999986 999999 999999999999
Q ss_pred CcCCCCCccccCCCCCCCEEeCCCCc-CCC-CCCCCC---------cccceeccccccccccCCC--CcCC-ccccEEEc
Q 003847 163 NALAGKLPVSLTTLQSLTIVSLKNNY-FSD-GLPSKF---------NSVQVLDLSSNLINGSLPP--DIGG-YSLRYLNL 228 (791)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l---------~~L~~L~ls~N~l~~~~p~--~~~~-~~L~~L~l 228 (791)
|++.+.+|..|.++++|++|+|++|+ +++ .+|..+ ++|++|+|++|+|+ .+|. .++. .+|++|+|
T Consensus 259 n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L 337 (636)
T 4eco_A 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLEC 337 (636)
T ss_dssp CTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEEC
T ss_pred CcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeC
Confidence 99999999999999999999999998 998 788644 78999999999999 8888 7776 58999999
Q ss_pred cCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-Ccccc-cccccccCCCC
Q 003847 229 SYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMN-QESSSFSGNLD 281 (791)
Q Consensus 229 ~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~-~~~~~~~~n~~ 281 (791)
++|+++|.+| .+.. +++|++|+|++|+++ .+|.. ..+.+ +..+.+.+|..
T Consensus 338 ~~N~l~g~ip-~~~~-l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l 389 (636)
T 4eco_A 338 LYNQLEGKLP-AFGS-EIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKL 389 (636)
T ss_dssp CSCCCEEECC-CCEE-EEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCC
T ss_pred cCCcCccchh-hhCC-CCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcC
Confidence 9999999999 6655 899999999999999 66654 34445 67777777753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=300.80 Aligned_cols=236 Identities=22% Similarity=0.341 Sum_probs=204.5
Q ss_pred CCChhhHHHHHHHHhhccCCCCCccCCCCCCC----CCC--cee------------eeeeeCCCCCCCCCCcEEEEEcCC
Q 003847 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWNYND----ENP--CSW------------NGVTCASPGEGNNDSRVIGLALPN 90 (791)
Q Consensus 29 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~----~~~--c~w------------~gv~C~~~~~~~~~~~v~~L~L~~ 90 (791)
++...|..||++||.++ .+| +|+.++ .+| |.| .||+|+. .++|+.|+|++
T Consensus 265 ~~~~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~------~~~V~~L~Ls~ 332 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN------NGRVTGLSLAG 332 (876)
T ss_dssp CHHHHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT------TSCEEEEECTT
T ss_pred ccchHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC------CCCEEEEECcc
Confidence 34557999999999998 455 787554 456 999 9999973 47999999999
Q ss_pred CCCccCCCcCCCCCCCCCEEeC-cCCCCCCC-------------------------------------------------
Q 003847 91 SQLLGSIPADLGMIEFLQYLDL-SNNSLNGS------------------------------------------------- 120 (791)
Q Consensus 91 ~~l~~~~~~~~~~l~~L~~L~L-~~N~l~~~------------------------------------------------- 120 (791)
|+|.|.+|+.|++|++|++|+| ++|.+.|.
T Consensus 333 ~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~ 412 (876)
T 4ecn_A 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412 (876)
T ss_dssp TCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCT
T ss_pred CCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCc
Confidence 9999999999999999999999 77765443
Q ss_pred ---------------------------CcccccCCCCccEEEccCCcCCC-----------------CCccccC--CCCC
Q 003847 121 ---------------------------LSFSLFNASQLRNLDLSNNLISG-----------------HLPETMG--SLHN 154 (791)
Q Consensus 121 ---------------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~ 154 (791)
+|..|+++++|++|+|++|+|+| .+|..++ ++++
T Consensus 413 ~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~ 492 (876)
T 4ecn_A 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492 (876)
T ss_dssp TSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred cccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCC
Confidence 78899999999999999999998 3999988 9999
Q ss_pred CCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCc-CCC-CCCCCC----------cccceeccccccccccCCC--CcCC
Q 003847 155 LQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNY-FSD-GLPSKF----------NSVQVLDLSSNLINGSLPP--DIGG 220 (791)
Q Consensus 155 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l----------~~L~~L~ls~N~l~~~~p~--~~~~ 220 (791)
|++|+|++|++.+.+|..|.++++|+.|+|++|+ |++ .+|..+ ++|+.|+|++|+|+ .+|. .+..
T Consensus 493 L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~ 571 (876)
T 4ecn_A 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571 (876)
T ss_dssp CCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTT
T ss_pred CCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhc
Confidence 9999999999999999999999999999999998 998 777543 48999999999999 8888 7776
Q ss_pred -ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-Ccccc-cccccccCCCC
Q 003847 221 -YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMN-QESSSFSGNLD 281 (791)
Q Consensus 221 -~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~-~~~~~~~~n~~ 281 (791)
.+|++|+|++|+|+ .+| .+.. +++|+.|+|++|+++ .+|.. ..+.+ +..+.+.+|..
T Consensus 572 L~~L~~L~Ls~N~l~-~lp-~~~~-L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 572 MVKLGLLDCVHNKVR-HLE-AFGT-NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp CTTCCEEECTTSCCC-BCC-CCCT-TSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred CCCCCEEECCCCCcc-cch-hhcC-CCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCC
Confidence 58999999999999 999 6655 999999999999999 67755 44445 77777777753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=238.83 Aligned_cols=216 Identities=22% Similarity=0.240 Sum_probs=183.6
Q ss_pred CCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCc
Q 003847 61 ENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140 (791)
Q Consensus 61 ~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 140 (791)
.+.|.|.|+.|.+. ..++.+++++++++. +|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 2 ~~~C~~~~~~C~c~------~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 72 (270)
T 2o6q_A 2 EALCKKDGGVCSCN------NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72 (270)
T ss_dssp CCCBGGGTCSBEEE------TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSC
T ss_pred CccCCCCCCCCEeC------CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCc
Confidence 46899999999753 345689999999985 666554 689999999999998877899999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCC
Q 003847 141 ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPD 217 (791)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~ 217 (791)
|+...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..| ++|++|+|++|+|++..+..
T Consensus 73 l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 152 (270)
T 2o6q_A 73 LQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGV 152 (270)
T ss_dssp CSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred cCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhH
Confidence 997666778999999999999999998777888999999999999999999777654 78999999999999666665
Q ss_pred cCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCC
Q 003847 218 IGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 218 ~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 286 (791)
+.. .+|++|+|++|+|+ .+|...+..+++|++|+|++|++++..+.. ..+.++..+.+.+|+|.|++.
T Consensus 153 ~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ccCCcccceeEecCCcCc-EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 665 58999999999999 566554445999999999999999766654 345678889999999999764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.50 Aligned_cols=207 Identities=23% Similarity=0.198 Sum_probs=185.0
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCc-CCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL-ISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L 158 (791)
..+++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|. ++...|..|.++++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 5689999999999999888899999999999999999998889999999999999999997 887778899999999999
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|++|++++..|..|.++++|++|+|++|++++..+..| ++|+.|+|++|+|++..+..+.. .+|++|+|++|+++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 999999998889999999999999999999998776544 78999999999999766666766 58999999999999
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 287 (791)
+..|..+.. +++|+.|+|++|++++..+.. ..+.++..+.+.+|++.|++++
T Consensus 191 ~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 191 HVHPHAFRD-LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp EECTTTTTT-CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCHhHccC-cccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 777887776 999999999999999866542 4566778899999999998764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=261.74 Aligned_cols=188 Identities=13% Similarity=0.120 Sum_probs=144.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCch--------hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSV--------DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
.++||+|+||.||++.. .++.+|+|+...... ...+.+.+|++++++++||||+++..++...+..|+|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 56899999999999954 578899998643211 113458999999999999999977777777888899999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+++++|.+++.. +..|+.|+++||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999998764 4589999999999999999999999999999998 999999999997653211
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC--CCCCCchhhHHHHHHHHHHHhCC
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS--IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwSlGvil~elltG~ 709 (791)
..... .......+||+.|||||++.. ..|+..+|+||..+-.++.+.++
T Consensus 485 ~~~~~-----------------------------~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 485 KAVDL-----------------------------IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp HHHHH-----------------------------HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred cccch-----------------------------hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 00000 000113459999999999986 56788899999999888888777
Q ss_pred cch
Q 003847 710 VIV 712 (791)
Q Consensus 710 ~pf 712 (791)
.+|
T Consensus 536 ~rY 538 (540)
T 3en9_A 536 ARY 538 (540)
T ss_dssp SCC
T ss_pred ccc
Confidence 665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=248.46 Aligned_cols=206 Identities=19% Similarity=0.186 Sum_probs=144.9
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
..++.|+|++|++.+..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 45666777777777666666777777777777777776666666666777777777777776555556666666777777
Q ss_pred cCCcCCCCCccc-------------------------cCCCCCCCEEeCCCCcCCCCCCC--CCcccceecccccccccc
Q 003847 161 SDNALAGKLPVS-------------------------LTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGS 213 (791)
Q Consensus 161 s~N~l~~~~p~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~ls~N~l~~~ 213 (791)
++|+|+...+.. |.++++|++|+|++|+|+. +|. .+++|+.|+|++|+|++.
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCcc
Confidence 666666444434 4555556666666666554 232 236788888888888877
Q ss_pred CCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCCC
Q 003847 214 LPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 214 ~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~~ 288 (791)
.|..+.. .+|++|+|++|+|++..|..+.. +++|+.|+|++|+|++..+.. ..+.++..+.+.+|+|.|+|.+.
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~ 298 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDN-LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTT-CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcC-CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCch
Confidence 7777766 47888888888888555555544 999999999999999776665 34667888999999999998643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=226.73 Aligned_cols=205 Identities=23% Similarity=0.169 Sum_probs=180.2
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 34699999999999998888999999999999999999987888999999999999999999988889999999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCC-CCCCC---cccceeccccccccccCCCCcCC-cccc----EEEccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDG-LPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLR----YLNLSY 230 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~----~L~l~~ 230 (791)
|++|++++..+..+.++++|++|+|++|++++. +|..| ++|++|+|++|+|++..+..+.. .+|+ +|++++
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 999999988777899999999999999999874 46655 78999999999999777766665 3566 899999
Q ss_pred CcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCC
Q 003847 231 NRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 231 N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 286 (791)
|+++ .+|...+. ..+|+.|+|++|++++..+.. ..+.++..+.+.+|++.|+++
T Consensus 187 n~l~-~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 187 NPMN-FIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp SCCC-EECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred Cccc-ccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 9999 66666665 568999999999999776654 456778889999999999875
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=231.47 Aligned_cols=224 Identities=22% Similarity=0.248 Sum_probs=160.9
Q ss_pred CCceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCC-----------------
Q 003847 62 NPCSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGS----------------- 120 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------------- 120 (791)
..|.|.+|.|+..+- .....+++.|+|++|+++...+..|.++++|++|+|++|+|+..
T Consensus 5 C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 448999999974321 11235799999999999866666689999999999999988732
Q ss_pred --------CcccccCCCCccEEEccCCcCCCCCc-cccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC
Q 003847 121 --------LSFSLFNASQLRNLDLSNNLISGHLP-ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191 (791)
Q Consensus 121 --------~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 191 (791)
+|..+.++++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++
T Consensus 85 Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 85 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 23345556666666666666664433 456677777777777777776667777777777777887777776
Q ss_pred -CCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC
Q 003847 192 -GLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266 (791)
Q Consensus 192 -~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~ 266 (791)
.+|..+ ++|++|+|++|+|++..|..+.. .+|++|+|++|++++..+..+. .+++|++|+|++|++++..|...
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK-CLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT-TCTTCCEEECTTSCCCBCSSSSC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc-CcccCCEeECCCCCCcccCHHHH
Confidence 445443 67888888888888777777765 5788888888888844443444 48888888888888888877654
Q ss_pred cc--cccccccccCCCCCCCCC
Q 003847 267 VF--MNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 267 ~~--~~~~~~~~~~n~~lc~~~ 286 (791)
.. .++..+.+.+|++.|++.
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGG
T ss_pred HhhhccCCEEEccCCCeecccC
Confidence 32 367778888888888754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=221.06 Aligned_cols=192 Identities=21% Similarity=0.195 Sum_probs=166.9
Q ss_pred CCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcC
Q 003847 62 NPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
+||.|.|.+|. ...+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 3 ~Cp~~~gC~C~--------~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 71 (251)
T 3m19_A 3 TCETVTGCTCN--------EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71 (251)
T ss_dssp -CHHHHSSEEE--------GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cCCCCCceEcC--------CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcC
Confidence 57899999995 23457999999998 5666665 6899999999999999999999999999999999999
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCC---CcccceeccccccccccCCCCc
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK---FNSVQVLDLSSNLINGSLPPDI 218 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~ls~N~l~~~~p~~~ 218 (791)
++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+.. +++|+.|+|++|+|++..+..+
T Consensus 72 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 72 QTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHc
Confidence 9988888999999999999999999888889999999999999999999877655 4789999999999997777677
Q ss_pred CC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 219 GG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 219 ~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
.. .+|++|+|++|+|+ .+|...+..+++|+.|+|++|++++..++.
T Consensus 152 ~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 198 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCSRCEI 198 (251)
T ss_dssp TTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCTTSTTH
T ss_pred CcCcCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeCCcccc
Confidence 66 58999999999999 455444445999999999999999875543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=233.20 Aligned_cols=223 Identities=22% Similarity=0.254 Sum_probs=165.8
Q ss_pred CCCceeeeeeeCCCCC------CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEE
Q 003847 61 ENPCSWNGVTCASPGE------GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNL 134 (791)
Q Consensus 61 ~~~c~w~gv~C~~~~~------~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 134 (791)
..+|.|.|+ |+..+. ..-..+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 356888887 653221 1123478999999999998777789999999999999999998778889999999999
Q ss_pred EccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCc-cccCCCCCCCEEeCCCC-cCCCCCCCCC---cccceecccccc
Q 003847 135 DLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLP-VSLTTLQSLTIVSLKNN-YFSDGLPSKF---NSVQVLDLSSNL 209 (791)
Q Consensus 135 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~l---~~L~~L~ls~N~ 209 (791)
+|++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+|++| .+.+..+..| ++|+.|+|++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999996666668999999999999999985444 47888999999999998 4666555544 678888999998
Q ss_pred ccccCCCCcCC-ccccEEEccCCcC------------------------ccc----------------------------
Q 003847 210 INGSLPPDIGG-YSLRYLNLSYNRL------------------------SGE---------------------------- 236 (791)
Q Consensus 210 l~~~~p~~~~~-~~L~~L~l~~N~l------------------------~g~---------------------------- 236 (791)
+++..|..+.. .+|++|++++|++ ++.
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~ 265 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHH
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcc
Confidence 88777777655 3455555555544 431
Q ss_pred ---CchhHhhcCCCCcEEEcccCcCcccCCCC--CcccccccccccCCCCCCCCC
Q 003847 237 ---IPPQFGEKIPVNATIDLSFNNLTGEIPES--NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 237 ---ip~~~~~~l~~l~~l~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~lc~~~ 286 (791)
+|..+.. +++|+.|+|++|+++ .+|.. ..+.++..+.+.+|++.|+++
T Consensus 266 l~~l~~~l~~-l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 266 LFQVMKLLNQ-ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHT-CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhhhHHHHhc-ccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 2233333 677788888888887 34443 356677778888888888754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=238.28 Aligned_cols=221 Identities=19% Similarity=0.176 Sum_probs=167.9
Q ss_pred eeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcC
Q 003847 66 WNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 66 w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
|..|.|...+- .....+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 45677753220 11235788999999999998888999999999999999999988888899999999999999999
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccC-------------------------CCCCCCEEeCCCCcCCCCCCC-
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLT-------------------------TLQSLTIVSLKNNYFSDGLPS- 195 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-------------------------~l~~L~~L~L~~N~l~~~~p~- 195 (791)
++..+..|.++++|++|+|++|+|++..+..|. ++++|++|+|++|+|++. |.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~ 214 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNL 214 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccc
Confidence 877777788899999999999988855554444 455555555555555542 22
Q ss_pred -CCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-Ccccccc
Q 003847 196 -KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQE 272 (791)
Q Consensus 196 -~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~ 272 (791)
.+++|+.|+|++|+|++..|..+.. .+|++|+|++|+|++..|..+.. +++|+.|+|++|+|++..+.. ..+.++.
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 293 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG-LASLVELNLAHNNLSSLPHDLFTPLRYLV 293 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC-CCCCCEEECCCCcCCccChHHhccccCCC
Confidence 2357777888888887777777766 47888888888888555655554 899999999999998766655 3456788
Q ss_pred cccccCCCCCCCCCCC
Q 003847 273 SSSFSGNLDLCGQPTK 288 (791)
Q Consensus 273 ~~~~~~n~~lc~~~~~ 288 (791)
.+.+.+|+|.|+|.+.
T Consensus 294 ~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 294 ELHLHHNPWNCDCDIL 309 (452)
T ss_dssp EEECCSSCEECSTTTH
T ss_pred EEEccCCCcCCCCCch
Confidence 8999999999998753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=231.83 Aligned_cols=189 Identities=25% Similarity=0.317 Sum_probs=172.3
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCC--
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGS-- 151 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-- 151 (791)
|..+....+++.|+|++|+++ .+|..|+.+++|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~ 174 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc
Confidence 333445789999999999999 88999999999999999999999 78999999999999999999999999988765
Q ss_pred -------CCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCC--CCcccceeccccccccccCCCCcCC-c
Q 003847 152 -------LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGSLPPDIGG-Y 221 (791)
Q Consensus 152 -------l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~ls~N~l~~~~p~~~~~-~ 221 (791)
+++|++|+|++|+|+ .+|..+.++++|++|+|++|++++..+. .+++|++|+|++|.+.+.+|..+.. .
T Consensus 175 ~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp -CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred chhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCC
Confidence 999999999999999 8899999999999999999999974432 3478999999999999999999887 5
Q ss_pred cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC
Q 003847 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~ 266 (791)
+|++|+|++|.+.+.+|..+.. +++|++|+|++|++.+.+|+..
T Consensus 254 ~L~~L~L~~n~~~~~~p~~~~~-l~~L~~L~L~~n~~~~~iP~~l 297 (328)
T 4fcg_A 254 PLKRLILKDCSNLLTLPLDIHR-LTQLEKLDLRGCVNLSRLPSLI 297 (328)
T ss_dssp CCCEEECTTCTTCCBCCTTGGG-CTTCCEEECTTCTTCCCCCGGG
T ss_pred CCCEEECCCCCchhhcchhhhc-CCCCCEEeCCCCCchhhccHHH
Confidence 8999999999999999999877 9999999999999999999764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=221.33 Aligned_cols=200 Identities=24% Similarity=0.208 Sum_probs=164.8
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|++++++|+. +|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++. +.. +.+++|++|+
T Consensus 9 l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~ 83 (290)
T 1p9a_G 9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLD 83 (290)
T ss_dssp STTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEE
T ss_pred cCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEE
Confidence 5678889999999874 555554 6889999999999988888899999999999999999854 433 7889999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g 235 (791)
|++|+|+ .+|..+..+++|++|+|++|+|++..+..| ++|++|+|++|+|++..+..+.. .+|++|+|++|+|+
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 161 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT- 161 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-
Confidence 9999998 788888899999999999999998776655 68999999999998666666655 58999999999998
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 286 (791)
.+|..++..+++|+.|+|++|+|+...+.......+..+.+.+|+|.|+|.
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 778777666999999999999998554444555677788889999999764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=224.25 Aligned_cols=210 Identities=22% Similarity=0.170 Sum_probs=179.8
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCC-CCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNS-LNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
+..+....+++.|+|++|++++..+..|..+++|++|+|++|. +....|..|.++++|++|+|++|++++..|..|.++
T Consensus 49 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 128 (285)
T 1ozn_A 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred HHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCC
Confidence 3456678899999999999999999999999999999999997 887778999999999999999999998889999999
Q ss_pred CCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEc
Q 003847 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNL 228 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l 228 (791)
++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..| ++|+.|+|++|+|++..|..+.. .+|++|+|
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 208 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeC
Confidence 999999999999998777889999999999999999998666544 78999999999999888988877 58999999
Q ss_pred cCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCC
Q 003847 229 SYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCG 284 (791)
Q Consensus 229 ~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 284 (791)
++|+|++ +|...+..+++|+.|+|++|++++..+....+..+.......|...|.
T Consensus 209 ~~n~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~ 263 (285)
T 1ozn_A 209 FANNLSA-LPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (285)
T ss_dssp CSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred CCCcCCc-CCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccC
Confidence 9999995 555544459999999999999998776543333333444445555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-23 Score=213.73 Aligned_cols=199 Identities=22% Similarity=0.197 Sum_probs=172.4
Q ss_pred eeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCc
Q 003847 65 SWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140 (791)
Q Consensus 65 ~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 140 (791)
.|..|.|....- ..-...++.|+|++|++.+..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|+
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~ 96 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC
T ss_pred CCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc
Confidence 477899973221 1123568999999999998888899999999999999999997777778999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCC
Q 003847 141 ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPD 217 (791)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~ 217 (791)
|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..| ++|+.|+|++|+|++..+..
T Consensus 97 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 176 (270)
T 2o6q_A 97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176 (270)
T ss_dssp CCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhH
Confidence 998777889999999999999999998888889999999999999999998766544 78999999999999776666
Q ss_pred cCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC
Q 003847 218 IGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264 (791)
Q Consensus 218 ~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~ 264 (791)
+.. .+|++|+|++|+|+ .+|...+..+++|+.|+|++|++.+..+.
T Consensus 177 ~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 177 FDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred hccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 765 68999999999999 67766555699999999999999987654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=233.67 Aligned_cols=122 Identities=19% Similarity=0.192 Sum_probs=84.1
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCch
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP 239 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~ 239 (791)
++++..|..|..+++|++|+|++|++++..|..| ++|++|+|++|+|++..|..+.. .+|++|+|++|++++..|.
T Consensus 286 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 286 KIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 3333344556666777777777777776655544 56777777777777666666665 4788888888888766666
Q ss_pred hHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCC
Q 003847 240 QFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 240 ~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 286 (791)
.+.. +++|++|+|++|++++..+.. ..+..+..+.+.+|++.|+++
T Consensus 366 ~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 366 SFLG-LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTT-CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hccc-cccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 6655 788888888888887655544 345567777888888888765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-22 Score=229.07 Aligned_cols=191 Identities=19% Similarity=0.146 Sum_probs=137.3
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
..++..+++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 46788888887 4666554 78999999999999988999999999999999999999888899999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cc-------------------------cceeccccccccccCC
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NS-------------------------VQVLDLSSNLINGSLP 215 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~-------------------------L~~L~ls~N~l~~~~p 215 (791)
+|++..+..|.++++|++|+|++|+|+...+..| ++ |++|+|++|+|++ +|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence 9998777889999999999999999987544322 34 4445555555542 23
Q ss_pred CCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC-cccccccccccCC
Q 003847 216 PDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN-VFMNQESSSFSGN 279 (791)
Q Consensus 216 ~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n 279 (791)
......+|++|+|++|+|++..|..+.. +++|+.|+|++|++++..|... .+.++..+.+.+|
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHG-LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cccccccccEEECcCCcCcccCcccccC-ccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence 2222235555566666665444444433 6666666666666665555432 2334444444444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-24 Score=229.31 Aligned_cols=186 Identities=29% Similarity=0.407 Sum_probs=132.1
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCC
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 153 (791)
|..+....+++.|+|++|++++.+|..|+.+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..+.+++
T Consensus 94 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173 (313)
T ss_dssp CGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC
T ss_pred ChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh
Confidence 33444555666666666666666666666666666666666666666666666666666666666666655666665555
Q ss_pred -CCCEEeCcCCcCC-----------------------CCCccccCCCCCCCEEeCCCCcCCCCCCC--CCcccceecccc
Q 003847 154 -NLQLLNLSDNALA-----------------------GKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSS 207 (791)
Q Consensus 154 -~L~~L~ls~N~l~-----------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~ls~ 207 (791)
+|++|+|++|+++ +.+|..|..+++|+.|+|++|++++.+|. .+++|++|+|++
T Consensus 174 ~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~ 253 (313)
T 1ogq_A 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN 253 (313)
T ss_dssp TTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCS
T ss_pred hcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcC
Confidence 5555555555554 45555666677777777777777765554 337899999999
Q ss_pred ccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCc-Cccc
Q 003847 208 NLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN-LTGE 261 (791)
Q Consensus 208 N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~-l~~~ 261 (791)
|+|++.+|..+.. .+|++|+|++|+|+|.+|.. . .+++|+.|++++|+ ++|.
T Consensus 254 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~-~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G-NLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-T-TGGGSCGGGTCSSSEEEST
T ss_pred CcccCcCChHHhcCcCCCEEECcCCcccccCCCC-c-cccccChHHhcCCCCccCC
Confidence 9999999998877 58999999999999999987 4 49999999999999 5553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=214.78 Aligned_cols=191 Identities=20% Similarity=0.180 Sum_probs=171.2
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCC
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH 153 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 153 (791)
+..+....+++.|+|++|++.+..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+++++
T Consensus 45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 124 (276)
T 2z62_A 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124 (276)
T ss_dssp TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCC
Confidence 34566788999999999999998888999999999999999999988888999999999999999999987777899999
Q ss_pred CCCEEeCcCCcCCCC-CccccCCCCCCCEEeCCCCcCCCCCCCCC---cccc----eeccccccccccCCCCcCCccccE
Q 003847 154 NLQLLNLSDNALAGK-LPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQ----VLDLSSNLINGSLPPDIGGYSLRY 225 (791)
Q Consensus 154 ~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~----~L~ls~N~l~~~~p~~~~~~~L~~ 225 (791)
+|++|+|++|++++. +|..|.++++|++|+|++|++++..+..+ .+|+ .|+|++|+|++..+..+...+|++
T Consensus 125 ~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~ 204 (276)
T 2z62_A 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKE 204 (276)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEE
T ss_pred CCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccE
Confidence 999999999999974 69999999999999999999999777666 4555 899999999977777777779999
Q ss_pred EEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 226 L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
|+|++|+|+ .+|..++..+++|+.|+|++|++++..|..
T Consensus 205 L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp EECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred EECCCCcee-ecCHhHhcccccccEEEccCCcccccCCch
Confidence 999999999 677766666999999999999999988755
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=232.28 Aligned_cols=211 Identities=22% Similarity=0.143 Sum_probs=116.7
Q ss_pred CCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCC
Q 003847 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNL 155 (791)
Q Consensus 76 ~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 155 (791)
.|....+++.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|
T Consensus 51 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 130 (477)
T 2id5_A 51 EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130 (477)
T ss_dssp TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccC
Confidence 34444555555555555555555555555555555555555554444444555555555555555554444445555555
Q ss_pred CEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC------------------------CC----------------
Q 003847 156 QLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL------------------------PS---------------- 195 (791)
Q Consensus 156 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~------------------------p~---------------- 195 (791)
+.|+|++|.+++..+..|.++++|+.|+|++|++++.. +.
T Consensus 131 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~ 210 (477)
T 2id5_A 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210 (477)
T ss_dssp CEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC
T ss_pred CEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC
Confidence 55555555544444444444444444444444433221 10
Q ss_pred -----------------------------------CCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCch
Q 003847 196 -----------------------------------KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP 239 (791)
Q Consensus 196 -----------------------------------~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~ 239 (791)
.+++|+.|+|++|+|++..+..+.. .+|++|+|++|+|++..|.
T Consensus 211 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 290 (477)
T 2id5_A 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290 (477)
T ss_dssp TTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred ccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence 1134455555555555444444444 3666777777777655555
Q ss_pred hHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCC
Q 003847 240 QFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 240 ~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 287 (791)
.+.. +++|+.|+|++|+|++..+.. ..+.++..+.+.+|++.|+|.+
T Consensus 291 ~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 291 AFRG-LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp TBTT-CTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred HhcC-cccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 5544 788888888888887655543 3455778888999999998753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=218.96 Aligned_cols=130 Identities=18% Similarity=0.199 Sum_probs=108.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCch------------------hhHHHHHHHHHHHhccCCCCccceeeEEE
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSV------------------DRFRDFETQVRVIAKLVHPNLVRIRGFYW 541 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 541 (791)
...||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999997899999999964321 13457899999999999 5 67777554
Q ss_pred ccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 542 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
. +..++||||+++++|.+ +. . .....++.|++.||+|||+.||+||||||+|||++ ++.+||+|||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred c-cceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 3 56799999999999987 31 1 22457999999999999999999999999999999 9999999999
Q ss_pred ccccc
Q 003847 622 LERLV 626 (791)
Q Consensus 622 la~~~ 626 (791)
+++..
T Consensus 238 ~a~~~ 242 (282)
T 1zar_A 238 QSVEV 242 (282)
T ss_dssp TCEET
T ss_pred CCeEC
Confidence 98743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=236.99 Aligned_cols=130 Identities=21% Similarity=0.117 Sum_probs=102.6
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
.+++.|+|++|++.+..+..|+.+++|++|+|++|.|++..|..|.++++|++|+|++|.|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 46778888888888888888888888888888888888888888888888888888888888656666788888888888
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccc
Q 003847 161 SDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLI 210 (791)
Q Consensus 161 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l 210 (791)
++|.|++..|..|.++++|+.|+|++|.|++..+..+++|+.|++++|.+
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcc
Confidence 88888888888888888888888888888875544444444444444433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-23 Score=208.67 Aligned_cols=194 Identities=19% Similarity=0.206 Sum_probs=164.8
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCC-CCCCCcccccCCCCccEEEccC-CcCCCCCccccCCCCCCCE
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNS-LNGSLSFSLFNASQLRNLDLSN-NLISGHLPETMGSLHNLQL 157 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~ 157 (791)
...++.|+|++|++++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++
T Consensus 30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 3479999999999999888899999999999999997 8877777899999999999999 9999777788999999999
Q ss_pred EeCcCCcCCCCCccccCCCCCCC---EEeCCCC-cCCCCCCCCC---cccc-eeccccccccccCCC-CcCCccccEEEc
Q 003847 158 LNLSDNALAGKLPVSLTTLQSLT---IVSLKNN-YFSDGLPSKF---NSVQ-VLDLSSNLINGSLPP-DIGGYSLRYLNL 228 (791)
Q Consensus 158 L~ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~l---~~L~-~L~ls~N~l~~~~p~-~~~~~~L~~L~l 228 (791)
|+|++|++++ +|. |..+++|+ +|+|++| ++++..+..| ++|+ .|+|++|+|+ .+|. .+...+|++|+|
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L 186 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEEC
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEc
Confidence 9999999996 776 89999998 9999999 9988666555 7899 9999999999 5554 445578999999
Q ss_pred cCCc-CcccCchhHhhcC-CCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 229 SYNR-LSGEIPPQFGEKI-PVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 229 ~~N~-l~g~ip~~~~~~l-~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
++|+ |+ .+|...+..+ ++|+.|+|++|++++..+. .+.++..+.+.++
T Consensus 187 ~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 187 NKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCCCcc-cCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 9995 98 6766655558 9999999999999965443 4555555555444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=246.56 Aligned_cols=209 Identities=26% Similarity=0.249 Sum_probs=143.5
Q ss_pred CCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCC
Q 003847 75 GEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHN 154 (791)
Q Consensus 75 ~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 154 (791)
..+....+++.|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 34455667777777777777777777777777777777777777666777777777777777777777666666777777
Q ss_pred CCEEeCcCCcCCCCC------------------c----------------------cccCCCCCCCEEeCCCCcCCCCCC
Q 003847 155 LQLLNLSDNALAGKL------------------P----------------------VSLTTLQSLTIVSLKNNYFSDGLP 194 (791)
Q Consensus 155 L~~L~ls~N~l~~~~------------------p----------------------~~~~~l~~L~~L~L~~N~l~~~~p 194 (791)
|+.|+|++|.+++.. | ..+.++++|+.|+|++|++++..+
T Consensus 364 L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 443 (844)
T 3j0a_A 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443 (844)
T ss_dssp CCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCS
T ss_pred CCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccc
Confidence 777777777665311 0 012245566666666666653211
Q ss_pred ------------------------------C---CCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchh
Q 003847 195 ------------------------------S---KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 195 ------------------------------~---~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
. .+++|+.|+|++|+|++..|..+.. .+|++|+|++|+|++ +|..
T Consensus 444 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~ 522 (844)
T 3j0a_A 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN 522 (844)
T ss_dssp SSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSS-CCCC
T ss_pred ccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCc-cChh
Confidence 1 1256777778888887777766665 578888888888884 4443
Q ss_pred HhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCC
Q 003847 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 288 (791)
.+ .++|+.|||++|+|++.+|.. +..+..+.+.+|++.|+|++.
T Consensus 523 ~~--~~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 523 DL--PANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp CC--CSCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSCC
T ss_pred hh--hccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccccH
Confidence 33 267888888888888888765 446778899999999988754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=221.65 Aligned_cols=197 Identities=27% Similarity=0.307 Sum_probs=168.7
Q ss_pred CCcEEEEEcCCCCCccCCCcCC--CCCCCCCEEeCcCCCCCCCCcccccCC-----CCccEEEccCCcCCCCCccccCCC
Q 003847 80 DSRVIGLALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLSFSLFNA-----SQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
..+++.|+|++|++++.+|..+ +.+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|+++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 6789999999999999999886 9999999999999999977 8888887 999999999999998888999999
Q ss_pred CCCCEEeCcCCcCCCC--Ccccc--CCCCCCCEEeCCCCcCCC--CCCC----CCcccceeccccccccccCCC-CcCC-
Q 003847 153 HNLQLLNLSDNALAGK--LPVSL--TTLQSLTIVSLKNNYFSD--GLPS----KFNSVQVLDLSSNLINGSLPP-DIGG- 220 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p~----~l~~L~~L~ls~N~l~~~~p~-~~~~- 220 (791)
++|++|+|++|++.+. +|..+ ..+++|++|+|++|+|++ .++. .+++|++|+|++|+|++.+|. .+..
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 9999999999998865 34444 899999999999999984 2222 347999999999999987753 3333
Q ss_pred ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCC
Q 003847 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDL 282 (791)
Q Consensus 221 ~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~l 282 (791)
.+|++|+|++|+|+ .+|..++ ++|++|||++|+|++. |....+.++..+.+.+|+..
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~---~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP---AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC---SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred CCCCEEECCCCccC-hhhhhcc---CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 68999999999999 8998775 7899999999999987 66666777888888888653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-22 Score=211.14 Aligned_cols=178 Identities=25% Similarity=0.146 Sum_probs=160.4
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...++.|+|++|++++..+..|..+++|++|+|++|.|++..+ ...+++|++|+|++|+|+ .+|..+.++++|++|+
T Consensus 30 ~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (290)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence 3678999999999999999999999999999999999995433 378999999999999998 7888999999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g 235 (791)
|++|+|++..|..|.++++|++|+|++|+|++..+..| ++|+.|+|++|+|++..+..+.. .+|++|+|++|+|+
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~- 185 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY- 185 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-
Confidence 99999998888899999999999999999998777554 78999999999999655555554 68999999999999
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEI 262 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~ 262 (791)
.+|..++. +.+|+.|+|++|++.+..
T Consensus 186 ~ip~~~~~-~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 186 TIPKGFFG-SHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCCTTTTT-TCCCSEEECCSCCBCCSG
T ss_pred ccChhhcc-cccCCeEEeCCCCccCcC
Confidence 99999987 889999999999998764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-22 Score=211.84 Aligned_cols=213 Identities=21% Similarity=0.248 Sum_probs=148.9
Q ss_pred CCceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEcc
Q 003847 62 NPCSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS 137 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 137 (791)
..|.|..+.|...+- ..-...++.|+|++|++++..+..|+++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 347899999973221 1123578999999999999888899999999999999999998889999999999999999
Q ss_pred CCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC--CCCCCC---cccceeccccccccc
Q 003847 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKF---NSVQVLDLSSNLING 212 (791)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l---~~L~~L~ls~N~l~~ 212 (791)
+|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++. ..+..+ ++|++|+|++|.++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~- 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence 99998 5665554 677788888887776666667777777777777777753 333333 56666666666666
Q ss_pred cCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCC
Q 003847 213 SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNL 280 (791)
Q Consensus 213 ~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~ 280 (791)
.+|..+. .+|++|+|++|++++..|..+.. +++|+.|+|++|++++..+.. ..+.++..+.+.+|.
T Consensus 185 ~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 251 (330)
T 1xku_A 185 TIPQGLP-PSLTELHLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251 (330)
T ss_dssp SCCSSCC-TTCSEEECTTSCCCEECTGGGTT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred cCCcccc-ccCCEEECCCCcCCccCHHHhcC-CCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence 3444333 45666666666666444444443 666666666666666555533 233344555555553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=237.82 Aligned_cols=211 Identities=19% Similarity=0.175 Sum_probs=158.0
Q ss_pred CCCCCCcEEEEEcCCCCCccCCC-cCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCC--CCCccccCCC
Q 003847 76 EGNNDSRVIGLALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS--GHLPETMGSL 152 (791)
Q Consensus 76 ~~~~~~~v~~L~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l 152 (791)
.+....+++.|+|++|.+.+.+| ..|..+++|++|+|++|++.+..+..|..+++|+.|+|++|.++ +.+|..|.++
T Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l 479 (680)
T 1ziw_A 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479 (680)
T ss_dssp TTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTC
T ss_pred hhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccC
Confidence 34445555666666666655444 45556666666666666665555566666666666666666665 4678888889
Q ss_pred CCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-----------CCCcccceeccccccccccCCCCcCC-
Q 003847 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-----------SKFNSVQVLDLSSNLINGSLPPDIGG- 220 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-----------~~l~~L~~L~ls~N~l~~~~p~~~~~- 220 (791)
++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+ ..+++|+.|+|++|+|+...+..+..
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 999999999999998777888999999999999999886421 23478999999999998443345665
Q ss_pred ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC--cccccccccccCCCCCCCCCC
Q 003847 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN--VFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 221 ~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~ 287 (791)
.+|++|+|++|+|+ .+|...+..+++|+.|+|++|+|++..|... .+.++..+.+.+|||.|+|+.
T Consensus 560 ~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCC-cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 58999999999999 7777776669999999999999998777543 467788899999999998764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-21 Score=211.55 Aligned_cols=213 Identities=19% Similarity=0.222 Sum_probs=154.6
Q ss_pred CceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccC
Q 003847 63 PCSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSN 138 (791)
Q Consensus 63 ~c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 138 (791)
.|.|..+.|...+- .....+++.|+|++|++.+..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 37899999973221 11235789999999999988888999999999999999999988899999999999999999
Q ss_pred CcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC--CCCCCC-------------------
Q 003847 139 NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD--GLPSKF------------------- 197 (791)
Q Consensus 139 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l------------------- 197 (791)
|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++. ..+..+
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIP 188 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCC
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccC
Confidence 9998 6666555 788888888888887666678888888888888888853 334333
Q ss_pred ----cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-Cccccc
Q 003847 198 ----NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQ 271 (791)
Q Consensus 198 ----~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~ 271 (791)
++|+.|+|++|++++..+..+.. .+|++|+|++|+|++..|..+.. +++|+.|+|++|+++ .+|.. ..+.++
T Consensus 189 ~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~-~lp~~l~~l~~L 266 (332)
T 2ft3_A 189 KDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF-LPTLRELHLDNNKLS-RVPAGLPDLKLL 266 (332)
T ss_dssp SSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGG-CTTCCEEECCSSCCC-BCCTTGGGCTTC
T ss_pred ccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhC-CCCCCEEECCCCcCe-ecChhhhcCccC
Confidence 35666666666666555555554 46777777777776444444443 677777777777776 44443 334455
Q ss_pred ccccccCCC
Q 003847 272 ESSSFSGNL 280 (791)
Q Consensus 272 ~~~~~~~n~ 280 (791)
..+.+.+|.
T Consensus 267 ~~L~l~~N~ 275 (332)
T 2ft3_A 267 QVVYLHTNN 275 (332)
T ss_dssp CEEECCSSC
T ss_pred CEEECCCCC
Confidence 555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.6e-22 Score=221.14 Aligned_cols=188 Identities=26% Similarity=0.250 Sum_probs=135.7
Q ss_pred EEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcC
Q 003847 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165 (791)
Q Consensus 86 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 165 (791)
++..+++|+ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 444455665 5666554 7899999999999988889999999999999999999988889999999999999999999
Q ss_pred CCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCC-CcCC-ccccEEEccCCcCcccCchh
Q 003847 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPP-DIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~-~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
++..+..|.++++|++|+|++|+|+...+..| ++|+.|+|++|...+.++. .+.. .+|++|+|++|+|+ .+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN- 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-
Confidence 97777789999999999999999987655433 5677777776433223333 3443 35666666666666 5553
Q ss_pred HhhcCCCCcEEEcccCcCcccCCCCC-cccccccccccCC
Q 003847 241 FGEKIPVNATIDLSFNNLTGEIPESN-VFMNQESSSFSGN 279 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n 279 (791)
+.. +++|+.|+|++|++++..|... .+.++..+.+.+|
T Consensus 203 ~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 241 (440)
T 3zyj_A 203 LTP-LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241 (440)
T ss_dssp CTT-CSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cCC-CcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence 222 5666666666666665555432 2333444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=236.86 Aligned_cols=209 Identities=22% Similarity=0.166 Sum_probs=182.8
Q ss_pred CCCCCcEEEEEcCCCCCccC--CCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCc-cccCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGS--IPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP-ETMGSLH 153 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~ 153 (791)
+....+++.|+|++|++++. ++..+..+++|++|+|++|.+++ +|..|.++++|+.|+|++|++++..| ..|.+++
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 424 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence 34567888999999999877 47889999999999999999984 66889999999999999999998877 6899999
Q ss_pred CCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCC-CCCCC---cccceeccccccccccCCCCcCC-ccccEEEc
Q 003847 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDG-LPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNL 228 (791)
Q Consensus 154 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l 228 (791)
+|++|+|++|++++..|..|.++++|++|+|++|++++. +|..+ ++|+.|+|++|++++..|..+.. .+|++|+|
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 999999999999999999999999999999999999984 66655 78999999999999988888877 58999999
Q ss_pred cCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-Cccc-ccccccccCCCCCCCCCCC
Q 003847 229 SYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFM-NQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 229 ~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~-~~~~~~~~~n~~lc~~~~~ 288 (791)
++|++++.+|..+.. +++|+.|+|++|+|+. +|.. ..+. .+..+.+.+|++.|+|++.
T Consensus 505 s~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 505 SHNNLLFLDSSHYNQ-LYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CSSCCSCEEGGGTTT-CTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CCCcCCCcCHHHccC-CCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 999999877888776 9999999999999994 5544 3333 4788899999999988753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=200.55 Aligned_cols=177 Identities=24% Similarity=0.248 Sum_probs=115.4
Q ss_pred CCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcC
Q 003847 62 NPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
..|+|.+|.|.. ++++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 5 C~C~~~~v~c~~-----------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (208)
T 2o6s_A 5 CSCSGTTVECYS-----------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL 64 (208)
T ss_dssp CEEETTEEECCS-----------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CEECCCEEEecC-----------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCcc
Confidence 458999999972 2222 223222 34667777777777655555566677777777777777
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCc
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDI 218 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~ 218 (791)
++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..| ++|+.|+|++|+|++..+..+
T Consensus 65 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 144 (208)
T 2o6s_A 65 QSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVF 144 (208)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred CccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHh
Confidence 65555556667777777777777765555556667777777777777766554433 567777777777765544445
Q ss_pred CC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC
Q 003847 219 GG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266 (791)
Q Consensus 219 ~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~ 266 (791)
.. .+|++|+|++|.+.+. +++|++|+++.|+++|.+|+..
T Consensus 145 ~~l~~L~~L~l~~N~~~~~--------~~~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 145 DRLTSLQYIWLHDNPWDCT--------CPGIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp TTCTTCCEEECCSCCBCCC--------TTTTHHHHHHHHHCTTTBBCTT
T ss_pred ccCCCccEEEecCCCeecC--------CCCHHHHHHHHHhCCceeeccC
Confidence 54 4778888888877643 4567777888888888887653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=230.79 Aligned_cols=212 Identities=20% Similarity=0.125 Sum_probs=167.0
Q ss_pred eeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc
Q 003847 69 VTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET 148 (791)
Q Consensus 69 v~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 148 (791)
++-..+..+....+++.|+|++|.+++..|..|+.+++|++|+|++|.|++..+..|.++++|++|+|++|.|++..|..
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 33334456677889999999999999988888999999999999999999766666789999999999999999888888
Q ss_pred cCCCCCCCEEeCcCCcCCCCCcc---------------------------------------------------------
Q 003847 149 MGSLHNLQLLNLSDNALAGKLPV--------------------------------------------------------- 171 (791)
Q Consensus 149 ~~~l~~L~~L~ls~N~l~~~~p~--------------------------------------------------------- 171 (791)
|+++++|++|+|++|.|++..+.
T Consensus 167 ~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD 246 (597)
T ss_dssp TTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC
T ss_pred hhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC
Confidence 99999999999999988754322
Q ss_pred --ccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcC
Q 003847 172 --SLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKI 245 (791)
Q Consensus 172 --~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l 245 (791)
.+..+++|+.|+|++|.|++.+|..| ++|+.|+|++|.|++ +|..+.. .+|++|+|++|.|+ .+|..+.. +
T Consensus 247 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~-l 323 (597)
T 3oja_B 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ-F 323 (597)
T ss_dssp CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH-H
T ss_pred ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCccccc-C
Confidence 24556677777777777777666544 678888888888875 4544443 57888888888888 78877766 8
Q ss_pred CCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCC
Q 003847 246 PVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQ 285 (791)
Q Consensus 246 ~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 285 (791)
++|++|+|++|+|++.. ...+..+..+.+.+|++.|.+
T Consensus 324 ~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 324 DRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp TTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChh
Confidence 88888888888887653 334557777888899888864
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.4e-23 Score=232.36 Aligned_cols=198 Identities=26% Similarity=0.241 Sum_probs=142.6
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCcc--------------
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE-------------- 147 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------- 147 (791)
+|+.|+|++|++++..|..|+.+++|++|+|++|.|++..| |.++++|++|+|++|.|++..+.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~ 112 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence 56666666666666555666666666666666666665443 55666666666555555432111
Q ss_pred --ccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC----cccceeccccccccccCCCCcCCc
Q 003847 148 --TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQVLDLSSNLINGSLPPDIGGY 221 (791)
Q Consensus 148 --~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----~~L~~L~ls~N~l~~~~p~~~~~~ 221 (791)
....+++|+.|+|++|.|++..|..|.++++|+.|+|++|.|++.+|..+ ++|+.|+|++|.|++. |......
T Consensus 113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~ 191 (487)
T 3oja_A 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFA 191 (487)
T ss_dssp CEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCT
T ss_pred CCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCC
Confidence 01245778888888999888888888889999999999999998776644 6899999999999865 4444456
Q ss_pred cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCC
Q 003847 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCG 284 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 284 (791)
+|++|+|++|.|++ +|..+.. +++|+.|+|++|+|++..+....+.++..+.+.+|++.|+
T Consensus 192 ~L~~L~Ls~N~l~~-~~~~~~~-l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 192 KLKTLDLSSNKLAF-MGPEFQS-AAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp TCCEEECCSSCCCE-ECGGGGG-GTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCEEECCCCCCCC-CCHhHcC-CCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 89999999999994 5556665 8999999999999997544445556778888889988886
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=235.23 Aligned_cols=208 Identities=21% Similarity=0.204 Sum_probs=166.5
Q ss_pred CCCCCcEEEEEcCCCCCccCC--CcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc-cCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSI--PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET-MGSLH 153 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~ 153 (791)
+....+++.|+|++|++.+.. +..+..+++|++|+|++|++.+..|..|.++++|++|+|++|++++..|.. |.+++
T Consensus 346 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 425 (606)
T 3t6q_A 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425 (606)
T ss_dssp TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCT
T ss_pred hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcc
Confidence 445667777777777777665 667777888888888888887777777888888888888888887666544 78888
Q ss_pred CCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-C--C---CCcccceeccccccccccCCCCcCC-ccccEE
Q 003847 154 NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-P--S---KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYL 226 (791)
Q Consensus 154 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p--~---~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L 226 (791)
+|+.|+|++|.+++..|..|..+++|++|+|++|++++.. + . .+++|+.|+|++|++++..|..+.. .+|++|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 8888888888888888888888888888888888887632 2 2 3478999999999999888888876 589999
Q ss_pred EccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCC
Q 003847 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 227 ~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 286 (791)
+|++|++++..|..+.. +++| +|+|++|++++.+|.. ..+..+..+.+.+|++.|+|+
T Consensus 506 ~Ls~N~l~~~~~~~l~~-l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALSH-LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECCSSCCCGGGGGGGTT-CCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ECCCCccCcCChhHhCc-cccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 99999999888877766 9999 9999999999887765 345677889999999999765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-22 Score=219.39 Aligned_cols=129 Identities=20% Similarity=0.089 Sum_probs=93.2
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 34667777888888777777788888888888888888877777778888888888888888744444467788888888
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N 208 (791)
|++|++++..|..|.++++|++|+|++|++++.....+++|+.|++++|
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 8888888777777888888888888888877654443444433333333
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=230.10 Aligned_cols=197 Identities=19% Similarity=0.228 Sum_probs=174.1
Q ss_pred CceeeeeeeCCCCC-C-----CCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEc
Q 003847 63 PCSWNGVTCASPGE-G-----NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDL 136 (791)
Q Consensus 63 ~c~w~gv~C~~~~~-~-----~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 136 (791)
.|.|.|+ |+.... . ....+++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5889998 863221 1 12358999999999999999999999999999999999999888899999999999999
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCcCCcCCC-CCccccCCCCCCCEEeCCCCcCCCCCC-CC---Ccccceecccccccc
Q 003847 137 SNNLISGHLPETMGSLHNLQLLNLSDNALAG-KLPVSLTTLQSLTIVSLKNNYFSDGLP-SK---FNSVQVLDLSSNLIN 211 (791)
Q Consensus 137 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~---l~~L~~L~ls~N~l~ 211 (791)
++|+|++..|..|+++++|++|+|++|++++ ..|..|.++++|++|+|++|++.+.+| .. +++|++|+|++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998888889999999999999999997 357889999999999999999655554 33 478999999999999
Q ss_pred ccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 212 GSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 212 ~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
+.+|..+.. .+|++|++++|.+. .+|..+...+++|++|+|++|++++.
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred ccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccc
Confidence 999999887 58999999999997 78888877799999999999999985
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.40 Aligned_cols=180 Identities=22% Similarity=0.206 Sum_probs=139.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|++++|++... +.+..+++|++|+|++|+|++. ..+.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 40 LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 45778888888887642 3577888888888888888753 3678888888888888888877777788888888888
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g 235 (791)
|++|++++..+..|.++++|++|+|++|+|++..+..| ++|+.|+|++|+|++..+..+.. .+|++|+|++|+|++
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 88888887777778888888888888888887666443 67888888888888666665655 578888888888885
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccCCC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEIPE 264 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~p~ 264 (791)
..|..+. .+++|+.|+|++|+++|.+|.
T Consensus 196 ~~~~~~~-~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 196 VPDGVFD-RLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCTTTTT-TCTTCCEEECCSSCBCCCTTT
T ss_pred cCHHHHh-CCcCCCEEEccCCCccccCcH
Confidence 4444444 488888888888888877764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=216.26 Aligned_cols=208 Identities=20% Similarity=0.128 Sum_probs=156.9
Q ss_pred CCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 73 SPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 73 ~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
.+..+....+++.|+|++|++.+..|..|+.+++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|.++
T Consensus 85 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 164 (390)
T 3o6n_A 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164 (390)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSC
T ss_pred ChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCC
Confidence 34456677889999999999988888888999999999999999985555557888999999999999987778888888
Q ss_pred CCCCEEeCcCCcCCCCCcc-----------------------------------------------------------cc
Q 003847 153 HNLQLLNLSDNALAGKLPV-----------------------------------------------------------SL 173 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~-----------------------------------------------------------~~ 173 (791)
++|++|+|++|++++.... .+
T Consensus 165 ~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l 244 (390)
T 3o6n_A 165 TSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWL 244 (390)
T ss_dssp TTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGG
T ss_pred CCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHH
Confidence 8999999888888753222 23
Q ss_pred CCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCc
Q 003847 174 TTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNA 249 (791)
Q Consensus 174 ~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~ 249 (791)
..+++|++|+|++|.+++..|..| ++|+.|+|++|+|++ +|..+.. .+|++|+|++|+|+ .+|..+.. +++|+
T Consensus 245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-l~~L~ 321 (390)
T 3o6n_A 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ-FDRLE 321 (390)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH-HTTCS
T ss_pred cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc-cCcCC
Confidence 445667777777777776655543 677778888887774 3444433 57888888888887 67777766 88888
Q ss_pred EEEcccCcCcccCCCCCcccccccccccCCCCCCCC
Q 003847 250 TIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQ 285 (791)
Q Consensus 250 ~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 285 (791)
.|+|++|+++... ...+.++..+.+.+|++.|.+
T Consensus 322 ~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 322 NLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp EEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred EEECCCCccceeC--chhhccCCEEEcCCCCccchh
Confidence 8888888887553 344566777888888888754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.4e-22 Score=205.82 Aligned_cols=180 Identities=23% Similarity=0.186 Sum_probs=161.7
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|++.+. +.+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 34467899999999999874 5899999999999999999988888899999999999999999988888899999999
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCC---CcccceeccccccccccCCCCcCC-ccccEEEccCCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK---FNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNR 232 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~ 232 (791)
+|+|++|++++..+..|..+++|+.|+|++|+|++..+.. +++|++|+|++|+|++..+..+.. .+|++|+|++|.
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 9999999999888888999999999999999999877754 478999999999999877777766 589999999999
Q ss_pred CcccCchhHhhcCCCCcEEEcccCcCcccCCCCC
Q 003847 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN 266 (791)
Q Consensus 233 l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~ 266 (791)
+.+. +++|+.|+++.|+++|.+|...
T Consensus 217 ~~~~--------~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 217 WDCT--------CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp BCCC--------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred cccc--------CcHHHHHHHHHHhCCCcccCcc
Confidence 9865 5568889999999999999753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-21 Score=208.95 Aligned_cols=206 Identities=21% Similarity=0.189 Sum_probs=166.5
Q ss_pred CCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 73 SPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 73 ~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
.+..+....+++.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..+..|.++
T Consensus 70 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l 146 (332)
T 2ft3_A 70 RKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGL 146 (332)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSC
T ss_pred CHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCC
Confidence 3445677889999999999999998999999999999999999998 5565554 788888888888886666678888
Q ss_pred CCCCEEeCcCCcCC--CCCccccCCC--------------------CCCCEEeCCCCcCCCCCCCCC---cccceecccc
Q 003847 153 HNLQLLNLSDNALA--GKLPVSLTTL--------------------QSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSS 207 (791)
Q Consensus 153 ~~L~~L~ls~N~l~--~~~p~~~~~l--------------------~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~ 207 (791)
++|+.|+|++|.++ +..|..+..+ ++|++|+|++|++++..+..| ++|+.|+|++
T Consensus 147 ~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~ 226 (332)
T 2ft3_A 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226 (332)
T ss_dssp SSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCS
T ss_pred ccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 88888888888885 3555555544 467777777777777666555 7899999999
Q ss_pred ccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCc-------ccccccccccCC
Q 003847 208 NLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNV-------FMNQESSSFSGN 279 (791)
Q Consensus 208 N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~-------~~~~~~~~~~~n 279 (791)
|+|++..+..+.. .+|++|+|++|+|+ .+|..+.. +++|++|+|++|++++..+.... +..+..+.+.+|
T Consensus 227 N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~-l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N 304 (332)
T 2ft3_A 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD-LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304 (332)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG-CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSS
T ss_pred CcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc-CccCCEEECCCCCCCccChhHccccccccccccccceEeecC
Confidence 9999877777766 58999999999999 99998876 99999999999999977665432 344566778888
Q ss_pred CCCC
Q 003847 280 LDLC 283 (791)
Q Consensus 280 ~~lc 283 (791)
++.+
T Consensus 305 ~~~~ 308 (332)
T 2ft3_A 305 PVPY 308 (332)
T ss_dssp SSCG
T ss_pred cccc
Confidence 8764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.4e-22 Score=221.39 Aligned_cols=117 Identities=17% Similarity=0.134 Sum_probs=60.9
Q ss_pred CCCCCCcEEEEEcCCCCCccCC-CcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc--cCCC
Q 003847 76 EGNNDSRVIGLALPNSQLLGSI-PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET--MGSL 152 (791)
Q Consensus 76 ~~~~~~~v~~L~L~~~~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l 152 (791)
.+....+++.|+|++|.+.+.+ +..|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++.+|.. |.++
T Consensus 49 ~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l 128 (455)
T 3v47_A 49 SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128 (455)
T ss_dssp TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTC
T ss_pred HhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCc
Confidence 3444555555555555554333 334555555555555555555555555555555555555555555433333 5555
Q ss_pred CCCCEEeCcCCcCCCCCccc-cCCCCCCCEEeCCCCcCCCC
Q 003847 153 HNLQLLNLSDNALAGKLPVS-LTTLQSLTIVSLKNNYFSDG 192 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ 192 (791)
++|++|+|++|++++..|.. |.++++|++|+|++|++++.
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred ccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 55555555555555444443 45555555555555555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-21 Score=199.13 Aligned_cols=172 Identities=20% Similarity=0.197 Sum_probs=151.5
Q ss_pred eeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCc
Q 003847 65 SWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL 140 (791)
Q Consensus 65 ~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 140 (791)
.|..+.|....- ..-...++.|+|++|++.+..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 466777763210 1123578999999999999999999999999999999999999888899999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCC
Q 003847 141 ISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPD 217 (791)
Q Consensus 141 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~ 217 (791)
|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..| ++|++|+|++|+|++..+..
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 998888889999999999999999998777788999999999999999998777555 78999999999999777777
Q ss_pred cCC-ccccEEEccCCcCccc
Q 003847 218 IGG-YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 218 ~~~-~~L~~L~l~~N~l~g~ 236 (791)
+.. .+|++|+|++|.+++.
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTT
T ss_pred HhCCCCCCEEEeeCCceeCC
Confidence 766 5899999999999976
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=214.32 Aligned_cols=197 Identities=24% Similarity=0.289 Sum_probs=167.0
Q ss_pred CcEEEEEcCCCCCccCCCcCC--CCCCCCCEEeCcCCCCCCCCc----ccccCCCCccEEEccCCcCCCCCccccCCCCC
Q 003847 81 SRVIGLALPNSQLLGSIPADL--GMIEFLQYLDLSNNSLNGSLS----FSLFNASQLRNLDLSNNLISGHLPETMGSLHN 154 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 154 (791)
.+++.|+|++|++.+..|..+ ..+++|++|+|++|+|++..+ ..+..+++|++|+|++|+|++..+..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 359999999999999999998 999999999999999997655 45567999999999999999888899999999
Q ss_pred CCEEeCcCCcCCCC--C--ccccCCCCCCCEEeCCCCcCCCCCC------CCCcccceeccccccccccCCCCcCC----
Q 003847 155 LQLLNLSDNALAGK--L--PVSLTTLQSLTIVSLKNNYFSDGLP------SKFNSVQVLDLSSNLINGSLPPDIGG---- 220 (791)
Q Consensus 155 L~~L~ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p------~~l~~L~~L~ls~N~l~~~~p~~~~~---- 220 (791)
|++|+|++|++.+. + +..+..+++|++|+|++|+|+.... ..+++|++|+|++|+|++.+|..+..
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999998753 2 2334789999999999999974221 23489999999999999887877765
Q ss_pred ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCC
Q 003847 221 YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDL 282 (791)
Q Consensus 221 ~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~l 282 (791)
.+|++|+|++|+|+ .+|..+ .++|+.|||++|+|++. |....+.++..+.+.+|+..
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~---~~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGL---PAKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCC---CSCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred CcCCEEECCCCCCC-chhhhh---cCCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence 38999999999999 889877 37999999999999974 44455677788888888653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=236.47 Aligned_cols=203 Identities=23% Similarity=0.324 Sum_probs=179.4
Q ss_pred CCCCCCCCcEEEEEcCCCCCccC-----------------CCcCCC--CCCCCCEEeCcCCCCCCCCcccccCCCCccEE
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGS-----------------IPADLG--MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNL 134 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 134 (791)
|..+....+++.|+|++|+++|. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|
T Consensus 199 p~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 278 (636)
T 4eco_A 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278 (636)
T ss_dssp CGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEE
T ss_pred CHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEE
Confidence 55677789999999999999996 999999 99999999999999999999999999999999
Q ss_pred EccCCc-CCC-CCccccCCC------CCCCEEeCcCCcCCCCCcc--ccCCCCCCCEEeCCCCcCCCCCCCCC---cccc
Q 003847 135 DLSNNL-ISG-HLPETMGSL------HNLQLLNLSDNALAGKLPV--SLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQ 201 (791)
Q Consensus 135 ~L~~N~-l~~-~~p~~~~~l------~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~ 201 (791)
+|++|+ |+| .+|..++++ ++|++|+|++|+++ .+|. .|.++++|++|+|++|+++|.+| .| ++|+
T Consensus 279 ~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~ 356 (636)
T 4eco_A 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLA 356 (636)
T ss_dssp ECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEES
T ss_pred ECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCC
Confidence 999998 998 899998887 99999999999999 8998 99999999999999999998888 66 7899
Q ss_pred eeccccccccccCCCCcCC-cc-ccEEEccCCcCcccCchhHhh-cCCCCcEEEcccCcCcccCCCCCc--------ccc
Q 003847 202 VLDLSSNLINGSLPPDIGG-YS-LRYLNLSYNRLSGEIPPQFGE-KIPVNATIDLSFNNLTGEIPESNV--------FMN 270 (791)
Q Consensus 202 ~L~ls~N~l~~~~p~~~~~-~~-L~~L~l~~N~l~g~ip~~~~~-~l~~l~~l~l~~N~l~~~~p~~~~--------~~~ 270 (791)
.|+|++|+|+ .+|..+.. .+ |++|+|++|+|+ .+|..+.. .+++|++|+|++|++++.+|.... ..+
T Consensus 357 ~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~ 434 (636)
T 4eco_A 357 SLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434 (636)
T ss_dssp EEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCC
T ss_pred EEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCC
Confidence 9999999999 88888876 46 999999999999 89987654 134899999999999998886533 335
Q ss_pred cccccccCCC
Q 003847 271 QESSSFSGNL 280 (791)
Q Consensus 271 ~~~~~~~~n~ 280 (791)
+..+.+.+|.
T Consensus 435 L~~L~Ls~N~ 444 (636)
T 4eco_A 435 VSSINLSNNQ 444 (636)
T ss_dssp EEEEECCSSC
T ss_pred CCEEECcCCc
Confidence 5556666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.6e-22 Score=226.04 Aligned_cols=198 Identities=26% Similarity=0.325 Sum_probs=152.7
Q ss_pred ccCCCCCCCCCCc-----eeeee-eeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccc
Q 003847 52 VLGSWNYNDENPC-----SWNGV-TCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSL 125 (791)
Q Consensus 52 ~l~sw~~~~~~~c-----~w~gv-~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 125 (791)
.+.+|.. +.+|| .|.|+ .|. ..+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+|
T Consensus 32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~-------~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip--- 96 (571)
T 3cvr_A 32 AWDKWEK-QALPGENRNEAVSLLKECL-------INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--- 96 (571)
T ss_dssp HHHHHHT-TCCTTCCHHHHHHHHHHHH-------HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---
T ss_pred HHHHHhc-cCCccccccchhhhccccc-------cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---
Confidence 3556754 45678 79999 786 3578999999999987 676663 78999999999998 566
Q ss_pred cCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceecc
Q 003847 126 FNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205 (791)
Q Consensus 126 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~l 205 (791)
..+++|++|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+++|+.|+|
T Consensus 97 ~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~L 167 (571)
T 3cvr_A 97 ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSV 167 (571)
T ss_dssp CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEEC
T ss_pred cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEEC
Confidence 457899999999999986 777 665 89999999999986 665 67889999999999887 5666788899999
Q ss_pred ccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCC-------cEEEcccCcCcccCCC-CCccccccccccc
Q 003847 206 SSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVN-------ATIDLSFNNLTGEIPE-SNVFMNQESSSFS 277 (791)
Q Consensus 206 s~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l-------~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~ 277 (791)
++|+|++ +|. +. .+|++|+|++|+|+ .+|. +.. +| +.|+|++|+|+. +|. ...+.++..+.+.
T Consensus 168 s~N~L~~-lp~-l~-~~L~~L~Ls~N~L~-~lp~-~~~---~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~ 238 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP-ESLEALDVSTNLLE-SLPA-VPV---RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILE 238 (571)
T ss_dssp CSSCCSC-CCC-CC-TTCCEEECCSSCCS-SCCC-CC-----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECC
T ss_pred CCCCCCC-cch-hh-CCCCEEECcCCCCC-chhh-HHH---hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEee
Confidence 9998885 666 55 78888888888888 7777 432 55 888888888885 454 3445566667777
Q ss_pred CCCCC
Q 003847 278 GNLDL 282 (791)
Q Consensus 278 ~n~~l 282 (791)
+|+..
T Consensus 239 ~N~l~ 243 (571)
T 3cvr_A 239 DNPLS 243 (571)
T ss_dssp SSSCC
T ss_pred CCcCC
Confidence 77654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-22 Score=212.88 Aligned_cols=178 Identities=22% Similarity=0.219 Sum_probs=155.1
Q ss_pred CCCCcEEEEEcCCCCCccCCCcCCCCC-----CCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCC--Ccccc-
Q 003847 78 NNDSRVIGLALPNSQLLGSIPADLGMI-----EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--LPETM- 149 (791)
Q Consensus 78 ~~~~~v~~L~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~- 149 (791)
....+++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. +|..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 5678999999999999988 8888877 9999999999999998889999999999999999999875 34455
Q ss_pred -CCCCCCCEEeCcCCcCCCC--Cc-cccCCCCCCCEEeCCCCcCCCCCCC-C---CcccceeccccccccccCCCCcCCc
Q 003847 150 -GSLHNLQLLNLSDNALAGK--LP-VSLTTLQSLTIVSLKNNYFSDGLPS-K---FNSVQVLDLSSNLINGSLPPDIGGY 221 (791)
Q Consensus 150 -~~l~~L~~L~ls~N~l~~~--~p-~~~~~l~~L~~L~L~~N~l~~~~p~-~---l~~L~~L~ls~N~l~~~~p~~~~~~ 221 (791)
.++++|++|+|++|+|++. ++ ..+.++++|++|+|++|+|++.+|. . +++|++|+|++|+|+ .+|..+. .
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~ 274 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-A 274 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-S
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-C
Confidence 8999999999999999832 22 4456889999999999999997752 2 379999999999999 7888777 8
Q ss_pred cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
+|++|+|++|+|++ +|. +.. +++|++|+|++|+|++.
T Consensus 275 ~L~~L~Ls~N~l~~-~p~-~~~-l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 275 KLSVLDLSYNRLDR-NPS-PDE-LPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp EEEEEECCSSCCCS-CCC-TTT-SCEEEEEECTTCTTTCC
T ss_pred CceEEECCCCCCCC-Chh-Hhh-CCCCCEEeccCCCCCCC
Confidence 99999999999995 476 554 99999999999999863
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=221.28 Aligned_cols=213 Identities=17% Similarity=0.123 Sum_probs=175.8
Q ss_pred eeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcC
Q 003847 66 WNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 66 w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
|..|.|...+- ..-...++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 67888863221 11245789999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCc
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDI 218 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~ 218 (791)
++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..| ++|+.|+|++|+|++..+..+
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 172 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHh
Confidence 97667779999999999999999999999999999999999999999998777655 789999999999996655556
Q ss_pred CC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCC
Q 003847 219 GG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGN 279 (791)
Q Consensus 219 ~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n 279 (791)
.. .+|+.|+|++|.+++..+..+. .+++|+.|+|++|++.+.+|.. ....++..+.+.+|
T Consensus 173 ~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n 234 (477)
T 2id5_A 173 SHLHGLIVLRLRHLNINAIRDYSFK-RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234 (477)
T ss_dssp TTCTTCCEEEEESCCCCEECTTCSC-SCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESS
T ss_pred cccCCCcEEeCCCCcCcEeChhhcc-cCcccceeeCCCCccccccCcccccCccccEEECcCC
Confidence 55 5899999999999854444444 4888888888888877776654 22234555555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=214.79 Aligned_cols=192 Identities=22% Similarity=0.197 Sum_probs=140.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++++..+ |..+++|++|+|++|+|++.. .+++|++|+|++|+|++..+. .+++|+.|+
T Consensus 57 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~ 126 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIY 126 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEE
T ss_pred CCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEE
Confidence 4455555555555554433 555555555555555555221 225566666666666544333 367899999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC----cccceeccccccccccCCCCcCCccccEEEccCCcCcc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSG 235 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g 235 (791)
|++|++++..+..+..+++|++|+|++|++++..+..+ ++|++|+|++|+|++. +......+|++|+|++|+|+
T Consensus 127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~- 204 (317)
T 3o53_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA- 204 (317)
T ss_dssp CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-
T ss_pred CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-
Confidence 99999998878889999999999999999998766543 7899999999999854 54444578999999999999
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCG 284 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 284 (791)
.+|..+.. +++|+.|+|++|++++..+....+.++..+.+.+|++.|+
T Consensus 205 ~l~~~~~~-l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 205 FMGPEFQS-AAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp EECGGGGG-GTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cchhhhcc-cCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 56767665 9999999999999996544445566788889999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=226.59 Aligned_cols=159 Identities=21% Similarity=0.263 Sum_probs=135.6
Q ss_pred cCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCC--CccccCCCCCCCEEeCCCCcCCCCCCCC----Ccc
Q 003847 126 FNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGK--LPVSLTTLQSLTIVSLKNNYFSDGLPSK----FNS 199 (791)
Q Consensus 126 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~----l~~ 199 (791)
..+++|++|+|++|++++.+|..++++++|+.|+|++|++++. +|..|.++++|++|+|++|++++.+|.. +++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 6778899999999999988899999999999999999999963 3567899999999999999999855543 378
Q ss_pred cceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC-CCcccccccccccC
Q 003847 200 VQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE-SNVFMNQESSSFSG 278 (791)
Q Consensus 200 L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~ 278 (791)
|+.|+|++|+|++.+|..+. .+|++|+|++|+|+ .+|..++. +++|++|+|++|+|+...+. ...+..+..+.+.+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~-~ip~~~~~-l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~ 506 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPKDVTH-LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC-TTCSEEECCSSCCC-CCCTTTTS-SCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred CCEEECCCCCCCcchhhhhc-CcCCEEECCCCcCc-ccChhhcC-CCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence 99999999999888877665 68999999999999 89999984 99999999999999954443 35566788899999
Q ss_pred CCCCCCCCC
Q 003847 279 NLDLCGQPT 287 (791)
Q Consensus 279 n~~lc~~~~ 287 (791)
|++.|+|++
T Consensus 507 N~~~c~c~~ 515 (562)
T 3a79_B 507 NPWDCTCPG 515 (562)
T ss_dssp CCBCCCHHH
T ss_pred CCcCCCcch
Confidence 999998753
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.2e-21 Score=204.22 Aligned_cols=208 Identities=20% Similarity=0.214 Sum_probs=171.6
Q ss_pred eeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc
Q 003847 69 VTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET 148 (791)
Q Consensus 69 v~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 148 (791)
++-..+..+....+++.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..+. ++|++|+|++|++++..+..
T Consensus 64 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~ 140 (330)
T 1xku_A 64 ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSV 140 (330)
T ss_dssp CCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHH
T ss_pred CCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhH
Confidence 33333445677889999999999999999999999999999999999998 5666554 79999999999999888888
Q ss_pred cCCCCCCCEEeCcCCcCCC--CCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccE
Q 003847 149 MGSLHNLQLLNLSDNALAG--KLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRY 225 (791)
Q Consensus 149 ~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~ 225 (791)
|.++++|+.|+|++|.+.. ..+..|.++++|++|+|++|+++......+++|+.|+|++|++++..|..+.. .+|++
T Consensus 141 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred hcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 9999999999999999964 77888999999999999999998744444588999999999998877777776 58999
Q ss_pred EEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCC
Q 003847 226 LNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLD 281 (791)
Q Consensus 226 L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 281 (791)
|+|++|++++..+..+.. +++|+.|+|++|+++ .+|.. ..+.++..+.+.+|..
T Consensus 221 L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLAN-TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp EECCSSCCCEECTTTGGG-STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCceeChhhccC-CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 999999998655555655 899999999999998 45543 4455666777777754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.2e-22 Score=209.27 Aligned_cols=182 Identities=21% Similarity=0.257 Sum_probs=160.9
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCc-ccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLS-FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
..+++.|+|++|++.+ +|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..+..|.++++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 4567778888887764 56678999999999999999997655 689999999999999999999899999999999999
Q ss_pred eCcCCcCCC-CCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcC
Q 003847 159 NLSDNALAG-KLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRL 233 (791)
Q Consensus 159 ~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l 233 (791)
+|++|.+++ .+|..+..+++|++|+|++|++++..|..| ++|+.|+|++|+|++..+..+.. .+|++|+|++|++
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 999999987 688999999999999999999999877765 78999999999999776666665 5899999999999
Q ss_pred cccCchhHhhcC-CCCcEEEcccCcCcccCC
Q 003847 234 SGEIPPQFGEKI-PVNATIDLSFNNLTGEIP 263 (791)
Q Consensus 234 ~g~ip~~~~~~l-~~l~~l~l~~N~l~~~~p 263 (791)
++..|..+.. + ++|++|+|++|++++..+
T Consensus 236 ~~~~~~~~~~-~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 236 MTSKKQELQH-FPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CBCSSSSCCC-CCTTCCEEECTTCCEECSGG
T ss_pred cccCHHHHHh-hhccCCEEEccCCCeecccC
Confidence 9888888776 6 599999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=221.62 Aligned_cols=159 Identities=23% Similarity=0.281 Sum_probs=139.2
Q ss_pred cCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCC--CCccccCCCCCCCEEeCCCCcCCCCCCCC----Ccc
Q 003847 126 FNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG--KLPVSLTTLQSLTIVSLKNNYFSDGLPSK----FNS 199 (791)
Q Consensus 126 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~----l~~ 199 (791)
..+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 678899999999999999899999999999999999999997 56678999999999999999999866543 378
Q ss_pred cceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC-CCcccccccccccC
Q 003847 200 VQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE-SNVFMNQESSSFSG 278 (791)
Q Consensus 200 L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~ 278 (791)
|+.|+|++|++++.+|..+. .+|++|+|++|+|+ .+|..++. +++|++|+|++|+|+...+. ...+.++..+.+.+
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~-~ip~~~~~-l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~ 477 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIK-SIPKQVVK-LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECcCCCCCcchhhhhc-ccCCEEECCCCccc-ccchhhhc-CCCCCEEECCCCcCCccCHHHhccCCcccEEECcC
Confidence 99999999999988887765 68999999999999 99999985 99999999999999954333 34566788899999
Q ss_pred CCCCCCCCC
Q 003847 279 NLDLCGQPT 287 (791)
Q Consensus 279 n~~lc~~~~ 287 (791)
|++.|+|++
T Consensus 478 N~~~c~c~~ 486 (520)
T 2z7x_B 478 NPWDCSCPR 486 (520)
T ss_dssp SCBCCCHHH
T ss_pred CCCcccCCc
Confidence 999998753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-22 Score=218.18 Aligned_cols=196 Identities=19% Similarity=0.159 Sum_probs=155.0
Q ss_pred eeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCc-
Q 003847 68 GVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP- 146 (791)
Q Consensus 68 gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p- 146 (791)
+++-..+..+....+++.|+|++|++++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+
T Consensus 63 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~ 142 (353)
T 2z80_A 63 RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET 142 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS
T ss_pred cCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch
Confidence 3333334456678889999999999998888889999999999999999997666668899999999999999984433
Q ss_pred cccCCCCCCCEEeCcCC-cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---------------------------c
Q 003847 147 ETMGSLHNLQLLNLSDN-ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---------------------------N 198 (791)
Q Consensus 147 ~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---------------------------~ 198 (791)
..|.++++|++|+|++| .+.+..+..|.++++|++|+|++|++++..|..+ +
T Consensus 143 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 222 (353)
T 2z80_A 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222 (353)
T ss_dssp CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTT
T ss_pred hhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcc
Confidence 47888999999999988 4776667788888888888888888887656433 4
Q ss_pred ccceeccccccccccCCC-------------------------------CcCC-ccccEEEccCCcCcccCchhHhhcCC
Q 003847 199 SVQVLDLSSNLINGSLPP-------------------------------DIGG-YSLRYLNLSYNRLSGEIPPQFGEKIP 246 (791)
Q Consensus 199 ~L~~L~ls~N~l~~~~p~-------------------------------~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~ 246 (791)
+|+.|+|++|++++..+. .+.. .+|++|+|++|+|+ .+|..++..++
T Consensus 223 ~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~ 301 (353)
T 2z80_A 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT 301 (353)
T ss_dssp TEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCT
T ss_pred cccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCC
Confidence 566666777776653322 1222 47999999999999 89998766699
Q ss_pred CCcEEEcccCcCcccCCC
Q 003847 247 VNATIDLSFNNLTGEIPE 264 (791)
Q Consensus 247 ~l~~l~l~~N~l~~~~p~ 264 (791)
+|++|+|++|++++.+|.
T Consensus 302 ~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 302 SLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp TCCEEECCSSCBCCCHHH
T ss_pred CCCEEEeeCCCccCcCCC
Confidence 999999999999998774
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.1e-22 Score=235.57 Aligned_cols=201 Identities=23% Similarity=0.281 Sum_probs=173.3
Q ss_pred CCCCCCCCcEEEEEcCCCCCcc-----------------CCCcCCC--CCCCCCEEeCcCCCCCCCCcccccCCCCccEE
Q 003847 74 PGEGNNDSRVIGLALPNSQLLG-----------------SIPADLG--MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNL 134 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 134 (791)
|..+..+.+++.|+|++|+|+| .+|..++ +|++|++|+|++|++.+.+|..|.++++|++|
T Consensus 441 P~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L 520 (876)
T 4ecn_A 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520 (876)
T ss_dssp CGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEE
T ss_pred hHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEE
Confidence 5557778999999999999999 4899988 99999999999999999999999999999999
Q ss_pred EccCCc-CCC-CCccccCCCC-------CCCEEeCcCCcCCCCCcc--ccCCCCCCCEEeCCCCcCCCCCCCCC---ccc
Q 003847 135 DLSNNL-ISG-HLPETMGSLH-------NLQLLNLSDNALAGKLPV--SLTTLQSLTIVSLKNNYFSDGLPSKF---NSV 200 (791)
Q Consensus 135 ~L~~N~-l~~-~~p~~~~~l~-------~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L 200 (791)
+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+|+ .+| .| ++|
T Consensus 521 ~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L 597 (876)
T 4ecn_A 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKL 597 (876)
T ss_dssp ECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEE
T ss_pred ECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcc
Confidence 999998 998 8888766655 9999999999999 8898 9999999999999999999 677 44 789
Q ss_pred ceeccccccccccCCCCcCC-cc-ccEEEccCCcCcccCchhHhhcCC--CCcEEEcccCcCcccCCCCC------cccc
Q 003847 201 QVLDLSSNLINGSLPPDIGG-YS-LRYLNLSYNRLSGEIPPQFGEKIP--VNATIDLSFNNLTGEIPESN------VFMN 270 (791)
Q Consensus 201 ~~L~ls~N~l~~~~p~~~~~-~~-L~~L~l~~N~l~g~ip~~~~~~l~--~l~~l~l~~N~l~~~~p~~~------~~~~ 270 (791)
+.|+|++|+|+ .+|..+.. .+ |++|+|++|+|+ .+|..+.. +. +|+.|+|++|+++|.+|... ...+
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~-~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA-KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCT-TCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred eEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhc-cccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 99999999999 88888877 46 999999999999 89977654 54 49999999999999877542 2224
Q ss_pred cccccccCCC
Q 003847 271 QESSSFSGNL 280 (791)
Q Consensus 271 ~~~~~~~~n~ 280 (791)
+..+.+.+|.
T Consensus 675 L~~L~Ls~N~ 684 (876)
T 4ecn_A 675 ASTVTLSYNE 684 (876)
T ss_dssp EEEEECCSSC
T ss_pred cCEEEccCCc
Confidence 5556666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.1e-20 Score=187.65 Aligned_cols=161 Identities=23% Similarity=0.232 Sum_probs=117.5
Q ss_pred CCCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC
Q 003847 60 DENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN 139 (791)
Q Consensus 60 ~~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 139 (791)
+.+.|+|.+|.|. ++++. .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 15 ~~~~Cs~~~v~c~-----------------~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 15 SQCSCSGTTVDCR-----------------SKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp TTCEEETTEEECT-----------------TSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCEEeCCEeEcc-----------------CCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 4577999999997 23343 4555443 88999999999999888888999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcC
Q 003847 140 LISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIG 219 (791)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~ 219 (791)
+|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|+. +|..+ .
T Consensus 75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~---------------------~ 132 (229)
T 3e6j_A 75 QLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGI---------------------E 132 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS-CCTTG---------------------G
T ss_pred CCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccc-cCccc---------------------c
Confidence 9986666778899999999999999997777778888888888888888873 34332 2
Q ss_pred C-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCC
Q 003847 220 G-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIP 263 (791)
Q Consensus 220 ~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p 263 (791)
. .+|++|+|++|+|+ .+|...+..+++|+.|+|++|++++..+
T Consensus 133 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 133 RLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp GCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 2 24555555566555 3443333346666666666666665554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-21 Score=221.09 Aligned_cols=198 Identities=22% Similarity=0.241 Sum_probs=169.0
Q ss_pred CcEEEEEcCCCCCccCCCcCC-CCCCCCCEEeCcCCCCCCCCcc---cccCCCCccEEEccCCcCCCCCc--cccCCCCC
Q 003847 81 SRVIGLALPNSQLLGSIPADL-GMIEFLQYLDLSNNSLNGSLSF---SLFNASQLRNLDLSNNLISGHLP--ETMGSLHN 154 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~ 154 (791)
++++.|+|++|++. .+|..+ ..+++|++|+|++|++++.+|. .+..+++|++|+|++|+|++..+ ..+..+++
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~ 388 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence 57889999999986 567665 5799999999999999987643 47889999999999999986533 56899999
Q ss_pred CCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCCccccEEEccCCcCc
Q 003847 155 LQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234 (791)
Q Consensus 155 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~ 234 (791)
|++|+|++|+|+ .+|..+..+++|++|+|++|+|++......++|++|+|++|+|++.+. ...+|++|+|++|+|+
T Consensus 389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~---~l~~L~~L~Ls~N~l~ 464 (549)
T 2z81_A 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLK 464 (549)
T ss_dssp CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCC---CCTTCCEEECCSSCCS
T ss_pred CCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcc---cCChhcEEECCCCccC
Confidence 999999999999 789999999999999999999987443444789999999999996531 2358999999999999
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQP 286 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 286 (791)
.+|.. .. +++|++|+|++|+|++.+|.. ..+..+..+.+.+|++.|+++
T Consensus 465 -~ip~~-~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 465 -TLPDA-SL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp -SCCCG-GG-CTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred -cCCCc-cc-CccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 89974 33 999999999999999988874 456678889999999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.9e-22 Score=223.84 Aligned_cols=183 Identities=23% Similarity=0.224 Sum_probs=146.8
Q ss_pred CCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcc----------------cccCCCCccEEEccCC
Q 003847 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSF----------------SLFNASQLRNLDLSNN 139 (791)
Q Consensus 76 ~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~N 139 (791)
.+....+++.|+|++|.+++..| |+.+++|++|+|++|.|++..+. ....+++|+.|+|++|
T Consensus 53 ~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N 130 (487)
T 3oja_A 53 DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANN 130 (487)
T ss_dssp GGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSS
T ss_pred HHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCC
Confidence 34456677777777777776554 67777777776666665532111 1124678999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCcCCcCCCCCccccC-CCCCCCEEeCCCCcCCCCCCCC-CcccceeccccccccccCCCC
Q 003847 140 LISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLT-TLQSLTIVSLKNNYFSDGLPSK-FNSVQVLDLSSNLINGSLPPD 217 (791)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~-l~~L~~L~ls~N~l~~~~p~~ 217 (791)
.|++..|..|+++++|+.|+|++|.|++..|..+. .+++|+.|+|++|.|++..+.. +++|+.|+|++|.|++..|.
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~- 209 (487)
T 3oja_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPE- 209 (487)
T ss_dssp CCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGG-
T ss_pred CCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCHh-
Confidence 99998899999999999999999999998888886 7999999999999999864433 58999999999999975554
Q ss_pred cCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCc-ccCC
Q 003847 218 IGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT-GEIP 263 (791)
Q Consensus 218 ~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~-~~~p 263 (791)
+.. .+|+.|+|++|.|+ .+|..+.. +++|+.|+|++|+++ +.+|
T Consensus 210 ~~~l~~L~~L~Ls~N~l~-~lp~~l~~-l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 210 FQSAAGVTWISLRNNKLV-LIEKALRF-SQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp GGGGTTCSEEECTTSCCC-EECTTCCC-CTTCCEEECTTCCBCHHHHH
T ss_pred HcCCCCccEEEecCCcCc-ccchhhcc-CCCCCEEEcCCCCCcCcchH
Confidence 554 68999999999999 58888765 999999999999998 4444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-20 Score=219.55 Aligned_cols=201 Identities=22% Similarity=0.157 Sum_probs=163.2
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|+++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 36899999999999988888899999999999999999998899999999999999999999966666799999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC---ccccEEEccCCcC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG---YSLRYLNLSYNRL 233 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~---~~L~~L~l~~N~l 233 (791)
|++|++++..|..|.++++|++|+|++|.+++..|..+ ++|++|+|++|++++..+..+.. .+|++|+|++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 99999998777889999999999999999998877654 78999999999998776665432 5899999999999
Q ss_pred cccCchhHhh--------------------------cCCCCcEEEcccCcCcccCCCCCccc---ccccccccCCC
Q 003847 234 SGEIPPQFGE--------------------------KIPVNATIDLSFNNLTGEIPESNVFM---NQESSSFSGNL 280 (791)
Q Consensus 234 ~g~ip~~~~~--------------------------~l~~l~~l~l~~N~l~~~~p~~~~~~---~~~~~~~~~n~ 280 (791)
++..|..+.. ..++|+.|+|++|.+++..|...... ++..+.+.+|.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~ 259 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSC
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCC
Confidence 8766655432 12566777777777777776653321 25555555553
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-20 Score=184.97 Aligned_cols=171 Identities=23% Similarity=0.222 Sum_probs=150.2
Q ss_pred ceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCC
Q 003847 64 CSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143 (791)
Q Consensus 64 c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 143 (791)
|+..|++-... ....+++.|+|++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|+|++
T Consensus 14 c~~~~l~~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 90 (208)
T 2o6s_A 14 CYSQGRTSVPT---GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90 (208)
T ss_dssp CCSSCCSSCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ecCCCccCCCC---CCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCc
Confidence 77777766532 224689999999999998888889999999999999999997777778999999999999999997
Q ss_pred CCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC
Q 003847 144 HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG 220 (791)
Q Consensus 144 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~ 220 (791)
..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..| ++|+.|+|++|.+.+..|
T Consensus 91 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----- 165 (208)
T 2o6s_A 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----- 165 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-----
T ss_pred cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-----
Confidence 777778999999999999999998777789999999999999999998766544 789999999999886543
Q ss_pred ccccEEEccCCcCcccCchhHhh
Q 003847 221 YSLRYLNLSYNRLSGEIPPQFGE 243 (791)
Q Consensus 221 ~~L~~L~l~~N~l~g~ip~~~~~ 243 (791)
+|++|+++.|+++|.+|..+..
T Consensus 166 -~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 166 -GIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp -TTHHHHHHHHHCTTTBBCTTSS
T ss_pred -CHHHHHHHHHhCCceeeccCcc
Confidence 7899999999999999988765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=217.28 Aligned_cols=156 Identities=19% Similarity=0.165 Sum_probs=124.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
...++.|+|++|++++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 35788999999999988888999999999999999999988888899999999999999999988888899999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCC--CcccceeccccccccccCCCCcCC-cccc--EEEccCCcC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSK--FNSVQVLDLSSNLINGSLPPDIGG-YSLR--YLNLSYNRL 233 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~--l~~L~~L~ls~N~l~~~~p~~~~~-~~L~--~L~l~~N~l 233 (791)
|++|++++..|..|.++++|++|+|++|++++.. |.. +++|++|+|++|++++..|..+.. .+|+ .|++++|++
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 9999998776788888999999999999888743 332 367777777777777555544443 2444 555555555
Q ss_pred cc
Q 003847 234 SG 235 (791)
Q Consensus 234 ~g 235 (791)
++
T Consensus 192 ~~ 193 (606)
T 3t6q_A 192 AG 193 (606)
T ss_dssp CE
T ss_pred Cc
Confidence 53
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=215.97 Aligned_cols=161 Identities=22% Similarity=0.264 Sum_probs=145.3
Q ss_pred CCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCC--CccccCCCCCCCEEeCcCCcCCCCCcc-ccCCCCC
Q 003847 102 GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--LPETMGSLHNLQLLNLSDNALAGKLPV-SLTTLQS 178 (791)
Q Consensus 102 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~ 178 (791)
..+++|++|+|++|++++.+|..+.++++|++|+|++|+|++. +|..|.++++|++|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 7889999999999999999999999999999999999999963 457799999999999999999985655 5889999
Q ss_pred CCEEeCCCCcCCCCCCCCC-cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccC
Q 003847 179 LTIVSLKNNYFSDGLPSKF-NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 179 L~~L~L~~N~l~~~~p~~l-~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
|++|+|++|+|++.+|..+ ++|+.|+|++|+|+ .+|..+.. .+|++|+|++|+|+ .+|...+..+++|+.|+|++|
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC
Confidence 9999999999999999888 69999999999999 67776655 58999999999999 899884445999999999999
Q ss_pred cCcccCCC
Q 003847 257 NLTGEIPE 264 (791)
Q Consensus 257 ~l~~~~p~ 264 (791)
+++|.+|.
T Consensus 508 ~~~c~c~~ 515 (562)
T 3a79_B 508 PWDCTCPG 515 (562)
T ss_dssp CBCCCHHH
T ss_pred CcCCCcch
Confidence 99988774
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=215.67 Aligned_cols=161 Identities=25% Similarity=0.297 Sum_probs=146.1
Q ss_pred CCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCC--CCccccCCCCCCCEEeCcCCcCCCCCcc-ccCCCCC
Q 003847 102 GMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG--HLPETMGSLHNLQLLNLSDNALAGKLPV-SLTTLQS 178 (791)
Q Consensus 102 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~ 178 (791)
..+++|++|+|++|++++.+|..+.++++|++|+|++|+|++ .+|..+.++++|++|+|++|++++.+|. .+..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 788999999999999999999999999999999999999996 5678899999999999999999985665 4889999
Q ss_pred CCEEeCCCCcCCCCCCCCC-cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccC
Q 003847 179 LTIVSLKNNYFSDGLPSKF-NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 179 L~~L~L~~N~l~~~~p~~l-~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
|++|+|++|++++.+|..+ ++|+.|+|++|+|+ .+|..+.. .+|++|+|++|+|+ .+|...+..+++|++|+|++|
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence 9999999999999888888 69999999999999 77876655 68999999999999 899885555999999999999
Q ss_pred cCcccCCC
Q 003847 257 NLTGEIPE 264 (791)
Q Consensus 257 ~l~~~~p~ 264 (791)
++++.++.
T Consensus 479 ~~~c~c~~ 486 (520)
T 2z7x_B 479 PWDCSCPR 486 (520)
T ss_dssp CBCCCHHH
T ss_pred CCcccCCc
Confidence 99987663
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=214.94 Aligned_cols=197 Identities=22% Similarity=0.201 Sum_probs=163.2
Q ss_pred CCCceee----eeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCcc
Q 003847 61 ENPCSWN----GVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLR 132 (791)
Q Consensus 61 ~~~c~w~----gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 132 (791)
.+||.|. .|.|...+- .....+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 3567663 467753110 11246899999999999999888999999999999999999988888999999999
Q ss_pred EEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC-CCCCCC---cccceeccccc
Q 003847 133 NLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD-GLPSKF---NSVQVLDLSSN 208 (791)
Q Consensus 133 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l---~~L~~L~ls~N 208 (791)
+|+|++|+|++..|..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++ .+|..| ++|++|+|++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998889999999999999999999998777889999999999999999986 557655 78999999999
Q ss_pred cccccCCCCcCCc-c----ccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCc
Q 003847 209 LINGSLPPDIGGY-S----LRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLT 259 (791)
Q Consensus 209 ~l~~~~p~~~~~~-~----L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~ 259 (791)
++++..|..+... + +.+|++++|.++ .+|...+. ..+|+.|+|++|.++
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~-~~~L~~L~L~~n~~~ 217 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQ-GIKLHELTLRGNFNS 217 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSC
T ss_pred cceecChhhhhhhhccccccceeeccCCCcc-eeCccccc-CceeeeeeccCCccc
Confidence 9998878777653 3 458999999998 66666666 448899999998875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=216.24 Aligned_cols=203 Identities=21% Similarity=0.240 Sum_probs=167.0
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCC--cccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSL--SFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
.+++.|++++|.+.+..+. ..+++|++|+|++|++++.. |..+.++++|++|+|++|.+++..+ .+.++++|+.|
T Consensus 325 ~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L 401 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHL 401 (570)
T ss_dssp SSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEE
T ss_pred cccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEE
Confidence 4455555555555544443 67888999999999988654 7788899999999999999985444 49999999999
Q ss_pred eCcCCcCCCCCc-cccCCCCCCCEEeCCCCcCCCCCCCCC---cccceecccccccc-ccCCCCcCC-ccccEEEccCCc
Q 003847 159 NLSDNALAGKLP-VSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLIN-GSLPPDIGG-YSLRYLNLSYNR 232 (791)
Q Consensus 159 ~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~-~~~p~~~~~-~~L~~L~l~~N~ 232 (791)
+|++|.+.+..| ..+.++++|++|+|++|++++..|..+ ++|+.|+|++|+++ +.+|..+.. .+|++|+|++|+
T Consensus 402 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~ 481 (570)
T 2z63_A 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481 (570)
T ss_dssp ECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred EccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCc
Confidence 999999997766 578899999999999999998887665 78999999999997 678888876 589999999999
Q ss_pred CcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCC
Q 003847 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 233 l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 287 (791)
+++..|..+.. +++|++|+|++|++++.+|.. ..+..+..+.+.+|++.|+++.
T Consensus 482 l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 482 LEQLSPTAFNS-LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CCEECTTTTTT-CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cccCChhhhhc-ccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99777877766 999999999999999887765 4566788889999999997653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.7e-21 Score=201.74 Aligned_cols=177 Identities=19% Similarity=0.163 Sum_probs=151.0
Q ss_pred CCCCcEEEEEcCCCCCccCCC----cCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCC--C--cccc
Q 003847 78 NNDSRVIGLALPNSQLLGSIP----ADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--L--PETM 149 (791)
Q Consensus 78 ~~~~~v~~L~L~~~~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~ 149 (791)
....+++.|+|++|.+.+..+ ..+..+++|++|+|++|+|.+..+..|.++++|++|+|++|++.+. + +..+
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 193 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP 193 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence 457789999999999998766 4566899999999999999998899999999999999999998753 2 2334
Q ss_pred CCCCCCCEEeCcCCcCCCCCcc----ccCCCCCCCEEeCCCCcCCCCCCCCC------cccceeccccccccccCCCCcC
Q 003847 150 GSLHNLQLLNLSDNALAGKLPV----SLTTLQSLTIVSLKNNYFSDGLPSKF------NSVQVLDLSSNLINGSLPPDIG 219 (791)
Q Consensus 150 ~~l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~l------~~L~~L~ls~N~l~~~~p~~~~ 219 (791)
+.+++|++|+|++|+++ .++. .+.++++|++|+|++|+|++..|..+ ++|++|+|++|+|+ .+|..+.
T Consensus 194 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 194 HKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp TSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred hcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence 78999999999999998 4443 35788999999999999999877543 58999999999999 7787775
Q ss_pred CccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcc
Q 003847 220 GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 220 ~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
.+|++|+|++|+|++ +|. + ..+++|+.|+|++|+|+.
T Consensus 272 -~~L~~L~Ls~N~l~~-~~~-~-~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 272 -AKLRVLDLSSNRLNR-APQ-P-DELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -SCCSCEECCSCCCCS-CCC-T-TSCCCCSCEECSSTTTSC
T ss_pred -CCCCEEECCCCcCCC-Cch-h-hhCCCccEEECcCCCCCC
Confidence 799999999999994 454 3 348999999999999974
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=7e-20 Score=198.56 Aligned_cols=213 Identities=18% Similarity=0.130 Sum_probs=171.4
Q ss_pred ceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCc-ccccCCCCccE-EEcc
Q 003847 64 CSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLS-FSLFNASQLRN-LDLS 137 (791)
Q Consensus 64 c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 137 (791)
|+|..|.|+..+- .+-..+++.|+|++|+|+.+.+..|.+|++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 7899999963221 0123578999999999998777889999999999999999987665 56889998775 7778
Q ss_pred CCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC-CcCCCCCCCCC----cccceeccccccccc
Q 003847 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN-NYFSDGLPSKF----NSVQVLDLSSNLING 212 (791)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l----~~L~~L~ls~N~l~~ 212 (791)
+|+|+...|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..| ..|+.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999988899999999999999999999977777788888899999965 67776555554 468899999999996
Q ss_pred cCCCCcCCccccEEEccC-CcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 213 SLPPDIGGYSLRYLNLSY-NRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 213 ~~p~~~~~~~L~~L~l~~-N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
..+..+...+|++|++++ |.++ .||...+..+++|++|||++|+|+...+. .+.++..+...++
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~--~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARST 233 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSS--SCTTCCEEECTTC
T ss_pred CChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChh--hhccchHhhhccC
Confidence 555566668999999985 6666 99988877799999999999999955442 3455555555554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.4e-20 Score=214.14 Aligned_cols=198 Identities=23% Similarity=0.156 Sum_probs=158.7
Q ss_pred CCceee----eeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccE
Q 003847 62 NPCSWN----GVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRN 133 (791)
Q Consensus 62 ~~c~w~----gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 133 (791)
+||.+. -|.|...+- .+-+..++.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 456553 367863221 112357899999999999888889999999999999999999877888999999999
Q ss_pred EEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCC-CCCC---Ccccceecccccc
Q 003847 134 LDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDG-LPSK---FNSVQVLDLSSNL 209 (791)
Q Consensus 134 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~---l~~L~~L~ls~N~ 209 (791)
|+|++|+|++..+..|.+|++|++|+|++|+|++..+..|+++++|++|+|++|++++. +|.. +++|++|+|++|+
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 99999999977778899999999999999999987777899999999999999999864 4544 4789999999999
Q ss_pred ccccCCCCcCCc-----cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 210 INGSLPPDIGGY-----SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 210 l~~~~p~~~~~~-----~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
|++..+..+... .+..++++.|.++ .++...+. ...+..+++.+|.....
T Consensus 185 l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~ 239 (635)
T 4g8a_A 185 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLN 239 (635)
T ss_dssp CCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHH
T ss_pred ccccccccccchhhhhhhhhhhhcccCccc-ccCccccc-chhhhhhhhhccccccc
Confidence 998777776542 3557889999998 56666555 55677888888876543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=218.72 Aligned_cols=116 Identities=19% Similarity=0.088 Sum_probs=49.3
Q ss_pred CCCCcEEEEEcCCCCCccCC-CcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccc--cCCCCC
Q 003847 78 NNDSRVIGLALPNSQLLGSI-PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPET--MGSLHN 154 (791)
Q Consensus 78 ~~~~~v~~L~L~~~~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~ 154 (791)
....+++.|+|++|++.+.+ |..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|.|++.+|.. |+++++
T Consensus 45 ~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~ 124 (844)
T 3j0a_A 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124 (844)
T ss_dssp SSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSS
T ss_pred cccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCC
Confidence 33344444444444333333 333444444444444444444444444444444444444444444333332 444444
Q ss_pred CCEEeCcCCcCCCCCc-cccCCCCCCCEEeCCCCcCCCCC
Q 003847 155 LQLLNLSDNALAGKLP-VSLTTLQSLTIVSLKNNYFSDGL 193 (791)
Q Consensus 155 L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 193 (791)
|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..
T Consensus 125 L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp CCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred CCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 4444444444443322 23444444444444444444433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-20 Score=187.66 Aligned_cols=178 Identities=15% Similarity=0.127 Sum_probs=155.0
Q ss_pred CCCCCCCCcEEEEEcCCCC-CccCCCcCCCCCCCCCEEeCcC-CCCCCCCcccccCCCCccEEEccCCcCCCCCccccCC
Q 003847 74 PGEGNNDSRVIGLALPNSQ-LLGSIPADLGMIEFLQYLDLSN-NSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGS 151 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 151 (791)
+..+....+++.|+|++|+ +++..+..|..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|++ +|. |.+
T Consensus 48 ~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~ 125 (239)
T 2xwt_C 48 SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTK 125 (239)
T ss_dssp TTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTT
T ss_pred HHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccc
Confidence 4456778899999999997 8887778999999999999999 99997777889999999999999999996 776 899
Q ss_pred CCCCC---EEeCcCC-cCCCCCccccCCCCCCC-EEeCCCCcCCCCCCCCC--cccceecccccc-ccccCCCCcCC--c
Q 003847 152 LHNLQ---LLNLSDN-ALAGKLPVSLTTLQSLT-IVSLKNNYFSDGLPSKF--NSVQVLDLSSNL-INGSLPPDIGG--Y 221 (791)
Q Consensus 152 l~~L~---~L~ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l--~~L~~L~ls~N~-l~~~~p~~~~~--~ 221 (791)
+++|+ +|+|++| ++++..+..|.++++|+ .|+|++|+++...+..| ++|+.|+|++|+ |++..+..+.. .
T Consensus 126 l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~ 205 (239)
T 2xwt_C 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205 (239)
T ss_dssp CCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSB
T ss_pred ccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcccc
Confidence 99998 9999999 99977778899999999 99999999995444444 689999999995 98666667765 4
Q ss_pred cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCc
Q 003847 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~ 257 (791)
+|++|+|++|+|+ .+|.. .+++|+.|+++++.
T Consensus 206 ~L~~L~l~~N~l~-~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 206 GPSLLDVSQTSVT-ALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp CCSEEECTTCCCC-CCCCT---TCTTCSEEECTTC-
T ss_pred CCcEEECCCCccc-cCChh---HhccCceeeccCcc
Confidence 8999999999999 77776 38899999998763
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=205.40 Aligned_cols=162 Identities=33% Similarity=0.487 Sum_probs=142.8
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
.+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 57999999999998 566 568999999999999997 776 665 99999999999996 776 6899999999
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC-cccceeccccccccccCCCCcCCccc-------cEEEccCCc
Q 003847 161 SDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF-NSVQVLDLSSNLINGSLPPDIGGYSL-------RYLNLSYNR 232 (791)
Q Consensus 161 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~L~~L~ls~N~l~~~~p~~~~~~~L-------~~L~l~~N~ 232 (791)
++|+|++ +|. .+++|+.|+|++|+|++ +|. | ++|+.|+|++|+|+ .+|. +.. +| ++|+|++|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N~L~-~lp~-~~~-~L~~~~~~L~~L~Ls~N~ 218 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTNLLE-SLPA-VPV-RNHHSEETEIFFRCRENR 218 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCS-SCCC-CC---------CCEEEECCSSC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCCCCC-chhh-HHH-hhhcccccceEEecCCCc
Confidence 9999996 665 67899999999999998 665 5 79999999999999 7777 655 77 999999999
Q ss_pred CcccCchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 233 l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
|+ .||..++. +++|+.|+|++|+|++.+|..
T Consensus 219 l~-~lp~~l~~-l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 219 IT-HIPENILS-LDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp CC-CCCGGGGG-SCTTEEEECCSSSCCHHHHHH
T ss_pred ce-ecCHHHhc-CCCCCEEEeeCCcCCCcCHHH
Confidence 99 89999998 999999999999999988865
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=190.27 Aligned_cols=188 Identities=19% Similarity=0.301 Sum_probs=136.8
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|++++|++.. ++ .+..+++|++|+|++|+|++..+ +.++++|++|+|++|+|++ ++ .+.++++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEE
Confidence 4577888888888765 33 57788888888888888875444 7888888888888888874 34 578888888888
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
|++|++++ ++. +..+++|++|+|++|++++..+ ..+++|+.|+|++|+|++. +. +.. .+|++|+|++|+++ .+
T Consensus 114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~-~~ 188 (308)
T 1h6u_A 114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKIS-DI 188 (308)
T ss_dssp CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CC
T ss_pred CCCCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccC-cC
Confidence 88888875 343 7888888888888888877543 2347788888888888753 33 444 57888888888887 44
Q ss_pred chhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
+. +.. +++|++|+|++|++++..| ...+.++..+.+.+|+.
T Consensus 189 ~~-l~~-l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 189 SP-LAS-LPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp GG-GGG-CTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEE
T ss_pred hh-hcC-CCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCee
Confidence 44 433 8888888888888886654 34455666666777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-20 Score=199.13 Aligned_cols=188 Identities=28% Similarity=0.224 Sum_probs=148.5
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++++..|..|..+++|++|+|++|+|++..+ |..+++|++|+|++|+|++. + .+++|++|+
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~ 105 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLH 105 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCCEEE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcCEEE
Confidence 4578899999999988877889999999999999999886554 88889999999999998843 2 337899999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC--ccccEEEccCCcCc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG--YSLRYLNLSYNRLS 234 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~--~~L~~L~l~~N~l~ 234 (791)
|++|++++..+.. +++|++|+|++|++++..+..+ ++|++|+|++|+|++..+..+.. .+|++|+|++|+|+
T Consensus 106 l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 9999998655443 5778999999999988766554 78899999999998777766642 58999999999998
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
.+|... . +++|+.|+|++|++++..+....+.++..+.+.+|.
T Consensus 183 -~~~~~~-~-l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~ 225 (317)
T 3o53_A 183 -DVKGQV-V-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNK 225 (317)
T ss_dssp -EEECCC-C-CTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSC
T ss_pred -cccccc-c-cccCCEEECCCCcCCcchhhhcccCcccEEECcCCc
Confidence 445443 2 888999999999998776665555667777777764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=196.74 Aligned_cols=174 Identities=29% Similarity=0.259 Sum_probs=136.1
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCccccc-CCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLF-NASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
.+++++++|+. +|..+. ..|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45666777764 565554 4588999999999977777777 8999999999999999777788999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCc---C-CccccEEEccCCcCccc
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDI---G-GYSLRYLNLSYNRLSGE 236 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~---~-~~~L~~L~l~~N~l~g~ 236 (791)
+|++..+..|.++++|+.|+|++|+|++..|..| ++|+.|+|++|+|++..+..+ . ..+|++|+|++|+|+ .
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ 177 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-K 177 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC-C
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC-c
Confidence 9997777788999999999999999988766655 678888888888885433333 2 258999999999998 6
Q ss_pred CchhHhhcCCC--CcEEEcccCcCcccC
Q 003847 237 IPPQFGEKIPV--NATIDLSFNNLTGEI 262 (791)
Q Consensus 237 ip~~~~~~l~~--l~~l~l~~N~l~~~~ 262 (791)
+|...+..++. ++.|+|++|++.+..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCc
Confidence 66554444776 377888888887543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.6e-20 Score=184.41 Aligned_cols=147 Identities=25% Similarity=0.270 Sum_probs=109.2
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCc-ccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLS-FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
.|++++|+++. +|..+. ..+++|+|++|+|++..+ ..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 79999999975 566654 457899999999997755 45889999999999999999888888999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|++..+..|.++++|++|+|++|+|++..|..| ++|++|+|++|+|++..|..+.. .+|++|+|++|.++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 9998888889999999999999998887666544 34444444444444433433332 23333333333333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=179.96 Aligned_cols=147 Identities=25% Similarity=0.262 Sum_probs=100.4
Q ss_pred CCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCC
Q 003847 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL 169 (791)
Q Consensus 90 ~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 169 (791)
+++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+...
T Consensus 20 ~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~ 96 (220)
T 2v9t_B 20 GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP 96 (220)
T ss_dssp TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccC
Confidence 45554 3455444 67888888888888777778888888888888888888777888888888888888888888666
Q ss_pred ccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCC
Q 003847 170 PVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVN 248 (791)
Q Consensus 170 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l 248 (791)
+..|.++++|++|+|++|+|++..|..| .. .+|++|+|++|+|+ .++...+..+++|
T Consensus 97 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~---------------------~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L 154 (220)
T 2v9t_B 97 KSLFEGLFSLQLLLLNANKINCLRVDAF---------------------QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154 (220)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTT---------------------TTCTTCCEEECCSSCCS-CCCTTTTTTCTTC
T ss_pred HhHccCCCCCCEEECCCCCCCEeCHHHc---------------------CCCCCCCEEECCCCcCC-EECHHHHhCCCCC
Confidence 6667788888888888888777555443 22 24444555555554 2332222235666
Q ss_pred cEEEcccCcCccc
Q 003847 249 ATIDLSFNNLTGE 261 (791)
Q Consensus 249 ~~l~l~~N~l~~~ 261 (791)
+.|+|++|++++.
T Consensus 155 ~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 155 QTMHLAQNPFICD 167 (220)
T ss_dssp CEEECCSSCEECS
T ss_pred CEEEeCCCCcCCC
Confidence 6666666666543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=207.62 Aligned_cols=153 Identities=25% Similarity=0.232 Sum_probs=81.5
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 45555555555555555555555555555555555555445555555555555555555555555555555555555555
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCC-CCCCCC---cccceeccccccccccCCCCcCC-ccc----cEEEccCCc
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSD-GLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSL----RYLNLSYNR 232 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L----~~L~l~~N~ 232 (791)
+|++++..+..|.++++|++|+|++|.+++ .+|..| ++|++|+|++|++++..+..+.. .+| +.|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 555554444445555555555555555554 234433 45555555555555444433333 123 444444444
Q ss_pred Cc
Q 003847 233 LS 234 (791)
Q Consensus 233 l~ 234 (791)
++
T Consensus 189 l~ 190 (570)
T 2z63_A 189 MN 190 (570)
T ss_dssp CC
T ss_pred ce
Confidence 44
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.2e-19 Score=178.28 Aligned_cols=151 Identities=23% Similarity=0.226 Sum_probs=84.5
Q ss_pred EEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCc-cccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCC
Q 003847 109 YLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP-ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187 (791)
Q Consensus 109 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 187 (791)
.|++++|.|+ .+|..+. ..+++|+|++|+|++..| ..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5666666665 3444332 234566666666664433 33556666666666666666555555666666666666666
Q ss_pred cCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCC
Q 003847 188 YFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIP 263 (791)
Q Consensus 188 ~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p 263 (791)
+|++..+..| ++|++|+|++|+|++..|..+.. .+|++|+|++|+|++..|..+.. +++|+.|+|++|+|++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT-LHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTT-CTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcC-CCCCCEEEecCcCCcCCCc
Confidence 6655544332 45666666666666555555544 35666666666666444444443 6666666666666655443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-20 Score=223.52 Aligned_cols=222 Identities=19% Similarity=0.228 Sum_probs=132.3
Q ss_pred ChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEE
Q 003847 31 LNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYL 110 (791)
Q Consensus 31 ~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L 110 (791)
...+..+|+++...........-.+|.......+.|.++.++ .++++.|+|.+|++... +..+ |+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-------~~~~~~l~L~~n~~~~~-~~~~-----l~~l 196 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVS-------TPLTPKIELFANGKDEA-NQAL-----LQHK 196 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceec-------CCccceEEeeCCCCCcc-hhhH-----hhcC
Confidence 345678899888776544455556776555566789999987 56899999999998764 3322 3334
Q ss_pred eCcCCCCCC---------CCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCE
Q 003847 111 DLSNNSLNG---------SLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTI 181 (791)
Q Consensus 111 ~L~~N~l~~---------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 181 (791)
+|+.|.|.+ ..|..|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|.+|++|++
T Consensus 197 ~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 274 (727)
T 4b8c_D 197 KLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRV 274 (727)
T ss_dssp -------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCE
T ss_pred ccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCE
Confidence 444444432 45788999999999999999998 78888889999999999999999 88999999999999
Q ss_pred EeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCc
Q 003847 182 VSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257 (791)
Q Consensus 182 L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~ 257 (791)
|+|++|+|+ .+|..| ++|++|+|++|.|+ .+|..|+. .+|++|+|++|.|+|.+|..+......+..|+|++|.
T Consensus 275 L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~ 352 (727)
T 4b8c_D 275 LDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNR 352 (727)
T ss_dssp EECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCC
T ss_pred EeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCc
Confidence 999999999 567766 78999999999997 78888877 5899999999999999888876522233457899999
Q ss_pred CcccCCCCCccc
Q 003847 258 LTGEIPESNVFM 269 (791)
Q Consensus 258 l~~~~p~~~~~~ 269 (791)
++|.+|....+.
T Consensus 353 l~~~~p~~l~~l 364 (727)
T 4b8c_D 353 PEIPLPHERRFI 364 (727)
T ss_dssp CCCCCCCC----
T ss_pred ccCcCcccccee
Confidence 999999865443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=196.13 Aligned_cols=176 Identities=26% Similarity=0.186 Sum_probs=148.6
Q ss_pred CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccC-CCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC
Q 003847 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG-SLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186 (791)
Q Consensus 108 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 186 (791)
+.+++++|+|+ .+|..+. ..|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 58999999999 5676654 4689999999999988888887 999999999999999988888999999999999999
Q ss_pred CcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHh---hcCCCCcEEEcccCcCc
Q 003847 187 NYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFG---EKIPVNATIDLSFNNLT 259 (791)
Q Consensus 187 N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~---~~l~~l~~l~l~~N~l~ 259 (791)
|+|++..+..| ++|+.|+|++|+|++..|..+.. .+|++|+|++|+|+ .+|..++ ..+++|+.|||++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99998766554 78999999999999888888877 58999999999999 7888775 34999999999999999
Q ss_pred ccCCCCCc-ccc--cccccccCCCCCCCCCC
Q 003847 260 GEIPESNV-FMN--QESSSFSGNLDLCGQPT 287 (791)
Q Consensus 260 ~~~p~~~~-~~~--~~~~~~~~n~~lc~~~~ 287 (791)
+..+.... +.. +..+.+.+|+|.|+|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 65443221 111 25678999999998754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=180.93 Aligned_cols=156 Identities=20% Similarity=0.248 Sum_probs=124.2
Q ss_pred CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCC
Q 003847 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187 (791)
Q Consensus 108 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 187 (791)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46888899888 5666554 68999999999998777778899999999999999999888888888888888888888
Q ss_pred cCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-
Q 003847 188 YFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES- 265 (791)
Q Consensus 188 ~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~- 265 (791)
+|+...+. .+.. .+|++|+|++|+|++..|..+.. +++|++|+|++|+|++..+..
T Consensus 91 ~l~~l~~~---------------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~ 148 (220)
T 2v9t_B 91 KITELPKS---------------------LFEGLFSLQLLLLNANKINCLRVDAFQD-LHNLNLLSLYDNKLQTIAKGTF 148 (220)
T ss_dssp CCCCCCTT---------------------TTTTCTTCCEEECCSSCCCCCCTTTTTT-CTTCCEEECCSSCCSCCCTTTT
T ss_pred cCCccCHh---------------------HccCCCCCCEEECCCCCCCEeCHHHcCC-CCCCCEEECCCCcCCEECHHHH
Confidence 87753322 2332 47888888888888555555554 999999999999999888764
Q ss_pred CcccccccccccCCCCCCCCCCC
Q 003847 266 NVFMNQESSSFSGNLDLCGQPTK 288 (791)
Q Consensus 266 ~~~~~~~~~~~~~n~~lc~~~~~ 288 (791)
..+.++..+.+.+|++.|+|.+.
T Consensus 149 ~~l~~L~~L~L~~N~~~c~c~l~ 171 (220)
T 2v9t_B 149 SPLRAIQTMHLAQNPFICDCHLK 171 (220)
T ss_dssp TTCTTCCEEECCSSCEECSGGGH
T ss_pred hCCCCCCEEEeCCCCcCCCCccH
Confidence 44667888999999999987643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-19 Score=187.14 Aligned_cols=172 Identities=26% Similarity=0.384 Sum_probs=147.0
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|++.+..+ +..+++|++|+|++|+|++. + .+.++++|++|+|++|+|++ ++. +..+++|+
T Consensus 59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~ 132 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQ 132 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCC
T ss_pred hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCC
Confidence 3446799999999999987655 99999999999999999964 4 69999999999999999995 454 99999999
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|+|++|++++..+ +..+++|+.|+|++|++++..+ ..+++|+.|+|++|+|++..+ +.. .+|++|+|++|+|+
T Consensus 133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCC
T ss_pred EEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccC
Confidence 99999999996544 8899999999999999998554 345899999999999985443 443 68999999999999
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
+ ++. +.. +++|+.|+|++|++++.
T Consensus 209 ~-~~~-l~~-l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 209 D-VSP-LAN-TSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp B-CGG-GTT-CTTCCEEEEEEEEEECC
T ss_pred c-ccc-ccC-CCCCCEEEccCCeeecC
Confidence 4 443 544 99999999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-19 Score=185.61 Aligned_cols=134 Identities=16% Similarity=0.176 Sum_probs=105.0
Q ss_pred ceeccccCceEEEEEEe-CCCcE--EEEEEcCCCchh------------------------hHHHHHHHHHHHhccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTA--LAVRRIGENSVD------------------------RFRDFETQVRVIAKLVHPN 532 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 532 (791)
...||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++++++.|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46899999999999997 78999 999987543111 1136889999999998886
Q ss_pred c--cceeeEEEccCceEEEEeccCC-C----ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCeecCCCC
Q 003847 533 L--VRIRGFYWGVDEKLIIYDFVPN-G----SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH-EKKHVHGNLKP 604 (791)
Q Consensus 533 I--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~ivHrDlkp 604 (791)
+ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| +.||+||||||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 4 344432 367899999942 4 66554322 234467889999999999999 99999999999
Q ss_pred CCeEecCCCCeEEeccCcccccC
Q 003847 605 RNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 605 ~NILl~~~~~~kL~DFGla~~~~ 627 (791)
+|||++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999988 99999999998754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=188.60 Aligned_cols=192 Identities=23% Similarity=0.326 Sum_probs=102.6
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCc------------
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLP------------ 146 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------ 146 (791)
...+++.|+|++|.....++. +..+++|++|++++|.+.+..+ +.++++|++|+|++|.+++..+
T Consensus 130 ~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l 206 (347)
T 4fmz_A 130 NLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTA 206 (347)
T ss_dssp TCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEEC
T ss_pred cCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccccccCCCccceeec
Confidence 345556666666644433332 5555555555555555543322 4445555555555555542211
Q ss_pred ---------cccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCC
Q 003847 147 ---------ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPP 216 (791)
Q Consensus 147 ---------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~ 216 (791)
. +..+++|+.|+|++|++++..+ +..+++|++|+|++|.+++.. ...+++|+.|+|++|++++. +
T Consensus 207 ~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~- 281 (347)
T 4fmz_A 207 YVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI-S- 281 (347)
T ss_dssp CSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-G-
T ss_pred ccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC-h-
Confidence 1 5555666666666666653322 556666666666666665531 12335666666666666632 2
Q ss_pred CcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 217 DIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 217 ~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
.+.. .+|++|+|++|++++..|..+.. +++|+.|+|++|++++..| ...+.++..+.+.+|+
T Consensus 282 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGG-LTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp GGGGCTTCSEEECCSSCCCGGGHHHHHT-CTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred hhcCCCCCCEEECcCCcCCCcChhHhhc-cccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 2222 46666666666666555555544 6666666666666666555 3344455555555553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=207.58 Aligned_cols=218 Identities=24% Similarity=0.255 Sum_probs=162.9
Q ss_pred CCCCccCCCCCCCCCCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccC
Q 003847 48 DPLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFN 127 (791)
Q Consensus 48 ~~~~~l~sw~~~~~~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 127 (791)
|+...+++|+. .-|..|..-.|..+ . +..+=++.+|+ .+|..+. +++++|||++|+|++..+..|.+
T Consensus 8 ~~~~~~~~~~~--~~p~~~~~c~~~~~-------~-~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~ 74 (635)
T 4g8a_A 8 DDDDKLAAANS--SIPESWEPCVEVVP-------N-ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFS 74 (635)
T ss_dssp -------------------CCSEEEET-------T-TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTT
T ss_pred CCcchhhcccC--CCCCCCCCccccCC-------C-CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhC
Confidence 33446777763 45778887666522 1 23466677777 5666553 57999999999999888889999
Q ss_pred CCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceec
Q 003847 128 ASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLD 204 (791)
Q Consensus 128 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ 204 (791)
+++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..| ++|++|+
T Consensus 75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 9999999999999998888899999999999999999998888899999999999999999998766544 7899999
Q ss_pred cccccccc-cCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCC----CcEEEcccCcCcccCCCCCcccccccccccC
Q 003847 205 LSSNLING-SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPV----NATIDLSFNNLTGEIPESNVFMNQESSSFSG 278 (791)
Q Consensus 205 ls~N~l~~-~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~----l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 278 (791)
|++|+|++ .+|..+.. .+|++|+|++|+|++..|..+.. +.+ +..++++.|+++...+..........+.+.+
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~ 233 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 233 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH-HHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEES
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccc-hhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhc
Confidence 99999975 45666665 58999999999999777766543 433 4579999999998777665555545555555
Q ss_pred C
Q 003847 279 N 279 (791)
Q Consensus 279 n 279 (791)
|
T Consensus 234 n 234 (635)
T 4g8a_A 234 N 234 (635)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=182.70 Aligned_cols=168 Identities=23% Similarity=0.286 Sum_probs=144.4
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|++++|++... +.+..+++|++|+|++|+|++..+ +.++++|++|+|++|+|++ +| .+.++++|++|+
T Consensus 45 l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~ 118 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (291)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence 46789999999999865 358999999999999999997655 9999999999999999985 44 499999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
|++|++++. ..+..+++|+.|+|++|++++.. ...+++|+.|+|++|+|++..+ +.. .+|++|+|++|+|+ .+
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~-~l 193 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL 193 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BC
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcchhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC-CC
Confidence 999999964 46889999999999999999852 1234899999999999996555 544 68999999999999 56
Q ss_pred chhHhhcCCCCcEEEcccCcCcc
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
|. +.. +++|+.|+|++|+++.
T Consensus 194 ~~-l~~-l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 RA-LAG-LKNLDVLELFSQECLN 214 (291)
T ss_dssp GG-GTT-CTTCSEEEEEEEEEEC
T ss_pred hh-hcc-CCCCCEEECcCCcccC
Confidence 64 544 9999999999999975
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-17 Score=187.62 Aligned_cols=182 Identities=21% Similarity=0.154 Sum_probs=109.4
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|++++. | ++.+++|++|+|++|+|++. + +.++++|++|+|++|+|++ +| ++++++|+
T Consensus 60 l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~ 130 (457)
T 3bz5_A 60 IEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLT 130 (457)
T ss_dssp GGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCC
T ss_pred hcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCC
Confidence 44567778888888888764 3 77788888888888888764 3 7777888888888888875 44 77777888
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|+|++|+|++. + +..+++|++|+|++|+..+.+ ...+++|+.|+|++|+|++ +| +.. .+|++|++++|+|+
T Consensus 131 ~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 131 YLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp EEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCS
T ss_pred EEECCCCcccee-c--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCC
Confidence 888888877753 2 556666666666666433332 2233556666666666654 33 222 34555555555555
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
+ ++ +.. +++|++|+|++|++++ +| ...+.++..+.+.+|
T Consensus 205 ~-~~--l~~-l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 205 K-LD--LNQ-NIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVN 243 (457)
T ss_dssp C-CC--CTT-CTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSS
T ss_pred e-ec--ccc-CCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCC
Confidence 3 22 222 5555555555555554 33 223333444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.5e-18 Score=188.19 Aligned_cols=182 Identities=19% Similarity=0.172 Sum_probs=155.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|++++. | .|+.+++|++|+|++|+|++. | +.++++|++|+|++|+|++. + ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 57899999999999975 4 799999999999999999975 4 89999999999999999974 4 99999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCc
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIP 238 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip 238 (791)
|++|++++ +| +..+++|++|+|++|+|++.....+++|++|++++|+..+.++ +.. .+|++|++++|+|++ +|
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~-l~ 186 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LD 186 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCCC-CC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccce-ec
Confidence 99999996 44 8999999999999999999755667999999999997666663 444 589999999999995 77
Q ss_pred hhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 239 PQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 239 ~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
+.. +++|+.|++++|++++. +...+.++..+.+.+|.
T Consensus 187 --l~~-l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~ 223 (457)
T 3bz5_A 187 --VSQ-NKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNK 223 (457)
T ss_dssp --CTT-CTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSC
T ss_pred --ccc-CCCCCEEECcCCcCCee--ccccCCCCCEEECcCCc
Confidence 444 99999999999999986 24445566666666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=193.67 Aligned_cols=189 Identities=24% Similarity=0.289 Sum_probs=102.5
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|.+.+. +.+..+++|++|+|++|.+++..| +..+++|+.|+|++|++++ + ..+..+++|+
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~ 246 (466)
T 1o6v_A 173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLT 246 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCS
T ss_pred hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCC
Confidence 34456677777777776543 236666677777777776665544 5556666666666666653 2 2355566666
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
.|+|++|.+++..+ +..+++|+.|+|++|++++..+ ..+++|+.|+|++|++++..+ +.. .+|++|+|++|+++
T Consensus 247 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~ 322 (466)
T 1o6v_A 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS 322 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS
T ss_pred EEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC
Confidence 66666666654433 5556666666666666655332 223555566666665554322 222 35555555555555
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
+..| +. .+++|+.|++++|++++. +....+.++..+.+.+|
T Consensus 323 ~~~~--~~-~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 323 DISP--VS-SLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHN 363 (466)
T ss_dssp CCGG--GG-GCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred Cchh--hc-cCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCC
Confidence 4333 22 255555555555555543 22223334444444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=171.38 Aligned_cols=124 Identities=27% Similarity=0.328 Sum_probs=94.6
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcc-cccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSF-SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
.|++++|+|. .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4455567774 56665543 889999999999866654 4888999999999999999888888999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceecccccccc
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLIN 211 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~ 211 (791)
+|++..+..|.++++|++|+|++|+|++.+|..| ++|++|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 9998888888888888888888888887655544 33444444444443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=194.80 Aligned_cols=149 Identities=26% Similarity=0.301 Sum_probs=67.5
Q ss_pred CCCCCCcEEEEEcCCCCCccCCCcCCCCCCCC-------------CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCC
Q 003847 76 EGNNDSRVIGLALPNSQLLGSIPADLGMIEFL-------------QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS 142 (791)
Q Consensus 76 ~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 142 (791)
.+....+++.|+|++|++.|.+|..++++.+| ++|+|++|.+++ +|.. .++|++|+|++|+++
T Consensus 29 ~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~ 104 (454)
T 1jl5_A 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT 104 (454)
T ss_dssp -----CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS
T ss_pred hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCC
Confidence 34445555666666666666666666655543 555555555543 2221 134555555555555
Q ss_pred CCCccccC----------------CC-CCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceecc
Q 003847 143 GHLPETMG----------------SL-HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205 (791)
Q Consensus 143 ~~~p~~~~----------------~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~l 205 (791)
+ +|..+. .+ ++|++|+|++|++++ +| .|.++++|++|+|++|++++ +|..+.+|++|+|
T Consensus 105 ~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~~~L~~L~L 180 (454)
T 1jl5_A 105 E-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAA 180 (454)
T ss_dssp S-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCCTTCCEEEC
T ss_pred c-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCcccccEEEC
Confidence 4 443221 01 244444444444443 33 34444444555554444443 3333444444444
Q ss_pred ccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 206 SSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 206 s~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
++|++++ +| .+.. .+|++|++++|+++
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~ 208 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLK 208 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCC
Confidence 4444443 33 2222 34444444444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=8.9e-18 Score=165.40 Aligned_cols=131 Identities=21% Similarity=0.270 Sum_probs=109.4
Q ss_pred CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCcc-ccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC
Q 003847 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPE-TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186 (791)
Q Consensus 108 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 186 (791)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999997 67776654 899999999999976665 489999999999999999998899999999999999999
Q ss_pred CcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhH
Q 003847 187 NYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQF 241 (791)
Q Consensus 187 N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~ 241 (791)
|+|++..+..| ++|++|+|++|+|++.+|..+.. .+|++|+|++|.+++..+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~ 146 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH
Confidence 99998777654 67888888888888777777765 478888888888877666443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=187.16 Aligned_cols=190 Identities=28% Similarity=0.349 Sum_probs=135.7
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|++. |++.+.. .+..+++|+.|+|++|.+++. + .+.++++|++|+|++|.+++..| ++.+++|+
T Consensus 152 ~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 224 (466)
T 1o6v_A 152 LSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQISDITP--LGILTNLD 224 (466)
T ss_dssp GTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred hccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccccccc--ccccCCCC
Confidence 4456677777775 4554432 378888888888888888753 2 47788888888888888886555 67788888
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
.|+|++|++++. ..+..+++|+.|+|++|++++..+ ..+++|+.|+|++|++++..+ +.. .+|++|+|++|+++
T Consensus 225 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~ 300 (466)
T 1o6v_A 225 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS
T ss_pred EEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc
Confidence 888888888743 357778888888888888887554 334778888888888875443 333 57888888888888
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
+. +. +.. +++|+.|+|++|++++..| ...+.++..+.+.+|..
T Consensus 301 ~~-~~-~~~-l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l 343 (466)
T 1o6v_A 301 DI-SP-ISN-LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKV 343 (466)
T ss_dssp CC-GG-GGG-CTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCC
T ss_pred Cc-hh-hcC-CCCCCEEECcCCcCCCchh-hccCccCCEeECCCCcc
Confidence 43 33 443 8888888888888887666 34555666666766643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.9e-18 Score=168.06 Aligned_cols=150 Identities=15% Similarity=0.232 Sum_probs=78.8
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+++.|+|++|++. .+| .+..+++|++|+|++|.++. +..+.++++|++|+|++|++++..+..|+.+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4455555555554 233 35555555555555554431 1244555555555555555554444555555555555555
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchh
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQ 240 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~ 240 (791)
+|++++..|..+..+++|++|+|++|++ ++ .+| .+.. .+|++|+|++|+++ .++ .
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~--------------------i~-~~~-~l~~l~~L~~L~l~~n~i~-~~~-~ 176 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGA--------------------IT-DIM-PLKTLPELKSLNIQFDGVH-DYR-G 176 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTB--------------------CC-CCG-GGGGCSSCCEEECTTBCCC-CCT-T
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCC--------------------cc-ccH-hhcCCCCCCEEECCCCCCc-ChH-H
Confidence 5555544445555555555555555541 22 333 2322 46777777777777 454 4
Q ss_pred HhhcCCCCcEEEcccCcCcc
Q 003847 241 FGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 241 ~~~~l~~l~~l~l~~N~l~~ 260 (791)
+.. +++|+.|++++|++.+
T Consensus 177 l~~-l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 177 IED-FPKLNQLYAFSQTIGG 195 (197)
T ss_dssp GGG-CSSCCEEEECBC----
T ss_pred hcc-CCCCCEEEeeCcccCC
Confidence 444 8888888888888753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-17 Score=180.99 Aligned_cols=140 Identities=30% Similarity=0.430 Sum_probs=70.7
Q ss_pred CCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeC
Q 003847 105 EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSL 184 (791)
Q Consensus 105 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 184 (791)
++|++|+|++|+|++ +| .|.++++|++|+|++|+|++ +|..+ .+|++|+|++|++++ +| .+.++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 345555555555553 44 35555555555555555553 33322 245555555555553 33 3555555555555
Q ss_pred CCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcc
Q 003847 185 KNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 185 ~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
++|++++ +|...++|++|+|++|+++ .+|. +.. .+|++|++++|+++ .+|.. +++|+.|++++|++++
T Consensus 203 ~~N~l~~-l~~~~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~-~l~~~----~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 203 DNNSLKK-LPDLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDL----PPSLEALNVRDNYLTD 271 (454)
T ss_dssp CSSCCSS-CCCCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-SCCSC----CTTCCEEECCSSCCSC
T ss_pred CCCcCCc-CCCCcCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCC-ccccc----ccccCEEECCCCcccc
Confidence 5555554 3433445555555555555 4443 333 35555555555555 24431 3455555555555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=192.63 Aligned_cols=170 Identities=24% Similarity=0.286 Sum_probs=146.1
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
+.+|+.|+|++|++... + .|..|++|+.|+|++|+|++..| +.++++|+.|+|++|+|++ +| .+..|++|+.|+
T Consensus 42 L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp HTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 56788999999999754 3 69999999999999999997665 8999999999999999985 44 699999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
|++|+|++ + ..+..|++|+.|+|++|+|++.. ...+++|+.|+|++|+|++..| +.. .+|++|+|++|+|++ +
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l 190 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L 190 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C
Confidence 99999995 3 46889999999999999999852 1245899999999999997666 544 689999999999994 5
Q ss_pred chhHhhcCCCCcEEEcccCcCcccC
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGEI 262 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~~ 262 (791)
| .+.. +++|+.|+|++|++++..
T Consensus 191 ~-~l~~-l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 191 R-ALAG-LKNLDVLELFSQECLNKP 213 (605)
T ss_dssp G-GGTT-CTTCSEEECCSEEEECCC
T ss_pred h-HHcc-CCCCCEEEccCCcCcCCc
Confidence 5 4555 999999999999998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=193.61 Aligned_cols=186 Identities=24% Similarity=0.247 Sum_probs=119.1
Q ss_pred CCccCCCCCCCCCCceeeeeeeCCCCCC-CCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCC
Q 003847 50 LGVLGSWNYNDENPCSWNGVTCASPGEG-NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNA 128 (791)
Q Consensus 50 ~~~l~sw~~~~~~~c~w~gv~C~~~~~~-~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 128 (791)
....++|.. +.+||.|.|..|..+... -....++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+
T Consensus 9 ~~~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 9 DAVWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp -CHHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 345566763 446788866432111000 00234777888888887 5666555 67888888888887 4554 46
Q ss_pred CCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccc
Q 003847 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208 (791)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N 208 (791)
++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+++|++|+|++|
T Consensus 81 ~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N 151 (622)
T 3g06_A 81 PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDN 151 (622)
T ss_dssp TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCC
Confidence 77888888888887 4555 56778888888888774 444 45677777777777776 5556677777777777
Q ss_pred cccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcc
Q 003847 209 LINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 209 ~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
+|++ +|..+ .+|+.|++++|+|+ .+| ..+++|+.|+|++|+|++
T Consensus 152 ~l~~-l~~~~--~~L~~L~L~~N~l~-~l~----~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 152 QLAS-LPALP--SELCKLWAYNNQLT-SLP----MLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp CCSC-CCCCC--TTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC
T ss_pred cCCC-cCCcc--CCCCEEECCCCCCC-CCc----ccCCCCcEEECCCCCCCC
Confidence 7763 34322 35666666666666 455 225666666666666664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.1e-17 Score=166.38 Aligned_cols=143 Identities=23% Similarity=0.206 Sum_probs=117.3
Q ss_pred ceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCC
Q 003847 64 CSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG 143 (791)
Q Consensus 64 c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 143 (791)
|+-.+++-. |.. ...+++.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++
T Consensus 26 c~~~~l~~i-p~~--~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 102 (229)
T 3e6j_A 26 CRSKRHASV-PAG--IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102 (229)
T ss_dssp CTTSCCSSC-CSC--CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ccCCCcCcc-CCC--CCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCc
Confidence 565555543 221 24789999999999999999999999999999999999987777788999999999999999998
Q ss_pred CCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccc
Q 003847 144 HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLI 210 (791)
Q Consensus 144 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l 210 (791)
..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..| ++|+.|+|++|.+
T Consensus 103 l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 171 (229)
T 3e6j_A 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW 171 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence 77888999999999999999999 889999999999999999999987544333 3344444444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.72 E-value=6e-17 Score=187.33 Aligned_cols=180 Identities=28% Similarity=0.309 Sum_probs=96.5
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
..+++.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.. +++|++|+
T Consensus 80 l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 4677788888888764 443 55667777777777664 232 23444444444444442 2221 13333333
Q ss_pred CcCCcCCCCCccccC-----------------CCCCCCEEeCCCCcCCC-------------------CCCCCCccccee
Q 003847 160 LSDNALAGKLPVSLT-----------------TLQSLTIVSLKNNYFSD-------------------GLPSKFNSVQVL 203 (791)
Q Consensus 160 ls~N~l~~~~p~~~~-----------------~l~~L~~L~L~~N~l~~-------------------~~p~~l~~L~~L 203 (791)
|++|+|++ +|..+. .+++|+.|+|++|+|++ .+|..+++|+.|
T Consensus 148 Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L 226 (622)
T 3g06_A 148 VSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKEL 226 (622)
T ss_dssp CCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred CcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCCccchhhEEECcCCcccccCCCCCCCCEE
Confidence 33333332 111111 11344444444444443 123333566777
Q ss_pred ccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCC
Q 003847 204 DLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLD 281 (791)
Q Consensus 204 ~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 281 (791)
+|++|+|++ +|.. ..+|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+.++..+.+.+|+.
T Consensus 227 ~Ls~N~L~~-lp~~--l~~L~~L~Ls~N~L~-~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l 296 (622)
T 3g06_A 227 IVSGNRLTS-LPVL--PSELKELMVSGNRLT-SLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296 (622)
T ss_dssp ECCSSCCSC-CCCC--CTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCC
T ss_pred EccCCccCc-CCCC--CCcCcEEECCCCCCC-cCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCC
Confidence 777777764 4421 146777777777777 6665 2677777777777777 44543 3344555566666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=172.99 Aligned_cols=167 Identities=21% Similarity=0.259 Sum_probs=132.0
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
.+++.++|.++++++.. .+..+++|+.|+|++|.|+ .++ .+..+++|++|+|++|+|++..+ +.++++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 45666778888887554 5788899999999999998 455 68889999999999999985444 889999999999
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCc
Q 003847 161 SDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIP 238 (791)
Q Consensus 161 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip 238 (791)
++|++++ +|.. .. ++|+.|+|++|+|++... ..+++|+.|+|++|+|++. + .+.. .+|++|+|++|+|++.
T Consensus 93 ~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-- 165 (263)
T 1xeu_A 93 NRNRLKN-LNGI-PS-ACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-- 165 (263)
T ss_dssp CSSCCSC-CTTC-CC-SSCCEEECCSSCCSBSGGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred CCCccCC-cCcc-cc-CcccEEEccCCccCCChhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence 9999985 4433 33 899999999999987421 2457899999999999854 4 3444 5899999999999854
Q ss_pred hhHhhcCCCCcEEEcccCcCccc
Q 003847 239 PQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 239 ~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
..+.. +++|+.|+|++|++++.
T Consensus 166 ~~l~~-l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 GGLTR-LKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSTT-CCCCCEEEEEEEEEECC
T ss_pred HHhcc-CCCCCEEeCCCCcccCC
Confidence 44444 99999999999999865
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.6e-17 Score=173.93 Aligned_cols=190 Identities=22% Similarity=0.306 Sum_probs=139.3
Q ss_pred CCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCE
Q 003847 78 NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQL 157 (791)
Q Consensus 78 ~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 157 (791)
....+++.|+|++|++++..+ |..+++|++|+|++|.+++ ++ .|.++++|++|+|++|++++ ++. +..+++|+.
T Consensus 63 ~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~ 136 (347)
T 4fmz_A 63 EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYS 136 (347)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCE
T ss_pred hhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeE
Confidence 346788888888888876533 8888888999998888885 34 58888888899998888884 444 888888888
Q ss_pred EeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcc
Q 003847 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSG 235 (791)
Q Consensus 158 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g 235 (791)
|++++|.....++ .+..+++|++|++++|.+.+..+ ..+++|+.|++++|.+++. +. +.. .+|++|++++|.+++
T Consensus 137 L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~ 213 (347)
T 4fmz_A 137 LNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITD 213 (347)
T ss_dssp EECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCC
T ss_pred EECCCCCCccccc-chhhCCCCcEEEecCCCcCCchhhccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCC
Confidence 8888886664444 48888888888888888877543 3447888888888888743 33 333 578888888888874
Q ss_pred cCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 236 EIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 236 ~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
. +. +.. +++|+.|+|++|++++..+ ...+.++..+.+.+|.
T Consensus 214 ~-~~-~~~-~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~ 254 (347)
T 4fmz_A 214 I-TP-VAN-MTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQ 254 (347)
T ss_dssp C-GG-GGG-CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred C-ch-hhc-CCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCc
Confidence 3 33 433 8888888888888876554 3444555556665553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-17 Score=162.91 Aligned_cols=131 Identities=17% Similarity=0.172 Sum_probs=109.9
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|.+. .++.+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..+.++++|+
T Consensus 62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 139 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139 (197)
T ss_dssp GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence 455778999999999764 345899999999999999999988899999999999999999999988899999999999
Q ss_pred EEeCcCCc-CCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceecccccccc
Q 003847 157 LLNLSDNA-LAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLIN 211 (791)
Q Consensus 157 ~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~ 211 (791)
+|+|++|+ ++ .+| .+..+++|+.|+|++|++++.. ...+++|+.|++++|+|.
T Consensus 140 ~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 140 SIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp EEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC---
T ss_pred EEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccC
Confidence 99999998 65 666 6899999999999999998742 123466777777777664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.1e-18 Score=200.93 Aligned_cols=150 Identities=25% Similarity=0.300 Sum_probs=110.5
Q ss_pred CCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCC
Q 003847 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTT 175 (791)
Q Consensus 96 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 175 (791)
..+..|..++.|+.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|.+
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 44677888888999999999888 67777778888999999999888 78888888889999999999988 77888888
Q ss_pred CCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCCc--cccEEEccCCcCcccCchhHhhcCCCCcE
Q 003847 176 LQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVNAT 250 (791)
Q Consensus 176 l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~~--~L~~L~l~~N~l~g~ip~~~~~~l~~l~~ 250 (791)
|++|++|+|++|.|+ .+|..| ++|++|+|++|.|++.+|..+... .+..|+|++|.++|.+|..+ ..
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l-------~~ 363 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER-------RF 363 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc-------ce
Confidence 889999999999887 456545 678888999999888888777653 33457888898888887644 44
Q ss_pred EEcccC
Q 003847 251 IDLSFN 256 (791)
Q Consensus 251 l~l~~N 256 (791)
|+++.|
T Consensus 364 l~l~~n 369 (727)
T 4b8c_D 364 IEINTD 369 (727)
T ss_dssp ------
T ss_pred eEeecc
Confidence 666666
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.70 E-value=7e-19 Score=191.65 Aligned_cols=200 Identities=21% Similarity=0.232 Sum_probs=146.2
Q ss_pred CCcEEEEEcCCCCCccCCC----cCCCCCC-CCCEEeCcCCCCCCCCcccccCC-----CCccEEEccCCcCCCCCcccc
Q 003847 80 DSRVIGLALPNSQLLGSIP----ADLGMIE-FLQYLDLSNNSLNGSLSFSLFNA-----SQLRNLDLSNNLISGHLPETM 149 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~ 149 (791)
..+++.|+|++|++++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|++|+|++|+|++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3458899999999887776 6778888 89999999999987777777765 889999999999987776644
Q ss_pred C----CC-CCCCEEeCcCCcCCCCCcccc----CC-CCCCCEEeCCCCcCCCCCCCC-------C-cccceecccccccc
Q 003847 150 G----SL-HNLQLLNLSDNALAGKLPVSL----TT-LQSLTIVSLKNNYFSDGLPSK-------F-NSVQVLDLSSNLIN 211 (791)
Q Consensus 150 ~----~l-~~L~~L~ls~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p~~-------l-~~L~~L~ls~N~l~ 211 (791)
. .+ ++|++|+|++|+|++..+..+ .. .++|++|+|++|+|++..+.. + ++|++|+|++|+|+
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 3 34 789999999999986666543 34 368999999999988644332 2 38999999999998
Q ss_pred ccCCCCcCC------ccccEEEccCCcCccc----CchhHhhcCCCCcEEEcccCcCcccCCCC-----Ccccccccccc
Q 003847 212 GSLPPDIGG------YSLRYLNLSYNRLSGE----IPPQFGEKIPVNATIDLSFNNLTGEIPES-----NVFMNQESSSF 276 (791)
Q Consensus 212 ~~~p~~~~~------~~L~~L~l~~N~l~g~----ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-----~~~~~~~~~~~ 276 (791)
+..+..+.. .+|++|+|++|.|++. ++..+....++|++|||++|++++..+.. ..+.++..+.+
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L 260 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEE
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEe
Confidence 666544332 3799999999998852 56666553458999999999987654311 22334555555
Q ss_pred cCC
Q 003847 277 SGN 279 (791)
Q Consensus 277 ~~n 279 (791)
.+|
T Consensus 261 ~~n 263 (362)
T 3goz_A 261 DYD 263 (362)
T ss_dssp EHH
T ss_pred ccC
Confidence 555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-19 Score=196.49 Aligned_cols=205 Identities=20% Similarity=0.179 Sum_probs=158.2
Q ss_pred CCCCcEEEEEcCCC---CCccCCCcCC-------CCCCCCCEEeCcCCCCCC----CCcccccCCCCccEEEccCCcCCC
Q 003847 78 NNDSRVIGLALPNS---QLLGSIPADL-------GMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLISG 143 (791)
Q Consensus 78 ~~~~~v~~L~L~~~---~l~~~~~~~~-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 143 (791)
....+++.|+|++| ++.+.+|..+ ..+++|++|+|++|.|++ .+|..+.++++|++|+|++|.|++
T Consensus 57 ~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 136 (386)
T 2ca6_A 57 ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 136 (386)
T ss_dssp TTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHH
T ss_pred HhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCH
Confidence 34678999999985 5566667655 789999999999999997 477788999999999999999975
Q ss_pred CCccc----cCCC---------CCCCEEeCcCCcCC-CCCc---cccCCCCCCCEEeCCCCcCCC-----CCC---CCCc
Q 003847 144 HLPET----MGSL---------HNLQLLNLSDNALA-GKLP---VSLTTLQSLTIVSLKNNYFSD-----GLP---SKFN 198 (791)
Q Consensus 144 ~~p~~----~~~l---------~~L~~L~ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p---~~l~ 198 (791)
..+.. +..+ ++|++|+|++|+++ +.++ ..+..+++|++|+|++|+|+. .++ ..++
T Consensus 137 ~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~ 216 (386)
T 2ca6_A 137 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCT
T ss_pred HHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCC
Confidence 44433 3334 89999999999997 4455 467788999999999999983 233 2347
Q ss_pred ccceecccccccc----ccCCCCcCC-ccccEEEccCCcCccc----CchhHh-hcCCCCcEEEcccCcCcc----cCCC
Q 003847 199 SVQVLDLSSNLIN----GSLPPDIGG-YSLRYLNLSYNRLSGE----IPPQFG-EKIPVNATIDLSFNNLTG----EIPE 264 (791)
Q Consensus 199 ~L~~L~ls~N~l~----~~~p~~~~~-~~L~~L~l~~N~l~g~----ip~~~~-~~l~~l~~l~l~~N~l~~----~~p~ 264 (791)
+|+.|+|++|.|+ +.+|..+.. .+|++|+|++|+|++. +|..+. ..+++|+.|+|++|++++ .+|.
T Consensus 217 ~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~ 296 (386)
T 2ca6_A 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296 (386)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHH
T ss_pred CccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHH
Confidence 8999999999996 567766655 5899999999999865 455542 127899999999999998 4665
Q ss_pred CC--cccccccccccCCCCC
Q 003847 265 SN--VFMNQESSSFSGNLDL 282 (791)
Q Consensus 265 ~~--~~~~~~~~~~~~n~~l 282 (791)
.. .+.++..+.+.+|+..
T Consensus 297 ~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 297 VIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHHHCTTCCEEECTTSBSC
T ss_pred HHHhcCCCceEEEccCCcCC
Confidence 43 2466777778787654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.3e-17 Score=171.65 Aligned_cols=184 Identities=21% Similarity=0.230 Sum_probs=147.0
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
..+.+..+.+.+.. .+..+++|+.|++++|.+... + .+..+++|++|+|++|+|++..+ +.++++|++|+|++|
T Consensus 27 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 34455566665443 345789999999999999854 4 48899999999999999996544 999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhH
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQF 241 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~ 241 (791)
++++ +| .+..+++|++|+|++|++++... ..+++|+.|+|++|+|++. ..+.. .+|++|+|++|+|++ ++. +
T Consensus 101 ~l~~-~~-~l~~l~~L~~L~L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~-~~~-l 174 (291)
T 1h6t_A 101 KVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP-L 174 (291)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG-G
T ss_pred cCCC-Ch-hhccCCCCCEEECCCCcCCCChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc-chh-h
Confidence 9985 44 49999999999999999998421 2358899999999999864 34444 689999999999995 444 5
Q ss_pred hhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 242 GEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 242 ~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
.. +++|+.|+|++|++++. |....+.++..+.+.+|+.
T Consensus 175 ~~-l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 175 AG-LTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp TT-CTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEE
T ss_pred cC-CCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcc
Confidence 44 99999999999999864 4455566777777777754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.3e-19 Score=189.86 Aligned_cols=173 Identities=24% Similarity=0.218 Sum_probs=78.3
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCC-CcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGS-LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
+++.|+|++|.+.+..+. +..+++|++|+|++|.+++. ++..+.++++|++|+|++|.+++..+..++++++|++|+|
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 444445555544444333 33445555555555554433 4444445555555555555554444444555555555555
Q ss_pred cCC-cCCCC-CccccCCCCCCCEEeCCCC-cCCCC-CCC---CCc-ccceeccccc--ccc-ccCCCCcCC-ccccEEEc
Q 003847 161 SDN-ALAGK-LPVSLTTLQSLTIVSLKNN-YFSDG-LPS---KFN-SVQVLDLSSN--LIN-GSLPPDIGG-YSLRYLNL 228 (791)
Q Consensus 161 s~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~---~l~-~L~~L~ls~N--~l~-~~~p~~~~~-~~L~~L~l 228 (791)
++| .+++. ++..+.++++|++|+|++| .+++. ++. .++ +|++|+|++| .++ +.+|..+.. .+|++|+|
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l 229 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence 555 34431 3334444555555555555 44432 121 123 4555555555 222 222222222 24555555
Q ss_pred cCCc-CcccCchhHhhcCCCCcEEEcccC
Q 003847 229 SYNR-LSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 229 ~~N~-l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
++|. +++..+..+.. +++|++|+|++|
T Consensus 230 ~~~~~l~~~~~~~l~~-l~~L~~L~l~~~ 257 (336)
T 2ast_B 230 SDSVMLKNDCFQEFFQ-LNYLQHLSLSRC 257 (336)
T ss_dssp TTCTTCCGGGGGGGGG-CTTCCEEECTTC
T ss_pred CCCCcCCHHHHHHHhC-CCCCCEeeCCCC
Confidence 5554 44444444433 455555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.5e-19 Score=193.20 Aligned_cols=200 Identities=16% Similarity=0.208 Sum_probs=155.7
Q ss_pred CCcEEEEEcCCCCCccC----CCcCCCCCCCCCEEeCcCCC---CCCCCcccc-------cCCCCccEEEccCCcCCC--
Q 003847 80 DSRVIGLALPNSQLLGS----IPADLGMIEFLQYLDLSNNS---LNGSLSFSL-------FNASQLRNLDLSNNLISG-- 143 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~----~~~~~~~l~~L~~L~L~~N~---l~~~~p~~~-------~~l~~L~~L~L~~N~l~~-- 143 (791)
..+++.|+|++|++... ++..|..+++|++|+|++|. +++.+|..+ .++++|++|+|++|.|++
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 45789999999999876 34458899999999999964 445566555 688999999999999997
Q ss_pred --CCccccCCCCCCCEEeCcCCcCCCCCccccC----CC---------CCCCEEeCCCCcCC-CCCC---C---CCcccc
Q 003847 144 --HLPETMGSLHNLQLLNLSDNALAGKLPVSLT----TL---------QSLTIVSLKNNYFS-DGLP---S---KFNSVQ 201 (791)
Q Consensus 144 --~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~---~l~~L~ 201 (791)
.+|..+.++++|++|+|++|.|+...+..+. .+ ++|++|+|++|+|+ +.++ . .+++|+
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 190 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcC
Confidence 4788899999999999999999754444333 34 89999999999998 3444 2 347899
Q ss_pred eecccccccc--c---cCCCCcCC-ccccEEEccCCcCc----ccCchhHhhcCCCCcEEEcccCcCccc----CCCC--
Q 003847 202 VLDLSSNLIN--G---SLPPDIGG-YSLRYLNLSYNRLS----GEIPPQFGEKIPVNATIDLSFNNLTGE----IPES-- 265 (791)
Q Consensus 202 ~L~ls~N~l~--~---~~p~~~~~-~~L~~L~l~~N~l~----g~ip~~~~~~l~~l~~l~l~~N~l~~~----~p~~-- 265 (791)
.|+|++|+|+ | .++..+.. .+|++|+|++|.|+ +.+|..+.. +++|++|+|++|++++. +|..
T Consensus 191 ~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~-~~~L~~L~L~~n~i~~~~~~~l~~~l~ 269 (386)
T 2ca6_A 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS-WPNLRELGLNDCLLSARGAAAVVDAFS 269 (386)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG-CTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred EEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc-CCCcCEEECCCCCCchhhHHHHHHHHh
Confidence 9999999997 3 34435544 58999999999996 578887776 99999999999999865 3332
Q ss_pred -CcccccccccccCCC
Q 003847 266 -NVFMNQESSSFSGNL 280 (791)
Q Consensus 266 -~~~~~~~~~~~~~n~ 280 (791)
....++..+.+.+|.
T Consensus 270 ~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 270 KLENIGLQTLRLQYNE 285 (386)
T ss_dssp TCSSCCCCEEECCSSC
T ss_pred hccCCCeEEEECcCCc
Confidence 124556666676664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-18 Score=186.02 Aligned_cols=207 Identities=20% Similarity=0.200 Sum_probs=153.6
Q ss_pred CCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCC--CCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC
Q 003847 62 NPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMI--EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN 139 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 139 (791)
-|..|.++.|+ ...++.|+|+++++. +..+..+ ++|+.|+|++|.+.+..+. +.++++|++|+|++|
T Consensus 35 vc~~W~~~~~~-------~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~ 103 (336)
T 2ast_B 35 VCKRWYRLASD-------ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNS 103 (336)
T ss_dssp SCHHHHHHHTC-------STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTC
T ss_pred HHHHHHHHhcC-------chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCC
Confidence 34578888875 234668888888776 4556666 7888899999888876664 567888999999988
Q ss_pred cCCCC-CccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCC-cCCCC-CCC---CCcccceeccccc-cccc
Q 003847 140 LISGH-LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN-YFSDG-LPS---KFNSVQVLDLSSN-LING 212 (791)
Q Consensus 140 ~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~---~l~~L~~L~ls~N-~l~~ 212 (791)
.+++. ++..+.++++|++|+|++|.+++..+..+..+++|++|+|++| .+++. ++. .+++|++|+|++| .+++
T Consensus 104 ~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 104 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp EECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred CcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 88765 7788888888999999988888778888888888999999888 67752 333 3478888899888 8875
Q ss_pred c-CCCCcCC-c-cccEEEccCC--cCc-ccCchhHhhcCCCCcEEEcccCc-CcccCCCC-CcccccccccccCCC
Q 003847 213 S-LPPDIGG-Y-SLRYLNLSYN--RLS-GEIPPQFGEKIPVNATIDLSFNN-LTGEIPES-NVFMNQESSSFSGNL 280 (791)
Q Consensus 213 ~-~p~~~~~-~-~L~~L~l~~N--~l~-g~ip~~~~~~l~~l~~l~l~~N~-l~~~~p~~-~~~~~~~~~~~~~n~ 280 (791)
. ++..+.. . +|++|+|++| .++ +.+|..+.. +++|+.|+|++|. +++..+.. ..+.++..+.+.+|.
T Consensus 184 ~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~-~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 184 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR-CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH-CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred HHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhh-CCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 3 4444443 5 7889999888 555 456666655 8888999998888 66544433 344566666676765
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-17 Score=189.62 Aligned_cols=186 Identities=20% Similarity=0.230 Sum_probs=152.0
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
.+..+.|..+.+...++ +..|++|+.|+|++|.|.. ++ .|..+++|+.|+|++|+|++..| +.+|++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 44556677777765544 5688999999999999984 44 58999999999999999996555 9999999999999
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCch
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP 239 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~ 239 (791)
+|+|++ +| .+..|++|+.|+|++|+|++... ..+++|+.|+|++|+|++. ..+.. .+|+.|+|++|+|++..|
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCCCGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCCCccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 999995 44 79999999999999999998421 2358999999999999964 34444 689999999999996655
Q ss_pred hHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCC
Q 003847 240 QFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLD 281 (791)
Q Consensus 240 ~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~ 281 (791)
+.. +++|+.|+|++|+|++. |....+.++..+.+.+|+.
T Consensus 171 -l~~-l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 171 -LAG-LTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp -GTT-CTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred -hcc-CCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 544 99999999999999975 5555666777777777754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-18 Score=186.95 Aligned_cols=196 Identities=23% Similarity=0.191 Sum_probs=155.8
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCc----ccccCCC-CccEEEccCCcCCCCCccccCCC-----CC
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLS----FSLFNAS-QLRNLDLSNNLISGHLPETMGSL-----HN 154 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 154 (791)
.+.|+.|+++|.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999999999988888889999999999997777 7788898 99999999999998888877775 99
Q ss_pred CCEEeCcCCcCCCCCcccc----CCC-CCCCEEeCCCCcCCCCCCCCC--------cccceeccccccccccCCCCc---
Q 003847 155 LQLLNLSDNALAGKLPVSL----TTL-QSLTIVSLKNNYFSDGLPSKF--------NSVQVLDLSSNLINGSLPPDI--- 218 (791)
Q Consensus 155 L~~L~ls~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~~p~~l--------~~L~~L~ls~N~l~~~~p~~~--- 218 (791)
|++|+|++|++++..+..+ ..+ ++|++|+|++|+|++..+..+ ++|++|+|++|+|+......+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997777644 444 899999999999988665432 489999999999985443333
Q ss_pred -CC--ccccEEEccCCcCcccCchhHhh---cC-CCCcEEEcccCcCcccC----CCCC-c-ccccccccccCCC
Q 003847 219 -GG--YSLRYLNLSYNRLSGEIPPQFGE---KI-PVNATIDLSFNNLTGEI----PESN-V-FMNQESSSFSGNL 280 (791)
Q Consensus 219 -~~--~~L~~L~l~~N~l~g~ip~~~~~---~l-~~l~~l~l~~N~l~~~~----p~~~-~-~~~~~~~~~~~n~ 280 (791)
.. .+|++|+|++|+|++..+..+.. .+ ++|++|||++|+++... +... . ..++..+.+.+|.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 236 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence 22 38999999999999777765543 24 59999999999998632 2211 1 1255666666663
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=170.43 Aligned_cols=169 Identities=21% Similarity=0.199 Sum_probs=141.2
Q ss_pred CCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEE
Q 003847 103 MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182 (791)
Q Consensus 103 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 182 (791)
.+.+|..|+|++|.+++ ++ .+..+++|++|+|++|.|+ .+| .+..+++|+.|+|++|+|++..+ +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 46778889999999984 44 6889999999999999998 566 68999999999999999996544 9999999999
Q ss_pred eCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 183 ~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
+|++|++++..+...++|+.|+|++|+|++ ++ .+.. .+|++|+|++|+|+ .+| .+.. +++|+.|+|++|++++.
T Consensus 91 ~L~~N~l~~l~~~~~~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~-~~~-~l~~-l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLK-SIV-MLGF-LSKLEVLDLHGNEITNT 165 (263)
T ss_dssp ECCSSCCSCCTTCCCSSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCC-BCG-GGGG-CTTCCEEECTTSCCCBC
T ss_pred ECCCCccCCcCccccCcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCC-CCh-HHcc-CCCCCEEECCCCcCcch
Confidence 999999998544334899999999999995 44 3544 68999999999999 555 4555 99999999999999987
Q ss_pred CCCCCcccccccccccCCCCCC
Q 003847 262 IPESNVFMNQESSSFSGNLDLC 283 (791)
Q Consensus 262 ~p~~~~~~~~~~~~~~~n~~lc 283 (791)
+....+.++..+.+.+|+..|
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEEC
T ss_pred -HHhccCCCCCEEeCCCCcccC
Confidence 555566677778888887554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.68 E-value=8.5e-17 Score=174.22 Aligned_cols=212 Identities=17% Similarity=0.114 Sum_probs=168.0
Q ss_pred eeeeeCCCCCCCCCCcEEEEEcCCCCCccCCC-cCCCCCCCCCE-EeCcCCCCCCCCcccccCCCCccEEEccCCcCCCC
Q 003847 67 NGVTCASPGEGNNDSRVIGLALPNSQLLGSIP-ADLGMIEFLQY-LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH 144 (791)
Q Consensus 67 ~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 144 (791)
+.++-..++.|.++.+++.|+|++|++.+.+| ..|.+|++|+. +++++|+|+...|..|.++++|++|+|++|+|++.
T Consensus 40 N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~ 119 (350)
T 4ay9_X 40 TKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 119 (350)
T ss_dssp CCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSC
T ss_pred CcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccC
Confidence 44554455668889999999999999987766 46899999875 67778999988889999999999999999999977
Q ss_pred CccccCCCCCCCEEeCcC-CcCCCCCccccCCCC-CCCEEeCCCCcCCCCCCCCC--cccceecccc-ccccccCCC-Cc
Q 003847 145 LPETMGSLHNLQLLNLSD-NALAGKLPVSLTTLQ-SLTIVSLKNNYFSDGLPSKF--NSVQVLDLSS-NLINGSLPP-DI 218 (791)
Q Consensus 145 ~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l--~~L~~L~ls~-N~l~~~~p~-~~ 218 (791)
.+..+....++..|++++ |++....+..|..+. .|+.|+|++|+|+...+..| .+|+.|++++ |.++ .+|. .|
T Consensus 120 ~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f 198 (350)
T 4ay9_X 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVF 198 (350)
T ss_dssp CCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTT
T ss_pred CchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHh
Confidence 777788888899999966 678866667788775 68999999999998666665 6799999985 6676 5654 55
Q ss_pred CC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCC
Q 003847 219 GG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCG 284 (791)
Q Consensus 219 ~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 284 (791)
.. .+|++|||++|+|+ .+|... +.+|+.|.+.+++--..+|....+.++....+ .|++.|.
T Consensus 199 ~~l~~L~~LdLs~N~l~-~lp~~~---~~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l-~~~~~c~ 260 (350)
T 4ay9_X 199 HGASGPVILDISRTRIH-SLPSYG---LENLKKLRARSTYNLKKLPTLEKLVALMEASL-TYPSHCC 260 (350)
T ss_dssp TTEECCSEEECTTSCCC-CCCSSS---CTTCCEEECTTCTTCCCCCCTTTCCSCCEEEC-SCHHHHH
T ss_pred ccCcccchhhcCCCCcC-ccChhh---hccchHhhhccCCCcCcCCCchhCcChhhCcC-CCCcccc
Confidence 65 58999999999999 888765 56777777766655557787666666655544 5677774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-16 Score=152.06 Aligned_cols=134 Identities=25% Similarity=0.281 Sum_probs=95.4
Q ss_pred CCceeeeeeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcC
Q 003847 62 NPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
..|+|.++.|. +++++ .+|..+ .++|+.|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 5 C~C~~~~l~~~-----------------~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (177)
T 2o6r_A 5 CSCSGTEIRCN-----------------SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI 64 (177)
T ss_dssp CEEETTEEECC-----------------SSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CEeCCCEEEec-----------------CCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcc
Confidence 34789888886 33443 233332 25778888888888766666677788888888888888
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCC---CcccceeccccccccccCC
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK---FNSVQVLDLSSNLINGSLP 215 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~ls~N~l~~~~p 215 (791)
++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+.. +++|++|+|++|.+++..|
T Consensus 65 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 65 QSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred eEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7666666777888888888888888666666777888888888888887655543 3677888888888775443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=153.06 Aligned_cols=130 Identities=28% Similarity=0.220 Sum_probs=100.1
Q ss_pred CCcEEEEEcCCCCCc-cCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLL-GSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
..+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|+|++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 457888888888887 77787788888888888888888865 677888888888888888887777777778888888
Q ss_pred eCcCCcCCCCC-ccccCCCCCCCEEeCCCCcCCCCCC------CCCcccceecccccccc
Q 003847 159 NLSDNALAGKL-PVSLTTLQSLTIVSLKNNYFSDGLP------SKFNSVQVLDLSSNLIN 211 (791)
Q Consensus 159 ~ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p------~~l~~L~~L~ls~N~l~ 211 (791)
+|++|+|++.. +..+..+++|+.|+|++|.+++..+ ..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 88888888532 2678888888888888888876544 13466777777777665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-17 Score=176.59 Aligned_cols=138 Identities=11% Similarity=0.083 Sum_probs=99.1
Q ss_pred hhcceeccccCceEEEEEEeCCCcEEEEEEcCCCch--------------hhHH--------HHHHHHHHHhccCCCCcc
Q 003847 477 KASAYILGASGSSIMYKAVLEDGTALAVRRIGENSV--------------DRFR--------DFETQVRVIAKLVHPNLV 534 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~nIv 534 (791)
+.....||.|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 334678999999999999988999999998753210 0001 124566777777544432
Q ss_pred ceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-
Q 003847 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM- 613 (791)
Q Consensus 535 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~- 613 (791)
-..- +.. ...+|||||++|++|.++.. . +....++.|++.+|.|||+.|||||||||.|||+++++
T Consensus 177 vp~p-~~~-~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEP-IAQ-SRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCE-EEE-ETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCee-eec-cCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 2111 111 23479999999988865321 1 23457889999999999999999999999999998776
Q ss_pred ---------CeEEeccCcccccC
Q 003847 614 ---------EPKIGDFGLERLVT 627 (791)
Q Consensus 614 ---------~~kL~DFGla~~~~ 627 (791)
.+.|+||+.+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=152.04 Aligned_cols=134 Identities=21% Similarity=0.151 Sum_probs=100.4
Q ss_pred CCCCCEEeCcCCCCC-CCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEE
Q 003847 104 IEFLQYLDLSNNSLN-GSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182 (791)
Q Consensus 104 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 182 (791)
.++|+.|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478899999999998 77888888899999999999999865 778889999999999999987788877778888888
Q ss_pred eCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCch---hHhhcCCCCcEEEcccCcC
Q 003847 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP---QFGEKIPVNATIDLSFNNL 258 (791)
Q Consensus 183 ~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~---~~~~~l~~l~~l~l~~N~l 258 (791)
+|++|+|++... +..+.. .+|++|+|++|.++ .+|. ..+..+++|++|++++|.+
T Consensus 101 ~Ls~N~l~~~~~--------------------~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 101 NLSGNKLKDIST--------------------LEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp ECBSSSCCSSGG--------------------GGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred eccCCccCcchh--------------------HHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCCh
Confidence 888888876321 012222 35666666666666 3443 2333477788888888777
Q ss_pred cc
Q 003847 259 TG 260 (791)
Q Consensus 259 ~~ 260 (791)
..
T Consensus 160 ~~ 161 (168)
T 2ell_A 160 QE 161 (168)
T ss_dssp CB
T ss_pred hh
Confidence 63
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-15 Score=149.66 Aligned_cols=107 Identities=28% Similarity=0.260 Sum_probs=89.6
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCc
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 164 (791)
.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4556677776 4565543 68999999999998 677889999999999999999998888889999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCCCCcCCCCCCC
Q 003847 165 LAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS 195 (791)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 195 (791)
|++..|..|.++++|+.|+|++|+|+...+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~ 120 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEG 120 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChh
Confidence 9988888899999999999998888864443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-19 Score=201.88 Aligned_cols=176 Identities=21% Similarity=0.216 Sum_probs=126.4
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCC-------------CCCCCcccccCCCCccEEE-ccCCcCCCCCcc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNS-------------LNGSLSFSLFNASQLRNLD-LSNNLISGHLPE 147 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~p~ 147 (791)
+++.|+|++|+|. .+|..+++|++|+.|++++|. +.+.+|..+.++++|+.|+ ++.|.+. .++.
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~ 427 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRS 427 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHH
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhh
Confidence 3445556666664 456666666666666665553 4445555566666666665 4444322 1110
Q ss_pred ------ccCC--CCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCC
Q 003847 148 ------TMGS--LHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPP 216 (791)
Q Consensus 148 ------~~~~--l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~ 216 (791)
.+.. ...|+.|+|++|+|++ +|. |.++++|+.|+|++|+|+ .+|..| ++|+.|+|++|+|++ +|
T Consensus 428 l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp- 502 (567)
T 1dce_A 428 KFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD- 502 (567)
T ss_dssp HHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-
T ss_pred hhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-
Confidence 0100 1258899999999995 676 999999999999999999 567655 789999999999996 67
Q ss_pred CcCC-ccccEEEccCCcCcccC-chhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 217 DIGG-YSLRYLNLSYNRLSGEI-PPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 217 ~~~~-~~L~~L~l~~N~l~g~i-p~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
.++. .+|++|+|++|+|++.+ |..+.. +++|+.|+|++|+|++.+|..
T Consensus 503 ~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~-l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 503 GVANLPRLQELLLCNNRLQQSAAIQPLVS-CPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp GGTTCSSCCEEECCSSCCCSSSTTGGGGG-CTTCCEEECTTSGGGGSSSCT
T ss_pred ccCCCCCCcEEECCCCCCCCCCCcHHHhc-CCCCCEEEecCCcCCCCccHH
Confidence 6655 58999999999999766 888877 999999999999999887754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.8e-16 Score=147.73 Aligned_cols=125 Identities=28% Similarity=0.260 Sum_probs=100.0
Q ss_pred CCcEEEEEcCCCCCc-cCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLL-GSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
..+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+.++++|++|+|++|+|++.+|..+.++++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 457888889998887 78888888888899999999888865 678888888889998888887788888888888888
Q ss_pred eCcCCcCCCC-CccccCCCCCCCEEeCCCCcCCCCCC---CC---Ccccceeccc
Q 003847 159 NLSDNALAGK-LPVSLTTLQSLTIVSLKNNYFSDGLP---SK---FNSVQVLDLS 206 (791)
Q Consensus 159 ~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~---l~~L~~L~ls 206 (791)
+|++|++++. .+..+..+++|++|+|++|.+++..+ .. +++|+.||++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 8888888853 34778888888888888888887544 22 3567776665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-15 Score=144.92 Aligned_cols=129 Identities=21% Similarity=0.214 Sum_probs=107.3
Q ss_pred CCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC
Q 003847 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186 (791)
Q Consensus 107 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 186 (791)
.+.+++++|+++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 478999999998 455444 36899999999999977777789999999999999999977777789999999999999
Q ss_pred CcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCc
Q 003847 187 NYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIP 238 (791)
Q Consensus 187 N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip 238 (791)
|+|++..+..| ++|++|+|++|+|++..+..+.. .+|++|+|++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99998776544 78999999999998655555554 589999999999997766
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=147.78 Aligned_cols=129 Identities=27% Similarity=0.318 Sum_probs=112.6
Q ss_pred CCceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEcc
Q 003847 62 NPCSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS 137 (791)
Q Consensus 62 ~~c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 137 (791)
..|.|..+.|+..+- ..-...++.|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 8 C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 347788888863210 112357999999999998 677899999999999999999998888999999999999999
Q ss_pred CCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC
Q 003847 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191 (791)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 191 (791)
+|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999998888899999999999999999997777789999999999999998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=9.8e-16 Score=144.03 Aligned_cols=130 Identities=22% Similarity=0.146 Sum_probs=90.1
Q ss_pred CCCCCEEeCcCCCCC-CCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEE
Q 003847 104 IEFLQYLDLSNNSLN-GSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIV 182 (791)
Q Consensus 104 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 182 (791)
.++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..++++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 367788888888887 67777777888888888888888754 667778888888888888876677777777777777
Q ss_pred eCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCc--hhHhhcCCCCcEEEccc
Q 003847 183 SLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIP--PQFGEKIPVNATIDLSF 255 (791)
Q Consensus 183 ~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip--~~~~~~l~~l~~l~l~~ 255 (791)
+|++|++++.. .+..+.. .+|++|++++|.+++..+ ...+..+++|++||+++
T Consensus 94 ~ls~N~i~~~~--------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLS--------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHH--------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChH--------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 77777776521 1122333 367777777777774333 13334488888888764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.56 E-value=5.9e-17 Score=182.39 Aligned_cols=201 Identities=18% Similarity=0.113 Sum_probs=133.0
Q ss_pred CCcEEEEEcCCCCCccCCCcCCC-----CCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCCC-----
Q 003847 80 DSRVIGLALPNSQLLGSIPADLG-----MIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGHL----- 145 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----- 145 (791)
..+++.|+|++|.+....+..+. .+++|++|+|++|.+++. ++..+..+++|++|+|++|.|++..
T Consensus 169 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~ 248 (461)
T 1z7x_W 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHH
Confidence 35788888888887655444443 256888888888888764 4666777888888888888876432
Q ss_pred ccccCCCCCCCEEeCcCCcCCCC----CccccCCCCCCCEEeCCCCcCCCCCCCC--------Ccccceecccccccccc
Q 003847 146 PETMGSLHNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSLKNNYFSDGLPSK--------FNSVQVLDLSSNLINGS 213 (791)
Q Consensus 146 p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~--------l~~L~~L~ls~N~l~~~ 213 (791)
+..+..+++|++|+|++|+++.. ++..+..+++|++|+|++|.+++..+.. .++|+.|+|++|.+++.
T Consensus 249 ~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 328 (461)
T 1z7x_W 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchH
Confidence 33344678888888888888753 5666777888888888888876533222 24788888888877754
Q ss_pred ----CCCCcCC-ccccEEEccCCcCcccCchhHhhc----CCCCcEEEcccCcCcc----cCCCC-CcccccccccccCC
Q 003847 214 ----LPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEK----IPVNATIDLSFNNLTG----EIPES-NVFMNQESSSFSGN 279 (791)
Q Consensus 214 ----~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~----l~~l~~l~l~~N~l~~----~~p~~-~~~~~~~~~~~~~n 279 (791)
++..+.. .+|++|+|++|++++..+..+... .++|++|+|++|++++ .+|.. ....++..+.+.+|
T Consensus 329 ~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp GHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred HHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence 2333322 467888888887775545444432 4577888888887774 44433 22345555666666
Q ss_pred C
Q 003847 280 L 280 (791)
Q Consensus 280 ~ 280 (791)
+
T Consensus 409 ~ 409 (461)
T 1z7x_W 409 C 409 (461)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-16 Score=180.27 Aligned_cols=111 Identities=23% Similarity=0.155 Sum_probs=52.5
Q ss_pred CCcEEEEEcCCCCCccCCCcC-----CCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCCCccccC
Q 003847 80 DSRVIGLALPNSQLLGSIPAD-----LGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGHLPETMG 150 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 150 (791)
..+++.|+|++|.+.+..+.. +..+++|++|+|++|++++. ++..+..+++|++|+|++|.++...+..+.
T Consensus 112 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 191 (461)
T 1z7x_W 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC 191 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH
Confidence 455666666666655332221 12234556666666655542 233344455555555555555432222221
Q ss_pred -----CCCCCCEEeCcCCcCCCC----CccccCCCCCCCEEeCCCCcCC
Q 003847 151 -----SLHNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 151 -----~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 190 (791)
.+++|++|+|++|.+++. ++..+..+++|++|+|++|+++
T Consensus 192 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 233455555555555432 2344444455555555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-14 Score=140.80 Aligned_cols=132 Identities=21% Similarity=0.184 Sum_probs=82.3
Q ss_pred CCCCCCCCCEEeCcCCCCCCCCcccccCCC-CccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCC
Q 003847 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNAS-QLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQS 178 (791)
Q Consensus 100 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 178 (791)
.+.++++|+.|+|++|+|+. +|. +..+. +|++|+|++|+|++. ..|.++++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 34556677777777777763 343 33333 777777777777643 45666777777777777776544444466666
Q ss_pred CCEEeCCCCcCCCCCCCCCcccceeccccccccccCCC--CcCC-ccccEEEccCCcCcccCchh----HhhcCCCCcEE
Q 003847 179 LTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPP--DIGG-YSLRYLNLSYNRLSGEIPPQ----FGEKIPVNATI 251 (791)
Q Consensus 179 L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~--~~~~-~~L~~L~l~~N~l~g~ip~~----~~~~l~~l~~l 251 (791)
|++|+|++|+|+. +|. .+.. .+|++|+|++|.++ .+|.. +.. +++|+.|
T Consensus 90 L~~L~L~~N~i~~----------------------~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~-l~~L~~L 145 (176)
T 1a9n_A 90 LTELILTNNSLVE----------------------LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYK-VPQVRVL 145 (176)
T ss_dssp CCEEECCSCCCCC----------------------GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHH-CTTCSEE
T ss_pred CCEEECCCCcCCc----------------------chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHH-CCcccee
Confidence 6666666666643 222 2222 35667777777776 56654 444 8888888
Q ss_pred EcccCcCc
Q 003847 252 DLSFNNLT 259 (791)
Q Consensus 252 ~l~~N~l~ 259 (791)
|+++|.+.
T Consensus 146 d~~~n~~~ 153 (176)
T 1a9n_A 146 DFQKVKLK 153 (176)
T ss_dssp TTEECCHH
T ss_pred CCCcCCHH
Confidence 88888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=7.8e-15 Score=142.09 Aligned_cols=126 Identities=25% Similarity=0.240 Sum_probs=103.4
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCC-CCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIE-FLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
...++.|+|++|++... +. +..+. +|++|+|++|.|++. ..|.++++|++|+|++|+|++..+..|..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 56899999999999854 54 55555 999999999999965 689999999999999999996655666999999999
Q ss_pred eCcCCcCCCCCcc--ccCCCCCCCEEeCCCCcCCCCCCC-------CCcccceecccccccc
Q 003847 159 NLSDNALAGKLPV--SLTTLQSLTIVSLKNNYFSDGLPS-------KFNSVQVLDLSSNLIN 211 (791)
Q Consensus 159 ~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~-------~l~~L~~L~ls~N~l~ 211 (791)
+|++|+|+ .+|. .+..+++|+.|+|++|.++.. |. .+++|+.||+++|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999997 5666 888999999999999999753 33 2356666666666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=7.2e-14 Score=134.37 Aligned_cols=104 Identities=26% Similarity=0.258 Sum_probs=89.0
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCc
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 164 (791)
.|++++|+|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 46666788875 566553 889999999999998889899999999999999999997777778999999999999999
Q ss_pred CCCCCccccCCCCCCCEEeCCCCcCCC
Q 003847 165 LAGKLPVSLTTLQSLTIVSLKNNYFSD 191 (791)
Q Consensus 165 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 191 (791)
|++..+..|.++++|+.|+|++|.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 997777788899999999999998875
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-14 Score=163.49 Aligned_cols=117 Identities=25% Similarity=0.284 Sum_probs=67.1
Q ss_pred CCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC
Q 003847 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186 (791)
Q Consensus 107 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 186 (791)
|+.|+|++|+|++ +|. |.++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|.++++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 5566666666664 443 666666666666666666 556666666666666666666664 44 566666666666666
Q ss_pred CcCCCCC-CCCC---cccceeccccccccccCCCCcC----CccccEEEc
Q 003847 187 NYFSDGL-PSKF---NSVQVLDLSSNLINGSLPPDIG----GYSLRYLNL 228 (791)
Q Consensus 187 N~l~~~~-p~~l---~~L~~L~ls~N~l~~~~p~~~~----~~~L~~L~l 228 (791)
|+|++.. |..| ++|+.|+|++|+|++.+|.... .++|+.|++
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 6666554 4433 5566666666666644332211 135666653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.5e-14 Score=134.03 Aligned_cols=105 Identities=26% Similarity=0.229 Sum_probs=90.9
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
+.|++++|+|. .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46888999985 5676664 88999999999999888999999999999999999999766667889999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCC
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSD 191 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 191 (791)
+|++..+..|..+++|+.|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9997666678899999999999998875
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=8e-17 Score=159.43 Aligned_cols=148 Identities=20% Similarity=0.239 Sum_probs=75.0
Q ss_pred CCCEEeCcCCCCCCCCcc------cccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCC
Q 003847 106 FLQYLDLSNNSLNGSLSF------SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179 (791)
Q Consensus 106 ~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 179 (791)
.++.++|+.|.+.|.+|. .|.++++|++|+|++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 344444444444444333 45555555555555555553 34 4555555555555555555 344444444555
Q ss_pred CEEeCCCCcCCCCCCC--CCcccceeccccccccccCC-CCcCC-ccccEEEccCCcCcccCch---------hHhhcCC
Q 003847 180 TIVSLKNNYFSDGLPS--KFNSVQVLDLSSNLINGSLP-PDIGG-YSLRYLNLSYNRLSGEIPP---------QFGEKIP 246 (791)
Q Consensus 180 ~~L~L~~N~l~~~~p~--~l~~L~~L~ls~N~l~~~~p-~~~~~-~~L~~L~l~~N~l~g~ip~---------~~~~~l~ 246 (791)
+.|+|++|+|++ +|. .+++|+.|+|++|+|++..+ ..+.. .+|++|++++|.+++.+|. .....++
T Consensus 96 ~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~ 174 (198)
T 1ds9_A 96 EELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp SEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCS
T ss_pred CEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCC
Confidence 555555555544 221 11445555555555552211 12333 4677777777777655443 2233488
Q ss_pred CCcEEEcccCcCc
Q 003847 247 VNATIDLSFNNLT 259 (791)
Q Consensus 247 ~l~~l~l~~N~l~ 259 (791)
+|+.|| +|+++
T Consensus 175 ~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 175 NLKKLD--GMPVD 185 (198)
T ss_dssp SCSEEC--CGGGT
T ss_pred CcEEEC--CcccC
Confidence 888776 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=131.44 Aligned_cols=86 Identities=26% Similarity=0.233 Sum_probs=69.4
Q ss_pred CCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCC
Q 003847 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKN 186 (791)
Q Consensus 107 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~ 186 (791)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468899999988 4666553 7888899999999887788888888999999999998877777778888888888888
Q ss_pred CcCCCCCCC
Q 003847 187 NYFSDGLPS 195 (791)
Q Consensus 187 N~l~~~~p~ 195 (791)
|+|++..+.
T Consensus 88 N~l~~~~~~ 96 (170)
T 3g39_A 88 NQLKSIPRG 96 (170)
T ss_dssp SCCCCCCTT
T ss_pred CccCEeCHH
Confidence 888764443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-16 Score=158.53 Aligned_cols=147 Identities=24% Similarity=0.314 Sum_probs=122.0
Q ss_pred CcEEEEEcCCCCCccCCCc------CCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCC
Q 003847 81 SRVIGLALPNSQLLGSIPA------DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHN 154 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 154 (791)
.+++.++|+.+++.|.+|. .|..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4566667777777777776 89999999999999999996 67 8999999999999999998 78888888899
Q ss_pred CCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC----CCCcccceeccccccccccCCCC----------cCC
Q 003847 155 LQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP----SKFNSVQVLDLSSNLINGSLPPD----------IGG 220 (791)
Q Consensus 155 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~L~~L~ls~N~l~~~~p~~----------~~~ 220 (791)
|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+++|++|+|++|.+++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999995 55 68889999999999999987332 35689999999999998776652 333
Q ss_pred -ccccEEEccCCcCc
Q 003847 221 -YSLRYLNLSYNRLS 234 (791)
Q Consensus 221 -~~L~~L~l~~N~l~ 234 (791)
.+|++|| +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 5789887 67765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.5e-13 Score=130.02 Aligned_cols=100 Identities=25% Similarity=0.250 Sum_probs=74.3
Q ss_pred CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCC
Q 003847 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187 (791)
Q Consensus 108 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 187 (791)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67899999886 6676654 78889999999998888888888888999999999888766666788888888888888
Q ss_pred cCCCCCCCCC---cccceeccccccc
Q 003847 188 YFSDGLPSKF---NSVQVLDLSSNLI 210 (791)
Q Consensus 188 ~l~~~~p~~l---~~L~~L~ls~N~l 210 (791)
+|++..+..| ++|++|+|++|.+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~ 117 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPW 117 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCc
Confidence 8876444322 3344444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=147.21 Aligned_cols=108 Identities=25% Similarity=0.195 Sum_probs=91.4
Q ss_pred ceeeeeeeCCCCCCCCCCcEEEEEcCCC-CCccCCCcCCCCCCCCCEEeCcC-CCCCCCCcccccCCCCccEEEccCCcC
Q 003847 64 CSWNGVTCASPGEGNNDSRVIGLALPNS-QLLGSIPADLGMIEFLQYLDLSN-NSLNGSLSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 64 c~w~gv~C~~~~~~~~~~~v~~L~L~~~-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l 141 (791)
|.|..|.|. ++ +|++ +|. |..+++|+.|+|++ |+|++..+..|.+|++|++|+|++|+|
T Consensus 8 C~~~~v~~~-----------------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 68 (347)
T 2ifg_A 8 HGSSGLRCT-----------------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68 (347)
T ss_dssp SSSSCEECC-----------------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCC
T ss_pred ccCCEEEcC-----------------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcc
Confidence 777777775 34 6664 677 99999999999996 999988888999999999999999999
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCC
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 191 (791)
++..|..|.+|++|+.|+|++|+|++..+..|..+. |+.|+|++|.|..
T Consensus 69 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 998898999999999999999999976666666665 8888888888764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=140.93 Aligned_cols=87 Identities=20% Similarity=0.159 Sum_probs=73.3
Q ss_pred CEEeCcCC-CCCCCCcccccCCCCccEEEccC-CcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCC
Q 003847 108 QYLDLSNN-SLNGSLSFSLFNASQLRNLDLSN-NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLK 185 (791)
Q Consensus 108 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 185 (791)
..+++++| +|+ .+|. |..+++|++|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788887 888 4777 88999999999996 99998888889999999999999999998888888999998888888
Q ss_pred CCcCCCCCCCC
Q 003847 186 NNYFSDGLPSK 196 (791)
Q Consensus 186 ~N~l~~~~p~~ 196 (791)
+|+|++..+..
T Consensus 89 ~N~l~~~~~~~ 99 (347)
T 2ifg_A 89 FNALESLSWKT 99 (347)
T ss_dssp SSCCSCCCSTT
T ss_pred CCccceeCHHH
Confidence 88887644443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=138.56 Aligned_cols=182 Identities=11% Similarity=0.020 Sum_probs=131.2
Q ss_pred CCcEEEEEcCCCCCc--------------------cCCCcCCCC--------CCCCCEEeCcCCCCCCCCcccccCCCCc
Q 003847 80 DSRVIGLALPNSQLL--------------------GSIPADLGM--------IEFLQYLDLSNNSLNGSLSFSLFNASQL 131 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~--------------------~~~~~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L 131 (791)
..+++.|+|++|++. .+.+..|.+ +++|+.|+|.+ +++.+.+..|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 356777888887776 223345667 88889999888 7876667788888899
Q ss_pred cEEEccCCcCCCCCccccCCCCCCCEEeCcCCcC----CCCCcccc----------------------------------
Q 003847 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL----AGKLPVSL---------------------------------- 173 (791)
Q Consensus 132 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l----~~~~p~~~---------------------------------- 173 (791)
+.|+|++|.++...+..|.++.++..|.++.+.. .......|
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 9999988888767777788877777777665321 10000001
Q ss_pred ----------------CCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-cccc-EEEccCCc
Q 003847 174 ----------------TTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLR-YLNLSYNR 232 (791)
Q Consensus 174 ----------------~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~-~L~l~~N~ 232 (791)
..+++|+.|+|++|+++......| .+|+.|+|++| ++..-+..|.+ .+|+ .|++.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 026789999999988887555555 68899999988 77555566666 4698 999988 7
Q ss_pred CcccCchhHhhcCCCCcEEEcccCcCcccCCCC
Q 003847 233 LSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265 (791)
Q Consensus 233 l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~ 265 (791)
++ .|+...|..+++|+.|++++|+++...+..
T Consensus 285 l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~a 316 (329)
T 3sb4_A 285 VT-AIEFGAFMGCDNLRYVLATGDKITTLGDEL 316 (329)
T ss_dssp CC-EECTTTTTTCTTEEEEEECSSCCCEECTTT
T ss_pred ce-EEchhhhhCCccCCEEEeCCCccCccchhh
Confidence 77 787777777999999999999988655433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=127.68 Aligned_cols=134 Identities=14% Similarity=0.073 Sum_probs=106.6
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
..++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888999999854 6899999987532222346889999999884 677889999998888999999999999987
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--------------------------------------------- 594 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------------------------------------------- 594 (791)
+... +......++.+++++|+.||+
T Consensus 99 ~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 6421 112235788999999999998
Q ss_pred --------------CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 595 --------------KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 595 --------------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
..++|+|++|.||+++++..+.|+||+.+..
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765667999998765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-13 Score=147.04 Aligned_cols=131 Identities=22% Similarity=0.246 Sum_probs=65.2
Q ss_pred CCccEEEccCCcCCCCCcccc-CCCCCCCEEeCcCCcCCCCCcccc-----CCCCCCCEEeCCCCcCCCC----CC---C
Q 003847 129 SQLRNLDLSNNLISGHLPETM-GSLHNLQLLNLSDNALAGKLPVSL-----TTLQSLTIVSLKNNYFSDG----LP---S 195 (791)
Q Consensus 129 ~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p---~ 195 (791)
.+|++|+|++|.|+......+ ..+++|+.|+|++|+|+......+ ...++|++|+|++|.|+.. ++ .
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555555442211111 123345555555555543222222 2334555555555555431 11 1
Q ss_pred CCcccceecccccccccc----CCCCcCC-ccccEEEccCCcCccc----CchhHhhcCCCCcEEEcccCcCcc
Q 003847 196 KFNSVQVLDLSSNLINGS----LPPDIGG-YSLRYLNLSYNRLSGE----IPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 196 ~l~~L~~L~ls~N~l~~~----~p~~~~~-~~L~~L~l~~N~l~g~----ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
..++|++|+|++|.|+.. +...+.. .+|++|+|++|.|+.. +...+.. .++|++|||++|+|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~-~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAARE-HPSLELLHLYFNELSS 253 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHH-CSSCCEEECTTSSCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHh-CCCCCEEeccCCCCCH
Confidence 124455555555555421 1222222 3688888888888743 2333333 6888899999988864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.2e-11 Score=130.38 Aligned_cols=195 Identities=18% Similarity=0.133 Sum_probs=140.5
Q ss_pred CcEEEEEcCCCCCccCCCcCCCC-CCCCCEEeCcCCCCC--------------------CCCcccccC--------CCCc
Q 003847 81 SRVIGLALPNSQLLGSIPADLGM-IEFLQYLDLSNNSLN--------------------GSLSFSLFN--------ASQL 131 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~-l~~L~~L~L~~N~l~--------------------~~~p~~~~~--------l~~L 131 (791)
.+++.|.++++ +.+.--..+.. +++|+.|||++|+|. ...+..|.+ +++|
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L 103 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTL 103 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTC
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCC
Confidence 45677777653 11111112223 788999999999998 223346777 9999
Q ss_pred cEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcC-------CCCC-----------
Q 003847 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF-------SDGL----------- 193 (791)
Q Consensus 132 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~----------- 193 (791)
+.|+|.+ +++.+-+..|.+|++|+.|+|++|.+....+..|.++.++..|.+..+.. ....
T Consensus 104 ~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i 182 (329)
T 3sb4_A 104 EKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTI 182 (329)
T ss_dssp CC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEE
T ss_pred cEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeE
Confidence 9999999 88867777899999999999999999878888899888888887766321 1000
Q ss_pred ------------------CC---------------------CCcccceeccccccccccCCCCcCC-ccccEEEccCCcC
Q 003847 194 ------------------PS---------------------KFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRL 233 (791)
Q Consensus 194 ------------------p~---------------------~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l 233 (791)
+. ..++|+.|+|++|+++...+..|.. .+|+.|+|.+| +
T Consensus 183 ~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i 261 (329)
T 3sb4_A 183 QVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-L 261 (329)
T ss_dssp EECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-C
T ss_pred EecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-c
Confidence 00 1468999999999999655566766 48999999999 7
Q ss_pred cccCchhHhhcCCCCc-EEEcccCcCcccCCCCCc-ccccccccccCCC
Q 003847 234 SGEIPPQFGEKIPVNA-TIDLSFNNLTGEIPESNV-FMNQESSSFSGNL 280 (791)
Q Consensus 234 ~g~ip~~~~~~l~~l~-~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~ 280 (791)
+ .|+...|..+.+|+ .|+|.+ +++...+.... ..++..+.+.+|.
T Consensus 262 ~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~ 308 (329)
T 3sb4_A 262 K-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDK 308 (329)
T ss_dssp C-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSC
T ss_pred c-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCc
Confidence 7 89998888899999 999998 67655444432 2345555554543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.4e-13 Score=149.66 Aligned_cols=163 Identities=21% Similarity=0.159 Sum_probs=120.1
Q ss_pred CcEEEEEcCCCCCccCCCcCCCC-----CCCCCEEeCcCCCCCCCCcccc-cCCCCccEEEccCCcCCCCCcccc-----
Q 003847 81 SRVIGLALPNSQLLGSIPADLGM-----IEFLQYLDLSNNSLNGSLSFSL-FNASQLRNLDLSNNLISGHLPETM----- 149 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~----- 149 (791)
..++.|+|++|+|+......|.. .++|+.|+|++|.|+......+ ..+.+|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 56889999999998654443333 3799999999999975433333 346789999999999985444443
Q ss_pred CCCCCCCEEeCcCCcCCC----CCccccCCCCCCCEEeCCCCcCCCCC----CC---CCcccceeccccccccccCC---
Q 003847 150 GSLHNLQLLNLSDNALAG----KLPVSLTTLQSLTIVSLKNNYFSDGL----PS---KFNSVQVLDLSSNLINGSLP--- 215 (791)
Q Consensus 150 ~~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~---~l~~L~~L~ls~N~l~~~~p--- 215 (791)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|++.. .. ..++|+.|+|++|.|+..-.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 456899999999999974 24455678899999999999998532 22 23689999999999974322
Q ss_pred -CCcC-CccccEEEccCCcCcccCchhHhh
Q 003847 216 -PDIG-GYSLRYLNLSYNRLSGEIPPQFGE 243 (791)
Q Consensus 216 -~~~~-~~~L~~L~l~~N~l~g~ip~~~~~ 243 (791)
..+. ..+|++|+|++|.|++.-...+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 2222 257999999999998655544443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=5.6e-11 Score=122.36 Aligned_cols=127 Identities=13% Similarity=0.141 Sum_probs=98.7
Q ss_pred cccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCC--ccceeeEEEccCceEEEEeccCCCChhHH
Q 003847 484 GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPN--LVRIRGFYWGVDEKLIIYDFVPNGSLANA 561 (791)
Q Consensus 484 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 561 (791)
+.|..+.||++...+|+.++||+..... ...+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 4556699999988778899999976542 245788999999886444 566889888888889999999998884
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 003847 562 RYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--------------------------------------------- 596 (791)
Q Consensus 562 l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------------------------- 596 (791)
. .. .. ...++.++++.|..||+..
T Consensus 104 ~-~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 S-SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp T-SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred c-Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 1 10 11 2356778888888888743
Q ss_pred -------------CeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 597 -------------HVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 597 -------------ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
++|+|++|.||++++++.+.|+|||.+..-
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766779999998753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.15 E-value=3.5e-13 Score=156.54 Aligned_cols=202 Identities=15% Similarity=0.082 Sum_probs=121.7
Q ss_pred CCCcEEEEEcCCCCCccCCC-cCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEcc-----------CCcCCCC-C
Q 003847 79 NDSRVIGLALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS-----------NNLISGH-L 145 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~-~ 145 (791)
...+++.|+|++|.+++... ..+..+++|+.|+|++|-..+.++..+.++++|++|+|+ .|.+++. +
T Consensus 291 ~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~ 370 (592)
T 3ogk_B 291 FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370 (592)
T ss_dssp GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence 35689999999999765443 346788888888888332223344444667788888888 3566533 2
Q ss_pred ccccCCCCCCCEEeCcCCcCCCCCccccCC-CCCCCEEeCC----CCcCCCCCC--------CCCcccceeccccc--cc
Q 003847 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTT-LQSLTIVSLK----NNYFSDGLP--------SKFNSVQVLDLSSN--LI 210 (791)
Q Consensus 146 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~~p--------~~l~~L~~L~ls~N--~l 210 (791)
+..+.++++|++|+|+.|++++..+..+.. +++|+.|+|+ .|++++... ..+++|+.|+|++| .+
T Consensus 371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l 450 (592)
T 3ogk_B 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL 450 (592)
T ss_dssp HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGC
T ss_pred HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCc
Confidence 233445777888888777777666655554 7777777775 666765311 12466777777632 34
Q ss_pred cccCCCCcCC--ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCC--CcccccccccccCCC
Q 003847 211 NGSLPPDIGG--YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES--NVFMNQESSSFSGNL 280 (791)
Q Consensus 211 ~~~~p~~~~~--~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~ 280 (791)
++..+..+.. .+|++|+|++|++++.....+...+++|++|+|++|++++..... ..+.++..+.+.+|.
T Consensus 451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 4433333322 357777777777765333333344677777777777765332111 123445555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-11 Score=143.49 Aligned_cols=130 Identities=15% Similarity=0.063 Sum_probs=81.3
Q ss_pred CCcEEEEEcCCCCCccC----CCcCCCCCCCCCEEeCcCCCCCC----CCcccccCCCCccEEEccCCcCCCCCccccCC
Q 003847 80 DSRVIGLALPNSQLLGS----IPADLGMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLISGHLPETMGS 151 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 151 (791)
..+++.|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+ +|..+.+
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 46788999999987665 33445678889999999998873 344555678889999999988874 6666777
Q ss_pred CCCCCEEeCcCCcCC---CCCccccCCCCCCCEEeCCCCcCCCCCCCC---Ccccceecccccccc
Q 003847 152 LHNLQLLNLSDNALA---GKLPVSLTTLQSLTIVSLKNNYFSDGLPSK---FNSVQVLDLSSNLIN 211 (791)
Q Consensus 152 l~~L~~L~ls~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~ls~N~l~ 211 (791)
+++|+.|+++.+... +..+..+..+++|+.|+++++... .+|.. +++|++|+|++|.++
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~ 306 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLE 306 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCC
Confidence 777777777653222 122334444555555555543211 12222 234555555555543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.9e-10 Score=121.37 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=104.5
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcC--CCc-hhhHHHHHHHHHHHhccC--CCCccceeeEEEcc---CceEEEEec
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIG--ENS-VDRFRDFETQVRVIAKLV--HPNLVRIRGFYWGV---DEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lv~e~ 552 (791)
..++.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468899999999998754 678889876 332 122356888999999996 45578899888766 457999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-------------------------------------- 594 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 594 (791)
++|..+.+... ..++..++..++.++++.|+.||+
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99988754111 127788899999999999999997
Q ss_pred --------------------CCCeecCCCCCCeEecCCCC--eEEeccCcccc
Q 003847 595 --------------------KKHVHGNLKPRNVLLGNDME--PKIGDFGLERL 625 (791)
Q Consensus 595 --------------------~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~ 625 (791)
..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997653 68999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.6e-09 Score=118.73 Aligned_cols=166 Identities=14% Similarity=0.096 Sum_probs=76.3
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+++.+.|.++ ++.+-..+|.+ .+|+.++|.+ .++..-+..|.++.+|+.++|++|+++......|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 4555555443 44444445555 2455555553 44434445555555566666655555533333343 3555555555
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC--cccceeccccccccccCCCCcCC-ccccEEEccCCcCc----
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF--NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS---- 234 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l--~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~---- 234 (791)
.| ++.+-...|.++++|+.|+|..| ++..-...| .+|+.++| .|.++..-...|.. .+|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~ 288 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPE 288 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcc
Confidence 33 44344455555555555555543 222222222 34444444 22333222333333 24444544444432
Q ss_pred ccCchhHhhcCCCCcEEEcc
Q 003847 235 GEIPPQFGEKIPVNATIDLS 254 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~ 254 (791)
..|+...|..+++|+.++|.
T Consensus 289 ~~I~~~aF~~c~~L~~l~l~ 308 (401)
T 4fdw_A 289 AMIHPYCLEGCPKLARFEIP 308 (401)
T ss_dssp CEECTTTTTTCTTCCEECCC
T ss_pred cEECHHHhhCCccCCeEEeC
Confidence 12344444444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.2e-09 Score=116.28 Aligned_cols=198 Identities=12% Similarity=0.052 Sum_probs=143.9
Q ss_pred CCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 73 SPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 73 ~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
....|.+ ..++.+.|.+ ++..+-+..|.++++|+.++|++|+++......|. .++|+.+.|.+| ++.+-...|.++
T Consensus 150 ~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~ 225 (401)
T 4fdw_A 150 GDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKT 225 (401)
T ss_dssp CTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTC
T ss_pred CHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCC
Confidence 3445555 4688899986 77777778899999999999999999855555555 689999999855 775677789999
Q ss_pred CCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceecccccccc-----ccCCCCcCC-ccc
Q 003847 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLIN-----GSLPPDIGG-YSL 223 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~-----~~~p~~~~~-~~L 223 (791)
++|+.|+|..| ++..-...|.+ .+|+.+.| .|.++......| ++|+.|+|.+|.+. ..-+..|.+ .+|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 99999999875 56466667777 78999988 455555444444 68888888888765 233445555 489
Q ss_pred cEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 224 RYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 224 ~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
+.++|. |.++ .|+...|..+.+|+.|+|..| ++..-+......++..+.+.+|.
T Consensus 303 ~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 303 ARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp CEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSS
T ss_pred CeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCC
Confidence 999988 4577 788877777889999998655 55444444333366667776663
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.94 E-value=9.4e-12 Score=144.49 Aligned_cols=198 Identities=14% Similarity=0.072 Sum_probs=132.3
Q ss_pred CCcEEEEEcCCCCCccCCC-cCCCCCCCCCEEeCcCCCCCCC-CcccccCCCCccEEEc---------cCCcCCCCCccc
Q 003847 80 DSRVIGLALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGS-LSFSLFNASQLRNLDL---------SNNLISGHLPET 148 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L---------~~N~l~~~~p~~ 148 (791)
..+++.|+|++|.+++... ..+..+++|+.|+|++| +... ++.....+++|++|+| +.|.+++.....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 3578889998888764432 23567888999999888 4322 2223345788899988 345555333233
Q ss_pred c-CCCCCCCEEeCcCCcCCCCCccccC-CCCCCCEEeCC--C----CcCCCCCC--------CCCcccceeccccccccc
Q 003847 149 M-GSLHNLQLLNLSDNALAGKLPVSLT-TLQSLTIVSLK--N----NYFSDGLP--------SKFNSVQVLDLSSNLING 212 (791)
Q Consensus 149 ~-~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~~p--------~~l~~L~~L~ls~N~l~~ 212 (791)
+ .++++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++... ..+++|+.|+|++ .++.
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 3 3478899998888888866555554 58899999998 4 56663221 2347899999977 5654
Q ss_pred cCCCCcC--CccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC--CCcccccccccccCC
Q 003847 213 SLPPDIG--GYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE--SNVFMNQESSSFSGN 279 (791)
Q Consensus 213 ~~p~~~~--~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~--~~~~~~~~~~~~~~n 279 (791)
..+..+. ..+|++|+|++|.+++..+..+...+++|+.|+|++|++++.... ...+.++..+.+.+|
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 4443443 247999999999998776666655589999999999998644332 122445555666555
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=115.04 Aligned_cols=133 Identities=16% Similarity=0.181 Sum_probs=99.0
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCC--ccceeeEEEccC---ceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPN--LVRIRGFYWGVD---EKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lv~e~~~ 554 (791)
+.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 358899999999873 56889986543 33467899999998884 333 344544433332 3488999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---------------------------------------- 594 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------------------------------------- 594 (791)
|.+|.+.... .++.+++..++.+++..|+.||+
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9998764332 27778888889999999988885
Q ss_pred ------------------CCCeecCCCCCCeEecC--CCCeEEeccCccccc
Q 003847 595 ------------------KKHVHGNLKPRNVLLGN--DMEPKIGDFGLERLV 626 (791)
Q Consensus 595 ------------------~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~ 626 (791)
..++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 23699999999999998 456789999998753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-10 Score=135.50 Aligned_cols=175 Identities=17% Similarity=0.097 Sum_probs=95.4
Q ss_pred CcEEEEEcCCCCCccCCCcCCC-CCCCCCEEeCcCC-CCCCC-CcccccCCCCccEEEccCCcCCCCCcccc----CCCC
Q 003847 81 SRVIGLALPNSQLLGSIPADLG-MIEFLQYLDLSNN-SLNGS-LSFSLFNASQLRNLDLSNNLISGHLPETM----GSLH 153 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~ 153 (791)
.+++.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4566777777766655555554 5677777777776 44422 33344466777777777777665443333 3556
Q ss_pred CCCEEeCcCCc--CCC-CCccccCCCCCCCEEeCCCC-cCCCCCCCC---Ccccceecccccc-----------------
Q 003847 154 NLQLLNLSDNA--LAG-KLPVSLTTLQSLTIVSLKNN-YFSDGLPSK---FNSVQVLDLSSNL----------------- 209 (791)
Q Consensus 154 ~L~~L~ls~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~---l~~L~~L~ls~N~----------------- 209 (791)
+|+.|+|++|. ++. .++..+.++++|+.|+|++| .+.+ ++.. +++|+.|+++.+.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 77777777765 210 01112234567777777766 2222 3322 2456666544331
Q ss_pred ---------ccc----cCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccC
Q 003847 210 ---------ING----SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 210 ---------l~~----~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
+.. .++..+.. .+|++|+|++|.+++.....+...+++|+.|+|++|
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 111 11111111 367777777777665444444445777777777766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=5.6e-10 Score=120.22 Aligned_cols=177 Identities=15% Similarity=0.128 Sum_probs=118.8
Q ss_pred CCcEEEEEcCCCCCcc-CC-------CcCCCCCCCCCEEeCcCCCCC---------CCCcccccCCCCccEEEccCCc-C
Q 003847 80 DSRVIGLALPNSQLLG-SI-------PADLGMIEFLQYLDLSNNSLN---------GSLSFSLFNASQLRNLDLSNNL-I 141 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~-~~-------~~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~-l 141 (791)
..+|+.|.+......| .. ...+..+++|+.|.+..+.+. +.+...+..+++|+.|+|++|. +
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 4578888888766543 21 233556789999998776442 1244556678999999998883 3
Q ss_pred CCCCccccCCCCCCCEEeCcCCcCCCCCccccC--CCCCCCEEeCCC--CcCCCC---------CC-CCCcccceecccc
Q 003847 142 SGHLPETMGSLHNLQLLNLSDNALAGKLPVSLT--TLQSLTIVSLKN--NYFSDG---------LP-SKFNSVQVLDLSS 207 (791)
Q Consensus 142 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~---------~p-~~l~~L~~L~ls~ 207 (791)
+ ++. + .+++|+.|+|..|.+.......+. .+++|+.|+|+. |...+. +. ..+++|+.|+|++
T Consensus 186 ~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~ 261 (362)
T 2ra8_A 186 S--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261 (362)
T ss_dssp B--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEES
T ss_pred e--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCC
Confidence 2 333 3 378999999998887644333343 688999999853 222111 11 2468999999999
Q ss_pred ccccccCCCCc----CCccccEEEccCCcCcccCchhHh---hcCCCCcEEEcccCcCcc
Q 003847 208 NLINGSLPPDI----GGYSLRYLNLSYNRLSGEIPPQFG---EKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 208 N~l~~~~p~~~----~~~~L~~L~l~~N~l~g~ip~~~~---~~l~~l~~l~l~~N~l~~ 260 (791)
|.+....+..+ ..++|++|+|+.|.|++.-...+. ..+++|+.|+|++|.++.
T Consensus 262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 99874333222 235899999999999864333332 237899999999998863
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.4e-10 Score=118.51 Aligned_cols=65 Identities=31% Similarity=0.428 Sum_probs=32.0
Q ss_pred CCCCccEEEccCCcCCC--CCccccCCCCCCCEEeCcCCcCCCCCccccCCCC--CCCEEeCCCCcCCCCC
Q 003847 127 NASQLRNLDLSNNLISG--HLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQ--SLTIVSLKNNYFSDGL 193 (791)
Q Consensus 127 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~ 193 (791)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence 45555555555555554 2334444555555555555555533 1222222 5555555555555433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.64 E-value=4.7e-09 Score=112.93 Aligned_cols=173 Identities=16% Similarity=0.234 Sum_probs=116.9
Q ss_pred CCcEEEEEcCCCCCc---------cCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccC
Q 003847 80 DSRVIGLALPNSQLL---------GSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMG 150 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 150 (791)
..+++.|.+.++... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......+.
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 457888888665431 224455677899999999998311 2333 3 389999999999988744333443
Q ss_pred --CCCCCCEEeCcC--CcCCCC-----Ccccc--CCCCCCCEEeCCCCcCCCCCC------CCCcccceecccccccccc
Q 003847 151 --SLHNLQLLNLSD--NALAGK-----LPVSL--TTLQSLTIVSLKNNYFSDGLP------SKFNSVQVLDLSSNLINGS 213 (791)
Q Consensus 151 --~l~~L~~L~ls~--N~l~~~-----~p~~~--~~l~~L~~L~L~~N~l~~~~p------~~l~~L~~L~ls~N~l~~~ 213 (791)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|.+|.+.+..+ ..+++|++|+|+.|.|+..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 789999999863 332221 11123 357999999999999875322 2458999999999999853
Q ss_pred ----CCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCc
Q 003847 214 ----LPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN 257 (791)
Q Consensus 214 ----~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~ 257 (791)
++..+.. .+|+.|+|++|.|+...-..+...+ ...++++.|+
T Consensus 295 G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 295 GARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 3333222 5899999999999855444443323 3568888887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=6.3e-07 Score=94.36 Aligned_cols=133 Identities=18% Similarity=0.171 Sum_probs=95.3
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCC---CccceeeEEE-ccCceEEEEeccCCC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHP---NLVRIRGFYW-GVDEKLIIYDFVPNG 556 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~~g 556 (791)
..++.|....||+. |..++||+-.. ......+.+|+++|+.+.+. .+.+.+.+.. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 35678888899988 57788898532 23346789999999999753 3567777764 445678999999998
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE------------------------------------------ 594 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~------------------------------------------ 594 (791)
++.+.... .++..+...++.++++.|+.||+
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88763221 14555555666666666666654
Q ss_pred ------------------CCCeecCCCCCCeEecC---CCC-eEEeccCccccc
Q 003847 595 ------------------KKHVHGNLKPRNVLLGN---DME-PKIGDFGLERLV 626 (791)
Q Consensus 595 ------------------~~ivHrDlkp~NILl~~---~~~-~kL~DFGla~~~ 626 (791)
..++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 23599999999999987 455 489999987753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=1.9e-08 Score=97.59 Aligned_cols=94 Identities=16% Similarity=0.171 Sum_probs=58.8
Q ss_pred CcCCCCCCCCCEEeCcCC-CCCCC----CcccccCCCCccEEEccCCcCCCC----CccccCCCCCCCEEeCcCCcCCCC
Q 003847 98 PADLGMIEFLQYLDLSNN-SLNGS----LSFSLFNASQLRNLDLSNNLISGH----LPETMGSLHNLQLLNLSDNALAGK 168 (791)
Q Consensus 98 ~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~ 168 (791)
...+...+.|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|...
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 344566677777777777 77632 334455567777777777777631 334445556777777777777632
Q ss_pred ----CccccCCCCCCCEEeC--CCCcCCC
Q 003847 169 ----LPVSLTTLQSLTIVSL--KNNYFSD 191 (791)
Q Consensus 169 ----~p~~~~~l~~L~~L~L--~~N~l~~ 191 (791)
+...+...++|++|+| ++|.|..
T Consensus 109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 109 GILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 3445556666777777 6666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=1.3e-07 Score=96.50 Aligned_cols=80 Identities=26% Similarity=0.284 Sum_probs=64.9
Q ss_pred CCCCCCCEEeCcCCCCCC--CCcccccCCCCccEEEccCCcCCCCCccccCCCC--CCCEEeCcCCcCCCCCcc------
Q 003847 102 GMIEFLQYLDLSNNSLNG--SLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH--NLQLLNLSDNALAGKLPV------ 171 (791)
Q Consensus 102 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~------ 171 (791)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 357899999999999998 4567788999999999999999965 3344444 999999999999987763
Q ss_pred -ccCCCCCCCEEe
Q 003847 172 -SLTTLQSLTIVS 183 (791)
Q Consensus 172 -~~~~l~~L~~L~ 183 (791)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356677777775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.9e-06 Score=88.91 Aligned_cols=132 Identities=15% Similarity=0.140 Sum_probs=94.7
Q ss_pred ccccCce-EEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 483 LGASGSS-IMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 483 lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
+..|..+ .||+.... ++..++||+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3344444 68988754 4678999986543 2356888999998884 334778899998889999999999998887
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-------------------------------------------- 595 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-------------------------------------------- 595 (791)
+...... .....++.+++..|..||+.
T Consensus 109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6543211 12234555566666666531
Q ss_pred --------------CCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 596 --------------KHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 596 --------------~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
.++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1689999999999998777789999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=5.6e-08 Score=94.30 Aligned_cols=111 Identities=19% Similarity=0.220 Sum_probs=87.0
Q ss_pred CCcEEEEEcCCC-CCccC----CCcCCCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCC----Cc
Q 003847 80 DSRVIGLALPNS-QLLGS----IPADLGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGH----LP 146 (791)
Q Consensus 80 ~~~v~~L~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 146 (791)
...++.|+|++| +|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 468999999999 88642 445677789999999999999743 344555668999999999999843 46
Q ss_pred cccCCCCCCCEEeC--cCCcCCCC----CccccCCCCCCCEEeCCCCcCC
Q 003847 147 ETMGSLHNLQLLNL--SDNALAGK----LPVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 147 ~~~~~l~~L~~L~l--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 190 (791)
..+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 66788889999999 88999843 3344555678888888888775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-06 Score=94.48 Aligned_cols=79 Identities=15% Similarity=-0.000 Sum_probs=55.8
Q ss_pred eec-cccCceEEEEEEeC-------CCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccC-C--CCccceeeEEEcc---
Q 003847 481 YIL-GASGSSIMYKAVLE-------DGTALAVRRIGENS---VDRFRDFETQVRVIAKLV-H--PNLVRIRGFYWGV--- 543 (791)
Q Consensus 481 ~~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~--- 543 (791)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78889999998764 26789999875432 101245788888888884 3 3577888877655
Q ss_pred CceEEEEeccCCCChh
Q 003847 544 DEKLIIYDFVPNGSLA 559 (791)
Q Consensus 544 ~~~~lv~e~~~~gsL~ 559 (791)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=4.2e-05 Score=81.52 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=80.6
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC--CCCccceee------EEEccCceEEEEecc
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV--HPNLVRIRG------FYWGVDEKLIIYDFV 553 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~------~~~~~~~~~lv~e~~ 553 (791)
.|+.|..+.||++...+| .+++|+.... . .++..|+++++.+. .-.+.+++. +....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456677899999987655 4899998763 1 33444555555542 112333433 123456778999999
Q ss_pred CCCChh--------------HHHHhhcCCC--C-------CCCCHHHH-------------------------------H
Q 003847 554 PNGSLA--------------NARYRKMGSS--P-------CHLPWEAR-------------------------------L 579 (791)
Q Consensus 554 ~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~-------------------------------~ 579 (791)
+|..+. ..++...... + ..-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1122221110 0 00123211 1
Q ss_pred HHHHHHHHHHHHHh-------------cCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 580 KIAKGVARGLAFLH-------------EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 580 ~i~~qi~~gL~yLH-------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.+..++..++++|+ ...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11223444566665 36799999999999998888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.5e-05 Score=87.07 Aligned_cols=74 Identities=7% Similarity=0.075 Sum_probs=49.2
Q ss_pred eeccccCceEEEEEEeC-CCcEEEEEEcCCCch-------hhHHHHHHHHHHHhccCC--CC-ccceeeEEEccCceEEE
Q 003847 481 YILGASGSSIMYKAVLE-DGTALAVRRIGENSV-------DRFRDFETQVRVIAKLVH--PN-LVRIRGFYWGVDEKLII 549 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~~~~~~~~~~~lv 549 (791)
+.||.|..+.||++... +++.|+||....... .....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 47899999999999754 468899998653211 123456778888887742 33 4455543 44567899
Q ss_pred EeccCCC
Q 003847 550 YDFVPNG 556 (791)
Q Consensus 550 ~e~~~~g 556 (791)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00014 Score=79.24 Aligned_cols=182 Identities=11% Similarity=0.063 Sum_probs=105.6
Q ss_pred eeeCCCCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCC---
Q 003847 69 VTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL--- 145 (791)
Q Consensus 69 v~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--- 145 (791)
|+=.....|.+...++.+.|.+ +++.+-..+|.++++|+.++|.+| ++..-...|.++.+|+.+.+..+- ...-
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeeccee
Confidence 4444556777888999999974 477666788999999999999865 554556678888888887776542 2122
Q ss_pred -------------------ccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---ccccee
Q 003847 146 -------------------PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVL 203 (791)
Q Consensus 146 -------------------p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L 203 (791)
...|.++++|+.+.|.++..+ .....|.++.+|+.+.+..| ++......| ..|+.+
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i 213 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENM 213 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBC
T ss_pred eecccccccccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhcccccccee
Confidence 233555666666666544322 44455666666666666554 222112222 445555
Q ss_pred ccccccccccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcC
Q 003847 204 DLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNL 258 (791)
Q Consensus 204 ~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l 258 (791)
.+..+... .-...+...+|+.+.+..+ ++ .|....+..+..|+.+.+..|..
T Consensus 214 ~~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~ 265 (394)
T 4fs7_A 214 EFPNSLYY-LGDFALSKTGVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKL 265 (394)
T ss_dssp CCCTTCCE-ECTTTTTTCCCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTC
T ss_pred ecCCCceE-eehhhcccCCCceEEECCC-ce-ecccccccccccceeEEcCCCcc
Confidence 55554332 1122222345666665433 22 34444444466666666665543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.76 E-value=9.9e-05 Score=80.44 Aligned_cols=177 Identities=14% Similarity=0.080 Sum_probs=98.3
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCC-----------
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLIS----------- 142 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~----------- 142 (791)
...|.....++.+.|.++ +..+-...|.++.+|+.++|..| ++......|.++..|+.+.+..+...
T Consensus 155 ~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l 232 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGV 232 (394)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCC
T ss_pred hhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCC
Confidence 345666778888888755 44455677888889999888776 44344556666666666665544321
Q ss_pred ----------CCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccc
Q 003847 143 ----------GHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLING 212 (791)
Q Consensus 143 ----------~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~ 212 (791)
..-...|.++.+|+.+.+..|... .....|.++..|+.+.+..+.+.........+|+.+.+.+| ++.
T Consensus 233 ~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~ 310 (394)
T 4fs7_A 233 KNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKF 310 (394)
T ss_dssp CEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCE
T ss_pred ceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-cce
Confidence 112233445555666655555433 34444555555555555444433322333355666666544 432
Q ss_pred cCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccC
Q 003847 213 SLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 213 ~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
.-...|.+ .+|+.++|.++ ++ .|....|..+.+|+.+++..|
T Consensus 311 I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 311 IGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp ECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred echhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 33334444 45666666533 44 555555555666666666554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=9.6e-05 Score=76.77 Aligned_cols=74 Identities=19% Similarity=0.271 Sum_probs=55.1
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCC---CccceeeEEEccCceEEEEeccCCCC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHP---NLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.-+|.|..+.||+.+..+|+.|+||+...........|+.|++.|+.|.-. -+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 457999999999999999999999997655443335688999999888422 34555554 23478999998765
Q ss_pred h
Q 003847 558 L 558 (791)
Q Consensus 558 L 558 (791)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00024 Score=78.12 Aligned_cols=72 Identities=15% Similarity=0.148 Sum_probs=45.4
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCC------c-h--hhHHHHHHHHHHHh-ccCCCCccceeeEEEccCceEEEE
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGEN------S-V--DRFRDFETQVRVIA-KLVHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
+.||.|..+.||++.. +++.++||..... . . .....++.|+..+. ......+.+++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 4688899999999965 4678999943211 0 0 02234444544332 22334567777665 56779999
Q ss_pred ecc-CC
Q 003847 551 DFV-PN 555 (791)
Q Consensus 551 e~~-~~ 555 (791)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00013 Score=79.51 Aligned_cols=137 Identities=9% Similarity=0.154 Sum_probs=87.0
Q ss_pred CCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCcc
Q 003847 92 QLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV 171 (791)
Q Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 171 (791)
++..+-..+|.++..|+.+.+.++..+ .....|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++.+-..
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 344444567888888888888766543 556678888888888886 4555455667888888888888765 6645667
Q ss_pred ccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCCccccEEEccCCcCc
Q 003847 172 SLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLS 234 (791)
Q Consensus 172 ~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~ 234 (791)
+|.++.+|+.+.|..+ ++..-...| .+|+.+++.+|.... .......+|+.|.+..|.+.
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC-----------
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCCEE
Confidence 8888888888888654 544333344 678888888876542 12223357888887776653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00037 Score=75.88 Aligned_cols=82 Identities=15% Similarity=0.160 Sum_probs=43.9
Q ss_pred ccCCCCCCCEEeCCCCcCC--CCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCC
Q 003847 172 SLTTLQSLTIVSLKNNYFS--DGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVN 248 (791)
Q Consensus 172 ~~~~l~~L~~L~L~~N~l~--~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l 248 (791)
.|.++..|+.+.+.++..+ ........+|+.+.+. +.++..-...|.+ .+|+.++|..| ++ .|.+..|..+.+|
T Consensus 260 aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTC
T ss_pred eeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCC
Confidence 4667778888887655322 1111222556666664 3344233334444 46666666544 44 5555555556666
Q ss_pred cEEEcccC
Q 003847 249 ATIDLSFN 256 (791)
Q Consensus 249 ~~l~l~~N 256 (791)
+.+.|..+
T Consensus 337 ~~i~ip~s 344 (394)
T 4gt6_A 337 ERIAIPSS 344 (394)
T ss_dssp CEEEECTT
T ss_pred CEEEECcc
Confidence 66666543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0006 Score=71.35 Aligned_cols=136 Identities=13% Similarity=0.102 Sum_probs=91.7
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC---CCCccceeeEEEccCceEEEEeccCCCC
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV---HPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..|+.|....+|+... ++..++||+.... ....+..|++.|+.|. ...+++++++....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4578899999999986 4678889987543 2467889999998883 3568899998888888999999999876
Q ss_pred hhH-----------HHHhhcCCC-----------------CCCCCHHHHH---HHH----------------HHHHHHH-
Q 003847 558 LAN-----------ARYRKMGSS-----------------PCHLPWEARL---KIA----------------KGVARGL- 589 (791)
Q Consensus 558 L~~-----------~l~~~~~~~-----------------~~~l~~~~~~---~i~----------------~qi~~gL- 589 (791)
+.. .++...... ...-+|.+.. ++. .+++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 233322100 0012454321 111 1122222
Q ss_pred HHHh----cCCCeecCCCCCCeEecCCCCeEEeccC
Q 003847 590 AFLH----EKKHVHGNLKPRNVLLGNDMEPKIGDFG 621 (791)
Q Consensus 590 ~yLH----~~~ivHrDlkp~NILl~~~~~~kL~DFG 621 (791)
+.|. ...+||+|+.+.|++++.++ +.|+||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2442 25699999999999999887 8999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00031 Score=73.33 Aligned_cols=71 Identities=6% Similarity=0.162 Sum_probs=44.9
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCc-cceeeEEEccCceEEEEecc-CCCCh
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNL-VRIRGFYWGVDEKLIIYDFV-PNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~gsL 558 (791)
..|+.|....+|++ +.+++|+....... .....+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 46778889999998 56888988654221 1233567877777743333 455543 444567899999 66555
Q ss_pred h
Q 003847 559 A 559 (791)
Q Consensus 559 ~ 559 (791)
.
T Consensus 96 ~ 96 (301)
T 3dxq_A 96 S 96 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0015 Score=69.02 Aligned_cols=140 Identities=14% Similarity=0.100 Sum_probs=81.9
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCC--CccceeeE-----EEccCceEEEEeccC
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHP--NLVRIRGF-----YWGVDEKLIIYDFVP 554 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lv~e~~~ 554 (791)
.++ |....||++...+|+.+++|+...... ....+..|..+++.+... .+++++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 778899998877788899999864321 234667788888777422 24444443 222445678999998
Q ss_pred CCChhH--------------HHHhhcCCC----CCCCCHHHH----------------------HHHHHHHHHHHHHH--
Q 003847 555 NGSLAN--------------ARYRKMGSS----PCHLPWEAR----------------------LKIAKGVARGLAFL-- 592 (791)
Q Consensus 555 ~gsL~~--------------~l~~~~~~~----~~~l~~~~~----------------------~~i~~qi~~gL~yL-- 592 (791)
|..+.. .++...... ....++... ...+.+++..++-+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 755421 122211110 011222211 11122222222222
Q ss_pred --hcCCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 593 --HEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 593 --H~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
+...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999998 4 899999988764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.29 E-value=4.4e-05 Score=72.17 Aligned_cols=34 Identities=6% Similarity=0.187 Sum_probs=15.8
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCC
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNN 115 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N 115 (791)
+++.|||+++.++..--..+..+++|++|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555543322233444444455555444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.28 E-value=7.3e-05 Score=70.70 Aligned_cols=87 Identities=11% Similarity=0.112 Sum_probs=67.6
Q ss_pred CCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCc-CCCCCccccCCC----CCCCEEeCcCCc-CCCCCccccCCCCC
Q 003847 105 EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNL-ISGHLPETMGSL----HNLQLLNLSDNA-LAGKLPVSLTTLQS 178 (791)
Q Consensus 105 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~~~~p~~~~~l~~ 178 (791)
-.|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+ ++|++|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999986555567899999999999995 664333345554 479999999974 87544456788999
Q ss_pred CCEEeCCCCc-CCC
Q 003847 179 LTIVSLKNNY-FSD 191 (791)
Q Consensus 179 L~~L~L~~N~-l~~ 191 (791)
|++|+|+++. ++.
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 9999999984 543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0015 Score=69.22 Aligned_cols=140 Identities=14% Similarity=0.074 Sum_probs=73.9
Q ss_pred eccccCceE-EEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC--CCccceeeEEEccCceEEEEeccCCCCh
Q 003847 482 ILGASGSSI-MYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH--PNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 482 ~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+.... -+++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 344554444 6677654467788887654321 234556677766632 2355676653322 3789999987776
Q ss_pred hHHHHhhcC---------------------CCCCCCCHHHHH-------H-H------------HHHHHHHHHHH-----
Q 003847 559 ANARYRKMG---------------------SSPCHLPWEARL-------K-I------------AKGVARGLAFL----- 592 (791)
Q Consensus 559 ~~~l~~~~~---------------------~~~~~l~~~~~~-------~-i------------~~qi~~gL~yL----- 592 (791)
.+++..... .....++..... . + ...+...++.+
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 554432110 000012211100 0 0 01111222333
Q ss_pred -hcCCCeecCCCCCCeEecCC----CCeEEeccCccccc
Q 003847 593 -HEKKHVHGNLKPRNVLLGND----MEPKIGDFGLERLV 626 (791)
Q Consensus 593 -H~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~ 626 (791)
+...++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23579999999999999874 67899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0015 Score=68.68 Aligned_cols=142 Identities=11% Similarity=0.037 Sum_probs=79.6
Q ss_pred eeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCC--ccceeeE------EEccCceEEEEec
Q 003847 481 YILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPN--LVRIRGF------YWGVDEKLIIYDF 552 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lv~e~ 552 (791)
..|+.|....+|++...+| .+++|+..... ..+.+..|+.+++.+.... +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3567788889999987665 68899887631 1234566777777663212 3333321 1223567899999
Q ss_pred cCCCChhH--------------HHHhhcCCCCCC----C---CHHHHHH------------HHHHHHHHHHHHhc-----
Q 003847 553 VPNGSLAN--------------ARYRKMGSSPCH----L---PWEARLK------------IAKGVARGLAFLHE----- 594 (791)
Q Consensus 553 ~~~gsL~~--------------~l~~~~~~~~~~----l---~~~~~~~------------i~~qi~~gL~yLH~----- 594 (791)
++|..+.. .++.....-..+ . .|..... +...+...++++++
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865421 122221110000 1 1221100 01123444555552
Q ss_pred --CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 595 --KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 595 --~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.+++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4689999999999998876568999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=71.37 Aligned_cols=140 Identities=13% Similarity=0.150 Sum_probs=83.9
Q ss_pred eeccccCceEEEEEEeC--------CCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEe
Q 003847 481 YILGASGSSIMYKAVLE--------DGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+..|-...+|++... +++.+++|+..... .....+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35667778889999864 25789999975432 22456678999998884 3334567766543 28999
Q ss_pred ccCCCChhH--------------H---HHhhcCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHHh
Q 003847 552 FVPNGSLAN--------------A---RYRKMGSSPCHL--PWEARLKIAKGVAR-------------------GLAFLH 593 (791)
Q Consensus 552 ~~~~gsL~~--------------~---l~~~~~~~~~~l--~~~~~~~i~~qi~~-------------------gL~yLH 593 (791)
|++|.+|.. . ++.......... -+.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999866531 1 111110000112 24556666554422 233333
Q ss_pred c--------CCCeecCCCCCCeEecCC----CCeEEeccCcccc
Q 003847 594 E--------KKHVHGNLKPRNVLLGND----MEPKIGDFGLERL 625 (791)
Q Consensus 594 ~--------~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~ 625 (791)
+ ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 358999999999999876 7899999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=71.70 Aligned_cols=142 Identities=11% Similarity=0.094 Sum_probs=89.7
Q ss_pred CCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCC
Q 003847 96 SIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTT 175 (791)
Q Consensus 96 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 175 (791)
.....+.....|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.+
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence 34455666777777777655 33344556777777777777665 54455566777777777777644 44345566777
Q ss_pred CCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhh
Q 003847 176 LQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGE 243 (791)
Q Consensus 176 l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~ 243 (791)
+.+|+.+.+.+|.++..-...| .+|+.++|..| ++..-..+|.+ .+|+.+.+..| ++ .|....|.
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~-~I~~~aF~ 353 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT-LIESGAFE 353 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTT
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC-EEchhHhh
Confidence 7778877777776665444444 56777777654 55333445555 46777777654 55 55555554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00095 Score=73.39 Aligned_cols=72 Identities=13% Similarity=0.231 Sum_probs=49.3
Q ss_pred eeccccCceEEEEEEeCC--------CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCc-cceeeEEEccCceEEEEe
Q 003847 481 YILGASGSSIMYKAVLED--------GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNL-VRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e 551 (791)
..|+.|....+|++...+ ++.+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998653 57899999854211 1345578888888843333 577765532 38999
Q ss_pred ccCCCCh
Q 003847 552 FVPNGSL 558 (791)
Q Consensus 552 ~~~~gsL 558 (791)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.12 E-value=7.6e-05 Score=71.93 Aligned_cols=87 Identities=23% Similarity=0.222 Sum_probs=44.2
Q ss_pred CCCCCCCCEEeCcCC-CCCCC----CcccccCCCCccEEEccCCcCCC----CCccccCCCCCCCEEeCcCCcCCCC---
Q 003847 101 LGMIEFLQYLDLSNN-SLNGS----LSFSLFNASQLRNLDLSNNLISG----HLPETMGSLHNLQLLNLSDNALAGK--- 168 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~--- 168 (791)
+.+-+.|++|+|++| +|... +-..+..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 334456667777664 55421 22334444566666666666652 2233333445566666666666521
Q ss_pred -CccccCCCCCCCEEeCCCC
Q 003847 169 -LPVSLTTLQSLTIVSLKNN 187 (791)
Q Consensus 169 -~p~~~~~l~~L~~L~L~~N 187 (791)
+-..+..-+.|++|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 1223334445555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00058 Score=61.44 Aligned_cols=57 Identities=25% Similarity=0.328 Sum_probs=36.9
Q ss_pred eecccccccc-ccCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcc
Q 003847 202 VLDLSSNLIN-GSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 202 ~L~ls~N~l~-~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
.++.+++.|+ ..+|..+. .+|++|+|++|+|+ .||...+..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp-~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP-VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC-TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC-cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeec
Confidence 3445555553 23443321 35777777777777 7777777778888888887777754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0019 Score=69.73 Aligned_cols=151 Identities=9% Similarity=0.069 Sum_probs=112.9
Q ss_pred CCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCC
Q 003847 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179 (791)
Q Consensus 100 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 179 (791)
.+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.++.+|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l 265 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL 265 (379)
T ss_dssp ECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence 4555666777766654332 45567778899999999776 44356677889999999999876 665667789999999
Q ss_pred CEEeCCCCcCCCCCC---CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEccc
Q 003847 180 TIVSLKNNYFSDGLP---SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSF 255 (791)
Q Consensus 180 ~~L~L~~N~l~~~~p---~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~ 255 (791)
+.+.+..+ ++.... ....+|+.+++.+|.++..-...|.+ .+|+.++|..| ++ .|....|..+.+|+.+.+..
T Consensus 266 ~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 266 KTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCT
T ss_pred cccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECC
Confidence 99999755 443223 33478999999999998555666766 68999999765 76 78888777789999888765
Q ss_pred C
Q 003847 256 N 256 (791)
Q Consensus 256 N 256 (791)
|
T Consensus 343 ~ 343 (379)
T 4h09_A 343 S 343 (379)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0036 Score=60.61 Aligned_cols=99 Identities=13% Similarity=0.005 Sum_probs=65.6
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
-+|.+++..... ++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|...+ ..+..
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~--------- 98 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADDA--------- 98 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccccc---------
Confidence 479998887754 59999999999999999887721 1111233456889999999988764 11110
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhC
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG 708 (791)
....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 99 ---------------------------------------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 99 ---------------------------------------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---------------------------------------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 112267888764 3456888999999999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.001 Score=71.68 Aligned_cols=73 Identities=10% Similarity=0.112 Sum_probs=45.1
Q ss_pred eeccccCceEEEEEEeCC---------CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCC-ccceeeEEEccCceEEEE
Q 003847 481 YILGASGSSIMYKAVLED---------GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPN-LVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~ 550 (791)
..++.|....+|++...+ ++.+++|+....... ......|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 356778888999998654 268899987654221 123467888888774333 44666544 2 36899
Q ss_pred eccCCCCh
Q 003847 551 DFVPNGSL 558 (791)
Q Consensus 551 e~~~~gsL 558 (791)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00021 Score=68.82 Aligned_cols=110 Identities=14% Similarity=0.189 Sum_probs=78.1
Q ss_pred CCcEEEEEcCCC-CCcc----CCCcCCCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCC----Cc
Q 003847 80 DSRVIGLALPNS-QLLG----SIPADLGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGH----LP 146 (791)
Q Consensus 80 ~~~v~~L~L~~~-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 146 (791)
...++.|+|++| +|.. .+...+..-+.|+.|+|++|+|... +...+..-+.|++|+|++|+|... +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 467899999986 7642 2445677778999999999999833 344444568899999999999832 34
Q ss_pred cccCCCCCCCEEeCcCCcC---CCC----CccccCCCCCCCEEeCCCCcC
Q 003847 147 ETMGSLHNLQLLNLSDNAL---AGK----LPVSLTTLQSLTIVSLKNNYF 189 (791)
Q Consensus 147 ~~~~~l~~L~~L~ls~N~l---~~~----~p~~~~~l~~L~~L~L~~N~l 189 (791)
+.+..-+.|+.|+|++|.. ... +-..+..-+.|+.|+|+.|.+
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 4566667899999997643 311 223444556778888876654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0026 Score=67.53 Aligned_cols=68 Identities=18% Similarity=0.106 Sum_probs=43.8
Q ss_pred cccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC---CCCccceeeE------EEccCceEEEEeccC
Q 003847 484 GASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV---HPNLVRIRGF------YWGVDEKLIIYDFVP 554 (791)
Q Consensus 484 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~------~~~~~~~~lv~e~~~ 554 (791)
|.|....||++...+| .+++|+...... ..|+.+++.|. -+.+++.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999997777 899998765432 34555555552 2224454432 233567789999999
Q ss_pred CCCh
Q 003847 555 NGSL 558 (791)
Q Consensus 555 ~gsL 558 (791)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0021 Score=57.73 Aligned_cols=56 Identities=23% Similarity=0.266 Sum_probs=30.5
Q ss_pred EEEccCCcCC-CCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCC
Q 003847 133 NLDLSNNLIS-GHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 133 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 190 (791)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4455555553 23443222 24666666666666554555666666666666666553
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0068 Score=66.91 Aligned_cols=73 Identities=18% Similarity=0.223 Sum_probs=48.3
Q ss_pred eeccccCceEEEEEEeCC-CcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCc-cceeeEEEccCceEEEEeccCCCCh
Q 003847 481 YILGASGSSIMYKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNL-VRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..|+.|-...+|++...+ +..+++|+....... .-+..+|..+++.|...++ .++++++. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999998765 578999987543221 1123678888988865444 57777662 2 359999987554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.009 Score=65.08 Aligned_cols=139 Identities=12% Similarity=0.113 Sum_probs=84.0
Q ss_pred eeccccCceEEEEEEeCC--------CcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEe
Q 003847 481 YILGASGSSIMYKAVLED--------GTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+..|-...+|++...+ ++.+++|+....... .-+.++|.++++.+. +.-..++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 356677788999998653 588999997654321 223467888888774 33345666533 2 378999
Q ss_pred ccCCCChhH-----------------HHHhhcC------C--CCCCCCHHHHHHHHHHHH-------------------H
Q 003847 552 FVPNGSLAN-----------------ARYRKMG------S--SPCHLPWEARLKIAKGVA-------------------R 587 (791)
Q Consensus 552 ~~~~gsL~~-----------------~l~~~~~------~--~~~~l~~~~~~~i~~qi~-------------------~ 587 (791)
|++|.+|.. .++.... . ...+.-+.++.++..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999866421 0111110 0 111123444444443321 2
Q ss_pred HHHHHh--------------------c----CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 588 GLAFLH--------------------E----KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 588 gL~yLH--------------------~----~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.+++|. . ..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223332 1 34899999999999 7888999999998764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.74 E-value=0.015 Score=39.08 Aligned_cols=31 Identities=26% Similarity=0.570 Sum_probs=22.1
Q ss_pred CCCCCCccEEEeehHHHHHHHHHHHHHhhhe
Q 003847 340 SQGLRPGTIIGIVIGDIAGIGILAVVFFYVY 370 (791)
Q Consensus 340 ~~~~~~~~ii~iv~g~~~~i~l~~~v~~~~~ 370 (791)
+.+.+...+.+||+|+++++++++.+++++|
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 3456677889999999888877666555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.34 E-value=0.17 Score=54.74 Aligned_cols=29 Identities=21% Similarity=0.339 Sum_probs=24.9
Q ss_pred CeecCCCCCCeEe------cCCCCeEEeccCcccc
Q 003847 597 HVHGNLKPRNVLL------GNDMEPKIGDFGLERL 625 (791)
Q Consensus 597 ivHrDlkp~NILl------~~~~~~kL~DFGla~~ 625 (791)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.96 E-value=0.087 Score=36.45 Aligned_cols=11 Identities=45% Similarity=0.597 Sum_probs=4.8
Q ss_pred eehHHHHHHHH
Q 003847 351 IVIGDIAGIGI 361 (791)
Q Consensus 351 iv~g~~~~i~l 361 (791)
|++|+++++++
T Consensus 12 IA~gVVgGv~~ 22 (44)
T 2l2t_A 12 IAAGVIGGLFI 22 (44)
T ss_dssp HHHHHHHHHHH
T ss_pred EEEeehHHHHH
Confidence 44444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.52 E-value=0.11 Score=36.00 Aligned_cols=11 Identities=18% Similarity=0.377 Sum_probs=4.9
Q ss_pred eehHHHHHHHH
Q 003847 351 IVIGDIAGIGI 361 (791)
Q Consensus 351 iv~g~~~~i~l 361 (791)
|++|+++++++
T Consensus 13 IA~gVVgGv~~ 23 (44)
T 2ks1_B 13 IATGMVGALLL 23 (44)
T ss_dssp STHHHHHHHHH
T ss_pred EEeehhHHHHH
Confidence 44444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.58 E-value=0.2 Score=34.78 Aligned_cols=23 Identities=13% Similarity=0.109 Sum_probs=12.6
Q ss_pred cEEEeehHHHHHHHHHHHHHhhh
Q 003847 347 TIIGIVIGDIAGIGILAVVFFYV 369 (791)
Q Consensus 347 ~ii~iv~g~~~~i~l~~~v~~~~ 369 (791)
.|.+.|+|.++++++++++++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~ 34 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLF 34 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHHHHHHHHH
Confidence 45555666566666655544443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.96 E-value=0.13 Score=35.63 Aligned_cols=27 Identities=26% Similarity=0.251 Sum_probs=15.8
Q ss_pred CccEEEeehHHHHHHHHHHHHHhhhee
Q 003847 345 PGTIIGIVIGDIAGIGILAVVFFYVYR 371 (791)
Q Consensus 345 ~~~ii~iv~g~~~~i~l~~~v~~~~~~ 371 (791)
...|.+.|+|.++++++++++++++++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~R 35 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVR 35 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhh
Confidence 345666677766666666655444333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.63 E-value=3.8 Score=39.41 Aligned_cols=85 Identities=15% Similarity=0.093 Sum_probs=60.1
Q ss_pred CCCCccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeE
Q 003847 529 VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVL 608 (791)
Q Consensus 529 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NIL 608 (791)
.||+++.. .+-.+.+...+.++.-+ +...+-.-. .++...+++++.+|+...++++ .-+|--|.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEE
Confidence 68888877 45556665555555433 333332222 2788999999999988775444 3468889999999
Q ss_pred ecCCCCeEEeccCccc
Q 003847 609 LGNDMEPKIGDFGLER 624 (791)
Q Consensus 609 l~~~~~~kL~DFGla~ 624 (791)
++.++.+++.-.|+-.
T Consensus 112 f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQN 127 (215)
T ss_dssp ECTTSCEEESCCEETT
T ss_pred EcCCCCEEEEEccCcc
Confidence 9999999998877643
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.05 E-value=0.33 Score=33.29 Aligned_cols=15 Identities=20% Similarity=0.445 Sum_probs=8.8
Q ss_pred EEeehHHHHHHHHHH
Q 003847 349 IGIVIGDIAGIGILA 363 (791)
Q Consensus 349 i~iv~g~~~~i~l~~ 363 (791)
.+|++|+++++++++
T Consensus 13 ~~I~~~vv~Gv~ll~ 27 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLL 27 (41)
T ss_dssp THHHHHHHHHHHHHH
T ss_pred EEEEeehhHHHHHHH
Confidence 345666666666555
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.93 E-value=4.4 Score=39.11 Aligned_cols=87 Identities=15% Similarity=0.165 Sum_probs=61.3
Q ss_pred CCCCccceeeEEEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCeecCCCCCCe
Q 003847 529 VHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLA-FLHEKKHVHGNLKPRNV 607 (791)
Q Consensus 529 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~ivHrDlkp~NI 607 (791)
.||++ -..+-.+++...+.++.-+++.=...+. .++..++++++.+|+...+ ++ ..-+|--|.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceE
Confidence 57887 4444456666666666543332222222 2788999999999887555 44 4457888999999
Q ss_pred EecCCCCeEEeccCcccccC
Q 003847 608 LLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 608 Ll~~~~~~kL~DFGla~~~~ 627 (791)
++|.++.+++.-.|+-..+.
T Consensus 116 ~f~~~~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLP 135 (219)
T ss_dssp EECTTCCEEESCCEETTTBS
T ss_pred EEeCCCcEEEEEcCCcccCC
Confidence 99999999999999866554
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.41 E-value=0.25 Score=34.08 Aligned_cols=7 Identities=57% Similarity=0.985 Sum_probs=3.7
Q ss_pred EEEeehH
Q 003847 348 IIGIVIG 354 (791)
Q Consensus 348 ii~iv~g 354 (791)
++++++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4455555
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 791 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 49/304 (16%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+G+ +YK A+ + + + + + F+ +V V+ K H N++ G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ + SL Y + + IA+ A+G+ +LH K +H +L
Sbjct: 76 -PQLAIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
K N+ L D+ KIGDFGL + + + S +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--------------------------- 163
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNP---KWDVYSFGVILLELLTGKVIVVDELGQG 719
L G + APE +R NP + DVY+FG++L EL+TG++ +
Sbjct: 164 -------EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--NN 214
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779
++ R D + + + + +L C +RP + L ++E
Sbjct: 215 RDQIIFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
Query: 780 IPSS 783
+ S
Sbjct: 270 LARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-48
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 51/301 (16%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+G+ +++ + +A++ I E ++ DF + V+ KL HP LV++ G
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
++++F+ +G L++ + E L + V G+A+L E +H +L
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RN L+G + K+ DFG+ R V D +S G
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-------------------------- 161
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+ +PE + + K DV+SFGV++ E+ + I + + N
Sbjct: 162 ---------TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSE 210
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782
+VED + RL + + +++ C P+ RP+ L+ L +I
Sbjct: 211 VVEDISTGFRLYKPRLAST---------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
Query: 783 S 783
S
Sbjct: 262 S 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 51/301 (16%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
LGA ++ T +AV+ + + S+ F + ++ +L H LVR+
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ II +++ NGSL + G L L +A +A G+AF+ E+ ++H +L
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
+ N+L+ + + KI DFGL RL+ + +++ G
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA------------------------- 170
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+ APE++ K DV+SFG++L E++T I G N
Sbjct: 171 ----------KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPE 218
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782
++++ R R+ + ++L C P+ RP+ LE +
Sbjct: 219 VIQNLERGYRMVR---------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 783 S 783
+
Sbjct: 270 A 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 58/304 (19%), Positives = 111/304 (36%), Gaps = 51/304 (16%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
LG ++ T +A++ + ++ F + +V+ KL H LV++
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 82
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
+ I+ +++ GSL + + G + +A +A G+A++ +VH +L
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
+ N+L+G ++ K+ DFGL RL+ + +++
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTAR---------------------------- 171
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+ APE+ + K DV+SFG++L EL T +
Sbjct: 172 -------QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------- 217
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782
+ + R E S L C P++RP+ + LE +
Sbjct: 218 --MVNREVLDQVERGYRMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
Query: 783 SPSP 786
S P
Sbjct: 274 STEP 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 1e-43
Identities = 57/309 (18%), Positives = 120/309 (38%), Gaps = 51/309 (16%)
Query: 482 ILGASGSSIMYKAVL----EDGTALAVRRIGENSVDRF-RDFETQVRVIAKLVHPNLVRI 536
++GA + L + +A++ + ++ RDF ++ ++ + HPN++ +
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92
Query: 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
G +II +F+ NGSL + + G + + +G+A G+ +L +
Sbjct: 93 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMN 148
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
+VH +L RN+L+ +++ K+ DFGL R + DTS + R
Sbjct: 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR---------- 198
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
+ APE+++ K DV+S+G+++ E+++ +
Sbjct: 199 ---------------------WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD- 236
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776
I + R + + +L C RP + +
Sbjct: 237 --------MTNQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 777 LEKIPSSPS 785
L+K+ +P+
Sbjct: 287 LDKMIRNPN 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 56/310 (18%), Positives = 124/310 (40%), Gaps = 54/310 (17%)
Query: 482 ILGASGSSIMYKAVLEDGT-----ALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVR 535
++GA +YK +L+ + +A++ + ++ R DF + ++ + H N++R
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ G +II +++ NG+ + + + + +G+A G+ +L
Sbjct: 74 LEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 129
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+VH +L RN+L+ +++ K+ DFGL R++ D ++
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY--------------------- 168
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
+ S + APE++ K DV+SFG+++ E++T E
Sbjct: 169 ------------TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
L + ++ + R + + ++L C +RP + +
Sbjct: 217 L---------SNHEVMKAINDGFRLPTP--MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
Query: 776 ALEKIPSSPS 785
L+K+ +P
Sbjct: 266 ILDKLIRAPD 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (395), Expect = 3e-43
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 51/305 (16%)
Query: 482 ILGASGSSIMYKAVLED-GTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LG +Y+ V + +AV+ + E++++ +F + V+ ++ HPNLV++ G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
II +F+ G+L + + + L +A ++ + +L +K +H
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+L RN L+G + K+ DFGL RL+TGDT ++ AG
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA----------------------- 176
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGN 720
+ APESL K + K DV++FGV+L E+ T +
Sbjct: 177 ------------KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----- 219
Query: 721 GLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
D ++ L + R + E ++L +C P RPS E QA E +
Sbjct: 220 ----IDLSQVYELLEKDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
Query: 781 PSSPS 785
S
Sbjct: 274 FQESS 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (391), Expect = 1e-42
Identities = 70/325 (21%), Positives = 121/325 (37%), Gaps = 73/325 (22%)
Query: 483 LGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVR 535
+G +++A E T +AV+ + E + + DF+ + ++A+ +PN+V+
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLAN-------------------ARYRKMGSSPCHLPWE 576
+ G ++++++ G L R R P L
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 577 ARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636
+L IA+ VA G+A+L E+K VH +L RN L+G +M KI DFGL R + G
Sbjct: 141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200
Query: 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696
A + PES+ + + DV+
Sbjct: 201 NDAIPIR----------------------------------WMPPESIFYNRYTTESDVW 226
Query: 697 SFGVILLELLTGKVIVVDELGQGNGL-LVEDKNRAIRLADAAIRADFEGKEEALLSCFKL 755
++GV+L E+ + + + + V D N E L + L
Sbjct: 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI------------LACPENCPLELYNL 274
Query: 756 GYSCASPLPQKRPSMKEALQALEKI 780
C S LP RPS + L+++
Sbjct: 275 MRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-42
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 51/298 (17%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
LG ++ +A++ I E S+ +F + +V+ L H LV++ G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 543 VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNL 602
II +++ NG L N + L++ K V + +L K+ +H +L
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 603 KPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPS 662
RN L+ + K+ DFGL R V D +S G
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-------------------------- 160
Query: 663 PSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNGL 722
+ PE L K + K D+++FGV++ E+ + + +
Sbjct: 161 ---------SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------ 205
Query: 723 LVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
+ +R A + + YSC +RP+ K L + +
Sbjct: 206 ---TNSETAEHIAQGLRLYRP--HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 65/323 (20%), Positives = 113/323 (34%), Gaps = 64/323 (19%)
Query: 482 ILGASGSSIMYKAVLEDG---TALAVRRI-GENSVDRFRDFETQVRVIAKLV-HPNLVRI 536
++G + KA ++ A++R+ S D RDF ++ V+ KL HPN++ +
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 537 RGFYWGVDEKLIIYDFVPNGSLA-----------NARYRKMGSSPCHLPWEARLKIAKGV 585
G + ++ P+G+L + + S+ L + L A V
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 586 ARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSK 645
ARG+ +L +K+ +H +L RN+L+G + KI DFGL R + R
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----- 191
Query: 646 RSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLEL 705
+ A ESL DV+S+GV+L E+
Sbjct: 192 --------------------------------WMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 706 LTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQ 765
++ R + + L C P
Sbjct: 220 VSLGGTPYCG---------MTCAELYEKLPQGYRLEKP--LNCDDEVYDLMRQCWREKPY 268
Query: 766 KRPSMKEALQALEKIPSSPSPYL 788
+RPS + L +L ++ Y+
Sbjct: 269 ERPSFAQILVSLNRMLEERKTYV 291
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 57/300 (19%)
Query: 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G + G +AV+ I ++ + F + V+ +L H NLV++ G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 542 GVDEKL-IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
L I+ +++ GSL + + S L + LK + V + +L VH
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+L RNVL+ D K+ DFGL +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEA---------------------------------- 153
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGN 720
S + + + APE+LR K + K DV+SFG++L E+ + +
Sbjct: 154 -----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR----- 203
Query: 721 GLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780
+ + + D + + +++ +C RPS + + LE I
Sbjct: 204 ----IPLKDVVPRVEKGYKMDAP--DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 56/327 (17%), Positives = 109/327 (33%), Gaps = 77/327 (23%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGFY 540
LGA +++K G +A + I R+ +++V+ + P +V G +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK-KHVH 599
+ E I + + GSL + +P + K++ V +GL +L EK K +H
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++KP N+L+ + E K+ DFG+ + ++S
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------------------------ 164
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK---------- 709
G Y +PE L+ + + D++S G+ L+E+ G+
Sbjct: 165 --------------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 710 ---VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPL--- 763
+ G + L+ + + LL P
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
Query: 764 ---------------PQKRPSMKEALQ 775
P +R +K+ +
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 65/325 (20%)
Query: 482 ILGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFRD-FETQVRVIAKLV-HPNL 533
LGA + +A + +AV+ + ++ R+ ++++V++ L H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 534 VRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCH-------------LPWEARLK 580
V + G L+I ++ G L N RK S C L E L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
+ VA+G+AFL K +H +L RN+LL + KI DFGL R + D++ G
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG---- 205
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGV 700
+ + APES+ + + DV+S+G+
Sbjct: 206 ------------------------------NARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 701 ILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA 760
L EL + + + + R+ E A + + +C
Sbjct: 236 FLWELFSLGSSPYPGMPV-DSKFYKMIKEGFRMLS---------PEHAPAEMYDIMKTCW 285
Query: 761 SPLPQKRPSMKEALQALEKIPSSPS 785
P KRP+ K+ +Q +EK S +
Sbjct: 286 DADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 54/302 (17%), Positives = 104/302 (34%), Gaps = 53/302 (17%)
Query: 483 LGASGSSIMYKAVL---EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVRIRG 538
LG + + V + +A++ + + + + + +++ +L +P +VR+ G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
+ +++ + G L K +P ++ V+ G+ +L EK V
Sbjct: 77 VCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H +L RNVLL N KI DFGL + + D S A + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK------------------ 173
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718
++APE + K + + DV+S+GV + E L+ +
Sbjct: 174 ---------------WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK--- 215
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALE 778
+ + R + E + L C + RP Q +
Sbjct: 216 ------MKGPEVMAFIEQGKRMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 779 KI 780
Sbjct: 268 AC 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 54/325 (16%), Positives = 104/325 (32%), Gaps = 67/325 (20%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG 542
+G +++ G +AV+ + E ++ L H N++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 543 VDEKL----IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE---- 594
+ ++ D+ +GSL + R + E +K+A A GLA LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 595 ----KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
H +LK +N+L+ + I D GL T +
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI----------------- 165
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS------IKPNPKWDVYSFGVILLE 704
+P+ G Y APE L + + D+Y+ G++ E
Sbjct: 166 ---------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210
Query: 705 LLTGKVI----VVDELGQGNGLLVEDKNRAIR--LADAAIRADFEGK---EEALLSCFKL 755
+ I +L + + + +R + + +R + + EAL K+
Sbjct: 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 270
Query: 756 GYSCASPLPQKRPSMKEALQALEKI 780
C R + + L ++
Sbjct: 271 MRECWYANGAARLTALRIKKTLSQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 54/303 (17%), Positives = 102/303 (33%), Gaps = 55/303 (18%)
Query: 483 LGASGSSIMYKAVLED---GTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIR 537
LG+ + K + +AV+ + + D + + V+ +L +P +VR+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
G + +++ + G L + H+ + +++ V+ G+ +L E
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
VH +L RNVLL KI DFGL + + D + KA
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--------------------- 167
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717
+ ++APE + K + K DV+SFGV++ E + +
Sbjct: 168 ------------THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM- 214
Query: 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
+ + + R + L C + + RP L
Sbjct: 215 --------KGSEVTAMLEKGERMGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 778 EKI 780
Sbjct: 265 RNY 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 65/328 (19%), Positives = 110/328 (33%), Gaps = 64/328 (19%)
Query: 460 TLVIVDGDKELELETLLKASAYILGASGSSIMYKAVLE----DGTALAVRRI---GENSV 512
T +I G+K+L L L G ++ + + ++AV+ + +
Sbjct: 2 TCLI--GEKDLRLLEKL-------GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 52
Query: 513 DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCH 572
+ DF +V + L H NL+R+ G ++ + P GSL + + G H
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG----H 107
Query: 573 LPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632
+ A VA G+ +L K+ +H +L RN+LL KIGDFGL R + +
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692
+ APESL++ +
Sbjct: 168 YVMQEHR---------------------------------KVPFAWCAPESLKTRTFSHA 194
Query: 693 WDVYSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSC 752
D + FGV L E+ T G + I E+
Sbjct: 195 SDTWMFGVTLWEMFTY----------GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 753 FKLGYSCASPLPQKRPSMKEALQALEKI 780
+ + C + P+ RP+ L +
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-39
Identities = 62/308 (20%), Positives = 111/308 (36%), Gaps = 53/308 (17%)
Query: 482 ILGASGSSIMYKAVLED----GTALAVRRI-GENSVDRFRDFETQVRVIAKLVHPNLVRI 536
++G +Y L D AV+ + + F T+ ++ HPN++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 537 RGFYWGVDEK-LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
G + L++ ++ +G L N + + + + VA+G+ FL K
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK 149
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
K VH +L RN +L K+ DFGL R + S
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS---------------------- 187
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
+ + + A ESL++ K K DV+SFGV+L EL+T +
Sbjct: 188 ----------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ + + + R + E +++ C P + RPS E +
Sbjct: 238 VNTFDITVYLLQGRRLLQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 776 ALEKIPSS 783
+ I S+
Sbjct: 287 RISAIFST 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 52/299 (17%), Positives = 94/299 (31%), Gaps = 56/299 (18%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG +YKA E A + I S + D+ ++ ++A HPN+V++ ++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+ I+ +F G++ L + K L +LH+ K +H +
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
LK N+L D + K+ DFG+ T
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---------------------------- 167
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKP-----NPKWDVYSFGVILLELLTGKVIVVDEL 716
S G + APE + + K DV+S G+ L+E+ + +
Sbjct: 168 --------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-- 217
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ R + + + C R + + LQ
Sbjct: 218 --------LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 57/311 (18%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G S +Y A+ + G +A+R++ + ++ V+ + +PN+V Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
DE ++ +++ GSL + + + + + L FLH + +H +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 602 LKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGP 661
+K N+LLG D K+ DFG +T + S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---------------------------- 173
Query: 662 SPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQGNG 721
S++ G + APE + PK D++S G++ +E++ G+ ++
Sbjct: 174 --------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN------- 218
Query: 722 LLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ----AL 777
E+ RA+ L + + E+ C +KR S KE LQ +
Sbjct: 219 ---ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 778 EKIPSSPSPYL 788
K SS +P +
Sbjct: 276 AKPLSSLTPLI 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 5e-38
Identities = 59/319 (18%), Positives = 112/319 (35%), Gaps = 71/319 (22%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIRG 538
+G +Y A + + +A++++ G+ S ++++D +VR + KL HPN ++ RG
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 539 FYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHV 598
Y ++ ++ + K L + G +GLA+LH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 599 HGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
H ++K N+LL K+GDFG ++
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------------------------- 169
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNP---KWDVYSFGVILLELLTGKVIVVDE 715
S G + APE + ++ K DV+S G+ +EL K + +
Sbjct: 170 ------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPSMKEA 773
A+ + + + S SC +PQ RP+ +
Sbjct: 218 -------------NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
Query: 774 LQ----ALEKIPSSPSPYL 788
L+ E+ P+ +
Sbjct: 265 LKHRFVLRERPPTVIMDLI 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 59/304 (19%), Positives = 105/304 (34%), Gaps = 56/304 (18%)
Query: 482 ILGASGSSIMYKAVL----EDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRI 536
+G +++ + A+A++ + D R+ F + + + HP++V++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
G + II + G L + + S L + + A ++ LA+L K+
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLESKR 128
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
VH ++ RNVL+ ++ K+GDFGL R + T + G
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------------------- 169
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
+ APES+ + DV+ FGV + E+L V
Sbjct: 170 ----------------KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG- 212
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776
N I + R + + L C + P +RP E
Sbjct: 213 --------VKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
Query: 777 LEKI 780
L I
Sbjct: 263 LSTI 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 61/305 (20%), Positives = 102/305 (33%), Gaps = 61/305 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRG 538
+G K DG L + + S+ + ++V ++ +L HPN+VR
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 539 FYWGVDEKL--IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
I+ ++ G LA+ K +L E L++ + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 597 H-----VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+H +LKP NV L K+GDFGL R++ DTS +K
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK----------------- 172
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711
+ +P Y +PE + + N K D++S G +L EL
Sbjct: 173 ----------AFVGTP---------YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM-- 211
Query: 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFK-LGYSCASPLPQKRPSM 770
++ LA F + + RPS+
Sbjct: 212 ----------PPFTAFSQK-ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSV 260
Query: 771 KEALQ 775
+E L+
Sbjct: 261 EEILE 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 58/324 (17%), Positives = 116/324 (35%), Gaps = 60/324 (18%)
Query: 475 LLKASAY----ILGASGSSIMYKAVL-----EDGTALAVRRIGENSVDRF-RDFETQVRV 524
+LK + + +LG+ +YK + + +A++ + E + + ++ + V
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 525 IAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKG 584
+A + +P++ R+ G +I +P G L + ++ + L
Sbjct: 65 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQ 119
Query: 585 VARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGS 644
+A+G+ +L +++ VH +L RNVL+ KI DFGL +L+ + A G
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK----- 174
Query: 645 KRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLE 704
+ A ES+ + DV+S+GV + E
Sbjct: 175 -----------------------------VPIKWMALESILHRIYTHQSDVWSYGVTVWE 205
Query: 705 LLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLP 764
L+T D + + + + R + + + C
Sbjct: 206 LMTFGSKPYDGI---------PASEISSILEKGERLPQP--PICTIDVYMIMVKCWMIDA 254
Query: 765 QKRPSMKEALQALEKIPSSPSPYL 788
RP +E + K+ P YL
Sbjct: 255 DSRPKFRELIIEFSKMARDPQRYL 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 65/325 (20%), Positives = 112/325 (34%), Gaps = 74/325 (22%)
Query: 482 ILGASGSSIMYKAVLED------GTALAVRRIGENSVDRFRD-FETQVRVIAKLV-HPNL 533
+LG+ + A +AV+ + E + R+ ++++++ +L H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 534 VRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCH------------------LPW 575
V + G +I+++ G L N K L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 576 EARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635
E L A VA+G+ FL K VH +L RNVL+ + KI DFGL R + D++
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223
Query: 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDV 695
G + + APESL K DV
Sbjct: 224 GNA----------------------------------RLPVKWMAPESLFEGIYTIKSDV 249
Query: 696 YSFGVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CF 753
+S+G++L E+ + G+ I+ F+ + + +
Sbjct: 250 WSYGILLWEIFSL------------GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY 297
Query: 754 KLGYSCASPLPQKRPSMKEALQALE 778
+ SC + +KRPS L
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 53/297 (17%), Positives = 101/297 (34%), Gaps = 52/297 (17%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI-GENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
LG + AV A+AV+ + + +VD + + ++ + L H N+V+ G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ + + ++ G L + +G +P + + G+ +LH H
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++KP N+LL KI DFGL + +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------------------------ 162
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTGKVIVVDELGQ 718
+ + G PY APE L+ + + DV+S G++L +L G++
Sbjct: 163 ----------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP--S 210
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ D + + D LL P R ++ + +
Sbjct: 211 DSCQEYSDWKEKKTYLNPWKKIDSAPLA--LLH------KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 57/310 (18%)
Query: 483 LGASGSSIMYKAVL------EDGTALAVRRIGENSVDRFR-DFETQVRVIAKLVHPNLVR 535
LG ++Y+ V E T +A++ + E + R R +F + V+ + ++VR
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLAN-----ARYRKMGSSPCHLPWEARLKIAKGVARGLA 590
+ G L+I + + G L + +++A +A G+A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 591 FLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
+L+ K VH +L RN ++ D KIGDFG+ R + K G
Sbjct: 148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------- 200
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710
+ +PESL+ DV+SFGV+L E+ T
Sbjct: 201 ---------------------------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770
L + +R D + F+L C P+ RPS
Sbjct: 234 QPYQGL---------SNEQVLRFVMEGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 771 KEALQALEKI 780
E + ++++
Sbjct: 283 LEIISSIKEE 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-36
Identities = 56/298 (18%), Positives = 104/298 (34%), Gaps = 60/298 (20%)
Query: 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSVDR---FRDFETQVRVIAKLVHPNLVRIR 537
LG +Y A + LA++ + + +++ +V + + L HPN++R+
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
G++ +I ++ P G++ +K+ + +A L++ H K+
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYR-ELQKLS----KFDEQRTATYITELANALSYCHSKRV 127
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H ++KP N+LLG+ E KI DFG ++
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------------------- 165
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717
G Y PE + + K D++S GV+ E L GK
Sbjct: 166 ----------------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF----- 204
Query: 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ N R +F + L P +RP ++E L+
Sbjct: 205 --------EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-35
Identities = 52/306 (16%), Positives = 105/306 (34%), Gaps = 68/306 (22%)
Query: 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRG 538
+G +YK + E +A + + + + + F+ + ++ L HPN+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 539 FYWGVDEK----LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+ + +++ + + +G+L R + + + + +GL FLH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 595 KKH--VHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+ +H +LK N+ + G KIGD GL L + + G
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG--------------- 175
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711
+P + APE K + DVY+FG+ +LE+ T +
Sbjct: 176 ----------TP-------------EFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE-- 209
Query: 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPS 769
+ A ++ + + ++ C +R S
Sbjct: 210 ----------YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 770 MKEALQ 775
+K+ L
Sbjct: 260 IKDLLN 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 131 bits (330), Expect = 6e-34
Identities = 52/297 (17%), Positives = 95/297 (31%), Gaps = 53/297 (17%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
LG ++++ G A + + +++ ++ L HP LV + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+E ++IY+F+ G L + + + ++ + V +GL +HE +VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 601 NLKPRNVLLGNDM--EPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
+LKP N++ E K+ DFGL +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHL-------------------------------- 176
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718
P S G + + APE D++S GV+ LL+G E
Sbjct: 177 -----DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--- 228
Query: 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
D + D P R ++ +AL+
Sbjct: 229 ------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 51/301 (16%), Positives = 100/301 (33%), Gaps = 56/301 (18%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAKLVHPNLVRIR 537
ILG S + A L A++ + + + ++ + V+++L HP V++
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ ++ + NG L + + L +LH K
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
+H +LKP N+LL DM +I DFG ++++ ++ ++A
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---------------------- 167
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717
+S G + Y +PE L D+++ G I+ +L+ G
Sbjct: 168 ------------NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL-------- 207
Query: 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
N + I+ +++ E+ L KR +E
Sbjct: 208 ----PPFRAGNE-YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262
Query: 778 E 778
Sbjct: 263 P 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-33
Identities = 62/320 (19%), Positives = 110/320 (34%), Gaps = 66/320 (20%)
Query: 482 ILGASGSSIMYKAVL--------EDGTALAVRRIGENSVDR-FRDFETQVRVIAKLV-HP 531
LG + A T +AV+ + ++ ++ D +++ ++ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 532 NLVRIRGFYWGVDEKLIIYDFVPNGSL-----------ANARYRKMGSSPCHLPWEARLK 580
N++ + G +I ++ G+L Y + L + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 581 IAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSAR 640
A VARG+ +L KK +H +L RNVL+ D KI DFGL R + K
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK------ 193
Query: 641 NFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGV 700
+ P + APE+L + DV+SFGV
Sbjct: 194 ------------TTNGRLP----------------VKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 701 ILLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCA 760
+L E+ T +L R D + + C
Sbjct: 226 LLWEIFTLGGSPYPG---------VPVEELFKLLKEGHRMDKP--SNCTNELYMMMRDCW 274
Query: 761 SPLPQKRPSMKEALQALEKI 780
+P +RP+ K+ ++ L++I
Sbjct: 275 HAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 47/315 (14%), Positives = 105/315 (33%), Gaps = 60/315 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG I+++ V + + D+ + ++ ++ H N++ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
++E ++I++F+ + + ++ +S L + V L FLH H +
Sbjct: 72 SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 602 LKPRNVLLGNDMEP--KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
++P N++ KI +FG R + + +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--------------------- 166
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719
Y+APE + + D++S G ++ LL+G + E
Sbjct: 167 ----------------PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---- 206
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL----- 774
++ + +A D E +E + + R + EAL
Sbjct: 207 -----TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
Query: 775 -QALEKIPSSPSPYL 788
Q +E++ + L
Sbjct: 262 KQKIERVSTKVIRTL 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 126 bits (318), Expect = 2e-32
Identities = 48/296 (16%), Positives = 97/296 (32%), Gaps = 53/296 (17%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG+ ++++ V G + I + ++ ++ +L HP L+ + +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
E ++I +F+ G L + ++ + + + + GL +HE VH +
Sbjct: 97 DKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 602 LKPRNVLL--GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+KP N++ KI DFGL + D +A
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA-------------------- 192
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQG 719
+ APE + D+++ GV+ LL+G E
Sbjct: 193 -----------------EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---- 231
Query: 720 NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+D + D + + P+KR ++ +AL+
Sbjct: 232 -----DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 59/324 (18%), Positives = 112/324 (34%), Gaps = 64/324 (19%)
Query: 482 ILGASGSSIMYKAV------LEDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVH-PNL 533
LG + +A +AV+ + E + R ++++++ + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 534 VRIRGFYWGVDEKL-IIYDFVPNGSLANARYRKMGSSPCH-----------LPWEARLKI 581
V + G L +I +F G+L+ K + L E +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 582 AKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARN 641
+ VA+G+ FL +K +H +L RN+LL KI DFGL R + D + G
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG----- 194
Query: 642 FGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVI 701
+ APE++ + DV+SFGV+
Sbjct: 195 -----------------------------DARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 702 LLELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCAS 761
L E+ + + + E+ R ++ + ++ C
Sbjct: 226 LWEIFSLGASPYPGVK-----IDEEFCRRLKEGT-----RMRAPDYTTPEMYQTMLDCWH 275
Query: 762 PLPQKRPSMKEALQALEKIPSSPS 785
P +RP+ E ++ L + + +
Sbjct: 276 GEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 118 bits (297), Expect = 3e-30
Identities = 60/307 (19%), Positives = 102/307 (33%), Gaps = 60/307 (19%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRF---------RDFETQVRVIAKL-VH 530
ILG SS++ + + AV+ I F +V ++ K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 531 PNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLA 590
PN+++++ Y +++D + G L + K+ L + KI + + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVIC 124
Query: 591 FLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTAS 650
LH+ VH +LKP N+LL +DM K+ DFG + + G+
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY--------- 175
Query: 651 RDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710
+P + + D++S GVI+ LL G
Sbjct: 176 ----------LAP------------EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRP 768
K + + F E S L PQKR
Sbjct: 214 -----------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262
Query: 769 SMKEALQ 775
+ +EAL
Sbjct: 263 TAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 1e-29
Identities = 63/299 (21%), Positives = 102/299 (34%), Gaps = 56/299 (18%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGF 539
+LG S + A +A++ I + +++ E ++ V+ K+ HPN+V +
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
Y +I V G L + K ++ V + +LH+ VH
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 600 GNLKPRNVLL---GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
+LKP N+L D + I DFGL ++ + S A G+
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG---------------- 174
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
Y APE L + D +S GVI LL G DE
Sbjct: 175 ---------------------YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE- 212
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
D ++ A D ++ S P+KR + ++ALQ
Sbjct: 213 --------NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 56/315 (17%), Positives = 105/315 (33%), Gaps = 56/315 (17%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD-FETQVRVIAKLVHPNLVRIRGF 539
+G ++ A + +A+++I + +++++ + H N++ I
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ + ++ + Y+ + + HL + + RGL ++H +H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLH 132
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP N+LL + KI DFGL R+ D
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDH--------------------------- 165
Query: 660 GPSPSPSPSPSSLGGISPYHAPESL-RSIKPNPKWDVYSFGVILLELLTGKVIVVDE--- 715
+ + Y APE + S D++S G IL E+L+ + I +
Sbjct: 166 ------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 716 ------LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS---------CFKLGYSCA 760
LG ED N I L K + + L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 761 SPLPQKRPSMKEALQ 775
+ P KR +++AL
Sbjct: 280 TFNPHKRIEVEQALA 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (288), Expect = 5e-29
Identities = 54/308 (17%), Positives = 108/308 (35%), Gaps = 56/308 (18%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIR 537
ILG G S ++ A L +AV+ + + F + + A L HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 538 GFYWGVDEKL----IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLH 593
I+ ++V +L + G + + +++ + L F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEG----PMTPKRAIEVIADACQALNFSH 128
Query: 594 EKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
+ +H ++KP N+++ K+ DFG+ R +
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAI--------------------------- 161
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713
S + +++ G + Y +PE R + + DVYS G +L E+LTG+
Sbjct: 162 ------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-SMKE 772
+ + R + +A +A++ + P+ R + E
Sbjct: 216 GDSPVS---VAYQHVREDPIPPSARHEGLSADLDAVVL------KALAKNPENRYQTAAE 266
Query: 773 ALQALEKI 780
L ++
Sbjct: 267 MRADLVRV 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 7e-29
Identities = 36/303 (11%), Positives = 85/303 (28%), Gaps = 46/303 (15%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
+G+ +Y + G +A++ + + ++ + + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGN 601
+ ++ + SL + + L +A + + ++H K +H +
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 602 LKPRNVL---LGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLG 658
+KP N L I DFGL + +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ------------------------- 163
Query: 659 PGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718
P +L G + Y + + I+ + + D+ S G +L+ G +
Sbjct: 164 ----HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 719 GNGLLVE-DKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777
E + + + + + L+ C S +P Q
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLF 273
Query: 778 EKI 780
+
Sbjct: 274 RNL 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 63/305 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGF 539
+LG + + + A++ + +V + + P++VRI
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 540 YWGVDEK----LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
Y + LI+ + + G L + R + G +I K + + +LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI 130
Query: 596 KHVHGNLKPRNVLLGNDMEP---KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
H ++KP N+L + K+ DFG + T S + +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY------------ 178
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712
Y APE L K + D++S GVI+ LL G
Sbjct: 179 -------------------------YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213
Query: 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPSM 770
G ++ + R + +F E + +S L + P +R ++
Sbjct: 214 YSNHGLAISPGMKTRIRMGQY-------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266
Query: 771 KEALQ 775
E +
Sbjct: 267 TEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 46/305 (15%), Positives = 92/305 (30%), Gaps = 72/305 (23%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI------GENSVDRFRDFETQVRVIAKL--VHPN 532
+LG+ G +Y + + D +A++ + + +V ++ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 533 LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFL 592
++R+ ++ D ++I + + G L E V +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 593 HEKKHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
H +H ++K N+L+ N E K+ DFG L+ + G
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT-------------- 172
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKV 710
Y PE +R + V+S G++L +++ G
Sbjct: 173 ------------------------RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD- 207
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770
+ IR ++ C L C + P RP+
Sbjct: 208 ------------------IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 249
Query: 771 KEALQ 775
+E
Sbjct: 250 EEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 4e-27
Identities = 37/305 (12%), Positives = 81/305 (26%), Gaps = 48/305 (15%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH-PNLVRIRGFY 540
+G ++++ L + +A++ S + R L + + F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+++ D + + AK + + +HEK V+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEKSLVYR 125
Query: 601 NLKPRNVLLGNDMEP-----KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
++KP N L+G + DFG+ + +
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ---------------------- 163
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715
P +L G + Y + + + + + D+ + G + + L G +
Sbjct: 164 -------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
N E + +R G E + P
Sbjct: 217 KAATNKQKYERIGEKKQSTP--LRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQG 271
Query: 776 ALEKI 780
K+
Sbjct: 272 LFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (272), Expect = 6e-27
Identities = 58/312 (18%), Positives = 107/312 (34%), Gaps = 60/312 (19%)
Query: 483 LGASGSSIMYKAVLEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRGFY 540
+G ++YKA G A+++I D ++ ++ +L H N+V++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 541 WGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHG 600
+++++ + + G L + G+A+ H+++ +H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 601 NLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPG 660
+LKP+N+L+ + E KI DFGL AR FG
Sbjct: 125 DLKPQNLLINREGELKIADFGL----------------ARAFG----------------- 151
Query: 661 PSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVI-------- 711
P + Y AP+ L K + D++S G I E++ G +
Sbjct: 152 ---IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 712 ----VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALL----SCFKLGYSCASPL 763
+ LG N + + + E L S L
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 764 PQKRPSMKEALQ 775
P +R + K+AL+
Sbjct: 269 PNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 59/306 (19%), Positives = 108/306 (35%), Gaps = 66/306 (21%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD------FETQVRVIAKLVHPNLVR 535
LG+ +++ K G A + I + R E +V ++ ++ HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ Y + ++I + V G L + K L E + K + G+ +LH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL 132
Query: 596 KHVHGNLKPRNVLLGNDMEP----KIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+ H +LKP N++L + P KI DFGL + G+
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT------------- 179
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711
+ APE + + D++S GVI LL+G
Sbjct: 180 ------------------------PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLS--CFKLGYSCASPLPQKRPS 769
+ D + +A+ +FE + + S P+KR +
Sbjct: 216 FLG-----------DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
Query: 770 MKEALQ 775
++++LQ
Sbjct: 265 IQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 57/316 (18%), Positives = 105/316 (33%), Gaps = 63/316 (19%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI-----GENSVDRFRDFETQVRVIAKLVHPNLVR 535
LG + +YKA +A+++I E R +++++ +L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEK 595
+ + +++DF+ + + L +GL +LH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 596 KHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQ 655
+H +LKP N+LL + K+ DFGL +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------------------- 151
Query: 656 DLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK----- 709
SP+ + + Y APE L + D+++ G IL ELL
Sbjct: 152 --------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
Query: 710 ---VIVVDELGQGNGLLVEDK-NRAIRLADAAIRADFEGKEEALL------SCFKLGYSC 759
+ + + + G E++ L D F G + L
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263
Query: 760 ASPLPQKRPSMKEALQ 775
P R + +AL+
Sbjct: 264 FLFNPCARITATQALK 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 59/300 (19%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSV---DRFRDFETQVRVIAK-LVHPNLVRI 536
+LG ++ A + A++ + ++ V D + RV++ HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 537 RGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK 596
+ + + +++ G L A + GL FLH K
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 597 HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
V+ +LK N+LL D KI DFG+ +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENM----------------------------- 154
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDEL 716
++ G Y APE L K N D +SFGV+L E+L G+
Sbjct: 155 -------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---- 203
Query: 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776
+G E+ +IR+ + E + + LL P+KR ++ ++
Sbjct: 204 ---HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV------KLFVREPEKRLGVRGDIRQ 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-26
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 70/320 (21%)
Query: 482 ILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFY 540
++G ++Y+A L + G +A++++ ++ R +++++ KL H N+VR+R F+
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 541 WGVDEK------LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+ EK ++ D+VP AR+ LP + R LA++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQLFRSLAYIHS 140
Query: 595 KKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDS 653
H ++KP+N+LL D K+ DFG + +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------------- 177
Query: 654 FQDLGPGPSPSPSPSPSSLGGISPYHAP-ESLRSIKPNPKWDVYSFGVILLELLTGKVI- 711
S Y AP + DV+S G +L ELL G+ I
Sbjct: 178 --------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 712 ----VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPL---- 763
VD+L + +L IR + +F+ + K+ P
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 764 --------PQKRPSMKEALQ 775
P R + EA
Sbjct: 283 CSRLLEYTPTARLTPLEACA 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 5e-26
Identities = 46/236 (19%), Positives = 78/236 (33%), Gaps = 51/236 (21%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI------GENSVDRFRDFETQVRVIAKLVHPNLV 534
I+G G +Y + G A++ + + + + +++ P +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 535 RIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE 594
+ + D+ I D + G L + A + GL +H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN 125
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
+ V+ +LKP N+LL +I D GL A +F K+ AS
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGL----------------ACDFSKKKPHASV--- 166
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK 709
G Y APE L+ + D +S G +L +LL G
Sbjct: 167 -------------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (261), Expect = 4e-25
Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 48/232 (20%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRD---FETQVRVIAKLVHPNLVRIR 537
LG ++ +G A++ + + V R + + +++ + HP ++R+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
G + + +I D++ G L + + P A V L +LH K
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
++ +LKP N+LL + KI DFG + V T +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----------------------- 162
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
G Y APE + + N D +SFG+++ E+L G
Sbjct: 163 ----------------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 61/328 (18%), Positives = 114/328 (34%), Gaps = 63/328 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRGF 539
+G ++YKA G +A+++I ++ ++ ++ +L HPN+V++
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
++ ++++F+ + +P + +GLAF H + +H
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP+N+L+ + K+ DFGL R
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFG-------------------------------- 153
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPN-PKWDVYSFGVILLELLTGKVI------- 711
P + + Y APE L K D++S G I E++T + +
Sbjct: 154 ----VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 712 -----VVDELGQGNGLLVEDKNRAIRLADA---AIRADFEGKEEALLSCFK-LGYSCASP 762
+ LG + ++ + R DF L + L
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269
Query: 763 LPQKRPSMKEALQA--LEKIPSSPSPYL 788
P KR S K AL + + P P+L
Sbjct: 270 DPNKRISAKAALAHPFFQDVT-KPVPHL 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 6e-25
Identities = 62/315 (19%), Positives = 103/315 (32%), Gaps = 59/315 (18%)
Query: 483 LGASGSSIMYKA--VLEDGTALAVRRI-----GENSVDRFRDFETQVRVIAKLVHPNLVR 535
+G ++KA + G +A++R+ E +R + HPN+VR
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 536 IRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCH-LPWEARLKIAKGVARGLAFLHE 594
+ + + + P +P E + + RGL FLH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 595 KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSF 654
+ VH +LKP+N+L+ + + K+ DFGL R+ + + + +
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW-------------- 180
Query: 655 QDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI--- 711
Y APE L D++S G I E+ K +
Sbjct: 181 -----------------------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217
Query: 712 --VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYS---------CA 760
VD+LG+ ++ A R F K + F C
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 277
Query: 761 SPLPQKRPSMKEALQ 775
+ P KR S AL
Sbjct: 278 TFNPAKRISAYSALS 292
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.8 bits (247), Expect = 2e-23
Identities = 70/310 (22%), Positives = 113/310 (36%), Gaps = 63/310 (20%)
Query: 33 TDGVLLLSFKYSVLSDPLGVLGSWNYNDENPC--SWNGVTCASPGEGNNDSRVIGLALPN 90
D LL K L +P L SW + C +W GV C + RV L L
Sbjct: 6 QDKQALLQIKKD-LGNP-TTLSSWL-PTTDCCNRTWLGVLCDT---DTQTYRVNNLDLSG 59
Query: 91 SQLLG--SIPADLGMIEFLQYLDLSNN-SLNGSLSFSLFNASQLRNLDLSN--------- 138
L IP+ L + +L +L + +L G + ++ +QL L +++
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 139 ---------------NLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183
N +SG LP ++ SL NL + N ++G +P S + L
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 184 LK--NNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGY-------------------- 221
N P+ N S + + G
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 222 -----SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSF 276
+L L+L NR+ G +P ++ ++++SFNNL GEIP+ + S++
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 277 SGNLDLCGQP 286
+ N LCG P
Sbjct: 299 ANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 88 LPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN--LISGHL 145
L N+++ G++P L ++FL L++S N+L G + N + +NN L L
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
Query: 146 P 146
P
Sbjct: 310 P 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 1e-06
Identities = 35/188 (18%), Positives = 63/188 (33%), Gaps = 27/188 (14%)
Query: 56 WNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQY-LDLSN 114
S+N ++ P ++ ++G+ +++ G+IP G L + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 115 NSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLH--------------------- 153
N L G + + N + N L +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 154 -NLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS--KFNSVQVLDLSSN-- 208
NL L+L +N + G LP LT L+ L +++ N +P V ++N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 209 LINGSLPP 216
L LP
Sbjct: 304 LCGSPLPA 311
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-23
Identities = 57/315 (18%), Positives = 103/315 (32%), Gaps = 62/315 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
+G+ + AV G +A++++ S + ++R++ + H N++ +
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ + DF K+ L + + + +GL ++H +H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIH 144
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP N+ + D E KI DFGL AR S+ +
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGL----------------ARQADSEMTGY---------- 178
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDELGQ 718
Y APE + + D++S G I+ E++TGK +
Sbjct: 179 -------------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 719 G------NGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPL--------- 763
RL + +G E F + ASPL
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 764 ---PQKRPSMKEALQ 775
++R + EAL
Sbjct: 286 VLDAEQRVTAGEALA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 5e-23
Identities = 50/325 (15%), Positives = 105/325 (32%), Gaps = 70/325 (21%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI-GENSVDRFR-DFETQVRVIAKLVHPNLVRIRGF 539
+G ++KA + G +A++++ EN + F +++++ L H N+V +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 540 YWGVDEK--------LIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAF 591
+++DF + + ++ + + GL +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYY 132
Query: 592 LHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASR 651
+H K +H ++K NVL+ D K+ DFGL R +
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA---------------------- 170
Query: 652 DSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKV 710
S ++ Y PE L + P D++ G I+ E+ T
Sbjct: 171 ----------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
Query: 711 I--------VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASP 762
I + + Q G + + + + + + ++ + +L P
Sbjct: 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK-DRLKAYVRDP 279
Query: 763 L------------PQKRPSMKEALQ 775
P +R +AL
Sbjct: 280 YALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 2e-22
Identities = 43/232 (18%), Positives = 76/232 (32%), Gaps = 45/232 (19%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRI---GENSVDRFRDFETQVRVIAKLVHPNLVRIR 537
+LG + G A++ + + D T+ RV+ HP L ++
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 538 GFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ D + ++ G L R+ E + L +LH +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 598 VHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDL 657
V+ ++K N++L D KI DFGL + D ++ K
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------------------- 163
Query: 658 GPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709
+ G Y APE L D + GV++ E++ G+
Sbjct: 164 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 2e-22
Identities = 48/313 (15%), Positives = 98/313 (31%), Gaps = 60/313 (19%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
+G ++KA E +A++R+ ++ ++ ++ +L H N+VR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ ++++F L E + +GL F H + +H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP+N+L+ + E K+ +FGL R A +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY----------------- 167
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK---------V 710
+ + D++S G I EL
Sbjct: 168 ------------------RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFK--------LGYSCASP 762
+ + + G E++ ++ +L++ L +
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 763 LPQKRPSMKEALQ 775
P +R S +EALQ
Sbjct: 270 NPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 43/269 (15%), Positives = 87/269 (32%), Gaps = 56/269 (20%)
Query: 453 ERQNKKGTLVIVDGDKELELETLLKASAYI--------LGASGSSIMYKAV-LEDGTALA 503
E+++ K L D + ET + +A + LG + E G A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 504 VRRIGENSVDRFRD---FETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLAN 560
++ + + V + + + R++ + P LV++ + ++ ++V G + +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 561 ARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDF 620
R A + +LH ++ +LKP N+L+ ++ DF
Sbjct: 131 HLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 621 GLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHA 680
G + +L G A
Sbjct: 186 GF---------------------------------------AKRVKGRTWTLCGTPEALA 206
Query: 681 PESLRSIKPNPKWDVYSFGVILLELLTGK 709
PE + S N D ++ GV++ E+ G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 8e-20
Identities = 50/332 (15%), Positives = 106/332 (31%), Gaps = 83/332 (25%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDR--FRDFETQVRVIAKLVHPNLVRIRG 538
+G+ I+ A +A++++ ++ + ++ ++ + H N++ +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 539 FYWG------VDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFL 592
+ + ++ + + + L E + + G+ L
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHL 135
Query: 593 HEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
H +H +LKP N+++ +D KI DFGL R + +
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------------ 183
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI- 711
Y APE + + D++S G I+ E++ K++
Sbjct: 184 -------------------------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 712 -----------VVDELGQGNGLLVEDKNRAIR-----------------LADAAIRADFE 743
V+++LG ++ +R D+ AD E
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 744 GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775
+ L P KR S+ +ALQ
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 1e-18
Identities = 55/317 (17%), Positives = 104/317 (32%), Gaps = 66/317 (20%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRI--GENSVDRFRDFETQVRVIAKLVHPNLVRIRGF 539
+G+ + A + G +AV+++ S+ + ++R++ + H N++ +
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVH 599
+ D L A + + + + RGL ++H +H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ-FLIYQILRGLKYIHSADIIH 144
Query: 600 GNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGP 659
+LKP N+ + D E KI DFGL
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGL------------------------------------- 167
Query: 660 GPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVI------- 711
+ + Y APE + + N D++S G I+ ELLTG+ +
Sbjct: 168 --ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 712 -VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPL------- 763
+ + + G + + I A R + + F + A+PL
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESA--RNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283
Query: 764 -----PQKRPSMKEALQ 775
KR + +AL
Sbjct: 284 MLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 84.1 bits (207), Expect = 4e-18
Identities = 41/325 (12%), Positives = 95/325 (29%), Gaps = 79/325 (24%)
Query: 482 ILGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGF 539
LG S +++A+ + + + V+ + + + +++++ L PN++ +
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNIITLADI 98
Query: 540 YWGVDEKLI--IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKH 597
+ +++ V N L + + L + H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGI 150
Query: 598 VHGNLKPRNVLLGND-MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQD 656
+H ++KP NV++ ++ + ++ D+GL + S
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS------------------ 192
Query: 657 LGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGK------ 709
+ PE L + + D++S G +L ++ K
Sbjct: 193 -------------------RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
Query: 710 -------VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASP 762
V + LG + DK ++ SP
Sbjct: 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 763 L------------PQKRPSMKEALQ 775
Q R + +EA++
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 1e-16
Identities = 49/310 (15%), Positives = 102/310 (32%), Gaps = 62/310 (20%)
Query: 482 ILGASGSSIMYKAVL----EDGTALAVRRIGENSVDR----FRDFETQVRVIAKLVH-PN 532
+LG ++ + G A++ + + ++ + T+ +V+ + P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 533 LVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFL 592
LV + + + +I D++ G L ++ + L L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHL 145
Query: 593 HEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRD 652
H+ ++ ++K N+LL ++ + DFGL ++ F + + + D
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGL----------------SKEFVADETERAYD 189
Query: 653 SFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK--PNPKWDVYSFGVILLELLTGKV 710
G Y AP+ +R + D +S GV++ ELLTG
Sbjct: 190 FC-------------------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
Query: 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSM 770
G + +R I ++ + + L+ P+KR
Sbjct: 231 PFT---VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ------RLLMKDPKKRLGC 281
Query: 771 KE--ALQALE 778
A + E
Sbjct: 282 GPRDADEIKE 291
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 24/153 (15%), Positives = 47/153 (30%), Gaps = 19/153 (12%)
Query: 482 ILGASGSSIMYKAVLEDGTALAV----------RRIGENSVDRFRDFETQVRVIAKLVHP 531
++G S ++ E V +++ E F A+
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 532 NLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAF 591
L +++G +Y + N L K + ++ + +A
Sbjct: 67 ALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEVAK 118
Query: 592 LHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLER 624
+ + VHG+L NVL+ + I DF
Sbjct: 119 FYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 3e-16
Identities = 48/234 (20%), Positives = 73/234 (31%), Gaps = 27/234 (11%)
Query: 64 CSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSF 123
C V C+ G L +P DL LDL NN +
Sbjct: 10 CHLRVVQCSDLG------------------LEKVPKDLP--PDTALLDLQNNKITEIKDG 49
Query: 124 SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183
N L L L NN IS P L L+ L LS N L TLQ L +
Sbjct: 50 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109
Query: 184 LKNNYFSDGLPSKFNSVQVLDLSS--NLINGSLPPDIGGY-SLRYLNLSYNRLSGEIPPQ 240
+ + + N + V++L + +G G L Y+ ++ ++ IP
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168
Query: 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPCPIP 294
+ + L N +T S +N + + + P
Sbjct: 169 LPPSL---TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.8 bits (133), Expect = 7e-09
Identities = 40/218 (18%), Positives = 73/218 (33%), Gaps = 32/218 (14%)
Query: 56 WNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQL--LGSIPADLGMIEFLQYLDLS 113
E N +T N +++I + L + L G ++ L Y+ ++
Sbjct: 99 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158
Query: 114 NNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSL 173
+ ++ ++ L L L L N I+ ++ L+NL L LS N+++ SL
Sbjct: 159 DTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215
Query: 174 TTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRL 233
L + L NN + ++ + L N +
Sbjct: 216 ANTPHLRELHLNNNKLVKVPGGLADH---------------------KYIQVVYLHNNNI 254
Query: 234 SG-----EIPPQFGEKIPVNATIDLSFNNLT-GEIPES 265
S PP + K + + L N + EI S
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 8e-16
Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 11/181 (6%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L N+Q+ P ++ L L L+ N L + + + + L +LDL+NN IS
Sbjct: 202 LIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLANNQISNLA 257
Query: 146 PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDL 205
P + L L L L N ++ P++ T + ++ +N S ++ L L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN-ENQLEDISPISNLKNLTYLTL 314
Query: 206 SSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
N I+ + P L+ L + N++S + + N ++ P +
Sbjct: 315 YFNNISD-ISPVSSLTKLQRLFFANNKVSD--VSSLA-NLTNINWLSAGHNQISDLTPLA 370
Query: 266 N 266
N
Sbjct: 371 N 371
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 2e-13
Identities = 39/168 (23%), Positives = 61/168 (36%), Gaps = 30/168 (17%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL 145
L+L +QL L + L LDL+NN ++ S ++L L L N IS
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNIS 279
Query: 146 P--------------------ETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLK 185
P + +L NL L L N ++ P +++L L +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 186 NNYFSDGLPS--KFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYN 231
NN S + S ++ L N I+ L P + L L+
Sbjct: 338 NNKVS-DVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 2e-11
Identities = 22/114 (19%), Positives = 40/114 (35%), Gaps = 6/114 (5%)
Query: 51 GVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYL 110
+ N +N + L L + + P + + LQ L
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 334
Query: 111 DLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164
+NN ++ S + N + + L +N IS P + +L + L L+D A
Sbjct: 335 FFANNKVSDVSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 110 LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL 169
L ++ ++S + + Q+ L I + + L+NL +N S+N L
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 170 PVS-LTTLQSL 179
P+ LT L +
Sbjct: 83 PLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 13/69 (18%), Positives = 21/69 (30%), Gaps = 12/69 (17%)
Query: 176 LQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLIN-----GSLPPDIGGYSLRYLNLS 229
L L +D + + + V L I L +L +N S
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLN------NLTQINFS 74
Query: 230 YNRLSGEIP 238
N+L+ P
Sbjct: 75 NNQLTDITP 83
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 3e-14
Identities = 46/342 (13%), Positives = 99/342 (28%), Gaps = 84/342 (24%)
Query: 483 LGASGSSIMYKAV-LEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYW 541
LG S ++ A + + T +A++ + + V E +++++ ++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 542 GVDEKLIIYDFVPNGSLANARYRKMGSSPCHL-----------PWEARLKIAKGVARGLA 590
KL+ + + + L P +I+K + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 591 FLHEK-KHVHGNLKPRNVLL-GNDMEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRST 648
++H + +H ++KP NVL+ D + + L
Sbjct: 140 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL----------------------- 176
Query: 649 ASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTG 708
G + ++ Y +PE L D++S ++ EL+TG
Sbjct: 177 -----------GNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225
Query: 709 KVIVVDELGQGNGLLVEDKNRAIRL--------------------ADAAIRADFEGKEEA 748
+ + G + + I L + +R + K
Sbjct: 226 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285
Query: 749 LLSCFKLGYSCASPL---------------PQKRPSMKEALQ 775
L Y + P+KR +
Sbjct: 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 3e-13
Identities = 44/209 (21%), Positives = 70/209 (33%), Gaps = 9/209 (4%)
Query: 56 WNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNN 115
+ + P + R+ L L L P + LQYL L +N
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 116 SLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTT 175
+L + + L +L L N IS LH+L L L N +A P +
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 176 LQSLTIVSLKNNYFS---DGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNR 232
L L + L N S + ++Q L L+ N L+ S +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSE 259
Query: 233 LSGEIPPQF-GEKIPVNATIDLSFNNLTG 260
+ +P + G + L+ N+L G
Sbjct: 260 VPCSLPQRLAGRDL-----KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (161), Expect = 1e-12
Identities = 37/192 (19%), Positives = 62/192 (32%), Gaps = 11/192 (5%)
Query: 98 PADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQL 157
PA + L L L L + L+ L L +N + +T L NL
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 158 LNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSL--- 214
L L N ++ + L SL + L N + P F + L N
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 215 -PPDIGGYSLRYLNLSYNRLSGEIPPQ-FGEKIPVNATIDLSFNNLTGEIPESNVFMNQE 272
+L+YL L+ N + + + S + + +P+ ++
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ---KFRGSSSEVPCSLPQR--LAGRD 272
Query: 273 SSSFSGNLDLCG 284
+ N DL G
Sbjct: 273 LKRLAAN-DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 38/223 (17%), Positives = 63/223 (28%), Gaps = 31/223 (13%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLR----------------- 132
Q L ++P + Q + L N ++ + S L
Sbjct: 19 PQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 133 --------NLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSL 184
N + P T L L L+L L P L +L + L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 185 KNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQ 240
++N F ++ L L N I+ G +SL L L NR++ P
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 241 FGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLC 283
F + + + N + + N +C
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 0.001
Identities = 23/142 (16%), Positives = 40/142 (28%), Gaps = 4/142 (2%)
Query: 49 PLGVLGSWNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQ 108
P N ++ + L L +++ P + L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 109 YLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGK 168
L L N+L+ + +L L+ L L++N LQ S + +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCS 263
Query: 169 LPVSLTTLQSLTIVSLKNNYFS 190
LP L + L N
Sbjct: 264 LPQR---LAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.004
Identities = 29/161 (18%), Positives = 52/161 (32%), Gaps = 9/161 (5%)
Query: 110 LDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKL 169
L ++ + + + + L N IS + + NL +L L N LA
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 170 PVSLTTLQSLTIVSLKNNYFSDGLP----SKFNSVQVLDLSSNLINGSLPPDIG-GYSLR 224
+ T L L + L +N + + L L + P +L+
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 225 YLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES 265
YL L N L F + + + L N ++ +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLT-HLFLHGNRISSVPERA 172
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.0 bits (143), Expect = 6e-10
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 21/107 (19%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-SQLRNLDLSNNLISG----HLPETMGSLHNLQLLNLS 161
+Q LD+ L+ + L Q + + L + ++ + + L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSN 208
N L + GL + +Q L L +
Sbjct: 64 SNELGDVGVHCV----------------LQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 1e-09
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 13/99 (13%)
Query: 98 PADLGMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLISG----HLPETM 149
L+ L L++ ++ SL+ +L LR LDLSNN + L E++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 150 GSLH-NLQLLNLSDNALAGKLPVSLTTLQ----SLTIVS 183
L+ L L D + ++ L L+ SL ++S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 186 NNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-----YSLRYLNLSYNRLSGEIPPQ 240
GL + ++VL L+ ++ S + +SLR L+LS N L Q
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 241 FGEKIPVNAT----IDLSFNNLTGEIPES 265
E + + L + E+ +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 17/98 (17%)
Query: 154 NLQLLNLSDNALAGK-LPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLING 212
++Q L++ L+ L LQ +V L + ++ + D+SS L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTE--------ARCKDISSALRVN 54
Query: 213 SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNAT 250
+L LNL N L + + +
Sbjct: 55 P--------ALAELNLRSNELGDVGVHCVLQGLQTPSC 84
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 25/106 (23%), Positives = 37/106 (34%), Gaps = 9/106 (8%)
Query: 56 WNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQL----LGSIPADLGMIEFLQYLD 111
N GV G G S + L L + + S+ A L L+ LD
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403
Query: 112 LSNNSLNGSLSFSLFNA-----SQLRNLDLSNNLISGHLPETMGSL 152
LSNN L + L + L L L + S + + + +L
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 15/98 (15%), Positives = 29/98 (29%), Gaps = 5/98 (5%)
Query: 199 SVQVLDLSSNLINGSLPPDIGGY--SLRYLNLSYNRLSGEIPPQFGEKIPVN---ATIDL 253
+Q LD+ ++ + ++ + + L L+ + VN A ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 254 SFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPC 291
N L + Q S L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 13/72 (18%), Positives = 30/72 (41%), Gaps = 9/72 (12%)
Query: 101 LGMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNNLISG----HLPETMGSL 152
L +++ Q + L + L +S +L L L+L +N + + + + +
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82
Query: 153 H-NLQLLNLSDN 163
+Q L+L +
Sbjct: 83 SCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 12/89 (13%)
Query: 153 HNLQLLNLSDNAL----AGKLPVSLTTLQSLTIVSLKNNYFSD--------GLPSKFNSV 200
L++L L+D + L +L SL + L NN D + +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 201 QVLDLSSNLINGSLPPDIGGYSLRYLNLS 229
+ L L + + + +L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 9/75 (12%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
L+ L++SNN L L +L L S N ++ +PE NL+ L++ N L
Sbjct: 286 LEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR 337
Query: 167 GKLPVSLTTLQSLTI 181
+ P +++ L +
Sbjct: 338 -EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 3e-08
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 9/96 (9%)
Query: 112 LSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV 171
N+ + + L L++SNN + LP L+ L S N L ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHL-AEVPE 321
Query: 172 SLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSS 207
L+ L ++ N P SV+ L ++S
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 6e-08
Identities = 22/101 (21%), Positives = 40/101 (39%), Gaps = 15/101 (14%)
Query: 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDI 218
NA + ++ SL +++ NN + LP+ ++ L S N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLA-EVPELP 323
Query: 219 GGYSLRYLNLSYNRLSG--EIPPQFGEKIPVNATIDLSFNN 257
+L+ L++ YN L +IP DL N+
Sbjct: 324 Q--NLKQLHVEYNPLREFPDIPESVE---------DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 19/59 (32%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
L+L+N L+ SL + L +L S N ++ LPE SL +L + N + AL
Sbjct: 40 AHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 12/45 (26%), Positives = 19/45 (42%), Gaps = 4/45 (8%)
Query: 198 NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242
L+L++ ++ SLP L L S N L+ E+P
Sbjct: 38 RQAHELELNNLGLS-SLPELPP--HLESLVASCNSLT-ELPELPQ 78
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 21/67 (31%), Positives = 32/67 (47%), Gaps = 5/67 (7%)
Query: 129 SQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNY 188
Q L+L+N +S LPE +L+ L S N+L +LP +L+SL + +
Sbjct: 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 189 FSDGLPS 195
SD P
Sbjct: 93 LSDLPPL 99
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 2e-08
Identities = 26/130 (20%), Positives = 44/130 (33%), Gaps = 25/130 (19%)
Query: 132 RNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSD 191
R L L++ ++ + L + L+LS N L P +L L+ L ++ +N +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 192 GLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATI 251
+ L+ L L NRL Q P +
Sbjct: 58 ----------------------VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95
Query: 252 DLSFNNLTGE 261
+L N+L E
Sbjct: 96 NLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 34/143 (23%), Positives = 51/143 (35%), Gaps = 30/143 (20%)
Query: 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG 167
+ L L++ L L L + +LDLS+N + P + +L L++L SDNAL
Sbjct: 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 168 KLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGY--SLRY 225
+ +Q L L +N + S L
Sbjct: 58 VDG-----------------------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94
Query: 226 LNLSYNRLSGE--IPPQFGEKIP 246
LNL N L E I + E +P
Sbjct: 95 LNLQGNSLCQEEGIQERLAEMLP 117
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 27/122 (22%), Positives = 45/122 (36%), Gaps = 30/122 (24%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSF---------------------S 124
L L + L ++ L + + +LDLS+N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 125 LFNASQLRNLDLSNNLI-SGHLPETMGSLHNLQLLNLSDNALAG------KLPVSLTTLQ 177
+ N +L+ L L NN + + + S L LLNL N+L +L L ++
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
Query: 178 SL 179
S+
Sbjct: 121 SI 122
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 20/105 (19%), Positives = 43/105 (40%), Gaps = 3/105 (2%)
Query: 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG-H 144
L L L + L + + + + ++ L F+ +++++DLSN++I
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVST 62
Query: 145 LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYF 189
L + LQ L+L L+ + +L +L ++L
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 19/91 (20%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAG 167
Q LDL+ +L+ ++ L + + + + L E S +Q ++LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 168 K-LPVSLTTLQSLTIVSLKNNYFSDGLPSKF 197
L L+ L +SL+ SD + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 8/88 (9%), Positives = 26/88 (29%), Gaps = 2/88 (2%)
Query: 180 TIVSLKNNYFSDGLPSKF--NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEI 237
+ L + + V + ++ L + +++++LS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 238 PPQFGEKIPVNATIDLSFNNLTGEIPES 265
+ + L L+ I +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNT 90
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (116), Expect = 2e-07
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 112 LSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV 171
L+ + + ++ NA + R LDL I + +L ++ SDN +
Sbjct: 3 LTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 172 SLTTLQSLTIVSLKNNYFSDGLP 194
L+ L + + NN
Sbjct: 60 P--LLRRLKTLLVNNNRICRIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 18/85 (21%), Positives = 31/85 (36%), Gaps = 3/85 (3%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
+ LDL + + Q +D S+N I + L L+ L +++N +
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRIC 76
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSD 191
L LT + L NN +
Sbjct: 77 RIGEGLDQALPDLTELILTNNSLVE 101
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 2e-06
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 8/136 (5%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--LPE 147
+ + L S P DL L+ ++ +L N +L +L+LSNN + +
Sbjct: 28 DLKGLRSDP-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSS 85
Query: 148 TMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQ-VLDLS 206
+ NL++LNLS N L + + L + L N SD + + + +
Sbjct: 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
Query: 207 SNL--ING-SLPPDIG 219
L ++G LPP I
Sbjct: 146 PKLLRLDGHELPPPIA 161
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 5/61 (8%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISG----HLPETMGSLHNLQLLNLSD 162
L+ ++ S+ L ++ + LS N I L E + S +L++ SD
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 163 N 163
Sbjct: 69 I 69
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 12/88 (13%)
Query: 103 MIEFLQYLDLSNNSLNGSLSFSLFNA------SQLRNLDLSNNLISG----HLPETM-GS 151
L+ L L++ L+ + ++ +A L+ L L N I L +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 152 LHNLQLLNLSDNALAGKLPVSLTTLQSL 179
+ +L L L+ N + + ++ +
Sbjct: 301 MPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 14/69 (20%), Positives = 23/69 (33%), Gaps = 13/69 (18%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNA-----SQLRNLDLSNNLISGHLPETMGSLHNL------ 155
LQ L L N + +L L L+L+ N S + + + +
Sbjct: 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGR 333
Query: 156 -QLLNLSDN 163
+L L D
Sbjct: 334 GELDELDDM 342
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 14/77 (18%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 90 NSQLLGSIPADLGMIEFLQYLDLSNNSLNG----SLSFSLFNASQLRNLDLSNN---LIS 142
++ S+ A L + ++ + LS N++ LS ++ + L + S+ +
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 143 GHLPETMGSLHNLQLLN 159
+PE + L L
Sbjct: 76 DEIPEALRLLLQALLKC 92
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNAT----IDLSFNNLTGEIPESNVFMNQESSSFS 277
L+ L L YN + + I ++L+ N + E + S+
Sbjct: 274 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 333
Query: 278 GNLD 281
G LD
Sbjct: 334 GELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 11/71 (15%), Positives = 28/71 (39%), Gaps = 6/71 (8%)
Query: 123 FSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL----AGKLPVSLTTLQS 178
FS+ S L+ ++ + + +++ + LS N + A L ++ + +
Sbjct: 3 FSIEGKS-LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 179 LTIVSLKNNYF 189
L I + +
Sbjct: 61 LEIAEFSDIFT 71
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 36/197 (18%), Positives = 55/197 (27%), Gaps = 13/197 (6%)
Query: 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166
++ +L +L L L LS NL+ T+ L LNL L
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 167 GKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYL 226
+ +S L ++ VLD+S N + + G
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 227 NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQ 285
+PP P + L+ NNLT N N ++ N
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN------ 182
Query: 286 PTKNPCPIPSSPFDLPN 302
+ IP F
Sbjct: 183 ---SLYTIPKGFFGSHL 196
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 20/84 (23%), Positives = 29/84 (34%), Gaps = 1/84 (1%)
Query: 56 WNYNDENPCSWNGVTCASPGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNN 115
E N + PG ++ L+L N+ L L +E L L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 116 SLNGSLSFSLFNASQLRNLDLSNN 139
SL ++ F + L L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 13/53 (24%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 113 SNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165
+NN+L + L L L L N + +P+ H L L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 13/58 (22%), Positives = 19/58 (32%), Gaps = 1/58 (1%)
Query: 176 LQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGY-SLRYLNLSYNR 232
+ S V+ + P +L LS NL+ + Y L LNL
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 4/62 (6%)
Query: 101 LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160
L + L L +N ++ + + L + L NN IS P + + NL ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 161 SD 162
++
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 125 LFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSL 184
L N S+L L +N IS P + SL NL ++L +N ++ P L +L IV+L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 185 KN 186
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 9/61 (14%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 105 EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNA 164
+ +++ +++ + + + L ++ E + L+NL L L DN
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 165 L 165
+
Sbjct: 75 I 75
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 6e-05
Identities = 11/56 (19%), Positives = 18/56 (32%), Gaps = 10/56 (17%)
Query: 124 SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179
AS LD+S I + +L L+ + +L L +L
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY----------NLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 12/85 (14%), Positives = 24/85 (28%)
Query: 103 MIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSD 162
+ L L+ N + + + NN + + +L++S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 163 NALAGKLPVSLTTLQSLTIVSLKNN 187
+ L L+ L S N
Sbjct: 211 TRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 25/181 (13%), Positives = 54/181 (29%), Gaps = 25/181 (13%)
Query: 78 NNDSRVIGLALPNSQLLGSIP-ADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDL 136
+ + I L + ++ +L + + +N+ + + + L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQNEL---NSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 137 SNNLISGH------------------LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQS 178
+ N ++ + + +L +LS L L
Sbjct: 76 NGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 179 LTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIP 238
L + L NN +D + + + P G L+ L LS N +S ++
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR 194
Query: 239 P 239
Sbjct: 195 A 195
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 14/38 (36%), Positives = 19/38 (50%), Gaps = 2/38 (5%)
Query: 124 SLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161
L ++L+NL LS N IS + L NL +L L
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 791 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.86 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.83 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.82 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.61 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.15 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.11 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.02 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.95 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.91 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.5 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.48 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.75 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=422.13 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=203.5
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 457899999999999996 568999999986532 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---- 160 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 160 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----
Confidence 999999998764 39999999999999999999999999999999999999999999999999997654211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+
T Consensus 161 ----------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 161 ----------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp ----------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ----------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 1234599999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... .+.........+..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 207 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 207 NTY-------------QETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SSH-------------HHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCH-------------HHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 311 122222223333333335678899999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=422.60 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=203.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 46799999999999994 57999999999766555567899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++... .+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~------- 171 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------- 171 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-------
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-------
Confidence 9987653 299999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+...
T Consensus 172 -----------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~- 221 (293)
T d1yhwa1 172 -----------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP- 221 (293)
T ss_dssp -----------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -----------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-
Confidence 11234699999999999999999999999999999999999999965321
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.......... .......+...+..+.+|+.+||+.||++|||++|+++
T Consensus 222 --------~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 222 --------LRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --------HHHHHHHHHH-CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------HHHHHHHHhC-CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111 11122223335678899999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=420.49 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||.||+|++.+++.||||+++..... .++|.+|++++++++|||||+++|++..++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4579999999999999988999999999865433 478999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..+..|+.||+.||+|||+++|+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------- 157 (263)
T d1sm2a_ 89 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT------- 157 (263)
T ss_dssp HHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred HHhhcccc----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce-------
Confidence 98876532 4899999999999999999999999999999999999999999999999999876432211
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc-chhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV-IVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~-pf~~~~~~ 718 (791)
......||+.|+|||++.+..|+.++|||||||++|||+|+.. ||....
T Consensus 158 ----------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-- 207 (263)
T d1sm2a_ 158 ----------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-- 207 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--
T ss_pred ----------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--
Confidence 1112358999999999999999999999999999999999655 443221
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.....+.+...... ..+...+.++.+|+.+||+.||++|||++||++.|++|..+
T Consensus 208 --------~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 208 --------NSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --------HHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHHHHhcCCC--CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11111112211111 11222456789999999999999999999999999987543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=423.52 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=209.3
Q ss_pred cceeccccCceEEEEEEeC-CCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVLE-DGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||+||+|++. +|+.||||+++.+.. ..++|.+|+++|++++|||||+++++|.+.+..++|||||++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 3568999999999999964 689999999976544 35789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .+++..++.|+.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.........
T Consensus 100 l~~~l~~~~~~---~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~---- 172 (287)
T d1opja_ 100 LLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---- 172 (287)
T ss_dssp HHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE----
T ss_pred hHHHhhhcccc---chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee----
Confidence 99998765432 48999999999999999999999999999999999999999999999999998765322111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 173 -------------------------------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 173 -------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp -------------------------------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -------------------------------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 1122378899999999999999999999999999999998776643211
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
.....+.+....... .+...+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus 222 ---------~~~~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 222 ---------LSQVYELLEKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---------HHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---------HHHHHHHHhcCCCCC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111222332222222 2223567889999999999999999999999999988654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=420.45 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=199.9
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||+||+|+.+ ..||||+++.. .....+.|.+|++++++++|||||++++++. .+..++|||||++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 3568999999999999864 36999999654 3455678999999999999999999999875 46789999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|.+++..... ++++..+..|+.||++||+|||+++||||||||+|||++.++.+||+|||+|+........
T Consensus 89 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~---- 160 (276)
T d1uwha_ 89 SLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---- 160 (276)
T ss_dssp EHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc----
Confidence 99999876543 4999999999999999999999999999999999999999999999999999876432111
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 161 ------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 161 ------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 11234569999999999864 358999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhh-hcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAI-RADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
+... ............ .+.. ......+..+.+|+.+||+.||++|||++||++.|+.|..+
T Consensus 211 ~~~~---------~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 211 NINN---------RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TCCC---------HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCh---------HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 5311 111112221111 1111 11122456789999999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=418.11 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=197.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||||++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 46899999999999995 579999999996543 2334678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++.... .+++.+++.|+.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.+......
T Consensus 90 L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~----- 159 (271)
T d1nvra_ 90 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----- 159 (271)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE-----
T ss_pred HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc-----
Confidence 999886543 3999999999999999999999999999999999999999999999999999876432111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 160 -----------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 160 -----------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp -----------------------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred -----------------------------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 11234569999999999988776 678999999999999999999996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
... ........... ........+.++.+|+.+||+.||++|||++|+++
T Consensus 211 ~~~--------~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 211 DSC--------QEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTS--------HHHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHH--------HHHHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 00111111111 11111224567889999999999999999999965
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=418.01 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=202.3
Q ss_pred cceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 479 SAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
..+.||+|+||.||+|++++++.||||+++.... ..+.|.+|++++++++|||||++++++. .+..++||||+++|+|
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred EeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcH
Confidence 4568999999999999998889999999976543 3468999999999999999999999875 4677999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... ++++..++.|+.||++||+|||+++|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 95 ~~~~~~~~~~---~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~------ 165 (272)
T d1qpca_ 95 VDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT------ 165 (272)
T ss_dssp HHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE------
T ss_pred HHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc------
Confidence 9977654432 3899999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhccccC
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELGQ 718 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~ 718 (791)
......||+.|+|||++.+..++.++|||||||++|||+||..|+.....
T Consensus 166 -----------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~- 215 (272)
T d1qpca_ 166 -----------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT- 215 (272)
T ss_dssp -----------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred -----------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-
Confidence 11234589999999999988999999999999999999997665433211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.......+..... ...+...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus 216 --------~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 216 --------NPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp --------HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0111111111111 112223556789999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-50 Score=421.42 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=197.5
Q ss_pred ceeccccCceEEEEEEeC-CC---cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DG---TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.++||+|+||+||+|+.+ ++ ..||||.+... .....++|.+|+++|++++|||||+++|++...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 578999999999999964 23 36999998764 44445789999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++..... .+++.++..|+.||++||+|||+++|+||||||+|||++.++.+||+|||+++.+........
T Consensus 111 ~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 111 NGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp TEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 9999998876543 399999999999999999999999999999999999999999999999999987654322111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~ 713 (791)
........||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 187 -------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 187 -------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp ----------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred -------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 011123458999999999999999999999999999999998 899986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
+.... .....+..... .+.+.+.+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 236 ~~~~~----------~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 236 DMTNQ----------DVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCHH----------HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCHH----------HHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 53211 11111111111 222333567889999999999999999999999999887544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=418.17 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 45799999999999995 57999999999876666678899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++..... .+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 97 ~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~------- 165 (288)
T d2jfla1 97 DAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------- 165 (288)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-------
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-------
Confidence 998776542 399999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-----CCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-----SIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|+|||++. +..|+.++|||||||++|||+||+.||.
T Consensus 166 -----------------------------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 166 -----------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp -----------------------------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -----------------------------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 011345999999999984 4568999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
+.... .....+.... ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~~---------~~~~~i~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 217 ELNPM---------RVLLKIAKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TSCGG---------GHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCHH---------HHHHHHHcCC-CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 54211 1111111111 1112222335678899999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=405.41 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=207.7
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCChh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+|+||+||+|+.++++.||||+++..... .++|.+|++++++++|||||+++|++.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 4689999999999999988999999999875443 468999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCCc
Q 003847 560 NARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGSA 639 (791)
Q Consensus 560 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 639 (791)
+++..... .+++..+.+|+.|+++||+|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 88 ~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~------- 156 (258)
T d1k2pa_ 88 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT------- 156 (258)
T ss_dssp HHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-------
T ss_pred Hhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-------
Confidence 98776543 3899999999999999999999999999999999999999999999999999876432211
Q ss_pred cccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccccC
Q 003847 640 RNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELGQ 718 (791)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~ 718 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 157 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 157 ----------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp ----------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ----------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 1123458999999999999999999999999999999998 78898654211
Q ss_pred CCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 719 GNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.....+....+. ..+...+..+.+|+.+||+.||++|||++|+++.|.+|
T Consensus 209 ----------~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 ----------ETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----------HHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----------HHHHHHHhCCCC--CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111111111111 22223556889999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=417.65 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=202.2
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 356899999999999995 579999999996532 2334679999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++.... .+++..++.++.|++.||+|||+.|||||||||+|||+++++.+||+|||+|+.+......
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-- 164 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-- 164 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc--
Confidence 999999888765 3999999999999999999999999999999999999999999999999999876532211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus 165 --------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 165 --------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp -------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 112245699999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
.. ..++........+..+...+.++.+|+.+||+.||++|||++|++
T Consensus 213 ~~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 213 GN-------------EYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp SS-------------HHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred cC-------------HHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 31 112222333333333334567889999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=413.03 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=202.0
Q ss_pred eccccCceEEEEEEeC---CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 482 ILGASGSSIMYKAVLE---DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||++++++.. +..|+|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999753 4568999999765 34456789999999999999999999999865 56899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++..... .+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 95 L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~---- 166 (285)
T d1u59a_ 95 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---- 166 (285)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE----
T ss_pred HHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc----
Confidence 9998765432 49999999999999999999999999999999999999999999999999999775432111
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~ 716 (791)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 167 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 167 -----------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp -----------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred -----------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 01223458999999999998899999999999999999998 899996532
Q ss_pred cCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 717 GQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.. .....+....+ .+.+...+.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 218 ~~----------~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 218 GP----------EVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TH----------HHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----------HHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11111111111 122233567889999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=413.45 Aligned_cols=257 Identities=22% Similarity=0.390 Sum_probs=200.1
Q ss_pred cceeccccCceEEEEEEeCCC-----cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 479 SAYILGASGSSIMYKAVLEDG-----TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
..++||+|+||.||+|.+++. ..||||++... ......+|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 457899999999999986432 47999999764 333456799999999999999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+.++++.+++..... .+++.++..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 91 ~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 91 MENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred cccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999988766543 3999999999999999999999999999999999999999999999999999876532211
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
. .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 167 ~---------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 167 T---------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred c---------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 0 1122345899999999999999999999999999999999977765
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
..... .....+.+....+. +.+...+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 214 ~~~~~---------~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 214 YWELS---------NHEVMKAINDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTCC---------HHHHHHHHHTTCCC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cccCC---------HHHHHHHHhccCCC--CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 43211 11122222222222 22233557789999999999999999999999999887544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=411.16 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=190.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc--cCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--VDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 554 (791)
.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+ .+..|+|||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46899999999999995 57999999999764 33445678999999999999999999999865 456799999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK-----HVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
+|+|.+++....... ..+++..++.|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 89 ~g~L~~~i~~~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 999999987543211 24999999999999999999999865 999999999999999999999999999876532
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCC
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~ 709 (791)
.. .....+||+.|||||++.+..|+.++|||||||++|||+||+
T Consensus 168 ~~------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 168 TS------------------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp --------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CC------------------------------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 21 112356999999999999999999999999999999999999
Q ss_pred cchhccccCCCCcchhchhHHHHHHHHhhhcCc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 710 VIVVDELGQGNGLLVEDKNRAIRLADAAIRADF-EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 710 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.||..... .++......+.. ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 212 ~Pf~~~~~-------------~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 212 PPFTAFSQ-------------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CSCCCSSH-------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCH-------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99965311 111111111111 112234567899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=410.54 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=199.1
Q ss_pred eeccccCceEEEEEEeC---CCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 481 YILGASGSSIMYKAVLE---DGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
+.||+|+||+||+|.++ +++.||||+++.. .....++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 3578999999754 33345689999999999999999999999865 567899999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... ++++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++.+........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~- 165 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 165 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE-
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc-
Confidence 99999987654 399999999999999999999999999999999999999999999999999987653321110
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVD 714 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~ 714 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 166 --------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 166 --------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp --------------------------------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred --------------------------------cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 1123458999999999999999999999999999999998 8999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcc
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEK 779 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 779 (791)
... ......+....+ .+.+...+.++.+|+.+||+.||++|||+++|++.|+.
T Consensus 214 ~~~----------~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 214 MKG----------SEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCH----------HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCH----------HHHHHHHHcCCC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 311 111222222111 12223356788999999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=404.59 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=193.4
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc----cCceEEEEecc
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG----VDEKLIIYDFV 553 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~ 553 (791)
+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....|+||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 4799999999999995 46899999998654 33445679999999999999999999999875 34579999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CeecCCCCCCeEec-CCCCeEEeccCcccccCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKK--HVHGNLKPRNVLLG-NDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~ 630 (791)
++|+|.+++.... .+++.+++.|+.||++||+|||+++ |+||||||+|||++ +++.+||+|||+|+......
T Consensus 95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 9999999998764 3999999999999999999999988 99999999999996 57899999999997543211
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
....+||+.|||||++.+ .++.++|||||||++|||++|+.
T Consensus 170 --------------------------------------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~ 210 (270)
T d1t4ha_ 170 --------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210 (270)
T ss_dssp --------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCC
Confidence 123469999999999876 69999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcCc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRADF--EGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||.+... . ..+......+.. ......+.++.+|+.+||+.||++|||++|+++
T Consensus 211 Pf~~~~~---------~---~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 211 PYSECQN---------A---AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTTCSS---------H---HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCccc---------H---HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 9964311 0 111111111111 111123456889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-49 Score=416.51 Aligned_cols=247 Identities=25% Similarity=0.280 Sum_probs=187.4
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCch-hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSV-DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||||+||
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 356899999999999995 4789999999975432 23456889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec---CCCCeEEeccCcccccCCCCCCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG---NDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
+|.+++.... .+++.++..|+.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+......
T Consensus 93 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--- 164 (307)
T d1a06a_ 93 ELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--- 164 (307)
T ss_dssp BHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred cHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---
Confidence 9999997643 399999999999999999999999999999999999994 57899999999998654221
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus 165 ----------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 165 ----------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp ------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ----------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 1123469999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
+.... .....+.........+.....+..+.+|+.+||+.||++|||++|+++.
T Consensus 211 ~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 211 DENDA---------KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CSSHH---------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHH---------HHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 53111 1111111111111111122355778999999999999999999999873
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=420.37 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=199.5
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
..+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+++|++++|||||+++++|.+++..|+||||+++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 346899999999999995 57999999999754 3334567899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
+|.+++.+.. .+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 90 ~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----- 159 (322)
T d1s9ja_ 90 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----- 159 (322)
T ss_dssp EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-----
T ss_pred cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-----
Confidence 9999998764 39999999999999999999997 599999999999999999999999999998754211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 160 ---------------------------------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ---------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ---------------------------------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ---------------------------------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 12356999999999999999999999999999999999999999653
Q ss_pred ccCCCCcch----hc-------------------------hhHHHHHHHHhhhcCcc--chHHHHHHHHHHHhhccCCCC
Q 003847 716 LGQGNGLLV----ED-------------------------KNRAIRLADAAIRADFE--GKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 716 ~~~~~~~~~----~~-------------------------~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP 764 (791)
......... .. .....+..+.......+ .....+.++.+|+.+||..||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 286 (322)
T d1s9ja_ 207 DAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286 (322)
T ss_dssp CTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCCh
Confidence 221000000 00 00000011111000000 000123578899999999999
Q ss_pred CCCCCHHHHHH
Q 003847 765 QKRPSMKEALQ 775 (791)
Q Consensus 765 ~~RPs~~evl~ 775 (791)
++|||++|+++
T Consensus 287 ~~R~ta~e~L~ 297 (322)
T d1s9ja_ 287 AERADLKQLMV 297 (322)
T ss_dssp TTSCCHHHHHT
T ss_pred hHCcCHHHHhh
Confidence 99999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=406.96 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=203.4
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
...+.||+|+||.||+|+.++++.||||+++.... ..+.|.+|+.++++++|||||++++++. .+..++||||+++|+
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 34568999999999999998888999999976543 3478999999999999999999999985 567899999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
|.+++...... .++|.+++.|+.||+.||+|||+.||+||||||+|||+|.++.+||+|||+++.+......
T Consensus 98 l~~~~~~~~~~---~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~----- 169 (285)
T d1fmka3 98 LLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT----- 169 (285)
T ss_dssp HHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred hhhhhhhcccc---cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce-----
Confidence 99988765432 3999999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDELG 717 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~ 717 (791)
......||+.|+|||++.+..++.++|||||||++|||+||..||.....
T Consensus 170 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 170 ------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp ------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 11234589999999999999999999999999999999997766533211
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSSPSP 786 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~p 786 (791)
.......+..... .+.....+.++.+++.+||+.||++||++++|+++|+++..+..|
T Consensus 220 ---------~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 220 ---------NREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ---------HHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---------HHHHHHHHHhcCC--CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 0111111111111 122333567889999999999999999999999999987654443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=412.07 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=195.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 45799999999999994 578999999996542 33456789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|..++.... ++++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------ 168 (309)
T d1u5ra_ 100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168 (309)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC------
Confidence 99977665443 3999999999999999999999999999999999999999999999999999764321
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC---CCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS---IKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
...+||+.|||||++.+ ..|+.++|||||||++|||++|+.||
T Consensus 169 ----------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 169 ----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp ----------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 12359999999999864 46899999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.+... ......+....... . .....+..+.+|+.+||+.||++|||++|+++
T Consensus 215 ~~~~~---------~~~~~~i~~~~~~~-~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 215 FNMNA---------MSALYHIAQNESPA-L-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCH---------HHHHHHHHHSCCCC-C-SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCH---------HHHHHHHHhCCCCC-C-CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 65311 11111111111111 1 11124567899999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-48 Score=417.35 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=204.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 356899999999999995 5799999999987766667889999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec--CCCCeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG--NDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.+++....+ ++++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+++.+.....
T Consensus 110 L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---- 181 (350)
T d1koaa2 110 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---- 181 (350)
T ss_dssp HHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC----
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc----
Confidence 9998865432 499999999999999999999999999999999999996 467899999999987653221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 182 ---------------------------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 182 ---------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp ---------------------------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------------------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 11345999999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. ......+...............+..+.+|+.+||+.||++|||++|+++.
T Consensus 229 ~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 229 ND---------DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SH---------HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CH---------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11111111111111111112245678999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=414.95 Aligned_cols=255 Identities=25% Similarity=0.286 Sum_probs=202.3
Q ss_pred cceeccccCceEEEEEEeCC-C-----cEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVLED-G-----TALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||+||+|+... + ..||||++... .......+.+|+.+++++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 45799999999999998532 2 37999998654 333456789999999998 8999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC
Q 003847 551 DFVPNGSLANARYRKMGS------------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~ 612 (791)
|||++|+|.+++...... ....+++..++.|+.||++||+|||+++||||||||+|||++.+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~ 200 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccC
Confidence 999999999999765421 11248999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
+.+||+|||+|+......... ......||+.|||||++.+..++.+
T Consensus 201 ~~~Kl~DFGla~~~~~~~~~~----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~ 246 (325)
T d1rjba_ 201 KVVKICDFGLARDIMSDSNYV----------------------------------VRGNARLPVKWMAPESLFEGIYTIK 246 (325)
T ss_dssp TEEEECCCGGGSCGGGCTTSE----------------------------------EETTEEECGGGCCHHHHHHCCCCHH
T ss_pred CeEEEeeccccccccCCCcee----------------------------------eeccccCCCccCChHHHcCCCCCcc
Confidence 999999999998764322111 0112348999999999999999999
Q ss_pred hhhHHHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 693 WDVYSFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 693 sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
+|||||||++|||+| |+.||.+.... .....+.....+. +.+...+.++.+|+.+||+.||++|||++
T Consensus 247 ~DiwS~Gvil~emlt~g~~Pf~~~~~~---------~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 247 SDVWSYGILLWEIFSLGVNPYPGIPVD---------ANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred eeccchhHHHHHHHhCCCCCCCCCCHH---------HHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999999999999998 89999653211 1122222222222 22223567889999999999999999999
Q ss_pred HHHHHhc
Q 003847 772 EALQALE 778 (791)
Q Consensus 772 evl~~L~ 778 (791)
||++.|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=411.01 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=205.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..++||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++||||+++++++.+.+..|+|||||+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 346899999999999995 67999999999754 22345778999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
+|+|.+++..... +++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 89 gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--- 160 (337)
T d1o6la_ 89 GGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--- 160 (337)
T ss_dssp TCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---
T ss_pred CCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc---
Confidence 9999999887653 89999999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 161 ---------------------------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 161 ---------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp ---------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 12345699999999999999999999999999999999999999966
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
... .++...........+...+.++.+||.+||+.||++||+ ++|+++
T Consensus 208 ~~~-------------~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 208 QDH-------------ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCH-------------HHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 421 222333333334444446678899999999999999995 888876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=404.99 Aligned_cols=242 Identities=22% Similarity=0.294 Sum_probs=200.7
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc------hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS------VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456899999999999995 579999999986431 1235789999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC----CeEEeccCcccccC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM----EPKIGDFGLERLVT 627 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~ 627 (791)
||++|+|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999998764 399999999999999999999999999999999999998776 49999999998764
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
.... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 169 ~~~~-------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 169 FGNE-------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211 (293)
T ss_dssp TSCB-------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCcc-------------------------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc
Confidence 3211 123458999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGK----EEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|+.||.+... .+............. ...+..+.+|+.+||+.||++|||++|+++
T Consensus 212 g~~Pf~~~~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 212 GASPFLGDTK-------------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SSCSSCCSSH-------------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCH-------------HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999965321 111122222222111 123467889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-48 Score=415.96 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=203.5
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||.||+|+. .+|+.||||++........+.+++|+++|++++|||||+++++|.+++..|+|||||++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 346899999999999995 5799999999987666566788999999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec--CCCCeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG--NDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.+++..... ++++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 113 L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---- 184 (352)
T d1koba_ 113 LFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---- 184 (352)
T ss_dssp HHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC----
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc----
Confidence 9887654432 499999999999999999999999999999999999998 578999999999987653221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 185 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 185 ---------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp ---------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---------------------------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 11235899999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCcc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFE----GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
.. .+........... .....+.++.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 232 DD-------------LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SH-------------HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CH-------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 21 1112222222111 112355778999999999999999999999873
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-47 Score=406.76 Aligned_cols=240 Identities=20% Similarity=0.296 Sum_probs=203.3
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..|+|||||+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 346899999999999995 57999999999753 22335778999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
||+|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----- 157 (316)
T d1fota_ 88 GGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157 (316)
T ss_dssp SCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred Ccccccccccccc-----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----
Confidence 9999998876653 889999999999999999999999999999999999999999999999999876421
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+
T Consensus 158 ----------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 158 ----------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp ----------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ----------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 1134699999999999999999999999999999999999999965
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
.. ..+.......+....+...+.++.+++.+||..||.+|+ |++|+++
T Consensus 204 ~~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 204 SN-------------TMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SS-------------HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred cC-------------HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 31 122223333333333333567789999999999999996 8999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=397.89 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=194.9
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEeccCCCCh
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYDFVPNGSL 558 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~~gsL 558 (791)
.+.||+|+||.||+|+.+ |+.||||+++.+. ..+.+.+|++++++++|||||+++|++.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 468999999999999984 7899999997653 34789999999999999999999999865 4568999999999999
Q ss_pred hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCCC
Q 003847 559 ANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGGS 638 (791)
Q Consensus 559 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 638 (791)
.+++...... .+++..+++|+.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-------- 157 (262)
T d1byga_ 89 VDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------- 157 (262)
T ss_dssp HHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHHHhcCCC---CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--------
Confidence 9999765422 38999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcchhcccc
Q 003847 639 ARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIVVDELG 717 (791)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~ 717 (791)
....+|..|+|||++.+..++.++|||||||++|||+| |++||.....
T Consensus 158 -------------------------------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 158 -------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp -----------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred -------------------------------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 12237888999999999999999999999999999998 6777754321
Q ss_pred CCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCC
Q 003847 718 QGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPS 782 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 782 (791)
. .....+....+... +...+.++.+|+.+||+.||++|||+.|++++|++|+.
T Consensus 207 ~----------~~~~~i~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 207 K----------DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp G----------GHHHHHTTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------HHHHHHHcCCCCCC--CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1 11111111111222 22345678999999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=396.05 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=194.0
Q ss_pred hcceeccccCceEEEEEEeCC----CcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 478 ASAYILGASGSSIMYKAVLED----GTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
...+.||+|+||.||+|++.. +..||||.++.. .....+.+.+|++++++++|||||++++++. ++..++||||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence 345789999999999998532 457999999754 3344567999999999999999999999985 5678999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|+|.+++..... .+++..++.++.||++||+|||+++|+||||||+||+++.++.+||+|||+|+........
T Consensus 89 ~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 89 CTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred ccCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 999999998765543 3899999999999999999999999999999999999999999999999999876432111
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |++|
T Consensus 165 -----------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 165 -----------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp -----------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -----------------------------------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence 1123458999999999999999999999999999999998 7888
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
|.+..... ....+... . ..+.+...+..+.+|+.+||+.||++|||+.||++.|++|.
T Consensus 210 ~~~~~~~~---------~~~~i~~~-~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 210 FQGVKNND---------VIGRIENG-E--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TTTCCGGG---------HHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHH---------HHHHHHcC-C--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 86542211 11111111 1 11222335678899999999999999999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-47 Score=398.04 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=198.2
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCc----eEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDE----KLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lv~e 551 (791)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46899999999999994 67999999999754 23345679999999999999999999999987653 789999
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|++|++|.+++.... ++++.+++.|+.||+.||+|||++||+||||||+|||++.++..+++|||.++.......
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 999999999887764 399999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~p 711 (791)
. .......+||+.|+|||++.+..+++++|||||||++|||+||+.|
T Consensus 167 ~---------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 167 S---------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp ---------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred c---------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCC
Confidence 1 0122345699999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCc----cchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhccCC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADF----EGKEEALLSCFKLGYSCASPLPQKRP-SMKEALQALEKIP 781 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 781 (791)
|.+... .+.....+.... ......+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 214 f~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 214 FTGDSP-------------VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCSSH-------------HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCcCH-------------HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 965321 111111111111 11122456789999999999999999 8999999988763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-47 Score=399.48 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=206.3
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCCc-hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGENS-VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||+||+|+.+ +++.||||+++... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 3568999999999999853 46799999997653 3345679999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC
Q 003847 552 FVPNGSLANARYRKMGS-------------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND 612 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~ 612 (791)
|+++|+|.+++...... ....+++..++.|+.|++.||+|||+.+||||||||+|||+|.+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~ 176 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCC
Confidence 99999999999754321 11348999999999999999999999999999999999999999
Q ss_pred CCeEEeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCc
Q 003847 613 MEPKIGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPK 692 (791)
Q Consensus 613 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~ 692 (791)
+.+||+|||+|+.+...... ......+||+.|+|||.+.+..|+.+
T Consensus 177 ~~~Kl~DFGls~~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~t~k 222 (301)
T d1lufa_ 177 MVVKIADFGLSRNIYSADYY----------------------------------KADGNDAIPIRWMPPESIFYNRYTTE 222 (301)
T ss_dssp GCEEECCCSCHHHHTGGGCB----------------------------------C----CCBCGGGCCHHHHHHCCCCHH
T ss_pred CcEEEccchhheeccCCccc----------------------------------cccCCCCcCcCcCCHHHHccCCCChh
Confidence 99999999999876432211 01223458999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCc-chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 693 WDVYSFGVILLELLTGKV-IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 693 sDvwSlGvil~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
+|||||||++|||++|.. ||.+... ......+.+... .+.+...+.++.+|+.+||+.||++||||.
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~---------~e~~~~v~~~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ 290 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAH---------EEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFC 290 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhccchhhHHHHHccCCCCCCCCCH---------HHHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence 999999999999999965 6654311 111111111111 112233566889999999999999999999
Q ss_pred HHHHHhccCCC
Q 003847 772 EALQALEKIPS 782 (791)
Q Consensus 772 evl~~L~~i~~ 782 (791)
||+++|++|..
T Consensus 291 ev~~~L~~i~~ 301 (301)
T d1lufa_ 291 SIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHHhcC
Confidence 99999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-47 Score=405.96 Aligned_cols=239 Identities=18% Similarity=0.221 Sum_probs=202.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 555 (791)
-+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++...+..++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46899999999999995 57999999998653 223356789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~----- 195 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----- 195 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----
Confidence 99999987765 39999999999999999999999999999999999999999999999999998764221
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
...+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 196 ----------------------------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 196 ----------------------------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp ----------------------------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 1245999999999999999999999999999999999999999653
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
. ...............+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 242 ~-------------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 Q-------------PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp S-------------HHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C-------------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 112222223333333334567889999999999999994 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=398.86 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=203.7
Q ss_pred ceeccccCceEEEEEEeCCC----cEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEc-cCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLEDG----TALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG-VDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~ 553 (791)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 36999999753 45556789999999999999999999999875 45789999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++..... .+++..+++++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999998876543 37889999999999999999999999999999999999999999999999998765432211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
. .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 188 ~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 188 V--------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp T--------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred c--------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 1 11223458999999999999999999999999999999999888775
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
....... ....+... .+. ..+...+..+.+|+.+||+.||++||+|.||++.|++|...
T Consensus 236 ~~~~~~~--------~~~~i~~g-~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 236 PDVNTFD--------ITVYLLQG-RRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp C--------------CHHHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHH--------HHHHHHcC-CCC--CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 4321100 00111111 011 11222456788999999999999999999999999988643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-46 Score=391.16 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=199.1
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---------hhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---------DRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 548 (791)
.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ |||||++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 57899999999999995 5799999999865321 12346889999999997 9999999999999999999
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
|||||++|+|.+++.... ++++.+++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 999999999999998754 399999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC------CCCCCchhhHHHHHHH
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS------IKPNPKWDVYSFGVIL 702 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~~sDvwSlGvil 702 (791)
... ....+||+.|+|||++.+ ..++.++||||+||++
T Consensus 163 ~~~-------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil 205 (277)
T d1phka_ 163 GEK-------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205 (277)
T ss_dssp TCC-------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred CCc-------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence 211 123459999999999853 4568899999999999
Q ss_pred HHHHhCCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 703 LELLTGKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 703 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
|||++|+.||.+... ......+.........+.....+.++.+|+.+||+.||++|||++|+++
T Consensus 206 yeml~g~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 206 YTLLAGSPPFWHRKQ---------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHSSCSSCCSSH---------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhccCCCCCCCCCH---------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999965421 1111112221111111122235678899999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=398.74 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=197.7
Q ss_pred ceeccccCceEEEEEEeC-CCc----EEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVLE-DGT----ALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
.++||+|+||+||+|+.. +|+ +||||+++.. .....++|.+|++++++++|||||++++++.++ ..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 469999999999999853 444 6899998654 334467899999999999999999999999764 577889999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
.+|+|.+++..... .+++..++.|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 93 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp TTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred cCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 99999998876543 49999999999999999999999999999999999999999999999999999765322111
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~pf 712 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 169 ----------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 169 ----------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp ----------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ----------------------------------cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 1123358999999999999999999999999999999999 67788
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
.+.... .....+....+. +.+...+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 215 ~~~~~~----------~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 215 DGIPAS----------EISSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp TTSCGG----------GHHHHHHHTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHH----------HHHHHHHcCCCC--CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 553211 112222222111 222235577899999999999999999999999987653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=394.95 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=202.8
Q ss_pred hcceeccccCceEEEEEEeC--------CCcEEEEEEcCCCch-hhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceE
Q 003847 478 ASAYILGASGSSIMYKAVLE--------DGTALAVRRIGENSV-DRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKL 547 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 547 (791)
...+.||+|+||.||+|+.. ++..||||+++.+.. ....++.+|+..+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 34578999999999999842 235799999977543 3457888999999888 8999999999999999999
Q ss_pred EEEeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeE
Q 003847 548 IIYDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPK 616 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~k 616 (791)
+||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+.+||||||||+|||++.++.+|
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeE
Confidence 999999999999999765421 123589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhH
Q 003847 617 IGDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVY 696 (791)
Q Consensus 617 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 696 (791)
|+|||+++........ .......||+.|+|||.+.+..|+.++|||
T Consensus 176 l~dfg~~~~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~l~~~~y~~k~Diw 221 (299)
T d1fgka_ 176 IADFGLARDIHHIDYY----------------------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVW 221 (299)
T ss_dssp ECSTTCCCCGGGCCTT----------------------------------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHH
T ss_pred eccchhhccccccccc----------------------------------cccccCCCChhhhhhhHhcCCCCCchhhhH
Confidence 9999999876532211 112244589999999999999999999999
Q ss_pred HHHHHHHHHHh-CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 697 SFGVILLELLT-GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 697 SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||||++|||++ |++||.+... ....+.+........ +...+..+.+|+.+||+.||++|||+.||++
T Consensus 222 S~Gvvl~ell~~g~~p~~~~~~----------~~~~~~i~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 222 SFGVLLWEIFTLGGSPYPGVPV----------EELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCH----------HHHHHHHHTTCCCCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhHHHHHHhccCCCCCCCCCCH----------HHHHHHHHcCCCCCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 99999999998 6778754321 112222222222222 2224567899999999999999999999999
Q ss_pred HhccCC
Q 003847 776 ALEKIP 781 (791)
Q Consensus 776 ~L~~i~ 781 (791)
.|++|.
T Consensus 290 ~L~~i~ 295 (299)
T d1fgka_ 290 DLDRIV 295 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-46 Score=403.82 Aligned_cols=243 Identities=19% Similarity=0.222 Sum_probs=195.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch---hhHHHH---HHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV---DRFRDF---ETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.++||+|+||.||+|+. .+|+.||||++..... .....+ ..|+++++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 46899999999999995 5799999999864311 111223 3457778888999999999999999999999999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
|++|+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence 99999999998764 38999999999999999999999999999999999999999999999999998764321
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~p 711 (791)
....+||+.|+|||++.. ..|+.++|||||||++|||+||+.|
T Consensus 162 ------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P 205 (364)
T d1omwa3 162 ------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205 (364)
T ss_dssp ------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence 123459999999999864 5689999999999999999999999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPS-----MKEALQ 775 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 775 (791)
|....... ...+...........+...+.++.+||.+||+.||++||| ++|+++
T Consensus 206 f~~~~~~~----------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 206 FRQHKTKD----------KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSSCSSC----------HHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCHHH----------HHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 96542211 1122222222222222235667899999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=400.24 Aligned_cols=242 Identities=20% Similarity=0.245 Sum_probs=193.9
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhcc-CCCCccceeeEEEc----cCceEEEEecc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWG----VDEKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~lv~e~~ 553 (791)
.++||+|+||+||+|+. .+|+.||||+++.. +.+.+|++++.++ +|||||+++++|.+ ....|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 45799999999999995 67999999998643 4677899987655 89999999999875 45689999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC---CCCeEEeccCcccccCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN---DMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~ 630 (791)
+||+|.+++...... .+++.+++.|+.||+.||+|||+.||+||||||+|||++. ++.+||+|||+|+......
T Consensus 92 ~gg~L~~~i~~~~~~---~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCC---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCC---CcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999765332 4999999999999999999999999999999999999985 5679999999998764321
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.
T Consensus 169 ~-------------------------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 169 S-------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp C-------------------------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred c-------------------------------------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 1 123459999999999999999999999999999999999999
Q ss_pred chhccccCCCCcchhchhHHHHHHHHhhhcC--cc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 711 IVVDELGQGNGLLVEDKNRAIRLADAAIRAD--FE--GKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
||.+.........+ ........ ++ .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 212 Pf~~~~~~~~~~~~---------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 212 PFYSNHGLAISPGM---------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCEETTCC-----------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHH---------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99765332211110 00011111 11 11234567899999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=398.42 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=195.2
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccC-ceEEE
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVD-EKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lv 549 (791)
..+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++...+ ..++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 4578999999999999842 3578999999764 334456788888888877 6899999999987654 67999
Q ss_pred EeccCCCChhHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEe
Q 003847 550 YDFVPNGSLANARYRKMGS-----------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIG 618 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~ 618 (791)
||||++|+|.+++...... ....+++.+++.|+.||++||+|||+++||||||||+|||++.++.+||+
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~ 176 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 176 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEc
Confidence 9999999999999765321 11248999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||+|+........ .......||+.|+|||++.+..++.++|||||
T Consensus 177 DFGla~~~~~~~~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 177 DFGLARDIYKDPDY----------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp C------CCSCTTS----------------------------------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cCcchhhccccccc----------------------------------cccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 99999865432211 11234569999999999999999999999999
Q ss_pred HHHHHHHHhCCc-chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 003847 699 GVILLELLTGKV-IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQAL 777 (791)
Q Consensus 699 Gvil~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 777 (791)
||++|||+||.. ||...... ............. +.+...+.++.+++.+||+.||++|||++||++.|
T Consensus 223 Gvil~ellt~~~~p~~~~~~~---------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 223 GVLLWEIFSLGASPYPGVKID---------EEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCCCS---------HHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHH---------HHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999754 66543111 1112222222111 22222456789999999999999999999999999
Q ss_pred ccCCC
Q 003847 778 EKIPS 782 (791)
Q Consensus 778 ~~i~~ 782 (791)
++|..
T Consensus 292 ~~ilq 296 (299)
T d1ywna1 292 GNLLQ 296 (299)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=398.78 Aligned_cols=243 Identities=22% Similarity=0.238 Sum_probs=199.8
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCc---hhhHHHHHHHHHHHh-ccCCCCccceeeEEEccCceEEEEecc
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENS---VDRFRDFETQVRVIA-KLVHPNLVRIRGFYWGVDEKLIIYDFV 553 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv~e~~ 553 (791)
..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+||||+
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 356899999999999995 579999999997532 223456677777765 689999999999999999999999999
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
++|+|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 86 NGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred CCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 9999999998765 389999999999999999999999999999999999999999999999999986542211
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.
T Consensus 159 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 159 ----------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp ----------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ----------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 1223469999999999999999999999999999999999999996
Q ss_pred ccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMK-EALQ 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 775 (791)
+... .++...........+...+.++.+|+.+||+.||++||++. |+++
T Consensus 205 ~~~~-------------~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 205 GQDE-------------EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CSSH-------------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCH-------------HHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 5421 11222222233333333567789999999999999999995 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=397.98 Aligned_cols=242 Identities=19% Similarity=0.238 Sum_probs=200.8
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
..+.||+|+||+||+|+. .+|+.||||+++....+ ...+.+|+++|++++|||||++++++.+++..|+|||||+||+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 346899999999999995 57899999999876443 3568899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC--CCeEEeccCcccccCCCCCCCcC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND--MEPKIGDFGLERLVTGDTSSSKA 635 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~ 635 (791)
|.+++..... ++++.+++.|+.||+.||+|||+.||+||||||+|||++.+ ..+||+|||+++.......
T Consensus 88 L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---- 159 (321)
T d1tkia_ 88 IFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---- 159 (321)
T ss_dssp HHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE----
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc----
Confidence 9999876532 39999999999999999999999999999999999999854 5799999999987543211
Q ss_pred CCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 636 GGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
....+||+.|+|||.+.+..|+.++||||+||++|||++|+.||...
T Consensus 160 ---------------------------------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 160 ---------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp ---------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------------------------------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 11234899999999999999999999999999999999999999654
Q ss_pred ccCCCCcchhchhHHHHHHHHhhhcCccchH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAAIRADFEGKE----EALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.. .++........+.... ..+.++.+|+.+||..||++|||++|+++
T Consensus 207 ~~-------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 207 TN-------------QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SH-------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CH-------------HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21 1222222223222221 23467899999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=390.62 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=192.9
Q ss_pred ceeccccCceEEEEEEeC--CC--cEEEEEEcCCC---chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEec
Q 003847 480 AYILGASGSSIMYKAVLE--DG--TALAVRRIGEN---SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDF 552 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 552 (791)
.+.||+|+||.||+|+.. ++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 357999999999999843 22 47999998754 33445789999999999999999999999965 567899999
Q ss_pred cCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCC
Q 003847 553 VPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 632 (791)
+++|++.+++..... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.+......
T Consensus 92 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 92 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred ecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 999999998776543 3999999999999999999999999999999999999999999999999999976543221
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh-CCcc
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT-GKVI 711 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt-G~~p 711 (791)
.. ......|+..|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 168 ~~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~P 214 (273)
T d1u46a_ 168 YV---------------------------------MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214 (273)
T ss_dssp EE---------------------------------C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ce---------------------------------ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCC
Confidence 11 1223457889999999999999999999999999999998 8999
Q ss_pred hhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 712 VVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 712 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
|.+.... .....+...... .+.....+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 215 f~~~~~~---------~~~~~i~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 215 WIGLNGS---------QILHKIDKEGER--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TTTCCHH---------HHHHHHHTSCCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCHH---------HHHHHHHhCCCC--CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9653211 111111111111 122233556789999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=393.55 Aligned_cols=250 Identities=20% Similarity=0.220 Sum_probs=192.3
Q ss_pred eeccccCceEEEEEEe-CCCcEEEEEEcCCCchh-----hHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccC
Q 003847 481 YILGASGSSIMYKAVL-EDGTALAVRRIGENSVD-----RFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5899999999999995 57999999999654222 13468899999999999999999999999999999999998
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCc
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
++++..+..... .+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--- 155 (299)
T d1ua2a_ 84 TDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--- 155 (299)
T ss_dssp EEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---
T ss_pred chHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc---
Confidence 887765543222 389999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchh
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVV 713 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~ 713 (791)
.....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 156 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 156 ---------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp ---------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 1223469999999999865 467999999999999999999999986
Q ss_pred ccccCCCCcchhchhHHHHHHHHhh------------------hcCcc-c-----hHHHHHHHHHHHhhccCCCCCCCCC
Q 003847 714 DELGQGNGLLVEDKNRAIRLADAAI------------------RADFE-G-----KEEALLSCFKLGYSCASPLPQKRPS 769 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs 769 (791)
..... .....+..... ....+ . .......+.+|+.+||+.||++|||
T Consensus 203 ~~~~~---------~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s 273 (299)
T d1ua2a_ 203 GDSDL---------DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273 (299)
T ss_dssp CSSHH---------HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred CCCHH---------HHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC
Confidence 53211 00111110000 00000 0 0012457889999999999999999
Q ss_pred HHHHHH--HhccC
Q 003847 770 MKEALQ--ALEKI 780 (791)
Q Consensus 770 ~~evl~--~L~~i 780 (791)
++|+++ .+++.
T Consensus 274 a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 274 ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHTSGGGTSS
T ss_pred HHHHhCCHhhCCC
Confidence 999997 36544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=393.95 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=206.8
Q ss_pred cceeccccCceEEEEEEe------CCCcEEEEEEcCCCc-hhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEE
Q 003847 479 SAYILGASGSSIMYKAVL------EDGTALAVRRIGENS-VDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 550 (791)
..+.||+|+||.||+|++ .+++.||||+++... .....++.+|+.+++++ +|||||++++++.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 356899999999999984 346799999997643 34456789999999999 6999999999999999999999
Q ss_pred eccCCCChhHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEE
Q 003847 551 DFVPNGSLANARYRKMGS-------------SPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKI 617 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL 617 (791)
|||++|+|.++++..... ....+++..+..|+.||+.||+|||+++||||||||+||+++.++.+|+
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki 186 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccc
Confidence 999999999999865421 1124899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHH
Q 003847 618 GDFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYS 697 (791)
Q Consensus 618 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS 697 (791)
+|||+++......... .....+||+.|+|||++.+..++.++||||
T Consensus 187 ~DfG~~~~~~~~~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS 232 (311)
T d1t46a_ 187 CDFGLARDIKNDSNYV----------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWS 232 (311)
T ss_dssp CCCGGGSCTTSCTTSE----------------------------------ECSSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred cccchheeccCCCcce----------------------------------EeeecccChHHcCHHHhcCCCCCCcccccc
Confidence 9999998765322111 112346899999999999999999999999
Q ss_pred HHHHHHHHHhCCc-chhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 698 FGVILLELLTGKV-IVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 698 lGvil~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
|||++|||+|++. ||..... ......+++...+...+ ...+..+.+||.+||+.||++|||++||+++
T Consensus 233 ~G~~l~ellt~g~p~~~~~~~---------~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 233 YGIFLWELFSLGSSPYPGMPV---------DSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHHHHHTTTCCSSTTCCS---------SHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999555 4433211 11223333333333222 2245778999999999999999999999999
Q ss_pred hccC
Q 003847 777 LEKI 780 (791)
Q Consensus 777 L~~i 780 (791)
|+++
T Consensus 302 L~~~ 305 (311)
T d1t46a_ 302 IEKQ 305 (311)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=391.73 Aligned_cols=263 Identities=21% Similarity=0.221 Sum_probs=196.8
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEccC----ceEEEEeccCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD----EKLIIYDFVPN 555 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e~~~~ 555 (791)
.+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++|||||++++++.+.+ ..|+|||||++
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 35799999999999997 5899999999754322 223445666667889999999999998765 57899999999
Q ss_pred CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc--------CCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 556 GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE--------KKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 556 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
|+|.+++++. .++|..+.+++.|++.||+|||+ +|||||||||+|||++.++.+||+|||+++...
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999764 28999999999999999999996 699999999999999999999999999998775
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC------CCCchhhHHHHHH
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK------PNPKWDVYSFGVI 701 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~~~~sDvwSlGvi 701 (791)
....... .......||+.|+|||++.+.. ++.++|||||||+
T Consensus 160 ~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv 207 (303)
T d1vjya_ 160 SATDTID--------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp TTTTEEC--------------------------------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CCCccee--------------------------------ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence 4322110 1122456999999999987642 5779999999999
Q ss_pred HHHHHhCCcchhccccCCCCc--chh---chh-HHHHHHHHhhhcCccc---hHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 702 LLELLTGKVIVVDELGQGNGL--LVE---DKN-RAIRLADAAIRADFEG---KEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 702 l~elltG~~pf~~~~~~~~~~--~~~---~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
+|||+||..||.......... ... ... ......+...++..+. ..+....+.+|+.+||+.||++|||+.|
T Consensus 208 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 999999998875432211110 000 001 1111122222222111 2235567899999999999999999999
Q ss_pred HHHHhccCCC
Q 003847 773 ALQALEKIPS 782 (791)
Q Consensus 773 vl~~L~~i~~ 782 (791)
|++.|++|..
T Consensus 288 i~~~L~~i~~ 297 (303)
T d1vjya_ 288 IKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=395.53 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=200.4
Q ss_pred ceeccccCceEEEEEEeC-CCc--EEEEEEcCCC-chhhHHHHHHHHHHHhcc-CCCCccceeeEEEccCceEEEEeccC
Q 003847 480 AYILGASGSSIMYKAVLE-DGT--ALAVRRIGEN-SVDRFRDFETQVRVIAKL-VHPNLVRIRGFYWGVDEKLIIYDFVP 554 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 554 (791)
.+.||+|+||.||+|+++ +|. .||||++... .....+.+.+|+++|+++ +|||||++++++.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 468999999999999954 444 5788888543 333456799999999999 79999999999999999999999999
Q ss_pred CCChhHHHHhhc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcc
Q 003847 555 NGSLANARYRKM-----------GSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLE 623 (791)
Q Consensus 555 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla 623 (791)
+|+|.++++... ......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a 174 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence 999999987542 111235999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHH
Q 003847 624 RLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILL 703 (791)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ 703 (791)
+....... .....||..|+|||.+.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~-------------------------------------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 175 RGQEVYVK-------------------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp ESSCEECC-------------------------------------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cccccccc-------------------------------------ccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 76432111 11234899999999999999999999999999999
Q ss_pred HHHhCCc-chhccccCCCCcchhchhHHHHHHHHhhhc-CccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCC
Q 003847 704 ELLTGKV-IVVDELGQGNGLLVEDKNRAIRLADAAIRA-DFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIP 781 (791)
Q Consensus 704 elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 781 (791)
||++|.. ||.+.. ..++.+....+ ..+.+...+.++.+||.+||+.||++||||+||++.|++|.
T Consensus 218 ell~~~~~p~~~~~-------------~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 218 EIVSLGGTPYCGMT-------------CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHTTSCCTTTTCC-------------HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCC-------------HHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999765 564321 11111111111 11222335578899999999999999999999999998875
Q ss_pred CCC
Q 003847 782 SSP 784 (791)
Q Consensus 782 ~~~ 784 (791)
...
T Consensus 285 ~~~ 287 (309)
T d1fvra_ 285 EER 287 (309)
T ss_dssp HSS
T ss_pred hcC
Confidence 443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=385.92 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=206.2
Q ss_pred cceeccccCceEEEEEEeC------CCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEe
Q 003847 479 SAYILGASGSSIMYKAVLE------DGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++|||||++++++..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999853 3679999999764 33444578999999999999999999999999999999999
Q ss_pred ccCCCChhHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCccccc
Q 003847 552 FVPNGSLANARYRKMG-----SSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLV 626 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 626 (791)
|+++|+|.+++..... .....+++..+..|+.|+++||+|||+++|+||||||+|||+++++++||+|||+++.+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~ 183 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceec
Confidence 9999999998875421 11124789999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHH
Q 003847 627 TGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELL 706 (791)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ell 706 (791)
....... ......||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 184 ~~~~~~~----------------------------------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 184 YETDYYR----------------------------------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229 (308)
T ss_dssp GGGGCEE----------------------------------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCccee----------------------------------eccceecccccCCHHHHccCCCCcccccccHHHHHHHHH
Confidence 4322110 011234899999999999999999999999999999999
Q ss_pred hCC-cchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccCCCC
Q 003847 707 TGK-VIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKIPSS 783 (791)
Q Consensus 707 tG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 783 (791)
||+ .||.+.. .......+.+... .+.+...+..+.+++.+||+.||++|||+.||++.|++..+.
T Consensus 230 t~~~~p~~~~~---------~~~~~~~i~~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 230 TLAEQPYQGLS---------NEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HTSCCTTTTSC---------HHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred hCCCCCCCCCC---------HHHHHHHHHhCCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 986 5664321 1111111222111 122223456799999999999999999999999999887553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=386.32 Aligned_cols=239 Identities=19% Similarity=0.313 Sum_probs=193.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch------hhHHHHHHHHHHHhccC--CCCccceeeEEEccCceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV------DRFRDFETQVRVIAKLV--HPNLVRIRGFYWGVDEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~ 550 (791)
.++||+|+||+||+|+. .+|+.||||++..... ....++.+|+.++++++ |||||++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 46899999999999995 5799999999865321 11234678999999996 899999999999999999999
Q ss_pred eccCC-CChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCC-CCeEEeccCcccccCC
Q 003847 551 DFVPN-GSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGND-MEPKIGDFGLERLVTG 628 (791)
Q Consensus 551 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~ 628 (791)
||+.+ +++.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 89 e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 99976 57778776654 39999999999999999999999999999999999999854 7899999999986532
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCC-CCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKP-NPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwSlGvil~ellt 707 (791)
.. .+..+||+.|+|||++.+..+ +.++||||+||++|||+|
T Consensus 164 ~~--------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~ 205 (273)
T d1xwsa_ 164 TV--------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205 (273)
T ss_dssp SC--------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence 11 123469999999999987665 677999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hccC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQA--LEKI 780 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 780 (791)
|+.||.... ++ ...........+.++.+|+.+||+.||++|||++|+++. ++++
T Consensus 206 g~~Pf~~~~---------------~i----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 206 GDIPFEHDE---------------EI----IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SSCSCCSHH---------------HH----HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCCCCch---------------HH----hhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999995431 11 111111222245678899999999999999999999873 5544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=380.31 Aligned_cols=254 Identities=21% Similarity=0.290 Sum_probs=195.3
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCch--hhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSV--DRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
-+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 36899999999999995 6799999999965432 2356889999999999999999999999999999999999965
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
++.+++...... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 86 ~~~~~~~~~~~~---~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~----- 157 (298)
T d1gz8a_ 86 DLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR----- 157 (298)
T ss_dssp EHHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-----
T ss_pred chhhhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc-----
Confidence 444544443322 399999999999999999999999999999999999999999999999999987643221
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
......||+.|+|||++.... ++.++||||+||++|||++|+.||.+.
T Consensus 158 -------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 158 -------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp -------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------------------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 122345999999999887655 588999999999999999999999643
Q ss_pred ccCCCCcchhchhHHHHHHHHh----------------hhcCc----c-----chHHHHHHHHHHHhhccCCCCCCCCCH
Q 003847 716 LGQGNGLLVEDKNRAIRLADAA----------------IRADF----E-----GKEEALLSCFKLGYSCASPLPQKRPSM 770 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~----~-----~~~~~~~~l~~li~~cl~~dP~~RPs~ 770 (791)
... .....+.... ..... . .......++.+|+.+||..||++|||+
T Consensus 207 ~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~ 277 (298)
T d1gz8a_ 207 SEI---------DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277 (298)
T ss_dssp SHH---------HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CHH---------HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 210 0000000000 00000 0 001123578899999999999999999
Q ss_pred HHHHHH--hccCCC
Q 003847 771 KEALQA--LEKIPS 782 (791)
Q Consensus 771 ~evl~~--L~~i~~ 782 (791)
+|+++. ++++..
T Consensus 278 ~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 278 KAALAHPFFQDVTK 291 (298)
T ss_dssp HHHHTSGGGTTCCC
T ss_pred HHHhCCHhhccCCC
Confidence 999985 777644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-44 Score=374.01 Aligned_cols=254 Identities=19% Similarity=0.223 Sum_probs=192.2
Q ss_pred ceeccccCceEEEEEEeCCCcEEEEEEcCCCc--hhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVLEDGTALAVRRIGENS--VDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
-+.||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 35799999999999999899999999997643 2235789999999999999999999999999999999999998776
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAGG 637 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 637 (791)
+..+..... .+++..++.|+.||+.||+|||+.+||||||||+|||++.++.+||+|||.+.........
T Consensus 87 ~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~----- 156 (286)
T d1ob3a_ 87 KKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----- 156 (286)
T ss_dssp HHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-----
Confidence 666544332 3999999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCCcchhccc
Q 003847 638 SARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGKVIVVDEL 716 (791)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~ 716 (791)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 157 -------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 157 -------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp ------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 112348899999999875 456999999999999999999999996432
Q ss_pred cCCC------------CcchhchhHHHHHHHHhhhc--C---ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003847 717 GQGN------------GLLVEDKNRAIRLADAAIRA--D---FEGKEEALLSCFKLGYSCASPLPQKRPSMKEALQ 775 (791)
Q Consensus 717 ~~~~------------~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 775 (791)
.... ............. ...... . ..........+.+|+.+||+.||++|||++|+++
T Consensus 206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 206 EADQLMRIFRILGTPNSKNWPNVTELPKY-DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhhCCCChhhccchhhhhhc-ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1000 0000000000000 000000 0 0001113457889999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=379.90 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=187.2
Q ss_pred hhcceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEE
Q 003847 477 KASAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLII 549 (791)
Q Consensus 477 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv 549 (791)
+...++||+|+||+||+|+. .+|+.||||++..... ...+|+++|++++||||++++++|... ...++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 33456899999999999995 5799999999976532 234799999999999999999998643 246899
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTG 628 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~ 628 (791)
||||+++.+..+........ .+++.+++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EeccCCccHHHHHhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99998765444433322222 499999999999999999999999999999999999999775 899999999987643
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~ellt 707 (791)
.. .....+||+.|+|||.+.+ ..++.++||||+||++|||++
T Consensus 176 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 176 GE-------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp TS-------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred Cc-------------------------------------ccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 21 1123458999999998765 578999999999999999999
Q ss_pred CCcchhccccCCCCcchh------chhHHHHHHHHhhhcCcc----------chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 708 GKVIVVDELGQGNGLLVE------DKNRAIRLADAAIRADFE----------GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
|+.||...........+. ................++ ........+.+|+.+||..||++|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999996532110000000 000000000000000000 0011345688999999999999999999
Q ss_pred HHHH
Q 003847 772 EALQ 775 (791)
Q Consensus 772 evl~ 775 (791)
|+++
T Consensus 299 e~L~ 302 (350)
T d1q5ka_ 299 EACA 302 (350)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=374.02 Aligned_cols=251 Identities=23% Similarity=0.273 Sum_probs=188.5
Q ss_pred ceeccccCceEEEEEEe-CC-CcEEEEEEcCCCch--hhHHHHHHHHHHHhcc---CCCCccceeeEEEc-----cCceE
Q 003847 480 AYILGASGSSIMYKAVL-ED-GTALAVRRIGENSV--DRFRDFETQVRVIAKL---VHPNLVRIRGFYWG-----VDEKL 547 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~~~~ 547 (791)
.+.||+|+||+||+|+. ++ ++.||||+++.... .....+.+|+.+++.+ +||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 45899999999999995 44 67899999864321 1223466777777665 79999999999863 34679
Q ss_pred EEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccC
Q 003847 548 IIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVT 627 (791)
Q Consensus 548 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 627 (791)
++|||++++.+......... .+++..++.++.|++.||+|||+++||||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEEEeccCCchhhhhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence 99999988777554433221 38999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHh
Q 003847 628 GDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~ellt 707 (791)
... .....+||+.|+|||++.+..|+.++||||+||++|||++
T Consensus 168 ~~~-------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~ 210 (305)
T d1blxa_ 168 FQM-------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210 (305)
T ss_dssp GGG-------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH
Confidence 211 1123459999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHh------------------hhcC-----ccchHHHHHHHHHHHhhccCCCC
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAA------------------IRAD-----FEGKEEALLSCFKLGYSCASPLP 764 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-----~~~~~~~~~~l~~li~~cl~~dP 764 (791)
|+.||.+.... .....+.... .... ..........+.+|+.+||+.||
T Consensus 211 g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 281 (305)
T d1blxa_ 211 RKPLFRGSSDV---------DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281 (305)
T ss_dssp SSCSCCCSSHH---------HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred CCCCCCCCCHH---------HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCCh
Confidence 99999653211 0001110000 0000 00011134567899999999999
Q ss_pred CCCCCHHHHHHH--hccC
Q 003847 765 QKRPSMKEALQA--LEKI 780 (791)
Q Consensus 765 ~~RPs~~evl~~--L~~i 780 (791)
++|||++|+++. +++|
T Consensus 282 ~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 282 AKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TTSCCHHHHHTSGGGTTC
T ss_pred hHCcCHHHHhcChhhcCc
Confidence 999999999873 5544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=371.78 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=189.4
Q ss_pred ceeccccCceEEEEEE-eCCCcEEEEEEcCCC-chhhHHHHHHHHHHHhccCCCCccceeeEEEccC----ceEEEEecc
Q 003847 480 AYILGASGSSIMYKAV-LEDGTALAVRRIGEN-SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD----EKLIIYDFV 553 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e~~ 553 (791)
-..||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+++|++++||||+++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 4689999999999998 468999999999754 3344567899999999999999999999997654 234555667
Q ss_pred CCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCC
Q 003847 554 PNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 554 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 633 (791)
.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 799999998654 39999999999999999999999999999999999999999999999999998754322110
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCccccc-CCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLR-SIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
......+||+.|+|||++. +..++.++||||+||++|||++|+.||
T Consensus 167 ---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 167 ---------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp ---------------------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------------------------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 1123456999999999985 456789999999999999999999999
Q ss_pred hccccCCCCcchh------chh--------HHHHHHHHhhhcC-ccc---hHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003847 713 VDELGQGNGLLVE------DKN--------RAIRLADAAIRAD-FEG---KEEALLSCFKLGYSCASPLPQKRPSMKEAL 774 (791)
Q Consensus 713 ~~~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl 774 (791)
............. ... ............. .+. ......++.+|+.+||+.||++|||++|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6532100000000 000 0000000000000 000 001224688999999999999999999999
Q ss_pred HH
Q 003847 775 QA 776 (791)
Q Consensus 775 ~~ 776 (791)
+.
T Consensus 294 ~h 295 (345)
T d1pmea_ 294 AH 295 (345)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=366.48 Aligned_cols=259 Identities=15% Similarity=0.182 Sum_probs=193.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCcc-ceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNLV-RIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||.||+|+. .+|+.||||++...... +++.+|++++++++|+|++ .+.+++.+.+..++||||+ +++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 46899999999999995 57899999998654332 4578899999999877655 5555667777889999999 567
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEec---CCCCeEEeccCcccccCCCCCCCc
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLG---NDMEPKIGDFGLERLVTGDTSSSK 634 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~ 634 (791)
|.+.+..... .+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+.+........
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 89 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred hhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 7666554432 399999999999999999999999999999999999986 355799999999998754332111
Q ss_pred CCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcchhc
Q 003847 635 AGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIVVD 714 (791)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf~~ 714 (791)
. .........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 165 ~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 165 I-----------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp C-----------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred e-----------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 0 11223456799999999999999999999999999999999999999976
Q ss_pred cccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 715 ELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
............ ..........+ .....+.++.+++..||+.+|++||++.++.+.|+.+
T Consensus 216 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 216 LKAATKRQKYER------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp CC-------HHH------HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHH------hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 433222221111 11111111000 0111346788999999999999999999998888764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=371.55 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=188.6
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccC------ceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVD------EKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~ 550 (791)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.|+||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 35899999999999995 57999999999754 3334567899999999999999999999998665 469999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+ +.+|..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+.....
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 999 66787766543 3999999999999999999999999999999999999999999999999999865421
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccC-CCCCCchhhHHHHHHHHHHHhCC
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRS-IKPNPKWDVYSFGVILLELLTGK 709 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwSlGvil~elltG~ 709 (791)
.+...||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 175 --------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 175 --------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216 (346)
T ss_dssp --------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCc
Confidence 123459999999999876 45689999999999999999999
Q ss_pred cchhccccCCCCc------------chhchh-HHHHHHHHhhhc----Ccc-chHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003847 710 VIVVDELGQGNGL------------LVEDKN-RAIRLADAAIRA----DFE-GKEEALLSCFKLGYSCASPLPQKRPSMK 771 (791)
Q Consensus 710 ~pf~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~----~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ 771 (791)
.||.+........ ...... ............ .+. ........+.+|+.+||..||++|||++
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9996532100000 000000 000000000000 000 0011245678999999999999999999
Q ss_pred HHHHH--hccCC
Q 003847 772 EALQA--LEKIP 781 (791)
Q Consensus 772 evl~~--L~~i~ 781 (791)
|+++. ++++.
T Consensus 297 eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 297 EALAHPYFESLH 308 (346)
T ss_dssp HHHHSGGGTTTC
T ss_pred HHhcChhhCcCC
Confidence 99984 66654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=368.10 Aligned_cols=258 Identities=18% Similarity=0.201 Sum_probs=187.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEc--------cCceEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWG--------VDEKLI 548 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~~~~~l 548 (791)
.+.||+|+||+||+|+. ++|+.||||++... .....+++.+|+++|++++||||+++++++.. ++..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 35899999999999995 57999999998653 23335678899999999999999999999865 346799
Q ss_pred EEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCC
Q 003847 549 IYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTG 628 (791)
Q Consensus 549 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 628 (791)
||||++++.+........ .+++..++.|+.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 v~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp EEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred EEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 999998776654332221 489999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHh
Q 003847 629 DTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~ellt 707 (791)
...... ......+||+.|+|||++.+. .+++++||||+||++|||++
T Consensus 170 ~~~~~~--------------------------------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 170 AKNSQP--------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp -----C--------------------------------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cccccc--------------------------------ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence 321111 112235699999999998764 68999999999999999999
Q ss_pred CCcchhccccCCCCc---------------chhchhHHHHHHHHhhhcCccchH------HHHHHHHHHHhhccCCCCCC
Q 003847 708 GKVIVVDELGQGNGL---------------LVEDKNRAIRLADAAIRADFEGKE------EALLSCFKLGYSCASPLPQK 766 (791)
Q Consensus 708 G~~pf~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~ 766 (791)
|+.||.+........ ...... ....... ......... .....+.+|+.+||+.||++
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~ 295 (318)
T d3blha1 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE-LYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295 (318)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh-hhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhH
Confidence 999996432100000 000000 0000000 000000000 11346678999999999999
Q ss_pred CCCHHHHHHH
Q 003847 767 RPSMKEALQA 776 (791)
Q Consensus 767 RPs~~evl~~ 776 (791)
|||++|+++.
T Consensus 296 R~sa~elL~H 305 (318)
T d3blha1 296 RIDSDDALNH 305 (318)
T ss_dssp SCCHHHHHHS
T ss_pred CcCHHHHHcC
Confidence 9999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-42 Score=362.06 Aligned_cols=259 Identities=14% Similarity=0.146 Sum_probs=200.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC-CCccceeeEEEccCceEEEEeccCCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH-PNLVRIRGFYWGVDEKLIIYDFVPNGS 557 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~gs 557 (791)
.+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++.++| +||+.+++++......++||||+ +++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 46899999999999994 5789999999865432 2457788999999965 89999999999999999999999 789
Q ss_pred hhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecC-----CCCeEEeccCcccccCCCCCC
Q 003847 558 LANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGN-----DMEPKIGDFGLERLVTGDTSS 632 (791)
Q Consensus 558 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~~~~~~~~ 632 (791)
|.+++..... .+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+........
T Consensus 87 l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 87 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred HHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 9998876543 3899999999999999999999999999999999999974 578999999999987543321
Q ss_pred CcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCcch
Q 003847 633 SKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~pf 712 (791)
... +.......+||+.|||||++.+..++.++|||||||++|||+||+.||
T Consensus 163 ~~~-----------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 163 QHI-----------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp CBC-----------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cce-----------------------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence 110 112234567999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchhchhHHHHHHHHhhhcCcc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhccC
Q 003847 713 VDELGQGNGLLVEDKNRAIRLADAAIRADFE-GKEEALLSCFKLGYSCASPLPQKRPSMKEALQALEKI 780 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 780 (791)
.......... ....+.......... .....+.++.+++..|+..+|++||+++.+.+.|+++
T Consensus 214 ~~~~~~~~~~------~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 214 QGLKAATNKQ------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SSCCSCCHHH------HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCccchhHHH------HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 6532221111 111111111111000 0011345788999999999999999999988877664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=368.46 Aligned_cols=248 Identities=18% Similarity=0.239 Sum_probs=199.2
Q ss_pred cceeccccCceEEEEEEe----CCCcEEEEEEcCCCc----hhhHHHHHHHHHHHhccCC-CCccceeeEEEccCceEEE
Q 003847 479 SAYILGASGSSIMYKAVL----EDGTALAVRRIGENS----VDRFRDFETQVRVIAKLVH-PNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv 549 (791)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 356899999999999984 258999999997532 2234568899999999976 8999999999999999999
Q ss_pred EeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCC
Q 003847 550 YDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGD 629 (791)
Q Consensus 550 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 629 (791)
|||+.+|+|.+++..... +++..+..++.||+.||+|||+.+||||||||+|||++.++.+||+|||+++.+...
T Consensus 108 ~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp ECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999887753 788999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC--CCCCchhhHHHHHHHHHHHh
Q 003847 630 TSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI--KPNPKWDVYSFGVILLELLT 707 (791)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~~sDvwSlGvil~ellt 707 (791)
.... .....|++.|+|||.+.+. .++.++|||||||++|||++
T Consensus 183 ~~~~-----------------------------------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 183 ETER-----------------------------------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp GGGG-----------------------------------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred cccc-----------------------------------ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 2110 1123489999999999754 46889999999999999999
Q ss_pred CCcchhccccCCCCcchhchhHHHHHHHHhhhcCccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003847 708 GKVIVVDELGQGNGLLVEDKNRAIRLADAAIRADFEGKEEALLSCFKLGYSCASPLPQKRP-----SMKEALQ 775 (791)
Q Consensus 708 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 775 (791)
|+.||......... ..+.........+.+...+.++.+|+.+||+.||++|| |++|+++
T Consensus 228 G~~PF~~~~~~~~~---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQ---------AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SSCTTSCTTSCCCH---------HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCCHHHHH---------HHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 99999765332221 12222222223333334677899999999999999999 5889986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=360.72 Aligned_cols=250 Identities=21% Similarity=0.224 Sum_probs=194.7
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEccCceEEEEeccCCC
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGVDEKLIIYDFVPNG 556 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 556 (791)
-+.||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+.+|++++||||+++++++.+.+..++|+|++.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 35899999999999995 57899999998643 3334678999999999999999999999999999999999999999
Q ss_pred ChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCCCCcCC
Q 003847 557 SLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTSSSKAG 636 (791)
Q Consensus 557 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 636 (791)
+|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++........
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~---- 157 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---- 157 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC----
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc----
Confidence 9888776543 3899999999999999999999999999999999999999999999999999876532211
Q ss_pred CCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCC-CCCchhhHHHHHHHHHHHhCCcchhcc
Q 003847 637 GSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIK-PNPKWDVYSFGVILLELLTGKVIVVDE 715 (791)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwSlGvil~elltG~~pf~~~ 715 (791)
.....+++.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 158 --------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 158 --------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp --------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred --------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 11234778899999987655 689999999999999999999987432
Q ss_pred ccCCCCcchhchhHHHHHHHH----------------------hhhcCccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003847 716 LGQGNGLLVEDKNRAIRLADA----------------------AIRADFEGKEEALLSCFKLGYSCASPLPQKRPSMKEA 773 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 773 (791)
.... ............ ...............+.+|+.+||+.||++|||++|+
T Consensus 206 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 206 NDVD-----DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp SSHH-----HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCHH-----HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1100 000000000000 0000000111234567899999999999999999999
Q ss_pred HH
Q 003847 774 LQ 775 (791)
Q Consensus 774 l~ 775 (791)
++
T Consensus 281 L~ 282 (292)
T d1unla_ 281 LQ 282 (292)
T ss_dssp TT
T ss_pred hc
Confidence 86
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-41 Score=361.89 Aligned_cols=249 Identities=15% Similarity=0.209 Sum_probs=189.1
Q ss_pred cceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEcc--CceEEEEeccC
Q 003847 479 SAYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGV--DEKLIIYDFVP 554 (791)
Q Consensus 479 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e~~~ 554 (791)
..+.||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++|||||+
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 346899999999999995 679999999997643 367889999999995 99999999999854 46899999999
Q ss_pred CCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCC-CeEEeccCcccccCCCCCCC
Q 003847 555 NGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDM-EPKIGDFGLERLVTGDTSSS 633 (791)
Q Consensus 555 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~ 633 (791)
+++|..+.. .+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 116 ~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--- 184 (328)
T d3bqca1 116 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 184 (328)
T ss_dssp SCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred CCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence 999976521 399999999999999999999999999999999999998655 58999999998764321
Q ss_pred cCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCcch
Q 003847 634 KAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKVIV 712 (791)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~pf 712 (791)
.....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||
T Consensus 185 ----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf 230 (328)
T d3bqca1 185 ----------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230 (328)
T ss_dssp ----------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ----------------------------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCC
Confidence 12234589999999998764 4799999999999999999999998
Q ss_pred hccccCCCCcc-hhc---hhHHHHHHHHh-hh--------------------cCccchHHHHHHHHHHHhhccCCCCCCC
Q 003847 713 VDELGQGNGLL-VED---KNRAIRLADAA-IR--------------------ADFEGKEEALLSCFKLGYSCASPLPQKR 767 (791)
Q Consensus 713 ~~~~~~~~~~~-~~~---~~~~~~~~~~~-~~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~R 767 (791)
........... +.. ........... .. ...........++.+|+.+||..||++|
T Consensus 231 ~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 310 (328)
T d3bqca1 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310 (328)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHC
Confidence 65322100000 000 00000000000 00 0000111134578899999999999999
Q ss_pred CCHHHHHH
Q 003847 768 PSMKEALQ 775 (791)
Q Consensus 768 Ps~~evl~ 775 (791)
||++|+++
T Consensus 311 ~ta~e~L~ 318 (328)
T d3bqca1 311 LTAREAME 318 (328)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=366.63 Aligned_cols=252 Identities=18% Similarity=0.208 Sum_probs=184.4
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc------CceEEEE
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV------DEKLIIY 550 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lv~ 550 (791)
-+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+.++++++|||||+++++|... ...|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 46899999999999995 47999999999754 334456789999999999999999999999643 5789999
Q ss_pred eccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCC
Q 003847 551 DFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDT 630 (791)
Q Consensus 551 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 630 (791)
||+.++.+ +.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 102 Ey~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 102 ELMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp ECCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 99976544 43322 38999999999999999999999999999999999999999999999999987654221
Q ss_pred CCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHHHHHHHHHHhCCc
Q 003847 631 SSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....+||+.|+|||++.+..+++++||||+||++|||++|+.
T Consensus 174 -------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 174 -------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp --------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCC
Confidence 1223458999999999999999999999999999999999999
Q ss_pred chhccccCCCCc------------chhc-hhHHHHHHHH----------------hhhcCccchHHHHHHHHHHHhhccC
Q 003847 711 IVVDELGQGNGL------------LVED-KNRAIRLADA----------------AIRADFEGKEEALLSCFKLGYSCAS 761 (791)
Q Consensus 711 pf~~~~~~~~~~------------~~~~-~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~ 761 (791)
||.+........ .+.. .......... ............+..+.+|+.+||.
T Consensus 217 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 296 (355)
T d2b1pa1 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence 995432100000 0000 0000000010 0011111223356788999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003847 762 PLPQKRPSMKEALQA 776 (791)
Q Consensus 762 ~dP~~RPs~~evl~~ 776 (791)
.||++|||++|+++.
T Consensus 297 ~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 297 IDPAKRISVDDALQH 311 (355)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=362.92 Aligned_cols=257 Identities=20% Similarity=0.238 Sum_probs=189.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCC--chhhHHHHHHHHHHHhccCCCCccceeeEEEcc-----CceEEEEe
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGEN--SVDRFRDFETQVRVIAKLVHPNLVRIRGFYWGV-----DEKLIIYD 551 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~lv~e 551 (791)
-+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 46899999999999994 67999999999764 333456788999999999999999999998643 34467778
Q ss_pred ccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEeccCcccccCCCCC
Q 003847 552 FVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGDFGLERLVTGDTS 631 (791)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 631 (791)
|+.+|+|.+++... ++++.+++.|+.||+.||+|||++||+||||||+|||++.++.+|++|||++......
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-- 174 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--
Confidence 88899999988543 3999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCC-CCCCchhhHHHHHHHHHHHhCCc
Q 003847 632 SSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSI-KPNPKWDVYSFGVILLELLTGKV 710 (791)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwSlGvil~elltG~~ 710 (791)
.....||+.|+|||.+.+. .++.++||||+||++|+|++|+.
T Consensus 175 -------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 175 -------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp -------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence 1123589999999987665 46899999999999999999999
Q ss_pred chhccccCCCCcchhc--------------hhHHHHHHHHhhhc-Cccc---hHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003847 711 IVVDELGQGNGLLVED--------------KNRAIRLADAAIRA-DFEG---KEEALLSCFKLGYSCASPLPQKRPSMKE 772 (791)
Q Consensus 711 pf~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~e 772 (791)
||.+.........+.. .............. .... .......+.+|+.+||..||++|||++|
T Consensus 218 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 9965321100000000 00000000000000 0000 0012356789999999999999999999
Q ss_pred HHH--HhccCC
Q 003847 773 ALQ--ALEKIP 781 (791)
Q Consensus 773 vl~--~L~~i~ 781 (791)
+++ .++++.
T Consensus 298 lL~Hp~f~~~~ 308 (348)
T d2gfsa1 298 ALAHAYFAQYH 308 (348)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCHhhCCCC
Confidence 998 466554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.1e-38 Score=333.80 Aligned_cols=255 Identities=29% Similarity=0.514 Sum_probs=217.4
Q ss_pred CCChhhHHHHHHHHhhccCCCCCccCCCCCCCCCCc--eeeeeeeCCCCCCCCCCcEEEEEcCCCCCcc--CCCcCCCCC
Q 003847 29 LGLNTDGVLLLSFKYSVLSDPLGVLGSWNYNDENPC--SWNGVTCASPGEGNNDSRVIGLALPNSQLLG--SIPADLGMI 104 (791)
Q Consensus 29 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c--~w~gv~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~~~~~~l 104 (791)
.|.++|++||++||+++. || ..+++|.. +.||| .|.||+|+.. ....||+.|+|+++++.| .+|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~-~~d~C~~~w~gv~C~~~---~~~~~v~~L~L~~~~l~g~~~lp~~l~~L 75 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLP-TTDCCNRTWLGVLCDTD---TQTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCT-TSCTTTTCSTTEEECCS---SSCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCC-CCCCCCCcCCCeEEeCC---CCcEEEEEEECCCCCCCCCCCCChHHhcC
Confidence 478999999999999985 55 37999974 56899 5999999842 235689999999999998 589999999
Q ss_pred CCCCEEeCcC-CCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEe
Q 003847 105 EFLQYLDLSN-NSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183 (791)
Q Consensus 105 ~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 183 (791)
++|++|+|++ |+|+|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.+++++|++.+.+|..+.+++.|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 9999999997 899999999999999999999999999998888888888899999998888888888888888888888
Q ss_pred CCCCcCCCCCCCCC---------------------------------------------------cccceeccccccccc
Q 003847 184 LKNNYFSDGLPSKF---------------------------------------------------NSVQVLDLSSNLING 212 (791)
Q Consensus 184 L~~N~l~~~~p~~l---------------------------------------------------~~L~~L~ls~N~l~~ 212 (791)
+++|.+++.+|..+ ++|+.|++++|.+++
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888877665421 345566666666665
Q ss_pred cCCCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCCCCCCCCCCCCC
Q 003847 213 SLPPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNLDLCGQPTKNPC 291 (791)
Q Consensus 213 ~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~c 291 (791)
.+|......+|++|+|++|+|+|.+|..+.+ +++|++|||++|+|+|.+|+...+.++..+.+.||+.+||.|++ +|
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~-L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGG-CTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccccccccccccCccCeecccCChHHhC-CCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 5553222358999999999999999999987 99999999999999999998888889999999999999998875 56
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-37 Score=331.87 Aligned_cols=255 Identities=17% Similarity=0.201 Sum_probs=184.8
Q ss_pred ceeccccCceEEEEEEe-CCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-----------CCCccceeeEEEcc--Cc
Q 003847 480 AYILGASGSSIMYKAVL-EDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-----------HPNLVRIRGFYWGV--DE 545 (791)
Q Consensus 480 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~--~~ 545 (791)
...||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+||+++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 46899999999999995 6799999999986533 2467788999988875 57899999988654 45
Q ss_pred eEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCeecCCCCCCeEecCCCC------eEEe
Q 003847 546 KLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHE-KKHVHGNLKPRNVLLGNDME------PKIG 618 (791)
Q Consensus 546 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~ivHrDlkp~NILl~~~~~------~kL~ 618 (791)
.+++++++..+............ ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++. +|++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~ 174 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred eeeeeeecccccccccccccccc--cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEe
Confidence 56677766555443333332222 248999999999999999999998 89999999999999986553 8999
Q ss_pred ccCcccccCCCCCCCcCCCCccccCCcccccccccccCCCCCCCCCCCCCCCCCCCCCcccCcccccCCCCCCchhhHHH
Q 003847 619 DFGLERLVTGDTSSSKAGGSARNFGSKRSTASRDSFQDLGPGPSPSPSPSPSSLGGISPYHAPESLRSIKPNPKWDVYSF 698 (791)
Q Consensus 619 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwSl 698 (791)
|||.+...... ....+||+.|+|||++.+..++.++||||+
T Consensus 175 dfg~s~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 175 DLGNACWYDEH---------------------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp CCTTCEETTBC---------------------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred ecccccccccc---------------------------------------cccccccccccChhhccccCCCccccccch
Confidence 99998754321 123459999999999999999999999999
Q ss_pred HHHHHHHHhCCcchhccccCCCCcchhchhHHHHH------------------H-----------------HHhhhcCcc
Q 003847 699 GVILLELLTGKVIVVDELGQGNGLLVEDKNRAIRL------------------A-----------------DAAIRADFE 743 (791)
Q Consensus 699 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~------------------~-----------------~~~~~~~~~ 743 (791)
||+++||++|+.||..................... . .........
T Consensus 216 G~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (362)
T d1q8ya_ 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295 (362)
T ss_dssp HHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC
T ss_pred HHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccc
Confidence 99999999999998654321111100000000000 0 000011112
Q ss_pred chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003847 744 GKEEALLSCFKLGYSCASPLPQKRPSMKEALQA 776 (791)
Q Consensus 744 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 776 (791)
........+.+|+.+||..||++|||++|+++.
T Consensus 296 ~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 234467789999999999999999999999874
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.8e-23 Score=213.71 Aligned_cols=198 Identities=26% Similarity=0.259 Sum_probs=138.6
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+...++.++++|+. +|+.|. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECC
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccc
Confidence 34445667777773 566554 56788888888887666667778888888888888887 4443 5677888888888
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
+|+++ ..+..+.++++|+.|+|++|.+.+..+..+ .+|+.|++++|.++...+..+.. .+|++|++++|+|+ .+
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~-~~ 163 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-EL 163 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc-cc
Confidence 88887 456677778888888888887776555443 66778888888887555554444 47888888888887 44
Q ss_pred chhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCC
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 287 (791)
|...+..+++|++|||++|+|+ .+|+. .....+..+.+.||||.|+|.+
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 4444444788888888888887 45543 4455667777888888887653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.3e-24 Score=208.26 Aligned_cols=133 Identities=17% Similarity=0.190 Sum_probs=106.9
Q ss_pred hcceeccccCceEEEEEEeCCCcEEEEEEcCCCch------------------hhHHHHHHHHHHHhccCCCCccceeeE
Q 003847 478 ASAYILGASGSSIMYKAVLEDGTALAVRRIGENSV------------------DRFRDFETQVRVIAKLVHPNLVRIRGF 539 (791)
Q Consensus 478 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 539 (791)
+.++.||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34678999999999999988999999998753110 112345678899999999999998765
Q ss_pred EEccCceEEEEeccCCCChhHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCeecCCCCCCeEecCCCCeEEec
Q 003847 540 YWGVDEKLIIYDFVPNGSLANARYRKMGSSPCHLPWEARLKIAKGVARGLAFLHEKKHVHGNLKPRNVLLGNDMEPKIGD 619 (791)
Q Consensus 540 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ivHrDlkp~NILl~~~~~~kL~D 619 (791)
. ..+++|||+++..+.+ ++......++.|++.||+|||+.||+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999998766532 4445567899999999999999999999999999999965 589999
Q ss_pred cCcccccC
Q 003847 620 FGLERLVT 627 (791)
Q Consensus 620 FGla~~~~ 627 (791)
||+|....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99987653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=3.7e-22 Score=207.39 Aligned_cols=207 Identities=23% Similarity=0.193 Sum_probs=180.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEcc-CCcCCCCCccccCCCCCCCEE
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLS-NNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L 158 (791)
...++.|+|++|+|+...+..|.++++|++|++++|+|.+..+..+.++..++.++.. .|.++...+..|.++++|++|
T Consensus 31 p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L 110 (284)
T d1ozna_ 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (284)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEE
Confidence 3467899999999998888889999999999999999998888888999999998764 677777778889999999999
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|++|.+....+..+..+.+|+.+++++|+|++..+..| ++|+.|+|++|+|++..+..+.. .+|++|++++|+++
T Consensus 111 ~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence 999999998888889999999999999999998776665 67999999999999877777776 58999999999999
Q ss_pred ccCchhHhhcCCCCcEEEcccCcCcccCCCC-CcccccccccccCCCCCCCCCC
Q 003847 235 GEIPPQFGEKIPVNATIDLSFNNLTGEIPES-NVFMNQESSSFSGNLDLCGQPT 287 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 287 (791)
+..|..+.. +++|++||+++|++++..|.. ....++..+.+.+|++.|+|++
T Consensus 191 ~i~~~~f~~-l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 191 HVHPHAFRD-LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp EECTTTTTT-CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred ccChhHhhh-hhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 766777655 999999999999999877755 3455678889999999998764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=5e-22 Score=204.26 Aligned_cols=177 Identities=25% Similarity=0.165 Sum_probs=160.7
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
..++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+|+ .++..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 57999999999999888889999999999999999998 455 4678999999999999998 56778999999999999
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCccc
Q 003847 161 SDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 161 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ 236 (791)
++|.+.+..+..+..+.+|++|++++|.++...+..+ ++|+.|++++|+|++..+..+.. .+|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 9999998888999999999999999999998766554 78999999999999877777776 58999999999999 9
Q ss_pred CchhHhhcCCCCcEEEcccCcCcccC
Q 003847 237 IPPQFGEKIPVNATIDLSFNNLTGEI 262 (791)
Q Consensus 237 ip~~~~~~l~~l~~l~l~~N~l~~~~ 262 (791)
||.+++. +++|+.|+|++|++.+..
T Consensus 187 lp~~~~~-~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 187 IPKGFFG-SHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCTTTTT-TCCCSEEECCSCCBCCSG
T ss_pred cChhHCC-CCCCCEEEecCCCCCCCc
Confidence 9999987 999999999999998754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.86 E-value=3.2e-23 Score=218.75 Aligned_cols=186 Identities=29% Similarity=0.413 Sum_probs=152.3
Q ss_pred CCCCCCCCcEEEEEcCC-CCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 74 PGEGNNDSRVIGLALPN-SQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~-~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
|..+..+.+++.|+|++ |+++|.+|.+|++|++|++|+|++|+|.+..+..+.++.+|+.|++++|++.+.+|..+.++
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccC
Confidence 34566788999999987 89999999999999999999999999998888888888888888888888888888888888
Q ss_pred CCCCEEeCcCCcCCCCCccccCC------------------------------------------------CCCCCEEeC
Q 003847 153 HNLQLLNLSDNALAGKLPVSLTT------------------------------------------------LQSLTIVSL 184 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~~~~------------------------------------------------l~~L~~L~L 184 (791)
++|+.+++++|.+++.+|..+.. +++|+.|++
T Consensus 149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~ 228 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEEC
T ss_pred cccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888888888777666654433 445555566
Q ss_pred CCCcCCCCCCCC--CcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCc-Ccc
Q 003847 185 KNNYFSDGLPSK--FNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNN-LTG 260 (791)
Q Consensus 185 ~~N~l~~~~p~~--l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~-l~~ 260 (791)
++|.+++.+|.. +++|+.|+|++|+|+|.+|..++. .+|++|+|++|+|+|.||. +.+ +.+|+.+++++|+ ++|
T Consensus 229 ~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~-L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN-LQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STT-GGGSCGGGTCSSSEEES
T ss_pred ccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-ccc-CCCCCHHHhCCCccccC
Confidence 666665555432 378999999999999999999987 5899999999999999996 344 8899999999998 566
Q ss_pred c
Q 003847 261 E 261 (791)
Q Consensus 261 ~ 261 (791)
.
T Consensus 307 ~ 307 (313)
T d1ogqa_ 307 S 307 (313)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.83 E-value=3.7e-20 Score=194.22 Aligned_cols=192 Identities=22% Similarity=0.281 Sum_probs=126.9
Q ss_pred ceeeeeeeCCCCCC----CCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC
Q 003847 64 CSWNGVTCASPGEG----NNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN 139 (791)
Q Consensus 64 c~w~gv~C~~~~~~----~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 139 (791)
|.|.+|.|+..+-. +-...++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 78999999742110 11367999999999999877788999999999999999999888899999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCcCCcCCCCC--------------------------ccccCCCCCCCEEeCCCCcCCC--
Q 003847 140 LISGHLPETMGSLHNLQLLNLSDNALAGKL--------------------------PVSLTTLQSLTIVSLKNNYFSD-- 191 (791)
Q Consensus 140 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~--------------------------p~~~~~l~~L~~L~L~~N~l~~-- 191 (791)
+|+ .+|..+ ...|+.|++++|.+.+.. +..|..+++|+.+++++|.++.
T Consensus 90 ~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~ 166 (305)
T d1xkua_ 90 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166 (305)
T ss_dssp CCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred ccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccC
Confidence 998 455432 235566666666655221 1233445556666666665554
Q ss_pred -------------------CCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCC
Q 003847 192 -------------------GLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVN 248 (791)
Q Consensus 192 -------------------~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l 248 (791)
..+..| +.++.|++++|.+++..+..+.. .+|++|+|++|+|+ .+|.++.. +++|
T Consensus 167 ~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~-l~~L 244 (305)
T d1xkua_ 167 QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD-HKYI 244 (305)
T ss_dssp SSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT-CSSC
T ss_pred cccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc-ccCC
Confidence 333222 34455555555555444444443 35666666666665 55555544 6666
Q ss_pred cEEEcccCcCcc
Q 003847 249 ATIDLSFNNLTG 260 (791)
Q Consensus 249 ~~l~l~~N~l~~ 260 (791)
++|+|++|+|+.
T Consensus 245 ~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 245 QVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCCC
T ss_pred CEEECCCCccCc
Confidence 666666666653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=2e-20 Score=194.14 Aligned_cols=190 Identities=23% Similarity=0.166 Sum_probs=169.3
Q ss_pred CCCCCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCc-CCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCC
Q 003847 74 PGEGNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLS-NNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSL 152 (791)
Q Consensus 74 ~~~~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 152 (791)
+..|.....++.|++++|++.+..+..+..++.++.|+.. .|.++...+..|.++++|++|+|++|.+....+..+..+
T Consensus 49 ~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 128 (284)
T d1ozna_ 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred HHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchh
Confidence 4456778899999999999999999999999999999875 567887788999999999999999999997788889999
Q ss_pred CCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEc
Q 003847 153 HNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNL 228 (791)
Q Consensus 153 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l 228 (791)
.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..| ++|+.|++++|++++..|..|.. .+|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 999999999999998778899999999999999999998777665 78999999999999988999887 58999999
Q ss_pred cCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCC
Q 003847 229 SYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPE 264 (791)
Q Consensus 229 ~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~ 264 (791)
++|++++..|..+ ..+++|++|+|++|++.+..+.
T Consensus 209 ~~N~i~~~~~~~~-~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 209 FANNLSALPTEAL-APLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CSSCCSCCCHHHH-TTCTTCCEEECCSSCEECSGGG
T ss_pred ccccccccccccc-ccccccCEEEecCCCCCCCccc
Confidence 9999995444444 4599999999999999987653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=4.3e-20 Score=179.67 Aligned_cols=168 Identities=23% Similarity=0.220 Sum_probs=118.2
Q ss_pred EcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCC-CcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcC
Q 003847 87 ALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGS-LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165 (791)
Q Consensus 87 ~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 165 (791)
+.++++|+ .+|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|+|
T Consensus 14 ~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 14 DCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp ECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence 33456666 4566553 6788899999998764 456778888999999999999888888888888999999999999
Q ss_pred CCCCccccCCCCCCCEEeCCCCcCCCCCCCCC---cccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHh
Q 003847 166 AGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242 (791)
Q Consensus 166 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~ 242 (791)
+...|..|.++++|++|+|++|+|++..+..| ++|++|+|++|.+.......+....|+.+.+..|.++...|..
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~-- 168 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK-- 168 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT--
T ss_pred cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh--
Confidence 87778888888888888888888888666655 5677777777776543222211123555556666666555543
Q ss_pred hcCCCCcEEEcccCcCccc
Q 003847 243 EKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 243 ~~l~~l~~l~l~~N~l~~~ 261 (791)
+..++.++|+.|.|++.
T Consensus 169 --l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 169 --VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp --TTTSBGGGSCTTTCCCC
T ss_pred --hcCCEeeecCHhhCcCC
Confidence 33445556666666543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=7.8e-18 Score=163.42 Aligned_cols=172 Identities=18% Similarity=0.172 Sum_probs=139.6
Q ss_pred CCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCC-ccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCC
Q 003847 107 LQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL-PETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLK 185 (791)
Q Consensus 107 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 185 (791)
.+.++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 357999999999 6776653 68999999999998644 6678999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCC---cccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCccc
Q 003847 186 NNYFSDGLPSKF---NSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 186 ~N~l~~~~p~~l---~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~ 261 (791)
+|+|+...+..| ++|++|+|++|+|++..+..|.. .+|++|+|++|.+....+..++ ...++.+.+..|.+++.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~--~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH--HHHHHHHCCSGGGCBBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH--hhhhhhhcccCCCeEeC
Confidence 999998777765 78999999999999877777766 5899999999999865554443 23356677888999888
Q ss_pred CCCCCcccccccccccCCCCCCCC
Q 003847 262 IPESNVFMNQESSSFSGNLDLCGQ 285 (791)
Q Consensus 262 ~p~~~~~~~~~~~~~~~n~~lc~~ 285 (791)
.|... .......+..|...|..
T Consensus 165 ~p~~l--~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 165 APSKV--RDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp SSTTT--TTSBGGGSCTTTCCCCC
T ss_pred CChhh--cCCEeeecCHhhCcCCC
Confidence 77643 33444556667666754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.72 E-value=5.1e-17 Score=169.86 Aligned_cols=187 Identities=24% Similarity=0.252 Sum_probs=126.8
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
+.++=++++|+ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+|++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 45788888888 5576664 68999999999999666678999999999999999999888999999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCCC-----------------------------CCcccceeccccccccccC
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPS-----------------------------KFNSVQVLDLSSNLINGSL 214 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-----------------------------~l~~L~~L~ls~N~l~~~~ 214 (791)
+|+ .+|..+ ...|..|++.+|.+.+..+. .+++|+.+++++|.++ .+
T Consensus 90 ~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l 165 (305)
T d1xkua_ 90 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165 (305)
T ss_dssp CCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SC
T ss_pred ccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-cc
Confidence 999 566543 35788888888887752210 1145666677777665 33
Q ss_pred CCCcCCccccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCC-cccccccccccCC
Q 003847 215 PPDIGGYSLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESN-VFMNQESSSFSGN 279 (791)
Q Consensus 215 p~~~~~~~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n 279 (791)
|..+ ..+|++|++++|.+++..+..+.. ++.+++|++++|.+++..+... .+.++..+.+.+|
T Consensus 166 ~~~~-~~~L~~L~l~~n~~~~~~~~~~~~-~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N 229 (305)
T d1xkua_ 166 PQGL-PPSLTELHLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229 (305)
T ss_dssp CSSC-CTTCSEEECTTSCCCEECTGGGTT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred Cccc-CCccCEEECCCCcCCCCChhHhhc-cccccccccccccccccccccccccccceeeecccc
Confidence 3332 235555555555555444444333 5555555555555554444332 2233344444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.1e-16 Score=157.50 Aligned_cols=163 Identities=24% Similarity=0.306 Sum_probs=135.4
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
+..++.|++++|++.... .+..+++|++|+|++|+|++.. .+.++++|++|+|++|+|++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 457889999999998643 3888999999999999999644 36889999999999999984 55 489999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
+++|.+. .+ ..+..+++|+.+++++|.+++..+ ..+++|+.+++++|++++ +++ +.. .+|++|+|++|+|+ .+
T Consensus 119 l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l 193 (210)
T d1h6ta2 119 LEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL 193 (210)
T ss_dssp CTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BC
T ss_pred ccccccc-cc-ccccccccccccccccccccccccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CC
Confidence 9999987 33 368889999999999999987442 346899999999999985 443 444 68999999999998 67
Q ss_pred chhHhhcCCCCcEEEccc
Q 003847 238 PPQFGEKIPVNATIDLSF 255 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~ 255 (791)
| .+.. +++|++|+|++
T Consensus 194 ~-~l~~-l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAG-LKNLDVLELFS 209 (210)
T ss_dssp G-GGTT-CTTCSEEEEEE
T ss_pred h-hhcC-CCCCCEEEccC
Confidence 7 4554 99999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=8.6e-17 Score=162.09 Aligned_cols=209 Identities=19% Similarity=0.166 Sum_probs=161.3
Q ss_pred ceeeeeeeCCCCC----CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCC-cccccCCCCccEEEcc-
Q 003847 64 CSWNGVTCASPGE----GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSL-SFSLFNASQLRNLDLS- 137 (791)
Q Consensus 64 c~w~gv~C~~~~~----~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~- 137 (791)
|++..|.|...+- ..-...++.|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 7788899963220 111357999999999999777778999999999999999998655 4578899999999986
Q ss_pred CCcCCCCCccccCCCCCCCEEeCcCCcCCCCCcc-ccCCCCCCCEEeCCCCcCCCCCCCCC----cccceeccccccccc
Q 003847 138 NNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV-SLTTLQSLTIVSLKNNYFSDGLPSKF----NSVQVLDLSSNLING 212 (791)
Q Consensus 138 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l----~~L~~L~ls~N~l~~ 212 (791)
.|++....+..|.++++|+.|++++|++....+. .+..+..|..+...++.+....+..| ..++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 4788878888899999999999999999844332 34456777777888888887655555 368889999999996
Q ss_pred cCCCCcCCccccEE-EccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCccccccccc
Q 003847 213 SLPPDIGGYSLRYL-NLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSS 275 (791)
Q Consensus 213 ~~p~~~~~~~L~~L-~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~ 275 (791)
..+..+...++.++ ++++|+|+ .+|...+..+++|++|+|++|+|+.. |. ..+.++..+.
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l-~~-~~~~~l~~L~ 228 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL-PS-YGLENLKKLR 228 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCC-CS-SSCTTCCEEE
T ss_pred cccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCcc-CH-HHHcCCcccc
Confidence 55555555666555 67889998 89888777799999999999999844 43 2344444433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=3.1e-16 Score=152.88 Aligned_cols=158 Identities=26% Similarity=0.357 Sum_probs=92.9
Q ss_pred CcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeC
Q 003847 81 SRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNL 160 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 160 (791)
.+++.|++++|++... +.+..+++|++|+|++|+|++..| +.++++|++|++++|.+. .++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 4566777777776542 236667777777777777764432 667777777777777765 333 2666777777777
Q ss_pred cCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCc
Q 003847 161 SDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIP 238 (791)
Q Consensus 161 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip 238 (791)
++|.+... ..+..+++|+.|++++|++.... ...+++|+.|++++|++++ ++. +.. .+|++|+|++|+++ .++
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~-l~~-l~~l~~L~~L~ls~N~i~-~i~ 188 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-LKP-LANLTTLERLDISSNKVS-DIS 188 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccC-Ccc-ccCCCCCCEEECCCCCCC-CCc
Confidence 77766632 23566677777777777665422 1233566666666666653 222 222 45666666666665 343
Q ss_pred hhHhhcCCCCcEE
Q 003847 239 PQFGEKIPVNATI 251 (791)
Q Consensus 239 ~~~~~~l~~l~~l 251 (791)
.+.. +++|+.|
T Consensus 189 -~l~~-L~~L~~L 199 (199)
T d2omxa2 189 -VLAK-LTNLESL 199 (199)
T ss_dssp -GGGG-CTTCSEE
T ss_pred -cccC-CCCCCcC
Confidence 2333 5555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=2.1e-16 Score=154.02 Aligned_cols=165 Identities=22% Similarity=0.363 Sum_probs=134.4
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
+.+.+..+++++.++ ...+.+|++|++++|.|+. ++ .+..+++|++|+|++|+|++..| ++++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 344566777766543 3467899999999999984 43 47889999999999999996443 999999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHh
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~ 242 (791)
.+. .++ .+.++++|+.|++++|.+....+ ..+++|+.|++++|++. .++......+|++|++++|+++ .++. +.
T Consensus 95 ~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~l~~~~~L~~L~l~~n~l~-~l~~-l~ 169 (199)
T d2omxa2 95 QIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS-DISALSGLTSLQQLNFSSNQVT-DLKP-LA 169 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCC-CCGG-GT
T ss_pred ccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhhhhhhc-cccccccccccccccccccccc-CCcc-cc
Confidence 998 444 48899999999999999987543 45689999999999997 4453333469999999999999 5553 54
Q ss_pred hcCCCCcEEEcccCcCcc
Q 003847 243 EKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 243 ~~l~~l~~l~l~~N~l~~ 260 (791)
. +++|++|+|++|+++.
T Consensus 170 ~-l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 170 N-LTTLERLDISSNKVSD 186 (199)
T ss_dssp T-CTTCCEEECCSSCCCC
T ss_pred C-CCCCCEEECCCCCCCC
Confidence 4 9999999999999985
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=2.2e-15 Score=149.98 Aligned_cols=170 Identities=19% Similarity=0.324 Sum_probs=140.6
Q ss_pred CCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEe
Q 003847 80 DSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLN 159 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 159 (791)
+..++.|++.+|+|+.. +.|..|++|++|+|++|+|++..| +.++++|++|++++|.++ .++ .+.++++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEE
T ss_pred cCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccc
Confidence 56789999999999854 358999999999999999996554 899999999999999998 454 488999999999
Q ss_pred CcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccC
Q 003847 160 LSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEI 237 (791)
Q Consensus 160 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~i 237 (791)
+++|...+.. .+...+.+..+.++++.+....+ ...++|+.|++++|.++...+ +.. .+|++|+|++|+++ .+
T Consensus 114 l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~-~l 188 (227)
T d1h6ua2 114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DI 188 (227)
T ss_dssp CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CC
T ss_pred cccccccccc--hhccccchhhhhchhhhhchhhhhccccccccccccccccccchh--hcccccceecccCCCccC-CC
Confidence 9999987543 46778999999999999887544 344789999999999974332 444 68999999999998 56
Q ss_pred chhHhhcCCCCcEEEcccCcCcccC
Q 003847 238 PPQFGEKIPVNATIDLSFNNLTGEI 262 (791)
Q Consensus 238 p~~~~~~l~~l~~l~l~~N~l~~~~ 262 (791)
+. +.. +++|++|+|++|+++...
T Consensus 189 ~~-l~~-l~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 189 SP-LAS-LPNLIEVHLKNNQISDVS 211 (227)
T ss_dssp GG-GGG-CTTCCEEECTTSCCCBCG
T ss_pred hh-hcC-CCCCCEEECcCCcCCCCc
Confidence 64 444 999999999999998654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=8.3e-16 Score=151.12 Aligned_cols=177 Identities=21% Similarity=0.256 Sum_probs=136.1
Q ss_pred EEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC
Q 003847 84 IGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN 163 (791)
Q Consensus 84 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 163 (791)
+..++..+.+++.++. ..|.+|++|++++|.++.. + .+..+++|++|+|++|+|++ ++ .++++++|++|++++|
T Consensus 27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccc
Confidence 3445666777665543 3577899999999999854 3 37889999999999999995 44 3789999999999999
Q ss_pred cCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCCccccEEEccCCcCcccCchhHh
Q 003847 164 ALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPPQFG 242 (791)
Q Consensus 164 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~~~~ 242 (791)
+|++ +| .+.++++|+.|++++|.+....+ ..+++|+.+++++|.+++ .+..-...+|+++++++|+++ .++. +.
T Consensus 101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~-~~~~~~l~~L~~l~l~~n~l~-~i~~-l~ 175 (210)
T d1h6ta2 101 KVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVP-LA 175 (210)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCC-CCGG-GT
T ss_pred cccc-cc-cccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc-cccc-cc
Confidence 9984 55 58999999999999999876321 234789999999999974 332222358999999999999 5654 54
Q ss_pred hcCCCCcEEEcccCcCcccCCCCCccccccc
Q 003847 243 EKIPVNATIDLSFNNLTGEIPESNVFMNQES 273 (791)
Q Consensus 243 ~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~ 273 (791)
. +++|+.|+|++|+++. +|....+.+++.
T Consensus 176 ~-l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~ 204 (210)
T d1h6ta2 176 G-LTKLQNLYLSKNHISD-LRALAGLKNLDV 204 (210)
T ss_dssp T-CTTCCEEECCSSCCCB-CGGGTTCTTCSE
T ss_pred C-CCCCCEEECCCCCCCC-ChhhcCCCCCCE
Confidence 4 9999999999999984 443333334333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.61 E-value=2e-15 Score=162.70 Aligned_cols=187 Identities=24% Similarity=0.331 Sum_probs=149.5
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
....+..|++++|.+++..| +...++|+.|++++|+++. + ..+..+++|+.|++++|.+++..+ +..+++|+.|
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L 268 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEe
Confidence 35678889999999987654 5667899999999999985 3 368889999999999999986443 8889999999
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCC-CCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCccc
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGL-PSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ 236 (791)
++++|++++.. .+..+..++.+++++|++++.. ...+.+++.|+|++|+|++..+ +.. .+|++|+|++|+|+ .
T Consensus 269 ~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~-~ 343 (384)
T d2omza2 269 KLGANQISNIS--PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS-D 343 (384)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC-C
T ss_pred eccCcccCCCC--ccccccccccccccccccccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC-C
Confidence 99999998543 3778999999999999998743 2345889999999999986432 433 58999999999998 5
Q ss_pred CchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCC
Q 003847 237 IPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGN 279 (791)
Q Consensus 237 ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 279 (791)
++ .+.. +++|++|+|++|+|++..| ...+.+++.+.+.+|
T Consensus 344 l~-~l~~-l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 VS-SLAN-LTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CG-GGGG-CTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred Ch-hHcC-CCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 66 4655 9999999999999998765 334455666665554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=4e-15 Score=160.22 Aligned_cols=165 Identities=25% Similarity=0.352 Sum_probs=140.4
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
...+++.|++++|+++.. +.+..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +.+++.++.+
T Consensus 217 ~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l 290 (384)
T d2omza2 217 ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290 (384)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred ccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--cccccccccc
Confidence 356889999999999763 468899999999999999997554 8889999999999999985433 7889999999
Q ss_pred eCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCccc
Q 003847 159 NLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 159 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ 236 (791)
+++.|.+++ + ..+..+++|+.|+|++|++++..+ ..+++|+.|+|++|+|++ ++ .+.. .+|++|+|++|+|++.
T Consensus 291 ~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 291 ELNENQLED-I-SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp ECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred ccccccccc-c-cccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 999999985 3 358889999999999999998653 567999999999999984 44 4555 6899999999999954
Q ss_pred CchhHhhcCCCCcEEEcccC
Q 003847 237 IPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 237 ip~~~~~~l~~l~~l~l~~N 256 (791)
.| +.. +++|+.|+|++|
T Consensus 367 ~~--l~~-l~~L~~L~L~~N 383 (384)
T d2omza2 367 TP--LAN-LTRITQLGLNDQ 383 (384)
T ss_dssp GG--GTT-CTTCSEEECCCE
T ss_pred hh--hcc-CCCCCEeeCCCC
Confidence 43 544 999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.54 E-value=2.7e-14 Score=142.00 Aligned_cols=166 Identities=25% Similarity=0.383 Sum_probs=138.0
Q ss_pred CCCCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCC
Q 003847 77 GNNDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQ 156 (791)
Q Consensus 77 ~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 156 (791)
+....+++.|+|++|++++..| |..+++|++|++++|.++ .++ .+.++++|++|++++|.+.+.. .+...+.++
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccc--hhccccchh
Confidence 3457899999999999987544 899999999999999998 444 5889999999999999987433 367788999
Q ss_pred EEeCcCCcCCCCCccccCCCCCCCEEeCCCCcCCCCCC-CCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 157 LLNLSDNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLP-SKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 157 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
.+.++++.+.... .+.++++|+.|++++|++++..+ ..+++|+.|+|++|+|++ ++. +.. .+|++|+|++|+|+
T Consensus 133 ~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 133 VLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp EEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC
T ss_pred hhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC
Confidence 9999999997543 47788999999999999987544 466899999999999985 444 443 68999999999999
Q ss_pred ccCchhHhhcCCCCcEEEccc
Q 003847 235 GEIPPQFGEKIPVNATIDLSF 255 (791)
Q Consensus 235 g~ip~~~~~~l~~l~~l~l~~ 255 (791)
.++. +. .+++|+.|+|++
T Consensus 209 -~i~~-l~-~l~~L~~L~lsn 226 (227)
T d1h6ua2 209 -DVSP-LA-NTSNLFIVTLTN 226 (227)
T ss_dssp -BCGG-GT-TCTTCCEEEEEE
T ss_pred -CCcc-cc-cCCCCCEEEeeC
Confidence 6664 44 499999999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=3.2e-14 Score=126.56 Aligned_cols=99 Identities=27% Similarity=0.325 Sum_probs=42.5
Q ss_pred EEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcC
Q 003847 86 LALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNAL 165 (791)
Q Consensus 86 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 165 (791)
|+|++|+|+. ++ .++.+++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+ .+| .+.++++|++|++++|+|
T Consensus 3 L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 4444444442 22 2444444444444444444 23334444444444444444444 222 244444444444444444
Q ss_pred CCCC-ccccCCCCCCCEEeCCCCcC
Q 003847 166 AGKL-PVSLTTLQSLTIVSLKNNYF 189 (791)
Q Consensus 166 ~~~~-p~~~~~l~~L~~L~L~~N~l 189 (791)
+... ...+..+++|+.|+|++|.+
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcC
Confidence 4221 12334444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=8.8e-14 Score=123.66 Aligned_cols=100 Identities=28% Similarity=0.391 Sum_probs=87.7
Q ss_pred CEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeCCCC
Q 003847 108 QYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSLKNN 187 (791)
Q Consensus 108 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 187 (791)
+.|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999998 455 4899999999999999998 678889999999999999999994 55 5899999999999999
Q ss_pred cCCCCCC-C---CCcccceeccccccccc
Q 003847 188 YFSDGLP-S---KFNSVQVLDLSSNLING 212 (791)
Q Consensus 188 ~l~~~~p-~---~l~~L~~L~ls~N~l~~ 212 (791)
+|+.... . .+++|+.|+|++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9987432 2 34789999999999984
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=8.5e-14 Score=139.69 Aligned_cols=192 Identities=16% Similarity=0.056 Sum_probs=149.3
Q ss_pred EEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCC-ccccCCCCCCCEEeCc-C
Q 003847 85 GLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHL-PETMGSLHNLQLLNLS-D 162 (791)
Q Consensus 85 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls-~ 162 (791)
.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 5777888887 6776653 58999999999999666668999999999999999998654 4568899999999976 5
Q ss_pred CcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCC----CcccceeccccccccccCCCCcCC--ccccEEEccCCcCccc
Q 003847 163 NALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSK----FNSVQVLDLSSNLINGSLPPDIGG--YSLRYLNLSYNRLSGE 236 (791)
Q Consensus 163 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~----l~~L~~L~ls~N~l~~~~p~~~~~--~~L~~L~l~~N~l~g~ 236 (791)
|++....+..|.++++|+.|++++|++....+.. +..|..+..+++.+....+..+.. ..++.|++++|+++ .
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~ 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-E
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-c
Confidence 7888788889999999999999999998654432 245666677888887655566654 37999999999999 7
Q ss_pred CchhHhhcCCCCcEE-EcccCcCcccCCCC-CcccccccccccCCCC
Q 003847 237 IPPQFGEKIPVNATI-DLSFNNLTGEIPES-NVFMNQESSSFSGNLD 281 (791)
Q Consensus 237 ip~~~~~~l~~l~~l-~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 281 (791)
++...+. ..++..+ ++++|+++...+.. ..+.++..+.+.+|..
T Consensus 168 i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l 213 (242)
T d1xwdc1 168 IHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213 (242)
T ss_dssp ECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCC
T ss_pred ccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcC
Confidence 8877777 5665555 57888888544443 3456777777777753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.8e-14 Score=132.52 Aligned_cols=129 Identities=22% Similarity=0.162 Sum_probs=80.6
Q ss_pred CCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCC
Q 003847 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSL 179 (791)
Q Consensus 100 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 179 (791)
.|.+...|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3556667777777777777 34555566777777777777776 333 36777777777777777775545555567777
Q ss_pred CEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCcccCch---hHhhcCCCCcEEE
Q 003847 180 TIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLSGEIPP---QFGEKIPVNATID 252 (791)
Q Consensus 180 ~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~g~ip~---~~~~~l~~l~~l~ 252 (791)
+.|+|++|+|+... + + ..+.. .+|++|++++|.++ ..|. .+...+++|++||
T Consensus 90 ~~L~L~~N~i~~~~-~------------------l-~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELG-D------------------L-DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGG-G------------------G-GGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccc-c------------------c-cccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777777665411 0 0 11222 35677777777766 4553 2233388888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.3e-14 Score=132.94 Aligned_cols=123 Identities=24% Similarity=0.213 Sum_probs=100.3
Q ss_pred CCCcEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEE
Q 003847 79 NDSRVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLL 158 (791)
Q Consensus 79 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 158 (791)
+..++..|+|++|+|+.+ +..+..+++|+.|+|++|+|+. ++ .|..+++|++|+|++|+|+...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 456789999999999865 6667889999999999999994 44 58899999999999999996666667889999999
Q ss_pred eCcCCcCCCCCc-cccCCCCCCCEEeCCCCcCCCCCC------CCCcccceec
Q 003847 159 NLSDNALAGKLP-VSLTTLQSLTIVSLKNNYFSDGLP------SKFNSVQVLD 204 (791)
Q Consensus 159 ~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p------~~l~~L~~L~ 204 (791)
+|++|+|+.... ..+..+++|++|++++|.++...- ..+++|++||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999984322 468889999999999999876321 1235666665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=2e-12 Score=119.77 Aligned_cols=99 Identities=25% Similarity=0.132 Sum_probs=76.2
Q ss_pred CCCCccCCCcCCCCCCCCCEEeCcCC-CCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCC
Q 003847 90 NSQLLGSIPADLGMIEFLQYLDLSNN-SLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGK 168 (791)
Q Consensus 90 ~~~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 168 (791)
++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+.+.|..|.++++|++|+|++|+|+..
T Consensus 17 ~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l 95 (156)
T d2ifga3 17 RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL 95 (156)
T ss_dssp SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCC
T ss_pred CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCccc
Confidence 44444 34667888889999999766 58866677888899999999999999877788888999999999999999844
Q ss_pred CccccCCCCCCCEEeCCCCcCC
Q 003847 169 LPVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 169 ~p~~~~~l~~L~~L~L~~N~l~ 190 (791)
.+..|. ..+|+.|+|++|.+.
T Consensus 96 ~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 96 SWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp CSTTTC-SCCCCEEECCSSCCC
T ss_pred Chhhhc-cccccccccCCCccc
Confidence 444444 446888888888774
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=7.2e-12 Score=115.92 Aligned_cols=87 Identities=16% Similarity=0.079 Sum_probs=69.1
Q ss_pred CCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC-cCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEe
Q 003847 105 EFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN-LISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVS 183 (791)
Q Consensus 105 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 183 (791)
...+.++.+++.+. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|.++++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556888888887 56777888888899998765 48866677788888888899988888877788888888888888
Q ss_pred CCCCcCCCC
Q 003847 184 LKNNYFSDG 192 (791)
Q Consensus 184 L~~N~l~~~ 192 (791)
|++|+|+..
T Consensus 87 Ls~N~l~~l 95 (156)
T d2ifga3 87 LSFNALESL 95 (156)
T ss_dssp CCSSCCSCC
T ss_pred ccCCCCccc
Confidence 888888753
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.27 E-value=7e-11 Score=124.49 Aligned_cols=51 Identities=37% Similarity=0.408 Sum_probs=36.1
Q ss_pred cccEEEccCCcCcccCchhHhhcCCCCcEEEcccCcCcccCCCCCcccccccccccCCC
Q 003847 222 SLRYLNLSYNRLSGEIPPQFGEKIPVNATIDLSFNNLTGEIPESNVFMNQESSSFSGNL 280 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~ip~~~~~~l~~l~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 280 (791)
+|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|+. ..++..+.+.+|+
T Consensus 285 ~L~~L~Ls~N~l~-~lp~~----~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 285 SLEELNVSNNKLI-ELPAL----PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNP 335 (353)
T ss_dssp TCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSC
T ss_pred CCCEEECCCCccC-ccccc----cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCc
Confidence 5888888888888 77742 677888888888887 45543 2355666666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=6.4e-14 Score=135.69 Aligned_cols=64 Identities=31% Similarity=0.366 Sum_probs=26.6
Q ss_pred CCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCC
Q 003847 100 DLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALA 166 (791)
Q Consensus 100 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 166 (791)
.|..|++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc
Confidence 34444444444444444442 22 2444444444444444443 23332223333444444444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.15 E-value=7.5e-13 Score=128.00 Aligned_cols=130 Identities=18% Similarity=0.209 Sum_probs=67.1
Q ss_pred CCEEeCcCC--CCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCccccCCCCCCCEEeC
Q 003847 107 LQYLDLSNN--SLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQSLTIVSL 184 (791)
Q Consensus 107 L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 184 (791)
++.++|+++ .++ .++..+..+++|++|+|++|+|+ .++ .|.+|++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 445555544 233 34555666666666666666666 333 3556666666666666665 34433333444555555
Q ss_pred CCCcCCCCCCCCCcccceeccccccccccCCCCcCCccccEEEccCCcCcccCch-hHhhcCCCCcEEEcccCcCcccCC
Q 003847 185 KNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGGYSLRYLNLSYNRLSGEIPP-QFGEKIPVNATIDLSFNNLTGEIP 263 (791)
Q Consensus 185 ~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~L~l~~N~l~g~ip~-~~~~~l~~l~~l~l~~N~l~~~~p 263 (791)
++|+|+. ++......+|++|+|++|+|+ .++. .....+++|+.|+|++|+++...+
T Consensus 101 ~~N~i~~----------------------l~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 101 SYNQIAS----------------------LSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECCC----------------------HHHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccc----------------------cccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 5555543 221111135556666666655 3332 222236666666666666654443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.11 E-value=8.7e-10 Score=115.83 Aligned_cols=136 Identities=29% Similarity=0.324 Sum_probs=98.1
Q ss_pred cEEEEEcCCCCCccCCCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCc
Q 003847 82 RVIGLALPNSQLLGSIPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLS 161 (791)
Q Consensus 82 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 161 (791)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++... ++|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccccc
Confidence 5678999999997 46653 578999999999998 667654 57899999999998 444321 469999999
Q ss_pred CCcCCCCCccccCCCCCCCEEeCCCCcCCCCCCCCCcccceeccccccccccCCCCcCC-ccccEEEccCCcCc
Q 003847 162 DNALAGKLPVSLTTLQSLTIVSLKNNYFSDGLPSKFNSVQVLDLSSNLINGSLPPDIGG-YSLRYLNLSYNRLS 234 (791)
Q Consensus 162 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~ls~N~l~~~~p~~~~~-~~L~~L~l~~N~l~ 234 (791)
+|.++ .+|. +..+++|+.|++++|.+.. .+.....+..|.+..+.... ...+.. ..++.|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-cccccccccchhhccccccc--cccccccccceeccccccccc
Confidence 99998 5664 6789999999999998876 34444556666666655531 222222 35666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=3.3e-12 Score=131.07 Aligned_cols=176 Identities=25% Similarity=0.224 Sum_probs=126.4
Q ss_pred CCcEEEEEcCCCCCccC-CCcCCCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCC-cCCCC-CccccCCCCCCC
Q 003847 80 DSRVIGLALPNSQLLGS-IPADLGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNN-LISGH-LPETMGSLHNLQ 156 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~ 156 (791)
..+++.|+|+++.+... +...+..+++|++|+|++|.+++..+..+..+++|++|+|+++ .++.. +...+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 45788999998887644 3455788899999999999988777788888999999999884 56522 233345788999
Q ss_pred EEeCcCC-cCCCC-CccccCC-CCCCCEEeCCCC--cCCCCC----CCCCcccceeccccc-cccccCCCCcCC-ccccE
Q 003847 157 LLNLSDN-ALAGK-LPVSLTT-LQSLTIVSLKNN--YFSDGL----PSKFNSVQVLDLSSN-LINGSLPPDIGG-YSLRY 225 (791)
Q Consensus 157 ~L~ls~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~~~----p~~l~~L~~L~ls~N-~l~~~~p~~~~~-~~L~~ 225 (791)
+|+|+++ .++.. +...+.. .++|+.|++++. .++... ...+++|++|+|++| .+++.....+.. .+|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 9999885 45421 1222333 468999999864 444321 123478999999886 466555555555 57999
Q ss_pred EEccC-CcCcccCchhHhhcCCCCcEEEcccC
Q 003847 226 LNLSY-NRLSGEIPPQFGEKIPVNATIDLSFN 256 (791)
Q Consensus 226 L~l~~-N~l~g~ip~~~~~~l~~l~~l~l~~N 256 (791)
|+|++ +.+++.....+.+ +++|+.|+++++
T Consensus 205 L~L~~C~~i~~~~l~~L~~-~~~L~~L~l~~~ 235 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGE-IPTLKTLQVFGI 235 (284)
T ss_dssp EECTTCTTCCGGGGGGGGG-CTTCCEEECTTS
T ss_pred EECCCCCCCChHHHHHHhc-CCCCCEEeeeCC
Confidence 99998 5777666667766 899999999876
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.02 E-value=5.5e-12 Score=133.38 Aligned_cols=40 Identities=28% Similarity=0.199 Sum_probs=18.5
Q ss_pred CCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcC
Q 003847 102 GMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLI 141 (791)
Q Consensus 102 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l 141 (791)
...++|+.|+|++|.+... +...+...++|+.|+|++|.|
T Consensus 90 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred hhCCCcccccccccccccccccchhhhhcccccchheecccccc
Confidence 3445555555555555432 122223344555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=5.4e-11 Score=121.86 Aligned_cols=160 Identities=24% Similarity=0.186 Sum_probs=119.0
Q ss_pred CCCCCCCCEEeCcCCCCCCC-CcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCC-cCCCC-CccccCCCC
Q 003847 101 LGMIEFLQYLDLSNNSLNGS-LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDN-ALAGK-LPVSLTTLQ 177 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~-~p~~~~~l~ 177 (791)
......|++|||++|.++.. +...+.++++|++|+|++|.+++..+..++.+++|++|+|+++ .++.. +...+.+++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~ 121 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence 34556899999999998744 4556788999999999999999888888999999999999994 66522 223345789
Q ss_pred CCCEEeCCCC-cCCCCC-C----CCCcccceeccccc--cccccCCCCc-C-CccccEEEccCC-cCcccCchhHhhcCC
Q 003847 178 SLTIVSLKNN-YFSDGL-P----SKFNSVQVLDLSSN--LINGSLPPDI-G-GYSLRYLNLSYN-RLSGEIPPQFGEKIP 246 (791)
Q Consensus 178 ~L~~L~L~~N-~l~~~~-p----~~l~~L~~L~ls~N--~l~~~~p~~~-~-~~~L~~L~l~~N-~l~g~ip~~~~~~l~ 246 (791)
+|++|+|+++ .++... . ...++|+.|+++++ .++...-..+ . .++|++|+|++| .+++.....+.+ ++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~-~~ 200 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ-LN 200 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG-CT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcc-cC
Confidence 9999999985 555321 1 12268999999864 3432111112 2 258999999986 578777788876 99
Q ss_pred CCcEEEccc-CcCccc
Q 003847 247 VNATIDLSF-NNLTGE 261 (791)
Q Consensus 247 ~l~~l~l~~-N~l~~~ 261 (791)
+|++|+|++ +.++..
T Consensus 201 ~L~~L~L~~C~~i~~~ 216 (284)
T d2astb2 201 YLQHLSLSRCYDIIPE 216 (284)
T ss_dssp TCCEEECTTCTTCCGG
T ss_pred cCCEEECCCCCCCChH
Confidence 999999999 466643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.91 E-value=1e-10 Score=123.35 Aligned_cols=180 Identities=17% Similarity=0.184 Sum_probs=126.9
Q ss_pred CCcEEEEEcCCCCCcc----CCCcCCCCCCCCCEEeCcCCCCCCC----------CcccccCCCCccEEEccCCcCCCC-
Q 003847 80 DSRVIGLALPNSQLLG----SIPADLGMIEFLQYLDLSNNSLNGS----------LSFSLFNASQLRNLDLSNNLISGH- 144 (791)
Q Consensus 80 ~~~v~~L~L~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~~N~l~~~- 144 (791)
...++.|+|++|++.. .+...+...++|+.|+|+++.+... +...+...++|+.|+|++|.++..
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 3568889999998753 2345678889999999998876532 122345678999999999999754
Q ss_pred ---CccccCCCCCCCEEeCcCCcCCCCCcc-------------ccCCCCCCCEEeCCCCcCCCCCCC-------CCcccc
Q 003847 145 ---LPETMGSLHNLQLLNLSDNALAGKLPV-------------SLTTLQSLTIVSLKNNYFSDGLPS-------KFNSVQ 201 (791)
Q Consensus 145 ---~p~~~~~l~~L~~L~ls~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~p~-------~l~~L~ 201 (791)
+...+...++|++|+|++|.+...-.. .....+.|+.|.+++|+++..... ..+.|+
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~ 189 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred ccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhc
Confidence 344456778999999999987521111 123567899999999988743222 226799
Q ss_pred eecccccccccc-----CCCCcCC-ccccEEEccCCcCccc----CchhHhhcCCCCcEEEcccCcCcc
Q 003847 202 VLDLSSNLINGS-----LPPDIGG-YSLRYLNLSYNRLSGE----IPPQFGEKIPVNATIDLSFNNLTG 260 (791)
Q Consensus 202 ~L~ls~N~l~~~-----~p~~~~~-~~L~~L~l~~N~l~g~----ip~~~~~~l~~l~~l~l~~N~l~~ 260 (791)
.|+|++|+|+.. +...+.. .+|+.|+|++|.++.. +...+.. .++|++|+|++|+++.
T Consensus 190 ~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~-~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS-WPNLRELGLNDCLLSA 257 (344)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG-CTTCCEEECTTCCCCH
T ss_pred ccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc-cccchhhhhhcCccCc
Confidence 999999998631 2223333 4799999999998643 3333334 8889999999999864
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.8e-09 Score=117.62 Aligned_cols=37 Identities=27% Similarity=0.177 Sum_probs=16.6
Q ss_pred cccEEEccCCcCccc----CchhHhhcCCCCcEEEcccCcCc
Q 003847 222 SLRYLNLSYNRLSGE----IPPQFGEKIPVNATIDLSFNNLT 259 (791)
Q Consensus 222 ~L~~L~l~~N~l~g~----ip~~~~~~l~~l~~l~l~~N~l~ 259 (791)
.|++|+|++|.|+.. +...+.. .++|++|||++|+++
T Consensus 370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~-~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 370 VLRVLWLADCDVSDSSCSSLAATLLA-NHSLRELDLSNNCLG 410 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHH-CCCCCEEECCSSSCC
T ss_pred CCCEEECCCCCCChHHHHHHHHHHhc-CCCCCEEECCCCcCC
Confidence 355555555555421 2222222 445555555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=3.7e-09 Score=115.08 Aligned_cols=181 Identities=22% Similarity=0.128 Sum_probs=127.4
Q ss_pred CcEEEEEcCCCCCcc-----CCCcCCCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCCCcc----
Q 003847 81 SRVIGLALPNSQLLG-----SIPADLGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGHLPE---- 147 (791)
Q Consensus 81 ~~v~~L~L~~~~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 147 (791)
..++.+++.+|.+.. .....+.....|+.|+|++|.+... ....+...+.++.+++++|.++.....
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 456788898887642 2334456678899999999998743 223445678999999999998632222
Q ss_pred cc-CCCCCCCEEeCcCCcCCCCCcc----ccCCCCCCCEEeCCCCcCCCC----CC----CCCcccceecccccccccc-
Q 003847 148 TM-GSLHNLQLLNLSDNALAGKLPV----SLTTLQSLTIVSLKNNYFSDG----LP----SKFNSVQVLDLSSNLINGS- 213 (791)
Q Consensus 148 ~~-~~l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~p----~~l~~L~~L~ls~N~l~~~- 213 (791)
.+ .....|+.+++++|.++..... .+...++|++|+|++|+|++. ++ ...+.|++|+|++|.|+..
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 12 2446899999999998854333 334567899999999998752 22 2235699999999999742
Q ss_pred ---CCCCcC-CccccEEEccCCcCcccCchhHhh----cCCCCcEEEcccCcCccc
Q 003847 214 ---LPPDIG-GYSLRYLNLSYNRLSGEIPPQFGE----KIPVNATIDLSFNNLTGE 261 (791)
Q Consensus 214 ---~p~~~~-~~~L~~L~l~~N~l~g~ip~~~~~----~l~~l~~l~l~~N~l~~~ 261 (791)
+...+. ..+|++|+|++|+|+......+.. ....|+.|++++|.+...
T Consensus 386 ~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 386 CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 222332 257999999999998654444432 344799999999998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=2.9e-09 Score=98.67 Aligned_cols=92 Identities=25% Similarity=0.224 Sum_probs=52.1
Q ss_pred CCCCCCCCEEeCcCCCCCCCCcccccCCCCccEEEccCCcCCCC--CccccCCCCCCCEEeCcCCcCCCCCccccCCCCC
Q 003847 101 LGMIEFLQYLDLSNNSLNGSLSFSLFNASQLRNLDLSNNLISGH--LPETMGSLHNLQLLNLSDNALAGKLPVSLTTLQS 178 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 178 (791)
+..+..+..|++.+|.+. .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+..+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444444444444333 3444445667777777777777643 2344556777777777777777433323334446
Q ss_pred CCEEeCCCCcCCCCC
Q 003847 179 LTIVSLKNNYFSDGL 193 (791)
Q Consensus 179 L~~L~L~~N~l~~~~ 193 (791)
|+.|+|++|.+....
T Consensus 117 L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 117 LEELWLDGNSLSDTF 131 (162)
T ss_dssp CSSCCCTTSTTSSSS
T ss_pred cceeecCCCCcCcCc
Confidence 677777777776543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=1.8e-06 Score=86.08 Aligned_cols=128 Identities=14% Similarity=0.112 Sum_probs=87.8
Q ss_pred CceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEeccCCCChhHHHHhh
Q 003847 487 GSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYDFVPNGSLANARYRK 565 (791)
Q Consensus 487 ~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 565 (791)
+.+.||+... +++.++||+...........+.+|...++.+. +--+.+++.+...++..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998875 46677889887654434446778888887774 434678888888888899999999998875432110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhc---------------------------------------------------
Q 003847 566 MGSSPCHLPWEARLKIAKGVARGLAFLHE--------------------------------------------------- 594 (791)
Q Consensus 566 ~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--------------------------------------------------- 594 (791)
.....++.++++.++.||+
T Consensus 105 ----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 ----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp ----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 1112233344444444442
Q ss_pred --------CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 595 --------KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 595 --------~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876667999998875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=2.8e-07 Score=84.93 Aligned_cols=86 Identities=24% Similarity=0.130 Sum_probs=65.3
Q ss_pred CcCCCCCCCCCEEeCcCCCCCCC--CcccccCCCCccEEEccCCcCCCCCccccCCCCCCCEEeCcCCcCCCCCcc----
Q 003847 98 PADLGMIEFLQYLDLSNNSLNGS--LSFSLFNASQLRNLDLSNNLISGHLPETMGSLHNLQLLNLSDNALAGKLPV---- 171 (791)
Q Consensus 98 ~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---- 171 (791)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 34445789999999999999965 345677899999999999999954443444556899999999999865543
Q ss_pred ---ccCCCCCCCEEe
Q 003847 172 ---SLTTLQSLTIVS 183 (791)
Q Consensus 172 ---~~~~l~~L~~L~ 183 (791)
.+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 255677777664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=2.9e-05 Score=76.50 Aligned_cols=69 Identities=9% Similarity=0.136 Sum_probs=52.3
Q ss_pred ceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC--CCccceeeEEEccCceEEEEeccCCCChh
Q 003847 488 SSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH--PNLVRIRGFYWGVDEKLIIYDFVPNGSLA 559 (791)
Q Consensus 488 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 559 (791)
.+.||+....++..+++|....... ..+..|+..++.+.. -.+.+++++..+++..++||+|++|.++.
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3679999988888899998765433 346777887777643 33677888888888899999999887653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=0.00013 Score=76.69 Aligned_cols=76 Identities=7% Similarity=0.044 Sum_probs=48.7
Q ss_pred eeccccCceEEEEEEeCC-CcEEEEEEcCCC-------chhhHHHHHHHHHHHhccC-C--CCccceeeEEEccCceEEE
Q 003847 481 YILGASGSSIMYKAVLED-GTALAVRRIGEN-------SVDRFRDFETQVRVIAKLV-H--PNLVRIRGFYWGVDEKLII 549 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lv 549 (791)
+-||.|....||++...+ ++.|+||.-... ......+...|++.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 357999999999998654 678999975321 1112234556788787662 2 345566544 55667899
Q ss_pred EeccCCCCh
Q 003847 550 YDFVPNGSL 558 (791)
Q Consensus 550 ~e~~~~gsL 558 (791)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.48 E-value=1.6e-05 Score=73.00 Aligned_cols=88 Identities=24% Similarity=0.222 Sum_probs=46.5
Q ss_pred CCCCCCEEeCcCC-CCCCC----CcccccCCCCccEEEccCCcCCC----CCccccCCCCCCCEEeCcCCcCCCC----C
Q 003847 103 MIEFLQYLDLSNN-SLNGS----LSFSLFNASQLRNLDLSNNLISG----HLPETMGSLHNLQLLNLSDNALAGK----L 169 (791)
Q Consensus 103 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~ 169 (791)
+.+.|++|+|+++ .++.. +-..+...++|++|+|++|.|.. .+...+...+.|+.|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3456666666653 34421 22234455666666666666652 1223344455666666666666532 1
Q ss_pred ccccCCCCCCCEEeCCCCcCC
Q 003847 170 PVSLTTLQSLTIVSLKNNYFS 190 (791)
Q Consensus 170 p~~~~~l~~L~~L~L~~N~l~ 190 (791)
-..+...++|++|+|++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 223455556666666666544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.47 E-value=1.4e-05 Score=73.42 Aligned_cols=109 Identities=13% Similarity=0.160 Sum_probs=79.4
Q ss_pred CCcEEEEEcCCC-CCccC----CCcCCCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCCCC----Cc
Q 003847 80 DSRVIGLALPNS-QLLGS----IPADLGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLISGH----LP 146 (791)
Q Consensus 80 ~~~v~~L~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 146 (791)
.+.++.|+|+++ .+... +...+...+.|++|+|++|.|... +...+...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 468999999975 45432 334677889999999999999732 334455678999999999999842 33
Q ss_pred cccCCCCCCCEEeCcCCcCCCC-------CccccCCCCCCCEEeCCCCc
Q 003847 147 ETMGSLHNLQLLNLSDNALAGK-------LPVSLTTLQSLTIVSLKNNY 188 (791)
Q Consensus 147 ~~~~~l~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~ 188 (791)
..+...++|++|+|++|++... +...+..-++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 4577788999999999987632 22344456778888876654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00037 Score=71.10 Aligned_cols=134 Identities=13% Similarity=0.097 Sum_probs=77.7
Q ss_pred eEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCCCCc--ccee-----eEEEccCceEEEEeccCCCChhH-
Q 003847 489 SIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVHPNL--VRIR-----GFYWGVDEKLIIYDFVPNGSLAN- 560 (791)
Q Consensus 489 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~-----~~~~~~~~~~lv~e~~~~gsL~~- 560 (791)
-.||++..++|+.|++|+...... ..+++..|...+..|....| +..+ ..+...+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999999999999999876532 23667788888877742222 1111 12334556788999997644311
Q ss_pred -------------HHHhhcCC----CCCCCCHH----------------------HHHHHHHHHHHHHHHHh-c---CCC
Q 003847 561 -------------ARYRKMGS----SPCHLPWE----------------------ARLKIAKGVARGLAFLH-E---KKH 597 (791)
Q Consensus 561 -------------~l~~~~~~----~~~~l~~~----------------------~~~~i~~qi~~gL~yLH-~---~~i 597 (791)
.++..... ....+++. .....+.++...+.-.- + .++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11111110 00111111 11222333333332221 1 468
Q ss_pred eecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 598 VHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 598 vHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 56899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.86 E-value=0.0013 Score=68.90 Aligned_cols=72 Identities=11% Similarity=0.172 Sum_probs=49.3
Q ss_pred eeccccCceEEEEEEeCC--------CcEEEEEEcCCCchhhHHHHHHHHHHHhccC-CCCccceeeEEEccCceEEEEe
Q 003847 481 YILGASGSSIMYKAVLED--------GTALAVRRIGENSVDRFRDFETQVRVIAKLV-HPNLVRIRGFYWGVDEKLIIYD 551 (791)
Q Consensus 481 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 551 (791)
..|+.|-.-.+|++...+ .+.|.+++..... ......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 357788889999998643 3567777766322 2345678888888884 4334577777642 58999
Q ss_pred ccCCCCh
Q 003847 552 FVPNGSL 558 (791)
Q Consensus 552 ~~~~gsL 558 (791)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.56 E-value=0.00011 Score=67.26 Aligned_cols=58 Identities=19% Similarity=0.289 Sum_probs=26.4
Q ss_pred CCCCccEEEccCCcCCCC----CccccCCCCCCCEEeCcCCcCCCC----CccccCCCCCCCEEeC
Q 003847 127 NASQLRNLDLSNNLISGH----LPETMGSLHNLQLLNLSDNALAGK----LPVSLTTLQSLTIVSL 184 (791)
Q Consensus 127 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L 184 (791)
..++|+.|+|++|.|+.. +-..+...++|+.|++++|.+... +-..+...++|+.++|
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L 109 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRI 109 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEEC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEee
Confidence 445555555555555421 122233445555555555555421 1133444555554433
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=0.00012 Score=66.83 Aligned_cols=42 Identities=21% Similarity=0.323 Sum_probs=18.1
Q ss_pred CCCCCCCCEEeCcCCCCCCC----CcccccCCCCccEEEccCCcCC
Q 003847 101 LGMIEFLQYLDLSNNSLNGS----LSFSLFNASQLRNLDLSNNLIS 142 (791)
Q Consensus 101 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 142 (791)
+...++|++|+|++|.++.. +-..+...++|+.|++++|.++
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 33444555555555544421 1112233344555555555443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.75 E-value=0.014 Score=58.57 Aligned_cols=141 Identities=13% Similarity=0.010 Sum_probs=73.7
Q ss_pred eccccCceEEEEEEeCCCcEEEEEEcCCCchhhHHHHHHHHHHHhccCC-----CCccceee---EEEccCceEEEEecc
Q 003847 482 ILGASGSSIMYKAVLEDGTALAVRRIGENSVDRFRDFETQVRVIAKLVH-----PNLVRIRG---FYWGVDEKLIIYDFV 553 (791)
Q Consensus 482 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-----~nIv~l~~---~~~~~~~~~lv~e~~ 553 (791)
.|..|---+.|+....+|+ +++|+...... .+++..|++++..|.. |..+...+ +....+....++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 4566777889999877665 89999865321 2345556666766632 22222111 122234456667776
Q ss_pred CCCChhH--------------HHHhhcCCC----CCCCCH------------------HHHHHHHHHHHHHHHHHhc---
Q 003847 554 PNGSLAN--------------ARYRKMGSS----PCHLPW------------------EARLKIAKGVARGLAFLHE--- 594 (791)
Q Consensus 554 ~~gsL~~--------------~l~~~~~~~----~~~l~~------------------~~~~~i~~qi~~gL~yLH~--- 594 (791)
.+..... .++...... ...... ......+..+...+...+.
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6543311 011100000 000000 1111223333333333333
Q ss_pred -CCCeecCCCCCCeEecCCCCeEEeccCcccc
Q 003847 595 -KKHVHGNLKPRNVLLGNDMEPKIGDFGLERL 625 (791)
Q Consensus 595 -~~ivHrDlkp~NILl~~~~~~kL~DFGla~~ 625 (791)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 5799999999999999887778999999864
|